
<html lang="en"     class="pb-page"  data-request-id="b021acbd-b6a8-4169-af98-9f4b4d714f1e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2021.64.issue-9;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.1c00172;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Covalent Small Molecule Immunomodulators Targeting the Protease Active Site" /></meta><meta name="dc.Creator" content="Hong-Rae  Kim" /></meta><meta name="dc.Creator" content="Ravichandra  Tagirasa" /></meta><meta name="dc.Creator" content="Euna  Yoo" /></meta><meta name="dc.Description" content="Cells of the immune system utilize multiple proteases to regulate cell functions and orchestrate innate and adaptive immune responses. Dysregulated protease activities are implicated in many immune..." /></meta><meta name="Description" content="Cells of the immune system utilize multiple proteases to regulate cell functions and orchestrate innate and adaptive immune responses. Dysregulated protease activities are implicated in many immune..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 27, 2021" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00172" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00172" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00172" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00172" /></link>
        
    
    

<title>Covalent Small Molecule Immunomodulators Targeting the Protease Active Site | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00172" /></meta><meta property="og:title" content="Covalent Small Molecule Immunomodulators Targeting the Protease Active Site" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0014.jpeg" /></meta><meta property="og:description" content="Cells of the immune system utilize multiple proteases to regulate cell functions and orchestrate innate and adaptive immune responses. Dysregulated protease activities are implicated in many immune-related disorders; thus, protease inhibitors have been actively investigated for pharmaceutical development. Although historically considered challenging with concerns about toxicity, compounds that covalently modify the protease active site represent an important class of agents, emerging not only as chemical probes but also as approved drugs. Here, we provide an overview of technologies useful for the study of proteases with the focus on recent advances in chemoproteomic methods and screening platforms. By highlighting covalent inhibitors that have been designed to target immunomodulatory proteases, we identify opportunities for the development of small molecule immunomodulators." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00172"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00172">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00172&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00172&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00172&amp;href=/doi/10.1021/acs.jmedchem.1c00172" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 5291-5322</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c02200" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c02154" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Covalent Small Molecule Immunomodulators Targeting the Protease Active Site</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Hong-Rae Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hong-Rae Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hong-Rae++Kim">Hong-Rae Kim</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Ravichandra Tagirasa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ravichandra Tagirasa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ravichandra++Tagirasa">Ravichandra Tagirasa</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Euna Yoo</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Euna Yoo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#3055455e511e495f5f705e59581e575f46"><span class="__cf_email__" data-cfemail="99fcecf7f8b7e0f6f6d9f7f0f1b7fef6ef">[emailÂ protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Euna++Yoo">Euna Yoo</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5982-1979" title="Orcid link">http://orcid.org/0000-0001-5982-1979</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00172&amp;href=/doi/10.1021%2Facs.jmedchem.1c00172" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 5291â5322</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 27, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 January 2021</li><li><span class="item_label"><b>Published</b> online</span>27 April 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00172" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00172</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5291%26pageCount%3D32%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHong-Rae%2BKim%252C%2BRavichandra%2BTagirasa%252C%2BEuna%2BYoo%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D9%26contentID%3Dacs.jmedchem.1c00172%26title%3DCovalent%2BSmall%2BMolecule%2BImmunomodulators%2BTargeting%2Bthe%2BProtease%2BActive%2BSite%26numPages%3D32%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5322%26publicationDate%3DMay%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00172"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1706</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00172" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Covalent Small Molecule Immunomodulators Targeting the Protease Active Site&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hong-Rae&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Ravichandra&quot;,&quot;last_name&quot;:&quot;Tagirasa&quot;},{&quot;first_name&quot;:&quot;Euna&quot;,&quot;last_name&quot;:&quot;Yoo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;5291-5322&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00172&quot;},&quot;abstract&quot;:&quot;Cells of the immune system utilize multiple proteases to regulate cell functions and orchestrate innate and adaptive immune responses. Dysregulated protease activities are implicated in many immune-related disorders; thus, protease inhibitors have been actively investigated for pharmaceutical development. Although historically considered challenging with concerns about toxicity, compounds that covalently modify the protease active site represent an important class of agents, emerging not only as chemical probes but also as approved drugs. Here, we provide an overview of technologies useful for the study of proteases with the focus on recent advances in chemoproteomic methods and screening platforms. By highlighting covalent inhibitors that have been designed to target immunomodulatory proteases, we identify opportunities for the development of small molecule immunomodulators.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00172&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00172" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00172&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00172" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00172&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00172" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00172&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00172&amp;href=/doi/10.1021/acs.jmedchem.1c00172" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00172" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00172" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00172%26sid%3Dliteratum%253Aachs%26pmid%3D33904753%26genre%3Darticle%26aulast%3DKim%26date%3D2021%26atitle%3DCovalent%2BSmall%2BMolecule%2BImmunomodulators%2BTargeting%2Bthe%2BProtease%2BActive%2BSite%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D9%26spage%3D5291%26epage%3D5322%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292601" title="Probes">Probes</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/jmcmar.2021.64.issue-9/20210513/jmcmar.2021.64.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cells of the immune system utilize multiple proteases to regulate cell functions and orchestrate innate and adaptive immune responses. Dysregulated protease activities are implicated in many immune-related disorders; thus, protease inhibitors have been actively investigated for pharmaceutical development. Although historically considered challenging with concerns about toxicity, compounds that covalently modify the protease active site represent an important class of agents, emerging not only as chemical probes but also as approved drugs. Here, we provide an overview of technologies useful for the study of proteases with the focus on recent advances in chemoproteomic methods and screening platforms. By highlighting covalent inhibitors that have been designed to target immunomodulatory proteases, we identify opportunities for the development of small molecule immunomodulators.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The human immune system that comprises two mutually nonexclusive componentsâthe innate and the adaptive immune systemâprotects us not only against invading pathogens but also from internal threats such as damaged cells and cancer. For optimal human health, the immune system needs to be tightly controlled and stay balanced. In fact, immune dysregulation is central to many disease-associated conditions, such as inflammation, autoimmune disorders, neurodegeneration, infection, and cancer. Immunomodulators are a diverse array of natural, recombinant, and synthetic agents that act at different cellular and molecular levels of the immune system. By modulating immune response to a desired level, as in immunostimulants or immunosuppressants, immunotherapeutic agents provide an avenue for prophylactic or chronic disease control.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Different types of therapeutics have been developed to activate or inhibit specific populations of immune cells and selectively target the signaling pathways engaged in immune regulation.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2â4)</a> Recently, the field of tumor immunology has gained a tremendous amount of momentum owing to the success of novel cancer immunotherapies. Most of these medicines are monoclonal antibodies blocking interactions between T cell checkpoint receptors and their cognate ligands (e.g., PD-1, PD-L1, and CTLA-4).<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Genetically engineered T cell therapies have also shown significant clinical outcomes in hematological cancers.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> These breakthroughs have led to a growing interest in developing novel immunotherapy agents. Small molecule immunomodulators, in particular, that are complementary to or potentially synergistic with the biologics or target defined pathways inaccessible to the biologics have the potential to offer rational, target- and mechanism-guided approaches and fulfill an unmet medical need in immunotherapy.</div><div class="NLM_p">Proteases are essential players in a multitude of biological processes, including cell growth and death, signal transduction, and homeostasis through their diverse functions in protein maturation, degradation, and post-translational modification. Proteases control several key functions of innate and adaptive immune cells.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Acting as enzymes and/or adapter proteins, proteases regulate dynamic immune cell signaling.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Endolysosomal proteases play vital roles in antigen processing and presentation. Many proteases are required for immune cell differentiation and development, cytokine regulation, and initiation and execution of apoptosis. Due to their irreversible nature, unlike most other post-translational modifications, proteolytic activity is highly regulated through multiple mechanisms. Most proteases are expressed as inactive zymogens and become active through proteolysis, cofactor binding, post-translational modification, conformational alteration, or changes in localization. Once it is activated, the protease activity is also controlled by the presence of endogenous protein inhibitors and degradation. Therefore, measures of activity in addition to abundance are necessary for the study of proteases. To dissect their complex roles and identify their substrates in a biologically relevant context, the development of highly selective probes is crucial given the functional redundancy of proteases.</div><div class="NLM_p">Small molecule modulators that bind selectively to target proteins serve not only as tools to understand the protein function but also as leads in drug discovery. While most small molecules function by interacting with their biological targets under equilibrium binding conditions, ligands that chemically modify proteins through covalent bond formation can offer potential advantages that include improved ligand potency, prolonged duration of action, increased ability to overcome resistant mutations, and capability to facilitate identification of target proteins. Compounds that properly combine the features of chemical reactivity and molecular recognition can have a better chance of tackling proteins that are considered undruggable. Covalent chemical probes have been widely used in imaging, proteome-wide target identification, and inhibitor development. Covalent ligands can target either catalytically essential residues, for example, cysteine and serine in hydrolases, or noncatalytic residues found in small molecule binding sites on kinases. Depending on the electrophile and nucleophile, they bind reversibly or irreversibly. Noncovalent interactions contributed by the scaffold are critical for specificity and for positioning the reactive electrophile relative to the protein nucleophile, thereby increasing the rate, selectivity, and stability of covalent bond formation. However, it is often difficult to find an optimal recognition scaffold that is specific for a single protease because of similarities in structure and substrate preference of closely related proteases. In addition, identifying reactive functional groups that do not make the molecule promiscuous is a challenge in developing covalent modulators. Promiscuous electrophiles that readily react with nucleophiles raise concerns about toxicity and metabolic liability. Despite these obstacles, three FDA approved drugsâbortezomib, carfilzomib, and ixazomibâthat covalently inhibit the proteolytic activity of proteasome have proven successful and are currently used as anticancer therapies for the treatment of multiple myeloma.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Understanding biochemical and structural differences between the human and parasite proteasome has also opened up an opportunity for the rational design of selective inhibitors that kill the protozoa while sparing the host.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a></div><div class="NLM_p last">This Review highlights recent advances in the development of covalent modulators targeting immune-relevant proteases. As proteases regulate essential pathways in all living organisms, pathogenic proteases are certainly viable targets for anti-infective agents. This Review, however, focuses on mammalian proteases and their roles in the initiation and regulation of immune responses. We aim to discuss lessons and opportunities for the development of covalent modulators in the field of chemical immunology by providing an overview of approaches that enable the identification of selective compounds and highlighting each application in the study of proteases.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Approaches to Protease Probe Discovery</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62036" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62036" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Advances in combinatorial library synthesis, structural biology, computational modeling, and high-throughput screening (HTS) have facilitated the discovery of protease inhibitors and helped study the complex roles of proteases. The classical, target-centric approach begins with target selection, which is inspired by genetic and/or biochemical information that provides insight about a biological function of the protein (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). Once a target is chosen, an appropriate assay that measures the protein activity is developed. For example, enzyme assays using fluorogenic substrates are commonly implemented to monitor the protease activity owing to their easy access and suitability for HTS. Compounds are screened and subsequently optimized through medicinal chemistry with the focus on potency and selectivity, which ultimately yields a hit compound that can be used in cell and/or animal models for functional study to further validate the target perturbation and phenotypic outcome. Often, this approach faces issues of in vivo efficacy and toxicity later in the process, possibly because this approach can overestimate the impact of pharmacological perturbation of individual proteases and lack a clear understanding of in vivo off-target effects. On the other hand, the chemocentric approach emphasizes identifying a hit compound that exerts an effect in a more complex and biological context where the protein remains in its native environment. This alleviates the need for recombinant expression and purification of protein in an early stage of screening and places pharmacology at the front (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). This approach is not biased toward a specific target protein and proceeds without a prior knowledge of compoundâprotein interactions as long as a specific and measurable biological effect is produced. Once a biologically active compound is identified, advanced technologies are required to identify target proteins that interact with the compound. As this approach can yield probes that have multiple targets, understanding precise mechanism of action might be challenging although target promiscuity can be advantageous for tackling related proteins that function together in important biological pathways.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Approaches to protease inhibitor discovery. (A) In a classical, target-centric drug discovery approach, the focus of screening and optimization is on identifying a highly potent hit compound for a given protease target. (B) In a chemocentric approach, compounds are directly screened in a more complex biological system and simultaneously evaluated for specificity. (C) In a competitive ABPP, a broad-spectrum probe labels reactive and functional protease in proteomes. The probe-conjugated proteases can be resolved on a gel, and pretreatment with an inhibitor that blocks the site for probe labeling results in reduced read-out. (D) In a competitive isoTOP-ABPP, proteomes are treated either with an inhibitor or vehicle followed by a reactive probe. The enriched proteins with isotopically differentiated tags are subjected to quantitative LC-MS/MS analysis to map the liganded sites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A chemoproteomic platform termed activity-based protein profiling (ABPP) has been a valuable strategy to develop selective inhibitors against many protease targets.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> ABPP uses covalent probes termed activity-based probes (ABPs) to map proteome-wide reactive proteins and evaluate the functional states of enzymes. In contrast to substrate-based probes that bind in the active site and produce a measurable signal upon processing by a protease (e.g., fluorogenic substrates or internally quenched fluorescent peptide substrates), ABPs remain covalently conjugated to the active site thereby inactivating the enzyme. Determined by active-site accessibility and reactivity of nucleophilic residues, probe labeling can dictate how dynamically proteins are regulated within the cell. Probe labeling can be used to substitute for the substrate assays and enable the analysis for poorly characterized enzymes that lack known substrates. Activity-based probes exploit a variety of chemical scaffolds, such as protein-reactive natural products, mechanism-based inhibitors, and electrophilic fragments. Most ABPs consist of three major components: a reactive group (an electrophilic warhead that reacts with a nucleophilic amino acid in the active site to form a covalent adduct), a recognition motif that directs to a desired protein, and a reporter tag (generally a fluorescent dye and/or an affinity handle). Each of these components needs to be carefully chosen to target the protein of interest and to be detected by an optimized assay platform. By targeting active sites, ABPP measures protease activity independently of expression and accounts for multiple layers of protease regulation. ABPP has been successfully used for comparative and spatiotemporal profiling of protease activity in disease-associated conditions and in functional proteomics studies. Competitive ABPP can be implemented to screen inhibitors directly in native proteomes or biological systems and has been particularly useful for simultaneously evaluating efficacy and selectivity of irreversible inhibitors against numerous enzymes (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C). Depending on a reporter tag appended to ABPs, probe labeling can be read out with different detection methods available. Using fluorophore-conjugated ABPs, probe-modified proteases are visualized and analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) followed by in-gel fluorescence scanning. Active proteases are also measured by fluorescent microscopy, flow cytometry, and in vivo imaging using fluorescently tagged probes. However, the fluorescent spectral overlap of commonly used fluorophores in fluorescent ABPs limits multiplex analysis of enzymes to some extent. Recently, Poreba and coworkers employed the stable isotopes of lanthanide metals compatible with mass cytometry as reporter groups.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> With the selective peptide recognition sequences incorporated, the time-of-flight activity-based probes (TOF-probes) were able to simultaneously measure the activity of multiple proteases, including cathepsin B and L, legumain, and neutrophil elastase in various subpopulations of human peripheral blood mononuclear cells (PBMCs). Combined with the power of CyTOF, metal-mass tagged ABPs thus provide a strategy for multiplexed profiling of protease activities. ABPs with a biotin tag can be employed for enrichment, identification, and quantitative analysis of probe-labeled proteins using liquid chromatography mass spectrometry (LC-MS) methods. One example of quantitative protein profiling in the proteome is the isotopic tandem orthogonal proteolysis-activity-based protein profiling (isoTOP-ABPP).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In a competitive isoTOP-ABPP, cells or cell lysates are treated first with either a covalent compound or control vehicle, respectively (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The samples are then labeled with a probe targeting reactive amino acids within proteins followed by subsequent capturing using click chemistry with biotinylated, isotopically differentiated tags. Compounds that bind to the protein with high affinity block the site for probe labeling. After mixing control and compound-treated samples, probe-labeled proteins are enriched on the streptavidin resin. The bound proteins are subjected to sequential digestions, and the eluted peptides are analyzed by LC-MS/MS. Liganded sites are defined with amino acid residues that exhibit changes in MS chromatographic peak area comparing the compound-treated and control samples. Competitive isoTOP-ABPP coupled with fragment-based ligand discovery can rapidly discover ligandable protein sites by covalent small molecules.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Chemical proteomic screening of electrophilic small molecules using isoTOP-ABPP method in primary human T cells has successfully identified several compoundâcysteine interactions that impair T cell activation through distinct mechanisms.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Design of Active Site Targeted Protease Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13047" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13047" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Proteases bind to their substrates through hydrogen bond, hydrophobic, and electrostatic interactions within the active site. A sequence of amino acids directly adjacent to the scissile bond is most critical for the substrate recognition (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). Endopeptidases cleave peptide bonds in the middle of a protein, while exopeptidases cleave off one or two terminal amino acids. Proteases are generally categorized into seven distinct groupsâcysteine, serine, threonine, aspartate, glutamate, metalloproteases, and asparagine peptide lyasesâbased on their catalytic mechanism. Nucleophilic residues in the active site of cysteine, serine, and threonine proteases directly attack and break the peptide bonds within proteins, whereas aspartyl, glutamyl, and metalloproteases use water molecules activated by the active site residues to hydrolyze the peptide bonds.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Substrate binding and active site directed inhibition of protease. (A) Protease binds to its substrate through interactions with the peptide backbone and the side chain residues (P and Pâ² residues) that occupy the protease pockets (S and Sâ² pockets). (B) Top: enzyme reaction, middle: interaction of a noncovalent reversible inhibitor with the enzyme, bottom: interaction of a covalent inhibitor with the enzyme.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite remarkable breakthroughs in developing allosteric inhibitors, most protease inhibitors that are clinically in use or in development are competitive inhibitors. By binding to the protease, usually at the active site, these inhibitors limit the formation of enzymeâsubstrate complex, which results in decreased product formation. The efficacy of small molecule inhibitors is dependent both on thermodynamics and kinetics of drugâtarget interactions. In noncovalent reversible inhibition, potency is normally used as a descriptor of the affinity of a compound. Given that the interaction of compound with its target leads to a biological response, optimization is often focused to maximize the strength of these noncovalent molecular interactions quantified by a decrease in the <i>K</i><sub>d</sub> or IC<sub>50</sub> value. Drugâtarget residence time (1/<i>k</i><sub>off</sub>) plays an important role in the efficacy of compound.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> A reversible inhibitor with a very slow off rate kinetic shows prolonged interaction with its target mimicking a covalent inhibitor.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In covalent inhibition, overall inhibition is determined by an initial binding and the subsequent covalent modification of the protein. Parameters such as <i>K</i><sub>i</sub> that describes the noncovalent binding affinity and <i>k</i><sub>inact</sub> that describes the kinetics of covalent modification are used to dissect the contributions of each to inhibition (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). The reversibility of covalent inhibitors are measured upon dialysis, competition with excess substrate, or extended incubation time. In covalent reversible inhibition, subsequent bond cleavage decreases the duration of inhibition and lowers affinity. This mitigates some of the potential liabilities associated with the formation of irreversible adducts. Although irreversible modification of protein inherits some disadvantages, irreversible covalent inhibitors have the benefit of long-lasting even after the concentration of compound in solution decreases and are amenable to direct isolation and identification of target proteins. This ability has facilitated protease discovery, assignment of functional roles of closely related enzymes, and assessment of potential off-targets of compounds.</div><div class="NLM_p">For covalent modifiers, electrophiles are chosen based on the reactivity of nucleophilic residue of the target protease. For example, electrophiles in cysteine protease inhibitors are softer than those in serine and threonine protease inhibitors as the sulfhydryl group in the active site of cysteine proteases is more soft or polarizable than the hydroxyl group in the active site of serine and threonine proteases. The reactivity of electrophile is important to achieve desired selectivity. Highly reactive electrophile with increased <i>k</i><sub>inact</sub> value can cancel out the effect of recognition motif and lead to significant off-target modification. On the other hand, a slow covalent bond formation by less reactive electrophile increases the contribution of molecular scaffold to the compound specificity determined by <i>K</i><sub>i</sub> value. If the covalent inactivation is too slow, it may result in overall inefficient labeling. Pharmacokinetic properties and ease of synthesis are also important factors to consider when choosing electrophiles. Examples of electrophilic warheads used in protease inhibitors are discussed in detail in the following sections.</div><div class="NLM_p">A peptide sequence that is derived from the sequence of an optimal substrate is most often used as the recognition element for designing active site targeted protease inhibitors. Recent advances in substrate screening methods have accelerated identification of recognition motifs that are specific enough to discriminate between closely related proteases. Multiplex substrate profiling by mass spectrometry (MSP-MS) approach compares the LC-MS/MS traces of a library of synthetic peptides that is designed to broadly cover potential substrate cleavage sites, with and without a given protease of interest.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Analysis of peptide fragments reveals the cleavage sites and amino acid residue preferences for the protease (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). Positional scanning substrate combinatorial libraries (PS-SCL) uses isokinetic mixtures of natural amino acids except at the investigated position of the substrate for synthesis, thus providing exhaustive coverage of potential substrates. Proteolytic events can be detected by fluorescent signals (e.g., 7-amino-4-methylcoumarin) that are produced upon cleavage of substrate. This method allows rapid profiling of amino acid specificity.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22â24)</a> To explore larger sequence space and identify motifs that are more selective, hybrid combinatorial substrate library (HyCoSuL) uses both natural and non-natural amino acids at the investigated position (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B).<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> Fluorogenic peptide substrate microarrays display peptides on a solid surface, which allows a quick analysis of data through direct scanning of the microarray slide with minimal usage of sample (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C).<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> Substrate activity screening (SAS) uses fragment-based substrate libraries to uncover nonpeptidic building blocks. The identified building blocks are sequentially built into small molecules that can be efficiently recognized by the given protease (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D).<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> To overcome limitations of chemically synthesized libraries and rapidly screen larger and more diverse sequence pools, biological tools have been explored. For substrate phage display, perhaps the best utilized technique, degenerated DNA sequences encoding randomized peptides are fused with the <i>pIII</i> gene (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> As a result, billions of peptides with much higher diversity are produced on the phage surface with their genetic information. The library is then immobilized to an affinity support and subjected to the protease cleavage. Optimal peptide sequences can be propagated and enriched over multiple rounds of selection. The recently reported method that employs two genetically encoded substrate phage display libraries coupled with next generation sequencing (SPD-NGS) is proven to be rapid and comprehensive allowing deeper substrate coverage compared to traditional synthetic peptide libraries.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Additionally, phage display can be used to express diverse peptides that contain constant cysteines with variable spacer residues. Chemical linking of cysteine residues generates monocyclic or bicyclic peptides on the phage surface, in which higher specificity and stability can be attributed to the rigidity of cyclic scaffold.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In a recent study from the Bogyo laboratory, a phage display-based method was used to produce cyclic peptides that bind to protein targets through irreversible covalent bond formation.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Using a reactive linker that is capable of forming cyclic peptides and simultaneously introducing an electrophilic warhead, the study yielded highly potent and selective covalent inhibitors for a cysteine protease and a serine hydrolase.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Substrate screening methods. (A) MSP-MS. (B) PS-SCL. (C) Fluorogenic peptide microarray. (D) SAS. (E) Phage substrate display.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on the notion that peptidic inhibitors tend to suffer from poor pharmacological properties, approaches that focus on identifying nonpeptidic scaffolds have also been actively pursued for the protease drug development. These campaigns mostly utilize high-throughput screening, fragment-based ligand library, and structure-aided drug design to identify molecular scaffolds with drug-likeness.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Once a promising scaffold is successfully identified, iterative optimization process is followed to develop potent drug leads.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">In the following sections, we discuss key proteases in the immune system in which covalent probes generated have helped assign biological functions to the protease in physiological and disease states and highlight compounds with potential immunomodulatory activity that best illustrate each application (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Proteases with Potential Immunomodulatory Activity and Representative Covalent Compounds Targeting the Protease Active Site</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">protease</th><th class="colsep0 rowsep0" align="center">catalytic residue</th><th class="colsep0 rowsep0" align="center">function</th><th class="colsep0 rowsep0" align="center">disease</th><th class="colsep0 rowsep0" align="center">compound</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">caspase</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Z-VAD-FMK, emricasan</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">caspase-1</td><td class="colsep0 rowsep0" align="left">Cys285</td><td class="colsep0 rowsep0" align="left">inflammation</td><td class="colsep0 rowsep0" align="left">multiple sclerosis, rheumatoid arthritis</td><td class="colsep0 rowsep0" align="left">Ac-WEHD-CHO, AWP28, pralnacasan, belnacasan</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">caspase-3</td><td class="colsep0 rowsep0" align="left">Cys163</td><td class="colsep0 rowsep0" align="left">apoptosis</td><td class="colsep0 rowsep0" align="left">cancer, neurodegenerative disorder</td><td class="colsep0 rowsep0" align="left">Ac-DEVD-CHO, AB50, WC-II-89, Ac-CV3-AOMK, Ac-DW3-KE, Ac-ATS010-KE, bMP-3.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">caspase-8</td><td class="colsep0 rowsep0" align="left">Cys360</td><td class="colsep0 rowsep0" align="left">apoptosis, T cell activation and expansion</td><td class="colsep0 rowsep0" align="left">cancer, neurodegenerative disorder</td><td class="colsep0 rowsep0" align="left">Ac-IETD-CHO, CV8/9-AOMK, zVAD-<i>iso</i>Pht-Trp, compound <b>7</b>, 63-<i>R</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MALT1</td><td class="colsep0 rowsep0" align="left">Cys464</td><td class="colsep0 rowsep0" align="left">lymphocyte activation</td><td class="colsep0 rowsep0" align="left">lymphoma</td><td class="colsep0 rowsep0" align="left">Z-VPRP-FMK, 4-Br-Ph-VPR-FMK, LE40, LE42, BODIPY-LVPipR-AOMK, PKG105, MI-2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">calpain 1/2</td><td class="colsep0 rowsep0" align="left">Cys105/Cys285</td><td class="colsep0 rowsep0" align="left">inflammation</td><td class="colsep0 rowsep0" align="left">muscular dystrophy, Alzheimerâs disease</td><td class="colsep0 rowsep0" align="left">DCG-04, SJA6017, BDA-410, AK295, A-705239, alicapistat</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cathepsin</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">CA-074, JPM-OEt, LVHS, GB111-NH<sub>2</sub>, BMV109</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cathepsinÂ K</td><td class="colsep0 rowsep0" align="left">Cys139</td><td class="colsep0 rowsep0" align="left">bone remodeling, TLR signaling</td><td class="colsep0 rowsep0" align="left">osteoporosis, osteoarthritis</td><td class="colsep0 rowsep0" align="left">balicatib, odanacatib, ONO-5334</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cathepsinÂ L</td><td class="colsep0 rowsep0" align="left">Cys25</td><td class="colsep0 rowsep0" align="left">antigen processing, inflammation</td><td class="colsep0 rowsep0" align="left">cancer, viral infection</td><td class="colsep0 rowsep0" align="left">Z-FY(tBu)-DMK, MP-cL3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cathepsinÂ S</td><td class="colsep0 rowsep0" align="left">Cys139</td><td class="colsep0 rowsep0" align="left">antigen processing, TLR signaling</td><td class="colsep0 rowsep0" align="left">cancer, psoriasis, rheumatoid arthritis,</td><td class="colsep0 rowsep0" align="left">RO5459072, BMV083, BMV117</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cathepsinÂ X</td><td class="colsep0 rowsep0" align="left">Cys92</td><td class="colsep0 rowsep0" align="left">TÂ cell activation</td><td class="colsep0 rowsep0" align="left">cancer</td><td class="colsep0 rowsep0" align="left">MGP140, sCy5-Val-SY</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">legumain</td><td class="colsep0 rowsep0" align="left">Cys189</td><td class="colsep0 rowsep0" align="left">antigen processing and presentation, inflammation</td><td class="colsep0 rowsep0" align="left">cancer, multiple sclerosis, Alzheimerâs disease</td><td class="colsep0 rowsep0" align="left">Z-AA-azaAsn-CMK, LI-0, LI-1, LE28, MP-L01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">USP4</td><td class="colsep0 rowsep0" align="left">Cys311</td><td class="colsep0 rowsep0" align="left">Th17 differentiation</td><td class="colsep0 rowsep0" align="left">cancer</td><td class="colsep0 rowsep0" align="left">4-chloroacetylpyrrole</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">USP7</td><td class="colsep0 rowsep0" align="left">Cys223</td><td class="colsep0 rowsep0" align="left">Treg function</td><td class="colsep0 rowsep0" align="left">cancer</td><td class="colsep0 rowsep0" align="left">HBX 19818, P22077, P50429, FT827, XL177A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">USP9X</td><td class="colsep0 rowsep0" align="left">Cys1566</td><td class="colsep0 rowsep0" align="left">TCR signaling</td><td class="colsep0 rowsep0" align="left">cancer</td><td class="colsep0 rowsep0" align="left">WP1130, EOAI3402143</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">granzymeÂ A</td><td class="colsep0 rowsep0" align="left">Ser195</td><td class="colsep0 rowsep0" align="left">inflammation</td><td class="colsep0 rowsep0" align="left">cancer</td><td class="colsep0 rowsep0" align="left">FUT-175, DCI, SK15.5, <i>Z</i>-(4-AmPhe)<sup>P</sup>(OPh)<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">granzymeÂ B</td><td class="colsep0 rowsep0" align="left">Ser195</td><td class="colsep0 rowsep0" align="left">apoptosis, inflammation</td><td class="colsep0 rowsep0" align="left">graft-versus-host disease, myasthenia gravis</td><td class="colsep0 rowsep0" align="left">Z-AAD-CMK, Ac-IEPD-CHO, TJ55i, VTI-1002, NOTA-GZP</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">neutrophil elastase</td><td class="colsep0 rowsep0" align="left">Ser195</td><td class="colsep0 rowsep0" align="left">inflammation, tissue remodeling</td><td class="colsep0 rowsep0" align="left">infection, COPD, cystic fibrosis, cancer</td><td class="colsep0 rowsep0" align="left">MeO-Suc-AAPV-CMK, GW311616, sivelestat, Cy5-V-DPP, PK101</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DPP4</td><td class="colsep0 rowsep0" align="left">Ser630</td><td class="colsep0 rowsep0" align="left">TÂ cell activation</td><td class="colsep0 rowsep0" align="left">autoimmune diabetes, cancer</td><td class="colsep0 rowsep0" align="left">vildagliptin, saxagliptin, Val-boroPro</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">immunoproteasome</td><td class="colsep0 rowsep0" align="left">Thr1</td><td class="colsep0 rowsep0" align="left">antigen processing and presentation, inflammation, T cell differentiation</td><td class="colsep0 rowsep0" align="left">systemic lupus erythematosus, rheumatoid arthritis, cancer</td><td class="colsep0 rowsep0" align="left">UK-101, KZR-504, IPSI-001, ML604440, ONX-0914, KZR-616</td></tr></tbody></table></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Caspase</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45363" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45363" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Caspases belong to a family of cysteine proteases playing central roles in apoptosis and inflammation. As the name <b>c</b>ysteine dependent <b>asp</b>artate-specific prote<b>ase</b> indicates, caspases catalyze the protein hydrolysis through a conserved cysteine nucleophile with high specificity for cleaving after aspartate residues on the C-terminal side (P1 Asp) of substrates. Caspases are classified into âapoptoticâ and âinflammatoryâ subgroups. Nonapoptotic, inflammatory members such as caspases-1, -4, -5, -11, and -12 are involved in processing and release of proinflammatory cytokines. Inflammasomes are multiprotein complexes that assemble in response to endogenous and exogenous insults and mediate activation of caspase-1. Upon detection of stimulus, a sensor protein oligomerizes with the scaffolding protein ASC, which recruits and activates procaspase-1 into its tetrameric form. Active caspase-1 mediates cleavage of proinflammatory cytokines interleukin (IL)-1Î² and IL-18 as well as gasdermin D (GSDMD) to induce inflammation and pyroptosis, which is an inflammatory form of programmed cell death accompanied by cell membrane pore formation that causes cellular swelling, membrane rupture, and release of intracellular contents.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Caspase-1/inflammasome complex regulates multiple processes including antimicrobial host defense, tissue repair, tumorigenesis, and metabolism and has been implicated in numerous inflammatory and autoimmune diseases.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> Within the apoptotic subgroup, caspases-2, -8, -9, and -10 initiate the cascade and caspase-3, -6, and -7 execute apoptosis. Other proteases, such as cathepsins, calpains, and granzymes, can also trigger the activation of effector caspases. Caspase-mediated apoptosis also plays an important role in maintaining lymphocyte homeostasis.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Besides their well-characterized role in apoptosis, most apoptotic caspases have nonapoptotic role(s), and recent studies have shown their involvement in a vast array of cellular processes and regulatory mechanisms, particularly in the immune system.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Caspase-8 is essential for lymphocyte activation and differentiation and is required for the activation of NF-ÎºB signaling.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> Deletion of caspase-8 is found to reduce the activation of dendritic cells (DC), macrophages, and B cells.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> Absent or defective caspase-10 activity is known to contribute to autoimmune lymphoproliferative syndrome (ALPS).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Caspase-3 activity is also linked to T cell activation and proliferation.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p">Many commonly used caspase inhibitors consist of tetrapeptide or tripeptide, in which the cleavage sequence derived from the natural substrates is coupled to an electrophilic warhead. These compounds include tetrapeptide aldehydes (e.g., Ac-WEHD-CHO (<b>1</b>), Ac-DEVD-CHO (<b>2</b>), Ac-IETD-CHO (<b>3</b>), <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A) and activated ketones such as halomethyl ketones and acyloxymethyl ketones. A peptide inhibitor Z-VAD-FMK (<b>4</b>), which was designed based on the specificity profile of nine human caspases, displayed a potent and broad spectrum of caspase inhibitory activity, except for caspase-2.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Evolved from the early tetrapeptide leads, a series of oxamyl dipeptides was optimized for pan-caspase inhibition. Among them, emricasan (also known as IDN-6556, <b>5</b>) that has antiapoptotic and anti-inflammatory effects, is the first irreversible pan-caspase inhibitor to enter clinical development and has received orphan drug status by the FDA for the treatment of liver diseases.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Structures of selected inhibitors and activity-based probes for caspases. Electrophilic warheads are shown in red. (B) Activation of photocaged caspase inhibitors upon irradiation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Given its central role in converting pro-IL-1Î² and pro-IL-18 into their active forms of IL-1Î² and IL-18, efforts to investigate caspase-1 as a therapeutic target emerged in the early 1990s. Initial approach primarily focused on utilizing the Tyr-Val-His-Asp (YVHD) sequence derived from the cleavage site of the natural substrate pro-IL-1Î².<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> Structureâactivity relationship (SAR) studies revealed that the P2 position can tolerate substitutions well, and improved <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub> value was observed when the histidine residue was replaced with alanine, which yielded a reversible covalent inhibitor Ac-YVAD-CHO (also known as L-709,049).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Later, PS-SCL discovered that the WEHD sequence, both in a fluorogenic AMC substrate and an aldehyde inhibitor, is more preferable for caspase-1 as it showed significantly improved binding affinity (14-fold) and catalytic turnover (50-fold).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Continuous efforts to optimize the P2âP4 residues and reduce the peptide characteristics led to the identification of novel inhibitors pralnacasan (VX-740, <b>6</b>)<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and belnacasan (VX-765, <b>7</b>)<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> in a prodrug form. The aldehyde warhead and the essential P1 Asp are tied as 5-ethoxydihydrofuran-2(3<i>H</i>)-one moiety, which upon cleavage by plasma and/or liver esterase releases its active compounds. Their high selectivity combined with drastically improved bioavailability advanced the compounds to clinical trials for rheumatoid arthritis (discontinued due to toxicological issues).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> By inhibiting caspase-1, belnacasan has been shown to block the inflammasome signaling, reduce cytokine-associated neurotoxicity, and prevent GSDMD-mediated pyroptosis in both myeloid cells and oligodendrocytes, resulting in tissue preservation and improved disease outcome in models of multiple sclerosis.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> A nitrile analogue of belnacasan replacing the aldehyde warhead showed an increase in potency for caspase-1 as well as selectivity over other caspases, especially against caspase-14, which demonstrates that the type of warhead not only influences reactivity but also contributes to selectivity. A fluorescent activity-based probe AWP28 (<b>8</b>) that features an acyloxymethyl ketone (AOMK) electrophile attached to an optimized recognition scaffold for caspase-1 (Tyr-Tle-Pro-Asp) was developed to characterize the inflammasome-mediated caspase-1 activation.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> With 10-fold selectivity for caspase-1 over other caspases, the probe was able to label the ASC foci. When applied to <i>Salmonella typhimurium</i>-infected macrophages, the probe detected active forms of caspase-1, which was lost over time as cells underwent pyroptosis. In the absence of inflammasome-mediated caspase-1 activation, however, active caspases-3 and -7 were robustly labeled by the probe, indicating that caspase-1 activity is required to suppress apoptosis in favor of proinflammatory pyroptotic cell death upon <i>Salmonella</i> infection.</div><div class="NLM_p">PS-SCL also identified an optimal tetrapeptide sequence DEVD for apoptotic caspase-3/7.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Powers and coworkers have demonstrated that the peptide analogues with aza-aspartic acid (AAsp) at the P1 position equipped with a variety of epoxide warheads could not only achieve caspase selectivity over other proteases but also gain selectivity within a caspase family.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> For instance, Z-DEV-AAsp-(<i>S,S</i>)-EP-COOEt (<b>9</b>) showed significantly higher inhibition rate for caspase-3 over caspase-1 (91-fold), caspase-6 (197-fold), and caspase-8 (11-fold) without inhibiting other cysteine and serine proteases such as papain, cathepsin B, chymotrypsin, and granzyme B. Although optimal for caspase-3/7, the DEVD sequence is also efficiently recognized by cathepsins and legumain.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> In an effort to develop molecular imaging probes for apoptosis, specifically targeting caspases, the Bogyo group developed an ABP containing the EPD-AOMK tagged with the Cy5 fluorophore (AB50-Cy5, <b>10</b>).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> The probe labeled caspase-3 and legumain without detectable labeling of cathepsin B. To further increase cellular uptake, the cell penetrating peptide trans-activating transcriptional activator (Tat) was incorporated into the probe. When used in the thymi of mice treated with dexamethasone and in tumor-bearing mice treated with the apoptosis-inducing monoclonal antibody, the probe provided direct measurements of apoptosis. Recently, Wolan and coworkers employed unnatural amino acids into the tetrapeptide sequence to improve caspase-3 selectivity. Combined with an AOMK warhead, a pentapeptide sequence 3 Pal-Asp-Î²hLeu-hLeu-Asp termed CV3 (<b>12</b>) exhibited comparable efficacy to Ac-DEVD-CHO, while maintaining substantial selectivity for caspase-3 over caspase-7.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Also, CV3-AOMK equipped with biotin or 5(6)-carboxyfluorescein (FAM) reporter tag was proven to be superior to its corresponding DEVD ABPs. To further resolve the cross-reactivity with caspase-8, 24 different warheads were screened. Among, 5-methyl-2-thiophene ketoester (KE) appeared to enhance both potency and selectivity.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> X-ray cocrystal structures of CV3 series bound to caspase-3, -7, and -8 provided detailed information on the structural basis for specificity, which eventually led to the replacement of the P2 homoleucine to phenylalanine. A pentapeptide inhibitor Ac-3 Pal-Asp-Î²hLeu-Phe-Asp-KE (also reported as Ac-DW3-KE) showed a remarkable selectivity profile against caspase-7 (118-fold) and caspase-8 (58-fold). However, DW3 inhibitor was not able to block staurosporine (STS)-induced apoptosis, partially due to poorer kinetic efficiency, indicating its slow caspase-3 inhibition. Structure analyses revealed that both CV3 and DW3 inhibitors had distorted peptide backbone orientations in respect to DEVD inhibitor when bound. After the P3 Î²hLeu was replaced with pentafluorophenylalanine (Phe(F<sub>5</sub>)), the inhibitor (Ac-ATS-010-KE, <b>13</b>) showed sufficient kinetic and selectivity profiles and was able to prevent MegaFasL-induced apoptosis in Jurkat cells.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Poreba and coworkers have also demonstrated the successful use of unnatural amino acids for selective caspase inhibitor discovery. Instead of introducing single amino acid substitutions individually at each position of the canonical caspase substrate sequence, they used a large-scale, hybrid combinatorial substrate library (HyCoSuL) approach.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Selective substrates identified for apoptotic caspases-3/7, -8, -9, and -10 were subsequently converted into ABPs utilizing the AOMK warhead. Overall, catalytic parameters were well correlated between ABPs and substrates. For example, biotin-ahx-Asp-Phe(F<sub>5</sub>)-Val-Asp-AOMK (bMP-3.01) was identified as a potent and selective inhibitor of caspase 3/7. However, the conversion of substrates into ABPs resulted in significant loss of selectivity. When examined in TRAIL-stimulated Jurkat T cells, individual probes could not label each caspase specifically due to overwhelming activity and concentration of caspases-3 and -7 in cells. Although it was not possible to define an ABP that can measure activity of individual caspases in complex mixtures, the authors were able to investigate TRAIL-induced apoptotic mechanism with a panel of ABPs. Continuous efforts using HyCoSuL have also yielded a highly selective caspase-2 inhibitor. The champion compound NH-23-C2 (<b>14</b>) inhibited MDM-2 cleavage in a concentration-dependent manner, while preventing TRAIL-mediated apoptosis in caspase-2-induced HCT116 colon cancer cells. The selectivity of the compound can be attributed to the P4 hGlu residue, which is poorly recognized by caspase-3 despite the structural similarity of the S4 pocket and the P5 Idc residue because caspase-2 has a unique feature that prefers pentapeptides to tetrapeptides for efficient catalysis.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div><div class="NLM_p">Although commonly used as caspase-8 inhibitors, Ac-IETD-CHO and Ac-LETD-AOMK are known to be promiscuous, particularly toward caspase-6 and -9.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The strategy incorporating unnatural amino acids identified H<sub>2</sub>N-Î²Ala-Leu-Gln-Hyp-Asp sequence termed CV8/9.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> CV8/9-AOMK (<b>15</b>) is not as potent as Ac-LETD-AOMK; however, drastic improvement in caspase-8 selectivity over executioner caspases-3, -6, and -7 was accomplished. The change in warhead from AOMK to KE brought further enhancement in selectivity against caspase-9. While most of protease inhibitors target nonprimed region of the active site, the primed site can also be explored using inhibitors. Groborz et al. installed <i>iso</i>- and <i>tere</i>-isomers of phthalic acid as a spacer to access the prime region of the active site.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Despite having a broad-spectrum caspase peptide z-VAD as the recognition motif on the nonprimed site, a single natural amino acid extension through a phthalic acid spacer was sufficient to gain selectivity within the caspases. For example, zVAD-<i>iso</i>Pht-Trp (<b>16</b>) was found to be 9.5- and 19-fold more potent for caspase-8 over caspase-9 and -10, respectively. The authors were also able to develop selective inhibitors for caspase-9 (zVAD-<i>tere</i>Pht-Ser, <b>17</b>) and caspase-10 (zVAD-<i>tere</i>Pht-Tyr, <b>18</b>). Through a quantitative analysis of cysteine-reactive small molecule fragments screened in human proteomes, the Cravatt laboratory recently discovered covalent ligands that react preferentially with pro-forms of caspase-8 and caspase-10.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> These compounds (<b>19</b> and <b>20</b>) were used to study extrinsic apoptosis pathways in primary human T cells and showed that inhibition of both caspase-8 and caspase-10 was required to suppress apoptosis in primary human T cells, while selective inhibition of caspase-8 by 63-<i>R</i> (<b>20</b>) was sufficient to block FasL-induced apoptosis in Jurkat cells, supporting that caspase-10 has important functions in primary human T cells and offering pro-caspase inhibitors as an alternative strategy in caspase inhibitor discovery.</div><div class="NLM_p">Among small and nonpeptidic caspase inhibitors explored, the isatin moiety that acts as an alkylating agent has been an attractive starting point because it can be easily extended or modified. A tetrahedral intermediate is formed upon nucleophilic attack of cysteine residue to the carbonyl group of the isatin. The pyrrolidine ring interacts with hydrophobic residues in the S2 pocket, which is a unique feature in caspase-3 and -7.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Following optimization led to the development of isotopically labeled isatin sulfonamide, [<sup>18</sup>F]WC-II-89 (<b>11</b>) that can be used to measure and image apoptosis in an animal model with positron emission tomography (PET).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><div class="NLM_p last">Recently, Chakrabarty and Verhelst developed photocaged caspase inhibitors, representing novel chemical tools for the study of apoptosis in space- and time-controlled manner (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Through a combination of the VAD or DEVD sequence with the photoprotecting group nitroindoline for the P1 aspartate, the photoactivatable derivatives were able to inhibit not only caspases in complex proteomes but also cellular apoptosis with an efficient turn-on of inhibitory activity after irradiation with light.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">MALT1</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The paracaspase Mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) belongs to a caspase family but prefers cleaving after the P1 arginine instead of aspartic acid. It has emerged as an important player in both innate and adaptive immune cells. MALT1 is involved in the activation and proliferation of lymphocytes and other immune cells such as myeloid cells, mast cells, and natural killer (NK) cells.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> As a part of the CARMA1-BCL10-MALT1 (CBM) complex, MALT1 transduces signals from immune receptors such as B and T cell receptors toward NF-ÎºB activation (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A).<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a> As a protease, MALT1 cleaves specific substrates that are mainly involved in regulation of immune responses, including TNFAIP3 (A20), BCL10, CYLD, HOIL1, RelB, regnase-1, and Roquin1/2. It also functions as a scaffolding protein, where it recruits TNF receptor-associated factor 6 (TRAF6), which in turn activates TGF-Î²-activated kinase 1 (TAK1) and IKK complex.<a onclick="showRef(event, 'ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref75 ref76">(75,76)</a> In addition, MALT1 is associated with NF-ÎºB regulation downstream of some G-protein coupled receptors or the epidermal growth factor receptor expressed by nonimmune cells.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> An oncogenic fusion of the cellular inhibitor of apoptosis 2 (cIAP2, also known as AIP2) with MALT1 (cIAP2-MALT1), which occurs in MALT lymphoma of different sites with varying frequencies, has been reported to cleave NF-ÎºB-inducing kinase (NIK).<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Patients with MALT1 mutation present the combined immunodeficiency (CID) characterized by severe and recurrent bacterial, fungal, and viral infections and impaired T cell activation with abnormal cellular and humoral immune responses despite normal lymphocyte counts. Constitutively active MALT1 has been found in lymphomas such as activated B cell-like diffuse large B cell lymphoma (ABC-DLBCL), MALT lymphoma, and mantle cell lymphoma.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> A recent study with mice expressing catalytically inactive MALT1 showed that MALT1 activity is required for maintaining homeostasis and function of regulatory T (Treg) cells that prevent autoimmunity.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> MALT1 proteolytic activity is also necessary for optimal T helper cell 17 (Th17) differentiation and granulocyte-macrophage colony-stimulating factor (GM-CSF) production by Th17 cells.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Therefore, therapeutic intervention of MALT1 protease activity has been considered as a promising approach for treating lymphomas and other autoimmune and inflammatory disorders.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) NF-ÎºB activation through CARMA1-BCL10-MALT1 complex in B or T cells. (B) Structures of selected inhibitors and activity-based probes for MALT1. Electrophilic warheads are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The first MALT1 inhibitor was derived from the optimal tetrapeptide substrate of the <i>Arabidopsis thaliana</i> metacaspase AtmC9, Z-VRPR.<a onclick="showRef(event, 'ref72 ref82'); return false;" href="javascript:void(0);" class="ref ref72 ref82">(72,82)</a> Through the electrophilic fluoromethyl ketone (FMK) warhead, the compound (<b>21</b>, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B) irreversibly inhibits MALT1, which resulted in inhibition of T cell activation and IL-2 secretion in Jurkat cells and in human antigen specific cytotoxic T lymphocytes (CTLs). Z-VRPR-FMK treatment preferentially reduced the viability of cell lines derived from ABC-DLBCL.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> A tripeptide analogue Z-VPR-FMK showed comparable in vitro potency but lost some cellular efficacy.<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83,84)</a> Further optimization yielded 4-bromo-benzamide derivative (<b>22</b>) that is 10- and 100-fold more potent in vitro and in vivo, respectively. The inhibitor treatment downregulated IL-10 expression and IL-10- and Janus kinase (JAK)-/signal transducer and activator of transcription (STAT)-related transcriptional signatures. MALT1 inhibition by 4-Br-Ph-VPR-FMK also led to upregulation of type I IFNs and MHC class II and IL-12 signaling.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></div><div class="NLM_p">Derived from the RelB substrate sequence LVSR and the BCL1 substrate sequence LRSR, the first generation of MALT1 ABPsâCy5-LVSR-AOMK (LE40),<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> biotin-LVSR-AOMK (LE42, <b>23</b>),<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> and BODIPY-LRSR-AOMK<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a>âthat effectively differentiate between active and inactive MALT1, when using recombinant enzyme, cellular overexpression, and endogenous MALT1 in an ABC-DLBCL cell line, was developed. Based on the observation that MALT1 substrates containing pentapeptide exhibit higher activity than substrates with tetrapeptide, Kasperkiewicz et al. explored the P5 position using unnatural amino acids and identified Ac-Phe(guan)-LVPR as the most active MALT1 substrate compared with the Ac-ALVSR substrate.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Equipped with the Cy5 and an AOMK, the resulting probe PKG105 selectively detected MALT1 activity in cell lysates. Additionally, using internally quenched fluorescence (IQF) substrates, it was demonstrated that MALT1 S1â² pocket is fairly restricted to glycine at the P1â² position, which agrees with the observation that cleavage of natural MALT1 substrates takes place between the P1 arginine and P1â² glycine residue. The S2â² pocket, on the other hand, is shown to have broad specificity accommodating small aliphatic amino acids and proline. More recently, Verhelst et al. developed a cell-permeable MALT1 fluorescent probe, BODIPY-LVPipR-AOMK (<b>24</b>), that contains pipecolinic acid in the P2 position, providing reduced cross-reactivity with cathepsin B.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><div class="NLM_p last">From high-throughput screening (HTS), Fontan and colleagues identified compound MI-2 (<b>25</b>) that directly binds and irreversibly inhibits MALT1 through covalent modification of the active site Cys464 residue.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> MI-2 was concentrated within the human ABC-DLBCL cells and inhibited cleavage of the MALT1 substrates, which was accompanied by suppression of NF-ÎºB reporter activity, inhibition of c-REL nuclear localization, and downregulation of NF-ÎºB target gene. MI-2 was nontoxic to mice and suppressed xenotransplant ABC-DLBCL tumors in vivo and primary human DLBCLs ex vivo.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Calpain</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Calpains belong to a family cysteine protease with calcium-dependent activity. Within the human genome, there are 15 genes that encode calpain-like protease domain (CAPN1 to CAPN16, no CAPN4). The first described members, calpain 1 and 2 (also called Î¼- and m-calpain) are two most widely studied isoforms of calpain. The activation of calpains is primarily dependent on increased intracellular Ca<sup>2+</sup> concentration<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> but some other factors may also activate calpain without calcium. For example, calpains may be activated through the extracellular signal-regulated kinases (ERKs) or mitogen-activated protein kinases (MAPKs) signaling pathways. The endogenous protein inhibitor calpastatin limits the function of calpain.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Despite a wide variety of proteins reported as calpain substrates, including cytoskeletal and plasma membrane-associated proteins, kinases and phosphatases, membrane receptors, transporters, and transcription factors, no consensus cleavage sequence has been defined for calpains. In addition to its involvement in cell mobility and cell cycle progression, calpains have been found to be involved in protein secretion by macrophages, promotion of neutrophil recruitment, regulation of NLR family pyrin domain containing 3 (NLRP3) inflammasome, pyroptosis, and lymphocyte migration and activation. The studies indicated that calpain inhibition plays a protective role in numerous inflammation-associated diseases.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div><div class="NLM_p">Most calpain inhibitors suffer from insufficient specificity to distinguish calpains from other proteases, partially due to lack of knowledge on the calpain substrate specificities. The first-generation calpain inhibitors include broad-spectrum cysteine protease inhibitors, E-64 (<b>26</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) and leupeptin (Ac-LLR-CHO), originating from actinomycete and fungus, respectively.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Based on the E-64 scaffold, a iodinatable phenol ring and a biotinylated lysine residue were incorporated to generate the epoxide probe DCG-04 (<b>27</b>), which is active toward calpains and cysteine cathepsins.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Using DCG-04, m-calpain and related Lp82 were identified as the active cysteine proteases responsible for mediating cleavage of Î³-crystalin during cataract formation in the eye lens. Aldehyde inhibitors, calpeptin (Z-Leu-Nle-CHO) and MDL28170 (Z-Val-Phe-CHO) that a hydrophobic benzyloxycarbonyl cap group was introduced instead of the terminal amino acid showed improved physicochemical characteristics. In rat models, a sulfonamide containing calpain inhibitor, SJA-6017 (<b>28</b>), was shown to prevent cataract formation.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of selected inhibitors and activity-based probes for calpain 1/2. Electrophilic warheads are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Another class of reversible covalent inhibitors reported for calpain is cyclopropenone containing compounds. Possible mechanisms for the inhibition by peptidyl cyclopropenone involve the nucleophilic attack of catalytic cysteine at either of the olefinic carbons and protonation of the carbonyl oxygen yielding a stabilized aromatic hydroxycyclopropenyl cation to form charge-transfer complex. An orally bioavailable BDA-410 (<b>29</b>) was found to be neuroprotective in Alzheimerâs disease mouse models.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Î±-Ketoacids, Î±-ketoesters, and Î±-ketoamides, electrophiles for reversible addition, can form a tetrahedral intermediate analogue upon nucleophilic attack of the active-site cysteine residue onto the Î±-keto carbon. Î±-ketoamide inhibitor AK295 (<b>30</b>) showed neuroprotective effects in a rat model of cerebral focal ischemia.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Extensive exploration of the P3 cap group led to the identification of A-705239 (<b>31</b>) and A-705253 (<b>32</b>) with improved pharmacokinetic properties.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Alicapistat (ABT-957, <b>33</b>)<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> developed by AbbVie had been in the clinical trials for the treatment of cognitive disorders until recently. However, it was found to be ineffective potentially due to insufficient concentration entered in the central nervous system.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Cathepsin</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05177" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05177" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cathepsins are major endolysosomal proteases involved in intracellular proteolysis as well as in various physiological and pathological processes. There are 15 human cathepsins which are divided into three groups depending on their active site catalytic residue: cysteine (cathepsins B, C, F, H, K, L, O, S, V, W, and X), serine (cathepsins A and G), and aspartate proteases (cathepsins D and E). Within a family of cysteine cathepsins, cathepsins S, K, V, F, and L exhibit endopeptidase activity and cathepsins B, H, X, and C exhibit both endo- and exopeptidase activity. Cathepsins have been detected not only in lysosomes but also in nuclei, cytosol, secretory vesicles, at the cell membrane, and in the extracellular space.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Cathepsins are transcribed as inactive zymogens in the endoplasmic reticulum (ER) and Golgi organelles. The prodomain blocks activity, and it becomes active either by autocatalysis under specific conditions, such as low pH or the presence of glycosaminoglycans, or through cleavage by other proteases. The activity of cathepsins is regulated by the presence of endogenous inhibitors such as cystatins, stefins, kininogens, thyropins, and serpins.</div><div class="NLM_p">The site- and substrate-specific activity of cathepsins regulates important biological processes, including antigen presentation, cytokine secretion, and cell differentiation and migration. Cathepsin B (CatB) has been implicated in the activation of NLRP3 inflammasomes and the production of IL-1Î² and tumor necrosis factor (TNF)-Î±.<a onclick="showRef(event, 'ref101 ref102'); return false;" href="javascript:void(0);" class="ref ref101 ref102">(101,102)</a> Cathepsin K (CatK) is involved in the proteolytic activation of toll-like receptor-7 (TLR7) or TLR9.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Cathepsin S (CatS) also regulates the TLR signaling transduction and MHC class II-dependent CD4<sup>+</sup> T cell activation.<a onclick="showRef(event, 'ref104 ref105'); return false;" href="javascript:void(0);" class="ref ref104 ref105">(104,105)</a> CatS inhibition by leucyl-homophenylalanine-vinylsulfone (LHVS, <b>41</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A) caused impaired Ii processing and antigen presentation.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Alterations of CatS expression and activity have been found to affect antigen processing and crosstalk between immune cells in the tumor microenvironment and contribute to lymphomagenesis.<a onclick="showRef(event, 'ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref106 ref107">(106,107)</a> Cathepsin L (CatL) is critical for Ii processing in thymic cortical epithelial cells and positive selection of CD4<sup>+</sup> T cells.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Macrophage-derived CatL activates heparanase, which is an important player in cancer, inflammatory diseases, and viral infection.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Recent studies have indicated that cathepsin L is required for glycoprotein processing and cleavage of the enveloped viruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), Ebola virus, Hendra virus, and Nipah virus, allowing them to enter the host cells and replicate.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> A pan-cysteine protease inhibitor K11777 (<b>37</b>) has been shown to inhibit Ebola virus and SARS-CoV entry.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Cathepsin X (CatX, also known as cathepsin Z or P) is predominantly expressed in immune cells, including monocytes, macrophages, and DCs, and has been proposed to play a role in T cell activation.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Structures of selected inhibitors and activity-based probes for cathepsins. Electrophilic warheads are shown in red. (B) Mechanism and tumor imaging of a fluorescently quenched activity-based probe (qABP), BMV109. The probe is intrinsically quenched and becomes fluorescent upon specific and covalent binding to cathepsins in an activity-dependent manner.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Taken from the observations that cysteine cathepsins are highly upregulated in certain cancer types, cathepsins have emerged as molecular targets for the development of diagnostic tools as well as therapeutic candidates in cancer. In particular, cathepsin B and L have been implicated most in tumorigenesis. Intraperitoneal administration of CA-074 (<b>34</b>), which is a synthetic analogue of E-64 designed to harness the dipeptidylcarboxypeptidase activity of CatB, reduced breast cancer metastasis to bone in tumor-bearing animals, indicating that cysteine cathepsins play important roles in metastasis.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> A cell-permeable broad-spectrum cysteine cathepsin inhibitor, JPM-OEt (<b>35</b>), significantly decreased tumor growth and invasiveness in a pancreatic neuroendocrine cancer model.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> However, JPM-OEt was found ineffective for the treatment of breast cancer in a mammary gland tumor model and breast-to-bone metastasis, largely due to poor bioavailability.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Cathepsin inhibition with GB111-NH<sub>2</sub> (Z-FK-AOMK, <b>36</b>), which is a potent inhibitor of cathepsins B, L, and S, led to the macrophage cell death and mammary tumor regression, likely caused by increased oxidative stress in tumor-associated macrophages (TAM), which are an important class of immune cells for regulation of cancer proliferation and invasion.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> A number of ABPs have been developed based on the Z-FK recognition motif. Particularly, fluorescently quenched ABPs (qABPs) that become fluorescent only upon specific and covalent binding to the cathepsins in an activity-dependent manner have been successfully employed for the noninvasive optical imaging of cancer. BMV109 (<b>48</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B), bearing a tetrafluoro-substituted phenoxymethyl ketone (PMK) electrophile, displayed a greater reactivity toward CatB, S, L, and X and overall improved in vivo properties compared to previously reported AOMK-based probes. It was able to demarcate the cancer region with substantial contrast soon after the administration in a syngeneic orthotopic mouse model of breast cancer.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> The HyCoSul-drived probe MP-cL3 (<b>45</b>) that features Cy5-6-ahx-His-<sub>D</sub>Thr-Phe(F<sub>5</sub>)-Cys(Bzl)-AOMK showed improved activity and selectivity for CatL.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> The probe was rapidly taken up by cells and labeled CatL with no detectable labeling of CatB up to 8 h of incubation with MDA-MB-231 cells. The same group reported an ABP for CatB (MP-CB2) containing the Cha-Leu-Glu(Bzl)-Arg sequence shortly after, which exhibited 3500-fold selectivity over CatL.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> The Cy5-labeled MP-CB2 probe selectively labeled cathepsin B in 18 cell lines covering different types of cancer and in cells collected from stage IV nonsmall lung cancer patient.</div><div class="NLM_p">One major challenge, however, with targeting cathepsins is that it requires significant optimization to provide sufficient selectivity because of high homology and overlapping substrate specificity within the cathepsin family. The most common therapeutic targets among cysteine cathepsins are cathepsin K and cathepsin S with several inhibitors evaluated in different phases of clinical trials. To date, there is no CatL inhibitor entered in clinical trials, and only one CatB inhibitor (VBY-376) has completed phase I clinical study investigating the safety of single dose in healthy adults.</div><div class="NLM_p">Cathepsin K is highly expressed in osteoclasts and is the major protease responsible for the degradation of type I collagen, which makes up 90% of the organic bone matrix.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Inhibition of CatK reduces bone resorption thus, CatK inhibitors have been investigated for the treatment of bone diseases such as osteoporosis and osteoarthritis. It has been also suggested that CatK may have an important role in atherosclerosis and rheumatoid arthritis.<a onclick="showRef(event, 'ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref121 ref122">(121,122)</a> A study showed that CatK inhibition results in impaired TLR9 signaling in DCs in response to unmethylated CpG DNA, which in turn leads to attenuated induction of Th17 cells without affecting antigen-presenting ability.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> For inhibitor design, a nitrile warhead that undergoes slow nucleophilic attack of enzyme to form the reversible thioimidate ester bond, has received much attention for targeting the active site of cysteine cathepsins. In the clinical study, balicatib (<b>38</b>), a peptidic nitrile inhibitor that potently inhibits CatK, showed increased bone mineral density and reduced bone resorption markers in the lumbar spine, femur, and hips over 18 months of treatment.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> However, its lysosomotropic character, which accumulates the basic compound as a protonated form in acidic compartments, led to dramatically decreased selectivity in cell-based assays compared to in vitro assays.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Balicatib has been reported to cause skin rashes, pruritus, and rare morphea-like skin thickening,<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> potentially through the inhibition of CatB and CatL that are highly expressed in the skin and skin-derived cells. Efforts to address the side effects caused by the basic character and the metabolic liability led to the discovery of odanacatib (<b>39</b>).<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Odanacatib is highly potent for reducing bone resorption markers and increasing bone mineral density.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> However, odanacatib was discontinued while in phase III clinical trials due to increased risk of stroke in postmenopausal patients. ONO-5334 (<b>40</b>), an Î±-ketoamide inhibitor, had been in phase II clinical trials by Ono Pharmaceutical for the treatment and prevention of osteoporosis,<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> but the development was subsequently discontinued for business-related reasons.</div><div class="NLM_p">Cathepsin S is primarily expressed in the lysosome of antigen presenting cells (DCs, macrophages, and B cells). Upregulated production and proteolytic activity of CatS have been implicated in chronic inflammatory diseases. Given its key role in antigen presentation, CatS has been intensely explored as a therapeutic target for rheumatoid arthritis, multiple sclerosis, myasthenia gravis, psoriasis, asthma, and wound healing. The Ellman laboratory applied the substrate activity screening (SAS) method to CatS and identified 1,4-disubstituted-1,2,3-triazole-based nonpeptidic aldehyde and nitrile inhibitors that display high selectivity for cathepsin S.<a onclick="showRef(event, 'ref30 ref130'); return false;" href="javascript:void(0);" class="ref ref30 ref130">(30,130)</a> Taking these nonpeptidic triazole scaffolds as a starting point, the Bogyo group developed qABPs for CatS (<b>42</b> and <b>43</b>). BMV083 (<b>42</b>) showed a high tumor-specific fluorescence when using the noninvasive optical imaging methods in a syngeneic breast cancer model.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> The probe primarily labeled macrophages with an M2 phenotype. As M2 macrophages generally exert an immune suppressive, tumor-promoting phenotype, BMV083 may find application as a potential in vivo reporter for tumor growth. Highly selective CatS inhibitors containing pyrrolidine ring that utilizes specific ligandâprotein interactions in the S2 pocket of CatS with the rigid cyclic scaffold showed favorable in vivo properties. Initial study reported that the compound reduced IL-2 production in a dose-dependent manner in a transgenic DO10.11 mouse model of antigen presentation, expressing an ovalbumin-specific T cell receptor.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> RO5459072 (<b>44</b>),<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> which is a potent, selective, and orally available inhibitor of CatS, passed the phase I for celiac disease and completed the phase II studies for Sjogrenâs syndrome.</div><div class="NLM_p last">Although the protease activity of cathepsin X has been linked to activation, maturation, and migration of immune cells, its physiological roles remain poorly understood. To study biological functions of CatX both in vitro and in vivo, Paulick and coworkers have developed an ABP, MGP140 (<b>46</b>) that labels CatX in addition to CatB, S, and L.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> The recently reported activity-based probe that contains a sulfoxonium ylide warhead (sCy5-Val-SY, <b>47</b>) exhibited improved specificity for CatX in cell lysates, intact cells, and human tissues.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Legumain</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Legumain, or asparaginyl endopeptidase (AEP), is another cysteine protease that is mainly present in the endolysosomal system. It was first identified in legumes as a vacuolar processing enzyme with high preference for processing the substrates after P1 asparagine residues.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Legumain belongs to the CD clan of proteases and family C13 of cysteine proteases that share the conserved His-Gly-spacer-Ala-Cys catalytic motif. Mammalian legumain has a broad tissue distribution and is localized to different types of antigen presenting cells. Similar to cathepsins, the proteolytic activity of legumain is regulated by expression as a proenzyme, pH, and complex formation with endogenous inhibitor cystatins. The protein substrates of legumain include prolegumain itself, autoantigens such as the myelin basic protein (MBP) or the tetanus toxin C-terminal fragment (TTCF), other lysosomal proteases such as cathepsins B, H, and L and their inhibitor cystatin, TLR7/9, invariant chain chaperone Ii, protein phosphatase 2 inhibitor SET, and tau protein, that share an asparagine or aspartic acid at the P1 position. Additionally, legumain exhibits ligase activity.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> As evidenced by its protein substrates, legumain is found to be involved in antigen processing and presentation on the MHC class II complex, TLR processing, and matrix degradation. Deregulated legumain activity has been implicated in multiple pathophysiological conditions, including inflammation, atherosclerosis, Alzheimerâs disease, and cancer. Overexpression of legumain has been reported in various solid tumors (e.g., breast, colon, lung, prostate, and ovarian cancer),<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> and upregulated legumain activity has been associated with an increase in tumor growth and metastasis and a poor prognosis for cancer patients.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Legumain is also highly expressed on the cell surface of tumor-associated macrophages in the tumor microenvironments.<a onclick="showRef(event, 'ref138 ref140'); return false;" href="javascript:void(0);" class="ref ref138 ref140">(138,140)</a></div><div class="NLM_p">Legumain is biochemically close to cysteine cathepsins. However, pan-cysteine protease inhibitor E-64 does not inhibit legumain. Legumain cleaves the substrates after asparagine residues with high level of specificity. However, when introduced in inhibitor, the amide side chain of the P1 Asn leads to intramolecular cyclization reaction with the electrophilic group and ultimately results in loss of inhibitory activity. To overcome this instability issue, a series of azaAsn inhibitors including azaAsn halomethyl ketones (e.g., <b>49</b>, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>), azaAsn epoxides, and azaAsn Michael acceptors has been developed and showed significantly higher stability while maintaining inhibitory potency toward mammalian legumain. A Pro-azaAsn dipeptide (LI-1, <b>50</b>), in which the P2 proline was incorporated to reduce the cross-reactivity toward other cysteine proteases, has been reported as a potent legumain inhibitor.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of selected inhibitors and activity-based probes for legumain. Electrophilic warheads are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A series of legumain inhibitors that utilizes a nitrile electrophilic warhead was discovered by the Williams group.<a onclick="showRef(event, 'ref142 ref143'); return false;" href="javascript:void(0);" class="ref ref142 ref143">(142,143)</a> The increase in inhibitory potency observed by the extension of P3 position with a biphenyl ring (<b>51</b>) suggested that the S3 pocket of legumain can well accommodate bulky and hydrophobic moieties. However, the inhibitor displayed low solubility and metabolic instability, preventing in vivo applications.</div><div class="NLM_p last">Because legumain is also able to hydrolyze the substrates after P1 aspartic acids when in the acidic lysosome, peptide inhibitors with the P1 Asp have been studied for legumain. Caspase inhibitors that feature the P1 Asp and halomethyl ketone warhead (e.g., Z-DEVD-CMK, Ac-YVAD-CMK, and Z-VAD-FMK) presented some cross-reactivity with legumain. A truncated, dipeptide inhibitor Ac-PD-AOMK (LI-0) was developed to minimize the off-target activity. Although more potent for legumain, the analysis of kinetics showed that the difference in inhibition between legumain and caspase-3 by LI-0 was not significant.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Based on the EPD-AOMK motif that targets both caspases and legumain, the Bogyo group developed a qABP.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Surprisingly, the probe LE28 (<b>52</b>) was found to be highly selective for legumain when used in whole cells and tissues. The authors attributed this specificity to the presence of hydrophobic fluorophore and quencher. Moreover, it appeared that the probe was taken up by cells and directed to endolysosomal compartments, bypassing the cytosol where caspases reside. A study reported that legumain is activated in the pancreas during caerulein-induced acute and chronic murine pancreatitis indicated by the LE28 probe labeling of legumain.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> The activity of legumain was found to be highly correlated with macrophage activation. In another recent study, the LE28 probe detected activated legumain in oral squamous cell carcinoma (OSCC).<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> It showed that legumain can cleave protease-activated receptor-2 (PAR2) at a unique site and act as a novel biased PAR2 agonist to promote oral cancer pain. Accordingly, legumain inhibitor LI-1 (<b>50</b>) was shown to prevent OSCC pain in mice. Poreba and coworkers discovered a highly selective tetrapeptide inhibitor of legumain, <i>D</i>Y-Tic-SD-AOMK, which was subsequently converted into a biotinylated ABP (MP-L01, <b>53</b>). The probe efficiently labeled legumain in live cells without detectable cross-reactivity against cathepsins.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Deubiquitinase (DUB)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16733" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16733" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Ubiquitination is a reversible post-translational protein modification, in which the amide bond between the C-terminal Gly residue of ubiquitin (Ub) and the lysine residue of substrate protein (or lysine on another ubiquitin) can be hydrolyzed by a family of isopeptidases known as deubiquitinases (DUBs) (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A). DUBs can be subdivided into six families: ubiquitin-specific protease (USP), ubiquitin C-terminal hydrolase (UCH), ovarian tumor domain protease, MachadoâJoseph disease (MJD), motif interacting with Ub-containing novel DUB (MINDY), and JAB1/MPN/Mov34 metalloenzyme (JAMM) families. The JAMM DUBs belong to zinc metalloproteases, whereas all the other families use the nucleophilic cysteine residue to hydrolyze the isopeptidic bond. DUBs differ in their specificity for substrate as well as for ubiquitin chain types.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) DUB active site. The isopeptide bond between the C-terminal Gly residue of ubiquitin and the Lys residue of the substrate protein is hydrolyzed by the DUB protease activity. (B) Structures of ubiquitin-based covalent inhibitors. (C) Structures of selected DUB inhibitors. Electrophilic warheads are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">DUBs play critical roles in maintaining protein homeostasis and regulating cellular trafficking and proteinâprotein interactions. In the adaptive immunity, DUBs have been linked to the development, activation, and differentiation of T cells and regulation of T cell tolerance. Among the members of USP family, USP4 deubiquitinates Lys63-linked polyubiquitin chains from TAK1, TRAF2 and TRAF6 negatively regulating TNFÎ±-induced NF-ÎºB activation.<a onclick="showRef(event, 'ref149 ref150'); return false;" href="javascript:void(0);" class="ref ref149 ref150">(149,150)</a> It has been reported that USP4 is highly expressed in Th17 cells and stabilizes the nuclear receptor retinoid-related orphan receptor-Î³t (RORÎ³t), promoting Th17 differentiation.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Its depletion or use of inhibitor also resulted in decreased expression of RORÎ³t and IL-17A.<a onclick="showRef(event, 'ref151 ref152'); return false;" href="javascript:void(0);" class="ref ref151 ref152">(151,152)</a> Moreover, CD4<sup>+</sup> T cells from patients with rheumatic heart disease exhibited significantly elevated USP4 and IL-17 mRNA, but not RORÎ³t mRNA, providing evidence for a role of USP4 in autoimmune diseases. USP7, one of the most widely studied DUBs, has been known to regulate numerous tumor suppressor proteins including p53 and murine double minute 2 protein (MDM2), an E3 ligase of p53, and phosphatase and tensin homologue (PTEN).<a onclick="showRef(event, 'ref153 ref154'); return false;" href="javascript:void(0);" class="ref ref153 ref154">(153,154)</a> Studies also have reported that USP7 is involved in maintenance of Treg cell function. Upregulated and active USP7 found in primary Treg cells positively regulates the stability of transcription factor Foxp3, which is critical in the development and function of Treg cells.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> USP7 also deubiquitinates and stabilizes Tip60, an essential acetyltransferase required for acetylation of histones and other nonhistone proteins. Tip60 is known to promote the acetylation-dependent dimerization of Foxp3 for maintaining Treg stability and immune tolerance.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> Genetic ablation or pharmacologic inhibition of USP7 has been shown to impair Treg functions.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> As Treg cells restrict the antitumor immune responses and promote tumor survival, these results suggest that specific USP7 inhibitors can promote antitumor immunity and enhance the efficacy of immunotherapeutic agents. USP9X has been found to be involved in regulation of cell survival and TGF-Î² signaling by deubiquitinating myeloid leukemia cell differentiation protein 1 (Mcl1), the HECT-type E3 ubiquitin ligase (E3) Itch, and Smad4.<a onclick="showRef(event, 'ref158 ref159'); return false;" href="javascript:void(0);" class="ref ref158 ref159">(158,159)</a> USP9X also positively regulates T cell receptor (TCR) signaling and T cell tolerance. USP9X appears to interact with BCL10 in the CBM complex and remove ubiquitin chains from TCR-stimulated BCL10.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> USP9X deficiency leads to expansion of antigen-experienced T cell populations and development of spontaneous lupus-like autoimmunity and lymphoproliferative disease.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a></div><div class="NLM_p">ABPs that contain Cys-targeting electrophiles in place of the C-terminal Gly of ubiquitin (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B) have proven to be powerful tools to identify DUBs in a physiologically relevant context, characterize DUB enzymatic activity, and study DUB inhibitors. Ubiquitin-aldehyde (Ubal) was used to solve the first structure of a DUB in complex with Ub, which revealed the conformational changes of DUB that occur upon Ub binding.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Ubiquitin-vinylmethyl sulfone (Ub-VS), ubiquitin-vinylmethyl ester (Ub-VME), and ubiquitin-propargyl amide (Ub-PA) are covalently and irreversibly attached to the catalytic cysteine of DUBs. A study showed that HA-Ub-VS can distinguish between the active and inactive forms of USP9X. The catalytic activity of USP9X was shown to be enhanced by TCR-dependent phosphorylation after T cell stimulation, determined by increased labeling of USP9X by HA-Ub-VS without an increase in protein levels.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> A propargyl amide warhead reacts via direct nucleophilic attack on the internal alkyne carbon, facilitated by stabilization of the carbanion by the oxyanion hole of the active site.</div><div class="NLM_p">Ubiquitin-based activity-based probes, however, lack target selectivity. To obtain a potent and selective tool for a particular DUB of interest, researchers have developed engineered Ub variants using phage display libraries or computational approaches.<a onclick="showRef(event, 'ref164 ref165 ref166'); return false;" href="javascript:void(0);" class="ref ref164 ref165 ref166">(164â166)</a> The Drag laboratory recently used also the HyCoSuL approach to develop a selective ABP for DUB. Substitution for the conserved Leu-Arg-Gly-Gly motif with the selected peptide sequences, Cha-Arg-Abu-Gly or <span class="smallcaps smallerCapital">d</span>-Arg-Phe(guan)-Ala-Gly, led to a highly active and selective ubiquitin probe that can detect UCH-L3 activity.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> Another challenge in developing chemical probes for deubiquitinases is that unlike ABPs for many proteases where only short peptide recognition motifs are required, full-length ubiquitin is often necessary for an efficient reaction between a probe and DUBs. Many catalytic domains of apo-DUB are in catalytically inactive conformations, and ubiquitin binding often induces structural rearrangements and brings the active site residues into the correct position for catalysis. Despite this, the Tate group recently reported the first cell permeable, small molecule DUB ABP. An alkyne-tagged analogue of 4-chloroacetylpyrrole derivative (<b>54</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C) that was discovered through HTS identified 12 USPs including USP4, USP16, and USP33 as the protein targets in osteosarcoma cells.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a></div><div class="NLM_p">The therapeutic potentials of inhibiting DUBs have been actively investigated given the important roles that DUBs play in many pathophysiological processes. In particular, developing USP7 inhibitors for cancer treatment has received an increasing interest in part due to the recent demonstration that USP7 is implicated in the ability of tumors to evade surveillance and immune-mediated killing. HBX 19818 (<b>59</b>) was discovered by Hybrigenics from a high-throughput USP7 screen using Ub-AMC as the fluorogenic substrate. It irreversibly binds to USP7 by the nucleophilic aromatic substitution with consequent loss of the chlorine and weakly inhibits USP7 (IC<sub>50</sub> 28 Î¼M).<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> The mechanism of covalent modification by this activated aromatic chlorine through a tetrahydroacridine system may be similar to the quiescent cysteine electrophile 4-chloro-pyridine.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> Using HBX 19818, it has been reported that disrupting USP7 reduces proliferation of human colon cancer cells, induces apoptosis, and disrupts the cell cycle.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> A thiophene containing compound P22077 (<b>56</b>), which inhibits both USP7 and USP47, has been shown to inhibit neuroblastoma growth.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> Further modification led to the development of P50429 (<b>57</b>).<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> Interestingly, a study indicated that both P22077 and P50429 covalently and irreversibly modify the cysteine residue at the active site of USP7 but via distinct chemical reactions.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Both reactions undergo the nucleophilic aromatic substitution; however, MS experiments revealed that different substructures are transferred to DUB cysteine from each inhibitor (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C). The authors speculated that the preferred attack on the pyridine in P50429 could be due to the reduced electrophilicity of the thiophene compared to the thiophene in P22077 or potentially more optimal trajectory for attack on the pyridine in the bound state. Using Ub-rhodamine assay, an USP7 inhibitor FT827 (<b>58</b>) was identified along with a noncovalent inhibitor FT671.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> FT827 covalently modifies the cysteine residue through a vinylsulfonamide moiety and exclusively inhibits USP7 among a panel of 38 DUBs from diverse families. Cocrystal structure indicated that FT827 binds to the inactive apo state of USP7. Elaboration of a noncovalent inhibitor XL188 by incorporating a tetrahydroacridine warhead yielded a highly potent and selective irreversible USP7 inhibitor XL177A (<b>60</b>). It has been demonstrated that selective USP7 inhibition by XL177A results in cytotoxicity toward cancer cells mainly through a p53-dependent mechanism, and the sensitivity to USP7 inhibition is highly correlated with mutational status of the tumor suppressor p53.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a></div><div class="NLM_p last">The best-described USP9X inhibitor is WP1130 (previously known as Degrasyn, <b>55</b>), which was originally identified in a screen for JAK2 inhibitors, but later found to inhibit DUB USP9X as well as USP5, USP14, and UCHL5.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> The 2-cyano-3-acrylamide warhead can reversibly modify the cysteine. WP1130-mediated inhibition of DUBs led to downregulation of antiapoptotic Mcl-1 and upregulation of proapoptotic p53.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> A derivative EOAI3402143 displayed improved aqueous solubility and greater inhibitory activity against USP9X and USP24. Intraperitoneal administration of the compound to MM1.S tumor-bearing mice significantly suppressed tumor growth, suggesting small molecule USP9X/USP24 inhibitors may have the therapeutic potential for treating myeloma.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a></div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Granzyme</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25010" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25010" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Granule-associated serine proteases known as granzymes (Gzms) are central to the function of CTL and NK cells and implicated in the pathogenesis of a broad range of human diseases. The pore-forming protein, perforin facilitates entry of granzymes into the cytoplasm of a target cell, where they access their substrates to carry out a series of proteolytic events, which result in cell death and elimination of infected and tumor cells.<a onclick="showRef(event, 'ref178 ref179'); return false;" href="javascript:void(0);" class="ref ref178 ref179">(178,179)</a> Granzymes also regulate immune and inflammatory responses by controlling the survival of activated lymphocytes and mediating cleavage of extracellular substrates. There are five human granzyme genes: GzmA/B/H/K/M. Different granzymes have been found in a variety of cells of hematopoietic and nonhematopoietic origins with GzmA and GzmB being the predominant constituents of granules. Granzymes can be classified according to their cleavage specificity. GzmA and GzmK have trypsin-like activity, cleaving their substrates after basic residues such as arginine and lysine. Similar to caspases, GzmB cleaves the substrates after acidic residues, aspartic acid or glutamic acid. GzmH has chymotrypsin-like activity, cleaving after tyrosine or phenylalanine, and GzmM cleaves after leucine or methionine. Gzms A, B, K, and H are expressed in higher quantities in CTLs compared with NK cells, whereas GzmM is more abundant in NK cells. Macrophages, mast cells, and DCs also express granzymes but not perforin, suggesting perforin-independent, extracellular roles of granzymes. An increasing number of studies have suggested the potential importance of GzmB expressed in tumor cells.<a onclick="showRef(event, 'ref180 ref181'); return false;" href="javascript:void(0);" class="ref ref180 ref181">(180,181)</a> Granzymes are stored within the granules as an inactive form to prevent host cell suicide. Endogenous inhibitors such as serpins also inhibit granzyme activity.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> SerpinB9 protects cells from misdirected GzmB activity. SerpinC1 prevents GzmA activity in plasma.</div><div class="NLM_p">Major intracellular functions of granzymes are cytotoxicity and cytokine signaling. Cytotoxicity is potently induced by GzmB, which cleaves the pro-apoptotic molecule Bid to activate the mitochondrial pathway of apoptosis as well as directly activates caspases. The proteolytic activity of granzymes is also involved in gasdermin-mediated pyroptosis. Chimeric antigen receptor (CAR) T cell-released GzmB has been shown to activate caspase-3 in target cells, which then cleaves gasdermin E (GSDME), leading to target cell pyroptosis.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> Recently, it has been demonstrated that GzmA from CTLs cleaves and activates gasdermin B (GSDMB) to induce target cell pyroptosis.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> The granzyme pathway is an important component of tumor surveillance and clearance. However, granzyme can potentially cause graft-versus-host disease (GVHD) and graft rejection in allogenic bone marrow transplantation by killing normal cells, mediated by CD8<sup>+</sup> CTL.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> Extracellular functions, independent of perforin, have been reported for GzmA and GzmB and involve cleavage of extracellular matrix (ECM) and cell surface receptors, possibly to facilitate cytotoxic lymphocyte migration and immune cell filtration.<a onclick="showRef(event, 'ref186 ref187'); return false;" href="javascript:void(0);" class="ref ref186 ref187">(186,187)</a> GzmA as a proinflammatory protease carries out cytokine signaling, which results in maturation and release of immunomodulating cytokines. In a recent study by Santiago et al., extracellular GzmA was found to contribute to gut inflammation and colorectal cancer development by inducing NF-ÎºB-dependent IL-6 production in macrophages, which in turn leads to STAT3 activation.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> The roles of GzmK and M remain unclear.</div><div class="NLM_p">Developing effective chemical tools for granzymes has largely been focused on GzmA and GzmB. In earlier studies, KrÃ¤henbÃ¼hl et al. identified GPR-AMC to be the best substrate for GzmA among 12 peptide analogues tested.<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> The substrates with P1 Arg are most effectively cleaved by GzmA, whereas GzmB prefers Asp, Asn, Met, Ser, or Thr at the P1 position.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> A few templates appeared to have potent inhibitory activity toward GzmA. FUT-175 (<b>61</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) and its structurally related analogues display comparable inhibition, and the general serine protease inhibitor dichloroisocoumarin (DCI, <b>62</b>) inhibits GzmA weakly.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> Ph-HNCONCH-CiTEtOIC (<b>63</b>) showed <i>K</i><sub>obs</sub>/[<i>I</i>] value of 94â¯000 M<sup>â1</sup> s<sup>â1</sup> for human recombinant GzmA.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> Several other unique structures such as guanidinobenzoates (<i>p</i>-Gua-C<sub>6</sub>H<sub>4</sub>-COOC<sub>6</sub>H<sub>4</sub>-CN) have been reported with potent GzmA inhibitory potential. However, their selectivity profiles have not been fully reported. A more systematic approach in identifying selective GzmA inhibitor was pursued with diphenyl phosphonate derivatives. Inspired by the potent inhibitory activities of ornithine, lysine, and amidino-based residues equipped with diphenyl phosphonate esters toward serine proteases, Powers and coworkers explored the templates for GzmA. In their initial screening, Z-(4-AmPhe)<sup>P</sup>(OPh)<sub>2</sub> was found to have >116-fold selectivity toward GzmA over other serine proteases such as GzmK, tryptase, and trypsin.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> Later, PS-SCL disclosed Ile-Gly-Asn (IGN) as the optimal recognition sequence for GzmA.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> Combined with the previously discovered Am(PhGly)<sup>P</sup>(OPh)<sub>2</sub> P1-warhead, a chemical probe bio-x-IGN(AmPhGly)<sup>P</sup>(OPh)<sub>2</sub> (<b>64</b>) exhibited highly specific activity toward GzmA. In addition to natural basic amino acids reported, Kasperkiewicz and coworkers described that GzmA also recognizes unnatural residues at the P1 position such as phenylalanine with a guanidine group. A cell permeable ABP, SK15.5 (<b>65</b>) containing Tic-Gly-Oic-Arg recognition motif was able to distinguish GzmA from other granzymes and successfully used to detect GzmA in NK92 cells.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of selected inhibitors and activity-based probes for granzyme A and B. Electrophilic warheads are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A tripeptide AAD was initially identified as an effective recognition sequence for GzmB, which led to the discovery of irreversible inhibitor Z-AAD-CMK (<b>66</b>), although its inhibition rate is rather slow.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> Later, PS-SCL revealed IEPD as the optimal sequence.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Truncation of the sequence proved to be ineffective, evidenced by a decrease in potency from Ac-IEPD-<i>p</i>NA to Ac-EPD-<i>p</i>NA. While these sequences were known to be important, a drastic influence was observed by different serine traps. GzmB clearly differentiated the substrates with the AMC fluorophore or <i>p</i>-nitroanilide showing the preference for IEPD sequence over IKPD. Surprisingly, the IEPD and IKPD substrates with a thiobenzyl ester were kinetically indistinguishable. Using a diphenyl phosphonate warhead, a chemical probe bio-x-IEPD<sup>P</sup>(OPh)<sub>2</sub> showed specific inhibition of GzmB.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> From the HyCoSuL screening, Nva-Ile-Glu-Oic-Asp was identified as a selective and potent leading sequence for GzmB.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> TJ55i (<b>68</b>) showed improved kinetic parameters and was able to detect active GzmB in lysates from different NK cell lines. Recently, activity-based imaging probes for GzmB have been employed for monitoring the treatment efficacy of cancer immunotherapy with PET.<a onclick="showRef(event, 'ref197 ref198'); return false;" href="javascript:void(0);" class="ref ref197 ref198">(197,198)</a> The study reported higher radionuclide signal intensity with <sup>68</sup>Ga-NOTA-GZP (<b>69</b>) in tumor when treated with a combination of anti-CTLA-4 and anti-PD-1 antibodies compared to monotherapy or untreated mice, which suggest that the probe can be utilized to differentiate nonresponders from responders for immune checkpoint therapy.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a></div><div class="NLM_p last">VTI-1002 (structure unavailable) is the only commercially available covalent reversible GzmB inhibitor that is highly selective and potent. It inhibits GzmB-mediated cleavage of two key ECM proteins, decorin and fibronectin. Topical application of VTI-1002 gel has been shown to promote wound closure and tissue remodeling in diabetic burn wounds.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> In the models of pemphigoid diseases, which are severe autoimmune skin blistering diseases induced by infiltration of autoantibody and immune cells at the dermalâepidermal junction, GzmB knockout or topical application of VTI-1002 significantly reduced total blistering area and severity, mediated by the inhibition of neutrophil accumulation and hemidesmosomal protein cleavage.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a></div></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Neutrophil Elastase</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Neutrophils are one of the effector immune cells to arrive at the site of infection, representing the first line innate immune defense. Neutrophils contain four serine proteases (NSPs)âcathepsin G (CatG), neutrophil elastase (NE), proteinase 3 (PR3), and the recently discovered neutrophil proteinase 4 (NSP4)âthat play important roles in the nonoxidative destruction of internalized pathogens, modulation of inflammatory processes, and controlling of cell signaling through cytokine/chemokine processing and activation of cell receptors. Deregulated NSPs have been implicated in the development of numerous inflammatory disorders.</div><div class="NLM_p">Human neutrophil elastase (HNE) belongs to a serine protease of chymotrypsin family. Displaying a broad substrate specificity, HNE degrades not only elastin but also a variety of ECM and plasma proteins, including collagen (types IâIV), fibronectin, laminin, and proteoglycans and pathogens. Owing to the shallow S1 pocket, HNE prefers substrates with small aliphatic P1 residues (Ala, Ile, or Val). Despite its name, neutrophil elastase is produced not only by neutrophils but also by immune cells such as macrophages and lymphocytes<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> and implicated in the control of immune responses and signal transduction. For example, HNE activates TLR4 to induce IL-8 expression and modulates cytokine signaling at the inflammation sites.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Neutrophil elastase is known to enhance IL-12p40 production by macrophages after stimulation with lipopolysaccharide (LPS) via transactivation of the PAR2/EGFR/TLR4 signaling pathway.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> Through PAR1 signaling, NE induces apoptosis of lung endothelial cells and regulates their barrier integrity.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> Neutrophil elastase has been shown to stimulate mucus hypersecretion from the airways of patients with chronic bronchitis and induce keratinocyte proliferation in psoriasis. Endogenous protein inhibitors that control the proteolytic activity of HNE are highly present in the respiratory tract and circulatory system.<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a> Dysregulated activity of HNE contributes to the development of several inflammatory disorders such as chronic obstructive pulmonary disease (COPD), bronchiectasis, respiratory distress syndrome, acute lung injury, cystic fibrosis, and rheumatoid arthritis. As NE is shown to enhance inflammation and disrupt matrix barrier integrity, it has been hypothesized that NE will likely facilitate cancer development. Indeed, neutrophil elastase expression and activity has been found to be upregulated in numerous cancer types.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> In lung cancer patients, elevated serological neutrophil elastase is positively correlated with disease state and progression.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a></div><div class="NLM_p">Almost every large pharmaceutical company has had an elastase inhibitor program, resulting in a myriad of HNE inhibitors with different pharmacophores. MeO-Suc-AAPV-CMK (<b>70</b>, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A) is an effective HNE inhibitor and has been particularly useful for structural studies.<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> Upon interaction with Ser195 in the active site, pyrrolidine <i>tran</i>-lactams and -lactones lead to ring opening that results in the formation of irreversible complex with the protein. SAR studies identified GW311616 (<b>71</b>) as one of the most potent inhibitors of HNE.<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a> ONO-5046 (also known as sivelestat, <b>72</b>) is one of the representative reversible inhibitors of neutrophil elastase.<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> ONO-5046 is found to undergo reversible acyl-deacylation mechanism, determined by LC-MS spectroscopy with four human sputum elastase isozymes.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> Sivelestat has been approved for the treatment of acute respiratory failure in Japan; however, efforts to expand the country or indication scope have not been successful.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) Structures of selected inhibitors and activity-based probes for neutrophil elastase. Electrophilic warheads are shown in red. (B) Crystal structure of the HNE (cyan surface)-PK101 (magenta) complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WVP">4WVP</a>). The active site serine Ser195 is shown in orange.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">SieÅczyk and coworkers have utilized Ugi and Passerini multicomponent reactions to rapidly construct a phosphonic peptidomimetic library with variations on the diphenyl phosphonate (DPP) warhead.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a> Among the synthesized pseudopeptides, Cbz-Met-O-Met-Val<sup>P</sup>(OC<sub>6</sub>H<sub>4</sub>-<i>p</i>-Cl)<sub>2</sub> (<b>73</b>) showed potent HNE inhibition with no inhibitory activities toward chymotrypsin and trypsin. Using the DPP moiety with the P1 valine, a fluorescent ABP, Cy5-V-DPP was synthesized and tested to monitor the NE activation during colitis.<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a> Cy5-V-DPP efficiently labeled recombinant NE and highly expressed NE in cells. However, it was unable to detect NE activity in colitis tissues, presumably due to insufficient sensitivity. The Drag laboratory identified Nle(O-Bzl)-Met(O)<sub>2</sub>-Oic-Abu as an optimal sequence for HNE. With high selectivity for HNE, ABPs PK101 (biotin tagged, <b>74</b>) and PK105 (Cy5 tagged)<a onclick="showRef(event, 'ref213 ref214'); return false;" href="javascript:void(0);" class="ref ref213 ref214">(213,214)</a> were used to define the presence of active elastase during the formation of neutrophil extracellular traps, which are the clusters of biologically active compounds, such as DNA and antipathogenic factors, that extrude into the extracellular space to trap and eliminate pathogens.<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a> Crystal structure of the HNE-PK101 complex revealed key interactions important for HNE recognition (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B).<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> In particular, the interaction of the P3Met(O)<sub>2</sub> residue within the S3 subsite showed how HNE can recognize post-translationally oxidized methionine residues in the oxidative environment of neutrophils during infection.<a onclick="showRef(event, 'ref217'); return false;" href="javascript:void(0);" class="ref ref217">(217)</a> Also, an exopocket adjacent to the S4 subsite is shown to interact with the unnatural amino acid Nle(O-Bzl) in the P4 position. When used in mucosal biopsies from the inflammatory bowel disease (IBD) patients, the Cy5-tagged PK105 probe detected activated NE.<a onclick="showRef(event, 'ref218'); return false;" href="javascript:void(0);" class="ref ref218">(218)</a> Followed by the success of using HyCoSuL method to identify selective recognition sequences for HNE, the same group developed a set of highly selective NSP small-molecule chemical tools that allow simultaneous detection of each serine protease in neutrophils. While CatG prefers large hydrophobic residues (Tyr or Phe) and NSP4 prefers Arg, both NE and PR3 prefer small hydrophobic residues such as Val or Ala. The comprehensive HyCoSuL screening led to the identification of optimal sequences of all four NSPs in addition to Nle(O-Bzl)-Met(O)<sub>2</sub>-Oic-Abu for NE: Glu(O-Bzl)-Lys(Ac)-hPro(Bzl)-Nva for PR3, His(Bzl)-Val-Pro-Phe for CatG, and hCha-Phe(guan)-Oic-Arg for NSP4.<a onclick="showRef(event, 'ref214 ref219'); return false;" href="javascript:void(0);" class="ref ref214 ref219">(214,219)</a> Selected sequences were converted into diphenyl phosphonate activity-based probes tagged with N-terminal biotin or one of four fluorophores (BODIPYFL, Cy3, Cy5, or Cy7). When applied to freshly prepared unstimulated and PMA-stimulated neutrophils, the NSP fluorescent imaging probes revealed that individual serine proteases are localized unevenly in distinctive neutrophil azurophil granules, suggesting unknown mechanism of granule packing system.</div><div class="NLM_p last">Alkyl and aryl sulfonyl fluorides have been known to covalently inhibit a number of serine proteases.<a onclick="showRef(event, 'ref220 ref221'); return false;" href="javascript:void(0);" class="ref ref220 ref221">(220,221)</a> Sulfur fluoride exchange (SuFEx) chemistry, recently developed by the Sharpless group, representing a new generation of click chemistry, has facilitated rapid assembly of diverse serine protease inhibitors.<a onclick="showRef(event, 'ref222'); return false;" href="javascript:void(0);" class="ref ref222">(222)</a> A covalent inhibitor, 2-(fluorosulfonyl)phenyl fluorosulfate (<b>75</b>) identified by SuFEx-enabled, agonistic approach showed IC<sub>50</sub> of 0.24 Î¼M for HNE and >833-fold selectivity over CatG.<a onclick="showRef(event, 'ref223'); return false;" href="javascript:void(0);" class="ref ref223">(223)</a> 3-Oxo-Î²-sultam, which features an endocyclic acyl moiety next to the Î²-sultam nitrogen atom, has been reported to irreversibly inactivate serine hydrolases in vitro.<a onclick="showRef(event, 'ref224 ref225'); return false;" href="javascript:void(0);" class="ref ref224 ref225">(224,225)</a> Nucleophilic attack on the 3-oxo-Î²-sultams could involve either acylation or sulfonylation. Cocrystal structure of HNE bound to the selected 3-oxo-Î²-sultam 8 (<b>76</b>) revealed that the mechanism of HNE inhibition by this chemotype is through sulfonylation of the catalytic serine residue.<a onclick="showRef(event, 'ref226'); return false;" href="javascript:void(0);" class="ref ref226">(226)</a> Using ABPP-MudPIT (multidimensional protein identification technology), a biotinylated 3-oxo-Î²-sultam probe enriched several serine proteases including dipeptidyl peptidase (DPP) family members DPP7/9, prolyl endopeptidases (PREP), and fibroblast activating protein (FAP) in addition to HNE. The 3-oxo-Î²-sultam moiety appeared also to react with the conserved catalytic threonine in the proteasome subunits. Recently, the Gois group reported that diazaborine compound <b>77</b>, in which the boron center is stabilized in the form of an aromatic BâN heterocycle, reversibly and selectively inhibits human neutrophil elastase with IC<sub>50</sub> value of 2.7 Î¼M, providing a new type of boron-containing warhead for serine proteases.<a onclick="showRef(event, 'ref227'); return false;" href="javascript:void(0);" class="ref ref227">(227)</a> Similar to boronic acids, the boron center of diazaboines reacts with the catalytic serine residue and forms a reversible covalent bond.</div></div><div id="sec12" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Dipeptidyl Peptidase 4</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03485" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03485" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The dipeptidyl peptidase (DPP) family has been implicated in various physiological and pathological processes of the immune system. Among them, dipeptidyl peptidase 4 (DPP4), also known as T cell surface marker cluster of differentiation 26 (CD26), is a highly conserved membrane glycoprotein and serine protease that cleaves off an N-terminal dipeptide from protein substrates with Pro or Ala (or to a lesser extent Ser) in the last position prior to the scissile amide bond.<a onclick="showRef(event, 'ref228 ref229'); return false;" href="javascript:void(0);" class="ref ref228 ref229">(228,229)</a> DPP4 is expressed ubiquitously in many tissues, including kidney, intestine, liver, lung, and also on immune cells (e.g., T cells, activated B and NK cells, and myeloid cells). DPP4 has been shown to cleave many gastrointestinal hormones, growth factors, and neuropeptides that share either the X-Pro or X-Ala motif at their N-terminus. DPP4 degrades insulinotrophic incretin hormones such as glucagon-like peptide-1 (GLP-1) and gastric inhibitory protein (GIP) and plays a major role in glucose homeostasis.<a onclick="showRef(event, 'ref230 ref231'); return false;" href="javascript:void(0);" class="ref ref230 ref231">(230,231)</a> Thus, DPP4 has been a validated therapeutic target for the treatment of type 2 diabetes. DPP4 modulates immune responses by mediating cleavage of many cytokines and chemokines.<a onclick="showRef(event, 'ref232 ref233'); return false;" href="javascript:void(0);" class="ref ref232 ref233">(232,233)</a> For example, stromal-derived factor 1 (SDF-1, also known as CXCL12) is rapidly degraded by circulating DPP4 in the peripheral blood. When treated with an orally active inhibitor of DPP4 in vivo, biologically active, full-length CXCL10 was preserved, which led to enhanced recruitment of lymphocytes into the tumor parenchyma.<a onclick="showRef(event, 'ref234'); return false;" href="javascript:void(0);" class="ref ref234">(234)</a> DPP4 inhibition was found to augment the efficacy of tumor immunity. A large number of studies demonstrated that CD26/DPP4 plays an integral role in T cell activation. Recent in vitro findings indicated that CD26/DPP4 is able to trigger T cell activation and proliferation directly via CARMA1-mediated NF-ÎºB activation.<a onclick="showRef(event, 'ref235'); return false;" href="javascript:void(0);" class="ref ref235">(235)</a> CD26/DPP4 has been also described as a mediator of lymphocyte migration through the thymus. DPP4 has been linked to a number of diseases including autoimmune diabetes, asthma, multiple sclerosis, arthritis, and inflammatory bowel disease. In nonobese diabetic mice, DPP-4 inhibition was found to deregulate Th1 immune response, increase secretion of Th2 anti-inflammatory cytokines, activate Tregs, and prevent IL-17 production.<a onclick="showRef(event, 'ref236'); return false;" href="javascript:void(0);" class="ref ref236">(236)</a></div><div class="NLM_p">Several DPP-4 inhibitors (gliptins) have been successfully approved and used for 2 diabetes with good efficacy and safety profiles. Among the marketed DPP-4 inhibitors, vildagliptin (<b>78</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>)<a onclick="showRef(event, 'ref237'); return false;" href="javascript:void(0);" class="ref ref237">(237)</a> and saxagliptin (<b>79</b>),<a onclick="showRef(event, 'ref238'); return false;" href="javascript:void(0);" class="ref ref238">(238)</a> discovered by building on the substrate-derived Gly-Pro dipeptide scaffold, represent the peptidomimetic reversible covalent inhibitors. The cyanopyrrolidine moieties bind to the S1 subsite, forming a covalent bond between the nitrile group and Ser630, and the hydroxy adamantyl groups bind to the S2 subsite. While they bind in a similar mode, saxagliptin has activity fivefold higher than that of vildagliptin, which is attributed to the cyclopropanated cyanopyrrolidine of saxagliptin. Introduction of the cyclopropane moiety to enhance chemical stability of the cyanopyrrolidine afforded an additional hydrophobic interaction in the S1 pocket.<a onclick="showRef(event, 'ref239'); return false;" href="javascript:void(0);" class="ref ref239">(239)</a> Saxagliptin has been shown to be effective and generally well tolerated and improve Î²-cell function in latent autoimmune diabetes in adults, a form of autoimmune diabetes caused primarily by autoimmune destruction of Î²-cells that has a later onset and slower progression toward absolute insulin dependency than type 1 diabetes.<a onclick="showRef(event, 'ref240'); return false;" href="javascript:void(0);" class="ref ref240">(240)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of selected DPP 4 inhibitors. Electrophilic warheads are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Many of the DPP4 inhibitors used in earlier studies have been found to be nonspecific, inhibiting more than one DPP family member such as DPP2, DPP8, DPP9, FAP, and/or prolyl PREP because of their structural homology and similarities in substrate specificity. Dipeptide boronic acids Xaa-boroPro or Xaa-boroAla are potent DPP4 inhibitors, having <i>K</i><sub>i</sub> values in the picomolar range.<a onclick="showRef(event, 'ref241'); return false;" href="javascript:void(0);" class="ref ref241">(241)</a> Val-boroPro (also called PT-100 and talabostat, <b>80</b>), which inhibits DPP4 as well as DPP7, DPP8/9, and FAP,<a onclick="showRef(event, 'ref242 ref243'); return false;" href="javascript:void(0);" class="ref ref242 ref243">(242,243)</a> has been in phase 3 clinical trials for cancer.<a onclick="showRef(event, 'ref244 ref245'); return false;" href="javascript:void(0);" class="ref ref244 ref245">(244,245)</a> The ability of Val-boroPro to induce substantial tumor regressions in syngeneic mouse tumor models has been demonstrated to be immune mediated because the efficacy of Val-boroPro was found to be attenuated in lymphocyte-deficient mice.<a onclick="showRef(event, 'ref246'); return false;" href="javascript:void(0);" class="ref ref246">(246)</a> It stimulates transcriptional upregulation of several immunomodulatory cytokines, including IL-1Î², IL-6, G-CSF, and CXCL1, in both tumors and tumor-draining lymph nodes and increases serum levels of several cytokines, including G-CSF and CXCL1.<a onclick="showRef(event, 'ref247'); return false;" href="javascript:void(0);" class="ref ref247">(247)</a> However, CD26/DPP4 appeared not to be involved in the antitumor activity of Val-boroPro since the antitumor activity was unchanged in CD26<sup>â</sup>/<sup>â</sup> mice. Recently, the Bachovchin group discovered that inhibition of DPP8 and DPP9 by Val-boroPro activates the inflammasome sensor protein NLRP1b in murine macrophages, which in turn activates procaspase-1 to mediate pyroptosis, suggesting that DPP8/9 serve as a checkpoint to restrain NLRP1b and the innate immune system.<a onclick="showRef(event, 'ref248 ref249'); return false;" href="javascript:void(0);" class="ref ref248 ref249">(248,249)</a> Furthermore, it has been shown that Val-boroPro is cytotoxic to human acute myeloid leukemia (AML) cells. The CARD-containing protein CARD8, an NLRP1 homologue, has been shown to mediate DPP8/9 inhibitor-induced procaspase-1-dependent pyroptosis in human myeloid cells.<a onclick="showRef(event, 'ref250'); return false;" href="javascript:void(0);" class="ref ref250">(250)</a></div></div><div id="sec13" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Immunoproteasome</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41144" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41144" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In most cells, the constitutive proteasome (CP), which is part of the ubiquitin-proteasome system (UPS), is responsible for degradation of damaged or misfolded intracellular proteins tagged with ubiquitin and plays a critical role in maintaining protein homeostasis and regulating a variety of cellular processes. The proteasome is a barrel-shaped protein complex composed of a 20S core made up of four heptameric rings consisting of Î± and Î² subunits with 19S caps on either end of the core. The 19S regulatory subunit recognizes the ubiquitinylated proteins and shuttles them into the 20S core, where they are degraded into smaller peptides. The proteolytic activity of the proteasome is mediated by the Î²1, Î²2, and Î²5 catalytic subunits. Immune cells express an isoform of proteasome containing three distinct catalytic subunits, LMP2 (low-molecular mass polypeptide-2, Î²1i), MECL-1 (multicatalytic endopeptidase complex-like 1, Î²2i), and LMP7 (Î²5i). The immunoproteasome (IP) is also expressed in most nonimmune cells in response to a viral infection or after exposure to immunomodulatory cytokines such as IFN-Î³ and TNF-Î±.<a onclick="showRef(event, 'ref251 ref252 ref253'); return false;" href="javascript:void(0);" class="ref ref251 ref252 ref253">(251â253)</a> The immunoproteasome plays an important role in antigen processing and presentation, cytokine production, and T cell differentiation. The immunoproteasome is assembled faster than the constitutive proteasomes and has a shorter lifespan, which indicates that the production and degradation of the immunoproteasome facilitate a dynamic turnover, allowing the rapid response to immune stressors and subsequent return to baseline levels after decline of the inflammatory challenge.<a onclick="showRef(event, 'ref254'); return false;" href="javascript:void(0);" class="ref ref254">(254)</a> The catalytic subunits of the immunoproteasome exhibit differential cleavage preferences and efficiencies to help diversify the antigenic peptide repertoire.<a onclick="showRef(event, 'ref255 ref256'); return false;" href="javascript:void(0);" class="ref ref255 ref256">(255,256)</a> Unlike standard Î²1 with caspase-like activity, the Î²1i has chymotrypsin-like activity that is capable of cleaving after hydrophobic amino acids. As a result, the immunoproteasome can produce more antigenic peptides with hydrophobic C-termini that can be processed to fit in the groove of MHC class I molecules to activate CD8<sup>+</sup> T lymphocytes. The immunoproteasome can also degrade misfolded or damaged proteins formed as a result of oxidative stress or cytokine-stimulated protein synthesis.<a onclick="showRef(event, 'ref257 ref258'); return false;" href="javascript:void(0);" class="ref ref257 ref258">(257,258)</a></div><div class="NLM_p">Given the role of inflammatory cytokines in the formation of the immunoproteasome, the functions of the immunoproteasome have been extensively investigated in the context of inflammatory and autoimmune diseases. Elevated levels of immunoproteasome have been associated with a number of diseases, including ulcerative colitis, Crohnâs disease, IBD, and hepatitis. Immunoproteasome upregulation has been linked to changes in the proteasomal activity observed in a mouse model of experimental autoimmune encephalomyelitis (EAE) and in clinical samples of multiple sclerosis patients.<a onclick="showRef(event, 'ref259'); return false;" href="javascript:void(0);" class="ref ref259">(259)</a> The detection of immunoproteasomes in certain cancers and neurodegenerative diseases suggests its involvement in modulating the disease states. Encouraged by the success of FDA-approved proteasome inhibitors (bortezomib and carfilzomib), developing immunoproteasome-specific inhibitors has received growing interest from researchers. The Overkleeft group developed a cocktail of activity-based probes (<b>81</b>, <b>82</b>, and <b>83</b>) that allows for simultaneous detection of all six catalytic human proteasome subunits (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>A).<a onclick="showRef(event, 'ref260'); return false;" href="javascript:void(0);" class="ref ref260">(260)</a> In addition to its utility in assessing active-site specificity of proteasome inhibitors, the probes further demonstrated that many hematologic malignancies predominantly express immunoproteasomes.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. (A) The proteasome 20S core particle. The expression and assembly of the immunoproteasome is induced in response to a viral infection or after exposure to immunomodulatory cytokines. A cocktail of activity-based probes (structures shown) enables simultaneous gel-based detection of all six catalytic human proteasome subunits and can be used to assess the specificity of inhibitors (I1 or I2). (B) Structures of selected immunoproteasome inhibitors. Electrophilic warheads are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Crystal structures of murine proteasomes revealed key structural differences between the catalytic subunits of CP and IP and provided significant insights that help design specific inhibitors of immunoproteasome.<a onclick="showRef(event, 'ref261 ref262'); return false;" href="javascript:void(0);" class="ref ref261 ref262">(261,262)</a> For example, bulky hydrophobic residues (Tyr, Trp, Phe) are well fit into the larger Î²5i S1 pocket whereas the S1 pocket of Î²5c only accommodates small amino acids (Ala or Val). The substitutions such as T20 V, T31F, R45L and T52A in the Î²1i S1 pocket were found to increase the hydrophobicity but reduce its dimension preferentially accommodating small hydrophobic residues. The substitutions T22A and A27 V in the Î²1i S3 subsite resulted also in a smaller pocket.</div><div class="NLM_p">Epoxyketone is the most commonly used warhead in proteasome inhibitors because of its high selectivity toward the N-terminal threonine residue. ONX-0914 (also called PR-957, <b>89</b>, <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>B), the first epoxyketone-based peptidyl immunoproteasome-selective inhibitor reported, showed 20-fold selectivity for the Î²5i over Î²5.<a onclick="showRef(event, 'ref263'); return false;" href="javascript:void(0);" class="ref ref263">(263)</a> ONX-0914 inhibited the production of IL-23, TNF-Î±, and IL-6 and offered significant therapeutic benefits in a mouse model of rheumatoid arthritis, reducing circulating autoantibodies. However, ONX-0914 suffers from poor solubility. The P1 substitution with a cyclopentene ring and the addition of a hydroxyl group to the Î² position of the P2 methyltyrosine increased solubility while maintaining selectivity for Î²5i. KZR-616 (<b>90</b>) exhibited overall improved activities toward all subunits of the immunoproteasome.<a onclick="showRef(event, 'ref264'); return false;" href="javascript:void(0);" class="ref ref264">(264)</a> Studies have shown that simultaneous inhibition of at least two catalytic subunits of immunoproteasome (Î²5i/Î²2i or Î²5i/Î²1i) is required for the inhibition of cytokine expression. With a good profile of in vivo potency, KZR-616 is currently in phase 1b/2 clinical trials as the first immunoproteasome inhibitor for systemic lupus erythematosus (SLE).<a onclick="showRef(event, 'ref265'); return false;" href="javascript:void(0);" class="ref ref265">(265)</a> With the dipeptide epoxyketone scaffold, selectivity for the Î²1i was achieved by introducing the motif that binds well within the S3 pocket. A selective Î²1i inhibitor KZR-504 (<b>85</b>) showed significantly improved in vivo stability.<a onclick="showRef(event, 'ref266'); return false;" href="javascript:void(0);" class="ref ref266">(266)</a></div><div class="NLM_p">UK-101 (<b>84</b>) was originated from the natural products epoxomicin and eponemycin.<a onclick="showRef(event, 'ref267'); return false;" href="javascript:void(0);" class="ref ref267">(267)</a> Compared with epoxomicin, eponemycin preferentially inactivates the immuno-subunits over the constitutive proteasome. While keeping the N-terminal hydrophobic tail and C-terminal hydroxyl group of eponemycin, alanine was identified most promising in the P2 position.<a onclick="showRef(event, 'ref268'); return false;" href="javascript:void(0);" class="ref ref268">(268)</a> UK-101 that contains a hydrophobic heptanoic tail at the N-terminus and a <i>tert</i>-butyldimethylsilyl (TBDMS) ether group at the C-terminus covalently modifies and inhibits the Î²1i. UK-101 induced cell death in prostate cancer cells and suppressed in vivo tumor growth in a mouse xenograft model of human prostate cancer.<a onclick="showRef(event, 'ref269'); return false;" href="javascript:void(0);" class="ref ref269">(269)</a> A peptide aldehyde inhibitor, IPSI-001 (Z-L-Nle-CHO, <b>86</b>), was found to have >100-fold selectivity for the Î²1i over the Î²1. When used in multiple myeloma cells resistant to bortezomib, IPSI-001 resulted in accumulation of proapoptotic proteins and led to caspase-mediated apoptosis.<a onclick="showRef(event, 'ref270'); return false;" href="javascript:void(0);" class="ref ref270">(270)</a> ML604440 (<b>87</b>), a boronate dipeptide, is a potent and specific inhibitor of the Î²1i.<a onclick="showRef(event, 'ref271'); return false;" href="javascript:void(0);" class="ref ref271">(271)</a></div><div class="NLM_p">A sulfonyl fluoride warhead was introduced to the peptide sequences identified optimal for the inhibition of immunoproteasome subunits.<a onclick="showRef(event, 'ref272'); return false;" href="javascript:void(0);" class="ref ref272">(272)</a> The sulfonyl fluoride induces irreversible deactivation of the proteasome through polarity inversion and intramolecular cross-linking between Thr1 and Lys33, providing a novel mechanism of proteasome inhibition.<a onclick="showRef(event, 'ref273'); return false;" href="javascript:void(0);" class="ref ref273">(273)</a> The PSF compound 3 (<b>91</b>), which features the extended peptide backbone of ONX-0914 by adding a homophenylalanine residue at the P4 site, showed improved selectivity for the Î²5i subunit.</div><div class="NLM_p last">Recently, structure-guided virtual screening discovered nonpeptidic and reversible inhibitors of immunoproteasomes.<a onclick="showRef(event, 'ref274 ref275'); return false;" href="javascript:void(0);" class="ref ref274 ref275">(274,275)</a> To further refine the potency, various electrophilic warheads were introduced to the initially identified reversible binders. Among them, the oxathiazolone warhead-bearing compound (<b>93</b>) offered selective Thr1 modification of the Î²5i.</div></div><div id="sec14" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Perspectives and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55350" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55350" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chemical developments have long been instrumental in studying the immune system. Recent advances in chemical proteomics have further facilitated the annotation of function to poorly characterized proteins in immune cell signaling pathways and provided insights into creating molecules that could address immunological problems. Particularly, small molecules that modulate immune responses by altering protein activity through covalent modification represent an important class of agents. In this Review, we focused our discussion on the development of covalent ligands that target protease active site and highlighted their applications in activity-based protein profiling, imaging probe development, and inhibitor design. Being essential players in immunology, proteases are considered suitable immunomodulatory targets. By reviewing compounds reported, we have identified exciting opportunities for protease inhibitors as chemical immunomodulators and laid out general strategies that can guide the development of potent and selective probes.</div><div class="NLM_p">Proteases within the same subfamily share similar substrate and inhibitor specificities; thus, achieving target specificity has been the main challenge in developing small molecule protease inhibitors. Recent progress made in solid-phase peptide chemistry, combinatorial library synthesis, and chemical strategies incorporating unnatural amino acids, cyclic scaffolds, or nonpeptidic fragments into the recognition element has increased the structural diversity and enabled the design of selective protease inhibitors. To further diversify small molecule scaffolds, robust chemical methods that mitigate the number of synthetic steps as well as the need for chromatographic purification are highly desirable. For example, modular click chemistries such as azideâalkyne cycloaddition and SuFEx reaction rapidly generate a library of compounds that can be directly screened in vitro. Additionally, computational screening can quickly identify nonpeptic scaffolds and accelerate the drug design process when used appropriately. The development of covalent docking methods combining features of noncovalent binding interaction and covalent bond formation has demonstrated broad utility for screening large virtual libraries of electrophilic small molecules.<a onclick="showRef(event, 'ref276'); return false;" href="javascript:void(0);" class="ref ref276">(276)</a> Docking protocols that can provide accurate and reliable predictions on how a molecular scaffold orients the electrophile in the active site will help make informed decisions while minimizing the number of compounds that need to be synthesized. Alternatively, approaches targeting the pro-forms of protease, locking the inactive conformation of the enzymes or exploring the primed side of substrates, might offer future opportunities to identify more potent and selective compounds.</div><div class="NLM_p">Once a recognition motif has been successfully optimized, careful consideration needs to be taken when choosing the electrophile because highly reactive electrophiles can negate the target specificity gained by the scaffold. Several recent studies have reported comprehensive examinations of intrinsic reactivity and promiscuity of various electrophiles,<a onclick="showRef(event, 'ref277 ref278'); return false;" href="javascript:void(0);" class="ref ref277 ref278">(277,278)</a> which provide a basic guideline that can be applied to the covalent compound design. Covalent inhibitors using quiescent or latent electrophiles such as 4-halopyridine and terminal alkyne, or reversible electrophiles such as Î±-ketoamide, Î±-cyanoacrylamide, and boronic acid have attracted particular attention in the field of protease inhibition. The nature of the reactive warhead contributes not only to reactivity and selectivity but also to metabolic stability and tissue distribution of the covalent ligands. There is still a high demand for novel warheads. As proven successful in the past (e.g., cathepsin and proteasome inhibitors), looking for molecules from natural sources will help discover new chemical entities and inspire researchers to come up with new chemistry. Reactivity-guided isolation for electrophilic natural products utilizing the inherent reactivity of a metabolite complements traditional bioactivity-guided isolation and physicochemical property-guided fractionation and offers a promising approach for the development of screening libraries.<a onclick="showRef(event, 'ref279'); return false;" href="javascript:void(0);" class="ref ref279">(279)</a> For metalloproteases and aspartyl proteases that use water as a nucleophile to hydrolyze peptide bonds, photochemical methods have been successfully used to form a covalent bond between the compound and the enzyme.</div><div class="NLM_p">Another major challenge in the development of protease inhibitors is obtaining a clear understanding of how proteases carry out their biological functions and validating them carefully as drug targets. This is extremely difficult because a single protease can have multiple functions, and multiple proteases can also work together to achieve the same goal. A further complication arises because of the high complexity of protease regulation. Activity-based probes have proven to be powerful chemical tools to assess and visualize the activity and localization of proteases in living cells, whole organisms, or in vivo. Use of a cocktail of probes that are differently labeled or a multivariate probe that requires the processing by multiple enzymes allows for parallel measurement of multiple protease activities in complex multifactorial diseases. Performing assays in a biological context, when coupled with effective tools, has the potential to provide more accurate information about potency, selectivity, efficacy, and toxicity of the inhibitor.</div><div class="NLM_p last">As typically flagged as structural alerts, covalent ligands have been rarely screened in HTS. However, high-throughput phenotypic screenings of mild electrophile fragments in combination with chemical proteomic methods will mitigate concerns about the in vivo promiscuity and idiosyncratic toxicity of covalent compounds. Although it remains highly challenging, development of high-throughput phenotypic screening and multiplex assay that recapitulate the complex immune response network will accelerate the discovery of small molecule immunomodulators with favorable pharmacological properties. Overall, we believe that the advent of new chemical tools and proteomic approaches that enable global protein profiling will bring synergies to the development of protease inhibitors within the field of chemical immunology.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00172" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27464" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27464" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Euna Yoo</span> - <span class="hlFld-Affiliation affiliation">Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5982-1979" title="Orcid link">http://orcid.org/0000-0001-5982-1979</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3451415a551a4d5b5b745a5d5c1a535b42"><span class="__cf_email__" data-cfemail="7613031817580f191936181f1e58111900">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong-Rae Kim</span> - <span class="hlFld-Affiliation affiliation">Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ravichandra Tagirasa</span> - <span class="hlFld-Affiliation affiliation">Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71517" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71517" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Hong-Rae Kim</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=BIO-d7e2743-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Hong-Rae Kim</b> received his Bachelorâs degree in chemistry from the University of Washington, Seattle and completed his Ph.D. in medicinal chemistry where he studied modified nucleosides at Seoul National University, Republic of Korea under the supervision of Professor Lak Shin Jeong. He joined the Yoo group as a postdoctoral fellow at the National Cancer Institute at Frederick, National Institutes of Health in 2020. He is currently conducting research on developing novel small molecules to investigate diverse biological processes in the human immune system.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Ravichandra Tagirasa</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=BIO-d7e2748-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ravichandra Tagirasa</b> received his Masterâs degree in Medical Biochemistry from the Jawaharlal Institute of Postgraduate Medical Education & Research, India. He then completed his Ph.D. in Immunology from the Institute of Life Sciences, Bhubaneswar, India under the supervision of Dr. Satish Devadas. During his Ph.D, he studied the role of TNF-Î± and GM-CSF in T helper cell activation, differentiation, and apoptosis. Currently, he is working as a visiting fellow (postdoc) in the laboratory of Dr. Euna Yoo at the National Cancer Institute, Frederick. He is using small molecule probes to decipher the mechanisms of activation, differentiation, and cytotoxic function of human T cells.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Euna Yoo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=BIO-d7e2753-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Euna Yoo</b> received a Ph.D. from the Department of Medicinal Chemistry, University of Kansas under the mentorship of Professor Sunil David in 2015. During her graduate studies, she performed research on the synthesis and biological evaluation of Toll-like receptor agonists as potential vaccine adjuvants. She then joined the laboratory of Professor Matthew Bogyo at Stanford University as a postdoctoral fellow. Her research focused on the development of activity-based probes and covalent inhibitors to study the functional roles of proteases. In 2019, she started working as a Stadtman Tenure Track Investigator at the Chemical Biology Laboratory, National Cancer Institute at Frederick, National Institutes of Health.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the Intramural Research Program of the NIH, National Cancer Institute, The Center for Cancer Research (ZIA BC011961).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ABC-DLBCL</td><td class="NLM_def"><p class="first last">activated B cell-like DLBCL</p></td></tr><tr><td class="NLM_term">ABP</td><td class="NLM_def"><p class="first last">activity-based probes</p></td></tr><tr><td class="NLM_term">ABPP</td><td class="NLM_def"><p class="first last">activity-based protein profiling</p></td></tr><tr><td class="NLM_term">AEP</td><td class="NLM_def"><p class="first last">asparaginyl endopeptidase</p></td></tr><tr><td class="NLM_term">ALPS</td><td class="NLM_def"><p class="first last">autoimmune lymphoproliferative syndrome</p></td></tr><tr><td class="NLM_term">AMC</td><td class="NLM_def"><p class="first last">7-amino-4-methylcoumarin</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">AOMK</td><td class="NLM_def"><p class="first last">acyloxymethyl ketone</p></td></tr><tr><td class="NLM_term">ASC</td><td class="NLM_def"><p class="first last">apoptosis-associated speck-like protein containing a CARD</p></td></tr><tr><td class="NLM_term">BODIPY</td><td class="NLM_def"><p class="first last">boron-dipyrromethene</p></td></tr><tr><td class="NLM_term">Bzl</td><td class="NLM_def"><p class="first last">benzoyl</p></td></tr><tr><td class="NLM_term">CAR</td><td class="NLM_def"><p class="first last">chimeric antigen receptor</p></td></tr><tr><td class="NLM_term">CARD</td><td class="NLM_def"><p class="first last">C-terminal caspase-recruitment domain</p></td></tr><tr><td class="NLM_term">CatG</td><td class="NLM_def"><p class="first last">cathepsin G</p></td></tr><tr><td class="NLM_term">CBM</td><td class="NLM_def"><p class="first last">CARD11-BCL10-MALT1</p></td></tr><tr><td class="NLM_term">CD</td><td class="NLM_def"><p class="first last">cluster of differentiation</p></td></tr><tr><td class="NLM_term">CMK</td><td class="NLM_def"><p class="first last">chloromethylketone</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">CP</td><td class="NLM_def"><p class="first last">constitutive proteasome</p></td></tr><tr><td class="NLM_term">CTL</td><td class="NLM_def"><p class="first last">cytotoxic T-lymphocyte</p></td></tr><tr><td class="NLM_term">CTLA</td><td class="NLM_def"><p class="first last">cytotoxic T-lymphocyte-associated protein</p></td></tr><tr><td class="NLM_term">CyTOF</td><td class="NLM_def"><p class="first last">cytometry by time-of-flight</p></td></tr><tr><td class="NLM_term">DC</td><td class="NLM_def"><p class="first last">dendritic cell</p></td></tr><tr><td class="NLM_term">DLBCL</td><td class="NLM_def"><p class="first last">diffuse large B cell lymphoma</p></td></tr><tr><td class="NLM_term">DNA</td><td class="NLM_def"><p class="first last">deoxyribonucleic acid</p></td></tr><tr><td class="NLM_term">DPP</td><td class="NLM_def"><p class="first last">diphenyl phosphate</p></td></tr><tr><td class="NLM_term">DPP</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase</p></td></tr><tr><td class="NLM_term">DUB</td><td class="NLM_def"><p class="first last">deubiquitinase</p></td></tr><tr><td class="NLM_term">EAE</td><td class="NLM_def"><p class="first last">experimental autoimmune encephalomyelitis</p></td></tr><tr><td class="NLM_term">ECM</td><td class="NLM_def"><p class="first last">extracellular matrix</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-function regulated kinase</p></td></tr><tr><td class="NLM_term">FAM</td><td class="NLM_def"><p class="first last">5(6)-carboxyfluorescein</p></td></tr><tr><td class="NLM_term">FAP</td><td class="NLM_def"><p class="first last">fibroblast activating protein</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">FMK</td><td class="NLM_def"><p class="first last">fluoromethyl ketone</p></td></tr><tr><td class="NLM_term">G-CSF</td><td class="NLM_def"><p class="first last">granulocyte colony-stimulating factor</p></td></tr><tr><td class="NLM_term">GIP</td><td class="NLM_def"><p class="first last">gastric inhibitory protein</p></td></tr><tr><td class="NLM_term">GM-CSF</td><td class="NLM_def"><p class="first last">granulocyte-macrophage colony-stimulating factor</p></td></tr><tr><td class="NLM_term">Gzm</td><td class="NLM_def"><p class="first last">granzyme</p></td></tr><tr><td class="NLM_term">GSDM</td><td class="NLM_def"><p class="first last">gasdermin</p></td></tr><tr><td class="NLM_term">GVHD</td><td class="NLM_def"><p class="first last">graft-versus-host disease</p></td></tr><tr><td class="NLM_term">HA</td><td class="NLM_def"><p class="first last">human influenza hemagglutinin</p></td></tr><tr><td class="NLM_term">HECT</td><td class="NLM_def"><p class="first last">homologous to the E6-AP carboxy terminus</p></td></tr><tr><td class="NLM_term">HNE</td><td class="NLM_def"><p class="first last">human neutrophil elastase</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">HyCoSuL</td><td class="NLM_def"><p class="first last">hybrid combinatorial substrate library</p></td></tr><tr><td class="NLM_term">IBD</td><td class="NLM_def"><p class="first last">inflammatory bowel disease</p></td></tr><tr><td class="NLM_term">IFN</td><td class="NLM_def"><p class="first last">interferon</p></td></tr><tr><td class="NLM_term">IKK</td><td class="NLM_def"><p class="first last">IÎºB kinase</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">immunoproteasome</p></td></tr><tr><td class="NLM_term">IQF</td><td class="NLM_def"><p class="first last">internally quenched fluorescence</p></td></tr><tr><td class="NLM_term">isoTOP</td><td class="NLM_def"><p class="first last">isotopic tandem orthogonal proteolysis</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">JAMM</td><td class="NLM_def"><p class="first last">JAB1/MPN/Mov34 metalloenzyme</p></td></tr><tr><td class="NLM_term">KE</td><td class="NLM_def"><p class="first last">ketoester</p></td></tr><tr><td class="NLM_term">LC-MS</td><td class="NLM_def"><p class="first last">liquid chromatography mass spectrometry</p></td></tr><tr><td class="NLM_term">LMP</td><td class="NLM_def"><p class="first last">low-molecular mass polypeptide</p></td></tr><tr><td class="NLM_term">MALT1</td><td class="NLM_def"><p class="first last">mucosa-associated lymphoid tissue lymphoma translocation 1</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">MBP</td><td class="NLM_def"><p class="first last">myelin basic protein</p></td></tr><tr><td class="NLM_term">Mcl1</td><td class="NLM_def"><p class="first last">myeloid leukemia cell differentiation protein 1</p></td></tr><tr><td class="NLM_term">MECL</td><td class="NLM_def"><p class="first last">multicatalytic endopeptidase complex-like</p></td></tr><tr><td class="NLM_term">MERS-CoV</td><td class="NLM_def"><p class="first last">Middle East respiratory syndrome coronavirus</p></td></tr><tr><td class="NLM_term">MHC</td><td class="NLM_def"><p class="first last">major histocompatibility complex</p></td></tr><tr><td class="NLM_term">MINDY</td><td class="NLM_def"><p class="first last">motif interacting with Ub-containing novel DUB</p></td></tr><tr><td class="NLM_term">MJD</td><td class="NLM_def"><p class="first last">MachadoâJoseph disease</p></td></tr><tr><td class="NLM_term">mRNA</td><td class="NLM_def"><p class="first last">messenger ribonucleic acid</p></td></tr><tr><td class="NLM_term">MSP</td><td class="NLM_def"><p class="first last">multiplex substrate profiling</p></td></tr><tr><td class="NLM_term">MudPIT</td><td class="NLM_def"><p class="first last">multidimensional protein identification technology</p></td></tr><tr><td class="NLM_term">NE</td><td class="NLM_def"><p class="first last">neutrophil elastase</p></td></tr><tr><td class="NLM_term">NF</td><td class="NLM_def"><p class="first last">nuclear factor</p></td></tr><tr><td class="NLM_term">NIK</td><td class="NLM_def"><p class="first last">necrosis factor-ÎºB-inducing kinase</p></td></tr><tr><td class="NLM_term">NK</td><td class="NLM_def"><p class="first last">natural killer</p></td></tr><tr><td class="NLM_term">NLR</td><td class="NLM_def"><p class="first last">nucleotide-binding oligomerization domain-like receptor</p></td></tr><tr><td class="NLM_term">NLRP3</td><td class="NLM_def"><p class="first last">NLR family pyrin domain containing 3</p></td></tr><tr><td class="NLM_term">NSP</td><td class="NLM_def"><p class="first last">neutrophil serine protease</p></td></tr><tr><td class="NLM_term">OSCC</td><td class="NLM_def"><p class="first last">oral squamous cell carcinoma</p></td></tr><tr><td class="NLM_term">PAR</td><td class="NLM_def"><p class="first last">protease-activated receptor</p></td></tr><tr><td class="NLM_term">PD-1</td><td class="NLM_def"><p class="first last">programmed cell death protein 1</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">PMA</td><td class="NLM_def"><p class="first last">phorbol 12-myristate 13-acetate</p></td></tr><tr><td class="NLM_term">PMBC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">PMK</td><td class="NLM_def"><p class="first last">phenoxymethyl ketone</p></td></tr><tr><td class="NLM_term">PR3</td><td class="NLM_def"><p class="first last">proteinase 3</p></td></tr><tr><td class="NLM_term">PREP</td><td class="NLM_def"><p class="first last">prolyl endopeptidase</p></td></tr><tr><td class="NLM_term">PSF</td><td class="NLM_def"><p class="first last">peptido sulfonyl fluoride</p></td></tr><tr><td class="NLM_term">PS-SCL</td><td class="NLM_def"><p class="first last">positional scanning substrate combinatorial library</p></td></tr><tr><td class="NLM_term">PTEN</td><td class="NLM_def"><p class="first last">phosphatase and tensin homologue</p></td></tr><tr><td class="NLM_term">qABP</td><td class="NLM_def"><p class="first last">fluorescently quenched activity-based probes</p></td></tr><tr><td class="NLM_term">RORÎ³t</td><td class="NLM_def"><p class="first last">retinoid-related orphan receptor-Î³t</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structureâactivity relationship</p></td></tr><tr><td class="NLM_term">SARS-CoV</td><td class="NLM_def"><p class="first last">severe acute respiratory syndrome coronavirus</p></td></tr><tr><td class="NLM_term">SAS</td><td class="NLM_def"><p class="first last">substrate activity screening</p></td></tr><tr><td class="NLM_term">SDS-PAGE</td><td class="NLM_def"><p class="first last">sodium dodecyl sulfate polyacrylamide gel electrophoresis</p></td></tr><tr><td class="NLM_term">SLE</td><td class="NLM_def"><p class="first last">systemic lupus erythematosus</p></td></tr><tr><td class="NLM_term">SPD-NGS</td><td class="NLM_def"><p class="first last">substrate phage display coupled with next generation sequencing</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">transducer and activator of transcription</p></td></tr><tr><td class="NLM_term">STS</td><td class="NLM_def"><p class="first last">staurosporine</p></td></tr><tr><td class="NLM_term">SuFEx</td><td class="NLM_def"><p class="first last">sulfur fluoride exchange</p></td></tr><tr><td class="NLM_term">TAM</td><td class="NLM_def"><p class="first last">tumor-associated macrophage</p></td></tr><tr><td class="NLM_term">TBDMS</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl</p></td></tr><tr><td class="NLM_term">TCR</td><td class="NLM_def"><p class="first last">T cell receptor</p></td></tr><tr><td class="NLM_term">TGF</td><td class="NLM_def"><p class="first last">transforming growth factor</p></td></tr><tr><td class="NLM_term">TLR</td><td class="NLM_def"><p class="first last">toll-like receptor</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">TNFAIP3</td><td class="NLM_def"><p class="first last">tumor necrosis factor alpha-induced protein 3</p></td></tr><tr><td class="NLM_term">TOF</td><td class="NLM_def"><p class="first last">time-of-flight</p></td></tr><tr><td class="NLM_term">TRAF</td><td class="NLM_def"><p class="first last">tumor necrosis factor receptor-associated factor</p></td></tr><tr><td class="NLM_term">TRAIL</td><td class="NLM_def"><p class="first last">tumor necrosis factor-related apoptosis-inducing ligand</p></td></tr><tr><td class="NLM_term">Treg</td><td class="NLM_def"><p class="first last">regulatory T cell</p></td></tr><tr><td class="NLM_term">TTCF</td><td class="NLM_def"><p class="first last">tetanus toxin C-terminal fragment</p></td></tr><tr><td class="NLM_term">Ub</td><td class="NLM_def"><p class="first last">ubiquitin</p></td></tr><tr><td class="NLM_term">Ubal</td><td class="NLM_def"><p class="first last">ubiquitin aldehyde</p></td></tr><tr><td class="NLM_term">Ub-PA</td><td class="NLM_def"><p class="first last">ubiquitin propargyl amide</p></td></tr><tr><td class="NLM_term">Ub-VME</td><td class="NLM_def"><p class="first last">ubiquitin vinylmethyl ester</p></td></tr><tr><td class="NLM_term">Ub-VS</td><td class="NLM_def"><p class="first last">ubiquitin vinylmethyl sulfone</p></td></tr><tr><td class="NLM_term">UCH</td><td class="NLM_def"><p class="first last">ubiquitin C-terminal hydrolase</p></td></tr><tr><td class="NLM_term">UPS</td><td class="NLM_def"><p class="first last">ubiquitin-proteasome system</p></td></tr><tr><td class="NLM_term">USP</td><td class="NLM_def"><p class="first last">ubiquitin-specific protease</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22566" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22566" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 279 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Kasteren, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neefjes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovaa, H.</span></span> <span> </span><span class="NLM_article-title">Creating molecules that modulate immune responses</span>. <i>Nat. Rev. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">184</span>â <span class="NLM_lpage">193</span>, <span class="refDoi">Â DOI: 10.1038/s41570-018-0023-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41570-018-0023-9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2018&pages=184-193&issue=8&author=S.+I.+van%0AKasterenauthor=J.+Neefjesauthor=H.+Ovaa&title=Creating+molecules+that+modulate+immune+responses&doi=10.1038%2Fs41570-018-0023-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fs41570-018-0023-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41570-018-0023-9%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BKasteren%26aufirst%3DS.%2BI.%26aulast%3DNeefjes%26aufirst%3DJ.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DCreating%2520molecules%2520that%2520modulate%2520immune%2520responses%26jtitle%3DNat.%2520Rev.%2520Chem.%26date%3D2018%26volume%3D2%26issue%3D8%26spage%3D184%26epage%3D193%26doi%3D10.1038%2Fs41570-018-0023-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borel, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gubler, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">StÃ¤helin, H.</span></span> <span> </span><span class="NLM_article-title">Biological effects of cyclosporin A: A new antilymphocytic agent</span>. <i>Agents Actions</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">468</span>â <span class="NLM_lpage">475</span>, <span class="refDoi">Â DOI: 10.1007/BF01973261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1007%2FBF01973261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaE28XltFKltrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1976&pages=468-475&issue=4&author=J.+F.+Borelauthor=C.+Feurerauthor=H.+U.+Gublerauthor=H.+St%C3%A4helin&title=Biological+effects+of+cyclosporin+A%3A+A+new+antilymphocytic+agent&doi=10.1007%2FBF01973261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Biological effects of cyclosporin A:  a new antilymphocytic agent</span></div><div class="casAuthors">Borel, J. F.; Feurer, Camille; Gubler, H. U.; Staehelin, H.</div><div class="citationInfo"><span class="NLM_cas:title">Agents and Actions</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">468-75</span>CODEN:
                <span class="NLM_cas:coden">AGACBH</span>;
        ISSN:<span class="NLM_cas:issn">0065-4299</span>.
    </div><div class="casAbstract">Cyclosporin A [59865-13-3] suppressed both humoral and cellular immunity in lab. animals in a reproducible and dose-dependent manner.  Cyclosporin A also exhibited antiphlogistic effects in a chronic, but not in acute inflammatory models.  Its low myelotoxicity indicates that cyclosporin A should undergo clin. investigation as an immunosuppressant and antiinflammatory agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIRcBnCEVYTbVg90H21EOLACvtfcHk0liycHUM61gx7Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltFKltrY%253D&md5=c62e0eb701d4a6321f27c28a926bbbab</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2FBF01973261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01973261%26sid%3Dliteratum%253Aachs%26aulast%3DBorel%26aufirst%3DJ.%2BF.%26aulast%3DFeurer%26aufirst%3DC.%26aulast%3DGubler%26aufirst%3DH.%2BU.%26aulast%3DSt%25C3%25A4helin%26aufirst%3DH.%26atitle%3DBiological%2520effects%2520of%2520cyclosporin%2520A%253A%2520A%2520new%2520antilymphocytic%2520agent%26jtitle%3DAgents%2520Actions%26date%3D1976%26volume%3D6%26issue%3D4%26spage%3D468%26epage%3D475%26doi%3D10.1007%2FBF01973261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. N.</span></span> <span> </span><span class="NLM_article-title">Cyclosporin A, FK506 and rapamycin: more than just immunosuppression</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">334</span>â <span class="NLM_lpage">338</span>, <span class="refDoi">Â DOI: 10.1016/0968-0004(93)90069-Y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2F0968-0004%2893%2990069-Y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=7694398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3sXlvFGjsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1993&pages=334-338&issue=9&author=J.+Kunzauthor=M.+N.+Hall&title=Cyclosporin+A%2C+FK506+and+rapamycin%3A+more+than+just+immunosuppression&doi=10.1016%2F0968-0004%2893%2990069-Y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporin A, FK506 and rapamycin: more than just immunosuppression</span></div><div class="casAuthors">Kunz, Jeannette; Hall, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">334-8</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    </div><div class="casAbstract">A review with 35 refs.  The mechanisms of action of the immunosuppressive drugs cyclosphorin A(CsA), FK506 and rapamycin are strikingly conserved from yeast to human T cells.  Recent results obtained with yeast corroborate calcineurin as the target of CsA-cyclophilin and FK506-FKBP complexes, and reveal a phosphatidylinositol 3-kinase homolog as the target of the rapamycin-FKBP complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro4ILcAHS6mrVg90H21EOLACvtfcHk0livUnE_P8GP0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvFGjsrg%253D&md5=3a97087838b164d58bb654a3defada7f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0968-0004%2893%2990069-Y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0968-0004%252893%252990069-Y%26sid%3Dliteratum%253Aachs%26aulast%3DKunz%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DM.%2BN.%26atitle%3DCyclosporin%2520A%252C%2520FK506%2520and%2520rapamycin%253A%2520more%2520than%2520just%2520immunosuppression%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D1993%26volume%3D18%26issue%3D9%26spage%3D334%26epage%3D338%26doi%3D10.1016%2F0968-0004%2893%2990069-Y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GarcÃ­a-MartÃ­nez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitter, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fucikova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spisek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zitvogel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span> <span> </span><span class="NLM_article-title">Trial Watch: Toll-like receptor agonists in cancer immunotherapy</span>. <i>Oncoimmunology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">12</span>), <span class="NLM_elocation-id">e1526250</span> <span class="refDoi">Â DOI: 10.1080/2162402X.2018.1526250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1080%2F2162402X.2018.1526250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30524908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFWit7fJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&issue=12&author=M.+Smithauthor=E.+Garc%C3%ADa-Mart%C3%ADnezauthor=M.+R.+Pitterauthor=J.+Fucikovaauthor=R.+Spisekauthor=L.+Zitvogelauthor=G.+Kroemerauthor=L.+Galluzzi&title=Trial+Watch%3A+Toll-like+receptor+agonists+in+cancer+immunotherapy&doi=10.1080%2F2162402X.2018.1526250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Trial Watch: Toll-like receptor agonists in cancer immunotherapy</span></div><div class="casAuthors">Smith, Melody; Garcia-Martinez, Elena; Pitter, Michael R.; Fucikova, Jitka; Spisek, Radek; Zitvogel, Laurence; Kroemer, Guido; Galluzzi, Lorenzo</div><div class="citationInfo"><span class="NLM_cas:title">OncoImmunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e1526250/1-e1526250/15</span>CODEN:
                <span class="NLM_cas:coden">ONCOGX</span>;
        ISSN:<span class="NLM_cas:issn">2162-402X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Toll-like receptor (TLR) agonists demonstrate therapeutic promise as immunol. adjuvants for anticancer immunotherapy.  To date, three TLR agonists have been approved by US regulatory agencies for use in cancer patients.  Addnl., the potential of hitherto exptl. TLR ligands to mediate clin. useful immunostimulatory effects has been extensively investigated over the past few years.  Here, we summarize recent preclin. and clin. advances in the development of TLR agonists for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowZcxxOGskNLVg90H21EOLACvtfcHk0livUnE_P8GP0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFWit7fJ&md5=289c71241e9d77fce45ebcac239bd7f8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1080%2F2162402X.2018.1526250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F2162402X.2018.1526250%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Mart%25C3%25ADnez%26aufirst%3DE.%26aulast%3DPitter%26aufirst%3DM.%2BR.%26aulast%3DFucikova%26aufirst%3DJ.%26aulast%3DSpisek%26aufirst%3DR.%26aulast%3DZitvogel%26aufirst%3DL.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DGalluzzi%26aufirst%3DL.%26atitle%3DTrial%2520Watch%253A%2520Toll-like%2520receptor%2520agonists%2520in%2520cancer%2520immunotherapy%26jtitle%3DOncoimmunology%26date%3D2018%26volume%3D7%26issue%3D12%26doi%3D10.1080%2F2162402X.2018.1526250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Page, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postow, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolchok, J. D.</span></span> <span> </span><span class="NLM_article-title">Immune modulation in cancer with antibodies</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">185</span>â <span class="NLM_lpage">202</span>, <span class="refDoi">Â DOI: 10.1146/annurev-med-092012-112807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1146%2Fannurev-med-092012-112807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24188664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktFeltbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2014&pages=185-202&issue=1&author=D.+B.+Pageauthor=M.+A.+Postowauthor=M.+K.+Callahanauthor=J.+P.+Allisonauthor=J.+D.+Wolchok&title=Immune+modulation+in+cancer+with+antibodies&doi=10.1146%2Fannurev-med-092012-112807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Immune modulation in cancer with antibodies</span></div><div class="casAuthors">Page, David B.; Postow, Michael A.; Callahan, Margaret K.; Allison, James P.; Wolchok, Jedd D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">185-202</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Ipilimumab is the prototypical immunomodulatory antibody, approved by the FDA in 2011 for advanced melanoma on the basis of survival benefit.  Since that time, we have made significant strides in optimizing this therapy: we have characterized the spectrum of immune-related adverse events and learned how to mitigate them with treatment algorithms, discovered potential biomarkers of activity, and identified the potential synergy between checkpoint modulation and other therapeutic modalities.  Recent phase I trials have established the efficacy and safety of next-generation checkpoint agents, including PD-1 and PD-L1 inhibitors, across multiple tumor types.  Much work lies ahead in developing these next-generation checkpoint agents, testing them in combination, and detg. how to integrate them into the treatment paradigms of various tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Xa4WySQX9LVg90H21EOLACvtfcHk0livUnE_P8GP0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktFeltbo%253D&md5=3f6332a9af46e4f57fc5e6716678b66b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-092012-112807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-092012-112807%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DD.%2BB.%26aulast%3DPostow%26aufirst%3DM.%2BA.%26aulast%3DCallahan%26aufirst%3DM.%2BK.%26aulast%3DAllison%26aufirst%3DJ.%2BP.%26aulast%3DWolchok%26aufirst%3DJ.%2BD.%26atitle%3DImmune%2520modulation%2520in%2520cancer%2520with%2520antibodies%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2014%26volume%3D65%26issue%3D1%26spage%3D185%26epage%3D202%26doi%3D10.1146%2Fannurev-med-092012-112807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swaika, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, R. W.</span></span> <span> </span><span class="NLM_article-title">Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">4</span>â <span class="NLM_lpage">17</span>, <span class="refDoi">Â DOI: 10.1016/j.molimm.2015.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.molimm.2015.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25749122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVyrsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=4-17&issue=2&author=A.+Swaikaauthor=W.+A.+Hammondauthor=R.+W.+Joseph&title=Current+state+of+anti-PD-L1+and+anti-PD-1+agents+in+cancer+therapy&doi=10.1016%2Fj.molimm.2015.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy</span></div><div class="casAuthors">Swaika, Abhisek; Hammond, William A.; Joseph, Richard W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2_Part_A</span>),
    <span class="NLM_cas:pages">4-17</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Immunotherapy for the treatment of cancer is rapidly evolving from therapies that globally and non-specifically simulate the immune system to more targeted activation of individual components of the immune system.  The net result of this targeted approach is decreased toxicity and increased efficacy of immunotherapy.  More specifically, therapies that inhibit the interaction between programmed death ligand 1 (PD-L1), present on the surface of tumor or antigen-presenting cells, and programmed death 1 (PD-1), present on the surface of activated lymphocytes, are generating much excitement and enthusiasm, even in malignancies that are not traditionally considered to be immunogenic.  Herein, we review the current landscape of anti-PD-1 and anti-PD-L1 therapies in the world of oncol.  We have performed a comprehensive literature search on the data available through PubMed, Medline, Scopus, the ClinicalTrials.gov registry, and abstrs. from major oncol. meetings in order to summarize the clin. data of anti-PD-1/PD-L1 therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUJBYFNoeR57Vg90H21EOLACvtfcHk0lhnRK9dsplrig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVyrsLc%253D&md5=c897e8ecbf612233ad4e07da5979ecc8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2015.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2015.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DSwaika%26aufirst%3DA.%26aulast%3DHammond%26aufirst%3DW.%2BA.%26aulast%3DJoseph%26aufirst%3DR.%2BW.%26atitle%3DCurrent%2520state%2520of%2520anti-PD-L1%2520and%2520anti-PD-1%2520agents%2520in%2520cancer%2520therapy%26jtitle%3DMol.%2520Immunol.%26date%3D2015%26volume%3D67%26issue%3D2%26spage%3D4%26epage%3D17%26doi%3D10.1016%2Fj.molimm.2015.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kershaw, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaney, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcy, P. K.</span></span> <span> </span><span class="NLM_article-title">Clinical application of genetically modified T cells in cancer therapy</span>. <i>Clin. Transl. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">5</span>), <span class="NLM_elocation-id">e16</span> <span class="refDoi">Â DOI: 10.1038/cti.2014.7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fcti.2014.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25505964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFCgsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&issue=5&author=M.+H.+Kershawauthor=J.+A.+Westwoodauthor=C.+Y.+Slaneyauthor=P.+K.+Darcy&title=Clinical+application+of+genetically+modified+T+cells+in+cancer+therapy&doi=10.1038%2Fcti.2014.7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical application of genetically modified T cells in cancer therapy</span></div><div class="casAuthors">Kershaw, Michael H.; Westwood, Jennifer A.; Slaney, Clare Y.; Darcy, Phillip K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Translational Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e16/1-e16/7, 7</span>CODEN:
                <span class="NLM_cas:coden">CTILBR</span>;
        ISSN:<span class="NLM_cas:issn">2050-0068</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">Immunotherapies are emerging as highly promising approaches for the treatment of cancer.  In these approaches, a variety of materials are used to boost immunity against malignant cells.  A key component of many of these approaches is functional tumor-specific T cells, but the existence and activity of sufficient T cells in the immune repertoire is not always the case.  Recent methods of generating tumor-specific T cells include the genetic modification of patient lymphocytes with receptors to endow them with tumor specificity.  These T cells are then expanded in vitro followed by infusion of the patient in adoptive cell transfer protocols.  Genes used to modify T cells include those encoding T-cell receptors and chimeric antigen receptors.  In this review, we provide an introduction to the field of genetic engineering of T cells followed by details of their use against cancer in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmwZH2cpT3-bVg90H21EOLACvtfcHk0lhnRK9dsplrig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFCgsL0%253D&md5=e38076f9672075a18c0cf6734acaaf76</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fcti.2014.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcti.2014.7%26sid%3Dliteratum%253Aachs%26aulast%3DKershaw%26aufirst%3DM.%2BH.%26aulast%3DWestwood%26aufirst%3DJ.%2BA.%26aulast%3DSlaney%26aufirst%3DC.%2BY.%26aulast%3DDarcy%26aufirst%3DP.%2BK.%26atitle%3DClinical%2520application%2520of%2520genetically%2520modified%2520T%2520cells%2520in%2520cancer%2520therapy%26jtitle%3DClin.%2520Transl.%2520Immunol.%26date%3D2014%26volume%3D3%26issue%3D5%26doi%3D10.1038%2Fcti.2014.7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, H. U.</span></span> <span> </span><span class="NLM_article-title">Cathepsins and their involvement in immune responses</span>. <i>Swiss Med. Wkly.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">w13042</span>, <span class="refDoi">Â DOI: 10.4414/smw.2010.13042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4414%2Fsmw.2010.13042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=20648403" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=w13042&author=S.+Conusauthor=H.+U.+Simon&title=Cathepsins+and+their+involvement+in+immune+responses&doi=10.4414%2Fsmw.2010.13042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.4414%2Fsmw.2010.13042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4414%252Fsmw.2010.13042%26sid%3Dliteratum%253Aachs%26aulast%3DConus%26aufirst%3DS.%26aulast%3DSimon%26aufirst%3DH.%2BU.%26atitle%3DCathepsins%2520and%2520their%2520involvement%2520in%2520immune%2520responses%26jtitle%3DSwiss%2520Med.%2520Wkly.%26date%3D2010%26volume%3D140%26spage%3Dw13042%26doi%3D10.4414%2Fsmw.2010.13042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hailfinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebeaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span> <span> </span><span class="NLM_article-title">Adapter and enzymatic functions of proteases in T-cell activation</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>232</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">334</span>â <span class="NLM_lpage">347</span>, <span class="refDoi">Â DOI: 10.1111/j.1600-065X.2009.00830.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1111%2Fj.1600-065X.2009.00830.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19909374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGlsLrN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2009&pages=334-347&issue=1&author=S.+Hailfingerauthor=F.+Rebeaudauthor=M.+Thome&title=Adapter+and+enzymatic+functions+of+proteases+in+T-cell+activation&doi=10.1111%2Fj.1600-065X.2009.00830.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Adapter and enzymatic functions of proteases in T-cell activation</span></div><div class="casAuthors">Hailfinger, Stephan; Rebeaud, Fabien; Thome, Margot</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">334-347</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Proteases control many vital aspects of humoral and cellular immune responses, including the maturation of cytokines and the killing of target cells.  Recently, it has become evident that triggering of the T-cell receptor controls T-cell proliferation through proteases such as mucosa-assocd. lymphoid tissue 1 (MALT1) and Caspase-8 that act both as adapters and enzymes.  Here, we discuss the role of these and other proteases that are relevant to the control of the T-cell response and represent interesting targets of therapeutic immunomodulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsdRX4UgiEZrVg90H21EOLACvtfcHk0lhnRK9dsplrig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGlsLrN&md5=518caa776a1b00b5d270d2dbe42e93ca</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2009.00830.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2009.00830.x%26sid%3Dliteratum%253Aachs%26aulast%3DHailfinger%26aufirst%3DS.%26aulast%3DRebeaud%26aufirst%3DF.%26aulast%3DThome%26aufirst%3DM.%26atitle%3DAdapter%2520and%2520enzymatic%2520functions%2520of%2520proteases%2520in%2520T-cell%2520activation%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D232%26issue%3D1%26spage%3D334%26epage%3D347%26doi%3D10.1111%2Fj.1600-065X.2009.00830.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cromm, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">The proteasome in modern drug discovery: second life of a highly valuable drug target</span>. <i>ACS Cent. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">830</span>â <span class="NLM_lpage">838</span>, <span class="refDoi">Â DOI: 10.1021/acscentsci.7b00252</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscentsci.7b00252" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Orsb3M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=830-838&issue=8&author=P.+M.+Crommauthor=C.+M.+Crews&title=The+proteasome+in+modern+drug+discovery%3A+second+life+of+a+highly+valuable+drug+target&doi=10.1021%2Facscentsci.7b00252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Proteasome in Modern Drug Discovery: Second Life of a Highly Valuable Drug Target</span></div><div class="casAuthors">Cromm, Philipp M.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Central Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">830-838</span>CODEN:
                <span class="NLM_cas:coden">ACSCII</span>;
        ISSN:<span class="NLM_cas:issn">2374-7951</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  As the central figure of the cellular protein degrdn. machinery, the proteasome is crit. for cell survival.  Having been extensively targeted for inhibition, the constitutive proteasome has proven its role as a highly valuable drug target.  However, recent advances in the protein homeostasis field suggest that addnl. chapters can be added to this successful story.  For example, selective immunoproteasome inhibition promises high clin. efficacy for autoimmune disorders and inflammation, and proteasome inhibitors might serve as novel therapeutics for malaria or other microorganisms.  Furthermore, utilizing the destructive force of the proteasome for selective degrdn. of essential drivers of human disorders has opened up a new and exciting area of drug discovery.  Thus, the field of proteasome drug discovery still holds exciting questions to be answered and does not simply end with inhibiting the constitutive proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKh_fEKiZT-7Vg90H21EOLACvtfcHk0ljtAraa6qq8rw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Orsb3M&md5=91f26fd1133db650c0b4b4f43a461354</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facscentsci.7b00252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscentsci.7b00252%26sid%3Dliteratum%253Aachs%26aulast%3DCromm%26aufirst%3DP.%2BM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DThe%2520proteasome%2520in%2520modern%2520drug%2520discovery%253A%2520second%2520life%2520of%2520a%2520highly%2520valuable%2520drug%2520target%26jtitle%3DACS%2520Cent.%2520Sci.%26date%3D2017%26volume%3D3%26issue%3D8%26spage%3D830%26epage%3D838%26doi%3D10.1021%2Facscentsci.7b00252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâDonoghue, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foe, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Fonseca, P. C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Structure- and function-based design of Plasmodium-selective proteasome inhibitors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>530</i></span> (<span class="NLM_issue">7589</span>),  <span class="NLM_fpage">233</span>â <span class="NLM_lpage">236</span>, <span class="refDoi">Â DOI: 10.1038/nature16936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature16936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26863983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVyrsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=530&publication_year=2016&pages=233-236&issue=7589&author=H.+Liauthor=A.+J.+O%E2%80%99Donoghueauthor=W.+A.+van+der+Lindenauthor=S.+C.+Xieauthor=E.+Yooauthor=I.+T.+Foeauthor=L.+Tilleyauthor=C.+S.+Craikauthor=P.+C.+A.+da+Fonsecaauthor=M.+Bogyo&title=Structure-+and+function-based+design+of+Plasmodium-selective+proteasome+inhibitors&doi=10.1038%2Fnature16936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and function-based design of Plasmodium-selective proteasome inhibitors</span></div><div class="casAuthors">Li, Hao; O'Donoghue, Anthony J.; van der Linden, Wouter A.; Xie, Stanley C.; Yoo, Euna; Foe, Ian T.; Tilley, Leann; Craik, Charles S.; da Fonseca, Paula C. A.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">530</span>
        (<span class="NLM_cas:issue">7589</span>),
    <span class="NLM_cas:pages">233-236</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The proteasome is a multi-component protease complex responsible for regulating key processes such as the cell cycle and antigen presentation.  Compds. that target the proteasome are potentially valuable tools for the treatment of pathogens that depend on proteasome function for survival and replication.  In particular, proteasome inhibitors have been shown to be toxic for the malaria parasite Plasmodium falciparum at all stages of its life cycle.  Most compds. that have been tested against the parasite also inhibit the mammalian proteasome, resulting in toxicity that precludes their use as therapeutic agents.  Therefore, better definition of the substrate specificity and structural properties of the Plasmodium proteasome could enable the development of compds. with sufficient selectivity to allow their use as anti-malarial agents.  To accomplish this goal, here the authors use a substrate profiling method to uncover differences in the specificities of the human and P. falciparum proteasome.  The authors design inhibitors based on amino-acid preferences specific to the parasite proteasome, and find that they preferentially inhibit the Î²2-subunit.  The authors det. the structure of the P. falciparum 20S proteasome bound to the inhibitor using cryo-electron microscopy and single-particle anal., to a resoln. of 3.6 Ã.  These data reveal the unusually open P. falciparum Î²2 active site and provide valuable information about active-site architecture that can be used to further refine inhibitor design.  Furthermore, consistent with the recent finding that the proteasome is important for stress pathways assocd. with resistance of artemisinin family anti-malarials, the authors observe growth inhibition synergism with low doses of this Î²2-selective inhibitor in artemisinin-sensitive and -resistant parasites.  Finally, the authors demonstrate that a parasite-selective inhibitor could be used to attenuate parasite growth in vivo without appreciable toxicity to the host.  Thus, the Plasmodium proteasome is a chem. tractable target that could be exploited by next-generation anti-malarial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriK0Li_WncVrVg90H21EOLACvtfcHk0ljtAraa6qq8rw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVyrsr8%253D&md5=f24a562efb64dd533a7dbcfeff4171af</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature16936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature16936%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Donoghue%26aufirst%3DA.%2BJ.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DW.%2BA.%26aulast%3DXie%26aufirst%3DS.%2BC.%26aulast%3DYoo%26aufirst%3DE.%26aulast%3DFoe%26aufirst%3DI.%2BT.%26aulast%3DTilley%26aufirst%3DL.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3Dda%2BFonseca%26aufirst%3DP.%2BC.%2BA.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DStructure-%2520and%2520function-based%2520design%2520of%2520Plasmodium-selective%2520proteasome%2520inhibitors%26jtitle%3DNature%26date%3D2016%26volume%3D530%26issue%3D7589%26spage%3D233%26epage%3D236%26doi%3D10.1038%2Fnature16936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanaerschot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, T. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Westhuyzen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Momper, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Defining the determinants of specificity of Plasmodium proteasome inhibitors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">36</span>),  <span class="NLM_fpage">11424</span>â <span class="NLM_lpage">11437</span>, <span class="refDoi">Â DOI: 10.1021/jacs.8b06656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b06656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsV2lsLbN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=11424-11437&issue=36&author=E.+Yooauthor=B.+H.+Stokesauthor=H.+de+Jongauthor=M.+Vanaerschotauthor=T.+R.+S.+Kumarauthor=N.+Lawrenceauthor=M.+Njorogeauthor=A.+Garciaauthor=R.+Van+der+Westhuyzenauthor=J.+D.+Momperauthor=C.+L.+Ngauthor=D.+A.+Fidockauthor=M.+Bogyo&title=Defining+the+determinants+of+specificity+of+Plasmodium+proteasome+inhibitors&doi=10.1021%2Fjacs.8b06656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the Determinants of Specificity of Plasmodium Proteasome Inhibitors</span></div><div class="casAuthors">Yoo, Euna; Stokes, Barbara H.; de Jong, Hanna; Vanaerschot, Manu; Kumar, T. R. S.; Lawrence, Nina; Njoroge, Mathew; Garcia, Arnold; Van der Westhuyzen, Renier; Momper, Jeremiah D.; Ng, Caroline L.; Fidock, David A.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">11424-11437</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Plasmodium proteasome is an emerging antimalarial target due to its essential role in all the major life cycle stages of the parasite and its contribution to the establishment of resistance to artemisinin (ART)-based therapies.  However, because of a similarly essential role for the host proteasome, the key property of any antiproteasome therapeutic is selectivity.  Several parasite-specific proteasome inhibitors have recently been reported, however, their selectivity must be improved to enable clin. development.  Here we describe screening of diverse libraries of non-natural synthetic fluorogenic substrates to identify determinants at multiple positions on the substrate that produce enhanced selectivity.  We find that selection of an optimal electrophilic "warhead" is essential to enable high selectivity that is driven by the peptide binding elements on the inhibitor.  We also find that host cell toxicity is dictated by the extent of coinhibition of the human Î²2 and Î²5 subunits.  Using this information, we identify compds. with over 3 orders of magnitude selectivity for the parasite enzyme.  Optimization of the pharmacol. properties resulted in mols. that retained high potency and selectivity, were sol., sufficiently metabolically stable and orally bioavailable.  These mols. are highly synergistic with ART and can clear parasites in a mouse model of infection, making them promising leads as antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzXchyqonWDrVg90H21EOLACvtfcHk0ljtAraa6qq8rw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsV2lsLbN&md5=990e0b5097087ff76681f901b2c8f35f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b06656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b06656%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DE.%26aulast%3DStokes%26aufirst%3DB.%2BH.%26aulast%3Dde%2BJong%26aufirst%3DH.%26aulast%3DVanaerschot%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DT.%2BR.%2BS.%26aulast%3DLawrence%26aufirst%3DN.%26aulast%3DNjoroge%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DVan%2Bder%2BWesthuyzen%26aufirst%3DR.%26aulast%3DMomper%26aufirst%3DJ.%2BD.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DDefining%2520the%2520determinants%2520of%2520specificity%2520of%2520Plasmodium%2520proteasome%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26issue%3D36%26spage%3D11424%26epage%3D11437%26doi%3D10.1021%2Fjacs.8b06656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozarich, J. W.</span></span> <span> </span><span class="NLM_article-title">Activity-based protein profiling: from enzyme chemistry to proteomic chemistry</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">383</span>â <span class="NLM_lpage">414</span>, <span class="refDoi">Â DOI: 10.1146/annurev.biochem.75.101304.124125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1146%2Fannurev.biochem.75.101304.124125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18366325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1ekur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2008&pages=383-414&issue=1&author=B.+F.+Cravattauthor=A.+T.+Wrightauthor=J.+W.+Kozarich&title=Activity-based+protein+profiling%3A+from+enzyme+chemistry+to+proteomic+chemistry&doi=10.1146%2Fannurev.biochem.75.101304.124125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-based protein profiling: From enzyme chemistry to proteomic chemistry</span></div><div class="casAuthors">Cravatt, Benjamin F.; Wright, Aaron T.; Kozarich, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">383-414</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Genome sequencing projects have provided researchers with a complete inventory of the predicted proteins produced by eukaryotic and prokaryotic organisms.  Assignment of functions to these proteins represents one of the principal challenges for the field of proteomics.  Activity-based protein profiling (ABPP) has emerged as a powerful chem. proteomic strategy to characterize enzyme function directly in native biol. systems on a global scale.  Here, the authors review the basic technol. of ABPP, the enzyme classes addressable by this method, and the biol. discoveries attributable to its application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQFnUWDsqzOLVg90H21EOLACvtfcHk0lh6u82HTJm3Ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1ekur0%253D&md5=2f2c471169d2473f7024eeb41d4eaecd</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.75.101304.124125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.75.101304.124125%26sid%3Dliteratum%253Aachs%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DWright%26aufirst%3DA.%2BT.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26atitle%3DActivity-based%2520protein%2520profiling%253A%2520from%2520enzyme%2520chemistry%2520to%2520proteomic%2520chemistry%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2008%26volume%3D77%26issue%3D1%26spage%3D383%26epage%3D414%26doi%3D10.1146%2Fannurev.biochem.75.101304.124125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groborz, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rut, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vizovisek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span> <span> </span><span class="NLM_article-title">Multiplexed probing of proteolytic enzymes using mass cytometry-compatible activity-based probes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">16704</span>â <span class="NLM_lpage">16715</span>, <span class="refDoi">Â DOI: 10.1021/jacs.0c06762</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.0c06762" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvValtbrP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2020&pages=16704-16715&issue=39&author=M.+Porebaauthor=K.+M.+Groborzauthor=W.+Rutauthor=M.+Poreauthor=S.+J.+Snipasauthor=M.+Vizovisekauthor=B.+Turkauthor=P.+Kuhnauthor=M.+Dragauthor=G.+S.+Salvesen&title=Multiplexed+probing+of+proteolytic+enzymes+using+mass+cytometry-compatible+activity-based+probes&doi=10.1021%2Fjacs.0c06762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Multiplexed Probing of Proteolytic Enzymes Using Mass Cytometry-Compatible Activity-Based Probes</span></div><div class="casAuthors">Poreba, Marcin; Groborz, Katarzyna M.; Rut, Wioletta; Pore, Milind; Snipas, Scott J.; Vizovisek, Matej; Turk, Boris; Kuhn, Peter; Drag, Marcin; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">16704-16715</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The subset of the proteome that contains enzymes in their catalytically active form can be interrogated by using probes targeted toward individual specific enzymes.  A subset of such enzymes are proteases that are frequently studied with activity-based probes, small inhibitors equipped with a detectable tag, commonly a fluorophore.  Due to the spectral overlap of these commonly used fluorophores, multiplex anal. becomes limited.  To overcome this, we developed a series of protease-selective lanthanide-labeled probes compatible with mass cytometry giving us the ability to monitor the activity of multiple proteases in parallel.  Using these probes, we were able to identify the distribution of four proteases with different active site geometries in three cell lines and peripheral blood mononuclear cells.  This provides a framework for the use of mass cytometry for multiplexed enzyme activity detection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC8-y5ZbgiX7Vg90H21EOLACvtfcHk0lh6u82HTJm3Ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvValtbrP&md5=ab26ce581c552d3cf9ebdad09a45fa30</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjacs.0c06762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.0c06762%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DGroborz%26aufirst%3DK.%2BM.%26aulast%3DRut%26aufirst%3DW.%26aulast%3DPore%26aufirst%3DM.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DVizovisek%26aufirst%3DM.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DMultiplexed%2520probing%2520of%2520proteolytic%2520enzymes%2520using%2520mass%2520cytometry-compatible%2520activity-based%2520probes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2020%26volume%3D142%26issue%3D39%26spage%3D16704%26epage%3D16715%26doi%3D10.1021%2Fjacs.0c06762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weerapana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, M. B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Quantitative reactivity profiling predicts functional cysteines in proteomes</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>468</i></span> (<span class="NLM_issue">7325</span>),  <span class="NLM_fpage">790</span>â <span class="NLM_lpage">795</span>, <span class="refDoi">Â DOI: 10.1038/nature09472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature09472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21085121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGhsr%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=790-795&issue=7325&author=E.+Weerapanaauthor=C.+Wangauthor=G.+M.+Simonauthor=F.+Richterauthor=S.+Khareauthor=M.+B.+D.+Dillonauthor=D.+A.+Bachovchinauthor=K.+Mowenauthor=D.+Bakerauthor=B.+F.+Cravatt&title=Quantitative+reactivity+profiling+predicts+functional+cysteines+in+proteomes&doi=10.1038%2Fnature09472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative reactivity profiling predicts functional cysteines in proteomes</span></div><div class="casAuthors">Weerapana, Eranthie; Wang, Chu; Simon, Gabriel M.; Richter, Florian; Khare, Sagar; Dillon, Myles B. D.; Bachovchin, Daniel A.; Mowen, Kerri; Baker, David; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7325</span>),
    <span class="NLM_cas:pages">790-795</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cysteine is the most intrinsically nucleophilic amino acid in proteins, where its reactivity is tuned to perform diverse biochem. functions.  The absence of a consensus sequence that defines functional cysteines in proteins has hindered their discovery and characterization.  Here we describe a proteomics method to profile quant. the intrinsic reactivity of cysteine residues en masse directly in native biol. systems.  Hyper-reactivity was a rare feature among cysteines and it was found to specify a wide range of activities, including nucleophilic and reductive catalysis and sites of oxidative modification.  Hyper-reactive cysteines were identified in several proteins of uncharacterized function, including a residue conserved across eukaryotic phylogeny that we show is required for yeast viability and is involved in iron-sulfur protein biogenesis.  We also demonstrate that quant. reactivity profiling can form the basis for screening and functional assignment of cysteines in computationally designed proteins, where it discriminated catalytically active from inactive cysteine hydrolase designs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe4hHN7L4cGbVg90H21EOLACvtfcHk0lh6u82HTJm3Ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGhsr%252FI&md5=277e436e7a8f4dfff0b548bce52ac40d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature09472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09472%26sid%3Dliteratum%253Aachs%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DSimon%26aufirst%3DG.%2BM.%26aulast%3DRichter%26aufirst%3DF.%26aulast%3DKhare%26aufirst%3DS.%26aulast%3DDillon%26aufirst%3DM.%2BB.%2BD.%26aulast%3DBachovchin%26aufirst%3DD.%2BA.%26aulast%3DMowen%26aufirst%3DK.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DQuantitative%2520reactivity%2520profiling%2520predicts%2520functional%2520cysteines%2520in%2520proteomes%26jtitle%3DNature%26date%3D2010%26volume%3D468%26issue%3D7325%26spage%3D790%26epage%3D795%26doi%3D10.1038%2Fnature09472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leung, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardouin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Discovering potent and selective reversible inhibitors of enzymes in complex proteomes</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">687</span>â <span class="NLM_lpage">691</span>, <span class="refDoi">Â DOI: 10.1038/nbt826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnbt826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=12740587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFSlu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=687-691&issue=6&author=D.+Leungauthor=C.+Hardouinauthor=D.+L.+Bogerauthor=B.+F.+Cravatt&title=Discovering+potent+and+selective+reversible+inhibitors+of+enzymes+in+complex+proteomes&doi=10.1038%2Fnbt826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering potent and selective reversible inhibitors of enzymes in complex proteomes</span></div><div class="casAuthors">Leung, Donmienne; Hardouin, Christophe; Boger, Dale L.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">687-691</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To realize the promise of genomics-based therapeutics, new methods are needed to accelerate the discovery of small mols. that selectively modulate protein activity.  Toward this end, advances in combinatorial synthesis have provided unprecedented access to large compd. libraries of considerable structural complexity and diversity, shifting the bottleneck in drug discovery to the development of efficient screens for protein targets.  Screening for reversible enzyme inhibitors typically requires extensive target-specific work, including protein expression and purifn., as well as the development of specific substrate assays.  Here we report a proteomic method for the discovery of reversible enzyme inhibitors that avoids these steps.  We show that competitive profiling of a library of candidate serine hydrolase inhibitors in complex proteomes with activity-based chem. probes identifies nanomolar reversible inhibitors of several enzymes simultaneously, including the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH), triacylglycerol hydrolase (TGH) and an uncharacterized membrane-assocd. hydrolase that lacks known substrates.  The strategy tests inhibitors against numerous enzymes in parallel, assigning both potency and selectivity factors to each agent.  In this way, promiscuous inhibitors were readily rejected in favor of equally potent compds. with 500-fold or greater selectivity for their targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7L8MJXutl27Vg90H21EOLACvtfcHk0lie1nELbxhf7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFSlu7o%253D&md5=3e9946306058b4a832fb046f1e49a9f0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnbt826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt826%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DHardouin%26aufirst%3DC.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDiscovering%2520potent%2520and%2520selective%2520reversible%2520inhibitors%2520of%2520enzymes%2520in%2520complex%2520proteomes%26jtitle%3DNat.%2520Biotechnol.%26date%3D2003%26volume%3D21%26issue%3D6%26spage%3D687%26epage%3D691%26doi%3D10.1038%2Fnbt826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Backus, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horning, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonzÃ¡lez-PÃ¡ez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanning, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teijaro, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolan, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Proteome-wide covalent ligand discovery in native biological systems</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>534</i></span> (<span class="NLM_issue">7608</span>),  <span class="NLM_fpage">570</span>â <span class="NLM_lpage">574</span>, <span class="refDoi">Â DOI: 10.1038/nature18002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature18002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27309814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSksbnN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=534&publication_year=2016&pages=570-574&issue=7608&author=K.+M.+Backusauthor=B.+E.+Correiaauthor=K.+M.+Lumauthor=S.+Forliauthor=B.+D.+Horningauthor=G.+E.+Gonz%C3%A1lez-P%C3%A1ezauthor=S.+Chatterjeeauthor=B.+R.+Lanningauthor=J.+R.+Teijaroauthor=A.+J.+Olsonauthor=D.+W.+Wolanauthor=B.+F.+Cravatt&title=Proteome-wide+covalent+ligand+discovery+in+native+biological+systems&doi=10.1038%2Fnature18002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Proteome-wide covalent ligand discovery in native biological systems</span></div><div class="casAuthors">Backus, Keriann M.; Correia, Bruno E.; Lum, Kenneth M.; Forli, Stefano; Horning, Benjamin D.; Gonzalez-Paez, Gonzalo E.; Chatterjee, Sandip; Lanning, Bryan R.; Teijaro, John R.; Olson, Arthur J.; Wolan, Dennis W.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">534</span>
        (<span class="NLM_cas:issue">7608</span>),
    <span class="NLM_cas:pages">570-574</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small mols. are powerful tools for investigating protein function and can serve as leads for new therapeutics.  Most human proteins, however, lack small-mol. ligands, and entire protein classes are considered 'undruggable'.  Fragment-based ligand discovery can identify small-mol. probes for proteins that have proven difficult to target using high-throughput screening of complex compd. libraries.  Although reversibly binding ligands are commonly pursued, covalent fragments provide an alternative route to small-mol. probes, including those that can access regions of proteins that are difficult to target through binding affinity alone.  Here we report a quant. anal. of cysteine-reactive small-mol. fragments screened against thousands of proteins in human proteomes and cells.  Covalent ligands were identified for >700 cysteines found in both druggable proteins and proteins deficient in chem. probes, including transcription factors, adaptor/scaffolding proteins, and uncharacterized proteins.  Among the atypical ligand-protein interactions discovered were compds. that react preferentially with pro- (inactive) caspases.  We used these ligands to distinguish extrinsic apoptosis pathways in human cell lines vs. primary human T cells, showing that the former is largely mediated by caspase-8 while the latter depends on both caspase-8 and -10.  Fragment-based covalent ligand discovery provides a greatly expanded portrait of the ligandable proteome and furnishes compds. that can illuminate protein functions in native biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgNJ88KALeSLVg90H21EOLACvtfcHk0lie1nELbxhf7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSksbnN&md5=6fab087c042de735f8a5931e9f5b946c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature18002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18002%26sid%3Dliteratum%253Aachs%26aulast%3DBackus%26aufirst%3DK.%2BM.%26aulast%3DCorreia%26aufirst%3DB.%2BE.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DHorning%26aufirst%3DB.%2BD.%26aulast%3DGonz%25C3%25A1lez-P%25C3%25A1ez%26aufirst%3DG.%2BE.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DLanning%26aufirst%3DB.%2BR.%26aulast%3DTeijaro%26aufirst%3DJ.%2BR.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DWolan%26aufirst%3DD.%2BW.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DProteome-wide%2520covalent%2520ligand%2520discovery%2520in%2520native%2520biological%2520systems%26jtitle%3DNature%26date%3D2016%26volume%3D534%26issue%3D7608%26spage%3D570%26epage%3D574%26doi%3D10.1038%2Fnature18002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vinogradova, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remillard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazar, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suciu, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafroth, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konrad, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemper, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazear, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blewett, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dix, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokhirev, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lairson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melillo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teijaro, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">An activity-guided map of electrophile-cysteine interactions in primary human T cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>182</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1009</span>â <span class="NLM_lpage">1026</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2020.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.cell.2020.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32730809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFShs7rJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2020&pages=1009-1026&issue=4&author=E.+V.+Vinogradovaauthor=X.+Zhangauthor=D.+Remillardauthor=D.+C.+Lazarauthor=R.+M.+Suciuauthor=Y.+Wangauthor=G.+Biancoauthor=Y.+Yamashitaauthor=V.+M.+Crowleyauthor=M.+A.+Schafrothauthor=M.+Yokoyamaauthor=D.+B.+Konradauthor=K.+M.+Lumauthor=G.+M.+Simonauthor=E.+K.+Kemperauthor=M.+R.+Lazearauthor=S.+Yinauthor=M.+M.+Blewettauthor=M.+M.+Dixauthor=N.+Nguyenauthor=M.+N.+Shokhirevauthor=E.+N.+Chinauthor=L.+L.+Lairsonauthor=B.+Melilloauthor=S.+L.+Schreiberauthor=S.+Forliauthor=J.+R.+Teijaroauthor=B.+F.+Cravatt&title=An+activity-guided+map+of+electrophile-cysteine+interactions+in+primary+human+T+cells&doi=10.1016%2Fj.cell.2020.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells</span></div><div class="casAuthors">Vinogradova, Ekaterina V.; Zhang, Xiaoyu; Remillard, David; Lazar, Daniel C.; Suciu, Radu M.; Wang, Yujia; Bianco, Giulia; Yamashita, Yu; Crowley, Vincent M.; Schafroth, Michael A.; Yokoyama, Minoru; Konrad, David B.; Lum, Kenneth M.; Simon, Gabriel M.; Kemper, Esther K.; Lazear, Michael R.; Yin, Sifei; Blewett, Megan M.; Dix, Melissa M.; Nguyen, Nhan; Shokhirev, Maxim N.; Chin, Emily N.; Lairson, Luke L.; Melillo, Bruno; Schreiber, Stuart L.; Forli, Stefano; Teijaro, John R.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1009-1026.e29</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Electrophilic compds. originating from nature or chem. synthesis have profound effects on immune cells.  These compds. are thought to act by cysteine modification to alter the functions of immune-relevant proteins; however, our understanding of electrophile-sensitive cysteines in the human immune proteome remains limited.  Here, we present a global map of cysteines in primary human T cells that are susceptible to covalent modification by electrophilic small mols.  More than 3,000 covalently liganded cysteines were found on functionally and structurally diverse proteins, including many that play fundamental roles in immunol.  We further show that electrophilic compds. can impair T cell activation by distinct mechanisms involving the direct functional perturbation and/or degrdn. of proteins.  Our findings reveal a rich content of ligandable cysteines in human T cells and point to electrophilic small mols. as a fertile source for chem. probes and ultimately therapeutics that modulate immunol. processes and their assocd. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8xoUPD51cKrVg90H21EOLACvtfcHk0lie1nELbxhf7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFShs7rJ&md5=9623b13c847b2088059b2157af63451f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DVinogradova%26aufirst%3DE.%2BV.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRemillard%26aufirst%3DD.%26aulast%3DLazar%26aufirst%3DD.%2BC.%26aulast%3DSuciu%26aufirst%3DR.%2BM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBianco%26aufirst%3DG.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DSchafroth%26aufirst%3DM.%2BA.%26aulast%3DYokoyama%26aufirst%3DM.%26aulast%3DKonrad%26aufirst%3DD.%2BB.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DSimon%26aufirst%3DG.%2BM.%26aulast%3DKemper%26aufirst%3DE.%2BK.%26aulast%3DLazear%26aufirst%3DM.%2BR.%26aulast%3DYin%26aufirst%3DS.%26aulast%3DBlewett%26aufirst%3DM.%2BM.%26aulast%3DDix%26aufirst%3DM.%2BM.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DShokhirev%26aufirst%3DM.%2BN.%26aulast%3DChin%26aufirst%3DE.%2BN.%26aulast%3DLairson%26aufirst%3DL.%2BL.%26aulast%3DMelillo%26aufirst%3DB.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DTeijaro%26aufirst%3DJ.%2BR.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DAn%2520activity-guided%2520map%2520of%2520electrophile-cysteine%2520interactions%2520in%2520primary%2520human%2520T%2520cells%26jtitle%3DCell%26date%3D2020%26volume%3D182%26issue%3D4%26spage%3D1009%26epage%3D1026%26doi%3D10.1016%2Fj.cell.2020.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tonge, P. J.</span></span> <span> </span><span class="NLM_article-title">Drug-target kinetics in drug discovery</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">29</span>â <span class="NLM_lpage">39</span>, <span class="refDoi">Â DOI: 10.1021/acschemneuro.7b00185</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVeku7%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=29-39&issue=1&author=P.+J.+Tonge&title=Drug-target+kinetics+in+drug+discovery&doi=10.1021%2Facschemneuro.7b00185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-Target Kinetics in Drug Discovery</span></div><div class="casAuthors">Tonge, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-39</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of therapies for the treatment of neurol. cancer faces a no. of major challenges including the synthesis of small mol. agents that can penetrate the blood brain barrier (BBB).  Given the likelihood that in many cases drug exposure will be lower in the CNS than in systemic circulation, it follows that strategies should be employed that can sustain target engagement at low drug concn.  Time dependent target occupancy is a function of both the drug and target concn. as well as the thermodn. and kinetic parameters that describe the binding reaction coordinate, and sustained target occupancy can be achieved through structural modifications that increase target (re)binding and/or that decrease the rate of drug dissocn.  The discovery and deployment of compds. with optimized kinetic effects requires information on the structure-kinetic relationships that modulate the kinetics of binding, and the mol. factors that control the translation of drug-target kinetics to time-dependent drug activity in the disease state.  This review first introduces the potential benefits of drug-target kinetics, such as the ability to delineate both thermodn. and kinetic selectivity, and then describes factors, such as target vulnerability, that impact the utility of kinetic selectivity.  The review concludes with a description of a mechanistic PK/PD model that integrates drug-target kinetics into predictions of drug activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ5Cj523Tg9rVg90H21EOLACvtfcHk0lg7gfyJwgPBYw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVeku7%252FN&md5=59dde9100672e664d4b3b77a5f171b68</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00185%26sid%3Dliteratum%253Aachs%26aulast%3DTonge%26aufirst%3DP.%2BJ.%26atitle%3DDrug-target%2520kinetics%2520in%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D29%26epage%3D39%26doi%3D10.1021%2Facschemneuro.7b00185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lebraud, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâReilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenzano, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span> <span> </span><span class="NLM_article-title">Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">45</span>),  <span class="NLM_fpage">8608</span>â <span class="NLM_lpage">8618</span>, <span class="refDoi">Â DOI: 10.1039/C8SC02754D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1039%2FC8SC02754D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30568786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslCnt7rP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=8608-8618&issue=45&author=H.+Lebraudauthor=O.+Surovaauthor=A.+Courtinauthor=M.+O%E2%80%99Reillyauthor=C.+R.+Valenzanoauthor=P.+Nordlundauthor=T.+D.+Heightman&title=Quantitation+of+ERK1%2F2+inhibitor+cellular+target+occupancies+with+a+reversible+slow+off-rate+probe&doi=10.1039%2FC8SC02754D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe</span></div><div class="casAuthors">Lebraud, Honorine; Surova, Olga; Courtin, Aurelie; O'Reilly, Marc; Valenzano, Chiara R.; Nordlund, Par; Heightman, Tom D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">8608-8618</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Target engagement is a key concept in drug discovery and its direct measurement can provide a quant. understanding of drug efficacy and/or toxicity.  Failure to demonstrate target occupancy in relevant cells and tissues has been recognized as a contributing factor to the low success rate of clin. drug development.  Several techniques are emerging to quantify target engagement in cells; however, in situ measurements remain challenging, mainly due to tech. limitations.  Here, we report the development of a non-covalent clickable probe, based on SCH772984, a slow off-rate ERK1/2 inhibitor, which enabled efficient pull down of ERK1/2 protein via click reaction with tetrazine tagged agarose beads.  This was used in a competition setting to measure relative target occupancy by selected ERK1/2 inhibitors.  As a ref. we used the cellular thermal shift assay, a label-free biophys. assay relying solely on ligand-induced thermodn. stabilization of proteins.  To validate the EC50 values measured by both methods, the results were compared with IC50 data for the phosphorylation of RSK, a downstream substrate of ERK1/2 used as a functional biomarker of ERK1/2 inhibition.  We showed that a slow off-rate reversible probe can be used to efficiently pull down cellular proteins, significantly extending the potential of the approach beyond the need for covalent or photoaffinity warheads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF5b9dAQEMwrVg90H21EOLACvtfcHk0lg7gfyJwgPBYw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslCnt7rP&md5=80d8668a3fc75e41bf4cb3ba1260d6ca</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2FC8SC02754D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8SC02754D%26sid%3Dliteratum%253Aachs%26aulast%3DLebraud%26aufirst%3DH.%26aulast%3DSurova%26aufirst%3DO.%26aulast%3DCourtin%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DValenzano%26aufirst%3DC.%2BR.%26aulast%3DNordlund%26aufirst%3DP.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3DQuantitation%2520of%2520ERK1%252F2%2520inhibitor%2520cellular%2520target%2520occupancies%2520with%2520a%2520reversible%2520slow%2520off-rate%2520probe%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26issue%3D45%26spage%3D8608%26epage%3D8618%26doi%3D10.1039%2FC8SC02754D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">OâDonoghue, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eroy-Reveles, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudsen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingram, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Statnekov, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greninger, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hostetter, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltby, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRisi, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlingame, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Global identification of peptidase specificity by multiplex substrate profiling</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1095</span>â <span class="NLM_lpage">1100</span>, <span class="refDoi">Â DOI: 10.1038/nmeth.2182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnmeth.2182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23023596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaqtrvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=1095-1100&issue=11&author=A.+J.+O%E2%80%99Donoghueauthor=A.+A.+Eroy-Revelesauthor=G.+M.+Knudsenauthor=J.+Ingramauthor=M.+Zhouauthor=J.+B.+Statnekovauthor=A.+L.+Greningerauthor=D.+R.+Hostetterauthor=G.+Quauthor=D.+A.+Maltbyauthor=M.+O.+Andersonauthor=J.+L.+DeRisiauthor=J.+H.+McKerrowauthor=A.+L.+Burlingameauthor=C.+S.+Craik&title=Global+identification+of+peptidase+specificity+by+multiplex+substrate+profiling&doi=10.1038%2Fnmeth.2182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Global identification of peptidase specificity by multiplex substrate profiling</span></div><div class="casAuthors">O'Donoghue, Anthony J.; Eroy-Reveles, A. Alegra; Knudsen, Giselle M.; Ingram, Jessica; Zhou, Min; Statnekov, Jacob B.; Greninger, Alexander L.; Hostetter, Daniel R.; Qu, Gang; Maltby, David A.; Anderson, Marc O.; DeRisi, Joseph L.; McKerrow, James H.; Burlingame, Alma L.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1095-1100</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors developed a simple and rapid multiplex substrate-profiling method to reveal the substrate specificity of any endo- or exopeptidase using liq. chromatog.-tandem mass spectrometry sequencing.  The authors generated a physicochem. diverse library of peptides by incorporating all combinations of neighbor and near-neighbor amino acid pairs into decapeptide sequences that are flanked by unique dipeptides at each terminus.  Addn. of a panel of evolutionarily diverse peptidases to a mixt. of these tetradecapeptides generated information on prime and nonprime sites as well as on substrate specificity that matched or expanded upon known substrate motifs.  This method biochem. confirmed the activity of the klassevirus 3C protein responsible for polypeptide processing and allowed granzyme B substrates to be ranked by enzymic turnover efficiency using label-free quantitation of precursor-ion abundance.  Addnl., the proteolytic secretions from schistosome parasitic flatworm larvae and a pancreatic cancer cell line were deconvoluted in a subtractive strategy using class-specific peptidase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHUJit7mNKQ7Vg90H21EOLACvtfcHk0lg7gfyJwgPBYw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaqtrvK&md5=76e0312242ac2cac53fd46957793e492</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.2182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.2182%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Donoghue%26aufirst%3DA.%2BJ.%26aulast%3DEroy-Reveles%26aufirst%3DA.%2BA.%26aulast%3DKnudsen%26aufirst%3DG.%2BM.%26aulast%3DIngram%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DStatnekov%26aufirst%3DJ.%2BB.%26aulast%3DGreninger%26aufirst%3DA.%2BL.%26aulast%3DHostetter%26aufirst%3DD.%2BR.%26aulast%3DQu%26aufirst%3DG.%26aulast%3DMaltby%26aufirst%3DD.%2BA.%26aulast%3DAnderson%26aufirst%3DM.%2BO.%26aulast%3DDeRisi%26aufirst%3DJ.%2BL.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DBurlingame%26aufirst%3DA.%2BL.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DGlobal%2520identification%2520of%2520peptidase%2520specificity%2520by%2520multiplex%2520substrate%2520profiling%26jtitle%3DNat.%2520Methods%26date%3D2012%26volume%3D9%26issue%3D11%26spage%3D1095%26epage%3D1100%26doi%3D10.1038%2Fnmeth.2182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backes, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahrus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">7754</span>â <span class="NLM_lpage">7759</span>, <span class="refDoi">Â DOI: 10.1073/pnas.140132697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.140132697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10869434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCnt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=7754-7759&issue=14&author=J.+L.+Harrisauthor=B.+J.+Backesauthor=F.+Leonettiauthor=S.+Mahrusauthor=J.+A.+Ellmanauthor=C.+S.+Craik&title=Rapid+and+general+profiling+of+protease+specificity+by+using+combinatorial+fluorogenic+substrate+libraries&doi=10.1073%2Fpnas.140132697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries</span></div><div class="casAuthors">Harris, Jennifer L.; Backes, Bradley J.; Leonetti, Francesco; Mahrus, Sami; Ellman, Jonathan A.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7754-7759</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A method is presented for the prepn. and use of fluorogenic peptide substrates that allows for the configuration of general substrate libraries to rapidly identify the primary and extended specificity of proteases.  The substrates contain the fluorogenic leaving group 7-amino-4-carbamoylmethylcoumarin (ACC).  Substrates incorporating the ACC leaving group show kinetic profiles comparable to those with the traditionally used 7-amino-4-methylcoumarin (AMC) leaving group.  The bifunctional nature of ACC allows for the efficient prodn. of single substrates and substrate libraries by using 9-fluorenylmethoxycarbonyl (Fmoc)-based solid-phase synthesis techniques.  The approx. 3-fold-increased quantum yield of ACC over AMC permits redn. in enzyme and substrate concns.  As a consequence, a greater no. of substrates can be tolerated in a single assay, thus enabling an increase in the diversity space of the library.  Sol. positional protease substrate libraries of 137,180 and 6859 members, possessing amino acid diversity at the P4-P3-P2-P1 and P4-P3-P2 positions, resp., were constructed.  Employing this screening method, we profiled the substrate specificities of a diverse array of proteases, including the serine proteases thrombin, plasmin, factor Xa, urokinase-type plasminogen activator, tissue plasminogen activator, granzyme B, trypsin, chymotrypsin, human neutrophil elastase, and the cysteine proteases papain and cruzain.  The resulting profiles create a pharmacophoric portrayal of the proteases to aid in the design of selective substrates and potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE5k5AkbXvLbVg90H21EOLACvtfcHk0ljDZRCWFkPKcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCnt7Y%253D&md5=669beba3367acd1911a2a39660117a78</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.140132697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.140132697%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26aulast%3DBackes%26aufirst%3DB.%2BJ.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DMahrus%26aufirst%3DS.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DRapid%2520and%2520general%2520profiling%2520of%2520protease%2520specificity%2520by%2520using%2520combinatorial%2520fluorogenic%2520substrate%2520libraries%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26issue%3D14%26spage%3D7754%26epage%3D7759%26doi%3D10.1073%2Fpnas.140132697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenbaum, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecaille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BrÃ¶mme, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">12824</span>â <span class="NLM_lpage">12832</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M513331200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.M513331200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=16520377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFKktLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=12824-12832&issue=18&author=Y.+Choeauthor=F.+Leonettiauthor=D.+C.+Greenbaumauthor=F.+Lecailleauthor=M.+Bogyoauthor=D.+Br%C3%B6mmeauthor=J.+A.+Ellmanauthor=C.+S.+Craik&title=Substrate+profiling+of+cysteine+proteases+using+a+combinatorial+peptide+library+identifies+functionally+unique+specificities&doi=10.1074%2Fjbc.M513331200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate Profiling of Cysteine Proteases Using a Combinatorial Peptide Library Identifies Functionally Unique Specificities</span></div><div class="casAuthors">Choe, Youngchool; Leonetti, Francesco; Greenbaum, Doron C.; Lecaille, Fabien; Bogyo, Matthew; Broemme, Dieter; Ellman, Jonathan A.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">12824-12832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The substrate specificities of papain-like cysteine proteases (clan CA, family C1) papain, bromelain, and human cathepsins L, V, K, S, F, B, and five proteases of parasitic origin were studied using a completely diversified positional scanning synthetic combinatorial library.  A bifunctional coumarin fluorophore was used that facilitated synthesis of the library and individual peptide substrates.  The library has a total of 160,000 tetrapeptide substrate sequences completely randomizing each of the P1, P2, P3, and P4 positions with 20 amino acids.  A microtiter plate assay format permitted a rapid detn. of the specificity profile of each enzyme.  Individual peptide substrates were then synthesized and tested for a quant. detn. of the specificity of the human cathepsins.  Despite the conserved three-dimensional structure and similar substrate specificity of the enzymes studied, distinct amino acid preferences that differentiate each enzyme were identified.  The specificities of cathepsins K and S partially match the cleavage site sequences in their physiol. substrates.  Capitalizing on its unique preference for proline and glycine at the P2 and P3 positions, resp., selective substrates and a substrate-based inhibitor were developed for cathepsin K.  A cluster anal. of the proteases based on the complete specificity profile provided a functional characterization distinct from std. sequence anal.  This approach provides useful information for developing selective chem. probes to study protease-related pathologies and physiologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd-Na7PpDSPLVg90H21EOLACvtfcHk0ljDZRCWFkPKcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFKktLY%253D&md5=8a90a92e810ac59436a9ea3a12536f27</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M513331200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M513331200%26sid%3Dliteratum%253Aachs%26aulast%3DChoe%26aufirst%3DY.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DGreenbaum%26aufirst%3DD.%2BC.%26aulast%3DLecaille%26aufirst%3DF.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DSubstrate%2520profiling%2520of%2520cysteine%2520proteases%2520using%2520a%2520combinatorial%2520peptide%2520library%2520identifies%2520functionally%2520unique%2520specificities%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D18%26spage%3D12824%26epage%3D12832%26doi%3D10.1074%2Fjbc.M513331200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rano, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasper, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timkey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Calvo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houtzager, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordstrom, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaillancourt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, D. W.</span></span> <span> </span><span class="NLM_article-title">A combinatorial approach defines specificities of members of the caspase family and granzyme B: Functional relationships established for key mediators of apoptosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span> (<span class="NLM_issue">29</span>),  <span class="NLM_fpage">17907</span>â <span class="NLM_lpage">17911</span>, <span class="refDoi">Â DOI: 10.1074/jbc.272.29.17907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.272.29.17907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=9218414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2sXkslKgtbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=17907-17911&issue=29&author=N.+A.+Thornberryauthor=T.+A.+Ranoauthor=E.+P.+Petersonauthor=D.+M.+Rasperauthor=T.+Timkeyauthor=M.+Garcia-Calvoauthor=V.+M.+Houtzagerauthor=P.+A.+Nordstromauthor=S.+Royauthor=J.+P.+Vaillancourtauthor=K.+T.+Chapmanauthor=D.+W.+Nicholson&title=A+combinatorial+approach+defines+specificities+of+members+of+the+caspase+family+and+granzyme+B%3A+Functional+relationships+established+for+key+mediators+of+apoptosis&doi=10.1074%2Fjbc.272.29.17907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis</span></div><div class="casAuthors">Thornberry, Nancy A.; Rano, Thomas A.; Peterson, Erin P.; Rasper, Dita M.; Timkey, Tracy; Garcia-Calvo, Margarita; Houtzager, Vicky M.; Nordstrom, Penny A.; Roy, Sophie; Vaillancourt, John P.; Chapman, Kevin T.; Nicholson, Donald W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">17907-17911</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">There is compelling evidence that members of the caspase (interleukin-1Î² converting enzyme/CED-3) family of cysteine proteases and the cytotoxic lymphocyte-derived serine protease granzyme B play essential roles in mammalian apoptosis.  Here we use a novel method employing a positional scanning substrate combinatorial library to rigorously define their individual specificities.  The results divide these proteases into three distinct groups and suggest that several have redundant functions.  The specificity of caspases 2, 3, and 7 and Caenorhabditis elegans CED-3 (DEXD) suggests that all of these enzymes function to incapacitate essential homeostatic pathways during the effector phase of apoptosis.  In contrast, the optimal sequence for caspases 6, 8, and 9 and granzyme B ((I/L/V)EXD) resembles activation sites in effector caspase proenzymes, consistent with a role for these enzymes in upstream components in a proteolytic cascade that amplifies the death signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqskfpc5Wd3RrVg90H21EOLACvtfcHk0ljDZRCWFkPKcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslKgtbc%253D&md5=44abe20ff00574bb756a1591ed77e110</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.29.17907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.29.17907%26sid%3Dliteratum%253Aachs%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DRano%26aufirst%3DT.%2BA.%26aulast%3DPeterson%26aufirst%3DE.%2BP.%26aulast%3DRasper%26aufirst%3DD.%2BM.%26aulast%3DTimkey%26aufirst%3DT.%26aulast%3DGarcia-Calvo%26aufirst%3DM.%26aulast%3DHoutzager%26aufirst%3DV.%2BM.%26aulast%3DNordstrom%26aufirst%3DP.%2BA.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DVaillancourt%26aufirst%3DJ.%2BP.%26aulast%3DChapman%26aufirst%3DK.%2BT.%26aulast%3DNicholson%26aufirst%3DD.%2BW.%26atitle%3DA%2520combinatorial%2520approach%2520defines%2520specificities%2520of%2520members%2520of%2520the%2520caspase%2520family%2520and%2520granzyme%2520B%253A%2520Functional%2520relationships%2520established%2520for%2520key%2520mediators%2520of%2520apoptosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26issue%3D29%26spage%3D17907%26epage%3D17911%26doi%3D10.1074%2Fjbc.272.29.17907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2189</span>â <span class="NLM_lpage">2214</span>, <span class="refDoi">Â DOI: 10.1038/nprot.2017.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnprot.2017.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=28933778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFehtrjF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2189-2214&issue=10&author=M.+Porebaauthor=G.+S.+Salvesenauthor=M.+Drag&title=Synthesis+of+a+HyCoSuL+peptide+substrate+library+to+dissect+protease+substrate+specificity&doi=10.1038%2Fnprot.2017.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity</span></div><div class="casAuthors">Poreba, Marcin; Salvesen, Guy S.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2189-2214</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Many biol. and chem. based approaches have been developed to design highly active and selective protease substrates and probes.  It is, however, difficult to find substrate sequences that are truly selective for any given protease, as different proteases can demonstrate a great deal of overlap in substrate specificities.  In some cases, better enzyme selectivity can be achieved using peptide libraries contg. unnatural amino acids such as the hybrid combinatorial substrate library (HyCoSuL), which uses both natural and unnatural amino acids.  HyCoSuL is a combinatorial library of tetrapeptides contg. amino acid mixts. at the P4-P2 positions, a fixed amino acid at the P1 position, and an ACC (7-amino-4-carbamoylmethylcoumarin) fluorescent tag occupying the P1' position.  Once the peptide is recognized and cleaved by a protease, the ACC is released and produces a readable fluorescence signal.  Here, we describe the synthesis and screening of HyCoSuL for human caspases and legumain.  We also discuss possible modifications and adaptations of this approach that make it a useful tool for developing highly active and selective reagents for a wide variety of proteolytic enzymes.  The protocol can be divided into three major parts: (i) solid-phase synthesis of the fluorescence-labeled HyCoSuL, (ii) screening of protease P4-P2 preferences, and (iii) synthesis of the optimized activity probes equipped with an AOMK (acyloxymethyl ketone) reactive group and a biotin label for easy detection.  Beginning with the library design, the entire protocol can be completed in 4-8 wk (HyCoSuL synthesis: 3-5 wk; HyCoSuL screening per enzyme: 4-8 d; and activity-based probe synthesis: 1-2 wk).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYBvdwWr2XhLVg90H21EOLACvtfcHk0liNl8BN37puWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFehtrjF&md5=5ece1429e76feedd3eb864f07da7f8b7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2017.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2017.091%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520a%2520HyCoSuL%2520peptide%2520substrate%2520library%2520to%2520dissect%2520protease%2520substrate%2520specificity%26jtitle%3DNat.%2520Protoc.%26date%3D2017%26volume%3D12%26issue%3D10%26spage%3D2189%26epage%3D2214%26doi%3D10.1038%2Fnprot.2017.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Unnatural amino acids increase sensitivity and provide for the design of highly selective caspase substrates</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1482</span>â <span class="NLM_lpage">1492</span>, <span class="refDoi">Â DOI: 10.1038/cdd.2014.64</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fcdd.2014.64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24832467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXot1ymsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1482-1492&issue=9&author=M.+Porebaauthor=P.+Kasperkiewiczauthor=S.+J.+Snipasauthor=D.+Fasciauthor=G.+S.+Salvesenauthor=M.+Drag&title=Unnatural+amino+acids+increase+sensitivity+and+provide+for+the+design+of+highly+selective+caspase+substrates&doi=10.1038%2Fcdd.2014.64"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Unnatural amino acids increase sensitivity and provide for the design of highly selective caspase substrates</span></div><div class="casAuthors">Poreba, M.; Kasperkiewicz, P.; Snipas, S. J.; Fasci, D.; Salvesen, G. S.; Drag, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1482-1492</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Traditional combinatorial peptidyl substrate library approaches generally utilize natural amino acids, limiting the usefulness of this tool in generating selective substrates for proteases that share similar substrate specificity profiles.  To address this limitation, we synthesized a Hybrid Combinatorial Substrate Library (HyCoSuL) with the general formula of Ac-P4-P3-P2-Asp-ACC, testing the approach on a family of closely related proteases - the human caspases.  The power of this library for caspase discrimination extends far beyond traditional PS-SCL approach, as in addn. to 19 natural amino acids we also used 110 diverse unnatural amino acids that can more extensively explore the chem. space represented by caspase-active sites.  Using this approach we identified and employed peptide-based substrates that provided excellent discrimination between individual caspases, allowing us to simultaneously resolve the individual contribution of the apical caspase-9 and the executioner caspase-3 and caspase-7 in the development of cytochrome-c-dependent apoptosis for the first time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSDqSSP6nnUrVg90H21EOLACvtfcHk0liNl8BN37puWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXot1ymsLs%253D&md5=319049bbe5679cb416e1698a900d2a47</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2014.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2014.64%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DFasci%26aufirst%3DD.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DUnnatural%2520amino%2520acids%2520increase%2520sensitivity%2520and%2520provide%2520for%2520the%2520design%2520of%2520highly%2520selective%2520caspase%2520substrates%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2014%26volume%3D21%26issue%3D9%26spage%3D1482%26epage%3D1492%26doi%3D10.1038%2Fcdd.2014.64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salisbury, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Peptide microarrays for the determination of protease substrate specificity</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>124</i></span> (<span class="NLM_issue">50</span>),  <span class="NLM_fpage">14868</span>â <span class="NLM_lpage">14870</span>, <span class="refDoi">Â DOI: 10.1021/ja027477q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja027477q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVChtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=14868-14870&issue=50&author=C.+M.+Salisburyauthor=D.+J.+Malyauthor=J.+A.+Ellman&title=Peptide+microarrays+for+the+determination+of+protease+substrate+specificity&doi=10.1021%2Fja027477q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide Microarrays for the Determination of Protease Substrate Specificity</span></div><div class="casAuthors">Salisbury, Cleo M.; Maly, Dustin J.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">14868-14870</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A method is described for the prepn. of substrate microarrays that allow for the rapid detn. of protease substrate specificity.  Peptidyl coumarin substrates, synthesized on solid support using std. techniques, are printed onto glass slides using DNA microarraying equipment.  The linkage from the peptide to the slide is formed through a chemoselective reaction, resulting in an array of uniformly displayed fluorogenic substrates.  The arrays can be treated with proteases to yield substrate specificity profiles.  Std. instrumentation for visualization of microarrays can be used to obtain comparisons of the specificity consts. for all of the prepd. substrates.  The utility of these arrays is demonstrated by the selective cleavage of preferred substrates with trypsin, thrombin, and granzyme B, and by assessing the extended substrate specificity of thrombin using a microarray of 361 different peptidyl coumarin substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_9UJFjPfXUrVg90H21EOLACvtfcHk0liNl8BN37puWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVChtr8%253D&md5=947f296baec5916ea2588d7b09c956b1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja027477q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja027477q%26sid%3Dliteratum%253Aachs%26aulast%3DSalisbury%26aufirst%3DC.%2BM.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DPeptide%2520microarrays%2520for%2520the%2520determination%2520of%2520protease%2520substrate%2520specificity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26issue%3D50%26spage%3D14868%26epage%3D14870%26doi%3D10.1021%2Fja027477q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gosalia, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salisbury, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, S. L.</span></span> <span> </span><span class="NLM_article-title">High throughput substrate specificity profiling of serine and cysteine proteases using solution-phase fluorogenic peptide microarrays</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">626</span>â <span class="NLM_lpage">636</span>, <span class="refDoi">Â DOI: 10.1074/mcp.M500004-MCP200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fmcp.M500004-MCP200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15705970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlSmsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=626-636&issue=5&author=D.+N.+Gosaliaauthor=C.+M.+Salisburyauthor=J.+A.+Ellmanauthor=S.+L.+Diamond&title=High+throughput+substrate+specificity+profiling+of+serine+and+cysteine+proteases+using+solution-phase+fluorogenic+peptide+microarrays&doi=10.1074%2Fmcp.M500004-MCP200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput substrate specificity profiling of serine and cysteine proteases using solution-phase fluorogenic peptide microarrays</span></div><div class="casAuthors">Gosalia, Dhaval N.; Salisbury, Cleo M.; Ellman, Jonathan A.; Diamond, Scott L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Proteomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">626-636</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9476</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Proteases regulate numerous biol. processes with a degree of specificity often dictated by the amino acid sequence of the substrate cleavage site.  To map protease/substrate interactions, a 722-member library of fluorogenic protease substrates of the general format Ac-Ala-X-X-(Arg/Lys)-coumarin was synthesized (X = all natural amino acids except cysteine) and microarrayed with fluorescent calibration stds. in glycerol nanodroplets on glass slides.  Specificities of 13 serine proteases (activated protein C, plasma kallikrein, factor VIIa, factor IXaÎ², factor XIa and factor Î± XIIa, activated complement C1s, C1r, and D, tryptase, trypsin, subtilisin Carlsberg, and cathepsin G) and 11 papain-like cysteine proteases (cathepsin B, H, K, L, S, and V, rhodesain, papain, chymopapain, ficin, and stem bromelain) were obtained from 103,968 sep. microarray fluorogenic reactions (722 substrates Ã 24 different proteases Ã 6 replicates).  This is the first comprehensive study to report the substrate specificity of rhodesain, a papain-like cysteine protease expressed by Trypanosoma brucei rhodesiense, a parasitic protozoa responsible for causing sleeping sickness.  Rhodesain displayed a strong P2 preference for Leu, Val, Phe, and Tyr in both the P1 = Lys and Arg libraries.  Soln.-phase microarrays facilitate protease/substrate specificity profiling in a rapid manner with minimal peptide library or enzyme usage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrShBLYt9S877Vg90H21EOLACvtfcHk0lhSoOaxgiBR1A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlSmsrY%253D&md5=f8560e365d168d1e8e0aa918dca621e9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M500004-MCP200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M500004-MCP200%26sid%3Dliteratum%253Aachs%26aulast%3DGosalia%26aufirst%3DD.%2BN.%26aulast%3DSalisbury%26aufirst%3DC.%2BM.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DDiamond%26aufirst%3DS.%2BL.%26atitle%3DHigh%2520throughput%2520substrate%2520specificity%2520profiling%2520of%2520serine%2520and%2520cysteine%2520proteases%2520using%2520solution-phase%2520fluorogenic%2520peptide%2520microarrays%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2005%26volume%3D4%26issue%3D5%26spage%3D626%26epage%3D636%26doi%3D10.1074%2Fmcp.M500004-MCP200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, W. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Substrate activity screening (SAS): a general procedure for the preparation and screening of a fragment-based non-peptidic protease substrate library for inhibitor discovery</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">424</span>â <span class="NLM_lpage">433</span>, <span class="refDoi">Â DOI: 10.1038/nprot.2007.28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnprot.2007.28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17406604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=424-433&issue=2&author=A.+W.+Pattersonauthor=W.+J.+L.+Woodauthor=J.+A.+Ellman&title=Substrate+activity+screening+%28SAS%29%3A+a+general+procedure+for+the+preparation+and+screening+of+a+fragment-based+non-peptidic+protease+substrate+library+for+inhibitor+discovery&doi=10.1038%2Fnprot.2007.28"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate activity screening (SAS): a general procedure for the preparation and screening of a fragment-based non-peptidic protease substrate library for inhibitor discovery</span></div><div class="casAuthors">Patterson, Andrew W.; Wood, Warren J. L.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">424-433</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Substrate activity screening (SAS) is a fragment-based method for the rapid development of novel substrates and their conversion into nonpeptidic inhibitors of Cys and Ser proteases.  The method consists of three steps.  A library of N-acyl aminocoumarins with diverse, low-mol.-wt. N-acyl groups is screened to identify protease substrates using a simple fluorescence-based assay;.  The identified N-acyl aminocoumarin substrates are optimized by rapid analog synthesis and evaluation; and.  The optimized substrates are converted into inhibitors by direct replacement of the aminocoumarin with known mechanism-based pharmacophores.  This protocol describes a general procedure for the solid-phase synthesis of a library of N-acyl aminocoumarin substrates and the screening procedure to identify weak binding substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6UUw0Ne1sF7Vg90H21EOLACvtfcHk0lhSoOaxgiBR1A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbjI&md5=fd74ca339edab953d74487f596263c43</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.28%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DA.%2BW.%26aulast%3DWood%26aufirst%3DW.%2BJ.%2BL.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DSubstrate%2520activity%2520screening%2520%2528SAS%2529%253A%2520a%2520general%2520procedure%2520for%2520the%2520preparation%2520and%2520screening%2520of%2520a%2520fragment-based%2520non-peptidic%2520protease%2520substrate%2520library%2520for%2520inhibitor%2520discovery%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26issue%3D2%26spage%3D424%26epage%3D433%26doi%3D10.1038%2Fnprot.2007.28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wood, W. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Substrate activity screening: A fragment-based method for the rapid identification of nonpeptidic protease inhibitors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">15521</span>â <span class="NLM_lpage">15527</span>, <span class="refDoi">Â DOI: 10.1021/ja0547230</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0547230" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2nu77O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=15521-15527&issue=44&author=W.+J.+L.+Woodauthor=A.+W.+Pattersonauthor=H.+Tsuruokaauthor=R.+K.+Jainauthor=J.+A.+Ellman&title=Substrate+activity+screening%3A+A+fragment-based+method+for+the+rapid+identification+of+nonpeptidic+protease+inhibitors&doi=10.1021%2Fja0547230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate activity screening: a fragment-based method for the rapid identification of nonpeptidic protease inhibitors</span></div><div class="casAuthors">Wood, Warren J. L.; Patterson, Andrew W.; Tsuruoka, Hiroyuki; Jain, Rishi K.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">15521-15527</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new fragment-based method for the rapid development of novel and distinct classes of nonpeptidic protease inhibitors, Substrate Activity Screening (SAS), is described.  This method consists of three steps: (1) a library of N-acyl aminocoumarins with diverse, low mol. wt. N-acyl groups is screened to identify protease substrates using a simple fluorescence-based assay, (2) the identified N-acyl aminocoumarin substrates are optimized by rapid analog synthesis and evaluation, and (3) the optimized substrates are converted to inhibitors by direct replacement of the aminocoumarin with known mechanism-based pharmacophores.  The SAS method was successfully applied to the cysteine protease cathepsin S, which is implicated in autoimmune diseases.  Multiple distinct classes of nonpeptidic substrates were identified upon screening an N-acyl aminocoumarin library.  Two of the nonpeptidic substrate classes were optimized to substrates with >8000-fold improvements in cleavage efficiency for each class.  Select nonpeptidic substrates were then directly converted to low mol. wt., novel aldehyde inhibitors with nanomolar affinity to cathepsin S.  This study demonstrates the unique characteristics and merits of this first substrate-based method for the rapid identification and optimization of weak fragments and provides the framework for the development of completely nonpeptidic inhibitors to many different proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwTBkUUwtYpbVg90H21EOLACvtfcHk0ljEDlsbnmZ8Rg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2nu77O&md5=9eceb09f7fc65840d37d465b98bf72af</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fja0547230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0547230%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DW.%2BJ.%2BL.%26aulast%3DPatterson%26aufirst%3DA.%2BW.%26aulast%3DTsuruoka%26aufirst%3DH.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DSubstrate%2520activity%2520screening%253A%2520A%2520fragment-based%2520method%2520for%2520the%2520rapid%2520identification%2520of%2520nonpeptidic%2520protease%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26issue%3D44%26spage%3D15521%26epage%3D15527%26doi%3D10.1021%2Fja0547230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span> <span> </span><span class="NLM_article-title">Substrate phage: selection of protease substrates by monovalent phage display</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>260</i></span> (<span class="NLM_issue">5111</span>),  <span class="NLM_fpage">1113</span>â <span class="NLM_lpage">1117</span>, <span class="refDoi">Â DOI: 10.1126/science.8493554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fscience.8493554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8493554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3sXltFWqtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1993&pages=1113-1117&issue=5111&author=D.+J.+Matthewsauthor=J.+A.+Wells&title=Substrate+phage%3A+selection+of+protease+substrates+by+monovalent+phage+display&doi=10.1126%2Fscience.8493554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate phage: selection of protease substrates by monovalent phage display</span></div><div class="casAuthors">Matthews, David J.; Wells, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">5111</span>),
    <span class="NLM_cas:pages">1113-17</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A method is described here for identifying good protease substrates among â¼107 possible sequences.  A library of fusion proteins was constructed contg. an N-terminal domain used to bind to an affinity support, followed by a randomized protease substrate sequence and the C-terminal domain of phage M13 gene III.  Each fusion protein was displayed as a single copy on filamentous phagemid particles (substrate phage).  Phage were then bound to an affinity support and treated with the protease of interest.  Phage with good protease substrates were released, whereas phage with substrates that resisted proteolysis remained bound.  After several rounds of binding, proteolysis, and phagemid propagation, sensitive and resistant substrate sequences were identified for 2 different proteases, a variant of subtilisin and blood-coagulation factor Xa.  The technique may also be useful for studying the sequence specificity of a variety of posttranslational modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEEI1NqViqFbVg90H21EOLACvtfcHk0ljEDlsbnmZ8Rg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltFWqtbY%253D&md5=1c9473b97653eb9af556ca93c1c828ba</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1126%2Fscience.8493554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8493554%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DD.%2BJ.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DSubstrate%2520phage%253A%2520selection%2520of%2520protease%2520substrates%2520by%2520monovalent%2520phage%2520display%26jtitle%3DScience%26date%3D1993%26volume%3D260%26issue%3D5111%26spage%3D1113%26epage%3D1117%26doi%3D10.1126%2Fscience.8493554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâDonovan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRisi, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span> <span> </span><span class="NLM_article-title">Deep profiling of protease substrate specificity enabled by dual random and scanned human proteome substrate phage libraries</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">25464</span>â <span class="NLM_lpage">25475</span>, <span class="refDoi">Â DOI: 10.1073/pnas.2009279117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.2009279117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32973096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVKktL%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2020&pages=25464-25475&issue=41&author=J.+Zhouauthor=S.+Liauthor=K.+K.+Leungauthor=B.+O%E2%80%99Donovanauthor=J.+Y.+Zouauthor=J.+L.+DeRisiauthor=J.+A.+Wells&title=Deep+profiling+of+protease+substrate+specificity+enabled+by+dual+random+and+scanned+human+proteome+substrate+phage+libraries&doi=10.1073%2Fpnas.2009279117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Deep profiling of protease substrate specificity enabled by dual random and scanned human proteome substrate phage libraries</span></div><div class="casAuthors">Zhou, Jie; Li, Shantao; Leung, Kevin K.; O'Donovan, Brian; Zou, James Y.; DeRisi, Joseph L.; Wells, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">25464-25475</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Proteolysis is a major posttranslational regulator of biol. inside and outside of cells.  Broad identification of optimal cleavage sites and natural substrates of proteases is crit. for drug discovery and to understand protease biol.  Here, we present a method that employs two genetically encoded substrate phage display libraries coupled with next generation sequencing (SPD-NGS) that allows up to 10,000-fold deeper sequence coverage of the typical six- to eight-residue protease cleavage sites compared to state-of-the-art synthetic peptide libraries or proteomics.  We applied SPD-NGS to two classes of proteases, the intracellular caspases, and the ectodomains of the sheddases, ADAMs 10 and 17.  The first library (Lib 10AA) allowed us to identify 104 to 105 unique cleavage sites over a 1,000-fold dynamic range of NGS counts and produced consensus and optimal cleavage motifs based position-specific scoring matrixes.  A second SPD-NGS library (Lib hP), which displayed virtually the entire human proteome tiled in contiguous 49 amino acid sequences with 25 amino acid overlaps, enabled us to identify candidate human proteome sequences.  We identified up to 104 natural linear cut sites, depending on the protease, and captured most of the examples previously identified by proteomics and predicted 10- to 100-fold more.  Structural bioinformatics was used to facilitate the identification of candidate natural protein substrates.  SPD-NGS is rapid, reproducible, simple to perform and analyze, inexpensive, and renewable, with unprecedented depth of coverage for substrate sequences, and is an important tool for protease biologists interested in protease specificity for specific assays and inhibitors and to facilitate identification of natural protein substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKDlFxpSWQmLVg90H21EOLACvtfcHk0ljEDlsbnmZ8Rg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVKktL%252FN&md5=ff50b0632e9c33de63a8be4fcb0c5f7d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2009279117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2009279117%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLeung%26aufirst%3DK.%2BK.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DB.%26aulast%3DZou%26aufirst%3DJ.%2BY.%26aulast%3DDeRisi%26aufirst%3DJ.%2BL.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DDeep%2520profiling%2520of%2520protease%2520substrate%2520specificity%2520enabled%2520by%2520dual%2520random%2520and%2520scanned%2520human%2520proteome%2520substrate%2520phage%2520libraries%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2020%26volume%3D117%26issue%3D41%26spage%3D25464%26epage%3D25475%26doi%3D10.1073%2Fpnas.2009279117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutherford, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, G.</span></span> <span> </span><span class="NLM_article-title">Phage-encoded combinatorial chemical libraries based on bicyclic peptides</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">502</span>â <span class="NLM_lpage">507</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnchembio.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19483697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1altbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=502-507&issue=7&author=C.+Heinisauthor=T.+Rutherfordauthor=S.+Freundauthor=G.+Winter&title=Phage-encoded+combinatorial+chemical+libraries+based+on+bicyclic+peptides&doi=10.1038%2Fnchembio.184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Phage-encoded combinatorial chemical libraries based on bicyclic peptides</span></div><div class="casAuthors">Heinis, Christian; Rutherford, Trevor; Freund, Stephan; Winter, Greg</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">502-507</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here we describe a phage strategy for the selection of ligands based on bicyclic or linear peptides attached covalently to an org. core.  We designed peptide repertoires with three reactive cysteine residues, each spaced apart by several random amino acid residues, and we fused the repertoires to the phage gene-3-protein.  Conjugation with tris-(bromomethyl)benzene via the reactive cysteines generated repertoires of peptide conjugates with two peptide loops anchored to a mesitylene core.  Iterative affinity selections yielded several enzyme inhibitors; after further mutagenesis and selection, we were able to chem. synthesize a lead inhibitor (PK15; Ki = 1.5 nM) specific to human plasma kallikrein that efficiently interrupted the intrinsic coagulation pathway in human plasma tested ex vivo.  This approach offers a powerful means of generating and selecting bicyclic macrocycles (or if cleaved, linear derivs. thereof) as ligands poised at the interface of small-mol. drugs and biologics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZhJRZyldisLVg90H21EOLACvtfcHk0ljsdbyIeHrDTw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1altbs%253D&md5=0634460f77b185fbcf85309c6dbf93e3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.184%26sid%3Dliteratum%253Aachs%26aulast%3DHeinis%26aufirst%3DC.%26aulast%3DRutherford%26aufirst%3DT.%26aulast%3DFreund%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DG.%26atitle%3DPhage-encoded%2520combinatorial%2520chemical%2520libraries%2520based%2520on%2520bicyclic%2520peptides%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26issue%3D7%26spage%3D502%26epage%3D507%26doi%3D10.1038%2Fnchembio.184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fellner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mace, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Identification of highly selective covalent inhibitors by phage display</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">490</span>, <span class="refDoi">Â DOI: 10.1038/s41587-020-0733-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41587-020-0733-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=33199876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlGjsb7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2021&pages=490&author=S.+Chenauthor=S.+Lovellauthor=S.+Leeauthor=M.+Fellnerauthor=P.+D.+Maceauthor=M.+Bogyo&title=Identification+of+highly+selective+covalent+inhibitors+by+phage+display&doi=10.1038%2Fs41587-020-0733-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of highly selective covalent inhibitors by phage display</span></div><div class="casAuthors">Chen, Shiyu; Lovell, Scott; Lee, Sumin; Fellner, Matthias; Mace, Peter D.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">490-498</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Portfolio</span>)
        </div><div class="casAbstract">Mols. that covalently bind macromol. targets have found widespread applications as activity-based probes and as irreversibly binding drugs.  However, the general reactivity of the electrophiles needed for covalent bond formation makes control of selectivity difficult.  There is currently no rapid, unbiased screening method to identify new classes of covalent inhibitors from highly diverse pools of candidate mols.  Here we describe a phage display method to directly screen for ligands that bind to protein targets through covalent bond formation.  This approach makes use of a reactive linker to form cyclic peptides on the phage surface while simultaneously introducing an electrophilic 'warhead' to covalently react with a nucleophile on the target.  Using this approach, we identified cyclic peptides that irreversibly inhibited a cysteine protease and a serine hydrolase with nanomolar potency and exceptional specificity.  This approach should enable rapid, unbiased screening to identify new classes of highly selective covalent inhibitors for diverse mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6VXSDuC_yqbVg90H21EOLACvtfcHk0ljsdbyIeHrDTw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlGjsb7M&md5=f4a2105dc2de93f13e110473fc19dfed</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fs41587-020-0733-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41587-020-0733-7%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLovell%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DFellner%26aufirst%3DM.%26aulast%3DMace%26aufirst%3DP.%2BD.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520highly%2520selective%2520covalent%2520inhibitors%2520by%2520phage%2520display%26jtitle%3DNat.%2520Biotechnol.%26date%3D2021%26volume%3D39%26spage%3D490%26doi%3D10.1038%2Fs41587-020-0733-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">Structure- and fragment-based approaches to protease inhibition</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">317</span>â <span class="NLM_lpage">329</span>, <span class="refDoi">Â DOI: 10.2174/156802606776287072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.2174%2F156802606776287072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=16611145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVahsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=317-329&issue=4&author=S.+Johnsonauthor=M.+Pellecchia&title=Structure-+and+fragment-based+approaches+to+protease+inhibition&doi=10.2174%2F156802606776287072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and fragment-based approaches to protease inhibition</span></div><div class="casAuthors">Johnson, Sherida L.; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-329</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Proteases are essential enzymes which regulate physiol. processes such as inflammation, infection, fertilization, allergic reactions, cell growth and death, blood clotting, tumor growth and bone remodeling.  The protease family consists of six major classes of enzymes which are aspartic-, serine-, cysteine-, threonine-, glutamic-, and metallo-proteases, all which are implicated in disease propagation.  Therefore, protease inhibitors have been of great interest as possible targets for the development of novel therapies.  Although, many protease inhibitors have followed a structural design based on either a peptidic or peptidomimetic backbone, other chem. scaffolds have recently emerged.  Utilizing structure- and fragment-based design guided by X-ray crystallog., NMR spectroscopy, computational and/or extended tethering approaches, potential non-peptidic therapeutic agents could be identified.  In this review, we will report on the recent developments of nonpeptidic cysteine- and metallo- protease inhibitors, focusing on their design by using such strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0HHEPP9rf9rVg90H21EOLACvtfcHk0ljsdbyIeHrDTw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVahsb4%253D&md5=c5039c54532ef1a389350fe6e2f85b5e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F156802606776287072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776287072%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DStructure-%2520and%2520fragment-based%2520approaches%2520to%2520protease%2520inhibition%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26issue%3D4%26spage%3D317%26epage%3D329%26doi%3D10.2174%2F156802606776287072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span> <span> </span><span class="NLM_article-title">Emerging principles in protease-based drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">690</span>â <span class="NLM_lpage">701</span>, <span class="refDoi">Â DOI: 10.1038/nrd3053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnrd3053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=20811381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSisbzP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=690-701&issue=9&author=M.+Dragauthor=G.+S.+Salvesen&title=Emerging+principles+in+protease-based+drug+discovery&doi=10.1038%2Fnrd3053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging principles in protease-based drug discovery</span></div><div class="casAuthors">Drag, Marcin; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">690-701</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Proteases have an important role in many signalling pathways, and represent potential drug targets for diseases ranging from cardiovascular disorders to cancer, as well as for combating many parasites and viruses.  Although inhibitors of well-established protease targets such as angiotensin-converting enzyme and HIV protease have shown substantial therapeutic success, developing drugs for new protease targets has proved challenging in recent years.  This in part could be due to issues such as the difficulty of achieving selectivity when targeting protease active sites.  This Perspective discusses the general principles in protease-based drug discovery, highlighting the lessons learned and the emerging strategies, such as targeting allosteric sites, which could help harness the therapeutic potential of new protease targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz3PQDA1pnT7Vg90H21EOLACvtfcHk0lggEFXc67BhPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSisbzP&md5=28a9571473c3f753027665b77d3257d0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnrd3053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3053%26sid%3Dliteratum%253Aachs%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DEmerging%2520principles%2520in%2520protease-based%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26issue%3D9%26spage%3D690%26epage%3D701%26doi%3D10.1038%2Fnrd3053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Man, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanneganti, T.-D.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>277</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">61</span>â <span class="NLM_lpage">75</span>, <span class="refDoi">Â DOI: 10.1111/imr.12534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1111%2Fimr.12534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=28462526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVeluro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2017&pages=61-75&issue=1&author=S.+M.+Manauthor=R.+Karkiauthor=T.-D.+Kanneganti&title=Molecular+mechanisms+and+functions+of+pyroptosis%2C+inflammatory+caspases+and+inflammasomes+in+infectious+diseases&doi=10.1111%2Fimr.12534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases</span></div><div class="casAuthors">Man, Si Ming; Karki, Rajendra; Kanneganti, Thirumala-Devi</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-75</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Cell death is a fundamental biol. phenomenon that is essential for the survival and development of an organism.  Emerging evidence also indicates that cell death contributes to immune defense against infectious diseases.  Pyroptosis is a form of inflammatory programmed cell death pathway activated by human and mouse caspase-1, human caspase-4 and caspase-5, or mouse caspase-11.  These inflammatory caspases are used by the host to control bacterial, viral, fungal, or protozoan pathogens.  Pyroptosis requires cleavage and activation of the pore-forming effector protein gasdermin D by inflammatory caspases.  Phys. rupture of the cell causes release of the pro-inflammatory cytokines IL-1Î² and IL-18, alarmins and endogenous danger-assocd. mol. patterns, signifying the inflammatory potential of pyroptosis.  Here, we describe the central role of inflammatory caspases and pyroptosis in mediating immunity to infection and clearance of pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVzNwDuy-jq7Vg90H21EOLACvtfcHk0lggEFXc67BhPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVeluro%253D&md5=02ac1bc04d31a2411878deece69e722a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fimr.12534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimr.12534%26sid%3Dliteratum%253Aachs%26aulast%3DMan%26aufirst%3DS.%2BM.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DKanneganti%26aufirst%3DT.-D.%26atitle%3DMolecular%2520mechanisms%2520and%2520functions%2520of%2520pyroptosis%252C%2520inflammatory%2520caspases%2520and%2520inflammasomes%2520in%2520infectious%2520diseases%26jtitle%3DImmunol.%2520Rev.%26date%3D2017%26volume%3D277%26issue%3D1%26spage%3D61%26epage%3D75%26doi%3D10.1111%2Fimr.12534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamkanfi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walle, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanneganti, T.-D.</span></span> <span> </span><span class="NLM_article-title">Deregulated inflammasome signaling in disease</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>243</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">163</span>â <span class="NLM_lpage">173</span>, <span class="refDoi">Â DOI: 10.1111/j.1600-065X.2011.01042.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1111%2Fj.1600-065X.2011.01042.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21884175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BC3Mfgs1Squw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=2011&pages=163-173&issue=1&author=M.+Lamkanfiauthor=L.+V.+Walleauthor=T.-D.+Kanneganti&title=Deregulated+inflammasome+signaling+in+disease&doi=10.1111%2Fj.1600-065X.2011.01042.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Deregulated inflammasome signaling in disease</span></div><div class="casAuthors">Lamkanfi Mohamed; Vande Walle Lieselotte; Kanneganti Thirumala-Devi</div><div class="citationInfo"><span class="NLM_cas:title">Immunological reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">243</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">163-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammasomes are multi-protein complexes that sense microbial molecules and endogenous danger signals in intracellular compartments.  Inflammasome assembly results in caspase-1 activation, which in turn drives maturation and secretion of the pro-inflammatory cytokines interleukin 1Î² (IL-1Î²) and IL-18, and induces pyroptosis to eliminate the infectious agent.  The importance of inflammasomes in regulating immune responses was recognized with the discovery of polymorphisms in genes encoding inflammasome components and their linkage to aberrant production of IL-1Î² and IL-18 in autoimmune and hereditary periodic fevers syndromes.  We review the current knowledge on the role of inflammasomes in regulating innate and adaptive immune responses with an emphasis on the role of these immune complexes in autoinflammatory disorders and autoimmune diseases such as colitis, type I diabetes, multiple sclerosis and vitiligo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSBmHinuMOvZIFEOhA_Im3cfW6udTcc2eYZ34xNg7wm4Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mfgs1Squw%253D%253D&md5=5f6c28e901cab1769004643da0d17a55</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2011.01042.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2011.01042.x%26sid%3Dliteratum%253Aachs%26aulast%3DLamkanfi%26aufirst%3DM.%26aulast%3DWalle%26aufirst%3DL.%2BV.%26aulast%3DKanneganti%26aufirst%3DT.-D.%26atitle%3DDeregulated%2520inflammasome%2520signaling%2520in%2520disease%26jtitle%3DImmunol.%2520Rev.%26date%3D2011%26volume%3D243%26issue%3D1%26spage%3D163%26epage%3D173%26doi%3D10.1111%2Fj.1600-065X.2011.01042.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamkanfi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Loo, G.</span></span> <span> </span><span class="NLM_article-title">Inflammasomes in neuroinflammatory and neurodegenerative diseases</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">6</span>), <span class="NLM_elocation-id">e10248</span> <span class="refDoi">Â DOI: 10.15252/emmm.201810248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.15252%2Femmm.201810248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31015277" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&issue=6&author=S.+Voetauthor=S.+Srinivasanauthor=M.+Lamkanfiauthor=G.+van+Loo&title=Inflammasomes+in+neuroinflammatory+and+neurodegenerative+diseases&doi=10.15252%2Femmm.201810248"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.15252%2Femmm.201810248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201810248%26sid%3Dliteratum%253Aachs%26aulast%3DVoet%26aufirst%3DS.%26aulast%3DSrinivasan%26aufirst%3DS.%26aulast%3DLamkanfi%26aufirst%3DM.%26aulast%3Dvan%2BLoo%26aufirst%3DG.%26atitle%3DInflammasomes%2520in%2520neuroinflammatory%2520and%2520neurodegenerative%2520diseases%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2019%26volume%3D11%26issue%3D6%26doi%3D10.15252%2Femmm.201810248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lenardo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornung, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span> <span> </span><span class="NLM_article-title">Mature T lymphocyte apoptosisâimmune regulation in a dynamic and unpredictable antigenic environment</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">221</span>â <span class="NLM_lpage">253</span>, <span class="refDoi">Â DOI: 10.1146/annurev.immunol.17.1.221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1146%2Fannurev.immunol.17.1.221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10358758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVSrtbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=221-253&issue=1&author=M.+Lenardoauthor=F.+K.-M.+Chanauthor=F.+Hornungauthor=H.+McFarlandauthor=R.+Siegelauthor=J.+Wangauthor=L.+Zheng&title=Mature+T+lymphocyte+apoptosis%E2%80%94immune+regulation+in+a+dynamic+and+unpredictable+antigenic+environment&doi=10.1146%2Fannurev.immunol.17.1.221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Mature T lymphocyte apoptosis: immune regulation in a dynamic and unpredictable antigenic environment</span></div><div class="casAuthors">Lenardo, Michael; Chan, Francis Ka-Ming; Hornung, Felicita; McFarland, Hugh; Siegel, Richard; Wang, Jin; Zheng, Lixin</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">221-253</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 347 refs.  Apoptosis of mature T lymphocytes preserves peripheral homeostasis and tolerance by countering the profound changes in the no. and types of T cells stimulated by diverse antigens.  T cell apoptosis occurs in at least two major forms: antigen-driven and lymphokine withdrawal.  These forms of death are controlled in response to local levels of IL-2 and antigen in a feedback mechanism termed propriocidal regulation.  Active antigen-driven death is mediated by the expression of death cytokines such as FasL and TNF.  These death cytokines engage specific receptors that assemble caspase-activating protein complexes.  These signaling complexes tightly regulate cell death but are vulnerable to inherited defects.  Passive lymphokine withdrawal death may result from the cytoplasmic activation of caspases that is regulated by mitochondria and the Bcl-2 protein.  The human disease, Autoimmune Lymphoproliferative Syndrome (ALPS) is due to dominant-interfering mutations in the Fas/APO-1/CD95 receptor and other components of the death pathway.  The study of ALPS patients reveals the necessity of apoptosis for preventing autoimmunity and allows the genetic investigation of apoptosis in humans.  Immunol., cellular, and mol. evidence indicates that throughout the life of a T cell, apoptosis may be evoked in excessive, harmful, or useless clonotypes to preserve a healthy and balanced immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnWbFgvijQRLVg90H21EOLACvtfcHk0lg3JBcjq4YReg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVSrtbc%253D&md5=979208a1854b52477705a7375a13af40</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.17.1.221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.17.1.221%26sid%3Dliteratum%253Aachs%26aulast%3DLenardo%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DF.%2BK.-M.%26aulast%3DHornung%26aufirst%3DF.%26aulast%3DMcFarland%26aufirst%3DH.%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DL.%26atitle%3DMature%2520T%2520lymphocyte%2520apoptosis%25E2%2580%2594immune%2520regulation%2520in%2520a%2520dynamic%2520and%2520unpredictable%2520antigenic%2520environment%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1999%26volume%3D17%26issue%3D1%26spage%3D221%26epage%3D253%26doi%3D10.1146%2Fannurev.immunol.17.1.221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwerk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze-Osthoff, K.</span></span> <span> </span><span class="NLM_article-title">Non-apoptotic functions of caspases in cellular proliferation and differentiation</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1453</span>â <span class="NLM_lpage">1458</span>, <span class="refDoi">Â DOI: 10.1016/S0006-2952(03)00497-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0006-2952%2803%2900497-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=14555221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVeqsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2003&pages=1453-1458&issue=8&author=C.+Schwerkauthor=K.+Schulze-Osthoff&title=Non-apoptotic+functions+of+caspases+in+cellular+proliferation+and+differentiation&doi=10.1016%2FS0006-2952%2803%2900497-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Non-apoptotic functions of caspases in cellular proliferation and differentiation</span></div><div class="casAuthors">Schwerk, Christian; Schulze-Osthoff, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1453-1458</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Caspases have been identified as key players in the cellular process termed programmed cell death or apoptosis.  During apoptosis, activated apoptotic caspases cleave selected target proteins to execute cell death.  Addnl. to their established function in cell death, a variety of recent publications have provided increasing evidence that apoptotic caspases also participate in several non-apoptotic cellular processes.  Activated caspases exhibit functions during T-cell proliferation and cell cycle regulation, but are also involved in the differentiation of a diverse array of cell types.  In some cell types, their differentiation can be morphol. viewed as a kind of incomplete apoptosis.  Anal. of well-known apoptotic targets of caspases implicates that the cleavage of a limited no. of selected substrates plays a major role during non-apoptotic functions of caspases.  Selective substrate cleavage might be regulated by activation of anti-apoptotic factors, via a compartmentalized activation of caspases, or through limited activity of caspases during apoptosis-independent functions.  The increasing evidence for caspase function in non-apoptotic cellular events suggests that caspases play a much more diverse role than previously assumed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRS72q787I8bVg90H21EOLACvtfcHk0lg3JBcjq4YReg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVeqsro%253D&md5=91113c4a09e0801a6980f0ccf9244987</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2803%2900497-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252803%252900497-0%26sid%3Dliteratum%253Aachs%26aulast%3DSchwerk%26aufirst%3DC.%26aulast%3DSchulze-Osthoff%26aufirst%3DK.%26atitle%3DNon-apoptotic%2520functions%2520of%2520caspases%2520in%2520cellular%2520proliferation%2520and%2520differentiation%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D66%26issue%3D8%26spage%3D1453%26epage%3D1458%26doi%3D10.1016%2FS0006-2952%2803%2900497-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chun, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speirs, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skoda-Smith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straus, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenardo, M. J.</span></span> <span> </span><span class="NLM_article-title">Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>419</i></span> (<span class="NLM_issue">6905</span>),  <span class="NLM_fpage">395</span>â <span class="NLM_lpage">399</span>, <span class="refDoi">Â DOI: 10.1038/nature01063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature01063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=12353035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD38XntlGgsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2002&pages=395-399&issue=6905&author=H.+J.+Chunauthor=L.+Zhengauthor=M.+Ahmadauthor=J.+Wangauthor=C.+K.+Speirsauthor=R.+M.+Siegelauthor=J.+K.+Daleauthor=J.+Puckauthor=J.+Davisauthor=C.+G.+Hallauthor=S.+Skoda-Smithauthor=T.+P.+Atkinsonauthor=S.+E.+Strausauthor=M.+J.+Lenardo&title=Pleiotropic+defects+in+lymphocyte+activation+caused+by+caspase-8+mutations+lead+to+human+immunodeficiency&doi=10.1038%2Fnature01063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency</span></div><div class="casAuthors">Chun, Hyung J.; Zheng, Lixin; Ahmad, Manzoor; Wang, Jin; Speirs, Christina K.; Siegel, Richard M.; Dale, Janet K.; Puck, Jennifer; Davis, Joie; Hall, Craig G.; Skoda-Smith, Suzanne; Atkinson, T. Prescott; Straus, Stephen E.; Lenardo, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">6905</span>),
    <span class="NLM_cas:pages">395-399</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is a form of programmed cell death that is controlled by aspartate-specific cysteine proteases called caspases.  In the immune system, apoptosis counters the proliferation of lymphocytes to achieve a homeostatic balance, which allows potent responses to pathogens but avoids autoimmunity.  The CD95 (Fas, Apo-1) receptor triggers lymphocyte apoptosis by recruiting Fas-assocd. death domain (FADD), caspase-8 and caspase-10 proteins into a death-inducing signalling complex.  Heterozygous mutations in CD95, CD95 ligand or caspase-10 underlie most cases of autoimmune lymphoproliferative syndrome (ALPS), a human disorder that is characterized by defective lymphocyte apoptosis, lymphadenopathy, splenomegaly and autoimmunity.  Mutations in caspase-8 have not been described in ALPS, and homozygous caspase-8 deficiency causes embryonic lethality in mice.  Here we describe a human kindred with an inherited genetic deficiency of caspase-8.  Homozygous individuals manifest defective lymphocyte apoptosis and homeostasis but, unlike individuals affected with ALPS, also have defects in their activation of T lymphocytes, B lymphocytes and natural killer cells, which leads to immunodeficiency.  Thus, caspase-8 deficiency in humans is compatible with normal development and shows that caspase-8 has a postnatal role in immune activation of naive lymphocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD7CuqDz2dVbVg90H21EOLACvtfcHk0lg3JBcjq4YReg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntlGgsbg%253D&md5=e0bc4de9463961d217a9f6e9a000ec1e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnature01063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01063%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DH.%2BJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DAhmad%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSpeirs%26aufirst%3DC.%2BK.%26aulast%3DSiegel%26aufirst%3DR.%2BM.%26aulast%3DDale%26aufirst%3DJ.%2BK.%26aulast%3DPuck%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DC.%2BG.%26aulast%3DSkoda-Smith%26aufirst%3DS.%26aulast%3DAtkinson%26aufirst%3DT.%2BP.%26aulast%3DStraus%26aufirst%3DS.%2BE.%26aulast%3DLenardo%26aufirst%3DM.%2BJ.%26atitle%3DPleiotropic%2520defects%2520in%2520lymphocyte%2520activation%2520caused%2520by%2520caspase-8%2520mutations%2520lead%2520to%2520human%2520immunodeficiency%26jtitle%3DNature%26date%3D2002%26volume%3D419%26issue%3D6905%26spage%3D395%26epage%3D399%26doi%3D10.1038%2Fnature01063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salmena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemmers, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matysiak-Zablocki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Au, P. Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamblyn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shehabeldin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakeham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouchard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGlade, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakem, R.</span></span> <span> </span><span class="NLM_article-title">Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">883</span>â <span class="NLM_lpage">895</span>, <span class="refDoi">Â DOI: 10.1101/gad.1063703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1101%2Fgad.1063703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=12654726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislOltro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=883-895&issue=7&author=L.+Salmenaauthor=B.+Lemmersauthor=A.+Hakemauthor=E.+Matysiak-Zablockiauthor=K.+Murakamiauthor=P.+Y.+B.+Auauthor=D.+M.+Berryauthor=L.+Tamblynauthor=A.+Shehabeldinauthor=E.+Migonauthor=A.+Wakehamauthor=D.+Bouchardauthor=W.+C.+Yehauthor=J.+C.+McGladeauthor=P.+S.+Ohashiauthor=R.+Hakem&title=Essential+role+for+caspase+8+in+T-cell+homeostasis+and+T-cell-mediated+immunity&doi=10.1101%2Fgad.1063703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity</span></div><div class="casAuthors">Salmena, Leonardo; Lemmers, Benedicte; Hakem, Anne; Matysiak-Zablocki, Elzbieta; Murakami, Kiichi; Au, P. Y. Billie; Berry, Donna M.; Tamblyn, Laura; Shehabeldin, Amro; Migon, Eva; Wakeham, Andrew; Bouchard, Denis; Yeh, Wen Chen; McGlade, Jane C.; Ohashi, Pamela S.; Hakem, Razqallah</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">883-895</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Defects in death receptor-mediated apoptosis have been linked to cancer and autoimmune disease in humans.  The in vivo role of caspase 8, a component of this pathway, has eluded anal. in postnatal tissues because of the lack of an appropriate animal model.  Targeted disruption of caspase 8 is lethal in utero.  We generated mice with a targeted caspase 8 mutation that is restricted to the T-cell lineage.  Despite normal thymocyte development in the absence of caspase 8, we obsd. a marked decrease in the no. of peripheral T-cells and impaired T-cell response ex vivo to activation stimuli.  Caspase 8 ablation protected thymocytes and activated T-cells from CD95 ligand but not anti-CD3-induced apoptosis, or apoptosis activated by agents that are known to act through the mitochondria.  Caspase 8 mutant mice were unable to mount an immune response to viral infection, indicating that caspase 8 deletion in T-cells leads to immunodeficiency.  These findings identify an essential, cell-stage-specific role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity.  This is consistent with the recent identification of caspase 8 mutations in human immunodeficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmz4vzdKxH3bVg90H21EOLACvtfcHk0lhTmLILtr7QFA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislOltro%253D&md5=fa3adcaff440274bc9d5748edbe8ea44</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1101%2Fgad.1063703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1063703%26sid%3Dliteratum%253Aachs%26aulast%3DSalmena%26aufirst%3DL.%26aulast%3DLemmers%26aufirst%3DB.%26aulast%3DHakem%26aufirst%3DA.%26aulast%3DMatysiak-Zablocki%26aufirst%3DE.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DAu%26aufirst%3DP.%2BY.%2BB.%26aulast%3DBerry%26aufirst%3DD.%2BM.%26aulast%3DTamblyn%26aufirst%3DL.%26aulast%3DShehabeldin%26aufirst%3DA.%26aulast%3DMigon%26aufirst%3DE.%26aulast%3DWakeham%26aufirst%3DA.%26aulast%3DBouchard%26aufirst%3DD.%26aulast%3DYeh%26aufirst%3DW.%2BC.%26aulast%3DMcGlade%26aufirst%3DJ.%2BC.%26aulast%3DOhashi%26aufirst%3DP.%2BS.%26aulast%3DHakem%26aufirst%3DR.%26atitle%3DEssential%2520role%2520for%2520caspase%25208%2520in%2520T-cell%2520homeostasis%2520and%2520T-cell-mediated%2520immunity%26jtitle%3DGenes%2520Dev.%26date%3D2003%26volume%3D17%26issue%3D7%26spage%3D883%26epage%3D895%26doi%3D10.1101%2Fgad.1063703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuda, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misharin, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gierut, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haines, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutcheson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budinger, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stehlik, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlman, H.</span></span> <span> </span><span class="NLM_article-title">Caspase-8 acts as a molecular rheostat to limit RIPK1- and MyD88-mediated dendritic cell activation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>192</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5548</span>â <span class="NLM_lpage">5560</span>, <span class="refDoi">Â DOI: 10.4049/jimmunol.1400122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4049%2Fjimmunol.1400122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24808358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVajt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2014&pages=5548-5560&issue=12&author=C.+M.+Cudaauthor=A.+V.+Misharinauthor=A.+K.+Gierutauthor=R.+Saberauthor=G.+K.+Hainesauthor=J.+Hutchesonauthor=S.+M.+Hedrickauthor=C.+Mohanauthor=G.+S.+Budingerauthor=C.+Stehlikauthor=H.+Perlman&title=Caspase-8+acts+as+a+molecular+rheostat+to+limit+RIPK1-+and+MyD88-mediated+dendritic+cell+activation&doi=10.4049%2Fjimmunol.1400122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase-8 Acts as a Molecular Rheostat To Limit RIPK1- and MyD88-Mediated Dendritic Cell Activation</span></div><div class="casAuthors">Cuda, Carla M.; Misharin, Alexander V.; Gierut, Angelica K.; Saber, Rana; Haines, G. Kenneth, III; Hutcheson, Jack; Hedrick, Stephen M.; Mohan, Chandra; Budinger, G. Scott; Stehlik, Christian; Perlman, Harris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5548-5560</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Caspase-8, an executioner enzyme in the death receptor pathway, was shown to initiate apoptosis and suppress necroptosis.  In this study, we identify a novel, cell death-independent role for caspase-8 in dendritic cells (DCs): DC-specific expression of caspase-8 prevents the onset of systemic autoimmunity.  Failure to express caspase-8 has no effect on the lifespan of DCs but instead leads to an enhanced intrinsic activation and, subsequently, more mature and autoreactive lymphocytes.  Uncontrolled TLR activation in a RIPK1-dependent manner is responsible for the enhanced functionality of caspase-8-deficient DCs, because deletion of the TLR-signaling mediator, MyD88, ameliorates systemic autoimmunity induced by caspase-8 deficiency.  Taken together, these data demonstrate that caspase-8 functions in a cell type-specific manner and acts uniquely in DCs to maintain tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ohClx0QOe7Vg90H21EOLACvtfcHk0lhANdEdO2B8_A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVajt7w%253D&md5=5d58c90aa1619249a8f725ae370b1cfb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1400122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1400122%26sid%3Dliteratum%253Aachs%26aulast%3DCuda%26aufirst%3DC.%2BM.%26aulast%3DMisharin%26aufirst%3DA.%2BV.%26aulast%3DGierut%26aufirst%3DA.%2BK.%26aulast%3DSaber%26aufirst%3DR.%26aulast%3DHaines%26aufirst%3DG.%2BK.%26aulast%3DHutcheson%26aufirst%3DJ.%26aulast%3DHedrick%26aufirst%3DS.%2BM.%26aulast%3DMohan%26aufirst%3DC.%26aulast%3DBudinger%26aufirst%3DG.%2BS.%26aulast%3DStehlik%26aufirst%3DC.%26aulast%3DPerlman%26aufirst%3DH.%26atitle%3DCaspase-8%2520acts%2520as%2520a%2520molecular%2520rheostat%2520to%2520limit%2520RIPK1-%2520and%2520MyD88-mediated%2520dendritic%2520cell%2520activation%26jtitle%3DJ.%2520Immunol.%26date%3D2014%26volume%3D192%26issue%3D12%26spage%3D5548%26epage%3D5560%26doi%3D10.4049%2Fjimmunol.1400122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuda, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misharin, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archer, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haines, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutcheson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorfleutner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budinger, G. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stehlik, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlman, H.</span></span> <span> </span><span class="NLM_article-title">Conditional deletion of caspase-8 in macrophages alters macrophage activation in a RIPK-dependent manner</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">291</span>, <span class="refDoi">Â DOI: 10.1186/s13075-015-0794-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1186%2Fs13075-015-0794-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26471282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVCns7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=291&issue=1&author=C.+M.+Cudaauthor=A.+V.+Misharinauthor=S.+Khareauthor=R.+Saberauthor=F.+Tsaiauthor=A.+M.+Archerauthor=P.+J.+Homanauthor=G.+K.+Hainesauthor=J.+Hutchesonauthor=A.+Dorfleutnerauthor=G.+R.+S.+Budingerauthor=C.+Stehlikauthor=H.+Perlman&title=Conditional+deletion+of+caspase-8+in+macrophages+alters+macrophage+activation+in+a+RIPK-dependent+manner&doi=10.1186%2Fs13075-015-0794-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Conditional deletion of caspase-8 in macrophages alters macrophage activation in a RIPK-dependent manner</span></div><div class="casAuthors">Cuda, Carla M.; Misharin, Alexander V.; Khare, Sonal; Saber, Rana; Tsai, Fu Nien; Archer, Amy M.; Homan, Philip J.; Haines, G. Kenneth, III; Hutcheson, Jack; Dorfleutner, Andrea; Budinger, G. R. Scott; Stehlik, Christian; Perlman, Harris</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291/1-291/16</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Introduction: Although caspase-8 is a well-established initiator of apoptosis and suppressor of necroptosis, recent evidence suggests that this enzyme maintains functions beyond its role in cell death.  As cells of the innate immune system, and in particular macrophages, are now at the forefront of autoimmune disease pathogenesis, we examd. the potential involvement of caspase-8 within this population.  Methods:CreLysMCasp8fl/fl mice were bred via a cross between Casp8fl/fl mice and CreLysM mice, and RIPK3-/-CreLysMCasp8fl/fl mice were generated to assess the contribution of receptor-interacting serine-threonine kinase (RIPK)3.  Immunohistochem. and immunofluorescence analyses were used to examine renal damage.  Flow cytometric anal. was employed to characterize splenocyte distribution and activation.  CreLysMCasp8fl/fl mice were treated with either Toll-like receptor (TLR) agonists or oral antibiotics to assess their response to TLR activation or TLR agonist removal.  Luminex-based assays and enzyme-linked immunosorbent assays were used to measure cytokine/chemokine and Ig levels in serum and cytokine levels in cell culture studies.  In vitro cell culture was used to assess macrophage response to cell death stimuli, TLR activation, and M1/M2 polarization.  Data were compared using the Mann-Whitney U test.  Results: Loss of caspase-8 expression in macrophages promotes onset of a mild systemic inflammatory disease, which is preventable by the deletion of RIPK3.  In vitro cell culture studies reveal that caspase-8-deficient macrophages are prone to a caspase-independent death in response to death receptor ligation; yet, caspase-8-deficient macrophages are not predisposed to unchecked survival, as anal. of mixed bone marrow chimeric mice demonstrates that caspase-8 deficiency does not confer preferential expansion of myeloid populations.  Loss of caspase-8 in macrophages dictates the response to TLR activation, as injection of TLR ligands upregulates expression of costimulatory CD86 on the Ly6ChighCD11b+F4/80+ splenic cells, and oral antibiotic treatment to remove microbiota prevents splenomegaly and lymphadenopathy in CreLysMCasp8fl/fl mice.  Further, caspase-8-deficient macrophages are hyperresponsive to TLR activation and exhibit aberrant M1 macrophage polarization due to RIPK activity.  Conclusions: These data demonstrate that caspase-8 functions uniquely in macrophages by controlling the response to TLR activation and macrophage polarization in an RIPK-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDmoH834c_DbVg90H21EOLACvtfcHk0lhANdEdO2B8_A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVCns7g%253D&md5=97217bc0c857cbeba31c027085f8f995</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1186%2Fs13075-015-0794-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13075-015-0794-z%26sid%3Dliteratum%253Aachs%26aulast%3DCuda%26aufirst%3DC.%2BM.%26aulast%3DMisharin%26aufirst%3DA.%2BV.%26aulast%3DKhare%26aufirst%3DS.%26aulast%3DSaber%26aufirst%3DR.%26aulast%3DTsai%26aufirst%3DF.%26aulast%3DArcher%26aufirst%3DA.%2BM.%26aulast%3DHoman%26aufirst%3DP.%2BJ.%26aulast%3DHaines%26aufirst%3DG.%2BK.%26aulast%3DHutcheson%26aufirst%3DJ.%26aulast%3DDorfleutner%26aufirst%3DA.%26aulast%3DBudinger%26aufirst%3DG.%2BR.%2BS.%26aulast%3DStehlik%26aufirst%3DC.%26aulast%3DPerlman%26aufirst%3DH.%26atitle%3DConditional%2520deletion%2520of%2520caspase-8%2520in%2520macrophages%2520alters%2520macrophage%2520activation%2520in%2520a%2520RIPK-dependent%2520manner%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2015%26volume%3D17%26issue%3D1%26spage%3D291%26doi%3D10.1186%2Fs13075-015-0794-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sneller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straus, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenardo, M. J.</span></span> <span> </span><span class="NLM_article-title">Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>98</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">47</span>â <span class="NLM_lpage">58</span>, <span class="refDoi">Â DOI: 10.1016/S0092-8674(00)80605-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0092-8674%2800%2980605-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10412980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1MXks1Kksbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1999&pages=47-58&issue=1&author=J.+Wangauthor=L.+Zhengauthor=A.+Lobitoauthor=F.+K.-M.+Chanauthor=J.+Daleauthor=M.+Snellerauthor=X.+Yaoauthor=J.+M.+Puckauthor=S.+E.+Strausauthor=M.+J.+Lenardo&title=Inherited+human+caspase+10+mutations+underlie+defective+lymphocyte+and+dendritic+cell+apoptosis+in+autoimmune+lymphoproliferative+syndrome+type+II&doi=10.1016%2FS0092-8674%2800%2980605-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II</span></div><div class="casAuthors">Wang, Jin; Zheng, Lixin; Lobito, Adrian; Chan, Francis Ka-Ming; Dale, Janet; Sneller, Michael; Yao, Xu; Puck, Jennifer M.; Straus, Stephen E.; Lenardo, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-58</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Caspases are cysteine proteases that mediate programmed cell death in phylogenetically diverse multi-cellular organisms.  The authors report 2 kindreds with autoimmune lymphoproliferative syndrome (ALPS) type II, characterized by abnormal lymphocyte and dendritic cell homeostasis and immune regulatory defects, that harbor independent missense mutations in caspase 10.  These encode amino acid substitutions that decrease caspase activity and interfere with death receptor-induced apoptosis, particularly that stimulated by Fas ligand and TRAIL.  These results provide evidence that inherited nonlethal caspase abnormalities cause pleiotropic apoptosis defects underlying autoimmunity in ALPS type II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjracbOzPztrVg90H21EOLACvtfcHk0lhIYuAM0Vrb_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXks1Kksbc%253D&md5=b60971d888311544a6eb37a76f35278d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980605-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980605-4%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DLobito%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DF.%2BK.-M.%26aulast%3DDale%26aufirst%3DJ.%26aulast%3DSneller%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DPuck%26aufirst%3DJ.%2BM.%26aulast%3DStraus%26aufirst%3DS.%2BE.%26aulast%3DLenardo%26aufirst%3DM.%2BJ.%26atitle%3DInherited%2520human%2520caspase%252010%2520mutations%2520underlie%2520defective%2520lymphocyte%2520and%2520dendritic%2520cell%2520apoptosis%2520in%2520autoimmune%2520lymphoproliferative%2520syndrome%2520type%2520II%26jtitle%3DCell%26date%3D1999%26volume%3D98%26issue%3D1%26spage%3D47%26epage%3D58%26doi%3D10.1016%2FS0092-8674%2800%2980605-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McComb, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sad, S.</span></span> <span> </span><span class="NLM_article-title">Caspase-3 is transiently activated without cell death during early antigen driven expansion of CD8+ T cells in vivo</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">12</span>), <span class="NLM_elocation-id">e15328</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0015328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1371%2Fjournal.pone.0015328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21203525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtlWjtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&issue=12&author=S.+McCombauthor=R.+Mulliganauthor=S.+Sad&title=Caspase-3+is+transiently+activated+without+cell+death+during+early+antigen+driven+expansion+of+CD8%2B+T+cells+in+vivo&doi=10.1371%2Fjournal.pone.0015328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase-3 is transiently activated without cell death during early antigen driven expansion of CD8+ T cells in vivo</span></div><div class="casAuthors">McComb, Scott; Mulligan, Rebecca; Sad, Subash</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e15328</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: CD8+ T cell responses develop rapidly during infection and are swiftly reduced during contraction, wherein >90% of primed CD8+ T cells are eliminated.  The role of apoptotic mechanisms in controlling this rapid proliferation and contraction of CD8+ T cells remains unclear.  Surprisingly, evidence has shown non-apoptotic activation of caspase-3 to occur during in vitro T-cell proliferation, but the relevance of these mechanisms to in vivo CD8+ T cell responses has yet to be examd.  Methods and Findings: We have evaluated the activity of caspase-3, a key downstream inducer of apoptosis, throughout the entirety of a CD8+ T cell response.  We utilized two infection models that differ in the intensity, onset and duration of antigen-presentation and inflammation.  Expression of cleaved caspase-3 in antigen specific CD8+ T cells was coupled to the timing and strength of antigen presentation in lymphoid organs.  We also obsd. coordinated activation of addnl. canonical apoptotic markers, including phosphatidylserine exposure.  Limiting diln. anal. directly showed that in the presence of IL7, very little cell death occurred in both caspase-3hi and caspase-3low CD8+ T cells.  The expression of active caspase-3 peaked before effector phenotype (CD62Llow) CD8+ T cells emerged, and was undetectable in effector-phenotype cells.  In addn., OVA-specific CD8+ cells remained active caspase-3low throughout the contraction phase.  Conclusions: Our results specifically implicate antigen and not inflammation in driving activation of apoptotic mechanisms without cell death in proliferating CD8+ T cells.  Furthermore, the contraction of CD8+ T cell response following expansion is likely not mediated by the key downstream apoptosis inducer, caspase-3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS4SXRGwrVFbVg90H21EOLACvtfcHk0lhIYuAM0Vrb_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtlWjtw%253D%253D&md5=cab1333decb8be32f1b0ed16b9f535c9</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0015328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0015328%26sid%3Dliteratum%253Aachs%26aulast%3DMcComb%26aufirst%3DS.%26aulast%3DMulligan%26aufirst%3DR.%26aulast%3DSad%26aufirst%3DS.%26atitle%3DCaspase-3%2520is%2520transiently%2520activated%2520without%2520cell%2520death%2520during%2520early%2520antigen%2520driven%2520expansion%2520of%2520CD8%252B%2520T%2520cells%2520in%2520vivo%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26issue%3D12%26doi%3D10.1371%2Fjournal.pone.0015328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slee, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, G. M.</span></span> <span> </span><span class="NLM_article-title">Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>315</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">21</span>â <span class="NLM_lpage">24</span>, <span class="refDoi">Â DOI: 10.1042/bj3150021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1042%2Fbj3150021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8670109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK28Xitlygsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=1996&pages=21-24&issue=1&author=E.+A.+Sleeauthor=H.+Zhuauthor=S.+C.+Chowauthor=M.+MacFarlaneauthor=D.+W.+Nicholsonauthor=G.+M.+Cohen&title=Benzyloxycarbonyl-Val-Ala-Asp+%28OMe%29+fluoromethylketone+%28Z-VAD.FMK%29+inhibits+apoptosis+by+blocking+the+processing+of+CPP32&doi=10.1042%2Fbj3150021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32</span></div><div class="casAuthors">Slee, Elizabeth A.; Zhu, Huijun; Chow, Sek C.; MacFarlane, Marion; Nicholson, Donald W.; Cohen, Gerald M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-4</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press</span>)
        </div><div class="casAbstract">Interleukin-1Î² converting enzyme (ICE)-like proteases, which are synthesized as inactive precursors, play a key role in the induction of apoptosis.  We now demonstrate that benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK), an ICE-like protease inhibitor, inhibits apoptosis by preventing the processing of CPP32 to its active form.  These results suggest that novel therapeutic agents, inhibitors of apoptosis, can be developed which prevent processing of proforms of ICE-like proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTPkRkVlXWZbVg90H21EOLACvtfcHk0lgGaX3NCDwylg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xitlygsb0%253D&md5=0de220cb7f160cbbd207974850c37a3c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1042%2Fbj3150021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3150021%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DE.%2BA.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DChow%26aufirst%3DS.%2BC.%26aulast%3DMacFarlane%26aufirst%3DM.%26aulast%3DNicholson%26aufirst%3DD.%2BW.%26aulast%3DCohen%26aufirst%3DG.%2BM.%26atitle%3DBenzyloxycarbonyl-Val-Ala-Asp%2520%2528OMe%2529%2520fluoromethylketone%2520%2528Z-VAD.FMK%2529%2520inhibits%2520apoptosis%2520by%2520blocking%2520the%2520processing%2520of%2520CPP32%26jtitle%3DBiochem.%2520J.%26date%3D1996%26volume%3D315%26issue%3D1%26spage%3D21%26epage%3D24%26doi%3D10.1042%2Fbj3150021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoglen, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirakawa, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras, P. C.</span></span> <span> </span><span class="NLM_article-title">Characterization of IDN-6556 (3-{2-(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid): a liver-targeted caspase inhibitor</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>309</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">634</span>â <span class="NLM_lpage">640</span>, <span class="refDoi">Â DOI: 10.1124/jpet.103.062034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1124%2Fjpet.103.062034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=14742742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1yhu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=634-640&issue=2&author=N.+C.+Hoglenauthor=L.-S.+Chenauthor=C.+D.+Fisherauthor=B.+P.+Hirakawaauthor=T.+Groesslauthor=P.+C.+Contreras&title=Characterization+of+IDN-6556+%283-%7B2-%282-tert-butyl-phenylaminooxalyl%29-amino%5D-propionylamino%7D-4-oxo-5-%282%2C3%2C5%2C6-tetrafluoro-phenoxy%29-pentanoic+acid%29%3A+a+liver-targeted+caspase+inhibitor&doi=10.1124%2Fjpet.103.062034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of IDN-6556 (3-{2-(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid): A liver-targeted caspase inhibitor</span></div><div class="casAuthors">Hoglen, Niel C.; Chen, Long-Shiuh; Fisher, Craig D.; Hirakawa, Brad P.; Groessl, Todd; Contreras, Patricia C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">634-640</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The potency, efficacy, and pharmacokinetic properties of IDN-6556 (3-{2-[(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid), a first-in-class caspase inhibitor in clin. trials for the treatment of liver diseases, were characterized in vivo in rodent models.  In the mouse Î±-Fas model of liver injury, i.p. administration of IDN-6556 resulted in marked redn. of alanine aminotransferase (ALT), apoptosis, and caspase activities at a dose of 3 mg/kg.  At this dose, IDN-6556 was also effective when given up to 2 h before Î±-Fas and as late as 4 h after Î±-Fas administration.  In both the Î±-Fas and D-galactosamine/lipopolysaccharide (D-Gln/LPS) model, ED50 values in the sub-milligram per kg range were established after a no. of routes of administration (i.p., i.v., i.m., or p.o.), ranging from 0.04 to 0.38 mg/kg.  Efficacy was also demonstrated in the rat D-Gln/LPS model with 67 and 72% redns. in ALT activities after i.p. and p.o. treatment with IDN-6556 (10 mg/kg), resp.  Pharmacokinetic anal. in the rat demonstrated rapid clearance after i.v., i.p., and s.c. administration with terminal t1/2 ranging from 46 to 51 min.  Low abs. bioavailability after p.o. administration was seen (2.7-4%), but portal drug concns. after oral administration were 3-fold higher than systemic concns. with a 3.7-fold increase in the terminal t1/2, indicating a significant first-pass effect.  Liver concns. remained const. after oral administration for at least a 4-h period, reaching a Cmax of 2558 ng/g liver at 120 min.  Last, 51 Â± 20 and 4.9 Â± 3.4% of IDN-6556 was excreted intact in bile after i.v. and p.o. administration, resp.  This evaluation indicates that IDN-6556 has marked efficacy in models of liver disease after oral administration and thus, is an excellent candidate for the treatment of liver diseases characterized by excessive apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphjgk47WN_J7Vg90H21EOLACvtfcHk0lhEEmahAwHPDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1yhu78%253D&md5=e1240d6cf5e4d3562ee8d515bb3ffba9</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062034%26sid%3Dliteratum%253Aachs%26aulast%3DHoglen%26aufirst%3DN.%2BC.%26aulast%3DChen%26aufirst%3DL.-S.%26aulast%3DFisher%26aufirst%3DC.%2BD.%26aulast%3DHirakawa%26aufirst%3DB.%2BP.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DContreras%26aufirst%3DP.%2BC.%26atitle%3DCharacterization%2520of%2520IDN-6556%2520%25283-%257B2-%25282-tert-butyl-phenylaminooxalyl%2529-amino%255D-propionylamino%257D-4-oxo-5-%25282%252C3%252C5%252C6-tetrafluoro-phenoxy%2529-pentanoic%2520acid%2529%253A%2520a%2520liver-targeted%2520caspase%2520inhibitor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26issue%3D2%26spage%3D634%26epage%3D640%26doi%3D10.1124%2Fjpet.103.062034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howard, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostura, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limjuco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salley, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogquist, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumford, R. A.</span></span> <span> </span><span class="NLM_article-title">IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>147</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2964</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1919001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK38XotFOqsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=1991&pages=2964&issue=9&author=A.+D.+Howardauthor=M.+J.+Kosturaauthor=N.+Thornberryauthor=G.+J.+Dingauthor=G.+Limjucoauthor=J.+Weidnerauthor=J.+P.+Salleyauthor=K.+A.+Hogquistauthor=D.+D.+Chaplinauthor=R.+A.+Mumford&title=IL-1-converting+enzyme+requires+aspartic+acid+residues+for+processing+of+the+IL-1+beta+precursor+at+two+distinct+sites+and+does+not+cleave+31-kDa+IL-1+alpha"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1Î² precursor at two distinct sites and does not cleave 31-kDa IL-1Î±</span></div><div class="casAuthors">Howard, Andrew D.; Kostura, Matthew J.; Thornberry, Nancy; Ding, Gloria J. F.; Limjuco, Guadalupe; Weidner, Jeffrey; Salley, J. Paul; Hogquist, Kristin A.; Chaplin, David D.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2964-9</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    </div><div class="casAbstract">IL-1 converting enzyme (ICE) specifically cleaves the human IL-1Î² precursor at two sequence-related sites: Asp27-Gly28 (site 1) and Asp116-Ala117 (site 2).  Cleavage at Asp116-Ala117 results in the generation of mature, biol. active IL-1Î².  ICE is unusual in that preferred cleavage at Asp-X bonds (where X is a small hydrophobic residue), has not been described for any other eukaryotic protease.  To further examine the substrate specificity of ICE, proteins that contain Asp-X linkages, including transferrin, actin, complement factor 9, the murine IL-1Î² precursor, and human and murine IL-Î± precursors, were assayed for cleavage by 500-fold purified ICE.  The human and murine IL-1Î² precursors were the only proteins cleaved by ICE, demonstrating that ICE is an IL-1Î² convertase.  Anal. of human IL-1Î² precursor mutants contg. amino acid substitutions or deletions within each processing site demonstrated that omission or replacement of Asp at site 1 or site 2 prevented cleavage by ICE.  To quant. assess the substrate requirements of ICE, a peptide-based cleavage assay was established using a 14-mer spanning site 2.  Cleavage between Asp [P1] and Ala [P1']2 was demonstrated.  Replacement of Asp with Ala, Glu, or Asn resulted in a >100-fold redn. in cleavage activity.  The rank order in position P1' was Gly > Ala Â» Leu > Lys > Glu.  Substitutions at P2'-P4' and P6' had relatively little effect on cleavage activity.  Thus, ICE is a highly specific IL-1Î² convertase with abs. requirements for Asp in P1 and a small hydrophobic amino acid in P1'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-Ve1RGAxs7rVg90H21EOLACvtfcHk0lhEEmahAwHPDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XotFOqsw%253D%253D&md5=83d2f808cb7d3fe8784118ed335a6f83</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DKostura%26aufirst%3DM.%2BJ.%26aulast%3DThornberry%26aufirst%3DN.%26aulast%3DDing%26aufirst%3DG.%2BJ.%26aulast%3DLimjuco%26aufirst%3DG.%26aulast%3DWeidner%26aufirst%3DJ.%26aulast%3DSalley%26aufirst%3DJ.%2BP.%26aulast%3DHogquist%26aufirst%3DK.%2BA.%26aulast%3DChaplin%26aufirst%3DD.%2BD.%26aulast%3DMumford%26aufirst%3DR.%2BA.%26atitle%3DIL-1-converting%2520enzyme%2520requires%2520aspartic%2520acid%2520residues%2520for%2520processing%2520of%2520the%2520IL-1%2520beta%2520precursor%2520at%2520two%2520distinct%2520sites%2520and%2520does%2520not%2520cleave%252031-kDa%2520IL-1%2520alpha%26jtitle%3DJ.%2520Immunol.%26date%3D1991%26volume%3D147%26issue%3D9%26spage%3D2964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sleath, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kronheim, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">March, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, R. A.</span></span> <span> </span><span class="NLM_article-title">Substrate specificity of the protease that processes human interleukin-1 beta</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>265</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">14526</span>â <span class="NLM_lpage">14528</span>, <span class="refDoi">Â DOI: 10.1016/S0021-9258(18)77334-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0021-9258%2818%2977334-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=2201686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3MXisFOr" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=14526-14528&issue=24&author=P.+R.+Sleathauthor=R.+C.+Hendricksonauthor=S.+R.+Kronheimauthor=C.+J.+Marchauthor=R.+A.+Black&title=Substrate+specificity+of+the+protease+that+processes+human+interleukin-1+beta&doi=10.1016%2FS0021-9258%2818%2977334-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate specificity of the protease that processes human interleukin-1Î²</span></div><div class="casAuthors">Sleath, Paul R.; Hendrickson, Ronald C.; Kronheim, Shirley R.; March, Carl J.; Black, Roy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">14526-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The substrate specificity of the protease which generates mature human interleukin-1Î² (IL-1Î²) from prointerleukin-1Î² was investigated using synthetic peptide substrates and recombinant pro-IL-1Î².  The requirement of an L-aspartate in the P-1 position was confirmed together with the need for a small hydrophobic residue in the P-1' position (Gly or Ala).  The enzyme can tolerate conservative substitutions in the P-2 and P-2' positions.  Little difference was found in the enzyme's ability to cleave denatured and native pro-IL-1Î², indicating that tertiary structure recognition is not involved in binding.  The enzyme did, however, require a peptide of >6 amino acids for cleavage to occur.  These results conclusively demonstrate the unusual specificity of this protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQCF5jhN0ecLVg90H21EOLACvtfcHk0lhia2RRddWp6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXisFOr&md5=cd0779009cd95ca26b3a1f6171836c93</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2977334-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252977334-1%26sid%3Dliteratum%253Aachs%26aulast%3DSleath%26aufirst%3DP.%2BR.%26aulast%3DHendrickson%26aufirst%3DR.%2BC.%26aulast%3DKronheim%26aufirst%3DS.%2BR.%26aulast%3DMarch%26aufirst%3DC.%2BJ.%26aulast%3DBlack%26aufirst%3DR.%2BA.%26atitle%3DSubstrate%2520specificity%2520of%2520the%2520protease%2520that%2520processes%2520human%2520interleukin-1%2520beta%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26issue%3D24%26spage%3D14526%26epage%3D14528%26doi%3D10.1016%2FS0021-9258%2818%2977334-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K. T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a potent, reversible inhibitor of interleukin-1Î² converting enzyme</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">613</span>â <span class="NLM_lpage">618</span>, <span class="refDoi">Â DOI: 10.1016/S0960-894X(01)81209-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0960-894X%2801%2981209-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3sXkvVGls7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1992&pages=613-618&issue=6&author=K.+T.+Chapman&title=Synthesis+of+a+potent%2C+reversible+inhibitor+of+interleukin-1%CE%B2+converting+enzyme&doi=10.1016%2FS0960-894X%2801%2981209-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a potent, reversible inhibitor of interleukin-1Î² converting enzyme</span></div><div class="casAuthors">Chapman, Kevin T.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">613-18</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    </div><div class="casAbstract">An efficient synthesis of L-709,049, a potent inhibitor of interleukin-1Î² converting enzyme (ICE) is reported.  The aspartic acid aldehyde moiety is protected as the corresponding O-benzylacyal which can be conveniently coupled to AcTyrValAla and hydrogenolyzed to afford the desired product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopN4JPRneNqrVg90H21EOLACvtfcHk0livpzgL0LUaNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvVGls7Y%253D&md5=60518b21ab4191d41c8a67fd56335ecc</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2981209-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252981209-9%26sid%3Dliteratum%253Aachs%26aulast%3DChapman%26aufirst%3DK.%2BT.%26atitle%3DSynthesis%2520of%2520a%2520potent%252C%2520reversible%2520inhibitor%2520of%2520interleukin-1%25CE%25B2%2520converting%2520enzyme%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1992%26volume%3D2%26issue%3D6%26spage%3D613%26epage%3D618%26doi%3D10.1016%2FS0960-894X%2801%2981209-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rano, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timkey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotonda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N. A.</span></span> <span> </span><span class="NLM_article-title">A combinatorial approach for determining protease specificities: application to interleukin-1Î² converting enzyme (ICE)</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">149</span>â <span class="NLM_lpage">155</span>, <span class="refDoi">Â DOI: 10.1016/S1074-5521(97)90258-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS1074-5521%2897%2990258-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=9190289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2sXitVynu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1997&pages=149-155&issue=2&author=T.+A.+Ranoauthor=T.+Timkeyauthor=E.+P.+Petersonauthor=J.+Rotondaauthor=D.+W.+Nicholsonauthor=J.+W.+Beckerauthor=K.+T.+Chapmanauthor=N.+A.+Thornberry&title=A+combinatorial+approach+for+determining+protease+specificities%3A+application+to+interleukin-1%CE%B2+converting+enzyme+%28ICE%29&doi=10.1016%2FS1074-5521%2897%2990258-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A combinatorial approach for determining protease specificities: application to interleukin-1Î² converting enzyme (ICE)</span></div><div class="casAuthors">Rano, Thomas A.; Timkey, Tracy; Peterson, Erin P.; Rotonda, Jennifer; Nicholson, Donald W.; Beckeer, Joseph W.; Chapman, Kevin T.; Thornberry, Nancy A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-155</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">Background: Interleukin-1Î² converting enzyme (ICE/capase-1) is the protease responsible for interleukin-1Î² (IL-1Î²) prodn. in monocytes.  It was the first member of a new cysteine protease family to be identified.  Members of this family have functions in both inflammation and apoptosis.  Results: A novel method for identifying protease specificity, employing a positional-scanning substrate library, was used to det. the amino-acid preferences of ICE.  Using this method, the complete specificity of a protease can be mapped in the time required to perform one assay.  The results indicate that the optimal tetrapeptide recognition sequence for ICE is WEHD, not YVAD, as previously believed, and this led to the synthesis of an unusually potent aldehyde inhibitor, Ac-WEHD-CHO (Ki = 56 pM).  The structural basis for this potent inhibition was detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ohbMT1kyLbVg90H21EOLACvtfcHk0lgZKRi8m5H72g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitVynu78%253D&md5=da4f472784a7149a48d311fbda213a2d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2897%2990258-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252897%252990258-1%26sid%3Dliteratum%253Aachs%26aulast%3DRano%26aufirst%3DT.%2BA.%26aulast%3DTimkey%26aufirst%3DT.%26aulast%3DPeterson%26aufirst%3DE.%2BP.%26aulast%3DRotonda%26aufirst%3DJ.%26aulast%3DNicholson%26aufirst%3DD.%2BW.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DChapman%26aufirst%3DK.%2BT.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26atitle%3DA%2520combinatorial%2520approach%2520for%2520determining%2520protease%2520specificities%253A%2520application%2520to%2520interleukin-1%25CE%25B2%2520converting%2520enzyme%2520%2528ICE%2529%26jtitle%3DChem.%2520Biol.%26date%3D1997%26volume%3D4%26issue%3D2%26spage%3D149%26epage%3D155%26doi%3D10.1016%2FS1074-5521%2897%2990258-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudolphi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verzijl, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Kraan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Berg, W.</span></span> <span> </span><span class="NLM_article-title">Pralnacasan, an inhibitor of interleukin-1Î² converting enzyme, reduces joint damage in two murine models of osteoarthritis</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">738</span>â <span class="NLM_lpage">746</span>, <span class="refDoi">Â DOI: 10.1016/S1063-4584(03)00153-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS1063-4584%2803%2900153-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=13129693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BD3svjsFOhtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=738-746&issue=10&author=K.+Rudolphiauthor=N.+Gerwinauthor=N.+Verzijlauthor=P.+van+der+Kraanauthor=W.+van+den+Berg&title=Pralnacasan%2C+an+inhibitor+of+interleukin-1%CE%B2+converting+enzyme%2C+reduces+joint+damage+in+two+murine+models+of+osteoarthritis&doi=10.1016%2FS1063-4584%2803%2900153-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis</span></div><div class="casAuthors">Rudolphi K; Gerwin N; Verzijl N; van der Kraan P; van den Berg W</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">738-46</span>
        ISSN:<span class="NLM_cas:issn">1063-4584</span>.
    </div><div class="casAbstract">OBJECTIVE:  To study the effect of pralnacasan, the orally bioavailable pro-drug of a potent, non-peptide inhibitor of interleukin-1beta converting enzyme (ICE), RU 36384/VRT-18858, on joint damage in two mouse models of knee osteoarthritis (OA).  DESIGN:  In a collagenase-induced OA model, pralnacasan was given orally by gavage to female Balb/c mice at 0, 12.5, 25 and 50 mg/kg twice a day.  In the second study, pralnacasan was tested in male STR/1N mice, which develop OA spontaneously, by administering food-drug mixtures ad libitum at concentrations of 0, 700 and 4200 ppm (mg/kg food).  OA joint damage was assessed by a semi-quantitative histopathological score in both studies.  In the STR/1N mouse study, urinary levels of collagen cross-links hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP) were determined by high-pressure liquid chromatography at baseline, after 3 and 6 weeks of treatment and RU 36384/VRT-18858 plasma concentrations was measured after 6 weeks.  RESULTS:  In both studies, the mice developed moderate to severe knee joint OA in the medial joint compartments (tibial plateau and femoral condyle), the non-treated control groups showing median histopathological scores from 18 to 21 of a maximal score of 32.  Pralnacasan was well tolerated.  At the doses of 12.5 and 50 mg/kg in collagenase-induced OA and at the high dose of 4200 ppm in STR/1N mice pralnacasan treatment significantly reduced OA by 13-22%.  In the STR/1N mice, urinary levels of HP cross-links and the ratio of HP/LP, which are indicators of joint damage in OA, were significantly reduced in the high dose group by 59 and 84%, respectively.  CONCLUSIONS:  The ICE inhibitor pralnacasan reduced joint damage in two experimental models of OA and has the potential to become a disease-modifying drug for the treatment of OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS00eZqsMAAocjl5L8hwNX0fW6udTcc2eb4bFYPHLG1ebntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svjsFOhtg%253D%253D&md5=ec8e69c841b711bb5c56cb1f9ac983c3</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS1063-4584%2803%2900153-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1063-4584%252803%252900153-5%26sid%3Dliteratum%253Aachs%26aulast%3DRudolphi%26aufirst%3DK.%26aulast%3DGerwin%26aufirst%3DN.%26aulast%3DVerzijl%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BKraan%26aufirst%3DP.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DW.%26atitle%3DPralnacasan%252C%2520an%2520inhibitor%2520of%2520interleukin-1%25CE%25B2%2520converting%2520enzyme%252C%2520reduces%2520joint%2520damage%2520in%2520two%2520murine%2520models%2520of%2520osteoarthritis%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2003%26volume%3D11%26issue%3D10%26spage%3D738%26epage%3D746%26doi%3D10.1016%2FS1063-4584%2803%2900153-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wannamaker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namchuk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germann, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randle, J. C. R.</span></span> <span> </span><span class="NLM_article-title">(S)-1-((S)-2-{[1-(4-Amino-3-chloro-phenyl)-methanoyl]-amino}-3,3,-dimethyl-butanoyl)-pyrrolidine-2-carb-oxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1Î² and IL-18</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>321</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">509</span>â <span class="NLM_lpage">516</span>, <span class="refDoi">Â DOI: 10.1124/jpet.106.111344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1124%2Fjpet.106.111344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17289835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFehtLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=509-516&issue=2&author=W.+Wannamakerauthor=R.+Daviesauthor=M.+Namchukauthor=J.+Pollardauthor=P.+Fordauthor=G.+Kuauthor=C.+Deckerauthor=P.+Charifsonauthor=P.+Weberauthor=U.+A.+Germannauthor=K.+Kuidaauthor=J.+C.+R.+Randle&title=%28S%29-1-%28%28S%29-2-%7B%5B1-%284-Amino-3-chloro-phenyl%29-methanoyl%5D-amino%7D-3%2C3%2C-dimethyl-butanoyl%29-pyrrolidine-2-carb-oxylic+acid+%28%282R%2C3S%29-2-ethoxy-5-oxo-tetrahydro-furan-3-yl%29-amide+%28VX-765%29%2C+an+orally+available+selective+interleukin+%28IL%29-converting+enzyme%2Fcaspase-1+inhibitor%2C+exhibits+potent+anti-inflammatory+activities+by+inhibiting+the+release+of+IL-1%CE%B2+and+IL-18&doi=10.1124%2Fjpet.106.111344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">(S)-1-((S)-2-{[1-(4-Amino-3-chlorophenyl)methanoyl]amino}-3,3-dimethylbutanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1Î² and IL-18</span></div><div class="casAuthors">Wannamaker, Woods; Davies, Robert; Namchuk, Mark; Pollard, John; Ford, Pamella; Ku, George; Decker, Caroline; Charifson, Paul; Weber, Peter; Germann, Ursula A.; Kuida, Keisuke; Randle, John C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">509-516</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">VX-765 is an orally absorbed prodrug of (S)-3-({1-[(S)-1-((S)-2-{[1-(4-amino-3-chlorophenyl)methanoyl]amino}-3,3-dimethyl-butanoyl)pyrrolidin-2-yl]-methanoyl}amino)-4-oxobutyric acid (VRT-043198), a potent and selective inhibitor of interleukin-converting enzyme/caspase-1 subfamily caspases.  VRT-043198 exhibits 100- to 10,000-fold selectivity against other caspase-3 and -6 to -9.  The therapeutic potential of VX-765 was assessed by detg. the effects of VRT-043198 on cytokine release by monocytes in vitro and of orally administered VX-765 in several animal models in vivo.  In cultures of peripheral blood mononuclear cells and whole blood from healthy subjects stimulated with bacterial products, VRT-043198 inhibited the release of interleukin (IL)-1Î² and IL-18, but it had little effect on the release of several other cytokines, including IL-1Î±, tumor necrosis factor-Î±, IL-6 and IL-8.  In contrast, VRT-043198 had little or no demonstrable activity in cellular models of apoptosis, and it did not affect the proliferation of activated primary T cells or T-cell lines.  VX-765 was efficiently converted to VRT-043198 when administered orally to mice, and it inhibited lipopolysaccharide-induced cytokine secretion.  In addn., VX-765 reduced disease severity and the expression of inflammatory mediators in models of rheumatoid arthritis and skin inflammation.  These data suggest that VX-765 is a novel cytokine inhibitor useful for treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUYnZtQc6cNrVg90H21EOLACvtfcHk0lgZwdyqUFNjow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFehtLY%253D&md5=f310c20314ee44357acd3027105a8b6a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.111344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.111344%26sid%3Dliteratum%253Aachs%26aulast%3DWannamaker%26aufirst%3DW.%26aulast%3DDavies%26aufirst%3DR.%26aulast%3DNamchuk%26aufirst%3DM.%26aulast%3DPollard%26aufirst%3DJ.%26aulast%3DFord%26aufirst%3DP.%26aulast%3DKu%26aufirst%3DG.%26aulast%3DDecker%26aufirst%3DC.%26aulast%3DCharifson%26aufirst%3DP.%26aulast%3DWeber%26aufirst%3DP.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DKuida%26aufirst%3DK.%26aulast%3DRandle%26aufirst%3DJ.%2BC.%2BR.%26atitle%3D%2528S%2529-1-%2528%2528S%2529-2-%257B%255B1-%25284-Amino-3-chloro-phenyl%2529-methanoyl%255D-amino%257D-3%252C3%252C-dimethyl-butanoyl%2529-pyrrolidine-2-carb-oxylic%2520acid%2520%2528%25282R%252C3S%2529-2-ethoxy-5-oxo-tetrahydro-furan-3-yl%2529-amide%2520%2528VX-765%2529%252C%2520an%2520orally%2520available%2520selective%2520interleukin%2520%2528IL%2529-converting%2520enzyme%252Fcaspase-1%2520inhibitor%252C%2520exhibits%2520potent%2520anti-inflammatory%2520activities%2520by%2520inhibiting%2520the%2520release%2520of%2520IL-1%25CE%25B2%2520and%2520IL-18%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26issue%3D2%26spage%3D509%26epage%3D516%26doi%3D10.1124%2Fjpet.106.111344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schipper, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. C.</span></span> <span> </span><span class="NLM_article-title">The potential for caspases in drug discovery</span>. <i>Curr. Opin. Drug Discovery Dev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">568</span>â <span class="NLM_lpage">576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=20812148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12jsLvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=568-576&issue=5&author=S.+H.+MacKenzieauthor=J.+L.+Schipperauthor=A.+C.+Clark&title=The+potential+for+caspases+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The potential for caspases in drug discovery</span></div><div class="casAuthors">MacKenzie, Sarah H.; Schipper, Joshua L.; Clark, A. Clay</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">568-576</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">2040-3437</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Caspases are a family of proteases that are involved in the execution of apoptosis and the inflammatory response.  A plethora of diseases occur as a result of the dysregulation of apoptosis and inflammation, and caspases were targeted as a therapeutic strategy to halt the progression of such diseases.  Hundreds of peptide and peptidomimetic inhibitors were designed and tested, but only a few have advanced to clin. trials because of poor drug-like properties and pharmacol. constraints.  Although much effort was focused on inhibiting caspases, there are many diseases that result from a decrease in apoptosis, thus activating procaspases could also be a viable therapeutic strategy.  To this end, recent efforts have focused on the design of procaspase-3 activators.  This review highlights the current progress in the rational design of both specific and pan-caspase inhibitors, as well as procaspase-3 activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyJ67VXw-127Vg90H21EOLACvtfcHk0lgJ5arSDVpKow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12jsLvP&md5=1ff7a76e34fcdaded9daab61b4d59735</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DS.%2BH.%26aulast%3DSchipper%26aufirst%3DJ.%2BL.%26aulast%3DClark%26aufirst%3DA.%2BC.%26atitle%3DThe%2520potential%2520for%2520caspases%2520in%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26issue%3D5%26spage%3D568%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamik, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghozian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaco, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Major, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branton, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Power, C.</span></span> <span> </span><span class="NLM_article-title">Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">E6065</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1722041115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.1722041115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29895691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFenu77K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E6065&issue=26&author=B.+A.+McKenzieauthor=M.+K.+Mamikauthor=L.+B.+Saitoauthor=R.+Boghozianauthor=M.+C.+Monacoauthor=E.+O.+Majorauthor=J.-Q.+Luauthor=W.+G.+Brantonauthor=C.+Power&title=Caspase-1+inhibition+prevents+glial+inflammasome+activation+and+pyroptosis+in+models+of+multiple+sclerosis&doi=10.1073%2Fpnas.1722041115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis</span></div><div class="casAuthors">Mckenzie, Brienne A.; Mamik, Manmeet K.; Saito, Leina B.; Boghozian, Roobina; Monaco, Maria Chiara; Major, Eugene O.; Lu, Jian-Qiang; Branton, William G.; Power, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">E6065-E6074</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Multiple sclerosis (MS) is a progressive inflammatory demyelinating disease of the CNS of unknown cause that remains incurable.  Inflammasome-assocd. caspases mediate the maturation and release of the proinflammatory cytokines IL-1Î² and IL-18 and activate the pore-forming protein gasdermin D (GSDMD).  Inflammatory programmed cell death, pyroptosis, was recently shown to be mediated by GSDMD.  Here, we report mol. evidence for GSDMD mediated inflammasome activation and pyroptosis in both myeloid cells (macrophages/microglia) and, unexpectedly, in myelin-forming oligodendrocytes (ODCs) in the CNS of patients with MS and in the MS animal model, exptl. autoimmune encephalomyelitis (EAE).  We obsd. inflammasome activation and pyroptosis in human microglia and ODCs in vitro after exposure to inflammatory stimuli and demonstrate caspase-1 inhibition by the small-mol. inhibitor VX-765 in both cell types.  GSDMD inhibition by siRNA transduction suppressed pyroptosis in human microglia.  VX-765 treatment of EAE animals reduced the expression of inflammasome and pyroptosis-assocd. proteins in the CNS, prevented axonal injury, and improved neurobehavioral performance.  Thus, GSDMD mediated pyroptosis in select glia cells is a previously unrecognized mechanism of inflammatory demyelination and represents a unique therapeutic opportunity for mitigating the disease process in MS and other CNS inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKphO9SsAzKbVg90H21EOLACvtfcHk0lgtcrdE23jVGA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFenu77K&md5=77b6d015647bb66ce29881383b9406d9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1722041115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1722041115%26sid%3Dliteratum%253Aachs%26aulast%3DMcKenzie%26aufirst%3DB.%2BA.%26aulast%3DMamik%26aufirst%3DM.%2BK.%26aulast%3DSaito%26aufirst%3DL.%2BB.%26aulast%3DBoghozian%26aufirst%3DR.%26aulast%3DMonaco%26aufirst%3DM.%2BC.%26aulast%3DMajor%26aufirst%3DE.%2BO.%26aulast%3DLu%26aufirst%3DJ.-Q.%26aulast%3DBranton%26aufirst%3DW.%2BG.%26aulast%3DPower%26aufirst%3DC.%26atitle%3DCaspase-1%2520inhibition%2520prevents%2520glial%2520inflammasome%2520activation%2520and%2520pyroptosis%2520in%2520models%2520of%2520multiple%2520sclerosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26issue%3D26%26spage%3DE6065%26doi%3D10.1073%2Fpnas.1722041115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puri, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monack, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Caspase-1 activity is required to bypass macrophage apoptosis upon Salmonella infection</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">745</span>â <span class="NLM_lpage">747</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.1023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnchembio.1023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22797665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVehsLnL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=745-747&issue=9&author=A.+W.+Puriauthor=P.+Brozauthor=A.+Shenauthor=D.+M.+Monackauthor=M.+Bogyo&title=Caspase-1+activity+is+required+to+bypass+macrophage+apoptosis+upon+Salmonella+infection&doi=10.1038%2Fnchembio.1023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase-1 activity is required to bypass macrophage apoptosis upon Salmonella infection</span></div><div class="casAuthors">Puri, Aaron W.; Broz, Petr; Shen, Aimee; Monack, Denise M.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">745-747</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here we report AWP28, an activity-based probe that can be used to biochem. monitor caspase-1 activation in response to proinflammatory stimuli.  Using AWP28, we show that apoptosis is triggered upon Salmonella enterica var. typhimurium infection in primary mouse bone marrow macrophages lacking caspase-1.  Typhimurium infection in primary mouse bone marrow macrophages lacking caspase-1.  Furthermore, we report that upon Salmonella infection, inflammasome-mediated caspase-1 activity is required to bypass apoptosis in favor of proinflammatory pyroptotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0UIc_vcG4-rVg90H21EOLACvtfcHk0litTB0Yuneu5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVehsLnL&md5=db797ca2a4a23fd5f8ca0382375c30ad</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1023%26sid%3Dliteratum%253Aachs%26aulast%3DPuri%26aufirst%3DA.%2BW.%26aulast%3DBroz%26aufirst%3DP.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DMonack%26aufirst%3DD.%2BM.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DCaspase-1%2520activity%2520is%2520required%2520to%2520bypass%2520macrophage%2520apoptosis%2520upon%2520Salmonella%2520infection%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26issue%3D9%26spage%3D745%26epage%3D747%26doi%3D10.1038%2Fnchembio.1023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">James, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asgian, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekici, Ã. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikolajczyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, â3, â6, and â8</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1553</span>â <span class="NLM_lpage">1574</span>, <span class="refDoi">Â DOI: 10.1021/jm0305016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0305016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVarsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1553-1574&issue=6&author=K.+E.+Jamesauthor=J.+L.+Asgianauthor=Z.+Z.+Liauthor=%C3%96.+D.+Ekiciauthor=J.+R.+Rubinauthor=J.+Mikolajczykauthor=G.+S.+Salvesenauthor=J.+C.+Powers&title=Design%2C+synthesis%2C+and+evaluation+of+aza-peptide+epoxides+as+selective+and+potent+inhibitors+of+caspases-1%2C+%E2%88%923%2C+%E2%88%926%2C+and+%E2%88%928&doi=10.1021%2Fjm0305016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Aza-Peptide Epoxides as Selective and Potent Inhibitors of Caspases-1, -3, -6, and -8</span></div><div class="casAuthors">James, Karen Ellis; Asgian, Juliana L.; Li, Zhao Zhao; Ekici, Oezlem Dogan; Rubin, John R.; Mikolajczyk, Jowita; Salvesen, Guy S.; Powers, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1553-1574</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aza-peptide epoxides, a novel class of irreversible protease inhibitors, are specific for the clan CD cysteine proteases.  Aza-peptide epoxides with an aza-Asp residue at P1 are excellent irreversible inhibitors of caspases-1, -3, -6, and -8 with second-order inhibition rates up to 1 910 000 M-1 s-1.  In general, the order of reactivity of aza-peptide epoxides is S,S > R,R > trans > cis.  Interestingly, some of the R,R epoxides while being less potent are actually more selective than the S,S epoxides.  Here, the aza-peptide epoxides designed for caspases are stable, potent, and specific inhibitors, as they show little to no inhibition of other proteases such as the aspartyl proteases porcine pepsin, human cathepsin D, plasmepsin 2 (from P. falciparum), HIV-1 protease, and the secreted aspartic proteinase 2 (SAP-2) from Candida albicans, the serine proteases granzyme B and Î±-chymotrypsin, and the cysteine proteases cathepsin B and papain (clan CA), and legumain (clan CD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3HF_f2tGTD7Vg90H21EOLACvtfcHk0litTB0Yuneu5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVarsLw%253D&md5=5de81f320fca00ccc5289e78c5a7cbbd</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm0305016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0305016%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DK.%2BE.%26aulast%3DAsgian%26aufirst%3DJ.%2BL.%26aulast%3DLi%26aufirst%3DZ.%2BZ.%26aulast%3DEkici%26aufirst%3D%25C3%2596.%2BD.%26aulast%3DRubin%26aufirst%3DJ.%2BR.%26aulast%3DMikolajczyk%26aufirst%3DJ.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520aza-peptide%2520epoxides%2520as%2520selective%2520and%2520potent%2520inhibitors%2520of%2520caspases-1%252C%2520%25E2%2588%25923%252C%2520%25E2%2588%25926%252C%2520and%2520%25E2%2588%25928%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D6%26spage%3D1553%26epage%3D1574%26doi%3D10.1021%2Fjm0305016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boatright, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazif, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chehade, K. A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Activity-based probes that target diverse cysteine protease families</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">33</span>â <span class="NLM_lpage">38</span>, <span class="refDoi">Â DOI: 10.1038/nchembio707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnchembio707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=16407991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXls1Oms70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=33-38&issue=1&author=D.+Katoauthor=K.+M.+Boatrightauthor=A.+B.+Bergerauthor=T.+Nazifauthor=G.+Blumauthor=C.+Ryanauthor=K.+A.+H.+Chehadeauthor=G.+S.+Salvesenauthor=M.+Bogyo&title=Activity-based+probes+that+target+diverse+cysteine+protease+families&doi=10.1038%2Fnchembio707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-based probes that target diverse cysteine protease families</span></div><div class="casAuthors">Kato, Daisuke; Boatright, Kelly M.; Berger, Alicia B.; Nazif, Tamim; Blum, Galia; Ryan, Ciara; Chehade, Kareem A. H.; Salvesen, Guy S.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-38</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteases are one of the largest and best-characterized families of enzymes in the human proteome.  Unfortunately, the understanding of protease function in the context of complex proteolytic cascades remains in its infancy.  One major reason for this gap in understanding is the lack of technologies that allow direct assessment of protease activity.  We report here an optimized solid-phase synthesis protocol that allows rapid generation of activity-based probes (ABPs) targeting a range of cysteine protease families.  These reagents selectively form covalent bonds with the active-site thiol of a cysteine protease, allowing direct biochem. profiling of protease activities in complex proteomes.  We present a no. of probes contg. either a single amino acid or an extended peptide sequence that target caspases, legumains, gingipains and cathepsins.  Biochem. studies using these reagents highlight their overall utility and provide insight into the biochem. functions of members of these protease families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb2GaeK1g3lrVg90H21EOLACvtfcHk0lidfdn_0JWvrg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXls1Oms70%253D&md5=d5971f49f168bb97f3d6214e27ce8dff</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnchembio707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio707%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DD.%26aulast%3DBoatright%26aufirst%3DK.%2BM.%26aulast%3DBerger%26aufirst%3DA.%2BB.%26aulast%3DNazif%26aufirst%3DT.%26aulast%3DBlum%26aufirst%3DG.%26aulast%3DRyan%26aufirst%3DC.%26aulast%3DChehade%26aufirst%3DK.%2BA.%2BH.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DActivity-based%2520probes%2520that%2520target%2520diverse%2520cysteine%2520protease%2520families%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2005%26volume%3D1%26issue%3D1%26spage%3D33%26epage%3D38%26doi%3D10.1038%2Fnchembio707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edgington, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrow, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulick, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineberry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">967</span>â <span class="NLM_lpage">973</span>, <span class="refDoi">Â DOI: 10.1038/nm.1938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnm.1938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19597506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFWiu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=967-973&issue=8&author=L.+E.+Edgingtonauthor=A.+B.+Bergerauthor=G.+Blumauthor=V.+E.+Albrowauthor=M.+G.+Paulickauthor=N.+Lineberryauthor=M.+Bogyo&title=Noninvasive+optical+imaging+of+apoptosis+by+caspase-targeted+activity-based+probes&doi=10.1038%2Fnm.1938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes</span></div><div class="casAuthors">Edgington, Laura E.; Berger, Alicia B.; Blum, Galia; Albrow, Victoria E.; Paulick, Margot G.; Lineberry, Neil; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">967-973</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Imaging agents that enable direct visualization and quantification of apoptosis in vivo have great potential value for monitoring chemotherapeutic response as well as for early diagnosis and disease monitoring.  We describe here the development of fluorescently labeled activity-based probes (ABPs) that covalently label active caspases in vivo.  We used these probes to monitor apoptosis in the thymi of mice treated with dexamethasone as well as in tumor-bearing mice treated with the apoptosis-inducing monoclonal antibody Apomab (Genentech).  Caspase ABPs provided direct readouts of the kinetics of apoptosis in live mice, whole organs and tissue exts.  The probes produced a max. fluorescent signal that could be monitored noninvasively and that coincided with the peak in caspase activity, as measured by gel anal.  Overall, these studies demonstrate that caspase-specific ABPs have the potential to be used for noninvasive imaging of apoptosis in both preclin. and clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4HA0pnOPRmrVg90H21EOLACvtfcHk0lidfdn_0JWvrg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFWiu7s%253D&md5=20d9bb5064ff28defbcda64f1196c83c</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnm.1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1938%26sid%3Dliteratum%253Aachs%26aulast%3DEdgington%26aufirst%3DL.%2BE.%26aulast%3DBerger%26aufirst%3DA.%2BB.%26aulast%3DBlum%26aufirst%3DG.%26aulast%3DAlbrow%26aufirst%3DV.%2BE.%26aulast%3DPaulick%26aufirst%3DM.%2BG.%26aulast%3DLineberry%26aufirst%3DN.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DNoninvasive%2520optical%2520imaging%2520of%2520apoptosis%2520by%2520caspase-targeted%2520activity-based%2520probes%26jtitle%3DNat.%2520Med.%26date%3D2009%26volume%3D15%26issue%3D8%26spage%3D967%26epage%3D973%26doi%3D10.1038%2Fnm.1938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonzÃ¡lez-PÃ¡ez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolan, D. W.</span></span> <span> </span><span class="NLM_article-title">Selective detection of caspase-3 versus caspase-7 using activity-based probes with key unnatural amino acids</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1558</span>â <span class="NLM_lpage">1566</span>, <span class="refDoi">Â DOI: 10.1021/cb400209w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400209w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVCgu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1558-1566&issue=7&author=C.+J.+Vickersauthor=G.+E.+Gonz%C3%A1lez-P%C3%A1ezauthor=D.+W.+Wolan&title=Selective+detection+of+caspase-3+versus+caspase-7+using+activity-based+probes+with+key+unnatural+amino+acids&doi=10.1021%2Fcb400209w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Selective detection of caspase-3 versus caspase-7 using activity-based probes with key unnatural amino acids</span></div><div class="casAuthors">Vickers, Chris J.; Gonzalez-Paez, Gonzalo E.; Wolan, Dennis W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1558-1566</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Caspases are required for essential biol. functions, most notably apoptosis and pyroptosis, but also cytokine prodn., cell proliferation, and differentiation.  One of the most well studied members of this cysteine protease family includes executioner caspase-3, which plays a central role in cell apoptosis and differentiation.  Unfortunately, there exists a dearth of chem. tools to selectively monitor caspase-3 activity under complex cellular and in vivo conditions due to its close homol. with executioner caspase-7.  Com. available activity-based probes and substrates rely on the canonical DEVD tetrapeptide sequence, which both caspases-3 and -7 recognize with similar affinity, and thus the individual contributions of caspase-3 and/or -7 toward important cellular processes are irresolvable.  Here, we analyzed a variety of permutations of the DEVD peptide sequence in order to discover peptides with biased activity and recognition of caspase-3 vs. caspases-6, -7, -8, and -9.  Through this study, we identify fluorescent and biotinylated probes capable of selective detection of caspase-3 using key unnatural amino acids.  Likewise, we detd. the X-ray crystal structures of caspases-3, -7, and -8 in complex with our lead peptide inhibitor to elucidate the binding mechanism and active site interactions that promote the selective recognition of caspase-3 over other highly homologous caspase family members.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNlhTpPBcCjbVg90H21EOLACvtfcHk0lhb_e-LH4Pnig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVCgu7g%253D&md5=4101d0c313f5277a09b47dc7ad5f5176</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fcb400209w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400209w%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DC.%2BJ.%26aulast%3DGonz%25C3%25A1lez-P%25C3%25A1ez%26aufirst%3DG.%2BE.%26aulast%3DWolan%26aufirst%3DD.%2BW.%26atitle%3DSelective%2520detection%2520of%2520caspase-3%2520versus%2520caspase-7%2520using%2520activity-based%2520probes%2520with%2520key%2520unnatural%2520amino%2520acids%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26issue%3D7%26spage%3D1558%26epage%3D1566%26doi%3D10.1021%2Fcb400209w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonzÃ¡lez-PÃ¡ez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolan, D. W.</span></span> <span> </span><span class="NLM_article-title">Selective detection and inhibition of active caspase-3 in cells with optimized peptides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">12869</span>â <span class="NLM_lpage">12876</span>, <span class="refDoi">Â DOI: 10.1021/ja406399r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja406399r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Wlt7rN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=12869-12876&issue=34&author=C.+J.+Vickersauthor=G.+E.+Gonz%C3%A1lez-P%C3%A1ezauthor=D.+W.+Wolan&title=Selective+detection+and+inhibition+of+active+caspase-3+in+cells+with+optimized+peptides&doi=10.1021%2Fja406399r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Detection and Inhibition of Active Caspase-3 in Cells with Optimized Peptides</span></div><div class="casAuthors">Vickers, Chris J.; Gonzalez-Paez, Gonzalo E.; Wolan, Dennis W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">12869-12876</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Caspases are a family of cysteine-aspartyl proteases that are well recognized for their essential roles in apoptosis and inflammation.  Recently, caspases have also been linked to the promotion of other biol. important phenomena, such as cellular differentiation and proliferation.  Dysregulation of the multifaceted and indispensable activities of caspases has been globally linked to several diseases, including cancer and neurodegenerative disorders; however, the specific caspase members responsible for these diseases have yet to be assigned.  Activity-based probes (ABPs) and peptide-based inhibitors are instrumental in the detection and control of protease activity and serve as alternative methods to genetic approaches.  Such mols. aid in the interrogation of specific proteases within cellular and animal models as well as help elucidate aberrant proteolytic function correlated to disease phenotypes.  No ABPs or inhibitors have been discovered that specifically target one of the eleven human caspases in a cellular context.  Therefore, ascribing distinct contributions to an individual caspase activity within naturally occurring biol. systems is not possible.  Herein, the authors describe a peptide series optimized for the selective detection and inhibition of active caspase-3 in cells.  These compds. exhibit low nanomolar potency against caspase-3 with >120-fold selectivity over caspase-7 which shares 77% active site identity.  The authors' ability to individually target wild-type active caspase-3 for detection and cell permeable inhibition is a valuable proof-of-concept methodol. that can be readily employed to probe the significance of caspase-3 in apoptosis, neurol. disorders, cardiovascular diseases, and sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCkB5AJ8ptFrVg90H21EOLACvtfcHk0lhb_e-LH4Pnig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Wlt7rN&md5=6a12e28e901f5f47e4d77191b0a39d93</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fja406399r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja406399r%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DC.%2BJ.%26aulast%3DGonz%25C3%25A1lez-P%25C3%25A1ez%26aufirst%3DG.%2BE.%26aulast%3DWolan%26aufirst%3DD.%2BW.%26atitle%3DSelective%2520detection%2520and%2520inhibition%2520of%2520active%2520caspase-3%2520in%2520cells%2520with%2520optimized%2520peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26issue%3D34%26spage%3D12869%26epage%3D12876%26doi%3D10.1021%2Fja406399r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solania, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonzÃ¡lez-PÃ¡ez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolan, D. W.</span></span> <span> </span><span class="NLM_article-title">Selective and rapid cell-permeable inhibitor of human caspase-3</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2463</span>â <span class="NLM_lpage">2470</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.9b00564</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.9b00564" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVamurjM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=2463-2470&issue=11&author=A.+Solaniaauthor=G.+E.+Gonz%C3%A1lez-P%C3%A1ezauthor=D.+W.+Wolan&title=Selective+and+rapid+cell-permeable+inhibitor+of+human+caspase-3&doi=10.1021%2Facschembio.9b00564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Selective and Rapid Cell-Permeable Inhibitor of Human Caspase-3</span></div><div class="casAuthors">Solania, Angelo; Gonzalez-Paez, Gonzalo E.; Wolan, Dennis W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2463-2470</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Individual roles and overlapping functionalities of 12 human caspases during apoptosis and other cellular processes remain poorly resolved primarily due to a lack of chem. tools.  Here we present a new selective caspase-3 inhibitor, termed Ac-ATS010-KE, with rapid and irreversible binding kinetics.  Relative to previously designed caspase-3-selective mols. that have tremendously abated inhibitory rates and thus limited use in biol. settings, the improved kinetics of Ac-ATS010-KE permits its use in a cell-based capacity.  We demonstrate that Ac-ATS010-KE prevents apoptosis with comparable efficacy to the general caspase inhibitor Ac-DEVD-KE and surprisingly does so without side-chain methylation.  This observation is in contrast to the well-established peptide modification strategy typically employed for improving cellular permeability.  Ac-ATS010-KE protects against extrinsic apoptosis, which demonstrates the utility of a thiophene carboxylate leaving group in biol. settings, challenges the requisite neutralization of free carboxylic acids to improve cell permeability, and provides a tool-like compd. to interrogate the role of caspase-3 in a variety of cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE4FLPCio2BLVg90H21EOLACvtfcHk0ljGb2EE-U7u4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVamurjM&md5=566ac057a74457686e7b076700f336d8</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facschembio.9b00564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.9b00564%26sid%3Dliteratum%253Aachs%26aulast%3DSolania%26aufirst%3DA.%26aulast%3DGonz%25C3%25A1lez-P%25C3%25A1ez%26aufirst%3DG.%2BE.%26aulast%3DWolan%26aufirst%3DD.%2BW.%26atitle%3DSelective%2520and%2520rapid%2520cell-permeable%2520inhibitor%2520of%2520human%2520caspase-3%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2019%26volume%3D14%26issue%3D11%26spage%3D2463%26epage%3D2470%26doi%3D10.1021%2Facschembio.9b00564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groborz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span> <span> </span><span class="NLM_article-title">Caspase selective reagents for diagnosing apoptotic mechanisms</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">229</span>â <span class="NLM_lpage">244</span>, <span class="refDoi">Â DOI: 10.1038/s41418-018-0110-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41418-018-0110-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29748600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVWks7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=229-244&issue=2&author=M.+Porebaauthor=K.+Groborzauthor=M.+Navarroauthor=S.+J.+Snipasauthor=M.+Dragauthor=G.+S.+Salvesen&title=Caspase+selective+reagents+for+diagnosing+apoptotic+mechanisms&doi=10.1038%2Fs41418-018-0110-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase selective reagents for diagnosing apoptotic mechanisms</span></div><div class="casAuthors">Poreba, Marcin; Groborz, Katarzyna; Navarro, Mario; Snipas, Scott J.; Drag, Marcin; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-244</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Apical caspases initiate and effector caspases execute apoptosis.  Reagents that can distinguish between caspases, particularly apical caspases-8, 9, and 10 are scarce and generally nonspecific.  Based upon a previously described large-scale screen of peptide-based caspase substrates termed HyCoSuL, we sought to develop reagents to distinguish between apical caspases in order to reveal their function in apoptotic cell death paradigms.  To this end, we selected tetrapeptide-based sequences that deliver optimal substrate selectivity and converted them to inhibitors equipped with a detectable tag (activity-based probes-ABPs).  We demonstrate a strong relationship between substrate kinetics and ABP kinetics.  To evaluate the utility of selective substrates and ABPs, we examd. distinct apoptosis pathways in Jurkat T lymphocyte and MDA-MB-231 breast cancer lines triggered to undergo cell death via extrinsic or intrinsic apoptosis.  We report the first highly selective substrate appropriate for quantitation of caspase-8 activity during apoptosis.  Converting substrates to ABPs promoted loss-of-activity and selectivity, thus we could not define a single ABP capable of detecting individual apical caspases in complex mixts.  To overcome this, we developed a panel strategy utilizing several caspase-selective ABPs to interrogate apoptosis, revealing the first chem.-based approach to uncover the participation of caspase-8, but not caspase-9 or -10 in TRAIL-induced extrinsic apoptosis.  We propose that using select panels of ABPs can provide information regarding caspase-8 apoptotic signaling more faithfully than can single, generally nonspecific reagents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozlNDFtXmlerVg90H21EOLACvtfcHk0ljGb2EE-U7u4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVWks7c%253D&md5=e8745e81bc7fe192d53793accf8fe21d</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fs41418-018-0110-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-018-0110-y%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DGroborz%26aufirst%3DK.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DCaspase%2520selective%2520reagents%2520for%2520diagnosing%2520apoptotic%2520mechanisms%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2019%26volume%3D26%26issue%3D2%26spage%3D229%26epage%3D244%26doi%3D10.1038%2Fs41418-018-0110-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rut, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groborz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2695</span>â <span class="NLM_lpage">2709</span>, <span class="refDoi">Â DOI: 10.1038/s41418-019-0329-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41418-019-0329-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30976094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFSmsb%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=2695-2709&issue=12&author=M.+Porebaauthor=W.+Rutauthor=K.+Groborzauthor=S.+J.+Snipasauthor=G.+S.+Salvesenauthor=M.+Drag&title=Potent+and+selective+caspase-2+inhibitor+prevents+MDM-2+cleavage+in+reversine-treated+colon+cancer+cells&doi=10.1038%2Fs41418-019-0329-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells</span></div><div class="casAuthors">Poreba, Marcin; Rut, Wioletta; Groborz, Katarzyna; Snipas, Scott J.; Salvesen, Guy S.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2695-2709</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Most caspases can be positioned unambiguously within the regulated cell death networks of apoptosis and pyroptosis, but the role of caspase-2, a highly conserved protease within the family, remains enigmatic.  This is mainly due to lack of selective chem. and biochem. tools for the investigation of this protease.  In this study, we used our hybrid combinatorial substrate library (HyCoSuL) approach to broadly profile caspase-2 substrate specificity using peptide scanning libraries.  This screen uncovered previously unknown caspase-2 peptidyl substrate preferences, which were further used to develop caspase-2 selective fluorogenic substrates and covalent, irreversible AOMK inhibitors.  Finally, we used the champion inhibitor (NH-23-C2) in reversine-treated HCT-116 colon cancer cells to selectively block caspase-2 activity and caspase-2-mediated MDM-2 cleavage.  In addn., we showed that NH-23-C2 does not block caspase-3 or caspase-8, which makes it a powerful chem. tool to dissect the true role of caspase-2 in various biol. setups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW3R6mnFIzR7Vg90H21EOLACvtfcHk0ljGb2EE-U7u4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFSmsb%252FI&md5=c64260f2a2da36fe01c745dd30495d83</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fs41418-019-0329-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-019-0329-2%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DRut%26aufirst%3DW.%26aulast%3DGroborz%26aufirst%3DK.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DPotent%2520and%2520selective%2520caspase-2%2520inhibitor%2520prevents%2520MDM-2%2520cleavage%2520in%2520reversine-treated%2520colon%2520cancer%2520cells%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2019%26volume%3D26%26issue%3D12%26spage%3D2695%26epage%3D2709%26doi%3D10.1038%2Fs41418-019-0329-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonzÃ¡lez-PÃ¡ez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litwin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umotoy, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutsias, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolan, D. W.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of initiator versus executioner caspases using small peptides containing unnatural amino acids</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2194</span>â <span class="NLM_lpage">2198</span>, <span class="refDoi">Â DOI: 10.1021/cb5004256</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5004256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Gns7fI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2194-2198&issue=10&author=C.+J.+Vickersauthor=G.+E.+Gonz%C3%A1lez-P%C3%A1ezauthor=K.+M.+Litwinauthor=J.+C.+Umotoyauthor=E.+A.+Coutsiasauthor=D.+W.+Wolan&title=Selective+inhibition+of+initiator+versus+executioner+caspases+using+small+peptides+containing+unnatural+amino+acids&doi=10.1021%2Fcb5004256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Initiator versus Executioner Caspases Using Small Peptides Containing Unnatural Amino Acids</span></div><div class="casAuthors">Vickers, Chris J.; Gonzalez-Paez, Gonzalo E.; Litwin, Kevin M.; Umotoy, Jeffrey C.; Coutsias, Evangelos A.; Wolan, Dennis W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2194-2198</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Caspases are fundamental to many essential biol. processes, including apoptosis, differentiation, and inflammation.  Unregulated caspase activity is also implicated in the development and progression of several diseases, such as cancer, neurodegenerative disorders, and sepsis.  Unfortunately, it is difficult to det. exactly which caspase(s) of the 11 isoforms that humans express is responsible for specific biol. functions.  This lack of resoln. is primarily due to highly homologous active sites and overlapping substrates.  Currently available peptide-based inhibitors and probes are based on specificity garnered from peptide substrate libraries.  For example, the canonical tetrapeptide LETD was discovered as the canonical sequence that is optimally recognized by caspase-8; however, LETD-based inhibitors and substrates promiscuously bind to other isoforms with equal affinity, including caspases-3, -6, and -9.  In order to mitigate this problem, we report the identification of a new series of compds. that are >100-fold selective for inhibiting the initiator caspases-8 and -9 over the executioner caspases-3, -6, and -7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIDCHV4InVobVg90H21EOLACvtfcHk0ljoRH540dPqcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Gns7fI&md5=478fe6cacc0338ef4a3f15509d1d4069</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fcb5004256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5004256%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DC.%2BJ.%26aulast%3DGonz%25C3%25A1lez-P%25C3%25A1ez%26aufirst%3DG.%2BE.%26aulast%3DLitwin%26aufirst%3DK.%2BM.%26aulast%3DUmotoy%26aufirst%3DJ.%2BC.%26aulast%3DCoutsias%26aufirst%3DE.%2BA.%26aulast%3DWolan%26aufirst%3DD.%2BW.%26atitle%3DSelective%2520inhibition%2520of%2520initiator%2520versus%2520executioner%2520caspases%2520using%2520small%2520peptides%2520containing%2520unnatural%2520amino%2520acids%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26issue%3D10%26spage%3D2194%26epage%3D2198%26doi%3D10.1021%2Fcb5004256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Groborz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez Ramirez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DraÌ§g, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PorÈ©ba, M.</span></span> <span> </span><span class="NLM_article-title">Exploring the prime site in caspases as a novel chemical strategy for understanding the mechanisms of cell death: a proof of concept study on necroptosis in cancer cells</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">451</span>â <span class="NLM_lpage">465</span>, <span class="refDoi">Â DOI: 10.1038/s41418-019-0364-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41418-019-0364-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31209360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BB3M3nslKksA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2020&pages=451-465&issue=2&author=K.+Groborzauthor=M.+L.+Gonzalez+Ramirezauthor=S.+J.+Snipasauthor=G.+S.+Salvesenauthor=M.+Dra%CC%A7gauthor=M.+Por%C8%A9ba&title=Exploring+the+prime+site+in+caspases+as+a+novel+chemical+strategy+for+understanding+the+mechanisms+of+cell+death%3A+a+proof+of+concept+study+on+necroptosis+in+cancer+cells&doi=10.1038%2Fs41418-019-0364-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the prime site in caspases as a novel chemical strategy for understanding the mechanisms of cell death: a proof of concept study on necroptosis in cancer cells</span></div><div class="casAuthors">Groborz Katarzyna; DrAg Marcin; Poreba Marcin; Gonzalez Ramirez Monica L; Snipas Scott J; Salvesen Guy S; DrAg Marcin; Poreba Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Cell death and differentiation</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">451-465</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Caspases participate in regulated cell death mechanisms and are divided into apoptotic and proinflammatory caspases.  The main problem in identifying the unique role of a particular caspase in the mechanisms of regulated cell death is their overlapping substrate specificity; caspases recognize and hydrolyze similar peptide substrates.  Most studies focus on examining the non-prime sites of the caspases, yet there is a need for novel and more precise chemical tools to identify the molecular participants and mechanisms of programmed cell death pathways.  Therefore, we developed an innovative chemical approach that examines the prime area of the caspase active sites.  This method permits the agile parallel solid-phase synthesis of caspase inhibitors with a high yield and purity.  Using synthesized compounds we have shown the similarities and differences in the prime area of the caspase active site and, as a proof of concept, we demonstrated the exclusive role of caspase-8 in necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVbFkOCQlNfEewzGPswiWOfW6udTcc2eYWO2qgGbv7T7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3nslKksA%253D%253D&md5=c436441a7bb7afed5231aafd08b32496</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fs41418-019-0364-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-019-0364-z%26sid%3Dliteratum%253Aachs%26aulast%3DGroborz%26aufirst%3DK.%26aulast%3DGonzalez%2BRamirez%26aufirst%3DM.%2BL.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDra%25CC%25A7g%26aufirst%3DM.%26aulast%3DPor%25C8%25A9ba%26aufirst%3DM.%26atitle%3DExploring%2520the%2520prime%2520site%2520in%2520caspases%2520as%2520a%2520novel%2520chemical%2520strategy%2520for%2520understanding%2520the%2520mechanisms%2520of%2520cell%2520death%253A%2520a%2520proof%2520of%2520concept%2520study%2520on%2520necroptosis%2520in%2520cancer%2520cells%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2020%26volume%3D27%26issue%3D2%26spage%3D451%26epage%3D465%26doi%3D10.1038%2Fs41418-019-0364-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, D. E.</span></span> <span> </span><span class="NLM_article-title">Docking and 3D-QSAR studies on isatin sulfonamide analogues as caspase-3 inhibitors</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1963</span>â <span class="NLM_lpage">1973</span>, <span class="refDoi">Â DOI: 10.1021/ci900144x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci900144x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1963-1973&issue=8&author=Q.+Wangauthor=R.+H.+Machauthor=D.+E.+Reichert&title=Docking+and+3D-QSAR+studies+on+isatin+sulfonamide+analogues+as+caspase-3+inhibitors&doi=10.1021%2Fci900144x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Docking and 3D-QSAR Studies on Isatin Sulfonamide Analogues as Caspase-3 Inhibitors</span></div><div class="casAuthors">Wang, Qi; Mach, Robert H.; Reichert, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1963-1973</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To provide insight of their inhibition mechanism and facilitate the design of more potent ligands, a series of 59 isatin sulfonamide analogs were docked to the x-ray structure of caspase-3, one of the important cysteine aspartyl-specific execution proteases in apoptosis, and their binding conformations were analyzed by 3D-QSAR studies.  Comparative mol. field anal. (CoMFA) and comparative mol. similarity index anal. (CoMSIA) studies suggest that both steric and electrostatic interactions contribute to the compds.' binding affinity, with the major contribution arising from hydrophobic interactions.  The models show excellent correlation and high predictive power even evaluated by the most stringent criteria for a QSAR model.  The results of this work demonstrate that structure-based design methods (such as docking) cultivate the development of reliable QSAR models; they also illustrate the utility of this procedure in design of new potent caspase-3 ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5G0bo_WOlx7Vg90H21EOLACvtfcHk0ljoRH540dPqcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbg%253D&md5=bd0c7b053b63eb9ebfcb4ea7c3f7c238</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fci900144x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci900144x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DReichert%26aufirst%3DD.%2BE.%26atitle%3DDocking%2520and%25203D-QSAR%2520studies%2520on%2520isatin%2520sulfonamide%2520analogues%2520as%2520caspase-3%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26issue%3D8%26spage%3D1963%26epage%3D1973%26doi%3D10.1021%2Fci900144x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothfuss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5041</span>â <span class="NLM_lpage">5046</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2006.07.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2006.07.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=16891117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD28XoslCnsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5041-5046&issue=19&author=D.+Zhouauthor=W.+Chuauthor=J.+Rothfussauthor=C.+Zengauthor=J.+Xuauthor=L.+Jonesauthor=M.+J.+Welchauthor=R.+H.+Mach&title=Synthesis%2C+radiolabeling%2C+and+in+vivo+evaluation+of+an+18F-labeled+isatin+analog+for+imaging+caspase-3+activation+in+apoptosis&doi=10.1016%2Fj.bmcl.2006.07.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis</span></div><div class="casAuthors">Zhou, Dong; Chu, Wenhua; Rothfuss, Justin; Zeng, Chenbo; Xu, Jinbin; Jones, Lynne; Welch, Michael J.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5041-5046</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A non-peptide-based isatin sulfonamide analog, WC-II-89, was synthesized and its inhibition toward recombinant human caspase-3 and other caspases was detd.  This compd. showed high potency for inhibiting caspase-3 and -7, and high selectivity against caspases-1, -6, and -8. [18F]WC-II-89 was synthesized via a nucleophilic substitution of the corresponding mesylate precursor in high yield and radiochem. purity.  Biodistribution studies using [18F]WC-II-89 revealed higher uptake in liver and spleen of cycloheximide-treated rats, an animal model of apoptosis, relative to control animals.  Western blot anal. confirmed the presence of activated caspase-3 in the liver and spleen of cycloheximide-treated animals.  MicroPET imaging studies revealed a high uptake of the radiotracer in the liver of a cycloheximide-treated rat relative to the untreated control.  These data suggest that [18F]WC-II-89 is a potential radiotracer for imaging caspase-3 activation in tissues undergoing apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooDEd3YRrF-LVg90H21EOLACvtfcHk0lj9MwUG4isu5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XoslCnsrc%253D&md5=1be5377d306e16cf3451b181669a2c65</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.07.045%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DW.%26aulast%3DRothfuss%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DL.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%252C%2520radiolabeling%252C%2520and%2520in%2520vivo%2520evaluation%2520of%2520an%252018F-labeled%2520isatin%2520analog%2520for%2520imaging%2520caspase-3%2520activation%2520in%2520apoptosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D19%26spage%3D5041%26epage%3D5046%26doi%3D10.1016%2Fj.bmcl.2006.07.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelst, S. H. L.</span></span> <span> </span><span class="NLM_article-title">Controlled inhibition of apoptosis by photoactivatable caspase inhibitors</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1434</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2020.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2020.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32814013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1Cku7rI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2020&pages=1434&issue=11&author=S.+Chakrabartyauthor=S.+H.+L.+Verhelst&title=Controlled+inhibition+of+apoptosis+by+photoactivatable+caspase+inhibitors&doi=10.1016%2Fj.chembiol.2020.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Controlled Inhibition of Apoptosis by Photoactivatable Caspase Inhibitors</span></div><div class="casAuthors">Chakrabarty, Suravi; Verhelst, Steven H. L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1434-1440.e10</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Caspases control regulated cell death (apoptosis), a process that is crucial in the development of multicellular organisms as well as in various diseases.  In order to spatiotemporally study apoptosis, we here develop photoactivatable caspase inhibitors.  These are based on cysteine-reactive acyloxymethyl ketone electrophiles connected to a peptide targeting caspases.  Importantly, the aspartate crucial for recognition by caspases is caged with a photoprotecting group.  Ester photocages were found to be labile, and it was crit. to have a nitroindoline cage, which forms a stable amide bond with the aspartate side chain.  The nitroindoline-protected inhibitors lead to an efficient turn-on of inhibitory activity after irradn. with light.  They are applicable in live cells, where they prevent anti-FAS-induced apoptosis only upon irradn.  Overall, these reagents will allow a better understanding of the spatial and temporal dimensions of apoptosis in complex, dynamic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoZj_GXGls4bVg90H21EOLACvtfcHk0lj9MwUG4isu5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1Cku7rI&md5=0303c70b79e08e80540bfe13f8a1db36</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2020.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2020.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarty%26aufirst%3DS.%26aulast%3DVerhelst%26aufirst%3DS.%2BH.%2BL.%26atitle%3DControlled%2520inhibition%2520of%2520apoptosis%2520by%2520photoactivatable%2520caspase%2520inhibitors%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2020%26volume%3D27%26issue%3D11%26spage%3D1434%26doi%3D10.1016%2Fj.chembiol.2020.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rebeaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hailfinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posevitz-Fejfar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapernoux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaide, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzzardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iancu, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rufer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span> <span> </span><span class="NLM_article-title">The proteolytic activity of the paracaspase MALT1 is key in T cell activation</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">272</span>â <span class="NLM_lpage">281</span>, <span class="refDoi">Â DOI: 10.1038/ni1568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fni1568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18264101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVOjt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=272-281&issue=3&author=F.+Rebeaudauthor=S.+Hailfingerauthor=A.+Posevitz-Fejfarauthor=M.+Tapernouxauthor=R.+Moserauthor=D.+Ruedaauthor=O.+Gaideauthor=M.+Guzzardiauthor=E.+M.+Iancuauthor=N.+Ruferauthor=N.+Faselauthor=M.+Thome&title=The+proteolytic+activity+of+the+paracaspase+MALT1+is+key+in+T+cell+activation&doi=10.1038%2Fni1568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The proteolytic activity of the paracaspase MALT1 is key in T cell activation</span></div><div class="casAuthors">Rebeaud, Fabien; Hailfinger, Stephan; Posevitz-Fejfar, Anita; Tapernoux, Myriam; Moser, Roger; Rueda, Daniel; Gaide, Olivier; Guzzardi, Montserrat; Iancu, Emanuela M.; Rufer, Nathalie; Fasel, Nicolas; Thome, Margot</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">272-281</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The paracaspase MALT1 is pivotal in antigen receptor-mediated lymphocyte activation and lymphomagenesis.  MALT1 contains a caspase-like domain, but it is unknown whether this domain is proteolytically active.  Here the authors report that MALT1 had arginine-directed proteolytic activity that was activated after T cell stimulation, and they identify the signaling protein Bcl-10 as a MALT1 substrate.  Processing of Bcl-10 after Arg228 was required for T cell receptor-induced cell adhesion to fibronectin.  In contrast, MALT1 activity but not Bcl-10 cleavage was essential for optimal activation of transcription factor NF-ÎºB and prodn. of interleukin 2.  Thus, the proteolytic activity of MALT1 is central to T cell activation, which suggests a possible target for the development of immunomodulatory or anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2kTzBRxfMGLVg90H21EOLACvtfcHk0lj9MwUG4isu5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVOjt7w%253D&md5=094b1afc1f65e8a21846b095129df581</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fni1568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1568%26sid%3Dliteratum%253Aachs%26aulast%3DRebeaud%26aufirst%3DF.%26aulast%3DHailfinger%26aufirst%3DS.%26aulast%3DPosevitz-Fejfar%26aufirst%3DA.%26aulast%3DTapernoux%26aufirst%3DM.%26aulast%3DMoser%26aufirst%3DR.%26aulast%3DRueda%26aufirst%3DD.%26aulast%3DGaide%26aufirst%3DO.%26aulast%3DGuzzardi%26aufirst%3DM.%26aulast%3DIancu%26aufirst%3DE.%2BM.%26aulast%3DRufer%26aufirst%3DN.%26aulast%3DFasel%26aufirst%3DN.%26aulast%3DThome%26aufirst%3DM.%26atitle%3DThe%2520proteolytic%2520activity%2520of%2520the%2520paracaspase%2520MALT1%2520is%2520key%2520in%2520T%2520cell%2520activation%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26issue%3D3%26spage%3D272%26epage%3D281%26doi%3D10.1038%2Fni1568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakeham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Differential requirement for Malt1 in T and B cell antigen receptor signaling</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">749</span>â <span class="NLM_lpage">758</span>, <span class="refDoi">Â DOI: 10.1016/S1074-7613(03)00293-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS1074-7613%2803%2900293-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=14614861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVCksLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2003&pages=749-758&issue=5&author=J.+Rulandauthor=G.+S.+Duncanauthor=A.+Wakehamauthor=T.+W.+Mak&title=Differential+requirement+for+Malt1+in+T+and+B+cell+antigen+receptor+signaling&doi=10.1016%2FS1074-7613%2803%2900293-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Requirement for Malt1 in T and B cell antigen receptor signaling</span></div><div class="casAuthors">Ruland, Juergen; Duncan, Gordon S.; Wakeham, Andrew; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">749-758</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The translocation t(11;18)(q21;q21) involving MALT1 is the most common chromosomal abnormality in lymphomas of mucosa-assocd. lymphoid tissue.  Although the paracaspase MALT1 can bind to BCL10, the physiol. function of MALT1 is unknown.  Using mouse models, the authors show that Malt1 is essential for T cell activation, proliferation, and IL-2 prodn. in response to TCR ligation and strictly required for signal-specific NF-ÎºB activation induced by the TCR but not TNF-Î± or IL-1 signaling.  Malt1 operates down-stream of Bcl10, controls the catalytic activity of the canonical IKK complex, and regulates the signaling of Jnk and p38 MAP kinases.  In contrast to Bcl10 disruption, however, inactivation of Malt1 has only mild effects on B cell activation and does not cause defects during neuro-development.  Thus, Malt1 is an essential regulator of Bcl10 signaling that is differentially required depending on cellular context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvcUWLMCBhwrVg90H21EOLACvtfcHk0lheKOgXlJAQ1A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVCksLw%253D&md5=8d1d5e371243556298a1db1fd15306e2</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS1074-7613%2803%2900293-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-7613%252803%252900293-0%26sid%3Dliteratum%253Aachs%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DDuncan%26aufirst%3DG.%2BS.%26aulast%3DWakeham%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DDifferential%2520requirement%2520for%2520Malt1%2520in%2520T%2520and%2520B%2520cell%2520antigen%2520receptor%2520signaling%26jtitle%3DImmunity%26date%3D2003%26volume%3D19%26issue%3D5%26spage%3D749%26epage%3D758%26doi%3D10.1016%2FS1074-7613%2803%2900293-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruefli-Brasse, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Regulation of NF-ÎºB-dependent lymphocyte activation and development by paracaspase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span> (<span class="NLM_issue">5650</span>),  <span class="NLM_fpage">1581</span>, <span class="refDoi">Â DOI: 10.1126/science.1090769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fscience.1090769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=14576442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Smsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=1581&issue=5650&author=A.+A.+Ruefli-Brasseauthor=D.+M.+Frenchauthor=V.+M.+Dixit&title=Regulation+of+NF-%CE%BAB-dependent+lymphocyte+activation+and+development+by+paracaspase&doi=10.1126%2Fscience.1090769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of NF-ÎºB-Dependent Lymphocyte Activation and Development by Paracaspase</span></div><div class="casAuthors">Ruefli-Brasse, Astrid A.; French, Dorothy M.; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5650</span>),
    <span class="NLM_cas:pages">1581-1584</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Paracaspase (MALT1), a member of an evolutionarily conserved superfamily of caspase-like proteins, has been shown to bind and colocalize with the protein Bcl10 in vitro and, because of this assocn., has been suggested to be involved in the CARMA1-Bcl10 pathway of antigen-induced nuclear factor ÎºB (NF-ÎºB) activation.  The authors demonstrate that primary T and B lymphocytes from paracaspase-deficient mice are defective in antigen-receptor-induced NF-ÎºB activation, cytokine prodn., and proliferation.  Paracaspase acts downstream of Bcl10 to induce NF-ÎºB activation and is required for the normal development of B cells, indicating that paracaspase provides the missing link between Bcl10 and activation of the IÎºB kinase complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmVLHvV66wsbVg90H21EOLACvtfcHk0lheKOgXlJAQ1A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Smsb8%253D&md5=9e22fb09686e44b51e1d94237e2dcc1d</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1126%2Fscience.1090769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1090769%26sid%3Dliteratum%253Aachs%26aulast%3DRuefli-Brasse%26aufirst%3DA.%2BA.%26aulast%3DFrench%26aufirst%3DD.%2BM.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DRegulation%2520of%2520NF-%25CE%25BAB-dependent%2520lymphocyte%2520activation%2520and%2520development%2520by%2520paracaspase%26jtitle%3DScience%26date%3D2003%26volume%3D302%26issue%3D5650%26spage%3D1581%26doi%3D10.1126%2Fscience.1090769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noels, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Loo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broeckx, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyaert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marynen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baens, M.</span></span> <span> </span><span class="NLM_article-title">A novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-ÎºB activation by API2Â·MALT1 fusions</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">10180</span>â <span class="NLM_lpage">10189</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M611038200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.M611038200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17287209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs1Sit7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=10180-10189&issue=14&author=H.+Noelsauthor=G.+van+Looauthor=S.+Hagensauthor=V.+Broeckxauthor=R.+Beyaertauthor=P.+Marynenauthor=M.+Baens&title=A+novel+TRAF6+binding+site+in+MALT1+defines+distinct+mechanisms+of+NF-%CE%BAB+activation+by+API2%C2%B7MALT1+fusions&doi=10.1074%2Fjbc.M611038200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel TRAF6 Binding Site in MALT1 Defines Distinct Mechanisms of NF-ÎºB Activation by API2Â·MALT1 Fusions</span></div><div class="casAuthors">Noels, Heidi; van Loo, Geert; Hagens, Sofie; Broeckx, Vicky; Beyaert, Rudi; Marynen, Peter; Baens, Mathijs</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">10180-10189</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The recurrent translocation t(11;18)(q21;q21) assocd. with mucosa-assocd. lymphoid tissue (MALT) lymphoma results in the expression of an API2Â·MALT1 fusion protein that constitutively activates NF-ÎºB.  The first baculovirus IAP repeat (BIR) domain of API2 and the C terminus of MALT1, which contains its caspase-like domain, are present in all reported fusion variants and interact with TRAF2 and TRAF6, resp., suggesting their contribution to NF-ÎºB signaling by API2Â·MALT1.  Also, the involvement of BCL10 has been suggested via binding to BIR1 of API2 and via its interaction with the Ig domains of MALT1, present in half of the fusion variants.  However, conflicting reports exist concerning their roles in API2Â·MALT1-induced NF-ÎºB signaling.  In this report, streptavidin pulldowns of biotinylated API2Â·MALT1 fusion variants showed that none of the fusion variants interacted with endogenous BCL10; its role in NF-ÎºB signaling by API2Â·MALT1 was further questioned by RNA interference expts.  In contrast, TRAF6 was essential for NF-ÎºB activation by all fusion variants, and the authors identified a novel TRAF6 binding site in the second Ig domain of MALT1, which enhanced NF-ÎºB activation when present in the fusion protein.  Furthermore, inclusion of both Ig domains in API2Â·MALT1 further enhanced NF-ÎºB signaling via intramol. TRAF6 activation.  Finally, binding of TRAF2 to BIR1 contributed to NF-ÎºB activation by API2Â·MALT1, although addnl. mechanisms involving BIR1-mediated raft assocn. are also important.  Taken together, these data reveal distinct mechanisms of NF-ÎºB activation by the different API2Â·MALT1 fusion variants with an essential role for TRAF6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtWU_hcGONf7Vg90H21EOLACvtfcHk0lheKOgXlJAQ1A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs1Sit7k%253D&md5=782830893bc1fcd6a2c205f1bc82b83e</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M611038200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M611038200%26sid%3Dliteratum%253Aachs%26aulast%3DNoels%26aufirst%3DH.%26aulast%3Dvan%2BLoo%26aufirst%3DG.%26aulast%3DHagens%26aufirst%3DS.%26aulast%3DBroeckx%26aufirst%3DV.%26aulast%3DBeyaert%26aufirst%3DR.%26aulast%3DMarynen%26aufirst%3DP.%26aulast%3DBaens%26aufirst%3DM.%26atitle%3DA%2520novel%2520TRAF6%2520binding%2520site%2520in%2520MALT1%2520defines%2520distinct%2520mechanisms%2520of%2520NF-%25CE%25BAB%2520activation%2520by%2520API2%25C2%25B7MALT1%2520fusions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26issue%3D14%26spage%3D10180%26epage%3D10189%26doi%3D10.1074%2Fjbc.M611038200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ea, C.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Z.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. J.</span></span> <span> </span><span class="NLM_article-title">The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">289</span>â <span class="NLM_lpage">301</span>, <span class="refDoi">Â DOI: 10.1016/S1097-2765(04)00236-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS1097-2765%2804%2900236-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15125833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1ClsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=289-301&issue=3&author=L.+Sunauthor=L.+Dengauthor=C.-K.+Eaauthor=Z.-P.+Xiaauthor=Z.+J.+Chen&title=The+TRAF6+ubiquitin+ligase+and+TAK1+kinase+mediate+IKK+activation+by+BCL10+and+MALT1+in+T+lymphocytes&doi=10.1016%2FS1097-2765%2804%2900236-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL 10 and MALT1 in T lymphocytes</span></div><div class="casAuthors">Sun, Lijun; Deng, Li; Ea, Chee-Kwee; Xia, Zong-Ping; Chen, Zhijian J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">289-301</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The CARD domain protein BCL 10 and paracaspase MALT1 are essential for the activation of IÎºB kinase (IKK) and NF-ÎºB in response to T cell receptor (TCR) stimulation.  Here we present evidence that TRAF6 ubiquitin ligase and TAK1 protein kinase mediate IKK activation by BCL 10 and MALT1.  RNAi-mediated silencing of MALT1, TAK1, TRAF6, and TRAF2 suppressed TCR-dependent IKK activation and interleukin-2 prodn. in T cells.  Furthermore, we have reconstituted the pathway from BCL 10 to IKK activation in vitro with purified proteins of MALT1, TRAF6, TAK1, and ubiquitination enzymes including Ubc13/Uev1A.  We find that a small fraction of BCL 10 and MALT1 proteins form high mol. wt. oligomers.  Strikingly, only these oligomeric forms of BCL 10 and MALT1 can activate IKK in vitro.  The MALT1 oligomers bind to TRAF6, induce TRAF6 oligomerization, and activate the ligase activity of TRAF6 to polyubiquitinate NEMO.  These results reveal an oligomerization â ubiquitination â phosphorylation cascade that culminates in NF-ÎºB activation in T lymphocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzcdyPuAHljLVg90H21EOLACvtfcHk0lhbduuEIf6qkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1ClsrY%253D&md5=24fa6f93abe311e1ac52e28490d83d8d</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2804%2900236-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252804%252900236-9%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DEa%26aufirst%3DC.-K.%26aulast%3DXia%26aufirst%3DZ.-P.%26aulast%3DChen%26aufirst%3DZ.%2BJ.%26atitle%3DThe%2520TRAF6%2520ubiquitin%2520ligase%2520and%2520TAK1%2520kinase%2520mediate%2520IKK%2520activation%2520by%2520BCL10%2520and%2520MALT1%2520in%2520T%2520lymphocytes%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D14%26issue%3D3%26spage%3D289%26epage%3D301%26doi%3D10.1016%2FS1097-2765%2804%2900236-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bank, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansorge, S.</span></span> <span> </span><span class="NLM_article-title">More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">197</span>â <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=11272269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1Ggs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=197-206&issue=2&author=U.+Bankauthor=S.+Ansorge&title=More+than+destructive%3A+neutrophil-derived+serine+proteases+in+cytokine+bioactivity+control"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control</span></div><div class="casAuthors">Bank, Ute; Ansorge, Siegfried</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-206</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review and discussion with 106 refs.  In addn. to the mechanisms inducing the expression and secretion of cytokines under distinct pathophysiol. conditions, the fate of cytokines after secretion at sites of inflammation is a field of growing interest.  Proteolysis has been suggested to be a fundamental mechanism of regulating the activities of various components of the cytokine network.  Evidence grows that besides highly specific cytokine converting proteases such as interleukin-1Î²-converting enzyme or tumor necrosis factor-converting enzyme, neutrophil-derived serine proteases are intimately involved in the modulation of the activities of cytokines and their receptors.  Particularly at sites of inflammation, high amts. of the active serine proteases elastase, cathepsin G, and proteinase 3 are released from infiltrating polymorphonuclear cells in close temporal correlation to elevated levels of inflammatory cytokines, strongly indicating that these proteases are involved in the control of cytokine bioactivity and availability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4SrG-Wd_XFrVg90H21EOLACvtfcHk0lhbduuEIf6qkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1Ggs7Y%253D&md5=48a4be126253b23f7ccf415fd8082c0d</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBank%26aufirst%3DU.%26aulast%3DAnsorge%26aufirst%3DS.%26atitle%3DMore%2520than%2520destructive%253A%2520neutrophil-derived%2520serine%2520proteases%2520in%2520cytokine%2520bioactivity%2520control%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2001%26volume%3D69%26issue%3D2%26spage%3D197%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farinha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascoyne, R. D.</span></span> <span> </span><span class="NLM_article-title">Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">6370</span>â <span class="NLM_lpage">6378</span>, <span class="refDoi">Â DOI: 10.1200/JCO.2005.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1200%2FJCO.2005.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=16155022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWntbbE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=6370-6378&issue=26&author=P.+Farinhaauthor=R.+D.+Gascoyne&title=Molecular+pathogenesis+of+mucosa-associated+lymphoid+tissue+lymphoma&doi=10.1200%2FJCO.2005.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma</span></div><div class="casAuthors">Farinha, Pedro; Gascoyne, Randy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">6370-6378</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  Extranodal marginal zone B-cell lymphomas of mucosa-assocd. lymphoid tissue (MALT) type occur in a no. of anat. sites, but share overlapping morphol. and immunophenotypic features.  Helicobacter pylori infection has been identified as an etiol. factor in gastric MALT lymphoma, and a growing list of other infectious organisms have recently been shown to be assocd. with MALT lymphomas at other anat. sites.  Although cause and effect has not been established for most of these infectious agents, our understanding of the biol. has significantly improved, in part through the application of std. cytogenetic analyses.  The common karyotypic alterations that characterize MALT lymphomas include the trisomies 3 and 18, the translocations t(11; 18)(q21; q21), t(1; 14)(p22; q32), t(14; 18)(q32; q21), t(3; 14)(q27; q32), and the recently described t(3; 14)(p14.1; q32).  This apparent complexity of cytogenetic alterations that have now been implicated in the pathogenesis of extranodal MALT lymphoma serves as a paradigm for mol. cross talk in neoplastic disease.  Recent data have shown that at least three of the disparate translocations affect a common signaling mechanism, and thus unify all three under a common pathogenesis, resulting in the constitutive activation of the nuclear factor kappa B (NF-ÎºB) pathway.  It may be that the new MALT-related translocation involving the FOXP1 gene and other as yet undiscovered translocations may all have in common increased NF-ÎºB signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQwhCgB_fvA7Vg90H21EOLACvtfcHk0lhbduuEIf6qkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWntbbE&md5=660c24ee283040e90c579e969f92e4b4</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DFarinha%26aufirst%3DP.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26atitle%3DMolecular%2520pathogenesis%2520of%2520mucosa-associated%2520lymphoid%2520tissue%2520lymphoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26issue%3D26%26spage%3D6370%26epage%3D6378%26doi%3D10.1200%2FJCO.2005.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hailfinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posvitz-Fejfar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebeaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzzardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penas, E.-M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierlamm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staudt, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span> <span> </span><span class="NLM_article-title">Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">47</span>),  <span class="NLM_fpage">19946</span>â <span class="NLM_lpage">19951</span>, <span class="refDoi">Â DOI: 10.1073/pnas.0907511106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.0907511106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19897720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGjtL3F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=19946-19951&issue=47&author=S.+Hailfingerauthor=G.+Lenzauthor=V.+Ngoauthor=A.+Posvitz-Fejfarauthor=F.+Rebeaudauthor=M.+Guzzardiauthor=E.-M.+M.+Penasauthor=J.+Dierlammauthor=W.+C.+Chanauthor=L.+M.+Staudtauthor=M.+Thome&title=Essential+role+of+MALT1+protease+activity+in+activated+B+cell-like+diffuse+large+B-cell+lymphoma&doi=10.1073%2Fpnas.0907511106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma</span></div><div class="casAuthors">Hailfinger, Stephan; Lenz, Georg; Ngo, Vu; Posvitz-Fejfar, Anita; Rebeaud, Fabien; Guzzardi, Montserrat; Murga Penas, Eva-Maria; Dierlamm, Judith; Chan, Wing C.; Staudt, Louis M.; Thome, Margot</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">19946-19951, S19946/1-S19946/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A key element for the development of suitable anti-cancer drugs is the identification of cancer-specific enzymic activities that can be therapeutically targeted.  Mucosa-assocd. lymphoid tissue transformation protein 1 (MALT1) is a proto-oncogene that contributes to tumorigenesis in diffuse large B-cell lymphoma (DLBCL) of the activated B-cell (ABC) subtype, the least curable subtype of DLBCL.  Recent data suggest that MALT1 has proteolytic activity, but it is unknown whether this activity is relevant for tumor growth.  Here the authors report that MALT1 is constitutively active in DLBCL lines of the ABC but not the GCB subtype.  Inhibition of the MALT1 proteolytic activity led to reduced expression of growth factors and apoptosis inhibitors, and specifically affected the growth and survival of ABC DLBCL lines.  These results demonstrate a key role for the proteolytic activity of MALT1 in DLBCL of the ABC subtype, and provide a rationale for the development of pharmacol. inhibitors of MALT1 in DLBCL therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrezepbuMe8ELVg90H21EOLACvtfcHk0lj7JJHC38_laA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGjtL3F&md5=45cf9c9b7b7b438325d45398f95cda4e</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0907511106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0907511106%26sid%3Dliteratum%253Aachs%26aulast%3DHailfinger%26aufirst%3DS.%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DNgo%26aufirst%3DV.%26aulast%3DPosvitz-Fejfar%26aufirst%3DA.%26aulast%3DRebeaud%26aufirst%3DF.%26aulast%3DGuzzardi%26aufirst%3DM.%26aulast%3DPenas%26aufirst%3DE.-M.%2BM.%26aulast%3DDierlamm%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26aulast%3DThome%26aufirst%3DM.%26atitle%3DEssential%2520role%2520of%2520MALT1%2520protease%2520activity%2520in%2520activated%2520B%2520cell-like%2520diffuse%2520large%2520B-cell%2520lymphoma%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D47%26spage%3D19946%26epage%3D19951%26doi%3D10.1073%2Fpnas.0907511106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Malt1 protease is critical in maintaining function of regulatory T cells and may be a therapeutic target for antitumor immunity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>202</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3008</span>, <span class="refDoi">Â DOI: 10.4049/jimmunol.1801614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4049%2Fjimmunol.1801614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30979818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvF2nsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2019&pages=3008&issue=10&author=L.+Chengauthor=N.+Dengauthor=N.+Yangauthor=X.+Zhaoauthor=X.+Lin&title=Malt1+protease+is+critical+in+maintaining+function+of+regulatory+T+cells+and+may+be+a+therapeutic+target+for+antitumor+immunity&doi=10.4049%2Fjimmunol.1801614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Malt1 protease is critical in maintaining function of regulatory T cells and may be a therapeutic target for antitumor immunity</span></div><div class="casAuthors">Cheng, Liqing; Deng, Nan; Yang, Naixue; Zhao, Xueqiang; Lin, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3008-3019</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The paracaspase Malt1 is a key mol. in mediating Ag receptor-induced NF-ÎºB activation in lymphocytes, but the role of Malt1 in the function of regulatory T (Treg) cells is still unclear.  In this article, we reported that specific deletion of Malt1 in Treg cells would lead to Scurfy-like lethal autoimmune disease, which was caused by Treg cell dysfunction but not no. loss.  Interestingly, Foxp3CreMalt1fl/C472A mice, in which Malt1 protease was specifically inactivated in Treg cells, also displayed spontaneous inflammatory disorders, with severe hair loss and skin hyperplasia.  Consistently, Foxp3CreMalt1fl/C472A mice showed enhanced antitumor response because of their decreased function and infiltration of Treg cells, as well as reduced CD8+ T cell exhaustion.  Gene expression profiling anal. revealed dysregulated expression pattern of Treg effector genes upon Malt1 deletion or its protease inactivation.  Together, our data unraveled a crit. role of Malt1, esp. its protease activity, in maintaining homeostasis and function of Treg cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyuNixqJyx5LVg90H21EOLACvtfcHk0lj7JJHC38_laA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvF2nsbs%253D&md5=d241d288a6a191e6243e8669726138e6</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1801614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1801614%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DMalt1%2520protease%2520is%2520critical%2520in%2520maintaining%2520function%2520of%2520regulatory%2520T%2520cells%2520and%2520may%2520be%2520a%2520therapeutic%2520target%2520for%2520antitumor%2520immunity%26jtitle%3DJ.%2520Immunol.%26date%3D2019%26volume%3D202%26issue%3D10%26spage%3D3008%26doi%3D10.4049%2Fjimmunol.1801614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">BrÃ¼stle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knobbe, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virtanen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hershenfield, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reardon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacher, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">The NF-ÎºB regulator MALT1 determines the encephalitogenic potential of Th17 cells</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4698</span>â <span class="NLM_lpage">4709</span>, <span class="refDoi">Â DOI: 10.1172/JCI63528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1172%2FJCI63528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23114599" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=4698-4709&issue=12&author=A.+Br%C3%BCstleauthor=D.+Brennerauthor=C.+B.+Knobbeauthor=P.+A.+Langauthor=C.+Virtanenauthor=B.+M.+Hershenfieldauthor=C.+Reardonauthor=S.+M.+Lacherauthor=J.+Rulandauthor=P.+S.+Ohashiauthor=T.+W.+Mak&title=The+NF-%CE%BAB+regulator+MALT1+determines+the+encephalitogenic+potential+of+Th17+cells&doi=10.1172%2FJCI63528"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1172%2FJCI63528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI63528%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25BCstle%26aufirst%3DA.%26aulast%3DBrenner%26aufirst%3DD.%26aulast%3DKnobbe%26aufirst%3DC.%2BB.%26aulast%3DLang%26aufirst%3DP.%2BA.%26aulast%3DVirtanen%26aufirst%3DC.%26aulast%3DHershenfield%26aufirst%3DB.%2BM.%26aulast%3DReardon%26aufirst%3DC.%26aulast%3DLacher%26aufirst%3DS.%2BM.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DOhashi%26aufirst%3DP.%2BS.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DThe%2520NF-%25CE%25BAB%2520regulator%2520MALT1%2520determines%2520the%2520encephalitogenic%2520potential%2520of%2520Th17%2520cells%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26issue%3D12%26spage%3D4698%26epage%3D4709%26doi%3D10.1172%2FJCI63528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">52</span>),  <span class="NLM_fpage">21004</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1111708108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.1111708108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22158899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVCquw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=21004&issue=52&author=J.+W.+Yuauthor=P.+D.+Jeffreyauthor=J.+Y.+Haauthor=X.+Yangauthor=Y.+Shi&title=Crystal+structure+of+the+mucosa-associated+lymphoid+tissue+lymphoma+translocation+1+%28MALT1%29+paracaspase+region&doi=10.1073%2Fpnas.1111708108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region</span></div><div class="casAuthors">Yu, Jong W.; Jeffrey, Philip D.; Ha, Jun Yong; Yang, Xiaolu; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">21004-21009, S21004/1-S21004/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The mucosa-assocd. lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase, a key component of the Carma1/Bcl10/MALT1 signalosome, is crit. for NF-ÎºB signaling in multiple contexts.  MALT1 is thought to function as a scaffold and protease to promote signaling; however, the biochem. and structural basis of paracaspase action remains largely unknown.  Here we report the 1.75-Ã resoln. crystal structure of the MALT1 paracaspase region, which contains the paracaspase domain and an ensuing Ig-like domain.  The paracaspase and the Ig domains appear as a single folding unit and interact with each other through extensive van der Waals contacts and hydrogen bonds.  The paracaspase domain adopts a fold that is nearly identical to that of classic caspases and homodimerizes similarly to form an active protease.  Unlike caspases, the active and mature form of the paracaspase domain remains a single uncleaved polypeptide and specifically recognizes the bound peptide inhibitor Val-Arg-Pro-Arg.  In particular, the carboxyl-terminal amino acid Arg of the inhibitor is coordinated by three highly conserved acidic residues.  This structure serves as an important framework for deciphering the function and mechanism of paracaspases exemplified by MALT1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL7uNcqMlhFrVg90H21EOLACvtfcHk0lj7JJHC38_laA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVCquw%253D%253D&md5=ae793746fbbdebb0d057565390da91bc</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1111708108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1111708108%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DJ.%2BW.%26aulast%3DJeffrey%26aufirst%3DP.%2BD.%26aulast%3DHa%26aufirst%3DJ.%2BY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DCrystal%2520structure%2520of%2520the%2520mucosa-associated%2520lymphoid%2520tissue%2520lymphoma%2520translocation%25201%2520%2528MALT1%2529%2520paracaspase%2520region%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26issue%3D52%26spage%3D21004%26doi%3D10.1073%2Fpnas.1111708108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hatcher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FontÃ¡n, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Us, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chennamadhavuni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. A.</span></span> <span> </span><span class="NLM_article-title">Peptide-based covalent inhibitors of MALT1 paracaspase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1336</span>â <span class="NLM_lpage">1339</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2019.03.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2019.03.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30954428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmslKmsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=1336-1339&issue=11&author=J.+M.+Hatcherauthor=G.+Duauthor=L.+Font%C3%A1nauthor=I.+Usauthor=Q.+Qiaoauthor=S.+Chennamadhavuniauthor=J.+Shaoauthor=H.+Wuauthor=A.+Melnickauthor=N.+S.+Grayauthor=D.+A.+Scott&title=Peptide-based+covalent+inhibitors+of+MALT1+paracaspase&doi=10.1016%2Fj.bmcl.2019.03.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-based covalent inhibitors of MALT1 paracaspase</span></div><div class="casAuthors">Hatcher, John M.; Du, Guangyan; Fontan, Lorena; Us, Ilkay; Qiao, Qi; Chennamadhavuni, Spandan; Shao, Jay; Wu, Hao; Melnick, Ari; Gray, Nathanael S.; Scott, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1336-1339</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Potent and selective substrate-based covalent inhibitors of MALT1 protease were developed from the tetrapeptide tool compd. Z-VRPR-fmk.  To improve cell permeability, we replaced one arginine residue.  We further optimized a series of tripeptides and identified compds. that were potent in both a GloSensor reporter assay measuring cellular MALT1 protease activity, and an OCI-Ly3 cell proliferation assay.  Example compds. showed good overall selectivity towards cysteine proteases, and one compd. was selected for further profiling in ABL-DLBCL cells and xenograft efficacy models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtEeKyPCVSNrVg90H21EOLACvtfcHk0liXNfXgPrmNvw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmslKmsbY%253D&md5=ab7bea6771526b16ddd7655676714880</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.03.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.03.046%26sid%3Dliteratum%253Aachs%26aulast%3DHatcher%26aufirst%3DJ.%2BM.%26aulast%3DDu%26aufirst%3DG.%26aulast%3DFont%25C3%25A1n%26aufirst%3DL.%26aulast%3DUs%26aufirst%3DI.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DChennamadhavuni%26aufirst%3DS.%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DScott%26aufirst%3DD.%2BA.%26atitle%3DPeptide-based%2520covalent%2520inhibitors%2520of%2520MALT1%2520paracaspase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26issue%3D11%26spage%3D1336%26epage%3D1339%26doi%3D10.1016%2Fj.bmcl.2019.03.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">FontÃ¡n, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatcher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casalena, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Us, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilchuk, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chennamadhavuni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palladino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inghirami, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philippar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span> <span> </span><span class="NLM_article-title">Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>128</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4397</span>â <span class="NLM_lpage">4412</span>, <span class="refDoi">Â DOI: 10.1172/JCI99436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1172%2FJCI99436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30024860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FpvVGisQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2018&pages=4397-4412&issue=10&author=L.+Font%C3%A1nauthor=Q.+Qiaoauthor=J.+M.+Hatcherauthor=G.+Casalenaauthor=I.+Usauthor=M.+Teaterauthor=M.+Durantauthor=G.+Duauthor=M.+Xiaauthor=N.+Bilchukauthor=S.+Chennamadhavuniauthor=G.+Palladinoauthor=G.+Inghiramiauthor=U.+Philipparauthor=H.+Wuauthor=D.+A.+Scottauthor=N.+S.+Grayauthor=A.+Melnick&title=Specific+covalent+inhibition+of+MALT1+paracaspase+suppresses+B+cell+lymphoma+growth&doi=10.1172%2FJCI99436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth</span></div><div class="casAuthors">Fontan Lorena; Casalena Gabriella; Us Ilkay; Teater Matt; Durant Matt; Xia Min; Bilchuk Natalia; Melnick Ari; Qiao Qi; Wu Hao; Hatcher John M; Du Guangyan; Chennamadhavuni Spandan; Scott David A; Gray Nathanael S; Hatcher John M; Du Guangyan; Chennamadhavuni Spandan; Scott David A; Gray Nathanael S; Palladino Giuseppe; Inghirami Giorgio; Inghirami Giorgio; Philippar Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4397-4412</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The paracaspase MALT1 plays an essential role in activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) downstream of B cell and TLR pathway genes mutated in these tumors.  Although MALT1 is considered a compelling therapeutic target, the development of tractable and specific MALT1 protease inhibitors has thus far been elusive.  Here, we developed a target engagement assay that provides a quantitative readout for specific MALT1-inhibitory effects in living cells.  This enabled a structure-guided medicinal chemistry effort culminating in the discovery of pharmacologically tractable, irreversible substrate-mimetic compounds that bind the MALT1 active site.  We confirmed that MALT1 targeting with compound 3 is effective at suppressing ABC DLBCL cells in vitro and in vivo.  We show that a reduction in serum IL-10 levels exquisitely correlates with the drug pharmacokinetics and degree of MALT1 inhibition in vitro and in vivo and could constitute a useful pharmacodynamic biomarker to evaluate these compounds in clinical trials.  Compound 3 revealed insights into the biology of MALT1 in ABC DLBCL, such as the role of MALT1 in driving JAK/STAT signaling and suppressing the type I IFN response and MHC class II expression, suggesting that MALT1 inhibition could prime lymphomas for immune recognition by cytotoxic immune cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCz33HBHJmvBOk4JA3soTqfW6udTcc2eZFPJ8BBeJ01rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FpvVGisQ%253D%253D&md5=e1ec2b4fd4f67628c716d3948da31751</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1172%2FJCI99436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI99436%26sid%3Dliteratum%253Aachs%26aulast%3DFont%25C3%25A1n%26aufirst%3DL.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DHatcher%26aufirst%3DJ.%2BM.%26aulast%3DCasalena%26aufirst%3DG.%26aulast%3DUs%26aufirst%3DI.%26aulast%3DTeater%26aufirst%3DM.%26aulast%3DDurant%26aufirst%3DM.%26aulast%3DDu%26aufirst%3DG.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DBilchuk%26aufirst%3DN.%26aulast%3DChennamadhavuni%26aufirst%3DS.%26aulast%3DPalladino%26aufirst%3DG.%26aulast%3DInghirami%26aufirst%3DG.%26aulast%3DPhilippar%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DMelnick%26aufirst%3DA.%26atitle%3DSpecific%2520covalent%2520inhibition%2520of%2520MALT1%2520paracaspase%2520suppresses%2520B%2520cell%2520lymphoma%2520growth%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2018%26volume%3D128%26issue%3D10%26spage%3D4397%26epage%3D4412%26doi%3D10.1172%2FJCI99436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hachmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington-Mitchell, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanman, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span> <span> </span><span class="NLM_article-title">Probes to monitor activity of the paracaspase MALT1</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">139</span>â <span class="NLM_lpage">147</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2014.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2014.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25556944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntV2ltw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=139-147&issue=1&author=J.+Hachmannauthor=L.+E.+Edgington-Mitchellauthor=M.+Porebaauthor=L.+E.+Sanmanauthor=M.+Dragauthor=M.+Bogyoauthor=G.+S.+Salvesen&title=Probes+to+monitor+activity+of+the+paracaspase+MALT1&doi=10.1016%2Fj.chembiol.2014.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Probes to Monitor Activity of the Paracaspase MALT1</span></div><div class="casAuthors">Hachmann, Janna; Edgington-Mitchell, Laura E.; Poreba, Marcin; Sanman, Laura E.; Drag, Marcin; Bogyo, Matthew; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The human paracaspase mucosa-assocd. lymphoid tissue lymphoma translocation protein 1 (MALT1) plays a central role in nuclear factor-ÎºB (NF-ÎºB) signaling as both a protease and scaffolding protein.  Knocking out MALT1 leads to impaired NF-ÎºB signaling and failure to mount an effective immune response.  However, it is unclear to which degree it is the scaffolding function vs. the proteolytic activity of MALT1 that is essential.  Previous work involving a MALT1 inhibitor with low selectivity suggests that the enzymic function plays an important role in different cell lines.  To help elucidate this proteolytic role of MALT1, we have designed activity-based probes that inhibit its proteolytic activity.  The probes selectively label active enzyme and can be used to inhibit MALT1 and trace its activity profile, helping to create a better picture of the significance of the proteolytic function of MALT1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojbrTWz6oQs7Vg90H21EOLACvtfcHk0liXNfXgPrmNvw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntV2ltw%253D%253D&md5=3a8d7aaa85c3e150bc2518a083b03ef0</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DHachmann%26aufirst%3DJ.%26aulast%3DEdgington-Mitchell%26aufirst%3DL.%2BE.%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DSanman%26aufirst%3DL.%2BE.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DProbes%2520to%2520monitor%2520activity%2520of%2520the%2520paracaspase%2520MALT1%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26issue%3D1%26spage%3D139%26epage%3D147%26doi%3D10.1016%2Fj.chembiol.2014.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eitelhuber, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vosyka, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bognar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenze, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammens, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlauderer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hlahla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopfner, K.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hummel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelst, S. H.L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span> <span> </span><span class="NLM_article-title">Activity-based probes for detection of active MALT1 paracaspase in immune cells and lymphomas</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">129</span>â <span class="NLM_lpage">138</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2014.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2014.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25556945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvFahtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=129-138&issue=1&author=A.+C.+Eitelhuberauthor=O.+Vosykaauthor=D.+Nagelauthor=M.+Bognarauthor=D.+Lenzeauthor=K.+Lammensauthor=F.+Schlaudererauthor=D.+Hlahlaauthor=K.-P.+Hopfnerauthor=G.+Lenzauthor=M.+Hummelauthor=S.+H.L.+Verhelstauthor=D.+Krappmann&title=Activity-based+probes+for+detection+of+active+MALT1+paracaspase+in+immune+cells+and+lymphomas&doi=10.1016%2Fj.chembiol.2014.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-Based Probes for Detection of Active MALT1 Paracaspase in Immune Cells and Lymphomas</span></div><div class="casAuthors">Eitelhuber, Andrea C.; Vosyka, Oliver; Nagel, Daniel; Bognar, Miriam; Lenze, Dido; Lammens, Katja; Schlauderer, Florian; Hlahla, Daniela; Hopfner, Karl-Peter; Lenz, Georg; Hummel, Michael; Verhelst, Steven H. L.; Krappmann, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-138</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">MALT1 paracaspase is activated upon antigen receptor stimulation to promote lymphocyte activation.  In addn., deregulated MALT1 protease activity drives survival of distinct lymphomas such as the activated B cell type of diffuse large B cell lymphoma (ABC-DLBCL).  Here, we designed fluorophore or biotin-coupled activity based-probes (ABP) that covalently modify the active center of MALT1.  MALT1-ABPs are exclusively labeling an active modified full length form of MALT1 upon T cell stimulation.  Further, despite the CARMA1 requirement for initial MALT1 activation, the MALT1-ABPs show that protease activity is not confined to the high-mol. CARMA1-BCL10-MALT1 (CBM) complex.  Using biotin-coupled ABPs, we developed a robust assay for sensitive and selective detection of active MALT1 in cell lines, primary lymphocytes, and DLBCL tumor biopsies.  Taken together, MALT1-ABPs represent powerful chem. tools to measure cellular MALT1 activation, det. efficacy of small mol. inhibitors, and classify lymphomas based on MALT1 activity status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6lkG4qu2iLVg90H21EOLACvtfcHk0lhq9VEhGt_JTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvFahtw%253D%253D&md5=4de07d113d7f5090494d248394538e47</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DEitelhuber%26aufirst%3DA.%2BC.%26aulast%3DVosyka%26aufirst%3DO.%26aulast%3DNagel%26aufirst%3DD.%26aulast%3DBognar%26aufirst%3DM.%26aulast%3DLenze%26aufirst%3DD.%26aulast%3DLammens%26aufirst%3DK.%26aulast%3DSchlauderer%26aufirst%3DF.%26aulast%3DHlahla%26aufirst%3DD.%26aulast%3DHopfner%26aufirst%3DK.-P.%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DHummel%26aufirst%3DM.%26aulast%3DVerhelst%26aufirst%3DS.%2BH.L.%26aulast%3DKrappmann%26aufirst%3DD.%26atitle%3DActivity-based%2520probes%2520for%2520detection%2520of%2520active%2520MALT1%2520paracaspase%2520in%2520immune%2520cells%2520and%2520lymphomas%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26issue%3D1%26spage%3D129%26epage%3D138%26doi%3D10.1016%2Fj.chembiol.2014.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KoÅt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janiszewski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groborz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PorÈ©ba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DraÌ§g, M.</span></span> <span> </span><span class="NLM_article-title">Determination of extended substrate specificity of the MALT1 as a strategy for the design of potent substrates and activity-based probes</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15998</span>, <span class="refDoi">Â DOI: 10.1038/s41598-018-34476-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41598-018-34476-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30375474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BB3cvkslCnug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=15998&issue=1&author=P.+Kasperkiewiczauthor=S.+Ko%C5%82tauthor=T.+Janiszewskiauthor=K.+Groborzauthor=M.+Por%C8%A9baauthor=S.+J.+Snipasauthor=G.+S.+Salvesenauthor=M.+Dra%CC%A7g&title=Determination+of+extended+substrate+specificity+of+the+MALT1+as+a+strategy+for+the+design+of+potent+substrates+and+activity-based+probes&doi=10.1038%2Fs41598-018-34476-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of extended substrate specificity of the MALT1 as a strategy for the design of potent substrates and activity-based probes</span></div><div class="casAuthors">Kasperkiewicz Paulina; Kolt Sonia; Janiszewski Tomasz; Groborz Katarzyna; Poreba Marcin; DrAg Marcin; Poreba Marcin; Snipas Scott J; Salvesen Guy S</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15998</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) belongs to the CD clan of cysteine proteases.  MALT1 is a unique enzyme among this clan because it recognizes the basic amino acid arginine in the P1 pocket.  Previous studies carried out with natural amino acids revealed the substrate specificity of the P4-P1 pockets of MALT1 but have provided only limited information about the catalytic preferences of this enzyme.  In this study, we exploited Hybrid Combinatorial Substrate Library and Internally Quenched Fluorescence substrate technologies to interrogate the extended substrate specificity profile of the S5-S2' active site pockets using unnatural amino acids.  This strategy resulted in the design of a peptide-based fluorogenic substrate, which exhibited significant activity toward MALT1.  Subsequently, the substrate sequence was further utilized to develop potent, irreversible activity-based probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRglXfZMl481eWhZTslLrfffW6udTcc2eZ-wkz_Uk6CrLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvkslCnug%253D%253D&md5=a96a58734e16479144f05d3f1484978d</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-34476-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-34476-7%26sid%3Dliteratum%253Aachs%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DKo%25C5%2582t%26aufirst%3DS.%26aulast%3DJaniszewski%26aufirst%3DT.%26aulast%3DGroborz%26aufirst%3DK.%26aulast%3DPor%25C8%25A9ba%26aufirst%3DM.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDra%25CC%25A7g%26aufirst%3DM.%26atitle%3DDetermination%2520of%2520extended%2520substrate%2520specificity%2520of%2520the%2520MALT1%2520as%2520a%2520strategy%2520for%2520the%2520design%2520of%2520potent%2520substrates%2520and%2520activity-based%2520probes%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26issue%3D1%26spage%3D15998%26doi%3D10.1038%2Fs41598-018-34476-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
de Plassche, M. A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâNeill, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeholzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelst, S. H. L.</span></span> <span> </span><span class="NLM_article-title">Use of non-natural amino acids for the design and synthesis of a selective, cell-permeable MALT1 activity-based probe</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3996</span>â <span class="NLM_lpage">4004</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.9b01879</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01879" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFCju7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3996-4004&issue=8&author=M.+A.+T.+van%0Ade+Plasscheauthor=T.+J.+O%E2%80%99Neillauthor=T.+Seeholzerauthor=B.+Turkauthor=D.+Krappmannauthor=S.+H.+L.+Verhelst&title=Use+of+non-natural+amino+acids+for+the+design+and+synthesis+of+a+selective%2C+cell-permeable+MALT1+activity-based+probe&doi=10.1021%2Facs.jmedchem.9b01879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Non-Natural Amino Acids for the Design and Synthesis of a Selective, Cell-Permeable MALT1 Activity-Based Probe</span></div><div class="casAuthors">van de Plassche, Merel A. T.; O'Neill, Thomas J.; Seeholzer, Thomas; Turk, Boris; Krappmann, Daniel; Verhelst, Steven H. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3996-4004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Constitutive proteolytic activity of MALT1 is assocd. with highly aggressive B-cell lymphomas.  Chem. tools that detect active MALT1 have been reported, but suffer from poor cell permeability and/or cross-reactivity with the cysteine protease cathepsin B.  Here, we report that the non-natural amino acid pipecolinic acid in the P2 position of substrates and chem. probes leads to improved selectivity toward MALT1 and results in cell-permeable fluorescent probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrneQOxyy4k_LVg90H21EOLACvtfcHk0litgSOxLAyjAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFCju7Y%253D&md5=654c8fce296a0ee5d681f9287f856c0d</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01879%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BPlassche%26aufirst%3DM.%2BA.%2BT.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DT.%2BJ.%26aulast%3DSeeholzer%26aufirst%3DT.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DKrappmann%26aufirst%3DD.%26aulast%3DVerhelst%26aufirst%3DS.%2BH.%2BL.%26atitle%3DUse%2520of%2520non-natural%2520amino%2520acids%2520for%2520the%2520design%2520and%2520synthesis%2520of%2520a%2520selective%252C%2520cell-permeable%2520MALT1%2520activity-based%2520probe%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D8%26spage%3D3996%26epage%3D4004%26doi%3D10.1021%2Facs.jmedchem.9b01879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabaleeswaran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerchietti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaknovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascoyne, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Climent, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span> <span> </span><span class="NLM_article-title">MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">812</span>â <span class="NLM_lpage">824</span>, <span class="refDoi">Â DOI: 10.1016/j.ccr.2012.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.ccr.2012.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23238016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVWgu7fJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=812-824&issue=6&author=L.+Fontanauthor=C.+Yangauthor=V.+Kabaleeswaranauthor=L.+Volponauthor=M.+J.+Osborneauthor=E.+Beltranauthor=M.+Garciaauthor=L.+Cerchiettiauthor=R.+Shaknovichauthor=S.+N.+Yangauthor=F.+Fangauthor=R.+D.+Gascoyneauthor=J.+A.+Martinez-Climentauthor=J.+F.+Glickmanauthor=K.+Bordenauthor=H.+Wuauthor=A.+Melnick&title=MALT1+small+molecule+inhibitors+specifically+suppress+ABC-DLBCL+in+vitro+and+in+vivo&doi=10.1016%2Fj.ccr.2012.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo</span></div><div class="casAuthors">Fontan, Lorena; Yang, Chenghua; Kabaleeswaran, Venkataraman; Volpon, Laurent; Osborne, Michael J.; Beltran, Elena; Garcia, Monica; Cerchietti, Leandro; Shaknovich, Rita; Yang, Shao Ning; Fang, Fang; Gascoyne, Randy D.; Martinez-Climent, Jose Angel; Glickman, J. Fraser; Borden, Katherine; Wu, Hao; Melnick, Ari</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">812-824</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">MALT1 cleavage activity is linked to the pathogenesis of activated B cell-like diffuse large B cell lymphoma (ABC-DLBCL), a chemoresistant form of DLBCL.  We developed a MALT1 activity assay and identified chem. diverse MALT1 inhibitors.  A selected lead compd., MI-2, featured direct binding to MALT1 and suppression of its protease function.  MI-2 concd. within human ABC-DLBCL cells and irreversibly inhibited cleavage of MALT1 substrates.  This was accompanied by NF-ÎºB reporter activity suppression, c-REL nuclear localization inhibition, and NF-ÎºB target gene downregulation.  Most notably, MI-2 was nontoxic to mice, and displayed selective activity against ABC-DLBCL cell lines in vitro and xenotransplanted ABC-DLBCL tumors in vivo.  The compd. was also effective against primary human non-germinal center B cell-like DLBCLs ex vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Pj5xKzCfyrVg90H21EOLACvtfcHk0litgSOxLAyjAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVWgu7fJ&md5=f8a19df22430725336d5620b4ccb269a</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DFontan%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DKabaleeswaran%26aufirst%3DV.%26aulast%3DVolpon%26aufirst%3DL.%26aulast%3DOsborne%26aufirst%3DM.%2BJ.%26aulast%3DBeltran%26aufirst%3DE.%26aulast%3DGarcia%26aufirst%3DM.%26aulast%3DCerchietti%26aufirst%3DL.%26aulast%3DShaknovich%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DS.%2BN.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DMartinez-Climent%26aufirst%3DJ.%2BA.%26aulast%3DGlickman%26aufirst%3DJ.%2BF.%26aulast%3DBorden%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DMelnick%26aufirst%3DA.%26atitle%3DMALT1%2520small%2520molecule%2520inhibitors%2520specifically%2520suppress%2520ABC-DLBCL%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D22%26issue%3D6%26spage%3D812%26epage%3D824%26doi%3D10.1016%2Fj.ccr.2012.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goll, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapprell, H. P.</span></span> <span> </span><span class="NLM_article-title">The role of autolysis in activity of the Ca2+-dependent proteinases (mu-calpain and m-calpain)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>264</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">10096</span>â <span class="NLM_lpage">10103</span>, <span class="refDoi">Â DOI: 10.1016/S0021-9258(18)81771-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0021-9258%2818%2981771-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=2542320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaL1MXltFWntrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=10096-10103&issue=17&author=J.+Congauthor=D.+E.+Gollauthor=A.+M.+Petersonauthor=H.+P.+Kapprell&title=The+role+of+autolysis+in+activity+of+the+Ca2%2B-dependent+proteinases+%28mu-calpain+and+m-calpain%29&doi=10.1016%2FS0021-9258%2818%2981771-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">The role of autolysis in activity of the calcium-dependent proteinases (Î¼-calpain and m-calpain)</span></div><div class="casAuthors">Cong, Jinyang; Goll, Darrel E.; Peterson, Ann M.; Kapprell, Hans Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">10096-103</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A recent hypothesis suggests that proteolytic activity of the micromolar and millimolar Ca2+-requiring forms of the Ca2+-dependent proteinases (Î¼- and m-calpain, resp.) is regulated in vivo by their assocn. with a phosphatidylinositol-contg. site on the plasma membrane followed by autolysis of the proteinases.  Phosphatidylinositol assocn. lowers the Ca2+ concn. needed for autolysis, and autolysis, in turn, lowers the Ca2+ concn. needed for proteolytic activity.  To test this hypothesis, the Ca2+ concns. needed for autolysis and for proteolytic activity of the calpains were compared in the presence and the absence of phosphatidylinositol.  Bovine skeletal muscle Î¼-calpain required 40-50 Î¼M Ca2+ for half-maximal rate of proteolysis of a casein substrate, 140-150 Î¼M Ca2+ for half-maximal autolysis in the presence of 80 Î¼M phosphatidylinositol, and 190-210 Î¼M Ca2+ for half-maximal autolysis in the absence of phosphatidylinositol.  Consequently, Î¼-calpain is an active proteinase and does not require autolysis for activation.  Bovine skeletal muscle m-calpain required 700-740 Î¼M Ca2+ for half-maximal autolysis in the presence of 80 Î¼M phosphatidylinositol, and 740-780 Î¼M Ca2+ for half-maximal autolysis in the absence of phosphatidylinositol.  Apparently, m-calpain functions in its autolyzed form, but the results do not demonstrate that unautolyzed m-calpain is inactive.  Phosphatidylinositol at 80 Î¼M had no effect on the Ca2+ requirement of the autolyzed forms of either Î¼- or m-calpain but lowered the specific activity of Î¼-calpain to 20% of its activity in the absence of phosphatidylinositol.  Of the 4 forms of the calpains, unautolyzed m-calpain, autolyzed m-calpain, and unautolyzed Î¼-calpain would not be proteolytically active at the free Ca2+ concns. of 300-1200 nM present inside normal cells, and neither Î¼- nor m-calpain would undergo autolysis at these Ca2+ concns., even in the presence of phosphatidylinositol.  Cells must contain a mechanism other than or in addn. to membrane assocn. and autolysis to activate the calpains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE0-Pz9DFgk7Vg90H21EOLACvtfcHk0litgSOxLAyjAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltFWntrg%253D&md5=00e5732cb3204ddf7b3b9a5145db7938</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2981771-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252981771-9%26sid%3Dliteratum%253Aachs%26aulast%3DCong%26aufirst%3DJ.%26aulast%3DGoll%26aufirst%3DD.%2BE.%26aulast%3DPeterson%26aufirst%3DA.%2BM.%26aulast%3DKapprell%26aufirst%3DH.%2BP.%26atitle%3DThe%2520role%2520of%2520autolysis%2520in%2520activity%2520of%2520the%2520Ca2%252B-dependent%2520proteinases%2520%2528mu-calpain%2520and%2520m-calpain%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26issue%3D17%26spage%3D10096%26epage%3D10103%26doi%3D10.1016%2FS0021-9258%2818%2981771-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P. L.</span></span> <span> </span><span class="NLM_article-title">Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>456</i></span> (<span class="NLM_issue">7220</span>),  <span class="NLM_fpage">409</span>â <span class="NLM_lpage">412</span>, <span class="refDoi">Â DOI: 10.1038/nature07451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature07451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19020623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSjsLjN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=456&publication_year=2008&pages=409-412&issue=7220&author=R.+A.+Hannaauthor=R.+L.+Campbellauthor=P.+L.+Davies&title=Calcium-bound+structure+of+calpain+and+its+mechanism+of+inhibition+by+calpastatin&doi=10.1038%2Fnature07451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin</span></div><div class="casAuthors">Hanna, Rachel A.; Campbell, Robert L.; Davies, Peter L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">456</span>
        (<span class="NLM_cas:issue">7220</span>),
    <span class="NLM_cas:pages">409-412</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Calpains are non-lysosomal Ca2+-dependent cysteine proteinases that selectively cleave proteins in response to Ca2+ signals and thereby control cellular functions such as cytoskeletal remodelling, cell cycle progression, gene expression, and apoptotic cell death.  In mammals, the 2 best-characterized members of the calpain family, calpain 1 and calpain 2 (Î¼-calpain and m-calpain, resp.), are ubiquitously expressed.  The activity of calpains is tightly controlled by the endogenous inhibitor, calpastatin, which is an intrinsically unstructured protein capable of reversibly binding and inhibiting 4 mols. of calpain, but only in the presence of Ca2+.  To date, the mechanism of inhibition by calpastatin and the basis for its abs. specificity have remained speculative.  It has not been clear how this unstructured protein inhibits calpains without being cleaved itself, nor is it known how Ca2+ induces changes that facilitate the binding of calpastatin to calpain.  Here, the authors report the 2.4-Ã-resoln. crystal structure of the Ca2+-bound calpain 2 heterodimer bound by inhibitory domain 4 of calpastatin.  Calpastatin was seen to inhibit calpain by occupying both sides of the active site cleft.  Although the inhibitor passed through the active site cleft it escaped cleavage in a novel manner by looping out and around the active site Cys residue.  Capastatin inhibitory domain 4 recognized multiple lower affinity sites present only in the Ca2+-bound form of the enzyme, resulting in an interaction that was tight, specific, and Ca2+-dependent.  This crystal structure, and that of a related complex, also revealed the conformational changes that calpain undergoes on binding Ca2+, which include opening of the active site cleft and movement of the domains relative to each other to produce a more compact enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmkUMcFT6IebVg90H21EOLACvtfcHk0lh8UjNcBJM08w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSjsLjN&md5=34329cc5c6aeb7058881a98fbf7ba4f7</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1038%2Fnature07451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07451%26sid%3Dliteratum%253Aachs%26aulast%3DHanna%26aufirst%3DR.%2BA.%26aulast%3DCampbell%26aufirst%3DR.%2BL.%26aulast%3DDavies%26aufirst%3DP.%2BL.%26atitle%3DCalcium-bound%2520structure%2520of%2520calpain%2520and%2520its%2520mechanism%2520of%2520inhibition%2520by%2520calpastatin%26jtitle%3DNature%26date%3D2008%26volume%3D456%26issue%3D7220%26spage%3D409%26epage%3D412%26doi%3D10.1038%2Fnature07451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Critical role of calpain in inflammation</span>. <i>Biomed. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">647</span>â <span class="NLM_lpage">652</span>, <span class="refDoi">Â DOI: 10.3892/br.2016.785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.3892%2Fbr.2016.785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=28101338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFGisb%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=647-652&issue=6&author=J.+Jiauthor=L.+Suauthor=Z.+Liu&title=Critical+role+of+calpain+in+inflammation&doi=10.3892%2Fbr.2016.785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Critical role of calpain in inflammation (Review)</span></div><div class="casAuthors">Ji, Jingjing; Su, Lei; Liu, Zhifeng</div><div class="citationInfo"><span class="NLM_cas:title">Biomedical Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-652</span>CODEN:
                <span class="NLM_cas:coden">BREIB7</span>;
        ISSN:<span class="NLM_cas:issn">2049-9442</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Calpains are a family of cysteine proteases, impli- cated in a wide range of cellular calcium-regulated functions.  Evidence from previous studies using an inhibitor of calpain indicates that calpain activation is involved in the process of numerous inflammation-assocd. diseases.  As a result of in-depth studies, calpains have been proposed to influence the process of inflammation via a variety of mechanisms.  The aim of the present study is to provide an overview of recent reports regarding the role of calpain in the process of inflammation, including regulation of immune cell migration, modulation of the activation of inflammatory mediators, degrdn. of certain assocd. proteins and induction of cell apoptosis.  Understanding these mechanisms may contribute to the investi- gation of novel therapeutic targets for inflammation-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGkFaP4Y3vbVg90H21EOLACvtfcHk0lh8UjNcBJM08w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFGisb%252FE&md5=f96afc2ba837b18fd3bce00fe7644480</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.3892%2Fbr.2016.785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fbr.2016.785%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DCritical%2520role%2520of%2520calpain%2520in%2520inflammation%26jtitle%3DBiomed.%2520Rep.%26date%3D2016%26volume%3D5%26issue%3D6%26spage%3D647%26epage%3D652%26doi%3D10.3892%2Fbr.2016.785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moldoveanu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuerrier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P. L.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>343</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1313</span>â <span class="NLM_lpage">1326</span>, <span class="refDoi">Â DOI: 10.1016/j.jmb.2004.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.jmb.2004.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15491615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2cXos1Klu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=1313-1326&issue=5&author=T.+Moldoveanuauthor=R.+L.+Campbellauthor=D.+Cuerrierauthor=P.+L.+Davies&title=Crystal+structures+of+calpain-E64+and+-leupeptin+inhibitor+complexes+reveal+mobile+loops+gating+the+active+site&doi=10.1016%2Fj.jmb.2004.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Calpain-E64 and -Leupeptin Inhibitor Complexes Reveal Mobile Loops Gating the Active Site</span></div><div class="casAuthors">Moldoveanu, T.; Campbell, R. L.; Cuerrier, D.; Davies, P. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1313-1326</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The endogenous calpain inhibitor, calpastatin, modulates some patho-physiol. aspects of calpain signaling.  Excess calpain can escape this inhibition and as well, many calpain isoforms and autolytically generated protease core fragments are not inhibited by calpastatin.  There is a need, therefore, to develop specific, cell-permeable calpain inhibitors to block uncontrolled proteolysis and prevent tissue damage during brain and heart ischemia, spinal-cord injury and Alzheimer's diseases.  Here, we report the first high-resoln. crystal structures of rat Î¼-calpain protease core complexed with two traditional, low mol. mass inhibitors, leupeptin and E64.  These structures show that access to a slightly deeper, but otherwise papain-like active site is gated by two flexible loops.  These loops are divergent among the calpain isoforms giving a potential structural basis for substrate/inhibitor selectivity over other papain-like cysteine proteases and between members of the calpain family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS2t60SFPuhLVg90H21EOLACvtfcHk0lh8UjNcBJM08w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXos1Klu7g%253D&md5=ddf5b2a125bcaa66d6b904362d60a8a4</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2004.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2004.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DMoldoveanu%26aufirst%3DT.%26aulast%3DCampbell%26aufirst%3DR.%2BL.%26aulast%3DCuerrier%26aufirst%3DD.%26aulast%3DDavies%26aufirst%3DP.%2BL.%26atitle%3DCrystal%2520structures%2520of%2520calpain-E64%2520and%2520-leupeptin%2520inhibitor%2520complexes%2520reveal%2520mobile%2520loops%2520gating%2520the%2520active%2520site%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26issue%3D5%26spage%3D1313%26epage%3D1326%26doi%3D10.1016%2Fj.jmb.2004.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greenbaum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medzihradszky, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlingame, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">569</span>â <span class="NLM_lpage">581</span>, <span class="refDoi">Â DOI: 10.1016/S1074-5521(00)00014-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS1074-5521%2800%2900014-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=11048948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1WnsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=569-581&issue=8&author=D.+Greenbaumauthor=K.+F.+Medzihradszkyauthor=A.+Burlingameauthor=M.+Bogyo&title=Epoxide+electrophiles+as+activity-dependent+cysteine+protease+profiling+and+discovery+tools&doi=10.1016%2FS1074-5521%2800%2900014-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools</span></div><div class="casAuthors">Greenbaum, Doron; Medzihradszky, Katalin F.; Burlingame, Alma; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">569-581</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: Anal. of global changes in gene transcription and translation by systems-based genomics and proteomics approaches provides only indirect information about protein function.  In many cases, enzymic activity fails to correlate with transcription or translation levels.  Therefore, a direct method for broadly detg. activities of an entire class of enzymes on a genome-wide scale would be of great utility.  Results: We have engineered chem. probes that can be used to broadly track activity of cysteine proteases.  The structure of the general cysteine protease inhibitor E-64 was used as a scaffold.  Analogs were synthesized by varying the core peptide recognition portion while adding affinity tags (biotin and radio-iodine) at distal sites.  The resulting probes contg. a P2 leucine residue (DCG-03 and DCG-04) targeted the same broad set of cysteine proteases as E-64 and were used to profile these proteases during the progression of a normal skin cell to a carcinoma.  A library of DCG-04 derivs. was constructed in which the leucine residue was replaced with all natural amino acids.  This library was used to obtain inhibitor activity profiles for multiple protease targets in crude cellular exts.  Finally, the affinity tag of DCG-04 allowed purifn. of modified proteases and identification by mass spectrometry.  Conclusions: We have created a simple and flexible method for functionally identifying cysteine proteases while simultaneously tracking their relative activity levels in crude protein mixts.  These probes were used to det. relative activities of multiple proteases throughout a defined model system for cancer progression.  Furthermore, information obtained from libraries of affinity probes provides a rapid method for obtaining detailed functional information without the need for prior purifn./identification of targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqlBq1FnhWH7Vg90H21EOLACvtfcHk0ljY7Zom94lVsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1WnsbY%253D&md5=4bfc0e299524198ec324c96c8981baf7</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2800%2900014-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252800%252900014-4%26sid%3Dliteratum%253Aachs%26aulast%3DGreenbaum%26aufirst%3DD.%26aulast%3DMedzihradszky%26aufirst%3DK.%2BF.%26aulast%3DBurlingame%26aufirst%3DA.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DEpoxide%2520electrophiles%2520as%2520activity-dependent%2520cysteine%2520protease%2520profiling%2520and%2520discovery%2520tools%26jtitle%3DChem.%2520Biol.%26date%3D2000%26volume%3D7%26issue%3D8%26spage%3D569%26epage%3D581%26doi%3D10.1016%2FS1074-5521%2800%2900014-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukiage, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, T. R.</span></span> <span> </span><span class="NLM_article-title">SJA6017, a newly synthesized peptide aldehyde inhibitor of calpain: amelioration of cataract in cultured rat lenses</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>1361</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">304</span>â <span class="NLM_lpage">312</span>, <span class="refDoi">Â DOI: 10.1016/S0925-4439(97)00043-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0925-4439%2897%2900043-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=9375805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2sXmtFKgsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1361&publication_year=1997&pages=304-312&issue=3&author=C.+Fukiageauthor=M.+Azumaauthor=Y.+Nakamuraauthor=Y.+Tamadaauthor=M.+Nakamuraauthor=T.+R.+Shearer&title=SJA6017%2C+a+newly+synthesized+peptide+aldehyde+inhibitor+of+calpain%3A+amelioration+of+cataract+in+cultured+rat+lenses&doi=10.1016%2FS0925-4439%2897%2900043-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">SJA6017, a newly synthesized peptide aldehyde inhibitor of calpain: amelioration of cataract in cultured rat lenses</span></div><div class="casAuthors">Fukiage, Chiho; Azuma, Mitsuyoshi; Nakamura, Yoshikuni; Tamada, Yoshiyuki; Nakamura, Masayuki; Shearer, Thomas R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1361</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">304-312</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purposes of this expt. were to: (1), characterize the peptide aldehyde SJA6017, N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal, a newly synthesized inhibitor of calpain, and (2) test the effect of SJA6017 in preventing calcium ionophore-induced cataract in cultured rat lenses.  In vitro, SJA6017 strongly inhibited purified m-calpain from porcine kidney.  Casein zymog. confirmed that SJA6017 reversibly bound to the active site of m-calpain.  SJA6017 was also confirmed to be a cell-permeable inhibitor in Molt-4 cells.  In cultured lenses, SJA6017 reduced nuclear opacity and proteolysis of crystallins and Î±-spectrin caused by calcium ionophore A23187.  These results suggested that SJA6017 is a reversible and cell-permeable calpain inhibitor which may possess great efficacy against calcium-induced models of cataract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv1AkyGIYh3bVg90H21EOLACvtfcHk0ljY7Zom94lVsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtFKgsLk%253D&md5=67fc174d4ddffe03c9c8798915d1314f</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2FS0925-4439%2897%2900043-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0925-4439%252897%252900043-4%26sid%3Dliteratum%253Aachs%26aulast%3DFukiage%26aufirst%3DC.%26aulast%3DAzuma%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DTamada%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DShearer%26aufirst%3DT.%2BR.%26atitle%3DSJA6017%252C%2520a%2520newly%2520synthesized%2520peptide%2520aldehyde%2520inhibitor%2520of%2520calpain%253A%2520amelioration%2520of%2520cataract%2520in%2520cultured%2520rat%2520lenses%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D1997%26volume%3D1361%26issue%3D3%26spage%3D304%26epage%3D312%26doi%3D10.1016%2FS0925-4439%2897%2900043-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trinchese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faâ, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixon, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>118</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2796</span>â <span class="NLM_lpage">2807</span>, <span class="refDoi">Â DOI: 10.1172/JCI34254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1172%2FJCI34254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18596919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVOktbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=2796-2807&issue=8&author=F.+Trincheseauthor=M.+Fa%E2%80%99author=S.+Liuauthor=H.+Zhangauthor=A.+Hidalgoauthor=S.+D.+Schmidtauthor=H.+Yamaguchiauthor=N.+Yoshiiauthor=P.+M.+Mathewsauthor=R.+A.+Nixonauthor=O.+Arancio&title=Inhibition+of+calpains+improves+memory+and+synaptic+transmission+in+a+mouse+model+of+Alzheimer+disease&doi=10.1172%2FJCI34254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease</span></div><div class="casAuthors">Trinchese, Fabrizio; Fa, Mauro; Liu, Shumin; Zhang, Hong; Hidalgo, Ariel; Schmidt, Stephen D.; Yamaguchi, Hisako; Yoshii, Narihiko; Mathews, Paul M.; Nixon, Ralph A.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2796-2807</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Calpains are calcium-dependent enzymes that det. the fate of proteins through regulated proteolytic activity.  Calpains have been linked to the modulation of memory and are key to the pathogenesis of Alzheimer disease (AD).  When abnormally activated, calpains can also initiate degrdn. of proteins essential for neuronal survival.  Here we show that calpain inhibition through E64, a cysteine protease inhibitor, and the highly specific calpain inhibitor BDA-410 restored normal synaptic function both in hippocampal cultures and in hippocampal slices from the APP/PS1 mouse, an animal model of AD.  Calpain inhibition also improved spatial-working memory and associative fear memory in APP/PS1 mice.  These beneficial effects of the calpain inhibitors were assocd. with restoration of normal phosphorylation levels of the transcription factor CREB and involved redistribution of the synaptic protein synapsin I.  Thus, calpain inhibition may prove useful in the alleviation of memory loss in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIy6cRZUZoYLVg90H21EOLACvtfcHk0ljY7Zom94lVsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVOktbw%253D&md5=034fd10ae83ab33a5b0512f3a6f6f393</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1172%2FJCI34254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI34254%26sid%3Dliteratum%253Aachs%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DFa%25E2%2580%2599%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHidalgo%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DS.%2BD.%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DYoshii%26aufirst%3DN.%26aulast%3DMathews%26aufirst%3DP.%2BM.%26aulast%3DNixon%26aufirst%3DR.%2BA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DInhibition%2520of%2520calpains%2520improves%2520memory%2520and%2520synaptic%2520transmission%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26issue%3D8%26spage%3D2796%26epage%3D2807%26doi%3D10.1172%2FJCI34254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartus, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straub, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbeson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration</span>. <i>Stroke</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2265</span>â <span class="NLM_lpage">2270</span>, <span class="refDoi">Â DOI: 10.1161/01.STR.25.11.2265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1161%2F01.STR.25.11.2265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=7974554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2MXit1ejtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=2265-2270&issue=11&author=R.+T.+Bartusauthor=N.+J.+Haywardauthor=P.+J.+Elliottauthor=S.+D.+Sawyerauthor=K.+L.+Bakerauthor=R.+L.+Deanauthor=A.+Akiyamaauthor=J.+A.+Straubauthor=S.+L.+Harbesonauthor=Z.+Li&title=Calpain+inhibitor+AK295+protects+neurons+from+focal+brain+ischemia.+Effects+of+postocclusion+intra-arterial+administration&doi=10.1161%2F01.STR.25.11.2265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Calpain inhibitor AK295 protects neurons from focal brain ischemia: effects of postocclusion intra-arterial administration</span></div><div class="casAuthors">Bartus, Raymond T.; Hayward, Neil J.; Elliott, Peter J.; Sawyer, Sean D.; Baker, Keith L.; Dean, Reginald L.; Akiyama, Alan; Straub, Julie A.; Harbeson, Scott L.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Stroke</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2265-70</span>CODEN:
                <span class="NLM_cas:coden">SJCCA7</span>;
        ISSN:<span class="NLM_cas:issn">0039-2499</span>.
    </div><div class="casAbstract">This research was performed to det. whether a selective inhibitor of the calcium-dependent protease, calpain, could reduce ischemia-assocd. brain damage when peripherally administered after a vascular occlusion.  A variation of the rat middle cerebral artery occlusion model was used.  A range of doses of AK295 (a novel calpain inhibitor synthesized for this purpose) was continuously infused through the internal carotid artery, beginning 1.25 h from the initiation of the occlusion.  Rats were killed at 21 h, and the infarct vol. was quantified.  Postocclusion (1.25-h) infusion of the calpain inhibitor AK295 elicited a dose-dependent neuroprotective effect after focal ischemia.  The highest dose tested (3 mg/kg per h) afforded the max. effect, illustrated by a 32% redn. in infarct vol. 21 h after the ischemia (vehicle, 81.7Â±4.7 mm3; AK295, 54.9Â±6.9 mm3; P<.007).  These data provide the first evidence that a peripherally administered calpain inhibitor can protect against ischemic brain damage.  They offer further support for an important role of calpain proteolysis in the brain degeneration assocd. with cerebral ischemic events and suggest that selective calpain inhibitors provide a rational, novel, and viable means of treating such neurodegenerative problems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0jeYQXd_W3rVg90H21EOLACvtfcHk0lh4nKw0xvRkyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXit1ejtbY%253D&md5=deb655c102ac330fc60e77d90475c97b</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1161%2F01.STR.25.11.2265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.STR.25.11.2265%26sid%3Dliteratum%253Aachs%26aulast%3DBartus%26aufirst%3DR.%2BT.%26aulast%3DHayward%26aufirst%3DN.%2BJ.%26aulast%3DElliott%26aufirst%3DP.%2BJ.%26aulast%3DSawyer%26aufirst%3DS.%2BD.%26aulast%3DBaker%26aufirst%3DK.%2BL.%26aulast%3DDean%26aufirst%3DR.%2BL.%26aulast%3DAkiyama%26aufirst%3DA.%26aulast%3DStraub%26aufirst%3DJ.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DCalpain%2520inhibitor%2520AK295%2520protects%2520neurons%2520from%2520focal%2520brain%2520ischemia.%2520Effects%2520of%2520postocclusion%2520intra-arterial%2520administration%26jtitle%3DStroke%26date%3D1994%26volume%3D25%26issue%3D11%26spage%3D2265%26epage%3D2270%26doi%3D10.1161%2F01.STR.25.11.2265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lubisch, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckenbach, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bopp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kartal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KÃ¤stel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz-Garrecht, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vierling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¶ller, A.</span></span> <span> </span><span class="NLM_article-title">Benzoylalanine-derived ketoamides carrying vinylbenzyl amino residues: Discovery of potent water-soluble calpain inhibitors with oral bioavailability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2404</span>â <span class="NLM_lpage">2412</span>, <span class="refDoi">Â DOI: 10.1021/jm0210717</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0210717" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsVSgurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2404-2412&issue=12&author=W.+Lubischauthor=E.+Beckenbachauthor=S.+Boppauthor=H.-P.+Hofmannauthor=A.+Kartalauthor=C.+K%C3%A4stelauthor=T.+Lindnerauthor=M.+Metz-Garrechtauthor=J.+Reebauthor=F.+Regnerauthor=M.+Vierlingauthor=A.+M%C3%B6ller&title=Benzoylalanine-derived+ketoamides+carrying+vinylbenzyl+amino+residues%3A+Discovery+of+potent+water-soluble+calpain+inhibitors+with+oral+bioavailability&doi=10.1021%2Fjm0210717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoylalanine-Derived Ketoamides Carrying Vinylbenzyl Amino Residues: Discovery of Potent Water-Soluble Calpain Inhibitors with Oral Bioavailability</span></div><div class="casAuthors">Lubisch, Wilfried; Beckenbach, Edith; Bopp, Sabina; Hofmann, Hans-Peter; Kartal, Arzu; Kaestel, Claudia; Lindner, Tanja; Metz-Garrecht, Marion; Reeb, Jutta; Regner, Ferdinand; Vierling, Michael; Moeller, Achim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2404-2412</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel benzoylalanine-derived ketoamides were prepd. and evaluated for calpain I inhibition.  Derivs. carrying vinylbenzyl amino residues in the P2-P3 region inhibited calpain in nanomolar concns. and thus represent a novel class of nonpeptidic calpain inhibitors.  Selected examples exhibited an improved pharmacokinetic profile including improved water-soly. and metabolic stability.  In particular, these calpain inhibitors showed oral bioavailability in rats as demonstrated by N-(1-benzyl-2-carbamoyl-2-oxoethyl)-2-[E-2-(4-diethylaminomethylphenyl)ethen-1-yl]benzamide.  The closely related deriv. N-(1-carbamoyl-1-oxohex-1-yl)-2-[E-2-(4-dimethylaminomethylphenyl)-ethen-1-yl]benzamide (I) was evaluated for neuroprotective efficacy after exptl. traumatic brain injury in a fluid percussion model in rats.  When administered after injury, I reduced the no. of damaged neurons by 41%, and this result would be in line with the suggested neuroprotective efficacy of calpain inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5xRdpOXZNk7Vg90H21EOLACvtfcHk0lh4nKw0xvRkyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsVSgurg%253D&md5=ec94d023880005b60ec94eafe8fb78e9</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm0210717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0210717%26sid%3Dliteratum%253Aachs%26aulast%3DLubisch%26aufirst%3DW.%26aulast%3DBeckenbach%26aufirst%3DE.%26aulast%3DBopp%26aufirst%3DS.%26aulast%3DHofmann%26aufirst%3DH.-P.%26aulast%3DKartal%26aufirst%3DA.%26aulast%3DK%25C3%25A4stel%26aufirst%3DC.%26aulast%3DLindner%26aufirst%3DT.%26aulast%3DMetz-Garrecht%26aufirst%3DM.%26aulast%3DReeb%26aufirst%3DJ.%26aulast%3DRegner%26aufirst%3DF.%26aulast%3DVierling%26aufirst%3DM.%26aulast%3DM%25C3%25B6ller%26aufirst%3DA.%26atitle%3DBenzoylalanine-derived%2520ketoamides%2520carrying%2520vinylbenzyl%2520amino%2520residues%253A%2520Discovery%2520of%2520potent%2520water-soluble%2520calpain%2520inhibitors%2520with%2520oral%2520bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D12%26spage%3D2404%26epage%3D2412%26doi%3D10.1021%2Fjm0210717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jantos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornberger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmrich, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijsen, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of ABT-957:1-Benzyl-5-oxopyrrolidine-2-carboxamides as selective calpain inhibitors with enhanced metabolic stability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">1968</span>â <span class="NLM_lpage">1973</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2019.05.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2019.05.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31133534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVKqu77O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=1968-1973&issue=15&author=K.+Jantosauthor=A.+Klingauthor=H.+Mackauthor=W.+Hornbergerauthor=A.+Moellerauthor=V.+Nimmrichauthor=Y.+Laoauthor=M.+Nijsen&title=Discovery+of+ABT-957%3A1-Benzyl-5-oxopyrrolidine-2-carboxamides+as+selective+calpain+inhibitors+with+enhanced+metabolic+stability&doi=10.1016%2Fj.bmcl.2019.05.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of ABT-957: 1-Benzyl-5-oxopyrrolidine-2-carboxamides as selective calpain inhibitors with enhanced metabolic stability</span></div><div class="casAuthors">Jantos, Katja; Kling, Andreas; Mack, Helmut; Hornberger, Wilfried; Moeller, Achim; Nimmrich, Volker; Lao, Yanbin; Nijsen, Marjoleen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1968-1973</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aberrant activation of calpain has been obsd. in various pathophysiol. disorders including neurodegenerative diseases such as Alzheimer's disease.  Here we describe our efforts on ketoamide-based 1-benzyl-5-oxopyrrolidine-2-carboxamides as a novel series of highly selective calpain inhibitors mitigating the metabolic liability of carbonyl redn.  The most advanced compd. from this new series, namely A-1212805 (ABT-957, Alicapistat) proceeded to clin. phase I studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcI58MCHHIBLVg90H21EOLACvtfcHk0lhcORP3WtHTwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVKqu77O&md5=c33c42c1648e78d0e02b8b5d02bcbdfd</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DJantos%26aufirst%3DK.%26aulast%3DKling%26aufirst%3DA.%26aulast%3DMack%26aufirst%3DH.%26aulast%3DHornberger%26aufirst%3DW.%26aulast%3DMoeller%26aufirst%3DA.%26aulast%3DNimmrich%26aufirst%3DV.%26aulast%3DLao%26aufirst%3DY.%26aulast%3DNijsen%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520ABT-957%253A1-Benzyl-5-oxopyrrolidine-2-carboxamides%2520as%2520selective%2520calpain%2520inhibitors%2520with%2520enhanced%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26issue%3D15%26spage%3D1968%26epage%3D1973%26doi%3D10.1016%2Fj.bmcl.2019.05.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">PiÅ¡lar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PeriÅ¡iÄ
Nanut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kos, J.</span></span> <span> </span><span class="NLM_article-title">Lysosomal cysteine peptidases - Molecules signaling tumor cell death and survival</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">168</span>â <span class="NLM_lpage">179</span>, <span class="refDoi">Â DOI: 10.1016/j.semcancer.2015.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.semcancer.2015.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26255843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSitLjM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=168-179&author=A.+Pi%C5%A1larauthor=M.+Peri%C5%A1i%C4%87%0ANanutauthor=J.+Kos&title=Lysosomal+cysteine+peptidases+-+Molecules+signaling+tumor+cell+death+and+survival&doi=10.1016%2Fj.semcancer.2015.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomal cysteine peptidases - Molecules signaling tumor cell death and survival</span></div><div class="casAuthors">Pislar, Anja; Perisic Nanut, Milica; Kos, Janko</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">168-179</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Lysosomal cysteine peptidases - cysteine cathepsins - are general intracellular protein-degrading enzymes that control also a variety of specific physiol. processes.  They can trigger irreversible events leading to signal transduction and activation of signaling pathways, resulting in cell survival and proliferation or cell death.  In cancer cells, lysosomal cysteine peptidases are involved in multiple processes during malignant progression.  Their translocation from the endosomal/lysosomal pathway to nucleus, cytoplasm, plasma membrane and extracellular space enables the activation and remodeling of a variety of tumor promoting proteins.  Thus, lysosomal cysteine peptidases interfere with cytokine/chemokine signaling, regulate cell adhesion and migration and endocytosis, are involved in the antitumor immune response and apoptosis, and promote cell invasion, angiogenesis and metastasis.  Further, lysosomal cysteine peptidases modify growth factors and receptors involved in tyrosine kinase dependent pathways such as MAPK, Akt and JNK, thus representing key signaling tools for the activation of tumor cell growth and proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDp2N5lWc85bVg90H21EOLACvtfcHk0lhcORP3WtHTwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSitLjM&md5=811f9b87640d025db6c076dca094b765</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2015.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2015.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DPi%25C5%25A1lar%26aufirst%3DA.%26aulast%3DPeri%25C5%25A1i%25C4%2587%2BNanut%26aufirst%3DM.%26aulast%3DKos%26aufirst%3DJ.%26atitle%3DLysosomal%2520cysteine%2520peptidases%2520-%2520Molecules%2520signaling%2520tumor%2520cell%2520death%2520and%2520survival%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2015%26volume%3D35%26spage%3D168%26epage%3D179%26doi%3D10.1016%2Fj.semcancer.2015.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campden, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>670</i></span>,  <span class="NLM_fpage">32</span>â <span class="NLM_lpage">42</span>, <span class="refDoi">Â DOI: 10.1016/j.abb.2019.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.abb.2019.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30807742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktFOqu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=670&publication_year=2019&pages=32-42&author=R.+I.+Campdenauthor=Y.+Zhang&title=The+role+of+lysosomal+cysteine+cathepsins+in+NLRP3+inflammasome+activation&doi=10.1016%2Fj.abb.2019.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation</span></div><div class="casAuthors">Campden, Rhiannon I.; Zhang, Yifei</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">670</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-42</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Lysosomal cysteine cathepsins are a family of proteases that are involved in a myriad of cellular processes from proteolytic degrdn. in the lysosome to bone resorption.  These proteins mature following the cleavage of a pro-domain in the lysosome to become either exo- or endo-peptidases.  The cathepsins B, C, L, S and Z have been implicated in NLRP3 inflammasome activation following their activation with ATP, monosodium urate, silica crystals, or bacterial components, among others.  These five cathepsins have both compensatory and independent functions in NLRP3 inflammasome activation.  There is much evidence in the literature to support the release of cathepsin B following lysosomal membrane degrdn. which leads to NLRP3 inflammasome activation.  This is likely due to a hitherto unidentified role of this protein in the cytoplasm, although other interactions with autophagy proteins and within lysosomes have been proposed.  Cathepsin C is involved in the processing of neutrophil IL-1Î² through processing of upstream proteases.  Cathepsin Z is non-redundantly required for NLRP3 inflammasome activation following nigericin, ATP and monosodium urate activation.  Lysosomal cysteine cathepsins are members of a diverse and complementary family, and likely share both overlapping and independent functions in NLRP3 inflammasome activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQjAezZNN_wbVg90H21EOLACvtfcHk0lhcORP3WtHTwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktFOqu74%253D&md5=1f05b83dc71939a82985ab9b97d46f7b</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2019.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2019.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DCampden%26aufirst%3DR.%2BI.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DThe%2520role%2520of%2520lysosomal%2520cysteine%2520cathepsins%2520in%2520NLRP3%2520inflammasome%2520activation%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2019%26volume%3D670%26spage%3D32%26epage%3D42%26doi%3D10.1016%2Fj.abb.2019.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ha, S.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khazaie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. O.</span></span> <span> </span><span class="NLM_article-title">Cathepsin B is involved in the trafficking of TNF-Î±-containing vesicles to the plasma membrane in macrophages</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>181</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">690</span>â <span class="NLM_lpage">697</span>, <span class="refDoi">Â DOI: 10.4049/jimmunol.181.1.690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4049%2Fjimmunol.181.1.690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18566436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVGitLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2008&pages=690-697&issue=1&author=S.-D.+Haauthor=A.+Martinsauthor=K.+Khazaieauthor=J.+Hanauthor=B.+M.+C.+Chanauthor=S.+O.+Kim&title=Cathepsin+B+is+involved+in+the+trafficking+of+TNF-%CE%B1-containing+vesicles+to+the+plasma+membrane+in+macrophages&doi=10.4049%2Fjimmunol.181.1.690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin B Is Involved in the Trafficking of TNF-Î±-Containing Vesicles to the Plasma Membrane in Macrophages</span></div><div class="casAuthors">Ha, Soon-Duck; Martins, Andrew; Khazaie, Khashayarsha; Han, Jiahuai; Chan, Bosco M. C.; Kim, Sung Ouk</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">690-697</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">TNF-Î± is a potent proinflammatory cytokine, essential for initiating innate immune responses against invading microbes and a key mediator involved in the pathogenesis of acute and chronic inflammatory diseases.  To identify mols. involved in the prodn. of TNF-Î±, the authors used a functional gene identification method using retroviral integration-mediated mutagenesis, followed by LPS-stimulated TNF-Î± prodn. anal. in macrophages.  They found that cathepsin B, a lysosomal cysteine proteinase, was required for optimal posttranslational processing of TNF-Î± in response to the bacterial cell wall component LPS.  Mouse bone marrow-derived macrophages from cathepsin B-deficient mice and macrophages treated with the cathepsin B-specific chem. inhibitor CA074 Me ester or small interfering RNA against cathepsin B secreted less TNF-Î± than wild-type or nontreated macrophages.  The authors further showed that the inhibition of cathepsin B caused accumulation of 26-kDa pro-TNF-contg. vesicles.  Ectopic expression of GFP-conjugated pro-TNF further suggests that pro-TNF failed to reach the plasma membrane without intracellular cathepsin B activity.  Altogether, these data suggest that intracellular cathepsin B activity is involved in the TNF-Î±-contg. vesicle trafficking to the plasma membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj6UqCkNeu0bVg90H21EOLACvtfcHk0lhcORP3WtHTwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVGitLg%253D&md5=001b16587da0624cff177bc5819d36de</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.181.1.690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.181.1.690%26sid%3Dliteratum%253Aachs%26aulast%3DHa%26aufirst%3DS.-D.%26aulast%3DMartins%26aufirst%3DA.%26aulast%3DKhazaie%26aufirst%3DK.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DB.%2BM.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BO.%26atitle%3DCathepsin%2520B%2520is%2520involved%2520in%2520the%2520trafficking%2520of%2520TNF-%25CE%25B1-containing%2520vesicles%2520to%2520the%2520plasma%2520membrane%2520in%2520macrophages%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D181%26issue%3D1%26spage%3D690%26epage%3D697%26doi%3D10.4049%2Fjimmunol.181.1.690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Ctsk modulates periodontitis with arthritis via downregulation of TLR9 and autophagy</span>. <i>Cell Proliferation</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">1</span>), <span class="NLM_elocation-id">e12722</span> <span class="refDoi">Â DOI: 10.1111/cpr.12722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1111%2Fcpr.12722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31737959" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2020&issue=1&author=W.+Weiauthor=J.+Renauthor=W.+Yinauthor=H.+Dingauthor=Q.+Luauthor=L.+Tanauthor=S.+Dengauthor=J.+Liuauthor=Q.+Yangauthor=J.+Wangauthor=M.+Wangauthor=Y.+Yueauthor=L.+Hao&title=Inhibition+of+Ctsk+modulates+periodontitis+with+arthritis+via+downregulation+of+TLR9+and+autophagy&doi=10.1111%2Fcpr.12722"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1111%2Fcpr.12722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcpr.12722%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DW.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DW.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DYue%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520Ctsk%2520modulates%2520periodontitis%2520with%2520arthritis%2520via%2520downregulation%2520of%2520TLR9%2520and%2520autophagy%26jtitle%3DCell%2520Proliferation%26date%3D2020%26volume%3D53%26issue%3D1%26doi%3D10.1111%2Fcpr.12722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissette, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrushova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeish, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S. R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosloniec, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudensky, A. Y.</span></span> <span> </span><span class="NLM_article-title">Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">207</span>â <span class="NLM_lpage">217</span>, <span class="refDoi">Â DOI: 10.1016/S1074-7613(00)80021-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS1074-7613%2800%2980021-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10072073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1yms78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=207-217&issue=2&author=T.+Y.+Nakagawaauthor=W.+H.+Brissetteauthor=P.+D.+Liraauthor=R.+J.+Griffithsauthor=N.+Petrushovaauthor=J.+Stockauthor=J.+D.+McNeishauthor=S.+E.+Eastmanauthor=E.+D.+Howardauthor=S.+R.+M.+Clarkeauthor=E.+F.+Rosloniecauthor=E.+A.+Elliottauthor=A.+Y.+Rudensky&title=Impaired+invariant+chain+degradation+and+antigen+presentation+and+diminished+collagen-induced+arthritis+in+cathepsin+S+null+mice&doi=10.1016%2FS1074-7613%2800%2980021-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice</span></div><div class="casAuthors">Nakagawa, Terry Y.; Brissette, William H.; Lira, Paul D.; Griffiths, Richard J.; Petrushova, Nina; Stock, Jeffrey; McNeish, John D.; Eastman, Susan E.; Howard, Edward D.; Clarke, Sally R. M.; Rosloniec, Edward F.; Elliott, Eileen A.; Rudensky, Alexander Y.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-217</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cathepsins have been implicated in the degrdn. of proteins destined for the MHC class II processing pathway and in the proteolytic removal of invariant chain (Ii), a crit. regulator of MHC class II function.  Mice lacking the lysosomal cysteine proteinase cathepsin S (catS) demonstrated a profound inhibition of Ii degrdn. in professional APC in vivo.  A marked variation in the generation of MHC class II-bound Ii fragments and presentation of exogenous proteins was obsd. between B cells, dendritic cells, and macrophages lacking catS.  CatS-deficient mice showed diminished susceptibility to collagen-induced arthritis, suggesting a potential therapeutic target for regulation of immune responsiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKLUTSeuqSQrVg90H21EOLACvtfcHk0liowLqCM5FZjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1yms78%253D&md5=45a1ce1cbc4ab6b5190b756cab9ac1f5</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2FS1074-7613%2800%2980021-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-7613%252800%252980021-7%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DT.%2BY.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DLira%26aufirst%3DP.%2BD.%26aulast%3DGriffiths%26aufirst%3DR.%2BJ.%26aulast%3DPetrushova%26aufirst%3DN.%26aulast%3DStock%26aufirst%3DJ.%26aulast%3DMcNeish%26aufirst%3DJ.%2BD.%26aulast%3DEastman%26aufirst%3DS.%2BE.%26aulast%3DHoward%26aufirst%3DE.%2BD.%26aulast%3DClarke%26aufirst%3DS.%2BR.%2BM.%26aulast%3DRosloniec%26aufirst%3DE.%2BF.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DRudensky%26aufirst%3DA.%2BY.%26atitle%3DImpaired%2520invariant%2520chain%2520degradation%2520and%2520antigen%2520presentation%2520and%2520diminished%2520collagen-induced%2520arthritis%2520in%2520cathepsin%2520S%2520null%2520mice%26jtitle%3DImmunity%26date%3D1999%26volume%3D10%26issue%3D2%26spage%3D207%26epage%3D217%26doi%3D10.1016%2FS1074-7613%2800%2980021-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riese, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villadangos, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karp, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Sanctis, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploegh, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, H. A.</span></span> <span> </span><span class="NLM_article-title">Cathepsin S activity regulates antigen presentation and immunity</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2351</span>â <span class="NLM_lpage">2363</span>, <span class="refDoi">Â DOI: 10.1172/JCI1158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1172%2FJCI1158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=9616206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1cXjvVWrtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1998&pages=2351-2363&issue=11&author=R.+J.+Rieseauthor=R.+N.+Mitchellauthor=J.+A.+Villadangosauthor=G.+P.+Shiauthor=J.+T.+Palmerauthor=E.+R.+Karpauthor=G.+T.+De+Sanctisauthor=H.+L.+Ploeghauthor=H.+A.+Chapman&title=Cathepsin+S+activity+regulates+antigen+presentation+and+immunity&doi=10.1172%2FJCI1158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin S activity regulates antigen presentation and immunity</span></div><div class="casAuthors">Riese, Richard J.; Mitchell, Richard N.; Villadangos, Jose A.; Shi, Guo-Ping; Palmer, James T.; Karp, Elena R.; De Sanctis, George T.; Ploegh, Hidde L.; Chapman, Harold A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2351-2363</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">MHC class II mols. display antigenic peptides on cell surfaces for recognition by CD4+ invariant chain (Ii) from class II-Ii complexes to allow subsequent binding of peptides, and for generation of the antigenic peptides.  The cysteine endoprotease, cathepsin S, mediates Ii degrdn. in human and mouse antigen-presenting cells.  Studies described here examine the functional significance of cathepsin S inhibition on antigen presentation and immunity.  Specific inhibition of cathepsin S in A20 cells markedly impaired presentation of an ovalbumin epitope by interfering with class II-peptide binding, not by obstructing generation of the antigen.  Administration of a cathepsin S inhibitor to mice in vivo selectively inhibited activity of cathepsin S in splenocytes, resulting in accumulation of a class II-assocd. Ii breakdown product, attenuation of class II-peptide complex formation, and inhibition of antigen presentation.  Mice treated with inhibitor had an attenuated antibody response when immunized with ovalbumin but not the T cell-independent antigen TNP-Ficoll.  In a mouse model of pulmonary hypersensitivity, treatment with the inhibitor also abrogated a rise in IgE titers and profoundly blocked eosinophilic infiltration in the lung.  Thus, inhibition of cathepsin S in vivo alters Ii processing, antigen presentation, and immunity.  These data identify selective inhibition of cysteine proteases as a potential therapeutic strategy for asthma and autoimmune disease processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Dx3Et_khvLVg90H21EOLACvtfcHk0liowLqCM5FZjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvVWrtLs%253D&md5=42b75c6acc049a2acebca41c1f0226c5</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1172%2FJCI1158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI1158%26sid%3Dliteratum%253Aachs%26aulast%3DRiese%26aufirst%3DR.%2BJ.%26aulast%3DMitchell%26aufirst%3DR.%2BN.%26aulast%3DVilladangos%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DG.%2BP.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DKarp%26aufirst%3DE.%2BR.%26aulast%3DDe%2BSanctis%26aufirst%3DG.%2BT.%26aulast%3DPloegh%26aufirst%3DH.%2BL.%26aulast%3DChapman%26aufirst%3DH.%2BA.%26atitle%3DCathepsin%2520S%2520activity%2520regulates%2520antigen%2520presentation%2520and%2520immunity%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1998%26volume%3D101%26issue%3D11%26spage%3D2351%26epage%3D2363%26doi%3D10.1172%2FJCI1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bararia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hildebrand, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haebe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevisani, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osorio-Barrios, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartoschek, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mentz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaitzsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heide, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurinovic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rautter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawardana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabdia, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczepanowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klapper, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louissaint, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bultmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonhardt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eustermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopfner, K.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiddemann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Bergwelt-Baildon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steidl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kridel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, J. W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt-Supprian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SÃ¡rosi, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudelius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passerini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mautner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigert, O.</span></span> <span> </span><span class="NLM_article-title">Cathepsin S alterations induce a tumor-promoting immune microenvironment in follicular lymphoma</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">107522</span>, <span class="refDoi">Â DOI: 10.1016/j.celrep.2020.107522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.celrep.2020.107522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32330423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotFCisb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2020&pages=107522&issue=5&author=D.+Barariaauthor=J.+A.+Hildebrandauthor=S.+Stolzauthor=S.+Haebeauthor=S.+Aligauthor=C.+P.+Trevisaniauthor=F.+Osorio-Barriosauthor=M.+D.+Bartoschekauthor=M.+Mentzauthor=A.+Pastoreauthor=E.+Gaitzschauthor=M.+Heideauthor=V.+Jurinovicauthor=K.+Rautterauthor=J.+Gunawardanaauthor=M.+B.+Sabdiaauthor=M.+Szczepanowskiauthor=J.+Richterauthor=W.+Klapperauthor=A.+Louissaintauthor=C.+Ludwigauthor=S.+Bultmannauthor=H.+Leonhardtauthor=S.+Eustermannauthor=K.-P.+Hopfnerauthor=W.+Hiddemannauthor=M.+von+Bergwelt-Baildonauthor=C.+Steidlauthor=R.+Kridelauthor=J.+W.+D.+Tobinauthor=M.+K.+Gandhiauthor=D.+M.+Weinstockauthor=M.+Schmidt-Supprianauthor=M.+B.+S%C3%A1rosiauthor=M.+Rudeliusauthor=V.+Passeriniauthor=J.+Mautnerauthor=O.+Weigert&title=Cathepsin+S+alterations+induce+a+tumor-promoting+immune+microenvironment+in+follicular+lymphoma&doi=10.1016%2Fj.celrep.2020.107522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma</span></div><div class="casAuthors">Bararia, Deepak; Hildebrand, Johannes A.; Stolz, Sebastian; Haebe, Sarah; Alig, Stefan; Trevisani, Christopher P.; Osorio-Barrios, Francisco; Bartoschek, Michael D.; Mentz, Michael; Pastore, Alessandro; Gaitzsch, Erik; Heide, Michael; Jurinovic, Vindi; Rautter, Katharina; Gunawardana, Jay; Sabdia, Muhammed B.; Szczepanowski, Monika; Richter, Julia; Klapper, Wolfram; Louissaint, Abner Jr.; Ludwig, Christina; Bultmann, Sebastian; Leonhardt, Heinrich; Eustermann, Sebastian; Hopfner, Karl-Peter; Hiddemann, Wolfgang; von Bergwelt-Baildon, Michael; Steidl, Christian; Kridel, Robert; Tobin, Joshua W. D.; Gandhi, Maher K.; Weinstock, David M.; Schmidt-Supprian, Marc; Sarosi, Menyhart B.; Rudelius, Martina; Passerini, Verena; Mautner, Josef; Weigert, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">107522</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Tumor cells orchestrate their microenvironment.  Here, we provide biochem., structural, functional, and clin. evidence that Cathepsin S (CTSS) alterations induce a tumor-promoting immune microenvironment in follicular lymphoma (FL).  We found CTSS mutations at Y132 in 6% of FL (19/305).  Another 13% (37/286) had CTSS amplification, which was assocd. with higher CTSS expression.  CTSS Y132 mutations lead to accelerated autocatalytic conversion from an enzymically inactive profrom to active CTSS and increased substrate cleavage, including CD74, which regulates major histocompatibility complex class II (MHC class II)-restricted antigen presentation.  Lymphoma cells with hyperactive CTSS more efficiently activated antigen-specific CD4+ T cells in vitro.  Tumors with hyperactive CTSS showed increased CD4+ T cell infiltration and proinflammatory cytokine perturbation in a mouse model and in human FLs.  In mice, this CTSS-induced immune microenvironment promoted tumor growth.  Clin., patients with CTSS-hyperactive FL had better treatment outcomes with std. immunochemotherapies, indicating that these immunosuppressive regimens target both the lymphoma cells and the tumor-promoting immune microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP8xP09_jpDLVg90H21EOLACvtfcHk0lhRzBAk5O-DTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotFCisb8%253D&md5=13677a964614767dd6691f05ff338b67</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2020.107522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2020.107522%26sid%3Dliteratum%253Aachs%26aulast%3DBararia%26aufirst%3DD.%26aulast%3DHildebrand%26aufirst%3DJ.%2BA.%26aulast%3DStolz%26aufirst%3DS.%26aulast%3DHaebe%26aufirst%3DS.%26aulast%3DAlig%26aufirst%3DS.%26aulast%3DTrevisani%26aufirst%3DC.%2BP.%26aulast%3DOsorio-Barrios%26aufirst%3DF.%26aulast%3DBartoschek%26aufirst%3DM.%2BD.%26aulast%3DMentz%26aufirst%3DM.%26aulast%3DPastore%26aufirst%3DA.%26aulast%3DGaitzsch%26aufirst%3DE.%26aulast%3DHeide%26aufirst%3DM.%26aulast%3DJurinovic%26aufirst%3DV.%26aulast%3DRautter%26aufirst%3DK.%26aulast%3DGunawardana%26aufirst%3DJ.%26aulast%3DSabdia%26aufirst%3DM.%2BB.%26aulast%3DSzczepanowski%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DJ.%26aulast%3DKlapper%26aufirst%3DW.%26aulast%3DLouissaint%26aufirst%3DA.%26aulast%3DLudwig%26aufirst%3DC.%26aulast%3DBultmann%26aufirst%3DS.%26aulast%3DLeonhardt%26aufirst%3DH.%26aulast%3DEustermann%26aufirst%3DS.%26aulast%3DHopfner%26aufirst%3DK.-P.%26aulast%3DHiddemann%26aufirst%3DW.%26aulast%3Dvon%2BBergwelt-Baildon%26aufirst%3DM.%26aulast%3DSteidl%26aufirst%3DC.%26aulast%3DKridel%26aufirst%3DR.%26aulast%3DTobin%26aufirst%3DJ.%2BW.%2BD.%26aulast%3DGandhi%26aufirst%3DM.%2BK.%26aulast%3DWeinstock%26aufirst%3DD.%2BM.%26aulast%3DSchmidt-Supprian%26aufirst%3DM.%26aulast%3DS%25C3%25A1rosi%26aufirst%3DM.%2BB.%26aulast%3DRudelius%26aufirst%3DM.%26aulast%3DPasserini%26aufirst%3DV.%26aulast%3DMautner%26aufirst%3DJ.%26aulast%3DWeigert%26aufirst%3DO.%26atitle%3DCathepsin%2520S%2520alterations%2520induce%2520a%2520tumor-promoting%2520immune%2520microenvironment%2520in%2520follicular%2520lymphoma%26jtitle%3DCell%2520Rep.%26date%3D2020%26volume%3D31%26issue%3D5%26spage%3D107522%26doi%3D10.1016%2Fj.celrep.2020.107522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dheilly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistello, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katanayeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sungalee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duns, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehrle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sordet-Dessimoz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Racle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farinha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coukos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gfeller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottok, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kridel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steidl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassani-Sternberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoete, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oricchio, E.</span></span> <span> </span><span class="NLM_article-title">Cathepsin S regulates antigen processing and T cell activity in non-Hodgkin lymphoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">674</span>â <span class="NLM_lpage">689</span>, <span class="refDoi">Â DOI: 10.1016/j.ccell.2020.03.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.ccell.2020.03.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32330455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotVCntb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2020&pages=674-689&issue=5&author=E.+Dheillyauthor=E.+Battistelloauthor=N.+Katanayevaauthor=S.+Sungaleeauthor=J.+Michauxauthor=G.+Dunsauthor=S.+Wehrleauthor=J.+Sordet-Dessimozauthor=M.+Minaauthor=J.+Racleauthor=P.+Farinhaauthor=G.+Coukosauthor=D.+Gfellerauthor=A.+Mottokauthor=R.+Kridelauthor=B.+E.+Correiaauthor=C.+Steidlauthor=M.+Bassani-Sternbergauthor=G.+Cirielloauthor=V.+Zoeteauthor=E.+Oricchio&title=Cathepsin+S+regulates+antigen+processing+and+T+cell+activity+in+non-Hodgkin+lymphoma&doi=10.1016%2Fj.ccell.2020.03.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin Lymphoma</span></div><div class="casAuthors">Dheilly, Elie; Battistello, Elena; Katanayeva, Natalya; Sungalee, Stephanie; Michaux, Justine; Duns, Gerben; Wehrle, Sarah; Sordet-Dessimoz, Jessica; Mina, Marco; Racle, Julien; Farinha, Pedro; Coukos, George; Gfeller, David; Mottok, Anja; Kridel, Robert; Correia, Bruno E.; Steidl, Christian; Bassani-Sternberg, Michal; Ciriello, Giovanni; Zoete, Vincent; Oricchio, Elisa</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">674-689.e12</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Genomic alterations in cancer cells can influence the immune system to favor tumor growth.  In non-Hodgkin lymphoma, physiol. interactions between B cells and the germinal center microenvironment are coopted to sustain cancer cell proliferation.  We found that follicular lymphoma patients harbor a recurrent hotspot mutation targeting tyrosine 132 (Y132D) in cathepsin S (CTSS) that enhances protein activity.  CTSS regulates antigen processing and CD4+ and CD8+ T cell-mediated immune responses.  Loss of CTSS activity reduces lymphoma growth by limiting communication with CD4+ T follicular helper cells while inducing antigen diversification and activation of CD8+ T cells.  Overall, our results suggest that CTSS inhibition has non-redundant therapeutic potential to enhance anti-tumor immune responses in indolent and aggressive lymphomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj25xCF6_F3rVg90H21EOLACvtfcHk0lhRzBAk5O-DTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotVCntb4%253D&md5=2087af71ae00eced7670303f9bd97951</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2020.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2020.03.016%26sid%3Dliteratum%253Aachs%26aulast%3DDheilly%26aufirst%3DE.%26aulast%3DBattistello%26aufirst%3DE.%26aulast%3DKatanayeva%26aufirst%3DN.%26aulast%3DSungalee%26aufirst%3DS.%26aulast%3DMichaux%26aufirst%3DJ.%26aulast%3DDuns%26aufirst%3DG.%26aulast%3DWehrle%26aufirst%3DS.%26aulast%3DSordet-Dessimoz%26aufirst%3DJ.%26aulast%3DMina%26aufirst%3DM.%26aulast%3DRacle%26aufirst%3DJ.%26aulast%3DFarinha%26aufirst%3DP.%26aulast%3DCoukos%26aufirst%3DG.%26aulast%3DGfeller%26aufirst%3DD.%26aulast%3DMottok%26aufirst%3DA.%26aulast%3DKridel%26aufirst%3DR.%26aulast%3DCorreia%26aufirst%3DB.%2BE.%26aulast%3DSteidl%26aufirst%3DC.%26aulast%3DBassani-Sternberg%26aufirst%3DM.%26aulast%3DCiriello%26aufirst%3DG.%26aulast%3DZoete%26aufirst%3DV.%26aulast%3DOricchio%26aufirst%3DE.%26atitle%3DCathepsin%2520S%2520regulates%2520antigen%2520processing%2520and%2520T%2520cell%2520activity%2520in%2520non-Hodgkin%2520lymphoma%26jtitle%3DCancer%2520Cell%26date%3D2020%26volume%3D37%26issue%3D5%26spage%3D674%26epage%3D689%26doi%3D10.1016%2Fj.ccell.2020.03.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deussing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villadangos, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploegh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudensky, A. Y.</span></span> <span> </span><span class="NLM_article-title">Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">5362</span>),  <span class="NLM_fpage">450</span>â <span class="NLM_lpage">453</span>, <span class="refDoi">Â DOI: 10.1126/science.280.5362.450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fscience.280.5362.450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=9545226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1cXivVeku7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1998&pages=450-453&issue=5362&author=T.+Nakagawaauthor=W.+Rothauthor=P.+Wongauthor=A.+Nelsonauthor=A.+Farrauthor=J.+Deussingauthor=J.+A.+Villadangosauthor=H.+Ploeghauthor=C.+Petersauthor=A.+Y.+Rudensky&title=Cathepsin+L%3A+critical+role+in+Ii+degradation+and+CD4+T+cell+selection+in+the+thymus&doi=10.1126%2Fscience.280.5362.450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus</span></div><div class="casAuthors">Nakagawa, Terry; Roth, Wera; Wong, Phillip; Nelson, Andrew; Farr, Andrew; Deussing, Jan; Villadangos, Jose A.; Ploegh, Hidde; Peters, Christoph; Rudensky, Alexander Y.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">5362</span>),
    <span class="NLM_cas:pages">450-453</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Degrdn. of invariant chain (Ii) is a crit. step in major histocompatibility complex class II-restricted antigen presentation.  Cathepsin L was necessary for Ii degrdn. in cortical thymic epithelial cells (cTECs), but not in bone marrow (BM)-derived antigen-presenting cells (APCs).  Consequently, pos. selection of CD4+ T cells was reduced.  Because different cysteine proteinases are responsible for specific Ii degrdn. steps in cTECs and BM-derived APCs, the proteolytic environment in cells mediating pos. and neg. selection may be distinct.  The identification of a protease involved in class II presentation in a tissue-specific manner suggests a potential means of manipulating CD4+ T cell responsiveness in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM9_4Xoc9yBbVg90H21EOLACvtfcHk0liO18DuJA9KUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivVeku7c%253D&md5=dad35a5f096ab400898fccc768797e4c</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1126%2Fscience.280.5362.450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.280.5362.450%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DT.%26aulast%3DRoth%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DP.%26aulast%3DNelson%26aufirst%3DA.%26aulast%3DFarr%26aufirst%3DA.%26aulast%3DDeussing%26aufirst%3DJ.%26aulast%3DVilladangos%26aufirst%3DJ.%2BA.%26aulast%3DPloegh%26aufirst%3DH.%26aulast%3DPeters%26aufirst%3DC.%26aulast%3DRudensky%26aufirst%3DA.%2BY.%26atitle%3DCathepsin%2520L%253A%2520critical%2520role%2520in%2520Ii%2520degradation%2520and%2520CD4%2520T%2520cell%2520selection%2520in%2520the%2520thymus%26jtitle%3DScience%26date%3D1998%26volume%3D280%26issue%3D5362%26spage%3D450%26epage%3D453%26doi%3D10.1126%2Fscience.280.5362.450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rops, A. L. W. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppevelt, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russel, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabelink, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berden, J. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinheckel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Vlag, J.</span></span> <span> </span><span class="NLM_article-title">Cathepsin L is crucial for the development of early experimental diabetic nephropathy</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>90</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1012</span>â <span class="NLM_lpage">1022</span>, <span class="refDoi">Â DOI: 10.1016/j.kint.2016.06.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.kint.2016.06.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27575559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVamsbzL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=1012-1022&issue=5&author=M.+Garsenauthor=A.+L.+W.+M.+M.+Ropsauthor=H.+Dijkmanauthor=B.+Willemsenauthor=T.+H.+van+Kuppeveltauthor=F.+G.+Russelauthor=T.+J.+Rabelinkauthor=J.+H.+M.+Berdenauthor=T.+Reinheckelauthor=J.+van+der+Vlag&title=Cathepsin+L+is+crucial+for+the+development+of+early+experimental+diabetic+nephropathy&doi=10.1016%2Fj.kint.2016.06.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin L is crucial for the development of early experimental diabetic nephropathy</span></div><div class="casAuthors">Garsen, Marjolein; Rops, Angelique L. W. M. M.; Dijkman, Henry; Willemsen, Brigith; van Kuppevelt, Toin H.; Russel, Frans G.; Rabelink, Ton J.; Berden, Jo H. M.; Reinheckel, Thomas; van der Vlag, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1012-1022</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Proteinuria is one of the first clin. signs of diabetic nephropathy and an independent predictor for the progression to renal failure.  Cathepsin L, a lysosomal cysteine protease, can be involved in the development of proteinuria by degrdn. of proteins that are important for normal podocyte architecture, such as the CD2-assocd. protein, synaptopodin, and dynamin.  Cathepsin L also activates heparanase, a heparan sulfate endoglycosidase previously shown to be crucial for the development of diabetic nephropathy.  Here, we evaluated the exact mode of action of cathepsin L in the development of proteinuria in streptozotocin-induced diabetes.  Cathepsin L-deficient mice, in contrast to their wild-type littermates, failed to develop albuminuria, mesangial matrix expansion, tubulointerstitial fibrosis, and renal macrophage influx and showed a normal renal function.  In wild-type mice the early development of albuminuria correlated with the activation of heparanase and loss of heparan sulfate expression, whereas loss of synaptopodin expression and podocyte damage occurred at a later stage.  Thus, cathepsin L is causally involved in the pathogenesis of exptl. diabetic nephropathy.  Most likely, cathepsin L-dependent heparanase activation is crucial for the development of albuminuria and renal damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq0mr5tpGrNLVg90H21EOLACvtfcHk0liO18DuJA9KUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVamsbzL&md5=896a93e38a2b25ab94b097543718f1fd</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.kint.2016.06.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.kint.2016.06.035%26sid%3Dliteratum%253Aachs%26aulast%3DGarsen%26aufirst%3DM.%26aulast%3DRops%26aufirst%3DA.%2BL.%2BW.%2BM.%2BM.%26aulast%3DDijkman%26aufirst%3DH.%26aulast%3DWillemsen%26aufirst%3DB.%26aulast%3Dvan%2BKuppevelt%26aufirst%3DT.%2BH.%26aulast%3DRussel%26aufirst%3DF.%2BG.%26aulast%3DRabelink%26aufirst%3DT.%2BJ.%26aulast%3DBerden%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DReinheckel%26aufirst%3DT.%26aulast%3Dvan%2Bder%2BVlag%26aufirst%3DJ.%26atitle%3DCathepsin%2520L%2520is%2520crucial%2520for%2520the%2520development%2520of%2520early%2520experimental%2520diabetic%2520nephropathy%26jtitle%3DKidney%2520Int.%26date%3D2016%26volume%3D90%26issue%3D5%26spage%3D1012%26epage%3D1022%26doi%3D10.1016%2Fj.kint.2016.06.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedantham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agudelo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrion, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunneley, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PÃ¶hlmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, G.</span></span> <span> </span><span class="NLM_article-title">Protease inhibitors targeting coronavirus and filovirus entry</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">76</span>â <span class="NLM_lpage">84</span>, <span class="refDoi">Â DOI: 10.1016/j.antiviral.2015.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.antiviral.2015.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25666761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVOrs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2015&pages=76-84&author=Y.+Zhouauthor=P.+Vedanthamauthor=K.+Luauthor=J.+Agudeloauthor=R.+Carrionauthor=J.+W.+Nunneleyauthor=D.+Barnardauthor=S.+P%C3%B6hlmannauthor=J.+H.+McKerrowauthor=A.+R.+Rensloauthor=G.+Simmons&title=Protease+inhibitors+targeting+coronavirus+and+filovirus+entry&doi=10.1016%2Fj.antiviral.2015.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Protease inhibitors targeting coronavirus and filovirus entry</span></div><div class="casAuthors">Zhou, Yanchen; Vedantham, Punitha; Lu, Kai; Agudelo, Juliet; Carrion, Ricardo; Nunneley, Jerritt W.; Barnard, Dale; Pohlmann, Stefan; McKerrow, James H.; Renslo, Adam R.; Simmons, Graham</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">76-84</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to gain entry into cells, diverse viruses, including Ebola virus, SARS-coronavirus and the emerging MERS-coronavirus, depend on activation of their envelope glycoproteins by host cell proteases.  The resp. enzymes are thus excellent targets for antiviral intervention.  In cell culture, activation of Ebola virus, as well as SARS- and MERS-coronavirus can be accomplished by the endosomal cysteine proteases, cathepsin L (CTSL) and cathepsin B (CTSB).  In addn., SARS- and MERS-coronavirus can use serine proteases localized at the cell surface, for their activation.  However, it is currently unclear which protease(s) facilitate viral spread in the infected host.  We report here that the cysteine protease inhibitor K11777, ((2S)-N-[(1E,3S)-1-(benzenesulfonyl)-5-phenylpent-1-en-3-yl]-2-{[(E)-4-methylpiperazine-1-carbonyl]amino}-3-phenylpropanamide) and closely-related vinylsulfones act as broad-spectrum antivirals by targeting cathepsin-mediated cell entry.  K11777 is already in advanced stages of development for a no. of parasitic diseases, such as Chagas disease, and has proven to be safe and effective in a range of animal models.  K11777 inhibition of SARS-CoV and Ebola virus entry was obsd. in the sub-nanomolar range.  In order to assess whether cysteine or serine proteases promote viral spread in the host, we compared the antiviral activity of an optimized K11777-deriv. with that of camostat, an inhibitor of TMPRSS2 and related serine proteases.  Employing a pathogenic animal model of SARS-CoV infection, we demonstrated that viral spread and pathogenesis of SARS-CoV is driven by serine rather than cysteine proteases and can be effectively prevented by camostat.  Camostat has been clin. used to treat chronic pancreatitis, and thus represents an exciting potential therapeutic for respiratory coronavirus infections.  Our results indicate that camostat, or similar serine protease inhibitors, might be an effective option for treatment of SARS and potentially MERS, while vinyl sulfone-based inhibitors are excellent lead candidates for Ebola virus therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqgkBpEfAc5bVg90H21EOLACvtfcHk0liO18DuJA9KUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVOrs7Y%253D&md5=5dc38edb19ade6920ba6ca860699b8cf</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2015.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2015.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DVedantham%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DAgudelo%26aufirst%3DJ.%26aulast%3DCarrion%26aufirst%3DR.%26aulast%3DNunneley%26aufirst%3DJ.%2BW.%26aulast%3DBarnard%26aufirst%3DD.%26aulast%3DP%25C3%25B6hlmann%26aufirst%3DS.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DSimmons%26aufirst%3DG.%26atitle%3DProtease%2520inhibitors%2520targeting%2520coronavirus%2520and%2520filovirus%2520entry%26jtitle%3DAntiviral%2520Res.%26date%3D2015%26volume%3D116%26spage%3D76%26epage%3D84%26doi%3D10.1016%2Fj.antiviral.2015.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libby, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, G.-P.</span></span> <span> </span><span class="NLM_article-title">Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>213</i></span>,  <span class="NLM_fpage">107587</span>, <span class="refDoi">Â DOI: 10.1016/j.pharmthera.2020.107587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.pharmthera.2020.107587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32470470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFylt7zP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2020&pages=107587&author=T.+Liuauthor=S.+Luoauthor=P.+Libbyauthor=G.-P.+Shi&title=Cathepsin+L-selective+inhibitors%3A+A+potentially+promising+treatment+for+COVID-19+patients&doi=10.1016%2Fj.pharmthera.2020.107587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients</span></div><div class="casAuthors">Liu, Tianxiao; Luo, Songyuan; Libby, Peter; Shi, Guo-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107587</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The widespread coronavirus SARS-CoV-2 has already infected over 4 million people worldwide, with a death toll over 280,000.  Current treatment of COVID-19 patients relies mainly on antiviral drugs lopinavir/ritonavir, arbidol, and remdesivir, the anti-malarial drugs hydroxychloroquine and chloroquine, and traditional Chinese medicine.  There are over 2,118 on-going clin. trials underway, but to date none of these drugs have consistently proven effective.  Cathepsin L (CatL) is an endosomal cysteine protease.  It mediates the cleavage of the S1 subunit of the coronavirus surface spike glycoprotein.  This cleavage is necessary for coronavirus entry into human host cells, virus and host cell endosome membrane fusion, and viral RNA release for next round of replication.  Here we summarize data regarding seven CatL-selective inhibitors that block coronavirus entry into cultured host cells and provide a mechanism to block SARS-CoV-2 infection in humans.  Given the rapid growth of the SARS-CoV-2-pos. population worldwide, ready-to-use CatL inhibitors should be explored as a treatment option.  We identify ten US FDA-approved drugs that have CatL inhibitory activity.  We provide evidence that supports the combined use of serine protease and CatL inhibitors as a possibly safer and more effective therapy than other available therapeutics to block coronavirus host cell entry and intracellular replication, without compromising the immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdnmNa8fpUXLVg90H21EOLACvtfcHk0lhI4K-pvxAORQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFylt7zP&md5=71ed67fbf7fa6fa5f2042b5700a56103</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2020.107587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2020.107587%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DLibby%26aufirst%3DP.%26aulast%3DShi%26aufirst%3DG.-P.%26atitle%3DCathepsin%2520L-selective%2520inhibitors%253A%2520A%2520potentially%2520promising%2520treatment%2520for%2520COVID-19%2520patients%26jtitle%3DPharmacol.%2520Ther.%26date%3D2020%26volume%3D213%26spage%3D107587%26doi%3D10.1016%2Fj.pharmthera.2020.107587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obermajer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repnik, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jevnikar, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreft, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kos, J.</span></span> <span> </span><span class="NLM_article-title">Cysteine protease cathepsin X modulates immune response via activation of Î²2 integrins</span>. <i>Immunology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>124</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">76</span>â <span class="NLM_lpage">88</span>, <span class="refDoi">Â DOI: 10.1111/j.1365-2567.2007.02740.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1111%2Fj.1365-2567.2007.02740.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18194276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlensLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2008&pages=76-88&issue=1&author=N.+Obermajerauthor=U.+Repnikauthor=Z.+Jevnikarauthor=B.+Turkauthor=M.+Kreftauthor=J.+Kos&title=Cysteine+protease+cathepsin+X+modulates+immune+response+via+activation+of+%CE%B22+integrins&doi=10.1111%2Fj.1365-2567.2007.02740.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine protease cathepsin X modulates immune response via activation of Î²2 integrins</span></div><div class="casAuthors">Obermajer, Natasa; Repnik, Urska; Jevnikar, Zala; Turk, Boris; Kreft, Marko; Kos, Janko</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-88</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Cathepsin X is a lysosomal, cysteine dependent carboxypeptidase.  Its expression is restricted to cells of the immune system, suggesting a function related to the processes of inflammatory and immune responses.  It has been shown to stimulate macrophage antigen-1 (Mac-1) receptor-dependent adhesion and phagocytosis via interaction with integrin Î²2 subunit.  Here its potential role in regulating lymphocyte proliferation via Mac-1 and the other Î²2 integrin receptor, lymphocyte function-assocd. antigen-1 (LFA-1) has been investigated.  Cathepsin X has been shown to suppress proliferation of human peripheral blood mononuclear cells, by activation of Mac-1, known as a suppressive factor for lymphocyte proliferation.  On the other hand, co-localization of cathepsin X and LAF-1 supports the role of cathepsin X in regulating LFA-1 activity, which enhances lymphocyte proliferation.  As shown by fluorescence resonance energy transfer, using U-937 and Jurkat cells transfected with Î±L-mCFP and Î²2-mYFP, recombinant cathepsin X directly activates LFA-1.  The activation was confirmed by increased binding of monoclonal antibody 24, recognizing active LFA-1.  We demonstrate that cathepsin X is involved in the regulation of two Î²2 integrin receptors, LFA-1 and Mac-1, which exhibit opposing roles in lymphocyte activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWTb5LBQgCJLVg90H21EOLACvtfcHk0lhI4K-pvxAORQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlensLw%253D&md5=eabf682ae18a37dfb8c0fa5c297e9d57</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2567.2007.02740.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2567.2007.02740.x%26sid%3Dliteratum%253Aachs%26aulast%3DObermajer%26aufirst%3DN.%26aulast%3DRepnik%26aufirst%3DU.%26aulast%3DJevnikar%26aufirst%3DZ.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DKreft%26aufirst%3DM.%26aulast%3DKos%26aufirst%3DJ.%26atitle%3DCysteine%2520protease%2520cathepsin%2520X%2520modulates%2520immune%2520response%2520via%2520activation%2520of%2520%25CE%25B22%2520integrins%26jtitle%3DImmunology%26date%3D2008%26volume%3D124%26issue%3D1%26spage%3D76%26epage%3D88%26doi%3D10.1111%2Fj.1365-2567.2007.02740.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Withana, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sameni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anbalagan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olive, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidwell, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloane, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, B. S.</span></span> <span> </span><span class="NLM_article-title">Cathepsin B inhibition limits bone metastasis in breast cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1199</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-11-2759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1158%2F0008-5472.CAN-11-2759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22266111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Wis74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=1199&issue=5&author=N.+P.+Withanaauthor=G.+Blumauthor=M.+Sameniauthor=C.+Slaneyauthor=A.+Anbalaganauthor=M.+B.+Oliveauthor=B.+N.+Bidwellauthor=L.+Edgingtonauthor=L.+Wangauthor=K.+Moinauthor=B.+F.+Sloaneauthor=R.+L.+Andersonauthor=M.+S.+Bogyoauthor=B.+S.+Parker&title=Cathepsin+B+inhibition+limits+bone+metastasis+in+breast+cancer&doi=10.1158%2F0008-5472.CAN-11-2759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin B Inhibition Limits Bone Metastasis in Breast Cancer</span></div><div class="casAuthors">Withana, Nimali P.; Blum, Galia; Sameni, Mansoureh; Slaney, Clare; Anbalagan, Arulselvi; Olive, Mary B.; Bidwell, Bradley N.; Edgington, Laura; Wang, Ling; Moin, Kamiar; Sloane, Bonnie F.; Anderson, Robin L.; Bogyo, Matthew S.; Parker, Belinda S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1199-1209</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Metastasis to bone is a major cause of morbidity in breast cancer patients, emphasizing the importance of identifying mol. drivers of bone metastasis for new therapeutic targets.  The endogenous cysteine cathepsin inhibitor stefin A is a suppressor of breast cancer metastasis to bone that is coexpressed with cathepsin B in bone metastases.  In this study, we used the immunocompetent 4T1.2 model of breast cancer which exhibits spontaneous bone metastasis to evaluate the function and therapeutic targeting potential of cathepsin B in this setting of advanced disease.  Cathepsin B abundancy in the model mimicked human disease, both at the level of primary tumors and matched spinal metastases.  RNA interference-mediated knockdown of cathepsin B in tumor cells reduced collagen I degrdn. in vitro and bone metastasis in vivo.  Similarly, i.p. administration of the highly selective cathepsin B inhibitor CA-074 reduced metastasis in tumor-bearing animals, a redn. that was not reproduced by the broad spectrum cysteine cathepsin inhibitor JPM-OEt.  Notably, metastasis suppression by CA-074 was maintained in a late treatment setting, pointing to a role in metastatic outgrowth.  Together, our findings established a prometastatic role for cathepsin B in distant metastasis and illustrated the therapeutic benefits of its selective inhibition in vivo.  Cancer Res; 72(5); 1199-209.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaVtPHsMReRLVg90H21EOLACvtfcHk0lhI4K-pvxAORQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Wis74%253D&md5=b66b32d65d9e9799412bb110b4c9d4e9</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-2759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-2759%26sid%3Dliteratum%253Aachs%26aulast%3DWithana%26aufirst%3DN.%2BP.%26aulast%3DBlum%26aufirst%3DG.%26aulast%3DSameni%26aufirst%3DM.%26aulast%3DSlaney%26aufirst%3DC.%26aulast%3DAnbalagan%26aufirst%3DA.%26aulast%3DOlive%26aufirst%3DM.%2BB.%26aulast%3DBidwell%26aufirst%3DB.%2BN.%26aulast%3DEdgington%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMoin%26aufirst%3DK.%26aulast%3DSloane%26aufirst%3DB.%2BF.%26aulast%3DAnderson%26aufirst%3DR.%2BL.%26aulast%3DBogyo%26aufirst%3DM.%2BS.%26aulast%3DParker%26aufirst%3DB.%2BS.%26atitle%3DCathepsin%2520B%2520inhibition%2520limits%2520bone%2520metastasis%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26issue%3D5%26spage%3D1199%26doi%3D10.1158%2F0008-5472.CAN-11-2759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell-McGuinn, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garfall, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">7378</span>â <span class="NLM_lpage">7385</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-07-0602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1158%2F0008-5472.CAN-07-0602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17671208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVemtL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=7378-7385&issue=15&author=K.+M.+Bell-McGuinnauthor=A.+L.+Garfallauthor=M.+Bogyoauthor=D.+Hanahanauthor=J.+A.+Joyce&title=Inhibition+of+cysteine+cathepsin+protease+activity+enhances+chemotherapy+regimens+by+decreasing+tumor+growth+and+invasiveness+in+a+mouse+model+of+multistage+cancer&doi=10.1158%2F0008-5472.CAN-07-0602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Cysteine Cathepsin Protease Activity Enhances Chemotherapy Regimens by Decreasing Tumor Growth and Invasiveness in a Mouse Model of Multistage Cancer</span></div><div class="casAuthors">Bell-McGuinn, Katherine M.; Garfall, Alfred L.; Bogyo, Matthew; Hanahan, Douglas; Joyce, Johanna A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7378-7385</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Increases in protease expression and activity are assocd. with malignant progression and poor patient prognosis in a no. of human cancers.  Members of the papain family of cysteine cathepsins are among the protease classes that have been functionally implicated in cancer.  Inhibition of the cysteine cathepsin family using a pan-cathepsin inhibitor, JPM-OEt, led to tumor regression in the RIP1-Tag2 (RT2) mouse model of pancreatic islet cell tumorigenesis.  The present study was designed to det. whether this cathepsin inhibitor, when used in combination with chemotherapy, would increase antitumor efficacy.  RT2 mice were treated in a late-stage regression trial with three different chemotherapy regimens, alone or in combination with the cathepsin inhibitor, JPM-OEt.  Cyclophosphamide was administered in either a max. tolerated dose (MTD) regimen, a "metronomic" continuous low-dose regimen, or a "chemo-switch" regimen consisting of MTD followed by metronomic dosing.  Mice were sacrificed at a defined end point and tumor burden was assessed followed by a detailed anal. of cell proliferation, apoptosis, vascularization, and invasiveness in the treated and control lesions.  An addnl. cohort of mice was followed for survival anal.  The cathepsin inhibitor plus the chemo-switch regimen of cyclophosphamide led to the most pronounced redn. in tumor burden and greatest increase in overall survival.  Cysteine cathepsin inhibition resulted in a significant decrease in tumor invasiveness, which was further augmented in combination with each of the chemotherapy dosing regimens.  These results encourage the development and continuing evaluation of cysteine cathepsin inhibitors as cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjpWRsw23b-bVg90H21EOLACvtfcHk0lj9GdYR3enbnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVemtL8%253D&md5=b59dc53ebe01709d7635a0ed688d558b</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-0602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-0602%26sid%3Dliteratum%253Aachs%26aulast%3DBell-McGuinn%26aufirst%3DK.%2BM.%26aulast%3DGarfall%26aufirst%3DA.%2BL.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26atitle%3DInhibition%2520of%2520cysteine%2520cathepsin%2520protease%2520activity%2520enhances%2520chemotherapy%2520regimens%2520by%2520decreasing%2520tumor%2520growth%2520and%2520invasiveness%2520in%2520a%2520mouse%2520model%2520of%2520multistage%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26issue%3D15%26spage%3D7378%26epage%3D7385%26doi%3D10.1158%2F0008-5472.CAN-07-0602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schurigt, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevenich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vannier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwinde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Elverfeldt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinheckel, T.</span></span> <span> </span><span class="NLM_article-title">Trial of the cysteine cathepsin inhibitor JPM-OEt on early and advanced mammary cancer stages in the MMTV-PyMT-transgenic mouse model</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>389</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1067</span>â <span class="NLM_lpage">1074</span>, <span class="refDoi">Â DOI: 10.1515/BC.2008.115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1515%2FBC.2008.115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18710344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Ohurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2008&pages=1067-1074&issue=8&author=U.+Schurigtauthor=L.+Sevenichauthor=C.+Vannierauthor=M.+Gajdaauthor=A.+Schwindeauthor=F.+Wernerauthor=A.+Stahlauthor=D.+von+Elverfeldtauthor=A.-K.+Beckerauthor=M.+Bogyoauthor=C.+Petersauthor=T.+Reinheckel&title=Trial+of+the+cysteine+cathepsin+inhibitor+JPM-OEt+on+early+and+advanced+mammary+cancer+stages+in+the+MMTV-PyMT-transgenic+mouse+model&doi=10.1515%2FBC.2008.115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Trial of the cysteine cathepsin inhibitor JPM-OEt on early and advanced mammary cancer stages in the MMTV-PyMT-transgenic mouse model</span></div><div class="casAuthors">Schurigt, Uta; Sevenich, Lisa; Vannier, Corinne; Gajda, Mieczyslaw; Schwinde, Anne; Werner, Fee; Stahl, Andreas; von Elverfeldt, Dominik; Becker, Anne-Katrin; Bogyo, Matthew; Peters, Christoph; Reinheckel, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1067-1074</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">Recent data suggest proteases of the papain-like cysteine cathepsin family as mol. targets for cancer therapy.  Here, we report the treatment of polyoma middle T oncogene-induced breast cancers in mice with the cell-permeable broad-spectrum cysteine cathepsin inhibitor JPM-OEt.  Up to 100 mg/kg inhibitor was i.p. injected once per day in two trials on early and advanced cancers.  In both trials, transient delays in tumor growth were obsd.  However, at the endpoint of both expts. no significant differences in tumor wts., histopathol. and lung metastasis were found between the inhibitor and the control group.  The invasive strand formation of collagen I-embedded tumor cell spheroids generated from primary tumors of inhibitor-treated mice in the early cancer trial could be inhibited in vitro by JPM-OEt; a result arguing against induction of resistance to the inhibitor.  Measurement of cysteine cathepsin activities in tissue exts. after i.p. injection of JPM-OEt revealed effective inhibition of cysteine cathepsins in pancreas, kidneys and liver, while activities in mammary cancers and in lungs were not significantly affected.  We conclude that the pharmacokinetic properties of JPM-OEt, which result in poor bioavailability, may prohibit its use for stand-alone treatment of solid mammary cancers and their lung metastases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyxpOV_XtD27Vg90H21EOLACvtfcHk0lj9GdYR3enbnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Ohurk%253D&md5=25ab2d52f96d301df3b993a7a2c01e61</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1515%2FBC.2008.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2008.115%26sid%3Dliteratum%253Aachs%26aulast%3DSchurigt%26aufirst%3DU.%26aulast%3DSevenich%26aufirst%3DL.%26aulast%3DVannier%26aufirst%3DC.%26aulast%3DGajda%26aufirst%3DM.%26aulast%3DSchwinde%26aufirst%3DA.%26aulast%3DWerner%26aufirst%3DF.%26aulast%3DStahl%26aufirst%3DA.%26aulast%3Dvon%2BElverfeldt%26aufirst%3DD.%26aulast%3DBecker%26aufirst%3DA.-K.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DPeters%26aufirst%3DC.%26aulast%3DReinheckel%26aufirst%3DT.%26atitle%3DTrial%2520of%2520the%2520cysteine%2520cathepsin%2520inhibitor%2520JPM-OEt%2520on%2520early%2520and%2520advanced%2520mammary%2520cancer%2520stages%2520in%2520the%2520MMTV-PyMT-transgenic%2520mouse%2520model%26jtitle%3DBiol.%2520Chem.%26date%3D2008%26volume%3D389%26issue%3D8%26spage%3D1067%26epage%3D1074%26doi%3D10.1515%2FBC.2008.115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salpeter, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozniak, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merquiol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Nun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, G.</span></span> <span> </span><span class="NLM_article-title">A novel cysteine cathepsin inhibitor yields macrophage cell death and mammary tumor regression</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">50</span>),  <span class="NLM_fpage">6066</span>â <span class="NLM_lpage">6078</span>, <span class="refDoi">Â DOI: 10.1038/onc.2015.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fonc.2015.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25798843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFejtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=6066-6078&issue=50&author=S.+J.+Salpeterauthor=Y.+Pozniakauthor=E.+Merquiolauthor=Y.+Ben-Nunauthor=T.+Geigerauthor=G.+Blum&title=A+novel+cysteine+cathepsin+inhibitor+yields+macrophage+cell+death+and+mammary+tumor+regression&doi=10.1038%2Fonc.2015.51"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cysteine cathepsin inhibitor yields macrophage cell death and mammary tumor regression</span></div><div class="casAuthors">Salpeter, S. J.; Pozniak, Y.; Merquiol, E.; Ben-Nun, Y.; Geiger, T.; Blum, G.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">6066-6078</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although cysteine cathepsins have been identified as key regulators of cancer growth, their specific role in tumor development remains unclear.  Recent studies have shown that high activity levels of tumor cathepsins are primarily a result of increased cathepsin activity in cancer-promoting tumor-assocd. macrophages (TAMs).  To further investigate the role of cysteine cathepsin activity in normal and polarized macrophages, we established in vitro and in vivo models of macrophage differentiation and polarization and used a novel cysteine cathepsin inhibitor, GB111-NH2, to block the activity of cathepsins B, L and S.  Here we show that in vitro, cysteine cathepsin inhibition yields both apoptosis and proliferation of macrophages, owing to increased oxidative stress.  Proteomic anal. of cathepsin- inhibited macrophages demonstrates inhibition of autophagy, suggesting a likely cause of elevated reactive oxygen species (ROS) levels.  In vivo models of mammary cancer further show that cathepsin inhibition yields TAM death owing to increased ROS levels.  Strikingly, apoptosis in TAMs yields a seemingly cell non-autonomous death of neighboring cancer cells, and regression of the primary growth.  These results show that cysteine cathepsin inhibitors can specifically trigger macrophage cell death and may function as an effective anticancer therapy in tumors with high levels of TAMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVQAmx4yymWLVg90H21EOLACvtfcHk0lj9GdYR3enbnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFejtLk%253D&md5=dfb543c900b8f4fd1e56274699dd0d79</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.51%26sid%3Dliteratum%253Aachs%26aulast%3DSalpeter%26aufirst%3DS.%2BJ.%26aulast%3DPozniak%26aufirst%3DY.%26aulast%3DMerquiol%26aufirst%3DE.%26aulast%3DBen-Nun%26aufirst%3DY.%26aulast%3DGeiger%26aufirst%3DT.%26aulast%3DBlum%26aufirst%3DG.%26atitle%3DA%2520novel%2520cysteine%2520cathepsin%2520inhibitor%2520yields%2520macrophage%2520cell%2520death%2520and%2520mammary%2520tumor%2520regression%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26issue%3D50%26spage%3D6066%26epage%3D6078%26doi%3D10.1038%2Fonc.2015.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdoes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oresic Bender, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Linden, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withana, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanman, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Improved quenched fluorescent probe for imaging of cysteine cathepsinactivity</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">14726</span>â <span class="NLM_lpage">14730</span>, <span class="refDoi">Â DOI: 10.1021/ja4056068</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja4056068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlamu7jJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=14726-14730&issue=39&author=M.+Verdoesauthor=K.+Oresic+Benderauthor=E.+Segalauthor=W.+A.+van+der%0ALindenauthor=S.+Syedauthor=N.+P.+Withanaauthor=L.+E.+Sanmanauthor=M.+Bogyo&title=Improved+quenched+fluorescent+probe+for+imaging+of+cysteine+cathepsinactivity&doi=10.1021%2Fja4056068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Quenched Fluorescent Probe for Imaging of Cysteine Cathepsin Activity</span></div><div class="casAuthors">Verdoes, Martijn; Oresic Bender, Kristina; Segal, Ehud; van der Linden, Wouter A.; Syed, Salahuddin; Withana, Nimali P.; Sanman, Laura E.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">14726-14730</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cysteine cathepsins are a family of proteases that play important roles in both normal cellular physiol. and many human diseases.  In cancer, the activity of many of the cysteine cathepsins is upregulated and can be exploited for tumor imaging.  Here we present the design and synthesis of a new class of quenched fluorescent activity-based probes (qABPs) contg. a phenoxymethyl ketone (PMK) electrophile.  These reagents show enhanced in vivo properties and broad reactivity resulting in dramatically improved labeling and tumor imaging properties compared to those of previously reported ABPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyCqZ94sGkvbVg90H21EOLACvtfcHk0lhYnO0G7eVquw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlamu7jJ&md5=dfa3206d83ceed10d2e43f408dcdf03f</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fja4056068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja4056068%26sid%3Dliteratum%253Aachs%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DOresic%2BBender%26aufirst%3DK.%26aulast%3DSegal%26aufirst%3DE.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DW.%2BA.%26aulast%3DSyed%26aufirst%3DS.%26aulast%3DWithana%26aufirst%3DN.%2BP.%26aulast%3DSanman%26aufirst%3DL.%2BE.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DImproved%2520quenched%2520fluorescent%2520probe%2520for%2520imaging%2520of%2520cysteine%2520cathepsinactivity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26issue%3D39%26spage%3D14726%26epage%3D14730%26doi%3D10.1021%2Fja4056068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rut, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vizovisek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groborz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2113</span>â <span class="NLM_lpage">2129</span>, <span class="refDoi">Â DOI: 10.1039/C7SC04303A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1039%2FC7SC04303A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29719685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosF2isA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=2113-2129&issue=8&author=M.+Porebaauthor=W.+Rutauthor=M.+Vizovisekauthor=K.+Groborzauthor=P.+Kasperkiewiczauthor=D.+Finlayauthor=K.+Vuoriauthor=D.+Turkauthor=B.+Turkauthor=G.+S.+Salvesenauthor=M.+Drag&title=Selective+imaging+of+cathepsin+L+in+breast+cancer+by+fluorescent+activity-based+probes&doi=10.1039%2FC7SC04303A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes</span></div><div class="casAuthors">Poreba, Marcin; Rut, Wioletta; Vizovisek, Matej; Groborz, Katarzyna; Kasperkiewicz, Paulina; Finlay, Darren; Vuori, Kristiina; Turk, Dusan; Turk, Boris; Salvesen, Guy S.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2113-2129</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cysteine cathepsins normally function in the lysosomal degrdn. system where they are crit. for the maintenance of cellular homeostasis and the MHC II immune response, and have been found to have major roles in several diseases and in tumor progression.  Selective visualization of individual protease activity within a complex proteome is of major importance to establish their roles in both normal and tumor cells, thereby facilitating our understanding of the regulation of proteolytic networks.  Here, we utilized HyCoSuL, a positional scanning substrate approach, to develop a highly-selective fluorogenic substrate and activity-based probe for monitoring cathepsin L activity in the breast cancer cell line MDA-MB-231.  Use of this probe enabled us to distinguish the activity of cathepsin L from that of other cathepsins, particularly cathepsin B, which is abundant and ubiquitously expressed in normal and transformed cell types.  We found that cathepsin L localization in MDA-MB-231 cells greatly overlaps with that of cathepsin B, however, several cathepsin L-rich lysosomes lacked cathepsin B activity.  Overall, these studies demonstrate that HyCoSuL-derived small mol. probes are valuable tools to image cathepsin L activity in living cells.  This approach thus enables evaluation of cathepsin L function in tumorigenesis and is applicable to other cysteine cathepsins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXkKiO1PSXPrVg90H21EOLACvtfcHk0lhYnO0G7eVquw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosF2isA%253D%253D&md5=53fab0ed5ebfbf8dd0b5a3dbc11dbee1</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1039%2FC7SC04303A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7SC04303A%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DRut%26aufirst%3DW.%26aulast%3DVizovisek%26aufirst%3DM.%26aulast%3DGroborz%26aufirst%3DK.%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DFinlay%26aufirst%3DD.%26aulast%3DVuori%26aufirst%3DK.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DSelective%2520imaging%2520of%2520cathepsin%2520L%2520in%2520breast%2520cancer%2520by%2520fluorescent%2520activity-based%2520probes%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26issue%3D8%26spage%3D2113%26epage%3D2129%26doi%3D10.1039%2FC7SC04303A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groborz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vizovisek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruggi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span> <span> </span><span class="NLM_article-title">Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">36</span>),  <span class="NLM_fpage">8461</span>â <span class="NLM_lpage">8477</span>, <span class="refDoi">Â DOI: 10.1039/C9SC00997C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1039%2FC9SC00997C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31803426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVOrs7%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=8461-8477&issue=36&author=M.+Porebaauthor=K.+Groborzauthor=M.+Vizovisekauthor=M.+Maruggiauthor=D.+Turkauthor=B.+Turkauthor=G.+Powisauthor=M.+Dragauthor=G.+S.+Salvesen&title=Fluorescent+probes+towards+selective+cathepsin+B+detection+and+visualization+in+cancer+cells+and+patient+samples&doi=10.1039%2FC9SC00997C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples</span></div><div class="casAuthors">Poreba, Marcin; Groborz, Katarzyna; Vizovisek, Matej; Maruggi, Marco; Turk, Dusan; Turk, Boris; Powis, Garth; Drag, Marcin; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">8461-8477</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Human cysteine cathepsins constitute an 11-membered family of proteases responsible for degrdn. of proteins in cellular endosomal-lysosomal compartments as such, they play important roles in antigen processing, cellular stress signaling, autophagy, and senescence.  Moreover, for many years these enzymes were also linked to tumor growth, invasion, angiogenesis and metastasis when upregulated.  Individual biol. roles of each cathepsin are difficult to establish, because of their redundancy and similar substrate specificities.  Selective chem. tools that enable imaging of individual cathepsin activities in living cells, tumors, and the tumor microenvironment may provide a better insight into their functions.  In this work, we used HyCoSuL technol. to profile the substrate specificity of human cathepsin B.  The use of unnatural amino acids in the substrate library enabled us to uncover the broad cathepsin B preferences that we utilized to design highly-selective substrates and fluorescent activity-based probes (ABPs).  We further demonstrated that Cy5-labeled MP-CB-2 probe can selectively label cathepsin B in eighteen cancer cell lines tested, making this ABP highly suitable for other biol. setups.  Moreover, using Cy5-labeled MP-CB-2 we were able to demonstrate by fluorescence microscopy that in cancer cells cathepsins B and L share overlapping, but not identical subcellular localization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkHJ2qvOHfoLVg90H21EOLACvtfcHk0lhYnO0G7eVquw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVOrs7%252FE&md5=fb74cdb9f3aab8ae9ba6b77473d5da3f</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1039%2FC9SC00997C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9SC00997C%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DGroborz%26aufirst%3DK.%26aulast%3DVizovisek%26aufirst%3DM.%26aulast%3DMaruggi%26aufirst%3DM.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DPowis%26aufirst%3DG.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DFluorescent%2520probes%2520towards%2520selective%2520cathepsin%2520B%2520detection%2520and%2520visualization%2520in%2520cancer%2520cells%2520and%2520patient%2520samples%26jtitle%3DChem.%2520Sci.%26date%3D2019%26volume%3D10%26issue%3D36%26spage%3D8461%26epage%3D8477%26doi%3D10.1039%2FC9SC00997C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bossard, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaszek, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amegadzie, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanning, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurdyla, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gowen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, M. A.</span></span> <span> </span><span class="NLM_article-title">Proteolytic activity of human osteoclast cathepsin K: expression, purification, activation, and substrate identification</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">12517</span>â <span class="NLM_lpage">12524</span>, <span class="refDoi">Â DOI: 10.1074/jbc.271.21.12517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.271.21.12517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8647860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK28XjtFantrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=12517-12524&issue=21&author=M.+J.+Bossardauthor=T.+A.+Tomaszekauthor=S.+K.+Thompsonauthor=B.+Y.+Amegadzieauthor=C.+R.+Hanningauthor=C.+Jonesauthor=J.+T.+Kurdylaauthor=D.+E.+McNultyauthor=F.+H.+Drakeauthor=M.+Gowenauthor=M.+A.+Levy&title=Proteolytic+activity+of+human+osteoclast+cathepsin+K%3A+expression%2C+purification%2C+activation%2C+and+substrate+identification&doi=10.1074%2Fjbc.271.21.12517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification</span></div><div class="casAuthors">Bossard, Mary J.; Tomaszek, Thaddeus A.; Thompson, Scott K.; Amegadzie, Bernard Y.; Hanning, Charles R.; Jones, Christopher; Kurdyla, Jeff T.; McNulty, Dean E.; Drake, Fred H.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">12517-12524</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human cathepsin K is a recently identified protein with high primary sequence homol. to members of the papain cysteine protease superfamily including cathepsins S, L, and B and is selectively expressed in osteoclasts (Drake, F. H., Dodds, R., James, I., Connor, J., Debouck, C., Richardson, S., Lee, E., Rieman, D., Barthlow, R., Hastings, G., and Gowen, M. (1996) J. Biol. Chem. 271, 12511-12516).  To characterize its catalytic properties, cathepsin K has been expressed in baculovirus-infected SF21 cells and the sol. recombinant protein isolated from growth media was purified.  Purified protein includes an inhibitory pro-leader sequence common to this family of protease.  Conditions for enzyme activation upon removal of the pro-sequence have been identified.  Fluorogenic peptides have been identified as substrates for mature cathepsin K.  In addn., two protein components of bone matrix, collagen and osteonectin, have been shown to be substrates of the activated protease.  Cathepsin K is inhibited by E-64 and leupeptin, but not by pepstatin, EDTA, phenylmethylsulfonyl fluoride or phenanthroline, consistent with its classification within the cysteine protease class.  Leupeptin has been characterized as a slow binding inhibitor of cathepsin K (kobs/[I] = 273,000 M-1Â·s-1).  Cathepsin K may represent the elusive protease implicated in degrdn. of protein matrix during bone resorption and represents a novel mol. target in treatment of disease states assocd. with excessive bone loss such as osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZEtDLODXbdLVg90H21EOLACvtfcHk0ljgZ71sNaPmtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtFantrc%253D&md5=74d14dc52a7752faafef77aa6c6f9e2c</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.21.12517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.21.12517%26sid%3Dliteratum%253Aachs%26aulast%3DBossard%26aufirst%3DM.%2BJ.%26aulast%3DTomaszek%26aufirst%3DT.%2BA.%26aulast%3DThompson%26aufirst%3DS.%2BK.%26aulast%3DAmegadzie%26aufirst%3DB.%2BY.%26aulast%3DHanning%26aufirst%3DC.%2BR.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DKurdyla%26aufirst%3DJ.%2BT.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DDrake%26aufirst%3DF.%2BH.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DLevy%26aufirst%3DM.%2BA.%26atitle%3DProteolytic%2520activity%2520of%2520human%2520osteoclast%2520cathepsin%2520K%253A%2520expression%252C%2520purification%252C%2520activation%252C%2520and%2520substrate%2520identification%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26issue%3D21%26spage%3D12517%26epage%3D12524%26doi%3D10.1074%2Fjbc.271.21.12517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jules, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span> <span> </span><span class="NLM_article-title">Deficiency of cathepsin K prevents inflammation and bone erosion in rheumatoid arthritis and periodontitis and reveals its shared osteoimmune role</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>589</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1331</span>â <span class="NLM_lpage">1339</span>, <span class="refDoi">Â DOI: 10.1016/j.febslet.2015.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.febslet.2015.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25896020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslGitLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=589&publication_year=2015&pages=1331-1339&issue=12&author=L.+Haoauthor=G.+Zhuauthor=Y.+Luauthor=M.+Wangauthor=J.+Julesauthor=X.+Zhouauthor=W.+Chen&title=Deficiency+of+cathepsin+K+prevents+inflammation+and+bone+erosion+in+rheumatoid+arthritis+and+periodontitis+and+reveals+its+shared+osteoimmune+role&doi=10.1016%2Fj.febslet.2015.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Deficiency of cathepsin K prevents inflammation and bone erosion in rheumatoid arthritis and periodontitis and reveals its shared osteoimmune role</span></div><div class="casAuthors">Hao, Liang; Zhu, Guochun; Lu, Yun; Wang, Min; Jules, Joel; Zhou, Xuedong; Chen, Wei</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">589</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1331-1339</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Using rheumatoid arthritis (RA) and periodontitis mouse models, we demonstrate that RA and periodontitis share many pathol. features, such as deregulated cytokine prodn., increased immune-cell infiltration, increased expression of Toll-like receptors (TLRs), and enhanced osteoclast activity and bone erosion.  We reveal that genetic deletion of cathepsin K (Ctsk) caused a radical redn. in inflammation and bone erosion within RA joint capsules and periodontal lesions, a drastic decrease in immune-cell infiltration, and a significant redn. in osteoclasts, macrophages, dendritic and T-cells.  Deficiency of Ctsk greatly decreased the expression of TLR-4, 5, and 9 and their downstream cytokines in periodontal gingival epithelial lesions and synovial RA lesions.  Hence, Ctsk may be targeted to treat RA and periodontitis simultaneously due to its shared osteoimmune role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTc2lPGq3nOrVg90H21EOLACvtfcHk0ljgZ71sNaPmtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslGitLs%253D&md5=a869758ebad51ebecbc2685905b3331f</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2015.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2015.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DJules%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DW.%26atitle%3DDeficiency%2520of%2520cathepsin%2520K%2520prevents%2520inflammation%2520and%2520bone%2520erosion%2520in%2520rheumatoid%2520arthritis%2520and%2520periodontitis%2520and%2520reveals%2520its%2520shared%2520osteoimmune%2520role%26jtitle%3DFEBS%2520Lett.%26date%3D2015%26volume%3D589%26issue%3D12%26spage%3D1331%26epage%3D1339%26doi%3D10.1016%2Fj.febslet.2015.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, B.</span></span> <span> </span><span class="NLM_article-title">Increased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability</span>. <i>Exp. Ther. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">3471</span>â <span class="NLM_lpage">3476</span>, <span class="refDoi">Â DOI: 10.3892/etm.2017.4935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.3892%2Fetm.2017.4935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29042935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOqsbfF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=3471-3476&issue=4&author=H.+Zhaoauthor=X.+Qinauthor=S.+Wangauthor=X.+Sunauthor=B.+Dong&title=Increased+cathepsin+K+levels+in+human+atherosclerotic+plaques+are+associated+with+plaque+instability&doi=10.3892%2Fetm.2017.4935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability</span></div><div class="casAuthors">Zhao, Huiying; Qin, Xiujiao; Wang, Shuai; Sun, Xiwei; Dong, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Therapeutic Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">3471-3476</span>CODEN:
                <span class="NLM_cas:coden">ETMXA2</span>;
        ISSN:<span class="NLM_cas:issn">1792-1015</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Investigating the determinants and dynamics of atherosclerotic plaque instability is a key area of current cardiovascular research.  Extracellular matrix degrdn. from excessive proteolysis induced by enzymes such as cathepsin K (Cat K) is implicated in the pathogenesis of unstable plaques.  The current study assessed the expression of Cat K in human unstable atherosclerotic plaques.  Specimens of popliteal arteries with atherosclerotic plaques were classified as stable (<40% lipid core plaque area; n=6) or unstable (â¥40% lipid core plaque area; n=14) based on histopathol. examns. of hematoxylin and eosin stained sections.  The expression of Cat K and cystatin C (Cys C) were assessed by immunohistochem. examn. and levels of Cat K mRNA were detected by semi-quant. reverse transcriptase polymerase chain reaction.  Morphol. changes including a larger lipid core, endothelial proliferation with foam cells and destruction of internal elastic lamina were obsd. in unstable atherosclerotic plaques.  In unstable plaques, the expression of Cat K protein and mRNA was upregulated, whereas Cys C protein expression was downregulated.  The interplay between Cat K and Cys C may underlie the progression of plaques from stable to unstable and the current study indicated that Cat K and Cys C are potential targets for preventing and treating vulnerable atherosclerotic plaque ruptures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMMZ2F1FHoubVg90H21EOLACvtfcHk0ljgZ71sNaPmtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOqsbfF&md5=e2dadfb175f49358db60b1152b4b1ea0</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.3892%2Fetm.2017.4935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fetm.2017.4935%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DB.%26atitle%3DIncreased%2520cathepsin%2520K%2520levels%2520in%2520human%2520atherosclerotic%2520plaques%2520are%2520associated%2520with%2520plaque%2520instability%26jtitle%3DExp.%2520Ther.%2520Med.%26date%3D2017%26volume%3D14%26issue%3D4%26spage%3D3471%26epage%3D3476%26doi%3D10.3892%2Fetm.2017.4935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asagiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunigami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gober, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golenbock, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazono, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saftig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takayanagi, H.</span></span> <span> </span><span class="NLM_article-title">Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>319</i></span> (<span class="NLM_issue">5863</span>),  <span class="NLM_fpage">624</span>â <span class="NLM_lpage">627</span>, <span class="refDoi">Â DOI: 10.1126/science.1150110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fscience.1150110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18239127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Knt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2008&pages=624-627&issue=5863&author=M.+Asagiriauthor=T.+Hiraiauthor=T.+Kunigamiauthor=S.+Kamanoauthor=H.-J.+Goberauthor=K.+Okamotoauthor=K.+Nishikawaauthor=E.+Latzauthor=D.+T.+Golenbockauthor=K.+Aokiauthor=K.+Ohyaauthor=Y.+Imaiauthor=Y.+Morishitaauthor=K.+Miyazonoauthor=S.+Katoauthor=P.+Saftigauthor=H.+Takayanagi&title=Cathepsin+K-dependent+toll-like+receptor+9+signaling+revealed+in+experimental+arthritis&doi=10.1126%2Fscience.1150110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin K-Dependent Toll-Like Receptor 9 Signaling Revealed in Experimental Arthritis</span></div><div class="casAuthors">Asagiri, Masataka; Hirai, Toshitake; Kunigami, Toshihiro; Kamano, Shunya; Gober, Hans-Juergen; Okamoto, Kazuo; Nishikawa, Keizo; Latz, Eicke; Golenbock, Douglas T.; Aoki, Kazuhiro; Ohya, Keiichi; Imai, Yuuki; Morishita, Yasuyuki; Miyazono, Kohei; Kato, Shigeaki; Saftig, Paul; Takayanagi, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">5863</span>),
    <span class="NLM_cas:pages">624-627</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cathepsin K was originally identified as an osteoclast-specific lysosomal protease, the inhibitor of which has been considered might have therapeutic potential.  We show that inhibition of cathepsin K could potently suppress autoimmune inflammation of the joints as well as osteoclastic bone resorption in autoimmune arthritis.  Furthermore, cathepsin K-/- mice were resistant to exptl. autoimmune encephalomyelitis.  Pharmacol. inhibition or targeted disruption of cathepsin K resulted in defective Toll-like receptor 9 signaling in dendritic cells in response to unmethylated CpG DNA, which in turn led to attenuated induction of T helper 17 cells, without affecting the antigen-presenting ability of dendritic cells.  These results suggest that cathepsin K plays an important role in the immune system and may serve as a valid therapeutic target in autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6uK-U5bRXorVg90H21EOLACvtfcHk0lh_rJaPJ4BWEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Knt7s%253D&md5=79d72a85f81d7cece7b762cf1239decd</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1126%2Fscience.1150110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1150110%26sid%3Dliteratum%253Aachs%26aulast%3DAsagiri%26aufirst%3DM.%26aulast%3DHirai%26aufirst%3DT.%26aulast%3DKunigami%26aufirst%3DT.%26aulast%3DKamano%26aufirst%3DS.%26aulast%3DGober%26aufirst%3DH.-J.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DNishikawa%26aufirst%3DK.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DOhya%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DMiyazono%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DTakayanagi%26aufirst%3DH.%26atitle%3DCathepsin%2520K-dependent%2520toll-like%2520receptor%25209%2520signaling%2520revealed%2520in%2520experimental%2520arthritis%26jtitle%3DScience%26date%3D2008%26volume%3D319%26issue%3D5863%26spage%3D624%26epage%3D627%26doi%3D10.1126%2Fscience.1150110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zerbini, C. A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClung, M. R.</span></span> <span> </span><span class="NLM_article-title">Odanacatib in postmenopausal women with low bone mineral density: a review of current clinical evidence</span>. <i>Ther. Adv. Musculoskeletal Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">199</span>â <span class="NLM_lpage">209</span>, <span class="refDoi">Â DOI: 10.1177/1759720X13490860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1177%2F1759720X13490860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23904864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSksrvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=199-209&issue=4&author=C.+A.+F.+Zerbiniauthor=M.+R.+McClung&title=Odanacatib+in+postmenopausal+women+with+low+bone+mineral+density%3A+a+review+of+current+clinical+evidence&doi=10.1177%2F1759720X13490860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Odanacatib in postmenopausal women with low bone mineral density: a review of current clinical evidence</span></div><div class="casAuthors">Zerbini, Cristiano A. F.; McClung, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Musculoskeletal Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">199-209</span>CODEN:
                <span class="NLM_cas:coden">TAMDDB</span>;
        ISSN:<span class="NLM_cas:issn">1759-720X</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Human bones are in a continuous process of remodeling that ensures renovation and maintenance of the skeletal mass.  Bone remodeling has two phases that are normally coupled and balanced: bone resorption mediated by osteoclasts and bone formation mediated by osteoblasts.  An increase in bone resorption over bone formation results in a progressive loss of bone mass and impairment of bone microarchitecture leading to osteoporosis and its assocd. fractures.  Recent advances in the understanding of the mol. and cellular mechanisms involved in the remodeling process have allowed the development of new targets for osteoporosis treatment.  Cathepsin K, a cysteine protease, is found in osteoclasts along the bone resorption surfaces and very efficiently degrades type I collagen, the major component of the org. bone matrix.  Inhibition of cathepsin K reduces bone resorption but does not impair bone formation particularly at cortical sites.  Odanacatib, a potent and highly selective cathepsin K inhibitor, showed prevention of bone loss without redn. of bone formation in preclin. and clin. trials (phase I and II).  Odanacatib is currently in a phase III fracture outcome international trial for the treatment of postmenopausal osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKPKoBhbIsObVg90H21EOLACvtfcHk0lh_rJaPJ4BWEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSksrvN&md5=002f6737b49719de00c3d234fdf7e44f</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1177%2F1759720X13490860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1759720X13490860%26sid%3Dliteratum%253Aachs%26aulast%3DZerbini%26aufirst%3DC.%2BA.%2BF.%26aulast%3DMcClung%26aufirst%3DM.%2BR.%26atitle%3DOdanacatib%2520in%2520postmenopausal%2520women%2520with%2520low%2520bone%2520mineral%2520density%253A%2520a%2520review%2520of%2520current%2520clinical%2520evidence%26jtitle%3DTher.%2520Adv.%2520Musculoskeletal%2520Dis.%26date%3D2013%26volume%3D5%26issue%3D4%26spage%3D199%26epage%3D209%26doi%3D10.1177%2F1759720X13490860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falgueyret, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmarais, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cromlish, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khougaz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamontagne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MassÃ©, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toulmond, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7535</span>â <span class="NLM_lpage">7543</span>, <span class="refDoi">Â DOI: 10.1021/jm0504961</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0504961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7535-7543&issue=24&author=J.-P.+Falgueyretauthor=S.+Desmaraisauthor=R.+Oballaauthor=W.+C.+Blackauthor=W.+Cromlishauthor=K.+Khougazauthor=S.+Lamontagneauthor=F.+Mass%C3%A9author=D.+Riendeauauthor=S.+Toulmondauthor=M.+D.+Percival&title=Lysosomotropism+of+basic+cathepsin+K+inhibitors+contributes+to+increased+cellular+potencies+against+off-target+cathepsins+and+reduced+functional+selectivity&doi=10.1021%2Fjm0504961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Desmarais, Sylvie; Oballa, Renata; Black, W. Cameron; Cromlish, Wanda; Khougaz, Karine; Lamontagne, Sonia; Masse, Frederic; Riendeau, Denis; Toulmond, Sylvie; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7535-7543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lysosomal cysteine protease cathepsin K is a target for osteoporosis therapy.  The aryl-piperazine-contg. cathepsin K inhibitor CRA-013783/L-006235 (1) displays greater than 4000-fold selectivity against the lysosomal/endosomal antitargets cathepsin B, L, and S.  However, 1 and other aryl-piperazine-contg. analogs, including balicatib (10), are â¼10-100-fold more potent in cell-based enzyme occupancy assays than against each purified enzyme.  This phenomenon arises from their basic, lipophilic nature, which results in lysosomal trapping.  Consistent with its lysosomotropic nature, 1 accumulates in cells and in rat tissues of high lysosome content.  In contrast, nonbasic aryl-morpholino-contg. analogs do not exhibit lysosomotropic properties.  Increased off-target activities of basic cathepsin K inhibitors were obsd. in a cell-based cathepsin S antigen presentation assay.  No potency increases of basic inhibitors in a functional cathepsin K bone resorption whole cell assay were detected.  Therefore, basic cathepsin K inhibitors, such as 1, suffer from reduced functional selectivities compared to those predicted using purified enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1NUHyZtwrwLVg90H21EOLACvtfcHk0lhcnh6FGC3Rng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE&md5=9522026bb34984bc66b462b2e95fcbb0</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm0504961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504961%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DKhougaz%26aufirst%3DK.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DToulmond%26aufirst%3DS.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DLysosomotropism%2520of%2520basic%2520cathepsin%2520K%2520inhibitors%2520contributes%2520to%2520increased%2520cellular%2520potencies%2520against%2520off-target%2520cathepsins%2520and%2520reduced%2520functional%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D24%26spage%3D7535%26epage%3D7543%26doi%3D10.1021%2Fjm0504961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rnger, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhamou, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwiski, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrerons, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendler, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mindeholm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realdi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, V.</span></span> <span> </span><span class="NLM_article-title">Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib</span>. <i>J. Am. Acad. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">3</span>), <span class="NLM_elocation-id">e89</span> <span class="refDoi">Â DOI: 10.1016/j.jaad.2010.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.jaad.2010.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21571394" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&issue=3&author=T.+M.+Rngerauthor=S.+Adamiauthor=C.-L.+Benhamouauthor=E.+Czerwiskiauthor=J.+Farreronsauthor=D.+L.+Kendlerauthor=L.+Mindeholmauthor=G.+Realdiauthor=C.+Rouxauthor=V.+Smith&title=Morphea-like+skin+reactions+in+patients+treated+with+the+cathepsin+K+inhibitor+balicatib&doi=10.1016%2Fj.jaad.2010.11.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2010.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2010.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DRnger%26aufirst%3DT.%2BM.%26aulast%3DAdami%26aufirst%3DS.%26aulast%3DBenhamou%26aufirst%3DC.-L.%26aulast%3DCzerwiski%26aufirst%3DE.%26aulast%3DFarrerons%26aufirst%3DJ.%26aulast%3DKendler%26aufirst%3DD.%2BL.%26aulast%3DMindeholm%26aufirst%3DL.%26aulast%3DRealdi%26aufirst%3DG.%26aulast%3DRoux%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DV.%26atitle%3DMorphea-like%2520skin%2520reactions%2520in%2520patients%2520treated%2520with%2520the%2520cathepsin%2520K%2520inhibitor%2520balicatib%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2012%26volume%3D66%26issue%3D3%26doi%3D10.1016%2Fj.jaad.2010.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauret, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cromlish, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmarais, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falgueyret, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmel, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamontagne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LÃ©ger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeRiche, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MassÃ©, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoll-Griffith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ThÃ©rien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, V.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venuti, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesolowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, W. C.</span></span> <span> </span><span class="NLM_article-title">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">923</span>â <span class="NLM_lpage">928</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2007.12.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2007.12.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18226527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=923-928&issue=3&author=J.+Y.+Gauthierauthor=N.+Chauretauthor=W.+Cromlishauthor=S.+Desmaraisauthor=L.+T.+Duongauthor=J.-P.+Falgueyretauthor=D.+B.+Kimmelauthor=S.+Lamontagneauthor=S.+L%C3%A9gerauthor=T.+LeRicheauthor=C.+S.+Liauthor=F.+Mass%C3%A9author=D.+J.+McKayauthor=D.+A.+Nicoll-Griffithauthor=R.+M.+Oballaauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=J.+Robichaudauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=C.+Setoauthor=M.+Th%C3%A9rienauthor=V.-L.+Truongauthor=M.+C.+Venutiauthor=G.+Wesolowskiauthor=R.+N.+Youngauthor=R.+Zamboniauthor=W.+C.+Black&title=The+discovery+of+odanacatib+%28MK-0822%29%2C+a+selective+inhibitor+of+cathepsin+K&doi=10.1016%2Fj.bmcl.2007.12.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span></div><div class="casAuthors">Gauthier, Jacques Yves; Chauret, Nathalie; Cromlish, Wanda; Desmarais, Sylvie; Duong, Le T.; Falgueyret, Jean-Pierre; Kimmel, Donald B.; Lamontagne, Sonia; Leger, Serge; LeRiche, Tammy; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Nicoll-Griffith, Deborah A.; Oballa, Renata M.; Palmer, James T.; Percival, M. David; Riendeau, Denis; Robichaud, Joel; Rodan, Gideon A.; Rodan, Sevgi B.; Seto, Carmai; Therien, Michel; Truong, Vouy-Linh; Venuti, Michael C.; Wesolowski, Gregg; Young, Robert N.; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724.  Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclin. species.  Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib.  Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ytNI-SBgarVg90H21EOLACvtfcHk0lhcnh6FGC3Rng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D&md5=e432a420a3ec99c784117750b9bbeda8</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.047%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DL%25C3%25A9ger%26aufirst%3DS.%26aulast%3DLeRiche%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DTh%25C3%25A9rien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.-L.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DThe%2520discovery%2520of%2520odanacatib%2520%2528MK-0822%2529%252C%2520a%2520selective%2520inhibitor%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D3%26spage%3D923%26epage%3D928%26doi%3D10.1016%2Fj.bmcl.2007.12.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chapurlat, R. D.</span></span> <span> </span><span class="NLM_article-title">Odanacatib: a review of its potential in the management of osteoporosis in postmenopausal women</span>. <i>Ther. Adv. Musculoskeletal Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">103</span>â <span class="NLM_lpage">109</span>, <span class="refDoi">Â DOI: 10.1177/1759720X15580903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1177%2F1759720X15580903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26029271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvVKqsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=103-109&issue=3&author=R.+D.+Chapurlat&title=Odanacatib%3A+a+review+of+its+potential+in+the+management+of+osteoporosis+in+postmenopausal+women&doi=10.1177%2F1759720X15580903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Odanacatib: a review of its potential in the management of osteoporosis in postmenopausal women</span></div><div class="casAuthors">Chapurlat, Roland D.</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Musculoskeletal Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">103-109</span>CODEN:
                <span class="NLM_cas:coden">TAMDDB</span>;
        ISSN:<span class="NLM_cas:issn">1759-720X</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a cathepsin K inhibitor developed for the treatment of postmenopausal osteoporosis.  It is a bone resorption inhibitor, but which preserves bone formation to some extent.  It can be administered once a week, in tablets also contg. vitamin D.  In a large clin. development program, it has been shown that odanacatib reduces bone resorption, with a redn. of about 60-70% in biochem. markers of resorption, while bone formation decreases to a lesser magnitude.  Odanacatib continuously increases bone mineral d. (BMD) at the hip and lumbar spine over 5 years.  Once it is stopped, a complete resoln. of effect is obsd., with declining BMD and increased bone turnover.  Bone microarchitecture and bone strength have also been improved in clin. trials using quant. computed tomog. (QCT) at the lumbar spine and hip, and high resoln. peripheral QCT at the distal radius and tibia.  In a phase III trial involving 16,713 postmenopausal women â¥65 years of age with low BMD, the risk of fragility fracture was significantly reduced at the spine, hip and other nonvertebral sites compared with the placebo group.  Odanacatib has been generally well tolerated, with no observation of osteonecrosis of the jaw so far, but with exceptional observations of subtrochanteric atypical fracture and morphea-like lesions.  Odanacatib appears a useful new option in the treatment of postmenopausal osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYiOWOkwC0fLVg90H21EOLACvtfcHk0lglMlXObfccLw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvVKqsr4%253D&md5=fd6991d52d3ea867b09818201d12ed8e</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1177%2F1759720X15580903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1759720X15580903%26sid%3Dliteratum%253Aachs%26aulast%3DChapurlat%26aufirst%3DR.%2BD.%26atitle%3DOdanacatib%253A%2520a%2520review%2520of%2520its%2520potential%2520in%2520the%2520management%2520of%2520osteoporosis%2520in%2520postmenopausal%2520women%26jtitle%3DTher.%2520Adv.%2520Musculoskeletal%2520Dis.%26date%3D2015%26volume%3D7%26issue%3D3%26spage%3D103%26epage%3D109%26doi%3D10.1177%2F1759720X15580903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayasuga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunishige, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugitani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawabata, K.</span></span> <span> </span><span class="NLM_article-title">Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism</span>. <i>Bone</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1351</span>â <span class="NLM_lpage">1356</span>, <span class="refDoi">Â DOI: 10.1016/j.bone.2011.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bone.2011.09.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21982869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2iur3N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2011&pages=1351-1356&issue=6&author=Y.+Ochiauthor=H.+Yamadaauthor=H.+Moriauthor=Y.+Nakanishiauthor=S.+Nishikawaauthor=R.+Kayasugaauthor=N.+Kawadaauthor=A.+Kunishigeauthor=Y.+Hashimotoauthor=M.+Tanakaauthor=M.+Sugitaniauthor=K.+Kawabata&title=Effects+of+ONO-5334%2C+a+novel+orally-active+inhibitor+of+cathepsin+K%2C+on+bone+metabolism&doi=10.1016%2Fj.bone.2011.09.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism</span></div><div class="casAuthors">Ochi, Yasuo; Yamada, Hiroyuki; Mori, Hiroshi; Nakanishi, Yasutomo; Nishikawa, Satoshi; Kayasuga, Ryoji; Kawada, Naoki; Kunishige, Akiko; Hashimoto, Yasuaki; Tanaka, Makoto; Sugitani, Masafumi; Kawabata, Kazuhito</div><div class="citationInfo"><span class="NLM_cas:title">Bone (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1351-1356</span>CODEN:
                <span class="NLM_cas:coden">BONEDL</span>;
        ISSN:<span class="NLM_cas:issn">8756-3282</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the present study, we examd. the in vitro and in vivo pharmacol. effects of ONO-5334, a novel inhibitor of cathepsin K, on bone metab.  In vitro expts. indicated that ONO-5334 is a potent inhibitor of cathepsin K with Ki value of 0.1 nM.  Although this compd. inhibited other cysteine proteases, such as cathepsin S, L and B, its inhibitory activity for these enzymes was 8 to 320 fold lower than that for cathepsin K.  ONO-5334 also inhibited human osteoclasts bone resorption in vitro at a concn. more than 100 fold lower than that of alendronate, a bisphosphonate.  While alendronate disrupted actin ring and induced pyknotic nuclei in osteoclasts, ONO-5334 did not have such effects, suggesting that this compd. does not affect osteoclasts viability.  In in vivo expts., oral administration of ONO-5334 dose-dependently reduced plasma calcium level increased by parathyroid hormone related peptide in thyroparathyroidectomized rats.  Furthermore, in vivo expt. using normal monkeys demonstrated that ONO-5334 decreases serum and urine C-telopeptide of type I collagen level, a bone resorption marker, soon after oral dosing.  These levels were consistently decreased below pre-dose levels by repeated oral dosing with ONO-5334 for 7 days.  ONO-5334 on the other hand did not affect bone formation markers, serum osteocalcin and bone specific alk. phosphatase.  These findings indicate that ONO-5334 is a specific inhibitor for cathepsin K and thus may be a novel therapeutic agent for metabolic bone diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQiGxQYGkKKbVg90H21EOLACvtfcHk0lglMlXObfccLw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2iur3N&md5=70a3433e811da8ab0aacabb9ebf8eb40</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2011.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2011.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DOchi%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DH.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DNishikawa%26aufirst%3DS.%26aulast%3DKayasuga%26aufirst%3DR.%26aulast%3DKawada%26aufirst%3DN.%26aulast%3DKunishige%26aufirst%3DA.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DSugitani%26aufirst%3DM.%26aulast%3DKawabata%26aufirst%3DK.%26atitle%3DEffects%2520of%2520ONO-5334%252C%2520a%2520novel%2520orally-active%2520inhibitor%2520of%2520cathepsin%2520K%252C%2520on%2520bone%2520metabolism%26jtitle%3DBone%26date%3D2011%26volume%3D49%26issue%3D6%26spage%3D1351%26epage%3D1356%26doi%3D10.1016%2Fj.bone.2011.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, W. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornsby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spraggon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Identification of selective, nonpeptidic nitrile inhibitors of cathepsin S using the substrate activity screening method</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6298</span>â <span class="NLM_lpage">6307</span>, <span class="refDoi">Â DOI: 10.1021/jm060701s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060701s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD28Xptl2hsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6298-6307&issue=21&author=A.+W.+Pattersonauthor=W.+J.+L.+Woodauthor=M.+Hornsbyauthor=S.+Lesleyauthor=G.+Spraggonauthor=J.+A.+Ellman&title=Identification+of+selective%2C+nonpeptidic+nitrile+inhibitors+of+cathepsin+S+using+the+substrate+activity+screening+method&doi=10.1021%2Fjm060701s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Selective, Nonpeptidic Nitrile Inhibitors of Cathepsin S Using the Substrate Activity Screening Method</span></div><div class="casAuthors">Patterson, Andrew W.; Wood, Warren J. L.; Hornsby, Michael; Lesley, Scott; Spraggon, Glen; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6298-6307</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The substrate activity screening method, a substrate-based fragment identification and optimization method for the development of enzyme inhibitors, was previously applied to cathepsin S to obtain low nanomolar 1,4-disubstituted-1,2,3-triazole-based aldehyde inhibitors (Wood, W. J. L.; Patterson, A. W.; Tsuruoka, H.; Jain, R. K.; Ellman, J. A. J. Am. Chem. Soc. 2005, 127, 15521-15527).  Replacement of the metabolically labile aldehyde pharmacophore with the nitrile pharmacophore provided inhibitors with moderate potency for cathepsin S.  The inhibitors showed good selectivity over cathepsins B and L but no selectivity over cathepsin K.  X-ray structures of two crystal forms (1.5 and 1.9 Ã) of a complex between cathepsin S and a triazole inhibitor incorporating a chloromethyl ketone pharmacophore guided the design of triazole substrates with increased cleavage efficiency and selectivity for cathepsin S over cathepsins B, L, and K.  Conversion of select substrates to nitrile inhibitors yielded a low mol. wt. (414 Da) and potent (15 nM) cathepsin S inhibitor that showed >1000-fold selectivity over cathepsins B, L, and K.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq64WREyCNFsbVg90H21EOLACvtfcHk0lglMlXObfccLw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xptl2hsLg%253D&md5=30ea16a66d37dac8fe5666c76e2307aa</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Fjm060701s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060701s%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DA.%2BW.%26aulast%3DWood%26aufirst%3DW.%2BJ.%2BL.%26aulast%3DHornsby%26aufirst%3DM.%26aulast%3DLesley%26aufirst%3DS.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DIdentification%2520of%2520selective%252C%2520nonpeptidic%2520nitrile%2520inhibitors%2520of%2520cathepsin%2520S%2520using%2520the%2520substrate%2520activity%2520screening%2520method%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D21%26spage%3D6298%26epage%3D6307%26doi%3D10.1021%2Fjm060701s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdoes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheeren, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiskopf, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachmann, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">A nonpeptidic cathepsin S activity-based probe for noninvasive optical imaging of tumor-associated macrophages</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">619</span>â <span class="NLM_lpage">628</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2012.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2012.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22633413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslSit7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=619-628&issue=5&author=M.+Verdoesauthor=L.+E.+Edgingtonauthor=F.+A.+Scheerenauthor=M.+Leyvaauthor=G.+Blumauthor=K.+Weiskopfauthor=M.+H.+Bachmannauthor=J.+A.+Ellmanauthor=M.+Bogyo&title=A+nonpeptidic+cathepsin+S+activity-based+probe+for+noninvasive+optical+imaging+of+tumor-associated+macrophages&doi=10.1016%2Fj.chembiol.2012.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">A Nonpeptidic Cathepsin S Activity-Based Probe for Noninvasive Optical Imaging of Tumor-Associated Macrophages</span></div><div class="casAuthors">Verdoes, Martijn; Edgington, Laura E.; Scheeren, Ferenc A.; Leyva, Melissa; Blum, Galia; Weiskopf, Kipp; Bachmann, Michael H.; Ellman, Jonathan A.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">619-628</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Macrophage infiltration into tumors has been correlated with poor clin. outcome in multiple cancer types.  Therefore, tools to image tumor-assocd. macrophages could be valuable for diagnosis and prognosis of cancer.  Herein, we describe the synthesis and characterization of a cathepsin S-directed, quenched activity-based probe (qABP), BMV083.  This probe makes use of an optimized nonpeptidic scaffold leading to enhanced in vivo properties relative to previously reported peptide-based probes.  In a syngeneic breast cancer model, BMV083 provides high tumor-specific fluorescence that can be visualized using noninvasive optical imaging methods.  Furthermore, anal. of probe-labeled cells demonstrates that the probe primarily targets macrophages with an M2 phenotype.  Thus, BMV083 is a potential valuable in vivo reporter for tumor-assocd. macrophages that could greatly facilitate the future studies of macrophage function in the process of tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRX4BmiwUeDLVg90H21EOLACvtfcHk0ljOOtPK38CpWw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslSit7g%253D&md5=679c9c1ce4a25ff05492ca4091e4dd95</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DEdgington%26aufirst%3DL.%2BE.%26aulast%3DScheeren%26aufirst%3DF.%2BA.%26aulast%3DLeyva%26aufirst%3DM.%26aulast%3DBlum%26aufirst%3DG.%26aulast%3DWeiskopf%26aufirst%3DK.%26aulast%3DBachmann%26aufirst%3DM.%2BH.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DA%2520nonpeptidic%2520cathepsin%2520S%2520activity-based%2520probe%2520for%2520noninvasive%2520optical%2520imaging%2520of%2520tumor-associated%2520macrophages%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26issue%3D5%26spage%3D619%26epage%3D628%26doi%3D10.1016%2Fj.chembiol.2012.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anselm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuehne, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruener, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gsell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stihle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haap, W.</span></span> <span> </span><span class="NLM_article-title">Identification of potent and selective cathepsin S inhibitors containing different central cyclic scaffolds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">9789</span>â <span class="NLM_lpage">9801</span>, <span class="refDoi">Â DOI: 10.1021/jm401528k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401528k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslOms7zJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9789-9801&issue=23&author=H.+Hilpertauthor=H.+Mauserauthor=R.+Hummauthor=L.+Anselmauthor=H.+Kuehneauthor=G.+Hartmannauthor=S.+Gruenerauthor=D.+W.+Bannerauthor=J.+Benzauthor=B.+Gsellauthor=A.+Kuglstatterauthor=M.+Stihleauthor=R.+Thomaauthor=R.+A.+Sanchezauthor=H.+Idingauthor=B.+Wirzauthor=W.+Haap&title=Identification+of+potent+and+selective+cathepsin+S+inhibitors+containing+different+central+cyclic+scaffolds&doi=10.1021%2Fjm401528k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent and Selective Cathepsin S Inhibitors Containing Different Central Cyclic Scaffolds</span></div><div class="casAuthors">Hilpert, Hans; Mauser, Harald; Humm, Roland; Anselm, Lilli; Kuehne, Holger; Hartmann, Guido; Gruener, Sabine; Banner, David W.; Benz, Joerg; Gsell, Bernard; Kuglstatter, Andreas; Stihle, Martine; Thoma, Ralf; Sanchez, Ruben Alvarez; Iding, Hans; Wirz, Beat; Haap, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9789-9801</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Starting from the weakly active dual CatS/K inhibitor 5, structure-based design supported by X-ray anal. led to the discovery of the potent and selective (>50 000-fold vs CatK) cyclopentane deriv. 22 by exploiting specific ligand-receptor interactions in the S2 pocket of CatS.  Changing the central cyclopentane scaffold to the analogous pyrrolidine deriv. 57 decreased the enzyme as well as the cell-based activity significantly by 24- and 69-fold, resp.  The most promising scaffold identified was the readily accessible proline deriv. (e.g., 79).  This compd., with an appealing ligand efficiency (LE) of 0.47, included addnl. structural modifications binding in the S1 and S3 pockets of CatS, leading to favorable in vitro and in vivo properties.  Compd. 79 reduced IL-2 prodn. in a transgenic DO10.11 mouse model of antigen presentation in a dose-dependent manner with an ED50 of 5 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFIPE94S2IcrVg90H21EOLACvtfcHk0ljOOtPK38CpWw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslOms7zJ&md5=06853f0edbef071d14cafb2ca6114c95</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fjm401528k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401528k%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DAnselm%26aufirst%3DL.%26aulast%3DKuehne%26aufirst%3DH.%26aulast%3DHartmann%26aufirst%3DG.%26aulast%3DGruener%26aufirst%3DS.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DSanchez%26aufirst%3DR.%2BA.%26aulast%3DIding%26aufirst%3DH.%26aulast%3DWirz%26aufirst%3DB.%26aulast%3DHaap%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520potent%2520and%2520selective%2520cathepsin%2520S%2520inhibitors%2520containing%2520different%2520central%2520cyclic%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D23%26spage%3D9789%26epage%3D9801%26doi%3D10.1021%2Fjm401528k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Theron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchester, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecabert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perret, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, B.</span></span> <span> </span><span class="NLM_article-title">Pharmacodynamic monitoring of RO5459072, a small molecule inhibitor of cathepsin S</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">806</span>, <span class="refDoi">Â DOI: 10.3389/fimmu.2017.00806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.3389%2Ffimmu.2017.00806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=28769925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWnt7rI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=806&author=M.+Theronauthor=D.+Bentleyauthor=S.+Nagelauthor=M.+Manchesterauthor=M.+Gergauthor=T.+Schindlerauthor=A.+Silvaauthor=B.+Ecabertauthor=P.+Teixeiraauthor=C.+Perretauthor=B.+Reis&title=Pharmacodynamic+monitoring+of+RO5459072%2C+a+small+molecule+inhibitor+of+cathepsin+S&doi=10.3389%2Ffimmu.2017.00806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic monitoring of RO5459072, a small molecule inhibitor of cathepsin s</span></div><div class="casAuthors">Theron, Michel; Bentley, Darren; Nagel, Sandra; Manchester, Marianne; Gerg, Michael; Schindler, Thomas; Silva, Ana; Ecabert, Barbara; Teixeira, Priscila; Perret, Camille; Reis, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">806/1-806/14</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Major histocompatibility complex class II (MHCII)-restricted antigen priming of CD4+ T cells is both involved in adaptive immune responses and the pathogenesis of auto-immune diseases.  Degrdn. of invariant chain Ii, a protein that prevents premature peptide loading, is a prerequisite for nascent MHCII-peptide complex formation.  A key proteolytic step in this process is mediated by cathepsin S.  Inhibition of this cysteine protease is known to result in the intracellular accumulation of Lip10 in B cells.  Here, we describe the development and application of a neoepitope-based flow cytometry assay measuring accumulation of Lip10.  This novel method enabled the investigation of cathepsin S-dependent MHCII maturation in professional antigen-presenting cell (APC) subsets.  Inhibition of cathepsin S by a specific inhibitor, RO5459072, in human PBMC ex vivo resulted in accumulation of Lip10 in B cells and myeloid dendritic cells, but not in plasmacytoid dendritic cells and only to a minor degree in monocytes.  We qualified Lip10 as a pharmacodynamic biomarker by showing the cathepsin S inhibitor-dependent accumulation of Lip10 in vivo in cynomolgus monkeys treated with RO5459072.  Finally, dosing of RO5459072 in a first-in-human clin. study exhibited a dose-dependent increase in Lip10, confirming target engagement and demonstrating desired pharmacol. inhibition in vivo.  The degree of cathepsin S antagonist-induced max. Lip10 accumulation in APCs varied significantly between individuals both in vitro and in vivo.  This finding has not been reported previously using alternative, less sensitive methods and demands further investigation as to the potential of this biomarker to predict response to treatment.  These results will help guide subsequent clin. studies investigating the pharmacokinetic and pharmacodynamic relationship of cathepsin S inhibitor RO5459072 after multiple dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruRhRnsAbqfbVg90H21EOLACvtfcHk0lis1_X-0wDGRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWnt7rI&md5=c3bbb276fa78b90d2d3957bc5f935b63</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.00806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.00806%26sid%3Dliteratum%253Aachs%26aulast%3DTheron%26aufirst%3DM.%26aulast%3DBentley%26aufirst%3DD.%26aulast%3DNagel%26aufirst%3DS.%26aulast%3DManchester%26aufirst%3DM.%26aulast%3DGerg%26aufirst%3DM.%26aulast%3DSchindler%26aufirst%3DT.%26aulast%3DSilva%26aufirst%3DA.%26aulast%3DEcabert%26aufirst%3DB.%26aulast%3DTeixeira%26aufirst%3DP.%26aulast%3DPerret%26aufirst%3DC.%26aulast%3DReis%26aufirst%3DB.%26atitle%3DPharmacodynamic%2520monitoring%2520of%2520RO5459072%252C%2520a%2520small%2520molecule%2520inhibitor%2520of%2520cathepsin%2520S%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26spage%3D806%26doi%3D10.3389%2Ffimmu.2017.00806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paulick, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Development of activity-based probes for cathepsin X</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">563</span>â <span class="NLM_lpage">572</span>, <span class="refDoi">Â DOI: 10.1021/cb100392r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100392r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVyks7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=563-572&issue=6&author=M.+G.+Paulickauthor=M.+Bogyo&title=Development+of+activity-based+probes+for+cathepsin+X&doi=10.1021%2Fcb100392r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Activity-Based Probes for Cathepsin X</span></div><div class="casAuthors">Paulick, Margot G.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">563-572</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cathepsin X is a lysosomal cysteine protease that functions as a carboxypeptidase with broad substrate specificity.  Cathepsin X was discovered only recently, and its physiol. roles are still not well understood.  A no. of studies suggest that cathepsin X may be involved in a variety of biol. processes, including cancer, aging and degenerative conditions of the brain, inflammation, and cellular communication.  Here we present the synthesis and characterization of several activity-based probes (ABPs) that target active cathepsin X.  These ABPs were used to label cathepsin X in complex lysates, whole cells, and in vivo.  Furthermore, we have developed a method for selectively labeling and visualizing active cathepsin X in vitro and in vivo.  Overall, the probes developed in this study are valuable tools for the study of cathepsin X function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPdP_r1uUXbbVg90H21EOLACvtfcHk0lis1_X-0wDGRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVyks7c%253D&md5=b75f86b834a7967dac6daa6bec510b1e</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fcb100392r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100392r%26sid%3Dliteratum%253Aachs%26aulast%3DPaulick%26aufirst%3DM.%2BG.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520activity-based%2520probes%2520for%2520cathepsin%2520X%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26issue%3D6%26spage%3D563%26epage%3D572%26doi%3D10.1021%2Fcb100392r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mountford, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, E. S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aurelio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campden, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LindstrÃ¶m, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloan, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnett, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington-Mitchell, L. E.</span></span> <span> </span><span class="NLM_article-title">Application of a sulfoxonium ylide electrophile to generate cathepsin X-selective activity-based probes</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">718</span>â <span class="NLM_lpage">727</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.9b00961</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.9b00961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1ektbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=718-727&issue=3&author=S.+J.+Mountfordauthor=B.+M.+Andersonauthor=B.+Xuauthor=E.+S.+V.+Tayauthor=M.+Szaboauthor=M.-L.+Hoangauthor=J.+Diaoauthor=L.+Aurelioauthor=R.+I.+Campdenauthor=E.+Lindstr%C3%B6mauthor=E.+K.+Sloanauthor=R.+M.+Yatesauthor=N.+W.+Bunnettauthor=P.+E.+Thompsonauthor=L.+E.+Edgington-Mitchell&title=Application+of+a+sulfoxonium+ylide+electrophile+to+generate+cathepsin+X-selective+activity-based+probes&doi=10.1021%2Facschembio.9b00961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a Sulfoxonium Ylide Electrophile to Generate Cathepsin X-Selective Activity-Based Probes</span></div><div class="casAuthors">Mountford, Simon J.; Anderson, Bethany M.; Xu, Bangyan; Tay, Elean S. V.; Szabo, Monika; Hoang, My-Linh; Diao, Jiayin; Aurelio, Luigi; Campden, Rhiannon I.; Lindstrom, Erik; Sloan, Erica K.; Yates, Robin M.; Bunnett, Nigel W.; Thompson, Philip E.; Edgington-Mitchell, Laura E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">718-727</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cathepsin X/Z/P is cysteine cathepsin with unique carboxypeptidase activity.  Its expression is assocd. with cancer and neurodegenerative diseases, although its roles during normal physiol. are still poorly understood.  Advances in our understanding of its function have been hindered by a lack of available tools that can specifically measure the proteolytic activity of cathepsin X.  We present a series of activity-based probes that incorporate a sulfoxonium ylide warhead, which exhibit improved specificity for cathepsin X compared to previously reported probes.  We apply these probes to detect cathepsin X activity in cell and tissue lysates, in live cells and in vivo, and to localize active cathepsin X in mouse tissues by microscopy.  Finally, we utilize an improved method to generate chloromethylketones, necessary intermediates for synthesis of acyloxymethylketones probes, by way of sulfoxonium ylide intermediates.  In conclusion, the probes presented in this study will be valuable for investigating cathepsin X pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOuvatbOdfZbVg90H21EOLACvtfcHk0lis1_X-0wDGRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1ektbs%253D&md5=02881b733002371b83b42011237e0d75</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Facschembio.9b00961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.9b00961%26sid%3Dliteratum%253Aachs%26aulast%3DMountford%26aufirst%3DS.%2BJ.%26aulast%3DAnderson%26aufirst%3DB.%2BM.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DTay%26aufirst%3DE.%2BS.%2BV.%26aulast%3DSzabo%26aufirst%3DM.%26aulast%3DHoang%26aufirst%3DM.-L.%26aulast%3DDiao%26aufirst%3DJ.%26aulast%3DAurelio%26aufirst%3DL.%26aulast%3DCampden%26aufirst%3DR.%2BI.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DE.%26aulast%3DSloan%26aufirst%3DE.%2BK.%26aulast%3DYates%26aufirst%3DR.%2BM.%26aulast%3DBunnett%26aufirst%3DN.%2BW.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DEdgington-Mitchell%26aufirst%3DL.%2BE.%26atitle%3DApplication%2520of%2520a%2520sulfoxonium%2520ylide%2520electrophile%2520to%2520generate%2520cathepsin%2520X-selective%2520activity-based%2520probes%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2020%26volume%3D15%26issue%3D3%26spage%3D718%26epage%3D727%26doi%3D10.1021%2Facschembio.9b00961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kembhavi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buttle, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, A. J.</span></span> <span> </span><span class="NLM_article-title">The two cysteine endopeptidases of Legume seeds: Purification and characterization by use of specific fluorometric assays</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>303</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">208</span>â <span class="NLM_lpage">213</span>, <span class="refDoi">Â DOI: 10.1006/abbi.1993.1274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1006%2Fabbi.1993.1274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8512309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3sXltlequ7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=1993&pages=208-213&issue=2&author=A.+A.+Kembhaviauthor=D.+J.+Buttleauthor=C.+G.+Knightauthor=A.+J.+Barrett&title=The+two+cysteine+endopeptidases+of+Legume+seeds%3A+Purification+and+characterization+by+use+of+specific+fluorometric+assays&doi=10.1006%2Fabbi.1993.1274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">The two cysteine endopeptidases of legume seeds: Purification and characterization by use of specific fluorometric assays</span></div><div class="casAuthors">Kembhavi, Asha A.; Buttle, David J.; Knight, C. Graham; Barrett, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">208-13</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">Two endopeptidases are present in the seeds of Vigna aconitifolia (moth bean), and their activities increase during germination.  One enzyme, termed vignain, can be assayed with benzyloxycarbonyl-phenylalanyl-arginyl-7-(4-methyl)coumarylamide as substrate.  The second is legumain (EC 3.4.22.34), which can be assayed with benzyloxycarbonyl-alanyl-alanyl-asparaginyl-7-(4-methyl)-coumarylamide.  The enzymes were purified, and their specificities for substrates and inhibitors were examd.  Vignain has properties expected of a cysteine endopeptidase of the papain family, with the exception of a remarkably low reactivity with iodoacetate.  Legumain is a very atypical cysteine endopeptidase, being insensitive to inhibition by chicken cystatin and E-64 (L-3-carboxy-2,3-trans-epoxypropionyl-leucyl-amido(4-guanidino)butane), and reacting more rapidly with iodoacetamide than with iodoacetate.  The findings are discussed in relation to the literature on the proteolytic enzymes of legume seeds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph11dMK_RYnLVg90H21EOLACvtfcHk0lhF3mpgNQzhKQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltlequ7w%253D&md5=d9141ecb232d95c73980e089e269c014</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1993.1274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1993.1274%26sid%3Dliteratum%253Aachs%26aulast%3DKembhavi%26aufirst%3DA.%2BA.%26aulast%3DButtle%26aufirst%3DD.%2BJ.%26aulast%3DKnight%26aufirst%3DC.%2BG.%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520two%2520cysteine%2520endopeptidases%2520of%2520Legume%2520seeds%253A%2520Purification%2520and%2520characterization%2520by%2520use%2520of%2520specific%2520fluorometric%2520assays%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1993%26volume%3D303%26issue%3D2%26spage%3D208%26epage%3D213%26doi%3D10.1006%2Fabbi.1993.1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dall, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fegg, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briza, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandstetter, H.</span></span> <span> </span><span class="NLM_article-title">Structure and mechanism of an aspartimide-dependent peptide ligase in human legumain</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2917</span>â <span class="NLM_lpage">2921</span>, <span class="refDoi">Â DOI: 10.1002/anie.201409135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fanie.201409135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtFCisbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=2917-2921&issue=10&author=E.+Dallauthor=J.+C.+Feggauthor=P.+Brizaauthor=H.+Brandstetter&title=Structure+and+mechanism+of+an+aspartimide-dependent+peptide+ligase+in+human+legumain&doi=10.1002%2Fanie.201409135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and Mechanism of an Aspartimide-Dependent Peptide Ligase in Human Legumain</span></div><div class="casAuthors">Dall, Elfriede; Fegg, Julia C.; Briza, Peter; Brandstetter, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2917-2921</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Peptide ligases expand the repertoire of genetically encoded protein architectures by synthesizing new peptide bonds, energetically driven by ATP or NTPs.  Here, we report the discovery of a genuine ligase activity in human legumain (AEP) which has important roles in immunity and tumor progression that were believed to be due to its established cysteine protease activity.  Defying dogma, the ligase reaction is independent of the catalytic cysteine but exploits an endogenous energy reservoir that results from the conversion of a conserved aspartate to a metastable aspartimide.  Legumain's dual protease-ligase activities are pH- and thus localization-controlled, with the former activity dominating in the acidic pH range and the latter activity dominating in the neutral pH range.  Their relevance includes reversible on-off switching of cystatin inhibitors and enzyme (in)activation, and may affect the generation of three-dimensional MHC epitopes.  The aspartate-aspartimide (succinimide) pair represents a new paradigm of coupling endergonic reactions in ATP-scarce environments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppzTbLas5UFLVg90H21EOLACvtfcHk0lhF3mpgNQzhKQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtFCisbg%253D&md5=aa92d4376e1d57e343b2f243d7b89ed3</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1002%2Fanie.201409135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201409135%26sid%3Dliteratum%253Aachs%26aulast%3DDall%26aufirst%3DE.%26aulast%3DFegg%26aufirst%3DJ.%2BC.%26aulast%3DBriza%26aufirst%3DP.%26aulast%3DBrandstetter%26aufirst%3DH.%26atitle%3DStructure%2520and%2520mechanism%2520of%2520an%2520aspartimide-dependent%2520peptide%2520ligase%2520in%2520human%2520legumain%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26issue%3D10%26spage%3D2917%26epage%3D2921%26doi%3D10.1002%2Fanie.201409135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington, T.</span></span> <span> </span><span class="NLM_article-title">Overexpression of legumain in tumors Is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2957</span>â <span class="NLM_lpage">2964</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=12782603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1aitL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=2957-2964&issue=11&author=C.+Liuauthor=C.+Sunauthor=H.+Huangauthor=K.+Jandaauthor=T.+Edgington&title=Overexpression+of+legumain+in+tumors+Is+significant+for+invasion%2Fmetastasis+and+a+candidate+enzymatic+target+for+prodrug+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Legumain in Tumors Is Significant for Invasion/Metastasis and a Candidate Enzymatic Target for Prodrug Therapy</span></div><div class="casAuthors">Liu, Cheng; Sun, Chengzao; Huang, Haining; Janda, Kim; Edgington, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2957-2964</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Expression of legumain, a novel asparaginyl endopeptidase, in tumors was identified from gene expression profiling and tumor tissue array anal.  Legumain was demonstrated in membrane-assocd. vesicles concd. at the invadopodia of tumor cells and on cell surfaces where it colocalized with integrins.  Legumain was demonstrated to activate progelatinase A.  Cells overexpressing legumain possessed increased migratory and invasive activity in vitro and adopted an invasive and metastatic phenotype in vivo, inferring significance of legumain in tumor invasion and metastasis.  A prodrug strategy incorporating a legumain-cleavable peptide substrate onto doxorubicin was developed.  The prototype compd., designated legubicin, exhibited reduced toxicity and was effectively tumoricidal in vivo in a murine colon carcinoma model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbzPhPINJ7zLVg90H21EOLACvtfcHk0lhF3mpgNQzhKQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1aitL8%253D&md5=6088fb45e7f42d07a4101a5fa040e519</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DJanda%26aufirst%3DK.%26aulast%3DEdgington%26aufirst%3DT.%26atitle%3DOverexpression%2520of%2520legumain%2520in%2520tumors%2520Is%2520significant%2520for%2520invasion%252Fmetastasis%2520and%2520a%2520candidate%2520enzymatic%2520target%2520for%2520prodrug%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26issue%3D11%26spage%3D2957%26epage%3D2964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span> <span> </span><span class="NLM_article-title">Effects of legumain as a potential prognostic factor on gastric cancers</span>. <i>Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">621</span>, <span class="refDoi">Â DOI: 10.1007/s12032-013-0621-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1007%2Fs12032-013-0621-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23740003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BC3snpvFyquw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=621&issue=3&author=N.+Liauthor=Q.+Liuauthor=Q.+Suauthor=C.+Weiauthor=B.+Lanauthor=J.+Wangauthor=G.+Baoauthor=F.+Yanauthor=Y.+Yuauthor=B.+Pengauthor=J.+Qiuauthor=X.+Yanauthor=S.+Zhangauthor=F.+Guo&title=Effects+of+legumain+as+a+potential+prognostic+factor+on+gastric+cancers&doi=10.1007%2Fs12032-013-0621-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of legumain as a potential prognostic factor on gastric cancers</span></div><div class="casAuthors">Li Na; Liu Qiaoling; Su Qi; Wei Chongyang; Lan Bin; Wang Jianyong; Bao Guoqing; Yan Fei; Yu Ying; Peng Baowei; Qiu Ju; Yan Xiangming; Zhang Sheng; Guo Fang</div><div class="citationInfo"><span class="NLM_cas:title">Medical oncology (Northwood, London, England)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">621</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although legumain has been found to be a prognostic factor in both breast cancer and colorectal cancer, its effects on gastric cancer are unknown.  In this study, we investigated effects of legumain on gastric cancer and the correlation between legumain expression and prognosis of gastric cancer patients.  SGC7901 cells were transduced with legumain cDNA (SGC7901-hLeg) for overexpression of legumain or with legumain shRNA to knock down legumain.  In vitro tumor migration was examined by wound healing assay.  Furthermore, a tumorigenicity and metastasis mouse model was used to examine legumain function in vivo; asparaginyl endopeptidase inhibitor (AEPI, an inhibitor of legumain) was injected to the mice (i.p.) to evaluate its therapeutic effect.  Tissue microarray analysis from 112 gastric cancer patients was performed to evaluate the association between legumain expression and the cumulative survival time.  Legumain was highly expressed in gastric cancer patients and some gastric cancer cell lines.  Legumain promoted gastric cell migration in vitro and promoted gastric tumor growth and metastasis in vivo, and these effects were reversed by knockdown of legumain with shRNA or treated with AEPI.  In gastric cancer clinical samples, legumain expression in tumor was significantly higher than in non-tumor and was negatively associated with the cumulative survival rate.  In conclusion, legumain was highly expressed in gastric adenocarcinoma; legumain promoted gastric cancer tumorigenesis and metastasis in vitro and in vivo.  Legumain expression in tumor was a poor prognostic factor for gastric cancer patients, and legumain could be a potential target molecule for gastric cancer therapy in clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQt-Yoxz0IgQJotVjB3IRIyfW6udTcc2ebT0eAvSR0Ambntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snpvFyquw%253D%253D&md5=d0b0d0655c6b1e4789d82bbfe5bfd0d3</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1007%2Fs12032-013-0621-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12032-013-0621-9%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSu%26aufirst%3DQ.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DG.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DF.%26atitle%3DEffects%2520of%2520legumain%2520as%2520a%2520potential%2520prognostic%2520factor%2520on%2520gastric%2520cancers%26jtitle%3DMed.%2520Oncol.%26date%3D2013%26volume%3D30%26issue%3D3%26spage%3D621%26doi%3D10.1007%2Fs12032-013-0621-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span> <span> </span><span class="NLM_article-title">Selective ablation of tumor associated macrophages suppresses metastasis and angiogenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1217</span>â <span class="NLM_lpage">1225</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=1217-1225&issue=9&author=F.+Guoauthor=Y.+Liuauthor=W.+Wuauthor=P.+Kuoauthor=Q.+Fangauthor=C.+Liu&title=Selective+ablation+of+tumor+associated+macrophages+suppresses+metastasis+and+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DKuo%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26atitle%3DSelective%2520ablation%2520of%2520tumor%2520associated%2520macrophages%2520suppresses%2520metastasis%2520and%2520angiogenesis%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D104%26issue%3D9%26spage%3D1217%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witte, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">649</span>â <span class="NLM_lpage">653</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2006.10.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2006.10.100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17189693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFagsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=649-653&issue=3&author=K.+B.+Sextonauthor=M.+D.+Witteauthor=G.+Blumauthor=M.+Bogyo&title=Design+of+cell-permeable%2C+fluorescent+activity-based+probes+for+the+lysosomal+cysteine+protease+asparaginyl+endopeptidase+%28AEP%29%2Flegumain&doi=10.1016%2Fj.bmcl.2006.10.100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain</span></div><div class="casAuthors">Sexton, Kelly B.; Witte, Martin D.; Blum, Galia; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">649-653</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Asparaginyl endopeptidase (AEP), also known as legumain, is a cysteine protease that has been ascribed roles in antigen presentation yet its exact role in human biol. remains poorly understood.  We report here, the use of a positional scanning combinatorial library of peptide AOMKs contg. a P1 aspartic acid to probe the P2, P3, and P4 subsite specificity of endogenous legumain.  Using inhibitor specificity profiles of cathepsin B and legumain, we designed fluorescent ABPs that are highly selective, cell-permeable reagents for monitoring legumain activity in complex proteomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYK4qY5O_637Vg90H21EOLACvtfcHk0lj-2VKB65V6SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFagsQ%253D%253D&md5=32c41dc7c017533cf357d2bce61db15f</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.10.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.10.100%26sid%3Dliteratum%253Aachs%26aulast%3DSexton%26aufirst%3DK.%2BB.%26aulast%3DWitte%26aufirst%3DM.%2BD.%26aulast%3DBlum%26aufirst%3DG.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DDesign%2520of%2520cell-permeable%252C%2520fluorescent%2520activity-based%2520probes%2520for%2520the%2520lysosomal%2520cysteine%2520protease%2520asparaginyl%2520endopeptidase%2520%2528AEP%2529%252Flegumain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D3%26spage%3D649%26epage%3D653%26doi%3D10.1016%2Fj.bmcl.2006.10.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eddie, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burden, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullan, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span> <span> </span><span class="NLM_article-title">Identification and SAR exploration of a novel series of legumain inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1546</span>â <span class="NLM_lpage">1548</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2019.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2019.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31005445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvFCrsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=1546-1548&issue=12&author=S.+L.+Eddieauthor=A.+Gregsonauthor=E.+Grahamauthor=S.+Burtonauthor=T.+Harrisonauthor=R.+Burdenauthor=C.+J.+Scottauthor=P.+B.+Mullanauthor=R.+Williams&title=Identification+and+SAR+exploration+of+a+novel+series+of+legumain+inhibitors&doi=10.1016%2Fj.bmcl.2019.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and SAR exploration of a novel series of Legumain inhibitors</span></div><div class="casAuthors">Eddie, Sharon L.; Gregson, Aaron; Graham, Emma; Burton, Stephanie; Harrison, Timothy; Burden, Roberta; Scott, Christopher J.; Mullan, Paul B.; Williams, Rich</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1546-1548</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This letter describes the development of a series of potent and selective small mol. Legumain inhibitors suitable as chem. probes for in vitro expts.  Our previous research had identified a dipeptide inhibitor utilizing a semi-reversible cyano warhead that generated 2, a cell active inhibitor.  This work explores an alternative P2-P3 linker and further SAR exploration of the P3 group which led to the identification of 16i, a highly potent inhibitor with excellent physiochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1H0LQIUMBrLVg90H21EOLACvtfcHk0lj-2VKB65V6SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvFCrsbw%253D&md5=77f8b08588ad2ae530a66821c6148981</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DEddie%26aufirst%3DS.%2BL.%26aulast%3DGregson%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DE.%26aulast%3DBurton%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DBurden%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DC.%2BJ.%26aulast%3DMullan%26aufirst%3DP.%2BB.%26aulast%3DWilliams%26aufirst%3DR.%26atitle%3DIdentification%2520and%2520SAR%2520exploration%2520of%2520a%2520novel%2520series%2520of%2520legumain%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26issue%3D12%26spage%3D1546%26epage%3D1548%26doi%3D10.1016%2Fj.bmcl.2019.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouazzaoui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaddale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DâCosta, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Templeman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâRourke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span> <span> </span><span class="NLM_article-title">P3 SAR exploration of biphenyl carbamate based legumain inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2521</span>â <span class="NLM_lpage">2524</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2014.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2014.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24775305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnt1ehur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2521-2524&issue=11&author=C.+Higginsauthor=S.+Bouazzaouiauthor=K.+Gaddaleauthor=Z.+D%E2%80%99Costaauthor=A.+Templemanauthor=M.+O%E2%80%99Rourkeauthor=A.+Youngauthor=C.+Scottauthor=T.+Harrisonauthor=P.+Mullanauthor=R.+Williams&title=P3+SAR+exploration+of+biphenyl+carbamate+based+legumain+inhibitors&doi=10.1016%2Fj.bmcl.2014.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">P3 SAR exploration of biphenyl carbamate based Legumain inhibitors</span></div><div class="casAuthors">Higgins, Catherine; Bouazzaoui, Samira; Gaddale, Kishore; D'Costa, Zenobia; Templeman, Amy; O'Rourke, Martin; Young, Andrew; Scott, Christopher; Harrison, Tim; Mullan, Paul; Williams, Rich</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2521-2524</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This Letter describes the further development and SAR exploration of a novel series of Legumain inhibitors.  Based upon a previously identified Legumain inhibitor from our group, we explored the SAR of the carbamate Ph ring system to probe the P3 pocket of the enzyme.  This led to the identification of a sub-nanomolar inhibitor of Legumain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnOgjnq6rM27Vg90H21EOLACvtfcHk0lifZ3latOU50g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnt1ehur0%253D&md5=5a316d1aab150c37b7388f16a92b8129</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DC.%26aulast%3DBouazzaoui%26aufirst%3DS.%26aulast%3DGaddale%26aufirst%3DK.%26aulast%3DD%25E2%2580%2599Costa%26aufirst%3DZ.%26aulast%3DTempleman%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DM.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DScott%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DMullan%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DR.%26atitle%3DP3%2520SAR%2520exploration%2520of%2520biphenyl%2520carbamate%2520based%2520legumain%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26issue%3D11%26spage%3D2521%26epage%3D2524%26doi%3D10.1016%2Fj.bmcl.2014.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Development of near-Infrared fluorophore (NIRF)-labeled activity-based probes for in vivo imaging of legumain</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">233</span>â <span class="NLM_lpage">243</span>, <span class="refDoi">Â DOI: 10.1021/cb900232a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb900232a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1yqtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=233-243&issue=2&author=J.+Leeauthor=M.+Bogyo&title=Development+of+near-Infrared+fluorophore+%28NIRF%29-labeled+activity-based+probes+for+in+vivo+imaging+of+legumain&doi=10.1021%2Fcb900232a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Near-Infrared Fluorophore (NIRF)-Labeled Activity-Based Probes for in Vivo Imaging of Legumain</span></div><div class="casAuthors">Lee, Jiyoun; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-243</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Asparaginyl endopeptidase, or legumain, is a lysosomal cysteine protease that was originally identified in plants and later found to be involved in antigen presentation in higher eukaryotes.  Legumain is also up-regulated in a no. of human cancers, and recent studies suggest that it may play important functional roles in the process of tumorigenesis.  However, detailed functional studies in relevant animal models of human disease have been hindered by the lack of suitably selective small mol. inhibitors and imaging reagents.  Here we present the design, optimization, and in vivo application of fluorescently labeled activity-based probes (ABPs) for legumain.  We demonstrate that optimized aza-peptidyl Asn epoxides are highly selective and potent inhibitors that can be readily converted into near-IR fluorophore-labeled ABPs for whole body, noninvasive imaging applications.  We show that these probes specifically label legumain in various normal tissues as well as in solid tumors when applied in vivo.  Interestingly, addn. of cell-penetrating peptides to the probes enhanced cellular uptake but resulted in increased cross-reactivity toward other lysosomal proteases as the result of their accumulation in lysosomes.  Overall, we find that aza-peptidyl Asn ABPs are valuable new tools for the future study of legumain function in more complex models of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxCJLNeNdH-bVg90H21EOLACvtfcHk0lifZ3latOU50g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1yqtw%253D%253D&md5=56417482a3ecdd58e0050128d2f2e830</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fcb900232a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb900232a%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520near-Infrared%2520fluorophore%2520%2528NIRF%2529-labeled%2520activity-based%2520probes%2520for%2520in%2520vivo%2520imaging%2520of%2520legumain%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26issue%3D2%26spage%3D233%26epage%3D243%26doi%3D10.1021%2Fcb900232a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edgington, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdoes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withana, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachmann, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Functional imaging of legumain in cancer using a new quenched activity-based probe</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">174</span>â <span class="NLM_lpage">182</span>, <span class="refDoi">Â DOI: 10.1021/ja307083b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja307083b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSqsbvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=174-182&issue=1&author=L.+E.+Edgingtonauthor=M.+Verdoesauthor=A.+Ortegaauthor=N.+P.+Withanaauthor=J.+Leeauthor=S.+Syedauthor=M.+H.+Bachmannauthor=G.+Blumauthor=M.+Bogyo&title=Functional+imaging+of+legumain+in+cancer+using+a+new+quenched+activity-based+probe&doi=10.1021%2Fja307083b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Functional Imaging of Legumain in Cancer Using a New Quenched Activity-Based Probe</span></div><div class="casAuthors">Edgington, Laura E.; Verdoes, Martijn; Ortega, Alberto; Withana, Nimali P.; Lee, Jiyoun; Syed, Salahuddin; Bachmann, Michael H.; Blum, Galia; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">174-182</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Legumain is a lysosomal cysteine protease whose biol. function remains poorly defined.  Legumain activity is up-regulated in most human cancers and inflammatory diseases most likely as the result of high expression in populations of activated macrophages.  Within the tumor microenvironment, legumain activity is thought to promote tumorigenesis.  To obtain a greater understanding of the role of legumain activity during cancer progression and inflammation, we developed an activity-based probe that becomes fluorescent only upon binding active legumain.  This probe is highly selective for legumain, even in the context of whole cells and tissues, and is also a more effective label of legumain than previously reported probes.  Here we present the synthesis and application of our probe to the anal. of legumain activity in primary macrophages and in two mouse models of cancer.  We find that legumain activity is highly correlated with macrophage activation and furthermore that it is an ideal marker for primary tumor inflammation and early stage metastatic lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmBlI6e_DeMbVg90H21EOLACvtfcHk0lg3530GZ3QtNg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSqsbvP&md5=51830cee1df9b60aef194be32d4ae310</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fja307083b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja307083b%26sid%3Dliteratum%253Aachs%26aulast%3DEdgington%26aufirst%3DL.%2BE.%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DOrtega%26aufirst%3DA.%26aulast%3DWithana%26aufirst%3DN.%2BP.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSyed%26aufirst%3DS.%26aulast%3DBachmann%26aufirst%3DM.%2BH.%26aulast%3DBlum%26aufirst%3DG.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DFunctional%2520imaging%2520of%2520legumain%2520in%2520cancer%2520using%2520a%2520new%2520quenched%2520activity-based%2520probe%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26issue%3D1%26spage%3D174%26epage%3D182%26doi%3D10.1021%2Fja307083b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edgington-Mitchell, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wartmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gocheva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withana, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdoes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aurelio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington-Mitchell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinheckel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furness, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halangk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnett, N. W.</span></span> <span> </span><span class="NLM_article-title">Legumain is activated in macrophages during pancreatitis</span>. <i>Am. J. Physiol. Gastrointest. Liver Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>311</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">G548</span>â <span class="NLM_lpage">G560</span>, <span class="refDoi">Â DOI: 10.1152/ajpgi.00047.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1152%2Fajpgi.00047.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27514475" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2016&pages=G548-G560&issue=3&author=L.+E.+Edgington-Mitchellauthor=T.+Wartmannauthor=A.+K.+Flemingauthor=V.+Gochevaauthor=W.+A.+van+der+Lindenauthor=N.+P.+Withanaauthor=M.+Verdoesauthor=L.+Aurelioauthor=D.+Edgington-Mitchellauthor=T.+Lieuauthor=B.+S.+Parkerauthor=B.+Grahamauthor=T.+Reinheckelauthor=J.+B.+Furnessauthor=J.+A.+Joyceauthor=P.+Storzauthor=W.+Halangkauthor=M.+Bogyoauthor=N.+W.+Bunnett&title=Legumain+is+activated+in+macrophages+during+pancreatitis&doi=10.1152%2Fajpgi.00047.2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1152%2Fajpgi.00047.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpgi.00047.2016%26sid%3Dliteratum%253Aachs%26aulast%3DEdgington-Mitchell%26aufirst%3DL.%2BE.%26aulast%3DWartmann%26aufirst%3DT.%26aulast%3DFleming%26aufirst%3DA.%2BK.%26aulast%3DGocheva%26aufirst%3DV.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DW.%2BA.%26aulast%3DWithana%26aufirst%3DN.%2BP.%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DAurelio%26aufirst%3DL.%26aulast%3DEdgington-Mitchell%26aufirst%3DD.%26aulast%3DLieu%26aufirst%3DT.%26aulast%3DParker%26aufirst%3DB.%2BS.%26aulast%3DGraham%26aufirst%3DB.%26aulast%3DReinheckel%26aufirst%3DT.%26aulast%3DFurness%26aufirst%3DJ.%2BB.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26aulast%3DStorz%26aufirst%3DP.%26aulast%3DHalangk%26aufirst%3DW.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DBunnett%26aufirst%3DN.%2BW.%26atitle%3DLegumain%2520is%2520activated%2520in%2520macrophages%2520during%2520pancreatitis%26jtitle%3DAm.%2520J.%2520Physiol.%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2016%26volume%3D311%26issue%3D3%26spage%3DG548%26epage%3DG560%26doi%3D10.1152%2Fajpgi.00047.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Vargas, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheff, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanner, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janal, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnett, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington-Mitchell, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B. L.</span></span> <span> </span><span class="NLM_article-title">Legumain induces oral cancer pain by biased agonism of protease-activated receptor-2</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">193</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.1211-20.2020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1523%2FJNEUROSCI.1211-20.2020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=33172978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3MXitl2gtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2021&pages=193&issue=1&author=N.+H.+Tuauthor=D.+D.+Jensenauthor=B.+M.+Andersonauthor=E.+Chenauthor=N.+N.+Jimenez-Vargasauthor=N.+N.+Scheffauthor=K.+Inoueauthor=H.+D.+Tranauthor=J.+C.+Dolanauthor=T.+A.+Meekauthor=M.+D.+Hollenbergauthor=C.+Z.+Liuauthor=S.+J.+Vannerauthor=M.+N.+Janalauthor=N.+W.+Bunnettauthor=L.+E.+Edgington-Mitchellauthor=B.+L.+Schmidt&title=Legumain+induces+oral+cancer+pain+by+biased+agonism+of+protease-activated+receptor-2&doi=10.1523%2FJNEUROSCI.1211-20.2020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Legumain induces oral cancer pain by biased agonism of protease-activated receptor-2</span></div><div class="casAuthors">Tu, Nguyen Huu; Jensen, Dane D.; Anderson, Bethany M.; Chen, Elyssa; Jimenez-Vargas, Nestor N.; Scheff, Nicole N.; Inoue, Kenji; Tran, Hung D.; Dolan, John C.; Meek, Tamaryn A.; Hollenberg, Morley D.; Liu, Cheng Z.; Vanner, Stephen J.; Janal, Malvin N.; Bunnett, Nigel W.; Edgington-Mitchell, Laura E.; Schmidt, Brian L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-210</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">1529-2401</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Oral squamous cell carcinoma (OSCC) is one of the most painful cancers, which interferes with orofacial function including talking and eating.  We report that legumain (Lgmn) cleaves protease-activated receptor-2 (PAR2) in the acidic OSCC microenvironment to cause pain.  Lgmn is a cysteine protease of late endosomes and lysosomes that can be secreted; it exhibits maximal activity in acidic environments.  The role of Lgmn in PAR2-dependent cancer pain is unknown.  We studied Lgmn activation in human oral cancers and oral cancer mouse models.  Lgmn was activated in OSCC patient tumors, compared with matched normal oral tissue.  After intraplantar, facial or lingual injection, Lgmn evoked nociception in wild-type (WT) female mice but not in female mice lacking PAR2 in NaV1.8-pos. neurons (Par2Nav1.8), nor in female mice treated with a Lgmn inhibitor, LI-1.  Lgmn caused PAR2-dependent hyperexcitability of trigeminal neurons from WT female mice.  Under acidified conditions, Lgmn cleaved within the extracellular N terminus of PAR2 at Asn30âArg31, proximal to the canonical trypsin activation site.  Lgmn activated PAR2 by biased mechanisms in HEK293 cells to induce Ca2+ mobilization, cAMP formation, and PKA/protein kinase D (PKD) activation, but not Î²-arrestin recruitment or PAR2 endocytosis.  Thus, in the acidified OSCC microenvironment, Lgmn activates PAR2 by biased mechanisms that evoke cancer pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj2ZwzNoOxrrVg90H21EOLACvtfcHk0lg3530GZ3QtNg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXitl2gtrk%253D&md5=9f3786843b4c6603c8da7010b2772388</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1211-20.2020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1211-20.2020%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DN.%2BH.%26aulast%3DJensen%26aufirst%3DD.%2BD.%26aulast%3DAnderson%26aufirst%3DB.%2BM.%26aulast%3DChen%26aufirst%3DE.%26aulast%3DJimenez-Vargas%26aufirst%3DN.%2BN.%26aulast%3DScheff%26aufirst%3DN.%2BN.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DTran%26aufirst%3DH.%2BD.%26aulast%3DDolan%26aufirst%3DJ.%2BC.%26aulast%3DMeek%26aufirst%3DT.%2BA.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DLiu%26aufirst%3DC.%2BZ.%26aulast%3DVanner%26aufirst%3DS.%2BJ.%26aulast%3DJanal%26aufirst%3DM.%2BN.%26aulast%3DBunnett%26aufirst%3DN.%2BW.%26aulast%3DEdgington-Mitchell%26aufirst%3DL.%2BE.%26aulast%3DSchmidt%26aufirst%3DB.%2BL.%26atitle%3DLegumain%2520induces%2520oral%2520cancer%2520pain%2520by%2520biased%2520agonism%2520of%2520protease-activated%2520receptor-2%26jtitle%3DJ.%2520Neurosci.%26date%3D2021%26volume%3D41%26issue%3D1%26spage%3D193%26doi%3D10.1523%2FJNEUROSCI.1211-20.2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rut, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lunde, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihelic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Counter selection substrate library strategy for developing specific protease substrates and probes</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1023</span>â <span class="NLM_lpage">1035</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2016.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2016.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27478158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1KlsbnN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1023-1035&issue=8&author=M.+Porebaauthor=R.+Solbergauthor=W.+Rutauthor=N.+N.+Lundeauthor=P.+Kasperkiewiczauthor=S.+J.+Snipasauthor=M.+Mihelicauthor=D.+Turkauthor=B.+Turkauthor=G.+S.+Salvesenauthor=M.+Drag&title=Counter+selection+substrate+library+strategy+for+developing+specific+protease+substrates+and+probes&doi=10.1016%2Fj.chembiol.2016.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Counter Selection Substrate Library Strategy for Developing Specific Protease Substrates and Probes</span></div><div class="casAuthors">Poreba, Marcin; Solberg, Rigmor; Rut, Wioletta; Lunde, Ngoc Nguyen; Kasperkiewicz, Paulina; Snipas, Scott J.; Mihelic, Marko; Turk, Dusan; Turk, Boris; Salvesen, Guy S.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1023-1035</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Legumain (AEP) is a lysosomal cysteine protease that was first characterized in leguminous seeds and later discovered in higher eukaryotes.  AEP upregulation is linked to a no. of diseases including inflammation, arteriosclerosis, and tumorigenesis.  Thus this protease is an excellent mol. target for the development of new chem. markers.  We deployed a hybrid combinatorial substrate library (HyCoSuL) approach to obtain P1-Asp fluorogenic substrates and biotin-labeled inhibitors that targeted legumain.  Since this approach led to probes that were also recognized by caspases, we introduced a Counter Selection Substrate Library (CoSeSuL) approach that biases the peptidic scaffold against caspases, thus delivering highly selective legumain probes.  The selectivity of these tools was validated using M38L and HEK293 cells.  We also propose that the CoSeSuL methodol. can be considered as a general principle in the design of selective probes for other protease families where selectivity is difficult to achieve by conventional sequence-based profiling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtgQyo_YeLk7Vg90H21EOLACvtfcHk0lgtY2G6TCxa2g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1KlsbnN&md5=96a607ad2ac4bbcb35c3dd106aad0688</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2016.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2016.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DSolberg%26aufirst%3DR.%26aulast%3DRut%26aufirst%3DW.%26aulast%3DLunde%26aufirst%3DN.%2BN.%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DMihelic%26aufirst%3DM.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DCounter%2520selection%2520substrate%2520library%2520strategy%2520for%2520developing%2520specific%2520protease%2520substrates%2520and%2520probes%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2016%26volume%3D23%26issue%3D8%26spage%3D1023%26epage%3D1035%26doi%3D10.1016%2Fj.chembiol.2016.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span> <span> </span><span class="NLM_article-title">Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFÎ±-induced cancer cell migration</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>441</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">979</span>â <span class="NLM_lpage">987</span>, <span class="refDoi">Â DOI: 10.1042/BJ20111358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1042%2FBJ20111358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22029577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFKqtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2012&pages=979-987&issue=3&author=N.+Xiaoauthor=H.+Liauthor=J.+Luoauthor=R.+Wangauthor=H.+Chenauthor=J.+Chenauthor=P.+Wang&title=Ubiquitin-specific+protease+4+%28USP4%29+targets+TRAF2+and+TRAF6+for+deubiquitination+and+inhibits+TNF%CE%B1-induced+cancer+cell+migration&doi=10.1042%2FBJ20111358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFÎ±-induced cancer cell migration</span></div><div class="casAuthors">Xiao, Ning; Li, Hui; Luo, Jian; Wang, Rui; Chen, Haiquan; Chen, Jiquan; Wang, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">441</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">979-986</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">TRAF [TNF (tumor necrosis factor)-receptor-assocd. factor] 2 and 6 are essential adaptor proteins for the NF-ÎºB (nuclear factor ÎºB) signalling pathway, which play important roles in inflammation and immune response.  Polyubiquitination of TRAF2 and TRAF6 is crit. to their activities and functions in TNFÎ±- and IL (interleukin)-1Î²-induced NF-ÎºB activation.  However, the regulation of TRAF2 and TRAF6 by deubiquitination remains incompletely understood.  In the present study, we identified USP (ubiquitin-specific protease) 4 as a novel deubiquitinase targeting TRAF2 and TRAF6 for deubiquitination.  We found that USP4 specifically interacts with TRAF2 and TRAF6, but not TRAF3.  Moreover, USP4 assocs. with TRAF6 both in vitro and in vivo, independent of its deubiquitinase activity.  The USP domain is responsible for USP4 to interact with TRAF6.  Ectopic expression of USP4 inhibits the TRAF2- and TRAF6-stimulated NF-ÎºB reporter gene and neg. regulates the TNFÎ±-induced IÎºBÎ± (inhibitor of NF-ÎºBÎ±) degrdn. and NF-ÎºB activation.  Knockdown of USP4 significantly increased TNFÎ±-induced cytokine expression.  Furthermore, we found that USP4 deubiquitinates both TRAF2 and TRAF6 in vivo and in vitro in a deubiquitinase activity-dependent manner.  Importantly, the results of the present study showed that USP4 is a neg. regulator of TNFÎ±- and IL-1Î²-induced cancer cell migration.  Taken together, the present study provides a novel insight into the regulation of the NF-ÎºB signalling pathway and uncovers a previously unknown function of USP4 in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod29nRxc2ojLVg90H21EOLACvtfcHk0lgtY2G6TCxa2g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFKqtw%253D%253D&md5=3751e6c0ba30213ebd41b246a8657170</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1042%2FBJ20111358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20111358%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26atitle%3DUbiquitin-specific%2520protease%25204%2520%2528USP4%2529%2520targets%2520TRAF2%2520and%2520TRAF6%2520for%2520deubiquitination%2520and%2520inhibits%2520TNF%25CE%25B1-induced%2520cancer%2520cell%2520migration%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D441%26issue%3D3%26spage%3D979%26epage%3D987%26doi%3D10.1042%2FBJ20111358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">USP4 targets TAK1 to downregulate TNFÎ±-induced NF-ÎºB activation</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1547</span>â <span class="NLM_lpage">1560</span>, <span class="refDoi">Â DOI: 10.1038/cdd.2011.11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fcdd.2011.11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21331078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKrtrrL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1547-1560&issue=10&author=Y.+H.+Fanauthor=Y.+Yuauthor=R.+F.+Maoauthor=X.+J.+Tanauthor=G.+F.+Xuauthor=H.+Zhangauthor=X.+B.+Luauthor=S.+B.+Fuauthor=J.+Yang&title=USP4+targets+TAK1+to+downregulate+TNF%CE%B1-induced+NF-%CE%BAB+activation&doi=10.1038%2Fcdd.2011.11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">USP4 targets TAK1 to downregulate TNFÎ±-induced NF-ÎºB activation</span></div><div class="casAuthors">Fan, Y.-H.; Yu, Y.; Mao, R.-F.; Tan, X.-J.; Xu, G.-F.; Zhang, H.; Lu, X.-B.; Fu, S.-B.; Yang, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1547-1560</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lys63-linked polyubiquitination of transforming growth factor-Î²-activated kinase 1 (TAK1) has an important role in tumor necrosis factor-Î± (TNFÎ±)-induced NF-ÎºB activation.  Using a functional genomic approach, we have identified ubiquitin-specific peptidase 4 (USP4) as a deubiquitinase for TAK1.  USP4 deubiquitinates TAK1 in vitro and in vivo.  TNFÎ± induces assocn. of USP4 with TAK1 to deubiquitinate TAK1 and downregulate TAK1-mediated NF-ÎºB activation.  Overexpression of USP4 wild type, but not deuibiquitinase-deficient C311A mutant, inhibits both TNFÎ±- and TAK1/TAB1 co-overexpression-induced TAK1 polyubiquitination and NF-ÎºB activation.  Notably, knockdown of USP4 in HeLa cells enhances TNFÎ±-induced TAK1 polyubiquitination, IÎºB kinase phosphorylation, IÎºBÎ± phosphorylation and ubiquitination, as well as NF-ÎºB-dependent gene expression.  Moreover, USP4 neg. regulates IL-1Î²-, LPS- and TGFÎ²-induced NF-ÎºB activation.  Together, our results demonstrate that USP4 serves as a crit. control to downregulate TNFÎ±-induced NF-ÎºB activation through deubiquitinating TAK1.  Cell Death and Differentiation (2011) 18, 1547-1560; doi:10.1038/cdd.2011.11; published online 18 Feb. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkl3era56kUbVg90H21EOLACvtfcHk0lgtY2G6TCxa2g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKrtrrL&md5=ff1283ad190785705e7b8180a402b57a</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2011.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2011.11%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DY.%2BH.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DMao%26aufirst%3DR.%2BF.%26aulast%3DTan%26aufirst%3DX.%2BJ.%26aulast%3DXu%26aufirst%3DG.%2BF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DX.%2BB.%26aulast%3DFu%26aufirst%3DS.%2BB.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DUSP4%2520targets%2520TAK1%2520to%2520downregulate%2520TNF%25CE%25B1-induced%2520NF-%25CE%25BAB%2520activation%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2011%26volume%3D18%26issue%3D10%26spage%3D1547%26epage%3D1560%26doi%3D10.1038%2Fcdd.2011.11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccioni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span> <span> </span><span class="NLM_article-title">Cutting edge: Ubiquitin-specific protease 4 promotes Th17 cell function under inflammation by deubiquitinating and stabilizing RORÎ³t</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>194</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4094</span>â <span class="NLM_lpage">4097</span>, <span class="refDoi">Â DOI: 10.4049/jimmunol.1401451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4049%2Fjimmunol.1401451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25821221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXms1GnsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2015&pages=4094-4097&issue=9&author=J.+Yangauthor=P.+Xuauthor=L.+Hanauthor=Z.+Guoauthor=X.+Wangauthor=Z.+Chenauthor=J.+Nieauthor=S.+Yinauthor=M.+Piccioniauthor=A.+Tsunauthor=L.+Lvauthor=S.+Geauthor=B.+Li&title=Cutting+edge%3A+Ubiquitin-specific+protease+4+promotes+Th17+cell+function+under+inflammation+by+deubiquitinating+and+stabilizing+ROR%CE%B3t&doi=10.4049%2Fjimmunol.1401451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Cutting Edge: Ubiquitin-Specific Protease 4 Promotes Th17 Cell Function under Inflammation by Deubiquitinating and Stabilizing RORÎ³t</span></div><div class="casAuthors">Yang, Jing; Xu, Peng; Han, Lei; Guo, Zhixiang; Wang, Xiuwen; Chen, Zuojia; Nie, Jia; Yin, Shuying; Piccioni, Miranda; Tsun, Andy; Lv, Ling; Ge, Shenglin; Li, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4094-4097</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">RORÎ³t is a key transcription factor that controls the development and function of inflammatory Th17.  The mechanisms that regulate RORÎ³t stability remain unclear.  We report that Th17 cells highly express the deubiquitinase ubiquitin-specific protease (USP)4, which is essential for maintaining RORÎ³t and Th17 cell function.  Inhibition of the catalytic activity of USP4 with vialinin A, a compd. derived from Chinese traditional medicine, dampened Th17 differentiation.  USP4 interacted and deubiquitinated K48-linked polyubiquitination of RORÎ³t, thereby promoting RORÎ³t function and IL-17A transcription.  Interestingly, TGF-Î² plus IL-6 enhanced USP4-mediated deubiquitination of RORÎ³t.  Moreover, USP4 and IL-17 mRNA, but not RORÎ³t mRNA, were significantly elevated in CD4+ T cells from patients with rheumatic heart disease.  Thus, USP4 could be a novel therapeutic target for the treatment of Th17-modulated autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHC9YrZAXjnbVg90H21EOLACvtfcHk0lhv_rtM5WGWZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXms1GnsLg%253D&md5=cdde10d3a9c4f64366e1057cad9a93a2</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1401451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1401451%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DNie%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DS.%26aulast%3DPiccioni%26aufirst%3DM.%26aulast%3DTsun%26aufirst%3DA.%26aulast%3DLv%26aufirst%3DL.%26aulast%3DGe%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DB.%26atitle%3DCutting%2520edge%253A%2520Ubiquitin-specific%2520protease%25204%2520promotes%2520Th17%2520cell%2520function%2520under%2520inflammation%2520by%2520deubiquitinating%2520and%2520stabilizing%2520ROR%25CE%25B3t%26jtitle%3DJ.%2520Immunol.%26date%3D2015%26volume%3D194%26issue%3D9%26spage%3D4094%26epage%3D4097%26doi%3D10.4049%2Fjimmunol.1401451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onose, J.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koshino, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yajima, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yajima, S.</span></span> <span> </span><span class="NLM_article-title">Vialinin A is a ubiquitin-specific peptidase inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4328</span>â <span class="NLM_lpage">4331</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2013.05.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2013.05.093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23791076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslGgurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4328-4331&issue=15&author=K.+Okadaauthor=Y.+Q.+Yeauthor=K.+Taniguchiauthor=A.+Yoshidaauthor=T.+Akiyamaauthor=Y.+Yoshiokaauthor=J.-i.+Onoseauthor=H.+Koshinoauthor=S.+Takahashiauthor=A.+Yajimaauthor=N.+Abeauthor=S.+Yajima&title=Vialinin+A+is+a+ubiquitin-specific+peptidase+inhibitor&doi=10.1016%2Fj.bmcl.2013.05.093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Vialinin A is a ubiquitin-specific peptidase inhibitor</span></div><div class="casAuthors">Okada, Kiyoshi; Ye, Yue Qi; Taniguchi, Kayoko; Yoshida, Ayaka; Akiyama, Tomonori; Yoshioka, Yasukiyo; Onose, Jun-ichi; Koshino, Hiroyuki; Takahashi, Shunya; Yajima, Arata; Abe, Naoki; Yajima, Shunsuke</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4328-4331</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Vialinin A, a small compd. isolated from the Chinese mushroom Thelephora vialis, exhibits more effective anti-inflammatory activity than the widely used immunosuppressive drug tacrolimus (FK506).  Here, we show that ubiquitin-specific peptidase 5/isopeptidase T (USP5/IsoT) is a target mol. of vialinin A, identified by using a beads-probe method.  Vialinin A inhibited the peptidase activity of USP5/IsoT and also inhibited the enzymic activities of USP4 among deubiquitinating enzymes tested.  Although USPs are a member of thiol protease family, vialinin A exhibited no inhibitions for other thiol proteases, such as calpain and cathepsin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbheFWIV9k7bVg90H21EOLACvtfcHk0lhv_rtM5WGWZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslGgurs%253D&md5=e9fdfdf55ec643197d52fa7bc309bc54</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.093%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DY.%2BQ.%26aulast%3DTaniguchi%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DA.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DYoshioka%26aufirst%3DY.%26aulast%3DOnose%26aufirst%3DJ.-i.%26aulast%3DKoshino%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DYajima%26aufirst%3DA.%26aulast%3DAbe%26aufirst%3DN.%26aulast%3DYajima%26aufirst%3DS.%26atitle%3DVialinin%2520A%2520is%2520a%2520ubiquitin-specific%2520peptidase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26issue%3D15%26spage%3D4328%26epage%3D4331%26doi%3D10.1016%2Fj.bmcl.2013.05.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rago, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span> <span> </span><span class="NLM_article-title">Disruption of HAUSP gene stabilizes p53</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>428</i></span> (<span class="NLM_issue">6982</span>),  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">2</span>, <span class="refDoi">Â DOI: 10.1038/nature02501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature02501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15058298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BD2c7msVGksA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=1-2&issue=6982&author=J.+M.+Cumminsauthor=C.+Ragoauthor=M.+Kohliauthor=K.+W.+Kinzlerauthor=C.+Lengauerauthor=B.+Vogelstein&title=Disruption+of+HAUSP+gene+stabilizes+p53&doi=10.1038%2Fnature02501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour suppression: disruption of HAUSP gene stabilizes p53</span></div><div class="casAuthors">Cummins Jordan M; Rago Carlo; Kohli Manu; Kinzler Kenneth W; Lengauer Christoph; Vogelstein Bert</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">6982</span>),
    <span class="NLM_cas:pages">1 p  following 486</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYwApJeSKG-LFU0A1HOshhfW6udTcc2eYn9R6lAJOcXbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7msVGksA%253D%253D&md5=18c9fc142054f30d6b8bf26cdbe85bd7</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1038%2Fnature02501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02501%26sid%3Dliteratum%253Aachs%26aulast%3DCummins%26aufirst%3DJ.%2BM.%26aulast%3DRago%26aufirst%3DC.%26aulast%3DKohli%26aufirst%3DM.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DDisruption%2520of%2520HAUSP%2520gene%2520stabilizes%2520p53%26jtitle%3DNature%26date%3D2004%26volume%3D428%26issue%3D6982%26spage%3D1%26epage%3D2%26doi%3D10.1038%2Fnature02501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, W.</span></span> <span> </span><span class="NLM_article-title">A dynamic role of HAUSP in the p53-Mdm2 pathway</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">879</span>â <span class="NLM_lpage">886</span>, <span class="refDoi">Â DOI: 10.1016/S1097-2765(04)00157-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS1097-2765%2804%2900157-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15053880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFajsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=879-886&issue=6&author=M.+Liauthor=C.+L.+Brooksauthor=N.+Konauthor=W.+Gu&title=A+dynamic+role+of+HAUSP+in+the+p53-Mdm2+pathway&doi=10.1016%2FS1097-2765%2804%2900157-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">A dynamic role of HAUSP in the p53-Mdm2 pathway</span></div><div class="casAuthors">Li, Muyang; Brooks, Christopher L.; Kon, Ning; Gu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">879-886</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Our previous study showed that ubiquitination of p53 is reversible and that the ubiquitin hydrolase HAUSP can stabilize p53 by deubiquitination.  Here, we found that partial redn. of endogenous HAUSP levels by RNAi indeed destabilizes endogenous p53; surprisingly, however, nearly complete ablation of HAUSP stabilizes and activates p53.  We further show that this phenomenon occurs because HAUSP stabilizes Mdm2 in a p53-independent manner, providing an interesting feedback loop in p53 regulation.  Notably, HAUSP is required for Mdm2 stability in normal cells; in HAUSP-ablated cells, self-ubiquitinated-Mdm2 becomes extremely unstable, leading to indirect p53 activation.  Furthermore, this feedback regulation is specific to Mdm2; in HeLa cells, where p53 is preferentially degraded by viral E6-dependent ubiquitination, depletion of HAUSP fails to activate p53.  This study provides an example of an ubiquitin ligase (Mdm2) that is directly regulated by a deubiquitinase (HAUSP) and also reveals a dynamic role of HAUSP in the p53-Mdm2 pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_0ojWOvYLg7Vg90H21EOLACvtfcHk0lhE1tp0ZzWFug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFajsrc%253D&md5=49bcdd861fd516419d842ee0165a9bd7</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2804%2900157-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252804%252900157-1%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DBrooks%26aufirst%3DC.%2BL.%26aulast%3DKon%26aufirst%3DN.%26aulast%3DGu%26aufirst%3DW.%26atitle%3DA%2520dynamic%2520role%2520of%2520HAUSP%2520in%2520the%2520p53-Mdm2%2520pathway%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D13%26issue%3D6%26spage%3D879%26epage%3D886%26doi%3D10.1016%2FS1097-2765%2804%2900157-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van Loosdregt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleskens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenkman, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekker, C. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pals, C. E. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meerding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkers, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GrÃ¶ne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sijts, A. J. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalkhoven, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakken, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovaa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaiss, D. M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffer, P. J.</span></span> <span> </span><span class="NLM_article-title">Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">259</span>â <span class="NLM_lpage">271</span>, <span class="refDoi">Â DOI: 10.1016/j.immuni.2013.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.immuni.2013.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23973222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlCgtr3F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2013&pages=259-271&issue=2&author=J.+van+Loosdregtauthor=V.+Fleskensauthor=J.+Fuauthor=A.+B.+Brenkmanauthor=C.+P.+J.+Bekkerauthor=C.+E.+G.+M.+Palsauthor=J.+Meerdingauthor=C.+R.+Berkersauthor=J.+Barbiauthor=A.+Gr%C3%B6neauthor=A.+J.+A.+M.+Sijtsauthor=M.+M.+Mauriceauthor=E.+Kalkhovenauthor=B.+J.+Prakkenauthor=H.+Ovaaauthor=F.+Panauthor=D.+M.+W.+Zaissauthor=P.+J.+Coffer&title=Stabilization+of+the+transcription+factor+Foxp3+by+the+deubiquitinase+USP7+increases+Treg-cell-suppressive+capacity&doi=10.1016%2Fj.immuni.2013.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of the Transcription Factor Foxp3 by the Deubiquitinase USP7 Increases Treg-Cell-Suppressive Capacity</span></div><div class="casAuthors">van Loosdregt, Jorg; Fleskens, Veerle; Fu, Juan; Brenkman, Arjan B.; Bekker, Cornelis P. J.; Pals, Cornelieke E. G. M.; Meerding, Jenny; Berkers, Celia R.; Barbi, Joseph; Grone, Andrea; Sijts, Alice J. A. M.; Maurice, Madelon M.; Kalkhoven, Eric; Prakken, Berent J.; Ovaa, Huib; Pan, Fan; Zaiss, Dietmar M. W.; Coffer, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">259-271</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Stable Foxp3 expression is required for the development of functional regulatory T (Treg) cells.  Here, we demonstrate that the expression of the transcription factor Foxp3 can be regulated through the polyubiquitination of multiple lysine residues, resulting in proteasome-mediated degrdn.  Expression of the deubiquitinase (DUB) USP7 was found to be upregulated and active in Treg cells, being assocd. with Foxp3 in the nucleus.  Ectopic expression of USP7 decreased Foxp3 polyubiquitination and increased Foxp3 expression.  Conversely, either treatment with DUB inhibitor or USP7 knockdown decreased endogenous Foxp3 protein expression and decreased Treg-cell-mediated suppression in vitro.  Furthermore, in a murine adoptive-transfer-induced colitis model, either inhibition of DUB activity or USP7 knockdown in Treg cells abrogated their ability to resolve inflammation in vivo.  Our data reveal a mol. mechanism in which rapid temporal control of Foxp3 expression in Treg cells can be regulated by USP7, thereby modulating Treg cell nos. and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Zpb6_zouu7Vg90H21EOLACvtfcHk0lhE1tp0ZzWFug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlCgtr3F&md5=78bd3e51a661ecac49461a3811d2e768</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2013.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2013.05.018%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BLoosdregt%26aufirst%3DJ.%26aulast%3DFleskens%26aufirst%3DV.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DBrenkman%26aufirst%3DA.%2BB.%26aulast%3DBekker%26aufirst%3DC.%2BP.%2BJ.%26aulast%3DPals%26aufirst%3DC.%2BE.%2BG.%2BM.%26aulast%3DMeerding%26aufirst%3DJ.%26aulast%3DBerkers%26aufirst%3DC.%2BR.%26aulast%3DBarbi%26aufirst%3DJ.%26aulast%3DGr%25C3%25B6ne%26aufirst%3DA.%26aulast%3DSijts%26aufirst%3DA.%2BJ.%2BA.%2BM.%26aulast%3DMaurice%26aufirst%3DM.%2BM.%26aulast%3DKalkhoven%26aufirst%3DE.%26aulast%3DPrakken%26aufirst%3DB.%2BJ.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DZaiss%26aufirst%3DD.%2BM.%2BW.%26aulast%3DCoffer%26aufirst%3DP.%2BJ.%26atitle%3DStabilization%2520of%2520the%2520transcription%2520factor%2520Foxp3%2520by%2520the%2520deubiquitinase%2520USP7%2520increases%2520Treg-cell-suppressive%2520capacity%26jtitle%3DImmunity%26date%3D2013%26volume%3D39%26issue%3D2%26spage%3D259%26epage%3D271%26doi%3D10.1016%2Fj.immuni.2013.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lough, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samanta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, M. I.</span></span> <span> </span><span class="NLM_article-title">Dynamic interactions between TIP60 and p300 regulate FOXP3 function through a structural switch defined by a single lysine on TIP60</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1471</span>â <span class="NLM_lpage">1480</span>, <span class="refDoi">Â DOI: 10.1016/j.celrep.2014.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.celrep.2014.04.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24835996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotFGlsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=1471-1480&issue=5&author=Y.+Xiaoauthor=Y.+Nagaiauthor=G.+Dengauthor=T.+Ohtaniauthor=Z.+Zhuauthor=Z.+Zhouauthor=H.+Zhangauthor=M.+Q.+Jiauthor=J.+W.+Loughauthor=A.+Samantaauthor=W.+W.+Hancockauthor=M.+I.+Greene&title=Dynamic+interactions+between+TIP60+and+p300+regulate+FOXP3+function+through+a+structural+switch+defined+by+a+single+lysine+on+TIP60&doi=10.1016%2Fj.celrep.2014.04.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic Interactions between TIP60 and p300 Regulate FOXP3 Function through a Structural Switch Defined by a Single Lysine on TIP60</span></div><div class="casAuthors">Xiao, Yan; Nagai, Yasuhiro; Deng, Guoping; Ohtani, Takuya; Zhu, Zhiqiang; Zhou, Zhaocai; Zhang, Hongtao; Ji, Mei Q.; Lough, John W.; Samanta, Arabinda; Hancock, Wayne W.; Greene, Mark I.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1471-1480</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The human FOXP3 mol. is an oligomeric transcriptional factor able to mediate activities that characterize T regulatory cells, a class of lymphocytes central to the regulation of immune responses.  The activity of FOXP3 is regulated at the posttranslational level, in part by two histone acetyltransferases (HATs): TIP60 and p300.  TIP60 and p300 work cooperatively to regulate FOXP3 activity.  Initially, p300 and TIP60 interactions lead to the activation of TIP60 and facilitate acetylation of K327 of TIP60, which functions as a mol. switch to allow TIP60 to change binding partners.  Subsequently, p300 is released from this complex, and TIP60 interacts with and acetylates FOXP3.  Maximal induction of FOXP3 activities is obsd. when both p300 and TIP60 are able to undergo cooperative interactions.  Conditional knockout of TIP60 in Treg cells significantly decreases the Treg population in the peripheral immune organs, leading to a scurfy-like fatal autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoisEBghRHaSrVg90H21EOLACvtfcHk0liUaBbgirH1ww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotFGlsbw%253D&md5=4d3ed5d4713140bd2e17e6288ad9f1af</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DOhtani%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DM.%2BQ.%26aulast%3DLough%26aufirst%3DJ.%2BW.%26aulast%3DSamanta%26aufirst%3DA.%26aulast%3DHancock%26aufirst%3DW.%2BW.%26aulast%3DGreene%26aufirst%3DM.%2BI.%26atitle%3DDynamic%2520interactions%2520between%2520TIP60%2520and%2520p300%2520regulate%2520FOXP3%2520function%2520through%2520a%2520structural%2520switch%2520defined%2520by%2520a%2520single%2520lysine%2520on%2520TIP60%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D7%26issue%3D5%26spage%3D1471%26epage%3D1480%26doi%3D10.1016%2Fj.celrep.2014.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newick, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samanta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beier, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akimova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatti, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodrasov, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterner, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albelda, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, W. W.</span></span> <span> </span><span class="NLM_article-title">Ubiquitin-specific protease-7 inhibition impairs Tip60-dependent Foxp3+ T-regulatory cell function and promotes antitumor immunity</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">99</span>â <span class="NLM_lpage">112</span>, <span class="refDoi">Â DOI: 10.1016/j.ebiom.2016.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.ebiom.2016.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27769803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BC2srltVWmsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=99-112&author=L.+Wangauthor=S.+Kumarauthor=S.+Dahiyaauthor=F.+Wangauthor=J.+Wuauthor=K.+Newickauthor=R.+Hanauthor=A.+Samantaauthor=U.+H.+Beierauthor=T.+Akimovaauthor=T.+R.+Bhattiauthor=B.+Nicholsonauthor=M.+P.+Kodrasovauthor=S.+Agarwalauthor=D.+E.+Sternerauthor=W.+Guauthor=J.+Weinstockauthor=T.+R.+Buttauthor=S.+M.+Albeldaauthor=W.+W.+Hancock&title=Ubiquitin-specific+protease-7+inhibition+impairs+Tip60-dependent+Foxp3%2B+T-regulatory+cell+function+and+promotes+antitumor+immunity&doi=10.1016%2Fj.ebiom.2016.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3+ T-regulatory Cell Function and Promotes Antitumor Immunity</span></div><div class="casAuthors">Wang Liqing; Dahiya Satinder; Han Rongxiang; Samanta Arabinda; Akimova Tatiana; Bhatti Tricia R; Kumar Suresh; Wang Feng; Wu Jian; Nicholson Benjamin; Kodrasov Mathew P; Agarwal Saket; Sterner David E; Weinstock Joseph; Butt Tauseef R; Newick Kheng; Albelda Steven M; Beier Ulf H; Gu Wei; Hancock Wayne W</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">99-112</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Foxp3+ T-regulatory (Treg) cells are known to suppress protective host immune responses to a wide variety of solid tumors, but their therapeutic targeting is largely restricted to their transient depletion or "secondary" modulation, e.g. using anti-CTLA-4 monoclonal antibody.  Our ongoing studies of the post-translational modifications that regulate Foxp3 demonstrated that the histone/protein acetyltransferase, Tip60, plays a dominant role in promoting acetylation, dimerization and function in Treg cells.  We now show that the ubiquitin-specific protease, Usp7, controls Treg function largely by stabilizing the expression and promoting the multimerization of Tip60 and Foxp3.  Genetic or pharmacologic targeting of Usp7 impairs Foxp3+ Treg suppressive functions, while conventional T cell responses remain intact.  As a result, pharmacologic inhibitors of Usp7 can limit tumor growth in immunocompetent mice, and promote the efficacy of antitumor vaccines and immune checkpoint therapy with anti-PD1 monoclonal antibody in murine models.  Hence, pharmacologic therapy with Usp7 inhibitors may have an important role in future cancer immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRx7G_irn6DIPtos8R3JUhXfW6udTcc2eYXWsfSyniD47ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srltVWmsQ%253D%253D&md5=f7456d0d7eddd4188ef4e6e2f3e8d691</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2016.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2016.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DDahiya%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DNewick%26aufirst%3DK.%26aulast%3DHan%26aufirst%3DR.%26aulast%3DSamanta%26aufirst%3DA.%26aulast%3DBeier%26aufirst%3DU.%2BH.%26aulast%3DAkimova%26aufirst%3DT.%26aulast%3DBhatti%26aufirst%3DT.%2BR.%26aulast%3DNicholson%26aufirst%3DB.%26aulast%3DKodrasov%26aufirst%3DM.%2BP.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DSterner%26aufirst%3DD.%2BE.%26aulast%3DGu%26aufirst%3DW.%26aulast%3DWeinstock%26aufirst%3DJ.%26aulast%3DButt%26aufirst%3DT.%2BR.%26aulast%3DAlbelda%26aufirst%3DS.%2BM.%26aulast%3DHancock%26aufirst%3DW.%2BW.%26atitle%3DUbiquitin-specific%2520protease-7%2520inhibition%2520impairs%2520Tip60-dependent%2520Foxp3%252B%2520T-regulatory%2520cell%2520function%2520and%2520promotes%2520antitumor%2520immunity%26jtitle%3DEBioMedicine%26date%3D2016%26volume%3D13%26spage%3D99%26epage%3D112%26doi%3D10.1016%2Fj.ebiom.2016.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwickart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrando, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâRourke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastham-Anderson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dornan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>463</i></span> (<span class="NLM_issue">7277</span>),  <span class="NLM_fpage">103</span>â <span class="NLM_lpage">107</span>, <span class="refDoi">Â DOI: 10.1038/nature08646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature08646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=20023629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFyhsLjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2010&pages=103-107&issue=7277&author=M.+Schwickartauthor=X.+Huangauthor=J.+R.+Lillauthor=J.+Liuauthor=R.+Ferrandoauthor=D.+M.+Frenchauthor=H.+Maeckerauthor=K.+O%E2%80%99Rourkeauthor=F.+Bazanauthor=J.+Eastham-Andersonauthor=P.+Yueauthor=D.+Dornanauthor=D.+C.+S.+Huangauthor=V.+M.+Dixit&title=Deubiquitinase+USP9X+stabilizes+MCL1+and+promotes+tumour+cell+survival&doi=10.1038%2Fnature08646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival</span></div><div class="casAuthors">Schwickart, Martin; Huang, Xiao-Dong; Lill, Jennie R.; Liu, Jin-Feng; Ferrando, Ronald; French, Dorothy M.; Maecker, Heather; O'Rourke, Karen; Bazan, Fernando; Eastham-Anderson, Jeffrey; Yue, Peng; Dornan, David; Huang, David C. S.; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">7277</span>),
    <span class="NLM_cas:pages">103-107</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">MCL1 is essential for the survival of stem and progenitor cells of multiple lineages, and is unique among pro-survival BCL2 family members in that it is rapidly turned over through the action of ubiquitin ligases.  B- and mantle-cell lymphomas, chronic myeloid leukemia, and multiple myeloma, however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse.  The mechanism of MCL1 overexpression in cancer is not well understood.  Here we show that the deubiquitinase USP9X stabilizes MCL1 and thereby promotes cell survival.  USP9X binds MCL1 and removes the Lys 48-linked polyubiquitin chains that normally mark MCL1 for proteasomal degrdn.  Increased USP9X expression correlates with increased MCL1 protein in human follicular lymphomas and diffuse large B-cell lymphomas.  Moreover, patients with multiple myeloma overexpressing USP9X have a poor prognosis.  Knockdown of USP9X increases MCL1 polyubiquitination, which enhances MCL1 turnover and cell killing by the BH3 mimetic ABT-737.  These results identify USP9X as a prognostic and therapeutic target, and they show that deubiquitinases may stabilize labile oncoproteins in human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4tfGDFZ1t4bVg90H21EOLACvtfcHk0liUaBbgirH1ww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFyhsLjI&md5=91325333f1228d292175c0ff0a547784</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1038%2Fnature08646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08646%26sid%3Dliteratum%253Aachs%26aulast%3DSchwickart%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLill%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFerrando%26aufirst%3DR.%26aulast%3DFrench%26aufirst%3DD.%2BM.%26aulast%3DMaecker%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DK.%26aulast%3DBazan%26aufirst%3DF.%26aulast%3DEastham-Anderson%26aufirst%3DJ.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DDornan%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DDeubiquitinase%2520USP9X%2520stabilizes%2520MCL1%2520and%2520promotes%2520tumour%2520cell%2520survival%26jtitle%3DNature%26date%3D2010%26volume%3D463%26issue%3D7277%26spage%3D103%26epage%3D107%26doi%3D10.1038%2Fnature08646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordenonsi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montagner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacchigna, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adorno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinchfield, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soligo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morsut, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modena, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argenton, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newfeld, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccolo, S.</span></span> <span> </span><span class="NLM_article-title">FAM/USP9X, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">123</span>â <span class="NLM_lpage">135</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2008.10.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.cell.2008.10.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19135894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOitr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2009&pages=123-135&issue=1&author=S.+Dupontauthor=A.+Mamidiauthor=M.+Cordenonsiauthor=M.+Montagnerauthor=L.+Zacchignaauthor=M.+Adornoauthor=G.+Martelloauthor=M.+J.+Stinchfieldauthor=S.+Soligoauthor=L.+Morsutauthor=M.+Inuiauthor=S.+Moroauthor=N.+Modenaauthor=F.+Argentonauthor=S.+J.+Newfeldauthor=S.+Piccolo&title=FAM%2FUSP9X%2C+a+deubiquitinating+enzyme+essential+for+TGFbeta+signaling%2C+controls+Smad4+monoubiquitination&doi=10.1016%2Fj.cell.2008.10.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">FAM/USP9x, a deubiquitinating enzyme essential for TGFÎ² signaling, controls Smad4 monoubiquitination</span></div><div class="casAuthors">Dupont, Sirio; Mamidi, Anant; Cordenonsi, Michelangelo; Montagner, Marco; Zacchigna, Luca; Adorno, Maddalena; Martello, Graziano; Stinchfield, Michael J.; Soligo, Sandra; Morsut, Leonardo; Inui, Masafumi; Moro, Stefano; Modena, Nicola; Argenton, Francesco; Newfeld, Stuart J.; Piccolo, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123-135</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The assembly of the Smad complex is crit. for TGFÎ² signaling, yet the mechanisms that inactivate or empower nuclear Smad complexes are less understood.  By means of siRNA screen we identified FAM (USP9x), a deubiquitinase acting as essential and evolutionarily conserved component in TGFÎ² and bone morphogenetic protein signaling.  Smad4 is monoubiquitinated in lysine 519 in vivo, a modification that inhibits Smad4 by impeding assocn. with phospho-Smad2.  FAM reverts this neg. modification, re-empowering Smad4 function.  FAM opposes the activity of Ectodermin/Tif1Î³ (Ecto), a nuclear factor for which we now clarify a prominent role as Smad4 monoubiquitin ligase.  Our study points to Smad4 monoubiquitination and deubiquitination as a way for cell to set their TGFÎ² responsiveness: loss of FAM disables Smad4-dependent responses in several model systems, with Ecto being epistatic to FAM.  This defines a regulative ubiquitination step controlling Smads that is parallel to those impinging on R-Smad phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohzmE0e5YUx7Vg90H21EOLACvtfcHk0ljRPWfgcy1QdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOitr4%253D&md5=4e673ea1b509246126f3d22e24835956</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2008.10.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2008.10.051%26sid%3Dliteratum%253Aachs%26aulast%3DDupont%26aufirst%3DS.%26aulast%3DMamidi%26aufirst%3DA.%26aulast%3DCordenonsi%26aufirst%3DM.%26aulast%3DMontagner%26aufirst%3DM.%26aulast%3DZacchigna%26aufirst%3DL.%26aulast%3DAdorno%26aufirst%3DM.%26aulast%3DMartello%26aufirst%3DG.%26aulast%3DStinchfield%26aufirst%3DM.%2BJ.%26aulast%3DSoligo%26aufirst%3DS.%26aulast%3DMorsut%26aufirst%3DL.%26aulast%3DInui%26aufirst%3DM.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DModena%26aufirst%3DN.%26aulast%3DArgenton%26aufirst%3DF.%26aulast%3DNewfeld%26aufirst%3DS.%2BJ.%26aulast%3DPiccolo%26aufirst%3DS.%26atitle%3DFAM%252FUSP9X%252C%2520a%2520deubiquitinating%2520enzyme%2520essential%2520for%2520TGFbeta%2520signaling%252C%2520controls%2520Smad4%2520monoubiquitination%26jtitle%3DCell%26date%3D2009%26volume%3D136%26issue%3D1%26spage%3D123%26epage%3D135%26doi%3D10.1016%2Fj.cell.2008.10.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.-s.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-C.</span></span> <span> </span><span class="NLM_article-title">Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">9433</span>â <span class="NLM_lpage">9438</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1221925110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.1221925110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23690623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFGrtrjL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=9433-9438&issue=23&author=Y.+Parkauthor=H.-s.+Jinauthor=Y.-C.+Liu&title=Regulation+of+T+cell+function+by+the+ubiquitin-specific+protease+USP9X+via+modulating+the+Carma1-Bcl10-Malt1+complex&doi=10.1073%2Fpnas.1221925110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex</span></div><div class="casAuthors">Park, Yoon; Jin, Hyung-seung; Liu, Yun-Cai</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9433-9438, S9433/1-S9433/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The ubiquitin conjugation system plays an important role in immune regulation; however, the ubiquitin-specific proteases (USPs) that carry out deubiquitination of cellular substrates are poorly understood.  Here the authors show that in vivo knockdown of the deubiquitinating enzyme USP9X attenuates T-cell proliferation.  In addn., naive CD4+ T cells from USP9X knockdown chimeric mice display decreased cytokine prodn. and T helper cell differentiation in vitro, which the authors confirmed in vivo by performing adoptive transfer of transgenic T cells and subsequent immunization.  USP9X silencing in both a human T-cell line and mouse primary T cells reduced T-cell receptor (TCR) signaling-induced NF-ÎºB activation.  Mechanistically, USP9X interacts with Bcl10 of the Carma1-Bcl10-Malt1 (CBM) complex and removes the TCR-induced ubiquitin chain from Bcl10, which facilitates the assocn. of Carma1 with Bcl0-Malt1.  These results demonstrate that USP9X is a crucial pos. regulator of the TCR signaling pathway and is required for T-cell function through the modulation of CBM complex formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRgm1qmFGuv7Vg90H21EOLACvtfcHk0ljRPWfgcy1QdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFGrtrjL&md5=a31e6fec0dc653eb7fa3ccb6119f312a</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1221925110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1221925110%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DH.-s.%26aulast%3DLiu%26aufirst%3DY.-C.%26atitle%3DRegulation%2520of%2520T%2520cell%2520function%2520by%2520the%2520ubiquitin-specific%2520protease%2520USP9X%2520via%2520modulating%2520the%2520Carma1-Bcl10-Malt1%2520complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D23%26spage%3D9433%26epage%3D9438%26doi%3D10.1073%2Fpnas.1221925110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suriben, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>211</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1947</span>â <span class="NLM_lpage">1955</span>, <span class="refDoi">Â DOI: 10.1084/jem.20140860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1084%2Fjem.20140860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25200027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CgtbbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2014&pages=1947-1955&issue=10&author=E.+Naikauthor=J.+D.+Websterauthor=J.+DeVossauthor=J.+Liuauthor=R.+Suribenauthor=V.+M.+Dixit&title=Regulation+of+proximal+T+cell+receptor+signaling+and+tolerance+induction+by+deubiquitinase+Usp9X&doi=10.1084%2Fjem.20140860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X</span></div><div class="casAuthors">Naik, Edwina; Webster, Joshua D.; DeVoss, Jason; Liu, Jinfeng; Suriben, Rowena; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1947-1955</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The T cell hyperproliferation and autoimmune phenotypes that manifest in mice lacking E3 ubiquitin ligases such as Cbl, ITCH, or GRAIL highlight the importance of ubiquitination for the maintenance of peripheral T cell tolerance.  Less is known, however, about the deubiquitinating enzymes that regulate T cell proliferation and effector function.  Here, we define a cell intrinsic role for the deubiquitinase Usp9X during proximal TCR signaling.  Usp9X-deficient T cells were hypoproliferative, yet mice with T cell-specific Usp9x deletion had elevated nos. of antigen-experienced T cells and expanded PD-1 and OX40-expressing populations consistent with immune hyperactivity.  Aged Usp9x KO mice developed lupus-like autoimmunity and lymphoproliferative disease, indicating that ubiquitin ligases and deubiquitinases maintain the delicate balance between effective immunity and self-tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp97o7GFRJV6LVg90H21EOLACvtfcHk0ljRPWfgcy1QdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CgtbbI&md5=80616d80fbc85dc8868eb676cbd801d1</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1084%2Fjem.20140860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20140860%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DE.%26aulast%3DWebster%26aufirst%3DJ.%2BD.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DSuriben%26aufirst%3DR.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DRegulation%2520of%2520proximal%2520T%2520cell%2520receptor%2520signaling%2520and%2520tolerance%2520induction%2520by%2520deubiquitinase%2520Usp9X%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2014%26volume%3D211%26issue%3D10%26spage%3D1947%26epage%3D1955%26doi%3D10.1084%2Fjem.20140860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddle, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, C. P.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the specificity of ubiquitin C-terminal hydrolases</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3877</span>â <span class="NLM_lpage">3887</span>, <span class="refDoi">Â DOI: 10.1093/emboj/18.14.3877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1093%2Femboj%2F18.14.3877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10406793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1MXkvV2isr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=3877-3887&issue=14&author=S.+C.+Johnstonauthor=S.+M.+Riddleauthor=R.+E.+Cohenauthor=C.+P.+Hill&title=Structural+basis+for+the+specificity+of+ubiquitin+C-terminal+hydrolases&doi=10.1093%2Femboj%2F18.14.3877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the specificity of ubiquitin C-terminal hydrolases</span></div><div class="casAuthors">Johnston, Steven C.; Riddle, Steven M.; Cohen, Robert E.; Hill, Christopher P.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3877-3887</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The release of ubiquitin from attachment to other proteins and adducts is crit. for ubiquitin biosynthesis, proteasomal degrdn., and other cellular processes.  De-ubiquitination is accomplished in part by members of the UCH (ubiquitin C-terminal hydrolase) family of enzymes.  Here, the authors detd. the 2.25 Ã resoln. crystal structure of the yeast UCH, Yuh1, in complex with the inhibitor, ubiquitin aldehyde (Ubal).  The structure mimicked the tetrahedral intermediate in the reaction pathway and explained the very high enzyme specificity.  Comparison with a related, unliganded UCH structure indicated that ubiquitin binding is coupled to rearrangements which block the active site cleft in the absence of authentic substrate.  Remarkably, a 21-residue loop that becomes ordered upon binding Ubal lies directly over the active site.  Efficiently processed substrates apparently pass through this loop, and constraints on the loop conformation probably function to control UCH specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM8eDBio4XerVg90H21EOLACvtfcHk0lju4JPQZDridg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvV2isr4%253D&md5=a1acd1d31c9385dff94ea080faac4307</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F18.14.3877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F18.14.3877%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DS.%2BC.%26aulast%3DRiddle%26aufirst%3DS.%2BM.%26aulast%3DCohen%26aufirst%3DR.%2BE.%26aulast%3DHill%26aufirst%3DC.%2BP.%26atitle%3DStructural%2520basis%2520for%2520the%2520specificity%2520of%2520ubiquitin%2520C-terminal%2520hydrolases%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26issue%3D14%26spage%3D3877%26epage%3D3887%26doi%3D10.1093%2Femboj%2F18.14.3877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Usp9X is required for lymphocyte activation and homeostasis through Its control of ZAP70 ubiquitination and PKCÎ² kinase activity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>196</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3438</span>â <span class="NLM_lpage">3451</span>, <span class="refDoi">Â DOI: 10.4049/jimmunol.1403165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4049%2Fjimmunol.1403165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26936881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlSks70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2016&pages=3438-3451&issue=8&author=E.+Naikauthor=V.+M.+Dixit&title=Usp9X+is+required+for+lymphocyte+activation+and+homeostasis+through+Its+control+of+ZAP70+ubiquitination+and+PKC%CE%B2+kinase+activity&doi=10.4049%2Fjimmunol.1403165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Usp9X Is Required for Lymphocyte Activation and Homeostasis through Its Control of ZAP70 Ubiquitination and PKCÎ² Kinase Activity</span></div><div class="casAuthors">Naik, Edwina; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3438-3451</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">To achieve a durable adaptive immune response, lymphocytes must undergo clonal expansion and induce a survival program that enables the persistence of Ag-experienced cells and the development of memory.  During the priming phase of this response, CD4+ T lymphocytes either remain tolerized or undergo clonal expansion.  In this article, we show that Usp9X functions as a pos. regulatory switch during T lymphocyte priming through removal of inhibitory monoubiquitination from ZAP70.  In the absence of Usp9X, an increased amt. of ZAP70 localized to early endosomes consistent with the role of monoubiquitin in endocytic sorting.  Usp9X becomes competent to deubiquitinate ZAP70 through TCR-dependent phosphorylation and enhancement of its catalytic activity and assocn. with the LAT signalosome.  In B lymphocytes, Usp9X is required for the induction of PKCÎ² kinase activity after BCR-dependent activation.  Accordingly, in Usp9X knockout B cells, there was a significant redn. in phospho-CARMA1 levels that resulted in reduced CARMA1/Bcl-10/MALT-1 complex formation and NF-ÎºB-dependent cell survival.  The pleiotropic effect of Usp9X during Ag-receptor signaling highlights its importance for the development of an effective and durable adaptive immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoedEATb8CHj7Vg90H21EOLACvtfcHk0lju4JPQZDridg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlSks70%253D&md5=1ff7fa52f0b0792a6248812437711339</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1403165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1403165%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DE.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DUsp9X%2520is%2520required%2520for%2520lymphocyte%2520activation%2520and%2520homeostasis%2520through%2520Its%2520control%2520of%2520ZAP70%2520ubiquitination%2520and%2520PKC%25CE%25B2%2520kinase%2520activity%26jtitle%3DJ.%2520Immunol.%26date%3D2016%26volume%3D196%26issue%3D8%26spage%3D3438%26epage%3D3451%26doi%3D10.4049%2Fjimmunol.1403165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avvakumov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neculai, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neculai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vorobyov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beatty, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, P.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juang, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeqiraj, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karamboulas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allali-Hassani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicheri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durocher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raught, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidhu, S. S.</span></span> <span> </span><span class="NLM_article-title">A strategy for modulation of enzymes in the ubiquitin system</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>339</i></span> (<span class="NLM_issue">6119</span>),  <span class="NLM_fpage">590</span>, <span class="refDoi">Â DOI: 10.1126/science.1230161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fscience.1230161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23287719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFGrsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2013&pages=590&issue=6119&author=A.+Ernstauthor=G.+Avvakumovauthor=J.+Tongauthor=Y.+Fanauthor=Y.+Zhaoauthor=P.+Albertsauthor=A.+Persaudauthor=J.+R.+Walkerauthor=A.-M.+Neculaiauthor=D.+Neculaiauthor=A.+Vorobyovauthor=P.+Gargauthor=L.+Beattyauthor=P.-K.+Chanauthor=Y.-C.+Juangauthor=M.-C.+Landryauthor=C.+Yehauthor=E.+Zeqirajauthor=K.+Karamboulasauthor=A.+Allali-Hassaniauthor=M.+Vedadiauthor=M.+Tyersauthor=J.+Moffatauthor=F.+Sicheriauthor=L.+Pelletierauthor=D.+Durocherauthor=B.+Raughtauthor=D.+Rotinauthor=J.+Yangauthor=M.+F.+Moranauthor=S.+Dhe-Paganonauthor=S.+S.+Sidhu&title=A+strategy+for+modulation+of+enzymes+in+the+ubiquitin+system&doi=10.1126%2Fscience.1230161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">A Strategy for Modulation of Enzymes in the Ubiquitin System</span></div><div class="casAuthors">Ernst, Andreas; Avvakumov, George; Tong, Jiefei; Fan, Yihui; Zhao, Yanling; Alberts, Philipp; Persaud, Avinash; Walker, John R.; Neculai, Ana-Mirela; Neculai, Dante; Vorobyov, Andrew; Garg, Pankaj; Beatty, Linda; Chan, Pak-Kei; Juang, Yu-Chi; Landry, Marie-Claude; Yeh, Christina; Zeqiraj, Elton; Karamboulas, Konstantina; Allali-Hassani, Abdellah; Vedadi, Masoud; Tyers, Mike; Moffat, Jason; Sicheri, Frank; Pelletier, Laurence; Durocher, Daniel; Raught, Brian; Rotin, Daniela; Yang, Jianhua; Moran, Michael F.; Dhe-Paganon, Sirano; Sidhu, Sachdev S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6119</span>),
    <span class="NLM_cas:pages">590-595</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The ubiquitin system regulates virtually all aspects of cellular function.  We report a method to target the myriad enzymes that govern ubiquitination of protein substrates.  We used massively diverse combinatorial libraries of ubiquitin variants to develop inhibitors of four deubiquitinases (DUBs) and analyzed the DUB-inhibitor complexes with crystallog.  We extended the selection strategy to the ubiquitin conjugating (E2) and ubiquitin ligase (E3) enzymes and found that ubiquitin variants can also enhance enzyme activity.  Last, we showed that ubiquitin variants can bind selectively to ubiquitin-binding domains.  Ubiquitin variants exhibit selective function in cells and thus enable orthogonal modulation of specific enzymic steps in the ubiquitin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre6vaTys1e-bVg90H21EOLACvtfcHk0lg58iK_5_bopQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGrsrg%253D&md5=324619497ce06d01d9231570fdb06bec</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1126%2Fscience.1230161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1230161%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DA.%26aulast%3DAvvakumov%26aufirst%3DG.%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DAlberts%26aufirst%3DP.%26aulast%3DPersaud%26aufirst%3DA.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DNeculai%26aufirst%3DA.-M.%26aulast%3DNeculai%26aufirst%3DD.%26aulast%3DVorobyov%26aufirst%3DA.%26aulast%3DGarg%26aufirst%3DP.%26aulast%3DBeatty%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DP.-K.%26aulast%3DJuang%26aufirst%3DY.-C.%26aulast%3DLandry%26aufirst%3DM.-C.%26aulast%3DYeh%26aufirst%3DC.%26aulast%3DZeqiraj%26aufirst%3DE.%26aulast%3DKaramboulas%26aufirst%3DK.%26aulast%3DAllali-Hassani%26aufirst%3DA.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DTyers%26aufirst%3DM.%26aulast%3DMoffat%26aufirst%3DJ.%26aulast%3DSicheri%26aufirst%3DF.%26aulast%3DPelletier%26aufirst%3DL.%26aulast%3DDurocher%26aufirst%3DD.%26aulast%3DRaught%26aufirst%3DB.%26aulast%3DRotin%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMoran%26aufirst%3DM.%2BF.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DSidhu%26aufirst%3DS.%2BS.%26atitle%3DA%2520strategy%2520for%2520modulation%2520of%2520enzymes%2520in%2520the%2520ubiquitin%2520system%26jtitle%3DScience%26date%3D2013%26volume%3D339%26issue%3D6119%26spage%3D590%26doi%3D10.1126%2Fscience.1230161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gjonaj, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapmaz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flierman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, G. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Veelen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovaa, H.</span></span> <span> </span><span class="NLM_article-title">Development of a DUB-selective fluorogenic substrate</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">10290</span>â <span class="NLM_lpage">10296</span>, <span class="refDoi">Â DOI: 10.1039/C9SC02226K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1039%2FC9SC02226K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32110315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVOhs7jJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=10290-10296&issue=44&author=L.+Gjonajauthor=A.+Sapmazauthor=D.+Fliermanauthor=G.+M.+C.+Janssenauthor=P.+A.+van+Veelenauthor=H.+Ovaa&title=Development+of+a+DUB-selective+fluorogenic+substrate&doi=10.1039%2FC9SC02226K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a DUB-selective fluorogenic substrate</span></div><div class="casAuthors">Gjonaj, Lorina; Sapmaz, Aysegul; Flierman, Dennis; Janssen, George M. C.; van Veelen, Peter A.; Ovaa, Huib</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">10290-10296</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Ubiquitination is a post-translational modification that is involved in a plethora of cellular processes.  Target proteins can be specifically modified with a single ubiquitin (Ub) mol. or with complex chains.  In recent years, research has focused on deubiquitinating enzymes (DUBs) as potential therapeutic candidates in various diseases.  USP16 is an emerging target due to its involvement in mitosis and stem cell self-renewal.  Generally, activity-based probes (ABPs) used to study DUBs are based on the ubiquitin scaffold, thus lacking target selectivity.  To overcome this issue, we designed a Ub-based activity probe bearing specific mutations to achieve selectivity for USP16, by combining structural modeling and anal. and mutational calcn. predictions.  We develop a fluorogenic substrate, the first of its kind, that is processed exclusively by USP16, which allows us to monitor USP16 activity in complex samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMnLMnBzhM37Vg90H21EOLACvtfcHk0lg58iK_5_bopQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVOhs7jJ&md5=c968414e3c92e22140ce8713f9e7f443</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1039%2FC9SC02226K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9SC02226K%26sid%3Dliteratum%253Aachs%26aulast%3DGjonaj%26aufirst%3DL.%26aulast%3DSapmaz%26aufirst%3DA.%26aulast%3DFlierman%26aufirst%3DD.%26aulast%3DJanssen%26aufirst%3DG.%2BM.%2BC.%26aulast%3Dvan%2BVeelen%26aufirst%3DP.%2BA.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DDevelopment%2520of%2520a%2520DUB-selective%2520fluorogenic%2520substrate%26jtitle%3DChem.%2520Sci.%26date%3D2019%26volume%3D10%26issue%3D44%26spage%3D10290%26epage%3D10296%26doi%3D10.1039%2FC9SC02226K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krabill, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, D. P.</span></span> <span> </span><span class="NLM_article-title">Development of ubiquitin variants with selectivity for ubiquitin C-terminal hydrolase deubiquitinases</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">3447</span>â <span class="NLM_lpage">3462</span>, <span class="refDoi">Â DOI: 10.1021/acs.biochem.9b01076</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.9b01076" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs12rtrjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2020&pages=3447-3462&issue=37&author=C.+S.+Hewittauthor=A.+D.+Krabillauthor=C.+Dasauthor=D.+P.+Flaherty&title=Development+of+ubiquitin+variants+with+selectivity+for+ubiquitin+C-terminal+hydrolase+deubiquitinases&doi=10.1021%2Facs.biochem.9b01076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Ubiquitin Variants with Selectivity for Ubiquitin C-Terminal Hydrolase Deubiquitinases</span></div><div class="casAuthors">Hewitt, Chad S.; Krabill, Aaron D.; Das, Chittaranjan; Flaherty, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">3447-3462</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ubiquitin (Ub) is a highly conserved protein that is covalently attached to substrate proteins as a post-translational modification to regulate signaling pathways such as proteasomal degrdn. and cell cycle/transcriptional regulation in the eukaryotic cellular environment.  Ub signaling is regulated by the homeostasis of substrate protein ubiquitination/deubiquitination by E3 ligases and deubiquitinating enzymes (DUBs) in healthy eukaryotic systems.  One such DUB, ubiquitin C-terminal hydrolase L1 (UCHL1), is endogenously expressed in the central nervous system under normal physiol. conditions, but overexpression and/or mutation was linked to various cancers and neurodegenerative diseases.  The lack of UCHL1 probing strategies suggests development of a selective Ub variant (UbV) for probing UCHL1's role in these disease states would be beneficial.  The authors describe a computational design approach to study UbVs that lend selectivity, both binding and inhibition, to UCHL1 over the close structural homolog UCHL3 and members of other DUB families.  A no. of UbVs, mainly those contg. Thr9 mutations, displayed appreciable binding and inhibition selectivity for UCHL1 over UCHL3, compared to wild-type Ub in in vitro assays.  By appending reactive electrophiles to the C-terminus of the UbVs, the authors created the first activity-based probe (ABP) with demonstrated reaction selectivity for UCH family DUBs over other families in cell lysates.  Further kinetic anal. of covalent inhibition by the UbV-ABP with UCHL1 and UCHL3 offers insight into the future design of UCHL1 selective UbV-ABP.  These studies serve as a proof of concept of the viability of the in silico design of ubiquitin variants for UCH family DUBs as a step toward the development of macromol. UCHL1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcs2rfAjxKIbVg90H21EOLACvtfcHk0lg58iK_5_bopQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs12rtrjI&md5=c406c6397a76bef7bc8527e75b225196</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.9b01076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.9b01076%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DC.%2BS.%26aulast%3DKrabill%26aufirst%3DA.%2BD.%26aulast%3DDas%26aufirst%3DC.%26aulast%3DFlaherty%26aufirst%3DD.%2BP.%26atitle%3DDevelopment%2520of%2520ubiquitin%2520variants%2520with%2520selectivity%2520for%2520ubiquitin%2520C-terminal%2520hydrolase%2520deubiquitinases%26jtitle%3DBiochemistry%26date%3D2020%26volume%3D59%26issue%3D37%26spage%3D3447%26epage%3D3462%26doi%3D10.1021%2Facs.biochem.9b01076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rut, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zmudzinski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">6058</span>â <span class="NLM_lpage">6069</span>, <span class="refDoi">Â DOI: 10.1039/D0SC01347A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1039%2FD0SC01347A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32953009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVyqurbF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=6058-6069&issue=23&author=W.+Rutauthor=M.+Zmudzinskiauthor=S.+J.+Snipasauthor=M.+Bekesauthor=T.+T.+Huangauthor=M.+Drag&title=Engineered+unnatural+ubiquitin+for+optimal+detection+of+deubiquitinating+enzymes&doi=10.1039%2FD0SC01347A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes</span></div><div class="casAuthors">Rut, Wioletta; Zmudzinski, Mikolaj; Snipas, Scott J.; Bekes, Miklos; Huang, Tony T.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6058-6069</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Deubiquitinating enzymes (DUBs) are responsible for removing ubiquitin (Ub) from its protein conjugates.  DUBs have been implicated as attractive therapeutic targets in the treatment of viral diseases, neurodegenerative disorders and cancer.  The lack of selective chem. tools for the exploration of these enzymes significantly impairs the detn. of their roles in both normal and pathol. states.  Com. available fluorogenic substrates are based on the C-terminal Ub motif or contain Ub coupled to a fluorophore (Z-LRGG-AMC, Ub-AMC); therefore, these substrates suffer from lack of selectivity.  By using a hybrid combinatorial substrate library (HyCoSuL) and a defined P2 library contg. a wide variety of nonproteinogenic amino acids, we established a full substrate specificity profile for two DUBs-MERS PLpro and human UCH-L3.  Based on these results, we designed and synthesized Ub-based substrates and activity-based probes (ABPs) contg. selected unnatural amino acids located in the C-terminal Ub motif.  Biochem. anal. and cell lysate expts. confirmed the activity and selectivity of engineered Ub-based substrates and probes.  Using this approach, we propose that for any protease that recognizes Ub and Ub-like substrates, a highly active and selective unnatural substrate or probe can be engineered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpapO-SAzjnX7Vg90H21EOLACvtfcHk0lhXhh92GQlgfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVyqurbF&md5=258c80b12a833f5ab367591376b61561</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1039%2FD0SC01347A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0SC01347A%26sid%3Dliteratum%253Aachs%26aulast%3DRut%26aufirst%3DW.%26aulast%3DZmudzinski%26aufirst%3DM.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DBekes%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DT.%2BT.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DEngineered%2520unnatural%2520ubiquitin%2520for%2520optimal%2520detection%2520of%2520deubiquitinating%2520enzymes%26jtitle%3DChem.%2520Sci.%26date%3D2020%26volume%3D11%26issue%3D23%26spage%3D6058%26epage%3D6069%26doi%3D10.1039%2FD0SC01347A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLellan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlock, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knights, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacq, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Quantitative chemical proteomic profiling of ubiquitin specific proteases in intact cancer cells</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3268</span>â <span class="NLM_lpage">3272</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.6b00766</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00766" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSns7nP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=3268-3272&issue=12&author=J.+A.+Wardauthor=L.+McLellanauthor=M.+Stockleyauthor=K.+R.+Gibsonauthor=G.+A.+Whitlockauthor=C.+Knightsauthor=J.+A.+Harriganauthor=X.+Jacqauthor=E.+W.+Tate&title=Quantitative+chemical+proteomic+profiling+of+ubiquitin+specific+proteases+in+intact+cancer+cells&doi=10.1021%2Facschembio.6b00766"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative Chemical Proteomic Profiling of Ubiquitin Specific Proteases in Intact Cancer Cells</span></div><div class="casAuthors">Ward, Jennifer A.; McLellan, Lauren; Stockley, Martin; Gibson, Karl R.; Whitlock, Gavin A.; Knights, Charlotte; Harrigan, Jeanine A.; Jacq, Xavier; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3268-3272</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Deubiquitinating enzymes play an important role in a plethora of therapeutically relevant processes and are emerging as pioneering drug targets.  Herein, we present a novel probe, Ubiquitin Specific Protease (USP) inhibitor, alongside an alkyne-tagged activity-based probe analog.  Activity-based proteome profiling identified 12 USPs, including USP4, USP16, and USP33, as inhibitor targets using submicromolar probe concns.  This represents the first intact cell activity-based profiling of deubiquitinating enzymes.  Further anal. demonstrated functional inhibition of USP33 and identified a synergistic relationship in combination with ATR inhibition, consistent with USP4 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM5PZxNI8jCrVg90H21EOLACvtfcHk0ljcCQnQt5KUMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSns7nP&md5=e77ba0b52c64b76d7e9fbf30a73808f4</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00766%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DJ.%2BA.%26aulast%3DMcLellan%26aufirst%3DL.%26aulast%3DStockley%26aufirst%3DM.%26aulast%3DGibson%26aufirst%3DK.%2BR.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26aulast%3DKnights%26aufirst%3DC.%26aulast%3DHarrigan%26aufirst%3DJ.%2BA.%26aulast%3DJacq%26aufirst%3DX.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DQuantitative%2520chemical%2520proteomic%2520profiling%2520of%2520ubiquitin%2520specific%2520proteases%2520in%2520intact%2520cancer%2520cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26issue%3D12%26spage%3D3268%26epage%3D3272%26doi%3D10.1021%2Facschembio.6b00766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reverdy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planquette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atmanene, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collura, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harpon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battaglia, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colland, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">467</span>â <span class="NLM_lpage">477</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2012.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2012.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22520753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFyruro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=467-477&issue=4&author=C.+Reverdyauthor=S.+Conrathauthor=R.+Lopezauthor=C.+Planquetteauthor=C.+Atmaneneauthor=V.+Colluraauthor=J.+Harponauthor=V.+Battagliaauthor=V.+Vivatauthor=W.+Sipplauthor=F.+Colland&title=Discovery+of+specific+inhibitors+of+human+USP7%2FHAUSP+deubiquitinating+enzyme&doi=10.1016%2Fj.chembiol.2012.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Specific Inhibitors of Human USP7/HAUSP Deubiquitinating Enzyme</span></div><div class="casAuthors">Reverdy, Celine; Conrath, Susan; Lopez, Roman; Planquette, Cecile; Atmanene, Cedric; Collura, Vincent; Harpon, Jane; Battaglia, Veronique; Vivat, Valerie; Sippl, Wolfgang; Colland, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">467-477</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The human USP7 deubiquitinating enzyme was shown to regulate many proteins involved in the cell cycle, as well as tumor suppressors and oncogenes.  Thus, USP7 offers a promising, strategic target for cancer therapy.  Using biochem. assays and activity-based protein profiling in living systems, we identified small-mol. antagonists of USP7 and demonstrated USP7 inhibitor occupancy and selectivity in cancer cell lines.  These compds. bind USP7 in the active site through a covalent mechanism.  In cancer cells, these active-site-targeting inhibitors were shown to regulate the level of several USP7 substrates and thus recapitulated the USP7 knockdown phenotype that leads to G1 arrest in colon cancer cells.  The data presented in this report provide proof of principle that USP7 inhibitors may be a valuable therapeutic for cancer.  In addn., the discovery of such mols. offers interesting tools for studying deubiquitination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt0GVteDWstbVg90H21EOLACvtfcHk0ljcCQnQt5KUMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFyruro%253D&md5=f5e3497c9893342571e3c97ae85d1361</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DReverdy%26aufirst%3DC.%26aulast%3DConrath%26aufirst%3DS.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DPlanquette%26aufirst%3DC.%26aulast%3DAtmanene%26aufirst%3DC.%26aulast%3DCollura%26aufirst%3DV.%26aulast%3DHarpon%26aufirst%3DJ.%26aulast%3DBattaglia%26aufirst%3DV.%26aulast%3DVivat%26aufirst%3DV.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DColland%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520specific%2520inhibitors%2520of%2520human%2520USP7%252FHAUSP%2520deubiquitinating%2520enzyme%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26issue%3D4%26spage%3D467%26epage%3D477%26doi%3D10.1016%2Fj.chembiol.2012.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schardon, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Er, J. A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swartzel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fast, W.</span></span> <span> </span><span class="NLM_article-title">Selective covalent protein modification by 4-halopyridines through catalysis</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">1551</span>â <span class="NLM_lpage">1556</span>, <span class="refDoi">Â DOI: 10.1002/cbic.201700104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fcbic.201700104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=28470883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKhsbrE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1551-1556&issue=15&author=C.+L.+Schardonauthor=A.+Tuleyauthor=J.+A.+V.+Erauthor=J.+C.+Swartzelauthor=W.+Fast&title=Selective+covalent+protein+modification+by+4-halopyridines+through+catalysis&doi=10.1002%2Fcbic.201700104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Covalent Protein Modification by 4-Halopyridines through Catalysis</span></div><div class="casAuthors">Schardon, Christopher L.; Tuley, Alfred; Er, Joyce A. V.; Swartzel, Jake C.; Fast, Walter</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1551-1556</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have investigated 4-halopyridines as selective, tunable, and switchable covalent protein modifiers for use in the development of chem. probes.  Nonenzymic reactivity of 4-chloropyridine with amino acids and thiols was ranked with respect to common covalent protein-modifying reagents and found to have reactivity similar to that of acrylamide, but could be switched to a reactivity similar to that of iodoacetamide upon stabilization of the pos. charged pyridinium.  Diverse, fragment-sized 4-halopyridines inactivated human dimethylarginine dimethylaminohydrolase-1 (DDAH1) through covalent modification of the active site cysteine, acting as quiescent affinity labels that required off-pathway catalysis through stabilization of the protonated pyridinium by a neighboring aspartate residue.  A series of 2-fluoromethyl-substituted 4-chloropyridines demonstrated that the pKa and kinact/KI values could be predictably varied over several orders of magnitude.  Covalent labeling of proteins in an Escherichia coli lysate was shown to require folded proteins, indicating that alternative proteins can be targeted, and modification is likely to be catalysisdependent. 4-Halopyridines, and quiescent affinity labels in general, represent an attractive strategy to develop reagents with switchable electrophilicity as selective covalent protein modifiers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquxK7slP-8o7Vg90H21EOLACvtfcHk0licW_uBQIeyxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKhsbrE&md5=c71e0d7b061645a374919194678cab1a</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201700104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201700104%26sid%3Dliteratum%253Aachs%26aulast%3DSchardon%26aufirst%3DC.%2BL.%26aulast%3DTuley%26aufirst%3DA.%26aulast%3DEr%26aufirst%3DJ.%2BA.%2BV.%26aulast%3DSwartzel%26aufirst%3DJ.%2BC.%26aulast%3DFast%26aufirst%3DW.%26atitle%3DSelective%2520covalent%2520protein%2520modification%2520by%25204-halopyridines%2520through%2520catalysis%26jtitle%3DChemBioChem%26date%3D2017%26volume%3D18%26issue%3D15%26spage%3D1551%26epage%3D1556%26doi%3D10.1002%2Fcbic.201700104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shohet, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuchtern, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">10</span>), <span class="NLM_elocation-id">e867</span> <span class="refDoi">Â DOI: 10.1038/cddis.2013.400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fcddis.2013.400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24136231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Olu77J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&issue=10&author=Y.+H.+Fanauthor=J.+Chengauthor=S.+A.+Vasudevanauthor=J.+Douauthor=H.+Zhangauthor=R.+H.+Patelauthor=I.+T.+Maauthor=Y.+Rojasauthor=Y.+Zhaoauthor=Y.+Yuauthor=H.+Zhangauthor=J.+M.+Shohetauthor=J.+G.+Nuchternauthor=E.+S.+Kimauthor=J.+Yang&title=USP7+inhibitor+P22077+inhibits+neuroblastoma+growth+via+inducing+p53-mediated+apoptosis&doi=10.1038%2Fcddis.2013.400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis</span></div><div class="casAuthors">Fan, Y.-H.; Cheng, J.; Vasudevan, S. A.; Dou, J.; Zhang, H.; Patel, R. H.; Ma, I. T.; Rojas, Y.; Zhao, Y.; Yu, Y.; Zhang, H.; Shohet, J. M.; Nuchtern, J. G.; Kim, E. S.; Yang, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Oct.</span>),
    <span class="NLM_cas:pages">e867</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuroblastoma (NB) is a common pediatric cancer and contributes to more than 15% of all pediatric cancer-related deaths.  Unlike adult tumors, recurrent somatic mutations in NB, such as tumor protein 53 (p53) mutations, occur with relative paucity.  In addn., p53 downstream function is intact in NB cells with wild-type p53, suggesting that reactivation of p53 may be a viable therapeutic strategy for NB treatment.  Herein, we report that the ubiquitin-specific protease 7 (USP7) inhibitor, P22077, potently induces apoptosis in NB cells with an intact USP7-HDM2-p53 axis but not in NB cells with mutant p53 or without human homolog of MDM2 (HDM2) expression.  In this study, we found that P22077 stabilized p53 by inducing HDM2 protein degrdn. in NB cells.  P22077 also significantly augmented the cytotoxic effects of doxorubicin (Dox) and etoposide (VP-16) in NB cells with an intact USP7-HDM2-p53 axis.  Moreover, P22077 was found to be able to sensitize chemoresistant LA-N-6 NB cells to chemotherapy.  In an in vivo orthotopic NB mouse model, P22077 significantly inhibited the xenograft growth of three NB cell lines.  Database anal. of NB patients shows that high expression of USP7 significantly predicts poor outcomes.  Together, our data strongly suggest that targeting USP7 is a novel concept in the treatment of NB.  USP7-specific inhibitors like P22077 may serve not only as a stand-alone therapy but also as an effective adjunct to current chemotherapeutic regimens for treating NB with an intact USP7-HDM2-p53 axis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsoNqHcbJCuLVg90H21EOLACvtfcHk0licW_uBQIeyxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Olu77J&md5=cd91e66041a54477fe081914da560a22</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.400%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DY.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DVasudevan%26aufirst%3DS.%2BA.%26aulast%3DDou%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DPatel%26aufirst%3DR.%2BH.%26aulast%3DMa%26aufirst%3DI.%2BT.%26aulast%3DRojas%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DShohet%26aufirst%3DJ.%2BM.%26aulast%3DNuchtern%26aufirst%3DJ.%2BG.%26aulast%3DKim%26aufirst%3DE.%2BS.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DUSP7%2520inhibitor%2520P22077%2520inhibits%2520neuroblastoma%2520growth%2520via%2520inducing%2520p53-mediated%2520apoptosis%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26issue%3D10%26doi%3D10.1038%2Fcddis.2013.400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kingsbury, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodrasov, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKelvey, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh
Kumar, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenberg, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattern, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, B.</span></span> <span> </span><span class="NLM_article-title">Selective dual inhibitors of the cancer-related deubiquitylating proteases USP7 and USP47</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">789</span>â <span class="NLM_lpage">792</span>, <span class="refDoi">Â DOI: 10.1021/ml200276j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200276j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlekt7vF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=789-792&issue=10&author=J.+Weinstockauthor=J.+Wuauthor=P.+Caoauthor=W.+D.+Kingsburyauthor=J.+L.+McDermottauthor=M.+P.+Kodrasovauthor=D.+M.+McKelveyauthor=K.+G.+Suresh%0AKumarauthor=S.+J.+Goldenbergauthor=M.+R.+Matternauthor=B.+Nicholson&title=Selective+dual+inhibitors+of+the+cancer-related+deubiquitylating+proteases+USP7+and+USP47&doi=10.1021%2Fml200276j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47</span></div><div class="casAuthors">Weinstock, Joseph; Wu, Jian; Cao, Ping; Kingsbury, William D.; McDermott, Jeffrey L.; Kodrasov, Matthew P.; McKelvey, Devin M.; Suresh Kumar, K. G.; Goldenberg, Seth J.; Mattern, Michael R.; Nicholson, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">789-792</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the cancer-related cysteine isopeptidase human ubiquitin-specific proteases 7 (USP7) and 47 (USP47) are considered to have potential as cancer therapeutics, owing to their ability to stabilize the tumor suppressor p53 and to decrease DNA polymerase Î² (PolÎ²), both of which are potential anticancer effects.  A new class of dual small mol. inhibitors of these enzymes has been discovered.  Compd. 1 (I), a selective inhibitor of USP7 and USP47 with moderate potency, demonstrates inhibition of USP7 in cells and induces elevated p53 and apoptosis in cancer cell lines.  Compd. 1 has been shown to demonstrate modest activity in human xenograft multiple myeloma and B-cell leukemia in vivo models.  This activity may be the result of dual inhibition of USP7 and USP47.  To address issues regarding potency and developability, analogs of compd. 1 have been synthesized and tested, leading to improvements in potency, soly., and metabolic reactivity profile.  Further optimization is expected to yield preclin. candidates and, ultimately, clin. candidates for the treatment of multiple myeloma, prostate cancer, and other cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdgMcsqTMS-LVg90H21EOLACvtfcHk0lgF12DaVtOGjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlekt7vF&md5=2f273cf8c501bc940ab60efb9f63f1a9</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Fml200276j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200276j%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstock%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DP.%26aulast%3DKingsbury%26aufirst%3DW.%2BD.%26aulast%3DMcDermott%26aufirst%3DJ.%2BL.%26aulast%3DKodrasov%26aufirst%3DM.%2BP.%26aulast%3DMcKelvey%26aufirst%3DD.%2BM.%26aulast%3DSuresh%2BKumar%26aufirst%3DK.%2BG.%26aulast%3DGoldenberg%26aufirst%3DS.%2BJ.%26aulast%3DMattern%26aufirst%3DM.%2BR.%26aulast%3DNicholson%26aufirst%3DB.%26atitle%3DSelective%2520dual%2520inhibitors%2520of%2520the%2520cancer-related%2520deubiquitylating%2520proteases%2520USP7%2520and%2520USP47%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26issue%3D10%26spage%3D789%26epage%3D792%26doi%3D10.1021%2Fml200276j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pozhidaeva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valles, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterner, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K. G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezsonova, I.</span></span> <span> </span><span class="NLM_article-title">USP7-specific inhibitors target and modify the enzymeâs active site via distinct chemical mechanisms</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1501</span>â <span class="NLM_lpage">1512</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2017.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2017.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29056420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yrt7nI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1501-1512&issue=12&author=A.+Pozhidaevaauthor=G.+Vallesauthor=F.+Wangauthor=J.+Wuauthor=D.+E.+Sternerauthor=P.+Nguyenauthor=J.+Weinstockauthor=K.+G.+S.+Kumarauthor=J.+Kanyoauthor=D.+Wrightauthor=I.+Bezsonova&title=USP7-specific+inhibitors+target+and+modify+the+enzyme%E2%80%99s+active+site+via+distinct+chemical+mechanisms&doi=10.1016%2Fj.chembiol.2017.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms</span></div><div class="casAuthors">Pozhidaeva, Alexandra; Valles, Gabrielle; Wang, Feng; Wu, Jian; Sterner, David E.; Nguyen, Phuong; Weinstock, Joseph; Kumar, K. G. Suresh; Kanyo, Jean; Wright, Dennis; Bezsonova, Irina</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1501-1512.e5</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">USP7 is a deubiquitinating enzyme that plays a pivotal role in multiple oncogenic pathways and therefore is a desirable target for new anti-cancer therapies.  However, the lack of structural information about the USP7-inhibitor interactions has been a crit. gap in the development of potent inhibitors.  USP7 is unique among USPs in that its active site is catalytically incompetent, and is postulated to rearrange into a productive conformation only upon binding to ubiquitin.  Surprisingly, we found that ubiquitin alone does not induce an active conformation in soln.  Using a combination of NMR, mass spectrometry, computational modeling, and cell-based assays, we found that DUB inhibitors P22077 and P50429 covalently modify the catalytic cysteine of USP7 and induce a conformational switch in the enzyme assocd. with active site rearrangement.  This work represents the first exptl. insights into USP7 activation and inhibition and provides a structural basis for rational development of potent anti-cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq6cfJxLOHFLVg90H21EOLACvtfcHk0lgF12DaVtOGjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yrt7nI&md5=8d8baef989ebbfb010640b2ecfd95ae4</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DPozhidaeva%26aufirst%3DA.%26aulast%3DValles%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSterner%26aufirst%3DD.%2BE.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DWeinstock%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DK.%2BG.%2BS.%26aulast%3DKanyo%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DD.%26aulast%3DBezsonova%26aufirst%3DI.%26atitle%3DUSP7-specific%2520inhibitors%2520target%2520and%2520modify%2520the%2520enzyme%25E2%2580%2599s%2520active%2520site%2520via%2520distinct%2520chemical%2520mechanisms%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26issue%3D12%26spage%3D1501%26epage%3D1512%26doi%3D10.1016%2Fj.chembiol.2017.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto-Fernandez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heride, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, A. C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonkin, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buker, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancia, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravella, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toms, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahdenranta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Follows, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stead, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarayskiy, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckmelter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saab, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGouran, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Century, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gersch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynham, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simcox, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, L. M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLoughlin, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escobedo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammonds, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">UrbÃ©, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clague, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komander, D.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of USP7 inhibition by selective small-molecule inhibitors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>550</i></span> (<span class="NLM_issue">7677</span>),  <span class="NLM_fpage">481</span>â <span class="NLM_lpage">486</span>, <span class="refDoi">Â DOI: 10.1038/nature24451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature24451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29045389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1OhtrnK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=550&publication_year=2017&pages=481-486&issue=7677&author=A.+P.+Turnbullauthor=S.+Ioannidisauthor=W.+W.+Krajewskiauthor=A.+Pinto-Fernandezauthor=C.+Herideauthor=A.+C.+L.+Martinauthor=L.+M.+Tonkinauthor=E.+C.+Townsendauthor=S.+M.+Bukerauthor=D.+R.+Lanciaauthor=J.+A.+Caravellaauthor=A.+V.+Tomsauthor=T.+M.+Charltonauthor=J.+Lahdenrantaauthor=E.+Wilkerauthor=B.+C.+Followsauthor=N.+J.+Evansauthor=L.+Steadauthor=C.+Alliauthor=V.+V.+Zarayskiyauthor=A.+C.+Talbotauthor=A.+J.+Buckmelterauthor=M.+Wangauthor=C.+L.+McKinnonauthor=F.+Saabauthor=J.+F.+McGouranauthor=H.+Centuryauthor=M.+Gerschauthor=M.+S.+Pittmanauthor=C.+G.+Marshallauthor=T.+M.+Raynhamauthor=M.+Simcoxauthor=L.+M.+D.+Stewartauthor=S.+B.+McLoughlinauthor=J.+A.+Escobedoauthor=K.+W.+Bairauthor=C.+J.+Dinsmoreauthor=T.+R.+Hammondsauthor=S.+Kimauthor=S.+Urb%C3%A9author=M.+J.+Clagueauthor=B.+M.+Kesslerauthor=D.+Komander&title=Molecular+basis+of+USP7+inhibition+by+selective+small-molecule+inhibitors&doi=10.1038%2Fnature24451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of USP7 inhibition by selective small-molecule inhibitors</span></div><div class="casAuthors">Turnbull, Andrew P.; Ioannidis, Stephanos; Krajewski, Wojciech W.; Pinto-Fernandez, Adan; Heride, Claire; Martin, Agnes C. L.; Tonkin, Louise M.; Townsend, Elizabeth C.; Buker, Shane M.; Lancia, David R.; Caravella, Justin A.; Toms, Angela V.; Charlton, Thomas M.; Lahdenranta, Johanna; Wilker, Erik; Follows, Bruce C.; Evans, Nicola J.; Stead, Lucy; Alli, Cristina; Zarayskiy, Vladislav V.; Talbot, Adam C.; Buckmelter, Alexandre J.; Wang, Minghua; McKinnon, Crystal L.; Saab, Fabienne; McGouran, Joanna F.; Century, Hannah; Gersch, Malte; Pittman, Marc S.; Marshall, C. Gary; Raynham, Tony M.; Simcox, Mary; Stewart, Lorna M. D.; McLoughlin, Sheila B.; Escobedo, Jaime A.; Bair, Kenneth W.; Dinsmore, Christopher J.; Hammonds, Tim R.; Kim, Sunkyu; Urbe, Sylvie; Clague, Michael J.; Kessler, Benedikt M.; Komander, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">550</span>
        (<span class="NLM_cas:issue">7677</span>),
    <span class="NLM_cas:pages">481-486</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Ubiquitination controls the stability of most cellular proteins, and its deregulation contributes to human diseases including cancer.  Deubiquitinases remove ubiquitin from proteins, and their inhibition can induce the degrdn. of selected proteins, potentially including otherwise 'undruggable' targets.  For example, the inhibition of ubiquitin-specific protease 7 (USP7) results in the degrdn. of the oncogenic E3 ligase MDM2, and leads to reactivation of the tumor suppressor p53 in various cancers.  Here the authors report that two compds., FT671 and FT827, inhibit USP7 with high affinity and specificity in vitro and within human cells.  Cocrystal structures reveal that both compds. target a dynamic pocket near the catalytic center of the auto-inhibited apo form of USP7, which differs from other USP deubiquitinases.  Consistent with USP7 target engagement in cells, FT671 destabilizes USP7 substrates including MDM2, increases levels of p53, and results in the transcription of p53 target genes, induction of the tumor suppressor p21, and inhibition of tumor growth in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR8apmCZU85rVg90H21EOLACvtfcHk0ljSe2xxz50CIA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1OhtrnK&md5=166efb5b9de6304829c09fa3e4fb540a</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1038%2Fnature24451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature24451%26sid%3Dliteratum%253Aachs%26aulast%3DTurnbull%26aufirst%3DA.%2BP.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DKrajewski%26aufirst%3DW.%2BW.%26aulast%3DPinto-Fernandez%26aufirst%3DA.%26aulast%3DHeride%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DA.%2BC.%2BL.%26aulast%3DTonkin%26aufirst%3DL.%2BM.%26aulast%3DTownsend%26aufirst%3DE.%2BC.%26aulast%3DBuker%26aufirst%3DS.%2BM.%26aulast%3DLancia%26aufirst%3DD.%2BR.%26aulast%3DCaravella%26aufirst%3DJ.%2BA.%26aulast%3DToms%26aufirst%3DA.%2BV.%26aulast%3DCharlton%26aufirst%3DT.%2BM.%26aulast%3DLahdenranta%26aufirst%3DJ.%26aulast%3DWilker%26aufirst%3DE.%26aulast%3DFollows%26aufirst%3DB.%2BC.%26aulast%3DEvans%26aufirst%3DN.%2BJ.%26aulast%3DStead%26aufirst%3DL.%26aulast%3DAlli%26aufirst%3DC.%26aulast%3DZarayskiy%26aufirst%3DV.%2BV.%26aulast%3DTalbot%26aufirst%3DA.%2BC.%26aulast%3DBuckmelter%26aufirst%3DA.%2BJ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DMcKinnon%26aufirst%3DC.%2BL.%26aulast%3DSaab%26aufirst%3DF.%26aulast%3DMcGouran%26aufirst%3DJ.%2BF.%26aulast%3DCentury%26aufirst%3DH.%26aulast%3DGersch%26aufirst%3DM.%26aulast%3DPittman%26aufirst%3DM.%2BS.%26aulast%3DMarshall%26aufirst%3DC.%2BG.%26aulast%3DRaynham%26aufirst%3DT.%2BM.%26aulast%3DSimcox%26aufirst%3DM.%26aulast%3DStewart%26aufirst%3DL.%2BM.%2BD.%26aulast%3DMcLoughlin%26aufirst%3DS.%2BB.%26aulast%3DEscobedo%26aufirst%3DJ.%2BA.%26aulast%3DBair%26aufirst%3DK.%2BW.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DHammonds%26aufirst%3DT.%2BR.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DUrb%25C3%25A9%26aufirst%3DS.%26aulast%3DClague%26aufirst%3DM.%2BJ.%26aulast%3DKessler%26aufirst%3DB.%2BM.%26aulast%3DKomander%26aufirst%3DD.%26atitle%3DMolecular%2520basis%2520of%2520USP7%2520inhibition%2520by%2520selective%2520small-molecule%2520inhibitors%26jtitle%3DNature%26date%3D2017%26volume%3D550%26issue%3D7677%26spage%3D481%26epage%3D486%26doi%3D10.1038%2Fnature24451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schauer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magin, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficarro, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacob, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacomelli, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boswell, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisberg, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorger, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmaier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span> <span> </span><span class="NLM_article-title">Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">5324</span>, <span class="refDoi">Â DOI: 10.1038/s41598-020-62076-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41598-020-62076-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32210275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFGgtbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=5324&issue=1&author=N.+J.+Schauerauthor=X.+Liuauthor=R.+S.+Maginauthor=L.+M.+Dohertyauthor=W.+C.+Chanauthor=S.+B.+Ficarroauthor=W.+Huauthor=R.+M.+Robertsauthor=R.+E.+Iacobauthor=B.+Stolteauthor=A.+O.+Giacomelliauthor=S.+Pereraauthor=K.+McKayauthor=S.+A.+Boswellauthor=E.+L.+Weisbergauthor=A.+Rayauthor=D.+Chauhanauthor=S.+Dhe-Paganonauthor=K.+C.+Andersonauthor=J.+D.+Griffinauthor=J.+Liauthor=W.+C.+Hahnauthor=P.+K.+Sorgerauthor=J.+R.+Engenauthor=K.+Stegmaierauthor=J.+A.+Martoauthor=S.+J.+Buhrlage&title=Selective+USP7+inhibition+elicits+cancer+cell+killing+through+a+p53-dependent+mechanism&doi=10.1038%2Fs41598-020-62076-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism</span></div><div class="casAuthors">Schauer, Nathan J.; Liu, Xiaoxi; Magin, Robert S.; Doherty, Laura M.; Chan, Wai Cheung; Ficarro, Scott B.; Hu, Wanyi; Roberts, Rebekka M.; Iacob, Roxana E.; Stolte, Bjorn; Giacomelli, Andrew O.; Perera, Sumner; McKay, Kyle; Boswell, Sarah A.; Weisberg, Ellen L.; Ray, Arghya; Chauhan, Dharminder; Dhe-Paganon, Sirano; Anderson, Ken C.; Griffin, James D.; Li, Jianing; Hahn, William C.; Sorger, Peter K.; Engen, John R.; Stegmaier, Kimberly; Marto, Jarrod A.; Buhrlage, Sara J.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5324</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Ubiquitin specific peptidase 7 (USP7) is a deubiquitinating enzyme (DUB) that removes ubiquitin tags from specific protein substrates in order to alter their degrdn. rate and sub-cellular localization.  USP7 has been proposed as a therapeutic target in several cancers because it has many reported substrates with a role in cancer progression, including FOXO4, MDM2, N-Myc, and PTEN.  The multi-substrate nature of USP7, combined with the modest potency and selectivity of early generation USP7 inhibitors, has presented a challenge in defining predictors of response to USP7 and potential patient populations that would benefit most from USP7-targeted drugs.  Here, we describe the structure-guided development of XL177A, which irreversibly inhibits USP7 with sub-nM potency and selectivity across the human proteome.  Evaluation of the cellular effects of XL177A reveals that selective USP7 inhibition suppresses cancer cell growth predominantly through a p53-dependent mechanism: XL177A specifically upregulates p53 transcriptional targets transcriptome-wide, hotspot mutations in TP53 but not any other genes predict response to XL177A across a panel of ~ 500 cancer cell lines, and TP53 knockout rescues XL177A-mediated growth suppression of TP53 wild-type (WT) cells.  Together, these findings suggest TP53 mutational status as a biomarker for response to USP7 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGgnv2Qj2wn7Vg90H21EOLACvtfcHk0ljwKlnnIVmLLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFGgtbo%253D&md5=bcb86b6713758ca9fb83b390c538267f</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-62076-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-62076-x%26sid%3Dliteratum%253Aachs%26aulast%3DSchauer%26aufirst%3DN.%2BJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMagin%26aufirst%3DR.%2BS.%26aulast%3DDoherty%26aufirst%3DL.%2BM.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DRoberts%26aufirst%3DR.%2BM.%26aulast%3DIacob%26aufirst%3DR.%2BE.%26aulast%3DStolte%26aufirst%3DB.%26aulast%3DGiacomelli%26aufirst%3DA.%2BO.%26aulast%3DPerera%26aufirst%3DS.%26aulast%3DMcKay%26aufirst%3DK.%26aulast%3DBoswell%26aufirst%3DS.%2BA.%26aulast%3DWeisberg%26aufirst%3DE.%2BL.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DSorger%26aufirst%3DP.%2BK.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DStegmaier%26aufirst%3DK.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26atitle%3DSelective%2520USP7%2520inhibition%2520elicits%2520cancer%2520cell%2520killing%2520through%2520a%2520p53-dependent%2520mechanism%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26issue%3D1%26spage%3D5324%26doi%3D10.1038%2Fs41598-020-62076-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapuria, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talpaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donato, N. J.</span></span> <span> </span><span class="NLM_article-title">Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">9265</span>â <span class="NLM_lpage">9276</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-10-1530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1158%2F0008-5472.CAN-10-1530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21045142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWmsLjM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=9265-9276&issue=22&author=V.+Kapuriaauthor=L.+F.+Petersonauthor=D.+Fangauthor=W.+G.+Bornmannauthor=M.+Talpazauthor=N.+J.+Donato&title=Deubiquitinase+inhibition+by+small-molecule+WP1130+triggers+aggresome+formation+and+tumor+cell+apoptosis&doi=10.1158%2F0008-5472.CAN-10-1530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Deubiquitinase Inhibition by Small-Molecule WP1130 Triggers Aggresome Formation and Tumor Cell Apoptosis</span></div><div class="casAuthors">Kapuria, Vaibhav; Peterson, Luke F.; Fang, Dexing; Bornmann, William G.; Talpaz, Moshe; Donato, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9265-9276</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Recent evidence suggests that several deubiquitinases (DUB) are overexpressed or activated in tumor cells and many contribute to the transformed phenotype.  Agents with DUB inhibitory activity may therefore have therapeutic value.  In this study, we describe the mechanism of action of WP1130, a small mol. derived from a compd. with Janus-activated kinase 2 (JAK2) kinase inhibitory activity.  WP1130 induces rapid accumulation of polyubiquitinated (K48/K63-linked) proteins into juxtanuclear aggresomes, without affecting 20S proteasome activity.  WP1130 acts as a partly selective DUB inhibitor, directly inhibiting DUB activity of USP9x, USP5, USP14, and UCH37, which are known to regulate survival protein stability and 26S proteasome function.  WP1130-mediated inhibition of tumor-activated DUBs results in downregulation of antiapoptotic and upregulation of proapoptotic proteins, such as MCL-1 and p53.  Our results show that chem. modification of a previously described JAK2 inhibitor results in the unexpected discovery of a novel DUB inhibitor with a unique antitumor mechanism.  Cancer Res; 70(22); 9265-76.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTYP-6z7_QxrVg90H21EOLACvtfcHk0ljUyVysqPY6xw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWmsLjM&md5=60ca96bc9a7c114292dc0dd259bf19c5</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1530%26sid%3Dliteratum%253Aachs%26aulast%3DKapuria%26aufirst%3DV.%26aulast%3DPeterson%26aufirst%3DL.%2BF.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DDonato%26aufirst%3DN.%2BJ.%26atitle%3DDeubiquitinase%2520inhibition%2520by%2520small-molecule%2520WP1130%2520triggers%2520aggresome%2520formation%2520and%2520tumor%2520cell%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D22%26spage%3D9265%26epage%3D9276%26doi%3D10.1158%2F0008-5472.CAN-10-1530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandarpa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakubowiak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talpaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donato, N. J.</span></span> <span> </span><span class="NLM_article-title">Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">3588</span>â <span class="NLM_lpage">3597</span>, <span class="refDoi">Â DOI: 10.1182/blood-2014-10-605584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1182%2Fblood-2014-10-605584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25814533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOgtrbO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=3588-3597&issue=23&author=L.+F.+Petersonauthor=H.+Sunauthor=Y.+Liuauthor=H.+Potuauthor=M.+Kandarpaauthor=M.+Ermannauthor=S.+M.+Courtneyauthor=M.+Youngauthor=H.+D.+Showalterauthor=D.+Sunauthor=A.+Jakubowiakauthor=S.+N.+Malekauthor=M.+Talpazauthor=N.+J.+Donato&title=Targeting+deubiquitinase+activity+with+a+novel+small-molecule+inhibitor+as+therapy+for+B-cell+malignancies&doi=10.1182%2Fblood-2014-10-605584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies</span></div><div class="casAuthors">Peterson, Luke F.; Sun, Hanshi; Liu, Yihong; Potu, Harish; Kandarpa, Malathi; Ermann, Monika; Courtney, Stephen M.; Young, Matthew; Showalter, Hollis D.; Sun, Duxin; Jakubowiak, Andrzej; Malek, Sami N.; Talpaz, Moshe; Donato, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3588-3597</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Usp9x was recently shown to be highly expressed in myeloma patients with short progression-free survival and is proposed to enhance stability of the survival protein Mcl-1.  In this study, we found that the partially selective Usp9x deubiquitinase inhibitor WP1130 induced apoptosis and reduced Mcl-1 protein levels.  However, short hairpin RNA-mediated knockdown (KD) of Usp9x in myeloma cells resulted in transient induction of apoptosis, followed by a sustained redn. in cell growth.  A compensatory upregulation of Usp24, a deubiquitinase closely related to Usp9x, in Usp9x KD cells was noted.  Direct Usp24 KD resulted in marked induction of myeloma cell death that was assocd. with a redn. of Mcl-1.  Usp24 was found to sustain myeloma cell survival and Mcl-1 regulation in the absence of Usp9x.  Both Usp9x and Usp24 were expressed and activated in primary myeloma cells whereas Usp24 protein overexpression was noted in some patients with drug-refractory myeloma and other B-cell malignancies.  Furthermore, we improved the drug-like properties of WP1130 and demonstrated that the novel compd. EOAI3402143 dose-dependently inhibited Usp9x and Usp24 activity, increased tumor cell apoptosis, and fully blocked or regressed myeloma tumors in mice.  We conclude that small-mol. Usp9x/Usp24 inhibitors may have therapeutic activity in myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVLMg6nhf7eLVg90H21EOLACvtfcHk0ljUyVysqPY6xw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOgtrbO&md5=9bdf0d51c8f32af963e30827f94f8a2c</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1182%2Fblood-2014-10-605584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2014-10-605584%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DL.%2BF.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPotu%26aufirst%3DH.%26aulast%3DKandarpa%26aufirst%3DM.%26aulast%3DErmann%26aufirst%3DM.%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26aulast%3DYoung%26aufirst%3DM.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DJakubowiak%26aufirst%3DA.%26aulast%3DMalek%26aufirst%3DS.%2BN.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DDonato%26aufirst%3DN.%2BJ.%26atitle%3DTargeting%2520deubiquitinase%2520activity%2520with%2520a%2520novel%2520small-molecule%2520inhibitor%2520as%2520therapy%2520for%2520B-cell%2520malignancies%26jtitle%3DBlood%26date%3D2015%26volume%3D125%26issue%3D23%26spage%3D3588%26epage%3D3597%26doi%3D10.1182%2Fblood-2014-10-605584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MartÃ­nez-Lostao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, J.</span></span> <span> </span><span class="NLM_article-title">How do cytotoxic lymphocytes kill cancer cells?</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">5047</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-15-0685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1158%2F1078-0432.CCR-15-0685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26567364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVajsbjF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=5047&issue=22&author=L.+Mart%C3%ADnez-Lostaoauthor=A.+Anelauthor=J.+Pardo&title=How+do+cytotoxic+lymphocytes+kill+cancer+cells%3F&doi=10.1158%2F1078-0432.CCR-15-0685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">How Do Cytotoxic Lymphocytes Kill Cancer Cells?</span></div><div class="casAuthors">Martinez-Lostao, Luis; Anel, Alberto; Pardo, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5047-5056</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In the past few years, cancer immunotherapy has emerged as a safe and effective alternative for treatment of cancers that do not respond to classical treatments, including those types with high aggressiveness.  New immune modulators, such as cytokines, blockers of CTLA-4 (cytotoxic T-lymphocyte-assocd. protein 4) and PD-1(programmed cell death protein 1)/PD-L1 (programmed death-ligand 1), and interaction or adoptive cell therapy, have been developed and approved to treat solid and hematol. carcinomas.  In these scenarios, cytotoxic lymphocytes (CL), mainly cytotoxic T cells (Tc) and natural killer (NK) cells, are ultimately responsible for killing the cancer cells and eradicating the tumor.  Extensive studies have been conducted to assess how Tc and NK cells get activated and recognize the cancer cell.  In contrast, few studies have focused on the effector mols. used by CLs to kill cancer cells during cancer immunosurveillance and immunotherapy.  In this article, the two main pathways involved in CL-mediated tumor cell death, granule exocytosis (perforin and granzymes) and death ligands, are briefly introduced, followed by a crit. discussion of the mols. involved in cell death during cancer immunosurveillance and immunotherapy.  This discussion also covers unexpected consequences of proinflammatory and survival effects of granzymes and death ligands and recent exptl. evidence indicating that perforin and granzymes of CLs can activate nonapoptotic pathways of cell death, overcoming apoptosis defects and chemoresistance.  The consequences of apoptosis vs. other modalities of cell death for an effective treatment of cancer by modulating the patient immune system are also briefly discussed.  Clin Cancer Res; 21(22); 5047-56. Â©2015 AACR.  See all articles in this CCR Focus section, "Cell Death and Cancer Therapy.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCQKr0bwj2mLVg90H21EOLACvtfcHk0ljUyVysqPY6xw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVajsbjF&md5=a7d0e6b7ce7122874a94c925252b7ea0</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-15-0685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-15-0685%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADnez-Lostao%26aufirst%3DL.%26aulast%3DAnel%26aufirst%3DA.%26aulast%3DPardo%26aufirst%3DJ.%26atitle%3DHow%2520do%2520cytotoxic%2520lymphocytes%2520kill%2520cancer%2520cells%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26issue%3D22%26spage%3D5047%26doi%3D10.1158%2F1078-0432.CCR-15-0685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voskoboinik, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapani, J. A.</span></span> <span> </span><span class="NLM_article-title">Perforin and granzymes: function, dysfunction and human pathology</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">388</span>â <span class="NLM_lpage">400</span>, <span class="refDoi">Â DOI: 10.1038/nri3839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnri3839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25998963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=388-400&issue=6&author=I.+Voskoboinikauthor=J.+C.+Whisstockauthor=J.+A.+Trapani&title=Perforin+and+granzymes%3A+function%2C+dysfunction+and+human+pathology&doi=10.1038%2Fnri3839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Perforin and granzymes: function, dysfunction and human pathology</span></div><div class="casAuthors">Voskoboinik, Ilia; Whisstock, James C.; Trapani, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">388-400</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A defining property of cytotoxic lymphocytes is their expression and regulated secretion of potent toxins, including the pore-forming protein perforin and serine protease granzymes.  Until recently, mechanisms of pore formation and granzyme transfer into the target cell were poorly understood, but advances in structural and cellular biol. have now begun to unravel how synergy between perforin and granzymes brings about target cell death.  These and other advances are demonstrating the surprisingly broad pathophysiol. roles of the perforin-granzyme pathway, and this has important implications for understanding immune homeostasis and for developing immunotherapies for cancer and other diseases.  In particular, we are beginning to define and understand a range of human diseases that are assocd. with a failure to deliver active perforin to target cells.  In this Review, we discuss the current understanding of the structural, cellular and clin. aspects of perforin and granzyme biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOyD8r4tQK67Vg90H21EOLACvtfcHk0liwP2KaM59MAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7jK&md5=751e132b6f0b5808387317645c902236</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1038%2Fnri3839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3839%26sid%3Dliteratum%253Aachs%26aulast%3DVoskoboinik%26aufirst%3DI.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26aulast%3DTrapani%26aufirst%3DJ.%2BA.%26atitle%3DPerforin%2520and%2520granzymes%253A%2520function%252C%2520dysfunction%2520and%2520human%2520pathology%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2015%26volume%3D15%26issue%3D6%26spage%3D388%26epage%3D400%26doi%3D10.1038%2Fnri3839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DâEliseo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Rocco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loria, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soddu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velotti, F.</span></span> <span> </span><span class="NLM_article-title">Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">24</span>, <span class="refDoi">Â DOI: 10.1186/s13046-016-0302-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1186%2Fs13046-016-0302-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26830472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWis7fM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=24&issue=1&author=D.+D%E2%80%99Eliseoauthor=G.+Di+Roccoauthor=R.+Loriaauthor=S.+Sodduauthor=A.+Santoniauthor=F.+Velotti&title=Epitelial-to-mesenchimal+transition+and+invasion+are+upmodulated+by+tumor-expressed+granzyme+B+and+inhibited+by+docosahexaenoic+acid+in+human+colorectal+cancer+cells&doi=10.1186%2Fs13046-016-0302-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells</span></div><div class="casAuthors">D'Eliseo, Donatella; Di Rocco, Giuliana; Loria, Rossella; Soddu, Silvia; Santoni, Angela; Velotti, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24/1-24/11</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Granzyme B (GrB) is a serine protease, traditionally known as expressed by cytotoxic lymphocytes to induce target cell apoptosis.  However, it is emerging that GrB, being also produced by a variety of normal and neoplastic cells and potentially acting on multiple targets, might represent a powerful regulator of a wide range of fundamental biol. processes.  We have previously shown that GrB is expressed in urothelial carcinoma tissues and its expression is assocd. to both pathol. tumor spreading and EMT.  We have also shown that docosahexaenoic acid (DHA), a dietary Ï-3 polyunsatd. fatty acid with anti-tumor activity, while inhibiting urothelial and pancreatic carcinoma cell invasion also inhibited their GrB expression in vitro.  In this study, we characterized a panel of colorectal carcinoma (CRC) cells, with different invasive capabilities, for GrB expression and for the contribution of GrB to their EMT and invasive phenotype.  In addn., we investigated the effect of DHA on CRC cell-assocd. GrB expression, EMT and invasion.  Methods: The expression levels of GrB and EMT-related markers were evaluated by Western blotting.  GrB knockdown was performed by Stealth RNAi small interfering RNA silencing and ectopic GrB expression by transfection of human GrB vector.  Cell invasion was detd. by the BioCoat Matrigel invasion chamber test.  Results: GrB was produced in 57.1 % CRC cell lines and 100 % CRC-derived Cancer Stem Cells.  Although GrB was constitutive expressed in both invasive and noninvasive CRC cells, GrB depletion in invasive CRC cells downmodulated their invasion in vitro, suggesting a contribution of GrB to CRC invasiveness.  GrB loss or gain of function downmodulated or upmodulated EMT, resp., according to the anal. of cancer cell expression of three EMT biomarkers (Snail1, E-cadherin, N-cadherin).  Moreover, TGF-Î²1-driven EMT was assocd. to the enhancement of GrB expression in CRC cell lines, and GrB depletion led to downmodulation of TGF-Î²1-driven EMT.  In addn., DHA inhibited GrB expression, EMT and invasion in CRC cells in vitro.  Conclusions: These findings present a novel role for GrB as upmodulator of EMT in CRC cells.  Moreover, these results support the use of DHA, a dietary compd. without toxic effects, as adjuvant in CRC therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJDcIJetZ3ebVg90H21EOLACvtfcHk0liwP2KaM59MAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWis7fM&md5=739dee1e8b1c5acd2fad89079952c237</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1186%2Fs13046-016-0302-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-016-0302-6%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Eliseo%26aufirst%3DD.%26aulast%3DDi%2BRocco%26aufirst%3DG.%26aulast%3DLoria%26aufirst%3DR.%26aulast%3DSoddu%26aufirst%3DS.%26aulast%3DSantoni%26aufirst%3DA.%26aulast%3DVelotti%26aufirst%3DF.%26atitle%3DEpitelial-to-mesenchimal%2520transition%2520and%2520invasion%2520are%2520upmodulated%2520by%2520tumor-expressed%2520granzyme%2520B%2520and%2520inhibited%2520by%2520docosahexaenoic%2520acid%2520in%2520human%2520colorectal%2520cancer%2520cells%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D35%26issue%3D1%26spage%3D24%26doi%3D10.1186%2Fs13046-016-0302-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DâEliseo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Nunzio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoppacciaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velotti, F.</span></span> <span> </span><span class="NLM_article-title">Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>127</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1283</span>â <span class="NLM_lpage">1294</span>, <span class="refDoi">Â DOI: 10.1002/ijc.25135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fijc.25135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=20027633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1OhsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2010&pages=1283-1294&issue=6&author=D.+D%E2%80%99Eliseoauthor=P.+Pisuauthor=C.+Romanoauthor=A.+Tubaroauthor=C.+De+Nunzioauthor=S.+Morroneauthor=A.+Santoniauthor=A.+Stoppacciaroauthor=F.+Velotti&title=Granzyme+B+is+expressed+in+urothelial+carcinoma+and+promotes+cancer+cell+invasion&doi=10.1002%2Fijc.25135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion</span></div><div class="casAuthors">D'Eliseo, Donatella; Pisu, Paola; Romano, Chiara; Tubaro, Andrea; De Nunzio, Cosimo; Morrone, Stefania; Santoni, Angela; Stoppacciaro, Antonella; Velotti, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1283-1294</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Granzyme B (GrB) is a serine proteinase known to be expressed by cytotoxic lymphocytes and to induce, in presence of perforin (Pf), apoptosis in target cells.  Recently, GrB expression has been shown (often in absence of Pf) in nonlymphoid cells, but its function is not defined.  In our study, we investigated GrB and Pf expression in bladder cancer cell lines and in urothelial carcinoma (UC) tissues by reverse transcription-polymerase chain reaction (RT-PCR), Western blot, ELISA, immunofluorescence and immunohistochem.  We also assessed the function of GrB in UC cells; the in vitro function of GrB was examd. by loss-of-function expts.  Our results revealed that GrB is expressed, in absence of Pf, in UC cells.  Significant differences were found between GrB expression and both increasing pathol. tumor spreading and high-grade vs. low-grade pTa tumors.  Notably, GrB in UC tissues was concd. at the cancer invasion front and was expressed in neoplastic cells undergoing epithelial-mesenchymal transition, a key event in carcinoma invasion.  Indeed, GrB-pos. cells also expressed Snail, N-cadherin or were neg. for E-cadherin.  GrB expressed in tumor cell lines was enzymically active and capable of vitronectin cleavage, implying extracellular matrix (ECM) remodeling by GrB.  Inhibition of GrB activity or Stealth RNA interference-mediated GrB gene silencing markedly suppressed bladder cancer cell invasion through matrigel.  This data provides the first evidence for a role of GrB in promoting cancer cell invasion.  Taken together, our findings suggest that GrB, via ECM degrdn., contributes to the establishment of the UC invasive phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoranTNLHFKebVg90H21EOLACvtfcHk0lhptZ0gt6co3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1OhsLc%253D&md5=4074d52ffbfd744fe2c67dab4134639b</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1002%2Fijc.25135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.25135%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Eliseo%26aufirst%3DD.%26aulast%3DPisu%26aufirst%3DP.%26aulast%3DRomano%26aufirst%3DC.%26aulast%3DTubaro%26aufirst%3DA.%26aulast%3DDe%2BNunzio%26aufirst%3DC.%26aulast%3DMorrone%26aufirst%3DS.%26aulast%3DSantoni%26aufirst%3DA.%26aulast%3DStoppacciaro%26aufirst%3DA.%26aulast%3DVelotti%26aufirst%3DF.%26atitle%3DGranzyme%2520B%2520is%2520expressed%2520in%2520urothelial%2520carcinoma%2520and%2520promotes%2520cancer%2520cell%2520invasion%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2010%26volume%3D127%26issue%3D6%26spage%3D1283%26epage%3D1294%26doi%3D10.1002%2Fijc.25135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaiserman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, P. I.</span></span> <span> </span><span class="NLM_article-title">Control of granzymes by serpins</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">586</span>â <span class="NLM_lpage">595</span>, <span class="refDoi">Â DOI: 10.1038/cdd.2009.169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fcdd.2009.169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19893573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1Ogsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=586-595&issue=4&author=D.+Kaisermanauthor=P.+I.+Bird&title=Control+of+granzymes+by+serpins&doi=10.1038%2Fcdd.2009.169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Control of granzymes by serpins</span></div><div class="casAuthors">Kaiserman, D.; Bird, P. I.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">586-595</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Although proteolysis mediated by granzymes has an important role in the immune response to infection or tumors, unrestrained granzyme activity may damage normal cells.  In this review, we discuss the role of serpins within the immune system, as specific regulators of granzymes.  The well-characterized human granzyme B-SERPINB9 interaction highlights the cytoprotective function that serpins have in safeguarding lymphocytes from granzymes that may leak from granules.  We also discuss some of the pitfalls inherent in using rodent models of granzyme-serpin interactions and the ways in which our understanding of serpins can help resolve some of the current, contentious issues in granzyme biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2tCSUFTe24rVg90H21EOLACvtfcHk0lhptZ0gt6co3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1Ogsb4%253D&md5=0a33b4e6e593228297779ec0013c8cbd</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2009.169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2009.169%26sid%3Dliteratum%253Aachs%26aulast%3DKaiserman%26aufirst%3DD.%26aulast%3DBird%26aufirst%3DP.%2BI.%26atitle%3DControl%2520of%2520granzymes%2520by%2520serpins%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2010%26volume%3D17%26issue%3D4%26spage%3D586%26epage%3D595%26doi%3D10.1038%2Fcdd.2009.169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span> <span> </span><span class="NLM_article-title">Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome</span>. <i>Sci. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">43</span>), <span class="NLM_elocation-id">eaax7969</span> <span class="refDoi">Â DOI: 10.1126/sciimmunol.aax7969</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fsciimmunol.aax7969" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31953257" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2020&issue=43&author=Y.+Liuauthor=Y.+Fangauthor=X.+Chenauthor=Z.+Wangauthor=X.+Liangauthor=T.+Zhangauthor=M.+Liuauthor=N.+Zhouauthor=J.+Lvauthor=K.+Tangauthor=J.+Xieauthor=Y.+Gaoauthor=F.+Chengauthor=Y.+Zhouauthor=Z.+Zhangauthor=Y.+Huauthor=X.+Zhangauthor=Q.+Gaoauthor=Y.+Zhangauthor=B.+Huang&title=Gasdermin+E-mediated+target+cell+pyroptosis+by+CAR+T+cells+triggers+cytokine+release+syndrome&doi=10.1126%2Fsciimmunol.aax7969"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1126%2Fsciimmunol.aax7969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciimmunol.aax7969%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DLv%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DK.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DB.%26atitle%3DGasdermin%2520E-mediated%2520target%2520cell%2520pyroptosis%2520by%2520CAR%2520T%2520cells%2520triggers%2520cytokine%2520release%2520syndrome%26jtitle%3DSci.%2520Immunol.%26date%3D2020%26volume%3D5%26issue%3D43%26doi%3D10.1126%2Fsciimmunol.aax7969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, F.</span></span> <span> </span><span class="NLM_article-title">Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>368</i></span> (<span class="NLM_issue">6494</span>), <span class="NLM_elocation-id">eaaz7548</span> <span class="refDoi">Â DOI: 10.1126/science.aaz7548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fscience.aaz7548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32299851" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2020&issue=6494&author=Z.+Zhouauthor=H.+Heauthor=K.+Wangauthor=X.+Shiauthor=Y.+Wangauthor=Y.+Suauthor=Y.+Wangauthor=D.+Liauthor=W.+Liuauthor=Y.+Zhangauthor=L.+Shenauthor=W.+Hanauthor=L.+Shenauthor=J.+Dingauthor=F.+Shao&title=Granzyme+A+from+cytotoxic+lymphocytes+cleaves+GSDMB+to+trigger+pyroptosis+in+target+cells&doi=10.1126%2Fscience.aaz7548"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaz7548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaz7548%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DF.%26atitle%3DGranzyme%2520A%2520from%2520cytotoxic%2520lymphocytes%2520cleaves%2520GSDMB%2520to%2520trigger%2520pyroptosis%2520in%2520target%2520cells%26jtitle%3DScience%26date%3D2020%26volume%3D368%26issue%3D6494%26doi%3D10.1126%2Fscience.aaz7548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graubert, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ley, T. J.</span></span> <span> </span><span class="NLM_article-title">The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1232</span>â <span class="NLM_lpage">1237</span>, <span class="refDoi">Â DOI: 10.1182/blood.V87.4.1232.bloodjournal8741232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1182%2Fblood.V87.4.1232.bloodjournal8741232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8608209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADyaK287ptVSgtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1996&pages=1232-1237&issue=4&author=T.+A.+Graubertauthor=J.+H.+Russellauthor=T.+J.+Ley&title=The+role+of+granzyme+B+in+murine+models+of+acute+graft-versus-host+disease+and+graft+rejection&doi=10.1182%2Fblood.V87.4.1232.bloodjournal8741232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection</span></div><div class="casAuthors">Graubert T A; Russell J H; Ley T J</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1232-7</span>
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">A complete molecular description of the syndromes of graft-versus-host disease (GVHD) and graft rejection could have a significant impact on clinical bone marrow transplantation.  Recent in vitro experiments (Heusel et al, Cell 76:977, 1994 and Shresta et al, Proc Natl Acad Sci USA 92:5679, 1995) have shown that the putative mediators of these two syndromes, cytotoxic lymphocytes (CTL) and natural killer (NK) cells, respectively, initiate a program of cell death (apoptosis) in susceptible target tissues in a manner critically dependent on the serine protease Granzyme B (gzm B).  In the present study, we have analyzed the phenotype of gzm B-deficient mice using experimental transplant models designed to isolate their CD8+ CTL, CD4+ CTL, and NK compartments.  We found a significant impairment in class I-dependent GVHD mediated by gzm B -/- CD8+ CTL, whereas class II-dependent GVHD was not altered using gzm B -/- CD4+ effectors.  In a hybrid resistance model, gzm B -/- hosts rejected haplo-identical marrow grafts as efficiently as did their wild-type littermates.  This result is surprising in light of a severe defect in the ability of gzm B -/- NK cells to induce apoptosis in susceptible targets in vitro.  These in vivo data define significant role for gzm B in cytotoxicity mediated by CD8+ CTL, but not by CD4+ CTL.  Furthermore, these results do not support a model of hybrid resistance in which NK cells play a pivotal role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnxcaOdJTc6jDnmmyUf5qOfW6udTcc2eZL9M9iArHwMLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK287ptVSgtw%253D%253D&md5=ed0933d7a00846cd3b4af5d86127af2d</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1182%2Fblood.V87.4.1232.bloodjournal8741232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V87.4.1232.bloodjournal8741232%26sid%3Dliteratum%253Aachs%26aulast%3DGraubert%26aufirst%3DT.%2BA.%26aulast%3DRussell%26aufirst%3DJ.%2BH.%26aulast%3DLey%26aufirst%3DT.%2BJ.%26atitle%3DThe%2520role%2520of%2520granzyme%2520B%2520in%2520murine%2520models%2520of%2520acute%2520graft-versus-host%2520disease%2520and%2520graft%2520rejection%26jtitle%3DBlood%26date%3D1996%26volume%3D87%26issue%3D4%26spage%3D1232%26epage%3D1237%26doi%3D10.1182%2Fblood.V87.4.1232.bloodjournal8741232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sower, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froelich, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegretto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimpel, G. R.</span></span> <span> </span><span class="NLM_article-title">Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>156</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2585</span>â <span class="NLM_lpage">2590</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8786323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK28XhvVGltLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1996&pages=2585-2590&issue=7&author=L.+E.+Sowerauthor=C.+J.+Froelichauthor=N.+Allegrettoauthor=P.+M.+Roseauthor=W.+D.+Hannaauthor=G.+R.+Klimpel&title=Extracellular+activities+of+human+granzyme+A.+Monocyte+activation+by+granzyme+A+versus+alpha-thrombin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus Î±-thrombin</span></div><div class="casAuthors">Sower, Laurie E.; Froelich, Christopher J.; Allegretto, Nick; Rose, Patricia M.; Hanna, William D.; Klimpel, Gary R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2585-90</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Granzymes, serine proteases located in the granules of cytotoxic T cells and NK cells, are essential for induction of target cell apoptosis.  However, since cytotoxic cells constitutively secrete a portion of their synthesized granzymes, these proteases could mediate extracellular functions independent of their role in the lytic event.  Thrombin, another serine protease, can induce cytokine prodn. in a no. of different cell types.  In this study, we test the hypothesis that granzymes, like thrombin, can regulate cell-mediated immunity by inducing the prodn. of different cytokines.  We show that granzyme A (GA) stimulates IL-6, IL-8, and TNF-Î± prodn. by human PBMC and purified monocytes.  In contrast, monocytes exposed to thrombin had enhanced IL-8 prodn. with no induction of IL-6 or TNF-Î± prodn.  However, monocytes exposed to either GA or thrombin had enhanced phagocytic activity.  The enzymic activity of GA and thrombin was required for the induction of cytokine prodn. and for the enhancement of phagocytic activity.  The induction of different cytokine profiles by GA vs thrombin suggested that GA activates monocytes via a receptor that was different from the thrombin receptor.  This conclusion was strengthened by the fact that GA was incapable of inducing Ca2+ mobilization in insect cells transfected with the thrombin receptor.  These results suggest that enzymically active GA mediates important immunoregulatory functions through signaling pathways that does not involve thrombin receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUs3XNB_Y_SbVg90H21EOLACvtfcHk0ljYZNYn38pWmQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVGltLg%253D&md5=078637d2e3292bdee106be6626ce40ff</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSower%26aufirst%3DL.%2BE.%26aulast%3DFroelich%26aufirst%3DC.%2BJ.%26aulast%3DAllegretto%26aufirst%3DN.%26aulast%3DRose%26aufirst%3DP.%2BM.%26aulast%3DHanna%26aufirst%3DW.%2BD.%26aulast%3DKlimpel%26aufirst%3DG.%2BR.%26atitle%3DExtracellular%2520activities%2520of%2520human%2520granzyme%2520A.%2520Monocyte%2520activation%2520by%2520granzyme%2520A%2520versus%2520alpha-thrombin%26jtitle%3DJ.%2520Immunol.%26date%3D1996%26volume%3D156%26issue%3D7%26spage%3D2585%26epage%3D2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buzza, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurs, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapani, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froelich, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nice, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, P. I.</span></span> <span> </span><span class="NLM_article-title">Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">23549</span>â <span class="NLM_lpage">23558</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M412001200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.M412001200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15843372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlKitbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=23549-23558&issue=25&author=M.+S.+Buzzaauthor=L.+Zamursauthor=J.+Sunauthor=C.+H.+Birdauthor=A.+I.+Smithauthor=J.+A.+Trapaniauthor=C.+J.+Froelichauthor=E.+C.+Niceauthor=P.+I.+Bird&title=Extracellular+matrix+remodeling+by+human+granzyme+B+via+cleavage+of+vitronectin%2C+fibronectin%2C+and+laminin&doi=10.1074%2Fjbc.M412001200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular Matrix Remodeling by Human Granzyme B via Cleavage of Vitronectin, Fibronectin, and Laminin</span></div><div class="casAuthors">Buzza, Marguerite S.; Zamurs, Laura; Sun, Jiuru; Bird, Catherina H.; Smith, A. Ian; Trapani, Joseph A.; Froelich, Christopher J.; Nice, Edouard C.; Bird, Phillip I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">23549-23558</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human granzyme B (GrB) released from cytotoxic lymphocytes plays a key role in the induction of target cell apoptosis when internalized in the presence of perforin.  Here the authors demonstrate that GrB also possesses a potent extracellular matrix remodeling activity.  Both native and recombinant GrB caused detachment of immortalized and transformed cell lines, primary endothelial cells, and chondrocytes.  Cell detachment by GrB induced endothelial cell death (anoikis).  GrB also inhibited tumor cell spreading, migration, and invasion in vitro.  Investigation into the underlying mechanism revealed that GrB efficiently cleaves three proteins involved in extracellular matrix structure and function: vitronectin, fibronectin, and laminin.  In vitronectin, GrB cleaves after an Arg-Lys-Asp (RGD) motif, which is part of the integrin-binding site found in matrix proteins.  The authors propose that targeting of the integrin-extracellular matrix interface by GrB may allow perforin-independent killing of target cells via anoikis, restrict motility of tumor cells, facilitate lymphocyte migration, or directly reduce virus infectivity.  It may also contribute to tissue destruction in diseases in which extracellular GrB is evident, such as rheumatoid arthritis and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj5WSM2Fe9krVg90H21EOLACvtfcHk0lizBoTa_7dVRQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlKitbY%253D&md5=e02df10ee16ffb6d5665a8201b354391</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M412001200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M412001200%26sid%3Dliteratum%253Aachs%26aulast%3DBuzza%26aufirst%3DM.%2BS.%26aulast%3DZamurs%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DBird%26aufirst%3DC.%2BH.%26aulast%3DSmith%26aufirst%3DA.%2BI.%26aulast%3DTrapani%26aufirst%3DJ.%2BA.%26aulast%3DFroelich%26aufirst%3DC.%2BJ.%26aulast%3DNice%26aufirst%3DE.%2BC.%26aulast%3DBird%26aufirst%3DP.%2BI.%26atitle%3DExtracellular%2520matrix%2520remodeling%2520by%2520human%2520granzyme%2520B%2520via%2520cleavage%2520of%2520vitronectin%252C%2520fibronectin%252C%2520and%2520laminin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26issue%3D25%26spage%3D23549%26epage%3D23558%26doi%3D10.1074%2Fjbc.M412001200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santiago, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz-Pamplona, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GarzÃ³n, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez-Labrada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layunta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil-GÃ³mez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PeÃ±a, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanuza, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaime-Sanchez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uranga-Murillo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Campo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PelegrÃ­n, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camerer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MartÃ­nez-Lostao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MuÃ±oz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uranga, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcalde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvez, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrandez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arias, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, J.</span></span> <span> </span><span class="NLM_article-title">Extracellular granzyme A promotes colorectal cancer development by enhancing gut inflammation</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">107847</span>, <span class="refDoi">Â DOI: 10.1016/j.celrep.2020.107847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.celrep.2020.107847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32640217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlKnsbnF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2020&pages=107847&issue=1&author=L.+Santiagoauthor=M.+Castroauthor=R.+Sanz-Pamplonaauthor=M.+Garz%C3%B3nauthor=A.+Ramirez-Labradaauthor=E.+Tapiaauthor=V.+Morenoauthor=E.+Layuntaauthor=G.+Gil-G%C3%B3mezauthor=M.+Garridoauthor=R.+Pe%C3%B1aauthor=P.+M.+Lanuzaauthor=L.+Comasauthor=P.+Jaime-Sanchezauthor=I.+Uranga-Murilloauthor=R.+del+Campoauthor=P.+Pelegr%C3%ADnauthor=E.+Camererauthor=L.+Mart%C3%ADnez-Lostaoauthor=G.+Mu%C3%B1ozauthor=J.+A.+Urangaauthor=A.+Alcaldeauthor=E.+M.+Galvezauthor=A.+Ferrandezauthor=P.+I.+Birdauthor=S.+Metkarauthor=M.+A.+Ariasauthor=J.+Pardo&title=Extracellular+granzyme+A+promotes+colorectal+cancer+development+by+enhancing+gut+inflammation&doi=10.1016%2Fj.celrep.2020.107847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular Granzyme A Promotes Colorectal Cancer Development by Enhancing Gut Inflammation</span></div><div class="casAuthors">Santiago, Llipsy; Castro, Marta; Sanz-Pamplona, Rebeca; Garzon, Marcela; Ramirez-Labrada, Ariel; Tapia, Elena; Moreno, Victor; Layunta, Elena; Gil-Gomez, Gabriel; Garrido, Marta; Pena, Raul; Lanuza, Pilar M.; Comas, Laura; Jaime-Sanchez, Paula; Uranga-Murillo, Iratxe; del Campo, Rosa; Pelegrin, Pablo; Camerer, Eric; Martinez-Lostao, Luis; Munoz, Guillermo; Uranga, Jose A.; Alcalde, Anabel; Galvez, Eva M.; Ferrandez, Angel; Bird, Phillip I.; Metkar, Sunil; Arias, Maykel A.; Pardo, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107847</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">If not properly regulated, the inflammatory immune response can promote carcinogenesis, as evident in colorectal cancer (CRC).  Aiming to gain mechanistic insight into the link between inflammation and CRC, we perform transcriptomics anal. of human CRC, identifying a strong correlation between expression of the serine protease granzyme A (GzmA) and inflammation.  In a dextran sodium sulfate and azoxymethane (DSS/AOM) mouse model, deficiency and pharmacol. inhibition of extracellular GzmA both attenuate gut inflammation and prevent CRC development, including the initial steps of cell transformation and epithelial-to-mesenchymal transition.  Mechanistically, extracellular GzmA induces NF-ÎºB-dependent IL-6 prodn. in macrophages, which in turn promotes STAT3 activation in cultured CRC cells.  Accordingly, colon tissues from DSS/AOM-treated, GzmA-deficient animals present reduced levels of pSTAT3.  By identifying GzmA as a proinflammatory protease that promotes CRC development, these findings provide information on mechanisms that link immune cell infiltration to cancer progression and present GzmA as a therapeutic target for CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxMUp-GHyjJLVg90H21EOLACvtfcHk0lizBoTa_7dVRQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlKnsbnF&md5=8dd4fc7017dcb25d3d3383d03a2bdf02</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2020.107847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2020.107847%26sid%3Dliteratum%253Aachs%26aulast%3DSantiago%26aufirst%3DL.%26aulast%3DCastro%26aufirst%3DM.%26aulast%3DSanz-Pamplona%26aufirst%3DR.%26aulast%3DGarz%25C3%25B3n%26aufirst%3DM.%26aulast%3DRamirez-Labrada%26aufirst%3DA.%26aulast%3DTapia%26aufirst%3DE.%26aulast%3DMoreno%26aufirst%3DV.%26aulast%3DLayunta%26aufirst%3DE.%26aulast%3DGil-G%25C3%25B3mez%26aufirst%3DG.%26aulast%3DGarrido%26aufirst%3DM.%26aulast%3DPe%25C3%25B1a%26aufirst%3DR.%26aulast%3DLanuza%26aufirst%3DP.%2BM.%26aulast%3DComas%26aufirst%3DL.%26aulast%3DJaime-Sanchez%26aufirst%3DP.%26aulast%3DUranga-Murillo%26aufirst%3DI.%26aulast%3Ddel%2BCampo%26aufirst%3DR.%26aulast%3DPelegr%25C3%25ADn%26aufirst%3DP.%26aulast%3DCamerer%26aufirst%3DE.%26aulast%3DMart%25C3%25ADnez-Lostao%26aufirst%3DL.%26aulast%3DMu%25C3%25B1oz%26aufirst%3DG.%26aulast%3DUranga%26aufirst%3DJ.%2BA.%26aulast%3DAlcalde%26aufirst%3DA.%26aulast%3DGalvez%26aufirst%3DE.%2BM.%26aulast%3DFerrandez%26aufirst%3DA.%26aulast%3DBird%26aufirst%3DP.%2BI.%26aulast%3DMetkar%26aufirst%3DS.%26aulast%3DArias%26aufirst%3DM.%2BA.%26aulast%3DPardo%26aufirst%3DJ.%26atitle%3DExtracellular%2520granzyme%2520A%2520promotes%2520colorectal%2520cancer%2520development%2520by%2520enhancing%2520gut%2520inflammation%26jtitle%3DCell%2520Rep.%26date%3D2020%26volume%3D32%26issue%3D1%26spage%3D107847%26doi%3D10.1016%2Fj.celrep.2020.107847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">KrÃ¤henbÃ¼hl, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzavecchia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groscurth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span> <span> </span><span class="NLM_article-title">Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>141</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3471</span>â <span class="NLM_lpage">3477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=3263427" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=1988&pages=3471-3477&issue=10&author=O.+Kr%C3%A4henb%C3%BChlauthor=C.+Reyauthor=D.+Jenneauthor=A.+Lanzavecchiaauthor=P.+Groscurthauthor=S.+Carrelauthor=J.+Tschopp&title=Characterization+of+granzymes+A+and+B+isolated+from+granules+of+cloned+human+cytotoxic+T+lymphocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKr%25C3%25A4henb%25C3%25BChl%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DC.%26aulast%3DJenne%26aufirst%3DD.%26aulast%3DLanzavecchia%26aufirst%3DA.%26aulast%3DGroscurth%26aufirst%3DP.%26aulast%3DCarrel%26aufirst%3DS.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520granzymes%2520A%2520and%2520B%2520isolated%2520from%2520granules%2520of%2520cloned%2520human%2520cytotoxic%2520T%2520lymphocytes%26jtitle%3DJ.%2520Immunol.%26date%3D1988%26volume%3D141%26issue%3D10%26spage%3D3471%26epage%3D3477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Odake, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kam, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krahenbuhl, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span> <span> </span><span class="NLM_article-title">Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2217</span>â <span class="NLM_lpage">2227</span>, <span class="refDoi">Â DOI: 10.1021/bi00222a027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00222a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3MXpslagtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1991&pages=2217-2227&issue=8&author=S.+Odakeauthor=C.+M.+Kamauthor=L.+Narasimhanauthor=M.+Poeauthor=J.+T.+Blakeauthor=O.+Krahenbuhlauthor=J.+Tschoppauthor=J.+C.+Powers&title=Human+and+murine+cytotoxic+T+lymphocyte+serine+proteases%3A+subsite+mapping+with+peptide+thioester+substrates+and+inhibition+of+enzyme+activity+and+cytolysis+by+isocoumarins&doi=10.1021%2Fbi00222a027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Human and murine cytotoxic T lymphocyte serine proteases:  subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins</span></div><div class="casAuthors">Odake, Shinjiro; Kam, Chih Min; Narasimhan, Lakshmi; Poe, Martin; Blake, Joseph T.; Krahenbuhl, Olivier; Tschopp, Juerg; Powers, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2217-27</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The active site structures of human Q31 granzyme A, murine granzymes (A, B, C, D, E, and F), and human granzymes (A, B, and 3) isolated from cytotoxic T lymphocytes (CTL) were studied with peptide thioester substrates, peptide chloromethyl ketones, and isocoumarin inhibitors.  Human Q31, murine, and human granzyme A hydrolyzed arginine- or lysine-contg. thioesters very efficiently with kcat/KM = 104-105M-1 s-1.  Murine granzyme B had aspartase activity and hydrolyzed Boc-Ala-Ala-Asp-Sbzl (where Boc = tert-butyloxycarbonyl and SBz = thiobenzyl ester) with kcat/KM = 2.3 Ã 105M-1 s-1.  The rate was accelerated 1.4-fold when the 0.05M NaCl in the assay was replaced with CaCl2.  The prepn. of granzyme B also had significant activity toward Boc-Ala-Ala-AA-SBzl substrates, where AA was asparagine, methionine, or serine [kcat/KM = (4-5) Ã 104M-1 s-1].  Murine granzymes C, D, and E did not hydrolyzed any thioester substrate but contained minor contaminating activity toward arginine- or lysine-contg. thioesters.  Murine granzyme F had small activity toward Suc-Phe-Leu-Phe-SBzl, along with some contaminating trypsin-like activity.  Human Q31 granzyme A, murine, and human granzyme A were inhibited quite efficiently by mechanism-based isocoumarin inhibitors substituted with basic groups (guanidino or isothiureidopropoxy).  Although the general serine protease inhibitor 3,4-dichloroisocoumarin (DCI) inactivated these tryptases poorly, it was the best isocoumarin inhibitor for murine granzyme B (kobs/[I] = 3700-4200M-1 s-1).  Murine and human granzyme B were also inhibited by Boc-Ala-Ala-Asp-CH2Cl; however, the inhibition was less potent than that with DCI.  DCI, 3-(3-aminopropoxy)-4-chloroisocoumarin, 4-chloro-3-(3-isothiureidopropoxy)isocoumarin, and 7-amino-4-chloro-3-(3-isothiureidopropoxy)isocoumarin inhibited Q31 cytotoxic T lymphocyte-mediated lysis of human JY lymphoblasts (ED50 = 0.5-5.0 Î¼M).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz30b93b_vdbVg90H21EOLACvtfcHk0ljow-PgOAZmwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXpslagtA%253D%253D&md5=35a3913b73e6310912601463bf65b073</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Fbi00222a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00222a027%26sid%3Dliteratum%253Aachs%26aulast%3DOdake%26aufirst%3DS.%26aulast%3DKam%26aufirst%3DC.%2BM.%26aulast%3DNarasimhan%26aufirst%3DL.%26aulast%3DPoe%26aufirst%3DM.%26aulast%3DBlake%26aufirst%3DJ.%2BT.%26aulast%3DKrahenbuhl%26aufirst%3DO.%26aulast%3DTschopp%26aufirst%3DJ.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DHuman%2520and%2520murine%2520cytotoxic%2520T%2520lymphocyte%2520serine%2520proteases%253A%2520subsite%2520mapping%2520with%2520peptide%2520thioester%2520substrates%2520and%2520inhibition%2520of%2520enzyme%2520activity%2520and%2520cytolysis%2520by%2520isocoumarins%26jtitle%3DBiochemistry%26date%3D1991%26volume%3D30%26issue%3D8%26spage%3D2217%26epage%3D2227%26doi%3D10.1021%2Fbi00222a027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zweerink, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigal, N. H.</span></span> <span> </span><span class="NLM_article-title">The enzymatic activity of human cytotoxic T-lymphocyte granzyme a and cytolysis mediated by cytotoxic T-lymphocytes are potently inhibited by a synthetic antiprotease, FUT-175</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>284</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">215</span>â <span class="NLM_lpage">218</span>, <span class="refDoi">Â DOI: 10.1016/0003-9861(91)90286-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2F0003-9861%2891%2990286-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1989498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3MXhtlGks7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1991&pages=215-218&issue=1&author=M.+Poeauthor=J.+K.+Wuauthor=J.+T.+Blakeauthor=H.+J.+Zweerinkauthor=N.+H.+Sigal&title=The+enzymatic+activity+of+human+cytotoxic+T-lymphocyte+granzyme+a+and+cytolysis+mediated+by+cytotoxic+T-lymphocytes+are+potently+inhibited+by+a+synthetic+antiprotease%2C+FUT-175&doi=10.1016%2F0003-9861%2891%2990286-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">The enzymic activity of human cytotoxic T-lymphocyte granzyme A and cytolysis mediated by cytotoxic T-lymphocytes are potently inhibited by a synthetic antiprotease, FUT-175</span></div><div class="casAuthors">Poe, Martin; Wu, Joseph K.; Blake, J. T.; Zweerink, H. J.; Sigal, N. H.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">215-18</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">The synthetic antiprotease, FUT-175 (I) was found to be an extraordinarily potent and rapid inhibitor of human Q31 cytotoxic T-lymphocyte granzyme A.  The granzyme A was inhibited in a time-dependent manner with kobs/i = 430,000 M-1 s-1.  Four other FUT-175 analogs were also found to be potent, rapid Q 31 granzyme A inhibitor.  All 5 compds. inhibited Q 31 cytotoxic T-lymphocyte-mediated cytolysis of human JY lymphoma cells, but at concns. far in excess of those needed for granzyme A inhibition.  The data presented suggest that postmarketing surveillance of FUT-175 should include a review of possible immunosuppressive side-effects, such as increased susceptibility to viral infections and to neoplastic transformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyN1HLXeSXL7Vg90H21EOLACvtfcHk0ljow-PgOAZmwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtlGks7g%253D&md5=ff8ff080250423dc709df8a98c52dfbb</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2891%2990286-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252891%252990286-R%26sid%3Dliteratum%253Aachs%26aulast%3DPoe%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DBlake%26aufirst%3DJ.%2BT.%26aulast%3DZweerink%26aufirst%3DH.%2BJ.%26aulast%3DSigal%26aufirst%3DN.%2BH.%26atitle%3DThe%2520enzymatic%2520activity%2520of%2520human%2520cytotoxic%2520T-lymphocyte%2520granzyme%2520a%2520and%2520cytolysis%2520mediated%2520by%2520cytotoxic%2520T-lymphocytes%2520are%2520potently%2520inhibited%2520by%2520a%2520synthetic%2520antiprotease%252C%2520FUT-175%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1991%26volume%3D284%26issue%3D1%26spage%3D215%26epage%3D218%26doi%3D10.1016%2F0003-9861%2891%2990286-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beresford, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kam, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, J.</span></span> <span> </span><span class="NLM_article-title">Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">9285</span>â <span class="NLM_lpage">9290</span>, <span class="refDoi">Â DOI: 10.1073/pnas.94.17.9285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.94.17.9285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=9256474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2sXls1KlsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=9285-9290&issue=17&author=P.+J.+Beresfordauthor=C.-M.+Kamauthor=J.+C.+Powersauthor=J.+Lieberman&title=Recombinant+human+granzyme+A+binds+to+two+putative+HLA-associated+proteins+and+cleaves+one+of+them&doi=10.1073%2Fpnas.94.17.9285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them</span></div><div class="casAuthors">Beresford, Paul J.; Kam, Chih-Min; Powers, James C.; Lieberman, Judy</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9285-9290</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The release of cytotoxic granule contents by cytotoxic T lymphocytes triggers apoptotic target cell death.  Cytotoxic granules contain a pore-forming protein, perforin, and a group of serine proteases called granzymes.  We expressed human granzyme A in bacteria as a proenzyme capable of in vitro activation by enterokinase.  The recombinant activated enzyme has catalytic activity against substrates with Arg, preferably, or Lys at the P1 position, comparable to trypsin.  An enzymically inactive recombinant granzyme A, with the active site Ser mutated to Ala, was produced and used with affinity chromatog. to identify potential substrates.  Two granzyme A-binding cytoplasmic proteins of mol. mass 33 and 44 kDa were isolated and identified by tryptic fragment sequencing as PHAP I and II, ubiquitous putative HLA-assocd. proteins, previously coisolated by binding to an HLA class II peptide.  PHAP II forms an SDS-stable complex with recombinant mutant granzyme A and coppts. with it from cytoplasmic exts.  PHAP II, either purified or in cell lysates, is cleaved by the recombinant enzyme at nanomolar concns. to a 25-kDa fragment.  PHAP II begins to be degraded within minutes of initiation of cytotoxic T lymphocyte attack.  PHAP I and II are candidate participants in the granzyme A pathway of cell-mediated cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptMh1eNGe6BbVg90H21EOLACvtfcHk0ljM3zlkblIagA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXls1KlsLk%253D&md5=566424501175e3a79aa345cd5fa192d7</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.17.9285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.17.9285%26sid%3Dliteratum%253Aachs%26aulast%3DBeresford%26aufirst%3DP.%2BJ.%26aulast%3DKam%26aufirst%3DC.-M.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26aulast%3DLieberman%26aufirst%3DJ.%26atitle%3DRecombinant%2520human%2520granzyme%2520A%2520binds%2520to%2520two%2520putative%2520HLA-associated%2520proteins%2520and%2520cleaves%2520one%2520of%2520them%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26issue%3D17%26spage%3D9285%26epage%3D9290%26doi%3D10.1073%2Fpnas.94.17.9285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, L.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kam, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froelich, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2289</span>â <span class="NLM_lpage">2301</span>, <span class="refDoi">Â DOI: 10.1021/jm970543s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970543s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1cXjtlyks7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2289-2301&issue=13&author=D.+S.+Jacksonauthor=S.+A.+Fraserauthor=L.-M.+Niauthor=C.-M.+Kamauthor=U.+Winklerauthor=D.+A.+Johnsonauthor=C.+J.+Froelichauthor=D.+Hudigauthor=J.+C.+Powers&title=Synthesis+and+evaluation+of+diphenyl+phosphonate+esters+as+inhibitors+of+the+trypsin-like+granzymes+A+and+K+and+mast+cell+tryptase&doi=10.1021%2Fjm970543s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Diphenyl Phosphonate Esters as Inhibitors of the Trypsin-like Granzymes A and K and Mast Cell Tryptase</span></div><div class="casAuthors">Jackson, Delwin S.; Fraser, Stephanie A.; Ni, Li-Ming; Kam, Chih-Min; Winkler, Ulrike; Johnson, David A.; Froelich, Christopher J.; Hudig, Dorothy; Powers, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2289-2301</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Thirty-six new amino acid and peptidyl phosphonate esters, e.g. I [R = PhCH2O2C (Cbz), HO2CCH2CH2CO (Suc), R1CH:CHCO, 3-PhOC6H4CO, 2-PhOC6H4CO, 1-C10H7SO2, 1-C10H7CH2O2C, Cbz-X, R2-Pro, Suc-Ala-Ala, Boc-D-Phe-Pro, PhCH2SO2-Gly-Pro; R1 = Ph, 2-furyl, 2-thienyl, 3-pyridyl; X = Ala, Val, Leu, Pro, Thr, Lys, Phe, Ala-Ala, Pro-Ala, Asp-Ala, Asp(OCMe3)-Ala, Lys-Ala, Lys(Boc)-Ala, Phe-Ala, Ala-Ala-Ala; R2 = 2-PhOC6H4CO, 3-PhOC6H4CO, Ph2CHCH2CO, PhCH2CH2CO; Boc = Me3CO2C] were synthesized and evaluated to identify potent and selective inhibitors for four trypsin-like proteases: lymphocyte granzymes A and K, human mast cell tryptase, and pancreatic trypsin.  Among five Lys and Arg homologs, II (R = Cbz) is the most potent inhibitor for granzyme A, and CbzNHCH(PO3Ph2)(CH2)4NH2.HCl (III) is the best inhibitor for granzyme K, mast tryptase, and trypsin.  Generally, phosphonates I inhibit granzyme A and trypsin more potently than granzyme K and tryptase.  Dipeptide phosphonates I (R = Cbz-Ala, Cbz-Thr) are the most potent inhibitors for granzyme A, and I (R = Cbz-Thr) (kobs/[I] = 2220 M-1 s-1) was quite specific with much lower inhibition rates for granzyme K and trypsin (kobs/[I] = 3 and 97 M-1 s-1, resp.) and no inhibition with tryptase.  The most effective inhibitor of granzyme A was I (R = PhCH2SO2-Gly-Pro) with a second-order rate const. of 3650 M-1 s-1.  The most potent inhibitor for granzyme K was I (R = Ph2CHCH2CO-Pro) with a kobs/[I] = 1830 M-1 s-1; all other phosphonates inhibited granzyme K weakly (kobs/[I] < 60 M-1 s-1).  Human mast cell tryptase was inhibited slowly by these phosphonates with III as the best inhibitor (kobs/[I] = 89 M-1 s-1).  The overall results suggest that scaffolds of II (R = Phe-Thr) and Phe-Pro-Lys will be useful to create selective phosphonate inhibitors for granzymes A and K, resp., and that P4 substituents offer opportunities to further enhance selectivity and reactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7r5zsvvYQj7Vg90H21EOLACvtfcHk0ljM3zlkblIagA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtlyks7w%253D&md5=086ed1b653675b4cb11f45e9f516c159</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1021%2Fjm970543s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970543s%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DD.%2BS.%26aulast%3DFraser%26aufirst%3DS.%2BA.%26aulast%3DNi%26aufirst%3DL.-M.%26aulast%3DKam%26aufirst%3DC.-M.%26aulast%3DWinkler%26aufirst%3DU.%26aulast%3DJohnson%26aufirst%3DD.%2BA.%26aulast%3DFroelich%26aufirst%3DC.%2BJ.%26aulast%3DHudig%26aufirst%3DD.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520diphenyl%2520phosphonate%2520esters%2520as%2520inhibitors%2520of%2520the%2520trypsin-like%2520granzymes%2520A%2520and%2520K%2520and%2520mast%2520cell%2520tryptase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26issue%3D13%26spage%3D2289%26epage%3D2301%26doi%3D10.1021%2Fjm970543s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahrus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cell-mediated lysis of target cells</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">567</span>â <span class="NLM_lpage">577</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2005.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2005.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15911377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1aku7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=567-577&issue=5&author=S.+Mahrusauthor=C.+S.+Craik&title=Selective+chemical+functional+probes+of+granzymes+A+and+B+reveal+granzyme+B+is+a+major+effector+of+natural+killer+cell-mediated+lysis+of+target+cells&doi=10.1016%2Fj.chembiol.2005.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Selective chemical functional probes of granzymes A and B reveal granzyme B Is a major effector of natural killer cell-mediated lysis of target cells</span></div><div class="casAuthors">Mahrus, Sami; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">567-577</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mechanism of target cell lysis in cytotoxic lymphocyte-mediated death is not well understood, and the role of granzymes in this process is unclear.  Chem. functional probes were thus prepd. for the major granzymes A and B to deconvolute their role in natural killer cell-mediated lysis of target cells.  These biotinylated and substrate specificity-based di-Ph phosphonates allowed facile evaluation of selectivity through activity-based profiling in cell lysates and intact cells.  Both inhibitors were extremely selective in vitro and in cells.  Use of these inhibitors in cell-based assays revealed granzyme A to be a minor effector and granzyme B to be a major effector of target cell lysis by natural killer cells.  These studies indicate that the proapoptotic granzyme B functions also as a pronecrotic effector of target cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBTIufZM9xDrVg90H21EOLACvtfcHk0ljS-HWJf7SgmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1aku7Y%253D&md5=07dbb4ea5f6e2186a0ab880280247391</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DMahrus%26aufirst%3DS.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DSelective%2520chemical%2520functional%2520probes%2520of%2520granzymes%2520A%2520and%2520B%2520reveal%2520granzyme%2520B%2520is%2520a%2520major%2520effector%2520of%2520natural%2520killer%2520cell-mediated%2520lysis%2520of%2520target%2520cells%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26issue%3D5%26spage%3D567%26epage%3D577%26doi%3D10.1016%2Fj.chembiol.2005.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">KoÅt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janiszewski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiserman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modrzycka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span> <span> </span><span class="NLM_article-title">Detection of active granzyme A in NK92 cells with fluorescent activity-based probe</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3359</span>â <span class="NLM_lpage">3369</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.9b02042</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b02042" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksFWqtbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3359-3369&issue=6&author=S.+Ko%C5%82tauthor=T.+Janiszewskiauthor=D.+Kaisermanauthor=S.+Modrzyckaauthor=S.+J.+Snipasauthor=G.+Salvesenauthor=M.+Dragauthor=P.+I.+Birdauthor=P.+Kasperkiewicz&title=Detection+of+active+granzyme+A+in+NK92+cells+with+fluorescent+activity-based+probe&doi=10.1021%2Facs.jmedchem.9b02042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of Active Granzyme A in NK92 Cells with Fluorescent Activity-Based Probe</span></div><div class="casAuthors">Kolt, Sonia; Janiszewski, Tomasz; Kaiserman, Dion; Modrzycka, Sylwia; Snipas, Scott J.; Salvesen, Guy; Drag, Marcin; Bird, Phillip I.; Kasperkiewicz, Paulina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3359-3369</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cytotoxic T-lymphocytes (CTLs) and natural killer cells (NKs) kill compromised cells to defend against tumor and viral infections.  Both effector cell types use multiple strategies to induce target cell death including Fas/CD95 activation and the release of perforin and a group of lymphocyte granule serine proteases called granzymes.  Granzymes have relatively broad and overlapping substrate specificities and may hydrolyze a wide range of peptidic epitopes; it is therefore challenging to identify their natural and synthetic substrates and to distinguish their localization and functions.  Here, we present a specific and potent substrate, an inhibitor, and an activity-based probe of Granzyme A (GrA) that can be used to follow functional GrA in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXVfoh54TZdrVg90H21EOLACvtfcHk0ljS-HWJf7SgmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksFWqtbg%253D&md5=4efddf846d803b54818ce50123eefe61</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b02042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b02042%26sid%3Dliteratum%253Aachs%26aulast%3DKo%25C5%2582t%26aufirst%3DS.%26aulast%3DJaniszewski%26aufirst%3DT.%26aulast%3DKaiserman%26aufirst%3DD.%26aulast%3DModrzycka%26aufirst%3DS.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DSalvesen%26aufirst%3DG.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DBird%26aufirst%3DP.%2BI.%26aulast%3DKasperkiewicz%26aufirst%3DP.%26atitle%3DDetection%2520of%2520active%2520granzyme%2520A%2520in%2520NK92%2520cells%2520with%2520fluorescent%2520activity-based%2520probe%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D6%26spage%3D3359%26epage%3D3369%26doi%3D10.1021%2Facs.jmedchem.9b02042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janiszewski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KoÅt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiserman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulbacka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saczko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovenschen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DraÌ§g, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span> <span> </span><span class="NLM_article-title">Noninvasive optical detection of granzyme B from natural killer cells with enzyme-activated fluorogenic probes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>295</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">9567</span>â <span class="NLM_lpage">9582</span>, <span class="refDoi">Â DOI: 10.1074/jbc.RA120.013204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.RA120.013204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32439802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFemsb3L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2020&pages=9567-9582&issue=28&author=T.+Janiszewskiauthor=S.+Ko%C5%82tauthor=D.+Kaisermanauthor=S.+J.+Snipasauthor=S.+Liauthor=J.+Kulbackaauthor=J.+Saczkoauthor=N.+Bovenschenauthor=G.+Salvesenauthor=M.+Dra%CC%A7gauthor=P.+I.+Birdauthor=P.+Kasperkiewicz&title=Noninvasive+optical+detection+of+granzyme+B+from+natural+killer+cells+with+enzyme-activated+fluorogenic+probes&doi=10.1074%2Fjbc.RA120.013204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Noninvasive optical detection of granzyme B from natural killer cells with enzyme-activated fluorogenic probes</span></div><div class="casAuthors">Janiszewski, Tomasz; Kolt, Sonia; Kaiserman, Dion; Snipas, Scott J.; Li, Shuang; Kulbacka, Julita; Saczko, Jolanta; Bovenschen, Niels; Salvesen, Guy; Drag, Marcin; Bird, Phillip I.; Kasperkiewicz, Paulina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9567-9582</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">1083-351X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Natural killer (NK) cells are key innate immunity effectors that combat viral infections and control several cancer types.  For their immune function, human NK cells rely largely on five different cytotoxic proteases, called granzymes (A/B/H/K/M).  Granzyme B (GrB) initiates at least three distinct cell death pathways, but key aspects of its function remain unexplored because selective probes that detect its activity are currently lacking.  The authors used a set of unnatural amino acids to fully map the substrate preferences of GrB, demonstrating previously unknown GrB substrate preferences.  The authors then used these preferences to design substrate-based inhibitors and a GrB-activatable activity-based fluorogenic probe.  The authors' GrB probes do not significantly react with caspases, making them ideal for in-depth analyses of GrB localization and function in cells.  Using the authors' quenched fluorescence substrate, the authors obsd. GrB within the cytotoxic granules of human YT cells.  When used as cytotoxic effectors, YT cells loaded with GrB attacked MDA-MB-231 target cells, and active GrB influenced its target cell-killing efficiency.  In summary, the authors have developed a set of mol. tools for studying GrB function in NK cells and demonstrate noninvasive visual detection of GrB with an enzyme-activated fluorescent substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo39j22pwi2L7Vg90H21EOLACvtfcHk0lipIc_dvuLnRA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFemsb3L&md5=38f76e70aa1e126e85dc5e44ff03afd2</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA120.013204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA120.013204%26sid%3Dliteratum%253Aachs%26aulast%3DJaniszewski%26aufirst%3DT.%26aulast%3DKo%25C5%2582t%26aufirst%3DS.%26aulast%3DKaiserman%26aufirst%3DD.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DKulbacka%26aufirst%3DJ.%26aulast%3DSaczko%26aufirst%3DJ.%26aulast%3DBovenschen%26aufirst%3DN.%26aulast%3DSalvesen%26aufirst%3DG.%26aulast%3DDra%25CC%25A7g%26aufirst%3DM.%26aulast%3DBird%26aufirst%3DP.%2BI.%26aulast%3DKasperkiewicz%26aufirst%3DP.%26atitle%3DNoninvasive%2520optical%2520detection%2520of%2520granzyme%2520B%2520from%2520natural%2520killer%2520cells%2520with%2520enzyme-activated%2520fluorogenic%2520probes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2020%26volume%3D295%26issue%3D28%26spage%3D9567%26epage%3D9582%26doi%3D10.1074%2Fjbc.RA120.013204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goggi, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartimath, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jieu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boominathan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chacko, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robins, E. G.</span></span> <span> </span><span class="NLM_article-title">Granzyme B PET imaging of immune checkpoint inhibitor combinations in colon cancer phenotypes</span>. <i>Mol. Imaging Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1392</span>â <span class="NLM_lpage">1402</span>, <span class="refDoi">Â DOI: 10.1007/s11307-020-01519-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1007%2Fs11307-020-01519-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32705455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVCltLnJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2020&pages=1392-1402&issue=5&author=J.+L.+Goggiauthor=Y.+X.+Tanauthor=S.+V.+Hartimathauthor=B.+Jieuauthor=Y.+Y.+Hwangauthor=L.+Jiangauthor=R.+Boominathanauthor=P.+Chengauthor=T.+Y.+Yuenauthor=H.+X.+Chinauthor=J.+R.+Tangauthor=A.+Larbiauthor=A.+M.+Chackoauthor=L.+Reniaauthor=C.+Johannesauthor=E.+G.+Robins&title=Granzyme+B+PET+imaging+of+immune+checkpoint+inhibitor+combinations+in+colon+cancer+phenotypes&doi=10.1007%2Fs11307-020-01519-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Granzyme B PET Imaging of Immune Checkpoint Inhibitor Combinations in Colon Cancer Phenotypes</span></div><div class="casAuthors">Goggi, J. L.; Tan, Y. X.; Hartimath, S. V.; Jieu, B.; Hwang, Y. Y.; Jiang, L.; Boominathan, R.; Cheng, P.; Yuen, T. Y.; Chin, H. X.; Tang, J. R.; Larbi, A.; Chacko, A. M.; Renia, L.; Johannes, C.; Robins, Edward G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Imaging and Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1392-1402</span>CODEN:
                <span class="NLM_cas:coden">MIBOCZ</span>;
        ISSN:<span class="NLM_cas:issn">1860-2002</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: Purpose: Immune checkpoint inhibitor (ICI) monotherapy and combination regimens are being actively pursued as strategies to improve durable response rates in cancer patients.  However, the biol. surrounding combination therapies is not well understood and may increase the likelihood of immune-mediated adverse events.  Accurate stratification of ICI response by non-invasive PET imaging may help ensure safe therapy management across a wide no. of cancer phenotypes.  Procedures: We have assessed the ability of a fluorine-labeled peptide, [18F]AlF-mNOTA-GZP, targeting granzyme B, to stratify ICI response in two syngeneic models of colon cancer, CT26 and MC38.  In vivo tumor uptake of [18F]AlF-mNOTA-GZP following ICI monotherapy, or in combination with PD-1 was characterised and correlated with changes in tumor-assocd. immune cell populations.  Results: [18F]AlF-mNOTA-GZP showed good predictive ability and correlated well with changes in tumor-assocd. T cells, esp. CD8+ T cells; however, overall uptake and response to monotherapy or combination therapies was very different in the CT26 and MC38 tumors, likely due to the immunostimulatory environment imbued by the MSI-high phenotype in MC38 tumors.  Conclusions: [18F]AlF-mNOTA-GZP uptake correlates well with changes in CD8+ T cell populations and is able to stratify tumor response to a range of ICIs administered as monotherapies or in combination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvKKKj4LaEwbVg90H21EOLACvtfcHk0lipIc_dvuLnRA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVCltLnJ&md5=d39dc72fc9b45f9b7964a0536366d40c</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1007%2Fs11307-020-01519-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-020-01519-3%26sid%3Dliteratum%253Aachs%26aulast%3DGoggi%26aufirst%3DJ.%2BL.%26aulast%3DTan%26aufirst%3DY.%2BX.%26aulast%3DHartimath%26aufirst%3DS.%2BV.%26aulast%3DJieu%26aufirst%3DB.%26aulast%3DHwang%26aufirst%3DY.%2BY.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DBoominathan%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DP.%26aulast%3DYuen%26aufirst%3DT.%2BY.%26aulast%3DChin%26aufirst%3DH.%2BX.%26aulast%3DTang%26aufirst%3DJ.%2BR.%26aulast%3DLarbi%26aufirst%3DA.%26aulast%3DChacko%26aufirst%3DA.%2BM.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DJohannes%26aufirst%3DC.%26aulast%3DRobins%26aufirst%3DE.%2BG.%26atitle%3DGranzyme%2520B%2520PET%2520imaging%2520of%2520immune%2520checkpoint%2520inhibitor%2520combinations%2520in%2520colon%2520cancer%2520phenotypes%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2020%26volume%3D22%26issue%3D5%26spage%3D1392%26epage%3D1402%26doi%3D10.1007%2Fs11307-020-01519-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larimer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehrenberg-Klee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalomeris, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boland, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmood, U.</span></span> <span> </span><span class="NLM_article-title">Granzyme B PET imaging as a predictive biomarker of immunotherapy response</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2318</span>â <span class="NLM_lpage">2327</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-16-3346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1158%2F0008-5472.CAN-16-3346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=28461564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFartrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=2318-2327&issue=9&author=B.+M.+Larimerauthor=E.+Wehrenberg-Kleeauthor=F.+Duboisauthor=A.+Mehtaauthor=T.+Kalomerisauthor=K.+Flahertyauthor=G.+Bolandauthor=U.+Mahmood&title=Granzyme+B+PET+imaging+as+a+predictive+biomarker+of+immunotherapy+response&doi=10.1158%2F0008-5472.CAN-16-3346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response</span></div><div class="casAuthors">Larimer, Benjamin M.; Wehrenberg-Klee, Eric; Dubois, Frank; Mehta, Anila; Kalomeris, Taylor; Flaherty, Keith; Boland, Genevieve; Mahmood, Umar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2318-2327</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">While cancer immunotherapy can produce dramatic responses, only a minority of patients respond to treatment.  Reliable response biomarkers are needed to identify responders, and conventional imaging modalities have not proved adequate.  Here, we provide a preclin. proof of concept for the use of granzyme B, a downstream effector of tumoral cytotoxic T cells, as an early biomarker for tumors responding to immunotherapy.  We designed novel PET imaging probes for the murine and human granzyme B isoforms that specifically and quant. bind granzyme B. Immunotherapy-treated mice were imaged prior to therapy-induced tumor vol. redn.  Imaging distinguished treated responders from nonresponders with excellent predictive ability.  To assess the clin. value of a granzyme B imaging paradigm, biopsy specimens from melanoma patients on checkpoint inhibitor therapy were analyzed.  A marked differential in granzyme B expression was obsd. between treated responders and nonresponders.  Addnl., our human probe was able to specifically detect granzyme B expression in human samples, providing a clear candidate for clin. application.  Overall, our results suggest granzyme B PET imaging can serve as a quant. useful predictive biomarker for efficacious responses to cancer immunotherapy.  Cancer Res; 77(9); 2318-27. Â©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzqLaYDBMrVrVg90H21EOLACvtfcHk0lj1mYhhmgBEZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFartrg%253D&md5=067c1214de9644011415501199938939</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-3346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-3346%26sid%3Dliteratum%253Aachs%26aulast%3DLarimer%26aufirst%3DB.%2BM.%26aulast%3DWehrenberg-Klee%26aufirst%3DE.%26aulast%3DDubois%26aufirst%3DF.%26aulast%3DMehta%26aufirst%3DA.%26aulast%3DKalomeris%26aufirst%3DT.%26aulast%3DFlaherty%26aufirst%3DK.%26aulast%3DBoland%26aufirst%3DG.%26aulast%3DMahmood%26aufirst%3DU.%26atitle%3DGranzyme%2520B%2520PET%2520imaging%2520as%2520a%2520predictive%2520biomarker%2520of%2520immunotherapy%2520response%26jtitle%3DCancer%2520Res.%26date%3D2017%26volume%3D77%26issue%3D9%26spage%3D2318%26epage%3D2327%26doi%3D10.1158%2F0008-5472.CAN-16-3346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeglinski, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raithatha, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oram, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiroyasu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westendorf, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopko, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arns, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liggins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaquith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papp, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granville, D. J.</span></span> <span> </span><span class="NLM_article-title">Topical small molecule granzyme B inhibitor improves remodeling in a murine model of impaired burn wound healing</span>. <i>Exp. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">11</span>, <span class="refDoi">Â DOI: 10.1038/s12276-018-0095-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs12276-018-0095-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOmtb%252FF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2018&pages=1-11&issue=5&author=Y.+Shenauthor=M.+R.+Zeglinskiauthor=C.+T.+Turnerauthor=S.+A.+Raithathaauthor=Z.+Wuauthor=V.+Russoauthor=C.+Oramauthor=S.+Hiroyasuauthor=L.+Nabaiauthor=H.+Zhaoauthor=T.+Bozinauthor=K.+Westendorfauthor=I.+Kopkoauthor=R.+Huangauthor=S.+Arnsauthor=J.+Tanauthor=H.+Zengauthor=A.+Boeyauthor=R.+Ligginsauthor=J.+Jaquithauthor=D.+R.+Cameronauthor=A.+Pappauthor=D.+J.+Granville&title=Topical+small+molecule+granzyme+B+inhibitor+improves+remodeling+in+a+murine+model+of+impaired+burn+wound+healing&doi=10.1038%2Fs12276-018-0095-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Topical small molecule granzyme B inhibitor improves remodeling in a murine model of impaired burn wound healing</span></div><div class="casAuthors">Shen, Yue; Zeglinski, Matthew R.; Turner, Christopher T.; Raithatha, Sheetal A.; Wu, Zhenguo; Russo, Valerio; Oram, Cameron; Hiroyasu, Sho; Nabai, Layla; Zhao, Hongyan; Bozin, Tatjana; Westendorf, Kathryn; Kopko, Irina; Huang, Rachel; Arns, Steve; Tan, Jason; Zeng, Haishan; Boey, Anthony; Liggins, Richard; Jaquith, James; Cameron, Dale R.; Papp, Anthony; Granville, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental & Molecular Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">EMMEF3</span>;
        ISSN:<span class="NLM_cas:issn">2092-6413</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Granzyme B (GzmB) is a serine protease that has long been thought to function exclusively in lymphocyte-mediated apoptosis.  In recent years, this paradigm has been revisited due to the recognition that GzmB accumulates in the extracellular milieu in many autoimmune and chronic inflammatory disorders, and contributes to impaired tissue remodeling due to the cleavage of extracellular matrix proteins.  Knockout studies suggest that GzmB-mediated cleavage of decorin (DCN) contributes to impaired collagen fibrillogenesis and remodeling.  As DCN is anti-fibrotic and contributes to reduced hypertrophic scarring, GzmB-induced DCN cleavage could play a role in wound healing following burn injury.  In the present study, a novel, gel-formulated, first-in-class small-mol. inhibitor of GzmB, VTI-1002, was assessed in a murine model of impaired, diabetic burn wound healing.  VTI-1002 exhibited high specificity, potency, and target selectivity.  Gel-formulated VTI-1002 was able to penetrate the stratum corneum and was retained in the skin with minimal systemic absorption.  Daily topical administration of VTI-1002 gel for 30 days following thermal injury showed significantly accelerated wound closure, increased DCN protein levels, and collagen organization that was translated into significantly increased wound tensile strength compared to controls.  Overall, VTI-1002 gel was well-tolerated in vivo and no adverse events were obsd.  Topical application of VTI-1002 represents a novel therapeutic approach for the treatment of cutaneous burn wounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0K8QSNOV3mbVg90H21EOLACvtfcHk0lj1mYhhmgBEZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOmtb%252FF&md5=ed4c467b8dbc0ad4d3b2f7d209b6f8d4</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1038%2Fs12276-018-0095-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs12276-018-0095-0%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DY.%26aulast%3DZeglinski%26aufirst%3DM.%2BR.%26aulast%3DTurner%26aufirst%3DC.%2BT.%26aulast%3DRaithatha%26aufirst%3DS.%2BA.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DRusso%26aufirst%3DV.%26aulast%3DOram%26aufirst%3DC.%26aulast%3DHiroyasu%26aufirst%3DS.%26aulast%3DNabai%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DBozin%26aufirst%3DT.%26aulast%3DWestendorf%26aufirst%3DK.%26aulast%3DKopko%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DArns%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DBoey%26aufirst%3DA.%26aulast%3DLiggins%26aufirst%3DR.%26aulast%3DJaquith%26aufirst%3DJ.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DPapp%26aufirst%3DA.%26aulast%3DGranville%26aufirst%3DD.%2BJ.%26atitle%3DTopical%2520small%2520molecule%2520granzyme%2520B%2520inhibitor%2520improves%2520remodeling%2520in%2520a%2520murine%2520model%2520of%2520impaired%2520burn%2520wound%2520healing%26jtitle%3DExp.%2520Mol.%2520Med.%26date%3D2018%26volume%3D50%26issue%3D5%26spage%3D1%26epage%3D11%26doi%3D10.1038%2Fs12276-018-0095-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiroyasu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeglinski, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawluk, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasprick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateishi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burleigh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennox, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Laeken, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granville, D. J.</span></span> <span> </span><span class="NLM_article-title">Granzyme B inhibition reduces disease severity in autoimmune blistering diseases</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">302</span>, <span class="refDoi">Â DOI: 10.1038/s41467-020-20604-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41467-020-20604-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=33436591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3MXhsVelsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2021&pages=302&issue=1&author=S.+Hiroyasuauthor=M.+R.+Zeglinskiauthor=H.+Zhaoauthor=M.+A.+Pawlukauthor=C.+T.+Turnerauthor=A.+Kasprickauthor=C.+Tateishiauthor=W.+Nishieauthor=A.+Burleighauthor=P.+A.+Lennoxauthor=N.+Van+Laekenauthor=N.+J.+Carrauthor=F.+Petersenauthor=R.+I.+Crawfordauthor=H.+Shimizuauthor=D.+Tsurutaauthor=R.+J.+Ludwigauthor=D.+J.+Granville&title=Granzyme+B+inhibition+reduces+disease+severity+in+autoimmune+blistering+diseases&doi=10.1038%2Fs41467-020-20604-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Granzyme B inhibition reduces disease severity in autoimmune blistering diseases</span></div><div class="casAuthors">Hiroyasu, Sho; Zeglinski, Matthew R.; Zhao, Hongyan; Pawluk, Megan A.; Turner, Christopher T.; Kasprick, Anika; Tateishi, Chiharu; Nishie, Wataru; Burleigh, Angela; Lennox, Peter A.; Van Laeken, Nancy; Carr, Nick J.; Petersen, Frank; Crawford, Richard I.; Shimizu, Hiroshi; Tsuruta, Daisuke; Ludwig, Ralf J.; Granville, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">302</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Pemphigoid diseases refer to a group of severe autoimmune skin blistering diseases characterized by subepidermal blistering and loss of dermal-epidermal adhesion induced by autoantibody and immune cell infiltrate at the dermal-epidermal junction and upper dermis.  Here, we explore the role of the immune cell-secreted serine protease, granzyme B, in pemphigoid disease pathogenesis using three independent murine models.  In all models, granzyme B knockout or topical pharmacol. inhibition significantly reduces total blistering area compared to controls.  In vivo and in vitro studies show that granzyme B contributes to blistering by degrading key anchoring proteins in the dermal-epidermal junction that are necessary for dermal-epidermal adhesion.  Further, granzyme B mediates IL-8/macrophage inflammatory protein-2 secretion, lesional neutrophil infiltration, and lesional neutrophil elastase activity.  Clin., granzyme B is elevated and abundant in human pemphigoid disease blister fluids and lesional skin.  Collectively, granzyme B is a potential therapeutic target in pemphigoid diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprjMs0pTs1OLVg90H21EOLACvtfcHk0lhA8RihQPYFow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXhsVelsbY%253D&md5=70283676449403d024c21aaeefdb21fe</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-20604-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-20604-3%26sid%3Dliteratum%253Aachs%26aulast%3DHiroyasu%26aufirst%3DS.%26aulast%3DZeglinski%26aufirst%3DM.%2BR.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DPawluk%26aufirst%3DM.%2BA.%26aulast%3DTurner%26aufirst%3DC.%2BT.%26aulast%3DKasprick%26aufirst%3DA.%26aulast%3DTateishi%26aufirst%3DC.%26aulast%3DNishie%26aufirst%3DW.%26aulast%3DBurleigh%26aufirst%3DA.%26aulast%3DLennox%26aufirst%3DP.%2BA.%26aulast%3DVan%2BLaeken%26aufirst%3DN.%26aulast%3DCarr%26aufirst%3DN.%2BJ.%26aulast%3DPetersen%26aufirst%3DF.%26aulast%3DCrawford%26aufirst%3DR.%2BI.%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DTsuruta%26aufirst%3DD.%26aulast%3DLudwig%26aufirst%3DR.%2BJ.%26aulast%3DGranville%26aufirst%3DD.%2BJ.%26atitle%3DGranzyme%2520B%2520inhibition%2520reduces%2520disease%2520severity%2520in%2520autoimmune%2520blistering%2520diseases%26jtitle%3DNat.%2520Commun.%26date%3D2021%26volume%3D12%26issue%3D1%26spage%3D302%26doi%3D10.1038%2Fs41467-020-20604-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">VicuÃ±a, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strochlic, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latremoliere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bali, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husainie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokosch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riva, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehrig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mall, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolf, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liberles, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costigan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuner, R.</span></span> <span> </span><span class="NLM_article-title">The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">518</span>â <span class="NLM_lpage">523</span>, <span class="refDoi">Â DOI: 10.1038/nm.3852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnm.3852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25915831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvFSqu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=518-523&issue=5&author=L.+Vicu%C3%B1aauthor=D.+E.+Strochlicauthor=A.+Latremoliereauthor=K.+K.+Baliauthor=M.+Simonettiauthor=D.+Husainieauthor=S.+Prokoschauthor=P.+Rivaauthor=R.+S.+Griffinauthor=C.+Njooauthor=S.+Gehrigauthor=M.+A.+Mallauthor=B.+Arnoldauthor=M.+Devorauthor=C.+J.+Woolfauthor=S.+D.+Liberlesauthor=M.+Costiganauthor=R.+Kuner&title=The+serine+protease+inhibitor+SerpinA3N+attenuates+neuropathic+pain+by+inhibiting+T+cell-derived+leukocyte+elastase&doi=10.1038%2Fnm.3852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase</span></div><div class="casAuthors">Vicuna, Lucas; Strochlic, David E.; Latremoliere, Alban; Bali, Kiran Kumar; Simonetti, Manuela; Husainie, Dewi; Prokosch, Sandra; Riva, Priscilla; Griffin, Robert S.; Njoo, Christian; Gehrig, Stefanie; Mall, Marcus A.; Arnold, Bernd; Devor, Marshall; Woolf, Clifford J.; Liberles, Stephen D.; Costigan, Michael; Kuner, Rohini</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">518-523</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuropathic pain is a major, intractable clin. problem and its pathophysiol. is not well understood.  Although recent gene expression profiling studies have enabled the identification of novel targets for pain therapy, classical study designs provide unclear results owing to the differential expression of hundreds of genes across sham and nerve-injured groups, which can be difficult to validate, particularly with respect to the specificity of pain modulation.  To circumvent this, we used two outbred lines of rats, which are genetically similar except for being genetically segregated as a result of selective breeding for differences in neuropathic pain hypersensitivity.  SerpinA3N, a serine protease inhibitor, was upregulated in the dorsal root ganglia (DRG) after nerve injury, which was further validated for its mouse homolog.  Mice lacking SerpinA3N developed more neuropathic mech. allodynia than wild-type (WT) mice, and exogenous delivery of SerpinA3N attenuated mech. allodynia in WT mice.  T lymphocytes infiltrate the DRG after nerve injury and release leukocyte elastase (LE), which was inhibited by SerpinA3N derived from DRG neurons.  Genetic loss of LE or exogenous application of a LE inhibitor (Sivelastat) in WT mice attenuated neuropathic mech. allodynia.  Overall, we reveal a novel and clin. relevant role for a member of the serpin superfamily and a leukocyte elastase and crosstalk between neurons and T cells in the modulation of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMteA4LZ-Gd7Vg90H21EOLACvtfcHk0lg2yZvy_qGKFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvFSqu7w%253D&md5=f8660f90daa0b419bbc6972a7c81cfb2</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1038%2Fnm.3852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3852%26sid%3Dliteratum%253Aachs%26aulast%3DVicu%25C3%25B1a%26aufirst%3DL.%26aulast%3DStrochlic%26aufirst%3DD.%2BE.%26aulast%3DLatremoliere%26aufirst%3DA.%26aulast%3DBali%26aufirst%3DK.%2BK.%26aulast%3DSimonetti%26aufirst%3DM.%26aulast%3DHusainie%26aufirst%3DD.%26aulast%3DProkosch%26aufirst%3DS.%26aulast%3DRiva%26aufirst%3DP.%26aulast%3DGriffin%26aufirst%3DR.%2BS.%26aulast%3DNjoo%26aufirst%3DC.%26aulast%3DGehrig%26aufirst%3DS.%26aulast%3DMall%26aufirst%3DM.%2BA.%26aulast%3DArnold%26aufirst%3DB.%26aulast%3DDevor%26aufirst%3DM.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26aulast%3DLiberles%26aufirst%3DS.%2BD.%26aulast%3DCostigan%26aufirst%3DM.%26aulast%3DKuner%26aufirst%3DR.%26atitle%3DThe%2520serine%2520protease%2520inhibitor%2520SerpinA3N%2520attenuates%2520neuropathic%2520pain%2520by%2520inhibiting%2520T%2520cell-derived%2520leukocyte%2520elastase%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26issue%3D5%26spage%3D518%26epage%3D523%26doi%3D10.1038%2Fnm.3852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narahara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiuchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, Y.</span></span> <span> </span><span class="NLM_article-title">Neutrophil elastase enhances IL-12p40 production by lipopolysaccharide-stimulated macrophages via transactivation of the PAR-2/EGFR/TLR4 signaling pathway</span>. <i>Blood Cells, Mol., Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">7</span>, <span class="refDoi">Â DOI: 10.1016/j.bcmd.2016.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bcmd.2016.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27282560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlslagsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1-7&author=R.+Yamaguchiauthor=T.+Yamamotoauthor=A.+Sakamotoauthor=S.+Naraharaauthor=H.+Sugiuchiauthor=Y.+Yamaguchi&title=Neutrophil+elastase+enhances+IL-12p40+production+by+lipopolysaccharide-stimulated+macrophages+via+transactivation+of+the+PAR-2%2FEGFR%2FTLR4+signaling+pathway&doi=10.1016%2Fj.bcmd.2016.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Neutrophil elastase enhances IL-12p40 production by lipopolysaccharide-stimulated macrophages via transactivation of the PAR-2/EGFR/TLR4 signaling pathway</span></div><div class="casAuthors">Yamaguchi, Rui; Yamamoto, Takatoshi; Sakamoto, Arisa; Narahara, Shinji; Sugiuchi, Hiroyuki; Yamaguchi, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Blood Cells, Molecules, & Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">BCMDFX</span>;
        ISSN:<span class="NLM_cas:issn">1079-9796</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Proteinase-activated receptor 2 (PAR-2) and toll-like receptor 4 (TLR4) are involved in innate immune responses and signaling cross-talk between these receptor mols. has the potential to augment an ongoing inflammatory response.  The aim of this study was to evaluate the possible cooperative influence of PAR-2 and TLR4 on IL-12p40 prodn. by macrophages after stimulation with lipopolysaccharide (LPS).  During culture, GM-CSF upregulated PAR-2 expression by macrophages in a time-dependent manner.  Stimulation with LPS enhanced IL-12p40 prodn. by macrophages in a concn.-dependent manner.  While human neutrophil elastase (HNE) did not induce IL-12p40 prodn., pretreatment of macrophages with HNE synergistically increased the IL-12p40 protein level after LPS exposure.  Silencing of TLR4 with small interfering RNA blunted the synergistic enhancement of IL-12p40 by HNE combined with LPS.  Silencing of Î²-arrestin 2, p22phox, or ERK1/2 also inhibited an increase of IL-12p40.  Interestingly, transfection of macrophages with small interfering RNA duplexes for DUOX-2, EGFR, TLR4, or TRAF6 significantly blunted the increase of IL-12p40 in response to treatment with HNE plus LPS.  U73122 and Rottlerin also inhibited the increased prodn. of IL-12p40.  In conclusion, HNE is involved in transactivation of TLR4 through activation of DUOX-2/EGFR and synergistically enhances IL-12p40 prodn. by macrophages stimulated with LPS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowvR2j-XVrlrVg90H21EOLACvtfcHk0lg2yZvy_qGKFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlslagsr8%253D&md5=671c84f100c1f15deb40b2aada5ae643</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1016%2Fj.bcmd.2016.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcmd.2016.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DR.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DA.%26aulast%3DNarahara%26aufirst%3DS.%26aulast%3DSugiuchi%26aufirst%3DH.%26aulast%3DYamaguchi%26aufirst%3DY.%26atitle%3DNeutrophil%2520elastase%2520enhances%2520IL-12p40%2520production%2520by%2520lipopolysaccharide-stimulated%2520macrophages%2520via%2520transactivation%2520of%2520the%2520PAR-2%252FEGFR%252FTLR4%2520signaling%2520pathway%26jtitle%3DBlood%2520Cells%252C%2520Mol.%252C%2520Dis.%26date%3D2016%26volume%3D59%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.bcmd.2016.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zemans, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briones, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Linden, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downey, G. P.</span></span> <span> </span><span class="NLM_article-title">Leukocyte elastase induces lung epithelial apoptosis via a PAR-1-, NF-ÎºB-, and p53-dependent Pathway</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">742</span>â <span class="NLM_lpage">755</span>, <span class="refDoi">Â DOI: 10.1165/rcmb.2008-0157OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1165%2Frcmb.2008-0157OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19307610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWisbnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=742-755&issue=6&author=T.+Suzukiauthor=C.+Yamashitaauthor=R.+L.+Zemansauthor=N.+Brionesauthor=A.+Van+Lindenauthor=G.+P.+Downey&title=Leukocyte+elastase+induces+lung+epithelial+apoptosis+via+a+PAR-1-%2C+NF-%CE%BAB-%2C+and+p53-dependent+Pathway&doi=10.1165%2Frcmb.2008-0157OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Leukocyte elastase induces lung epithelial apoptosis via a PAR-1-, NF-ÎºB-, and p53-dependent pathway</span></div><div class="casAuthors">Suzuki, Tomoko; Yamashita, Cory; Zemans, Rachel L.; Briones, Natalie; Van Linden, Annemie; Downey, Gregory P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">742-755</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Leukocyte elastase induces apoptosis of lung epithelial cells via alterations in mitochondrial permeability, but the signaling pathways regulating this response remain uncertain.  Here we investigated the involvement of proteinase-activated receptor-1 (PAR-1), the transcription factor NF-ÎºB, and the protooncogene p53 in this pathway.  Elastase-induced apoptosis of lung epithelial cells correlated temporally with activation of NF-ÎºB, phosphorylation, and nuclear translocation of p53, increased p53 up-regulated modulator of apoptosis (PUMA) expression, and mitochondrial translocation of Bax resulting in enhanced permeability.  Elastase-induced apoptosis was also prevented by pharmacol. inhibitors of NF-ÎºB and p53 and by short interfering RNA knockdown of PAR-1, p53, or PUMA.  These inhibitors prevented elastase-induced PUMA expression, mitochondrial translocation of Bax, increased mitochondrial permeability, and attenuated apoptosis.  NF-ÎºB inhibitors also reduced p53 phosphorylation.  We conclude that elastase-induced apoptosis of lung epithelial cells is mediated by a PAR-1-triggered pathway involving activation of NF-ÎºB and p53, and a PUMA- and Bax-dependent increase in mitochondrial permeability leading to activation of distal caspases.  Further, p53 contributes to elastase-induced apoptosis by both transcriptional and post-transcriptional mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofOFPz_cvX0bVg90H21EOLACvtfcHk0lh_pBllmLBteQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWisbnM&md5=030bcb96976ac0bd3a1e5e7ca0c8e632</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2008-0157OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2008-0157OC%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DC.%26aulast%3DZemans%26aufirst%3DR.%2BL.%26aulast%3DBriones%26aufirst%3DN.%26aulast%3DVan%2BLinden%26aufirst%3DA.%26aulast%3DDowney%26aufirst%3DG.%2BP.%26atitle%3DLeukocyte%2520elastase%2520induces%2520lung%2520epithelial%2520apoptosis%2520via%2520a%2520PAR-1-%252C%2520NF-%25CE%25BAB-%252C%2520and%2520p53-dependent%2520Pathway%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2009%26volume%3D41%26issue%3D6%26spage%3D742%26epage%3D755%26doi%3D10.1165%2Frcmb.2008-0157OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boudier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieth, J. G.</span></span> <span> </span><span class="NLM_article-title">Mucus proteinase inhibitor: a fast-acting inhibitor of leucocyte elastase</span>. <i>Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>995</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">36</span>â <span class="NLM_lpage">41</span>, <span class="refDoi">Â DOI: 10.1016/0167-4838(89)90230-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2F0167-4838%2889%2990230-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=2923915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaL1MXktF2qtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=995&publication_year=1989&pages=36-41&issue=1&author=C.+Boudierauthor=J.+G.+Bieth&title=Mucus+proteinase+inhibitor%3A+a+fast-acting+inhibitor+of+leucocyte+elastase&doi=10.1016%2F0167-4838%2889%2990230-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Mucus proteinase inhibitor:  a fast-acting inhibitor of leukocyte elastase</span></div><div class="casAuthors">Boudier, Christian; Bieth, Joseph G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">995</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-41</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    </div><div class="casAbstract">Human mucus proteinase inhibitor is a fast-acting inhibitor of human leukocyte elastase (EC 3.4.21.37) and forms a stable complex with this enzyme.  At physiol. ionic strength and temp. and in the presence of 10 mg/mL albumin, the kinetic consts. characterizing the interaction between elastase and the nondegraded inhibitor are: kass = 6.4 Ã 106 M-1 s-1, kdiss = 2.3 Ã 10-3 s-1, Ki = 3 Ã 10-10M.  The partially degraded inhibitor isolated by chymotrypsin-Sepharose chromatog. inhibits elastase with similar efficiency, suggesting that if partial proteolysis of the inhibitor occurs in vivo, the latter may still act as a potent antielastase.  Mucus proteinase inhibitor therefore plays a physiol. antielastase function in upper respiratory tract secretions, since it inhibits elastase with a delay time of 150 ms and behaves like an irreversible inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlyniTGzTjkLVg90H21EOLACvtfcHk0lh_pBllmLBteQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktF2qtrY%253D&md5=1911bfe36f1d4b493a86c0be3f6061bb</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1016%2F0167-4838%2889%2990230-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-4838%252889%252990230-6%26sid%3Dliteratum%253Aachs%26aulast%3DBoudier%26aufirst%3DC.%26aulast%3DBieth%26aufirst%3DJ.%2BG.%26atitle%3DMucus%2520proteinase%2520inhibitor%253A%2520a%2520fast-acting%2520inhibitor%2520of%2520leucocyte%2520elastase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Protein%2520Struct.%2520Mol.%2520Enzymol.%26date%3D1989%26volume%3D995%26issue%3D1%26spage%3D36%26epage%3D41%26doi%3D10.1016%2F0167-4838%2889%2990230-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kistowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DÈ©bski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karczmarski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paziewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OlÈ©dzki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dadlez, M.</span></span> <span> </span><span class="NLM_article-title">A strong neutrophil elastase proteolytic fingerprint marks the carcinoma tumor proteome</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">213</span>â <span class="NLM_lpage">227</span>, <span class="refDoi">Â DOI: 10.1074/mcp.M116.058818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fmcp.M116.058818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27927741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVynurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=213-227&issue=2&author=M.+Kistowskiauthor=J.+D%C8%A9bskiauthor=J.+Karczmarskiauthor=A.+Paziewskaauthor=J.+Ol%C8%A9dzkiauthor=M.+Mikulaauthor=J.+Ostrowskiauthor=M.+Dadlez&title=A+strong+neutrophil+elastase+proteolytic+fingerprint+marks+the+carcinoma+tumor+proteome&doi=10.1074%2Fmcp.M116.058818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">A Strong Neutrophil Elastase Proteolytic Fingerprint Marks the Carcinoma Tumor Proteome</span></div><div class="casAuthors">Kistowski, Michal; Debski, Janusz; Karczmarski, Jakub; Paziewska, Agnieszka; Oledzki, Jacek; Mikula, Michal; Ostrowski, Jerzy; Dadlez, Michal</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Proteomics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-227</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9484</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Proteolytic cascades are deeply involved in crit. stages of cancer progression.  During the course of peptide-wise anal. of shotgun proteomic data sets representative of colon adenocarcinoma (AC) and ulcerative colitis (UC), we detected a cancer-specific proteolytic fingerprint composed of a set of numerous protein fragments cleaved C-terminally to V, I, A, T, or C residues, significantly overrepresented in AC.  A peptide set linked by a common VIATC cleavage consensus was the only prominent cancer-specific proteolytic fingerprint detected.  This sequence consensus indicated neutrophil elastase as a source of the fingerprint.  We also found that a large fraction of affected proteins are RNA processing proteins assocd. with the nuclear fraction and mostly cleaved within their functionally important RNA-binding domains.  Thus, we detected a new class of cancer-specific peptides that are possible markers of tumor-infiltrating neutrophil activity, which often correlates with the clin. outcome.  Data are available via ProteomeXchange with identifiers: PXD005274 (Data set 1) and PXD004249 (Data set 2).  Our results indicate the value of peptide-wise anal. of large global proteomic anal. data sets as opposed to protein-wise anal., in which outlier differential peptides are usually neglected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz-B2IhI4YybVg90H21EOLACvtfcHk0ljHrYx9SNqvRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVynurw%253D&md5=bd37440ace94df97a8ba6bf59139ab27</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M116.058818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M116.058818%26sid%3Dliteratum%253Aachs%26aulast%3DKistowski%26aufirst%3DM.%26aulast%3DD%25C8%25A9bski%26aufirst%3DJ.%26aulast%3DKarczmarski%26aufirst%3DJ.%26aulast%3DPaziewska%26aufirst%3DA.%26aulast%3DOl%25C8%25A9dzki%26aufirst%3DJ.%26aulast%3DMikula%26aufirst%3DM.%26aulast%3DOstrowski%26aufirst%3DJ.%26aulast%3DDadlez%26aufirst%3DM.%26atitle%3DA%2520strong%2520neutrophil%2520elastase%2520proteolytic%2520fingerprint%2520marks%2520the%2520carcinoma%2520tumor%2520proteome%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2017%26volume%3D16%26issue%3D2%26spage%3D213%26epage%3D227%26doi%3D10.1074%2Fmcp.M116.058818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaguliene, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zemaitis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavinskiene, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miliauskas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakalauskas, R.</span></span> <span> </span><span class="NLM_article-title">Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease</span>. <i>BMC Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">36</span>, <span class="refDoi">Â DOI: 10.1186/1471-2172-14-36</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1186%2F1471-2172-14-36" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23919722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlajsrbL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=36&issue=1&author=N.+Vagulieneauthor=M.+Zemaitisauthor=S.+Lavinskieneauthor=S.+Miliauskasauthor=R.+Sakalauskas&title=Local+and+systemic+neutrophilic+inflammation+in+patients+with+lung+cancer+and+chronic+obstructive+pulmonary+disease&doi=10.1186%2F1471-2172-14-36"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease</span></div><div class="casAuthors">Vaguliene, Neringa; Zemaitis, Marius; Lavinskiene, Simona; Miliauskas, Skaidrius; Sakalauskas, Raimundas</div><div class="citationInfo"><span class="NLM_cas:title">BMC Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">BIMMCV</span>;
        ISSN:<span class="NLM_cas:issn">1471-2172</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Recent investigations suggest that neutrophils play an important role in the immune response to lung cancer as well as chronic obstructive pulmonary disease (COPD).  The aim of this study was to evaluate the amt. of neutrophils and markers of their activity in lung cancer and COPD and in coexistence of these two diseases.  Methods: In total, 267 persons were included in the study: 139 patients with lung cancer, 55 patients with lung cancer and COPD, 40 patients with COPD and 33 healthy subjects.  Peripheral blood and BAL fluid samples were obtained for cell count anal. and detn. of NE, MPO levels and ROS prodn.  NE and MPO levels in the serum and BAL fluid were detd. by ELISA.  ROS prodn. was analyzed by flow cytometer.  Results: The percentage, cell count of neutrophils and neutrophil to lymphocyte ratio in the peripheral blood were significantly higher in lung cancer patients with or without COPD compared to COPD patients or healthy individuals (P < 0.05).  The percentage and cell count of neutrophils in BAL fluid were significantly lower in patients with lung cancer with or without COPD than in patients with COPD (P < 0.05).  However, BAL fluid and serum levels of both NE and MPO were significantly higher in patients with lung cancer than COPD patients or healthy individuals (P < 0.05).  Neutrophils produced higher amts. of ROS in patients with lung cancer with or without COPD compared with COPD patients or healthy individuals (P < 0.05).  Conclusions: The results from this study demonstrate higher degree of local and systemic neutrophilic inflammation in patients with lung cancer (with or without COPD) than in patients with COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvz5B46-Csb7Vg90H21EOLACvtfcHk0ljHrYx9SNqvRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlajsrbL&md5=7686a5ea2aa72ca3a15952b85f17cf12</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1186%2F1471-2172-14-36&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2172-14-36%26sid%3Dliteratum%253Aachs%26aulast%3DVaguliene%26aufirst%3DN.%26aulast%3DZemaitis%26aufirst%3DM.%26aulast%3DLavinskiene%26aufirst%3DS.%26aulast%3DMiliauskas%26aufirst%3DS.%26aulast%3DSakalauskas%26aufirst%3DR.%26atitle%3DLocal%2520and%2520systemic%2520neutrophilic%2520inflammation%2520in%2520patients%2520with%2520lung%2520cancer%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DBMC%2520Immunol.%26date%3D2013%26volume%3D14%26issue%3D1%26spage%3D36%26doi%3D10.1186%2F1471-2172-14-36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tuhy, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span> <span> </span><span class="NLM_article-title">Inhibition of human leukocyte elastase by peptide chloromethyl ketones</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">359</span>â <span class="NLM_lpage">361</span>, <span class="refDoi">Â DOI: 10.1016/0014-5793(75)80527-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2F0014-5793%2875%2980527-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1116607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaE2MXhtlCktrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1975&pages=359-361&issue=3&author=P.+M.+Tuhyauthor=J.+C.+Powers&title=Inhibition+of+human+leukocyte+elastase+by+peptide+chloromethyl+ketones&doi=10.1016%2F0014-5793%2875%2980527-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human leukocyte elastase by peptide chloromethyl ketones</span></div><div class="casAuthors">Tuhy, Peter M.; Powers, James C.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-61</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">The inhibition of human leukocyte elastase by a series of peptide chloromethyl ketones was studied in order to define structural features necessary for an effective inhibitor which could lead to treatment for emphysema and related diseases.  The tetrapeptides studied were about 3-4-fold more reactive than the tripeptides.  The inhibitors with a P1 alanine, a P2 proline or leucine, no P3 proline (in the case of tripeptides), and a large hydrophobic group (phenyl) or alanine in P4 exhibited optimal inhibition of leukocyte elastase.  Ac-Ala-Ala-Pro-AlaCH2Cl was the most effective inhibitor for human leukocyte and porcine pancreatic elastase.  However, Ac-Ala-Pro-Ala-AlaCH2Cl was a good inhibitor for leukocyte elastase but did not affect the pancreatic enzyme, suggesting that the 2 enzymes are distinct entities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonWkZpCscyY7Vg90H21EOLACvtfcHk0ljHrYx9SNqvRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXhtlCktrY%253D&md5=5d8e59e0d9e3aaa8075563a006d0e0c2</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2875%2980527-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252875%252980527-8%26sid%3Dliteratum%253Aachs%26aulast%3DTuhy%26aufirst%3DP.%2BM.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DInhibition%2520of%2520human%2520leukocyte%2520elastase%2520by%2520peptide%2520chloromethyl%2520ketones%26jtitle%3DFEBS%2520Lett.%26date%3D1975%26volume%3D50%26issue%3D3%26spage%3D359%26epage%3D361%26doi%3D10.1016%2F0014-5793%2875%2980527-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowle, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, G. G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, G. D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molloy, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murkitt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godward, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padfield, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skarzynski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, O. M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleetwood, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finch, H.</span></span> <span> </span><span class="NLM_article-title">The discovery of a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastaseâGW311616A a development candidate</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">895</span>â <span class="NLM_lpage">898</span>, <span class="refDoi">Â DOI: 10.1016/S0960-894X(01)00078-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0960-894X%2801%2900078-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=11294386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVKgs7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=895-898&issue=7&author=S.+J.+F.+Macdonaldauthor=M.+D.+Dowleauthor=L.+A.+Harrisonauthor=P.+Shahauthor=M.+R.+Johnsonauthor=G.+G.+A.+Inglisauthor=G.+D.+E.+Clarkeauthor=R.+A.+Smithauthor=D.+Humphreysauthor=C.+R.+Molloyauthor=A.+Amourauthor=M.+Dixonauthor=G.+Murkittauthor=R.+E.+Godwardauthor=T.+Padfieldauthor=T.+Skarzynskiauthor=O.+M.+P.+Singhauthor=K.+A.+Kumarauthor=G.+Fleetwoodauthor=S.+T.+Hodgsonauthor=G.+W.+Hardyauthor=H.+Finch&title=The+discovery+of+a+potent%2C+intracellular%2C+orally+bioavailable%2C+long+duration+inhibitor+of+human+neutrophil+elastase%E2%80%94GW311616A+a+development+candidate&doi=10.1016%2FS0960-894X%2801%2900078-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastase-GW311616A a development candidate</span></div><div class="casAuthors">Macdonald, S. J. F.; Dowle, M. D.; Harrison, L. A.; Shah, P.; Johnson, M. R.; Inglis, G. G.; Clarke, G. D.; Smith, R. A.; Humphreys, D.; Molloy, C. R.; Amour, A.; Dixon, M.; Murkitt, G.; Godward, R. E.; Padfield, T.; Skarzynski, T.; Singh, O. M.; Kumar, K. A.; Fleetwood, G.; Hodgson, S. T.; Hardy, G. W.; Finch, H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">895-898</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The discovery of a potent intracellular inhibitor of human neutrophil elastase which is orally active and has a long duration of action is described.  The pharmacodynamic and pharmacokinetic properties of a trans-lactam development candidate, GW311616A, are described.  The medicinal chem. leading to development candidate GW311616A-a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastase-is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCj0I-MVbICbVg90H21EOLACvtfcHk0lhpfk0NZJ19JQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVKgs7s%253D&md5=458c9b5785879882677c278e58f88ac5</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900078-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900078-6%26sid%3Dliteratum%253Aachs%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DDowle%26aufirst%3DM.%2BD.%26aulast%3DHarrison%26aufirst%3DL.%2BA.%26aulast%3DShah%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DM.%2BR.%26aulast%3DInglis%26aufirst%3DG.%2BG.%2BA.%26aulast%3DClarke%26aufirst%3DG.%2BD.%2BE.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DHumphreys%26aufirst%3DD.%26aulast%3DMolloy%26aufirst%3DC.%2BR.%26aulast%3DAmour%26aufirst%3DA.%26aulast%3DDixon%26aufirst%3DM.%26aulast%3DMurkitt%26aufirst%3DG.%26aulast%3DGodward%26aufirst%3DR.%2BE.%26aulast%3DPadfield%26aufirst%3DT.%26aulast%3DSkarzynski%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DO.%2BM.%2BP.%26aulast%3DKumar%26aufirst%3DK.%2BA.%26aulast%3DFleetwood%26aufirst%3DG.%26aulast%3DHodgson%26aufirst%3DS.%2BT.%26aulast%3DHardy%26aufirst%3DG.%2BW.%26aulast%3DFinch%26aufirst%3DH.%26atitle%3DThe%2520discovery%2520of%2520a%2520potent%252C%2520intracellular%252C%2520orally%2520bioavailable%252C%2520long%2520duration%2520inhibitor%2520of%2520human%2520neutrophil%2520elastase%25E2%2580%2594GW311616A%2520a%2520development%2520candidate%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26issue%3D7%26spage%3D895%26epage%3D898%26doi%3D10.1016%2FS0960-894X%2801%2900078-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawabata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugitani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, T.</span></span> <span> </span><span class="NLM_article-title">ONO-5046, a novel inhibitor of human neutrophil elastase</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>177</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">814</span>â <span class="NLM_lpage">820</span>, <span class="refDoi">Â DOI: 10.1016/0006-291X(91)91862-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2F0006-291X%2891%2991862-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=2049103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3MXksVWqt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=1991&pages=814-820&issue=2&author=K.+Kawabataauthor=M.+Suzukiauthor=M.+Sugitaniauthor=K.+Imakiauthor=M.+Todaauthor=T.+Miyamoto&title=ONO-5046%2C+a+novel+inhibitor+of+human+neutrophil+elastase&doi=10.1016%2F0006-291X%2891%2991862-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">ONO-5046, a novel inhibitor of human neutrophil elastase</span></div><div class="casAuthors">Kawabata, Kazuhito; Suzuki, Mayumi; Sugitani, Masafumi; Imaki, Katsuhiro; Toda, Masaaki; Miyamoto, Tsumoru</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">814-20</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">ONO-5046 (I) competitively inhibited human neutrophil elastase (IC50 = 0.044 Î¼M, (ki = 0.2 Î¼M).  It also inhibited leukocyte elastase obtained from rabbits, rats, hamsters and mice.  However, ONO-5046 did not inhibit trypsin, thrombin, plasmin, plasma kallikrein, pancreas kallikrein, chymotrypsin or cathepsin G, even at 100 Î¼M.  In vivo, ONO-5046 suppressed lung hemorrhage in hamsters (ID50 = 82 Î¼g/kg) and the increase of skin capillary permeability in guinea pig (ID50 = 9.6 mg/kg) induced by human neutrophil elastase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMW9werm75QbVg90H21EOLACvtfcHk0lhpfk0NZJ19JQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVWqt7g%253D&md5=3534b9114486a679f3b637d2ffa00650</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2891%2991862-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252891%252991862-7%26sid%3Dliteratum%253Aachs%26aulast%3DKawabata%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DSugitani%26aufirst%3DM.%26aulast%3DImaki%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DM.%26aulast%3DMiyamoto%26aufirst%3DT.%26atitle%3DONO-5046%252C%2520a%2520novel%2520inhibitor%2520of%2520human%2520neutrophil%2520elastase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1991%26volume%3D177%26issue%3D2%26spage%3D814%26epage%3D820%26doi%3D10.1016%2F0006-291X%2891%2991862-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odagaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamanaka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toda, M.</span></span> <span> </span><span class="NLM_article-title">Clarification of mechanism of human sputum elastase inhibition by a new Inhibitor, ONO-5046, using electrospray ionization mass spectrometry</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2349</span>â <span class="NLM_lpage">2353</span>, <span class="refDoi">Â DOI: 10.1016/S0960-894X(02)00393-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0960-894X%2802%2900393-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=12161131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvVGjtL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2349-2353&issue=17&author=Y.+Nakayamaauthor=Y.+Odagakiauthor=S.+Fujitaauthor=S.+Matsuokaauthor=N.+Hamanakaauthor=H.+Nakaiauthor=M.+Toda&title=Clarification+of+mechanism+of+human+sputum+elastase+inhibition+by+a+new+Inhibitor%2C+ONO-5046%2C+using+electrospray+ionization+mass+spectrometry&doi=10.1016%2FS0960-894X%2802%2900393-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Clarification of Mechanism of Human Sputum Elastase Inhibition by a New Inhibitor, ONO-5046, Using Electrospray Ionization Mass Spectrometry</span></div><div class="casAuthors">Nakayama, Yoshisuke; Odagaki, Yoshihiko; Fujita, Setsuko; Matsuoka, Shozo; Hamanaka, Nobuyuki; Nakai, Hisao; Toda, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2349-2353</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Liq. chromatog. electrospray ionization mass spectrometry (LC/ESI-MS) to probe the nature of the covalent E-I complex was successfully applied to clarify the mechanism of human sputum elastase (HSE) inhibition by a new inhibitor, ONO-5046.  The mass spectrum of the four HSE isoenzymes displayed their mol. ion peaks at m/z = 26018, 25929, 25200, and 25054, resp.  Immediately after incubation, inactivation of HSE with ONO-5046 increased the four mol. ion peaks by approx. 84 amu, which was assigned to the mass unit of the pivaloyl moiety of ONO-5046.  An addnl. minute of incubation of E-I complex restored the original mol. ion peaks.  These observations strongly suggested that ONO-5046 inactivates HSE by a reversible 'acylation-deacylation' mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp19apMc4QQ4rVg90H21EOLACvtfcHk0lgUAPdRgJrKsw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvVGjtL8%253D&md5=730c1987d1cedc3d4d94e8e3aef72ab0</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900393-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900393-1%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DY.%26aulast%3DOdagaki%26aufirst%3DY.%26aulast%3DFujita%26aufirst%3DS.%26aulast%3DMatsuoka%26aufirst%3DS.%26aulast%3DHamanaka%26aufirst%3DN.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DClarification%2520of%2520mechanism%2520of%2520human%2520sputum%2520elastase%2520inhibition%2520by%2520a%2520new%2520Inhibitor%252C%2520ONO-5046%252C%2520using%2520electrospray%2520ionization%2520mass%2520spectrometry%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26issue%3D17%26spage%3D2349%26epage%3D2353%26doi%3D10.1016%2FS0960-894X%2802%2900393-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">SieÅczyk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PodgÃ³rski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BÅazejewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulbacka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saczko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksyszyn, J.</span></span> <span> </span><span class="NLM_article-title">Phosphonic pseudopeptides as human neutrophil elastase inhibitorsâa combinatorial approach</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1277</span>â <span class="NLM_lpage">1284</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2010.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmc.2010.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21216608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKks70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1277-1284&issue=3&author=M.+Sie%C5%84czykauthor=D.+Podg%C3%B3rskiauthor=A.+B%C5%82azejewskaauthor=J.+Kulbackaauthor=J.+Saczkoauthor=J.+Oleksyszyn&title=Phosphonic+pseudopeptides+as+human+neutrophil+elastase+inhibitors%E2%80%94a+combinatorial+approach&doi=10.1016%2Fj.bmc.2010.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphonic pseudopeptides as human neutrophil elastase inhibitors-a combinatorial approach</span></div><div class="casAuthors">Sienczyk, Marcin; Podgorski, Dawid; Blazejewska, Aleksandra; Kulbacka, Julita; Saczko, Jolanta; Oleksyszyn, Jozef</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1277-1284</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here we present a simple and rapid method for the construction of phosphonic peptide mimetic inhibitor libraries-products of Ugi and Passerini multicomponent condensations-leading to the selection of new biol. active phosphonic pseudopeptides.  As the starting isonitriles, 1-isocyanoalkylphosphonate diaryl ester derivs. were applied.  The structure of the synthesized inhibitors was designed to target human neutrophil elastase, a serine protease whose uncontrolled activity may lead to development of several pathophysiol. states such as rheumatoid arthritis, cystic fibrosis or tumor growth and invasion.  After screening the inhibitory activity of our constructed libraries, the most active compds. were synthesized as single mols.  One of the obtained inhibitors, Cbz-Met-O-Met-ValP(OC6H4-p-Cl)2, displayed apparent second-order inhibition value at 40,105 M-1 s-1 as the diastereomers mixt.  Inhibition potency and selectivity of action toward other serine proteases as well as the results of initial in vitro expts. regarding inhibitors influence on cancer cell proliferation are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnnORoQHUwDLVg90H21EOLACvtfcHk0lgUAPdRgJrKsw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKks70%253D&md5=528307259230055ec8b329fa3e2b3d34</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DSie%25C5%2584czyk%26aufirst%3DM.%26aulast%3DPodg%25C3%25B3rski%26aufirst%3DD.%26aulast%3DB%25C5%2582azejewska%26aufirst%3DA.%26aulast%3DKulbacka%26aufirst%3DJ.%26aulast%3DSaczko%26aufirst%3DJ.%26aulast%3DOleksyszyn%26aufirst%3DJ.%26atitle%3DPhosphonic%2520pseudopeptides%2520as%2520human%2520neutrophil%2520elastase%2520inhibitors%25E2%2580%2594a%2520combinatorial%2520approach%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26issue%3D3%26spage%3D1277%26epage%3D1284%26doi%3D10.1016%2Fj.bmc.2010.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edgington-Mitchell, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlow, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aurelio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnett, N.</span></span> <span> </span><span class="NLM_article-title">Fluorescent diphenylphosphonate-based probes for detection of serine protease activity during inflammation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">254</span>â <span class="NLM_lpage">260</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.11.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2016.11.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27923620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWmtLvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=254-260&issue=2&author=L.+E.+Edgington-Mitchellauthor=N.+Barlowauthor=L.+Aurelioauthor=A.+Samhaauthor=M.+Szaboauthor=B.+Grahamauthor=N.+Bunnett&title=Fluorescent+diphenylphosphonate-based+probes+for+detection+of+serine+protease+activity+during+inflammation&doi=10.1016%2Fj.bmcl.2016.11.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent diphenylphosphonate-based probes for detection of serine protease activity during inflammation</span></div><div class="casAuthors">Edgington-Mitchell, Laura E.; Barlow, Nicholas; Aurelio, Luigi; Samha, Aminath; Szabo, Monika; Graham, Bim; Bunnett, Nigel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">254-260</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Activity-based probes are small mols. that covalently bind to the active site of a protease in an activity-dependent manner.  We synthesized and characterized two fluorescent activity-based probes that target serine proteases with trypsin-like or elastase-like activity.  We assessed the selectivity and potency of these probes against recombinant enzymes and demonstrated that while they are efficacious at labeling active proteases in complex protein mixts. in vitro, they are less valuable for in vivo studies.  We used these probes to evaluate serine protease activity in two mouse models of acute inflammation, including pancreatitis and colitis.  As anticipated, the activity of trypsin-like proteases was increased during pancreatitis.  Levels of elastase-like proteases were low in pancreatic lysates and colonic luminal fluids, whether healthy or inflamed.  Exogenously added recombinant neutrophil elastase was inhibited upon incubation with these samples, an effect that was augmented in inflamed samples compared to controls.  These data suggest that endogenous inhibitors and elastase-degrading proteases are upregulated during inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2IHs8fBs_IbVg90H21EOLACvtfcHk0lhLO6bycdyERw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWmtLvP&md5=5121d5a31883aeb0801f58b039e20e9b</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.11.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.11.064%26sid%3Dliteratum%253Aachs%26aulast%3DEdgington-Mitchell%26aufirst%3DL.%2BE.%26aulast%3DBarlow%26aufirst%3DN.%26aulast%3DAurelio%26aufirst%3DL.%26aulast%3DSamha%26aufirst%3DA.%26aulast%3DSzabo%26aufirst%3DM.%26aulast%3DGraham%26aufirst%3DB.%26aulast%3DBunnett%26aufirst%3DN.%26atitle%3DFluorescent%2520diphenylphosphonate-based%2520probes%2520for%2520detection%2520of%2520serine%2520protease%2520activity%2520during%2520inflammation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D2%26spage%3D254%26epage%3D260%26doi%3D10.1016%2Fj.bmcl.2016.11.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winterbourn, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Design of ultrasensitive probes for human neutrophil elastase through hybrid combinatorial substrate library profiling</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2518</span>â <span class="NLM_lpage">2523</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1318548111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.1318548111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24550277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivFaht7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=2518-2523&issue=7&author=P.+Kasperkiewiczauthor=M.+Porebaauthor=S.+J.+Snipasauthor=H.+Parkerauthor=C.+C.+Winterbournauthor=G.+S.+Salvesenauthor=M.+Drag&title=Design+of+ultrasensitive+probes+for+human+neutrophil+elastase+through+hybrid+combinatorial+substrate+library+profiling&doi=10.1073%2Fpnas.1318548111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Design of ultrasensitive probes for human neutrophil elastase through hybrid combinatorial substrate library profiling</span></div><div class="casAuthors">Kasperkiewicz, Paulina; Poreba, Marcin; Snipas, Scott J.; Parker, Heather; Winterbourn, Christine C.; Salvesen, Guy S.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2518-2523</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The exploration of protease substrate specificity is generally restricted to naturally occurring amino acids, limiting the degree of conformational space that can be surveyed.  We substantially enhanced this by incorporating 102 unnatural amino acids to explore the S1-S4 pockets of human neutrophil elastase (NE).  This approach provides hybrid natural and unnatural amino acid sequences, and thus we termed it the Hybrid Combinatorial Substrate Library (HyCoSuL).  Library results were validated by the synthesis of individual tetrapeptide substrates, with the optimal substrate demonstrating more than three orders of magnitude higher catalytic efficiency than commonly used substrates of elastase.  This optimal substrate was converted to an activity-based probe that demonstrated high selectivity and revealed the specific presence of active elastase during the process of neutrophil extracellular trap formation.  We propose that this approach can be successfully used for any type of endopeptidase to deliver high activity and selectivity in substrates and probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMwdujTniBZbVg90H21EOLACvtfcHk0lhLO6bycdyERw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivFaht7o%253D&md5=048b0dd58455cd95a3def76ee8942337</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1318548111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1318548111%26sid%3Dliteratum%253Aachs%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DParker%26aufirst%3DH.%26aulast%3DWinterbourn%26aufirst%3DC.%2BC.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DDesign%2520of%2520ultrasensitive%2520probes%2520for%2520human%2520neutrophil%2520elastase%2520through%2520hybrid%2520combinatorial%2520substrate%2520library%2520profiling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D7%26spage%3D2518%26epage%3D2523%26doi%3D10.1073%2Fpnas.1318548111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DâAngelo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Toolbox of fluorescent probes for parallel imaging reveals uneven location of serine proteases in neutrophils</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span> (<span class="NLM_issue">29</span>),  <span class="NLM_fpage">10115</span>â <span class="NLM_lpage">10125</span>, <span class="refDoi">Â DOI: 10.1021/jacs.7b04394</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b04394" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2ru7zM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=10115-10125&issue=29&author=P.+Kasperkiewiczauthor=Y.+Altmanauthor=M.+D%E2%80%99Angeloauthor=G.+S.+Salvesenauthor=M.+Drag&title=Toolbox+of+fluorescent+probes+for+parallel+imaging+reveals+uneven+location+of+serine+proteases+in+neutrophils&doi=10.1021%2Fjacs.7b04394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Toolbox of Fluorescent Probes for Parallel Imaging Reveals Uneven Location of Serine Proteases in Neutrophils</span></div><div class="casAuthors">Kasperkiewicz, Paulina; Altman, Yoav; D'Angelo, Maximiliano; Salvesen, Guy S.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">10115-10125</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neutrophils, the front line defenders against infection, express four serine proteases (NSPs) that play roles in the control of cell-signaling pathways and defense against pathogens and whose imbalance leads to pathol. conditions.  Dissecting the roles of individual NSPs in humans is problematic because neutrophils are end-stage cells with a short half-life and minimal ongoing protein synthesis.  To gain insight into the regulation of NSP activity we have generated a small-mol. chem. toolbox consisting of activity-based probes with different fluorophore-detecting groups with minimal wavelength overlap and highly selective natural and unnatural amino acid recognition sequences.  The key feature of these activity-based probes is the ability to use them for simultaneous observation and detection of all four individual NSPs by fluorescence microscopy, a feature never achieved in previous studies.  Using these probes we demonstrate uneven distribution of NSPs in neutrophil azurophil granules, such that they seem to be mutually excluded from each other, suggesting the existence of unknown granule-targeting mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCQyFRKT-WtrVg90H21EOLACvtfcHk0ljM9Tyzd5ZPQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2ru7zM&md5=72b3e9e59a26a034fa66aa9cbd714b61</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b04394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b04394%26sid%3Dliteratum%253Aachs%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DAltman%26aufirst%3DY.%26aulast%3DD%25E2%2580%2599Angelo%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DToolbox%2520of%2520fluorescent%2520probes%2520for%2520parallel%2520imaging%2520reveals%2520uneven%2520location%2520of%2520serine%2520proteases%2520in%2520neutrophils%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26issue%3D29%26spage%3D10115%26epage%3D10125%26doi%3D10.1021%2Fjacs.7b04394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichard, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goosmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlemann, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinrauch, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zychlinsky, A.</span></span> <span> </span><span class="NLM_article-title">Neutrophil extracellular traps kill bacteria</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>303</i></span> (<span class="NLM_issue">5663</span>),  <span class="NLM_fpage">1532</span>â <span class="NLM_lpage">1535</span>, <span class="refDoi">Â DOI: 10.1126/science.1092385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fscience.1092385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15001782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhslCgsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=1532-1535&issue=5663&author=V.+Brinkmannauthor=U.+Reichardauthor=C.+Goosmannauthor=B.+Faulerauthor=Y.+Uhlemannauthor=D.+S.+Weissauthor=Y.+Weinrauchauthor=A.+Zychlinsky&title=Neutrophil+extracellular+traps+kill+bacteria&doi=10.1126%2Fscience.1092385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Neutrophil Extracellular Traps Kill Bacteria</span></div><div class="casAuthors">Brinkmann, Volker; Reichard, Ulrike; Goosmann, Christian; Fauler, Beatrix; Uhlemann, Yvonne; Weiss, David S.; Weinrauch, Yvette; Zychlinsky, Arturo</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5663</span>),
    <span class="NLM_cas:pages">1532-1535</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Neutrophils engulf and kill bacteria when their antimicrobial granules fuse with the phagosome.  Here, the authors describe that, upon activation, neutrophils release granule proteins and chromatin that together form extracellular fibers that bind Gram-pos. and -neg. bacteria.  These neutrophil extracellular traps (NETs) degrade virulence factors and kill bacteria.  NETs are abundant in vivo in exptl. dysentery and spontaneous human appendicitis, two examples of acute inflammation.  NETs appear to be a form of innate response that binds microorganisms, prevents them from spreading, and ensures a high local concn. of antimicrobial agents to degrade virulence factors and kill bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot7js5LhZu87Vg90H21EOLACvtfcHk0ljM9Tyzd5ZPQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhslCgsb8%253D&md5=54d14d74ebe66b044b47ff7af759adb1</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1126%2Fscience.1092385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1092385%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DReichard%26aufirst%3DU.%26aulast%3DGoosmann%26aufirst%3DC.%26aulast%3DFauler%26aufirst%3DB.%26aulast%3DUhlemann%26aufirst%3DY.%26aulast%3DWeiss%26aufirst%3DD.%2BS.%26aulast%3DWeinrauch%26aufirst%3DY.%26aulast%3DZychlinsky%26aufirst%3DA.%26atitle%3DNeutrophil%2520extracellular%2520traps%2520kill%2520bacteria%26jtitle%3DScience%26date%3D2004%26volume%3D303%26issue%3D5663%26spage%3D1532%26epage%3D1535%26doi%3D10.1126%2Fscience.1092385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lechtenberg, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, S. J.</span></span> <span> </span><span class="NLM_article-title">The elastase-PK101 structure: mechanism of an ultrasensitive activity-based probe revealed</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">945</span>â <span class="NLM_lpage">951</span>, <span class="refDoi">Â DOI: 10.1021/cb500909n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500909n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmt1Oquw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=945-951&issue=4&author=B.+C.+Lechtenbergauthor=P.+Kasperkiewiczauthor=H.+Robinsonauthor=M.+Dragauthor=S.+J.+Riedl&title=The+elastase-PK101+structure%3A+mechanism+of+an+ultrasensitive+activity-based+probe+revealed&doi=10.1021%2Fcb500909n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">The elastase-PK 101 structure: Mechanism of an ultrasensitive activity-based probe revealed</span></div><div class="casAuthors">Lechtenberg, Bernhard C.; Kasperkiewicz, Paulina; Robinson, Howard; Drag, Marcin; Riedl, Stefan J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">945-951</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human neutrophil elastase (HNE) plays a central role in neutrophil host defense, but its broad specificity makes HNE a difficult target for both inhibitor and probe development.  Recently, the authors identified the unnatural amino acid-contg. activity-based probe PK 101, which exhibited astounding sensitivity and selectivity for HNE, yet completely lacked mechanistic explanation for its unique characteristics.  Here, the authors present the crystal structure of the HNE-PK 101 complex which not only reveals the basis for PK 101 ultrasensitivity but also uncovers so far unrecognized HNE features.  Strikingly, the Nle(O-Bzl) function in the P4 position of PK 101 revealed and leveraged an "exo-pocket" on HNE as a crit. factor for selectivity.  Furthermore, the PK 101 P3 position harbored a methionine dioxide function, which mimicked a post-translationally oxidized Met residue and forms a crit. H-bond to the backbone amide of Gly-219 of HNE.  Gly-219 resided in a Gly-Gly motif that was unique to HNE, yet compulsory for this interaction.  Consequently, this feature enabled HNE to accommodate substrates that have undergone Met oxidn., which constitutes a hallmark post-translational modification of neutrophil signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUhGxLWVVUQ7Vg90H21EOLACvtfcHk0liBsqAOVHqDCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmt1Oquw%253D%253D&md5=36a0537ede18a9c308557217f3e9985e</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1021%2Fcb500909n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500909n%26sid%3Dliteratum%253Aachs%26aulast%3DLechtenberg%26aufirst%3DB.%2BC.%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DRobinson%26aufirst%3DH.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520elastase-PK101%2520structure%253A%2520mechanism%2520of%2520an%2520ultrasensitive%2520activity-based%2520probe%2520revealed%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D4%26spage%3D945%26epage%3D951%26doi%3D10.1021%2Fcb500909n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebanoff, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinecke, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.</span></span> <span> </span><span class="NLM_article-title">Methionine oxidation contributes to bacterial killing by the myeloperoxidase system of neutrophils</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">18686</span>â <span class="NLM_lpage">18691</span>, <span class="refDoi">Â DOI: 10.1073/pnas.0909464106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.0909464106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19833874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKnu7nN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=18686-18691&issue=44&author=H.+Rosenauthor=S.+J.+Klebanoffauthor=Y.+Wangauthor=N.+Brotauthor=J.+W.+Heineckeauthor=X.+Fu&title=Methionine+oxidation+contributes+to+bacterial+killing+by+the+myeloperoxidase+system+of+neutrophils&doi=10.1073%2Fpnas.0909464106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">Methionine oxidation contributes to bacterial killing by the myeloperoxidase system of neutrophils</span></div><div class="casAuthors">Rosen, Henry; Klebanoff, Seymour J.; Wang, Yi; Brot, Nathan; Heinecke, Jay W.; Fu, Xiaoyun</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">18686-18691, S18686/1-S18686/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Reactive oxygen intermediates generated by neutrophils kill bacteria and are implicated in inflammatory tissue injury, but precise mol. targets are undefined.  We demonstrate that neutrophils use myeloperoxidase (MPO) to convert methionine residues of ingested Escherichia coli to methionine sulfoxide in high yield.  Neutrophils deficient in individual components of the MPO system (MPO, H2O2, chloride) exhibited impaired bactericidal activity and impaired capacity to oxidize methionine.  HOCl, the principal physiol. product of the MPO system, is a highly efficient oxidant for methionine, and its microbicidal effects were found to correspond linearly with oxidn. of methionine residues in bacterial cytosolic and inner membrane proteins.  In contrast, outer envelope proteins were initially oxidized without assocd. microbicidal effect.  Disruption of bacterial methionine sulfoxide repair systems rendered E. coli more susceptible to killing by HOCl, whereas over-expression of a repair enzyme, methionine sulfoxide reductase A, rendered them resistant, suggesting a direct role for methionine oxidn. in bactericidal activity.  Prominent among oxidized bacterial proteins were those engaged in synthesis and translocation of peptides to the cell envelope, an essential physiol. function.  Moreover, HOCl impaired protein translocation early in the course of bacterial killing.  Together, our findings indicate that MPO-mediated methionine oxidn. contributes to bacterial killing by neutrophils.  The findings further suggest that protein translocation to the cell envelope is one important pathway targeted for damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxoGHsQLa7W7Vg90H21EOLACvtfcHk0liBsqAOVHqDCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKnu7nN&md5=1647061663af9c3a06dc68ccfaef8c1f</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0909464106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0909464106%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DKlebanoff%26aufirst%3DS.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBrot%26aufirst%3DN.%26aulast%3DHeinecke%26aufirst%3DJ.%2BW.%26aulast%3DFu%26aufirst%3DX.%26atitle%3DMethionine%2520oxidation%2520contributes%2520to%2520bacterial%2520killing%2520by%2520the%2520myeloperoxidase%2520system%2520of%2520neutrophils%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D44%26spage%3D18686%26epage%3D18691%26doi%3D10.1073%2Fpnas.0909464106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poole, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aurelio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, G. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleischmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morissette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Driel, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanner, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnett, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington-Mitchell, L. E.</span></span> <span> </span><span class="NLM_article-title">Application of a chemical probe to detect neutrophil elastase activation during inflammatory bowel disease</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">13295</span>, <span class="refDoi">Â DOI: 10.1038/s41598-019-49840-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41598-019-49840-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31527638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BB3MrpsVaqug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=13295&issue=1&author=B.+M.+Andersonauthor=D.+P.+Pooleauthor=L.+Aurelioauthor=G.+Z.+Ngauthor=M.+Fleischmannauthor=P.+Kasperkiewiczauthor=C.+Morissetteauthor=M.+Dragauthor=I.+R.+van+Drielauthor=B.+L.+Schmidtauthor=S.+J.+Vannerauthor=N.+W.+Bunnettauthor=L.+E.+Edgington-Mitchell&title=Application+of+a+chemical+probe+to+detect+neutrophil+elastase+activation+during+inflammatory+bowel+disease&doi=10.1038%2Fs41598-019-49840-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a chemical probe to detect neutrophil elastase activation during inflammatory bowel disease</span></div><div class="casAuthors">Anderson Bethany M; Ng Garrett Z; Fleischmann Markus; van Driel Ian R; Edgington-Mitchell Laura E; Anderson Bethany M; Poole Daniel P; Bunnett Nigel W; Edgington-Mitchell Laura E; Aurelio Luigi; Fleischmann Markus; Kasperkiewicz Paulina; Drag Marcin; Morissette Celine; Vanner Stephen J; Schmidt Brian L; Edgington-Mitchell Laura E; Bunnett Nigel W; Bunnett Nigel W</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13295</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neutrophil elastase is a serine protease that has been implicated in the pathogenesis of inflammatory bowel disease.  Due to post-translational control of its activation and high expression of its inhibitors in the gut, measurements of total expression poorly reflect the pool of active, functional neutrophil elastase.  Fluorogenic substrate probes have been used to measure neutrophil elastase activity, though these tools lack specificity and traceability.  PK105 is a recently described fluorescent activity-based probe, which binds to neutrophil elastase in an activity-dependent manner.  The irreversible nature of this probe allows for accurate identification of its targets in complex protein mixtures.  We describe the reactivity profile of PK105b, a new analogue of PK105, against recombinant serine proteases and in tissue extracts from healthy mice and from models of inflammation induced by oral cancer and Legionella pneumophila infection.  We apply PK105b to measure neutrophil elastase activation in an acute model of experimental colitis.  Neutrophil elastase activity is detected in inflamed, but not healthy, colons.  We corroborate this finding in mucosal biopsies from patients with ulcerative colitis.  Thus, PK105b facilitates detection of neutrophil elastase activity in tissue lysates, and we have applied it to demonstrate that this protease is unequivocally activated during colitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4GG7aPDCwMoYPsCkJIw00fW6udTcc2eZ9pqrTJ6_rubntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MrpsVaqug%253D%253D&md5=06e4aa00811979c6f5c9c87ebeaf14d0</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-49840-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-49840-4%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DB.%2BM.%26aulast%3DPoole%26aufirst%3DD.%2BP.%26aulast%3DAurelio%26aufirst%3DL.%26aulast%3DNg%26aufirst%3DG.%2BZ.%26aulast%3DFleischmann%26aufirst%3DM.%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DMorissette%26aufirst%3DC.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3Dvan%2BDriel%26aufirst%3DI.%2BR.%26aulast%3DSchmidt%26aufirst%3DB.%2BL.%26aulast%3DVanner%26aufirst%3DS.%2BJ.%26aulast%3DBunnett%26aufirst%3DN.%2BW.%26aulast%3DEdgington-Mitchell%26aufirst%3DL.%2BE.%26atitle%3DApplication%2520of%2520a%2520chemical%2520probe%2520to%2520detect%2520neutrophil%2520elastase%2520activation%2520during%2520inflammatory%2520bowel%2520disease%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26issue%3D1%26spage%3D13295%26doi%3D10.1038%2Fs41598-019-49840-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref219"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref219'); return false;" data-citation="" class="refNumLink">219</a></strong><div class="NLM_citation" id="cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchhofer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Design of a selective substrate and activity based probe for human neutrophil serine protease 4</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">7</span>), <span class="NLM_elocation-id">e0132818</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0132818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1371%2Fjournal.pone.0132818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26172376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVSrtLnE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&issue=7&author=P.+Kasperkiewiczauthor=M.+Porebaauthor=S.+J.+Snipasauthor=S.+J.+Linauthor=D.+Kirchhoferauthor=G.+S.+Salvesenauthor=M.+Drag&title=Design+of+a+selective+substrate+and+activity+based+probe+for+human+neutrophil+serine+protease+4&doi=10.1371%2Fjournal.pone.0132818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Design of a selective substrate and activity based probe for human neutrophil serine protease 4</span></div><div class="casAuthors">Kasperkiewicz, Paulina; Poreba, Marcin; Snipas, Scott J.; Jack, Lin S.; Kirchhofer, Daniel; Salvesen, Guy S.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e0132818/1-e0132818/12</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Human neutrophil serine protease 4 (NSP4), also known as PRSS57, is a recently discovered fourth member of the neutrophil serine proteases family.  Although its biol. function is not precisely defined, it is suggested to regulate neutrophil response and innate immune reactions.  To create optimal substrates and visualization probes for NSP4 that distinguish it from other NSPs we have employed a Hybrid Combinatorial Substrate Library approach that utilizes natural and unnatural amino acids to explore protease subsite preferences.  Library results were validated by synthesizing individual substrates, leading to the identification of an optimal substrate peptide.  This substrate was converted to a covalent di-Ph phosphonate probe with an embedded biotin tag.  This probe demonstrated high inhibitory activity and stringent specificity and may be suitable for visualizing NSP4 in the background of other NSPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Dosrmw75eLVg90H21EOLACvtfcHk0ljJjLLfWC82yA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVSrtLnE&md5=b2323901d336008609b238a1bc344eca</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132818%26sid%3Dliteratum%253Aachs%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DLin%26aufirst%3DS.%2BJ.%26aulast%3DKirchhofer%26aufirst%3DD.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DDesign%2520of%2520a%2520selective%2520substrate%2520and%2520activity%2520based%2520probe%2520for%2520human%2520neutrophil%2520serine%2520protease%25204%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26issue%3D7%26doi%3D10.1371%2Fjournal.pone.0132818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref220"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref220'); return false;" data-citation="" class="refNumLink">220</a></strong><div class="NLM_citation" id="cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Hoorn, R. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weerapana, E.</span></span> <span> </span><span class="NLM_article-title">Sulfonyl fluoride analogues as activity-based probes for serine proteases</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">2327</span>â <span class="NLM_lpage">2330</span>, <span class="refDoi">Â DOI: 10.1002/cbic.201200531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fcbic.201200531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23008217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlyqsLnP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=2327-2330&issue=16&author=D.+A.+Shannonauthor=C.+Guauthor=C.+J.+McLaughlinauthor=M.+Kaiserauthor=R.+A.+L.+van+der+Hoornauthor=E.+Weerapana&title=Sulfonyl+fluoride+analogues+as+activity-based+probes+for+serine+proteases&doi=10.1002%2Fcbic.201200531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit220R"><div class="casContent"><span class="casTitleNuber">220</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonyl Fluoride Analogues as Activity-Based Probes for Serine Proteases</span></div><div class="casAuthors">Shannon, D. Alexander; Gu, Christian; McLaughlin, Christopher J.; Kaiser, Markus; van der Hoorn, Renier A. L.; Weerapana, Eranthie</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2327-2330, S2327/1-S2327/16</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The tools of activity-based protein profiling (ABPP) have played a pervasive role in the functional characterization of enzymes within complex biol. systems.  As the application of ABPP technologies becomes more widespread, there is a const. need for an ever-expanding library of activity-based probes (ABPs) of varying reactivity and specificity.  ABPP methods are particularly important for the study of proteases, which are often subject to stringent post-translational regulation.  Compared to the armory of ABPs available for cysteine proteases, ABPs for the serine protease family are poorly represented, mostly due to the lower reactivity of the serine nucleophile relative to its cysteine counterpart.  Fluorophosphonate (FP) based ABPs are known to target serine proteases, together with the entire family of serine hydrolases that encompass approx. 1 % of the human genome.  Although sulfonate esters have previously been used as carbon electrophiles in ABPs for targeting diverse enzyme classes, there are no previous reports on adapting sulfonyl fluorides into chem. probes for activity-based profiling.  Converting AEBSF into an ABP requires the incorporation of a reporter group in the form of a fluorophore, biotin or a click-chem. handle to enable visualization and enrichment of active enzymes.  Three modified versions of AEBSF were synthesized, including the rhodamine-tagged DS6R and the alkyne-functionalized DAS1 and DAS2.  DS6R and DAS1 were synthesized using an amide coupling reaction to the primary amine of AEBSF, whereas DAS2 was obtained using a reductive amination reaction to incorporate the alkyne functionality.  DAS1 was identified as a potent and activity-based covalent modifier of serine proteases and was used to continue characterization of protease labeling.  Here, the application of sulfonyl fluorides as an activity-based probe that covalently modifies endogenous serine proteases and allows for gel-based anal. of protein activity, as well as enrichment and identification using mass spectrometry was demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIZgVarY5YD7Vg90H21EOLACvtfcHk0liBQYLaNqK3SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlyqsLnP&md5=920f5f4b4b90924725c225d5166677a5</span></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201200531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201200531%26sid%3Dliteratum%253Aachs%26aulast%3DShannon%26aufirst%3DD.%2BA.%26aulast%3DGu%26aufirst%3DC.%26aulast%3DMcLaughlin%26aufirst%3DC.%2BJ.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BHoorn%26aufirst%3DR.%2BA.%2BL.%26aulast%3DWeerapana%26aufirst%3DE.%26atitle%3DSulfonyl%2520fluoride%2520analogues%2520as%2520activity-based%2520probes%2520for%2520serine%2520proteases%26jtitle%3DChemBioChem%26date%3D2012%26volume%3D13%26issue%3D16%26spage%3D2327%26epage%3D2330%26doi%3D10.1002%2Fcbic.201200531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref221"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref221'); return false;" data-citation="" class="refNumLink">221</a></strong><div class="NLM_citation" id="cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span> <span> </span><span class="NLM_article-title">Specificity and reactivity of human leukocyte elastase, porcine pancreatic elastase, human granulocyte cathepsin G, and bovine pancreatic chymotrypsin with arylsulfonyl fluorides. Discovery of a new series of potent and specific irreversible elastase inhibitors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>257</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">5077</span>â <span class="NLM_lpage">5084</span>, <span class="refDoi">Â DOI: 10.1016/S0021-9258(18)34637-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0021-9258%2818%2934637-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=6917853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaL38XkvVOlsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1982&pages=5077-5084&issue=9&author=T.+Yoshimuraauthor=L.+N.+Barkerauthor=J.+C.+Powers&title=Specificity+and+reactivity+of+human+leukocyte+elastase%2C+porcine+pancreatic+elastase%2C+human+granulocyte+cathepsin+G%2C+and+bovine+pancreatic+chymotrypsin+with+arylsulfonyl+fluorides.+Discovery+of+a+new+series+of+potent+and+specific+irreversible+elastase+inhibitors&doi=10.1016%2FS0021-9258%2818%2934637-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity and reactivity of human leukocyte elastase, porcine pancreatic elastase, human granulocyte cathepsin G, and bovine pancreatic chymotrypsin with arylsulfonyl fluorides.  Discovery of a new series of potent and specific irreversible elastase inhibitors</span></div><div class="casAuthors">Yoshimura, Toshiaki; Barker, Larry N.; Powers, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5077-84</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The reactivity and specificity of a series of substituted benzenesulfonyl fluorides with human leukocyte (HL) elastase, cathepsin G, porcine pancreatic (PP) elastase, and bovine chymotrypsin are reported.  Benzenesulfonyl fluorides with 2-fluoroacyl substituents were found to be potent and specific inhibitors of elastase.  HL elastase was inhibited most rapidly by 2-(CF3CF2CONH)-C6H4SO2F which was slightly better than the best peptide chloromethyl ketone inhibitor of this enzyme.  PP elastase was most rapidly inhibited by 2-(CF3CONH)-C6H4SO2F.  The 2-(CF3CF2CF2CONH) and 2-(CF3SNH) derivs. were quite selective for HL elastase and inhibited PP elastase, cathepsin G, and chymotrypsin quite slowly.  A specific and potent chymotrypsin inhibitor, 2-(Z-Gly-NH)C6H4SO2F (where Z = benzyloxycarbonyl), was also discovered.  A model for the elastase inhibition reaction was proposed which involves interaction of the fluoroacyl group of the inhibitor with the primary substrate recognition site S1 of the enzyme.  H-bonding also occurs between the inhibitor NH group and a backbone peptide carbonyl group, probably from residue 214.  The 2-fluoroacyl group plays the dual role of binding in the hydrophobic S1 pocket and through electronic effects, increasing the strength of the H-bond.  Thus, it is possible to construct simple org. mols. which are specific inhibitors of HL elastase, PP elastase, or chymotrypsin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9aawB91oKybVg90H21EOLACvtfcHk0liBQYLaNqK3SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XkvVOlsLw%253D&md5=b74a9ed434bfcd8b31b3419123be966e</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2934637-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252934637-4%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimura%26aufirst%3DT.%26aulast%3DBarker%26aufirst%3DL.%2BN.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DSpecificity%2520and%2520reactivity%2520of%2520human%2520leukocyte%2520elastase%252C%2520porcine%2520pancreatic%2520elastase%252C%2520human%2520granulocyte%2520cathepsin%2520G%252C%2520and%2520bovine%2520pancreatic%2520chymotrypsin%2520with%2520arylsulfonyl%2520fluorides.%2520Discovery%2520of%2520a%2520new%2520series%2520of%2520potent%2520and%2520specific%2520irreversible%2520elastase%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1982%26volume%3D257%26issue%3D9%26spage%3D5077%26epage%3D5084%26doi%3D10.1016%2FS0021-9258%2818%2934637-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref222"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref222'); return false;" data-citation="" class="refNumLink">222</a></strong><div class="NLM_citation" id="cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krasnova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span> <span> </span><span class="NLM_article-title">Sulfur(VI) fluoride exchange (SuFEx): another good reaction for click chemistry</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">36</span>),  <span class="NLM_fpage">9430</span>â <span class="NLM_lpage">9448</span>, <span class="refDoi">Â DOI: 10.1002/anie.201309399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fanie.201309399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtleisbzJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=9430-9448&issue=36&author=J.+Dongauthor=L.+Krasnovaauthor=M.+G.+Finnauthor=K.+B.+Sharpless&title=Sulfur%28VI%29+fluoride+exchange+%28SuFEx%29%3A+another+good+reaction+for+click+chemistry&doi=10.1002%2Fanie.201309399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click Chemistry</span></div><div class="casAuthors">Dong, Jiajia; Krasnova, Larissa; Finn, M. G.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">9430-9448</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Aryl sulfonyl chlorides (e.g. Ts-Cl) are beloved of org. chemists as the most commonly used SVI electrophiles, and the parent sulfuryl chloride, O2SVICl2, also was relied on to create sulfates and sulfamides.  However, the desired halide substitution event is often defeated by destruction of the sulfur electrophile because the SVI-Cl bond is exceedingly sensitive to reductive collapse yielding SIV species and Cl-.  Fortunately, the use of sulfur(VI) fluorides (e.g., R-SO2-F and SO2F2) leaves only the substitution pathway open.  As with most of click chem., many essential features of sulfur(VI) fluoride reactivity were discovered long ago in Germany.  Surprisingly, this extraordinary work faded from view rather abruptly in the mid-20th century.  Here the authors seek to revive it, along with John Hyatt's unnoticed 1979 full paper exposition on CH2=CH-SO2-F, the most perfect Michael acceptor ever found.  To this history the authors add several new observations, including that the otherwise very stable gas SO2F2 has excellent reactivity under the right circumstances.  Also proton or silicon centers can activate the exchange of S-F bonds for S-O bonds to make functional products, and the sulfate connector is surprisingly stable toward hydrolysis.  Applications of this controllable ligation chem. to small mols., polymers, and biomols. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoygcyccCW7irVg90H21EOLACvtfcHk0liBQYLaNqK3SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtleisbzJ&md5=78e251c607d42f2506a9420f2f2f9835</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1002%2Fanie.201309399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201309399%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DKrasnova%26aufirst%3DL.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DSulfur%2528VI%2529%2520fluoride%2520exchange%2520%2528SuFEx%2529%253A%2520another%2520good%2520reaction%2520for%2520click%2520chemistry%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26issue%3D36%26spage%3D9430%26epage%3D9448%26doi%3D10.1002%2Fanie.201309399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref223"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref223'); return false;" data-citation="" class="refNumLink">223</a></strong><div class="NLM_citation" id="cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woehl, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Martins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smedley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolan, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span> <span> </span><span class="NLM_article-title">SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">18808</span>â <span class="NLM_lpage">18814</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1909972116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.1909972116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31484779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVSku73J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=18808-18814&issue=38&author=Q.+Zhengauthor=J.+L.+Woehlauthor=S.+Kitamuraauthor=D.+Santos-Martinsauthor=C.+J.+Smedleyauthor=G.+Liauthor=S.+Forliauthor=J.+E.+Mosesauthor=D.+W.+Wolanauthor=K.+B.+Sharpless&title=SuFEx-enabled%2C+agnostic+discovery+of+covalent+inhibitors+of+human+neutrophil+elastase&doi=10.1073%2Fpnas.1909972116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase</span></div><div class="casAuthors">Zheng, Qinheng; Woehl, Jordan L.; Kitamura, Seiya; Santos-Martins, Diogo; Smedley, Christopher J.; Li, Gencheng; Forli, Stefano; Moses, John E.; Wolan, Dennis W.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">18808-18814</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Sulfur fluoride exchange (SuFEx) has emerged as the new generation of click chem.  We report here a SuFEx-enabled, agnostic approach for the discovery and optimization of covalent inhibitors of human neutrophil elastase (hNE).  Evaluation of our ever-growing collection of SuFExable compds. toward various biol. assays unexpectedly revealed a selective and covalent hNE inhibitor: benzene-1,2-disulfonyl fluoride.  Synthetic derivatization of the initial hit led to a more potent agent, 2-(fluorosulfonyl)phenyl fluorosulfate with IC50 0.24Î¼M and greater than 833-fold selectivity over the homologous neutrophil serine protease, cathepsin G.  The optimized, yet simple benzenoid probe only modified active hNE and not its denatured form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrULhhywsqN37Vg90H21EOLACvtfcHk0lh1WpWwAUZXGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVSku73J&md5=40375fdaac0abdaf4615694f16342bf3</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1909972116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1909972116%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DQ.%26aulast%3DWoehl%26aufirst%3DJ.%2BL.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DSantos-Martins%26aufirst%3DD.%26aulast%3DSmedley%26aufirst%3DC.%2BJ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DMoses%26aufirst%3DJ.%2BE.%26aulast%3DWolan%26aufirst%3DD.%2BW.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DSuFEx-enabled%252C%2520agnostic%2520discovery%2520of%2520covalent%2520inhibitors%2520of%2520human%2520neutrophil%2520elastase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26issue%3D38%26spage%3D18808%26epage%3D18814%26doi%3D10.1073%2Fpnas.1909972116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref224"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref224'); return false;" data-citation="" class="refNumLink">224</a></strong><div class="NLM_citation" id="cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemming, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, M. I.</span></span> <span> </span><span class="NLM_article-title">Reactivity and selectivity in the inhibition of elastase by 3-oxo-Î²-sultams and in their hydrolysis</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">3993</span>â <span class="NLM_lpage">4000</span>, <span class="refDoi">Â DOI: 10.1039/b713899g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1039%2Fb713899g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18043805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGnsr3K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=3993-4000&issue=24&author=W.-Y.+Tsangauthor=N.+Ahmedauthor=K.+Hemmingauthor=M.+I.+Page&title=Reactivity+and+selectivity+in+the+inhibition+of+elastase+by+3-oxo-%CE%B2-sultams+and+in+their+hydrolysis&doi=10.1039%2Fb713899g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivity and selectivity in the inhibition of elastase by 3-oxo-Î²-sultams and in their hydrolysis</span></div><div class="casAuthors">Tsang, Wing-Yin; Ahmed, Naveed; Hemming, Karl; Page, Michael I.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3993-4000</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">3-Oxo-Î²-sultams are both Î²-sultams and Î²-lactams and are a novel class of time-dependent inhibitors of elastase.  The inhibition involves formation of a covalent enzyme-inhibitor adduct with transient stability by acylation of the active-site serine resulting from substitution at the carbonyl center of the 3-oxo-Î²-sultam, C-N fission, and expulsion of the sulfonamide.  The lead compd., N-benzyl-4,4-dimethyl-3-oxo-Î²-sultam 1 is a reasonably potent inhibitor against porcine pancreatic elastase with a second-order rate const. of 768 M-1s-1 at pH 6, but also possesses high chem. reactivity with a half-life for hydrolysis of only 6 mins at the same pH in water.  Interestingly, the hydrolysis of 3-oxo-Î²-sultams occurs at the sulfonyl center with S-N fission and expulsion of the amide leaving group, whereas the enzyme reaction occurs at the acyl center.  Increasing selectivity between these two reactive centers was explored by examg. the effect of substituents on the reactivity of 3-oxo-Î²-sultam towards hydrolysis and enzyme inhibition.  The inhibition activity against porcine pancreatic elastase has a much higher sensitivity to substituent variation than does the rate of alk. hydrolysis.  A difference of 2000-fold is obsd. in the second-order rate consts., ki, for inhibition whereas there is only a 100-fold difference in the second-order rate consts., kOH, for alk. hydrolysis within the series.  The higher sensitivity of enzyme inhibition to substituents than that of simple chem. reactivity indicates a significant degree of mol. recognition of the 3-oxo-Î²-sultams by the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE4VpfylQIAbVg90H21EOLACvtfcHk0lh1WpWwAUZXGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGnsr3K&md5=272d0064cb4e8f0207ca5e6e5a76a7a7</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1039%2Fb713899g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb713899g%26sid%3Dliteratum%253Aachs%26aulast%3DTsang%26aufirst%3DW.-Y.%26aulast%3DAhmed%26aufirst%3DN.%26aulast%3DHemming%26aufirst%3DK.%26aulast%3DPage%26aufirst%3DM.%2BI.%26atitle%3DReactivity%2520and%2520selectivity%2520in%2520the%2520inhibition%2520of%2520elastase%2520by%25203-oxo-%25CE%25B2-sultams%2520and%2520in%2520their%2520hydrolysis%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2007%26volume%3D5%26issue%3D24%26spage%3D3993%26epage%3D4000%26doi%3D10.1039%2Fb713899g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref225"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref225'); return false;" data-citation="" class="refNumLink">225</a></strong><div class="NLM_citation" id="cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemming, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laws, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, M. I.</span></span> <span> </span><span class="NLM_article-title">Acylation versus sulfonylation in the inhibition of elastase by 3-oxo-Î²-sultams</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">8946</span>â <span class="NLM_lpage">8947</span>, <span class="refDoi">Â DOI: 10.1021/ja050787z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja050787z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslSgu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=8946-8947&issue=25&author=W.+Y.+Tsangauthor=N.+Ahmedauthor=L.+P.+Hardingauthor=K.+Hemmingauthor=A.+P.+Lawsauthor=M.+I.+Page&title=Acylation+versus+sulfonylation+in+the+inhibition+of+elastase+by+3-oxo-%CE%B2-sultams&doi=10.1021%2Fja050787z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Acylation versus Sulfonylation in the Inhibition of Elastase by 3-Oxo-Î²-Sultams</span></div><div class="casAuthors">Tsang, Wing Y.; Ahmed, Naveed; Harding, Lindsay P.; Hemming, Karl; Laws, Andrew P.; Page, Michael I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8946-8947</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Î²-Sultams are the sulfonyl analogs of Î²-lactams, and 3-oxo-Î²-sultams are both Î²-lactams and Î²-sultams and, therefore, susceptible to nucleophilic attack at either the acyl or the sulfonyl center.  They are novel inactivators of serine enzymes.  The second-order rate const. for the inactivation of elastase at pH 6 by N-benzyl-4,4-dimethyl-3-oxo-Î²-sultam is 768 M-1 s-1, which is 103-fold greater than that with N-benzoyl Î²-sultam.  However, in contrast to N-acyl Î²-sultams, which sulfonylate the active site serine residue to form a sulfonate ester, 3-oxo-Î²-sultams inhibit the enzyme by acylation followed by slow deacylation to regenerate the active enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5mZOowgzNDbVg90H21EOLACvtfcHk0lhk3OHPxHLvzw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslSgu7c%253D&md5=d65f061e549038b4bc566476efaa4f45</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1021%2Fja050787z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja050787z%26sid%3Dliteratum%253Aachs%26aulast%3DTsang%26aufirst%3DW.%2BY.%26aulast%3DAhmed%26aufirst%3DN.%26aulast%3DHarding%26aufirst%3DL.%2BP.%26aulast%3DHemming%26aufirst%3DK.%26aulast%3DLaws%26aufirst%3DA.%2BP.%26aulast%3DPage%26aufirst%3DM.%2BI.%26atitle%3DAcylation%2520versus%2520sulfonylation%2520in%2520the%2520inhibition%2520of%2520elastase%2520by%25203-oxo-%25CE%25B2-sultams%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26issue%3D25%26spage%3D8946%26epage%3D8947%26doi%3D10.1021%2Fja050787z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref226"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref226'); return false;" data-citation="" class="refNumLink">226</a></strong><div class="NLM_citation" id="cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, L. A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brito, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guedes, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonÃ§alves, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, R.</span></span> <span> </span><span class="NLM_article-title">3-Oxo-Î²-sultam as a sulfonylating chemotype for inhibition of serine hydrolases and activity-based protein profiling</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">878</span>â <span class="NLM_lpage">883</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.0c00090</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.0c00090" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvFyhur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=878-883&issue=4&author=L.+A.+R.+Carvalhoauthor=V.+T.+Almeidaauthor=J.+A.+Britoauthor=K.+M.+Lumauthor=T.+F.+Oliveiraauthor=R.+C.+Guedesauthor=L.+M.+Gon%C3%A7alvesauthor=S.+D.+Lucasauthor=B.+F.+Cravattauthor=M.+Archerauthor=R.+Moreira&title=3-Oxo-%CE%B2-sultam+as+a+sulfonylating+chemotype+for+inhibition+of+serine+hydrolases+and+activity-based+protein+profiling&doi=10.1021%2Facschembio.0c00090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">3-Oxo-Î²-sultam as a sulfonylating chemotype for inhibition of serine hydrolases and activity-based protein profiling</span></div><div class="casAuthors">Carvalho, Luis A. R.; Almeida, Vanessa T.; Brito, Jose A.; Lum, Kenneth M.; Oliveira, Tania F.; Guedes, Rita C.; Goncalves, Lidia M.; Lucas, Susana D.; Cravatt, Benjamin F.; Archer, Margarida; Moreira, Rui</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">878-883</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Oxo-Î²-sultams are four-membered ring ambident electrophiles that can react with nucleophiles either at the carbonyl carbon or at the sulfonyl sulfur atoms, and that have been reported to inhibit serine hydrolases via acylation of the active-site serine residue.  We have developed a panel of 3-oxo-Î²-sultam inhibitors and show, through crystallog. data, that they are regioselective sulfonylating electrophiles, covalently binding to the catalytic serine of human and porcine elastases through the sulfur atom.  Application of 3-oxo-Î²-sultam-derived activity-based probes in a human proteome revealed their potential to label disease-related serine hydrolases and proteasome subunits.  Activity-based protein profiling applications of 3-oxo-Î²-sultams should open up new opportunities to investigate these classes of enzymes in complex proteomes and expand the toolbox of available sulfur-based covalent protein modifiers in chem. biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEsMpvad_cBbVg90H21EOLACvtfcHk0lhk3OHPxHLvzw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvFyhur0%253D&md5=bce244ee35ced134635154656e34fb6d</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1021%2Facschembio.0c00090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.0c00090%26sid%3Dliteratum%253Aachs%26aulast%3DCarvalho%26aufirst%3DL.%2BA.%2BR.%26aulast%3DAlmeida%26aufirst%3DV.%2BT.%26aulast%3DBrito%26aufirst%3DJ.%2BA.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DOliveira%26aufirst%3DT.%2BF.%26aulast%3DGuedes%26aufirst%3DR.%2BC.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DL.%2BM.%26aulast%3DLucas%26aufirst%3DS.%2BD.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DArcher%26aufirst%3DM.%26aulast%3DMoreira%26aufirst%3DR.%26atitle%3D3-Oxo-%25CE%25B2-sultam%2520as%2520a%2520sulfonylating%2520chemotype%2520for%2520inhibition%2520of%2520serine%2520hydrolases%2520and%2520activity-based%2520protein%2520profiling%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2020%26volume%3D15%26issue%3D4%26spage%3D878%26epage%3D883%26doi%3D10.1021%2Facschembio.0c00090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref227"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref227'); return false;" data-citation="" class="refNumLink">227</a></strong><div class="NLM_citation" id="cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">AntÃ³nio, J. P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonÃ§alves, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guedes, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gois, P. M. P.</span></span> <span> </span><span class="NLM_article-title">Diazaborines as new inhibitors of human neutrophil elastase</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">7418</span>â <span class="NLM_lpage">7423</span>, <span class="refDoi">Â DOI: 10.1021/acsomega.8b00702</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.8b00702" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Kmt7jL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2018&pages=7418-7423&issue=7&author=J.+P.+M.+Ant%C3%B3nioauthor=L.+M.+Gon%C3%A7alvesauthor=R.+C.+Guedesauthor=R.+Moreiraauthor=P.+M.+P.+Gois&title=Diazaborines+as+new+inhibitors+of+human+neutrophil+elastase&doi=10.1021%2Facsomega.8b00702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Diazaborines as New Inhibitors of Human Neutrophil Elastase</span></div><div class="casAuthors">Antonio, Joao P. M.; Goncalves, Lidia M.; Guedes, Rita C.; Moreira, Rui; Gois, Pedro M. P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">7418-7423</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Boronic acids (BAs) are a prominent functionality extensively used to design biol. active compds. and functional biomaterials.  Boron open shells can lead to unspecific reactivity of BAs with endogenous nucleophiles and to undesired off-target effects.  Here, diazaborines are presented as a new class of boron-based warheads for serine proteases inhibition, in which the boron function is stabilized in the form of an arom. boron-based heterocycle.  In this study, diazaborines were readily synthesized in a single step in yields up to 96%, without any chromatog. operation and were shown to reversibly inhibit human neutrophil elastase (HNE) serine protease with IC50 values in the low Î¼M range.  Diazaborines were also selective toward HNE, as no inhibition was obsd. against a panel of five closely related serine proteases.  Synthetic and theor. studies performed on this system suggest that, similar to BAs, the reaction mechanism involves the formation of a reversible covalent bond between the diazaborine boron center and the catalytic serine oxygen.  Finally, different from BAs, diazaborines were shown to be very stable in pH 7.4 phosphate buffer and human plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWGfHcX-logrVg90H21EOLACvtfcHk0liw9vK6zNNT5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Kmt7jL&md5=375fb4cdd0663d11c2fcc6bae15b2866</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1021%2Facsomega.8b00702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.8b00702%26sid%3Dliteratum%253Aachs%26aulast%3DAnt%25C3%25B3nio%26aufirst%3DJ.%2BP.%2BM.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DL.%2BM.%26aulast%3DGuedes%26aufirst%3DR.%2BC.%26aulast%3DMoreira%26aufirst%3DR.%26aulast%3DGois%26aufirst%3DP.%2BM.%2BP.%26atitle%3DDiazaborines%2520as%2520new%2520inhibitors%2520of%2520human%2520neutrophil%2520elastase%26jtitle%3DACS%2520Omega%26date%3D2018%26volume%3D3%26issue%3D7%26spage%3D7418%26epage%3D7423%26doi%3D10.1021%2Facsomega.8b00702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref228"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref228'); return false;" data-citation="" class="refNumLink">228</a></strong><div class="NLM_citation" id="cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Meester, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ScharpÃ©, S.</span></span> <span> </span><span class="NLM_article-title">CD26, let it cut or cut it down</span>. <i>Immunol. Today</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">367</span>â <span class="NLM_lpage">375</span>, <span class="refDoi">Â DOI: 10.1016/S0167-5699(99)01486-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0167-5699%2899%2901486-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10431157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1MXlt1Oltb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=367-375&issue=8&author=I.+De+Meesterauthor=S.+Koromauthor=J.+Van+Dammeauthor=S.+Scharp%C3%A9&title=CD26%2C+let+it+cut+or+cut+it+down&doi=10.1016%2FS0167-5699%2899%2901486-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">CD26, let it cut or cut it down</span></div><div class="casAuthors">De Meester, Ingrid; Korom, Stephan; Van Damme, Jo; Scharpe, Simon</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Today</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">367-375</span>CODEN:
                <span class="NLM_cas:coden">IMTOD8</span>;
        ISSN:<span class="NLM_cas:issn">0167-4919</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 82 refs.  The costimulatory properties of CD26 have been studied extensively and significant progress has been made in unraveling the complex nature of this mol.  Here, we summarize recent findings on mol. and functional characteristics of CD26.  We argue that a multidisciplinary approach might reveal the mol. events underlying the role of CD26 in HIV infection and immune, inflammatory and endocrine responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaAi-Ov3EJzLVg90H21EOLACvtfcHk0liw9vK6zNNT5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlt1Oltb0%253D&md5=79c9ca0c3e5eefaef238b8e87530afc7</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1016%2FS0167-5699%2899%2901486-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-5699%252899%252901486-3%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DKorom%26aufirst%3DS.%26aulast%3DVan%2BDamme%26aufirst%3DJ.%26aulast%3DScharp%25C3%25A9%26aufirst%3DS.%26atitle%3DCD26%252C%2520let%2520it%2520cut%2520or%2520cut%2520it%2520down%26jtitle%3DImmunol.%2520Today%26date%3D1999%26volume%3D20%26issue%3D8%26spage%3D367%26epage%3D375%26doi%3D10.1016%2FS0167-5699%2899%2901486-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref229"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref229'); return false;" data-citation="" class="refNumLink">229</a></strong><div class="NLM_citation" id="cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leiting, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pryor, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsilio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N. A.</span></span> <span> </span><span class="NLM_article-title">Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>371</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">525</span>â <span class="NLM_lpage">532</span>, <span class="refDoi">Â DOI: 10.1042/bj20021643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1042%2Fbj20021643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=12529175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisleqs7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=525-532&issue=2&author=B.+Leitingauthor=K.+D.+Pryorauthor=J.+K.+Wuauthor=F.+Marsilioauthor=R.+A.+Patelauthor=C.+S.+Craikauthor=J.+A.+Ellmanauthor=R.+T.+Cummingsauthor=N.+A.+Thornberry&title=Catalytic+properties+and+inhibition+of+proline-specific+dipeptidyl+peptidases+II%2C+IV+and+VII&doi=10.1042%2Fbj20021643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII</span></div><div class="casAuthors">Leiting, Barbara; Pryor, KellyAnn D.; Wu, Joseph K.; Marsilio, Frank; Patel, Reshma A.; Craik, Charles S.; Ellman, Jonathan A.; Cummings, Richard T.; Thornberry, Nancy A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">525-532</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">There is currently intense interest in the emerging group of proline-specific dipeptidases, and their roles in the regulation of biol. processes.  Dipeptidyl peptidase IV (DPP-IV) is involved in glucose metab. by contributing to the regulation of glucagon family peptides and has emerged as a potential target for the treatment of metabolic diseases.  Two other proline-specific dipeptidases, DPP-VII (also known as quiescent cell proline dipeptidase) and DPP-II, have unknown functions and have recently been suggested to be identical proteases based on a sequence comparison of human DPP-VII and rat DPP-II (78% identity).  To facilitate the identification of selective substrates and inhibitors for these enzymes, a complete biochem. profile of these enzymes was obtained.  The pH profiles, substrate specificities as detd. by positional scanning, Michaelis-Menten consts. and inhibition profiles for DPP-VII and DPP-II were shown to be virtually identical, strongly supporting the hypothesis that they are the same protease.  In addn., substrate specificities, catalytic consts. and IC50 values were shown to be markedly different from those of DPP-IV.  Selective DPP-IV and DPP-VII substrates were identified, and they can be used to design selective inhibitors and probe further into the biol. of these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_SJ3G9gCruLVg90H21EOLACvtfcHk0li5GLzLI1Phaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisleqs7o%253D&md5=5165326f312e7e5e49dba18a059d7ca2</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1042%2Fbj20021643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021643%26sid%3Dliteratum%253Aachs%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DPryor%26aufirst%3DK.%2BD.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26atitle%3DCatalytic%2520properties%2520and%2520inhibition%2520of%2520proline-specific%2520dipeptidyl%2520peptidases%2520II%252C%2520IV%2520and%2520VII%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26issue%3D2%26spage%3D525%26epage%3D532%26doi%3D10.1042%2Fbj20021643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref230"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref230'); return false;" data-citation="" class="refNumLink">230</a></strong><div class="NLM_citation" id="cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pederson, R. A.</span></span> <span> </span><span class="NLM_article-title">Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3585</span>â <span class="NLM_lpage">3596</span>, <span class="refDoi">Â DOI: 10.1210/endo.136.8.7628397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1210%2Fendo.136.8.7628397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=7628397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2MXntFKntLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1995&pages=3585-3596&issue=8&author=T.+J.+Kiefferauthor=C.+H.+McIntoshauthor=R.+A.+Pederson&title=Degradation+of+glucose-dependent+insulinotropic+polypeptide+and+truncated+glucagon-like+peptide+1+in+vitro+and+in+vivo+by+dipeptidyl+peptidase+IV&doi=10.1210%2Fendo.136.8.7628397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV</span></div><div class="casAuthors">Kieffer, Timothy J.; McIntosh, Christopher H. S.; Pederson, Raymond A.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3585-97</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The combined actions of glucose-dependent insulinotropic polypeptide (GIP) and truncated glucagon-like peptide-1 (tGLP-1) may fully account for the incretin effect.  These hormones are released from the small intestine in response to oral glucose and stimulate insulin release.  Recently, evidence has been provided demonstrating the degrdn. of GIP-(1-42) and GLP-1-(7-36)NH2 by the serum enzyme dipeptidyl peptidase IV (DPP IV) into the biol. inactive products GIP-(3-42) and GLP-1-(9-36)NH2.  The objective of the current investigation was to develop a method to monitor the degrdn. of these hormones in vivo.  Synthetic peptides were radiolabeled and purified by HPLC.  Subsequent degrdn. of the peptides under various conditions was then monitored by further HPLC anal.  Incubation of [125I]GIP-(1-42) or [125I]GLP-1-(7-36)NH2 with Wistar rat serum or purified DPP IV resulted in the major N-terminal-truncated products [125I]GIP-(3-42) and [125I]GLP-1-(9-36)NH2.  These products were significantly reduced when the specific DPP IV inhibitor diprotin A was included in the incubation mixt. and were absent when serum from DPP IV-deficient rats was used.  When the labeled peptides were infused into rats at hormone levels within the physiol. range, over 50% was metabolized to the truncated forms within 2 min.  These products were absent when the tracers were infused into DPP IV-deficient animals.  It is concluded that DPP IV may be a primary inactivating enzyme of both GIP and tGLP-1 in vivo.  As the N-terminal-truncated products of the DPP IV cleavage may not be distinguished from the biol. active hormone by currently employed assays, reports of circulating hormone levels should be reconsidered.  The method described in this manuscript may be useful for investigating the durations of action of GIP and tGLP-1 in normal and pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq593ilo39xZrVg90H21EOLACvtfcHk0li5GLzLI1Phaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntFKntLc%253D&md5=15775ebc1ca71f838ee24a8f526496f9</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1210%2Fendo.136.8.7628397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fendo.136.8.7628397%26sid%3Dliteratum%253Aachs%26aulast%3DKieffer%26aufirst%3DT.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DC.%2BH.%26aulast%3DPederson%26aufirst%3DR.%2BA.%26atitle%3DDegradation%2520of%2520glucose-dependent%2520insulinotropic%2520polypeptide%2520and%2520truncated%2520glucagon-like%2520peptide%25201%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DEndocrinology%26date%3D1995%26volume%3D136%26issue%3D8%26spage%3D3585%26epage%3D3596%26doi%3D10.1210%2Fendo.136.8.7628397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref231"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref231'); return false;" data-citation="" class="refNumLink">231</a></strong><div class="NLM_citation" id="cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pauly, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosche, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, C. H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pederson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H.-U.</span></span> <span> </span><span class="NLM_article-title">Investigation of glucose-dependent insulinotropic polypeptide-(1â42) and glucagon-like peptide-1-(7â36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. A novel kinetic approach</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">23222</span>â <span class="NLM_lpage">23229</span>, <span class="refDoi">Â DOI: 10.1074/jbc.271.38.23222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.271.38.23222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8798518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK28XlvVCgsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=23222-23229&issue=38&author=R.+P.+Paulyauthor=F.+Roscheauthor=M.+Wermannauthor=C.+H.+S.+McIntoshauthor=R.+A.+Pedersonauthor=H.-U.+Demuth&title=Investigation+of+glucose-dependent+insulinotropic+polypeptide-%281%E2%80%9342%29+and+glucagon-like+peptide-1-%287%E2%80%9336%29+degradation+in+vitro+by+dipeptidyl+peptidase+IV+using+matrix-assisted+laser+desorption%2Fionization-time+of+flight+mass+spectrometry.+A+novel+kinetic+approach&doi=10.1074%2Fjbc.271.38.23222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of glucose-dependent insulinotropic polypeptide-(1-42) and glucagon-like peptide-1-(7-36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. A novel kinetic approach</span></div><div class="casAuthors">Pauly, Robert P.; Rosche, Fred; Wermann, Michael; McIntosh, Christopher H. S.; Pederson, Raymond A.; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">23222-23229</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The incretins glucose-dependent insulinotropic polypeptide (GIP1-42) and glucagon-like peptide-1-(7-36)-amide (GLP-17-36), hormones that potentiate glucose-induced insulin secretion from the endocrine pancreas, are substrates of the circulating exopeptidase dipeptidyl peptidase IV and are rendered biol. inactive upon cleavage of their N-terminal dipeptides.  This study was designed to det. if matrix-assisted laser desorption/ionization-time of flight mass spectrometry is a useful anal. tool to study the hydrolysis of these hormones by dipeptidyl peptidase IV, including kinetic anal.  Spectra indicated that serum-incubated peptides were cleaved by this enzyme with only minor secondary degrdn. due to other serum protease activity.  Quantification of the mass spectrometric signals allowed kinetic consts. for both porcine kidney- and human serum dipeptidyl peptidase IV-catalyzed incretin hydrolysis to be calcd.  The binding consts. (Km) of these incretins to purified porcine kidney-derived enzyme were 1.8 and 3.8 Î¼M, whereas the binding consts. obsd. in human serum were 39 and 13 Î¼M for glucose-dependent-insulinotropic polypeptide and glucagon-like peptide-1-(7-36), resp.  The large range of Km values found in human serum suggests a heterogeneous pool of enzyme.  The close correlation between the reported kinetic consts. and those previously described validates this novel approach to kinetic anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFsv2kdL0MjbVg90H21EOLACvtfcHk0lh3yx5r5hlWkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvVCgsL0%253D&md5=861ce1e9cc411c266e41e2b4288d053e</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.38.23222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.38.23222%26sid%3Dliteratum%253Aachs%26aulast%3DPauly%26aufirst%3DR.%2BP.%26aulast%3DRosche%26aufirst%3DF.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DMcIntosh%26aufirst%3DC.%2BH.%2BS.%26aulast%3DPederson%26aufirst%3DR.%2BA.%26aulast%3DDemuth%26aufirst%3DH.-U.%26atitle%3DInvestigation%2520of%2520glucose-dependent%2520insulinotropic%2520polypeptide-%25281%25E2%2580%259342%2529%2520and%2520glucagon-like%2520peptide-1-%25287%25E2%2580%259336%2529%2520degradation%2520in%2520vitro%2520by%2520dipeptidyl%2520peptidase%2520IV%2520using%2520matrix-assisted%2520laser%2520desorption%252Fionization-time%2520of%2520flight%2520mass%2520spectrometry.%2520A%2520novel%2520kinetic%2520approach%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26issue%3D38%26spage%3D23222%26epage%3D23229%26doi%3D10.1074%2Fjbc.271.38.23222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref232"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref232'); return false;" data-citation="" class="refNumLink">232</a></strong><div class="NLM_citation" id="cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâLeary, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broxmeyer, H. E.</span></span> <span> </span><span class="NLM_article-title">Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">161</span>â <span class="NLM_lpage">169</span>, <span class="refDoi">Â DOI: 10.1182/blood-2013-02-487470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1182%2Fblood-2013-02-487470" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23637126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=161-169&issue=2&author=X.+Ouauthor=H.+A.+O%E2%80%99Learyauthor=H.+E.+Broxmeyer&title=Implications+of+DPP4+modification+of+proteins+that+regulate+stem%2Fprogenitor+and+more+mature+cell+types&doi=10.1182%2Fblood-2013-02-487470"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types</span></div><div class="casAuthors">Ou, Xuan; O'Leary, Heather A.; Broxmeyer, Hal E.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-169</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  Dipeptidylpeptidase (DPP) 4 has the potential to truncate proteins with a penultimate alanine, proline, or other selective amino acids at the N-terminus.  DPP4 truncation of certain chemokines, colony-stimulating factors, and interleukins have recently been linked to regulation of hematopoietic stem/progenitor cells, more mature blood cells, and other cell types.  We believe that the potential role of DPP4 in modification of many regulatory proteins, and their subsequent effects on numerous stem/progenitor and other cell-type functions has not been adequately appreciated.  This review addresses the potential implications of the modifying effects of DPP4 on a large no. of cytokines and other growth-regulating factors with either proven or putative DPP4 truncation sites on hematopoietic cells, and subsequent effects of DPP4-truncated proteins on multiple aspects of steady-state and stressed hematopoiesis, including stem/progenitor cell, and more mature cell, function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG60FR8TezlbVg90H21EOLACvtfcHk0lh3yx5r5hlWkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLfI&md5=be94ebc6ff137b7a10d6e67210ae6532</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-02-487470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-02-487470%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DX.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DH.%2BA.%26aulast%3DBroxmeyer%26aufirst%3DH.%2BE.%26atitle%3DImplications%2520of%2520DPP4%2520modification%2520of%2520proteins%2520that%2520regulate%2520stem%252Fprogenitor%2520and%2520more%2520mature%2520cell%2520types%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26issue%3D2%26spage%3D161%26epage%3D169%26doi%3D10.1182%2Fblood-2013-02-487470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref233"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref233'); return false;" data-citation="" class="refNumLink">233</a></strong><div class="NLM_citation" id="cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antonsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lys, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechavanne, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevalet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boschert, U.</span></span> <span> </span><span class="NLM_article-title">In vivo processing of CXCL12Î±/SDF-1Î± after intravenous and subcutaneous administration to mice</span>. <i>Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">4342</span>â <span class="NLM_lpage">4351</span>, <span class="refDoi">Â DOI: 10.1002/pmic.201000331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fpmic.201000331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21136589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFagsrnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=4342-4351&issue=24&author=B.+Antonssonauthor=P.+De+Lysauthor=V.+Dechavanneauthor=L.+Chevaletauthor=U.+Boschert&title=In+vivo+processing+of+CXCL12%CE%B1%2FSDF-1%CE%B1+after+intravenous+and+subcutaneous+administration+to+mice&doi=10.1002%2Fpmic.201000331"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo processing of CXCL12Î±/SDF-1Î± after intravenous and subcutaneous administration to mice</span></div><div class="casAuthors">Antonsson, Bruno; De Lys, Patricia; Dechavanne, Vincent; Chevalet, Laurent; Boschert, Ursula</div><div class="citationInfo"><span class="NLM_cas:title">Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4342-4351</span>CODEN:
                <span class="NLM_cas:coden">PROTC7</span>;
        ISSN:<span class="NLM_cas:issn">1615-9853</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">CXCL12Î± has been shown to be selectively processed at the N- and C-termini in blood and plasma in vitro.  In order to study the processing in vivo, several versions of CXCL12Î± were expressed and purified.  The protein was administered either iv or s.c. to mice, and at different time points postadministration plasma was collected and analyzed.  To detect modifications of the CXCL12Î± mol. in crude plasma a SELDI TOF-MS-based method was developed.  Anti-CXCL12 antibodies were immobilized on the SELDI chip and CXCL12Î± binding to the antibodies was detected by SELDI-TOF-MS.  The protein was found to be processed both at the C- and N-termini.  The same processed CXCL12Î± forms as detected in vitro were found; however, in addn. further processing was detected at the N-terminus, where altogether seven amino acids were removed.  At the C-terminus the lysine was removed as has been seen in vitro, and no further processing was detected.  The full-length CXCL12Î± disappeared within minutes after administration, whereas the processed forms of the protein were detectable for up to 6-8 h postadministration.  The same processed forms appeared after iv and s.c. administration, only the kinetics was different.  When the shortest processed form detected in plasma, 7ÎN1ÎC-CXCL12Î±, was administered directly, no further processed forms were detected.  Interestingly, a version of CXCL12Î± contg. a N-terminal methionine was protected against N-terminal processing in plasma in vitro; however, in vivo no protection was seen, the protein was processed in the same way as full-length CXCL12Î±.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriAo7WPDgfR7Vg90H21EOLACvtfcHk0ljxQxyN8fYfTw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFagsrnM&md5=5486c8dd256eb574e722711c00a38672</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1002%2Fpmic.201000331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpmic.201000331%26sid%3Dliteratum%253Aachs%26aulast%3DAntonsson%26aufirst%3DB.%26aulast%3DDe%2BLys%26aufirst%3DP.%26aulast%3DDechavanne%26aufirst%3DV.%26aulast%3DChevalet%26aufirst%3DL.%26aulast%3DBoschert%26aufirst%3DU.%26atitle%3DIn%2520vivo%2520processing%2520of%2520CXCL12%25CE%25B1%252FSDF-1%25CE%25B1%2520after%2520intravenous%2520and%2520subcutaneous%2520administration%2520to%2520mice%26jtitle%3DProteomics%26date%3D2010%26volume%3D10%26issue%3D24%26spage%3D4342%26epage%3D4351%26doi%3D10.1002%2Fpmic.201000331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref234"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref234'); return false;" data-citation="" class="refNumLink">234</a></strong><div class="NLM_citation" id="cit234"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barreira da Silva, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yatim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiette, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingersoll, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, M. L.</span></span> <span> </span><span class="NLM_article-title">Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">850</span>â <span class="NLM_lpage">858</span>, <span class="refDoi">Â DOI: 10.1038/ni.3201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fni.3201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26075911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFSktLjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=850-858&issue=8&author=R.+Barreira+da+Silvaauthor=M.+E.+Lairdauthor=N.+Yatimauthor=L.+Fietteauthor=M.+A.+Ingersollauthor=M.+L.+Albert&title=Dipeptidylpeptidase+4+inhibition+enhances+lymphocyte+trafficking%2C+improving+both+naturally+occurring+tumor+immunity+and+immunotherapy&doi=10.1038%2Fni.3201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy</span></div><div class="casAuthors">Barreira da Silva, Rosa; Laird, Melissa E.; Yatim, Nader; Fiette, Laurence; Ingersoll, Molly A.; Albert, Matthew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">850-858</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The success of antitumor immune responses depends on the infiltration of solid tumors by effector T cells, a process guided by chemokines.  Here we show that in vivo post-translational processing of chemokines by dipeptidylpeptidase 4 (DPP4, also known as CD26) limits lymphocyte migration to sites of inflammation and tumors.  Inhibition of DPP4 enzymic activity enhanced tumor rejection by preserving biol. active CXCL10 and increasing trafficking into the tumor by lymphocytes expressing the counter-receptor CXCR3.  Furthermore, DPP4 inhibition improved adjuvant-based immunotherapy, adoptive T cell transfer and checkpoint blockade.  These findings provide direct in vivo evidence for control of lymphocyte trafficking via CXCL10 cleavage and support the use of DPP4 inhibitors for stabilizing biol. active forms of chemokines as a strategy to enhance tumor immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7lebakVsDQbVg90H21EOLACvtfcHk0ljxQxyN8fYfTw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFSktLjI&md5=8d8481e29324813e94008f337680c937</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.1038%2Fni.3201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.3201%26sid%3Dliteratum%253Aachs%26aulast%3DBarreira%2Bda%2BSilva%26aufirst%3DR.%26aulast%3DLaird%26aufirst%3DM.%2BE.%26aulast%3DYatim%26aufirst%3DN.%26aulast%3DFiette%26aufirst%3DL.%26aulast%3DIngersoll%26aufirst%3DM.%2BA.%26aulast%3DAlbert%26aufirst%3DM.%2BL.%26atitle%3DDipeptidylpeptidase%25204%2520inhibition%2520enhances%2520lymphocyte%2520trafficking%252C%2520improving%2520both%2520naturally%2520occurring%2520tumor%2520immunity%2520and%2520immunotherapy%26jtitle%3DNat.%2520Immunol.%26date%3D2015%26volume%3D16%26issue%3D8%26spage%3D850%26epage%3D858%26doi%3D10.1038%2Fni.3201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref235"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref235'); return false;" data-citation="" class="refNumLink">235</a></strong><div class="NLM_citation" id="cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohnuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamochi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishibashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, C.</span></span> <span> </span><span class="NLM_article-title">Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">10117</span>â <span class="NLM_lpage">10131</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M609157200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.M609157200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17287217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlCisb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=10117-10131&issue=13&author=K.+Ohnumaauthor=M.+Uchiyamaauthor=T.+Yamochiauthor=K.+Nishibashiauthor=O.+Hosonoauthor=N.+Takahashiauthor=S.+Kinaauthor=H.+Tanakaauthor=X.+Linauthor=N.+H.+Dangauthor=C.+Morimoto&title=Caveolin-1+triggers+T-cell+activation+via+CD26+in+association+with+CARMA1&doi=10.1074%2Fjbc.M609157200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">Caveolin-1 Triggers T-cell Activation via CD26 in Association with CARMA1</span></div><div class="casAuthors">Ohnuma, Kei; Uchiyama, Masahiko; Yamochi, Tadanori; Nishibashi, Kunika; Hosono, Osamu; Takahashi, Nozomu; Kina, Shinichiro; Tanaka, Hirotoshi; Lin, Xin; Dang, Nam H.; Morimoto, Chikao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">10117-10131</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">CD26 is a widely distributed 110-kDa cell surface glycoprotein with an important role in T-cell costimulation.  We demonstrated previously that CD26 binds to caveolin-1 in antigen-presenting cells, and following exogenous CD26 stimulation, Tollip and IRAK-1 disengage from caveolin-1 in antigen-presenting cells.  IRAK-1 is then subsequently phosphorylated to up-regulate CD86 expression, resulting in subsequent T-cell proliferation.  However, it is unclear whether caveolin-1 is a costimulatory ligand for CD26 in T-cells.  Using sol. caveolin-1-Fc fusion protein, we now show that caveolin-1 is the costimulatory ligand for CD26, and that ligation of CD26 by caveolin-1 induces T-cell proliferation and NF-ÎºB activation in a T-cell receptor/CD3-dependent manner.  We also demonstrated that the cytoplasmic tail of CD26 interacts with CARMA1 in T-cells, resulting in signaling events that lead to NF-ÎºB activation.  Ligation of CD26 by caveolin-1 recruits a complex consisting of CD26, CARMA1, Bcl10, and IÎºB kinase to lipid rafts.  Taken together, our findings provide novel insights into the regulation of T-cell costimulation via the CD26 mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoavTGuU3pFC7Vg90H21EOLACvtfcHk0lhfyNaIZML2LQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlCisb0%253D&md5=597e804b42979fd89949939603ffb9b0</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M609157200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M609157200%26sid%3Dliteratum%253Aachs%26aulast%3DOhnuma%26aufirst%3DK.%26aulast%3DUchiyama%26aufirst%3DM.%26aulast%3DYamochi%26aufirst%3DT.%26aulast%3DNishibashi%26aufirst%3DK.%26aulast%3DHosono%26aufirst%3DO.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DKina%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DDang%26aufirst%3DN.%2BH.%26aulast%3DMorimoto%26aufirst%3DC.%26atitle%3DCaveolin-1%2520triggers%2520T-cell%2520activation%2520via%2520CD26%2520in%2520association%2520with%2520CARMA1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26issue%3D13%26spage%3D10117%26epage%3D10131%26doi%3D10.1074%2Fjbc.M609157200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref236"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref236'); return false;" data-citation="" class="refNumLink">236</a></strong><div class="NLM_citation" id="cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinheiro, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoppa, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valduga, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuyama, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GorjÃ£o, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, R. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diniz, S. N.</span></span> <span> </span><span class="NLM_article-title">Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">17</span>â <span class="NLM_lpage">24</span>, <span class="refDoi">Â DOI: 10.1016/j.ejps.2016.12.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.ejps.2016.12.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=28065853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKkurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2017&pages=17-24&author=M.+M.+Pinheiroauthor=C.+L.+Stoppaauthor=C.+J.+Valdugaauthor=C.+E.+Okuyamaauthor=R.+Gorj%C3%A3oauthor=R.+M.+S.+Pereiraauthor=S.+N.+Diniz&title=Sitagliptin+inhibit+human+lymphocytes+proliferation+and+Th1%2FTh17+differentiation+in+vitro&doi=10.1016%2Fj.ejps.2016.12.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro</span></div><div class="casAuthors">Pinheiro, Marcelo Maia; Stoppa, Caroline Lais; Valduga, Claudete Justina; Okuyama, Cristina Eunice; Gorjao, Renata; Pereira, Regina Mara Silva; Diniz, Susana Nogueira</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-24</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of anti-diabetic agents that are widely used in clin. practice to improve glycemic control in patients with type 2 diabetes.  DPP-4 is also known as lymphocyte cell surface protein, CD26, and plays an important role in T-cell immunity.  Recent studies suggest that DPP-4 inhibitors improve beta-cell function and attenuate autoimmunity in type 1 diabetic mouse models.  To investigate the direct effect of DPP4 in immune response, human peripheral blood mononuclear cells (PBMC) from healthy volunteers were obtained by Ficoll gradient and cultivated in the absence (control) or presence of phytohemagglutinin (PHA), or stimulated with PHA and treated with sitagliptin.  The immune modulation mechanisms analyzed were: cell proliferation, by MTT assay; cytokine quantification by ELISA or cytometric bead array (CBA), Th1/Th2/Th17 phenotyping by flow cytometric anal. and CD26 gene expression by real time PCR.  The results showed that sitagliptin treatment inhibited the proliferation of PBMC-PHA stimulated cells in a dose dependent manner and decreased CD26 expression by these cells, suggesting that sitagliptin may interfere in CD26 expression, dimerization and cell signaling.  Sitagliptin treatment not only inhibited IL-10 (p < 0.05) and IFN-gamma (p = 0.07) cytokines, but also completely abolish IL-6 expression by PBMCs (p < 0.001).  On the other hand, IL-4 were secreted in culture supernatants from sitagliptin treated cells.  A statistically significant increase (p < 0.05) in the ratio of TGF-beta/proliferation index after sitagliptin treatment (2627.97 Â± 1351.65), when comparing to untreated cells (646.28 Â± 376.94), was also demonstrated, indicating higher TGF-beta1 prodn. by viable cells in cultures.  Sitagliptin treatment induced a significantly (p < 0.05) decrease in IL-17 and IFN-gamma intracellular expression compared with PHA alone.  Also, the percentage of T CD4+ IL-17+, T CD4+ IFNgamma+ and T CD4+ IL-4+ cells were significantly reduced (p < 0.05) by sitagliptin.  Our data demonstrated an immunosuppressive effect of sitagliptin on Th1, Th17 and Th2 lymphocytes differentiation that leads to the generation of regulatory TGF-beta1 secreting cells with low CD26 gene expression that may influence the state of pancreatic beta-cells and controlling DM1 patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRpb2WyJIVI7Vg90H21EOLACvtfcHk0lhfyNaIZML2LQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKkurk%253D&md5=e7f78744dec977c849529e10ea997687</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2016.12.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2016.12.040%26sid%3Dliteratum%253Aachs%26aulast%3DPinheiro%26aufirst%3DM.%2BM.%26aulast%3DStoppa%26aufirst%3DC.%2BL.%26aulast%3DValduga%26aufirst%3DC.%2BJ.%26aulast%3DOkuyama%26aufirst%3DC.%2BE.%26aulast%3DGorj%25C3%25A3o%26aufirst%3DR.%26aulast%3DPereira%26aufirst%3DR.%2BM.%2BS.%26aulast%3DDiniz%26aufirst%3DS.%2BN.%26atitle%3DSitagliptin%2520inhibit%2520human%2520lymphocytes%2520proliferation%2520and%2520Th1%252FTh17%2520differentiation%2520in%2520vitro%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2017%26volume%3D100%26spage%3D17%26epage%3D24%26doi%3D10.1016%2Fj.ejps.2016.12.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref237"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref237'); return false;" data-citation="" class="refNumLink">237</a></strong><div class="NLM_citation" id="cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villhauer, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naderi, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkey, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunning, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangold, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. E.</span></span> <span> </span><span class="NLM_article-title">1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2774</span>â <span class="NLM_lpage">2789</span>, <span class="refDoi">Â DOI: 10.1021/jm030091l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030091l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvFOiurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2774-2789&issue=13&author=E.+B.+Villhauerauthor=J.+A.+Brinkmanauthor=G.+B.+Naderiauthor=B.+F.+Burkeyauthor=B.+E.+Dunningauthor=K.+Prasadauthor=B.+L.+Mangoldauthor=M.+E.+Russellauthor=T.+E.+Hughes&title=1-%5B%5B%283-Hydroxy-1-adamantyl%29amino%5Dacetyl%5D-2-cyano-%28S%29-pyrrolidine%3A+A+potent%2C+selective%2C+and+orally+bioavailable+dipeptidyl+peptidase+IV+inhibitor+with+antihyperglycemic+properties&doi=10.1021%2Fjm030091l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties</span></div><div class="casAuthors">Villhauer, Edwin B.; Brinkman, John A.; Naderi, Goli B.; Burkey, Bryan F.; Dunning, Beth E.; Prasad, Kapa; Mangold, Bonnie L.; Russell, Mary E.; Hughes, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2774-2789</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPP-IV) inhibition has the potential to become a valuable therapy for type 2 diabetes.  The synthesis and structure-activity relationship of a new DPP-IV inhibitor class, N-substituted-glycyl-2-cyanopyrrolidines, are described as well as the path leading from the clin. development compd., 1-[2-[(5-cyanopyridin-2-yl)amino]ethylamino]acetyl-2-cyano-(S)-pyrrolidine I (NVP-DPP728), to its follow-up, 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine II (NVP-LAF237).  The pharmacol. profile of II in obese Zucker fa/fa rats along with pharmacokinetic profile comparison of I and II in normal cynomolgus monkeys is discussed.  The results suggest that II is a potent, stable, selective DPP-IV inhibitor possessing excellent oral bioavailability and potent antihyperglycemic activity with potential for once-a-day administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeytC93XyU9LVg90H21EOLACvtfcHk0liLOe0pYULevg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvFOiurY%253D&md5=877aeef8cb5f62672b5afd9bf7e022b9</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1021%2Fjm030091l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030091l%26sid%3Dliteratum%253Aachs%26aulast%3DVillhauer%26aufirst%3DE.%2BB.%26aulast%3DBrinkman%26aufirst%3DJ.%2BA.%26aulast%3DNaderi%26aufirst%3DG.%2BB.%26aulast%3DBurkey%26aufirst%3DB.%2BF.%26aulast%3DDunning%26aufirst%3DB.%2BE.%26aulast%3DPrasad%26aufirst%3DK.%26aulast%3DMangold%26aufirst%3DB.%2BL.%26aulast%3DRussell%26aufirst%3DM.%2BE.%26aulast%3DHughes%26aufirst%3DT.%2BE.%26atitle%3D1-%255B%255B%25283-Hydroxy-1-adamantyl%2529amino%255Dacetyl%255D-2-cyano-%2528S%2529-pyrrolidine%253A%2520A%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520with%2520antihyperglycemic%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D13%26spage%3D2774%26epage%3D2789%26doi%3D10.1021%2Fjm030091l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref238"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref238'); return false;" data-citation="" class="refNumLink">238</a></strong><div class="NLM_citation" id="cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Augeri, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robl, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betebenner, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnin, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpkins, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboa-Offei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cap, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welzel, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcinkeviciene, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, L. G.</span></span> <span> </span><span class="NLM_article-title">Discovery and preclinical profile of saxagliptin (BMS-477118): A highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5025</span>â <span class="NLM_lpage">5037</span>, <span class="refDoi">Â DOI: 10.1021/jm050261p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050261p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5025-5037&issue=15&author=D.+J.+Augeriauthor=J.+A.+Roblauthor=D.+A.+Betebennerauthor=D.+R.+Magninauthor=A.+Khannaauthor=J.+G.+Robertsonauthor=A.+Wangauthor=L.+M.+Simpkinsauthor=P.+Taunkauthor=Q.+Huangauthor=S.-P.+Hanauthor=B.+Abboa-Offeiauthor=M.+Capauthor=L.+Xinauthor=L.+Taoauthor=E.+Tozzoauthor=G.+E.+Welzelauthor=D.+M.+Eganauthor=J.+Marcinkevicieneauthor=S.+Y.+Changauthor=S.+A.+Billerauthor=M.+S.+Kirbyauthor=R.+A.+Parkerauthor=L.+G.+Hamann&title=Discovery+and+preclinical+profile+of+saxagliptin+%28BMS-477118%29%3A+A+highly+potent%2C+long-acting%2C+orally+active+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type+2+diabetes&doi=10.1021%2Fjm050261p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Augeri, David J.; Robl, Jeffrey A.; Betebenner, David A.; Magnin, David R.; Khanna, Ashish; Robertson, James G.; Wang, Aiying; Simpkins, Ligaya M.; Taunk, Prakash; Huang, Qi; Han, Song-Ping; Abboa-Offei, Benoni; Cap, Michael; Xin, Li; Tao, Li; Tozzo, Effie; Welzel, Gustav E.; Egan, Donald M.; Marcinkeviciene, Jovita; Chang, Shu Y.; Biller, Scott A.; Kirby, Mark S.; Parker, Rex A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5025-5037</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Efforts to further elucidate structure-activity relationships (SAR) within the authors previously disclosed series of Î²-quaternary amino acid linked L-cis-4,5-methanoprolinenitrile dipeptidyl peptidase IV (DPP-IV) inhibitors led to the investigation of vinyl substitution at the Î²-position of Î±-cycloalkyl-substituted glycines.  Despite poor systemic exposure, vinyl-substituted compds. showed extended duration of action in acute rat ex vivo plasma DPP-IV inhibition models.  Oxygenated putative metabolites were prepd. and were shown to exhibit the potency and extended duration of action of their precursors in efficacy models measuring glucose clearance in Zuckerfa/fa rats.  Extension of this approach to adamantylglycine-derived inhibitors led to the discovery of highly potent inhibitors, including hydroxyadamantyl compd. BMS-477118 (saxagliptin), a highly efficacious, stable, and long-acting DPP-IV inhibitor, which is currently undergoing clin. trials for treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrIJX7K8p67Vg90H21EOLACvtfcHk0liLOe0pYULevg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D&md5=878355880133bb0ddd6bd14ecbf1d070</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.1021%2Fjm050261p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050261p%26sid%3Dliteratum%253Aachs%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DTaunk%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.-P.%26aulast%3DAbboa-Offei%26aufirst%3DB.%26aulast%3DCap%26aufirst%3DM.%26aulast%3DXin%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DWelzel%26aufirst%3DG.%2BE.%26aulast%3DEgan%26aufirst%3DD.%2BM.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DS.%2BY.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DDiscovery%2520and%2520preclinical%2520profile%2520of%2520saxagliptin%2520%2528BMS-477118%2529%253A%2520A%2520highly%2520potent%252C%2520long-acting%252C%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D15%26spage%3D5025%26epage%3D5037%26doi%3D10.1021%2Fjm050261p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref239"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref239'); return false;" data-citation="" class="refNumLink">239</a></strong><div class="NLM_citation" id="cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nabeno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akahoshi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyaguchi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadowaki, T.</span></span> <span> </span><span class="NLM_article-title">A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>434</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">191</span>â <span class="NLM_lpage">196</span>, <span class="refDoi">Â DOI: 10.1016/j.bbrc.2013.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bbrc.2013.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23501107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1ClsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2013&pages=191-196&issue=2&author=M.+Nabenoauthor=F.+Akahoshiauthor=H.+Kishidaauthor=I.+Miyaguchiauthor=Y.+Tanakaauthor=S.+Ishiiauthor=T.+Kadowaki&title=A+comparative+study+of+the+binding+modes+of+recently+launched+dipeptidyl+peptidase+IV+inhibitors+in+the+active+site&doi=10.1016%2Fj.bbrc.2013.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site</span></div><div class="casAuthors">Nabeno, Mika; Akahoshi, Fumihiko; Kishida, Hiroyuki; Miyaguchi, Ikuko; Tanaka, Yoshihito; Ishii, Shinichi; Kadowaki, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-196</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In recent years, various dipeptidyl peptidase IV (I) inhibitors have been released as therapeutic drugs for type 2 diabetes in many countries.  In spite of their diverse chem. structures, no comparative studies of their binding modes in the active site of I have been disclosed.  Here, the authors detd. the co-crystal structure of vildagliptin with I by x-ray crystallog. and compared the binding modes of 6 launched inhibitors in I.  The inhibitors were categorized into 3 classes on the basis of their binding subsites: (1) vildagliptin and saxagliptin (class 1) formed interactions with the core S1 and S2 subsites and a covalent bond with Ser-630 in the catalytic triad; (2) alogliptin and linagliptin (class 2) formed interactions with the S1' and/or S2' subsites in addn. to the S1 and S2 subsites; and (3) sitagliptin and teneligliptin (class 3) formed interactions with the S1, S2, and S2 extensive subsites.  The present study revealed that the addnl. interactions with the S1', S2' or S2 extensive subsite may increase I inhibition beyond the level afforded by the fundamental interactions with the S1 and S2 subsites and are more effective than forming a covalent bond with Ser-630.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot0q2mkCn137Vg90H21EOLACvtfcHk0lgnp1RXNX9MIA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1ClsrY%253D&md5=917cf85fddb832f207c67cd70d38c657</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2013.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2013.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DNabeno%26aufirst%3DM.%26aulast%3DAkahoshi%26aufirst%3DF.%26aulast%3DKishida%26aufirst%3DH.%26aulast%3DMiyaguchi%26aufirst%3DI.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DS.%26aulast%3DKadowaki%26aufirst%3DT.%26atitle%3DA%2520comparative%2520study%2520of%2520the%2520binding%2520modes%2520of%2520recently%2520launched%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%2520in%2520the%2520active%2520site%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2013%26volume%3D434%26issue%3D2%26spage%3D191%26epage%3D196%26doi%3D10.1016%2Fj.bbrc.2013.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref240"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref240'); return false;" data-citation="" class="refNumLink">240</a></strong><div class="NLM_citation" id="cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buzzetti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzilli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirshberg, B.</span></span> <span> </span><span class="NLM_article-title">Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA)</span>. <i>Diabetes/Metab. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">289</span>â <span class="NLM_lpage">296</span>, <span class="refDoi">Â DOI: 10.1002/dmrr.2717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fdmrr.2717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26385269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1yqu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=289-296&issue=3&author=R.+Buzzettiauthor=P.+Pozzilliauthor=R.+Frederichauthor=N.+Iqbalauthor=B.+Hirshberg&title=Saxagliptin+improves+glycaemic+control+and+C-peptide+secretion+in+latent+autoimmune+diabetes+in+adults+%28LADA%29&doi=10.1002%2Fdmrr.2717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA)</span></div><div class="casAuthors">Buzzetti, R.; Pozzilli, P.; Frederich, R.; Iqbal, N.; Hirshberg, B.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes/Metabolism Research and Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">289-296</span>CODEN:
                <span class="NLM_cas:coden">DMRRFM</span>;
        ISSN:<span class="NLM_cas:issn">1520-7552</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background : To assess the efficacy and tolerability of saxagliptin and C-peptide secretion in patients with diagnosed type 2 diabetes classified as glutamic acid decarboxylase antibody (GADA)-pos. or GADA-neg.  Methods : Post hoc anal. of data pooled from five randomized, placebo-controlled, 24-wk phase 3 studies (n = 2709) was conducted.  We evaluated mean change from baseline at week 24 in HbA1c, fasting plasma glucose, postprandial plasma glucose, fasting and postprandial C-peptide, and HOMA2-%Î² and the proportion of patients achieving HbA1c < 7% (53 mmol/mol) at week 24.  Results : Saxagliptin produced greater adjusted mean redns. from baseline in HbA1c vs. placebo for GADA-neg. [difference vs placebo (95% CI), -0.62% (-0.71% to -0.54%); -6.8 mmol/mol (-7.8, -5.9)] and GADA-pos. patients [-0.64% (-1.01% to -0.27%); -7.0 mmol/mol (-11.0, -3.0)].  Consistently, saxagliptin produced a greater redn. from baseline in fasting plasma glucose and postprandial plasma glucose vs. placebo in GADA-pos. vs. GADA-neg. patients, and more patients achieved HbA1c < 7% (53 mmol/mol) with saxagliptin vs. placebo in both GADA-neg. and GADA-pos. patients.  Saxagliptin increased Î²-cell function as assessed by HOMA2-%Î² and postprandial C-peptide area under the curve from baseline in patients in both GADA-pos. and GADA-neg. patients.  Adverse events and hypoglycemic events were similar across treatment groups and GADA categories.  Conclusion : Saxagliptin was effective in lowering blood glucose levels and generally well tolerated in GADA-pos. patients.  Interestingly, saxagliptin appears to improve Î²-cell function in these patients, although a longer treatment duration may be needed to confirm this finding.  Copyright Â© 2015 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZMKLfPeoYULVg90H21EOLACvtfcHk0lgnp1RXNX9MIA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1yqu7w%253D&md5=a30af81612002c5a48db2695f58d9303</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1002%2Fdmrr.2717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdmrr.2717%26sid%3Dliteratum%253Aachs%26aulast%3DBuzzetti%26aufirst%3DR.%26aulast%3DPozzilli%26aufirst%3DP.%26aulast%3DFrederich%26aufirst%3DR.%26aulast%3DIqbal%26aufirst%3DN.%26aulast%3DHirshberg%26aufirst%3DB.%26atitle%3DSaxagliptin%2520improves%2520glycaemic%2520control%2520and%2520C-peptide%2520secretion%2520in%2520latent%2520autoimmune%2520diabetes%2520in%2520adults%2520%2528LADA%2529%26jtitle%3DDiabetes%252FMetab.%2520Res.%2520Rev.%26date%3D2016%26volume%3D32%26issue%3D3%26spage%3D289%26epage%3D296%26doi%3D10.1002%2Fdmrr.2717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref241"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref241'); return false;" data-citation="" class="refNumLink">241</a></strong><div class="NLM_citation" id="cit241"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flentke, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plaut, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettner, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, W. W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>88</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1556</span>â <span class="NLM_lpage">1559</span>, <span class="refDoi">Â DOI: 10.1073/pnas.88.4.1556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.88.4.1556" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1671716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3MXitVGgt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=1556-1559&issue=4&author=G.+R.+Flentkeauthor=E.+Munozauthor=B.+T.+Huberauthor=A.+G.+Plautauthor=C.+A.+Kettnerauthor=W.+W.+Bachovchin&title=Inhibition+of+dipeptidyl+aminopeptidase+IV+%28DP-IV%29+by+Xaa-boroPro+dipeptides+and+use+of+these+inhibitors+to+examine+the+role+of+DP-IV+in+T-cell+function&doi=10.1073%2Fpnas.88.4.1556"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit241R"><div class="casContent"><span class="casTitleNuber">241</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function</span></div><div class="casAuthors">Flentke, George R.; Munoz, Eduardo; Huber, Brigitte T.; Plaut, Andrew G.; Kettner, Charles A.; Bachovchin, William W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1556-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Dipeptidyl peptidase IV (DP-IV; dipeptidyl-peptide hydrolase, EC 3.4.14.5) is a serine protease with a specificity for cleaving Xaa-Pro dipeptides from polypeptides and proteins.  It is found in a variety of mammalian cells and tissues, including those of lymphoid origin where it is found specifically on the surface of CD4+ T cells.  Although the functional significance of this enzyme has not been established, a role in T-cell activation and immune regulation has been proposed.  Here is reported that Ala-boroPro and Pro-boroPro, where boroPro is the Î±-amino boronic acid analog of proline, are potent and specific inhibitors of DP-IV, having Ki values in the nanomolar range.  Blocking the N terminus of Ala-boroPro abolishes the affinity of this inhibitor for DP-IV, while removal of the N-terminal residue, to give boroPro, reduces the affinity for DP-IV by 5 orders of magnitude.  The dipeptide boronic acids exhibit slow-binding kinetics, while boroPro does not.  Low concns. of Pro-boroPro inhibit antigen-induced proliferation and interleukin 2 prodn. in murine T-cell lines but do not inhibit the response of these T cells to the mitogen Con A.  Thus, DP-IV plays a role in antigen-induced, but not mitogen-induced, activation of T lymphocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1cfUVBGZEjrVg90H21EOLACvtfcHk0lgnp1RXNX9MIA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXitVGgt78%253D&md5=204a1c08a97b5b73f42dc353370337c3</span></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.4.1556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.4.1556%26sid%3Dliteratum%253Aachs%26aulast%3DFlentke%26aufirst%3DG.%2BR.%26aulast%3DMunoz%26aufirst%3DE.%26aulast%3DHuber%26aufirst%3DB.%2BT.%26aulast%3DPlaut%26aufirst%3DA.%2BG.%26aulast%3DKettner%26aufirst%3DC.%2BA.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26atitle%3DInhibition%2520of%2520dipeptidyl%2520aminopeptidase%2520IV%2520%2528DP-IV%2529%2520by%2520Xaa-boroPro%2520dipeptides%2520and%2520use%2520of%2520these%2520inhibitors%2520to%2520examine%2520the%2520role%2520of%2520DP-IV%2520in%2520T-cell%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1991%26volume%3D88%26issue%3D4%26spage%3D1556%26epage%3D1559%26doi%3D10.1073%2Fpnas.88.4.1556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref242"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref242'); return false;" data-citation="" class="refNumLink">242</a></strong><div class="NLM_citation" id="cit242"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lankas, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiting, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiermann, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beconi, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biftu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ippolito, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ok, H. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pryor, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reigle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N. A.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2988</span>â <span class="NLM_lpage">2994</span>, <span class="refDoi">Â DOI: 10.2337/diabetes.54.10.2988</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.2337%2Fdiabetes.54.10.2988" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=16186403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2rs7zO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=2988-2994&issue=10&author=G.+R.+Lankasauthor=B.+Leitingauthor=R.+S.+Royauthor=G.+J.+Eiermannauthor=M.+G.+Beconiauthor=T.+Biftuauthor=C.-C.+Chanauthor=S.+Edmondsonauthor=W.+P.+Feeneyauthor=H.+Heauthor=D.+E.+Ippolitoauthor=D.+Kimauthor=K.+A.+Lyonsauthor=H.+O.+Okauthor=R.+A.+Patelauthor=A.+N.+Petrovauthor=K.+A.+Pryorauthor=X.+Qianauthor=L.+Reigleauthor=A.+Woodsauthor=J.+K.+Wuauthor=D.+Zallerauthor=X.+Zhangauthor=L.+Zhuauthor=A.+E.+Weberauthor=N.+A.+Thornberry&title=Dipeptidyl+peptidase+IV+inhibition+for+the+treatment+of+type+2+diabetes%3A+potential+importance+of+selectivity+over+dipeptidyl+peptidases+8+and+9&doi=10.2337%2Fdiabetes.54.10.2988"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit242R"><div class="casContent"><span class="casTitleNuber">242</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes. Potential importance of selectivity over dipeptidyl peptidases 8 and 9</span></div><div class="casAuthors">Lankas, George R.; Leiting, Barbara; Roy, Ranabir Sinha; Eiermann, George J.; Beconi, Maria G.; Biftu, Tesfaye; Chan, Chi-Chung; Edmondson, Scott; Feeney, William P.; He, Huaibing; Ippolito, Dawn E.; Kim, Dooseop; Lyons, Kathryn A.; Ok, Hyun O.; Patel, Reshma A.; Petrov, Aleksandr N.; Pryor, Kelly Ann; Qian, Xiaoxia; Reigle, Leah; Woods, Andrea; Wu, Joseph K.; Zaller, Dennis; Zhang, Xiaoping; Zhu, Lan; Weber, Ann E.; Thornberry, Nancy A.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2988-2994</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase (DPP)-IV inhibitors are a new approach to the treatment of type 2 diabetes.  DPP-IV is a member of a family of serine peptidases that includes quiescent cell proline dipeptidase (QPP), DPP8, and DPP9; DPP-IV is a key regulator of incretin hormones, but the functions of other family members are unknown.  To det. the importance of selective DPP-IV inhibition for the treatment of diabetes, we tested selective inhibitors of DPP-IV, DPP8/DPP9, or QPP in 2-wk rat toxicity studies and in acute dog tolerability studies.  In rats, the DPP8/9 inhibitor produced alopecia, thrombocytopenia, reticulocytopenia, enlarged spleen, multiorgan histopathol. changes, and mortality.  In dogs, the DPP8/9 inhibitor produced gastrointestinal toxicity.  The QPP inhibitor produced reticulocytopenia in rats only, and no toxicities were noted in either species for the selective DPP-IV inhibitor.  The DPP8/9 inhibitor was also shown to attenuate T-cell activation in human in vitro models; a selective DPP-IV inhibitor was inactive in these assays.  Moreover, we found DPP-IV inhibitors that were previously reported to be active in models of immune function to be more potent inhibitors of DPP8/9.  These results suggest that assessment of selectivity of potential clin. candidates may be important to an optimal safety profile for this new class of antihyperglycemic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5jJ2LSMqwcbVg90H21EOLACvtfcHk0lhZ3whvhN4FUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2rs7zO&md5=31b9677bd3b0ec4109e05a06e7e019cf</span></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.54.10.2988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.54.10.2988%26sid%3Dliteratum%253Aachs%26aulast%3DLankas%26aufirst%3DG.%2BR.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DBeconi%26aufirst%3DM.%2BG.%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DC.-C.%26aulast%3DEdmondson%26aufirst%3DS.%26aulast%3DFeeney%26aufirst%3DW.%2BP.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DIppolito%26aufirst%3DD.%2BE.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DOk%26aufirst%3DH.%2BO.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%2BN.%26aulast%3DPryor%26aufirst%3DK.%2BA.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DReigle%26aufirst%3DL.%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520inhibition%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%253A%2520potential%2520importance%2520of%2520selectivity%2520over%2520dipeptidyl%2520peptidases%25208%2520and%25209%26jtitle%3DDiabetes%26date%3D2005%26volume%3D54%26issue%3D10%26spage%3D2988%26epage%3D2994%26doi%3D10.2337%2Fdiabetes.54.10.2988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref243"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref243'); return false;" data-citation="" class="refNumLink">243</a></strong><div class="NLM_citation" id="cit243"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanford, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiluwal, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Healey, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimare, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maw, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudmeier, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, W. W.</span></span> <span> </span><span class="NLM_article-title">Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: Determinants of potency and in vivo efficacy and safety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">6005</span>â <span class="NLM_lpage">6013</span>, <span class="refDoi">Â DOI: 10.1021/jm800390n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800390n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSjtr3L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6005-6013&issue=19&author=B.+A.+Connollyauthor=D.+G.+Sanfordauthor=A.+K.+Chiluwalauthor=S.+E.+Healeyauthor=D.+E.+Petersauthor=M.+T.+Dimareauthor=W.+Wuauthor=Y.+Liuauthor=H.+Mawauthor=Y.+Zhouauthor=Y.+Liauthor=Z.+Jinauthor=J.+L.+Sudmeierauthor=J.+H.+Laiauthor=W.+W.+Bachovchin&title=Dipeptide+boronic+acid+inhibitors+of+dipeptidyl+peptidase+IV%3A+Determinants+of+potency+and+in+vivo+efficacy+and+safety&doi=10.1021%2Fjm800390n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptide Boronic Acid Inhibitors of Dipeptidyl Peptidase IV: Determinants of Potency and in Vivo Efficacy and Safety</span></div><div class="casAuthors">Connolly, Beth A.; Sanford, David G.; Chiluwal, Amrita K.; Healey, Sarah E.; Peters, Diane E.; Dimare, Matthew T.; Wu, Wengen; Liu, Yuxin; Maw, Hlaing; Zhou, Yuhong; Li, Youhua; Jin, Zhiping; Sudmeier, James L.; Lai, Jack H.; Bachovchin, William W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6005-6013</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPP-IV; E.C. 3.4.14.5), a serine protease that degrades the incretin hormones GLP-1 and GIP, is now a validated target for the treatment of type 2 diabetes.  Dipeptide boronic acids, among the first, and still among the most potent DPP-IV inhibitors known, suffer from a concern over their safety.  Here we evaluate the potency, in vivo efficacy, and safety of a selected set of these inhibitors.  The adverse effects induced by boronic acid-based DPP-IV inhibitors are essentially limited to what has been obsd. previously for non-boronic acid inhibitors and attributed to cross-reactivity with DPP8/9.  While consistent with the DPP8/9 hypothesis, they are also consistent with cross-reactivity with some other intracellular target.  The results further show that the potency of simple dipeptide boronic acid-based inhibitors can be combined with selectivity against DPP8/9 in vivo to produce agents with a relatively wide therapeutic index (>500) in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgbBB8ZNyTD7Vg90H21EOLACvtfcHk0lgtwRQn7yV58Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSjtr3L&md5=5fd0b18c273e595716737192d6fed573</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.1021%2Fjm800390n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800390n%26sid%3Dliteratum%253Aachs%26aulast%3DConnolly%26aufirst%3DB.%2BA.%26aulast%3DSanford%26aufirst%3DD.%2BG.%26aulast%3DChiluwal%26aufirst%3DA.%2BK.%26aulast%3DHealey%26aufirst%3DS.%2BE.%26aulast%3DPeters%26aufirst%3DD.%2BE.%26aulast%3DDimare%26aufirst%3DM.%2BT.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMaw%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DSudmeier%26aufirst%3DJ.%2BL.%26aulast%3DLai%26aufirst%3DJ.%2BH.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26atitle%3DDipeptide%2520boronic%2520acid%2520inhibitors%2520of%2520dipeptidyl%2520peptidase%2520IV%253A%2520Determinants%2520of%2520potency%2520and%2520in%2520vivo%2520efficacy%2520and%2520safety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D19%26spage%3D6005%26epage%3D6013%26doi%3D10.1021%2Fjm800390n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref244"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref244'); return false;" data-citation="" class="refNumLink">244</a></strong><div class="NLM_citation" id="cit244"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strzemkowski-Brun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egleston, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiner, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meropol, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. D.</span></span> <span> </span><span class="NLM_article-title">Phase II trial of single agent Val-boroPro (talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1691</span>â <span class="NLM_lpage">1699</span>, <span class="refDoi">Â DOI: 10.4161/cbt.6.11.4874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4161%2Fcbt.6.11.4874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18032930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1Whsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1691-1699&issue=11&author=K.+Narraauthor=S.+R.+Mullinsauthor=H.-O.+Leeauthor=B.+Strzemkowski-Brunauthor=K.+Magalongauthor=V.+J.+Christiansenauthor=P.+A.+McKeeauthor=B.+Eglestonauthor=S.+J.+Cohenauthor=L.+M.+Weinerauthor=N.+J.+Meropolauthor=J.+D.+Cheng&title=Phase+II+trial+of+single+agent+Val-boroPro+%28talabostat%29+inhibiting+fibroblast+activation+protein+in+patients+with+metastatic+colorectal+cancer&doi=10.4161%2Fcbt.6.11.4874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer</span></div><div class="casAuthors">Narra, Kalyani; Mullins, Stefanie R.; Lee, Hyung-Ok; Strzemkowski-Brun, Brenda; Magalong, Kimberly; Christiansen, Victoria J.; McKee, Patrick A.; Egleston, Brian; Cohen, Steven J.; Weiner, Louis M.; Meropol, Neal J.; Cheng, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1691-1699</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Purpose: Fibroblost Activation Protein (FAP) is a tumor fibroblast protease that has been shown to potentiate colorectal cancer growth.  The clin. impact of FAP inhibition was tested using Val-boroPro (Talabostat), the first clin. inhibitor of FAP enzymic activity, in a phase II study of patients with metastatic colorectal cancer.  Methods: Patients with metastatic colorectal cancer who had previously received systemic chemotherapies were treated with single agent Val-boroPro 200 Î¼g p.o. BID continuously.  Eligibility included measurable disease, performance status of 0 to 2, and adequate organ function.  Lab. correlates evaluated the pharmacodynamic effects of Val-boroPro on FAP enzymic function in the peripheral blood.  Results: Twenty-eight patients (median age 62; 12 males, 16 females) were enrolled in this study.  There were no objective responses.  Six of 28 (21%) patients had stable disease for a median of 25 wk (range 11-38 wk).  Lab. anal. demonstrated significant, although incomplete inhibition of FAP enzymic activity in the peripheral blood.  Conclusion: This phase II trial of Val-boroPro demonstrated minimal clin. activity in patients with previously treated metastatic colorectal cancer.  However it provides the initial proof-of-concept that physiol. inhibition of FAP activity can be accomplished in patients with colorectal cancer, and lays the groundwork for future studies targeting the tumor stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_1F424osEbVg90H21EOLACvtfcHk0lgtwRQn7yV58Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1Whsb8%253D&md5=7e69e1187b364d4c1ed43fef5d717c48</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.4161%2Fcbt.6.11.4874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.6.11.4874%26sid%3Dliteratum%253Aachs%26aulast%3DNarra%26aufirst%3DK.%26aulast%3DMullins%26aufirst%3DS.%2BR.%26aulast%3DLee%26aufirst%3DH.-O.%26aulast%3DStrzemkowski-Brun%26aufirst%3DB.%26aulast%3DMagalong%26aufirst%3DK.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26aulast%3DEgleston%26aufirst%3DB.%26aulast%3DCohen%26aufirst%3DS.%2BJ.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26aulast%3DMeropol%26aufirst%3DN.%2BJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26atitle%3DPhase%2520II%2520trial%2520of%2520single%2520agent%2520Val-boroPro%2520%2528talabostat%2529%2520inhibiting%2520fibroblast%2520activation%2520protein%2520in%2520patients%2520with%2520metastatic%2520colorectal%2520cancer%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2007%26volume%3D6%26issue%3D11%26spage%3D1691%26epage%3D1699%26doi%3D10.4161%2Fcbt.6.11.4874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref245"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref245'); return false;" data-citation="" class="refNumLink">245</a></strong><div class="NLM_citation" id="cit245"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eager, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senzer, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâDay, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenette, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlick, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uprichard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemunaitis, J.</span></span> <span> </span><span class="NLM_article-title">Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">263</span>, <span class="refDoi">Â DOI: 10.1186/1471-2407-9-263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1186%2F1471-2407-9-263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19643020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BD1MrnvVWlsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=263&issue=1&author=R.+M.+Eagerauthor=C.+C.+Cunninghamauthor=N.+N.+Senzerauthor=J.+Stephensonauthor=S.+P.+Anthonyauthor=S.+J.+O%E2%80%99Dayauthor=G.+Frenetteauthor=A.+C.+Pavlickauthor=B.+Jonesauthor=M.+Uprichardauthor=J.+Nemunaitis&title=Phase+II+assessment+of+talabostat+and+cisplatin+in+second-line+stage+IV+melanoma&doi=10.1186%2F1471-2407-9-263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit245R"><div class="casContent"><span class="casTitleNuber">245</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma</span></div><div class="casAuthors">Eager Robert M; Cunningham C Casey; Senzer Neil N; Stephenson Joe Jr; Anthony Stephen P; O'Day Steven J; Frenette Gary; Pavlick Anna C; Jones Barry; Uprichard Margaret; Nemunaitis John</div><div class="citationInfo"><span class="NLM_cas:title">BMC cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">263</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Metastatic melanoma is an incurable disease with an average survival of less than one year.  Talabostat is a novel dipeptidyl peptidase inhibitor with immunostimulatory properties.  METHODS:  This phase II, open label, single arm study was conducted to evaluate the safety and efficacy of 75-100 mg/m2 cisplatin combined with 300-400 mcg talabostat bid for 6, 21-day cycles.  The primary endpoint was overall response.  The rate of complete responses, duration of overall objective response, progression-free survival (PFS), and overall survival were the secondary endpoints.  RESULTS:  Six objective partial responses were recorded in the 74 patients (8.1%) in the intention-to-treat population.  Five of these responses involved the 40 evaluable patients (12.5%).  Thirty-one percent of patients reported SAEs to the combination of talabostat and cisplatin.  CONCLUSION:  Acceptable tolerability was observed in the intention-to-treat population and antitumor activity was observed in 12.5% of evaluable patients, which is not greater than historical expectation with cisplatin alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQSzL0c3BDb0bxh97K6Vt6fW6udTcc2eb0PG9i7z83cLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrnvVWlsQ%253D%253D&md5=7201b71b68c676616fce03005c2cb55e</span></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-9-263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-9-263%26sid%3Dliteratum%253Aachs%26aulast%3DEager%26aufirst%3DR.%2BM.%26aulast%3DCunningham%26aufirst%3DC.%2BC.%26aulast%3DSenzer%26aufirst%3DN.%2BN.%26aulast%3DStephenson%26aufirst%3DJ.%26aulast%3DAnthony%26aufirst%3DS.%2BP.%26aulast%3DO%25E2%2580%2599Day%26aufirst%3DS.%2BJ.%26aulast%3DFrenette%26aufirst%3DG.%26aulast%3DPavlick%26aufirst%3DA.%2BC.%26aulast%3DJones%26aufirst%3DB.%26aulast%3DUprichard%26aufirst%3DM.%26aulast%3DNemunaitis%26aufirst%3DJ.%26atitle%3DPhase%2520II%2520assessment%2520of%2520talabostat%2520and%2520cisplatin%2520in%2520second-line%2520stage%2520IV%2520melanoma%26jtitle%3DBMC%2520Cancer%26date%3D2009%26volume%3D9%26issue%3D1%26spage%3D263%26doi%3D10.1186%2F1471-2407-9-263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref246"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref246'); return false;" data-citation="" class="refNumLink">246</a></strong><div class="NLM_citation" id="cit246"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jesson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallner, B. P.</span></span> <span> </span><span class="NLM_article-title">PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5471</span>â <span class="NLM_lpage">5480</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-04-0447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1158%2F0008-5472.CAN-04-0447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15289357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtF2lsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=5471-5480&issue=15&author=S.+Adamsauthor=G.+T.+Millerauthor=M.+I.+Jessonauthor=T.+Watanabeauthor=B.+Jonesauthor=B.+P.+Wallner&title=PT-100%2C+a+small+molecule+dipeptidyl+peptidase+inhibitor%2C+has+potent+antitumor+effects+and+augments+antibody-mediated+cytotoxicity+via+a+novel+immune+mechanism&doi=10.1158%2F0008-5472.CAN-04-0447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit246R"><div class="casContent"><span class="casTitleNuber">246</span><div class="casTitle"><span class="NLM_cas:atitle">PT-100, a Small Molecule Dipeptidyl Peptidase Inhibitor, Has Potent Antitumor Effects and Augments Antibody-Mediated Cytotoxicity via a Novel Immune Mechanism</span></div><div class="casAuthors">Adams, Sharlene; Miller, Glenn T.; Jesson, Michael I.; Watanabe, Takeshi; Jones, Barry; Wallner, Barbara P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5471-5480</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The amino boronic dipeptide, PT-100 (Val-boro-Pro), a dipeptidyl peptidase (DPP) inhibitor, has been shown to up-regulate gene expression of certain cytokines in hematopoietic tissue via a high-affinity interaction, which appears to involve fibroblast activation protein.  Because fibroblast activation protein is also expressed in stroma of lymphoid tissue and tumors, the effect of PT-100 on tumor growth was studied in mice in vivo.  PT-100 has no direct cytotoxic effect on tumors in vitro.  Oral administration of PT-100 to mice slowed growth of syngeneic tumors derived from fibrosarcoma, lymphoma, melanoma, and mastocytoma cell lines.  In WEHI 164 fibrosarcoma and EL4 and A20/2J lymphoma models, PT-100 caused regression and rejection of tumors.  The antitumor effect appeared to involve tumor-specific CTL and protective immunol. memory.  PT-100 treatment of WEHI 164-inoculated mice increased mRNA expression of cytokines and chemokines known to promote T-cell priming and chemoattraction of T cells and innate effector cells.  The role of innate activity was further implicated by observation of significant, although reduced, inhibition of WEHI 164 and A20/2J tumors in immunodeficient mice.  PT-100 also demonstrated ability to augment antitumor activity of rituximab and trastuzumab in xenograft models of human CD20+ B-cell lymphoma and HER-2+ colon carcinoma where antibody-dependent cytotoxicity can be mediated by innate effector cells responsive to the cytokines and chemokines up-regulated by PT-100.  Although CD26/DPP-IV is a potential target for PT-100 in the immune system, it appeared not to be involved because antitumor activity and stimulation of cytokine and chemokine prodn. was undiminished in CD26-/- mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBUQaRQ3nZ4LVg90H21EOLACvtfcHk0lh6UAvpz9PJZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtF2lsr0%253D&md5=77a065748628574b88c83b9e1476d249</span></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-0447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-0447%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DG.%2BT.%26aulast%3DJesson%26aufirst%3DM.%2BI.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DB.%26aulast%3DWallner%26aufirst%3DB.%2BP.%26atitle%3DPT-100%252C%2520a%2520small%2520molecule%2520dipeptidyl%2520peptidase%2520inhibitor%252C%2520has%2520potent%2520antitumor%2520effects%2520and%2520augments%2520antibody-mediated%2520cytotoxicity%2520via%2520a%2520novel%2520immune%2520mechanism%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26issue%3D15%26spage%3D5471%26epage%3D5480%26doi%3D10.1158%2F0008-5472.CAN-04-0447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref247"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref247'); return false;" data-citation="" class="refNumLink">247</a></strong><div class="NLM_citation" id="cit247"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, C. C.</span></span> <span> </span><span class="NLM_article-title">Talabostat</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1459</span>â <span class="NLM_lpage">1465</span>, <span class="refDoi">Â DOI: 10.1517/13543784.16.9.1459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1517%2F13543784.16.9.1459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17714031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptlSrt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=1459-1465&issue=9&author=C.+C.+Cunningham&title=Talabostat&doi=10.1517%2F13543784.16.9.1459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit247R"><div class="casContent"><span class="casTitleNuber">247</span><div class="casTitle"><span class="NLM_cas:atitle">Talabostat</span></div><div class="casAuthors">Cunningham, Charles Casey</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1459-1465</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Talabostat mesylate is an orally active, specific inhibitor of dipeptidyl peptidases, including tumor-assocd. fibroblast activation protein.  However, by an independent mechanism, talabostat also stimulates the upregulation of cytokines and chemokines to engender a tumor-specific host immune response, thus giving it a unique dual mechanism of action.  In clin. trials, talabostat has demonstrated significant activity, including achieving complete responses in patients with non-small-cell lung cancer and malignant melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog2iuGokqzwbVg90H21EOLACvtfcHk0lh6UAvpz9PJZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptlSrt7g%253D&md5=e53bfb06df81af3bd9c4fb09a5a83c7a</span></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1517%2F13543784.16.9.1459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.16.9.1459%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DC.%2BC.%26atitle%3DTalabostat%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D16%26issue%3D9%26spage%3D1459%26epage%3D1465%26doi%3D10.1517%2F13543784.16.9.1459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref248"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref248'); return false;" data-citation="" class="refNumLink">248</a></strong><div class="NLM_citation" id="cit248"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okondo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chui, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poplawski, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanford, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arciprete, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, D. A.</span></span> <span> </span><span class="NLM_article-title">DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">46</span>â <span class="NLM_lpage">53</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.2229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnchembio.2229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27820798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSntLnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=46-53&issue=1&author=M.+C.+Okondoauthor=D.+C.+Johnsonauthor=R.+Sridharanauthor=E.+B.+Goauthor=A.+J.+Chuiauthor=M.+S.+Wangauthor=S.+E.+Poplawskiauthor=W.+Wuauthor=Y.+Liuauthor=J.+H.+Laiauthor=D.+G.+Sanfordauthor=M.+O.+Arcipreteauthor=T.+R.+Golubauthor=W.+W.+Bachovchinauthor=D.+A.+Bachovchin&title=DPP8+and+DPP9+inhibition+induces+pro-caspase-1-dependent+monocyte+and+macrophage+pyroptosis&doi=10.1038%2Fnchembio.2229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit248R"><div class="casContent"><span class="casTitleNuber">248</span><div class="casTitle"><span class="NLM_cas:atitle">DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis</span></div><div class="casAuthors">Okondo, Marian C.; Johnson, Darren C.; Sridharan, Ramya; Go, Eun Bin; Chui, Ashley J.; Wang, Mitchell S.; Poplawski, Sarah E.; Wu, Wengen; Liu, Yuxin; Lai, Jack H.; Sanford, David G.; Arciprete, Michael O.; Golub, Todd R.; Bachovchin, William W.; Bachovchin, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-53</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Val-boroPro (Talabostat, PT-100), a nonselective inhibitor of postproline cleaving serine proteases, stimulates mammalian immune systems through an unknown mechanism of action.  Despite this lack of mechanistic understanding, Val-boroPro has attracted substantial interest as a potential anticancer agent, reaching phase 3 trials in humans.  Here the authors show that Val-boroPro stimulates the immune system by triggering a proinflammatory form of cell death in monocytes and macrophages known as pyroptosis.  The authors demonstrate that the inhibition of two serine proteases, DPP8 and DPP9, activates the pro-protein form of caspase-1 independent of the inflammasome adaptor ASC.  Activated pro-caspase-1 does not efficiently process itself or IL-1Î² but does cleave and activate gasdermin D to induce pyroptosis.  Mice lacking caspase-1 do not show immune stimulation after treatment with Val-boroPro.  The data identify what is to the knowledge the first small mol. that induces pyroptosis and reveals a new checkpoint that controls the activation of the innate immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY7fE7Q7ygd7Vg90H21EOLACvtfcHk0liCbCnnbrYlkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSntLnM&md5=6e8e326aa107f0198d2817876d6d6cbd</span></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2229%26sid%3Dliteratum%253Aachs%26aulast%3DOkondo%26aufirst%3DM.%2BC.%26aulast%3DJohnson%26aufirst%3DD.%2BC.%26aulast%3DSridharan%26aufirst%3DR.%26aulast%3DGo%26aufirst%3DE.%2BB.%26aulast%3DChui%26aufirst%3DA.%2BJ.%26aulast%3DWang%26aufirst%3DM.%2BS.%26aulast%3DPoplawski%26aufirst%3DS.%2BE.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DJ.%2BH.%26aulast%3DSanford%26aufirst%3DD.%2BG.%26aulast%3DArciprete%26aufirst%3DM.%2BO.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26aulast%3DBachovchin%26aufirst%3DD.%2BA.%26atitle%3DDPP8%2520and%2520DPP9%2520inhibition%2520induces%2520pro-caspase-1-dependent%2520monocyte%2520and%2520macrophage%2520pyroptosis%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D13%26issue%3D1%26spage%3D46%26epage%3D53%26doi%3D10.1038%2Fnchembio.2229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref249"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref249'); return false;" data-citation="" class="refNumLink">249</a></strong><div class="NLM_citation" id="cit249"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okondo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taabazuing, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chui, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poplawski, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, D. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Dpp8/9 activates the Nlrp1b inflammasome</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">262</span>â <span class="NLM_lpage">267</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2017.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2017.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29396289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVShur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=262-267&issue=3&author=M.+C.+Okondoauthor=S.+D.+Raoauthor=C.+Y.+Taabazuingauthor=A.+J.+Chuiauthor=S.+E.+Poplawskiauthor=D.+C.+Johnsonauthor=D.+A.+Bachovchin&title=Inhibition+of+Dpp8%2F9+activates+the+Nlrp1b+inflammasome&doi=10.1016%2Fj.chembiol.2017.12.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit249R"><div class="casContent"><span class="casTitleNuber">249</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Dpp8/9 Activates the Nlrp1b Inflammasome</span></div><div class="casAuthors">Okondo, Marian C.; Rao, Sahana D.; Taabazuing, Cornelius Y.; Chui, Ashley J.; Poplawski, Sarah E.; Johnson, Darren C.; Bachovchin, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">262-267.e5</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Val-boroPro (PT-100, Talabostat) induces powerful anti-tumor immune responses in syngeneic cancer models, but its mechanism of action has not yet been established.  Val-boroPro is a non-selective inhibitor of post-proline-cleaving serine proteases, and the inhibition of the highly related cytosolic serine proteases Dpp8 and Dpp9 (Dpp8/9) by Val-boroPro was recently demonstrated to trigger an immunostimulatory form of programmed cell death known as pyroptosis selectively in monocytes and macrophages.  Here we show that Dpp8/9 inhibition activates the inflammasome sensor protein Nlrp1b, which in turn activates pro-caspase-1 to mediate pyroptosis.  This work reveals a previously unrecognized mechanism for activating an innate immune pattern recognition receptor and suggests that Dpp8/9 serve as an intracellular checkpoint to restrain Nlrp1b and the innate immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8tSVd3u86r7Vg90H21EOLACvtfcHk0liCbCnnbrYlkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVShur0%253D&md5=2a7d7e3d11918599e332c3e6beb1682f</span></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DOkondo%26aufirst%3DM.%2BC.%26aulast%3DRao%26aufirst%3DS.%2BD.%26aulast%3DTaabazuing%26aufirst%3DC.%2BY.%26aulast%3DChui%26aufirst%3DA.%2BJ.%26aulast%3DPoplawski%26aufirst%3DS.%2BE.%26aulast%3DJohnson%26aufirst%3DD.%2BC.%26aulast%3DBachovchin%26aufirst%3DD.%2BA.%26atitle%3DInhibition%2520of%2520Dpp8%252F9%2520activates%2520the%2520Nlrp1b%2520inflammasome%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2018%26volume%3D25%26issue%3D3%26spage%3D262%26epage%3D267%26doi%3D10.1016%2Fj.chembiol.2017.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref250"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref250'); return false;" data-citation="" class="refNumLink">250</a></strong><div class="NLM_citation" id="cit250"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taabazuing, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okondo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chui, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peguero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Stanchina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kentsis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, D. A.</span></span> <span> </span><span class="NLM_article-title">DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1151</span>â <span class="NLM_lpage">1156</span>, <span class="refDoi">Â DOI: 10.1038/s41591-018-0082-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41591-018-0082-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29967349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1OjsrfJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=1151-1156&issue=8&author=D.+C.+Johnsonauthor=C.+Y.+Taabazuingauthor=M.+C.+Okondoauthor=A.+J.+Chuiauthor=S.+D.+Raoauthor=F.+C.+Brownauthor=C.+Reedauthor=E.+Pegueroauthor=E.+de+Stanchinaauthor=A.+Kentsisauthor=D.+A.+Bachovchin&title=DPP8%2FDPP9+inhibitor-induced+pyroptosis+for+treatment+of+acute+myeloid+leukemia&doi=10.1038%2Fs41591-018-0082-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit250R"><div class="casContent"><span class="casTitleNuber">250</span><div class="casTitle"><span class="NLM_cas:atitle">DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia</span></div><div class="casAuthors">Johnson, Darren C.; Taabazuing, Cornelius Y.; Okondo, Marian C.; Chui, Ashley J.; Rao, Sahana D.; Brown, Fiona C.; Reed, Casie; Peguero, Elizabeth; de Stanchina, Elisa; Kentsis, Alex; Bachovchin, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1151-1156</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Small-mol. inhibitors of the serine dipeptidases DPP8 and DPP9 (DPP8/9) induce a lytic form of cell death called pyroptosis in mouse and human monocytes and macrophages1,2.  In mouse myeloid cells, Dpp8/9 inhibition activates the inflammasome sensor Nlrp1b, which in turn activates pro-caspase-1 to mediate cell death3, but the mechanism of DPP8/9 inhibitor-induced pyroptosis in human myeloid cells is not yet known.  Here we show that the CARD-contg. protein CARD8 mediates DPP8/9 inhibitor-induced pro-caspase-1-dependent pyroptosis in human myeloid cells.  We further show that DPP8/9 inhibitors induce pyroptosis in the majority of human acute myeloid leukemia (AML) cell lines and primary AML samples, but not in cells from many other lineages, and that these inhibitors inhibit human AML progression in mouse models.  Overall, this work identifies an activator of CARD8 in human cells and indicates that its activation by small-mol. DPP8/9 inhibitors represents a new potential therapeutic strategy for AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmCnNK2rgGy7Vg90H21EOLACvtfcHk0liNcrTc4lKsng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1OjsrfJ&md5=3b2cdc38848d4957b51e2db9ebc049ee</span></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=10.1038%2Fs41591-018-0082-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41591-018-0082-y%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BC.%26aulast%3DTaabazuing%26aufirst%3DC.%2BY.%26aulast%3DOkondo%26aufirst%3DM.%2BC.%26aulast%3DChui%26aufirst%3DA.%2BJ.%26aulast%3DRao%26aufirst%3DS.%2BD.%26aulast%3DBrown%26aufirst%3DF.%2BC.%26aulast%3DReed%26aufirst%3DC.%26aulast%3DPeguero%26aufirst%3DE.%26aulast%3Dde%2BStanchina%26aufirst%3DE.%26aulast%3DKentsis%26aufirst%3DA.%26aulast%3DBachovchin%26aufirst%3DD.%2BA.%26atitle%3DDPP8%252FDPP9%2520inhibitor-induced%2520pyroptosis%2520for%2520treatment%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DNat.%2520Med.%26date%3D2018%26volume%3D24%26issue%3D8%26spage%3D1151%26epage%3D1156%26doi%3D10.1038%2Fs41591-018-0082-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref251"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref251'); return false;" data-citation="" class="refNumLink">251</a></strong><div class="NLM_citation" id="cit251"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span> <span> </span><span class="NLM_article-title">Role of proteasomes modified by interferon-Î³ in antigen processing</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">571</span>â <span class="NLM_lpage">575</span>, <span class="refDoi">Â DOI: 10.1002/jlb.56.5.571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fjlb.56.5.571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=7964165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2cXmvFymtbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1994&pages=571-575&issue=5&author=K.+Tanaka&title=Role+of+proteasomes+modified+by+interferon-%CE%B3+in+antigen+processing&doi=10.1002%2Fjlb.56.5.571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">Role of proteasomes modified by interferon-Î³ in antigen processing</span></div><div class="casAuthors">Tanaka, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">571-5</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review with 31 refs. of the possible function of proteasomes in antigen processing with special ref. to the influence of interferon-Î³ on their function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI--bWlvkbibVg90H21EOLACvtfcHk0liNcrTc4lKsng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvFymtbg%253D&md5=4b225932ff9e7fb1fb67ebd9b8cf7444</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.1002%2Fjlb.56.5.571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlb.56.5.571%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DK.%26atitle%3DRole%2520of%2520proteasomes%2520modified%2520by%2520interferon-%25CE%25B3%2520in%2520antigen%2520processing%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D1994%26volume%3D56%26issue%3D5%26spage%3D571%26epage%3D575%26doi%3D10.1002%2Fjlb.56.5.571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref252"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref252'); return false;" data-citation="" class="refNumLink">252</a></strong><div class="NLM_citation" id="cit252"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimbara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichihara, A.</span></span> <span> </span><span class="NLM_article-title">Interferon-Î³ induces different subunit organizations and functional diversity of proteasomes</span>. <i>J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>115</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">257</span>â <span class="NLM_lpage">269</span>, <span class="refDoi">Â DOI: 10.1093/oxfordjournals.jbchem.a124327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1093%2Foxfordjournals.jbchem.a124327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8206875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2cXhs1WgsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1994&pages=257-269&issue=2&author=M.+Akiauthor=N.+Shimbaraauthor=M.+Takashinaauthor=K.+Akiyamaauthor=S.+Kagawaauthor=T.+Tamuraauthor=N.+Tanahashiauthor=T.+Yoshimuraauthor=K.+Tanakaauthor=A.+Ichihara&title=Interferon-%CE%B3+induces+different+subunit+organizations+and+functional+diversity+of+proteasomes&doi=10.1093%2Foxfordjournals.jbchem.a124327"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit252R"><div class="casContent"><span class="casTitleNuber">252</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon-Î³ induces different subunit organizations and functional diversity of proteasomes</span></div><div class="casAuthors">Aki, Masashi; Shimbara, Naoki; Takashina, Makoto; Akiyama, Kinya; Kagawa, Susumu; Tamura, Tomohiro; Tanahashi, Nobuyuki; Yoshimura, Tetsuro; Tanaka, Keiji; Ichihara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry </span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-69</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    </div><div class="casAbstract">To obtain information on the role of proteasomes in the immune system, the authors examd. the effect of a major immunomodulatory cytokine, gamma interferon (IFN-Î³), on the expressions, structures, and functions of proteasomes,.  IFN-Î³ greatly increased the levels of the mRNAs encoding LMP2 and LMP7, putative immuno-proteasome subunits encoded by genes within the class II MHC region, and these two subunits synthesized were assembled completely into the proteasomal multi-subunit complex in various types of human cells.  The subunit organization of the proteasome changed in response to IFN-Î³ stimulation, due to assembly of newly synthesized subunits through up- and down-expressions of at least 6 proteasome genes including LMP2/LMP7 without change in the structure of pre-existing proteasomes.  Interestingly, IFN-Î³ dramatically stimulated the trypsin-like and chymotrypsin-like activities of the multifunctional proteasome and depressed the peptidylglutamyl-peptide-hydrolyzing activity, without affecting the activity for ATP-, ubiquitin-dependent proteolysis.  These results indicate that IFN-Î³ modifies not only the structural organization of the proteasome, but also its functions.  Based on these findings, the authors discuss the role in the antigen processing/presentation pathway of proteasomes with functional diversity acquired through alteration of their subunit assembly in response to IFN-Î³ stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjnsqNQStGLLVg90H21EOLACvtfcHk0liuO2z52uePfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhs1WgsbY%253D&md5=68702387a6ac451dbe67180e99072afc</span></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.jbchem.a124327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.jbchem.a124327%26sid%3Dliteratum%253Aachs%26aulast%3DAki%26aufirst%3DM.%26aulast%3DShimbara%26aufirst%3DN.%26aulast%3DTakashina%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DK.%26aulast%3DKagawa%26aufirst%3DS.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DTanahashi%26aufirst%3DN.%26aulast%3DYoshimura%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DIchihara%26aufirst%3DA.%26atitle%3DInterferon-%25CE%25B3%2520induces%2520different%2520subunit%2520organizations%2520and%2520functional%2520diversity%2520of%2520proteasomes%26jtitle%3DJ.%2520Biochem.%26date%3D1994%26volume%3D115%26issue%3D2%26spage%3D257%26epage%3D269%26doi%3D10.1093%2Foxfordjournals.jbchem.a124327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref253"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref253'); return false;" data-citation="" class="refNumLink">253</a></strong><div class="NLM_citation" id="cit253"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span> <span> </span><span class="NLM_article-title">The immunoproteasome and thymoproteasome: functions, evolution and human disease</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">923</span>â <span class="NLM_lpage">931</span>, <span class="refDoi">Â DOI: 10.1038/s41590-018-0186-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41590-018-0186-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30104634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsV2itL7O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=923-931&issue=9&author=S.+Murataauthor=Y.+Takahamaauthor=M.+Kasaharaauthor=K.+Tanaka&title=The+immunoproteasome+and+thymoproteasome%3A+functions%2C+evolution+and+human+disease&doi=10.1038%2Fs41590-018-0186-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit253R"><div class="casContent"><span class="casTitleNuber">253</span><div class="casTitle"><span class="NLM_cas:atitle">The immunoproteasome and thymoproteasome: functions, evolution and human disease</span></div><div class="casAuthors">Murata, Shigeo; Takahama, Yousuke; Kasahara, Masanori; Tanaka, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">923-931</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The basic principle of adaptive immunity is to strictly discriminate between self and non-self, and a central challenge to overcome is the enormous variety of pathogens that might be encountered.  In cell-mediated immunity, immunol. discernment takes place at a mol. or cellular level.  Central to both mechanisms of discernment is the generation of antigenic peptides assocd. with MHC class I mols., which is achieved by a proteolytic complex called the proteasome.  To adequately accomplish the discrimination between self and non-self that is essential for adaptive immunity and self-tolerance, two proteasome subtypes have evolved via gene duplication: the immunoproteasome and the thymoproteasome.  In this Review, we describe various aspects of these immunity-dedicated proteasomes, from their discovery to recent findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNchyXJLQcFLVg90H21EOLACvtfcHk0liuO2z52uePfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsV2itL7O&md5=190f16d0da1875cdc25d67d539aa7d1c</span></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.1038%2Fs41590-018-0186-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41590-018-0186-z%26sid%3Dliteratum%253Aachs%26aulast%3DMurata%26aufirst%3DS.%26aulast%3DTakahama%26aufirst%3DY.%26aulast%3DKasahara%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DK.%26atitle%3DThe%2520immunoproteasome%2520and%2520thymoproteasome%253A%2520functions%252C%2520evolution%2520and%2520human%2520disease%26jtitle%3DNat.%2520Immunol.%26date%3D2018%26volume%3D19%26issue%3D9%26spage%3D923%26epage%3D931%26doi%3D10.1038%2Fs41590-018-0186-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref254"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref254'); return false;" data-citation="" class="refNumLink">254</a></strong><div class="NLM_citation" id="cit254"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heink, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloetzel, P.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KrÃ¼ger, E.</span></span> <span> </span><span class="NLM_article-title">IFN-Î³-induced immune adaptation of the proteasome system is an accelerated and transient response</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">9241</span>â <span class="NLM_lpage">9246</span>, <span class="refDoi">Â DOI: 10.1073/pnas.0501711102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.0501711102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15944226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvF2rsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=9241-9246&issue=26&author=S.+Heinkauthor=D.+Ludwigauthor=P.-M.+Kloetzelauthor=E.+Kr%C3%BCger&title=IFN-%CE%B3-induced+immune+adaptation+of+the+proteasome+system+is+an+accelerated+and+transient+response&doi=10.1073%2Fpnas.0501711102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit254R"><div class="casContent"><span class="casTitleNuber">254</span><div class="casTitle"><span class="NLM_cas:atitle">IFN-Î³-induced immune adaptation of the proteasome system is an accelerated and transient response</span></div><div class="casAuthors">Heink, Sylvia; Ludwig, Daniela; Kloetzel, Peter-M.; Krueger, Elke</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9241-9246</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Peptide generation by the proteasome is rate-limiting in MHC class I-restricted antigen presentation in response to IFN-Î³.  IFN-Î³-induced de novo formation of immunoproteasomes, therefore, essentially supports the rapid adjustment of the mammalian immune system.  Here, the authors report that the mol. interplay between the proteasome maturation protein (POMP) and the proteasomal Î²5i subunit low mol. wt. protein 7 (LMP7) has a key position in this immune adaptive program.  IFN-Î³-induced coincident biosynthesis of POMP and LMP7 and their direct interaction essentially accelerate immunoproteasome biogenesis compared with constitutive 205 proteasome assembly.  The dynamics of this process is detd. by rapid LMP7 activation and the immediate LMP7-dependent degrdn. of POMP.  Silencing of POMP expression impairs recruitment of both Î²5 subunits into the proteasome complex, resulting in decreased proteasome activity, reduced MHC class I surface expression, and induction of apoptosis.  Furthermore, the authors' data reveal that immunoproteasomes exhibit a considerably shortened half-life, compared with constitutive proteasomes.  In consequence, the authors' studies demonstrate that the cytokine-induced rapid immune adaptation of the proteasome system is a tightly regulated and transient response allowing cells to return rapidly to a normal situation once immunoproteasome function is no longer required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnpIGQGkl5ALVg90H21EOLACvtfcHk0liuO2z52uePfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvF2rsrw%253D&md5=b49c42d7ce4bf9ecc93f590c3b6af6b0</span></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0501711102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0501711102%26sid%3Dliteratum%253Aachs%26aulast%3DHeink%26aufirst%3DS.%26aulast%3DLudwig%26aufirst%3DD.%26aulast%3DKloetzel%26aufirst%3DP.-M.%26aulast%3DKr%25C3%25BCger%26aufirst%3DE.%26atitle%3DIFN-%25CE%25B3-induced%2520immune%2520adaptation%2520of%2520the%2520proteasome%2520system%2520is%2520an%2520accelerated%2520and%2520transient%2520response%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26issue%3D26%26spage%3D9241%26epage%3D9246%26doi%3D10.1073%2Fpnas.0501711102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref255"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref255'); return false;" data-citation="" class="refNumLink">255</a></strong><div class="NLM_citation" id="cit255"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaczynska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spies, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, A. L.</span></span> <span> </span><span class="NLM_article-title">Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>91</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">9213</span>, <span class="refDoi">Â DOI: 10.1073/pnas.91.20.9213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.91.20.9213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=7937744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2cXmvFylsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=9213&issue=20&author=M.+Gaczynskaauthor=K.+L.+Rockauthor=T.+Spiesauthor=A.+L.+Goldberg&title=Peptidase+activities+of+proteasomes+are+differentially+regulated+by+the+major+histocompatibility+complex-encoded+genes+for+LMP2+and+LMP7&doi=10.1073%2Fpnas.91.20.9213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit255R"><div class="casContent"><span class="casTitleNuber">255</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7</span></div><div class="casAuthors">Gaczynska, Maria; Rock, Kenneth L.; Spies, Thomas; Goldberg, Alfred L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9213-17</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Recent studies have implicated proteasomes in the generation of the antigenic peptides that are presented on major histocompatibility complex class I mols. to T lymphocytes.  Interferon Î³ modifies the subunit compn. of proteasomes and causes changes in their peptidase activities that should favor the prodn. of peptides with hydrophobic or basic C-termini (i.e., the types found on major histocompatibility complex class I mols.).  It has been proposed that these changes in peptidase activity are due to incorporation into proteasomes of the major histocompatibility complex-encoded subunits LMP2 and -7, which are induced by interferon Î³.  Here the authors show by gene transfection into lymphoblasts or HeLa cells that LMP7 increases the capacity (Vmax) of 20S and 26S proteasomes to cleave peptides after hydrophobic and basic residues without affecting hydrolysis after acidic residues.  These changes depend on the amt. of LMP7 subunits incorporated into proteasomes.  Transfection of LMP2 reduced cleavage of peptides after acidic residues, increased hydrolysis after basic residues, and did not affect the hydrophobic activity.  Since the activity of the total proteasome population changed after incorporation of only small amts. of LMP2 or -7, these subunits must cause major alterations in peptidase activity.  Thus, their expression can account for the changes in proteasome activity induced by interferon Î³, and these findings lend further support to the proposed roles of LMPs in altering the nature of the peptides generated for antigen presentation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEzIhWjyVNBbVg90H21EOLACvtfcHk0lgJyuQ9pX7fVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvFylsbY%253D&md5=64402642f14d57b9ccb6929e4563890b</span></div><a href="/servlet/linkout?suffix=cit255&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.20.9213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.20.9213%26sid%3Dliteratum%253Aachs%26aulast%3DGaczynska%26aufirst%3DM.%26aulast%3DRock%26aufirst%3DK.%2BL.%26aulast%3DSpies%26aufirst%3DT.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26atitle%3DPeptidase%2520activities%2520of%2520proteasomes%2520are%2520differentially%2520regulated%2520by%2520the%2520major%2520histocompatibility%2520complex-encoded%2520genes%2520for%2520LMP2%2520and%2520LMP7%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26issue%3D20%26spage%3D9213%26doi%3D10.1073%2Fpnas.91.20.9213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref256"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref256'); return false;" data-citation="" class="refNumLink">256</a></strong><div class="NLM_citation" id="cit256"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaczynska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendil, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, K. L.</span></span> <span> </span><span class="NLM_article-title">Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-Î³-induced subunits LMP2 and LMP7</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span> (<span class="NLM_issue">29</span>),  <span class="NLM_fpage">17275</span>â <span class="NLM_lpage">17280</span>, <span class="refDoi">Â DOI: 10.1074/jbc.271.29.17275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.271.29.17275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8663318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK28XksFamt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=17275-17280&issue=29&author=M.+Gaczynskaauthor=A.+L.+Goldbergauthor=K.+Tanakaauthor=K.+B.+Hendilauthor=K.+L.+Rock&title=Proteasome+subunits+X+and+Y+alter+peptidase+activities+in+opposite+ways+to+the+interferon-%CE%B3-induced+subunits+LMP2+and+LMP7&doi=10.1074%2Fjbc.271.29.17275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit256R"><div class="casContent"><span class="casTitleNuber">256</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-Î³-induced subunits LMP2 and LMP7</span></div><div class="casAuthors">Gaczynska, Maria; Goldberg, Alfred L.; Tanaka, Keiji; Hendil, Klavs B.; Rock, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">17275-17280</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Most antigenic peptides presented on major histocompatibility complex class I mols. are generated by proteasomes.  Interferon-Î³, which stimulates antigen presentation, induces new proteasome Î²-subunits LMP2 and LMP7, which replace the homologous Î²-subunits Y (Î´) and X (Îµ).  As a result, the capacity of the proteasome to cleave model peptides increases after hydrophobic and basic residues and falls after acidic residues.  To clarify the function of these subunits, we examd. the effects of overexpressing subunits X (Î´) and Y (Îµ).  Transfection of the Y gene into HeLa cells stimulated the proteasomal cleavage after acidic residues without altering other peptidase activities.  This effect was proportional to the amt. of the Y subunits and opposite to the effect of its homolog, LMP2.  Y appears to promote cleavages after acidic residues.  Furthermore, in mutants lacking the LMP genes (in contrast to wild-type cells), interferon-Î³ treatment increased the proteasome content of Y subunits and enhanced postacidic cleavages.  Transfection with cDNA for the X subunit reduced hydrolysis after hydrophobic and basic residues, an effect opposite to transfection of LMP2 and LMP7.  Surprisingly, transfection of X increased the amts. not only of X, but also of Y, while decreasing LMP2 content.  Thus, the loss of the Y subunit upon interferon-Î³ treatment or LMP2 transfection accounts for the suppression of postacidic cleavages, and the loss of X contributes to the increased hydrolysis after hydrophobic and basic residues.  These adaptations should favor the prodn. of the kinds of peptides that are presented on major histocompatibility complex class I mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo117jG_lAOGbVg90H21EOLACvtfcHk0lgJyuQ9pX7fVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksFamt7g%253D&md5=69562a1c132dcf655b2345d85cdf7170</span></div><a href="/servlet/linkout?suffix=cit256&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.29.17275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.29.17275%26sid%3Dliteratum%253Aachs%26aulast%3DGaczynska%26aufirst%3DM.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DHendil%26aufirst%3DK.%2BB.%26aulast%3DRock%26aufirst%3DK.%2BL.%26atitle%3DProteasome%2520subunits%2520X%2520and%2520Y%2520alter%2520peptidase%2520activities%2520in%2520opposite%2520ways%2520to%2520the%2520interferon-%25CE%25B3-induced%2520subunits%2520LMP2%2520and%2520LMP7%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26issue%3D29%26spage%3D17275%26epage%3D17280%26doi%3D10.1074%2Fjbc.271.29.17275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref257"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref257'); return false;" data-citation="" class="refNumLink">257</a></strong><div class="NLM_citation" id="cit257"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bialy, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebstein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bech-Otschir, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SchrÃ¶ter, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prozorovski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rieger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuckelkorn, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aktas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloetzel, P.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KrÃ¼ger, E.</span></span> <span> </span><span class="NLM_article-title">Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">613</span>â <span class="NLM_lpage">624</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2010.07.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.cell.2010.07.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=20723761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVKhurzK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2010&pages=613-624&issue=4&author=U.+Seifertauthor=L.+P.+Bialyauthor=F.+Ebsteinauthor=D.+Bech-Otschirauthor=A.+Voigtauthor=F.+Schr%C3%B6terauthor=T.+Prozorovskiauthor=N.+Langeauthor=J.+Steffenauthor=M.+Riegerauthor=U.+Kuckelkornauthor=O.+Aktasauthor=P.-M.+Kloetzelauthor=E.+Kr%C3%BCger&title=Immunoproteasomes+preserve+protein+homeostasis+upon+interferon-induced+oxidative+stress&doi=10.1016%2Fj.cell.2010.07.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit257R"><div class="casContent"><span class="casTitleNuber">257</span><div class="casTitle"><span class="NLM_cas:atitle">Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress</span></div><div class="casAuthors">Seifert, Ulrike; Bialy, Lukasz P.; Ebstein, Frederic; Bech-Otschir, Dawadschargal; Voigt, Antje; Schroeter, Friederike; Prozorovski, Timour; Lange, Nicole; Steffen, Janos; Rieger, Melanie; Kuckelkorn, Ulrike; Aktas, Orhan; Kloetzel, Peter-M.; Krueger, Elke</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">613-624</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Interferon (IFN)-induced immunoproteasomes (i-proteasomes) have been assocd. with improved processing of major histocompatibility complex (MHC) class I antigens.  Here, we show that i-proteasomes function to protect cell viability under conditions of IFN-induced oxidative stress.  IFNs trigger the prodn. of reactive oxygen species, which induce protein oxidn. and the formation of nascent, oxidant-damaged proteins.  We find that the ubiquitylation machinery is concomitantly upregulated in response to IFNs, functioning to target defective ribosomal products (DRiPs) for degrdn. by i-proteasomes.  I-proteasome-deficiency in cells and in murine inflammation models results in the formation of aggresome-like induced structures and increased sensitivity to apoptosis.  Efficient clearance of these aggregates by the enhanced proteolytic activity of the i-proteasome is important for the preservation of cell viability upon IFN-induced oxidative stress.  Our findings suggest that rather than having a specific role in the prodn. of class I antigens, i-proteasomes increase the peptide supply for antigen presentation as part of a more general role in the maintenance of protein homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrke2GhhFrNT7Vg90H21EOLACvtfcHk0libUZUIioxSDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVKhurzK&md5=62106a7fef1d42e8f50dc55f5938a097</span></div><a href="/servlet/linkout?suffix=cit257&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DSeifert%26aufirst%3DU.%26aulast%3DBialy%26aufirst%3DL.%2BP.%26aulast%3DEbstein%26aufirst%3DF.%26aulast%3DBech-Otschir%26aufirst%3DD.%26aulast%3DVoigt%26aufirst%3DA.%26aulast%3DSchr%25C3%25B6ter%26aufirst%3DF.%26aulast%3DProzorovski%26aufirst%3DT.%26aulast%3DLange%26aufirst%3DN.%26aulast%3DSteffen%26aufirst%3DJ.%26aulast%3DRieger%26aufirst%3DM.%26aulast%3DKuckelkorn%26aufirst%3DU.%26aulast%3DAktas%26aufirst%3DO.%26aulast%3DKloetzel%26aufirst%3DP.-M.%26aulast%3DKr%25C3%25BCger%26aufirst%3DE.%26atitle%3DImmunoproteasomes%2520preserve%2520protein%2520homeostasis%2520upon%2520interferon-induced%2520oxidative%2520stress%26jtitle%3DCell%26date%3D2010%26volume%3D142%26issue%3D4%26spage%3D613%26epage%3D624%26doi%3D10.1016%2Fj.cell.2010.07.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref258"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref258'); return false;" data-citation="" class="refNumLink">258</a></strong><div class="NLM_citation" id="cit258"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van Deventer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neefjes, J.</span></span> <span> </span><span class="NLM_article-title">The immunoproteasome cleans up after inflammation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">517</span>â <span class="NLM_lpage">518</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2010.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.cell.2010.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=20723753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVKhur%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2010&pages=517-518&issue=4&author=S.+van+Deventerauthor=J.+Neefjes&title=The+immunoproteasome+cleans+up+after+inflammation&doi=10.1016%2Fj.cell.2010.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit258R"><div class="casContent"><span class="casTitleNuber">258</span><div class="casTitle"><span class="NLM_cas:atitle">The Immunoproteasome Cleans up after Inflammation</span></div><div class="casAuthors">van Deventer, Sjoerd; Neefjes, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">517-518</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Immune cells and cells activated by the inflammatory cytokine interferon express variant proteasomes called immunoproteasomes that are characterized by unique catalytic subunits.  Other labs now show in mouse models of inflammatory disease that immunoproteasomes help prevent the accumulation of harmful protein aggregates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZbEDrXg6XobVg90H21EOLACvtfcHk0libUZUIioxSDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVKhur%252FL&md5=c1037c8fdb79e3b7bf865b6bbdf98f0a</span></div><a href="/servlet/linkout?suffix=cit258&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.08.002%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDeventer%26aufirst%3DS.%26aulast%3DNeefjes%26aufirst%3DJ.%26atitle%3DThe%2520immunoproteasome%2520cleans%2520up%2520after%2520inflammation%26jtitle%3DCell%26date%3D2010%26volume%3D142%26issue%3D4%26spage%3D517%26epage%3D518%26doi%3D10.1016%2Fj.cell.2010.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref259"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref259'); return false;" data-citation="" class="refNumLink">259</a></strong><div class="NLM_citation" id="cit259"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mundt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muchamuel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groettrup, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">226</span>â <span class="NLM_lpage">238</span>, <span class="refDoi">Â DOI: 10.1002/emmm.201303543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Femmm.201303543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24399752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWkur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=226-238&issue=2&author=M.+Baslerauthor=S.+Mundtauthor=T.+Muchamuelauthor=C.+Mollauthor=J.+Jiangauthor=M.+Groettrupauthor=C.+J.+Kirk&title=Inhibition+of+the+immunoproteasome+ameliorates+experimental+autoimmune+encephalomyelitis&doi=10.1002%2Femmm.201303543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit259R"><div class="casContent"><span class="casTitleNuber">259</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis</span></div><div class="casAuthors">Basler, Michael; Mundt, Sarah; Muchamuel, Tony; Moll, Carlo; Jiang, Jing; Groettrup, Marcus; Kirk, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-238</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Multiple sclerosis (MS) is a chronic demyelinating immune mediated disease of the central nervous system.  The immunoproteasome is a distinct class of proteasomes found predominantly in monocytes and lymphocytes.  Recently, we demonstrated a novel function of immunoproteasomes in cytokine prodn. and T cell differentiation.  In this study, we investigated the therapeutic efficacy of an inhibitor of the immunoproteasome (ONX 0914) in two different mouse models of MS.  ONX 0914 attenuated disease progression after active and passive induction of exptl. autoimmune encephalomyelitis (EAE), both in MOG35-55 and PLP139-151-induced EAE.  Isolation of lymphocytes from the brain or spinal cord revealed a strong redn. of cytokine-producing CD4+ cells in ONX 0914 treated mice.  Addnl., ONX 0914 treatment prevented disease exacerbation in a relapsing-remitting model.  An anal. of draining lymph nodes after induction of EAE revealed that the differentiation to Th17 or Th1 cells was strongly impaired in ONX 0914 treated mice.  These results implicate the immunoproteasome in the development of EAE and suggest that immunoproteasome inhibitors are promising drugs for the treatment of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7NZVATJbqxLVg90H21EOLACvtfcHk0libUZUIioxSDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWkur4%253D&md5=b092b6f79d66e9bcc23c4477cce19a67</span></div><a href="/servlet/linkout?suffix=cit259&amp;dbid=16384&amp;doi=10.1002%2Femmm.201303543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201303543%26sid%3Dliteratum%253Aachs%26aulast%3DBasler%26aufirst%3DM.%26aulast%3DMundt%26aufirst%3DS.%26aulast%3DMuchamuel%26aufirst%3DT.%26aulast%3DMoll%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DGroettrup%26aufirst%3DM.%26aulast%3DKirk%26aufirst%3DC.%2BJ.%26atitle%3DInhibition%2520of%2520the%2520immunoproteasome%2520ameliorates%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2014%26volume%3D6%26issue%3D2%26spage%3D226%26epage%3D238%26doi%3D10.1002%2Femmm.201303543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref260"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref260'); return false;" data-citation="" class="refNumLink">260</a></strong><div class="NLM_citation" id="cit260"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span> <span> </span><span class="NLM_article-title">A set of activity-based probes to visualize human (immuno)proteasome activities</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">4199</span>â <span class="NLM_lpage">4203</span>, <span class="refDoi">Â DOI: 10.1002/anie.201509092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fanie.201509092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCntLbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=4199-4203&issue=13&author=G.+de+Bruinauthor=B.+T.+Xinauthor=M.+Krausauthor=M.+van+der%0ASteltauthor=G.+A.+van+der+Marelauthor=A.+F.+Kisselevauthor=C.+Driessenauthor=B.+I.+Floreaauthor=H.+S.+Overkleeft&title=A+set+of+activity-based+probes+to+visualize+human+%28immuno%29proteasome+activities&doi=10.1002%2Fanie.201509092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit260R"><div class="casContent"><span class="casTitleNuber">260</span><div class="casTitle"><span class="NLM_cas:atitle">A set of activity-based probes to visualize human (immuno)proteasome activities</span></div><div class="casAuthors">de Bruin, Gerjan; Xin, Bo Tao; Kraus, Marianne; van der Stelt, Mario; van der Marel, Gijsbert A.; Kisselev, Alexei F.; Driessen, Christoph; Florea, Bogdan I.; Overkleeft, Herman S.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4199-4203</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Proteasomes are therapeutic targets for various cancers and autoimmune diseases.  Constitutively expressed proteasomes have three active sites, Î²1c, Î²2c, and Î²5c.  Lymphoid tissues also express the immunoproteasome subunits Î²1i, Î²2i, and Î²5i.  Rapid and simultaneous measurement of the activity of these catalytic subunits would assist in the discovery of new inhibitors, improve anal. of proteasome inhibitors in clin. trials, and simplify anal. of subunit expression.  In this work, we present a cocktail of activity-based probes that enables simultaneous gel-based detection of all six catalytic human proteasome subunits.  We used this cocktail to develop specific inhibitors for Î²1c, Î²2c, Î²5c, and Î²2i, to compare the active-site specificity of clin. proteasome inhibitors, and to demonstrate that many hematol. malignancies predominantly express immunoproteasomes.  Furthermore, we show that selective and complete inhibition of Î²5i and Î²1i is cytotoxic to primary cells from acute lymphocytic leukemia (ALL) patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrebn-jSmyOmLVg90H21EOLACvtfcHk0libUZUIioxSDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCntLbJ&md5=b04c6ea92827f327395fc313444e5126</span></div><a href="/servlet/linkout?suffix=cit260&amp;dbid=16384&amp;doi=10.1002%2Fanie.201509092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201509092%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBruin%26aufirst%3DG.%26aulast%3DXin%26aufirst%3DB.%2BT.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DDriessen%26aufirst%3DC.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DA%2520set%2520of%2520activity-based%2520probes%2520to%2520visualize%2520human%2520%2528immuno%2529proteasome%2520activities%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26issue%3D13%26spage%3D4199%26epage%3D4203%26doi%3D10.1002%2Fanie.201509092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref261"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref261'); return false;" data-citation="" class="refNumLink">261</a></strong><div class="NLM_citation" id="cit261"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, B.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rooden, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Ayed, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of Î²1i or Î²5i specific inhibitors of human immunoproteasomes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">6197</span>â <span class="NLM_lpage">6209</span>, <span class="refDoi">Â DOI: 10.1021/jm500716s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500716s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFajtr7L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6197-6209&issue=14&author=G.+de+Bruinauthor=E.+M.+Huberauthor=B.-T.+Xinauthor=E.+J.+van+Roodenauthor=K.+Al-Ayedauthor=K.-B.+Kimauthor=A.+F.+Kisselevauthor=C.+Driessenauthor=M.+van+der+Steltauthor=G.+A.+van+der+Marelauthor=M.+Grollauthor=H.+S.+Overkleeft&title=Structure-based+design+of+%CE%B21i+or+%CE%B25i+specific+inhibitors+of+human+immunoproteasomes&doi=10.1021%2Fjm500716s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit261R"><div class="casContent"><span class="casTitleNuber">261</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Î²1i or Î²5i Specific Inhibitors of Human Immunoproteasomes</span></div><div class="casAuthors">de Bruin, Gerjan; Huber, Eva M.; Xin, Bo-Tao; van Rooden, Eva J.; Al-Ayed, Karol; Kim, Kyung-Bo; Kisselev, Alexei F.; Driessen, Christoph; van der Stelt, Mario; van der Marel, Gijsbert A.; Groll, Michael; Overkleeft, Herman S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6197-6209</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mammalian genomes encode seven catalytic proteasome subunits, namely, Î²1c, Î²2c, Î²5c (assembled into constitutive 20S proteasome core particles), Î²1i, Î²2i, Î²5i (incorporated into immunoproteasomes), and the thymoproteasome-specific subunit Î²5t.  Extensive research in the past decades has yielded numerous potent proteasome inhibitors including compds. currently used in the clinic to treat multiple myeloma and mantle cell lymphoma.  Proteasome inhibitors that selectively target combinations of Î²1c/Î²1i, Î²2c/Î²2i, or Î²5c/Î²5i are available, yet ligands truly selective for a single proteasome activity are scarce.  The authors report the development of cell-permeable Î²1i and Î²5i selective inhibitors that outperform existing leads in terms of selectivity and/or potency.  These compds. are the result of a rational design strategy using known inhibitors as starting points and introducing structural features according to the x-ray structures of the murine constitutive and immunoproteasome 20S core particles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojHorcgmi4YLVg90H21EOLACvtfcHk0lhcPsCRAW_CIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFajtr7L&md5=d8ce36059ee0381966e9a6d4cf080c18</span></div><a href="/servlet/linkout?suffix=cit261&amp;dbid=16384&amp;doi=10.1021%2Fjm500716s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500716s%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBruin%26aufirst%3DG.%26aulast%3DHuber%26aufirst%3DE.%2BM.%26aulast%3DXin%26aufirst%3DB.-T.%26aulast%3Dvan%2BRooden%26aufirst%3DE.%2BJ.%26aulast%3DAl-Ayed%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DK.-B.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DDriessen%26aufirst%3DC.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DStructure-based%2520design%2520of%2520%25CE%25B21i%2520or%2520%25CE%25B25i%2520specific%2520inhibitors%2520of%2520human%2520immunoproteasomes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D14%26spage%3D6197%26epage%3D6209%26doi%3D10.1021%2Fjm500716s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref262"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref262'); return false;" data-citation="" class="refNumLink">262</a></strong><div class="NLM_citation" id="cit262"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwab, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemeyer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groettrup, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span> <span> </span><span class="NLM_article-title">Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>148</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">727</span>â <span class="NLM_lpage">738</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2011.12.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.cell.2011.12.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22341445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtV2qsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=727-738&issue=4&author=E.+M.+Huberauthor=M.+Baslerauthor=R.+Schwabauthor=W.+Heinemeyerauthor=C.+J.+Kirkauthor=M.+Groettrupauthor=M.+Groll&title=Immuno-+and+constitutive+proteasome+crystal+structures+reveal+differences+in+substrate+and+inhibitor+specificity&doi=10.1016%2Fj.cell.2011.12.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit262R"><div class="casContent"><span class="casTitleNuber">262</span><div class="casTitle"><span class="NLM_cas:atitle">Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity</span></div><div class="casAuthors">Huber, Eva M.; Basler, Michael; Schwab, Ricarda; Heinemeyer, Wolfgang; Kirk, Christopher J.; Groettrup, Marcus; Groll, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">727-738</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Constitutive proteasomes and immunoproteasomes shape the peptide repertoire presented by major histocompatibility complex class I (MHC-I) mols. by harboring different sets of catalytically active subunits.  Here, we present the crystal structures of constitutive proteasomes and immunoproteasomes from mouse in the presence and absence of the epoxyketone inhibitor PR-957 (ONX 0914) at 2.9 Ã resoln.  Based on our X-ray data, we propose a unique catalytic feature for the immunoproteasome subunit Î²5i/LMP7.  Comparison of ligand-free and ligand-bound proteasomes reveals conformational changes in the S1 pocket of Î²5c/X but not Î²5i, thereby explaining the selectivity of PR-957 for Î²5i.  Time-resolved structures of yeast proteasome:PR-957 complexes indicate that ligand docking to the active site occurs only via the reactive head group and the P1 side chain.  Together, our results support structure-guided design of inhibitory lead structures selective for immunoproteasomes that are linked to cytokine prodn. and diseases like cancer and autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2OWN02GZMFbVg90H21EOLACvtfcHk0lhcPsCRAW_CIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtV2qsL8%253D&md5=ee9f24ec6a0720808e4baf27bf87fcad</span></div><a href="/servlet/linkout?suffix=cit262&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.12.030%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DE.%2BM.%26aulast%3DBasler%26aufirst%3DM.%26aulast%3DSchwab%26aufirst%3DR.%26aulast%3DHeinemeyer%26aufirst%3DW.%26aulast%3DKirk%26aufirst%3DC.%2BJ.%26aulast%3DGroettrup%26aufirst%3DM.%26aulast%3DGroll%26aufirst%3DM.%26atitle%3DImmuno-%2520and%2520constitutive%2520proteasome%2520crystal%2520structures%2520reveal%2520differences%2520in%2520substrate%2520and%2520inhibitor%2520specificity%26jtitle%3DCell%26date%3D2012%26volume%3D148%26issue%3D4%26spage%3D727%26epage%3D738%26doi%3D10.1016%2Fj.cell.2011.12.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref263"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref263'); return false;" data-citation="" class="refNumLink">263</a></strong><div class="NLM_citation" id="cit263"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muchamuel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aujay, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalim, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylvain, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shields, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shwonek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demo, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groettrup, M.</span></span> <span> </span><span class="NLM_article-title">A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">781</span>â <span class="NLM_lpage">787</span>, <span class="refDoi">Â DOI: 10.1038/nm.1978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnm.1978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19525961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1ShtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=781-787&issue=7&author=T.+Muchamuelauthor=M.+Baslerauthor=M.+A.+Aujayauthor=E.+Suzukiauthor=K.+W.+Kalimauthor=C.+Lauerauthor=C.+Sylvainauthor=E.+R.+Ringauthor=J.+Shieldsauthor=J.+Jiangauthor=P.+Shwonekauthor=F.+Parlatiauthor=S.+D.+Demoauthor=M.+K.+Bennettauthor=C.+J.+Kirkauthor=M.+Groettrup&title=A+selective+inhibitor+of+the+immunoproteasome+subunit+LMP7+blocks+cytokine+production+and+attenuates+progression+of+experimental+arthritis&doi=10.1038%2Fnm.1978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit263R"><div class="casContent"><span class="casTitleNuber">263</span><div class="casTitle"><span class="NLM_cas:atitle">A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis</span></div><div class="casAuthors">Muchamuel, Tony; Basler, Michael; Aujay, Monette A.; Suzuki, Erika; Kalim, Khalid W.; Lauer, Christoph; Sylvain, Catherine; Ring, Eileen R.; Shields, Jamie; Jiang, Jing; Shwonek, Peter; Parlati, Francesco; Demo, Susan D.; Bennett, Mark K.; Kirk, Christopher J.; Groettrup, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">781-787</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The immunoproteasome, a distinct class of proteasome found predominantly in monocytes and lymphocytes, is known to shape the antigenic repertoire presented on class I major histocompatibility complexes (MHC-I).  However, a specific role for the immunoproteasome in regulating other facets of immune responses has not been established.  The authors describe here the characterization of PR-957, a selective inhibitor of low-mol. mass polypeptide-7 (LMP7, encoded by Psmb8), the chymotrypsin-like subunit of the immunoproteasome.  PR-957 blocked presentation of LMP7-specific, MHC-I-restricted antigens in vitro and in vivo.  Selective inhibition of LMP7 by PR-957 blocked prodn. of interleukin-23 (IL-23) by activated monocytes and interferon-Î³ and IL-2 by T cells.  In mouse models of rheumatoid arthritis, PR-957 treatment reversed signs of disease and resulted in redns. in cellular infiltration, cytokine prodn. and autoantibody levels.  These studies reveal a unique role for LMP7 in controlling pathogenic immune responses and provide a therapeutic rationale for targeting LMP7 in autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJsuXHN4oyBbVg90H21EOLACvtfcHk0lhGUWZ41Zdubg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1ShtLs%253D&md5=3961ba1ec6786d0318bfa2b64e5e7cfa</span></div><a href="/servlet/linkout?suffix=cit263&amp;dbid=16384&amp;doi=10.1038%2Fnm.1978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1978%26sid%3Dliteratum%253Aachs%26aulast%3DMuchamuel%26aufirst%3DT.%26aulast%3DBasler%26aufirst%3DM.%26aulast%3DAujay%26aufirst%3DM.%2BA.%26aulast%3DSuzuki%26aufirst%3DE.%26aulast%3DKalim%26aufirst%3DK.%2BW.%26aulast%3DLauer%26aufirst%3DC.%26aulast%3DSylvain%26aufirst%3DC.%26aulast%3DRing%26aufirst%3DE.%2BR.%26aulast%3DShields%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DShwonek%26aufirst%3DP.%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DDemo%26aufirst%3DS.%2BD.%26aulast%3DBennett%26aufirst%3DM.%2BK.%26aulast%3DKirk%26aufirst%3DC.%2BJ.%26aulast%3DGroettrup%26aufirst%3DM.%26atitle%3DA%2520selective%2520inhibitor%2520of%2520the%2520immunoproteasome%2520subunit%2520LMP7%2520blocks%2520cytokine%2520production%2520and%2520attenuates%2520progression%2520of%2520experimental%2520arthritis%26jtitle%3DNat.%2520Med.%26date%3D2009%26volume%3D15%26issue%3D7%26spage%3D781%26epage%3D787%26doi%3D10.1038%2Fnm.1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref264"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref264'); return false;" data-citation="" class="refNumLink">264</a></strong><div class="NLM_citation" id="cit264"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, H. W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderl, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muchamuel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moebius, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMinn, D. L.</span></span> <span> </span><span class="NLM_article-title">Required immunoproteasome subunit inhibition profile for anti-inflammatory efficacy and clinical candidate KZR-616 ((2S,3R)-N-((S)-3-(Cyclopent-1-en-1-yl)-1-((R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propenamide)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">11127</span>â <span class="NLM_lpage">11143</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b01201</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01201" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVKltLfF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11127-11143&issue=24&author=H.+W.+B.+Johnsonauthor=E.+Loweauthor=J.+L.+Anderlauthor=A.+Fanauthor=T.+Muchamuelauthor=S.+Bowersauthor=D.+C.+Moebiusauthor=C.+Kirkauthor=D.+L.+McMinn&title=Required+immunoproteasome+subunit+inhibition+profile+for+anti-inflammatory+efficacy+and+clinical+candidate+KZR-616+%28%282S%2C3R%29-N-%28%28S%29-3-%28Cyclopent-1-en-1-yl%29-1-%28%28R%29-2-methyloxiran-2-yl%29-1-oxopropan-2-yl%29-3-hydroxy-3-%284-methoxyphenyl%29-2-%28%28S%29-2-%282-morpholinoacetamido%29propanamido%29propenamide%29&doi=10.1021%2Facs.jmedchem.8b01201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit264R"><div class="casContent"><span class="casTitleNuber">264</span><div class="casTitle"><span class="NLM_cas:atitle">Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2S,3R)-N-((S)-3-(Cyclopent-1-en-1-yl)-1-((R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propenamide)</span></div><div class="casAuthors">Johnson, Henry W. B.; Lowe, Eric; Anderl, Janet L.; Fan, Andrea; Muchamuel, Tony; Bowers, Simeon; Moebius, David C.; Kirk, Christopher; McMinn, Dustin L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11127-11143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective immunoproteasome inhibition is a promising approach for treating autoimmune disorders, but optimal proteolytic active site subunit inhibition profiles remain unknown.  We reveal here our design of peptide epoxyketone-based selective low mol. mass polypeptide-7 (LMP7) and multicatalytic endopeptidase complex subunit-1 (MECL-1) subunit inhibitors.  Utilizing these and our previously disclosed low mol. mass polypeptide-2 (LMP2) inhibitor, we demonstrate a requirement of dual LMP7/LMP2 or LMP7/MECL-1 subunit inhibition profiles for potent cytokine expression inhibition and in vivo efficacy in an inflammatory disease model.  These and addnl. findings toward optimized soly. led the design and selection of KZR-616 disclosed here and presently in clin. trials for treatment of rheumatic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNq1pg3kpVXrVg90H21EOLACvtfcHk0lhGUWZ41Zdubg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVKltLfF&md5=70170b636fbb858edda5f571af45ca7f</span></div><a href="/servlet/linkout?suffix=cit264&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01201%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DH.%2BW.%2BB.%26aulast%3DLowe%26aufirst%3DE.%26aulast%3DAnderl%26aufirst%3DJ.%2BL.%26aulast%3DFan%26aufirst%3DA.%26aulast%3DMuchamuel%26aufirst%3DT.%26aulast%3DBowers%26aufirst%3DS.%26aulast%3DMoebius%26aufirst%3DD.%2BC.%26aulast%3DKirk%26aufirst%3DC.%26aulast%3DMcMinn%26aufirst%3DD.%2BL.%26atitle%3DRequired%2520immunoproteasome%2520subunit%2520inhibition%2520profile%2520for%2520anti-inflammatory%2520efficacy%2520and%2520clinical%2520candidate%2520KZR-616%2520%2528%25282S%252C3R%2529-N-%2528%2528S%2529-3-%2528Cyclopent-1-en-1-yl%2529-1-%2528%2528R%2529-2-methyloxiran-2-yl%2529-1-oxopropan-2-yl%2529-3-hydroxy-3-%25284-methoxyphenyl%2529-2-%2528%2528S%2529-2-%25282-morpholinoacetamido%2529propanamido%2529propenamide%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D24%26spage%3D11127%26epage%3D11143%26doi%3D10.1021%2Facs.jmedchem.8b01201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref265"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref265'); return false;" data-citation="" class="refNumLink">265</a></strong><div class="NLM_citation" id="cit265"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muchamuel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderl, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, H. W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, E.</span></span> <span> </span><span class="NLM_article-title">FRI0296 Kzr-616, a selective inhibitor of the immunoproteasome, blocks the disease progression in multiple models of systemic lupus erythematosus (SLE)</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">685</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2018&pages=685&author=T.+Muchamuelauthor=J.+L.+Anderlauthor=R.+A.+Fanauthor=H.+W.+B.+Johnsonauthor=C.+J.+Kirkauthor=E.+Lowe&title=FRI0296+Kzr-616%2C+a+selective+inhibitor+of+the+immunoproteasome%2C+blocks+the+disease+progression+in+multiple+models+of+systemic+lupus+erythematosus+%28SLE%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit265&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuchamuel%26aufirst%3DT.%26aulast%3DAnderl%26aufirst%3DJ.%2BL.%26aulast%3DFan%26aufirst%3DR.%2BA.%26aulast%3DJohnson%26aufirst%3DH.%2BW.%2BB.%26aulast%3DKirk%26aufirst%3DC.%2BJ.%26aulast%3DLowe%26aufirst%3DE.%26atitle%3DFRI0296%2520Kzr-616%252C%2520a%2520selective%2520inhibitor%2520of%2520the%2520immunoproteasome%252C%2520blocks%2520the%2520disease%2520progression%2520in%2520multiple%2520models%2520of%2520systemic%2520lupus%2520erythematosus%2520%2528SLE%2529%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2018%26volume%3D77%26spage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref266"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref266'); return false;" data-citation="" class="refNumLink">266</a></strong><div class="NLM_citation" id="cit266"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, H. W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderl, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arastu-Kapur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moebius, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muchamuel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMinn, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly selective inhibitors of the immunoproteasome low molecular mass polypeptide 2 (LMP2) subunit</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">413</span>â <span class="NLM_lpage">417</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.6b00496</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00496" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVahtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=413-417&issue=4&author=H.+W.+B.+Johnsonauthor=J.+L.+Anderlauthor=E.+K.+Bradleyauthor=J.+Buiauthor=J.+Jonesauthor=S.+Arastu-Kapurauthor=L.+M.+Kellyauthor=E.+Loweauthor=D.+C.+Moebiusauthor=T.+Muchamuelauthor=C.+Kirkauthor=Z.+Wangauthor=D.+McMinn&title=Discovery+of+highly+selective+inhibitors+of+the+immunoproteasome+low+molecular+mass+polypeptide+2+%28LMP2%29+subunit&doi=10.1021%2Facsmedchemlett.6b00496"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit266R"><div class="casContent"><span class="casTitleNuber">266</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit</span></div><div class="casAuthors">Johnson, Henry W. B.; Anderl, Janet L.; Bradley, Erin K.; Bui, John; Jones, Jeffrey; Arastu-Kapur, Shirin; Kelly, Lisa M.; Lowe, Eric; Moebius, David C.; Muchamuel, Tony; Kirk, Christopher; Wang, Zhengping; McMinn, Dustin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">413-417</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Building upon the success of bortezomib (VELCADE) and carfilzomib (KYPROLIS), the design of a next generation of inhibitors targeting specific subunits within the immunoproteasome is of interest for the treatment of autoimmune disease.  There are three catalytic subunits within the immunoproteasome (low mol. mass polypeptide-7, -2, and multicatalytic endopeptidase complex subunit-1; LMP7, LMP2, and MECL-1), and a campaign was undertaken to design a potent and selective LMP2 inhibitor with sufficient properties to allow for sustained inhibition in vivo.  Screening a focused library of epoxyketones revealed a series of potent dipeptides that were optimized to provide the highly selective inhibitor KZR-504 (12).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL-9Mx7yA1VLVg90H21EOLACvtfcHk0lg2UWV3TNbWgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVahtLs%253D&md5=5abf3912c1dbcc6f77d271235c75b17c</span></div><a href="/servlet/linkout?suffix=cit266&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00496%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DH.%2BW.%2BB.%26aulast%3DAnderl%26aufirst%3DJ.%2BL.%26aulast%3DBradley%26aufirst%3DE.%2BK.%26aulast%3DBui%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DJ.%26aulast%3DArastu-Kapur%26aufirst%3DS.%26aulast%3DKelly%26aufirst%3DL.%2BM.%26aulast%3DLowe%26aufirst%3DE.%26aulast%3DMoebius%26aufirst%3DD.%2BC.%26aulast%3DMuchamuel%26aufirst%3DT.%26aulast%3DKirk%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DMcMinn%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520highly%2520selective%2520inhibitors%2520of%2520the%2520immunoproteasome%2520low%2520molecular%2520mass%2520polypeptide%25202%2520%2528LMP2%2529%2520subunit%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D4%26spage%3D413%26epage%3D417%26doi%3D10.1021%2Facsmedchemlett.6b00496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref267"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref267'); return false;" data-citation="" class="refNumLink">267</a></strong><div class="NLM_citation" id="cit267"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: Insights into specificity and potency</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">3335</span>â <span class="NLM_lpage">3340</span>, <span class="refDoi">Â DOI: 10.1016/S0960-894X(99)00612-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0960-894X%2899%2900612-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10612595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1MXotFSrsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=3335-3340&issue=23&author=K.+B.+Kimauthor=J.+Myungauthor=N.+Sinauthor=C.+M.+Crews&title=Proteasome+inhibition+by+the+natural+products+epoxomicin+and+dihydroeponemycin%3A+Insights+into+specificity+and+potency&doi=10.1016%2FS0960-894X%2899%2900612-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit267R"><div class="casContent"><span class="casTitleNuber">267</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency</span></div><div class="casAuthors">Kim, Kyung Bo; Myung, Jayhyuk; Sin, Ny; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3335-3340</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">While two structurally related epoxyketone-contg. antitumor natural products, epoxomicin and eponemycin, share the proteasome as a common intracellular target, they differ in their antiproliferative activity, proteasome subunit binding specificity, and rates of proteasome inhibition.  As a first step towards understanding such differences and developing novel proteasome subunit-specific inhibitors, the authors report here the synthesis and characterization of epoxomicin/dihydroeponemycin chimerae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdGLgLcWtf2bVg90H21EOLACvtfcHk0lg2UWV3TNbWgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFSrsLw%253D&md5=22d279a74a2c4051ee980f2f844be12b</span></div><a href="/servlet/linkout?suffix=cit267&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900612-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900612-5%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DMyung%26aufirst%3DJ.%26aulast%3DSin%26aufirst%3DN.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DProteasome%2520inhibition%2520by%2520the%2520natural%2520products%2520epoxomicin%2520and%2520dihydroeponemycin%253A%2520Insights%2520into%2520specificity%2520and%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26issue%3D23%26spage%3D3335%26epage%3D3340%26doi%3D10.1016%2FS0960-894X%2899%2900612-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref268"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref268'); return false;" data-citation="" class="refNumLink">268</a></strong><div class="NLM_citation" id="cit268"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bargagna-Mohan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehenkel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-B.</span></span> <span> </span><span class="NLM_article-title">LMP2-specific inhibitors: Chemical genetic tools for proteasome biology</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">419</span>â <span class="NLM_lpage">430</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2007.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2007.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17462577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslaitbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=419-430&issue=4&author=Y.+K.+Hoauthor=P.+Bargagna-Mohanauthor=M.+Wehenkelauthor=R.+Mohanauthor=K.-B.+Kim&title=LMP2-specific+inhibitors%3A+Chemical+genetic+tools+for+proteasome+biology&doi=10.1016%2Fj.chembiol.2007.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit268R"><div class="casContent"><span class="casTitleNuber">268</span><div class="casTitle"><span class="NLM_cas:atitle">LMP2-Specific Inhibitors: Chemical Genetic Tools for Proteasome Biology</span></div><div class="casAuthors">Ho, Yik Khuan; Bargagna-Mohan, Paola; Wehenkel, Marie; Mohan, Royce; Kim, Kyung-Bo</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-430</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The immunoproteasome, having been linked to neurodegenerative diseases and hematol. cancers, has been shown to play an important role in MHC class I antigen presentation.  However, its other pathophysiol. functions are still not very well understood.  This can be attributed mainly to a lack of appropriate mol. probes that can selectively modulate the immunoproteasome catalytic subunits.  Herein, the authors report the development of mol. probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome.  The authors show that these compds. irreversibly modify the LMP2 subunit with high specificity.  Importantly, LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.  Thus, the development of the immunoproteasome catalytic subunit LMP2-specific inhibitors may not only hold great potential as a therapeutic agent for certain diseases but can also provide a valuable chem. genetic probe to investigate immunoproteasome biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDvEUufIJ3K7Vg90H21EOLACvtfcHk0lg2UWV3TNbWgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslaitbY%253D&md5=d12fa5065f6bdd4aee8ad12491a1c072</span></div><a href="/servlet/linkout?suffix=cit268&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DY.%2BK.%26aulast%3DBargagna-Mohan%26aufirst%3DP.%26aulast%3DWehenkel%26aufirst%3DM.%26aulast%3DMohan%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DK.-B.%26atitle%3DLMP2-specific%2520inhibitors%253A%2520Chemical%2520genetic%2520tools%2520for%2520proteasome%2520biology%26jtitle%3DChem.%2520Biol.%26date%3D2007%26volume%3D14%26issue%3D4%26spage%3D419%26epage%3D430%26doi%3D10.1016%2Fj.chembiol.2007.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref269"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref269'); return false;" data-citation="" class="refNumLink">269</a></strong><div class="NLM_citation" id="cit269"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wehenkel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ban, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmony, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. B.</span></span> <span> </span><span class="NLM_article-title">A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>107</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">53</span>â <span class="NLM_lpage">62</span>, <span class="refDoi">Â DOI: 10.1038/bjc.2012.243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fbjc.2012.243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22677907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38Xptl2isbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=53-62&issue=1&author=M.+Wehenkelauthor=J.+O.+Banauthor=Y.+K.+Hoauthor=K.+C.+Carmonyauthor=J.+T.+Hongauthor=K.+B.+Kim&title=A+selective+inhibitor+of+the+immunoproteasome+subunit+LMP2+induces+apoptosis+in+PC-3+cells+and+suppresses+tumour+growth+in+nude+mice&doi=10.1038%2Fbjc.2012.243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit269R"><div class="casContent"><span class="casTitleNuber">269</span><div class="casTitle"><span class="NLM_cas:atitle">A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice</span></div><div class="casAuthors">Wehenkel, M.; Ban, J.-O.; Ho, Y.-K.; Carmony, K. C.; Hong, J. T.; Kim, K. B.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-62</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Although the proteasome is a validated anticancer target, the clin. application of its inhibitors has been limited because of inherent systemic toxicity.  To broaden clin. utility of proteasome inhibitors as anticancer agents, it is crit. to develop strategies to selectively target proteasomes in cancer cells.  The immunoproteasome is an alternative form of the constitutive proteasome that is expressed at high levels in cancer tissues, but not in most normal cells in the body.  Methods: To validate the immunoproteasome as a chemotherapeutic target, an immunoproteasome catalytic subunit LMP2-targeting inhibitor and siRNA were used.  The sensitivity of PC-3 prostate cancer cells to these reagents was investigated using viability assays.  Further, a xenograft model of prostate cancer was studied to test the in vivo effects of LMP2 inhibition.  Results: A small mol. inhibitor of the immunoproteasome subunit LMP2, UK-101, induced apoptosis of PC-3 cells and resulted in significant inhibition (â¼50-60%) of tumor growth in vivo.  Interestingly, UK-101 did not block degrdn. of IÎºBÎ± in PC-3 cells treated with TNF-Î±, suggesting that its mode of action may be different from that of general proteasome inhibitors, such as bortezomib, which block IÎºBÎ± degrdn.  Conclusion: These results strongly suggest that the immunoproteasome has important roles in cancer cell growth and thus provide a rationale for targeting the immunoproteasome in the treatment of prostate cancer.  British Journal of Cancer (2012) 107, 53-62. doi:10.1038/bjc.2012.243 www.bjcancer.com published online 7 June 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrLJQKXNlNKrVg90H21EOLACvtfcHk0ljjokk1zl3udQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xptl2isbk%253D&md5=59390ce6295216a78e584049754b2c03</span></div><a href="/servlet/linkout?suffix=cit269&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2012.243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2012.243%26sid%3Dliteratum%253Aachs%26aulast%3DWehenkel%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DJ.%2BO.%26aulast%3DHo%26aufirst%3DY.%2BK.%26aulast%3DCarmony%26aufirst%3DK.%2BC.%26aulast%3DHong%26aufirst%3DJ.%2BT.%26aulast%3DKim%26aufirst%3DK.%2BB.%26atitle%3DA%2520selective%2520inhibitor%2520of%2520the%2520immunoproteasome%2520subunit%2520LMP2%2520induces%2520apoptosis%2520in%2520PC-3%2520cells%2520and%2520suppresses%2520tumour%2520growth%2520in%2520nude%2520mice%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2012%26volume%3D107%26issue%3D1%26spage%3D53%26epage%3D62%26doi%3D10.1038%2Fbjc.2012.243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref270"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref270'); return false;" data-citation="" class="refNumLink">270</a></strong><div class="NLM_citation" id="cit270"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunsucker, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voorhees, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, R. Z.</span></span> <span> </span><span class="NLM_article-title">Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">4667</span>â <span class="NLM_lpage">4676</span>, <span class="refDoi">Â DOI: 10.1182/blood-2008-07-171637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1182%2Fblood-2008-07-171637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19050304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvVyqurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=4667-4676&issue=19&author=D.+J.+Kuhnauthor=S.+A.+Hunsuckerauthor=Q.+Chenauthor=P.+M.+Voorheesauthor=M.+Orlowskiauthor=R.+Z.+Orlowski&title=Targeted+inhibition+of+the+immunoproteasome+is+a+potent+strategy+against+models+of+multiple+myeloma+that+overcomes+resistance+to+conventional+drugs+and+nonspecific+proteasome+inhibitors&doi=10.1182%2Fblood-2008-07-171637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit270R"><div class="casContent"><span class="casTitleNuber">270</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors</span></div><div class="casAuthors">Kuhn, Deborah J.; Hunsucker, Sally A.; Chen, Qing; Voorhees, Peter M.; Orlowski, Marian; Orlowski, Robert Z.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4667-4676</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Proteasome inhibition is a validated strategy for therapy of multiple myeloma, but this disease remains challenging as relapses are common, and often assocd. with increasing chemoresistance.  Moreover, nonspecific proteasome inhibitors such as bortezomib can induce peripheral neuropathy and other toxicities that may compromise the ability to deliver therapy at full doses, thereby decreasing efficacy.  One novel approach may be to target the immunoproteasome, a proteasomal variant found predominantly in cells of hematopoietic origin that differs from the constitutive proteasome found in most other cell types.  Using purified prepns. of constitutive and immunoproteasomes, we screened a rationally designed series of peptidyl-aldehydes and identified several with relative specificity for the immunoproteasome.  The most potent immunoproteasome-specific inhibitor, IPSI-001, preferentially targeted the Î²1i subunit of the immunoproteasome in vitro and in cellulo in a dose-dependent manner.  This agent induced accumulation of ubiquitin-protein conjugates, proapoptotic proteins, and activated caspase-mediated apoptosis.  IPSI-001 potently inhibited proliferation in myeloma patient samples and other hematol. malignancies.  Importantly, IPSI-001 was able to overcome conventional and novel drug resistance, including resistance to bortezomib.  These findings provide a rationale for the translation of IPSIs to the clinic, where they may provide antimyeloma activity with greater specificity and less toxicity than current inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyFUysXTzcsrVg90H21EOLACvtfcHk0ljjokk1zl3udQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvVyqurk%253D&md5=6753f40ae6057eeadbbde2f6650828fc</span></div><a href="/servlet/linkout?suffix=cit270&amp;dbid=16384&amp;doi=10.1182%2Fblood-2008-07-171637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2008-07-171637%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DD.%2BJ.%26aulast%3DHunsucker%26aufirst%3DS.%2BA.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DVoorhees%26aufirst%3DP.%2BM.%26aulast%3DOrlowski%26aufirst%3DM.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26atitle%3DTargeted%2520inhibition%2520of%2520the%2520immunoproteasome%2520is%2520a%2520potent%2520strategy%2520against%2520models%2520of%2520multiple%2520myeloma%2520that%2520overcomes%2520resistance%2520to%2520conventional%2520drugs%2520and%2520nonspecific%2520proteasome%2520inhibitors%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26issue%3D19%26spage%3D4667%26epage%3D4676%26doi%3D10.1182%2Fblood-2008-07-171637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref271"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref271'); return false;" data-citation="" class="refNumLink">271</a></strong><div class="NLM_citation" id="cit271"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moebius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybylski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groettrup, M.</span></span> <span> </span><span class="NLM_article-title">Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>189</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1868</span>, <span class="refDoi">Â DOI: 10.4049/jimmunol.1103592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4049%2Fjimmunol.1103592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22772448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFaqsLrI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2012&pages=1868&issue=4&author=M.+Baslerauthor=C.+Lauerauthor=J.+Moebiusauthor=R.+Weberauthor=M.+Przybylskiauthor=A.+F.+Kisselevauthor=C.+Tsuauthor=M.+Groettrup&title=Why+the+structure+but+not+the+activity+of+the+immunoproteasome+subunit+low+molecular+mass+polypeptide+2+rescues+antigen+presentation&doi=10.4049%2Fjimmunol.1103592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit271R"><div class="casContent"><span class="casTitleNuber">271</span><div class="casTitle"><span class="NLM_cas:atitle">Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation</span></div><div class="casAuthors">Basler, Michael; Lauer, Christoph; Moebius, Jacqueline; Weber, Reinhold; Przybylski, Michael; Kisselev, Alexei F.; Tsu, Christopher; Groettrup, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1868-1877</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The proteasome is responsible for the generation of most epitopes presented on MHC class I mols.  Treatment of cells with IFN-Î³ leads to the replacement of the constitutive catalytic subunits Î²1, Î²2, and Î²5 by the inducible subunits low mol. mass polypeptide (LMP) 2 (Î²1i), multicatalytic endopeptidase complex-like-1 (Î²2i), and LMP7 (Î²5i), resp.  The incorporation of these subunits is required for the prodn. of numerous MHC class I-restricted T cell epitopes.  The structural features rather than the proteolytic activity of an immunoproteasome subunit are needed for the generation of some epitopes, but the underlying mechanisms have remained elusive.  Expts. with LMP2-deficient splenocytes revealed that the generation of the male HY-derived CTL-epitope UTY246-254 was dependent on LMP2.  Treatment of male splenocytes with an LMP2-selective inhibitor did not reduce UTY246-254 presentation, whereas silencing of Î²1 activity increased presentation of UTY246-254.  In vitro degrdn. expts. showed that the caspase-like activity of Î²1 was responsible for the destruction of this CTL epitope, whereas it was preserved when LMP2 replaced Î²1.  Moreover, inhibition of the Î²5 subunit rescued the presentation of the influenza matrix 58-66 epitope, thus suggesting that a similar mechanism can apply to the exchange of Î²5 by LMP7.  Taken together, our data provide a rationale why the structural property of an immunoproteasome subunit rather than its activity is required for the generation of a CTL epitope.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0j0BHHqtejLVg90H21EOLACvtfcHk0ljjokk1zl3udQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFaqsLrI&md5=ae63a6056e45a922f22534b5032c9e52</span></div><a href="/servlet/linkout?suffix=cit271&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1103592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1103592%26sid%3Dliteratum%253Aachs%26aulast%3DBasler%26aufirst%3DM.%26aulast%3DLauer%26aufirst%3DC.%26aulast%3DMoebius%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DR.%26aulast%3DPrzybylski%26aufirst%3DM.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DTsu%26aufirst%3DC.%26aulast%3DGroettrup%26aufirst%3DM.%26atitle%3DWhy%2520the%2520structure%2520but%2520not%2520the%2520activity%2520of%2520the%2520immunoproteasome%2520subunit%2520low%2520molecular%2520mass%2520polypeptide%25202%2520rescues%2520antigen%2520presentation%26jtitle%3DJ.%2520Immunol.%26date%3D2012%26volume%3D189%26issue%3D4%26spage%3D1868%26doi%3D10.4049%2Fjimmunol.1103592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref272"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref272'); return false;" data-citation="" class="refNumLink">272</a></strong><div class="NLM_citation" id="cit272"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werkhoven, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallastegui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmink, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span> <span> </span><span class="NLM_article-title">Peptido sulfonyl fluorides as new powerful proteasome inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">10995</span>â <span class="NLM_lpage">11003</span>, <span class="refDoi">Â DOI: 10.1021/jm301443r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301443r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslalurjE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10995-11003&issue=24&author=A.+J.+Brouwerauthor=A.+Jonkerauthor=P.+Werkhovenauthor=E.+Kuoauthor=N.+Liauthor=N.+Gallasteguiauthor=J.+Kemminkauthor=B.+I.+Floreaauthor=M.+Grollauthor=H.+S.+Overkleeftauthor=R.+M.+J.+Liskamp&title=Peptido+sulfonyl+fluorides+as+new+powerful+proteasome+inhibitors&doi=10.1021%2Fjm301443r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit272R"><div class="casContent"><span class="casTitleNuber">272</span><div class="casTitle"><span class="NLM_cas:atitle">Peptido sulfonyl fluorides as new powerful proteasome inhibitors</span></div><div class="casAuthors">Brouwer, Arwin J.; Jonker, Anika; Werkhoven, Paul; Kuo, Ethan; Li, Nan; Gallastegui, Nerea; Kemmink, Johan; Florea, Bogdan I.; Groll, Michael; Overkleeft, Herman S.; Liskamp, Rob M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10995-11003</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of potent proteasome inhibitors is described, of which the members contain an amino acid inspired sulfonyl fluoride as the electrophilic trap.  In total, 24 peptido sulfonyl fluoride inhibitors have been designed and synthesized, which were inspired by the backbone sequences of the proteasome inhibitors bortezomib, epoxomicin, and Cbz-Leu3-aldehyde.  Nine of them were very potent proteasome inhibitors, the best of which had an IC50 of 7 nM.  A no. of the peptido sulfonyl fluoride inhibitors were found to be highly selective for the Î²5 proteasome subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMpjkcOVPvyLVg90H21EOLACvtfcHk0lgvaFTM_dOLRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslalurjE&md5=e84873c90746c6642013c03b51b40bcf</span></div><a href="/servlet/linkout?suffix=cit272&amp;dbid=16384&amp;doi=10.1021%2Fjm301443r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301443r%26sid%3Dliteratum%253Aachs%26aulast%3DBrouwer%26aufirst%3DA.%2BJ.%26aulast%3DJonker%26aufirst%3DA.%26aulast%3DWerkhoven%26aufirst%3DP.%26aulast%3DKuo%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DGallastegui%26aufirst%3DN.%26aulast%3DKemmink%26aufirst%3DJ.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26atitle%3DPeptido%2520sulfonyl%2520fluorides%2520as%2520new%2520powerful%2520proteasome%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D24%26spage%3D10995%26epage%3D11003%26doi%3D10.1021%2Fjm301443r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref273"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref273'); return false;" data-citation="" class="refNumLink">273</a></strong><div class="NLM_citation" id="cit273"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubiella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gersch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KrÃ¼ger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of the immunoproteasome by ligand-induced crosslinking of the active site</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">11969</span>â <span class="NLM_lpage">11973</span>, <span class="refDoi">Â DOI: 10.1002/anie.201406964</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fanie.201406964" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOkurfM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=11969-11973&issue=44&author=C.+Dubiellaauthor=H.+Cuiauthor=M.+Gerschauthor=A.+J.+Brouwerauthor=S.+A.+Sieberauthor=A.+Kr%C3%BCgerauthor=R.+M.+J.+Liskampauthor=M.+Groll&title=Selective+inhibition+of+the+immunoproteasome+by+ligand-induced+crosslinking+of+the+active+site&doi=10.1002%2Fanie.201406964"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit273R"><div class="casContent"><span class="casTitleNuber">273</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of the Immunoproteasome by Ligand-Induced Crosslinking of the Active Site</span></div><div class="casAuthors">Dubiella, Christian; Cui, Haissi; Gersch, Malte; Brouwer, Arwin J.; Sieber, Stephan A.; Krueger, Achim; Liskamp, Rob M. J.; Groll, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">11969-11973</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The concept of proteasome inhibition ranks among the latest achievements in the treatment of blood cancer and represents a promising strategy for modulating autoimmune diseases.  In this study, we describe peptidic sulfonyl fluoride inhibitors that selectively block the catalytic Î²5 subunit of the immunoproteasome by inducing only marginal cytotoxic effects.  Structural and mass spectrometric analyses revealed a novel reaction mechanism involving polarity inversion and irreversible crosslinking of the proteasomal active site.  We thus identified the sulfonyl fluoride headgroup for the development and optimization of immunoproteasome selective compds. and their possible application in autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnN6CJub2ORrVg90H21EOLACvtfcHk0lgvaFTM_dOLRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOkurfM&md5=00d726fdbc6f2e391f9650516b2d6c30</span></div><a href="/servlet/linkout?suffix=cit273&amp;dbid=16384&amp;doi=10.1002%2Fanie.201406964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201406964%26sid%3Dliteratum%253Aachs%26aulast%3DDubiella%26aufirst%3DC.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DGersch%26aufirst%3DM.%26aulast%3DBrouwer%26aufirst%3DA.%2BJ.%26aulast%3DSieber%26aufirst%3DS.%2BA.%26aulast%3DKr%25C3%25BCger%26aufirst%3DA.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26aulast%3DGroll%26aufirst%3DM.%26atitle%3DSelective%2520inhibition%2520of%2520the%2520immunoproteasome%2520by%2520ligand-induced%2520crosslinking%2520of%2520the%2520active%2520site%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26issue%3D44%26spage%3D11969%26epage%3D11973%26doi%3D10.1002%2Fanie.201406964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref274"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref274'); return false;" data-citation="" class="refNumLink">274</a></strong><div class="NLM_citation" id="cit274"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angelo, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathan, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span> <span> </span><span class="NLM_article-title">Oxathiazolones selectively inhibit the human immunoproteasome over the constitutive proteasome</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">405</span>â <span class="NLM_lpage">410</span>, <span class="refDoi">Â DOI: 10.1021/ml400531d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400531d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslyhsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=405-410&issue=4&author=H.+Fanauthor=N.+G.+Angeloauthor=J.+D.+Warrenauthor=C.+F.+Nathanauthor=G.+Lin&title=Oxathiazolones+selectively+inhibit+the+human+immunoproteasome+over+the+constitutive+proteasome&doi=10.1021%2Fml400531d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit274R"><div class="casContent"><span class="casTitleNuber">274</span><div class="casTitle"><span class="NLM_cas:atitle">Oxathiazolones Selectively Inhibit the Human Immunoproteasome over the Constitutive Proteasome</span></div><div class="casAuthors">Fan, Hao; Angelo, Nicholas G.; Warren, J. David; Nathan, Carl F.; Lin, Gang</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">405-410</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibitors for the human immunoproteasome LMP7 (Î²5i) subunit over the constitutive proteasome hold promise for the treatment of autoimmune and inflammatory diseases and hematol. malignancies.  Here we report that oxathiazolones inhibit the immunoproteasome Î²5i with up to 4700-fold selectivity over the constitutive proteasome, are cell permeable, and inhibit proteasomes inside cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Z_edRpQdj7Vg90H21EOLACvtfcHk0lgvaFTM_dOLRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslyhsLY%253D&md5=e9dcdf8a691515c95172ab283b92a5be</span></div><a href="/servlet/linkout?suffix=cit274&amp;dbid=16384&amp;doi=10.1021%2Fml400531d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400531d%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DH.%26aulast%3DAngelo%26aufirst%3DN.%2BG.%26aulast%3DWarren%26aufirst%3DJ.%2BD.%26aulast%3DNathan%26aufirst%3DC.%2BF.%26aulast%3DLin%26aufirst%3DG.%26atitle%3DOxathiazolones%2520selectively%2520inhibit%2520the%2520human%2520immunoproteasome%2520over%2520the%2520constitutive%2520proteasome%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D4%26spage%3D405%26epage%3D410%26doi%3D10.1021%2Fml400531d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref275"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref275'); return false;" data-citation="" class="refNumLink">275</a></strong><div class="NLM_citation" id="cit275"><span><span class="NLM_contrib-group"><span class="NLM_string-name">SosiÄ, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Å½ivec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konc, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeÅ¡nik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogrizek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obreza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Å½igon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">JaneÅ¾iÄ, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MlinariÄ-RaÅ¡Äan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">Nonpeptidic selective inhibitors of the chymotrypsin-like (Î²5 i) subunit of the immunoproteasome</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5745</span>â <span class="NLM_lpage">5748</span>, <span class="refDoi">Â DOI: 10.1002/anie.201600190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fanie.201600190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1yisrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=5745-5748&issue=19&author=I.+Sosi%C4%8Dauthor=M.+Gobecauthor=B.+Brusauthor=D.+Knezauthor=M.+%C5%BDivecauthor=J.+Koncauthor=S.+Le%C5%A1nikauthor=M.+Ogrizekauthor=A.+Obrezaauthor=D.+%C5%BDigonauthor=D.+Jane%C5%BEi%C4%8Dauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=S.+Gobec&title=Nonpeptidic+selective+inhibitors+of+the+chymotrypsin-like+%28%CE%B25+i%29+subunit+of+the+immunoproteasome&doi=10.1002%2Fanie.201600190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit275R"><div class="casContent"><span class="casTitleNuber">275</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (Î²5i) Subunit of the Immunoproteasome</span></div><div class="casAuthors">Sosic, Izidor; Gobec, Martina; Brus, Boris; Knez, Damijan; Zivec, Matej; Konc, Janez; Lesnik, Samo; Ogrizek, Mitja; Obreza, Ales; Zigon, Dusan; Janezic, Dusanka; Mlinaric-Rascan, Irena; Gobec, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5745-5748</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Elevated expression of the immunoproteasome has been assocd. with autoimmune diseases, inflammatory diseases, and various types of cancer.  Selective inhibitors of the immunoproteasome are not only scarce, but also almost entirely restricted to peptide-based compds.  Herein, we describe nonpeptidic reversible inhibitors that selectively block the chymotrypsin-like (Î²5i) subunit of the human immunoproteasome in the low micromolar range.  The most potent of the reversibly acting compds. were then converted into covalent, irreversible, nonpeptidic inhibitors that retained selectivity for the Î²5i subunit.  In addn., these inhibitors discriminate between the immunoproteasome and the constitutive proteasome in cell-based assays.  Along with their lack of cytotoxicity, these data point to these nonpeptidic compds. being suitable for further investigation as Î²5i-selective probes for possible application in noncancer diseases related to the immunoproteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVzWe9nWrjVbVg90H21EOLACvtfcHk0lhwBqV7l_M2kA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1yisrs%253D&md5=37d04d39e7d6ff3cf58241bc16f8bd3e</span></div><a href="/servlet/linkout?suffix=cit275&amp;dbid=16384&amp;doi=10.1002%2Fanie.201600190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201600190%26sid%3Dliteratum%253Aachs%26aulast%3DSosi%25C4%258D%26aufirst%3DI.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DBrus%26aufirst%3DB.%26aulast%3DKnez%26aufirst%3DD.%26aulast%3D%25C5%25BDivec%26aufirst%3DM.%26aulast%3DKonc%26aufirst%3DJ.%26aulast%3DLe%25C5%25A1nik%26aufirst%3DS.%26aulast%3DOgrizek%26aufirst%3DM.%26aulast%3DObreza%26aufirst%3DA.%26aulast%3D%25C5%25BDigon%26aufirst%3DD.%26aulast%3DJane%25C5%25BEi%25C4%258D%26aufirst%3DD.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DNonpeptidic%2520selective%2520inhibitors%2520of%2520the%2520chymotrypsin-like%2520%2528%25CE%25B25%2520i%2529%2520subunit%2520of%2520the%2520immunoproteasome%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26issue%3D19%26spage%3D5745%26epage%3D5748%26doi%3D10.1002%2Fanie.201600190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref276"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref276'); return false;" data-citation="" class="refNumLink">276</a></strong><div class="NLM_citation" id="cit276"><span><span class="NLM_contrib-group"><span class="NLM_string-name">London, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">CimermanÄiÄ, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Covalent docking of large libraries for the discovery of chemical probes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1066</span>â <span class="NLM_lpage">1072</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.1666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnchembio.1666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25344815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbjE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1066-1072&issue=12&author=N.+Londonauthor=R.+M.+Millerauthor=S.+Krishnanauthor=K.+Uchidaauthor=J.+J.+Irwinauthor=O.+Eidamauthor=L.+Giboldauthor=P.+Cimerman%C4%8Di%C4%8Dauthor=R.+Bonnetauthor=B.+K.+Shoichetauthor=J.+Taunton&title=Covalent+docking+of+large+libraries+for+the+discovery+of+chemical+probes&doi=10.1038%2Fnchembio.1666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit276R"><div class="casContent"><span class="casTitleNuber">276</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent docking of large libraries for the discovery of chemical probes</span></div><div class="casAuthors">London, Nir; Miller, Rand M.; Krishnan, Shyam; Uchida, Kenji; Irwin, John J.; Eidam, Oliv; Gibold, Lucie; Cimermancic, Peter; Bonnet, Richard; Shoichet, Brian K.; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1066-1072</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes that form a covalent bond with a protein target often show enhanced selectivity, potency and utility for biol. studies.  Despite these advantages, protein-reactive compds. are usually avoided in high-throughput screening campaigns.  Here we describe a general method (DOCKovalent) for screening large virtual libraries of electrophilic small mols.  We apply this method prospectively to discover reversible covalent fragments that target distinct protein nucleophiles, including the catalytic serine of AmpC Î²-lactamase and noncatalytic cysteines in RSK2, MSK1 and JAK3 kinases.  We identify submicromolar to low-nanomolar hits with high ligand efficiency, cellular activity and selectivity, including what are to our knowledge the first reported reversible covalent inhibitors of JAK3.  Crystal structures of inhibitor complexes with AmpC and RSK2 confirm the docking predictions and guide further optimization.  As covalent virtual screening may have broad utility for the rapid discovery of chem. probes, we have made the method freely available through an automated web server (http://covalent.docking.org/).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngQdIYqslNLVg90H21EOLACvtfcHk0lhwBqV7l_M2kA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbjE&md5=4e5fbeb8f67cb82d464d57069ba0c93a</span></div><a href="/servlet/linkout?suffix=cit276&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1666%26sid%3Dliteratum%253Aachs%26aulast%3DLondon%26aufirst%3DN.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DEidam%26aufirst%3DO.%26aulast%3DGibold%26aufirst%3DL.%26aulast%3DCimerman%25C4%258Di%25C4%258D%26aufirst%3DP.%26aulast%3DBonnet%26aufirst%3DR.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DCovalent%2520docking%2520of%2520large%2520libraries%2520for%2520the%2520discovery%2520of%2520chemical%2520probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D12%26spage%3D1066%26epage%3D1072%26doi%3D10.1038%2Fnchembio.1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref277"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref277'); return false;" data-citation="" class="refNumLink">277</a></strong><div class="NLM_citation" id="cit277"><span><span class="NLM_contrib-group"><span class="NLM_string-name">ÃbrÃ¡nyi-Balogh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imre, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szijj, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrast, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MitroviÄ, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FonoviÄ, U. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">NÃ©meth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreteau, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roper, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HorvÃ¡ti, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferenczy, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IlaÅ¡, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">A road map for prioritizing warheads for cysteine targeting covalent inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">94</span>â <span class="NLM_lpage">107</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2018.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.ejmech.2018.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30321804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFeqtrbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2018&pages=94-107&author=P.+%C3%81br%C3%A1nyi-Baloghauthor=L.+Petriauthor=T.+Imreauthor=P.+Szijjauthor=A.+Scarpinoauthor=M.+Hrastauthor=A.+Mitrovi%C4%87author=U.+P.+Fonovi%C4%8Dauthor=K.+N%C3%A9methauthor=H.+Barreteauauthor=D.+I.+Roperauthor=K.+Horv%C3%A1tiauthor=G.+G.+Ferenczyauthor=J.+Kosauthor=J.+Ila%C5%A1author=S.+Gobecauthor=G.+M.+Keseru&title=A+road+map+for+prioritizing+warheads+for+cysteine+targeting+covalent+inhibitors&doi=10.1016%2Fj.ejmech.2018.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit277R"><div class="casContent"><span class="casTitleNuber">277</span><div class="casTitle"><span class="NLM_cas:atitle">A road map for prioritizing warheads for cysteine targeting covalent inhibitors</span></div><div class="casAuthors">Abranyi-Balogh, Peter; Petri, Laszlo; Imre, Timea; Szijj, Peter; Scarpino, Andrea; Hrast, Martina; Mitrovic, Ana; Fonovic, Ursa Pecar; Nemeth, Krisztina; Barreteau, Helene; Roper, David I.; Horvati, Kata; Ferenczy, Gyorgy G.; Kos, Janko; Ilas, Janez; Gobec, Stanislav; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">94-107</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Targeted covalent inhibitors have become an integral part of a no. of therapeutic protocols and are the subject of intense research.  The mechanism of action of these compds. involves the formation of a covalent bond with protein nucleophiles, mostly cysteines.  Given the abundance of cysteines in the proteome, the specificity of the covalent inhibitors is of utmost importance and requires careful optimization of the applied warheads.  In most of the cysteine targeting covalent inhibitor programs the design strategy involves incorporating Michael acceptors into a ligand that is already known to bind noncovalently.  In contrast, the authors suggest that the reactive warhead itself should be tailored to the reactivity of the specific cysteine being targeted, and the authors describe a strategy to achieve this goal.  Here, the authors have extended and systematically explored the available org. chem. toolbox and characterized a large no. of warheads representing different chemistries.  The authors demonstrate that in addn. to the common Michael addn., there are other nucleophilic addn., addn.-elimination, nucleophilic substitution and oxidn. reactions suitable for specific covalent protein modification.  Importantly, the authors reveal that warheads for these chemistries impact the reactivity and specificity of covalent fragments at both protein and proteome levels.  By integrating surrogate reactivity and selectivity models and subsequent protein assays, the authors define a road map to help enable new or largely unexplored covalent chemistries for the optimization of cysteine targeting inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogAumXXtgqXbVg90H21EOLACvtfcHk0lgBNHHzLeJu0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFeqtrbJ&md5=5649a7a5b95adc70756caddf765cf67c</span></div><a href="/servlet/linkout?suffix=cit277&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.10.010%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%2581br%25C3%25A1nyi-Balogh%26aufirst%3DP.%26aulast%3DPetri%26aufirst%3DL.%26aulast%3DImre%26aufirst%3DT.%26aulast%3DSzijj%26aufirst%3DP.%26aulast%3DScarpino%26aufirst%3DA.%26aulast%3DHrast%26aufirst%3DM.%26aulast%3DMitrovi%25C4%2587%26aufirst%3DA.%26aulast%3DFonovi%25C4%258D%26aufirst%3DU.%2BP.%26aulast%3DN%25C3%25A9meth%26aufirst%3DK.%26aulast%3DBarreteau%26aufirst%3DH.%26aulast%3DRoper%26aufirst%3DD.%2BI.%26aulast%3DHorv%25C3%25A1ti%26aufirst%3DK.%26aulast%3DFerenczy%26aufirst%3DG.%2BG.%26aulast%3DKos%26aufirst%3DJ.%26aulast%3DIla%25C5%25A1%26aufirst%3DJ.%26aulast%3DGobec%26aufirst%3DS.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DA%2520road%2520map%2520for%2520prioritizing%2520warheads%2520for%2520cysteine%2520targeting%2520covalent%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D160%26spage%3D94%26epage%3D107%26doi%3D10.1016%2Fj.ejmech.2018.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref278"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref278'); return false;" data-citation="" class="refNumLink">278</a></strong><div class="NLM_citation" id="cit278"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Emerging and re-emerging warheads for targeted covalent Inhibitors: Applications in medicinal chemistry and chemical biology</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5673</span>â <span class="NLM_lpage">5724</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b01153</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01153" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFKiur%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5673-5724&issue=12&author=M.+Gehringerauthor=S.+A.+Laufer&title=Emerging+and+re-emerging+warheads+for+targeted+covalent+Inhibitors%3A+Applications+in+medicinal+chemistry+and+chemical+biology&doi=10.1021%2Facs.jmedchem.8b01153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit278R"><div class="casContent"><span class="casTitleNuber">278</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology</span></div><div class="casAuthors">Gehringer, Matthias; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5673-5724</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Targeted covalent inhibitors (TCIs) are designed to bind poorly conserved amino acids by means of reactive groups, the so-called warheads.  Currently, targeting noncatalytic cysteine residues with acrylamides and other Î±,Î²-unsatd. carbonyl compds. is the predominant strategy in TCI development.  The recent ascent of covalent drugs has stimulated considerable efforts to characterize alternative warheads for the covalent-reversible and irreversible engagement of noncatalytic cysteine residues as well as other amino acids.  This Perspective article provides an overview of warheads-beyond Î±,Î²-unsatd. amides-recently used in the design of targeted covalent ligands.  Promising reactive groups that have not yet demonstrated their utility in TCI development are also highlighted.  Special emphasis is placed on the discussion of reactivity and of case studies illustrating applications in medicinal chem. and chem. biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDhc4PWV293LVg90H21EOLACvtfcHk0lgBNHHzLeJu0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFKiur%252FL&md5=4623733558ff99aadebfc13950b816ad</span></div><a href="/servlet/linkout?suffix=cit278&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01153%26sid%3Dliteratum%253Aachs%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DEmerging%2520and%2520re-emerging%2520warheads%2520for%2520targeted%2520covalent%2520Inhibitors%253A%2520Applications%2520in%2520medicinal%2520chemistry%2520and%2520chemical%2520biology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D12%26spage%3D5673%26epage%3D5724%26doi%3D10.1021%2Facs.jmedchem.8b01153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref279"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref279'); return false;" data-citation="" class="refNumLink">279</a></strong><div class="NLM_citation" id="cit279"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro-FalcÃ³n, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, C. C.</span></span> <span> </span><span class="NLM_article-title">Thiol probes to detect electrophilic natural products based on their mechanism of action</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2328</span>â <span class="NLM_lpage">2336</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.5b00924</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00924" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref279/cit279&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2mt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2328-2336&issue=8&author=G.+Castro-Falc%C3%B3nauthor=D.+Hahnauthor=D.+Reimerauthor=C.+C.+Hughes&title=Thiol+probes+to+detect+electrophilic+natural+products+based+on+their+mechanism+of+action&doi=10.1021%2Facschembio.5b00924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit279R"><div class="casContent"><span class="casTitleNuber">279</span><div class="casTitle"><span class="NLM_cas:atitle">Thiol Probes To Detect Electrophilic Natural Products Based on Their Mechanism of Action</span></div><div class="casAuthors">Castro-Falcon, Gabriel; Hahn, Dongyup; Reimer, Daniela; Hughes, Chambers C.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2328-2336</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New methods are urgently needed to find novel natural products as structural leads for the development of new drugs against emerging diseases such as cancer and multiresistant bacterial infections.  Here we introduce a reactivity-guided drug discovery approach for electrophilic natural products, a therapeutically relevant class of natural products that covalently modify their cellular targets, in crude exts.  Using carefully designed halogenated arom. reagents, the process furnishes derivs. that are UV-active and highly conspicuous via mass spectrometry by virtue of an isotopically unique bromine or chlorine tag.  In addn. to the identification of high-value metabolites, the process facilitates the difficult task of structure elucidation by providing derivs. that are primed for X-ray crystallog. anal.  We show that a cysteine probe efficiently and chemoselectively labels enone-, Î²-lactam-, and Î²-lactone-based electrophilic natural products (parthenolide, andrographolide, wortmannin, penicillin G, salinosporamide), while a thiophenol probe preferentially labels epoxide-based electrophilic natural products (triptolide, epoxomicin, eponemycin, cyclomarin, salinamide).  Using the optimized method, we were able to detect and isolate the epoxide-bearing natural product tirandalydigin from Salinispora and thereby link an orphan gene cluster to its gene product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_VJhjyqvV2LVg90H21EOLACvtfcHk0lgBNHHzLeJu0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2mt7k%253D&md5=106b4dc36df6e75d3ef52ae3c8314d5e</span></div><a href="/servlet/linkout?suffix=cit279&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00924%26sid%3Dliteratum%253Aachs%26aulast%3DCastro-Falc%25C3%25B3n%26aufirst%3DG.%26aulast%3DHahn%26aufirst%3DD.%26aulast%3DReimer%26aufirst%3DD.%26aulast%3DHughes%26aufirst%3DC.%2BC.%26atitle%3DThiol%2520probes%2520to%2520detect%2520electrophilic%2520natural%2520products%2520based%2520on%2520their%2520mechanism%2520of%2520action%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26issue%3D8%26spage%3D2328%26epage%3D2336%26doi%3D10.1021%2Facschembio.5b00924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218'],'ref219':['cit219'],'ref220':['cit220'],'ref221':['cit221'],'ref222':['cit222'],'ref223':['cit223'],'ref224':['cit224'],'ref225':['cit225'],'ref226':['cit226'],'ref227':['cit227'],'ref228':['cit228'],'ref229':['cit229'],'ref230':['cit230'],'ref231':['cit231'],'ref232':['cit232'],'ref233':['cit233'],'ref234':['cit234'],'ref235':['cit235'],'ref236':['cit236'],'ref237':['cit237'],'ref238':['cit238'],'ref239':['cit239'],'ref240':['cit240'],'ref241':['cit241'],'ref242':['cit242'],'ref243':['cit243'],'ref244':['cit244'],'ref245':['cit245'],'ref246':['cit246'],'ref247':['cit247'],'ref248':['cit248'],'ref249':['cit249'],'ref250':['cit250'],'ref251':['cit251'],'ref252':['cit252'],'ref253':['cit253'],'ref254':['cit254'],'ref255':['cit255'],'ref256':['cit256'],'ref257':['cit257'],'ref258':['cit258'],'ref259':['cit259'],'ref260':['cit260'],'ref261':['cit261'],'ref262':['cit262'],'ref263':['cit263'],'ref264':['cit264'],'ref265':['cit265'],'ref266':['cit266'],'ref267':['cit267'],'ref268':['cit268'],'ref269':['cit269'],'ref270':['cit270'],'ref271':['cit271'],'ref272':['cit272'],'ref273':['cit273'],'ref274':['cit274'],'ref275':['cit275'],'ref276':['cit276'],'ref277':['cit277'],'ref278':['cit278'],'ref279':['cit279']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Approaches to protease inhibitor discovery. (A) In a classical, target-centric drug discovery approach, the focus of screening and optimization is on identifying a highly potent hit compound for a given protease target. (B) In a chemocentric approach, compounds are directly screened in a more complex biological system and simultaneously evaluated for specificity. (C) In a competitive ABPP, a broad-spectrum probe labels reactive and functional protease in proteomes. The probe-conjugated proteases can be resolved on a gel, and pretreatment with an inhibitor that blocks the site for probe labeling results in reduced read-out. (D) In a competitive isoTOP-ABPP, proteomes are treated either with an inhibitor or vehicle followed by a reactive probe. The enriched proteins with isotopically differentiated tags are subjected to quantitative LC-MS/MS analysis to map the liganded sites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Substrate binding and active site directed inhibition of protease. (A) Protease binds to its substrate through interactions with the peptide backbone and the side chain residues (P and Pâ² residues) that occupy the protease pockets (S and Sâ² pockets). (B) Top: enzyme reaction, middle: interaction of a noncovalent reversible inhibitor with the enzyme, bottom: interaction of a covalent inhibitor with the enzyme.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Substrate screening methods. (A) MSP-MS. (B) PS-SCL. (C) Fluorogenic peptide microarray. (D) SAS. (E) Phage substrate display.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Structures of selected inhibitors and activity-based probes for caspases. Electrophilic warheads are shown in red. (B) Activation of photocaged caspase inhibitors upon irradiation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) NF-ÎºB activation through CARMA1-BCL10-MALT1 complex in B or T cells. (B) Structures of selected inhibitors and activity-based probes for MALT1. Electrophilic warheads are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of selected inhibitors and activity-based probes for calpain 1/2. Electrophilic warheads are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Structures of selected inhibitors and activity-based probes for cathepsins. Electrophilic warheads are shown in red. (B) Mechanism and tumor imaging of a fluorescently quenched activity-based probe (qABP), BMV109. The probe is intrinsically quenched and becomes fluorescent upon specific and covalent binding to cathepsins in an activity-dependent manner.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of selected inhibitors and activity-based probes for legumain. Electrophilic warheads are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) DUB active site. The isopeptide bond between the C-terminal Gly residue of ubiquitin and the Lys residue of the substrate protein is hydrolyzed by the DUB protease activity. (B) Structures of ubiquitin-based covalent inhibitors. (C) Structures of selected DUB inhibitors. Electrophilic warheads are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of selected inhibitors and activity-based probes for granzyme A and B. Electrophilic warheads are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) Structures of selected inhibitors and activity-based probes for neutrophil elastase. Electrophilic warheads are shown in red. (B) Crystal structure of the HNE (cyan surface)-PK101 (magenta) complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WVP">4WVP</a>). The active site serine Ser195 is shown in orange.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of selected DPP 4 inhibitors. Electrophilic warheads are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/medium/jm1c00172_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. (A) The proteasome 20S core particle. The expression and assembly of the immunoproteasome is induced in response to a viral infection or after exposure to immunomodulatory cytokines. A cocktail of activity-based probes (structures shown) enables simultaneous gel-based detection of all six catalytic human proteasome subunits and can be used to assess the specificity of inhibitors (I1 or I2). (B) Structures of selected immunoproteasome inhibitors. Electrophilic warheads are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00172/20210506/images/large/jm1c00172_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00172&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i22">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 279 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Kasteren, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neefjes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovaa, H.</span></span> <span> </span><span class="NLM_article-title">Creating molecules that modulate immune responses</span>. <i>Nat. Rev. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">184</span>â <span class="NLM_lpage">193</span>, <span class="refDoi">Â DOI: 10.1038/s41570-018-0023-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41570-018-0023-9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2018&pages=184-193&issue=8&author=S.+I.+van%0AKasterenauthor=J.+Neefjesauthor=H.+Ovaa&title=Creating+molecules+that+modulate+immune+responses&doi=10.1038%2Fs41570-018-0023-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fs41570-018-0023-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41570-018-0023-9%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BKasteren%26aufirst%3DS.%2BI.%26aulast%3DNeefjes%26aufirst%3DJ.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DCreating%2520molecules%2520that%2520modulate%2520immune%2520responses%26jtitle%3DNat.%2520Rev.%2520Chem.%26date%3D2018%26volume%3D2%26issue%3D8%26spage%3D184%26epage%3D193%26doi%3D10.1038%2Fs41570-018-0023-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borel, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gubler, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">StÃ¤helin, H.</span></span> <span> </span><span class="NLM_article-title">Biological effects of cyclosporin A: A new antilymphocytic agent</span>. <i>Agents Actions</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">468</span>â <span class="NLM_lpage">475</span>, <span class="refDoi">Â DOI: 10.1007/BF01973261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1007%2FBF01973261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaE28XltFKltrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1976&pages=468-475&issue=4&author=J.+F.+Borelauthor=C.+Feurerauthor=H.+U.+Gublerauthor=H.+St%C3%A4helin&title=Biological+effects+of+cyclosporin+A%3A+A+new+antilymphocytic+agent&doi=10.1007%2FBF01973261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Biological effects of cyclosporin A:  a new antilymphocytic agent</span></div><div class="casAuthors">Borel, J. F.; Feurer, Camille; Gubler, H. U.; Staehelin, H.</div><div class="citationInfo"><span class="NLM_cas:title">Agents and Actions</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">468-75</span>CODEN:
                <span class="NLM_cas:coden">AGACBH</span>;
        ISSN:<span class="NLM_cas:issn">0065-4299</span>.
    </div><div class="casAbstract">Cyclosporin A [59865-13-3] suppressed both humoral and cellular immunity in lab. animals in a reproducible and dose-dependent manner.  Cyclosporin A also exhibited antiphlogistic effects in a chronic, but not in acute inflammatory models.  Its low myelotoxicity indicates that cyclosporin A should undergo clin. investigation as an immunosuppressant and antiinflammatory agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIRcBnCEVYTbVg90H21EOLACvtfcHk0ljSNRt8yW7ckA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltFKltrY%253D&md5=c62e0eb701d4a6321f27c28a926bbbab</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2FBF01973261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01973261%26sid%3Dliteratum%253Aachs%26aulast%3DBorel%26aufirst%3DJ.%2BF.%26aulast%3DFeurer%26aufirst%3DC.%26aulast%3DGubler%26aufirst%3DH.%2BU.%26aulast%3DSt%25C3%25A4helin%26aufirst%3DH.%26atitle%3DBiological%2520effects%2520of%2520cyclosporin%2520A%253A%2520A%2520new%2520antilymphocytic%2520agent%26jtitle%3DAgents%2520Actions%26date%3D1976%26volume%3D6%26issue%3D4%26spage%3D468%26epage%3D475%26doi%3D10.1007%2FBF01973261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. N.</span></span> <span> </span><span class="NLM_article-title">Cyclosporin A, FK506 and rapamycin: more than just immunosuppression</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">334</span>â <span class="NLM_lpage">338</span>, <span class="refDoi">Â DOI: 10.1016/0968-0004(93)90069-Y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2F0968-0004%2893%2990069-Y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=7694398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3sXlvFGjsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1993&pages=334-338&issue=9&author=J.+Kunzauthor=M.+N.+Hall&title=Cyclosporin+A%2C+FK506+and+rapamycin%3A+more+than+just+immunosuppression&doi=10.1016%2F0968-0004%2893%2990069-Y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporin A, FK506 and rapamycin: more than just immunosuppression</span></div><div class="casAuthors">Kunz, Jeannette; Hall, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">334-8</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    </div><div class="casAbstract">A review with 35 refs.  The mechanisms of action of the immunosuppressive drugs cyclosphorin A(CsA), FK506 and rapamycin are strikingly conserved from yeast to human T cells.  Recent results obtained with yeast corroborate calcineurin as the target of CsA-cyclophilin and FK506-FKBP complexes, and reveal a phosphatidylinositol 3-kinase homolog as the target of the rapamycin-FKBP complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro4ILcAHS6mrVg90H21EOLACvtfcHk0ljSNRt8yW7ckA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvFGjsrg%253D&md5=3a97087838b164d58bb654a3defada7f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0968-0004%2893%2990069-Y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0968-0004%252893%252990069-Y%26sid%3Dliteratum%253Aachs%26aulast%3DKunz%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DM.%2BN.%26atitle%3DCyclosporin%2520A%252C%2520FK506%2520and%2520rapamycin%253A%2520more%2520than%2520just%2520immunosuppression%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D1993%26volume%3D18%26issue%3D9%26spage%3D334%26epage%3D338%26doi%3D10.1016%2F0968-0004%2893%2990069-Y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GarcÃ­a-MartÃ­nez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitter, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fucikova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spisek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zitvogel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span> <span> </span><span class="NLM_article-title">Trial Watch: Toll-like receptor agonists in cancer immunotherapy</span>. <i>Oncoimmunology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">12</span>), <span class="NLM_elocation-id">e1526250</span> <span class="refDoi">Â DOI: 10.1080/2162402X.2018.1526250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1080%2F2162402X.2018.1526250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30524908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFWit7fJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&issue=12&author=M.+Smithauthor=E.+Garc%C3%ADa-Mart%C3%ADnezauthor=M.+R.+Pitterauthor=J.+Fucikovaauthor=R.+Spisekauthor=L.+Zitvogelauthor=G.+Kroemerauthor=L.+Galluzzi&title=Trial+Watch%3A+Toll-like+receptor+agonists+in+cancer+immunotherapy&doi=10.1080%2F2162402X.2018.1526250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Trial Watch: Toll-like receptor agonists in cancer immunotherapy</span></div><div class="casAuthors">Smith, Melody; Garcia-Martinez, Elena; Pitter, Michael R.; Fucikova, Jitka; Spisek, Radek; Zitvogel, Laurence; Kroemer, Guido; Galluzzi, Lorenzo</div><div class="citationInfo"><span class="NLM_cas:title">OncoImmunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e1526250/1-e1526250/15</span>CODEN:
                <span class="NLM_cas:coden">ONCOGX</span>;
        ISSN:<span class="NLM_cas:issn">2162-402X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Toll-like receptor (TLR) agonists demonstrate therapeutic promise as immunol. adjuvants for anticancer immunotherapy.  To date, three TLR agonists have been approved by US regulatory agencies for use in cancer patients.  Addnl., the potential of hitherto exptl. TLR ligands to mediate clin. useful immunostimulatory effects has been extensively investigated over the past few years.  Here, we summarize recent preclin. and clin. advances in the development of TLR agonists for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowZcxxOGskNLVg90H21EOLACvtfcHk0ljJpiDng-qunw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFWit7fJ&md5=289c71241e9d77fce45ebcac239bd7f8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1080%2F2162402X.2018.1526250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F2162402X.2018.1526250%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Mart%25C3%25ADnez%26aufirst%3DE.%26aulast%3DPitter%26aufirst%3DM.%2BR.%26aulast%3DFucikova%26aufirst%3DJ.%26aulast%3DSpisek%26aufirst%3DR.%26aulast%3DZitvogel%26aufirst%3DL.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DGalluzzi%26aufirst%3DL.%26atitle%3DTrial%2520Watch%253A%2520Toll-like%2520receptor%2520agonists%2520in%2520cancer%2520immunotherapy%26jtitle%3DOncoimmunology%26date%3D2018%26volume%3D7%26issue%3D12%26doi%3D10.1080%2F2162402X.2018.1526250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Page, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postow, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolchok, J. D.</span></span> <span> </span><span class="NLM_article-title">Immune modulation in cancer with antibodies</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">185</span>â <span class="NLM_lpage">202</span>, <span class="refDoi">Â DOI: 10.1146/annurev-med-092012-112807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1146%2Fannurev-med-092012-112807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24188664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktFeltbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2014&pages=185-202&issue=1&author=D.+B.+Pageauthor=M.+A.+Postowauthor=M.+K.+Callahanauthor=J.+P.+Allisonauthor=J.+D.+Wolchok&title=Immune+modulation+in+cancer+with+antibodies&doi=10.1146%2Fannurev-med-092012-112807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Immune modulation in cancer with antibodies</span></div><div class="casAuthors">Page, David B.; Postow, Michael A.; Callahan, Margaret K.; Allison, James P.; Wolchok, Jedd D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">185-202</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Ipilimumab is the prototypical immunomodulatory antibody, approved by the FDA in 2011 for advanced melanoma on the basis of survival benefit.  Since that time, we have made significant strides in optimizing this therapy: we have characterized the spectrum of immune-related adverse events and learned how to mitigate them with treatment algorithms, discovered potential biomarkers of activity, and identified the potential synergy between checkpoint modulation and other therapeutic modalities.  Recent phase I trials have established the efficacy and safety of next-generation checkpoint agents, including PD-1 and PD-L1 inhibitors, across multiple tumor types.  Much work lies ahead in developing these next-generation checkpoint agents, testing them in combination, and detg. how to integrate them into the treatment paradigms of various tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Xa4WySQX9LVg90H21EOLACvtfcHk0ljJpiDng-qunw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktFeltbo%253D&md5=3f6332a9af46e4f57fc5e6716678b66b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-092012-112807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-092012-112807%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DD.%2BB.%26aulast%3DPostow%26aufirst%3DM.%2BA.%26aulast%3DCallahan%26aufirst%3DM.%2BK.%26aulast%3DAllison%26aufirst%3DJ.%2BP.%26aulast%3DWolchok%26aufirst%3DJ.%2BD.%26atitle%3DImmune%2520modulation%2520in%2520cancer%2520with%2520antibodies%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2014%26volume%3D65%26issue%3D1%26spage%3D185%26epage%3D202%26doi%3D10.1146%2Fannurev-med-092012-112807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swaika, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, R. W.</span></span> <span> </span><span class="NLM_article-title">Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">4</span>â <span class="NLM_lpage">17</span>, <span class="refDoi">Â DOI: 10.1016/j.molimm.2015.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.molimm.2015.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25749122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVyrsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=4-17&issue=2&author=A.+Swaikaauthor=W.+A.+Hammondauthor=R.+W.+Joseph&title=Current+state+of+anti-PD-L1+and+anti-PD-1+agents+in+cancer+therapy&doi=10.1016%2Fj.molimm.2015.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy</span></div><div class="casAuthors">Swaika, Abhisek; Hammond, William A.; Joseph, Richard W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2_Part_A</span>),
    <span class="NLM_cas:pages">4-17</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Immunotherapy for the treatment of cancer is rapidly evolving from therapies that globally and non-specifically simulate the immune system to more targeted activation of individual components of the immune system.  The net result of this targeted approach is decreased toxicity and increased efficacy of immunotherapy.  More specifically, therapies that inhibit the interaction between programmed death ligand 1 (PD-L1), present on the surface of tumor or antigen-presenting cells, and programmed death 1 (PD-1), present on the surface of activated lymphocytes, are generating much excitement and enthusiasm, even in malignancies that are not traditionally considered to be immunogenic.  Herein, we review the current landscape of anti-PD-1 and anti-PD-L1 therapies in the world of oncol.  We have performed a comprehensive literature search on the data available through PubMed, Medline, Scopus, the ClinicalTrials.gov registry, and abstrs. from major oncol. meetings in order to summarize the clin. data of anti-PD-1/PD-L1 therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUJBYFNoeR57Vg90H21EOLACvtfcHk0ljJpiDng-qunw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVyrsLc%253D&md5=c897e8ecbf612233ad4e07da5979ecc8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2015.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2015.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DSwaika%26aufirst%3DA.%26aulast%3DHammond%26aufirst%3DW.%2BA.%26aulast%3DJoseph%26aufirst%3DR.%2BW.%26atitle%3DCurrent%2520state%2520of%2520anti-PD-L1%2520and%2520anti-PD-1%2520agents%2520in%2520cancer%2520therapy%26jtitle%3DMol.%2520Immunol.%26date%3D2015%26volume%3D67%26issue%3D2%26spage%3D4%26epage%3D17%26doi%3D10.1016%2Fj.molimm.2015.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kershaw, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaney, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcy, P. K.</span></span> <span> </span><span class="NLM_article-title">Clinical application of genetically modified T cells in cancer therapy</span>. <i>Clin. Transl. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">5</span>), <span class="NLM_elocation-id">e16</span> <span class="refDoi">Â DOI: 10.1038/cti.2014.7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fcti.2014.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25505964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFCgsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&issue=5&author=M.+H.+Kershawauthor=J.+A.+Westwoodauthor=C.+Y.+Slaneyauthor=P.+K.+Darcy&title=Clinical+application+of+genetically+modified+T+cells+in+cancer+therapy&doi=10.1038%2Fcti.2014.7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical application of genetically modified T cells in cancer therapy</span></div><div class="casAuthors">Kershaw, Michael H.; Westwood, Jennifer A.; Slaney, Clare Y.; Darcy, Phillip K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Translational Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e16/1-e16/7, 7</span>CODEN:
                <span class="NLM_cas:coden">CTILBR</span>;
        ISSN:<span class="NLM_cas:issn">2050-0068</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">Immunotherapies are emerging as highly promising approaches for the treatment of cancer.  In these approaches, a variety of materials are used to boost immunity against malignant cells.  A key component of many of these approaches is functional tumor-specific T cells, but the existence and activity of sufficient T cells in the immune repertoire is not always the case.  Recent methods of generating tumor-specific T cells include the genetic modification of patient lymphocytes with receptors to endow them with tumor specificity.  These T cells are then expanded in vitro followed by infusion of the patient in adoptive cell transfer protocols.  Genes used to modify T cells include those encoding T-cell receptors and chimeric antigen receptors.  In this review, we provide an introduction to the field of genetic engineering of T cells followed by details of their use against cancer in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmwZH2cpT3-bVg90H21EOLACvtfcHk0lh9kUFDBFbrYA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFCgsL0%253D&md5=e38076f9672075a18c0cf6734acaaf76</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fcti.2014.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcti.2014.7%26sid%3Dliteratum%253Aachs%26aulast%3DKershaw%26aufirst%3DM.%2BH.%26aulast%3DWestwood%26aufirst%3DJ.%2BA.%26aulast%3DSlaney%26aufirst%3DC.%2BY.%26aulast%3DDarcy%26aufirst%3DP.%2BK.%26atitle%3DClinical%2520application%2520of%2520genetically%2520modified%2520T%2520cells%2520in%2520cancer%2520therapy%26jtitle%3DClin.%2520Transl.%2520Immunol.%26date%3D2014%26volume%3D3%26issue%3D5%26doi%3D10.1038%2Fcti.2014.7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, H. U.</span></span> <span> </span><span class="NLM_article-title">Cathepsins and their involvement in immune responses</span>. <i>Swiss Med. Wkly.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">w13042</span>, <span class="refDoi">Â DOI: 10.4414/smw.2010.13042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4414%2Fsmw.2010.13042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=20648403" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=w13042&author=S.+Conusauthor=H.+U.+Simon&title=Cathepsins+and+their+involvement+in+immune+responses&doi=10.4414%2Fsmw.2010.13042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.4414%2Fsmw.2010.13042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4414%252Fsmw.2010.13042%26sid%3Dliteratum%253Aachs%26aulast%3DConus%26aufirst%3DS.%26aulast%3DSimon%26aufirst%3DH.%2BU.%26atitle%3DCathepsins%2520and%2520their%2520involvement%2520in%2520immune%2520responses%26jtitle%3DSwiss%2520Med.%2520Wkly.%26date%3D2010%26volume%3D140%26spage%3Dw13042%26doi%3D10.4414%2Fsmw.2010.13042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hailfinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebeaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span> <span> </span><span class="NLM_article-title">Adapter and enzymatic functions of proteases in T-cell activation</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>232</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">334</span>â <span class="NLM_lpage">347</span>, <span class="refDoi">Â DOI: 10.1111/j.1600-065X.2009.00830.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1111%2Fj.1600-065X.2009.00830.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19909374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGlsLrN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2009&pages=334-347&issue=1&author=S.+Hailfingerauthor=F.+Rebeaudauthor=M.+Thome&title=Adapter+and+enzymatic+functions+of+proteases+in+T-cell+activation&doi=10.1111%2Fj.1600-065X.2009.00830.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Adapter and enzymatic functions of proteases in T-cell activation</span></div><div class="casAuthors">Hailfinger, Stephan; Rebeaud, Fabien; Thome, Margot</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">334-347</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Proteases control many vital aspects of humoral and cellular immune responses, including the maturation of cytokines and the killing of target cells.  Recently, it has become evident that triggering of the T-cell receptor controls T-cell proliferation through proteases such as mucosa-assocd. lymphoid tissue 1 (MALT1) and Caspase-8 that act both as adapters and enzymes.  Here, we discuss the role of these and other proteases that are relevant to the control of the T-cell response and represent interesting targets of therapeutic immunomodulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsdRX4UgiEZrVg90H21EOLACvtfcHk0lh9kUFDBFbrYA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGlsLrN&md5=518caa776a1b00b5d270d2dbe42e93ca</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2009.00830.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2009.00830.x%26sid%3Dliteratum%253Aachs%26aulast%3DHailfinger%26aufirst%3DS.%26aulast%3DRebeaud%26aufirst%3DF.%26aulast%3DThome%26aufirst%3DM.%26atitle%3DAdapter%2520and%2520enzymatic%2520functions%2520of%2520proteases%2520in%2520T-cell%2520activation%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D232%26issue%3D1%26spage%3D334%26epage%3D347%26doi%3D10.1111%2Fj.1600-065X.2009.00830.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cromm, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">The proteasome in modern drug discovery: second life of a highly valuable drug target</span>. <i>ACS Cent. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">830</span>â <span class="NLM_lpage">838</span>, <span class="refDoi">Â DOI: 10.1021/acscentsci.7b00252</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscentsci.7b00252" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Orsb3M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=830-838&issue=8&author=P.+M.+Crommauthor=C.+M.+Crews&title=The+proteasome+in+modern+drug+discovery%3A+second+life+of+a+highly+valuable+drug+target&doi=10.1021%2Facscentsci.7b00252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Proteasome in Modern Drug Discovery: Second Life of a Highly Valuable Drug Target</span></div><div class="casAuthors">Cromm, Philipp M.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Central Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">830-838</span>CODEN:
                <span class="NLM_cas:coden">ACSCII</span>;
        ISSN:<span class="NLM_cas:issn">2374-7951</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  As the central figure of the cellular protein degrdn. machinery, the proteasome is crit. for cell survival.  Having been extensively targeted for inhibition, the constitutive proteasome has proven its role as a highly valuable drug target.  However, recent advances in the protein homeostasis field suggest that addnl. chapters can be added to this successful story.  For example, selective immunoproteasome inhibition promises high clin. efficacy for autoimmune disorders and inflammation, and proteasome inhibitors might serve as novel therapeutics for malaria or other microorganisms.  Furthermore, utilizing the destructive force of the proteasome for selective degrdn. of essential drivers of human disorders has opened up a new and exciting area of drug discovery.  Thus, the field of proteasome drug discovery still holds exciting questions to be answered and does not simply end with inhibiting the constitutive proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKh_fEKiZT-7Vg90H21EOLACvtfcHk0liqUt-7Ey-8-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Orsb3M&md5=91f26fd1133db650c0b4b4f43a461354</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facscentsci.7b00252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscentsci.7b00252%26sid%3Dliteratum%253Aachs%26aulast%3DCromm%26aufirst%3DP.%2BM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DThe%2520proteasome%2520in%2520modern%2520drug%2520discovery%253A%2520second%2520life%2520of%2520a%2520highly%2520valuable%2520drug%2520target%26jtitle%3DACS%2520Cent.%2520Sci.%26date%3D2017%26volume%3D3%26issue%3D8%26spage%3D830%26epage%3D838%26doi%3D10.1021%2Facscentsci.7b00252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâDonoghue, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foe, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Fonseca, P. C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Structure- and function-based design of Plasmodium-selective proteasome inhibitors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>530</i></span> (<span class="NLM_issue">7589</span>),  <span class="NLM_fpage">233</span>â <span class="NLM_lpage">236</span>, <span class="refDoi">Â DOI: 10.1038/nature16936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature16936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26863983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVyrsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=530&publication_year=2016&pages=233-236&issue=7589&author=H.+Liauthor=A.+J.+O%E2%80%99Donoghueauthor=W.+A.+van+der+Lindenauthor=S.+C.+Xieauthor=E.+Yooauthor=I.+T.+Foeauthor=L.+Tilleyauthor=C.+S.+Craikauthor=P.+C.+A.+da+Fonsecaauthor=M.+Bogyo&title=Structure-+and+function-based+design+of+Plasmodium-selective+proteasome+inhibitors&doi=10.1038%2Fnature16936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and function-based design of Plasmodium-selective proteasome inhibitors</span></div><div class="casAuthors">Li, Hao; O'Donoghue, Anthony J.; van der Linden, Wouter A.; Xie, Stanley C.; Yoo, Euna; Foe, Ian T.; Tilley, Leann; Craik, Charles S.; da Fonseca, Paula C. A.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">530</span>
        (<span class="NLM_cas:issue">7589</span>),
    <span class="NLM_cas:pages">233-236</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The proteasome is a multi-component protease complex responsible for regulating key processes such as the cell cycle and antigen presentation.  Compds. that target the proteasome are potentially valuable tools for the treatment of pathogens that depend on proteasome function for survival and replication.  In particular, proteasome inhibitors have been shown to be toxic for the malaria parasite Plasmodium falciparum at all stages of its life cycle.  Most compds. that have been tested against the parasite also inhibit the mammalian proteasome, resulting in toxicity that precludes their use as therapeutic agents.  Therefore, better definition of the substrate specificity and structural properties of the Plasmodium proteasome could enable the development of compds. with sufficient selectivity to allow their use as anti-malarial agents.  To accomplish this goal, here the authors use a substrate profiling method to uncover differences in the specificities of the human and P. falciparum proteasome.  The authors design inhibitors based on amino-acid preferences specific to the parasite proteasome, and find that they preferentially inhibit the Î²2-subunit.  The authors det. the structure of the P. falciparum 20S proteasome bound to the inhibitor using cryo-electron microscopy and single-particle anal., to a resoln. of 3.6 Ã.  These data reveal the unusually open P. falciparum Î²2 active site and provide valuable information about active-site architecture that can be used to further refine inhibitor design.  Furthermore, consistent with the recent finding that the proteasome is important for stress pathways assocd. with resistance of artemisinin family anti-malarials, the authors observe growth inhibition synergism with low doses of this Î²2-selective inhibitor in artemisinin-sensitive and -resistant parasites.  Finally, the authors demonstrate that a parasite-selective inhibitor could be used to attenuate parasite growth in vivo without appreciable toxicity to the host.  Thus, the Plasmodium proteasome is a chem. tractable target that could be exploited by next-generation anti-malarial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriK0Li_WncVrVg90H21EOLACvtfcHk0ljRpx7Z_xhWmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVyrsr8%253D&md5=f24a562efb64dd533a7dbcfeff4171af</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature16936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature16936%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Donoghue%26aufirst%3DA.%2BJ.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DW.%2BA.%26aulast%3DXie%26aufirst%3DS.%2BC.%26aulast%3DYoo%26aufirst%3DE.%26aulast%3DFoe%26aufirst%3DI.%2BT.%26aulast%3DTilley%26aufirst%3DL.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3Dda%2BFonseca%26aufirst%3DP.%2BC.%2BA.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DStructure-%2520and%2520function-based%2520design%2520of%2520Plasmodium-selective%2520proteasome%2520inhibitors%26jtitle%3DNature%26date%3D2016%26volume%3D530%26issue%3D7589%26spage%3D233%26epage%3D236%26doi%3D10.1038%2Fnature16936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanaerschot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, T. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Westhuyzen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Momper, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Defining the determinants of specificity of Plasmodium proteasome inhibitors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">36</span>),  <span class="NLM_fpage">11424</span>â <span class="NLM_lpage">11437</span>, <span class="refDoi">Â DOI: 10.1021/jacs.8b06656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b06656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsV2lsLbN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=11424-11437&issue=36&author=E.+Yooauthor=B.+H.+Stokesauthor=H.+de+Jongauthor=M.+Vanaerschotauthor=T.+R.+S.+Kumarauthor=N.+Lawrenceauthor=M.+Njorogeauthor=A.+Garciaauthor=R.+Van+der+Westhuyzenauthor=J.+D.+Momperauthor=C.+L.+Ngauthor=D.+A.+Fidockauthor=M.+Bogyo&title=Defining+the+determinants+of+specificity+of+Plasmodium+proteasome+inhibitors&doi=10.1021%2Fjacs.8b06656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the Determinants of Specificity of Plasmodium Proteasome Inhibitors</span></div><div class="casAuthors">Yoo, Euna; Stokes, Barbara H.; de Jong, Hanna; Vanaerschot, Manu; Kumar, T. R. S.; Lawrence, Nina; Njoroge, Mathew; Garcia, Arnold; Van der Westhuyzen, Renier; Momper, Jeremiah D.; Ng, Caroline L.; Fidock, David A.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">11424-11437</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Plasmodium proteasome is an emerging antimalarial target due to its essential role in all the major life cycle stages of the parasite and its contribution to the establishment of resistance to artemisinin (ART)-based therapies.  However, because of a similarly essential role for the host proteasome, the key property of any antiproteasome therapeutic is selectivity.  Several parasite-specific proteasome inhibitors have recently been reported, however, their selectivity must be improved to enable clin. development.  Here we describe screening of diverse libraries of non-natural synthetic fluorogenic substrates to identify determinants at multiple positions on the substrate that produce enhanced selectivity.  We find that selection of an optimal electrophilic "warhead" is essential to enable high selectivity that is driven by the peptide binding elements on the inhibitor.  We also find that host cell toxicity is dictated by the extent of coinhibition of the human Î²2 and Î²5 subunits.  Using this information, we identify compds. with over 3 orders of magnitude selectivity for the parasite enzyme.  Optimization of the pharmacol. properties resulted in mols. that retained high potency and selectivity, were sol., sufficiently metabolically stable and orally bioavailable.  These mols. are highly synergistic with ART and can clear parasites in a mouse model of infection, making them promising leads as antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzXchyqonWDrVg90H21EOLACvtfcHk0ljRpx7Z_xhWmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsV2lsLbN&md5=990e0b5097087ff76681f901b2c8f35f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b06656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b06656%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DE.%26aulast%3DStokes%26aufirst%3DB.%2BH.%26aulast%3Dde%2BJong%26aufirst%3DH.%26aulast%3DVanaerschot%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DT.%2BR.%2BS.%26aulast%3DLawrence%26aufirst%3DN.%26aulast%3DNjoroge%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DVan%2Bder%2BWesthuyzen%26aufirst%3DR.%26aulast%3DMomper%26aufirst%3DJ.%2BD.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DDefining%2520the%2520determinants%2520of%2520specificity%2520of%2520Plasmodium%2520proteasome%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26issue%3D36%26spage%3D11424%26epage%3D11437%26doi%3D10.1021%2Fjacs.8b06656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozarich, J. W.</span></span> <span> </span><span class="NLM_article-title">Activity-based protein profiling: from enzyme chemistry to proteomic chemistry</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">383</span>â <span class="NLM_lpage">414</span>, <span class="refDoi">Â DOI: 10.1146/annurev.biochem.75.101304.124125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1146%2Fannurev.biochem.75.101304.124125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18366325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1ekur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2008&pages=383-414&issue=1&author=B.+F.+Cravattauthor=A.+T.+Wrightauthor=J.+W.+Kozarich&title=Activity-based+protein+profiling%3A+from+enzyme+chemistry+to+proteomic+chemistry&doi=10.1146%2Fannurev.biochem.75.101304.124125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-based protein profiling: From enzyme chemistry to proteomic chemistry</span></div><div class="casAuthors">Cravatt, Benjamin F.; Wright, Aaron T.; Kozarich, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">383-414</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Genome sequencing projects have provided researchers with a complete inventory of the predicted proteins produced by eukaryotic and prokaryotic organisms.  Assignment of functions to these proteins represents one of the principal challenges for the field of proteomics.  Activity-based protein profiling (ABPP) has emerged as a powerful chem. proteomic strategy to characterize enzyme function directly in native biol. systems on a global scale.  Here, the authors review the basic technol. of ABPP, the enzyme classes addressable by this method, and the biol. discoveries attributable to its application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQFnUWDsqzOLVg90H21EOLACvtfcHk0ljRpx7Z_xhWmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1ekur0%253D&md5=2f2c471169d2473f7024eeb41d4eaecd</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.75.101304.124125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.75.101304.124125%26sid%3Dliteratum%253Aachs%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DWright%26aufirst%3DA.%2BT.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26atitle%3DActivity-based%2520protein%2520profiling%253A%2520from%2520enzyme%2520chemistry%2520to%2520proteomic%2520chemistry%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2008%26volume%3D77%26issue%3D1%26spage%3D383%26epage%3D414%26doi%3D10.1146%2Fannurev.biochem.75.101304.124125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groborz, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rut, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vizovisek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span> <span> </span><span class="NLM_article-title">Multiplexed probing of proteolytic enzymes using mass cytometry-compatible activity-based probes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">16704</span>â <span class="NLM_lpage">16715</span>, <span class="refDoi">Â DOI: 10.1021/jacs.0c06762</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.0c06762" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvValtbrP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2020&pages=16704-16715&issue=39&author=M.+Porebaauthor=K.+M.+Groborzauthor=W.+Rutauthor=M.+Poreauthor=S.+J.+Snipasauthor=M.+Vizovisekauthor=B.+Turkauthor=P.+Kuhnauthor=M.+Dragauthor=G.+S.+Salvesen&title=Multiplexed+probing+of+proteolytic+enzymes+using+mass+cytometry-compatible+activity-based+probes&doi=10.1021%2Fjacs.0c06762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Multiplexed Probing of Proteolytic Enzymes Using Mass Cytometry-Compatible Activity-Based Probes</span></div><div class="casAuthors">Poreba, Marcin; Groborz, Katarzyna M.; Rut, Wioletta; Pore, Milind; Snipas, Scott J.; Vizovisek, Matej; Turk, Boris; Kuhn, Peter; Drag, Marcin; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">16704-16715</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The subset of the proteome that contains enzymes in their catalytically active form can be interrogated by using probes targeted toward individual specific enzymes.  A subset of such enzymes are proteases that are frequently studied with activity-based probes, small inhibitors equipped with a detectable tag, commonly a fluorophore.  Due to the spectral overlap of these commonly used fluorophores, multiplex anal. becomes limited.  To overcome this, we developed a series of protease-selective lanthanide-labeled probes compatible with mass cytometry giving us the ability to monitor the activity of multiple proteases in parallel.  Using these probes, we were able to identify the distribution of four proteases with different active site geometries in three cell lines and peripheral blood mononuclear cells.  This provides a framework for the use of mass cytometry for multiplexed enzyme activity detection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC8-y5ZbgiX7Vg90H21EOLACvtfcHk0lgrH5kIQ3EP6A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvValtbrP&md5=ab26ce581c552d3cf9ebdad09a45fa30</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjacs.0c06762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.0c06762%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DGroborz%26aufirst%3DK.%2BM.%26aulast%3DRut%26aufirst%3DW.%26aulast%3DPore%26aufirst%3DM.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DVizovisek%26aufirst%3DM.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DMultiplexed%2520probing%2520of%2520proteolytic%2520enzymes%2520using%2520mass%2520cytometry-compatible%2520activity-based%2520probes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2020%26volume%3D142%26issue%3D39%26spage%3D16704%26epage%3D16715%26doi%3D10.1021%2Fjacs.0c06762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weerapana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, M. B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Quantitative reactivity profiling predicts functional cysteines in proteomes</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>468</i></span> (<span class="NLM_issue">7325</span>),  <span class="NLM_fpage">790</span>â <span class="NLM_lpage">795</span>, <span class="refDoi">Â DOI: 10.1038/nature09472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature09472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21085121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGhsr%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=790-795&issue=7325&author=E.+Weerapanaauthor=C.+Wangauthor=G.+M.+Simonauthor=F.+Richterauthor=S.+Khareauthor=M.+B.+D.+Dillonauthor=D.+A.+Bachovchinauthor=K.+Mowenauthor=D.+Bakerauthor=B.+F.+Cravatt&title=Quantitative+reactivity+profiling+predicts+functional+cysteines+in+proteomes&doi=10.1038%2Fnature09472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative reactivity profiling predicts functional cysteines in proteomes</span></div><div class="casAuthors">Weerapana, Eranthie; Wang, Chu; Simon, Gabriel M.; Richter, Florian; Khare, Sagar; Dillon, Myles B. D.; Bachovchin, Daniel A.; Mowen, Kerri; Baker, David; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7325</span>),
    <span class="NLM_cas:pages">790-795</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cysteine is the most intrinsically nucleophilic amino acid in proteins, where its reactivity is tuned to perform diverse biochem. functions.  The absence of a consensus sequence that defines functional cysteines in proteins has hindered their discovery and characterization.  Here we describe a proteomics method to profile quant. the intrinsic reactivity of cysteine residues en masse directly in native biol. systems.  Hyper-reactivity was a rare feature among cysteines and it was found to specify a wide range of activities, including nucleophilic and reductive catalysis and sites of oxidative modification.  Hyper-reactive cysteines were identified in several proteins of uncharacterized function, including a residue conserved across eukaryotic phylogeny that we show is required for yeast viability and is involved in iron-sulfur protein biogenesis.  We also demonstrate that quant. reactivity profiling can form the basis for screening and functional assignment of cysteines in computationally designed proteins, where it discriminated catalytically active from inactive cysteine hydrolase designs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe4hHN7L4cGbVg90H21EOLACvtfcHk0lgrH5kIQ3EP6A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGhsr%252FI&md5=277e436e7a8f4dfff0b548bce52ac40d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature09472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09472%26sid%3Dliteratum%253Aachs%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DSimon%26aufirst%3DG.%2BM.%26aulast%3DRichter%26aufirst%3DF.%26aulast%3DKhare%26aufirst%3DS.%26aulast%3DDillon%26aufirst%3DM.%2BB.%2BD.%26aulast%3DBachovchin%26aufirst%3DD.%2BA.%26aulast%3DMowen%26aufirst%3DK.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DQuantitative%2520reactivity%2520profiling%2520predicts%2520functional%2520cysteines%2520in%2520proteomes%26jtitle%3DNature%26date%3D2010%26volume%3D468%26issue%3D7325%26spage%3D790%26epage%3D795%26doi%3D10.1038%2Fnature09472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leung, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardouin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Discovering potent and selective reversible inhibitors of enzymes in complex proteomes</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">687</span>â <span class="NLM_lpage">691</span>, <span class="refDoi">Â DOI: 10.1038/nbt826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnbt826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=12740587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFSlu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=687-691&issue=6&author=D.+Leungauthor=C.+Hardouinauthor=D.+L.+Bogerauthor=B.+F.+Cravatt&title=Discovering+potent+and+selective+reversible+inhibitors+of+enzymes+in+complex+proteomes&doi=10.1038%2Fnbt826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering potent and selective reversible inhibitors of enzymes in complex proteomes</span></div><div class="casAuthors">Leung, Donmienne; Hardouin, Christophe; Boger, Dale L.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">687-691</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To realize the promise of genomics-based therapeutics, new methods are needed to accelerate the discovery of small mols. that selectively modulate protein activity.  Toward this end, advances in combinatorial synthesis have provided unprecedented access to large compd. libraries of considerable structural complexity and diversity, shifting the bottleneck in drug discovery to the development of efficient screens for protein targets.  Screening for reversible enzyme inhibitors typically requires extensive target-specific work, including protein expression and purifn., as well as the development of specific substrate assays.  Here we report a proteomic method for the discovery of reversible enzyme inhibitors that avoids these steps.  We show that competitive profiling of a library of candidate serine hydrolase inhibitors in complex proteomes with activity-based chem. probes identifies nanomolar reversible inhibitors of several enzymes simultaneously, including the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH), triacylglycerol hydrolase (TGH) and an uncharacterized membrane-assocd. hydrolase that lacks known substrates.  The strategy tests inhibitors against numerous enzymes in parallel, assigning both potency and selectivity factors to each agent.  In this way, promiscuous inhibitors were readily rejected in favor of equally potent compds. with 500-fold or greater selectivity for their targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7L8MJXutl27Vg90H21EOLACvtfcHk0lhhFtHocgkTHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFSlu7o%253D&md5=3e9946306058b4a832fb046f1e49a9f0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnbt826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt826%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DHardouin%26aufirst%3DC.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDiscovering%2520potent%2520and%2520selective%2520reversible%2520inhibitors%2520of%2520enzymes%2520in%2520complex%2520proteomes%26jtitle%3DNat.%2520Biotechnol.%26date%3D2003%26volume%3D21%26issue%3D6%26spage%3D687%26epage%3D691%26doi%3D10.1038%2Fnbt826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Backus, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horning, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonzÃ¡lez-PÃ¡ez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanning, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teijaro, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolan, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Proteome-wide covalent ligand discovery in native biological systems</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>534</i></span> (<span class="NLM_issue">7608</span>),  <span class="NLM_fpage">570</span>â <span class="NLM_lpage">574</span>, <span class="refDoi">Â DOI: 10.1038/nature18002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature18002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27309814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSksbnN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=534&publication_year=2016&pages=570-574&issue=7608&author=K.+M.+Backusauthor=B.+E.+Correiaauthor=K.+M.+Lumauthor=S.+Forliauthor=B.+D.+Horningauthor=G.+E.+Gonz%C3%A1lez-P%C3%A1ezauthor=S.+Chatterjeeauthor=B.+R.+Lanningauthor=J.+R.+Teijaroauthor=A.+J.+Olsonauthor=D.+W.+Wolanauthor=B.+F.+Cravatt&title=Proteome-wide+covalent+ligand+discovery+in+native+biological+systems&doi=10.1038%2Fnature18002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Proteome-wide covalent ligand discovery in native biological systems</span></div><div class="casAuthors">Backus, Keriann M.; Correia, Bruno E.; Lum, Kenneth M.; Forli, Stefano; Horning, Benjamin D.; Gonzalez-Paez, Gonzalo E.; Chatterjee, Sandip; Lanning, Bryan R.; Teijaro, John R.; Olson, Arthur J.; Wolan, Dennis W.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">534</span>
        (<span class="NLM_cas:issue">7608</span>),
    <span class="NLM_cas:pages">570-574</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small mols. are powerful tools for investigating protein function and can serve as leads for new therapeutics.  Most human proteins, however, lack small-mol. ligands, and entire protein classes are considered 'undruggable'.  Fragment-based ligand discovery can identify small-mol. probes for proteins that have proven difficult to target using high-throughput screening of complex compd. libraries.  Although reversibly binding ligands are commonly pursued, covalent fragments provide an alternative route to small-mol. probes, including those that can access regions of proteins that are difficult to target through binding affinity alone.  Here we report a quant. anal. of cysteine-reactive small-mol. fragments screened against thousands of proteins in human proteomes and cells.  Covalent ligands were identified for >700 cysteines found in both druggable proteins and proteins deficient in chem. probes, including transcription factors, adaptor/scaffolding proteins, and uncharacterized proteins.  Among the atypical ligand-protein interactions discovered were compds. that react preferentially with pro- (inactive) caspases.  We used these ligands to distinguish extrinsic apoptosis pathways in human cell lines vs. primary human T cells, showing that the former is largely mediated by caspase-8 while the latter depends on both caspase-8 and -10.  Fragment-based covalent ligand discovery provides a greatly expanded portrait of the ligandable proteome and furnishes compds. that can illuminate protein functions in native biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgNJ88KALeSLVg90H21EOLACvtfcHk0lhhFtHocgkTHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSksbnN&md5=6fab087c042de735f8a5931e9f5b946c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature18002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18002%26sid%3Dliteratum%253Aachs%26aulast%3DBackus%26aufirst%3DK.%2BM.%26aulast%3DCorreia%26aufirst%3DB.%2BE.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DHorning%26aufirst%3DB.%2BD.%26aulast%3DGonz%25C3%25A1lez-P%25C3%25A1ez%26aufirst%3DG.%2BE.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DLanning%26aufirst%3DB.%2BR.%26aulast%3DTeijaro%26aufirst%3DJ.%2BR.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DWolan%26aufirst%3DD.%2BW.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DProteome-wide%2520covalent%2520ligand%2520discovery%2520in%2520native%2520biological%2520systems%26jtitle%3DNature%26date%3D2016%26volume%3D534%26issue%3D7608%26spage%3D570%26epage%3D574%26doi%3D10.1038%2Fnature18002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vinogradova, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remillard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazar, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suciu, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafroth, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konrad, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemper, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazear, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blewett, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dix, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokhirev, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lairson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melillo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teijaro, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">An activity-guided map of electrophile-cysteine interactions in primary human T cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>182</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1009</span>â <span class="NLM_lpage">1026</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2020.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.cell.2020.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32730809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFShs7rJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2020&pages=1009-1026&issue=4&author=E.+V.+Vinogradovaauthor=X.+Zhangauthor=D.+Remillardauthor=D.+C.+Lazarauthor=R.+M.+Suciuauthor=Y.+Wangauthor=G.+Biancoauthor=Y.+Yamashitaauthor=V.+M.+Crowleyauthor=M.+A.+Schafrothauthor=M.+Yokoyamaauthor=D.+B.+Konradauthor=K.+M.+Lumauthor=G.+M.+Simonauthor=E.+K.+Kemperauthor=M.+R.+Lazearauthor=S.+Yinauthor=M.+M.+Blewettauthor=M.+M.+Dixauthor=N.+Nguyenauthor=M.+N.+Shokhirevauthor=E.+N.+Chinauthor=L.+L.+Lairsonauthor=B.+Melilloauthor=S.+L.+Schreiberauthor=S.+Forliauthor=J.+R.+Teijaroauthor=B.+F.+Cravatt&title=An+activity-guided+map+of+electrophile-cysteine+interactions+in+primary+human+T+cells&doi=10.1016%2Fj.cell.2020.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells</span></div><div class="casAuthors">Vinogradova, Ekaterina V.; Zhang, Xiaoyu; Remillard, David; Lazar, Daniel C.; Suciu, Radu M.; Wang, Yujia; Bianco, Giulia; Yamashita, Yu; Crowley, Vincent M.; Schafroth, Michael A.; Yokoyama, Minoru; Konrad, David B.; Lum, Kenneth M.; Simon, Gabriel M.; Kemper, Esther K.; Lazear, Michael R.; Yin, Sifei; Blewett, Megan M.; Dix, Melissa M.; Nguyen, Nhan; Shokhirev, Maxim N.; Chin, Emily N.; Lairson, Luke L.; Melillo, Bruno; Schreiber, Stuart L.; Forli, Stefano; Teijaro, John R.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1009-1026.e29</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Electrophilic compds. originating from nature or chem. synthesis have profound effects on immune cells.  These compds. are thought to act by cysteine modification to alter the functions of immune-relevant proteins; however, our understanding of electrophile-sensitive cysteines in the human immune proteome remains limited.  Here, we present a global map of cysteines in primary human T cells that are susceptible to covalent modification by electrophilic small mols.  More than 3,000 covalently liganded cysteines were found on functionally and structurally diverse proteins, including many that play fundamental roles in immunol.  We further show that electrophilic compds. can impair T cell activation by distinct mechanisms involving the direct functional perturbation and/or degrdn. of proteins.  Our findings reveal a rich content of ligandable cysteines in human T cells and point to electrophilic small mols. as a fertile source for chem. probes and ultimately therapeutics that modulate immunol. processes and their assocd. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8xoUPD51cKrVg90H21EOLACvtfcHk0lhhFtHocgkTHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFShs7rJ&md5=9623b13c847b2088059b2157af63451f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DVinogradova%26aufirst%3DE.%2BV.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRemillard%26aufirst%3DD.%26aulast%3DLazar%26aufirst%3DD.%2BC.%26aulast%3DSuciu%26aufirst%3DR.%2BM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBianco%26aufirst%3DG.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DSchafroth%26aufirst%3DM.%2BA.%26aulast%3DYokoyama%26aufirst%3DM.%26aulast%3DKonrad%26aufirst%3DD.%2BB.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DSimon%26aufirst%3DG.%2BM.%26aulast%3DKemper%26aufirst%3DE.%2BK.%26aulast%3DLazear%26aufirst%3DM.%2BR.%26aulast%3DYin%26aufirst%3DS.%26aulast%3DBlewett%26aufirst%3DM.%2BM.%26aulast%3DDix%26aufirst%3DM.%2BM.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DShokhirev%26aufirst%3DM.%2BN.%26aulast%3DChin%26aufirst%3DE.%2BN.%26aulast%3DLairson%26aufirst%3DL.%2BL.%26aulast%3DMelillo%26aufirst%3DB.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DTeijaro%26aufirst%3DJ.%2BR.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DAn%2520activity-guided%2520map%2520of%2520electrophile-cysteine%2520interactions%2520in%2520primary%2520human%2520T%2520cells%26jtitle%3DCell%26date%3D2020%26volume%3D182%26issue%3D4%26spage%3D1009%26epage%3D1026%26doi%3D10.1016%2Fj.cell.2020.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tonge, P. J.</span></span> <span> </span><span class="NLM_article-title">Drug-target kinetics in drug discovery</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">29</span>â <span class="NLM_lpage">39</span>, <span class="refDoi">Â DOI: 10.1021/acschemneuro.7b00185</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVeku7%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=29-39&issue=1&author=P.+J.+Tonge&title=Drug-target+kinetics+in+drug+discovery&doi=10.1021%2Facschemneuro.7b00185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-Target Kinetics in Drug Discovery</span></div><div class="casAuthors">Tonge, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-39</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of therapies for the treatment of neurol. cancer faces a no. of major challenges including the synthesis of small mol. agents that can penetrate the blood brain barrier (BBB).  Given the likelihood that in many cases drug exposure will be lower in the CNS than in systemic circulation, it follows that strategies should be employed that can sustain target engagement at low drug concn.  Time dependent target occupancy is a function of both the drug and target concn. as well as the thermodn. and kinetic parameters that describe the binding reaction coordinate, and sustained target occupancy can be achieved through structural modifications that increase target (re)binding and/or that decrease the rate of drug dissocn.  The discovery and deployment of compds. with optimized kinetic effects requires information on the structure-kinetic relationships that modulate the kinetics of binding, and the mol. factors that control the translation of drug-target kinetics to time-dependent drug activity in the disease state.  This review first introduces the potential benefits of drug-target kinetics, such as the ability to delineate both thermodn. and kinetic selectivity, and then describes factors, such as target vulnerability, that impact the utility of kinetic selectivity.  The review concludes with a description of a mechanistic PK/PD model that integrates drug-target kinetics into predictions of drug activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ5Cj523Tg9rVg90H21EOLACvtfcHk0ljy_BXWHVc0zw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVeku7%252FN&md5=59dde9100672e664d4b3b77a5f171b68</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00185%26sid%3Dliteratum%253Aachs%26aulast%3DTonge%26aufirst%3DP.%2BJ.%26atitle%3DDrug-target%2520kinetics%2520in%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D29%26epage%3D39%26doi%3D10.1021%2Facschemneuro.7b00185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lebraud, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâReilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenzano, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span> <span> </span><span class="NLM_article-title">Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">45</span>),  <span class="NLM_fpage">8608</span>â <span class="NLM_lpage">8618</span>, <span class="refDoi">Â DOI: 10.1039/C8SC02754D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1039%2FC8SC02754D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30568786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslCnt7rP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=8608-8618&issue=45&author=H.+Lebraudauthor=O.+Surovaauthor=A.+Courtinauthor=M.+O%E2%80%99Reillyauthor=C.+R.+Valenzanoauthor=P.+Nordlundauthor=T.+D.+Heightman&title=Quantitation+of+ERK1%2F2+inhibitor+cellular+target+occupancies+with+a+reversible+slow+off-rate+probe&doi=10.1039%2FC8SC02754D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe</span></div><div class="casAuthors">Lebraud, Honorine; Surova, Olga; Courtin, Aurelie; O'Reilly, Marc; Valenzano, Chiara R.; Nordlund, Par; Heightman, Tom D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">8608-8618</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Target engagement is a key concept in drug discovery and its direct measurement can provide a quant. understanding of drug efficacy and/or toxicity.  Failure to demonstrate target occupancy in relevant cells and tissues has been recognized as a contributing factor to the low success rate of clin. drug development.  Several techniques are emerging to quantify target engagement in cells; however, in situ measurements remain challenging, mainly due to tech. limitations.  Here, we report the development of a non-covalent clickable probe, based on SCH772984, a slow off-rate ERK1/2 inhibitor, which enabled efficient pull down of ERK1/2 protein via click reaction with tetrazine tagged agarose beads.  This was used in a competition setting to measure relative target occupancy by selected ERK1/2 inhibitors.  As a ref. we used the cellular thermal shift assay, a label-free biophys. assay relying solely on ligand-induced thermodn. stabilization of proteins.  To validate the EC50 values measured by both methods, the results were compared with IC50 data for the phosphorylation of RSK, a downstream substrate of ERK1/2 used as a functional biomarker of ERK1/2 inhibition.  We showed that a slow off-rate reversible probe can be used to efficiently pull down cellular proteins, significantly extending the potential of the approach beyond the need for covalent or photoaffinity warheads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF5b9dAQEMwrVg90H21EOLACvtfcHk0ljy_BXWHVc0zw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslCnt7rP&md5=80d8668a3fc75e41bf4cb3ba1260d6ca</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2FC8SC02754D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8SC02754D%26sid%3Dliteratum%253Aachs%26aulast%3DLebraud%26aufirst%3DH.%26aulast%3DSurova%26aufirst%3DO.%26aulast%3DCourtin%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DValenzano%26aufirst%3DC.%2BR.%26aulast%3DNordlund%26aufirst%3DP.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3DQuantitation%2520of%2520ERK1%252F2%2520inhibitor%2520cellular%2520target%2520occupancies%2520with%2520a%2520reversible%2520slow%2520off-rate%2520probe%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26issue%3D45%26spage%3D8608%26epage%3D8618%26doi%3D10.1039%2FC8SC02754D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">OâDonoghue, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eroy-Reveles, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudsen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingram, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Statnekov, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greninger, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hostetter, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltby, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRisi, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlingame, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Global identification of peptidase specificity by multiplex substrate profiling</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1095</span>â <span class="NLM_lpage">1100</span>, <span class="refDoi">Â DOI: 10.1038/nmeth.2182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnmeth.2182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23023596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaqtrvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=1095-1100&issue=11&author=A.+J.+O%E2%80%99Donoghueauthor=A.+A.+Eroy-Revelesauthor=G.+M.+Knudsenauthor=J.+Ingramauthor=M.+Zhouauthor=J.+B.+Statnekovauthor=A.+L.+Greningerauthor=D.+R.+Hostetterauthor=G.+Quauthor=D.+A.+Maltbyauthor=M.+O.+Andersonauthor=J.+L.+DeRisiauthor=J.+H.+McKerrowauthor=A.+L.+Burlingameauthor=C.+S.+Craik&title=Global+identification+of+peptidase+specificity+by+multiplex+substrate+profiling&doi=10.1038%2Fnmeth.2182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Global identification of peptidase specificity by multiplex substrate profiling</span></div><div class="casAuthors">O'Donoghue, Anthony J.; Eroy-Reveles, A. Alegra; Knudsen, Giselle M.; Ingram, Jessica; Zhou, Min; Statnekov, Jacob B.; Greninger, Alexander L.; Hostetter, Daniel R.; Qu, Gang; Maltby, David A.; Anderson, Marc O.; DeRisi, Joseph L.; McKerrow, James H.; Burlingame, Alma L.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1095-1100</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors developed a simple and rapid multiplex substrate-profiling method to reveal the substrate specificity of any endo- or exopeptidase using liq. chromatog.-tandem mass spectrometry sequencing.  The authors generated a physicochem. diverse library of peptides by incorporating all combinations of neighbor and near-neighbor amino acid pairs into decapeptide sequences that are flanked by unique dipeptides at each terminus.  Addn. of a panel of evolutionarily diverse peptidases to a mixt. of these tetradecapeptides generated information on prime and nonprime sites as well as on substrate specificity that matched or expanded upon known substrate motifs.  This method biochem. confirmed the activity of the klassevirus 3C protein responsible for polypeptide processing and allowed granzyme B substrates to be ranked by enzymic turnover efficiency using label-free quantitation of precursor-ion abundance.  Addnl., the proteolytic secretions from schistosome parasitic flatworm larvae and a pancreatic cancer cell line were deconvoluted in a subtractive strategy using class-specific peptidase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHUJit7mNKQ7Vg90H21EOLACvtfcHk0li3uKoPtINEng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaqtrvK&md5=76e0312242ac2cac53fd46957793e492</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.2182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.2182%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Donoghue%26aufirst%3DA.%2BJ.%26aulast%3DEroy-Reveles%26aufirst%3DA.%2BA.%26aulast%3DKnudsen%26aufirst%3DG.%2BM.%26aulast%3DIngram%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DStatnekov%26aufirst%3DJ.%2BB.%26aulast%3DGreninger%26aufirst%3DA.%2BL.%26aulast%3DHostetter%26aufirst%3DD.%2BR.%26aulast%3DQu%26aufirst%3DG.%26aulast%3DMaltby%26aufirst%3DD.%2BA.%26aulast%3DAnderson%26aufirst%3DM.%2BO.%26aulast%3DDeRisi%26aufirst%3DJ.%2BL.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DBurlingame%26aufirst%3DA.%2BL.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DGlobal%2520identification%2520of%2520peptidase%2520specificity%2520by%2520multiplex%2520substrate%2520profiling%26jtitle%3DNat.%2520Methods%26date%3D2012%26volume%3D9%26issue%3D11%26spage%3D1095%26epage%3D1100%26doi%3D10.1038%2Fnmeth.2182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backes, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahrus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">7754</span>â <span class="NLM_lpage">7759</span>, <span class="refDoi">Â DOI: 10.1073/pnas.140132697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.140132697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10869434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCnt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=7754-7759&issue=14&author=J.+L.+Harrisauthor=B.+J.+Backesauthor=F.+Leonettiauthor=S.+Mahrusauthor=J.+A.+Ellmanauthor=C.+S.+Craik&title=Rapid+and+general+profiling+of+protease+specificity+by+using+combinatorial+fluorogenic+substrate+libraries&doi=10.1073%2Fpnas.140132697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries</span></div><div class="casAuthors">Harris, Jennifer L.; Backes, Bradley J.; Leonetti, Francesco; Mahrus, Sami; Ellman, Jonathan A.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7754-7759</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A method is presented for the prepn. and use of fluorogenic peptide substrates that allows for the configuration of general substrate libraries to rapidly identify the primary and extended specificity of proteases.  The substrates contain the fluorogenic leaving group 7-amino-4-carbamoylmethylcoumarin (ACC).  Substrates incorporating the ACC leaving group show kinetic profiles comparable to those with the traditionally used 7-amino-4-methylcoumarin (AMC) leaving group.  The bifunctional nature of ACC allows for the efficient prodn. of single substrates and substrate libraries by using 9-fluorenylmethoxycarbonyl (Fmoc)-based solid-phase synthesis techniques.  The approx. 3-fold-increased quantum yield of ACC over AMC permits redn. in enzyme and substrate concns.  As a consequence, a greater no. of substrates can be tolerated in a single assay, thus enabling an increase in the diversity space of the library.  Sol. positional protease substrate libraries of 137,180 and 6859 members, possessing amino acid diversity at the P4-P3-P2-P1 and P4-P3-P2 positions, resp., were constructed.  Employing this screening method, we profiled the substrate specificities of a diverse array of proteases, including the serine proteases thrombin, plasmin, factor Xa, urokinase-type plasminogen activator, tissue plasminogen activator, granzyme B, trypsin, chymotrypsin, human neutrophil elastase, and the cysteine proteases papain and cruzain.  The resulting profiles create a pharmacophoric portrayal of the proteases to aid in the design of selective substrates and potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE5k5AkbXvLbVg90H21EOLACvtfcHk0li3uKoPtINEng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCnt7Y%253D&md5=669beba3367acd1911a2a39660117a78</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.140132697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.140132697%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26aulast%3DBackes%26aufirst%3DB.%2BJ.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DMahrus%26aufirst%3DS.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DRapid%2520and%2520general%2520profiling%2520of%2520protease%2520specificity%2520by%2520using%2520combinatorial%2520fluorogenic%2520substrate%2520libraries%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26issue%3D14%26spage%3D7754%26epage%3D7759%26doi%3D10.1073%2Fpnas.140132697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenbaum, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecaille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BrÃ¶mme, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">12824</span>â <span class="NLM_lpage">12832</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M513331200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.M513331200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=16520377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFKktLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=12824-12832&issue=18&author=Y.+Choeauthor=F.+Leonettiauthor=D.+C.+Greenbaumauthor=F.+Lecailleauthor=M.+Bogyoauthor=D.+Br%C3%B6mmeauthor=J.+A.+Ellmanauthor=C.+S.+Craik&title=Substrate+profiling+of+cysteine+proteases+using+a+combinatorial+peptide+library+identifies+functionally+unique+specificities&doi=10.1074%2Fjbc.M513331200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate Profiling of Cysteine Proteases Using a Combinatorial Peptide Library Identifies Functionally Unique Specificities</span></div><div class="casAuthors">Choe, Youngchool; Leonetti, Francesco; Greenbaum, Doron C.; Lecaille, Fabien; Bogyo, Matthew; Broemme, Dieter; Ellman, Jonathan A.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">12824-12832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The substrate specificities of papain-like cysteine proteases (clan CA, family C1) papain, bromelain, and human cathepsins L, V, K, S, F, B, and five proteases of parasitic origin were studied using a completely diversified positional scanning synthetic combinatorial library.  A bifunctional coumarin fluorophore was used that facilitated synthesis of the library and individual peptide substrates.  The library has a total of 160,000 tetrapeptide substrate sequences completely randomizing each of the P1, P2, P3, and P4 positions with 20 amino acids.  A microtiter plate assay format permitted a rapid detn. of the specificity profile of each enzyme.  Individual peptide substrates were then synthesized and tested for a quant. detn. of the specificity of the human cathepsins.  Despite the conserved three-dimensional structure and similar substrate specificity of the enzymes studied, distinct amino acid preferences that differentiate each enzyme were identified.  The specificities of cathepsins K and S partially match the cleavage site sequences in their physiol. substrates.  Capitalizing on its unique preference for proline and glycine at the P2 and P3 positions, resp., selective substrates and a substrate-based inhibitor were developed for cathepsin K.  A cluster anal. of the proteases based on the complete specificity profile provided a functional characterization distinct from std. sequence anal.  This approach provides useful information for developing selective chem. probes to study protease-related pathologies and physiologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd-Na7PpDSPLVg90H21EOLACvtfcHk0li3uKoPtINEng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFKktLY%253D&md5=8a90a92e810ac59436a9ea3a12536f27</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M513331200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M513331200%26sid%3Dliteratum%253Aachs%26aulast%3DChoe%26aufirst%3DY.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DGreenbaum%26aufirst%3DD.%2BC.%26aulast%3DLecaille%26aufirst%3DF.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DSubstrate%2520profiling%2520of%2520cysteine%2520proteases%2520using%2520a%2520combinatorial%2520peptide%2520library%2520identifies%2520functionally%2520unique%2520specificities%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D18%26spage%3D12824%26epage%3D12832%26doi%3D10.1074%2Fjbc.M513331200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rano, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasper, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timkey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Calvo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houtzager, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordstrom, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaillancourt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, D. W.</span></span> <span> </span><span class="NLM_article-title">A combinatorial approach defines specificities of members of the caspase family and granzyme B: Functional relationships established for key mediators of apoptosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span> (<span class="NLM_issue">29</span>),  <span class="NLM_fpage">17907</span>â <span class="NLM_lpage">17911</span>, <span class="refDoi">Â DOI: 10.1074/jbc.272.29.17907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.272.29.17907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=9218414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2sXkslKgtbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=17907-17911&issue=29&author=N.+A.+Thornberryauthor=T.+A.+Ranoauthor=E.+P.+Petersonauthor=D.+M.+Rasperauthor=T.+Timkeyauthor=M.+Garcia-Calvoauthor=V.+M.+Houtzagerauthor=P.+A.+Nordstromauthor=S.+Royauthor=J.+P.+Vaillancourtauthor=K.+T.+Chapmanauthor=D.+W.+Nicholson&title=A+combinatorial+approach+defines+specificities+of+members+of+the+caspase+family+and+granzyme+B%3A+Functional+relationships+established+for+key+mediators+of+apoptosis&doi=10.1074%2Fjbc.272.29.17907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis</span></div><div class="casAuthors">Thornberry, Nancy A.; Rano, Thomas A.; Peterson, Erin P.; Rasper, Dita M.; Timkey, Tracy; Garcia-Calvo, Margarita; Houtzager, Vicky M.; Nordstrom, Penny A.; Roy, Sophie; Vaillancourt, John P.; Chapman, Kevin T.; Nicholson, Donald W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">17907-17911</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">There is compelling evidence that members of the caspase (interleukin-1Î² converting enzyme/CED-3) family of cysteine proteases and the cytotoxic lymphocyte-derived serine protease granzyme B play essential roles in mammalian apoptosis.  Here we use a novel method employing a positional scanning substrate combinatorial library to rigorously define their individual specificities.  The results divide these proteases into three distinct groups and suggest that several have redundant functions.  The specificity of caspases 2, 3, and 7 and Caenorhabditis elegans CED-3 (DEXD) suggests that all of these enzymes function to incapacitate essential homeostatic pathways during the effector phase of apoptosis.  In contrast, the optimal sequence for caspases 6, 8, and 9 and granzyme B ((I/L/V)EXD) resembles activation sites in effector caspase proenzymes, consistent with a role for these enzymes in upstream components in a proteolytic cascade that amplifies the death signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqskfpc5Wd3RrVg90H21EOLACvtfcHk0lhwGTPcIO6rsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslKgtbc%253D&md5=44abe20ff00574bb756a1591ed77e110</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.29.17907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.29.17907%26sid%3Dliteratum%253Aachs%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DRano%26aufirst%3DT.%2BA.%26aulast%3DPeterson%26aufirst%3DE.%2BP.%26aulast%3DRasper%26aufirst%3DD.%2BM.%26aulast%3DTimkey%26aufirst%3DT.%26aulast%3DGarcia-Calvo%26aufirst%3DM.%26aulast%3DHoutzager%26aufirst%3DV.%2BM.%26aulast%3DNordstrom%26aufirst%3DP.%2BA.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DVaillancourt%26aufirst%3DJ.%2BP.%26aulast%3DChapman%26aufirst%3DK.%2BT.%26aulast%3DNicholson%26aufirst%3DD.%2BW.%26atitle%3DA%2520combinatorial%2520approach%2520defines%2520specificities%2520of%2520members%2520of%2520the%2520caspase%2520family%2520and%2520granzyme%2520B%253A%2520Functional%2520relationships%2520established%2520for%2520key%2520mediators%2520of%2520apoptosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26issue%3D29%26spage%3D17907%26epage%3D17911%26doi%3D10.1074%2Fjbc.272.29.17907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2189</span>â <span class="NLM_lpage">2214</span>, <span class="refDoi">Â DOI: 10.1038/nprot.2017.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnprot.2017.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=28933778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFehtrjF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2189-2214&issue=10&author=M.+Porebaauthor=G.+S.+Salvesenauthor=M.+Drag&title=Synthesis+of+a+HyCoSuL+peptide+substrate+library+to+dissect+protease+substrate+specificity&doi=10.1038%2Fnprot.2017.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity</span></div><div class="casAuthors">Poreba, Marcin; Salvesen, Guy S.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2189-2214</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Many biol. and chem. based approaches have been developed to design highly active and selective protease substrates and probes.  It is, however, difficult to find substrate sequences that are truly selective for any given protease, as different proteases can demonstrate a great deal of overlap in substrate specificities.  In some cases, better enzyme selectivity can be achieved using peptide libraries contg. unnatural amino acids such as the hybrid combinatorial substrate library (HyCoSuL), which uses both natural and unnatural amino acids.  HyCoSuL is a combinatorial library of tetrapeptides contg. amino acid mixts. at the P4-P2 positions, a fixed amino acid at the P1 position, and an ACC (7-amino-4-carbamoylmethylcoumarin) fluorescent tag occupying the P1' position.  Once the peptide is recognized and cleaved by a protease, the ACC is released and produces a readable fluorescence signal.  Here, we describe the synthesis and screening of HyCoSuL for human caspases and legumain.  We also discuss possible modifications and adaptations of this approach that make it a useful tool for developing highly active and selective reagents for a wide variety of proteolytic enzymes.  The protocol can be divided into three major parts: (i) solid-phase synthesis of the fluorescence-labeled HyCoSuL, (ii) screening of protease P4-P2 preferences, and (iii) synthesis of the optimized activity probes equipped with an AOMK (acyloxymethyl ketone) reactive group and a biotin label for easy detection.  Beginning with the library design, the entire protocol can be completed in 4-8 wk (HyCoSuL synthesis: 3-5 wk; HyCoSuL screening per enzyme: 4-8 d; and activity-based probe synthesis: 1-2 wk).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYBvdwWr2XhLVg90H21EOLACvtfcHk0lhwGTPcIO6rsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFehtrjF&md5=5ece1429e76feedd3eb864f07da7f8b7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2017.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2017.091%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520a%2520HyCoSuL%2520peptide%2520substrate%2520library%2520to%2520dissect%2520protease%2520substrate%2520specificity%26jtitle%3DNat.%2520Protoc.%26date%3D2017%26volume%3D12%26issue%3D10%26spage%3D2189%26epage%3D2214%26doi%3D10.1038%2Fnprot.2017.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Unnatural amino acids increase sensitivity and provide for the design of highly selective caspase substrates</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1482</span>â <span class="NLM_lpage">1492</span>, <span class="refDoi">Â DOI: 10.1038/cdd.2014.64</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fcdd.2014.64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24832467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXot1ymsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1482-1492&issue=9&author=M.+Porebaauthor=P.+Kasperkiewiczauthor=S.+J.+Snipasauthor=D.+Fasciauthor=G.+S.+Salvesenauthor=M.+Drag&title=Unnatural+amino+acids+increase+sensitivity+and+provide+for+the+design+of+highly+selective+caspase+substrates&doi=10.1038%2Fcdd.2014.64"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Unnatural amino acids increase sensitivity and provide for the design of highly selective caspase substrates</span></div><div class="casAuthors">Poreba, M.; Kasperkiewicz, P.; Snipas, S. J.; Fasci, D.; Salvesen, G. S.; Drag, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1482-1492</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Traditional combinatorial peptidyl substrate library approaches generally utilize natural amino acids, limiting the usefulness of this tool in generating selective substrates for proteases that share similar substrate specificity profiles.  To address this limitation, we synthesized a Hybrid Combinatorial Substrate Library (HyCoSuL) with the general formula of Ac-P4-P3-P2-Asp-ACC, testing the approach on a family of closely related proteases - the human caspases.  The power of this library for caspase discrimination extends far beyond traditional PS-SCL approach, as in addn. to 19 natural amino acids we also used 110 diverse unnatural amino acids that can more extensively explore the chem. space represented by caspase-active sites.  Using this approach we identified and employed peptide-based substrates that provided excellent discrimination between individual caspases, allowing us to simultaneously resolve the individual contribution of the apical caspase-9 and the executioner caspase-3 and caspase-7 in the development of cytochrome-c-dependent apoptosis for the first time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSDqSSP6nnUrVg90H21EOLACvtfcHk0lhIhVr7pGVZEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXot1ymsLs%253D&md5=319049bbe5679cb416e1698a900d2a47</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2014.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2014.64%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DFasci%26aufirst%3DD.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DUnnatural%2520amino%2520acids%2520increase%2520sensitivity%2520and%2520provide%2520for%2520the%2520design%2520of%2520highly%2520selective%2520caspase%2520substrates%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2014%26volume%3D21%26issue%3D9%26spage%3D1482%26epage%3D1492%26doi%3D10.1038%2Fcdd.2014.64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salisbury, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Peptide microarrays for the determination of protease substrate specificity</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>124</i></span> (<span class="NLM_issue">50</span>),  <span class="NLM_fpage">14868</span>â <span class="NLM_lpage">14870</span>, <span class="refDoi">Â DOI: 10.1021/ja027477q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja027477q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVChtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=14868-14870&issue=50&author=C.+M.+Salisburyauthor=D.+J.+Malyauthor=J.+A.+Ellman&title=Peptide+microarrays+for+the+determination+of+protease+substrate+specificity&doi=10.1021%2Fja027477q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide Microarrays for the Determination of Protease Substrate Specificity</span></div><div class="casAuthors">Salisbury, Cleo M.; Maly, Dustin J.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">14868-14870</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A method is described for the prepn. of substrate microarrays that allow for the rapid detn. of protease substrate specificity.  Peptidyl coumarin substrates, synthesized on solid support using std. techniques, are printed onto glass slides using DNA microarraying equipment.  The linkage from the peptide to the slide is formed through a chemoselective reaction, resulting in an array of uniformly displayed fluorogenic substrates.  The arrays can be treated with proteases to yield substrate specificity profiles.  Std. instrumentation for visualization of microarrays can be used to obtain comparisons of the specificity consts. for all of the prepd. substrates.  The utility of these arrays is demonstrated by the selective cleavage of preferred substrates with trypsin, thrombin, and granzyme B, and by assessing the extended substrate specificity of thrombin using a microarray of 361 different peptidyl coumarin substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_9UJFjPfXUrVg90H21EOLACvtfcHk0lhIhVr7pGVZEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVChtr8%253D&md5=947f296baec5916ea2588d7b09c956b1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja027477q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja027477q%26sid%3Dliteratum%253Aachs%26aulast%3DSalisbury%26aufirst%3DC.%2BM.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DPeptide%2520microarrays%2520for%2520the%2520determination%2520of%2520protease%2520substrate%2520specificity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26issue%3D50%26spage%3D14868%26epage%3D14870%26doi%3D10.1021%2Fja027477q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gosalia, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salisbury, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, S. L.</span></span> <span> </span><span class="NLM_article-title">High throughput substrate specificity profiling of serine and cysteine proteases using solution-phase fluorogenic peptide microarrays</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">626</span>â <span class="NLM_lpage">636</span>, <span class="refDoi">Â DOI: 10.1074/mcp.M500004-MCP200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fmcp.M500004-MCP200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15705970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlSmsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=626-636&issue=5&author=D.+N.+Gosaliaauthor=C.+M.+Salisburyauthor=J.+A.+Ellmanauthor=S.+L.+Diamond&title=High+throughput+substrate+specificity+profiling+of+serine+and+cysteine+proteases+using+solution-phase+fluorogenic+peptide+microarrays&doi=10.1074%2Fmcp.M500004-MCP200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput substrate specificity profiling of serine and cysteine proteases using solution-phase fluorogenic peptide microarrays</span></div><div class="casAuthors">Gosalia, Dhaval N.; Salisbury, Cleo M.; Ellman, Jonathan A.; Diamond, Scott L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Proteomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">626-636</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9476</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Proteases regulate numerous biol. processes with a degree of specificity often dictated by the amino acid sequence of the substrate cleavage site.  To map protease/substrate interactions, a 722-member library of fluorogenic protease substrates of the general format Ac-Ala-X-X-(Arg/Lys)-coumarin was synthesized (X = all natural amino acids except cysteine) and microarrayed with fluorescent calibration stds. in glycerol nanodroplets on glass slides.  Specificities of 13 serine proteases (activated protein C, plasma kallikrein, factor VIIa, factor IXaÎ², factor XIa and factor Î± XIIa, activated complement C1s, C1r, and D, tryptase, trypsin, subtilisin Carlsberg, and cathepsin G) and 11 papain-like cysteine proteases (cathepsin B, H, K, L, S, and V, rhodesain, papain, chymopapain, ficin, and stem bromelain) were obtained from 103,968 sep. microarray fluorogenic reactions (722 substrates Ã 24 different proteases Ã 6 replicates).  This is the first comprehensive study to report the substrate specificity of rhodesain, a papain-like cysteine protease expressed by Trypanosoma brucei rhodesiense, a parasitic protozoa responsible for causing sleeping sickness.  Rhodesain displayed a strong P2 preference for Leu, Val, Phe, and Tyr in both the P1 = Lys and Arg libraries.  Soln.-phase microarrays facilitate protease/substrate specificity profiling in a rapid manner with minimal peptide library or enzyme usage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrShBLYt9S877Vg90H21EOLACvtfcHk0lid5n4F10d7AA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlSmsrY%253D&md5=f8560e365d168d1e8e0aa918dca621e9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M500004-MCP200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M500004-MCP200%26sid%3Dliteratum%253Aachs%26aulast%3DGosalia%26aufirst%3DD.%2BN.%26aulast%3DSalisbury%26aufirst%3DC.%2BM.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DDiamond%26aufirst%3DS.%2BL.%26atitle%3DHigh%2520throughput%2520substrate%2520specificity%2520profiling%2520of%2520serine%2520and%2520cysteine%2520proteases%2520using%2520solution-phase%2520fluorogenic%2520peptide%2520microarrays%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2005%26volume%3D4%26issue%3D5%26spage%3D626%26epage%3D636%26doi%3D10.1074%2Fmcp.M500004-MCP200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, W. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Substrate activity screening (SAS): a general procedure for the preparation and screening of a fragment-based non-peptidic protease substrate library for inhibitor discovery</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">424</span>â <span class="NLM_lpage">433</span>, <span class="refDoi">Â DOI: 10.1038/nprot.2007.28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnprot.2007.28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17406604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=424-433&issue=2&author=A.+W.+Pattersonauthor=W.+J.+L.+Woodauthor=J.+A.+Ellman&title=Substrate+activity+screening+%28SAS%29%3A+a+general+procedure+for+the+preparation+and+screening+of+a+fragment-based+non-peptidic+protease+substrate+library+for+inhibitor+discovery&doi=10.1038%2Fnprot.2007.28"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate activity screening (SAS): a general procedure for the preparation and screening of a fragment-based non-peptidic protease substrate library for inhibitor discovery</span></div><div class="casAuthors">Patterson, Andrew W.; Wood, Warren J. L.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">424-433</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Substrate activity screening (SAS) is a fragment-based method for the rapid development of novel substrates and their conversion into nonpeptidic inhibitors of Cys and Ser proteases.  The method consists of three steps.  A library of N-acyl aminocoumarins with diverse, low-mol.-wt. N-acyl groups is screened to identify protease substrates using a simple fluorescence-based assay;.  The identified N-acyl aminocoumarin substrates are optimized by rapid analog synthesis and evaluation; and.  The optimized substrates are converted into inhibitors by direct replacement of the aminocoumarin with known mechanism-based pharmacophores.  This protocol describes a general procedure for the solid-phase synthesis of a library of N-acyl aminocoumarin substrates and the screening procedure to identify weak binding substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6UUw0Ne1sF7Vg90H21EOLACvtfcHk0lid5n4F10d7AA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbjI&md5=fd74ca339edab953d74487f596263c43</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.28%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DA.%2BW.%26aulast%3DWood%26aufirst%3DW.%2BJ.%2BL.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DSubstrate%2520activity%2520screening%2520%2528SAS%2529%253A%2520a%2520general%2520procedure%2520for%2520the%2520preparation%2520and%2520screening%2520of%2520a%2520fragment-based%2520non-peptidic%2520protease%2520substrate%2520library%2520for%2520inhibitor%2520discovery%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26issue%3D2%26spage%3D424%26epage%3D433%26doi%3D10.1038%2Fnprot.2007.28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wood, W. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Substrate activity screening: A fragment-based method for the rapid identification of nonpeptidic protease inhibitors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">15521</span>â <span class="NLM_lpage">15527</span>, <span class="refDoi">Â DOI: 10.1021/ja0547230</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0547230" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2nu77O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=15521-15527&issue=44&author=W.+J.+L.+Woodauthor=A.+W.+Pattersonauthor=H.+Tsuruokaauthor=R.+K.+Jainauthor=J.+A.+Ellman&title=Substrate+activity+screening%3A+A+fragment-based+method+for+the+rapid+identification+of+nonpeptidic+protease+inhibitors&doi=10.1021%2Fja0547230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate activity screening: a fragment-based method for the rapid identification of nonpeptidic protease inhibitors</span></div><div class="casAuthors">Wood, Warren J. L.; Patterson, Andrew W.; Tsuruoka, Hiroyuki; Jain, Rishi K.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">15521-15527</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new fragment-based method for the rapid development of novel and distinct classes of nonpeptidic protease inhibitors, Substrate Activity Screening (SAS), is described.  This method consists of three steps: (1) a library of N-acyl aminocoumarins with diverse, low mol. wt. N-acyl groups is screened to identify protease substrates using a simple fluorescence-based assay, (2) the identified N-acyl aminocoumarin substrates are optimized by rapid analog synthesis and evaluation, and (3) the optimized substrates are converted to inhibitors by direct replacement of the aminocoumarin with known mechanism-based pharmacophores.  The SAS method was successfully applied to the cysteine protease cathepsin S, which is implicated in autoimmune diseases.  Multiple distinct classes of nonpeptidic substrates were identified upon screening an N-acyl aminocoumarin library.  Two of the nonpeptidic substrate classes were optimized to substrates with >8000-fold improvements in cleavage efficiency for each class.  Select nonpeptidic substrates were then directly converted to low mol. wt., novel aldehyde inhibitors with nanomolar affinity to cathepsin S.  This study demonstrates the unique characteristics and merits of this first substrate-based method for the rapid identification and optimization of weak fragments and provides the framework for the development of completely nonpeptidic inhibitors to many different proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwTBkUUwtYpbVg90H21EOLACvtfcHk0lhJ0_vQnBT1YA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2nu77O&md5=9eceb09f7fc65840d37d465b98bf72af</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fja0547230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0547230%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DW.%2BJ.%2BL.%26aulast%3DPatterson%26aufirst%3DA.%2BW.%26aulast%3DTsuruoka%26aufirst%3DH.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DSubstrate%2520activity%2520screening%253A%2520A%2520fragment-based%2520method%2520for%2520the%2520rapid%2520identification%2520of%2520nonpeptidic%2520protease%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26issue%3D44%26spage%3D15521%26epage%3D15527%26doi%3D10.1021%2Fja0547230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span> <span> </span><span class="NLM_article-title">Substrate phage: selection of protease substrates by monovalent phage display</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>260</i></span> (<span class="NLM_issue">5111</span>),  <span class="NLM_fpage">1113</span>â <span class="NLM_lpage">1117</span>, <span class="refDoi">Â DOI: 10.1126/science.8493554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fscience.8493554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8493554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3sXltFWqtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1993&pages=1113-1117&issue=5111&author=D.+J.+Matthewsauthor=J.+A.+Wells&title=Substrate+phage%3A+selection+of+protease+substrates+by+monovalent+phage+display&doi=10.1126%2Fscience.8493554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate phage: selection of protease substrates by monovalent phage display</span></div><div class="casAuthors">Matthews, David J.; Wells, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">5111</span>),
    <span class="NLM_cas:pages">1113-17</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A method is described here for identifying good protease substrates among â¼107 possible sequences.  A library of fusion proteins was constructed contg. an N-terminal domain used to bind to an affinity support, followed by a randomized protease substrate sequence and the C-terminal domain of phage M13 gene III.  Each fusion protein was displayed as a single copy on filamentous phagemid particles (substrate phage).  Phage were then bound to an affinity support and treated with the protease of interest.  Phage with good protease substrates were released, whereas phage with substrates that resisted proteolysis remained bound.  After several rounds of binding, proteolysis, and phagemid propagation, sensitive and resistant substrate sequences were identified for 2 different proteases, a variant of subtilisin and blood-coagulation factor Xa.  The technique may also be useful for studying the sequence specificity of a variety of posttranslational modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEEI1NqViqFbVg90H21EOLACvtfcHk0lhJ0_vQnBT1YA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltFWqtbY%253D&md5=1c9473b97653eb9af556ca93c1c828ba</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1126%2Fscience.8493554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8493554%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DD.%2BJ.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DSubstrate%2520phage%253A%2520selection%2520of%2520protease%2520substrates%2520by%2520monovalent%2520phage%2520display%26jtitle%3DScience%26date%3D1993%26volume%3D260%26issue%3D5111%26spage%3D1113%26epage%3D1117%26doi%3D10.1126%2Fscience.8493554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâDonovan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRisi, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span> <span> </span><span class="NLM_article-title">Deep profiling of protease substrate specificity enabled by dual random and scanned human proteome substrate phage libraries</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">25464</span>â <span class="NLM_lpage">25475</span>, <span class="refDoi">Â DOI: 10.1073/pnas.2009279117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.2009279117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32973096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVKktL%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2020&pages=25464-25475&issue=41&author=J.+Zhouauthor=S.+Liauthor=K.+K.+Leungauthor=B.+O%E2%80%99Donovanauthor=J.+Y.+Zouauthor=J.+L.+DeRisiauthor=J.+A.+Wells&title=Deep+profiling+of+protease+substrate+specificity+enabled+by+dual+random+and+scanned+human+proteome+substrate+phage+libraries&doi=10.1073%2Fpnas.2009279117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Deep profiling of protease substrate specificity enabled by dual random and scanned human proteome substrate phage libraries</span></div><div class="casAuthors">Zhou, Jie; Li, Shantao; Leung, Kevin K.; O'Donovan, Brian; Zou, James Y.; DeRisi, Joseph L.; Wells, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">25464-25475</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Proteolysis is a major posttranslational regulator of biol. inside and outside of cells.  Broad identification of optimal cleavage sites and natural substrates of proteases is crit. for drug discovery and to understand protease biol.  Here, we present a method that employs two genetically encoded substrate phage display libraries coupled with next generation sequencing (SPD-NGS) that allows up to 10,000-fold deeper sequence coverage of the typical six- to eight-residue protease cleavage sites compared to state-of-the-art synthetic peptide libraries or proteomics.  We applied SPD-NGS to two classes of proteases, the intracellular caspases, and the ectodomains of the sheddases, ADAMs 10 and 17.  The first library (Lib 10AA) allowed us to identify 104 to 105 unique cleavage sites over a 1,000-fold dynamic range of NGS counts and produced consensus and optimal cleavage motifs based position-specific scoring matrixes.  A second SPD-NGS library (Lib hP), which displayed virtually the entire human proteome tiled in contiguous 49 amino acid sequences with 25 amino acid overlaps, enabled us to identify candidate human proteome sequences.  We identified up to 104 natural linear cut sites, depending on the protease, and captured most of the examples previously identified by proteomics and predicted 10- to 100-fold more.  Structural bioinformatics was used to facilitate the identification of candidate natural protein substrates.  SPD-NGS is rapid, reproducible, simple to perform and analyze, inexpensive, and renewable, with unprecedented depth of coverage for substrate sequences, and is an important tool for protease biologists interested in protease specificity for specific assays and inhibitors and to facilitate identification of natural protein substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKDlFxpSWQmLVg90H21EOLACvtfcHk0lhJ0_vQnBT1YA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVKktL%252FN&md5=ff50b0632e9c33de63a8be4fcb0c5f7d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2009279117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2009279117%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLeung%26aufirst%3DK.%2BK.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DB.%26aulast%3DZou%26aufirst%3DJ.%2BY.%26aulast%3DDeRisi%26aufirst%3DJ.%2BL.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DDeep%2520profiling%2520of%2520protease%2520substrate%2520specificity%2520enabled%2520by%2520dual%2520random%2520and%2520scanned%2520human%2520proteome%2520substrate%2520phage%2520libraries%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2020%26volume%3D117%26issue%3D41%26spage%3D25464%26epage%3D25475%26doi%3D10.1073%2Fpnas.2009279117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutherford, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, G.</span></span> <span> </span><span class="NLM_article-title">Phage-encoded combinatorial chemical libraries based on bicyclic peptides</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">502</span>â <span class="NLM_lpage">507</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnchembio.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19483697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1altbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=502-507&issue=7&author=C.+Heinisauthor=T.+Rutherfordauthor=S.+Freundauthor=G.+Winter&title=Phage-encoded+combinatorial+chemical+libraries+based+on+bicyclic+peptides&doi=10.1038%2Fnchembio.184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Phage-encoded combinatorial chemical libraries based on bicyclic peptides</span></div><div class="casAuthors">Heinis, Christian; Rutherford, Trevor; Freund, Stephan; Winter, Greg</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">502-507</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here we describe a phage strategy for the selection of ligands based on bicyclic or linear peptides attached covalently to an org. core.  We designed peptide repertoires with three reactive cysteine residues, each spaced apart by several random amino acid residues, and we fused the repertoires to the phage gene-3-protein.  Conjugation with tris-(bromomethyl)benzene via the reactive cysteines generated repertoires of peptide conjugates with two peptide loops anchored to a mesitylene core.  Iterative affinity selections yielded several enzyme inhibitors; after further mutagenesis and selection, we were able to chem. synthesize a lead inhibitor (PK15; Ki = 1.5 nM) specific to human plasma kallikrein that efficiently interrupted the intrinsic coagulation pathway in human plasma tested ex vivo.  This approach offers a powerful means of generating and selecting bicyclic macrocycles (or if cleaved, linear derivs. thereof) as ligands poised at the interface of small-mol. drugs and biologics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZhJRZyldisLVg90H21EOLACvtfcHk0limmmr3CoV9Vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1altbs%253D&md5=0634460f77b185fbcf85309c6dbf93e3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.184%26sid%3Dliteratum%253Aachs%26aulast%3DHeinis%26aufirst%3DC.%26aulast%3DRutherford%26aufirst%3DT.%26aulast%3DFreund%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DG.%26atitle%3DPhage-encoded%2520combinatorial%2520chemical%2520libraries%2520based%2520on%2520bicyclic%2520peptides%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26issue%3D7%26spage%3D502%26epage%3D507%26doi%3D10.1038%2Fnchembio.184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fellner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mace, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Identification of highly selective covalent inhibitors by phage display</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">490</span>, <span class="refDoi">Â DOI: 10.1038/s41587-020-0733-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41587-020-0733-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=33199876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlGjsb7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2021&pages=490&author=S.+Chenauthor=S.+Lovellauthor=S.+Leeauthor=M.+Fellnerauthor=P.+D.+Maceauthor=M.+Bogyo&title=Identification+of+highly+selective+covalent+inhibitors+by+phage+display&doi=10.1038%2Fs41587-020-0733-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of highly selective covalent inhibitors by phage display</span></div><div class="casAuthors">Chen, Shiyu; Lovell, Scott; Lee, Sumin; Fellner, Matthias; Mace, Peter D.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">490-498</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Portfolio</span>)
        </div><div class="casAbstract">Mols. that covalently bind macromol. targets have found widespread applications as activity-based probes and as irreversibly binding drugs.  However, the general reactivity of the electrophiles needed for covalent bond formation makes control of selectivity difficult.  There is currently no rapid, unbiased screening method to identify new classes of covalent inhibitors from highly diverse pools of candidate mols.  Here we describe a phage display method to directly screen for ligands that bind to protein targets through covalent bond formation.  This approach makes use of a reactive linker to form cyclic peptides on the phage surface while simultaneously introducing an electrophilic 'warhead' to covalently react with a nucleophile on the target.  Using this approach, we identified cyclic peptides that irreversibly inhibited a cysteine protease and a serine hydrolase with nanomolar potency and exceptional specificity.  This approach should enable rapid, unbiased screening to identify new classes of highly selective covalent inhibitors for diverse mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6VXSDuC_yqbVg90H21EOLACvtfcHk0limmmr3CoV9Vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlGjsb7M&md5=f4a2105dc2de93f13e110473fc19dfed</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fs41587-020-0733-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41587-020-0733-7%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLovell%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DFellner%26aufirst%3DM.%26aulast%3DMace%26aufirst%3DP.%2BD.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520highly%2520selective%2520covalent%2520inhibitors%2520by%2520phage%2520display%26jtitle%3DNat.%2520Biotechnol.%26date%3D2021%26volume%3D39%26spage%3D490%26doi%3D10.1038%2Fs41587-020-0733-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">Structure- and fragment-based approaches to protease inhibition</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">317</span>â <span class="NLM_lpage">329</span>, <span class="refDoi">Â DOI: 10.2174/156802606776287072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.2174%2F156802606776287072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=16611145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVahsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=317-329&issue=4&author=S.+Johnsonauthor=M.+Pellecchia&title=Structure-+and+fragment-based+approaches+to+protease+inhibition&doi=10.2174%2F156802606776287072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and fragment-based approaches to protease inhibition</span></div><div class="casAuthors">Johnson, Sherida L.; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-329</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Proteases are essential enzymes which regulate physiol. processes such as inflammation, infection, fertilization, allergic reactions, cell growth and death, blood clotting, tumor growth and bone remodeling.  The protease family consists of six major classes of enzymes which are aspartic-, serine-, cysteine-, threonine-, glutamic-, and metallo-proteases, all which are implicated in disease propagation.  Therefore, protease inhibitors have been of great interest as possible targets for the development of novel therapies.  Although, many protease inhibitors have followed a structural design based on either a peptidic or peptidomimetic backbone, other chem. scaffolds have recently emerged.  Utilizing structure- and fragment-based design guided by X-ray crystallog., NMR spectroscopy, computational and/or extended tethering approaches, potential non-peptidic therapeutic agents could be identified.  In this review, we will report on the recent developments of nonpeptidic cysteine- and metallo- protease inhibitors, focusing on their design by using such strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0HHEPP9rf9rVg90H21EOLACvtfcHk0limmmr3CoV9Vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVahsb4%253D&md5=c5039c54532ef1a389350fe6e2f85b5e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F156802606776287072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776287072%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DStructure-%2520and%2520fragment-based%2520approaches%2520to%2520protease%2520inhibition%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26issue%3D4%26spage%3D317%26epage%3D329%26doi%3D10.2174%2F156802606776287072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span> <span> </span><span class="NLM_article-title">Emerging principles in protease-based drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">690</span>â <span class="NLM_lpage">701</span>, <span class="refDoi">Â DOI: 10.1038/nrd3053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnrd3053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=20811381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSisbzP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=690-701&issue=9&author=M.+Dragauthor=G.+S.+Salvesen&title=Emerging+principles+in+protease-based+drug+discovery&doi=10.1038%2Fnrd3053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging principles in protease-based drug discovery</span></div><div class="casAuthors">Drag, Marcin; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">690-701</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Proteases have an important role in many signalling pathways, and represent potential drug targets for diseases ranging from cardiovascular disorders to cancer, as well as for combating many parasites and viruses.  Although inhibitors of well-established protease targets such as angiotensin-converting enzyme and HIV protease have shown substantial therapeutic success, developing drugs for new protease targets has proved challenging in recent years.  This in part could be due to issues such as the difficulty of achieving selectivity when targeting protease active sites.  This Perspective discusses the general principles in protease-based drug discovery, highlighting the lessons learned and the emerging strategies, such as targeting allosteric sites, which could help harness the therapeutic potential of new protease targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz3PQDA1pnT7Vg90H21EOLACvtfcHk0ljngtERVCH6AA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSisbzP&md5=28a9571473c3f753027665b77d3257d0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnrd3053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3053%26sid%3Dliteratum%253Aachs%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DEmerging%2520principles%2520in%2520protease-based%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26issue%3D9%26spage%3D690%26epage%3D701%26doi%3D10.1038%2Fnrd3053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Man, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanneganti, T.-D.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>277</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">61</span>â <span class="NLM_lpage">75</span>, <span class="refDoi">Â DOI: 10.1111/imr.12534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1111%2Fimr.12534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=28462526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVeluro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2017&pages=61-75&issue=1&author=S.+M.+Manauthor=R.+Karkiauthor=T.-D.+Kanneganti&title=Molecular+mechanisms+and+functions+of+pyroptosis%2C+inflammatory+caspases+and+inflammasomes+in+infectious+diseases&doi=10.1111%2Fimr.12534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases</span></div><div class="casAuthors">Man, Si Ming; Karki, Rajendra; Kanneganti, Thirumala-Devi</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-75</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Cell death is a fundamental biol. phenomenon that is essential for the survival and development of an organism.  Emerging evidence also indicates that cell death contributes to immune defense against infectious diseases.  Pyroptosis is a form of inflammatory programmed cell death pathway activated by human and mouse caspase-1, human caspase-4 and caspase-5, or mouse caspase-11.  These inflammatory caspases are used by the host to control bacterial, viral, fungal, or protozoan pathogens.  Pyroptosis requires cleavage and activation of the pore-forming effector protein gasdermin D by inflammatory caspases.  Phys. rupture of the cell causes release of the pro-inflammatory cytokines IL-1Î² and IL-18, alarmins and endogenous danger-assocd. mol. patterns, signifying the inflammatory potential of pyroptosis.  Here, we describe the central role of inflammatory caspases and pyroptosis in mediating immunity to infection and clearance of pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVzNwDuy-jq7Vg90H21EOLACvtfcHk0ljngtERVCH6AA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVeluro%253D&md5=02ac1bc04d31a2411878deece69e722a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fimr.12534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimr.12534%26sid%3Dliteratum%253Aachs%26aulast%3DMan%26aufirst%3DS.%2BM.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DKanneganti%26aufirst%3DT.-D.%26atitle%3DMolecular%2520mechanisms%2520and%2520functions%2520of%2520pyroptosis%252C%2520inflammatory%2520caspases%2520and%2520inflammasomes%2520in%2520infectious%2520diseases%26jtitle%3DImmunol.%2520Rev.%26date%3D2017%26volume%3D277%26issue%3D1%26spage%3D61%26epage%3D75%26doi%3D10.1111%2Fimr.12534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamkanfi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walle, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanneganti, T.-D.</span></span> <span> </span><span class="NLM_article-title">Deregulated inflammasome signaling in disease</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>243</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">163</span>â <span class="NLM_lpage">173</span>, <span class="refDoi">Â DOI: 10.1111/j.1600-065X.2011.01042.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1111%2Fj.1600-065X.2011.01042.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21884175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BC3Mfgs1Squw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=2011&pages=163-173&issue=1&author=M.+Lamkanfiauthor=L.+V.+Walleauthor=T.-D.+Kanneganti&title=Deregulated+inflammasome+signaling+in+disease&doi=10.1111%2Fj.1600-065X.2011.01042.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Deregulated inflammasome signaling in disease</span></div><div class="casAuthors">Lamkanfi Mohamed; Vande Walle Lieselotte; Kanneganti Thirumala-Devi</div><div class="citationInfo"><span class="NLM_cas:title">Immunological reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">243</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">163-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammasomes are multi-protein complexes that sense microbial molecules and endogenous danger signals in intracellular compartments.  Inflammasome assembly results in caspase-1 activation, which in turn drives maturation and secretion of the pro-inflammatory cytokines interleukin 1Î² (IL-1Î²) and IL-18, and induces pyroptosis to eliminate the infectious agent.  The importance of inflammasomes in regulating immune responses was recognized with the discovery of polymorphisms in genes encoding inflammasome components and their linkage to aberrant production of IL-1Î² and IL-18 in autoimmune and hereditary periodic fevers syndromes.  We review the current knowledge on the role of inflammasomes in regulating innate and adaptive immune responses with an emphasis on the role of these immune complexes in autoinflammatory disorders and autoimmune diseases such as colitis, type I diabetes, multiple sclerosis and vitiligo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSBmHinuMOvZIFEOhA_Im3cfW6udTcc2eYzVq7PXuLHEbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mfgs1Squw%253D%253D&md5=5f6c28e901cab1769004643da0d17a55</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2011.01042.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2011.01042.x%26sid%3Dliteratum%253Aachs%26aulast%3DLamkanfi%26aufirst%3DM.%26aulast%3DWalle%26aufirst%3DL.%2BV.%26aulast%3DKanneganti%26aufirst%3DT.-D.%26atitle%3DDeregulated%2520inflammasome%2520signaling%2520in%2520disease%26jtitle%3DImmunol.%2520Rev.%26date%3D2011%26volume%3D243%26issue%3D1%26spage%3D163%26epage%3D173%26doi%3D10.1111%2Fj.1600-065X.2011.01042.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamkanfi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Loo, G.</span></span> <span> </span><span class="NLM_article-title">Inflammasomes in neuroinflammatory and neurodegenerative diseases</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">6</span>), <span class="NLM_elocation-id">e10248</span> <span class="refDoi">Â DOI: 10.15252/emmm.201810248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.15252%2Femmm.201810248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31015277" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&issue=6&author=S.+Voetauthor=S.+Srinivasanauthor=M.+Lamkanfiauthor=G.+van+Loo&title=Inflammasomes+in+neuroinflammatory+and+neurodegenerative+diseases&doi=10.15252%2Femmm.201810248"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.15252%2Femmm.201810248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201810248%26sid%3Dliteratum%253Aachs%26aulast%3DVoet%26aufirst%3DS.%26aulast%3DSrinivasan%26aufirst%3DS.%26aulast%3DLamkanfi%26aufirst%3DM.%26aulast%3Dvan%2BLoo%26aufirst%3DG.%26atitle%3DInflammasomes%2520in%2520neuroinflammatory%2520and%2520neurodegenerative%2520diseases%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2019%26volume%3D11%26issue%3D6%26doi%3D10.15252%2Femmm.201810248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lenardo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornung, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span> <span> </span><span class="NLM_article-title">Mature T lymphocyte apoptosisâimmune regulation in a dynamic and unpredictable antigenic environment</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">221</span>â <span class="NLM_lpage">253</span>, <span class="refDoi">Â DOI: 10.1146/annurev.immunol.17.1.221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1146%2Fannurev.immunol.17.1.221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10358758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVSrtbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=221-253&issue=1&author=M.+Lenardoauthor=F.+K.-M.+Chanauthor=F.+Hornungauthor=H.+McFarlandauthor=R.+Siegelauthor=J.+Wangauthor=L.+Zheng&title=Mature+T+lymphocyte+apoptosis%E2%80%94immune+regulation+in+a+dynamic+and+unpredictable+antigenic+environment&doi=10.1146%2Fannurev.immunol.17.1.221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Mature T lymphocyte apoptosis: immune regulation in a dynamic and unpredictable antigenic environment</span></div><div class="casAuthors">Lenardo, Michael; Chan, Francis Ka-Ming; Hornung, Felicita; McFarland, Hugh; Siegel, Richard; Wang, Jin; Zheng, Lixin</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">221-253</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 347 refs.  Apoptosis of mature T lymphocytes preserves peripheral homeostasis and tolerance by countering the profound changes in the no. and types of T cells stimulated by diverse antigens.  T cell apoptosis occurs in at least two major forms: antigen-driven and lymphokine withdrawal.  These forms of death are controlled in response to local levels of IL-2 and antigen in a feedback mechanism termed propriocidal regulation.  Active antigen-driven death is mediated by the expression of death cytokines such as FasL and TNF.  These death cytokines engage specific receptors that assemble caspase-activating protein complexes.  These signaling complexes tightly regulate cell death but are vulnerable to inherited defects.  Passive lymphokine withdrawal death may result from the cytoplasmic activation of caspases that is regulated by mitochondria and the Bcl-2 protein.  The human disease, Autoimmune Lymphoproliferative Syndrome (ALPS) is due to dominant-interfering mutations in the Fas/APO-1/CD95 receptor and other components of the death pathway.  The study of ALPS patients reveals the necessity of apoptosis for preventing autoimmunity and allows the genetic investigation of apoptosis in humans.  Immunol., cellular, and mol. evidence indicates that throughout the life of a T cell, apoptosis may be evoked in excessive, harmful, or useless clonotypes to preserve a healthy and balanced immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnWbFgvijQRLVg90H21EOLACvtfcHk0lhEAmZ540m3vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVSrtbc%253D&md5=979208a1854b52477705a7375a13af40</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.17.1.221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.17.1.221%26sid%3Dliteratum%253Aachs%26aulast%3DLenardo%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DF.%2BK.-M.%26aulast%3DHornung%26aufirst%3DF.%26aulast%3DMcFarland%26aufirst%3DH.%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DL.%26atitle%3DMature%2520T%2520lymphocyte%2520apoptosis%25E2%2580%2594immune%2520regulation%2520in%2520a%2520dynamic%2520and%2520unpredictable%2520antigenic%2520environment%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1999%26volume%3D17%26issue%3D1%26spage%3D221%26epage%3D253%26doi%3D10.1146%2Fannurev.immunol.17.1.221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwerk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze-Osthoff, K.</span></span> <span> </span><span class="NLM_article-title">Non-apoptotic functions of caspases in cellular proliferation and differentiation</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1453</span>â <span class="NLM_lpage">1458</span>, <span class="refDoi">Â DOI: 10.1016/S0006-2952(03)00497-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0006-2952%2803%2900497-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=14555221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVeqsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2003&pages=1453-1458&issue=8&author=C.+Schwerkauthor=K.+Schulze-Osthoff&title=Non-apoptotic+functions+of+caspases+in+cellular+proliferation+and+differentiation&doi=10.1016%2FS0006-2952%2803%2900497-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Non-apoptotic functions of caspases in cellular proliferation and differentiation</span></div><div class="casAuthors">Schwerk, Christian; Schulze-Osthoff, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1453-1458</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Caspases have been identified as key players in the cellular process termed programmed cell death or apoptosis.  During apoptosis, activated apoptotic caspases cleave selected target proteins to execute cell death.  Addnl. to their established function in cell death, a variety of recent publications have provided increasing evidence that apoptotic caspases also participate in several non-apoptotic cellular processes.  Activated caspases exhibit functions during T-cell proliferation and cell cycle regulation, but are also involved in the differentiation of a diverse array of cell types.  In some cell types, their differentiation can be morphol. viewed as a kind of incomplete apoptosis.  Anal. of well-known apoptotic targets of caspases implicates that the cleavage of a limited no. of selected substrates plays a major role during non-apoptotic functions of caspases.  Selective substrate cleavage might be regulated by activation of anti-apoptotic factors, via a compartmentalized activation of caspases, or through limited activity of caspases during apoptosis-independent functions.  The increasing evidence for caspase function in non-apoptotic cellular events suggests that caspases play a much more diverse role than previously assumed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRS72q787I8bVg90H21EOLACvtfcHk0lhEAmZ540m3vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVeqsro%253D&md5=91113c4a09e0801a6980f0ccf9244987</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2803%2900497-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252803%252900497-0%26sid%3Dliteratum%253Aachs%26aulast%3DSchwerk%26aufirst%3DC.%26aulast%3DSchulze-Osthoff%26aufirst%3DK.%26atitle%3DNon-apoptotic%2520functions%2520of%2520caspases%2520in%2520cellular%2520proliferation%2520and%2520differentiation%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D66%26issue%3D8%26spage%3D1453%26epage%3D1458%26doi%3D10.1016%2FS0006-2952%2803%2900497-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chun, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speirs, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skoda-Smith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straus, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenardo, M. J.</span></span> <span> </span><span class="NLM_article-title">Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>419</i></span> (<span class="NLM_issue">6905</span>),  <span class="NLM_fpage">395</span>â <span class="NLM_lpage">399</span>, <span class="refDoi">Â DOI: 10.1038/nature01063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature01063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=12353035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD38XntlGgsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2002&pages=395-399&issue=6905&author=H.+J.+Chunauthor=L.+Zhengauthor=M.+Ahmadauthor=J.+Wangauthor=C.+K.+Speirsauthor=R.+M.+Siegelauthor=J.+K.+Daleauthor=J.+Puckauthor=J.+Davisauthor=C.+G.+Hallauthor=S.+Skoda-Smithauthor=T.+P.+Atkinsonauthor=S.+E.+Strausauthor=M.+J.+Lenardo&title=Pleiotropic+defects+in+lymphocyte+activation+caused+by+caspase-8+mutations+lead+to+human+immunodeficiency&doi=10.1038%2Fnature01063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency</span></div><div class="casAuthors">Chun, Hyung J.; Zheng, Lixin; Ahmad, Manzoor; Wang, Jin; Speirs, Christina K.; Siegel, Richard M.; Dale, Janet K.; Puck, Jennifer; Davis, Joie; Hall, Craig G.; Skoda-Smith, Suzanne; Atkinson, T. Prescott; Straus, Stephen E.; Lenardo, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">6905</span>),
    <span class="NLM_cas:pages">395-399</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is a form of programmed cell death that is controlled by aspartate-specific cysteine proteases called caspases.  In the immune system, apoptosis counters the proliferation of lymphocytes to achieve a homeostatic balance, which allows potent responses to pathogens but avoids autoimmunity.  The CD95 (Fas, Apo-1) receptor triggers lymphocyte apoptosis by recruiting Fas-assocd. death domain (FADD), caspase-8 and caspase-10 proteins into a death-inducing signalling complex.  Heterozygous mutations in CD95, CD95 ligand or caspase-10 underlie most cases of autoimmune lymphoproliferative syndrome (ALPS), a human disorder that is characterized by defective lymphocyte apoptosis, lymphadenopathy, splenomegaly and autoimmunity.  Mutations in caspase-8 have not been described in ALPS, and homozygous caspase-8 deficiency causes embryonic lethality in mice.  Here we describe a human kindred with an inherited genetic deficiency of caspase-8.  Homozygous individuals manifest defective lymphocyte apoptosis and homeostasis but, unlike individuals affected with ALPS, also have defects in their activation of T lymphocytes, B lymphocytes and natural killer cells, which leads to immunodeficiency.  Thus, caspase-8 deficiency in humans is compatible with normal development and shows that caspase-8 has a postnatal role in immune activation of naive lymphocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD7CuqDz2dVbVg90H21EOLACvtfcHk0lhEAmZ540m3vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntlGgsbg%253D&md5=e0bc4de9463961d217a9f6e9a000ec1e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnature01063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01063%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DH.%2BJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DAhmad%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSpeirs%26aufirst%3DC.%2BK.%26aulast%3DSiegel%26aufirst%3DR.%2BM.%26aulast%3DDale%26aufirst%3DJ.%2BK.%26aulast%3DPuck%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DC.%2BG.%26aulast%3DSkoda-Smith%26aufirst%3DS.%26aulast%3DAtkinson%26aufirst%3DT.%2BP.%26aulast%3DStraus%26aufirst%3DS.%2BE.%26aulast%3DLenardo%26aufirst%3DM.%2BJ.%26atitle%3DPleiotropic%2520defects%2520in%2520lymphocyte%2520activation%2520caused%2520by%2520caspase-8%2520mutations%2520lead%2520to%2520human%2520immunodeficiency%26jtitle%3DNature%26date%3D2002%26volume%3D419%26issue%3D6905%26spage%3D395%26epage%3D399%26doi%3D10.1038%2Fnature01063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salmena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemmers, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matysiak-Zablocki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Au, P. Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamblyn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shehabeldin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakeham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouchard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGlade, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakem, R.</span></span> <span> </span><span class="NLM_article-title">Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">883</span>â <span class="NLM_lpage">895</span>, <span class="refDoi">Â DOI: 10.1101/gad.1063703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1101%2Fgad.1063703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=12654726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislOltro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=883-895&issue=7&author=L.+Salmenaauthor=B.+Lemmersauthor=A.+Hakemauthor=E.+Matysiak-Zablockiauthor=K.+Murakamiauthor=P.+Y.+B.+Auauthor=D.+M.+Berryauthor=L.+Tamblynauthor=A.+Shehabeldinauthor=E.+Migonauthor=A.+Wakehamauthor=D.+Bouchardauthor=W.+C.+Yehauthor=J.+C.+McGladeauthor=P.+S.+Ohashiauthor=R.+Hakem&title=Essential+role+for+caspase+8+in+T-cell+homeostasis+and+T-cell-mediated+immunity&doi=10.1101%2Fgad.1063703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity</span></div><div class="casAuthors">Salmena, Leonardo; Lemmers, Benedicte; Hakem, Anne; Matysiak-Zablocki, Elzbieta; Murakami, Kiichi; Au, P. Y. Billie; Berry, Donna M.; Tamblyn, Laura; Shehabeldin, Amro; Migon, Eva; Wakeham, Andrew; Bouchard, Denis; Yeh, Wen Chen; McGlade, Jane C.; Ohashi, Pamela S.; Hakem, Razqallah</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">883-895</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Defects in death receptor-mediated apoptosis have been linked to cancer and autoimmune disease in humans.  The in vivo role of caspase 8, a component of this pathway, has eluded anal. in postnatal tissues because of the lack of an appropriate animal model.  Targeted disruption of caspase 8 is lethal in utero.  We generated mice with a targeted caspase 8 mutation that is restricted to the T-cell lineage.  Despite normal thymocyte development in the absence of caspase 8, we obsd. a marked decrease in the no. of peripheral T-cells and impaired T-cell response ex vivo to activation stimuli.  Caspase 8 ablation protected thymocytes and activated T-cells from CD95 ligand but not anti-CD3-induced apoptosis, or apoptosis activated by agents that are known to act through the mitochondria.  Caspase 8 mutant mice were unable to mount an immune response to viral infection, indicating that caspase 8 deletion in T-cells leads to immunodeficiency.  These findings identify an essential, cell-stage-specific role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity.  This is consistent with the recent identification of caspase 8 mutations in human immunodeficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmz4vzdKxH3bVg90H21EOLACvtfcHk0lgF7RUOUvt3Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislOltro%253D&md5=fa3adcaff440274bc9d5748edbe8ea44</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1101%2Fgad.1063703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1063703%26sid%3Dliteratum%253Aachs%26aulast%3DSalmena%26aufirst%3DL.%26aulast%3DLemmers%26aufirst%3DB.%26aulast%3DHakem%26aufirst%3DA.%26aulast%3DMatysiak-Zablocki%26aufirst%3DE.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DAu%26aufirst%3DP.%2BY.%2BB.%26aulast%3DBerry%26aufirst%3DD.%2BM.%26aulast%3DTamblyn%26aufirst%3DL.%26aulast%3DShehabeldin%26aufirst%3DA.%26aulast%3DMigon%26aufirst%3DE.%26aulast%3DWakeham%26aufirst%3DA.%26aulast%3DBouchard%26aufirst%3DD.%26aulast%3DYeh%26aufirst%3DW.%2BC.%26aulast%3DMcGlade%26aufirst%3DJ.%2BC.%26aulast%3DOhashi%26aufirst%3DP.%2BS.%26aulast%3DHakem%26aufirst%3DR.%26atitle%3DEssential%2520role%2520for%2520caspase%25208%2520in%2520T-cell%2520homeostasis%2520and%2520T-cell-mediated%2520immunity%26jtitle%3DGenes%2520Dev.%26date%3D2003%26volume%3D17%26issue%3D7%26spage%3D883%26epage%3D895%26doi%3D10.1101%2Fgad.1063703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuda, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misharin, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gierut, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haines, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutcheson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budinger, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stehlik, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlman, H.</span></span> <span> </span><span class="NLM_article-title">Caspase-8 acts as a molecular rheostat to limit RIPK1- and MyD88-mediated dendritic cell activation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>192</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5548</span>â <span class="NLM_lpage">5560</span>, <span class="refDoi">Â DOI: 10.4049/jimmunol.1400122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4049%2Fjimmunol.1400122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24808358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVajt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2014&pages=5548-5560&issue=12&author=C.+M.+Cudaauthor=A.+V.+Misharinauthor=A.+K.+Gierutauthor=R.+Saberauthor=G.+K.+Hainesauthor=J.+Hutchesonauthor=S.+M.+Hedrickauthor=C.+Mohanauthor=G.+S.+Budingerauthor=C.+Stehlikauthor=H.+Perlman&title=Caspase-8+acts+as+a+molecular+rheostat+to+limit+RIPK1-+and+MyD88-mediated+dendritic+cell+activation&doi=10.4049%2Fjimmunol.1400122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase-8 Acts as a Molecular Rheostat To Limit RIPK1- and MyD88-Mediated Dendritic Cell Activation</span></div><div class="casAuthors">Cuda, Carla M.; Misharin, Alexander V.; Gierut, Angelica K.; Saber, Rana; Haines, G. Kenneth, III; Hutcheson, Jack; Hedrick, Stephen M.; Mohan, Chandra; Budinger, G. Scott; Stehlik, Christian; Perlman, Harris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5548-5560</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Caspase-8, an executioner enzyme in the death receptor pathway, was shown to initiate apoptosis and suppress necroptosis.  In this study, we identify a novel, cell death-independent role for caspase-8 in dendritic cells (DCs): DC-specific expression of caspase-8 prevents the onset of systemic autoimmunity.  Failure to express caspase-8 has no effect on the lifespan of DCs but instead leads to an enhanced intrinsic activation and, subsequently, more mature and autoreactive lymphocytes.  Uncontrolled TLR activation in a RIPK1-dependent manner is responsible for the enhanced functionality of caspase-8-deficient DCs, because deletion of the TLR-signaling mediator, MyD88, ameliorates systemic autoimmunity induced by caspase-8 deficiency.  Taken together, these data demonstrate that caspase-8 functions in a cell type-specific manner and acts uniquely in DCs to maintain tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ohClx0QOe7Vg90H21EOLACvtfcHk0lgF7RUOUvt3Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVajt7w%253D&md5=5d58c90aa1619249a8f725ae370b1cfb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1400122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1400122%26sid%3Dliteratum%253Aachs%26aulast%3DCuda%26aufirst%3DC.%2BM.%26aulast%3DMisharin%26aufirst%3DA.%2BV.%26aulast%3DGierut%26aufirst%3DA.%2BK.%26aulast%3DSaber%26aufirst%3DR.%26aulast%3DHaines%26aufirst%3DG.%2BK.%26aulast%3DHutcheson%26aufirst%3DJ.%26aulast%3DHedrick%26aufirst%3DS.%2BM.%26aulast%3DMohan%26aufirst%3DC.%26aulast%3DBudinger%26aufirst%3DG.%2BS.%26aulast%3DStehlik%26aufirst%3DC.%26aulast%3DPerlman%26aufirst%3DH.%26atitle%3DCaspase-8%2520acts%2520as%2520a%2520molecular%2520rheostat%2520to%2520limit%2520RIPK1-%2520and%2520MyD88-mediated%2520dendritic%2520cell%2520activation%26jtitle%3DJ.%2520Immunol.%26date%3D2014%26volume%3D192%26issue%3D12%26spage%3D5548%26epage%3D5560%26doi%3D10.4049%2Fjimmunol.1400122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuda, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misharin, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archer, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haines, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutcheson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorfleutner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budinger, G. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stehlik, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlman, H.</span></span> <span> </span><span class="NLM_article-title">Conditional deletion of caspase-8 in macrophages alters macrophage activation in a RIPK-dependent manner</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">291</span>, <span class="refDoi">Â DOI: 10.1186/s13075-015-0794-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1186%2Fs13075-015-0794-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26471282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVCns7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=291&issue=1&author=C.+M.+Cudaauthor=A.+V.+Misharinauthor=S.+Khareauthor=R.+Saberauthor=F.+Tsaiauthor=A.+M.+Archerauthor=P.+J.+Homanauthor=G.+K.+Hainesauthor=J.+Hutchesonauthor=A.+Dorfleutnerauthor=G.+R.+S.+Budingerauthor=C.+Stehlikauthor=H.+Perlman&title=Conditional+deletion+of+caspase-8+in+macrophages+alters+macrophage+activation+in+a+RIPK-dependent+manner&doi=10.1186%2Fs13075-015-0794-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Conditional deletion of caspase-8 in macrophages alters macrophage activation in a RIPK-dependent manner</span></div><div class="casAuthors">Cuda, Carla M.; Misharin, Alexander V.; Khare, Sonal; Saber, Rana; Tsai, Fu Nien; Archer, Amy M.; Homan, Philip J.; Haines, G. Kenneth, III; Hutcheson, Jack; Dorfleutner, Andrea; Budinger, G. R. Scott; Stehlik, Christian; Perlman, Harris</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291/1-291/16</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Introduction: Although caspase-8 is a well-established initiator of apoptosis and suppressor of necroptosis, recent evidence suggests that this enzyme maintains functions beyond its role in cell death.  As cells of the innate immune system, and in particular macrophages, are now at the forefront of autoimmune disease pathogenesis, we examd. the potential involvement of caspase-8 within this population.  Methods:CreLysMCasp8fl/fl mice were bred via a cross between Casp8fl/fl mice and CreLysM mice, and RIPK3-/-CreLysMCasp8fl/fl mice were generated to assess the contribution of receptor-interacting serine-threonine kinase (RIPK)3.  Immunohistochem. and immunofluorescence analyses were used to examine renal damage.  Flow cytometric anal. was employed to characterize splenocyte distribution and activation.  CreLysMCasp8fl/fl mice were treated with either Toll-like receptor (TLR) agonists or oral antibiotics to assess their response to TLR activation or TLR agonist removal.  Luminex-based assays and enzyme-linked immunosorbent assays were used to measure cytokine/chemokine and Ig levels in serum and cytokine levels in cell culture studies.  In vitro cell culture was used to assess macrophage response to cell death stimuli, TLR activation, and M1/M2 polarization.  Data were compared using the Mann-Whitney U test.  Results: Loss of caspase-8 expression in macrophages promotes onset of a mild systemic inflammatory disease, which is preventable by the deletion of RIPK3.  In vitro cell culture studies reveal that caspase-8-deficient macrophages are prone to a caspase-independent death in response to death receptor ligation; yet, caspase-8-deficient macrophages are not predisposed to unchecked survival, as anal. of mixed bone marrow chimeric mice demonstrates that caspase-8 deficiency does not confer preferential expansion of myeloid populations.  Loss of caspase-8 in macrophages dictates the response to TLR activation, as injection of TLR ligands upregulates expression of costimulatory CD86 on the Ly6ChighCD11b+F4/80+ splenic cells, and oral antibiotic treatment to remove microbiota prevents splenomegaly and lymphadenopathy in CreLysMCasp8fl/fl mice.  Further, caspase-8-deficient macrophages are hyperresponsive to TLR activation and exhibit aberrant M1 macrophage polarization due to RIPK activity.  Conclusions: These data demonstrate that caspase-8 functions uniquely in macrophages by controlling the response to TLR activation and macrophage polarization in an RIPK-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDmoH834c_DbVg90H21EOLACvtfcHk0lgF7RUOUvt3Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVCns7g%253D&md5=97217bc0c857cbeba31c027085f8f995</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1186%2Fs13075-015-0794-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13075-015-0794-z%26sid%3Dliteratum%253Aachs%26aulast%3DCuda%26aufirst%3DC.%2BM.%26aulast%3DMisharin%26aufirst%3DA.%2BV.%26aulast%3DKhare%26aufirst%3DS.%26aulast%3DSaber%26aufirst%3DR.%26aulast%3DTsai%26aufirst%3DF.%26aulast%3DArcher%26aufirst%3DA.%2BM.%26aulast%3DHoman%26aufirst%3DP.%2BJ.%26aulast%3DHaines%26aufirst%3DG.%2BK.%26aulast%3DHutcheson%26aufirst%3DJ.%26aulast%3DDorfleutner%26aufirst%3DA.%26aulast%3DBudinger%26aufirst%3DG.%2BR.%2BS.%26aulast%3DStehlik%26aufirst%3DC.%26aulast%3DPerlman%26aufirst%3DH.%26atitle%3DConditional%2520deletion%2520of%2520caspase-8%2520in%2520macrophages%2520alters%2520macrophage%2520activation%2520in%2520a%2520RIPK-dependent%2520manner%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2015%26volume%3D17%26issue%3D1%26spage%3D291%26doi%3D10.1186%2Fs13075-015-0794-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sneller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straus, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenardo, M. J.</span></span> <span> </span><span class="NLM_article-title">Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>98</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">47</span>â <span class="NLM_lpage">58</span>, <span class="refDoi">Â DOI: 10.1016/S0092-8674(00)80605-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0092-8674%2800%2980605-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10412980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1MXks1Kksbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1999&pages=47-58&issue=1&author=J.+Wangauthor=L.+Zhengauthor=A.+Lobitoauthor=F.+K.-M.+Chanauthor=J.+Daleauthor=M.+Snellerauthor=X.+Yaoauthor=J.+M.+Puckauthor=S.+E.+Strausauthor=M.+J.+Lenardo&title=Inherited+human+caspase+10+mutations+underlie+defective+lymphocyte+and+dendritic+cell+apoptosis+in+autoimmune+lymphoproliferative+syndrome+type+II&doi=10.1016%2FS0092-8674%2800%2980605-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II</span></div><div class="casAuthors">Wang, Jin; Zheng, Lixin; Lobito, Adrian; Chan, Francis Ka-Ming; Dale, Janet; Sneller, Michael; Yao, Xu; Puck, Jennifer M.; Straus, Stephen E.; Lenardo, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-58</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Caspases are cysteine proteases that mediate programmed cell death in phylogenetically diverse multi-cellular organisms.  The authors report 2 kindreds with autoimmune lymphoproliferative syndrome (ALPS) type II, characterized by abnormal lymphocyte and dendritic cell homeostasis and immune regulatory defects, that harbor independent missense mutations in caspase 10.  These encode amino acid substitutions that decrease caspase activity and interfere with death receptor-induced apoptosis, particularly that stimulated by Fas ligand and TRAIL.  These results provide evidence that inherited nonlethal caspase abnormalities cause pleiotropic apoptosis defects underlying autoimmunity in ALPS type II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjracbOzPztrVg90H21EOLACvtfcHk0limErjsJ_kedg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXks1Kksbc%253D&md5=b60971d888311544a6eb37a76f35278d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980605-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980605-4%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DLobito%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DF.%2BK.-M.%26aulast%3DDale%26aufirst%3DJ.%26aulast%3DSneller%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DPuck%26aufirst%3DJ.%2BM.%26aulast%3DStraus%26aufirst%3DS.%2BE.%26aulast%3DLenardo%26aufirst%3DM.%2BJ.%26atitle%3DInherited%2520human%2520caspase%252010%2520mutations%2520underlie%2520defective%2520lymphocyte%2520and%2520dendritic%2520cell%2520apoptosis%2520in%2520autoimmune%2520lymphoproliferative%2520syndrome%2520type%2520II%26jtitle%3DCell%26date%3D1999%26volume%3D98%26issue%3D1%26spage%3D47%26epage%3D58%26doi%3D10.1016%2FS0092-8674%2800%2980605-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McComb, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sad, S.</span></span> <span> </span><span class="NLM_article-title">Caspase-3 is transiently activated without cell death during early antigen driven expansion of CD8+ T cells in vivo</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">12</span>), <span class="NLM_elocation-id">e15328</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0015328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1371%2Fjournal.pone.0015328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21203525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtlWjtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&issue=12&author=S.+McCombauthor=R.+Mulliganauthor=S.+Sad&title=Caspase-3+is+transiently+activated+without+cell+death+during+early+antigen+driven+expansion+of+CD8%2B+T+cells+in+vivo&doi=10.1371%2Fjournal.pone.0015328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase-3 is transiently activated without cell death during early antigen driven expansion of CD8+ T cells in vivo</span></div><div class="casAuthors">McComb, Scott; Mulligan, Rebecca; Sad, Subash</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e15328</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: CD8+ T cell responses develop rapidly during infection and are swiftly reduced during contraction, wherein >90% of primed CD8+ T cells are eliminated.  The role of apoptotic mechanisms in controlling this rapid proliferation and contraction of CD8+ T cells remains unclear.  Surprisingly, evidence has shown non-apoptotic activation of caspase-3 to occur during in vitro T-cell proliferation, but the relevance of these mechanisms to in vivo CD8+ T cell responses has yet to be examd.  Methods and Findings: We have evaluated the activity of caspase-3, a key downstream inducer of apoptosis, throughout the entirety of a CD8+ T cell response.  We utilized two infection models that differ in the intensity, onset and duration of antigen-presentation and inflammation.  Expression of cleaved caspase-3 in antigen specific CD8+ T cells was coupled to the timing and strength of antigen presentation in lymphoid organs.  We also obsd. coordinated activation of addnl. canonical apoptotic markers, including phosphatidylserine exposure.  Limiting diln. anal. directly showed that in the presence of IL7, very little cell death occurred in both caspase-3hi and caspase-3low CD8+ T cells.  The expression of active caspase-3 peaked before effector phenotype (CD62Llow) CD8+ T cells emerged, and was undetectable in effector-phenotype cells.  In addn., OVA-specific CD8+ cells remained active caspase-3low throughout the contraction phase.  Conclusions: Our results specifically implicate antigen and not inflammation in driving activation of apoptotic mechanisms without cell death in proliferating CD8+ T cells.  Furthermore, the contraction of CD8+ T cell response following expansion is likely not mediated by the key downstream apoptosis inducer, caspase-3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS4SXRGwrVFbVg90H21EOLACvtfcHk0limErjsJ_kedg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtlWjtw%253D%253D&md5=cab1333decb8be32f1b0ed16b9f535c9</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0015328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0015328%26sid%3Dliteratum%253Aachs%26aulast%3DMcComb%26aufirst%3DS.%26aulast%3DMulligan%26aufirst%3DR.%26aulast%3DSad%26aufirst%3DS.%26atitle%3DCaspase-3%2520is%2520transiently%2520activated%2520without%2520cell%2520death%2520during%2520early%2520antigen%2520driven%2520expansion%2520of%2520CD8%252B%2520T%2520cells%2520in%2520vivo%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26issue%3D12%26doi%3D10.1371%2Fjournal.pone.0015328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slee, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, G. M.</span></span> <span> </span><span class="NLM_article-title">Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>315</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">21</span>â <span class="NLM_lpage">24</span>, <span class="refDoi">Â DOI: 10.1042/bj3150021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1042%2Fbj3150021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8670109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK28Xitlygsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=1996&pages=21-24&issue=1&author=E.+A.+Sleeauthor=H.+Zhuauthor=S.+C.+Chowauthor=M.+MacFarlaneauthor=D.+W.+Nicholsonauthor=G.+M.+Cohen&title=Benzyloxycarbonyl-Val-Ala-Asp+%28OMe%29+fluoromethylketone+%28Z-VAD.FMK%29+inhibits+apoptosis+by+blocking+the+processing+of+CPP32&doi=10.1042%2Fbj3150021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32</span></div><div class="casAuthors">Slee, Elizabeth A.; Zhu, Huijun; Chow, Sek C.; MacFarlane, Marion; Nicholson, Donald W.; Cohen, Gerald M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-4</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press</span>)
        </div><div class="casAbstract">Interleukin-1Î² converting enzyme (ICE)-like proteases, which are synthesized as inactive precursors, play a key role in the induction of apoptosis.  We now demonstrate that benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK), an ICE-like protease inhibitor, inhibits apoptosis by preventing the processing of CPP32 to its active form.  These results suggest that novel therapeutic agents, inhibitors of apoptosis, can be developed which prevent processing of proforms of ICE-like proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTPkRkVlXWZbVg90H21EOLACvtfcHk0limErjsJ_kedg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xitlygsb0%253D&md5=0de220cb7f160cbbd207974850c37a3c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1042%2Fbj3150021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3150021%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DE.%2BA.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DChow%26aufirst%3DS.%2BC.%26aulast%3DMacFarlane%26aufirst%3DM.%26aulast%3DNicholson%26aufirst%3DD.%2BW.%26aulast%3DCohen%26aufirst%3DG.%2BM.%26atitle%3DBenzyloxycarbonyl-Val-Ala-Asp%2520%2528OMe%2529%2520fluoromethylketone%2520%2528Z-VAD.FMK%2529%2520inhibits%2520apoptosis%2520by%2520blocking%2520the%2520processing%2520of%2520CPP32%26jtitle%3DBiochem.%2520J.%26date%3D1996%26volume%3D315%26issue%3D1%26spage%3D21%26epage%3D24%26doi%3D10.1042%2Fbj3150021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoglen, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirakawa, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras, P. C.</span></span> <span> </span><span class="NLM_article-title">Characterization of IDN-6556 (3-{2-(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid): a liver-targeted caspase inhibitor</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>309</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">634</span>â <span class="NLM_lpage">640</span>, <span class="refDoi">Â DOI: 10.1124/jpet.103.062034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1124%2Fjpet.103.062034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=14742742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1yhu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=634-640&issue=2&author=N.+C.+Hoglenauthor=L.-S.+Chenauthor=C.+D.+Fisherauthor=B.+P.+Hirakawaauthor=T.+Groesslauthor=P.+C.+Contreras&title=Characterization+of+IDN-6556+%283-%7B2-%282-tert-butyl-phenylaminooxalyl%29-amino%5D-propionylamino%7D-4-oxo-5-%282%2C3%2C5%2C6-tetrafluoro-phenoxy%29-pentanoic+acid%29%3A+a+liver-targeted+caspase+inhibitor&doi=10.1124%2Fjpet.103.062034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of IDN-6556 (3-{2-(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid): A liver-targeted caspase inhibitor</span></div><div class="casAuthors">Hoglen, Niel C.; Chen, Long-Shiuh; Fisher, Craig D.; Hirakawa, Brad P.; Groessl, Todd; Contreras, Patricia C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">634-640</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The potency, efficacy, and pharmacokinetic properties of IDN-6556 (3-{2-[(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid), a first-in-class caspase inhibitor in clin. trials for the treatment of liver diseases, were characterized in vivo in rodent models.  In the mouse Î±-Fas model of liver injury, i.p. administration of IDN-6556 resulted in marked redn. of alanine aminotransferase (ALT), apoptosis, and caspase activities at a dose of 3 mg/kg.  At this dose, IDN-6556 was also effective when given up to 2 h before Î±-Fas and as late as 4 h after Î±-Fas administration.  In both the Î±-Fas and D-galactosamine/lipopolysaccharide (D-Gln/LPS) model, ED50 values in the sub-milligram per kg range were established after a no. of routes of administration (i.p., i.v., i.m., or p.o.), ranging from 0.04 to 0.38 mg/kg.  Efficacy was also demonstrated in the rat D-Gln/LPS model with 67 and 72% redns. in ALT activities after i.p. and p.o. treatment with IDN-6556 (10 mg/kg), resp.  Pharmacokinetic anal. in the rat demonstrated rapid clearance after i.v., i.p., and s.c. administration with terminal t1/2 ranging from 46 to 51 min.  Low abs. bioavailability after p.o. administration was seen (2.7-4%), but portal drug concns. after oral administration were 3-fold higher than systemic concns. with a 3.7-fold increase in the terminal t1/2, indicating a significant first-pass effect.  Liver concns. remained const. after oral administration for at least a 4-h period, reaching a Cmax of 2558 ng/g liver at 120 min.  Last, 51 Â± 20 and 4.9 Â± 3.4% of IDN-6556 was excreted intact in bile after i.v. and p.o. administration, resp.  This evaluation indicates that IDN-6556 has marked efficacy in models of liver disease after oral administration and thus, is an excellent candidate for the treatment of liver diseases characterized by excessive apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphjgk47WN_J7Vg90H21EOLACvtfcHk0ljlmII5yqk_Ew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1yhu78%253D&md5=e1240d6cf5e4d3562ee8d515bb3ffba9</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062034%26sid%3Dliteratum%253Aachs%26aulast%3DHoglen%26aufirst%3DN.%2BC.%26aulast%3DChen%26aufirst%3DL.-S.%26aulast%3DFisher%26aufirst%3DC.%2BD.%26aulast%3DHirakawa%26aufirst%3DB.%2BP.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DContreras%26aufirst%3DP.%2BC.%26atitle%3DCharacterization%2520of%2520IDN-6556%2520%25283-%257B2-%25282-tert-butyl-phenylaminooxalyl%2529-amino%255D-propionylamino%257D-4-oxo-5-%25282%252C3%252C5%252C6-tetrafluoro-phenoxy%2529-pentanoic%2520acid%2529%253A%2520a%2520liver-targeted%2520caspase%2520inhibitor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26issue%3D2%26spage%3D634%26epage%3D640%26doi%3D10.1124%2Fjpet.103.062034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howard, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostura, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limjuco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salley, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogquist, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumford, R. A.</span></span> <span> </span><span class="NLM_article-title">IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>147</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2964</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1919001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK38XotFOqsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=1991&pages=2964&issue=9&author=A.+D.+Howardauthor=M.+J.+Kosturaauthor=N.+Thornberryauthor=G.+J.+Dingauthor=G.+Limjucoauthor=J.+Weidnerauthor=J.+P.+Salleyauthor=K.+A.+Hogquistauthor=D.+D.+Chaplinauthor=R.+A.+Mumford&title=IL-1-converting+enzyme+requires+aspartic+acid+residues+for+processing+of+the+IL-1+beta+precursor+at+two+distinct+sites+and+does+not+cleave+31-kDa+IL-1+alpha"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1Î² precursor at two distinct sites and does not cleave 31-kDa IL-1Î±</span></div><div class="casAuthors">Howard, Andrew D.; Kostura, Matthew J.; Thornberry, Nancy; Ding, Gloria J. F.; Limjuco, Guadalupe; Weidner, Jeffrey; Salley, J. Paul; Hogquist, Kristin A.; Chaplin, David D.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2964-9</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    </div><div class="casAbstract">IL-1 converting enzyme (ICE) specifically cleaves the human IL-1Î² precursor at two sequence-related sites: Asp27-Gly28 (site 1) and Asp116-Ala117 (site 2).  Cleavage at Asp116-Ala117 results in the generation of mature, biol. active IL-1Î².  ICE is unusual in that preferred cleavage at Asp-X bonds (where X is a small hydrophobic residue), has not been described for any other eukaryotic protease.  To further examine the substrate specificity of ICE, proteins that contain Asp-X linkages, including transferrin, actin, complement factor 9, the murine IL-1Î² precursor, and human and murine IL-Î± precursors, were assayed for cleavage by 500-fold purified ICE.  The human and murine IL-1Î² precursors were the only proteins cleaved by ICE, demonstrating that ICE is an IL-1Î² convertase.  Anal. of human IL-1Î² precursor mutants contg. amino acid substitutions or deletions within each processing site demonstrated that omission or replacement of Asp at site 1 or site 2 prevented cleavage by ICE.  To quant. assess the substrate requirements of ICE, a peptide-based cleavage assay was established using a 14-mer spanning site 2.  Cleavage between Asp [P1] and Ala [P1']2 was demonstrated.  Replacement of Asp with Ala, Glu, or Asn resulted in a >100-fold redn. in cleavage activity.  The rank order in position P1' was Gly > Ala Â» Leu > Lys > Glu.  Substitutions at P2'-P4' and P6' had relatively little effect on cleavage activity.  Thus, ICE is a highly specific IL-1Î² convertase with abs. requirements for Asp in P1 and a small hydrophobic amino acid in P1'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-Ve1RGAxs7rVg90H21EOLACvtfcHk0ljlmII5yqk_Ew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XotFOqsw%253D%253D&md5=83d2f808cb7d3fe8784118ed335a6f83</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DKostura%26aufirst%3DM.%2BJ.%26aulast%3DThornberry%26aufirst%3DN.%26aulast%3DDing%26aufirst%3DG.%2BJ.%26aulast%3DLimjuco%26aufirst%3DG.%26aulast%3DWeidner%26aufirst%3DJ.%26aulast%3DSalley%26aufirst%3DJ.%2BP.%26aulast%3DHogquist%26aufirst%3DK.%2BA.%26aulast%3DChaplin%26aufirst%3DD.%2BD.%26aulast%3DMumford%26aufirst%3DR.%2BA.%26atitle%3DIL-1-converting%2520enzyme%2520requires%2520aspartic%2520acid%2520residues%2520for%2520processing%2520of%2520the%2520IL-1%2520beta%2520precursor%2520at%2520two%2520distinct%2520sites%2520and%2520does%2520not%2520cleave%252031-kDa%2520IL-1%2520alpha%26jtitle%3DJ.%2520Immunol.%26date%3D1991%26volume%3D147%26issue%3D9%26spage%3D2964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sleath, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kronheim, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">March, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, R. A.</span></span> <span> </span><span class="NLM_article-title">Substrate specificity of the protease that processes human interleukin-1 beta</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>265</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">14526</span>â <span class="NLM_lpage">14528</span>, <span class="refDoi">Â DOI: 10.1016/S0021-9258(18)77334-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0021-9258%2818%2977334-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=2201686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3MXisFOr" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=14526-14528&issue=24&author=P.+R.+Sleathauthor=R.+C.+Hendricksonauthor=S.+R.+Kronheimauthor=C.+J.+Marchauthor=R.+A.+Black&title=Substrate+specificity+of+the+protease+that+processes+human+interleukin-1+beta&doi=10.1016%2FS0021-9258%2818%2977334-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate specificity of the protease that processes human interleukin-1Î²</span></div><div class="casAuthors">Sleath, Paul R.; Hendrickson, Ronald C.; Kronheim, Shirley R.; March, Carl J.; Black, Roy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">14526-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The substrate specificity of the protease which generates mature human interleukin-1Î² (IL-1Î²) from prointerleukin-1Î² was investigated using synthetic peptide substrates and recombinant pro-IL-1Î².  The requirement of an L-aspartate in the P-1 position was confirmed together with the need for a small hydrophobic residue in the P-1' position (Gly or Ala).  The enzyme can tolerate conservative substitutions in the P-2 and P-2' positions.  Little difference was found in the enzyme's ability to cleave denatured and native pro-IL-1Î², indicating that tertiary structure recognition is not involved in binding.  The enzyme did, however, require a peptide of >6 amino acids for cleavage to occur.  These results conclusively demonstrate the unusual specificity of this protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQCF5jhN0ecLVg90H21EOLACvtfcHk0ljlmII5yqk_Ew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXisFOr&md5=cd0779009cd95ca26b3a1f6171836c93</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2977334-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252977334-1%26sid%3Dliteratum%253Aachs%26aulast%3DSleath%26aufirst%3DP.%2BR.%26aulast%3DHendrickson%26aufirst%3DR.%2BC.%26aulast%3DKronheim%26aufirst%3DS.%2BR.%26aulast%3DMarch%26aufirst%3DC.%2BJ.%26aulast%3DBlack%26aufirst%3DR.%2BA.%26atitle%3DSubstrate%2520specificity%2520of%2520the%2520protease%2520that%2520processes%2520human%2520interleukin-1%2520beta%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26issue%3D24%26spage%3D14526%26epage%3D14528%26doi%3D10.1016%2FS0021-9258%2818%2977334-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K. T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a potent, reversible inhibitor of interleukin-1Î² converting enzyme</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">613</span>â <span class="NLM_lpage">618</span>, <span class="refDoi">Â DOI: 10.1016/S0960-894X(01)81209-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0960-894X%2801%2981209-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3sXkvVGls7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1992&pages=613-618&issue=6&author=K.+T.+Chapman&title=Synthesis+of+a+potent%2C+reversible+inhibitor+of+interleukin-1%CE%B2+converting+enzyme&doi=10.1016%2FS0960-894X%2801%2981209-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a potent, reversible inhibitor of interleukin-1Î² converting enzyme</span></div><div class="casAuthors">Chapman, Kevin T.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">613-18</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    </div><div class="casAbstract">An efficient synthesis of L-709,049, a potent inhibitor of interleukin-1Î² converting enzyme (ICE) is reported.  The aspartic acid aldehyde moiety is protected as the corresponding O-benzylacyal which can be conveniently coupled to AcTyrValAla and hydrogenolyzed to afford the desired product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopN4JPRneNqrVg90H21EOLACvtfcHk0liKqBAl34FDpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvVGls7Y%253D&md5=60518b21ab4191d41c8a67fd56335ecc</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2981209-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252981209-9%26sid%3Dliteratum%253Aachs%26aulast%3DChapman%26aufirst%3DK.%2BT.%26atitle%3DSynthesis%2520of%2520a%2520potent%252C%2520reversible%2520inhibitor%2520of%2520interleukin-1%25CE%25B2%2520converting%2520enzyme%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1992%26volume%3D2%26issue%3D6%26spage%3D613%26epage%3D618%26doi%3D10.1016%2FS0960-894X%2801%2981209-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rano, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timkey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotonda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N. A.</span></span> <span> </span><span class="NLM_article-title">A combinatorial approach for determining protease specificities: application to interleukin-1Î² converting enzyme (ICE)</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">149</span>â <span class="NLM_lpage">155</span>, <span class="refDoi">Â DOI: 10.1016/S1074-5521(97)90258-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS1074-5521%2897%2990258-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=9190289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2sXitVynu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1997&pages=149-155&issue=2&author=T.+A.+Ranoauthor=T.+Timkeyauthor=E.+P.+Petersonauthor=J.+Rotondaauthor=D.+W.+Nicholsonauthor=J.+W.+Beckerauthor=K.+T.+Chapmanauthor=N.+A.+Thornberry&title=A+combinatorial+approach+for+determining+protease+specificities%3A+application+to+interleukin-1%CE%B2+converting+enzyme+%28ICE%29&doi=10.1016%2FS1074-5521%2897%2990258-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A combinatorial approach for determining protease specificities: application to interleukin-1Î² converting enzyme (ICE)</span></div><div class="casAuthors">Rano, Thomas A.; Timkey, Tracy; Peterson, Erin P.; Rotonda, Jennifer; Nicholson, Donald W.; Beckeer, Joseph W.; Chapman, Kevin T.; Thornberry, Nancy A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-155</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">Background: Interleukin-1Î² converting enzyme (ICE/capase-1) is the protease responsible for interleukin-1Î² (IL-1Î²) prodn. in monocytes.  It was the first member of a new cysteine protease family to be identified.  Members of this family have functions in both inflammation and apoptosis.  Results: A novel method for identifying protease specificity, employing a positional-scanning substrate library, was used to det. the amino-acid preferences of ICE.  Using this method, the complete specificity of a protease can be mapped in the time required to perform one assay.  The results indicate that the optimal tetrapeptide recognition sequence for ICE is WEHD, not YVAD, as previously believed, and this led to the synthesis of an unusually potent aldehyde inhibitor, Ac-WEHD-CHO (Ki = 56 pM).  The structural basis for this potent inhibition was detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ohbMT1kyLbVg90H21EOLACvtfcHk0liKqBAl34FDpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitVynu78%253D&md5=da4f472784a7149a48d311fbda213a2d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2897%2990258-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252897%252990258-1%26sid%3Dliteratum%253Aachs%26aulast%3DRano%26aufirst%3DT.%2BA.%26aulast%3DTimkey%26aufirst%3DT.%26aulast%3DPeterson%26aufirst%3DE.%2BP.%26aulast%3DRotonda%26aufirst%3DJ.%26aulast%3DNicholson%26aufirst%3DD.%2BW.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DChapman%26aufirst%3DK.%2BT.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26atitle%3DA%2520combinatorial%2520approach%2520for%2520determining%2520protease%2520specificities%253A%2520application%2520to%2520interleukin-1%25CE%25B2%2520converting%2520enzyme%2520%2528ICE%2529%26jtitle%3DChem.%2520Biol.%26date%3D1997%26volume%3D4%26issue%3D2%26spage%3D149%26epage%3D155%26doi%3D10.1016%2FS1074-5521%2897%2990258-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudolphi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verzijl, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Kraan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Berg, W.</span></span> <span> </span><span class="NLM_article-title">Pralnacasan, an inhibitor of interleukin-1Î² converting enzyme, reduces joint damage in two murine models of osteoarthritis</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">738</span>â <span class="NLM_lpage">746</span>, <span class="refDoi">Â DOI: 10.1016/S1063-4584(03)00153-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS1063-4584%2803%2900153-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=13129693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BD3svjsFOhtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=738-746&issue=10&author=K.+Rudolphiauthor=N.+Gerwinauthor=N.+Verzijlauthor=P.+van+der+Kraanauthor=W.+van+den+Berg&title=Pralnacasan%2C+an+inhibitor+of+interleukin-1%CE%B2+converting+enzyme%2C+reduces+joint+damage+in+two+murine+models+of+osteoarthritis&doi=10.1016%2FS1063-4584%2803%2900153-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis</span></div><div class="casAuthors">Rudolphi K; Gerwin N; Verzijl N; van der Kraan P; van den Berg W</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">738-46</span>
        ISSN:<span class="NLM_cas:issn">1063-4584</span>.
    </div><div class="casAbstract">OBJECTIVE:  To study the effect of pralnacasan, the orally bioavailable pro-drug of a potent, non-peptide inhibitor of interleukin-1beta converting enzyme (ICE), RU 36384/VRT-18858, on joint damage in two mouse models of knee osteoarthritis (OA).  DESIGN:  In a collagenase-induced OA model, pralnacasan was given orally by gavage to female Balb/c mice at 0, 12.5, 25 and 50 mg/kg twice a day.  In the second study, pralnacasan was tested in male STR/1N mice, which develop OA spontaneously, by administering food-drug mixtures ad libitum at concentrations of 0, 700 and 4200 ppm (mg/kg food).  OA joint damage was assessed by a semi-quantitative histopathological score in both studies.  In the STR/1N mouse study, urinary levels of collagen cross-links hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP) were determined by high-pressure liquid chromatography at baseline, after 3 and 6 weeks of treatment and RU 36384/VRT-18858 plasma concentrations was measured after 6 weeks.  RESULTS:  In both studies, the mice developed moderate to severe knee joint OA in the medial joint compartments (tibial plateau and femoral condyle), the non-treated control groups showing median histopathological scores from 18 to 21 of a maximal score of 32.  Pralnacasan was well tolerated.  At the doses of 12.5 and 50 mg/kg in collagenase-induced OA and at the high dose of 4200 ppm in STR/1N mice pralnacasan treatment significantly reduced OA by 13-22%.  In the STR/1N mice, urinary levels of HP cross-links and the ratio of HP/LP, which are indicators of joint damage in OA, were significantly reduced in the high dose group by 59 and 84%, respectively.  CONCLUSIONS:  The ICE inhibitor pralnacasan reduced joint damage in two experimental models of OA and has the potential to become a disease-modifying drug for the treatment of OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS00eZqsMAAocjl5L8hwNX0fW6udTcc2eaLzFdrVbKc6Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svjsFOhtg%253D%253D&md5=ec8e69c841b711bb5c56cb1f9ac983c3</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS1063-4584%2803%2900153-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1063-4584%252803%252900153-5%26sid%3Dliteratum%253Aachs%26aulast%3DRudolphi%26aufirst%3DK.%26aulast%3DGerwin%26aufirst%3DN.%26aulast%3DVerzijl%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BKraan%26aufirst%3DP.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DW.%26atitle%3DPralnacasan%252C%2520an%2520inhibitor%2520of%2520interleukin-1%25CE%25B2%2520converting%2520enzyme%252C%2520reduces%2520joint%2520damage%2520in%2520two%2520murine%2520models%2520of%2520osteoarthritis%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2003%26volume%3D11%26issue%3D10%26spage%3D738%26epage%3D746%26doi%3D10.1016%2FS1063-4584%2803%2900153-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wannamaker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namchuk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germann, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randle, J. C. R.</span></span> <span> </span><span class="NLM_article-title">(S)-1-((S)-2-{[1-(4-Amino-3-chloro-phenyl)-methanoyl]-amino}-3,3,-dimethyl-butanoyl)-pyrrolidine-2-carb-oxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1Î² and IL-18</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>321</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">509</span>â <span class="NLM_lpage">516</span>, <span class="refDoi">Â DOI: 10.1124/jpet.106.111344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1124%2Fjpet.106.111344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17289835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFehtLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=509-516&issue=2&author=W.+Wannamakerauthor=R.+Daviesauthor=M.+Namchukauthor=J.+Pollardauthor=P.+Fordauthor=G.+Kuauthor=C.+Deckerauthor=P.+Charifsonauthor=P.+Weberauthor=U.+A.+Germannauthor=K.+Kuidaauthor=J.+C.+R.+Randle&title=%28S%29-1-%28%28S%29-2-%7B%5B1-%284-Amino-3-chloro-phenyl%29-methanoyl%5D-amino%7D-3%2C3%2C-dimethyl-butanoyl%29-pyrrolidine-2-carb-oxylic+acid+%28%282R%2C3S%29-2-ethoxy-5-oxo-tetrahydro-furan-3-yl%29-amide+%28VX-765%29%2C+an+orally+available+selective+interleukin+%28IL%29-converting+enzyme%2Fcaspase-1+inhibitor%2C+exhibits+potent+anti-inflammatory+activities+by+inhibiting+the+release+of+IL-1%CE%B2+and+IL-18&doi=10.1124%2Fjpet.106.111344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">(S)-1-((S)-2-{[1-(4-Amino-3-chlorophenyl)methanoyl]amino}-3,3-dimethylbutanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1Î² and IL-18</span></div><div class="casAuthors">Wannamaker, Woods; Davies, Robert; Namchuk, Mark; Pollard, John; Ford, Pamella; Ku, George; Decker, Caroline; Charifson, Paul; Weber, Peter; Germann, Ursula A.; Kuida, Keisuke; Randle, John C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">509-516</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">VX-765 is an orally absorbed prodrug of (S)-3-({1-[(S)-1-((S)-2-{[1-(4-amino-3-chlorophenyl)methanoyl]amino}-3,3-dimethyl-butanoyl)pyrrolidin-2-yl]-methanoyl}amino)-4-oxobutyric acid (VRT-043198), a potent and selective inhibitor of interleukin-converting enzyme/caspase-1 subfamily caspases.  VRT-043198 exhibits 100- to 10,000-fold selectivity against other caspase-3 and -6 to -9.  The therapeutic potential of VX-765 was assessed by detg. the effects of VRT-043198 on cytokine release by monocytes in vitro and of orally administered VX-765 in several animal models in vivo.  In cultures of peripheral blood mononuclear cells and whole blood from healthy subjects stimulated with bacterial products, VRT-043198 inhibited the release of interleukin (IL)-1Î² and IL-18, but it had little effect on the release of several other cytokines, including IL-1Î±, tumor necrosis factor-Î±, IL-6 and IL-8.  In contrast, VRT-043198 had little or no demonstrable activity in cellular models of apoptosis, and it did not affect the proliferation of activated primary T cells or T-cell lines.  VX-765 was efficiently converted to VRT-043198 when administered orally to mice, and it inhibited lipopolysaccharide-induced cytokine secretion.  In addn., VX-765 reduced disease severity and the expression of inflammatory mediators in models of rheumatoid arthritis and skin inflammation.  These data suggest that VX-765 is a novel cytokine inhibitor useful for treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUYnZtQc6cNrVg90H21EOLACvtfcHk0lj-V0eElqYwew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFehtLY%253D&md5=f310c20314ee44357acd3027105a8b6a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.111344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.111344%26sid%3Dliteratum%253Aachs%26aulast%3DWannamaker%26aufirst%3DW.%26aulast%3DDavies%26aufirst%3DR.%26aulast%3DNamchuk%26aufirst%3DM.%26aulast%3DPollard%26aufirst%3DJ.%26aulast%3DFord%26aufirst%3DP.%26aulast%3DKu%26aufirst%3DG.%26aulast%3DDecker%26aufirst%3DC.%26aulast%3DCharifson%26aufirst%3DP.%26aulast%3DWeber%26aufirst%3DP.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DKuida%26aufirst%3DK.%26aulast%3DRandle%26aufirst%3DJ.%2BC.%2BR.%26atitle%3D%2528S%2529-1-%2528%2528S%2529-2-%257B%255B1-%25284-Amino-3-chloro-phenyl%2529-methanoyl%255D-amino%257D-3%252C3%252C-dimethyl-butanoyl%2529-pyrrolidine-2-carb-oxylic%2520acid%2520%2528%25282R%252C3S%2529-2-ethoxy-5-oxo-tetrahydro-furan-3-yl%2529-amide%2520%2528VX-765%2529%252C%2520an%2520orally%2520available%2520selective%2520interleukin%2520%2528IL%2529-converting%2520enzyme%252Fcaspase-1%2520inhibitor%252C%2520exhibits%2520potent%2520anti-inflammatory%2520activities%2520by%2520inhibiting%2520the%2520release%2520of%2520IL-1%25CE%25B2%2520and%2520IL-18%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26issue%3D2%26spage%3D509%26epage%3D516%26doi%3D10.1124%2Fjpet.106.111344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schipper, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. C.</span></span> <span> </span><span class="NLM_article-title">The potential for caspases in drug discovery</span>. <i>Curr. Opin. Drug Discovery Dev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">568</span>â <span class="NLM_lpage">576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=20812148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12jsLvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=568-576&issue=5&author=S.+H.+MacKenzieauthor=J.+L.+Schipperauthor=A.+C.+Clark&title=The+potential+for+caspases+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The potential for caspases in drug discovery</span></div><div class="casAuthors">MacKenzie, Sarah H.; Schipper, Joshua L.; Clark, A. Clay</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">568-576</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">2040-3437</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Caspases are a family of proteases that are involved in the execution of apoptosis and the inflammatory response.  A plethora of diseases occur as a result of the dysregulation of apoptosis and inflammation, and caspases were targeted as a therapeutic strategy to halt the progression of such diseases.  Hundreds of peptide and peptidomimetic inhibitors were designed and tested, but only a few have advanced to clin. trials because of poor drug-like properties and pharmacol. constraints.  Although much effort was focused on inhibiting caspases, there are many diseases that result from a decrease in apoptosis, thus activating procaspases could also be a viable therapeutic strategy.  To this end, recent efforts have focused on the design of procaspase-3 activators.  This review highlights the current progress in the rational design of both specific and pan-caspase inhibitors, as well as procaspase-3 activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyJ67VXw-127Vg90H21EOLACvtfcHk0limgfMOYE3_KA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12jsLvP&md5=1ff7a76e34fcdaded9daab61b4d59735</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DS.%2BH.%26aulast%3DSchipper%26aufirst%3DJ.%2BL.%26aulast%3DClark%26aufirst%3DA.%2BC.%26atitle%3DThe%2520potential%2520for%2520caspases%2520in%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26issue%3D5%26spage%3D568%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamik, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghozian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaco, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Major, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branton, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Power, C.</span></span> <span> </span><span class="NLM_article-title">Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">E6065</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1722041115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.1722041115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29895691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFenu77K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E6065&issue=26&author=B.+A.+McKenzieauthor=M.+K.+Mamikauthor=L.+B.+Saitoauthor=R.+Boghozianauthor=M.+C.+Monacoauthor=E.+O.+Majorauthor=J.-Q.+Luauthor=W.+G.+Brantonauthor=C.+Power&title=Caspase-1+inhibition+prevents+glial+inflammasome+activation+and+pyroptosis+in+models+of+multiple+sclerosis&doi=10.1073%2Fpnas.1722041115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis</span></div><div class="casAuthors">Mckenzie, Brienne A.; Mamik, Manmeet K.; Saito, Leina B.; Boghozian, Roobina; Monaco, Maria Chiara; Major, Eugene O.; Lu, Jian-Qiang; Branton, William G.; Power, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">E6065-E6074</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Multiple sclerosis (MS) is a progressive inflammatory demyelinating disease of the CNS of unknown cause that remains incurable.  Inflammasome-assocd. caspases mediate the maturation and release of the proinflammatory cytokines IL-1Î² and IL-18 and activate the pore-forming protein gasdermin D (GSDMD).  Inflammatory programmed cell death, pyroptosis, was recently shown to be mediated by GSDMD.  Here, we report mol. evidence for GSDMD mediated inflammasome activation and pyroptosis in both myeloid cells (macrophages/microglia) and, unexpectedly, in myelin-forming oligodendrocytes (ODCs) in the CNS of patients with MS and in the MS animal model, exptl. autoimmune encephalomyelitis (EAE).  We obsd. inflammasome activation and pyroptosis in human microglia and ODCs in vitro after exposure to inflammatory stimuli and demonstrate caspase-1 inhibition by the small-mol. inhibitor VX-765 in both cell types.  GSDMD inhibition by siRNA transduction suppressed pyroptosis in human microglia.  VX-765 treatment of EAE animals reduced the expression of inflammasome and pyroptosis-assocd. proteins in the CNS, prevented axonal injury, and improved neurobehavioral performance.  Thus, GSDMD mediated pyroptosis in select glia cells is a previously unrecognized mechanism of inflammatory demyelination and represents a unique therapeutic opportunity for mitigating the disease process in MS and other CNS inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKphO9SsAzKbVg90H21EOLACvtfcHk0limgfMOYE3_KA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFenu77K&md5=77b6d015647bb66ce29881383b9406d9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1722041115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1722041115%26sid%3Dliteratum%253Aachs%26aulast%3DMcKenzie%26aufirst%3DB.%2BA.%26aulast%3DMamik%26aufirst%3DM.%2BK.%26aulast%3DSaito%26aufirst%3DL.%2BB.%26aulast%3DBoghozian%26aufirst%3DR.%26aulast%3DMonaco%26aufirst%3DM.%2BC.%26aulast%3DMajor%26aufirst%3DE.%2BO.%26aulast%3DLu%26aufirst%3DJ.-Q.%26aulast%3DBranton%26aufirst%3DW.%2BG.%26aulast%3DPower%26aufirst%3DC.%26atitle%3DCaspase-1%2520inhibition%2520prevents%2520glial%2520inflammasome%2520activation%2520and%2520pyroptosis%2520in%2520models%2520of%2520multiple%2520sclerosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26issue%3D26%26spage%3DE6065%26doi%3D10.1073%2Fpnas.1722041115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puri, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monack, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Caspase-1 activity is required to bypass macrophage apoptosis upon Salmonella infection</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">745</span>â <span class="NLM_lpage">747</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.1023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnchembio.1023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22797665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVehsLnL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=745-747&issue=9&author=A.+W.+Puriauthor=P.+Brozauthor=A.+Shenauthor=D.+M.+Monackauthor=M.+Bogyo&title=Caspase-1+activity+is+required+to+bypass+macrophage+apoptosis+upon+Salmonella+infection&doi=10.1038%2Fnchembio.1023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase-1 activity is required to bypass macrophage apoptosis upon Salmonella infection</span></div><div class="casAuthors">Puri, Aaron W.; Broz, Petr; Shen, Aimee; Monack, Denise M.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">745-747</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here we report AWP28, an activity-based probe that can be used to biochem. monitor caspase-1 activation in response to proinflammatory stimuli.  Using AWP28, we show that apoptosis is triggered upon Salmonella enterica var. typhimurium infection in primary mouse bone marrow macrophages lacking caspase-1.  Typhimurium infection in primary mouse bone marrow macrophages lacking caspase-1.  Furthermore, we report that upon Salmonella infection, inflammasome-mediated caspase-1 activity is required to bypass apoptosis in favor of proinflammatory pyroptotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0UIc_vcG4-rVg90H21EOLACvtfcHk0limgfMOYE3_KA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVehsLnL&md5=db797ca2a4a23fd5f8ca0382375c30ad</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1023%26sid%3Dliteratum%253Aachs%26aulast%3DPuri%26aufirst%3DA.%2BW.%26aulast%3DBroz%26aufirst%3DP.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DMonack%26aufirst%3DD.%2BM.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DCaspase-1%2520activity%2520is%2520required%2520to%2520bypass%2520macrophage%2520apoptosis%2520upon%2520Salmonella%2520infection%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26issue%3D9%26spage%3D745%26epage%3D747%26doi%3D10.1038%2Fnchembio.1023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">James, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asgian, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekici, Ã. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikolajczyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, â3, â6, and â8</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1553</span>â <span class="NLM_lpage">1574</span>, <span class="refDoi">Â DOI: 10.1021/jm0305016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0305016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVarsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1553-1574&issue=6&author=K.+E.+Jamesauthor=J.+L.+Asgianauthor=Z.+Z.+Liauthor=%C3%96.+D.+Ekiciauthor=J.+R.+Rubinauthor=J.+Mikolajczykauthor=G.+S.+Salvesenauthor=J.+C.+Powers&title=Design%2C+synthesis%2C+and+evaluation+of+aza-peptide+epoxides+as+selective+and+potent+inhibitors+of+caspases-1%2C+%E2%88%923%2C+%E2%88%926%2C+and+%E2%88%928&doi=10.1021%2Fjm0305016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Aza-Peptide Epoxides as Selective and Potent Inhibitors of Caspases-1, -3, -6, and -8</span></div><div class="casAuthors">James, Karen Ellis; Asgian, Juliana L.; Li, Zhao Zhao; Ekici, Oezlem Dogan; Rubin, John R.; Mikolajczyk, Jowita; Salvesen, Guy S.; Powers, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1553-1574</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aza-peptide epoxides, a novel class of irreversible protease inhibitors, are specific for the clan CD cysteine proteases.  Aza-peptide epoxides with an aza-Asp residue at P1 are excellent irreversible inhibitors of caspases-1, -3, -6, and -8 with second-order inhibition rates up to 1 910 000 M-1 s-1.  In general, the order of reactivity of aza-peptide epoxides is S,S > R,R > trans > cis.  Interestingly, some of the R,R epoxides while being less potent are actually more selective than the S,S epoxides.  Here, the aza-peptide epoxides designed for caspases are stable, potent, and specific inhibitors, as they show little to no inhibition of other proteases such as the aspartyl proteases porcine pepsin, human cathepsin D, plasmepsin 2 (from P. falciparum), HIV-1 protease, and the secreted aspartic proteinase 2 (SAP-2) from Candida albicans, the serine proteases granzyme B and Î±-chymotrypsin, and the cysteine proteases cathepsin B and papain (clan CA), and legumain (clan CD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3HF_f2tGTD7Vg90H21EOLACvtfcHk0lhrQNhrXE4qbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVarsLw%253D&md5=5de81f320fca00ccc5289e78c5a7cbbd</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm0305016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0305016%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DK.%2BE.%26aulast%3DAsgian%26aufirst%3DJ.%2BL.%26aulast%3DLi%26aufirst%3DZ.%2BZ.%26aulast%3DEkici%26aufirst%3D%25C3%2596.%2BD.%26aulast%3DRubin%26aufirst%3DJ.%2BR.%26aulast%3DMikolajczyk%26aufirst%3DJ.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520aza-peptide%2520epoxides%2520as%2520selective%2520and%2520potent%2520inhibitors%2520of%2520caspases-1%252C%2520%25E2%2588%25923%252C%2520%25E2%2588%25926%252C%2520and%2520%25E2%2588%25928%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D6%26spage%3D1553%26epage%3D1574%26doi%3D10.1021%2Fjm0305016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boatright, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazif, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chehade, K. A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Activity-based probes that target diverse cysteine protease families</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">33</span>â <span class="NLM_lpage">38</span>, <span class="refDoi">Â DOI: 10.1038/nchembio707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnchembio707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=16407991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXls1Oms70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=33-38&issue=1&author=D.+Katoauthor=K.+M.+Boatrightauthor=A.+B.+Bergerauthor=T.+Nazifauthor=G.+Blumauthor=C.+Ryanauthor=K.+A.+H.+Chehadeauthor=G.+S.+Salvesenauthor=M.+Bogyo&title=Activity-based+probes+that+target+diverse+cysteine+protease+families&doi=10.1038%2Fnchembio707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-based probes that target diverse cysteine protease families</span></div><div class="casAuthors">Kato, Daisuke; Boatright, Kelly M.; Berger, Alicia B.; Nazif, Tamim; Blum, Galia; Ryan, Ciara; Chehade, Kareem A. H.; Salvesen, Guy S.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-38</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteases are one of the largest and best-characterized families of enzymes in the human proteome.  Unfortunately, the understanding of protease function in the context of complex proteolytic cascades remains in its infancy.  One major reason for this gap in understanding is the lack of technologies that allow direct assessment of protease activity.  We report here an optimized solid-phase synthesis protocol that allows rapid generation of activity-based probes (ABPs) targeting a range of cysteine protease families.  These reagents selectively form covalent bonds with the active-site thiol of a cysteine protease, allowing direct biochem. profiling of protease activities in complex proteomes.  We present a no. of probes contg. either a single amino acid or an extended peptide sequence that target caspases, legumains, gingipains and cathepsins.  Biochem. studies using these reagents highlight their overall utility and provide insight into the biochem. functions of members of these protease families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb2GaeK1g3lrVg90H21EOLACvtfcHk0lhrQNhrXE4qbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXls1Oms70%253D&md5=d5971f49f168bb97f3d6214e27ce8dff</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnchembio707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio707%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DD.%26aulast%3DBoatright%26aufirst%3DK.%2BM.%26aulast%3DBerger%26aufirst%3DA.%2BB.%26aulast%3DNazif%26aufirst%3DT.%26aulast%3DBlum%26aufirst%3DG.%26aulast%3DRyan%26aufirst%3DC.%26aulast%3DChehade%26aufirst%3DK.%2BA.%2BH.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DActivity-based%2520probes%2520that%2520target%2520diverse%2520cysteine%2520protease%2520families%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2005%26volume%3D1%26issue%3D1%26spage%3D33%26epage%3D38%26doi%3D10.1038%2Fnchembio707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edgington, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrow, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulick, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineberry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">967</span>â <span class="NLM_lpage">973</span>, <span class="refDoi">Â DOI: 10.1038/nm.1938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnm.1938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19597506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFWiu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=967-973&issue=8&author=L.+E.+Edgingtonauthor=A.+B.+Bergerauthor=G.+Blumauthor=V.+E.+Albrowauthor=M.+G.+Paulickauthor=N.+Lineberryauthor=M.+Bogyo&title=Noninvasive+optical+imaging+of+apoptosis+by+caspase-targeted+activity-based+probes&doi=10.1038%2Fnm.1938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes</span></div><div class="casAuthors">Edgington, Laura E.; Berger, Alicia B.; Blum, Galia; Albrow, Victoria E.; Paulick, Margot G.; Lineberry, Neil; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">967-973</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Imaging agents that enable direct visualization and quantification of apoptosis in vivo have great potential value for monitoring chemotherapeutic response as well as for early diagnosis and disease monitoring.  We describe here the development of fluorescently labeled activity-based probes (ABPs) that covalently label active caspases in vivo.  We used these probes to monitor apoptosis in the thymi of mice treated with dexamethasone as well as in tumor-bearing mice treated with the apoptosis-inducing monoclonal antibody Apomab (Genentech).  Caspase ABPs provided direct readouts of the kinetics of apoptosis in live mice, whole organs and tissue exts.  The probes produced a max. fluorescent signal that could be monitored noninvasively and that coincided with the peak in caspase activity, as measured by gel anal.  Overall, these studies demonstrate that caspase-specific ABPs have the potential to be used for noninvasive imaging of apoptosis in both preclin. and clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4HA0pnOPRmrVg90H21EOLACvtfcHk0ljHncO-LHoZKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFWiu7s%253D&md5=20d9bb5064ff28defbcda64f1196c83c</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnm.1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1938%26sid%3Dliteratum%253Aachs%26aulast%3DEdgington%26aufirst%3DL.%2BE.%26aulast%3DBerger%26aufirst%3DA.%2BB.%26aulast%3DBlum%26aufirst%3DG.%26aulast%3DAlbrow%26aufirst%3DV.%2BE.%26aulast%3DPaulick%26aufirst%3DM.%2BG.%26aulast%3DLineberry%26aufirst%3DN.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DNoninvasive%2520optical%2520imaging%2520of%2520apoptosis%2520by%2520caspase-targeted%2520activity-based%2520probes%26jtitle%3DNat.%2520Med.%26date%3D2009%26volume%3D15%26issue%3D8%26spage%3D967%26epage%3D973%26doi%3D10.1038%2Fnm.1938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonzÃ¡lez-PÃ¡ez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolan, D. W.</span></span> <span> </span><span class="NLM_article-title">Selective detection of caspase-3 versus caspase-7 using activity-based probes with key unnatural amino acids</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1558</span>â <span class="NLM_lpage">1566</span>, <span class="refDoi">Â DOI: 10.1021/cb400209w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400209w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVCgu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1558-1566&issue=7&author=C.+J.+Vickersauthor=G.+E.+Gonz%C3%A1lez-P%C3%A1ezauthor=D.+W.+Wolan&title=Selective+detection+of+caspase-3+versus+caspase-7+using+activity-based+probes+with+key+unnatural+amino+acids&doi=10.1021%2Fcb400209w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Selective detection of caspase-3 versus caspase-7 using activity-based probes with key unnatural amino acids</span></div><div class="casAuthors">Vickers, Chris J.; Gonzalez-Paez, Gonzalo E.; Wolan, Dennis W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1558-1566</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Caspases are required for essential biol. functions, most notably apoptosis and pyroptosis, but also cytokine prodn., cell proliferation, and differentiation.  One of the most well studied members of this cysteine protease family includes executioner caspase-3, which plays a central role in cell apoptosis and differentiation.  Unfortunately, there exists a dearth of chem. tools to selectively monitor caspase-3 activity under complex cellular and in vivo conditions due to its close homol. with executioner caspase-7.  Com. available activity-based probes and substrates rely on the canonical DEVD tetrapeptide sequence, which both caspases-3 and -7 recognize with similar affinity, and thus the individual contributions of caspase-3 and/or -7 toward important cellular processes are irresolvable.  Here, we analyzed a variety of permutations of the DEVD peptide sequence in order to discover peptides with biased activity and recognition of caspase-3 vs. caspases-6, -7, -8, and -9.  Through this study, we identify fluorescent and biotinylated probes capable of selective detection of caspase-3 using key unnatural amino acids.  Likewise, we detd. the X-ray crystal structures of caspases-3, -7, and -8 in complex with our lead peptide inhibitor to elucidate the binding mechanism and active site interactions that promote the selective recognition of caspase-3 over other highly homologous caspase family members.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNlhTpPBcCjbVg90H21EOLACvtfcHk0ljHncO-LHoZKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVCgu7g%253D&md5=4101d0c313f5277a09b47dc7ad5f5176</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fcb400209w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400209w%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DC.%2BJ.%26aulast%3DGonz%25C3%25A1lez-P%25C3%25A1ez%26aufirst%3DG.%2BE.%26aulast%3DWolan%26aufirst%3DD.%2BW.%26atitle%3DSelective%2520detection%2520of%2520caspase-3%2520versus%2520caspase-7%2520using%2520activity-based%2520probes%2520with%2520key%2520unnatural%2520amino%2520acids%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26issue%3D7%26spage%3D1558%26epage%3D1566%26doi%3D10.1021%2Fcb400209w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonzÃ¡lez-PÃ¡ez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolan, D. W.</span></span> <span> </span><span class="NLM_article-title">Selective detection and inhibition of active caspase-3 in cells with optimized peptides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">12869</span>â <span class="NLM_lpage">12876</span>, <span class="refDoi">Â DOI: 10.1021/ja406399r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja406399r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Wlt7rN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=12869-12876&issue=34&author=C.+J.+Vickersauthor=G.+E.+Gonz%C3%A1lez-P%C3%A1ezauthor=D.+W.+Wolan&title=Selective+detection+and+inhibition+of+active+caspase-3+in+cells+with+optimized+peptides&doi=10.1021%2Fja406399r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Detection and Inhibition of Active Caspase-3 in Cells with Optimized Peptides</span></div><div class="casAuthors">Vickers, Chris J.; Gonzalez-Paez, Gonzalo E.; Wolan, Dennis W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">12869-12876</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Caspases are a family of cysteine-aspartyl proteases that are well recognized for their essential roles in apoptosis and inflammation.  Recently, caspases have also been linked to the promotion of other biol. important phenomena, such as cellular differentiation and proliferation.  Dysregulation of the multifaceted and indispensable activities of caspases has been globally linked to several diseases, including cancer and neurodegenerative disorders; however, the specific caspase members responsible for these diseases have yet to be assigned.  Activity-based probes (ABPs) and peptide-based inhibitors are instrumental in the detection and control of protease activity and serve as alternative methods to genetic approaches.  Such mols. aid in the interrogation of specific proteases within cellular and animal models as well as help elucidate aberrant proteolytic function correlated to disease phenotypes.  No ABPs or inhibitors have been discovered that specifically target one of the eleven human caspases in a cellular context.  Therefore, ascribing distinct contributions to an individual caspase activity within naturally occurring biol. systems is not possible.  Herein, the authors describe a peptide series optimized for the selective detection and inhibition of active caspase-3 in cells.  These compds. exhibit low nanomolar potency against caspase-3 with >120-fold selectivity over caspase-7 which shares 77% active site identity.  The authors' ability to individually target wild-type active caspase-3 for detection and cell permeable inhibition is a valuable proof-of-concept methodol. that can be readily employed to probe the significance of caspase-3 in apoptosis, neurol. disorders, cardiovascular diseases, and sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCkB5AJ8ptFrVg90H21EOLACvtfcHk0lg-RZPdYP0o-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Wlt7rN&md5=6a12e28e901f5f47e4d77191b0a39d93</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fja406399r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja406399r%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DC.%2BJ.%26aulast%3DGonz%25C3%25A1lez-P%25C3%25A1ez%26aufirst%3DG.%2BE.%26aulast%3DWolan%26aufirst%3DD.%2BW.%26atitle%3DSelective%2520detection%2520and%2520inhibition%2520of%2520active%2520caspase-3%2520in%2520cells%2520with%2520optimized%2520peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26issue%3D34%26spage%3D12869%26epage%3D12876%26doi%3D10.1021%2Fja406399r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solania, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonzÃ¡lez-PÃ¡ez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolan, D. W.</span></span> <span> </span><span class="NLM_article-title">Selective and rapid cell-permeable inhibitor of human caspase-3</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2463</span>â <span class="NLM_lpage">2470</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.9b00564</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.9b00564" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVamurjM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=2463-2470&issue=11&author=A.+Solaniaauthor=G.+E.+Gonz%C3%A1lez-P%C3%A1ezauthor=D.+W.+Wolan&title=Selective+and+rapid+cell-permeable+inhibitor+of+human+caspase-3&doi=10.1021%2Facschembio.9b00564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Selective and Rapid Cell-Permeable Inhibitor of Human Caspase-3</span></div><div class="casAuthors">Solania, Angelo; Gonzalez-Paez, Gonzalo E.; Wolan, Dennis W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2463-2470</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Individual roles and overlapping functionalities of 12 human caspases during apoptosis and other cellular processes remain poorly resolved primarily due to a lack of chem. tools.  Here we present a new selective caspase-3 inhibitor, termed Ac-ATS010-KE, with rapid and irreversible binding kinetics.  Relative to previously designed caspase-3-selective mols. that have tremendously abated inhibitory rates and thus limited use in biol. settings, the improved kinetics of Ac-ATS010-KE permits its use in a cell-based capacity.  We demonstrate that Ac-ATS010-KE prevents apoptosis with comparable efficacy to the general caspase inhibitor Ac-DEVD-KE and surprisingly does so without side-chain methylation.  This observation is in contrast to the well-established peptide modification strategy typically employed for improving cellular permeability.  Ac-ATS010-KE protects against extrinsic apoptosis, which demonstrates the utility of a thiophene carboxylate leaving group in biol. settings, challenges the requisite neutralization of free carboxylic acids to improve cell permeability, and provides a tool-like compd. to interrogate the role of caspase-3 in a variety of cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE4FLPCio2BLVg90H21EOLACvtfcHk0lg-RZPdYP0o-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVamurjM&md5=566ac057a74457686e7b076700f336d8</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facschembio.9b00564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.9b00564%26sid%3Dliteratum%253Aachs%26aulast%3DSolania%26aufirst%3DA.%26aulast%3DGonz%25C3%25A1lez-P%25C3%25A1ez%26aufirst%3DG.%2BE.%26aulast%3DWolan%26aufirst%3DD.%2BW.%26atitle%3DSelective%2520and%2520rapid%2520cell-permeable%2520inhibitor%2520of%2520human%2520caspase-3%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2019%26volume%3D14%26issue%3D11%26spage%3D2463%26epage%3D2470%26doi%3D10.1021%2Facschembio.9b00564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groborz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span> <span> </span><span class="NLM_article-title">Caspase selective reagents for diagnosing apoptotic mechanisms</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">229</span>â <span class="NLM_lpage">244</span>, <span class="refDoi">Â DOI: 10.1038/s41418-018-0110-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41418-018-0110-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29748600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVWks7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=229-244&issue=2&author=M.+Porebaauthor=K.+Groborzauthor=M.+Navarroauthor=S.+J.+Snipasauthor=M.+Dragauthor=G.+S.+Salvesen&title=Caspase+selective+reagents+for+diagnosing+apoptotic+mechanisms&doi=10.1038%2Fs41418-018-0110-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase selective reagents for diagnosing apoptotic mechanisms</span></div><div class="casAuthors">Poreba, Marcin; Groborz, Katarzyna; Navarro, Mario; Snipas, Scott J.; Drag, Marcin; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-244</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Apical caspases initiate and effector caspases execute apoptosis.  Reagents that can distinguish between caspases, particularly apical caspases-8, 9, and 10 are scarce and generally nonspecific.  Based upon a previously described large-scale screen of peptide-based caspase substrates termed HyCoSuL, we sought to develop reagents to distinguish between apical caspases in order to reveal their function in apoptotic cell death paradigms.  To this end, we selected tetrapeptide-based sequences that deliver optimal substrate selectivity and converted them to inhibitors equipped with a detectable tag (activity-based probes-ABPs).  We demonstrate a strong relationship between substrate kinetics and ABP kinetics.  To evaluate the utility of selective substrates and ABPs, we examd. distinct apoptosis pathways in Jurkat T lymphocyte and MDA-MB-231 breast cancer lines triggered to undergo cell death via extrinsic or intrinsic apoptosis.  We report the first highly selective substrate appropriate for quantitation of caspase-8 activity during apoptosis.  Converting substrates to ABPs promoted loss-of-activity and selectivity, thus we could not define a single ABP capable of detecting individual apical caspases in complex mixts.  To overcome this, we developed a panel strategy utilizing several caspase-selective ABPs to interrogate apoptosis, revealing the first chem.-based approach to uncover the participation of caspase-8, but not caspase-9 or -10 in TRAIL-induced extrinsic apoptosis.  We propose that using select panels of ABPs can provide information regarding caspase-8 apoptotic signaling more faithfully than can single, generally nonspecific reagents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozlNDFtXmlerVg90H21EOLACvtfcHk0lg-RZPdYP0o-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVWks7c%253D&md5=e8745e81bc7fe192d53793accf8fe21d</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fs41418-018-0110-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-018-0110-y%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DGroborz%26aufirst%3DK.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DCaspase%2520selective%2520reagents%2520for%2520diagnosing%2520apoptotic%2520mechanisms%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2019%26volume%3D26%26issue%3D2%26spage%3D229%26epage%3D244%26doi%3D10.1038%2Fs41418-018-0110-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rut, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groborz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2695</span>â <span class="NLM_lpage">2709</span>, <span class="refDoi">Â DOI: 10.1038/s41418-019-0329-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41418-019-0329-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30976094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFSmsb%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=2695-2709&issue=12&author=M.+Porebaauthor=W.+Rutauthor=K.+Groborzauthor=S.+J.+Snipasauthor=G.+S.+Salvesenauthor=M.+Drag&title=Potent+and+selective+caspase-2+inhibitor+prevents+MDM-2+cleavage+in+reversine-treated+colon+cancer+cells&doi=10.1038%2Fs41418-019-0329-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells</span></div><div class="casAuthors">Poreba, Marcin; Rut, Wioletta; Groborz, Katarzyna; Snipas, Scott J.; Salvesen, Guy S.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2695-2709</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Most caspases can be positioned unambiguously within the regulated cell death networks of apoptosis and pyroptosis, but the role of caspase-2, a highly conserved protease within the family, remains enigmatic.  This is mainly due to lack of selective chem. and biochem. tools for the investigation of this protease.  In this study, we used our hybrid combinatorial substrate library (HyCoSuL) approach to broadly profile caspase-2 substrate specificity using peptide scanning libraries.  This screen uncovered previously unknown caspase-2 peptidyl substrate preferences, which were further used to develop caspase-2 selective fluorogenic substrates and covalent, irreversible AOMK inhibitors.  Finally, we used the champion inhibitor (NH-23-C2) in reversine-treated HCT-116 colon cancer cells to selectively block caspase-2 activity and caspase-2-mediated MDM-2 cleavage.  In addn., we showed that NH-23-C2 does not block caspase-3 or caspase-8, which makes it a powerful chem. tool to dissect the true role of caspase-2 in various biol. setups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW3R6mnFIzR7Vg90H21EOLACvtfcHk0ljcMyIwcPlELQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFSmsb%252FI&md5=c64260f2a2da36fe01c745dd30495d83</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fs41418-019-0329-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-019-0329-2%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DRut%26aufirst%3DW.%26aulast%3DGroborz%26aufirst%3DK.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DPotent%2520and%2520selective%2520caspase-2%2520inhibitor%2520prevents%2520MDM-2%2520cleavage%2520in%2520reversine-treated%2520colon%2520cancer%2520cells%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2019%26volume%3D26%26issue%3D12%26spage%3D2695%26epage%3D2709%26doi%3D10.1038%2Fs41418-019-0329-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonzÃ¡lez-PÃ¡ez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litwin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umotoy, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutsias, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolan, D. W.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of initiator versus executioner caspases using small peptides containing unnatural amino acids</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2194</span>â <span class="NLM_lpage">2198</span>, <span class="refDoi">Â DOI: 10.1021/cb5004256</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5004256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Gns7fI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2194-2198&issue=10&author=C.+J.+Vickersauthor=G.+E.+Gonz%C3%A1lez-P%C3%A1ezauthor=K.+M.+Litwinauthor=J.+C.+Umotoyauthor=E.+A.+Coutsiasauthor=D.+W.+Wolan&title=Selective+inhibition+of+initiator+versus+executioner+caspases+using+small+peptides+containing+unnatural+amino+acids&doi=10.1021%2Fcb5004256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Initiator versus Executioner Caspases Using Small Peptides Containing Unnatural Amino Acids</span></div><div class="casAuthors">Vickers, Chris J.; Gonzalez-Paez, Gonzalo E.; Litwin, Kevin M.; Umotoy, Jeffrey C.; Coutsias, Evangelos A.; Wolan, Dennis W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2194-2198</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Caspases are fundamental to many essential biol. processes, including apoptosis, differentiation, and inflammation.  Unregulated caspase activity is also implicated in the development and progression of several diseases, such as cancer, neurodegenerative disorders, and sepsis.  Unfortunately, it is difficult to det. exactly which caspase(s) of the 11 isoforms that humans express is responsible for specific biol. functions.  This lack of resoln. is primarily due to highly homologous active sites and overlapping substrates.  Currently available peptide-based inhibitors and probes are based on specificity garnered from peptide substrate libraries.  For example, the canonical tetrapeptide LETD was discovered as the canonical sequence that is optimally recognized by caspase-8; however, LETD-based inhibitors and substrates promiscuously bind to other isoforms with equal affinity, including caspases-3, -6, and -9.  In order to mitigate this problem, we report the identification of a new series of compds. that are >100-fold selective for inhibiting the initiator caspases-8 and -9 over the executioner caspases-3, -6, and -7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIDCHV4InVobVg90H21EOLACvtfcHk0ljcMyIwcPlELQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Gns7fI&md5=478fe6cacc0338ef4a3f15509d1d4069</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fcb5004256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5004256%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DC.%2BJ.%26aulast%3DGonz%25C3%25A1lez-P%25C3%25A1ez%26aufirst%3DG.%2BE.%26aulast%3DLitwin%26aufirst%3DK.%2BM.%26aulast%3DUmotoy%26aufirst%3DJ.%2BC.%26aulast%3DCoutsias%26aufirst%3DE.%2BA.%26aulast%3DWolan%26aufirst%3DD.%2BW.%26atitle%3DSelective%2520inhibition%2520of%2520initiator%2520versus%2520executioner%2520caspases%2520using%2520small%2520peptides%2520containing%2520unnatural%2520amino%2520acids%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26issue%3D10%26spage%3D2194%26epage%3D2198%26doi%3D10.1021%2Fcb5004256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Groborz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez Ramirez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DraÌ§g, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PorÈ©ba, M.</span></span> <span> </span><span class="NLM_article-title">Exploring the prime site in caspases as a novel chemical strategy for understanding the mechanisms of cell death: a proof of concept study on necroptosis in cancer cells</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">451</span>â <span class="NLM_lpage">465</span>, <span class="refDoi">Â DOI: 10.1038/s41418-019-0364-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41418-019-0364-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31209360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BB3M3nslKksA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2020&pages=451-465&issue=2&author=K.+Groborzauthor=M.+L.+Gonzalez+Ramirezauthor=S.+J.+Snipasauthor=G.+S.+Salvesenauthor=M.+Dra%CC%A7gauthor=M.+Por%C8%A9ba&title=Exploring+the+prime+site+in+caspases+as+a+novel+chemical+strategy+for+understanding+the+mechanisms+of+cell+death%3A+a+proof+of+concept+study+on+necroptosis+in+cancer+cells&doi=10.1038%2Fs41418-019-0364-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the prime site in caspases as a novel chemical strategy for understanding the mechanisms of cell death: a proof of concept study on necroptosis in cancer cells</span></div><div class="casAuthors">Groborz Katarzyna; DrAg Marcin; Poreba Marcin; Gonzalez Ramirez Monica L; Snipas Scott J; Salvesen Guy S; DrAg Marcin; Poreba Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Cell death and differentiation</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">451-465</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Caspases participate in regulated cell death mechanisms and are divided into apoptotic and proinflammatory caspases.  The main problem in identifying the unique role of a particular caspase in the mechanisms of regulated cell death is their overlapping substrate specificity; caspases recognize and hydrolyze similar peptide substrates.  Most studies focus on examining the non-prime sites of the caspases, yet there is a need for novel and more precise chemical tools to identify the molecular participants and mechanisms of programmed cell death pathways.  Therefore, we developed an innovative chemical approach that examines the prime area of the caspase active sites.  This method permits the agile parallel solid-phase synthesis of caspase inhibitors with a high yield and purity.  Using synthesized compounds we have shown the similarities and differences in the prime area of the caspase active site and, as a proof of concept, we demonstrated the exclusive role of caspase-8 in necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVbFkOCQlNfEewzGPswiWOfW6udTcc2eaG9VWtk3mIRrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3nslKksA%253D%253D&md5=c436441a7bb7afed5231aafd08b32496</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fs41418-019-0364-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-019-0364-z%26sid%3Dliteratum%253Aachs%26aulast%3DGroborz%26aufirst%3DK.%26aulast%3DGonzalez%2BRamirez%26aufirst%3DM.%2BL.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDra%25CC%25A7g%26aufirst%3DM.%26aulast%3DPor%25C8%25A9ba%26aufirst%3DM.%26atitle%3DExploring%2520the%2520prime%2520site%2520in%2520caspases%2520as%2520a%2520novel%2520chemical%2520strategy%2520for%2520understanding%2520the%2520mechanisms%2520of%2520cell%2520death%253A%2520a%2520proof%2520of%2520concept%2520study%2520on%2520necroptosis%2520in%2520cancer%2520cells%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2020%26volume%3D27%26issue%3D2%26spage%3D451%26epage%3D465%26doi%3D10.1038%2Fs41418-019-0364-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, D. E.</span></span> <span> </span><span class="NLM_article-title">Docking and 3D-QSAR studies on isatin sulfonamide analogues as caspase-3 inhibitors</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1963</span>â <span class="NLM_lpage">1973</span>, <span class="refDoi">Â DOI: 10.1021/ci900144x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci900144x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1963-1973&issue=8&author=Q.+Wangauthor=R.+H.+Machauthor=D.+E.+Reichert&title=Docking+and+3D-QSAR+studies+on+isatin+sulfonamide+analogues+as+caspase-3+inhibitors&doi=10.1021%2Fci900144x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Docking and 3D-QSAR Studies on Isatin Sulfonamide Analogues as Caspase-3 Inhibitors</span></div><div class="casAuthors">Wang, Qi; Mach, Robert H.; Reichert, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1963-1973</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To provide insight of their inhibition mechanism and facilitate the design of more potent ligands, a series of 59 isatin sulfonamide analogs were docked to the x-ray structure of caspase-3, one of the important cysteine aspartyl-specific execution proteases in apoptosis, and their binding conformations were analyzed by 3D-QSAR studies.  Comparative mol. field anal. (CoMFA) and comparative mol. similarity index anal. (CoMSIA) studies suggest that both steric and electrostatic interactions contribute to the compds.' binding affinity, with the major contribution arising from hydrophobic interactions.  The models show excellent correlation and high predictive power even evaluated by the most stringent criteria for a QSAR model.  The results of this work demonstrate that structure-based design methods (such as docking) cultivate the development of reliable QSAR models; they also illustrate the utility of this procedure in design of new potent caspase-3 ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5G0bo_WOlx7Vg90H21EOLACvtfcHk0lgBKWtX-AQFSg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbg%253D&md5=bd0c7b053b63eb9ebfcb4ea7c3f7c238</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fci900144x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci900144x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DReichert%26aufirst%3DD.%2BE.%26atitle%3DDocking%2520and%25203D-QSAR%2520studies%2520on%2520isatin%2520sulfonamide%2520analogues%2520as%2520caspase-3%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26issue%3D8%26spage%3D1963%26epage%3D1973%26doi%3D10.1021%2Fci900144x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothfuss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5041</span>â <span class="NLM_lpage">5046</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2006.07.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2006.07.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=16891117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD28XoslCnsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5041-5046&issue=19&author=D.+Zhouauthor=W.+Chuauthor=J.+Rothfussauthor=C.+Zengauthor=J.+Xuauthor=L.+Jonesauthor=M.+J.+Welchauthor=R.+H.+Mach&title=Synthesis%2C+radiolabeling%2C+and+in+vivo+evaluation+of+an+18F-labeled+isatin+analog+for+imaging+caspase-3+activation+in+apoptosis&doi=10.1016%2Fj.bmcl.2006.07.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis</span></div><div class="casAuthors">Zhou, Dong; Chu, Wenhua; Rothfuss, Justin; Zeng, Chenbo; Xu, Jinbin; Jones, Lynne; Welch, Michael J.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5041-5046</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A non-peptide-based isatin sulfonamide analog, WC-II-89, was synthesized and its inhibition toward recombinant human caspase-3 and other caspases was detd.  This compd. showed high potency for inhibiting caspase-3 and -7, and high selectivity against caspases-1, -6, and -8. [18F]WC-II-89 was synthesized via a nucleophilic substitution of the corresponding mesylate precursor in high yield and radiochem. purity.  Biodistribution studies using [18F]WC-II-89 revealed higher uptake in liver and spleen of cycloheximide-treated rats, an animal model of apoptosis, relative to control animals.  Western blot anal. confirmed the presence of activated caspase-3 in the liver and spleen of cycloheximide-treated animals.  MicroPET imaging studies revealed a high uptake of the radiotracer in the liver of a cycloheximide-treated rat relative to the untreated control.  These data suggest that [18F]WC-II-89 is a potential radiotracer for imaging caspase-3 activation in tissues undergoing apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooDEd3YRrF-LVg90H21EOLACvtfcHk0lgBKWtX-AQFSg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XoslCnsrc%253D&md5=1be5377d306e16cf3451b181669a2c65</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.07.045%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DW.%26aulast%3DRothfuss%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DL.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%252C%2520radiolabeling%252C%2520and%2520in%2520vivo%2520evaluation%2520of%2520an%252018F-labeled%2520isatin%2520analog%2520for%2520imaging%2520caspase-3%2520activation%2520in%2520apoptosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D19%26spage%3D5041%26epage%3D5046%26doi%3D10.1016%2Fj.bmcl.2006.07.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelst, S. H. L.</span></span> <span> </span><span class="NLM_article-title">Controlled inhibition of apoptosis by photoactivatable caspase inhibitors</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1434</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2020.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2020.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32814013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1Cku7rI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2020&pages=1434&issue=11&author=S.+Chakrabartyauthor=S.+H.+L.+Verhelst&title=Controlled+inhibition+of+apoptosis+by+photoactivatable+caspase+inhibitors&doi=10.1016%2Fj.chembiol.2020.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Controlled Inhibition of Apoptosis by Photoactivatable Caspase Inhibitors</span></div><div class="casAuthors">Chakrabarty, Suravi; Verhelst, Steven H. L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1434-1440.e10</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Caspases control regulated cell death (apoptosis), a process that is crucial in the development of multicellular organisms as well as in various diseases.  In order to spatiotemporally study apoptosis, we here develop photoactivatable caspase inhibitors.  These are based on cysteine-reactive acyloxymethyl ketone electrophiles connected to a peptide targeting caspases.  Importantly, the aspartate crucial for recognition by caspases is caged with a photoprotecting group.  Ester photocages were found to be labile, and it was crit. to have a nitroindoline cage, which forms a stable amide bond with the aspartate side chain.  The nitroindoline-protected inhibitors lead to an efficient turn-on of inhibitory activity after irradn. with light.  They are applicable in live cells, where they prevent anti-FAS-induced apoptosis only upon irradn.  Overall, these reagents will allow a better understanding of the spatial and temporal dimensions of apoptosis in complex, dynamic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoZj_GXGls4bVg90H21EOLACvtfcHk0lgBKWtX-AQFSg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1Cku7rI&md5=0303c70b79e08e80540bfe13f8a1db36</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2020.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2020.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarty%26aufirst%3DS.%26aulast%3DVerhelst%26aufirst%3DS.%2BH.%2BL.%26atitle%3DControlled%2520inhibition%2520of%2520apoptosis%2520by%2520photoactivatable%2520caspase%2520inhibitors%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2020%26volume%3D27%26issue%3D11%26spage%3D1434%26doi%3D10.1016%2Fj.chembiol.2020.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rebeaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hailfinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posevitz-Fejfar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapernoux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaide, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzzardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iancu, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rufer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span> <span> </span><span class="NLM_article-title">The proteolytic activity of the paracaspase MALT1 is key in T cell activation</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">272</span>â <span class="NLM_lpage">281</span>, <span class="refDoi">Â DOI: 10.1038/ni1568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fni1568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18264101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVOjt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=272-281&issue=3&author=F.+Rebeaudauthor=S.+Hailfingerauthor=A.+Posevitz-Fejfarauthor=M.+Tapernouxauthor=R.+Moserauthor=D.+Ruedaauthor=O.+Gaideauthor=M.+Guzzardiauthor=E.+M.+Iancuauthor=N.+Ruferauthor=N.+Faselauthor=M.+Thome&title=The+proteolytic+activity+of+the+paracaspase+MALT1+is+key+in+T+cell+activation&doi=10.1038%2Fni1568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The proteolytic activity of the paracaspase MALT1 is key in T cell activation</span></div><div class="casAuthors">Rebeaud, Fabien; Hailfinger, Stephan; Posevitz-Fejfar, Anita; Tapernoux, Myriam; Moser, Roger; Rueda, Daniel; Gaide, Olivier; Guzzardi, Montserrat; Iancu, Emanuela M.; Rufer, Nathalie; Fasel, Nicolas; Thome, Margot</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">272-281</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The paracaspase MALT1 is pivotal in antigen receptor-mediated lymphocyte activation and lymphomagenesis.  MALT1 contains a caspase-like domain, but it is unknown whether this domain is proteolytically active.  Here the authors report that MALT1 had arginine-directed proteolytic activity that was activated after T cell stimulation, and they identify the signaling protein Bcl-10 as a MALT1 substrate.  Processing of Bcl-10 after Arg228 was required for T cell receptor-induced cell adhesion to fibronectin.  In contrast, MALT1 activity but not Bcl-10 cleavage was essential for optimal activation of transcription factor NF-ÎºB and prodn. of interleukin 2.  Thus, the proteolytic activity of MALT1 is central to T cell activation, which suggests a possible target for the development of immunomodulatory or anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2kTzBRxfMGLVg90H21EOLACvtfcHk0lim5yWFhwQpuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVOjt7w%253D&md5=094b1afc1f65e8a21846b095129df581</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fni1568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1568%26sid%3Dliteratum%253Aachs%26aulast%3DRebeaud%26aufirst%3DF.%26aulast%3DHailfinger%26aufirst%3DS.%26aulast%3DPosevitz-Fejfar%26aufirst%3DA.%26aulast%3DTapernoux%26aufirst%3DM.%26aulast%3DMoser%26aufirst%3DR.%26aulast%3DRueda%26aufirst%3DD.%26aulast%3DGaide%26aufirst%3DO.%26aulast%3DGuzzardi%26aufirst%3DM.%26aulast%3DIancu%26aufirst%3DE.%2BM.%26aulast%3DRufer%26aufirst%3DN.%26aulast%3DFasel%26aufirst%3DN.%26aulast%3DThome%26aufirst%3DM.%26atitle%3DThe%2520proteolytic%2520activity%2520of%2520the%2520paracaspase%2520MALT1%2520is%2520key%2520in%2520T%2520cell%2520activation%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26issue%3D3%26spage%3D272%26epage%3D281%26doi%3D10.1038%2Fni1568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakeham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Differential requirement for Malt1 in T and B cell antigen receptor signaling</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">749</span>â <span class="NLM_lpage">758</span>, <span class="refDoi">Â DOI: 10.1016/S1074-7613(03)00293-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS1074-7613%2803%2900293-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=14614861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVCksLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2003&pages=749-758&issue=5&author=J.+Rulandauthor=G.+S.+Duncanauthor=A.+Wakehamauthor=T.+W.+Mak&title=Differential+requirement+for+Malt1+in+T+and+B+cell+antigen+receptor+signaling&doi=10.1016%2FS1074-7613%2803%2900293-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Requirement for Malt1 in T and B cell antigen receptor signaling</span></div><div class="casAuthors">Ruland, Juergen; Duncan, Gordon S.; Wakeham, Andrew; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">749-758</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The translocation t(11;18)(q21;q21) involving MALT1 is the most common chromosomal abnormality in lymphomas of mucosa-assocd. lymphoid tissue.  Although the paracaspase MALT1 can bind to BCL10, the physiol. function of MALT1 is unknown.  Using mouse models, the authors show that Malt1 is essential for T cell activation, proliferation, and IL-2 prodn. in response to TCR ligation and strictly required for signal-specific NF-ÎºB activation induced by the TCR but not TNF-Î± or IL-1 signaling.  Malt1 operates down-stream of Bcl10, controls the catalytic activity of the canonical IKK complex, and regulates the signaling of Jnk and p38 MAP kinases.  In contrast to Bcl10 disruption, however, inactivation of Malt1 has only mild effects on B cell activation and does not cause defects during neuro-development.  Thus, Malt1 is an essential regulator of Bcl10 signaling that is differentially required depending on cellular context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvcUWLMCBhwrVg90H21EOLACvtfcHk0lim5yWFhwQpuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVCksLw%253D&md5=8d1d5e371243556298a1db1fd15306e2</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS1074-7613%2803%2900293-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-7613%252803%252900293-0%26sid%3Dliteratum%253Aachs%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DDuncan%26aufirst%3DG.%2BS.%26aulast%3DWakeham%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DDifferential%2520requirement%2520for%2520Malt1%2520in%2520T%2520and%2520B%2520cell%2520antigen%2520receptor%2520signaling%26jtitle%3DImmunity%26date%3D2003%26volume%3D19%26issue%3D5%26spage%3D749%26epage%3D758%26doi%3D10.1016%2FS1074-7613%2803%2900293-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruefli-Brasse, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Regulation of NF-ÎºB-dependent lymphocyte activation and development by paracaspase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span> (<span class="NLM_issue">5650</span>),  <span class="NLM_fpage">1581</span>, <span class="refDoi">Â DOI: 10.1126/science.1090769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fscience.1090769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=14576442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Smsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=1581&issue=5650&author=A.+A.+Ruefli-Brasseauthor=D.+M.+Frenchauthor=V.+M.+Dixit&title=Regulation+of+NF-%CE%BAB-dependent+lymphocyte+activation+and+development+by+paracaspase&doi=10.1126%2Fscience.1090769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of NF-ÎºB-Dependent Lymphocyte Activation and Development by Paracaspase</span></div><div class="casAuthors">Ruefli-Brasse, Astrid A.; French, Dorothy M.; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5650</span>),
    <span class="NLM_cas:pages">1581-1584</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Paracaspase (MALT1), a member of an evolutionarily conserved superfamily of caspase-like proteins, has been shown to bind and colocalize with the protein Bcl10 in vitro and, because of this assocn., has been suggested to be involved in the CARMA1-Bcl10 pathway of antigen-induced nuclear factor ÎºB (NF-ÎºB) activation.  The authors demonstrate that primary T and B lymphocytes from paracaspase-deficient mice are defective in antigen-receptor-induced NF-ÎºB activation, cytokine prodn., and proliferation.  Paracaspase acts downstream of Bcl10 to induce NF-ÎºB activation and is required for the normal development of B cells, indicating that paracaspase provides the missing link between Bcl10 and activation of the IÎºB kinase complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmVLHvV66wsbVg90H21EOLACvtfcHk0lim5yWFhwQpuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Smsb8%253D&md5=9e22fb09686e44b51e1d94237e2dcc1d</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1126%2Fscience.1090769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1090769%26sid%3Dliteratum%253Aachs%26aulast%3DRuefli-Brasse%26aufirst%3DA.%2BA.%26aulast%3DFrench%26aufirst%3DD.%2BM.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DRegulation%2520of%2520NF-%25CE%25BAB-dependent%2520lymphocyte%2520activation%2520and%2520development%2520by%2520paracaspase%26jtitle%3DScience%26date%3D2003%26volume%3D302%26issue%3D5650%26spage%3D1581%26doi%3D10.1126%2Fscience.1090769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noels, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Loo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broeckx, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyaert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marynen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baens, M.</span></span> <span> </span><span class="NLM_article-title">A novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-ÎºB activation by API2Â·MALT1 fusions</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">10180</span>â <span class="NLM_lpage">10189</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M611038200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.M611038200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17287209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs1Sit7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=10180-10189&issue=14&author=H.+Noelsauthor=G.+van+Looauthor=S.+Hagensauthor=V.+Broeckxauthor=R.+Beyaertauthor=P.+Marynenauthor=M.+Baens&title=A+novel+TRAF6+binding+site+in+MALT1+defines+distinct+mechanisms+of+NF-%CE%BAB+activation+by+API2%C2%B7MALT1+fusions&doi=10.1074%2Fjbc.M611038200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel TRAF6 Binding Site in MALT1 Defines Distinct Mechanisms of NF-ÎºB Activation by API2Â·MALT1 Fusions</span></div><div class="casAuthors">Noels, Heidi; van Loo, Geert; Hagens, Sofie; Broeckx, Vicky; Beyaert, Rudi; Marynen, Peter; Baens, Mathijs</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">10180-10189</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The recurrent translocation t(11;18)(q21;q21) assocd. with mucosa-assocd. lymphoid tissue (MALT) lymphoma results in the expression of an API2Â·MALT1 fusion protein that constitutively activates NF-ÎºB.  The first baculovirus IAP repeat (BIR) domain of API2 and the C terminus of MALT1, which contains its caspase-like domain, are present in all reported fusion variants and interact with TRAF2 and TRAF6, resp., suggesting their contribution to NF-ÎºB signaling by API2Â·MALT1.  Also, the involvement of BCL10 has been suggested via binding to BIR1 of API2 and via its interaction with the Ig domains of MALT1, present in half of the fusion variants.  However, conflicting reports exist concerning their roles in API2Â·MALT1-induced NF-ÎºB signaling.  In this report, streptavidin pulldowns of biotinylated API2Â·MALT1 fusion variants showed that none of the fusion variants interacted with endogenous BCL10; its role in NF-ÎºB signaling by API2Â·MALT1 was further questioned by RNA interference expts.  In contrast, TRAF6 was essential for NF-ÎºB activation by all fusion variants, and the authors identified a novel TRAF6 binding site in the second Ig domain of MALT1, which enhanced NF-ÎºB activation when present in the fusion protein.  Furthermore, inclusion of both Ig domains in API2Â·MALT1 further enhanced NF-ÎºB signaling via intramol. TRAF6 activation.  Finally, binding of TRAF2 to BIR1 contributed to NF-ÎºB activation by API2Â·MALT1, although addnl. mechanisms involving BIR1-mediated raft assocn. are also important.  Taken together, these data reveal distinct mechanisms of NF-ÎºB activation by the different API2Â·MALT1 fusion variants with an essential role for TRAF6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtWU_hcGONf7Vg90H21EOLACvtfcHk0lgH7LI37YP12w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs1Sit7k%253D&md5=782830893bc1fcd6a2c205f1bc82b83e</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M611038200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M611038200%26sid%3Dliteratum%253Aachs%26aulast%3DNoels%26aufirst%3DH.%26aulast%3Dvan%2BLoo%26aufirst%3DG.%26aulast%3DHagens%26aufirst%3DS.%26aulast%3DBroeckx%26aufirst%3DV.%26aulast%3DBeyaert%26aufirst%3DR.%26aulast%3DMarynen%26aufirst%3DP.%26aulast%3DBaens%26aufirst%3DM.%26atitle%3DA%2520novel%2520TRAF6%2520binding%2520site%2520in%2520MALT1%2520defines%2520distinct%2520mechanisms%2520of%2520NF-%25CE%25BAB%2520activation%2520by%2520API2%25C2%25B7MALT1%2520fusions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26issue%3D14%26spage%3D10180%26epage%3D10189%26doi%3D10.1074%2Fjbc.M611038200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ea, C.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Z.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. J.</span></span> <span> </span><span class="NLM_article-title">The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">289</span>â <span class="NLM_lpage">301</span>, <span class="refDoi">Â DOI: 10.1016/S1097-2765(04)00236-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS1097-2765%2804%2900236-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15125833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1ClsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=289-301&issue=3&author=L.+Sunauthor=L.+Dengauthor=C.-K.+Eaauthor=Z.-P.+Xiaauthor=Z.+J.+Chen&title=The+TRAF6+ubiquitin+ligase+and+TAK1+kinase+mediate+IKK+activation+by+BCL10+and+MALT1+in+T+lymphocytes&doi=10.1016%2FS1097-2765%2804%2900236-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL 10 and MALT1 in T lymphocytes</span></div><div class="casAuthors">Sun, Lijun; Deng, Li; Ea, Chee-Kwee; Xia, Zong-Ping; Chen, Zhijian J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">289-301</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The CARD domain protein BCL 10 and paracaspase MALT1 are essential for the activation of IÎºB kinase (IKK) and NF-ÎºB in response to T cell receptor (TCR) stimulation.  Here we present evidence that TRAF6 ubiquitin ligase and TAK1 protein kinase mediate IKK activation by BCL 10 and MALT1.  RNAi-mediated silencing of MALT1, TAK1, TRAF6, and TRAF2 suppressed TCR-dependent IKK activation and interleukin-2 prodn. in T cells.  Furthermore, we have reconstituted the pathway from BCL 10 to IKK activation in vitro with purified proteins of MALT1, TRAF6, TAK1, and ubiquitination enzymes including Ubc13/Uev1A.  We find that a small fraction of BCL 10 and MALT1 proteins form high mol. wt. oligomers.  Strikingly, only these oligomeric forms of BCL 10 and MALT1 can activate IKK in vitro.  The MALT1 oligomers bind to TRAF6, induce TRAF6 oligomerization, and activate the ligase activity of TRAF6 to polyubiquitinate NEMO.  These results reveal an oligomerization â ubiquitination â phosphorylation cascade that culminates in NF-ÎºB activation in T lymphocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzcdyPuAHljLVg90H21EOLACvtfcHk0lgH7LI37YP12w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1ClsrY%253D&md5=24fa6f93abe311e1ac52e28490d83d8d</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2804%2900236-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252804%252900236-9%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DEa%26aufirst%3DC.-K.%26aulast%3DXia%26aufirst%3DZ.-P.%26aulast%3DChen%26aufirst%3DZ.%2BJ.%26atitle%3DThe%2520TRAF6%2520ubiquitin%2520ligase%2520and%2520TAK1%2520kinase%2520mediate%2520IKK%2520activation%2520by%2520BCL10%2520and%2520MALT1%2520in%2520T%2520lymphocytes%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D14%26issue%3D3%26spage%3D289%26epage%3D301%26doi%3D10.1016%2FS1097-2765%2804%2900236-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bank, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansorge, S.</span></span> <span> </span><span class="NLM_article-title">More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">197</span>â <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=11272269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1Ggs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=197-206&issue=2&author=U.+Bankauthor=S.+Ansorge&title=More+than+destructive%3A+neutrophil-derived+serine+proteases+in+cytokine+bioactivity+control"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control</span></div><div class="casAuthors">Bank, Ute; Ansorge, Siegfried</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-206</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review and discussion with 106 refs.  In addn. to the mechanisms inducing the expression and secretion of cytokines under distinct pathophysiol. conditions, the fate of cytokines after secretion at sites of inflammation is a field of growing interest.  Proteolysis has been suggested to be a fundamental mechanism of regulating the activities of various components of the cytokine network.  Evidence grows that besides highly specific cytokine converting proteases such as interleukin-1Î²-converting enzyme or tumor necrosis factor-converting enzyme, neutrophil-derived serine proteases are intimately involved in the modulation of the activities of cytokines and their receptors.  Particularly at sites of inflammation, high amts. of the active serine proteases elastase, cathepsin G, and proteinase 3 are released from infiltrating polymorphonuclear cells in close temporal correlation to elevated levels of inflammatory cytokines, strongly indicating that these proteases are involved in the control of cytokine bioactivity and availability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4SrG-Wd_XFrVg90H21EOLACvtfcHk0lgH7LI37YP12w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1Ggs7Y%253D&md5=48a4be126253b23f7ccf415fd8082c0d</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBank%26aufirst%3DU.%26aulast%3DAnsorge%26aufirst%3DS.%26atitle%3DMore%2520than%2520destructive%253A%2520neutrophil-derived%2520serine%2520proteases%2520in%2520cytokine%2520bioactivity%2520control%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2001%26volume%3D69%26issue%3D2%26spage%3D197%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farinha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascoyne, R. D.</span></span> <span> </span><span class="NLM_article-title">Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">6370</span>â <span class="NLM_lpage">6378</span>, <span class="refDoi">Â DOI: 10.1200/JCO.2005.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1200%2FJCO.2005.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=16155022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWntbbE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=6370-6378&issue=26&author=P.+Farinhaauthor=R.+D.+Gascoyne&title=Molecular+pathogenesis+of+mucosa-associated+lymphoid+tissue+lymphoma&doi=10.1200%2FJCO.2005.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma</span></div><div class="casAuthors">Farinha, Pedro; Gascoyne, Randy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">6370-6378</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  Extranodal marginal zone B-cell lymphomas of mucosa-assocd. lymphoid tissue (MALT) type occur in a no. of anat. sites, but share overlapping morphol. and immunophenotypic features.  Helicobacter pylori infection has been identified as an etiol. factor in gastric MALT lymphoma, and a growing list of other infectious organisms have recently been shown to be assocd. with MALT lymphomas at other anat. sites.  Although cause and effect has not been established for most of these infectious agents, our understanding of the biol. has significantly improved, in part through the application of std. cytogenetic analyses.  The common karyotypic alterations that characterize MALT lymphomas include the trisomies 3 and 18, the translocations t(11; 18)(q21; q21), t(1; 14)(p22; q32), t(14; 18)(q32; q21), t(3; 14)(q27; q32), and the recently described t(3; 14)(p14.1; q32).  This apparent complexity of cytogenetic alterations that have now been implicated in the pathogenesis of extranodal MALT lymphoma serves as a paradigm for mol. cross talk in neoplastic disease.  Recent data have shown that at least three of the disparate translocations affect a common signaling mechanism, and thus unify all three under a common pathogenesis, resulting in the constitutive activation of the nuclear factor kappa B (NF-ÎºB) pathway.  It may be that the new MALT-related translocation involving the FOXP1 gene and other as yet undiscovered translocations may all have in common increased NF-ÎºB signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQwhCgB_fvA7Vg90H21EOLACvtfcHk0lhSgT7Q_-jKnw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWntbbE&md5=660c24ee283040e90c579e969f92e4b4</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DFarinha%26aufirst%3DP.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26atitle%3DMolecular%2520pathogenesis%2520of%2520mucosa-associated%2520lymphoid%2520tissue%2520lymphoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26issue%3D26%26spage%3D6370%26epage%3D6378%26doi%3D10.1200%2FJCO.2005.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hailfinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posvitz-Fejfar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebeaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzzardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penas, E.-M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierlamm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staudt, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span> <span> </span><span class="NLM_article-title">Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">47</span>),  <span class="NLM_fpage">19946</span>â <span class="NLM_lpage">19951</span>, <span class="refDoi">Â DOI: 10.1073/pnas.0907511106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.0907511106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19897720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGjtL3F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=19946-19951&issue=47&author=S.+Hailfingerauthor=G.+Lenzauthor=V.+Ngoauthor=A.+Posvitz-Fejfarauthor=F.+Rebeaudauthor=M.+Guzzardiauthor=E.-M.+M.+Penasauthor=J.+Dierlammauthor=W.+C.+Chanauthor=L.+M.+Staudtauthor=M.+Thome&title=Essential+role+of+MALT1+protease+activity+in+activated+B+cell-like+diffuse+large+B-cell+lymphoma&doi=10.1073%2Fpnas.0907511106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma</span></div><div class="casAuthors">Hailfinger, Stephan; Lenz, Georg; Ngo, Vu; Posvitz-Fejfar, Anita; Rebeaud, Fabien; Guzzardi, Montserrat; Murga Penas, Eva-Maria; Dierlamm, Judith; Chan, Wing C.; Staudt, Louis M.; Thome, Margot</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">19946-19951, S19946/1-S19946/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A key element for the development of suitable anti-cancer drugs is the identification of cancer-specific enzymic activities that can be therapeutically targeted.  Mucosa-assocd. lymphoid tissue transformation protein 1 (MALT1) is a proto-oncogene that contributes to tumorigenesis in diffuse large B-cell lymphoma (DLBCL) of the activated B-cell (ABC) subtype, the least curable subtype of DLBCL.  Recent data suggest that MALT1 has proteolytic activity, but it is unknown whether this activity is relevant for tumor growth.  Here the authors report that MALT1 is constitutively active in DLBCL lines of the ABC but not the GCB subtype.  Inhibition of the MALT1 proteolytic activity led to reduced expression of growth factors and apoptosis inhibitors, and specifically affected the growth and survival of ABC DLBCL lines.  These results demonstrate a key role for the proteolytic activity of MALT1 in DLBCL of the ABC subtype, and provide a rationale for the development of pharmacol. inhibitors of MALT1 in DLBCL therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrezepbuMe8ELVg90H21EOLACvtfcHk0lhSgT7Q_-jKnw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGjtL3F&md5=45cf9c9b7b7b438325d45398f95cda4e</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0907511106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0907511106%26sid%3Dliteratum%253Aachs%26aulast%3DHailfinger%26aufirst%3DS.%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DNgo%26aufirst%3DV.%26aulast%3DPosvitz-Fejfar%26aufirst%3DA.%26aulast%3DRebeaud%26aufirst%3DF.%26aulast%3DGuzzardi%26aufirst%3DM.%26aulast%3DPenas%26aufirst%3DE.-M.%2BM.%26aulast%3DDierlamm%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26aulast%3DThome%26aufirst%3DM.%26atitle%3DEssential%2520role%2520of%2520MALT1%2520protease%2520activity%2520in%2520activated%2520B%2520cell-like%2520diffuse%2520large%2520B-cell%2520lymphoma%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D47%26spage%3D19946%26epage%3D19951%26doi%3D10.1073%2Fpnas.0907511106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Malt1 protease is critical in maintaining function of regulatory T cells and may be a therapeutic target for antitumor immunity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>202</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3008</span>, <span class="refDoi">Â DOI: 10.4049/jimmunol.1801614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4049%2Fjimmunol.1801614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30979818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvF2nsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2019&pages=3008&issue=10&author=L.+Chengauthor=N.+Dengauthor=N.+Yangauthor=X.+Zhaoauthor=X.+Lin&title=Malt1+protease+is+critical+in+maintaining+function+of+regulatory+T+cells+and+may+be+a+therapeutic+target+for+antitumor+immunity&doi=10.4049%2Fjimmunol.1801614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Malt1 protease is critical in maintaining function of regulatory T cells and may be a therapeutic target for antitumor immunity</span></div><div class="casAuthors">Cheng, Liqing; Deng, Nan; Yang, Naixue; Zhao, Xueqiang; Lin, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3008-3019</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The paracaspase Malt1 is a key mol. in mediating Ag receptor-induced NF-ÎºB activation in lymphocytes, but the role of Malt1 in the function of regulatory T (Treg) cells is still unclear.  In this article, we reported that specific deletion of Malt1 in Treg cells would lead to Scurfy-like lethal autoimmune disease, which was caused by Treg cell dysfunction but not no. loss.  Interestingly, Foxp3CreMalt1fl/C472A mice, in which Malt1 protease was specifically inactivated in Treg cells, also displayed spontaneous inflammatory disorders, with severe hair loss and skin hyperplasia.  Consistently, Foxp3CreMalt1fl/C472A mice showed enhanced antitumor response because of their decreased function and infiltration of Treg cells, as well as reduced CD8+ T cell exhaustion.  Gene expression profiling anal. revealed dysregulated expression pattern of Treg effector genes upon Malt1 deletion or its protease inactivation.  Together, our data unraveled a crit. role of Malt1, esp. its protease activity, in maintaining homeostasis and function of Treg cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyuNixqJyx5LVg90H21EOLACvtfcHk0lhSgT7Q_-jKnw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvF2nsbs%253D&md5=d241d288a6a191e6243e8669726138e6</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1801614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1801614%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DMalt1%2520protease%2520is%2520critical%2520in%2520maintaining%2520function%2520of%2520regulatory%2520T%2520cells%2520and%2520may%2520be%2520a%2520therapeutic%2520target%2520for%2520antitumor%2520immunity%26jtitle%3DJ.%2520Immunol.%26date%3D2019%26volume%3D202%26issue%3D10%26spage%3D3008%26doi%3D10.4049%2Fjimmunol.1801614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">BrÃ¼stle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knobbe, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virtanen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hershenfield, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reardon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacher, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">The NF-ÎºB regulator MALT1 determines the encephalitogenic potential of Th17 cells</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4698</span>â <span class="NLM_lpage">4709</span>, <span class="refDoi">Â DOI: 10.1172/JCI63528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1172%2FJCI63528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23114599" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=4698-4709&issue=12&author=A.+Br%C3%BCstleauthor=D.+Brennerauthor=C.+B.+Knobbeauthor=P.+A.+Langauthor=C.+Virtanenauthor=B.+M.+Hershenfieldauthor=C.+Reardonauthor=S.+M.+Lacherauthor=J.+Rulandauthor=P.+S.+Ohashiauthor=T.+W.+Mak&title=The+NF-%CE%BAB+regulator+MALT1+determines+the+encephalitogenic+potential+of+Th17+cells&doi=10.1172%2FJCI63528"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1172%2FJCI63528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI63528%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25BCstle%26aufirst%3DA.%26aulast%3DBrenner%26aufirst%3DD.%26aulast%3DKnobbe%26aufirst%3DC.%2BB.%26aulast%3DLang%26aufirst%3DP.%2BA.%26aulast%3DVirtanen%26aufirst%3DC.%26aulast%3DHershenfield%26aufirst%3DB.%2BM.%26aulast%3DReardon%26aufirst%3DC.%26aulast%3DLacher%26aufirst%3DS.%2BM.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DOhashi%26aufirst%3DP.%2BS.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DThe%2520NF-%25CE%25BAB%2520regulator%2520MALT1%2520determines%2520the%2520encephalitogenic%2520potential%2520of%2520Th17%2520cells%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26issue%3D12%26spage%3D4698%26epage%3D4709%26doi%3D10.1172%2FJCI63528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">52</span>),  <span class="NLM_fpage">21004</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1111708108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.1111708108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22158899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVCquw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=21004&issue=52&author=J.+W.+Yuauthor=P.+D.+Jeffreyauthor=J.+Y.+Haauthor=X.+Yangauthor=Y.+Shi&title=Crystal+structure+of+the+mucosa-associated+lymphoid+tissue+lymphoma+translocation+1+%28MALT1%29+paracaspase+region&doi=10.1073%2Fpnas.1111708108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region</span></div><div class="casAuthors">Yu, Jong W.; Jeffrey, Philip D.; Ha, Jun Yong; Yang, Xiaolu; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">21004-21009, S21004/1-S21004/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The mucosa-assocd. lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase, a key component of the Carma1/Bcl10/MALT1 signalosome, is crit. for NF-ÎºB signaling in multiple contexts.  MALT1 is thought to function as a scaffold and protease to promote signaling; however, the biochem. and structural basis of paracaspase action remains largely unknown.  Here we report the 1.75-Ã resoln. crystal structure of the MALT1 paracaspase region, which contains the paracaspase domain and an ensuing Ig-like domain.  The paracaspase and the Ig domains appear as a single folding unit and interact with each other through extensive van der Waals contacts and hydrogen bonds.  The paracaspase domain adopts a fold that is nearly identical to that of classic caspases and homodimerizes similarly to form an active protease.  Unlike caspases, the active and mature form of the paracaspase domain remains a single uncleaved polypeptide and specifically recognizes the bound peptide inhibitor Val-Arg-Pro-Arg.  In particular, the carboxyl-terminal amino acid Arg of the inhibitor is coordinated by three highly conserved acidic residues.  This structure serves as an important framework for deciphering the function and mechanism of paracaspases exemplified by MALT1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL7uNcqMlhFrVg90H21EOLACvtfcHk0lh8Kwwv4V2mfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVCquw%253D%253D&md5=ae793746fbbdebb0d057565390da91bc</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1111708108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1111708108%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DJ.%2BW.%26aulast%3DJeffrey%26aufirst%3DP.%2BD.%26aulast%3DHa%26aufirst%3DJ.%2BY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DCrystal%2520structure%2520of%2520the%2520mucosa-associated%2520lymphoid%2520tissue%2520lymphoma%2520translocation%25201%2520%2528MALT1%2529%2520paracaspase%2520region%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26issue%3D52%26spage%3D21004%26doi%3D10.1073%2Fpnas.1111708108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hatcher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FontÃ¡n, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Us, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chennamadhavuni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. A.</span></span> <span> </span><span class="NLM_article-title">Peptide-based covalent inhibitors of MALT1 paracaspase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1336</span>â <span class="NLM_lpage">1339</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2019.03.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2019.03.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30954428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmslKmsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=1336-1339&issue=11&author=J.+M.+Hatcherauthor=G.+Duauthor=L.+Font%C3%A1nauthor=I.+Usauthor=Q.+Qiaoauthor=S.+Chennamadhavuniauthor=J.+Shaoauthor=H.+Wuauthor=A.+Melnickauthor=N.+S.+Grayauthor=D.+A.+Scott&title=Peptide-based+covalent+inhibitors+of+MALT1+paracaspase&doi=10.1016%2Fj.bmcl.2019.03.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-based covalent inhibitors of MALT1 paracaspase</span></div><div class="casAuthors">Hatcher, John M.; Du, Guangyan; Fontan, Lorena; Us, Ilkay; Qiao, Qi; Chennamadhavuni, Spandan; Shao, Jay; Wu, Hao; Melnick, Ari; Gray, Nathanael S.; Scott, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1336-1339</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Potent and selective substrate-based covalent inhibitors of MALT1 protease were developed from the tetrapeptide tool compd. Z-VRPR-fmk.  To improve cell permeability, we replaced one arginine residue.  We further optimized a series of tripeptides and identified compds. that were potent in both a GloSensor reporter assay measuring cellular MALT1 protease activity, and an OCI-Ly3 cell proliferation assay.  Example compds. showed good overall selectivity towards cysteine proteases, and one compd. was selected for further profiling in ABL-DLBCL cells and xenograft efficacy models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtEeKyPCVSNrVg90H21EOLACvtfcHk0lh8Kwwv4V2mfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmslKmsbY%253D&md5=ab7bea6771526b16ddd7655676714880</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.03.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.03.046%26sid%3Dliteratum%253Aachs%26aulast%3DHatcher%26aufirst%3DJ.%2BM.%26aulast%3DDu%26aufirst%3DG.%26aulast%3DFont%25C3%25A1n%26aufirst%3DL.%26aulast%3DUs%26aufirst%3DI.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DChennamadhavuni%26aufirst%3DS.%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DScott%26aufirst%3DD.%2BA.%26atitle%3DPeptide-based%2520covalent%2520inhibitors%2520of%2520MALT1%2520paracaspase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26issue%3D11%26spage%3D1336%26epage%3D1339%26doi%3D10.1016%2Fj.bmcl.2019.03.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">FontÃ¡n, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatcher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casalena, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Us, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilchuk, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chennamadhavuni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palladino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inghirami, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philippar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span> <span> </span><span class="NLM_article-title">Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>128</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4397</span>â <span class="NLM_lpage">4412</span>, <span class="refDoi">Â DOI: 10.1172/JCI99436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1172%2FJCI99436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30024860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FpvVGisQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2018&pages=4397-4412&issue=10&author=L.+Font%C3%A1nauthor=Q.+Qiaoauthor=J.+M.+Hatcherauthor=G.+Casalenaauthor=I.+Usauthor=M.+Teaterauthor=M.+Durantauthor=G.+Duauthor=M.+Xiaauthor=N.+Bilchukauthor=S.+Chennamadhavuniauthor=G.+Palladinoauthor=G.+Inghiramiauthor=U.+Philipparauthor=H.+Wuauthor=D.+A.+Scottauthor=N.+S.+Grayauthor=A.+Melnick&title=Specific+covalent+inhibition+of+MALT1+paracaspase+suppresses+B+cell+lymphoma+growth&doi=10.1172%2FJCI99436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth</span></div><div class="casAuthors">Fontan Lorena; Casalena Gabriella; Us Ilkay; Teater Matt; Durant Matt; Xia Min; Bilchuk Natalia; Melnick Ari; Qiao Qi; Wu Hao; Hatcher John M; Du Guangyan; Chennamadhavuni Spandan; Scott David A; Gray Nathanael S; Hatcher John M; Du Guangyan; Chennamadhavuni Spandan; Scott David A; Gray Nathanael S; Palladino Giuseppe; Inghirami Giorgio; Inghirami Giorgio; Philippar Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4397-4412</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The paracaspase MALT1 plays an essential role in activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) downstream of B cell and TLR pathway genes mutated in these tumors.  Although MALT1 is considered a compelling therapeutic target, the development of tractable and specific MALT1 protease inhibitors has thus far been elusive.  Here, we developed a target engagement assay that provides a quantitative readout for specific MALT1-inhibitory effects in living cells.  This enabled a structure-guided medicinal chemistry effort culminating in the discovery of pharmacologically tractable, irreversible substrate-mimetic compounds that bind the MALT1 active site.  We confirmed that MALT1 targeting with compound 3 is effective at suppressing ABC DLBCL cells in vitro and in vivo.  We show that a reduction in serum IL-10 levels exquisitely correlates with the drug pharmacokinetics and degree of MALT1 inhibition in vitro and in vivo and could constitute a useful pharmacodynamic biomarker to evaluate these compounds in clinical trials.  Compound 3 revealed insights into the biology of MALT1 in ABC DLBCL, such as the role of MALT1 in driving JAK/STAT signaling and suppressing the type I IFN response and MHC class II expression, suggesting that MALT1 inhibition could prime lymphomas for immune recognition by cytotoxic immune cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCz33HBHJmvBOk4JA3soTqfW6udTcc2ebojNjDKz441bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FpvVGisQ%253D%253D&md5=e1ec2b4fd4f67628c716d3948da31751</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1172%2FJCI99436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI99436%26sid%3Dliteratum%253Aachs%26aulast%3DFont%25C3%25A1n%26aufirst%3DL.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DHatcher%26aufirst%3DJ.%2BM.%26aulast%3DCasalena%26aufirst%3DG.%26aulast%3DUs%26aufirst%3DI.%26aulast%3DTeater%26aufirst%3DM.%26aulast%3DDurant%26aufirst%3DM.%26aulast%3DDu%26aufirst%3DG.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DBilchuk%26aufirst%3DN.%26aulast%3DChennamadhavuni%26aufirst%3DS.%26aulast%3DPalladino%26aufirst%3DG.%26aulast%3DInghirami%26aufirst%3DG.%26aulast%3DPhilippar%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DMelnick%26aufirst%3DA.%26atitle%3DSpecific%2520covalent%2520inhibition%2520of%2520MALT1%2520paracaspase%2520suppresses%2520B%2520cell%2520lymphoma%2520growth%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2018%26volume%3D128%26issue%3D10%26spage%3D4397%26epage%3D4412%26doi%3D10.1172%2FJCI99436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hachmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington-Mitchell, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanman, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span> <span> </span><span class="NLM_article-title">Probes to monitor activity of the paracaspase MALT1</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">139</span>â <span class="NLM_lpage">147</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2014.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2014.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25556944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntV2ltw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=139-147&issue=1&author=J.+Hachmannauthor=L.+E.+Edgington-Mitchellauthor=M.+Porebaauthor=L.+E.+Sanmanauthor=M.+Dragauthor=M.+Bogyoauthor=G.+S.+Salvesen&title=Probes+to+monitor+activity+of+the+paracaspase+MALT1&doi=10.1016%2Fj.chembiol.2014.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Probes to Monitor Activity of the Paracaspase MALT1</span></div><div class="casAuthors">Hachmann, Janna; Edgington-Mitchell, Laura E.; Poreba, Marcin; Sanman, Laura E.; Drag, Marcin; Bogyo, Matthew; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The human paracaspase mucosa-assocd. lymphoid tissue lymphoma translocation protein 1 (MALT1) plays a central role in nuclear factor-ÎºB (NF-ÎºB) signaling as both a protease and scaffolding protein.  Knocking out MALT1 leads to impaired NF-ÎºB signaling and failure to mount an effective immune response.  However, it is unclear to which degree it is the scaffolding function vs. the proteolytic activity of MALT1 that is essential.  Previous work involving a MALT1 inhibitor with low selectivity suggests that the enzymic function plays an important role in different cell lines.  To help elucidate this proteolytic role of MALT1, we have designed activity-based probes that inhibit its proteolytic activity.  The probes selectively label active enzyme and can be used to inhibit MALT1 and trace its activity profile, helping to create a better picture of the significance of the proteolytic function of MALT1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojbrTWz6oQs7Vg90H21EOLACvtfcHk0likF9Wyb4uZ7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntV2ltw%253D%253D&md5=3a8d7aaa85c3e150bc2518a083b03ef0</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DHachmann%26aufirst%3DJ.%26aulast%3DEdgington-Mitchell%26aufirst%3DL.%2BE.%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DSanman%26aufirst%3DL.%2BE.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DProbes%2520to%2520monitor%2520activity%2520of%2520the%2520paracaspase%2520MALT1%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26issue%3D1%26spage%3D139%26epage%3D147%26doi%3D10.1016%2Fj.chembiol.2014.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eitelhuber, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vosyka, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bognar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenze, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammens, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlauderer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hlahla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopfner, K.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hummel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelst, S. H.L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span> <span> </span><span class="NLM_article-title">Activity-based probes for detection of active MALT1 paracaspase in immune cells and lymphomas</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">129</span>â <span class="NLM_lpage">138</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2014.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2014.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25556945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvFahtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=129-138&issue=1&author=A.+C.+Eitelhuberauthor=O.+Vosykaauthor=D.+Nagelauthor=M.+Bognarauthor=D.+Lenzeauthor=K.+Lammensauthor=F.+Schlaudererauthor=D.+Hlahlaauthor=K.-P.+Hopfnerauthor=G.+Lenzauthor=M.+Hummelauthor=S.+H.L.+Verhelstauthor=D.+Krappmann&title=Activity-based+probes+for+detection+of+active+MALT1+paracaspase+in+immune+cells+and+lymphomas&doi=10.1016%2Fj.chembiol.2014.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-Based Probes for Detection of Active MALT1 Paracaspase in Immune Cells and Lymphomas</span></div><div class="casAuthors">Eitelhuber, Andrea C.; Vosyka, Oliver; Nagel, Daniel; Bognar, Miriam; Lenze, Dido; Lammens, Katja; Schlauderer, Florian; Hlahla, Daniela; Hopfner, Karl-Peter; Lenz, Georg; Hummel, Michael; Verhelst, Steven H. L.; Krappmann, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-138</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">MALT1 paracaspase is activated upon antigen receptor stimulation to promote lymphocyte activation.  In addn., deregulated MALT1 protease activity drives survival of distinct lymphomas such as the activated B cell type of diffuse large B cell lymphoma (ABC-DLBCL).  Here, we designed fluorophore or biotin-coupled activity based-probes (ABP) that covalently modify the active center of MALT1.  MALT1-ABPs are exclusively labeling an active modified full length form of MALT1 upon T cell stimulation.  Further, despite the CARMA1 requirement for initial MALT1 activation, the MALT1-ABPs show that protease activity is not confined to the high-mol. CARMA1-BCL10-MALT1 (CBM) complex.  Using biotin-coupled ABPs, we developed a robust assay for sensitive and selective detection of active MALT1 in cell lines, primary lymphocytes, and DLBCL tumor biopsies.  Taken together, MALT1-ABPs represent powerful chem. tools to measure cellular MALT1 activation, det. efficacy of small mol. inhibitors, and classify lymphomas based on MALT1 activity status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6lkG4qu2iLVg90H21EOLACvtfcHk0likF9Wyb4uZ7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvFahtw%253D%253D&md5=4de07d113d7f5090494d248394538e47</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DEitelhuber%26aufirst%3DA.%2BC.%26aulast%3DVosyka%26aufirst%3DO.%26aulast%3DNagel%26aufirst%3DD.%26aulast%3DBognar%26aufirst%3DM.%26aulast%3DLenze%26aufirst%3DD.%26aulast%3DLammens%26aufirst%3DK.%26aulast%3DSchlauderer%26aufirst%3DF.%26aulast%3DHlahla%26aufirst%3DD.%26aulast%3DHopfner%26aufirst%3DK.-P.%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DHummel%26aufirst%3DM.%26aulast%3DVerhelst%26aufirst%3DS.%2BH.L.%26aulast%3DKrappmann%26aufirst%3DD.%26atitle%3DActivity-based%2520probes%2520for%2520detection%2520of%2520active%2520MALT1%2520paracaspase%2520in%2520immune%2520cells%2520and%2520lymphomas%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26issue%3D1%26spage%3D129%26epage%3D138%26doi%3D10.1016%2Fj.chembiol.2014.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KoÅt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janiszewski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groborz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PorÈ©ba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DraÌ§g, M.</span></span> <span> </span><span class="NLM_article-title">Determination of extended substrate specificity of the MALT1 as a strategy for the design of potent substrates and activity-based probes</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15998</span>, <span class="refDoi">Â DOI: 10.1038/s41598-018-34476-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41598-018-34476-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30375474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BB3cvkslCnug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=15998&issue=1&author=P.+Kasperkiewiczauthor=S.+Ko%C5%82tauthor=T.+Janiszewskiauthor=K.+Groborzauthor=M.+Por%C8%A9baauthor=S.+J.+Snipasauthor=G.+S.+Salvesenauthor=M.+Dra%CC%A7g&title=Determination+of+extended+substrate+specificity+of+the+MALT1+as+a+strategy+for+the+design+of+potent+substrates+and+activity-based+probes&doi=10.1038%2Fs41598-018-34476-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of extended substrate specificity of the MALT1 as a strategy for the design of potent substrates and activity-based probes</span></div><div class="casAuthors">Kasperkiewicz Paulina; Kolt Sonia; Janiszewski Tomasz; Groborz Katarzyna; Poreba Marcin; DrAg Marcin; Poreba Marcin; Snipas Scott J; Salvesen Guy S</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15998</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) belongs to the CD clan of cysteine proteases.  MALT1 is a unique enzyme among this clan because it recognizes the basic amino acid arginine in the P1 pocket.  Previous studies carried out with natural amino acids revealed the substrate specificity of the P4-P1 pockets of MALT1 but have provided only limited information about the catalytic preferences of this enzyme.  In this study, we exploited Hybrid Combinatorial Substrate Library and Internally Quenched Fluorescence substrate technologies to interrogate the extended substrate specificity profile of the S5-S2' active site pockets using unnatural amino acids.  This strategy resulted in the design of a peptide-based fluorogenic substrate, which exhibited significant activity toward MALT1.  Subsequently, the substrate sequence was further utilized to develop potent, irreversible activity-based probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRglXfZMl481eWhZTslLrfffW6udTcc2eYIdelwMplnpLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvkslCnug%253D%253D&md5=a96a58734e16479144f05d3f1484978d</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-34476-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-34476-7%26sid%3Dliteratum%253Aachs%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DKo%25C5%2582t%26aufirst%3DS.%26aulast%3DJaniszewski%26aufirst%3DT.%26aulast%3DGroborz%26aufirst%3DK.%26aulast%3DPor%25C8%25A9ba%26aufirst%3DM.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDra%25CC%25A7g%26aufirst%3DM.%26atitle%3DDetermination%2520of%2520extended%2520substrate%2520specificity%2520of%2520the%2520MALT1%2520as%2520a%2520strategy%2520for%2520the%2520design%2520of%2520potent%2520substrates%2520and%2520activity-based%2520probes%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26issue%3D1%26spage%3D15998%26doi%3D10.1038%2Fs41598-018-34476-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
de Plassche, M. A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâNeill, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeholzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelst, S. H. L.</span></span> <span> </span><span class="NLM_article-title">Use of non-natural amino acids for the design and synthesis of a selective, cell-permeable MALT1 activity-based probe</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3996</span>â <span class="NLM_lpage">4004</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.9b01879</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01879" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFCju7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3996-4004&issue=8&author=M.+A.+T.+van%0Ade+Plasscheauthor=T.+J.+O%E2%80%99Neillauthor=T.+Seeholzerauthor=B.+Turkauthor=D.+Krappmannauthor=S.+H.+L.+Verhelst&title=Use+of+non-natural+amino+acids+for+the+design+and+synthesis+of+a+selective%2C+cell-permeable+MALT1+activity-based+probe&doi=10.1021%2Facs.jmedchem.9b01879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Non-Natural Amino Acids for the Design and Synthesis of a Selective, Cell-Permeable MALT1 Activity-Based Probe</span></div><div class="casAuthors">van de Plassche, Merel A. T.; O'Neill, Thomas J.; Seeholzer, Thomas; Turk, Boris; Krappmann, Daniel; Verhelst, Steven H. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3996-4004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Constitutive proteolytic activity of MALT1 is assocd. with highly aggressive B-cell lymphomas.  Chem. tools that detect active MALT1 have been reported, but suffer from poor cell permeability and/or cross-reactivity with the cysteine protease cathepsin B.  Here, we report that the non-natural amino acid pipecolinic acid in the P2 position of substrates and chem. probes leads to improved selectivity toward MALT1 and results in cell-permeable fluorescent probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrneQOxyy4k_LVg90H21EOLACvtfcHk0ljakCz8j_2ICA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFCju7Y%253D&md5=654c8fce296a0ee5d681f9287f856c0d</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01879%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BPlassche%26aufirst%3DM.%2BA.%2BT.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DT.%2BJ.%26aulast%3DSeeholzer%26aufirst%3DT.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DKrappmann%26aufirst%3DD.%26aulast%3DVerhelst%26aufirst%3DS.%2BH.%2BL.%26atitle%3DUse%2520of%2520non-natural%2520amino%2520acids%2520for%2520the%2520design%2520and%2520synthesis%2520of%2520a%2520selective%252C%2520cell-permeable%2520MALT1%2520activity-based%2520probe%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D8%26spage%3D3996%26epage%3D4004%26doi%3D10.1021%2Facs.jmedchem.9b01879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabaleeswaran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerchietti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaknovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascoyne, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Climent, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span> <span> </span><span class="NLM_article-title">MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">812</span>â <span class="NLM_lpage">824</span>, <span class="refDoi">Â DOI: 10.1016/j.ccr.2012.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.ccr.2012.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23238016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVWgu7fJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=812-824&issue=6&author=L.+Fontanauthor=C.+Yangauthor=V.+Kabaleeswaranauthor=L.+Volponauthor=M.+J.+Osborneauthor=E.+Beltranauthor=M.+Garciaauthor=L.+Cerchiettiauthor=R.+Shaknovichauthor=S.+N.+Yangauthor=F.+Fangauthor=R.+D.+Gascoyneauthor=J.+A.+Martinez-Climentauthor=J.+F.+Glickmanauthor=K.+Bordenauthor=H.+Wuauthor=A.+Melnick&title=MALT1+small+molecule+inhibitors+specifically+suppress+ABC-DLBCL+in+vitro+and+in+vivo&doi=10.1016%2Fj.ccr.2012.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo</span></div><div class="casAuthors">Fontan, Lorena; Yang, Chenghua; Kabaleeswaran, Venkataraman; Volpon, Laurent; Osborne, Michael J.; Beltran, Elena; Garcia, Monica; Cerchietti, Leandro; Shaknovich, Rita; Yang, Shao Ning; Fang, Fang; Gascoyne, Randy D.; Martinez-Climent, Jose Angel; Glickman, J. Fraser; Borden, Katherine; Wu, Hao; Melnick, Ari</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">812-824</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">MALT1 cleavage activity is linked to the pathogenesis of activated B cell-like diffuse large B cell lymphoma (ABC-DLBCL), a chemoresistant form of DLBCL.  We developed a MALT1 activity assay and identified chem. diverse MALT1 inhibitors.  A selected lead compd., MI-2, featured direct binding to MALT1 and suppression of its protease function.  MI-2 concd. within human ABC-DLBCL cells and irreversibly inhibited cleavage of MALT1 substrates.  This was accompanied by NF-ÎºB reporter activity suppression, c-REL nuclear localization inhibition, and NF-ÎºB target gene downregulation.  Most notably, MI-2 was nontoxic to mice, and displayed selective activity against ABC-DLBCL cell lines in vitro and xenotransplanted ABC-DLBCL tumors in vivo.  The compd. was also effective against primary human non-germinal center B cell-like DLBCLs ex vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Pj5xKzCfyrVg90H21EOLACvtfcHk0ljakCz8j_2ICA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVWgu7fJ&md5=f8a19df22430725336d5620b4ccb269a</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DFontan%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DKabaleeswaran%26aufirst%3DV.%26aulast%3DVolpon%26aufirst%3DL.%26aulast%3DOsborne%26aufirst%3DM.%2BJ.%26aulast%3DBeltran%26aufirst%3DE.%26aulast%3DGarcia%26aufirst%3DM.%26aulast%3DCerchietti%26aufirst%3DL.%26aulast%3DShaknovich%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DS.%2BN.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DMartinez-Climent%26aufirst%3DJ.%2BA.%26aulast%3DGlickman%26aufirst%3DJ.%2BF.%26aulast%3DBorden%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DMelnick%26aufirst%3DA.%26atitle%3DMALT1%2520small%2520molecule%2520inhibitors%2520specifically%2520suppress%2520ABC-DLBCL%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D22%26issue%3D6%26spage%3D812%26epage%3D824%26doi%3D10.1016%2Fj.ccr.2012.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goll, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapprell, H. P.</span></span> <span> </span><span class="NLM_article-title">The role of autolysis in activity of the Ca2+-dependent proteinases (mu-calpain and m-calpain)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>264</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">10096</span>â <span class="NLM_lpage">10103</span>, <span class="refDoi">Â DOI: 10.1016/S0021-9258(18)81771-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0021-9258%2818%2981771-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=2542320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaL1MXltFWntrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=10096-10103&issue=17&author=J.+Congauthor=D.+E.+Gollauthor=A.+M.+Petersonauthor=H.+P.+Kapprell&title=The+role+of+autolysis+in+activity+of+the+Ca2%2B-dependent+proteinases+%28mu-calpain+and+m-calpain%29&doi=10.1016%2FS0021-9258%2818%2981771-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">The role of autolysis in activity of the calcium-dependent proteinases (Î¼-calpain and m-calpain)</span></div><div class="casAuthors">Cong, Jinyang; Goll, Darrel E.; Peterson, Ann M.; Kapprell, Hans Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">10096-103</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A recent hypothesis suggests that proteolytic activity of the micromolar and millimolar Ca2+-requiring forms of the Ca2+-dependent proteinases (Î¼- and m-calpain, resp.) is regulated in vivo by their assocn. with a phosphatidylinositol-contg. site on the plasma membrane followed by autolysis of the proteinases.  Phosphatidylinositol assocn. lowers the Ca2+ concn. needed for autolysis, and autolysis, in turn, lowers the Ca2+ concn. needed for proteolytic activity.  To test this hypothesis, the Ca2+ concns. needed for autolysis and for proteolytic activity of the calpains were compared in the presence and the absence of phosphatidylinositol.  Bovine skeletal muscle Î¼-calpain required 40-50 Î¼M Ca2+ for half-maximal rate of proteolysis of a casein substrate, 140-150 Î¼M Ca2+ for half-maximal autolysis in the presence of 80 Î¼M phosphatidylinositol, and 190-210 Î¼M Ca2+ for half-maximal autolysis in the absence of phosphatidylinositol.  Consequently, Î¼-calpain is an active proteinase and does not require autolysis for activation.  Bovine skeletal muscle m-calpain required 700-740 Î¼M Ca2+ for half-maximal autolysis in the presence of 80 Î¼M phosphatidylinositol, and 740-780 Î¼M Ca2+ for half-maximal autolysis in the absence of phosphatidylinositol.  Apparently, m-calpain functions in its autolyzed form, but the results do not demonstrate that unautolyzed m-calpain is inactive.  Phosphatidylinositol at 80 Î¼M had no effect on the Ca2+ requirement of the autolyzed forms of either Î¼- or m-calpain but lowered the specific activity of Î¼-calpain to 20% of its activity in the absence of phosphatidylinositol.  Of the 4 forms of the calpains, unautolyzed m-calpain, autolyzed m-calpain, and unautolyzed Î¼-calpain would not be proteolytically active at the free Ca2+ concns. of 300-1200 nM present inside normal cells, and neither Î¼- nor m-calpain would undergo autolysis at these Ca2+ concns., even in the presence of phosphatidylinositol.  Cells must contain a mechanism other than or in addn. to membrane assocn. and autolysis to activate the calpains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE0-Pz9DFgk7Vg90H21EOLACvtfcHk0ljakCz8j_2ICA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltFWntrg%253D&md5=00e5732cb3204ddf7b3b9a5145db7938</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2981771-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252981771-9%26sid%3Dliteratum%253Aachs%26aulast%3DCong%26aufirst%3DJ.%26aulast%3DGoll%26aufirst%3DD.%2BE.%26aulast%3DPeterson%26aufirst%3DA.%2BM.%26aulast%3DKapprell%26aufirst%3DH.%2BP.%26atitle%3DThe%2520role%2520of%2520autolysis%2520in%2520activity%2520of%2520the%2520Ca2%252B-dependent%2520proteinases%2520%2528mu-calpain%2520and%2520m-calpain%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26issue%3D17%26spage%3D10096%26epage%3D10103%26doi%3D10.1016%2FS0021-9258%2818%2981771-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P. L.</span></span> <span> </span><span class="NLM_article-title">Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>456</i></span> (<span class="NLM_issue">7220</span>),  <span class="NLM_fpage">409</span>â <span class="NLM_lpage">412</span>, <span class="refDoi">Â DOI: 10.1038/nature07451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature07451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19020623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSjsLjN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=456&publication_year=2008&pages=409-412&issue=7220&author=R.+A.+Hannaauthor=R.+L.+Campbellauthor=P.+L.+Davies&title=Calcium-bound+structure+of+calpain+and+its+mechanism+of+inhibition+by+calpastatin&doi=10.1038%2Fnature07451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin</span></div><div class="casAuthors">Hanna, Rachel A.; Campbell, Robert L.; Davies, Peter L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">456</span>
        (<span class="NLM_cas:issue">7220</span>),
    <span class="NLM_cas:pages">409-412</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Calpains are non-lysosomal Ca2+-dependent cysteine proteinases that selectively cleave proteins in response to Ca2+ signals and thereby control cellular functions such as cytoskeletal remodelling, cell cycle progression, gene expression, and apoptotic cell death.  In mammals, the 2 best-characterized members of the calpain family, calpain 1 and calpain 2 (Î¼-calpain and m-calpain, resp.), are ubiquitously expressed.  The activity of calpains is tightly controlled by the endogenous inhibitor, calpastatin, which is an intrinsically unstructured protein capable of reversibly binding and inhibiting 4 mols. of calpain, but only in the presence of Ca2+.  To date, the mechanism of inhibition by calpastatin and the basis for its abs. specificity have remained speculative.  It has not been clear how this unstructured protein inhibits calpains without being cleaved itself, nor is it known how Ca2+ induces changes that facilitate the binding of calpastatin to calpain.  Here, the authors report the 2.4-Ã-resoln. crystal structure of the Ca2+-bound calpain 2 heterodimer bound by inhibitory domain 4 of calpastatin.  Calpastatin was seen to inhibit calpain by occupying both sides of the active site cleft.  Although the inhibitor passed through the active site cleft it escaped cleavage in a novel manner by looping out and around the active site Cys residue.  Capastatin inhibitory domain 4 recognized multiple lower affinity sites present only in the Ca2+-bound form of the enzyme, resulting in an interaction that was tight, specific, and Ca2+-dependent.  This crystal structure, and that of a related complex, also revealed the conformational changes that calpain undergoes on binding Ca2+, which include opening of the active site cleft and movement of the domains relative to each other to produce a more compact enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmkUMcFT6IebVg90H21EOLACvtfcHk0ljPPwQIIEqU4A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSjsLjN&md5=34329cc5c6aeb7058881a98fbf7ba4f7</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1038%2Fnature07451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07451%26sid%3Dliteratum%253Aachs%26aulast%3DHanna%26aufirst%3DR.%2BA.%26aulast%3DCampbell%26aufirst%3DR.%2BL.%26aulast%3DDavies%26aufirst%3DP.%2BL.%26atitle%3DCalcium-bound%2520structure%2520of%2520calpain%2520and%2520its%2520mechanism%2520of%2520inhibition%2520by%2520calpastatin%26jtitle%3DNature%26date%3D2008%26volume%3D456%26issue%3D7220%26spage%3D409%26epage%3D412%26doi%3D10.1038%2Fnature07451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Critical role of calpain in inflammation</span>. <i>Biomed. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">647</span>â <span class="NLM_lpage">652</span>, <span class="refDoi">Â DOI: 10.3892/br.2016.785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.3892%2Fbr.2016.785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=28101338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFGisb%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=647-652&issue=6&author=J.+Jiauthor=L.+Suauthor=Z.+Liu&title=Critical+role+of+calpain+in+inflammation&doi=10.3892%2Fbr.2016.785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Critical role of calpain in inflammation (Review)</span></div><div class="casAuthors">Ji, Jingjing; Su, Lei; Liu, Zhifeng</div><div class="citationInfo"><span class="NLM_cas:title">Biomedical Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-652</span>CODEN:
                <span class="NLM_cas:coden">BREIB7</span>;
        ISSN:<span class="NLM_cas:issn">2049-9442</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Calpains are a family of cysteine proteases, impli- cated in a wide range of cellular calcium-regulated functions.  Evidence from previous studies using an inhibitor of calpain indicates that calpain activation is involved in the process of numerous inflammation-assocd. diseases.  As a result of in-depth studies, calpains have been proposed to influence the process of inflammation via a variety of mechanisms.  The aim of the present study is to provide an overview of recent reports regarding the role of calpain in the process of inflammation, including regulation of immune cell migration, modulation of the activation of inflammatory mediators, degrdn. of certain assocd. proteins and induction of cell apoptosis.  Understanding these mechanisms may contribute to the investi- gation of novel therapeutic targets for inflammation-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGkFaP4Y3vbVg90H21EOLACvtfcHk0ljPPwQIIEqU4A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFGisb%252FE&md5=f96afc2ba837b18fd3bce00fe7644480</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.3892%2Fbr.2016.785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fbr.2016.785%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DCritical%2520role%2520of%2520calpain%2520in%2520inflammation%26jtitle%3DBiomed.%2520Rep.%26date%3D2016%26volume%3D5%26issue%3D6%26spage%3D647%26epage%3D652%26doi%3D10.3892%2Fbr.2016.785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moldoveanu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuerrier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P. L.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>343</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1313</span>â <span class="NLM_lpage">1326</span>, <span class="refDoi">Â DOI: 10.1016/j.jmb.2004.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.jmb.2004.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15491615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2cXos1Klu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=1313-1326&issue=5&author=T.+Moldoveanuauthor=R.+L.+Campbellauthor=D.+Cuerrierauthor=P.+L.+Davies&title=Crystal+structures+of+calpain-E64+and+-leupeptin+inhibitor+complexes+reveal+mobile+loops+gating+the+active+site&doi=10.1016%2Fj.jmb.2004.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Calpain-E64 and -Leupeptin Inhibitor Complexes Reveal Mobile Loops Gating the Active Site</span></div><div class="casAuthors">Moldoveanu, T.; Campbell, R. L.; Cuerrier, D.; Davies, P. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1313-1326</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The endogenous calpain inhibitor, calpastatin, modulates some patho-physiol. aspects of calpain signaling.  Excess calpain can escape this inhibition and as well, many calpain isoforms and autolytically generated protease core fragments are not inhibited by calpastatin.  There is a need, therefore, to develop specific, cell-permeable calpain inhibitors to block uncontrolled proteolysis and prevent tissue damage during brain and heart ischemia, spinal-cord injury and Alzheimer's diseases.  Here, we report the first high-resoln. crystal structures of rat Î¼-calpain protease core complexed with two traditional, low mol. mass inhibitors, leupeptin and E64.  These structures show that access to a slightly deeper, but otherwise papain-like active site is gated by two flexible loops.  These loops are divergent among the calpain isoforms giving a potential structural basis for substrate/inhibitor selectivity over other papain-like cysteine proteases and between members of the calpain family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS2t60SFPuhLVg90H21EOLACvtfcHk0ljPPwQIIEqU4A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXos1Klu7g%253D&md5=ddf5b2a125bcaa66d6b904362d60a8a4</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2004.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2004.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DMoldoveanu%26aufirst%3DT.%26aulast%3DCampbell%26aufirst%3DR.%2BL.%26aulast%3DCuerrier%26aufirst%3DD.%26aulast%3DDavies%26aufirst%3DP.%2BL.%26atitle%3DCrystal%2520structures%2520of%2520calpain-E64%2520and%2520-leupeptin%2520inhibitor%2520complexes%2520reveal%2520mobile%2520loops%2520gating%2520the%2520active%2520site%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26issue%3D5%26spage%3D1313%26epage%3D1326%26doi%3D10.1016%2Fj.jmb.2004.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greenbaum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medzihradszky, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlingame, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">569</span>â <span class="NLM_lpage">581</span>, <span class="refDoi">Â DOI: 10.1016/S1074-5521(00)00014-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS1074-5521%2800%2900014-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=11048948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1WnsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=569-581&issue=8&author=D.+Greenbaumauthor=K.+F.+Medzihradszkyauthor=A.+Burlingameauthor=M.+Bogyo&title=Epoxide+electrophiles+as+activity-dependent+cysteine+protease+profiling+and+discovery+tools&doi=10.1016%2FS1074-5521%2800%2900014-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools</span></div><div class="casAuthors">Greenbaum, Doron; Medzihradszky, Katalin F.; Burlingame, Alma; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">569-581</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: Anal. of global changes in gene transcription and translation by systems-based genomics and proteomics approaches provides only indirect information about protein function.  In many cases, enzymic activity fails to correlate with transcription or translation levels.  Therefore, a direct method for broadly detg. activities of an entire class of enzymes on a genome-wide scale would be of great utility.  Results: We have engineered chem. probes that can be used to broadly track activity of cysteine proteases.  The structure of the general cysteine protease inhibitor E-64 was used as a scaffold.  Analogs were synthesized by varying the core peptide recognition portion while adding affinity tags (biotin and radio-iodine) at distal sites.  The resulting probes contg. a P2 leucine residue (DCG-03 and DCG-04) targeted the same broad set of cysteine proteases as E-64 and were used to profile these proteases during the progression of a normal skin cell to a carcinoma.  A library of DCG-04 derivs. was constructed in which the leucine residue was replaced with all natural amino acids.  This library was used to obtain inhibitor activity profiles for multiple protease targets in crude cellular exts.  Finally, the affinity tag of DCG-04 allowed purifn. of modified proteases and identification by mass spectrometry.  Conclusions: We have created a simple and flexible method for functionally identifying cysteine proteases while simultaneously tracking their relative activity levels in crude protein mixts.  These probes were used to det. relative activities of multiple proteases throughout a defined model system for cancer progression.  Furthermore, information obtained from libraries of affinity probes provides a rapid method for obtaining detailed functional information without the need for prior purifn./identification of targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqlBq1FnhWH7Vg90H21EOLACvtfcHk0lg7T8w7vBNJLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1WnsbY%253D&md5=4bfc0e299524198ec324c96c8981baf7</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2800%2900014-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252800%252900014-4%26sid%3Dliteratum%253Aachs%26aulast%3DGreenbaum%26aufirst%3DD.%26aulast%3DMedzihradszky%26aufirst%3DK.%2BF.%26aulast%3DBurlingame%26aufirst%3DA.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DEpoxide%2520electrophiles%2520as%2520activity-dependent%2520cysteine%2520protease%2520profiling%2520and%2520discovery%2520tools%26jtitle%3DChem.%2520Biol.%26date%3D2000%26volume%3D7%26issue%3D8%26spage%3D569%26epage%3D581%26doi%3D10.1016%2FS1074-5521%2800%2900014-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukiage, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, T. R.</span></span> <span> </span><span class="NLM_article-title">SJA6017, a newly synthesized peptide aldehyde inhibitor of calpain: amelioration of cataract in cultured rat lenses</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>1361</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">304</span>â <span class="NLM_lpage">312</span>, <span class="refDoi">Â DOI: 10.1016/S0925-4439(97)00043-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0925-4439%2897%2900043-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=9375805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2sXmtFKgsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1361&publication_year=1997&pages=304-312&issue=3&author=C.+Fukiageauthor=M.+Azumaauthor=Y.+Nakamuraauthor=Y.+Tamadaauthor=M.+Nakamuraauthor=T.+R.+Shearer&title=SJA6017%2C+a+newly+synthesized+peptide+aldehyde+inhibitor+of+calpain%3A+amelioration+of+cataract+in+cultured+rat+lenses&doi=10.1016%2FS0925-4439%2897%2900043-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">SJA6017, a newly synthesized peptide aldehyde inhibitor of calpain: amelioration of cataract in cultured rat lenses</span></div><div class="casAuthors">Fukiage, Chiho; Azuma, Mitsuyoshi; Nakamura, Yoshikuni; Tamada, Yoshiyuki; Nakamura, Masayuki; Shearer, Thomas R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1361</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">304-312</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purposes of this expt. were to: (1), characterize the peptide aldehyde SJA6017, N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal, a newly synthesized inhibitor of calpain, and (2) test the effect of SJA6017 in preventing calcium ionophore-induced cataract in cultured rat lenses.  In vitro, SJA6017 strongly inhibited purified m-calpain from porcine kidney.  Casein zymog. confirmed that SJA6017 reversibly bound to the active site of m-calpain.  SJA6017 was also confirmed to be a cell-permeable inhibitor in Molt-4 cells.  In cultured lenses, SJA6017 reduced nuclear opacity and proteolysis of crystallins and Î±-spectrin caused by calcium ionophore A23187.  These results suggested that SJA6017 is a reversible and cell-permeable calpain inhibitor which may possess great efficacy against calcium-induced models of cataract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv1AkyGIYh3bVg90H21EOLACvtfcHk0lg7T8w7vBNJLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtFKgsLk%253D&md5=67fc174d4ddffe03c9c8798915d1314f</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2FS0925-4439%2897%2900043-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0925-4439%252897%252900043-4%26sid%3Dliteratum%253Aachs%26aulast%3DFukiage%26aufirst%3DC.%26aulast%3DAzuma%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DTamada%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DShearer%26aufirst%3DT.%2BR.%26atitle%3DSJA6017%252C%2520a%2520newly%2520synthesized%2520peptide%2520aldehyde%2520inhibitor%2520of%2520calpain%253A%2520amelioration%2520of%2520cataract%2520in%2520cultured%2520rat%2520lenses%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D1997%26volume%3D1361%26issue%3D3%26spage%3D304%26epage%3D312%26doi%3D10.1016%2FS0925-4439%2897%2900043-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trinchese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faâ, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixon, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>118</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2796</span>â <span class="NLM_lpage">2807</span>, <span class="refDoi">Â DOI: 10.1172/JCI34254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1172%2FJCI34254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18596919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVOktbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=2796-2807&issue=8&author=F.+Trincheseauthor=M.+Fa%E2%80%99author=S.+Liuauthor=H.+Zhangauthor=A.+Hidalgoauthor=S.+D.+Schmidtauthor=H.+Yamaguchiauthor=N.+Yoshiiauthor=P.+M.+Mathewsauthor=R.+A.+Nixonauthor=O.+Arancio&title=Inhibition+of+calpains+improves+memory+and+synaptic+transmission+in+a+mouse+model+of+Alzheimer+disease&doi=10.1172%2FJCI34254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease</span></div><div class="casAuthors">Trinchese, Fabrizio; Fa, Mauro; Liu, Shumin; Zhang, Hong; Hidalgo, Ariel; Schmidt, Stephen D.; Yamaguchi, Hisako; Yoshii, Narihiko; Mathews, Paul M.; Nixon, Ralph A.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2796-2807</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Calpains are calcium-dependent enzymes that det. the fate of proteins through regulated proteolytic activity.  Calpains have been linked to the modulation of memory and are key to the pathogenesis of Alzheimer disease (AD).  When abnormally activated, calpains can also initiate degrdn. of proteins essential for neuronal survival.  Here we show that calpain inhibition through E64, a cysteine protease inhibitor, and the highly specific calpain inhibitor BDA-410 restored normal synaptic function both in hippocampal cultures and in hippocampal slices from the APP/PS1 mouse, an animal model of AD.  Calpain inhibition also improved spatial-working memory and associative fear memory in APP/PS1 mice.  These beneficial effects of the calpain inhibitors were assocd. with restoration of normal phosphorylation levels of the transcription factor CREB and involved redistribution of the synaptic protein synapsin I.  Thus, calpain inhibition may prove useful in the alleviation of memory loss in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIy6cRZUZoYLVg90H21EOLACvtfcHk0lg7T8w7vBNJLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVOktbw%253D&md5=034fd10ae83ab33a5b0512f3a6f6f393</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1172%2FJCI34254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI34254%26sid%3Dliteratum%253Aachs%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DFa%25E2%2580%2599%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHidalgo%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DS.%2BD.%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DYoshii%26aufirst%3DN.%26aulast%3DMathews%26aufirst%3DP.%2BM.%26aulast%3DNixon%26aufirst%3DR.%2BA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DInhibition%2520of%2520calpains%2520improves%2520memory%2520and%2520synaptic%2520transmission%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26issue%3D8%26spage%3D2796%26epage%3D2807%26doi%3D10.1172%2FJCI34254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartus, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straub, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbeson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration</span>. <i>Stroke</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2265</span>â <span class="NLM_lpage">2270</span>, <span class="refDoi">Â DOI: 10.1161/01.STR.25.11.2265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1161%2F01.STR.25.11.2265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=7974554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2MXit1ejtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=2265-2270&issue=11&author=R.+T.+Bartusauthor=N.+J.+Haywardauthor=P.+J.+Elliottauthor=S.+D.+Sawyerauthor=K.+L.+Bakerauthor=R.+L.+Deanauthor=A.+Akiyamaauthor=J.+A.+Straubauthor=S.+L.+Harbesonauthor=Z.+Li&title=Calpain+inhibitor+AK295+protects+neurons+from+focal+brain+ischemia.+Effects+of+postocclusion+intra-arterial+administration&doi=10.1161%2F01.STR.25.11.2265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Calpain inhibitor AK295 protects neurons from focal brain ischemia: effects of postocclusion intra-arterial administration</span></div><div class="casAuthors">Bartus, Raymond T.; Hayward, Neil J.; Elliott, Peter J.; Sawyer, Sean D.; Baker, Keith L.; Dean, Reginald L.; Akiyama, Alan; Straub, Julie A.; Harbeson, Scott L.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Stroke</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2265-70</span>CODEN:
                <span class="NLM_cas:coden">SJCCA7</span>;
        ISSN:<span class="NLM_cas:issn">0039-2499</span>.
    </div><div class="casAbstract">This research was performed to det. whether a selective inhibitor of the calcium-dependent protease, calpain, could reduce ischemia-assocd. brain damage when peripherally administered after a vascular occlusion.  A variation of the rat middle cerebral artery occlusion model was used.  A range of doses of AK295 (a novel calpain inhibitor synthesized for this purpose) was continuously infused through the internal carotid artery, beginning 1.25 h from the initiation of the occlusion.  Rats were killed at 21 h, and the infarct vol. was quantified.  Postocclusion (1.25-h) infusion of the calpain inhibitor AK295 elicited a dose-dependent neuroprotective effect after focal ischemia.  The highest dose tested (3 mg/kg per h) afforded the max. effect, illustrated by a 32% redn. in infarct vol. 21 h after the ischemia (vehicle, 81.7Â±4.7 mm3; AK295, 54.9Â±6.9 mm3; P<.007).  These data provide the first evidence that a peripherally administered calpain inhibitor can protect against ischemic brain damage.  They offer further support for an important role of calpain proteolysis in the brain degeneration assocd. with cerebral ischemic events and suggest that selective calpain inhibitors provide a rational, novel, and viable means of treating such neurodegenerative problems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0jeYQXd_W3rVg90H21EOLACvtfcHk0ljkunHD75TGdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXit1ejtbY%253D&md5=deb655c102ac330fc60e77d90475c97b</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1161%2F01.STR.25.11.2265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.STR.25.11.2265%26sid%3Dliteratum%253Aachs%26aulast%3DBartus%26aufirst%3DR.%2BT.%26aulast%3DHayward%26aufirst%3DN.%2BJ.%26aulast%3DElliott%26aufirst%3DP.%2BJ.%26aulast%3DSawyer%26aufirst%3DS.%2BD.%26aulast%3DBaker%26aufirst%3DK.%2BL.%26aulast%3DDean%26aufirst%3DR.%2BL.%26aulast%3DAkiyama%26aufirst%3DA.%26aulast%3DStraub%26aufirst%3DJ.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DCalpain%2520inhibitor%2520AK295%2520protects%2520neurons%2520from%2520focal%2520brain%2520ischemia.%2520Effects%2520of%2520postocclusion%2520intra-arterial%2520administration%26jtitle%3DStroke%26date%3D1994%26volume%3D25%26issue%3D11%26spage%3D2265%26epage%3D2270%26doi%3D10.1161%2F01.STR.25.11.2265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lubisch, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckenbach, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bopp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kartal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KÃ¤stel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz-Garrecht, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vierling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¶ller, A.</span></span> <span> </span><span class="NLM_article-title">Benzoylalanine-derived ketoamides carrying vinylbenzyl amino residues: Discovery of potent water-soluble calpain inhibitors with oral bioavailability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2404</span>â <span class="NLM_lpage">2412</span>, <span class="refDoi">Â DOI: 10.1021/jm0210717</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0210717" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsVSgurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2404-2412&issue=12&author=W.+Lubischauthor=E.+Beckenbachauthor=S.+Boppauthor=H.-P.+Hofmannauthor=A.+Kartalauthor=C.+K%C3%A4stelauthor=T.+Lindnerauthor=M.+Metz-Garrechtauthor=J.+Reebauthor=F.+Regnerauthor=M.+Vierlingauthor=A.+M%C3%B6ller&title=Benzoylalanine-derived+ketoamides+carrying+vinylbenzyl+amino+residues%3A+Discovery+of+potent+water-soluble+calpain+inhibitors+with+oral+bioavailability&doi=10.1021%2Fjm0210717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoylalanine-Derived Ketoamides Carrying Vinylbenzyl Amino Residues: Discovery of Potent Water-Soluble Calpain Inhibitors with Oral Bioavailability</span></div><div class="casAuthors">Lubisch, Wilfried; Beckenbach, Edith; Bopp, Sabina; Hofmann, Hans-Peter; Kartal, Arzu; Kaestel, Claudia; Lindner, Tanja; Metz-Garrecht, Marion; Reeb, Jutta; Regner, Ferdinand; Vierling, Michael; Moeller, Achim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2404-2412</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel benzoylalanine-derived ketoamides were prepd. and evaluated for calpain I inhibition.  Derivs. carrying vinylbenzyl amino residues in the P2-P3 region inhibited calpain in nanomolar concns. and thus represent a novel class of nonpeptidic calpain inhibitors.  Selected examples exhibited an improved pharmacokinetic profile including improved water-soly. and metabolic stability.  In particular, these calpain inhibitors showed oral bioavailability in rats as demonstrated by N-(1-benzyl-2-carbamoyl-2-oxoethyl)-2-[E-2-(4-diethylaminomethylphenyl)ethen-1-yl]benzamide.  The closely related deriv. N-(1-carbamoyl-1-oxohex-1-yl)-2-[E-2-(4-dimethylaminomethylphenyl)-ethen-1-yl]benzamide (I) was evaluated for neuroprotective efficacy after exptl. traumatic brain injury in a fluid percussion model in rats.  When administered after injury, I reduced the no. of damaged neurons by 41%, and this result would be in line with the suggested neuroprotective efficacy of calpain inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5xRdpOXZNk7Vg90H21EOLACvtfcHk0ljkunHD75TGdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsVSgurg%253D&md5=ec94d023880005b60ec94eafe8fb78e9</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm0210717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0210717%26sid%3Dliteratum%253Aachs%26aulast%3DLubisch%26aufirst%3DW.%26aulast%3DBeckenbach%26aufirst%3DE.%26aulast%3DBopp%26aufirst%3DS.%26aulast%3DHofmann%26aufirst%3DH.-P.%26aulast%3DKartal%26aufirst%3DA.%26aulast%3DK%25C3%25A4stel%26aufirst%3DC.%26aulast%3DLindner%26aufirst%3DT.%26aulast%3DMetz-Garrecht%26aufirst%3DM.%26aulast%3DReeb%26aufirst%3DJ.%26aulast%3DRegner%26aufirst%3DF.%26aulast%3DVierling%26aufirst%3DM.%26aulast%3DM%25C3%25B6ller%26aufirst%3DA.%26atitle%3DBenzoylalanine-derived%2520ketoamides%2520carrying%2520vinylbenzyl%2520amino%2520residues%253A%2520Discovery%2520of%2520potent%2520water-soluble%2520calpain%2520inhibitors%2520with%2520oral%2520bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D12%26spage%3D2404%26epage%3D2412%26doi%3D10.1021%2Fjm0210717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jantos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornberger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmrich, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijsen, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of ABT-957:1-Benzyl-5-oxopyrrolidine-2-carboxamides as selective calpain inhibitors with enhanced metabolic stability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">1968</span>â <span class="NLM_lpage">1973</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2019.05.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2019.05.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31133534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVKqu77O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=1968-1973&issue=15&author=K.+Jantosauthor=A.+Klingauthor=H.+Mackauthor=W.+Hornbergerauthor=A.+Moellerauthor=V.+Nimmrichauthor=Y.+Laoauthor=M.+Nijsen&title=Discovery+of+ABT-957%3A1-Benzyl-5-oxopyrrolidine-2-carboxamides+as+selective+calpain+inhibitors+with+enhanced+metabolic+stability&doi=10.1016%2Fj.bmcl.2019.05.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of ABT-957: 1-Benzyl-5-oxopyrrolidine-2-carboxamides as selective calpain inhibitors with enhanced metabolic stability</span></div><div class="casAuthors">Jantos, Katja; Kling, Andreas; Mack, Helmut; Hornberger, Wilfried; Moeller, Achim; Nimmrich, Volker; Lao, Yanbin; Nijsen, Marjoleen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1968-1973</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aberrant activation of calpain has been obsd. in various pathophysiol. disorders including neurodegenerative diseases such as Alzheimer's disease.  Here we describe our efforts on ketoamide-based 1-benzyl-5-oxopyrrolidine-2-carboxamides as a novel series of highly selective calpain inhibitors mitigating the metabolic liability of carbonyl redn.  The most advanced compd. from this new series, namely A-1212805 (ABT-957, Alicapistat) proceeded to clin. phase I studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcI58MCHHIBLVg90H21EOLACvtfcHk0ljkunHD75TGdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVKqu77O&md5=c33c42c1648e78d0e02b8b5d02bcbdfd</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DJantos%26aufirst%3DK.%26aulast%3DKling%26aufirst%3DA.%26aulast%3DMack%26aufirst%3DH.%26aulast%3DHornberger%26aufirst%3DW.%26aulast%3DMoeller%26aufirst%3DA.%26aulast%3DNimmrich%26aufirst%3DV.%26aulast%3DLao%26aufirst%3DY.%26aulast%3DNijsen%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520ABT-957%253A1-Benzyl-5-oxopyrrolidine-2-carboxamides%2520as%2520selective%2520calpain%2520inhibitors%2520with%2520enhanced%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26issue%3D15%26spage%3D1968%26epage%3D1973%26doi%3D10.1016%2Fj.bmcl.2019.05.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">PiÅ¡lar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PeriÅ¡iÄ
Nanut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kos, J.</span></span> <span> </span><span class="NLM_article-title">Lysosomal cysteine peptidases - Molecules signaling tumor cell death and survival</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">168</span>â <span class="NLM_lpage">179</span>, <span class="refDoi">Â DOI: 10.1016/j.semcancer.2015.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.semcancer.2015.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26255843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSitLjM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=168-179&author=A.+Pi%C5%A1larauthor=M.+Peri%C5%A1i%C4%87%0ANanutauthor=J.+Kos&title=Lysosomal+cysteine+peptidases+-+Molecules+signaling+tumor+cell+death+and+survival&doi=10.1016%2Fj.semcancer.2015.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomal cysteine peptidases - Molecules signaling tumor cell death and survival</span></div><div class="casAuthors">Pislar, Anja; Perisic Nanut, Milica; Kos, Janko</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">168-179</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Lysosomal cysteine peptidases - cysteine cathepsins - are general intracellular protein-degrading enzymes that control also a variety of specific physiol. processes.  They can trigger irreversible events leading to signal transduction and activation of signaling pathways, resulting in cell survival and proliferation or cell death.  In cancer cells, lysosomal cysteine peptidases are involved in multiple processes during malignant progression.  Their translocation from the endosomal/lysosomal pathway to nucleus, cytoplasm, plasma membrane and extracellular space enables the activation and remodeling of a variety of tumor promoting proteins.  Thus, lysosomal cysteine peptidases interfere with cytokine/chemokine signaling, regulate cell adhesion and migration and endocytosis, are involved in the antitumor immune response and apoptosis, and promote cell invasion, angiogenesis and metastasis.  Further, lysosomal cysteine peptidases modify growth factors and receptors involved in tyrosine kinase dependent pathways such as MAPK, Akt and JNK, thus representing key signaling tools for the activation of tumor cell growth and proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDp2N5lWc85bVg90H21EOLACvtfcHk0lgHqJP-Fv0LCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSitLjM&md5=811f9b87640d025db6c076dca094b765</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2015.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2015.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DPi%25C5%25A1lar%26aufirst%3DA.%26aulast%3DPeri%25C5%25A1i%25C4%2587%2BNanut%26aufirst%3DM.%26aulast%3DKos%26aufirst%3DJ.%26atitle%3DLysosomal%2520cysteine%2520peptidases%2520-%2520Molecules%2520signaling%2520tumor%2520cell%2520death%2520and%2520survival%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2015%26volume%3D35%26spage%3D168%26epage%3D179%26doi%3D10.1016%2Fj.semcancer.2015.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campden, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>670</i></span>,  <span class="NLM_fpage">32</span>â <span class="NLM_lpage">42</span>, <span class="refDoi">Â DOI: 10.1016/j.abb.2019.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.abb.2019.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30807742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktFOqu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=670&publication_year=2019&pages=32-42&author=R.+I.+Campdenauthor=Y.+Zhang&title=The+role+of+lysosomal+cysteine+cathepsins+in+NLRP3+inflammasome+activation&doi=10.1016%2Fj.abb.2019.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation</span></div><div class="casAuthors">Campden, Rhiannon I.; Zhang, Yifei</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">670</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-42</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Lysosomal cysteine cathepsins are a family of proteases that are involved in a myriad of cellular processes from proteolytic degrdn. in the lysosome to bone resorption.  These proteins mature following the cleavage of a pro-domain in the lysosome to become either exo- or endo-peptidases.  The cathepsins B, C, L, S and Z have been implicated in NLRP3 inflammasome activation following their activation with ATP, monosodium urate, silica crystals, or bacterial components, among others.  These five cathepsins have both compensatory and independent functions in NLRP3 inflammasome activation.  There is much evidence in the literature to support the release of cathepsin B following lysosomal membrane degrdn. which leads to NLRP3 inflammasome activation.  This is likely due to a hitherto unidentified role of this protein in the cytoplasm, although other interactions with autophagy proteins and within lysosomes have been proposed.  Cathepsin C is involved in the processing of neutrophil IL-1Î² through processing of upstream proteases.  Cathepsin Z is non-redundantly required for NLRP3 inflammasome activation following nigericin, ATP and monosodium urate activation.  Lysosomal cysteine cathepsins are members of a diverse and complementary family, and likely share both overlapping and independent functions in NLRP3 inflammasome activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQjAezZNN_wbVg90H21EOLACvtfcHk0lgHqJP-Fv0LCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktFOqu74%253D&md5=1f05b83dc71939a82985ab9b97d46f7b</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2019.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2019.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DCampden%26aufirst%3DR.%2BI.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DThe%2520role%2520of%2520lysosomal%2520cysteine%2520cathepsins%2520in%2520NLRP3%2520inflammasome%2520activation%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2019%26volume%3D670%26spage%3D32%26epage%3D42%26doi%3D10.1016%2Fj.abb.2019.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ha, S.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khazaie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. O.</span></span> <span> </span><span class="NLM_article-title">Cathepsin B is involved in the trafficking of TNF-Î±-containing vesicles to the plasma membrane in macrophages</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>181</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">690</span>â <span class="NLM_lpage">697</span>, <span class="refDoi">Â DOI: 10.4049/jimmunol.181.1.690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4049%2Fjimmunol.181.1.690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18566436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVGitLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2008&pages=690-697&issue=1&author=S.-D.+Haauthor=A.+Martinsauthor=K.+Khazaieauthor=J.+Hanauthor=B.+M.+C.+Chanauthor=S.+O.+Kim&title=Cathepsin+B+is+involved+in+the+trafficking+of+TNF-%CE%B1-containing+vesicles+to+the+plasma+membrane+in+macrophages&doi=10.4049%2Fjimmunol.181.1.690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin B Is Involved in the Trafficking of TNF-Î±-Containing Vesicles to the Plasma Membrane in Macrophages</span></div><div class="casAuthors">Ha, Soon-Duck; Martins, Andrew; Khazaie, Khashayarsha; Han, Jiahuai; Chan, Bosco M. C.; Kim, Sung Ouk</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">690-697</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">TNF-Î± is a potent proinflammatory cytokine, essential for initiating innate immune responses against invading microbes and a key mediator involved in the pathogenesis of acute and chronic inflammatory diseases.  To identify mols. involved in the prodn. of TNF-Î±, the authors used a functional gene identification method using retroviral integration-mediated mutagenesis, followed by LPS-stimulated TNF-Î± prodn. anal. in macrophages.  They found that cathepsin B, a lysosomal cysteine proteinase, was required for optimal posttranslational processing of TNF-Î± in response to the bacterial cell wall component LPS.  Mouse bone marrow-derived macrophages from cathepsin B-deficient mice and macrophages treated with the cathepsin B-specific chem. inhibitor CA074 Me ester or small interfering RNA against cathepsin B secreted less TNF-Î± than wild-type or nontreated macrophages.  The authors further showed that the inhibition of cathepsin B caused accumulation of 26-kDa pro-TNF-contg. vesicles.  Ectopic expression of GFP-conjugated pro-TNF further suggests that pro-TNF failed to reach the plasma membrane without intracellular cathepsin B activity.  Altogether, these data suggest that intracellular cathepsin B activity is involved in the TNF-Î±-contg. vesicle trafficking to the plasma membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj6UqCkNeu0bVg90H21EOLACvtfcHk0lgHqJP-Fv0LCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVGitLg%253D&md5=001b16587da0624cff177bc5819d36de</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.181.1.690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.181.1.690%26sid%3Dliteratum%253Aachs%26aulast%3DHa%26aufirst%3DS.-D.%26aulast%3DMartins%26aufirst%3DA.%26aulast%3DKhazaie%26aufirst%3DK.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DB.%2BM.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BO.%26atitle%3DCathepsin%2520B%2520is%2520involved%2520in%2520the%2520trafficking%2520of%2520TNF-%25CE%25B1-containing%2520vesicles%2520to%2520the%2520plasma%2520membrane%2520in%2520macrophages%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D181%26issue%3D1%26spage%3D690%26epage%3D697%26doi%3D10.4049%2Fjimmunol.181.1.690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Ctsk modulates periodontitis with arthritis via downregulation of TLR9 and autophagy</span>. <i>Cell Proliferation</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">1</span>), <span class="NLM_elocation-id">e12722</span> <span class="refDoi">Â DOI: 10.1111/cpr.12722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1111%2Fcpr.12722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31737959" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2020&issue=1&author=W.+Weiauthor=J.+Renauthor=W.+Yinauthor=H.+Dingauthor=Q.+Luauthor=L.+Tanauthor=S.+Dengauthor=J.+Liuauthor=Q.+Yangauthor=J.+Wangauthor=M.+Wangauthor=Y.+Yueauthor=L.+Hao&title=Inhibition+of+Ctsk+modulates+periodontitis+with+arthritis+via+downregulation+of+TLR9+and+autophagy&doi=10.1111%2Fcpr.12722"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1111%2Fcpr.12722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcpr.12722%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DW.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DW.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DYue%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520Ctsk%2520modulates%2520periodontitis%2520with%2520arthritis%2520via%2520downregulation%2520of%2520TLR9%2520and%2520autophagy%26jtitle%3DCell%2520Proliferation%26date%3D2020%26volume%3D53%26issue%3D1%26doi%3D10.1111%2Fcpr.12722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissette, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrushova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeish, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S. R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosloniec, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudensky, A. Y.</span></span> <span> </span><span class="NLM_article-title">Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">207</span>â <span class="NLM_lpage">217</span>, <span class="refDoi">Â DOI: 10.1016/S1074-7613(00)80021-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS1074-7613%2800%2980021-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10072073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1yms78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=207-217&issue=2&author=T.+Y.+Nakagawaauthor=W.+H.+Brissetteauthor=P.+D.+Liraauthor=R.+J.+Griffithsauthor=N.+Petrushovaauthor=J.+Stockauthor=J.+D.+McNeishauthor=S.+E.+Eastmanauthor=E.+D.+Howardauthor=S.+R.+M.+Clarkeauthor=E.+F.+Rosloniecauthor=E.+A.+Elliottauthor=A.+Y.+Rudensky&title=Impaired+invariant+chain+degradation+and+antigen+presentation+and+diminished+collagen-induced+arthritis+in+cathepsin+S+null+mice&doi=10.1016%2FS1074-7613%2800%2980021-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice</span></div><div class="casAuthors">Nakagawa, Terry Y.; Brissette, William H.; Lira, Paul D.; Griffiths, Richard J.; Petrushova, Nina; Stock, Jeffrey; McNeish, John D.; Eastman, Susan E.; Howard, Edward D.; Clarke, Sally R. M.; Rosloniec, Edward F.; Elliott, Eileen A.; Rudensky, Alexander Y.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-217</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cathepsins have been implicated in the degrdn. of proteins destined for the MHC class II processing pathway and in the proteolytic removal of invariant chain (Ii), a crit. regulator of MHC class II function.  Mice lacking the lysosomal cysteine proteinase cathepsin S (catS) demonstrated a profound inhibition of Ii degrdn. in professional APC in vivo.  A marked variation in the generation of MHC class II-bound Ii fragments and presentation of exogenous proteins was obsd. between B cells, dendritic cells, and macrophages lacking catS.  CatS-deficient mice showed diminished susceptibility to collagen-induced arthritis, suggesting a potential therapeutic target for regulation of immune responsiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKLUTSeuqSQrVg90H21EOLACvtfcHk0ljuqyF_7Uz1mQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1yms78%253D&md5=45a1ce1cbc4ab6b5190b756cab9ac1f5</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2FS1074-7613%2800%2980021-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-7613%252800%252980021-7%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DT.%2BY.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DLira%26aufirst%3DP.%2BD.%26aulast%3DGriffiths%26aufirst%3DR.%2BJ.%26aulast%3DPetrushova%26aufirst%3DN.%26aulast%3DStock%26aufirst%3DJ.%26aulast%3DMcNeish%26aufirst%3DJ.%2BD.%26aulast%3DEastman%26aufirst%3DS.%2BE.%26aulast%3DHoward%26aufirst%3DE.%2BD.%26aulast%3DClarke%26aufirst%3DS.%2BR.%2BM.%26aulast%3DRosloniec%26aufirst%3DE.%2BF.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DRudensky%26aufirst%3DA.%2BY.%26atitle%3DImpaired%2520invariant%2520chain%2520degradation%2520and%2520antigen%2520presentation%2520and%2520diminished%2520collagen-induced%2520arthritis%2520in%2520cathepsin%2520S%2520null%2520mice%26jtitle%3DImmunity%26date%3D1999%26volume%3D10%26issue%3D2%26spage%3D207%26epage%3D217%26doi%3D10.1016%2FS1074-7613%2800%2980021-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riese, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villadangos, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karp, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Sanctis, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploegh, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, H. A.</span></span> <span> </span><span class="NLM_article-title">Cathepsin S activity regulates antigen presentation and immunity</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2351</span>â <span class="NLM_lpage">2363</span>, <span class="refDoi">Â DOI: 10.1172/JCI1158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1172%2FJCI1158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=9616206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1cXjvVWrtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1998&pages=2351-2363&issue=11&author=R.+J.+Rieseauthor=R.+N.+Mitchellauthor=J.+A.+Villadangosauthor=G.+P.+Shiauthor=J.+T.+Palmerauthor=E.+R.+Karpauthor=G.+T.+De+Sanctisauthor=H.+L.+Ploeghauthor=H.+A.+Chapman&title=Cathepsin+S+activity+regulates+antigen+presentation+and+immunity&doi=10.1172%2FJCI1158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin S activity regulates antigen presentation and immunity</span></div><div class="casAuthors">Riese, Richard J.; Mitchell, Richard N.; Villadangos, Jose A.; Shi, Guo-Ping; Palmer, James T.; Karp, Elena R.; De Sanctis, George T.; Ploegh, Hidde L.; Chapman, Harold A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2351-2363</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">MHC class II mols. display antigenic peptides on cell surfaces for recognition by CD4+ invariant chain (Ii) from class II-Ii complexes to allow subsequent binding of peptides, and for generation of the antigenic peptides.  The cysteine endoprotease, cathepsin S, mediates Ii degrdn. in human and mouse antigen-presenting cells.  Studies described here examine the functional significance of cathepsin S inhibition on antigen presentation and immunity.  Specific inhibition of cathepsin S in A20 cells markedly impaired presentation of an ovalbumin epitope by interfering with class II-peptide binding, not by obstructing generation of the antigen.  Administration of a cathepsin S inhibitor to mice in vivo selectively inhibited activity of cathepsin S in splenocytes, resulting in accumulation of a class II-assocd. Ii breakdown product, attenuation of class II-peptide complex formation, and inhibition of antigen presentation.  Mice treated with inhibitor had an attenuated antibody response when immunized with ovalbumin but not the T cell-independent antigen TNP-Ficoll.  In a mouse model of pulmonary hypersensitivity, treatment with the inhibitor also abrogated a rise in IgE titers and profoundly blocked eosinophilic infiltration in the lung.  Thus, inhibition of cathepsin S in vivo alters Ii processing, antigen presentation, and immunity.  These data identify selective inhibition of cysteine proteases as a potential therapeutic strategy for asthma and autoimmune disease processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Dx3Et_khvLVg90H21EOLACvtfcHk0ljuqyF_7Uz1mQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvVWrtLs%253D&md5=42b75c6acc049a2acebca41c1f0226c5</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1172%2FJCI1158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI1158%26sid%3Dliteratum%253Aachs%26aulast%3DRiese%26aufirst%3DR.%2BJ.%26aulast%3DMitchell%26aufirst%3DR.%2BN.%26aulast%3DVilladangos%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DG.%2BP.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DKarp%26aufirst%3DE.%2BR.%26aulast%3DDe%2BSanctis%26aufirst%3DG.%2BT.%26aulast%3DPloegh%26aufirst%3DH.%2BL.%26aulast%3DChapman%26aufirst%3DH.%2BA.%26atitle%3DCathepsin%2520S%2520activity%2520regulates%2520antigen%2520presentation%2520and%2520immunity%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1998%26volume%3D101%26issue%3D11%26spage%3D2351%26epage%3D2363%26doi%3D10.1172%2FJCI1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bararia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hildebrand, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haebe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevisani, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osorio-Barrios, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartoschek, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mentz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaitzsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heide, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurinovic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rautter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawardana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabdia, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczepanowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klapper, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louissaint, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bultmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonhardt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eustermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopfner, K.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiddemann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Bergwelt-Baildon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steidl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kridel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, J. W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt-Supprian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SÃ¡rosi, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudelius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passerini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mautner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigert, O.</span></span> <span> </span><span class="NLM_article-title">Cathepsin S alterations induce a tumor-promoting immune microenvironment in follicular lymphoma</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">107522</span>, <span class="refDoi">Â DOI: 10.1016/j.celrep.2020.107522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.celrep.2020.107522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32330423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotFCisb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2020&pages=107522&issue=5&author=D.+Barariaauthor=J.+A.+Hildebrandauthor=S.+Stolzauthor=S.+Haebeauthor=S.+Aligauthor=C.+P.+Trevisaniauthor=F.+Osorio-Barriosauthor=M.+D.+Bartoschekauthor=M.+Mentzauthor=A.+Pastoreauthor=E.+Gaitzschauthor=M.+Heideauthor=V.+Jurinovicauthor=K.+Rautterauthor=J.+Gunawardanaauthor=M.+B.+Sabdiaauthor=M.+Szczepanowskiauthor=J.+Richterauthor=W.+Klapperauthor=A.+Louissaintauthor=C.+Ludwigauthor=S.+Bultmannauthor=H.+Leonhardtauthor=S.+Eustermannauthor=K.-P.+Hopfnerauthor=W.+Hiddemannauthor=M.+von+Bergwelt-Baildonauthor=C.+Steidlauthor=R.+Kridelauthor=J.+W.+D.+Tobinauthor=M.+K.+Gandhiauthor=D.+M.+Weinstockauthor=M.+Schmidt-Supprianauthor=M.+B.+S%C3%A1rosiauthor=M.+Rudeliusauthor=V.+Passeriniauthor=J.+Mautnerauthor=O.+Weigert&title=Cathepsin+S+alterations+induce+a+tumor-promoting+immune+microenvironment+in+follicular+lymphoma&doi=10.1016%2Fj.celrep.2020.107522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma</span></div><div class="casAuthors">Bararia, Deepak; Hildebrand, Johannes A.; Stolz, Sebastian; Haebe, Sarah; Alig, Stefan; Trevisani, Christopher P.; Osorio-Barrios, Francisco; Bartoschek, Michael D.; Mentz, Michael; Pastore, Alessandro; Gaitzsch, Erik; Heide, Michael; Jurinovic, Vindi; Rautter, Katharina; Gunawardana, Jay; Sabdia, Muhammed B.; Szczepanowski, Monika; Richter, Julia; Klapper, Wolfram; Louissaint, Abner Jr.; Ludwig, Christina; Bultmann, Sebastian; Leonhardt, Heinrich; Eustermann, Sebastian; Hopfner, Karl-Peter; Hiddemann, Wolfgang; von Bergwelt-Baildon, Michael; Steidl, Christian; Kridel, Robert; Tobin, Joshua W. D.; Gandhi, Maher K.; Weinstock, David M.; Schmidt-Supprian, Marc; Sarosi, Menyhart B.; Rudelius, Martina; Passerini, Verena; Mautner, Josef; Weigert, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">107522</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Tumor cells orchestrate their microenvironment.  Here, we provide biochem., structural, functional, and clin. evidence that Cathepsin S (CTSS) alterations induce a tumor-promoting immune microenvironment in follicular lymphoma (FL).  We found CTSS mutations at Y132 in 6% of FL (19/305).  Another 13% (37/286) had CTSS amplification, which was assocd. with higher CTSS expression.  CTSS Y132 mutations lead to accelerated autocatalytic conversion from an enzymically inactive profrom to active CTSS and increased substrate cleavage, including CD74, which regulates major histocompatibility complex class II (MHC class II)-restricted antigen presentation.  Lymphoma cells with hyperactive CTSS more efficiently activated antigen-specific CD4+ T cells in vitro.  Tumors with hyperactive CTSS showed increased CD4+ T cell infiltration and proinflammatory cytokine perturbation in a mouse model and in human FLs.  In mice, this CTSS-induced immune microenvironment promoted tumor growth.  Clin., patients with CTSS-hyperactive FL had better treatment outcomes with std. immunochemotherapies, indicating that these immunosuppressive regimens target both the lymphoma cells and the tumor-promoting immune microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP8xP09_jpDLVg90H21EOLACvtfcHk0ljvOtmpcmHWog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotFCisb8%253D&md5=13677a964614767dd6691f05ff338b67</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2020.107522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2020.107522%26sid%3Dliteratum%253Aachs%26aulast%3DBararia%26aufirst%3DD.%26aulast%3DHildebrand%26aufirst%3DJ.%2BA.%26aulast%3DStolz%26aufirst%3DS.%26aulast%3DHaebe%26aufirst%3DS.%26aulast%3DAlig%26aufirst%3DS.%26aulast%3DTrevisani%26aufirst%3DC.%2BP.%26aulast%3DOsorio-Barrios%26aufirst%3DF.%26aulast%3DBartoschek%26aufirst%3DM.%2BD.%26aulast%3DMentz%26aufirst%3DM.%26aulast%3DPastore%26aufirst%3DA.%26aulast%3DGaitzsch%26aufirst%3DE.%26aulast%3DHeide%26aufirst%3DM.%26aulast%3DJurinovic%26aufirst%3DV.%26aulast%3DRautter%26aufirst%3DK.%26aulast%3DGunawardana%26aufirst%3DJ.%26aulast%3DSabdia%26aufirst%3DM.%2BB.%26aulast%3DSzczepanowski%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DJ.%26aulast%3DKlapper%26aufirst%3DW.%26aulast%3DLouissaint%26aufirst%3DA.%26aulast%3DLudwig%26aufirst%3DC.%26aulast%3DBultmann%26aufirst%3DS.%26aulast%3DLeonhardt%26aufirst%3DH.%26aulast%3DEustermann%26aufirst%3DS.%26aulast%3DHopfner%26aufirst%3DK.-P.%26aulast%3DHiddemann%26aufirst%3DW.%26aulast%3Dvon%2BBergwelt-Baildon%26aufirst%3DM.%26aulast%3DSteidl%26aufirst%3DC.%26aulast%3DKridel%26aufirst%3DR.%26aulast%3DTobin%26aufirst%3DJ.%2BW.%2BD.%26aulast%3DGandhi%26aufirst%3DM.%2BK.%26aulast%3DWeinstock%26aufirst%3DD.%2BM.%26aulast%3DSchmidt-Supprian%26aufirst%3DM.%26aulast%3DS%25C3%25A1rosi%26aufirst%3DM.%2BB.%26aulast%3DRudelius%26aufirst%3DM.%26aulast%3DPasserini%26aufirst%3DV.%26aulast%3DMautner%26aufirst%3DJ.%26aulast%3DWeigert%26aufirst%3DO.%26atitle%3DCathepsin%2520S%2520alterations%2520induce%2520a%2520tumor-promoting%2520immune%2520microenvironment%2520in%2520follicular%2520lymphoma%26jtitle%3DCell%2520Rep.%26date%3D2020%26volume%3D31%26issue%3D5%26spage%3D107522%26doi%3D10.1016%2Fj.celrep.2020.107522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dheilly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistello, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katanayeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sungalee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duns, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehrle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sordet-Dessimoz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Racle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farinha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coukos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gfeller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottok, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kridel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steidl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassani-Sternberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoete, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oricchio, E.</span></span> <span> </span><span class="NLM_article-title">Cathepsin S regulates antigen processing and T cell activity in non-Hodgkin lymphoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">674</span>â <span class="NLM_lpage">689</span>, <span class="refDoi">Â DOI: 10.1016/j.ccell.2020.03.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.ccell.2020.03.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32330455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotVCntb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2020&pages=674-689&issue=5&author=E.+Dheillyauthor=E.+Battistelloauthor=N.+Katanayevaauthor=S.+Sungaleeauthor=J.+Michauxauthor=G.+Dunsauthor=S.+Wehrleauthor=J.+Sordet-Dessimozauthor=M.+Minaauthor=J.+Racleauthor=P.+Farinhaauthor=G.+Coukosauthor=D.+Gfellerauthor=A.+Mottokauthor=R.+Kridelauthor=B.+E.+Correiaauthor=C.+Steidlauthor=M.+Bassani-Sternbergauthor=G.+Cirielloauthor=V.+Zoeteauthor=E.+Oricchio&title=Cathepsin+S+regulates+antigen+processing+and+T+cell+activity+in+non-Hodgkin+lymphoma&doi=10.1016%2Fj.ccell.2020.03.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin Lymphoma</span></div><div class="casAuthors">Dheilly, Elie; Battistello, Elena; Katanayeva, Natalya; Sungalee, Stephanie; Michaux, Justine; Duns, Gerben; Wehrle, Sarah; Sordet-Dessimoz, Jessica; Mina, Marco; Racle, Julien; Farinha, Pedro; Coukos, George; Gfeller, David; Mottok, Anja; Kridel, Robert; Correia, Bruno E.; Steidl, Christian; Bassani-Sternberg, Michal; Ciriello, Giovanni; Zoete, Vincent; Oricchio, Elisa</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">674-689.e12</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Genomic alterations in cancer cells can influence the immune system to favor tumor growth.  In non-Hodgkin lymphoma, physiol. interactions between B cells and the germinal center microenvironment are coopted to sustain cancer cell proliferation.  We found that follicular lymphoma patients harbor a recurrent hotspot mutation targeting tyrosine 132 (Y132D) in cathepsin S (CTSS) that enhances protein activity.  CTSS regulates antigen processing and CD4+ and CD8+ T cell-mediated immune responses.  Loss of CTSS activity reduces lymphoma growth by limiting communication with CD4+ T follicular helper cells while inducing antigen diversification and activation of CD8+ T cells.  Overall, our results suggest that CTSS inhibition has non-redundant therapeutic potential to enhance anti-tumor immune responses in indolent and aggressive lymphomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj25xCF6_F3rVg90H21EOLACvtfcHk0ljvOtmpcmHWog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotVCntb4%253D&md5=2087af71ae00eced7670303f9bd97951</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2020.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2020.03.016%26sid%3Dliteratum%253Aachs%26aulast%3DDheilly%26aufirst%3DE.%26aulast%3DBattistello%26aufirst%3DE.%26aulast%3DKatanayeva%26aufirst%3DN.%26aulast%3DSungalee%26aufirst%3DS.%26aulast%3DMichaux%26aufirst%3DJ.%26aulast%3DDuns%26aufirst%3DG.%26aulast%3DWehrle%26aufirst%3DS.%26aulast%3DSordet-Dessimoz%26aufirst%3DJ.%26aulast%3DMina%26aufirst%3DM.%26aulast%3DRacle%26aufirst%3DJ.%26aulast%3DFarinha%26aufirst%3DP.%26aulast%3DCoukos%26aufirst%3DG.%26aulast%3DGfeller%26aufirst%3DD.%26aulast%3DMottok%26aufirst%3DA.%26aulast%3DKridel%26aufirst%3DR.%26aulast%3DCorreia%26aufirst%3DB.%2BE.%26aulast%3DSteidl%26aufirst%3DC.%26aulast%3DBassani-Sternberg%26aufirst%3DM.%26aulast%3DCiriello%26aufirst%3DG.%26aulast%3DZoete%26aufirst%3DV.%26aulast%3DOricchio%26aufirst%3DE.%26atitle%3DCathepsin%2520S%2520regulates%2520antigen%2520processing%2520and%2520T%2520cell%2520activity%2520in%2520non-Hodgkin%2520lymphoma%26jtitle%3DCancer%2520Cell%26date%3D2020%26volume%3D37%26issue%3D5%26spage%3D674%26epage%3D689%26doi%3D10.1016%2Fj.ccell.2020.03.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deussing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villadangos, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploegh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudensky, A. Y.</span></span> <span> </span><span class="NLM_article-title">Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">5362</span>),  <span class="NLM_fpage">450</span>â <span class="NLM_lpage">453</span>, <span class="refDoi">Â DOI: 10.1126/science.280.5362.450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fscience.280.5362.450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=9545226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1cXivVeku7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1998&pages=450-453&issue=5362&author=T.+Nakagawaauthor=W.+Rothauthor=P.+Wongauthor=A.+Nelsonauthor=A.+Farrauthor=J.+Deussingauthor=J.+A.+Villadangosauthor=H.+Ploeghauthor=C.+Petersauthor=A.+Y.+Rudensky&title=Cathepsin+L%3A+critical+role+in+Ii+degradation+and+CD4+T+cell+selection+in+the+thymus&doi=10.1126%2Fscience.280.5362.450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus</span></div><div class="casAuthors">Nakagawa, Terry; Roth, Wera; Wong, Phillip; Nelson, Andrew; Farr, Andrew; Deussing, Jan; Villadangos, Jose A.; Ploegh, Hidde; Peters, Christoph; Rudensky, Alexander Y.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">5362</span>),
    <span class="NLM_cas:pages">450-453</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Degrdn. of invariant chain (Ii) is a crit. step in major histocompatibility complex class II-restricted antigen presentation.  Cathepsin L was necessary for Ii degrdn. in cortical thymic epithelial cells (cTECs), but not in bone marrow (BM)-derived antigen-presenting cells (APCs).  Consequently, pos. selection of CD4+ T cells was reduced.  Because different cysteine proteinases are responsible for specific Ii degrdn. steps in cTECs and BM-derived APCs, the proteolytic environment in cells mediating pos. and neg. selection may be distinct.  The identification of a protease involved in class II presentation in a tissue-specific manner suggests a potential means of manipulating CD4+ T cell responsiveness in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM9_4Xoc9yBbVg90H21EOLACvtfcHk0ljvOtmpcmHWog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivVeku7c%253D&md5=dad35a5f096ab400898fccc768797e4c</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1126%2Fscience.280.5362.450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.280.5362.450%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DT.%26aulast%3DRoth%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DP.%26aulast%3DNelson%26aufirst%3DA.%26aulast%3DFarr%26aufirst%3DA.%26aulast%3DDeussing%26aufirst%3DJ.%26aulast%3DVilladangos%26aufirst%3DJ.%2BA.%26aulast%3DPloegh%26aufirst%3DH.%26aulast%3DPeters%26aufirst%3DC.%26aulast%3DRudensky%26aufirst%3DA.%2BY.%26atitle%3DCathepsin%2520L%253A%2520critical%2520role%2520in%2520Ii%2520degradation%2520and%2520CD4%2520T%2520cell%2520selection%2520in%2520the%2520thymus%26jtitle%3DScience%26date%3D1998%26volume%3D280%26issue%3D5362%26spage%3D450%26epage%3D453%26doi%3D10.1126%2Fscience.280.5362.450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rops, A. L. W. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppevelt, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russel, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabelink, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berden, J. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinheckel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Vlag, J.</span></span> <span> </span><span class="NLM_article-title">Cathepsin L is crucial for the development of early experimental diabetic nephropathy</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>90</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1012</span>â <span class="NLM_lpage">1022</span>, <span class="refDoi">Â DOI: 10.1016/j.kint.2016.06.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.kint.2016.06.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27575559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVamsbzL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=1012-1022&issue=5&author=M.+Garsenauthor=A.+L.+W.+M.+M.+Ropsauthor=H.+Dijkmanauthor=B.+Willemsenauthor=T.+H.+van+Kuppeveltauthor=F.+G.+Russelauthor=T.+J.+Rabelinkauthor=J.+H.+M.+Berdenauthor=T.+Reinheckelauthor=J.+van+der+Vlag&title=Cathepsin+L+is+crucial+for+the+development+of+early+experimental+diabetic+nephropathy&doi=10.1016%2Fj.kint.2016.06.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin L is crucial for the development of early experimental diabetic nephropathy</span></div><div class="casAuthors">Garsen, Marjolein; Rops, Angelique L. W. M. M.; Dijkman, Henry; Willemsen, Brigith; van Kuppevelt, Toin H.; Russel, Frans G.; Rabelink, Ton J.; Berden, Jo H. M.; Reinheckel, Thomas; van der Vlag, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1012-1022</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Proteinuria is one of the first clin. signs of diabetic nephropathy and an independent predictor for the progression to renal failure.  Cathepsin L, a lysosomal cysteine protease, can be involved in the development of proteinuria by degrdn. of proteins that are important for normal podocyte architecture, such as the CD2-assocd. protein, synaptopodin, and dynamin.  Cathepsin L also activates heparanase, a heparan sulfate endoglycosidase previously shown to be crucial for the development of diabetic nephropathy.  Here, we evaluated the exact mode of action of cathepsin L in the development of proteinuria in streptozotocin-induced diabetes.  Cathepsin L-deficient mice, in contrast to their wild-type littermates, failed to develop albuminuria, mesangial matrix expansion, tubulointerstitial fibrosis, and renal macrophage influx and showed a normal renal function.  In wild-type mice the early development of albuminuria correlated with the activation of heparanase and loss of heparan sulfate expression, whereas loss of synaptopodin expression and podocyte damage occurred at a later stage.  Thus, cathepsin L is causally involved in the pathogenesis of exptl. diabetic nephropathy.  Most likely, cathepsin L-dependent heparanase activation is crucial for the development of albuminuria and renal damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq0mr5tpGrNLVg90H21EOLACvtfcHk0lhktSxU2Y2Mdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVamsbzL&md5=896a93e38a2b25ab94b097543718f1fd</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.kint.2016.06.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.kint.2016.06.035%26sid%3Dliteratum%253Aachs%26aulast%3DGarsen%26aufirst%3DM.%26aulast%3DRops%26aufirst%3DA.%2BL.%2BW.%2BM.%2BM.%26aulast%3DDijkman%26aufirst%3DH.%26aulast%3DWillemsen%26aufirst%3DB.%26aulast%3Dvan%2BKuppevelt%26aufirst%3DT.%2BH.%26aulast%3DRussel%26aufirst%3DF.%2BG.%26aulast%3DRabelink%26aufirst%3DT.%2BJ.%26aulast%3DBerden%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DReinheckel%26aufirst%3DT.%26aulast%3Dvan%2Bder%2BVlag%26aufirst%3DJ.%26atitle%3DCathepsin%2520L%2520is%2520crucial%2520for%2520the%2520development%2520of%2520early%2520experimental%2520diabetic%2520nephropathy%26jtitle%3DKidney%2520Int.%26date%3D2016%26volume%3D90%26issue%3D5%26spage%3D1012%26epage%3D1022%26doi%3D10.1016%2Fj.kint.2016.06.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedantham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agudelo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrion, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunneley, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PÃ¶hlmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, G.</span></span> <span> </span><span class="NLM_article-title">Protease inhibitors targeting coronavirus and filovirus entry</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">76</span>â <span class="NLM_lpage">84</span>, <span class="refDoi">Â DOI: 10.1016/j.antiviral.2015.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.antiviral.2015.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25666761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVOrs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2015&pages=76-84&author=Y.+Zhouauthor=P.+Vedanthamauthor=K.+Luauthor=J.+Agudeloauthor=R.+Carrionauthor=J.+W.+Nunneleyauthor=D.+Barnardauthor=S.+P%C3%B6hlmannauthor=J.+H.+McKerrowauthor=A.+R.+Rensloauthor=G.+Simmons&title=Protease+inhibitors+targeting+coronavirus+and+filovirus+entry&doi=10.1016%2Fj.antiviral.2015.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Protease inhibitors targeting coronavirus and filovirus entry</span></div><div class="casAuthors">Zhou, Yanchen; Vedantham, Punitha; Lu, Kai; Agudelo, Juliet; Carrion, Ricardo; Nunneley, Jerritt W.; Barnard, Dale; Pohlmann, Stefan; McKerrow, James H.; Renslo, Adam R.; Simmons, Graham</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">76-84</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to gain entry into cells, diverse viruses, including Ebola virus, SARS-coronavirus and the emerging MERS-coronavirus, depend on activation of their envelope glycoproteins by host cell proteases.  The resp. enzymes are thus excellent targets for antiviral intervention.  In cell culture, activation of Ebola virus, as well as SARS- and MERS-coronavirus can be accomplished by the endosomal cysteine proteases, cathepsin L (CTSL) and cathepsin B (CTSB).  In addn., SARS- and MERS-coronavirus can use serine proteases localized at the cell surface, for their activation.  However, it is currently unclear which protease(s) facilitate viral spread in the infected host.  We report here that the cysteine protease inhibitor K11777, ((2S)-N-[(1E,3S)-1-(benzenesulfonyl)-5-phenylpent-1-en-3-yl]-2-{[(E)-4-methylpiperazine-1-carbonyl]amino}-3-phenylpropanamide) and closely-related vinylsulfones act as broad-spectrum antivirals by targeting cathepsin-mediated cell entry.  K11777 is already in advanced stages of development for a no. of parasitic diseases, such as Chagas disease, and has proven to be safe and effective in a range of animal models.  K11777 inhibition of SARS-CoV and Ebola virus entry was obsd. in the sub-nanomolar range.  In order to assess whether cysteine or serine proteases promote viral spread in the host, we compared the antiviral activity of an optimized K11777-deriv. with that of camostat, an inhibitor of TMPRSS2 and related serine proteases.  Employing a pathogenic animal model of SARS-CoV infection, we demonstrated that viral spread and pathogenesis of SARS-CoV is driven by serine rather than cysteine proteases and can be effectively prevented by camostat.  Camostat has been clin. used to treat chronic pancreatitis, and thus represents an exciting potential therapeutic for respiratory coronavirus infections.  Our results indicate that camostat, or similar serine protease inhibitors, might be an effective option for treatment of SARS and potentially MERS, while vinyl sulfone-based inhibitors are excellent lead candidates for Ebola virus therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqgkBpEfAc5bVg90H21EOLACvtfcHk0lhktSxU2Y2Mdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVOrs7Y%253D&md5=5dc38edb19ade6920ba6ca860699b8cf</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2015.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2015.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DVedantham%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DAgudelo%26aufirst%3DJ.%26aulast%3DCarrion%26aufirst%3DR.%26aulast%3DNunneley%26aufirst%3DJ.%2BW.%26aulast%3DBarnard%26aufirst%3DD.%26aulast%3DP%25C3%25B6hlmann%26aufirst%3DS.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DSimmons%26aufirst%3DG.%26atitle%3DProtease%2520inhibitors%2520targeting%2520coronavirus%2520and%2520filovirus%2520entry%26jtitle%3DAntiviral%2520Res.%26date%3D2015%26volume%3D116%26spage%3D76%26epage%3D84%26doi%3D10.1016%2Fj.antiviral.2015.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libby, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, G.-P.</span></span> <span> </span><span class="NLM_article-title">Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>213</i></span>,  <span class="NLM_fpage">107587</span>, <span class="refDoi">Â DOI: 10.1016/j.pharmthera.2020.107587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.pharmthera.2020.107587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32470470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFylt7zP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2020&pages=107587&author=T.+Liuauthor=S.+Luoauthor=P.+Libbyauthor=G.-P.+Shi&title=Cathepsin+L-selective+inhibitors%3A+A+potentially+promising+treatment+for+COVID-19+patients&doi=10.1016%2Fj.pharmthera.2020.107587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients</span></div><div class="casAuthors">Liu, Tianxiao; Luo, Songyuan; Libby, Peter; Shi, Guo-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107587</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The widespread coronavirus SARS-CoV-2 has already infected over 4 million people worldwide, with a death toll over 280,000.  Current treatment of COVID-19 patients relies mainly on antiviral drugs lopinavir/ritonavir, arbidol, and remdesivir, the anti-malarial drugs hydroxychloroquine and chloroquine, and traditional Chinese medicine.  There are over 2,118 on-going clin. trials underway, but to date none of these drugs have consistently proven effective.  Cathepsin L (CatL) is an endosomal cysteine protease.  It mediates the cleavage of the S1 subunit of the coronavirus surface spike glycoprotein.  This cleavage is necessary for coronavirus entry into human host cells, virus and host cell endosome membrane fusion, and viral RNA release for next round of replication.  Here we summarize data regarding seven CatL-selective inhibitors that block coronavirus entry into cultured host cells and provide a mechanism to block SARS-CoV-2 infection in humans.  Given the rapid growth of the SARS-CoV-2-pos. population worldwide, ready-to-use CatL inhibitors should be explored as a treatment option.  We identify ten US FDA-approved drugs that have CatL inhibitory activity.  We provide evidence that supports the combined use of serine protease and CatL inhibitors as a possibly safer and more effective therapy than other available therapeutics to block coronavirus host cell entry and intracellular replication, without compromising the immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdnmNa8fpUXLVg90H21EOLACvtfcHk0li8jee_fG_heg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFylt7zP&md5=71ed67fbf7fa6fa5f2042b5700a56103</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2020.107587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2020.107587%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DLibby%26aufirst%3DP.%26aulast%3DShi%26aufirst%3DG.-P.%26atitle%3DCathepsin%2520L-selective%2520inhibitors%253A%2520A%2520potentially%2520promising%2520treatment%2520for%2520COVID-19%2520patients%26jtitle%3DPharmacol.%2520Ther.%26date%3D2020%26volume%3D213%26spage%3D107587%26doi%3D10.1016%2Fj.pharmthera.2020.107587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obermajer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repnik, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jevnikar, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreft, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kos, J.</span></span> <span> </span><span class="NLM_article-title">Cysteine protease cathepsin X modulates immune response via activation of Î²2 integrins</span>. <i>Immunology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>124</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">76</span>â <span class="NLM_lpage">88</span>, <span class="refDoi">Â DOI: 10.1111/j.1365-2567.2007.02740.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1111%2Fj.1365-2567.2007.02740.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18194276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlensLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2008&pages=76-88&issue=1&author=N.+Obermajerauthor=U.+Repnikauthor=Z.+Jevnikarauthor=B.+Turkauthor=M.+Kreftauthor=J.+Kos&title=Cysteine+protease+cathepsin+X+modulates+immune+response+via+activation+of+%CE%B22+integrins&doi=10.1111%2Fj.1365-2567.2007.02740.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine protease cathepsin X modulates immune response via activation of Î²2 integrins</span></div><div class="casAuthors">Obermajer, Natasa; Repnik, Urska; Jevnikar, Zala; Turk, Boris; Kreft, Marko; Kos, Janko</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-88</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Cathepsin X is a lysosomal, cysteine dependent carboxypeptidase.  Its expression is restricted to cells of the immune system, suggesting a function related to the processes of inflammatory and immune responses.  It has been shown to stimulate macrophage antigen-1 (Mac-1) receptor-dependent adhesion and phagocytosis via interaction with integrin Î²2 subunit.  Here its potential role in regulating lymphocyte proliferation via Mac-1 and the other Î²2 integrin receptor, lymphocyte function-assocd. antigen-1 (LFA-1) has been investigated.  Cathepsin X has been shown to suppress proliferation of human peripheral blood mononuclear cells, by activation of Mac-1, known as a suppressive factor for lymphocyte proliferation.  On the other hand, co-localization of cathepsin X and LAF-1 supports the role of cathepsin X in regulating LFA-1 activity, which enhances lymphocyte proliferation.  As shown by fluorescence resonance energy transfer, using U-937 and Jurkat cells transfected with Î±L-mCFP and Î²2-mYFP, recombinant cathepsin X directly activates LFA-1.  The activation was confirmed by increased binding of monoclonal antibody 24, recognizing active LFA-1.  We demonstrate that cathepsin X is involved in the regulation of two Î²2 integrin receptors, LFA-1 and Mac-1, which exhibit opposing roles in lymphocyte activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWTb5LBQgCJLVg90H21EOLACvtfcHk0li8jee_fG_heg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlensLw%253D&md5=eabf682ae18a37dfb8c0fa5c297e9d57</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2567.2007.02740.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2567.2007.02740.x%26sid%3Dliteratum%253Aachs%26aulast%3DObermajer%26aufirst%3DN.%26aulast%3DRepnik%26aufirst%3DU.%26aulast%3DJevnikar%26aufirst%3DZ.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DKreft%26aufirst%3DM.%26aulast%3DKos%26aufirst%3DJ.%26atitle%3DCysteine%2520protease%2520cathepsin%2520X%2520modulates%2520immune%2520response%2520via%2520activation%2520of%2520%25CE%25B22%2520integrins%26jtitle%3DImmunology%26date%3D2008%26volume%3D124%26issue%3D1%26spage%3D76%26epage%3D88%26doi%3D10.1111%2Fj.1365-2567.2007.02740.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Withana, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sameni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anbalagan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olive, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidwell, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloane, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, B. S.</span></span> <span> </span><span class="NLM_article-title">Cathepsin B inhibition limits bone metastasis in breast cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1199</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-11-2759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1158%2F0008-5472.CAN-11-2759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22266111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Wis74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=1199&issue=5&author=N.+P.+Withanaauthor=G.+Blumauthor=M.+Sameniauthor=C.+Slaneyauthor=A.+Anbalaganauthor=M.+B.+Oliveauthor=B.+N.+Bidwellauthor=L.+Edgingtonauthor=L.+Wangauthor=K.+Moinauthor=B.+F.+Sloaneauthor=R.+L.+Andersonauthor=M.+S.+Bogyoauthor=B.+S.+Parker&title=Cathepsin+B+inhibition+limits+bone+metastasis+in+breast+cancer&doi=10.1158%2F0008-5472.CAN-11-2759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin B Inhibition Limits Bone Metastasis in Breast Cancer</span></div><div class="casAuthors">Withana, Nimali P.; Blum, Galia; Sameni, Mansoureh; Slaney, Clare; Anbalagan, Arulselvi; Olive, Mary B.; Bidwell, Bradley N.; Edgington, Laura; Wang, Ling; Moin, Kamiar; Sloane, Bonnie F.; Anderson, Robin L.; Bogyo, Matthew S.; Parker, Belinda S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1199-1209</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Metastasis to bone is a major cause of morbidity in breast cancer patients, emphasizing the importance of identifying mol. drivers of bone metastasis for new therapeutic targets.  The endogenous cysteine cathepsin inhibitor stefin A is a suppressor of breast cancer metastasis to bone that is coexpressed with cathepsin B in bone metastases.  In this study, we used the immunocompetent 4T1.2 model of breast cancer which exhibits spontaneous bone metastasis to evaluate the function and therapeutic targeting potential of cathepsin B in this setting of advanced disease.  Cathepsin B abundancy in the model mimicked human disease, both at the level of primary tumors and matched spinal metastases.  RNA interference-mediated knockdown of cathepsin B in tumor cells reduced collagen I degrdn. in vitro and bone metastasis in vivo.  Similarly, i.p. administration of the highly selective cathepsin B inhibitor CA-074 reduced metastasis in tumor-bearing animals, a redn. that was not reproduced by the broad spectrum cysteine cathepsin inhibitor JPM-OEt.  Notably, metastasis suppression by CA-074 was maintained in a late treatment setting, pointing to a role in metastatic outgrowth.  Together, our findings established a prometastatic role for cathepsin B in distant metastasis and illustrated the therapeutic benefits of its selective inhibition in vivo.  Cancer Res; 72(5); 1199-209.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaVtPHsMReRLVg90H21EOLACvtfcHk0li8jee_fG_heg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Wis74%253D&md5=b66b32d65d9e9799412bb110b4c9d4e9</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-2759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-2759%26sid%3Dliteratum%253Aachs%26aulast%3DWithana%26aufirst%3DN.%2BP.%26aulast%3DBlum%26aufirst%3DG.%26aulast%3DSameni%26aufirst%3DM.%26aulast%3DSlaney%26aufirst%3DC.%26aulast%3DAnbalagan%26aufirst%3DA.%26aulast%3DOlive%26aufirst%3DM.%2BB.%26aulast%3DBidwell%26aufirst%3DB.%2BN.%26aulast%3DEdgington%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMoin%26aufirst%3DK.%26aulast%3DSloane%26aufirst%3DB.%2BF.%26aulast%3DAnderson%26aufirst%3DR.%2BL.%26aulast%3DBogyo%26aufirst%3DM.%2BS.%26aulast%3DParker%26aufirst%3DB.%2BS.%26atitle%3DCathepsin%2520B%2520inhibition%2520limits%2520bone%2520metastasis%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26issue%3D5%26spage%3D1199%26doi%3D10.1158%2F0008-5472.CAN-11-2759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell-McGuinn, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garfall, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">7378</span>â <span class="NLM_lpage">7385</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-07-0602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1158%2F0008-5472.CAN-07-0602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17671208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVemtL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=7378-7385&issue=15&author=K.+M.+Bell-McGuinnauthor=A.+L.+Garfallauthor=M.+Bogyoauthor=D.+Hanahanauthor=J.+A.+Joyce&title=Inhibition+of+cysteine+cathepsin+protease+activity+enhances+chemotherapy+regimens+by+decreasing+tumor+growth+and+invasiveness+in+a+mouse+model+of+multistage+cancer&doi=10.1158%2F0008-5472.CAN-07-0602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Cysteine Cathepsin Protease Activity Enhances Chemotherapy Regimens by Decreasing Tumor Growth and Invasiveness in a Mouse Model of Multistage Cancer</span></div><div class="casAuthors">Bell-McGuinn, Katherine M.; Garfall, Alfred L.; Bogyo, Matthew; Hanahan, Douglas; Joyce, Johanna A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7378-7385</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Increases in protease expression and activity are assocd. with malignant progression and poor patient prognosis in a no. of human cancers.  Members of the papain family of cysteine cathepsins are among the protease classes that have been functionally implicated in cancer.  Inhibition of the cysteine cathepsin family using a pan-cathepsin inhibitor, JPM-OEt, led to tumor regression in the RIP1-Tag2 (RT2) mouse model of pancreatic islet cell tumorigenesis.  The present study was designed to det. whether this cathepsin inhibitor, when used in combination with chemotherapy, would increase antitumor efficacy.  RT2 mice were treated in a late-stage regression trial with three different chemotherapy regimens, alone or in combination with the cathepsin inhibitor, JPM-OEt.  Cyclophosphamide was administered in either a max. tolerated dose (MTD) regimen, a "metronomic" continuous low-dose regimen, or a "chemo-switch" regimen consisting of MTD followed by metronomic dosing.  Mice were sacrificed at a defined end point and tumor burden was assessed followed by a detailed anal. of cell proliferation, apoptosis, vascularization, and invasiveness in the treated and control lesions.  An addnl. cohort of mice was followed for survival anal.  The cathepsin inhibitor plus the chemo-switch regimen of cyclophosphamide led to the most pronounced redn. in tumor burden and greatest increase in overall survival.  Cysteine cathepsin inhibition resulted in a significant decrease in tumor invasiveness, which was further augmented in combination with each of the chemotherapy dosing regimens.  These results encourage the development and continuing evaluation of cysteine cathepsin inhibitors as cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjpWRsw23b-bVg90H21EOLACvtfcHk0li7iC7f64UP0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVemtL8%253D&md5=b59dc53ebe01709d7635a0ed688d558b</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-0602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-0602%26sid%3Dliteratum%253Aachs%26aulast%3DBell-McGuinn%26aufirst%3DK.%2BM.%26aulast%3DGarfall%26aufirst%3DA.%2BL.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26atitle%3DInhibition%2520of%2520cysteine%2520cathepsin%2520protease%2520activity%2520enhances%2520chemotherapy%2520regimens%2520by%2520decreasing%2520tumor%2520growth%2520and%2520invasiveness%2520in%2520a%2520mouse%2520model%2520of%2520multistage%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26issue%3D15%26spage%3D7378%26epage%3D7385%26doi%3D10.1158%2F0008-5472.CAN-07-0602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schurigt, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevenich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vannier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwinde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Elverfeldt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinheckel, T.</span></span> <span> </span><span class="NLM_article-title">Trial of the cysteine cathepsin inhibitor JPM-OEt on early and advanced mammary cancer stages in the MMTV-PyMT-transgenic mouse model</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>389</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1067</span>â <span class="NLM_lpage">1074</span>, <span class="refDoi">Â DOI: 10.1515/BC.2008.115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1515%2FBC.2008.115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18710344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Ohurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2008&pages=1067-1074&issue=8&author=U.+Schurigtauthor=L.+Sevenichauthor=C.+Vannierauthor=M.+Gajdaauthor=A.+Schwindeauthor=F.+Wernerauthor=A.+Stahlauthor=D.+von+Elverfeldtauthor=A.-K.+Beckerauthor=M.+Bogyoauthor=C.+Petersauthor=T.+Reinheckel&title=Trial+of+the+cysteine+cathepsin+inhibitor+JPM-OEt+on+early+and+advanced+mammary+cancer+stages+in+the+MMTV-PyMT-transgenic+mouse+model&doi=10.1515%2FBC.2008.115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Trial of the cysteine cathepsin inhibitor JPM-OEt on early and advanced mammary cancer stages in the MMTV-PyMT-transgenic mouse model</span></div><div class="casAuthors">Schurigt, Uta; Sevenich, Lisa; Vannier, Corinne; Gajda, Mieczyslaw; Schwinde, Anne; Werner, Fee; Stahl, Andreas; von Elverfeldt, Dominik; Becker, Anne-Katrin; Bogyo, Matthew; Peters, Christoph; Reinheckel, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1067-1074</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">Recent data suggest proteases of the papain-like cysteine cathepsin family as mol. targets for cancer therapy.  Here, we report the treatment of polyoma middle T oncogene-induced breast cancers in mice with the cell-permeable broad-spectrum cysteine cathepsin inhibitor JPM-OEt.  Up to 100 mg/kg inhibitor was i.p. injected once per day in two trials on early and advanced cancers.  In both trials, transient delays in tumor growth were obsd.  However, at the endpoint of both expts. no significant differences in tumor wts., histopathol. and lung metastasis were found between the inhibitor and the control group.  The invasive strand formation of collagen I-embedded tumor cell spheroids generated from primary tumors of inhibitor-treated mice in the early cancer trial could be inhibited in vitro by JPM-OEt; a result arguing against induction of resistance to the inhibitor.  Measurement of cysteine cathepsin activities in tissue exts. after i.p. injection of JPM-OEt revealed effective inhibition of cysteine cathepsins in pancreas, kidneys and liver, while activities in mammary cancers and in lungs were not significantly affected.  We conclude that the pharmacokinetic properties of JPM-OEt, which result in poor bioavailability, may prohibit its use for stand-alone treatment of solid mammary cancers and their lung metastases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyxpOV_XtD27Vg90H21EOLACvtfcHk0li7iC7f64UP0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Ohurk%253D&md5=25ab2d52f96d301df3b993a7a2c01e61</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1515%2FBC.2008.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2008.115%26sid%3Dliteratum%253Aachs%26aulast%3DSchurigt%26aufirst%3DU.%26aulast%3DSevenich%26aufirst%3DL.%26aulast%3DVannier%26aufirst%3DC.%26aulast%3DGajda%26aufirst%3DM.%26aulast%3DSchwinde%26aufirst%3DA.%26aulast%3DWerner%26aufirst%3DF.%26aulast%3DStahl%26aufirst%3DA.%26aulast%3Dvon%2BElverfeldt%26aufirst%3DD.%26aulast%3DBecker%26aufirst%3DA.-K.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DPeters%26aufirst%3DC.%26aulast%3DReinheckel%26aufirst%3DT.%26atitle%3DTrial%2520of%2520the%2520cysteine%2520cathepsin%2520inhibitor%2520JPM-OEt%2520on%2520early%2520and%2520advanced%2520mammary%2520cancer%2520stages%2520in%2520the%2520MMTV-PyMT-transgenic%2520mouse%2520model%26jtitle%3DBiol.%2520Chem.%26date%3D2008%26volume%3D389%26issue%3D8%26spage%3D1067%26epage%3D1074%26doi%3D10.1515%2FBC.2008.115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salpeter, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozniak, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merquiol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Nun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, G.</span></span> <span> </span><span class="NLM_article-title">A novel cysteine cathepsin inhibitor yields macrophage cell death and mammary tumor regression</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">50</span>),  <span class="NLM_fpage">6066</span>â <span class="NLM_lpage">6078</span>, <span class="refDoi">Â DOI: 10.1038/onc.2015.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fonc.2015.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25798843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFejtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=6066-6078&issue=50&author=S.+J.+Salpeterauthor=Y.+Pozniakauthor=E.+Merquiolauthor=Y.+Ben-Nunauthor=T.+Geigerauthor=G.+Blum&title=A+novel+cysteine+cathepsin+inhibitor+yields+macrophage+cell+death+and+mammary+tumor+regression&doi=10.1038%2Fonc.2015.51"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cysteine cathepsin inhibitor yields macrophage cell death and mammary tumor regression</span></div><div class="casAuthors">Salpeter, S. J.; Pozniak, Y.; Merquiol, E.; Ben-Nun, Y.; Geiger, T.; Blum, G.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">6066-6078</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although cysteine cathepsins have been identified as key regulators of cancer growth, their specific role in tumor development remains unclear.  Recent studies have shown that high activity levels of tumor cathepsins are primarily a result of increased cathepsin activity in cancer-promoting tumor-assocd. macrophages (TAMs).  To further investigate the role of cysteine cathepsin activity in normal and polarized macrophages, we established in vitro and in vivo models of macrophage differentiation and polarization and used a novel cysteine cathepsin inhibitor, GB111-NH2, to block the activity of cathepsins B, L and S.  Here we show that in vitro, cysteine cathepsin inhibition yields both apoptosis and proliferation of macrophages, owing to increased oxidative stress.  Proteomic anal. of cathepsin- inhibited macrophages demonstrates inhibition of autophagy, suggesting a likely cause of elevated reactive oxygen species (ROS) levels.  In vivo models of mammary cancer further show that cathepsin inhibition yields TAM death owing to increased ROS levels.  Strikingly, apoptosis in TAMs yields a seemingly cell non-autonomous death of neighboring cancer cells, and regression of the primary growth.  These results show that cysteine cathepsin inhibitors can specifically trigger macrophage cell death and may function as an effective anticancer therapy in tumors with high levels of TAMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVQAmx4yymWLVg90H21EOLACvtfcHk0li7iC7f64UP0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFejtLk%253D&md5=dfb543c900b8f4fd1e56274699dd0d79</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.51%26sid%3Dliteratum%253Aachs%26aulast%3DSalpeter%26aufirst%3DS.%2BJ.%26aulast%3DPozniak%26aufirst%3DY.%26aulast%3DMerquiol%26aufirst%3DE.%26aulast%3DBen-Nun%26aufirst%3DY.%26aulast%3DGeiger%26aufirst%3DT.%26aulast%3DBlum%26aufirst%3DG.%26atitle%3DA%2520novel%2520cysteine%2520cathepsin%2520inhibitor%2520yields%2520macrophage%2520cell%2520death%2520and%2520mammary%2520tumor%2520regression%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26issue%3D50%26spage%3D6066%26epage%3D6078%26doi%3D10.1038%2Fonc.2015.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdoes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oresic Bender, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Linden, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withana, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanman, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Improved quenched fluorescent probe for imaging of cysteine cathepsinactivity</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">14726</span>â <span class="NLM_lpage">14730</span>, <span class="refDoi">Â DOI: 10.1021/ja4056068</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja4056068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlamu7jJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=14726-14730&issue=39&author=M.+Verdoesauthor=K.+Oresic+Benderauthor=E.+Segalauthor=W.+A.+van+der%0ALindenauthor=S.+Syedauthor=N.+P.+Withanaauthor=L.+E.+Sanmanauthor=M.+Bogyo&title=Improved+quenched+fluorescent+probe+for+imaging+of+cysteine+cathepsinactivity&doi=10.1021%2Fja4056068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Quenched Fluorescent Probe for Imaging of Cysteine Cathepsin Activity</span></div><div class="casAuthors">Verdoes, Martijn; Oresic Bender, Kristina; Segal, Ehud; van der Linden, Wouter A.; Syed, Salahuddin; Withana, Nimali P.; Sanman, Laura E.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">14726-14730</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cysteine cathepsins are a family of proteases that play important roles in both normal cellular physiol. and many human diseases.  In cancer, the activity of many of the cysteine cathepsins is upregulated and can be exploited for tumor imaging.  Here we present the design and synthesis of a new class of quenched fluorescent activity-based probes (qABPs) contg. a phenoxymethyl ketone (PMK) electrophile.  These reagents show enhanced in vivo properties and broad reactivity resulting in dramatically improved labeling and tumor imaging properties compared to those of previously reported ABPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyCqZ94sGkvbVg90H21EOLACvtfcHk0lh5avBoxo43IA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlamu7jJ&md5=dfa3206d83ceed10d2e43f408dcdf03f</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fja4056068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja4056068%26sid%3Dliteratum%253Aachs%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DOresic%2BBender%26aufirst%3DK.%26aulast%3DSegal%26aufirst%3DE.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DW.%2BA.%26aulast%3DSyed%26aufirst%3DS.%26aulast%3DWithana%26aufirst%3DN.%2BP.%26aulast%3DSanman%26aufirst%3DL.%2BE.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DImproved%2520quenched%2520fluorescent%2520probe%2520for%2520imaging%2520of%2520cysteine%2520cathepsinactivity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26issue%3D39%26spage%3D14726%26epage%3D14730%26doi%3D10.1021%2Fja4056068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rut, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vizovisek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groborz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2113</span>â <span class="NLM_lpage">2129</span>, <span class="refDoi">Â DOI: 10.1039/C7SC04303A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1039%2FC7SC04303A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29719685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosF2isA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=2113-2129&issue=8&author=M.+Porebaauthor=W.+Rutauthor=M.+Vizovisekauthor=K.+Groborzauthor=P.+Kasperkiewiczauthor=D.+Finlayauthor=K.+Vuoriauthor=D.+Turkauthor=B.+Turkauthor=G.+S.+Salvesenauthor=M.+Drag&title=Selective+imaging+of+cathepsin+L+in+breast+cancer+by+fluorescent+activity-based+probes&doi=10.1039%2FC7SC04303A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes</span></div><div class="casAuthors">Poreba, Marcin; Rut, Wioletta; Vizovisek, Matej; Groborz, Katarzyna; Kasperkiewicz, Paulina; Finlay, Darren; Vuori, Kristiina; Turk, Dusan; Turk, Boris; Salvesen, Guy S.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2113-2129</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cysteine cathepsins normally function in the lysosomal degrdn. system where they are crit. for the maintenance of cellular homeostasis and the MHC II immune response, and have been found to have major roles in several diseases and in tumor progression.  Selective visualization of individual protease activity within a complex proteome is of major importance to establish their roles in both normal and tumor cells, thereby facilitating our understanding of the regulation of proteolytic networks.  Here, we utilized HyCoSuL, a positional scanning substrate approach, to develop a highly-selective fluorogenic substrate and activity-based probe for monitoring cathepsin L activity in the breast cancer cell line MDA-MB-231.  Use of this probe enabled us to distinguish the activity of cathepsin L from that of other cathepsins, particularly cathepsin B, which is abundant and ubiquitously expressed in normal and transformed cell types.  We found that cathepsin L localization in MDA-MB-231 cells greatly overlaps with that of cathepsin B, however, several cathepsin L-rich lysosomes lacked cathepsin B activity.  Overall, these studies demonstrate that HyCoSuL-derived small mol. probes are valuable tools to image cathepsin L activity in living cells.  This approach thus enables evaluation of cathepsin L function in tumorigenesis and is applicable to other cysteine cathepsins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXkKiO1PSXPrVg90H21EOLACvtfcHk0lh5avBoxo43IA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosF2isA%253D%253D&md5=53fab0ed5ebfbf8dd0b5a3dbc11dbee1</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1039%2FC7SC04303A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7SC04303A%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DRut%26aufirst%3DW.%26aulast%3DVizovisek%26aufirst%3DM.%26aulast%3DGroborz%26aufirst%3DK.%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DFinlay%26aufirst%3DD.%26aulast%3DVuori%26aufirst%3DK.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DSelective%2520imaging%2520of%2520cathepsin%2520L%2520in%2520breast%2520cancer%2520by%2520fluorescent%2520activity-based%2520probes%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26issue%3D8%26spage%3D2113%26epage%3D2129%26doi%3D10.1039%2FC7SC04303A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groborz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vizovisek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruggi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span> <span> </span><span class="NLM_article-title">Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">36</span>),  <span class="NLM_fpage">8461</span>â <span class="NLM_lpage">8477</span>, <span class="refDoi">Â DOI: 10.1039/C9SC00997C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1039%2FC9SC00997C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31803426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVOrs7%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=8461-8477&issue=36&author=M.+Porebaauthor=K.+Groborzauthor=M.+Vizovisekauthor=M.+Maruggiauthor=D.+Turkauthor=B.+Turkauthor=G.+Powisauthor=M.+Dragauthor=G.+S.+Salvesen&title=Fluorescent+probes+towards+selective+cathepsin+B+detection+and+visualization+in+cancer+cells+and+patient+samples&doi=10.1039%2FC9SC00997C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples</span></div><div class="casAuthors">Poreba, Marcin; Groborz, Katarzyna; Vizovisek, Matej; Maruggi, Marco; Turk, Dusan; Turk, Boris; Powis, Garth; Drag, Marcin; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">8461-8477</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Human cysteine cathepsins constitute an 11-membered family of proteases responsible for degrdn. of proteins in cellular endosomal-lysosomal compartments as such, they play important roles in antigen processing, cellular stress signaling, autophagy, and senescence.  Moreover, for many years these enzymes were also linked to tumor growth, invasion, angiogenesis and metastasis when upregulated.  Individual biol. roles of each cathepsin are difficult to establish, because of their redundancy and similar substrate specificities.  Selective chem. tools that enable imaging of individual cathepsin activities in living cells, tumors, and the tumor microenvironment may provide a better insight into their functions.  In this work, we used HyCoSuL technol. to profile the substrate specificity of human cathepsin B.  The use of unnatural amino acids in the substrate library enabled us to uncover the broad cathepsin B preferences that we utilized to design highly-selective substrates and fluorescent activity-based probes (ABPs).  We further demonstrated that Cy5-labeled MP-CB-2 probe can selectively label cathepsin B in eighteen cancer cell lines tested, making this ABP highly suitable for other biol. setups.  Moreover, using Cy5-labeled MP-CB-2 we were able to demonstrate by fluorescence microscopy that in cancer cells cathepsins B and L share overlapping, but not identical subcellular localization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkHJ2qvOHfoLVg90H21EOLACvtfcHk0lh5avBoxo43IA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVOrs7%252FE&md5=fb74cdb9f3aab8ae9ba6b77473d5da3f</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1039%2FC9SC00997C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9SC00997C%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DGroborz%26aufirst%3DK.%26aulast%3DVizovisek%26aufirst%3DM.%26aulast%3DMaruggi%26aufirst%3DM.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DPowis%26aufirst%3DG.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DFluorescent%2520probes%2520towards%2520selective%2520cathepsin%2520B%2520detection%2520and%2520visualization%2520in%2520cancer%2520cells%2520and%2520patient%2520samples%26jtitle%3DChem.%2520Sci.%26date%3D2019%26volume%3D10%26issue%3D36%26spage%3D8461%26epage%3D8477%26doi%3D10.1039%2FC9SC00997C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bossard, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaszek, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amegadzie, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanning, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurdyla, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gowen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, M. A.</span></span> <span> </span><span class="NLM_article-title">Proteolytic activity of human osteoclast cathepsin K: expression, purification, activation, and substrate identification</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">12517</span>â <span class="NLM_lpage">12524</span>, <span class="refDoi">Â DOI: 10.1074/jbc.271.21.12517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.271.21.12517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8647860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK28XjtFantrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=12517-12524&issue=21&author=M.+J.+Bossardauthor=T.+A.+Tomaszekauthor=S.+K.+Thompsonauthor=B.+Y.+Amegadzieauthor=C.+R.+Hanningauthor=C.+Jonesauthor=J.+T.+Kurdylaauthor=D.+E.+McNultyauthor=F.+H.+Drakeauthor=M.+Gowenauthor=M.+A.+Levy&title=Proteolytic+activity+of+human+osteoclast+cathepsin+K%3A+expression%2C+purification%2C+activation%2C+and+substrate+identification&doi=10.1074%2Fjbc.271.21.12517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification</span></div><div class="casAuthors">Bossard, Mary J.; Tomaszek, Thaddeus A.; Thompson, Scott K.; Amegadzie, Bernard Y.; Hanning, Charles R.; Jones, Christopher; Kurdyla, Jeff T.; McNulty, Dean E.; Drake, Fred H.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">12517-12524</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human cathepsin K is a recently identified protein with high primary sequence homol. to members of the papain cysteine protease superfamily including cathepsins S, L, and B and is selectively expressed in osteoclasts (Drake, F. H., Dodds, R., James, I., Connor, J., Debouck, C., Richardson, S., Lee, E., Rieman, D., Barthlow, R., Hastings, G., and Gowen, M. (1996) J. Biol. Chem. 271, 12511-12516).  To characterize its catalytic properties, cathepsin K has been expressed in baculovirus-infected SF21 cells and the sol. recombinant protein isolated from growth media was purified.  Purified protein includes an inhibitory pro-leader sequence common to this family of protease.  Conditions for enzyme activation upon removal of the pro-sequence have been identified.  Fluorogenic peptides have been identified as substrates for mature cathepsin K.  In addn., two protein components of bone matrix, collagen and osteonectin, have been shown to be substrates of the activated protease.  Cathepsin K is inhibited by E-64 and leupeptin, but not by pepstatin, EDTA, phenylmethylsulfonyl fluoride or phenanthroline, consistent with its classification within the cysteine protease class.  Leupeptin has been characterized as a slow binding inhibitor of cathepsin K (kobs/[I] = 273,000 M-1Â·s-1).  Cathepsin K may represent the elusive protease implicated in degrdn. of protein matrix during bone resorption and represents a novel mol. target in treatment of disease states assocd. with excessive bone loss such as osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZEtDLODXbdLVg90H21EOLACvtfcHk0lh6gh8eFcP21g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtFantrc%253D&md5=74d14dc52a7752faafef77aa6c6f9e2c</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.21.12517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.21.12517%26sid%3Dliteratum%253Aachs%26aulast%3DBossard%26aufirst%3DM.%2BJ.%26aulast%3DTomaszek%26aufirst%3DT.%2BA.%26aulast%3DThompson%26aufirst%3DS.%2BK.%26aulast%3DAmegadzie%26aufirst%3DB.%2BY.%26aulast%3DHanning%26aufirst%3DC.%2BR.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DKurdyla%26aufirst%3DJ.%2BT.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DDrake%26aufirst%3DF.%2BH.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DLevy%26aufirst%3DM.%2BA.%26atitle%3DProteolytic%2520activity%2520of%2520human%2520osteoclast%2520cathepsin%2520K%253A%2520expression%252C%2520purification%252C%2520activation%252C%2520and%2520substrate%2520identification%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26issue%3D21%26spage%3D12517%26epage%3D12524%26doi%3D10.1074%2Fjbc.271.21.12517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jules, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span> <span> </span><span class="NLM_article-title">Deficiency of cathepsin K prevents inflammation and bone erosion in rheumatoid arthritis and periodontitis and reveals its shared osteoimmune role</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>589</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1331</span>â <span class="NLM_lpage">1339</span>, <span class="refDoi">Â DOI: 10.1016/j.febslet.2015.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.febslet.2015.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25896020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslGitLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=589&publication_year=2015&pages=1331-1339&issue=12&author=L.+Haoauthor=G.+Zhuauthor=Y.+Luauthor=M.+Wangauthor=J.+Julesauthor=X.+Zhouauthor=W.+Chen&title=Deficiency+of+cathepsin+K+prevents+inflammation+and+bone+erosion+in+rheumatoid+arthritis+and+periodontitis+and+reveals+its+shared+osteoimmune+role&doi=10.1016%2Fj.febslet.2015.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Deficiency of cathepsin K prevents inflammation and bone erosion in rheumatoid arthritis and periodontitis and reveals its shared osteoimmune role</span></div><div class="casAuthors">Hao, Liang; Zhu, Guochun; Lu, Yun; Wang, Min; Jules, Joel; Zhou, Xuedong; Chen, Wei</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">589</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1331-1339</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Using rheumatoid arthritis (RA) and periodontitis mouse models, we demonstrate that RA and periodontitis share many pathol. features, such as deregulated cytokine prodn., increased immune-cell infiltration, increased expression of Toll-like receptors (TLRs), and enhanced osteoclast activity and bone erosion.  We reveal that genetic deletion of cathepsin K (Ctsk) caused a radical redn. in inflammation and bone erosion within RA joint capsules and periodontal lesions, a drastic decrease in immune-cell infiltration, and a significant redn. in osteoclasts, macrophages, dendritic and T-cells.  Deficiency of Ctsk greatly decreased the expression of TLR-4, 5, and 9 and their downstream cytokines in periodontal gingival epithelial lesions and synovial RA lesions.  Hence, Ctsk may be targeted to treat RA and periodontitis simultaneously due to its shared osteoimmune role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTc2lPGq3nOrVg90H21EOLACvtfcHk0lh6gh8eFcP21g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslGitLs%253D&md5=a869758ebad51ebecbc2685905b3331f</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2015.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2015.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DJules%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DW.%26atitle%3DDeficiency%2520of%2520cathepsin%2520K%2520prevents%2520inflammation%2520and%2520bone%2520erosion%2520in%2520rheumatoid%2520arthritis%2520and%2520periodontitis%2520and%2520reveals%2520its%2520shared%2520osteoimmune%2520role%26jtitle%3DFEBS%2520Lett.%26date%3D2015%26volume%3D589%26issue%3D12%26spage%3D1331%26epage%3D1339%26doi%3D10.1016%2Fj.febslet.2015.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, B.</span></span> <span> </span><span class="NLM_article-title">Increased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability</span>. <i>Exp. Ther. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">3471</span>â <span class="NLM_lpage">3476</span>, <span class="refDoi">Â DOI: 10.3892/etm.2017.4935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.3892%2Fetm.2017.4935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29042935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOqsbfF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=3471-3476&issue=4&author=H.+Zhaoauthor=X.+Qinauthor=S.+Wangauthor=X.+Sunauthor=B.+Dong&title=Increased+cathepsin+K+levels+in+human+atherosclerotic+plaques+are+associated+with+plaque+instability&doi=10.3892%2Fetm.2017.4935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability</span></div><div class="casAuthors">Zhao, Huiying; Qin, Xiujiao; Wang, Shuai; Sun, Xiwei; Dong, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Therapeutic Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">3471-3476</span>CODEN:
                <span class="NLM_cas:coden">ETMXA2</span>;
        ISSN:<span class="NLM_cas:issn">1792-1015</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Investigating the determinants and dynamics of atherosclerotic plaque instability is a key area of current cardiovascular research.  Extracellular matrix degrdn. from excessive proteolysis induced by enzymes such as cathepsin K (Cat K) is implicated in the pathogenesis of unstable plaques.  The current study assessed the expression of Cat K in human unstable atherosclerotic plaques.  Specimens of popliteal arteries with atherosclerotic plaques were classified as stable (<40% lipid core plaque area; n=6) or unstable (â¥40% lipid core plaque area; n=14) based on histopathol. examns. of hematoxylin and eosin stained sections.  The expression of Cat K and cystatin C (Cys C) were assessed by immunohistochem. examn. and levels of Cat K mRNA were detected by semi-quant. reverse transcriptase polymerase chain reaction.  Morphol. changes including a larger lipid core, endothelial proliferation with foam cells and destruction of internal elastic lamina were obsd. in unstable atherosclerotic plaques.  In unstable plaques, the expression of Cat K protein and mRNA was upregulated, whereas Cys C protein expression was downregulated.  The interplay between Cat K and Cys C may underlie the progression of plaques from stable to unstable and the current study indicated that Cat K and Cys C are potential targets for preventing and treating vulnerable atherosclerotic plaque ruptures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMMZ2F1FHoubVg90H21EOLACvtfcHk0lh6gh8eFcP21g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOqsbfF&md5=e2dadfb175f49358db60b1152b4b1ea0</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.3892%2Fetm.2017.4935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fetm.2017.4935%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DB.%26atitle%3DIncreased%2520cathepsin%2520K%2520levels%2520in%2520human%2520atherosclerotic%2520plaques%2520are%2520associated%2520with%2520plaque%2520instability%26jtitle%3DExp.%2520Ther.%2520Med.%26date%3D2017%26volume%3D14%26issue%3D4%26spage%3D3471%26epage%3D3476%26doi%3D10.3892%2Fetm.2017.4935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asagiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunigami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gober, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golenbock, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazono, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saftig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takayanagi, H.</span></span> <span> </span><span class="NLM_article-title">Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>319</i></span> (<span class="NLM_issue">5863</span>),  <span class="NLM_fpage">624</span>â <span class="NLM_lpage">627</span>, <span class="refDoi">Â DOI: 10.1126/science.1150110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fscience.1150110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18239127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Knt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2008&pages=624-627&issue=5863&author=M.+Asagiriauthor=T.+Hiraiauthor=T.+Kunigamiauthor=S.+Kamanoauthor=H.-J.+Goberauthor=K.+Okamotoauthor=K.+Nishikawaauthor=E.+Latzauthor=D.+T.+Golenbockauthor=K.+Aokiauthor=K.+Ohyaauthor=Y.+Imaiauthor=Y.+Morishitaauthor=K.+Miyazonoauthor=S.+Katoauthor=P.+Saftigauthor=H.+Takayanagi&title=Cathepsin+K-dependent+toll-like+receptor+9+signaling+revealed+in+experimental+arthritis&doi=10.1126%2Fscience.1150110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin K-Dependent Toll-Like Receptor 9 Signaling Revealed in Experimental Arthritis</span></div><div class="casAuthors">Asagiri, Masataka; Hirai, Toshitake; Kunigami, Toshihiro; Kamano, Shunya; Gober, Hans-Juergen; Okamoto, Kazuo; Nishikawa, Keizo; Latz, Eicke; Golenbock, Douglas T.; Aoki, Kazuhiro; Ohya, Keiichi; Imai, Yuuki; Morishita, Yasuyuki; Miyazono, Kohei; Kato, Shigeaki; Saftig, Paul; Takayanagi, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">5863</span>),
    <span class="NLM_cas:pages">624-627</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cathepsin K was originally identified as an osteoclast-specific lysosomal protease, the inhibitor of which has been considered might have therapeutic potential.  We show that inhibition of cathepsin K could potently suppress autoimmune inflammation of the joints as well as osteoclastic bone resorption in autoimmune arthritis.  Furthermore, cathepsin K-/- mice were resistant to exptl. autoimmune encephalomyelitis.  Pharmacol. inhibition or targeted disruption of cathepsin K resulted in defective Toll-like receptor 9 signaling in dendritic cells in response to unmethylated CpG DNA, which in turn led to attenuated induction of T helper 17 cells, without affecting the antigen-presenting ability of dendritic cells.  These results suggest that cathepsin K plays an important role in the immune system and may serve as a valid therapeutic target in autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6uK-U5bRXorVg90H21EOLACvtfcHk0lhuJIo2SVBT-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Knt7s%253D&md5=79d72a85f81d7cece7b762cf1239decd</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1126%2Fscience.1150110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1150110%26sid%3Dliteratum%253Aachs%26aulast%3DAsagiri%26aufirst%3DM.%26aulast%3DHirai%26aufirst%3DT.%26aulast%3DKunigami%26aufirst%3DT.%26aulast%3DKamano%26aufirst%3DS.%26aulast%3DGober%26aufirst%3DH.-J.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DNishikawa%26aufirst%3DK.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DOhya%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DMiyazono%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DTakayanagi%26aufirst%3DH.%26atitle%3DCathepsin%2520K-dependent%2520toll-like%2520receptor%25209%2520signaling%2520revealed%2520in%2520experimental%2520arthritis%26jtitle%3DScience%26date%3D2008%26volume%3D319%26issue%3D5863%26spage%3D624%26epage%3D627%26doi%3D10.1126%2Fscience.1150110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zerbini, C. A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClung, M. R.</span></span> <span> </span><span class="NLM_article-title">Odanacatib in postmenopausal women with low bone mineral density: a review of current clinical evidence</span>. <i>Ther. Adv. Musculoskeletal Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">199</span>â <span class="NLM_lpage">209</span>, <span class="refDoi">Â DOI: 10.1177/1759720X13490860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1177%2F1759720X13490860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23904864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSksrvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=199-209&issue=4&author=C.+A.+F.+Zerbiniauthor=M.+R.+McClung&title=Odanacatib+in+postmenopausal+women+with+low+bone+mineral+density%3A+a+review+of+current+clinical+evidence&doi=10.1177%2F1759720X13490860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Odanacatib in postmenopausal women with low bone mineral density: a review of current clinical evidence</span></div><div class="casAuthors">Zerbini, Cristiano A. F.; McClung, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Musculoskeletal Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">199-209</span>CODEN:
                <span class="NLM_cas:coden">TAMDDB</span>;
        ISSN:<span class="NLM_cas:issn">1759-720X</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Human bones are in a continuous process of remodeling that ensures renovation and maintenance of the skeletal mass.  Bone remodeling has two phases that are normally coupled and balanced: bone resorption mediated by osteoclasts and bone formation mediated by osteoblasts.  An increase in bone resorption over bone formation results in a progressive loss of bone mass and impairment of bone microarchitecture leading to osteoporosis and its assocd. fractures.  Recent advances in the understanding of the mol. and cellular mechanisms involved in the remodeling process have allowed the development of new targets for osteoporosis treatment.  Cathepsin K, a cysteine protease, is found in osteoclasts along the bone resorption surfaces and very efficiently degrades type I collagen, the major component of the org. bone matrix.  Inhibition of cathepsin K reduces bone resorption but does not impair bone formation particularly at cortical sites.  Odanacatib, a potent and highly selective cathepsin K inhibitor, showed prevention of bone loss without redn. of bone formation in preclin. and clin. trials (phase I and II).  Odanacatib is currently in a phase III fracture outcome international trial for the treatment of postmenopausal osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKPKoBhbIsObVg90H21EOLACvtfcHk0lhuJIo2SVBT-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSksrvN&md5=002f6737b49719de00c3d234fdf7e44f</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1177%2F1759720X13490860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1759720X13490860%26sid%3Dliteratum%253Aachs%26aulast%3DZerbini%26aufirst%3DC.%2BA.%2BF.%26aulast%3DMcClung%26aufirst%3DM.%2BR.%26atitle%3DOdanacatib%2520in%2520postmenopausal%2520women%2520with%2520low%2520bone%2520mineral%2520density%253A%2520a%2520review%2520of%2520current%2520clinical%2520evidence%26jtitle%3DTher.%2520Adv.%2520Musculoskeletal%2520Dis.%26date%3D2013%26volume%3D5%26issue%3D4%26spage%3D199%26epage%3D209%26doi%3D10.1177%2F1759720X13490860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falgueyret, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmarais, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cromlish, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khougaz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamontagne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MassÃ©, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toulmond, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7535</span>â <span class="NLM_lpage">7543</span>, <span class="refDoi">Â DOI: 10.1021/jm0504961</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0504961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7535-7543&issue=24&author=J.-P.+Falgueyretauthor=S.+Desmaraisauthor=R.+Oballaauthor=W.+C.+Blackauthor=W.+Cromlishauthor=K.+Khougazauthor=S.+Lamontagneauthor=F.+Mass%C3%A9author=D.+Riendeauauthor=S.+Toulmondauthor=M.+D.+Percival&title=Lysosomotropism+of+basic+cathepsin+K+inhibitors+contributes+to+increased+cellular+potencies+against+off-target+cathepsins+and+reduced+functional+selectivity&doi=10.1021%2Fjm0504961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Desmarais, Sylvie; Oballa, Renata; Black, W. Cameron; Cromlish, Wanda; Khougaz, Karine; Lamontagne, Sonia; Masse, Frederic; Riendeau, Denis; Toulmond, Sylvie; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7535-7543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lysosomal cysteine protease cathepsin K is a target for osteoporosis therapy.  The aryl-piperazine-contg. cathepsin K inhibitor CRA-013783/L-006235 (1) displays greater than 4000-fold selectivity against the lysosomal/endosomal antitargets cathepsin B, L, and S.  However, 1 and other aryl-piperazine-contg. analogs, including balicatib (10), are â¼10-100-fold more potent in cell-based enzyme occupancy assays than against each purified enzyme.  This phenomenon arises from their basic, lipophilic nature, which results in lysosomal trapping.  Consistent with its lysosomotropic nature, 1 accumulates in cells and in rat tissues of high lysosome content.  In contrast, nonbasic aryl-morpholino-contg. analogs do not exhibit lysosomotropic properties.  Increased off-target activities of basic cathepsin K inhibitors were obsd. in a cell-based cathepsin S antigen presentation assay.  No potency increases of basic inhibitors in a functional cathepsin K bone resorption whole cell assay were detected.  Therefore, basic cathepsin K inhibitors, such as 1, suffer from reduced functional selectivities compared to those predicted using purified enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1NUHyZtwrwLVg90H21EOLACvtfcHk0lhuJIo2SVBT-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE&md5=9522026bb34984bc66b462b2e95fcbb0</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm0504961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504961%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DKhougaz%26aufirst%3DK.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DToulmond%26aufirst%3DS.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DLysosomotropism%2520of%2520basic%2520cathepsin%2520K%2520inhibitors%2520contributes%2520to%2520increased%2520cellular%2520potencies%2520against%2520off-target%2520cathepsins%2520and%2520reduced%2520functional%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D24%26spage%3D7535%26epage%3D7543%26doi%3D10.1021%2Fjm0504961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rnger, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhamou, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwiski, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrerons, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendler, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mindeholm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realdi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, V.</span></span> <span> </span><span class="NLM_article-title">Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib</span>. <i>J. Am. Acad. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">3</span>), <span class="NLM_elocation-id">e89</span> <span class="refDoi">Â DOI: 10.1016/j.jaad.2010.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.jaad.2010.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21571394" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&issue=3&author=T.+M.+Rngerauthor=S.+Adamiauthor=C.-L.+Benhamouauthor=E.+Czerwiskiauthor=J.+Farreronsauthor=D.+L.+Kendlerauthor=L.+Mindeholmauthor=G.+Realdiauthor=C.+Rouxauthor=V.+Smith&title=Morphea-like+skin+reactions+in+patients+treated+with+the+cathepsin+K+inhibitor+balicatib&doi=10.1016%2Fj.jaad.2010.11.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2010.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2010.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DRnger%26aufirst%3DT.%2BM.%26aulast%3DAdami%26aufirst%3DS.%26aulast%3DBenhamou%26aufirst%3DC.-L.%26aulast%3DCzerwiski%26aufirst%3DE.%26aulast%3DFarrerons%26aufirst%3DJ.%26aulast%3DKendler%26aufirst%3DD.%2BL.%26aulast%3DMindeholm%26aufirst%3DL.%26aulast%3DRealdi%26aufirst%3DG.%26aulast%3DRoux%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DV.%26atitle%3DMorphea-like%2520skin%2520reactions%2520in%2520patients%2520treated%2520with%2520the%2520cathepsin%2520K%2520inhibitor%2520balicatib%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2012%26volume%3D66%26issue%3D3%26doi%3D10.1016%2Fj.jaad.2010.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauret, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cromlish, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmarais, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falgueyret, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmel, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamontagne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LÃ©ger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeRiche, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MassÃ©, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoll-Griffith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ThÃ©rien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, V.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venuti, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesolowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, W. C.</span></span> <span> </span><span class="NLM_article-title">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">923</span>â <span class="NLM_lpage">928</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2007.12.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2007.12.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18226527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=923-928&issue=3&author=J.+Y.+Gauthierauthor=N.+Chauretauthor=W.+Cromlishauthor=S.+Desmaraisauthor=L.+T.+Duongauthor=J.-P.+Falgueyretauthor=D.+B.+Kimmelauthor=S.+Lamontagneauthor=S.+L%C3%A9gerauthor=T.+LeRicheauthor=C.+S.+Liauthor=F.+Mass%C3%A9author=D.+J.+McKayauthor=D.+A.+Nicoll-Griffithauthor=R.+M.+Oballaauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=J.+Robichaudauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=C.+Setoauthor=M.+Th%C3%A9rienauthor=V.-L.+Truongauthor=M.+C.+Venutiauthor=G.+Wesolowskiauthor=R.+N.+Youngauthor=R.+Zamboniauthor=W.+C.+Black&title=The+discovery+of+odanacatib+%28MK-0822%29%2C+a+selective+inhibitor+of+cathepsin+K&doi=10.1016%2Fj.bmcl.2007.12.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span></div><div class="casAuthors">Gauthier, Jacques Yves; Chauret, Nathalie; Cromlish, Wanda; Desmarais, Sylvie; Duong, Le T.; Falgueyret, Jean-Pierre; Kimmel, Donald B.; Lamontagne, Sonia; Leger, Serge; LeRiche, Tammy; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Nicoll-Griffith, Deborah A.; Oballa, Renata M.; Palmer, James T.; Percival, M. David; Riendeau, Denis; Robichaud, Joel; Rodan, Gideon A.; Rodan, Sevgi B.; Seto, Carmai; Therien, Michel; Truong, Vouy-Linh; Venuti, Michael C.; Wesolowski, Gregg; Young, Robert N.; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724.  Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclin. species.  Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib.  Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ytNI-SBgarVg90H21EOLACvtfcHk0liIoT7I0A5Lbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D&md5=e432a420a3ec99c784117750b9bbeda8</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.047%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DL%25C3%25A9ger%26aufirst%3DS.%26aulast%3DLeRiche%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DTh%25C3%25A9rien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.-L.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DThe%2520discovery%2520of%2520odanacatib%2520%2528MK-0822%2529%252C%2520a%2520selective%2520inhibitor%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D3%26spage%3D923%26epage%3D928%26doi%3D10.1016%2Fj.bmcl.2007.12.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chapurlat, R. D.</span></span> <span> </span><span class="NLM_article-title">Odanacatib: a review of its potential in the management of osteoporosis in postmenopausal women</span>. <i>Ther. Adv. Musculoskeletal Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">103</span>â <span class="NLM_lpage">109</span>, <span class="refDoi">Â DOI: 10.1177/1759720X15580903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1177%2F1759720X15580903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26029271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvVKqsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=103-109&issue=3&author=R.+D.+Chapurlat&title=Odanacatib%3A+a+review+of+its+potential+in+the+management+of+osteoporosis+in+postmenopausal+women&doi=10.1177%2F1759720X15580903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Odanacatib: a review of its potential in the management of osteoporosis in postmenopausal women</span></div><div class="casAuthors">Chapurlat, Roland D.</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Musculoskeletal Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">103-109</span>CODEN:
                <span class="NLM_cas:coden">TAMDDB</span>;
        ISSN:<span class="NLM_cas:issn">1759-720X</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a cathepsin K inhibitor developed for the treatment of postmenopausal osteoporosis.  It is a bone resorption inhibitor, but which preserves bone formation to some extent.  It can be administered once a week, in tablets also contg. vitamin D.  In a large clin. development program, it has been shown that odanacatib reduces bone resorption, with a redn. of about 60-70% in biochem. markers of resorption, while bone formation decreases to a lesser magnitude.  Odanacatib continuously increases bone mineral d. (BMD) at the hip and lumbar spine over 5 years.  Once it is stopped, a complete resoln. of effect is obsd., with declining BMD and increased bone turnover.  Bone microarchitecture and bone strength have also been improved in clin. trials using quant. computed tomog. (QCT) at the lumbar spine and hip, and high resoln. peripheral QCT at the distal radius and tibia.  In a phase III trial involving 16,713 postmenopausal women â¥65 years of age with low BMD, the risk of fragility fracture was significantly reduced at the spine, hip and other nonvertebral sites compared with the placebo group.  Odanacatib has been generally well tolerated, with no observation of osteonecrosis of the jaw so far, but with exceptional observations of subtrochanteric atypical fracture and morphea-like lesions.  Odanacatib appears a useful new option in the treatment of postmenopausal osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYiOWOkwC0fLVg90H21EOLACvtfcHk0lggKWLziYvT6A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvVKqsr4%253D&md5=fd6991d52d3ea867b09818201d12ed8e</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1177%2F1759720X15580903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1759720X15580903%26sid%3Dliteratum%253Aachs%26aulast%3DChapurlat%26aufirst%3DR.%2BD.%26atitle%3DOdanacatib%253A%2520a%2520review%2520of%2520its%2520potential%2520in%2520the%2520management%2520of%2520osteoporosis%2520in%2520postmenopausal%2520women%26jtitle%3DTher.%2520Adv.%2520Musculoskeletal%2520Dis.%26date%3D2015%26volume%3D7%26issue%3D3%26spage%3D103%26epage%3D109%26doi%3D10.1177%2F1759720X15580903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayasuga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunishige, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugitani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawabata, K.</span></span> <span> </span><span class="NLM_article-title">Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism</span>. <i>Bone</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1351</span>â <span class="NLM_lpage">1356</span>, <span class="refDoi">Â DOI: 10.1016/j.bone.2011.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bone.2011.09.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21982869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2iur3N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2011&pages=1351-1356&issue=6&author=Y.+Ochiauthor=H.+Yamadaauthor=H.+Moriauthor=Y.+Nakanishiauthor=S.+Nishikawaauthor=R.+Kayasugaauthor=N.+Kawadaauthor=A.+Kunishigeauthor=Y.+Hashimotoauthor=M.+Tanakaauthor=M.+Sugitaniauthor=K.+Kawabata&title=Effects+of+ONO-5334%2C+a+novel+orally-active+inhibitor+of+cathepsin+K%2C+on+bone+metabolism&doi=10.1016%2Fj.bone.2011.09.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism</span></div><div class="casAuthors">Ochi, Yasuo; Yamada, Hiroyuki; Mori, Hiroshi; Nakanishi, Yasutomo; Nishikawa, Satoshi; Kayasuga, Ryoji; Kawada, Naoki; Kunishige, Akiko; Hashimoto, Yasuaki; Tanaka, Makoto; Sugitani, Masafumi; Kawabata, Kazuhito</div><div class="citationInfo"><span class="NLM_cas:title">Bone (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1351-1356</span>CODEN:
                <span class="NLM_cas:coden">BONEDL</span>;
        ISSN:<span class="NLM_cas:issn">8756-3282</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the present study, we examd. the in vitro and in vivo pharmacol. effects of ONO-5334, a novel inhibitor of cathepsin K, on bone metab.  In vitro expts. indicated that ONO-5334 is a potent inhibitor of cathepsin K with Ki value of 0.1 nM.  Although this compd. inhibited other cysteine proteases, such as cathepsin S, L and B, its inhibitory activity for these enzymes was 8 to 320 fold lower than that for cathepsin K.  ONO-5334 also inhibited human osteoclasts bone resorption in vitro at a concn. more than 100 fold lower than that of alendronate, a bisphosphonate.  While alendronate disrupted actin ring and induced pyknotic nuclei in osteoclasts, ONO-5334 did not have such effects, suggesting that this compd. does not affect osteoclasts viability.  In in vivo expts., oral administration of ONO-5334 dose-dependently reduced plasma calcium level increased by parathyroid hormone related peptide in thyroparathyroidectomized rats.  Furthermore, in vivo expt. using normal monkeys demonstrated that ONO-5334 decreases serum and urine C-telopeptide of type I collagen level, a bone resorption marker, soon after oral dosing.  These levels were consistently decreased below pre-dose levels by repeated oral dosing with ONO-5334 for 7 days.  ONO-5334 on the other hand did not affect bone formation markers, serum osteocalcin and bone specific alk. phosphatase.  These findings indicate that ONO-5334 is a specific inhibitor for cathepsin K and thus may be a novel therapeutic agent for metabolic bone diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQiGxQYGkKKbVg90H21EOLACvtfcHk0lggKWLziYvT6A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2iur3N&md5=70a3433e811da8ab0aacabb9ebf8eb40</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2011.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2011.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DOchi%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DH.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DNishikawa%26aufirst%3DS.%26aulast%3DKayasuga%26aufirst%3DR.%26aulast%3DKawada%26aufirst%3DN.%26aulast%3DKunishige%26aufirst%3DA.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DSugitani%26aufirst%3DM.%26aulast%3DKawabata%26aufirst%3DK.%26atitle%3DEffects%2520of%2520ONO-5334%252C%2520a%2520novel%2520orally-active%2520inhibitor%2520of%2520cathepsin%2520K%252C%2520on%2520bone%2520metabolism%26jtitle%3DBone%26date%3D2011%26volume%3D49%26issue%3D6%26spage%3D1351%26epage%3D1356%26doi%3D10.1016%2Fj.bone.2011.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, W. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornsby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spraggon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Identification of selective, nonpeptidic nitrile inhibitors of cathepsin S using the substrate activity screening method</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6298</span>â <span class="NLM_lpage">6307</span>, <span class="refDoi">Â DOI: 10.1021/jm060701s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060701s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD28Xptl2hsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6298-6307&issue=21&author=A.+W.+Pattersonauthor=W.+J.+L.+Woodauthor=M.+Hornsbyauthor=S.+Lesleyauthor=G.+Spraggonauthor=J.+A.+Ellman&title=Identification+of+selective%2C+nonpeptidic+nitrile+inhibitors+of+cathepsin+S+using+the+substrate+activity+screening+method&doi=10.1021%2Fjm060701s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Selective, Nonpeptidic Nitrile Inhibitors of Cathepsin S Using the Substrate Activity Screening Method</span></div><div class="casAuthors">Patterson, Andrew W.; Wood, Warren J. L.; Hornsby, Michael; Lesley, Scott; Spraggon, Glen; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6298-6307</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The substrate activity screening method, a substrate-based fragment identification and optimization method for the development of enzyme inhibitors, was previously applied to cathepsin S to obtain low nanomolar 1,4-disubstituted-1,2,3-triazole-based aldehyde inhibitors (Wood, W. J. L.; Patterson, A. W.; Tsuruoka, H.; Jain, R. K.; Ellman, J. A. J. Am. Chem. Soc. 2005, 127, 15521-15527).  Replacement of the metabolically labile aldehyde pharmacophore with the nitrile pharmacophore provided inhibitors with moderate potency for cathepsin S.  The inhibitors showed good selectivity over cathepsins B and L but no selectivity over cathepsin K.  X-ray structures of two crystal forms (1.5 and 1.9 Ã) of a complex between cathepsin S and a triazole inhibitor incorporating a chloromethyl ketone pharmacophore guided the design of triazole substrates with increased cleavage efficiency and selectivity for cathepsin S over cathepsins B, L, and K.  Conversion of select substrates to nitrile inhibitors yielded a low mol. wt. (414 Da) and potent (15 nM) cathepsin S inhibitor that showed >1000-fold selectivity over cathepsins B, L, and K.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq64WREyCNFsbVg90H21EOLACvtfcHk0lggKWLziYvT6A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xptl2hsLg%253D&md5=30ea16a66d37dac8fe5666c76e2307aa</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Fjm060701s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060701s%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DA.%2BW.%26aulast%3DWood%26aufirst%3DW.%2BJ.%2BL.%26aulast%3DHornsby%26aufirst%3DM.%26aulast%3DLesley%26aufirst%3DS.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DIdentification%2520of%2520selective%252C%2520nonpeptidic%2520nitrile%2520inhibitors%2520of%2520cathepsin%2520S%2520using%2520the%2520substrate%2520activity%2520screening%2520method%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D21%26spage%3D6298%26epage%3D6307%26doi%3D10.1021%2Fjm060701s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdoes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheeren, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiskopf, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachmann, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">A nonpeptidic cathepsin S activity-based probe for noninvasive optical imaging of tumor-associated macrophages</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">619</span>â <span class="NLM_lpage">628</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2012.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2012.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22633413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslSit7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=619-628&issue=5&author=M.+Verdoesauthor=L.+E.+Edgingtonauthor=F.+A.+Scheerenauthor=M.+Leyvaauthor=G.+Blumauthor=K.+Weiskopfauthor=M.+H.+Bachmannauthor=J.+A.+Ellmanauthor=M.+Bogyo&title=A+nonpeptidic+cathepsin+S+activity-based+probe+for+noninvasive+optical+imaging+of+tumor-associated+macrophages&doi=10.1016%2Fj.chembiol.2012.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">A Nonpeptidic Cathepsin S Activity-Based Probe for Noninvasive Optical Imaging of Tumor-Associated Macrophages</span></div><div class="casAuthors">Verdoes, Martijn; Edgington, Laura E.; Scheeren, Ferenc A.; Leyva, Melissa; Blum, Galia; Weiskopf, Kipp; Bachmann, Michael H.; Ellman, Jonathan A.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">619-628</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Macrophage infiltration into tumors has been correlated with poor clin. outcome in multiple cancer types.  Therefore, tools to image tumor-assocd. macrophages could be valuable for diagnosis and prognosis of cancer.  Herein, we describe the synthesis and characterization of a cathepsin S-directed, quenched activity-based probe (qABP), BMV083.  This probe makes use of an optimized nonpeptidic scaffold leading to enhanced in vivo properties relative to previously reported peptide-based probes.  In a syngeneic breast cancer model, BMV083 provides high tumor-specific fluorescence that can be visualized using noninvasive optical imaging methods.  Furthermore, anal. of probe-labeled cells demonstrates that the probe primarily targets macrophages with an M2 phenotype.  Thus, BMV083 is a potential valuable in vivo reporter for tumor-assocd. macrophages that could greatly facilitate the future studies of macrophage function in the process of tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRX4BmiwUeDLVg90H21EOLACvtfcHk0lgMSZV34fafNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslSit7g%253D&md5=679c9c1ce4a25ff05492ca4091e4dd95</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DEdgington%26aufirst%3DL.%2BE.%26aulast%3DScheeren%26aufirst%3DF.%2BA.%26aulast%3DLeyva%26aufirst%3DM.%26aulast%3DBlum%26aufirst%3DG.%26aulast%3DWeiskopf%26aufirst%3DK.%26aulast%3DBachmann%26aufirst%3DM.%2BH.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DA%2520nonpeptidic%2520cathepsin%2520S%2520activity-based%2520probe%2520for%2520noninvasive%2520optical%2520imaging%2520of%2520tumor-associated%2520macrophages%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26issue%3D5%26spage%3D619%26epage%3D628%26doi%3D10.1016%2Fj.chembiol.2012.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anselm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuehne, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruener, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gsell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stihle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haap, W.</span></span> <span> </span><span class="NLM_article-title">Identification of potent and selective cathepsin S inhibitors containing different central cyclic scaffolds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">9789</span>â <span class="NLM_lpage">9801</span>, <span class="refDoi">Â DOI: 10.1021/jm401528k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401528k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslOms7zJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9789-9801&issue=23&author=H.+Hilpertauthor=H.+Mauserauthor=R.+Hummauthor=L.+Anselmauthor=H.+Kuehneauthor=G.+Hartmannauthor=S.+Gruenerauthor=D.+W.+Bannerauthor=J.+Benzauthor=B.+Gsellauthor=A.+Kuglstatterauthor=M.+Stihleauthor=R.+Thomaauthor=R.+A.+Sanchezauthor=H.+Idingauthor=B.+Wirzauthor=W.+Haap&title=Identification+of+potent+and+selective+cathepsin+S+inhibitors+containing+different+central+cyclic+scaffolds&doi=10.1021%2Fjm401528k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent and Selective Cathepsin S Inhibitors Containing Different Central Cyclic Scaffolds</span></div><div class="casAuthors">Hilpert, Hans; Mauser, Harald; Humm, Roland; Anselm, Lilli; Kuehne, Holger; Hartmann, Guido; Gruener, Sabine; Banner, David W.; Benz, Joerg; Gsell, Bernard; Kuglstatter, Andreas; Stihle, Martine; Thoma, Ralf; Sanchez, Ruben Alvarez; Iding, Hans; Wirz, Beat; Haap, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9789-9801</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Starting from the weakly active dual CatS/K inhibitor 5, structure-based design supported by X-ray anal. led to the discovery of the potent and selective (>50 000-fold vs CatK) cyclopentane deriv. 22 by exploiting specific ligand-receptor interactions in the S2 pocket of CatS.  Changing the central cyclopentane scaffold to the analogous pyrrolidine deriv. 57 decreased the enzyme as well as the cell-based activity significantly by 24- and 69-fold, resp.  The most promising scaffold identified was the readily accessible proline deriv. (e.g., 79).  This compd., with an appealing ligand efficiency (LE) of 0.47, included addnl. structural modifications binding in the S1 and S3 pockets of CatS, leading to favorable in vitro and in vivo properties.  Compd. 79 reduced IL-2 prodn. in a transgenic DO10.11 mouse model of antigen presentation in a dose-dependent manner with an ED50 of 5 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFIPE94S2IcrVg90H21EOLACvtfcHk0lgMSZV34fafNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslOms7zJ&md5=06853f0edbef071d14cafb2ca6114c95</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fjm401528k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401528k%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DAnselm%26aufirst%3DL.%26aulast%3DKuehne%26aufirst%3DH.%26aulast%3DHartmann%26aufirst%3DG.%26aulast%3DGruener%26aufirst%3DS.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DSanchez%26aufirst%3DR.%2BA.%26aulast%3DIding%26aufirst%3DH.%26aulast%3DWirz%26aufirst%3DB.%26aulast%3DHaap%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520potent%2520and%2520selective%2520cathepsin%2520S%2520inhibitors%2520containing%2520different%2520central%2520cyclic%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D23%26spage%3D9789%26epage%3D9801%26doi%3D10.1021%2Fjm401528k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Theron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchester, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecabert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perret, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, B.</span></span> <span> </span><span class="NLM_article-title">Pharmacodynamic monitoring of RO5459072, a small molecule inhibitor of cathepsin S</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">806</span>, <span class="refDoi">Â DOI: 10.3389/fimmu.2017.00806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.3389%2Ffimmu.2017.00806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=28769925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWnt7rI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=806&author=M.+Theronauthor=D.+Bentleyauthor=S.+Nagelauthor=M.+Manchesterauthor=M.+Gergauthor=T.+Schindlerauthor=A.+Silvaauthor=B.+Ecabertauthor=P.+Teixeiraauthor=C.+Perretauthor=B.+Reis&title=Pharmacodynamic+monitoring+of+RO5459072%2C+a+small+molecule+inhibitor+of+cathepsin+S&doi=10.3389%2Ffimmu.2017.00806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic monitoring of RO5459072, a small molecule inhibitor of cathepsin s</span></div><div class="casAuthors">Theron, Michel; Bentley, Darren; Nagel, Sandra; Manchester, Marianne; Gerg, Michael; Schindler, Thomas; Silva, Ana; Ecabert, Barbara; Teixeira, Priscila; Perret, Camille; Reis, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">806/1-806/14</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Major histocompatibility complex class II (MHCII)-restricted antigen priming of CD4+ T cells is both involved in adaptive immune responses and the pathogenesis of auto-immune diseases.  Degrdn. of invariant chain Ii, a protein that prevents premature peptide loading, is a prerequisite for nascent MHCII-peptide complex formation.  A key proteolytic step in this process is mediated by cathepsin S.  Inhibition of this cysteine protease is known to result in the intracellular accumulation of Lip10 in B cells.  Here, we describe the development and application of a neoepitope-based flow cytometry assay measuring accumulation of Lip10.  This novel method enabled the investigation of cathepsin S-dependent MHCII maturation in professional antigen-presenting cell (APC) subsets.  Inhibition of cathepsin S by a specific inhibitor, RO5459072, in human PBMC ex vivo resulted in accumulation of Lip10 in B cells and myeloid dendritic cells, but not in plasmacytoid dendritic cells and only to a minor degree in monocytes.  We qualified Lip10 as a pharmacodynamic biomarker by showing the cathepsin S inhibitor-dependent accumulation of Lip10 in vivo in cynomolgus monkeys treated with RO5459072.  Finally, dosing of RO5459072 in a first-in-human clin. study exhibited a dose-dependent increase in Lip10, confirming target engagement and demonstrating desired pharmacol. inhibition in vivo.  The degree of cathepsin S antagonist-induced max. Lip10 accumulation in APCs varied significantly between individuals both in vitro and in vivo.  This finding has not been reported previously using alternative, less sensitive methods and demands further investigation as to the potential of this biomarker to predict response to treatment.  These results will help guide subsequent clin. studies investigating the pharmacokinetic and pharmacodynamic relationship of cathepsin S inhibitor RO5459072 after multiple dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruRhRnsAbqfbVg90H21EOLACvtfcHk0lgVQZoYnFhRtg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWnt7rI&md5=c3bbb276fa78b90d2d3957bc5f935b63</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.00806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.00806%26sid%3Dliteratum%253Aachs%26aulast%3DTheron%26aufirst%3DM.%26aulast%3DBentley%26aufirst%3DD.%26aulast%3DNagel%26aufirst%3DS.%26aulast%3DManchester%26aufirst%3DM.%26aulast%3DGerg%26aufirst%3DM.%26aulast%3DSchindler%26aufirst%3DT.%26aulast%3DSilva%26aufirst%3DA.%26aulast%3DEcabert%26aufirst%3DB.%26aulast%3DTeixeira%26aufirst%3DP.%26aulast%3DPerret%26aufirst%3DC.%26aulast%3DReis%26aufirst%3DB.%26atitle%3DPharmacodynamic%2520monitoring%2520of%2520RO5459072%252C%2520a%2520small%2520molecule%2520inhibitor%2520of%2520cathepsin%2520S%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26spage%3D806%26doi%3D10.3389%2Ffimmu.2017.00806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paulick, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Development of activity-based probes for cathepsin X</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">563</span>â <span class="NLM_lpage">572</span>, <span class="refDoi">Â DOI: 10.1021/cb100392r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100392r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVyks7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=563-572&issue=6&author=M.+G.+Paulickauthor=M.+Bogyo&title=Development+of+activity-based+probes+for+cathepsin+X&doi=10.1021%2Fcb100392r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Activity-Based Probes for Cathepsin X</span></div><div class="casAuthors">Paulick, Margot G.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">563-572</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cathepsin X is a lysosomal cysteine protease that functions as a carboxypeptidase with broad substrate specificity.  Cathepsin X was discovered only recently, and its physiol. roles are still not well understood.  A no. of studies suggest that cathepsin X may be involved in a variety of biol. processes, including cancer, aging and degenerative conditions of the brain, inflammation, and cellular communication.  Here we present the synthesis and characterization of several activity-based probes (ABPs) that target active cathepsin X.  These ABPs were used to label cathepsin X in complex lysates, whole cells, and in vivo.  Furthermore, we have developed a method for selectively labeling and visualizing active cathepsin X in vitro and in vivo.  Overall, the probes developed in this study are valuable tools for the study of cathepsin X function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPdP_r1uUXbbVg90H21EOLACvtfcHk0lgVQZoYnFhRtg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVyks7c%253D&md5=b75f86b834a7967dac6daa6bec510b1e</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fcb100392r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100392r%26sid%3Dliteratum%253Aachs%26aulast%3DPaulick%26aufirst%3DM.%2BG.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520activity-based%2520probes%2520for%2520cathepsin%2520X%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26issue%3D6%26spage%3D563%26epage%3D572%26doi%3D10.1021%2Fcb100392r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mountford, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, E. S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aurelio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campden, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LindstrÃ¶m, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloan, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnett, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington-Mitchell, L. E.</span></span> <span> </span><span class="NLM_article-title">Application of a sulfoxonium ylide electrophile to generate cathepsin X-selective activity-based probes</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">718</span>â <span class="NLM_lpage">727</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.9b00961</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.9b00961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1ektbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=718-727&issue=3&author=S.+J.+Mountfordauthor=B.+M.+Andersonauthor=B.+Xuauthor=E.+S.+V.+Tayauthor=M.+Szaboauthor=M.-L.+Hoangauthor=J.+Diaoauthor=L.+Aurelioauthor=R.+I.+Campdenauthor=E.+Lindstr%C3%B6mauthor=E.+K.+Sloanauthor=R.+M.+Yatesauthor=N.+W.+Bunnettauthor=P.+E.+Thompsonauthor=L.+E.+Edgington-Mitchell&title=Application+of+a+sulfoxonium+ylide+electrophile+to+generate+cathepsin+X-selective+activity-based+probes&doi=10.1021%2Facschembio.9b00961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a Sulfoxonium Ylide Electrophile to Generate Cathepsin X-Selective Activity-Based Probes</span></div><div class="casAuthors">Mountford, Simon J.; Anderson, Bethany M.; Xu, Bangyan; Tay, Elean S. V.; Szabo, Monika; Hoang, My-Linh; Diao, Jiayin; Aurelio, Luigi; Campden, Rhiannon I.; Lindstrom, Erik; Sloan, Erica K.; Yates, Robin M.; Bunnett, Nigel W.; Thompson, Philip E.; Edgington-Mitchell, Laura E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">718-727</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cathepsin X/Z/P is cysteine cathepsin with unique carboxypeptidase activity.  Its expression is assocd. with cancer and neurodegenerative diseases, although its roles during normal physiol. are still poorly understood.  Advances in our understanding of its function have been hindered by a lack of available tools that can specifically measure the proteolytic activity of cathepsin X.  We present a series of activity-based probes that incorporate a sulfoxonium ylide warhead, which exhibit improved specificity for cathepsin X compared to previously reported probes.  We apply these probes to detect cathepsin X activity in cell and tissue lysates, in live cells and in vivo, and to localize active cathepsin X in mouse tissues by microscopy.  Finally, we utilize an improved method to generate chloromethylketones, necessary intermediates for synthesis of acyloxymethylketones probes, by way of sulfoxonium ylide intermediates.  In conclusion, the probes presented in this study will be valuable for investigating cathepsin X pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOuvatbOdfZbVg90H21EOLACvtfcHk0lgVQZoYnFhRtg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1ektbs%253D&md5=02881b733002371b83b42011237e0d75</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Facschembio.9b00961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.9b00961%26sid%3Dliteratum%253Aachs%26aulast%3DMountford%26aufirst%3DS.%2BJ.%26aulast%3DAnderson%26aufirst%3DB.%2BM.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DTay%26aufirst%3DE.%2BS.%2BV.%26aulast%3DSzabo%26aufirst%3DM.%26aulast%3DHoang%26aufirst%3DM.-L.%26aulast%3DDiao%26aufirst%3DJ.%26aulast%3DAurelio%26aufirst%3DL.%26aulast%3DCampden%26aufirst%3DR.%2BI.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DE.%26aulast%3DSloan%26aufirst%3DE.%2BK.%26aulast%3DYates%26aufirst%3DR.%2BM.%26aulast%3DBunnett%26aufirst%3DN.%2BW.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DEdgington-Mitchell%26aufirst%3DL.%2BE.%26atitle%3DApplication%2520of%2520a%2520sulfoxonium%2520ylide%2520electrophile%2520to%2520generate%2520cathepsin%2520X-selective%2520activity-based%2520probes%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2020%26volume%3D15%26issue%3D3%26spage%3D718%26epage%3D727%26doi%3D10.1021%2Facschembio.9b00961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kembhavi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buttle, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, A. J.</span></span> <span> </span><span class="NLM_article-title">The two cysteine endopeptidases of Legume seeds: Purification and characterization by use of specific fluorometric assays</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>303</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">208</span>â <span class="NLM_lpage">213</span>, <span class="refDoi">Â DOI: 10.1006/abbi.1993.1274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1006%2Fabbi.1993.1274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8512309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3sXltlequ7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=1993&pages=208-213&issue=2&author=A.+A.+Kembhaviauthor=D.+J.+Buttleauthor=C.+G.+Knightauthor=A.+J.+Barrett&title=The+two+cysteine+endopeptidases+of+Legume+seeds%3A+Purification+and+characterization+by+use+of+specific+fluorometric+assays&doi=10.1006%2Fabbi.1993.1274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">The two cysteine endopeptidases of legume seeds: Purification and characterization by use of specific fluorometric assays</span></div><div class="casAuthors">Kembhavi, Asha A.; Buttle, David J.; Knight, C. Graham; Barrett, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">208-13</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">Two endopeptidases are present in the seeds of Vigna aconitifolia (moth bean), and their activities increase during germination.  One enzyme, termed vignain, can be assayed with benzyloxycarbonyl-phenylalanyl-arginyl-7-(4-methyl)coumarylamide as substrate.  The second is legumain (EC 3.4.22.34), which can be assayed with benzyloxycarbonyl-alanyl-alanyl-asparaginyl-7-(4-methyl)-coumarylamide.  The enzymes were purified, and their specificities for substrates and inhibitors were examd.  Vignain has properties expected of a cysteine endopeptidase of the papain family, with the exception of a remarkably low reactivity with iodoacetate.  Legumain is a very atypical cysteine endopeptidase, being insensitive to inhibition by chicken cystatin and E-64 (L-3-carboxy-2,3-trans-epoxypropionyl-leucyl-amido(4-guanidino)butane), and reacting more rapidly with iodoacetamide than with iodoacetate.  The findings are discussed in relation to the literature on the proteolytic enzymes of legume seeds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph11dMK_RYnLVg90H21EOLACvtfcHk0lgqPe8i0PpaTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltlequ7w%253D&md5=d9141ecb232d95c73980e089e269c014</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1993.1274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1993.1274%26sid%3Dliteratum%253Aachs%26aulast%3DKembhavi%26aufirst%3DA.%2BA.%26aulast%3DButtle%26aufirst%3DD.%2BJ.%26aulast%3DKnight%26aufirst%3DC.%2BG.%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520two%2520cysteine%2520endopeptidases%2520of%2520Legume%2520seeds%253A%2520Purification%2520and%2520characterization%2520by%2520use%2520of%2520specific%2520fluorometric%2520assays%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1993%26volume%3D303%26issue%3D2%26spage%3D208%26epage%3D213%26doi%3D10.1006%2Fabbi.1993.1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dall, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fegg, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briza, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandstetter, H.</span></span> <span> </span><span class="NLM_article-title">Structure and mechanism of an aspartimide-dependent peptide ligase in human legumain</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2917</span>â <span class="NLM_lpage">2921</span>, <span class="refDoi">Â DOI: 10.1002/anie.201409135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fanie.201409135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtFCisbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=2917-2921&issue=10&author=E.+Dallauthor=J.+C.+Feggauthor=P.+Brizaauthor=H.+Brandstetter&title=Structure+and+mechanism+of+an+aspartimide-dependent+peptide+ligase+in+human+legumain&doi=10.1002%2Fanie.201409135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and Mechanism of an Aspartimide-Dependent Peptide Ligase in Human Legumain</span></div><div class="casAuthors">Dall, Elfriede; Fegg, Julia C.; Briza, Peter; Brandstetter, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2917-2921</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Peptide ligases expand the repertoire of genetically encoded protein architectures by synthesizing new peptide bonds, energetically driven by ATP or NTPs.  Here, we report the discovery of a genuine ligase activity in human legumain (AEP) which has important roles in immunity and tumor progression that were believed to be due to its established cysteine protease activity.  Defying dogma, the ligase reaction is independent of the catalytic cysteine but exploits an endogenous energy reservoir that results from the conversion of a conserved aspartate to a metastable aspartimide.  Legumain's dual protease-ligase activities are pH- and thus localization-controlled, with the former activity dominating in the acidic pH range and the latter activity dominating in the neutral pH range.  Their relevance includes reversible on-off switching of cystatin inhibitors and enzyme (in)activation, and may affect the generation of three-dimensional MHC epitopes.  The aspartate-aspartimide (succinimide) pair represents a new paradigm of coupling endergonic reactions in ATP-scarce environments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppzTbLas5UFLVg90H21EOLACvtfcHk0lgqPe8i0PpaTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtFCisbg%253D&md5=aa92d4376e1d57e343b2f243d7b89ed3</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1002%2Fanie.201409135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201409135%26sid%3Dliteratum%253Aachs%26aulast%3DDall%26aufirst%3DE.%26aulast%3DFegg%26aufirst%3DJ.%2BC.%26aulast%3DBriza%26aufirst%3DP.%26aulast%3DBrandstetter%26aufirst%3DH.%26atitle%3DStructure%2520and%2520mechanism%2520of%2520an%2520aspartimide-dependent%2520peptide%2520ligase%2520in%2520human%2520legumain%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26issue%3D10%26spage%3D2917%26epage%3D2921%26doi%3D10.1002%2Fanie.201409135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington, T.</span></span> <span> </span><span class="NLM_article-title">Overexpression of legumain in tumors Is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2957</span>â <span class="NLM_lpage">2964</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=12782603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1aitL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=2957-2964&issue=11&author=C.+Liuauthor=C.+Sunauthor=H.+Huangauthor=K.+Jandaauthor=T.+Edgington&title=Overexpression+of+legumain+in+tumors+Is+significant+for+invasion%2Fmetastasis+and+a+candidate+enzymatic+target+for+prodrug+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Legumain in Tumors Is Significant for Invasion/Metastasis and a Candidate Enzymatic Target for Prodrug Therapy</span></div><div class="casAuthors">Liu, Cheng; Sun, Chengzao; Huang, Haining; Janda, Kim; Edgington, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2957-2964</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Expression of legumain, a novel asparaginyl endopeptidase, in tumors was identified from gene expression profiling and tumor tissue array anal.  Legumain was demonstrated in membrane-assocd. vesicles concd. at the invadopodia of tumor cells and on cell surfaces where it colocalized with integrins.  Legumain was demonstrated to activate progelatinase A.  Cells overexpressing legumain possessed increased migratory and invasive activity in vitro and adopted an invasive and metastatic phenotype in vivo, inferring significance of legumain in tumor invasion and metastasis.  A prodrug strategy incorporating a legumain-cleavable peptide substrate onto doxorubicin was developed.  The prototype compd., designated legubicin, exhibited reduced toxicity and was effectively tumoricidal in vivo in a murine colon carcinoma model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbzPhPINJ7zLVg90H21EOLACvtfcHk0lgqPe8i0PpaTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1aitL8%253D&md5=6088fb45e7f42d07a4101a5fa040e519</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DJanda%26aufirst%3DK.%26aulast%3DEdgington%26aufirst%3DT.%26atitle%3DOverexpression%2520of%2520legumain%2520in%2520tumors%2520Is%2520significant%2520for%2520invasion%252Fmetastasis%2520and%2520a%2520candidate%2520enzymatic%2520target%2520for%2520prodrug%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26issue%3D11%26spage%3D2957%26epage%3D2964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span> <span> </span><span class="NLM_article-title">Effects of legumain as a potential prognostic factor on gastric cancers</span>. <i>Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">621</span>, <span class="refDoi">Â DOI: 10.1007/s12032-013-0621-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1007%2Fs12032-013-0621-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23740003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BC3snpvFyquw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=621&issue=3&author=N.+Liauthor=Q.+Liuauthor=Q.+Suauthor=C.+Weiauthor=B.+Lanauthor=J.+Wangauthor=G.+Baoauthor=F.+Yanauthor=Y.+Yuauthor=B.+Pengauthor=J.+Qiuauthor=X.+Yanauthor=S.+Zhangauthor=F.+Guo&title=Effects+of+legumain+as+a+potential+prognostic+factor+on+gastric+cancers&doi=10.1007%2Fs12032-013-0621-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of legumain as a potential prognostic factor on gastric cancers</span></div><div class="casAuthors">Li Na; Liu Qiaoling; Su Qi; Wei Chongyang; Lan Bin; Wang Jianyong; Bao Guoqing; Yan Fei; Yu Ying; Peng Baowei; Qiu Ju; Yan Xiangming; Zhang Sheng; Guo Fang</div><div class="citationInfo"><span class="NLM_cas:title">Medical oncology (Northwood, London, England)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">621</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although legumain has been found to be a prognostic factor in both breast cancer and colorectal cancer, its effects on gastric cancer are unknown.  In this study, we investigated effects of legumain on gastric cancer and the correlation between legumain expression and prognosis of gastric cancer patients.  SGC7901 cells were transduced with legumain cDNA (SGC7901-hLeg) for overexpression of legumain or with legumain shRNA to knock down legumain.  In vitro tumor migration was examined by wound healing assay.  Furthermore, a tumorigenicity and metastasis mouse model was used to examine legumain function in vivo; asparaginyl endopeptidase inhibitor (AEPI, an inhibitor of legumain) was injected to the mice (i.p.) to evaluate its therapeutic effect.  Tissue microarray analysis from 112 gastric cancer patients was performed to evaluate the association between legumain expression and the cumulative survival time.  Legumain was highly expressed in gastric cancer patients and some gastric cancer cell lines.  Legumain promoted gastric cell migration in vitro and promoted gastric tumor growth and metastasis in vivo, and these effects were reversed by knockdown of legumain with shRNA or treated with AEPI.  In gastric cancer clinical samples, legumain expression in tumor was significantly higher than in non-tumor and was negatively associated with the cumulative survival rate.  In conclusion, legumain was highly expressed in gastric adenocarcinoma; legumain promoted gastric cancer tumorigenesis and metastasis in vitro and in vivo.  Legumain expression in tumor was a poor prognostic factor for gastric cancer patients, and legumain could be a potential target molecule for gastric cancer therapy in clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQt-Yoxz0IgQJotVjB3IRIyfW6udTcc2eaztkJXM4_jcLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snpvFyquw%253D%253D&md5=d0b0d0655c6b1e4789d82bbfe5bfd0d3</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1007%2Fs12032-013-0621-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12032-013-0621-9%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSu%26aufirst%3DQ.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DG.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DF.%26atitle%3DEffects%2520of%2520legumain%2520as%2520a%2520potential%2520prognostic%2520factor%2520on%2520gastric%2520cancers%26jtitle%3DMed.%2520Oncol.%26date%3D2013%26volume%3D30%26issue%3D3%26spage%3D621%26doi%3D10.1007%2Fs12032-013-0621-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span> <span> </span><span class="NLM_article-title">Selective ablation of tumor associated macrophages suppresses metastasis and angiogenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1217</span>â <span class="NLM_lpage">1225</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=1217-1225&issue=9&author=F.+Guoauthor=Y.+Liuauthor=W.+Wuauthor=P.+Kuoauthor=Q.+Fangauthor=C.+Liu&title=Selective+ablation+of+tumor+associated+macrophages+suppresses+metastasis+and+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DKuo%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26atitle%3DSelective%2520ablation%2520of%2520tumor%2520associated%2520macrophages%2520suppresses%2520metastasis%2520and%2520angiogenesis%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D104%26issue%3D9%26spage%3D1217%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witte, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">649</span>â <span class="NLM_lpage">653</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2006.10.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2006.10.100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17189693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFagsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=649-653&issue=3&author=K.+B.+Sextonauthor=M.+D.+Witteauthor=G.+Blumauthor=M.+Bogyo&title=Design+of+cell-permeable%2C+fluorescent+activity-based+probes+for+the+lysosomal+cysteine+protease+asparaginyl+endopeptidase+%28AEP%29%2Flegumain&doi=10.1016%2Fj.bmcl.2006.10.100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain</span></div><div class="casAuthors">Sexton, Kelly B.; Witte, Martin D.; Blum, Galia; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">649-653</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Asparaginyl endopeptidase (AEP), also known as legumain, is a cysteine protease that has been ascribed roles in antigen presentation yet its exact role in human biol. remains poorly understood.  We report here, the use of a positional scanning combinatorial library of peptide AOMKs contg. a P1 aspartic acid to probe the P2, P3, and P4 subsite specificity of endogenous legumain.  Using inhibitor specificity profiles of cathepsin B and legumain, we designed fluorescent ABPs that are highly selective, cell-permeable reagents for monitoring legumain activity in complex proteomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYK4qY5O_637Vg90H21EOLACvtfcHk0lix2q2yoeH2bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFagsQ%253D%253D&md5=32c41dc7c017533cf357d2bce61db15f</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.10.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.10.100%26sid%3Dliteratum%253Aachs%26aulast%3DSexton%26aufirst%3DK.%2BB.%26aulast%3DWitte%26aufirst%3DM.%2BD.%26aulast%3DBlum%26aufirst%3DG.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DDesign%2520of%2520cell-permeable%252C%2520fluorescent%2520activity-based%2520probes%2520for%2520the%2520lysosomal%2520cysteine%2520protease%2520asparaginyl%2520endopeptidase%2520%2528AEP%2529%252Flegumain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D3%26spage%3D649%26epage%3D653%26doi%3D10.1016%2Fj.bmcl.2006.10.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eddie, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burden, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullan, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span> <span> </span><span class="NLM_article-title">Identification and SAR exploration of a novel series of legumain inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1546</span>â <span class="NLM_lpage">1548</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2019.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2019.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31005445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvFCrsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=1546-1548&issue=12&author=S.+L.+Eddieauthor=A.+Gregsonauthor=E.+Grahamauthor=S.+Burtonauthor=T.+Harrisonauthor=R.+Burdenauthor=C.+J.+Scottauthor=P.+B.+Mullanauthor=R.+Williams&title=Identification+and+SAR+exploration+of+a+novel+series+of+legumain+inhibitors&doi=10.1016%2Fj.bmcl.2019.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and SAR exploration of a novel series of Legumain inhibitors</span></div><div class="casAuthors">Eddie, Sharon L.; Gregson, Aaron; Graham, Emma; Burton, Stephanie; Harrison, Timothy; Burden, Roberta; Scott, Christopher J.; Mullan, Paul B.; Williams, Rich</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1546-1548</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This letter describes the development of a series of potent and selective small mol. Legumain inhibitors suitable as chem. probes for in vitro expts.  Our previous research had identified a dipeptide inhibitor utilizing a semi-reversible cyano warhead that generated 2, a cell active inhibitor.  This work explores an alternative P2-P3 linker and further SAR exploration of the P3 group which led to the identification of 16i, a highly potent inhibitor with excellent physiochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1H0LQIUMBrLVg90H21EOLACvtfcHk0lix2q2yoeH2bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvFCrsbw%253D&md5=77f8b08588ad2ae530a66821c6148981</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DEddie%26aufirst%3DS.%2BL.%26aulast%3DGregson%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DE.%26aulast%3DBurton%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DBurden%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DC.%2BJ.%26aulast%3DMullan%26aufirst%3DP.%2BB.%26aulast%3DWilliams%26aufirst%3DR.%26atitle%3DIdentification%2520and%2520SAR%2520exploration%2520of%2520a%2520novel%2520series%2520of%2520legumain%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26issue%3D12%26spage%3D1546%26epage%3D1548%26doi%3D10.1016%2Fj.bmcl.2019.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouazzaoui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaddale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DâCosta, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Templeman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâRourke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span> <span> </span><span class="NLM_article-title">P3 SAR exploration of biphenyl carbamate based legumain inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2521</span>â <span class="NLM_lpage">2524</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2014.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2014.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24775305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnt1ehur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2521-2524&issue=11&author=C.+Higginsauthor=S.+Bouazzaouiauthor=K.+Gaddaleauthor=Z.+D%E2%80%99Costaauthor=A.+Templemanauthor=M.+O%E2%80%99Rourkeauthor=A.+Youngauthor=C.+Scottauthor=T.+Harrisonauthor=P.+Mullanauthor=R.+Williams&title=P3+SAR+exploration+of+biphenyl+carbamate+based+legumain+inhibitors&doi=10.1016%2Fj.bmcl.2014.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">P3 SAR exploration of biphenyl carbamate based Legumain inhibitors</span></div><div class="casAuthors">Higgins, Catherine; Bouazzaoui, Samira; Gaddale, Kishore; D'Costa, Zenobia; Templeman, Amy; O'Rourke, Martin; Young, Andrew; Scott, Christopher; Harrison, Tim; Mullan, Paul; Williams, Rich</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2521-2524</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This Letter describes the further development and SAR exploration of a novel series of Legumain inhibitors.  Based upon a previously identified Legumain inhibitor from our group, we explored the SAR of the carbamate Ph ring system to probe the P3 pocket of the enzyme.  This led to the identification of a sub-nanomolar inhibitor of Legumain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnOgjnq6rM27Vg90H21EOLACvtfcHk0lj3ia8R61Ga_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnt1ehur0%253D&md5=5a316d1aab150c37b7388f16a92b8129</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DC.%26aulast%3DBouazzaoui%26aufirst%3DS.%26aulast%3DGaddale%26aufirst%3DK.%26aulast%3DD%25E2%2580%2599Costa%26aufirst%3DZ.%26aulast%3DTempleman%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DM.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DScott%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DMullan%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DR.%26atitle%3DP3%2520SAR%2520exploration%2520of%2520biphenyl%2520carbamate%2520based%2520legumain%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26issue%3D11%26spage%3D2521%26epage%3D2524%26doi%3D10.1016%2Fj.bmcl.2014.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Development of near-Infrared fluorophore (NIRF)-labeled activity-based probes for in vivo imaging of legumain</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">233</span>â <span class="NLM_lpage">243</span>, <span class="refDoi">Â DOI: 10.1021/cb900232a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb900232a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1yqtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=233-243&issue=2&author=J.+Leeauthor=M.+Bogyo&title=Development+of+near-Infrared+fluorophore+%28NIRF%29-labeled+activity-based+probes+for+in+vivo+imaging+of+legumain&doi=10.1021%2Fcb900232a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Near-Infrared Fluorophore (NIRF)-Labeled Activity-Based Probes for in Vivo Imaging of Legumain</span></div><div class="casAuthors">Lee, Jiyoun; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-243</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Asparaginyl endopeptidase, or legumain, is a lysosomal cysteine protease that was originally identified in plants and later found to be involved in antigen presentation in higher eukaryotes.  Legumain is also up-regulated in a no. of human cancers, and recent studies suggest that it may play important functional roles in the process of tumorigenesis.  However, detailed functional studies in relevant animal models of human disease have been hindered by the lack of suitably selective small mol. inhibitors and imaging reagents.  Here we present the design, optimization, and in vivo application of fluorescently labeled activity-based probes (ABPs) for legumain.  We demonstrate that optimized aza-peptidyl Asn epoxides are highly selective and potent inhibitors that can be readily converted into near-IR fluorophore-labeled ABPs for whole body, noninvasive imaging applications.  We show that these probes specifically label legumain in various normal tissues as well as in solid tumors when applied in vivo.  Interestingly, addn. of cell-penetrating peptides to the probes enhanced cellular uptake but resulted in increased cross-reactivity toward other lysosomal proteases as the result of their accumulation in lysosomes.  Overall, we find that aza-peptidyl Asn ABPs are valuable new tools for the future study of legumain function in more complex models of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxCJLNeNdH-bVg90H21EOLACvtfcHk0lj3ia8R61Ga_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1yqtw%253D%253D&md5=56417482a3ecdd58e0050128d2f2e830</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fcb900232a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb900232a%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520near-Infrared%2520fluorophore%2520%2528NIRF%2529-labeled%2520activity-based%2520probes%2520for%2520in%2520vivo%2520imaging%2520of%2520legumain%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26issue%3D2%26spage%3D233%26epage%3D243%26doi%3D10.1021%2Fcb900232a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edgington, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdoes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withana, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachmann, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Functional imaging of legumain in cancer using a new quenched activity-based probe</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">174</span>â <span class="NLM_lpage">182</span>, <span class="refDoi">Â DOI: 10.1021/ja307083b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja307083b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSqsbvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=174-182&issue=1&author=L.+E.+Edgingtonauthor=M.+Verdoesauthor=A.+Ortegaauthor=N.+P.+Withanaauthor=J.+Leeauthor=S.+Syedauthor=M.+H.+Bachmannauthor=G.+Blumauthor=M.+Bogyo&title=Functional+imaging+of+legumain+in+cancer+using+a+new+quenched+activity-based+probe&doi=10.1021%2Fja307083b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Functional Imaging of Legumain in Cancer Using a New Quenched Activity-Based Probe</span></div><div class="casAuthors">Edgington, Laura E.; Verdoes, Martijn; Ortega, Alberto; Withana, Nimali P.; Lee, Jiyoun; Syed, Salahuddin; Bachmann, Michael H.; Blum, Galia; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">174-182</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Legumain is a lysosomal cysteine protease whose biol. function remains poorly defined.  Legumain activity is up-regulated in most human cancers and inflammatory diseases most likely as the result of high expression in populations of activated macrophages.  Within the tumor microenvironment, legumain activity is thought to promote tumorigenesis.  To obtain a greater understanding of the role of legumain activity during cancer progression and inflammation, we developed an activity-based probe that becomes fluorescent only upon binding active legumain.  This probe is highly selective for legumain, even in the context of whole cells and tissues, and is also a more effective label of legumain than previously reported probes.  Here we present the synthesis and application of our probe to the anal. of legumain activity in primary macrophages and in two mouse models of cancer.  We find that legumain activity is highly correlated with macrophage activation and furthermore that it is an ideal marker for primary tumor inflammation and early stage metastatic lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmBlI6e_DeMbVg90H21EOLACvtfcHk0lj3ia8R61Ga_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSqsbvP&md5=51830cee1df9b60aef194be32d4ae310</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fja307083b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja307083b%26sid%3Dliteratum%253Aachs%26aulast%3DEdgington%26aufirst%3DL.%2BE.%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DOrtega%26aufirst%3DA.%26aulast%3DWithana%26aufirst%3DN.%2BP.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSyed%26aufirst%3DS.%26aulast%3DBachmann%26aufirst%3DM.%2BH.%26aulast%3DBlum%26aufirst%3DG.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DFunctional%2520imaging%2520of%2520legumain%2520in%2520cancer%2520using%2520a%2520new%2520quenched%2520activity-based%2520probe%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26issue%3D1%26spage%3D174%26epage%3D182%26doi%3D10.1021%2Fja307083b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edgington-Mitchell, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wartmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gocheva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withana, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdoes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aurelio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington-Mitchell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinheckel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furness, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halangk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnett, N. W.</span></span> <span> </span><span class="NLM_article-title">Legumain is activated in macrophages during pancreatitis</span>. <i>Am. J. Physiol. Gastrointest. Liver Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>311</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">G548</span>â <span class="NLM_lpage">G560</span>, <span class="refDoi">Â DOI: 10.1152/ajpgi.00047.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1152%2Fajpgi.00047.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27514475" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2016&pages=G548-G560&issue=3&author=L.+E.+Edgington-Mitchellauthor=T.+Wartmannauthor=A.+K.+Flemingauthor=V.+Gochevaauthor=W.+A.+van+der+Lindenauthor=N.+P.+Withanaauthor=M.+Verdoesauthor=L.+Aurelioauthor=D.+Edgington-Mitchellauthor=T.+Lieuauthor=B.+S.+Parkerauthor=B.+Grahamauthor=T.+Reinheckelauthor=J.+B.+Furnessauthor=J.+A.+Joyceauthor=P.+Storzauthor=W.+Halangkauthor=M.+Bogyoauthor=N.+W.+Bunnett&title=Legumain+is+activated+in+macrophages+during+pancreatitis&doi=10.1152%2Fajpgi.00047.2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1152%2Fajpgi.00047.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpgi.00047.2016%26sid%3Dliteratum%253Aachs%26aulast%3DEdgington-Mitchell%26aufirst%3DL.%2BE.%26aulast%3DWartmann%26aufirst%3DT.%26aulast%3DFleming%26aufirst%3DA.%2BK.%26aulast%3DGocheva%26aufirst%3DV.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DW.%2BA.%26aulast%3DWithana%26aufirst%3DN.%2BP.%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DAurelio%26aufirst%3DL.%26aulast%3DEdgington-Mitchell%26aufirst%3DD.%26aulast%3DLieu%26aufirst%3DT.%26aulast%3DParker%26aufirst%3DB.%2BS.%26aulast%3DGraham%26aufirst%3DB.%26aulast%3DReinheckel%26aufirst%3DT.%26aulast%3DFurness%26aufirst%3DJ.%2BB.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26aulast%3DStorz%26aufirst%3DP.%26aulast%3DHalangk%26aufirst%3DW.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DBunnett%26aufirst%3DN.%2BW.%26atitle%3DLegumain%2520is%2520activated%2520in%2520macrophages%2520during%2520pancreatitis%26jtitle%3DAm.%2520J.%2520Physiol.%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2016%26volume%3D311%26issue%3D3%26spage%3DG548%26epage%3DG560%26doi%3D10.1152%2Fajpgi.00047.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Vargas, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheff, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanner, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janal, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnett, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington-Mitchell, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B. L.</span></span> <span> </span><span class="NLM_article-title">Legumain induces oral cancer pain by biased agonism of protease-activated receptor-2</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">193</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.1211-20.2020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1523%2FJNEUROSCI.1211-20.2020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=33172978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3MXitl2gtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2021&pages=193&issue=1&author=N.+H.+Tuauthor=D.+D.+Jensenauthor=B.+M.+Andersonauthor=E.+Chenauthor=N.+N.+Jimenez-Vargasauthor=N.+N.+Scheffauthor=K.+Inoueauthor=H.+D.+Tranauthor=J.+C.+Dolanauthor=T.+A.+Meekauthor=M.+D.+Hollenbergauthor=C.+Z.+Liuauthor=S.+J.+Vannerauthor=M.+N.+Janalauthor=N.+W.+Bunnettauthor=L.+E.+Edgington-Mitchellauthor=B.+L.+Schmidt&title=Legumain+induces+oral+cancer+pain+by+biased+agonism+of+protease-activated+receptor-2&doi=10.1523%2FJNEUROSCI.1211-20.2020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Legumain induces oral cancer pain by biased agonism of protease-activated receptor-2</span></div><div class="casAuthors">Tu, Nguyen Huu; Jensen, Dane D.; Anderson, Bethany M.; Chen, Elyssa; Jimenez-Vargas, Nestor N.; Scheff, Nicole N.; Inoue, Kenji; Tran, Hung D.; Dolan, John C.; Meek, Tamaryn A.; Hollenberg, Morley D.; Liu, Cheng Z.; Vanner, Stephen J.; Janal, Malvin N.; Bunnett, Nigel W.; Edgington-Mitchell, Laura E.; Schmidt, Brian L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-210</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">1529-2401</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Oral squamous cell carcinoma (OSCC) is one of the most painful cancers, which interferes with orofacial function including talking and eating.  We report that legumain (Lgmn) cleaves protease-activated receptor-2 (PAR2) in the acidic OSCC microenvironment to cause pain.  Lgmn is a cysteine protease of late endosomes and lysosomes that can be secreted; it exhibits maximal activity in acidic environments.  The role of Lgmn in PAR2-dependent cancer pain is unknown.  We studied Lgmn activation in human oral cancers and oral cancer mouse models.  Lgmn was activated in OSCC patient tumors, compared with matched normal oral tissue.  After intraplantar, facial or lingual injection, Lgmn evoked nociception in wild-type (WT) female mice but not in female mice lacking PAR2 in NaV1.8-pos. neurons (Par2Nav1.8), nor in female mice treated with a Lgmn inhibitor, LI-1.  Lgmn caused PAR2-dependent hyperexcitability of trigeminal neurons from WT female mice.  Under acidified conditions, Lgmn cleaved within the extracellular N terminus of PAR2 at Asn30âArg31, proximal to the canonical trypsin activation site.  Lgmn activated PAR2 by biased mechanisms in HEK293 cells to induce Ca2+ mobilization, cAMP formation, and PKA/protein kinase D (PKD) activation, but not Î²-arrestin recruitment or PAR2 endocytosis.  Thus, in the acidified OSCC microenvironment, Lgmn activates PAR2 by biased mechanisms that evoke cancer pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj2ZwzNoOxrrVg90H21EOLACvtfcHk0lhc1Qz2nOUBsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXitl2gtrk%253D&md5=9f3786843b4c6603c8da7010b2772388</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1211-20.2020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1211-20.2020%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DN.%2BH.%26aulast%3DJensen%26aufirst%3DD.%2BD.%26aulast%3DAnderson%26aufirst%3DB.%2BM.%26aulast%3DChen%26aufirst%3DE.%26aulast%3DJimenez-Vargas%26aufirst%3DN.%2BN.%26aulast%3DScheff%26aufirst%3DN.%2BN.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DTran%26aufirst%3DH.%2BD.%26aulast%3DDolan%26aufirst%3DJ.%2BC.%26aulast%3DMeek%26aufirst%3DT.%2BA.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DLiu%26aufirst%3DC.%2BZ.%26aulast%3DVanner%26aufirst%3DS.%2BJ.%26aulast%3DJanal%26aufirst%3DM.%2BN.%26aulast%3DBunnett%26aufirst%3DN.%2BW.%26aulast%3DEdgington-Mitchell%26aufirst%3DL.%2BE.%26aulast%3DSchmidt%26aufirst%3DB.%2BL.%26atitle%3DLegumain%2520induces%2520oral%2520cancer%2520pain%2520by%2520biased%2520agonism%2520of%2520protease-activated%2520receptor-2%26jtitle%3DJ.%2520Neurosci.%26date%3D2021%26volume%3D41%26issue%3D1%26spage%3D193%26doi%3D10.1523%2FJNEUROSCI.1211-20.2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rut, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lunde, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihelic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Counter selection substrate library strategy for developing specific protease substrates and probes</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1023</span>â <span class="NLM_lpage">1035</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2016.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2016.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27478158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1KlsbnN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1023-1035&issue=8&author=M.+Porebaauthor=R.+Solbergauthor=W.+Rutauthor=N.+N.+Lundeauthor=P.+Kasperkiewiczauthor=S.+J.+Snipasauthor=M.+Mihelicauthor=D.+Turkauthor=B.+Turkauthor=G.+S.+Salvesenauthor=M.+Drag&title=Counter+selection+substrate+library+strategy+for+developing+specific+protease+substrates+and+probes&doi=10.1016%2Fj.chembiol.2016.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Counter Selection Substrate Library Strategy for Developing Specific Protease Substrates and Probes</span></div><div class="casAuthors">Poreba, Marcin; Solberg, Rigmor; Rut, Wioletta; Lunde, Ngoc Nguyen; Kasperkiewicz, Paulina; Snipas, Scott J.; Mihelic, Marko; Turk, Dusan; Turk, Boris; Salvesen, Guy S.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1023-1035</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Legumain (AEP) is a lysosomal cysteine protease that was first characterized in leguminous seeds and later discovered in higher eukaryotes.  AEP upregulation is linked to a no. of diseases including inflammation, arteriosclerosis, and tumorigenesis.  Thus this protease is an excellent mol. target for the development of new chem. markers.  We deployed a hybrid combinatorial substrate library (HyCoSuL) approach to obtain P1-Asp fluorogenic substrates and biotin-labeled inhibitors that targeted legumain.  Since this approach led to probes that were also recognized by caspases, we introduced a Counter Selection Substrate Library (CoSeSuL) approach that biases the peptidic scaffold against caspases, thus delivering highly selective legumain probes.  The selectivity of these tools was validated using M38L and HEK293 cells.  We also propose that the CoSeSuL methodol. can be considered as a general principle in the design of selective probes for other protease families where selectivity is difficult to achieve by conventional sequence-based profiling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtgQyo_YeLk7Vg90H21EOLACvtfcHk0lhc1Qz2nOUBsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1KlsbnN&md5=96a607ad2ac4bbcb35c3dd106aad0688</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2016.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2016.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DSolberg%26aufirst%3DR.%26aulast%3DRut%26aufirst%3DW.%26aulast%3DLunde%26aufirst%3DN.%2BN.%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DMihelic%26aufirst%3DM.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DCounter%2520selection%2520substrate%2520library%2520strategy%2520for%2520developing%2520specific%2520protease%2520substrates%2520and%2520probes%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2016%26volume%3D23%26issue%3D8%26spage%3D1023%26epage%3D1035%26doi%3D10.1016%2Fj.chembiol.2016.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span> <span> </span><span class="NLM_article-title">Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFÎ±-induced cancer cell migration</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>441</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">979</span>â <span class="NLM_lpage">987</span>, <span class="refDoi">Â DOI: 10.1042/BJ20111358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1042%2FBJ20111358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22029577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFKqtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2012&pages=979-987&issue=3&author=N.+Xiaoauthor=H.+Liauthor=J.+Luoauthor=R.+Wangauthor=H.+Chenauthor=J.+Chenauthor=P.+Wang&title=Ubiquitin-specific+protease+4+%28USP4%29+targets+TRAF2+and+TRAF6+for+deubiquitination+and+inhibits+TNF%CE%B1-induced+cancer+cell+migration&doi=10.1042%2FBJ20111358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFÎ±-induced cancer cell migration</span></div><div class="casAuthors">Xiao, Ning; Li, Hui; Luo, Jian; Wang, Rui; Chen, Haiquan; Chen, Jiquan; Wang, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">441</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">979-986</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">TRAF [TNF (tumor necrosis factor)-receptor-assocd. factor] 2 and 6 are essential adaptor proteins for the NF-ÎºB (nuclear factor ÎºB) signalling pathway, which play important roles in inflammation and immune response.  Polyubiquitination of TRAF2 and TRAF6 is crit. to their activities and functions in TNFÎ±- and IL (interleukin)-1Î²-induced NF-ÎºB activation.  However, the regulation of TRAF2 and TRAF6 by deubiquitination remains incompletely understood.  In the present study, we identified USP (ubiquitin-specific protease) 4 as a novel deubiquitinase targeting TRAF2 and TRAF6 for deubiquitination.  We found that USP4 specifically interacts with TRAF2 and TRAF6, but not TRAF3.  Moreover, USP4 assocs. with TRAF6 both in vitro and in vivo, independent of its deubiquitinase activity.  The USP domain is responsible for USP4 to interact with TRAF6.  Ectopic expression of USP4 inhibits the TRAF2- and TRAF6-stimulated NF-ÎºB reporter gene and neg. regulates the TNFÎ±-induced IÎºBÎ± (inhibitor of NF-ÎºBÎ±) degrdn. and NF-ÎºB activation.  Knockdown of USP4 significantly increased TNFÎ±-induced cytokine expression.  Furthermore, we found that USP4 deubiquitinates both TRAF2 and TRAF6 in vivo and in vitro in a deubiquitinase activity-dependent manner.  Importantly, the results of the present study showed that USP4 is a neg. regulator of TNFÎ±- and IL-1Î²-induced cancer cell migration.  Taken together, the present study provides a novel insight into the regulation of the NF-ÎºB signalling pathway and uncovers a previously unknown function of USP4 in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod29nRxc2ojLVg90H21EOLACvtfcHk0lj63U_oY3yNUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFKqtw%253D%253D&md5=3751e6c0ba30213ebd41b246a8657170</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1042%2FBJ20111358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20111358%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26atitle%3DUbiquitin-specific%2520protease%25204%2520%2528USP4%2529%2520targets%2520TRAF2%2520and%2520TRAF6%2520for%2520deubiquitination%2520and%2520inhibits%2520TNF%25CE%25B1-induced%2520cancer%2520cell%2520migration%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D441%26issue%3D3%26spage%3D979%26epage%3D987%26doi%3D10.1042%2FBJ20111358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">USP4 targets TAK1 to downregulate TNFÎ±-induced NF-ÎºB activation</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1547</span>â <span class="NLM_lpage">1560</span>, <span class="refDoi">Â DOI: 10.1038/cdd.2011.11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fcdd.2011.11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21331078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKrtrrL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1547-1560&issue=10&author=Y.+H.+Fanauthor=Y.+Yuauthor=R.+F.+Maoauthor=X.+J.+Tanauthor=G.+F.+Xuauthor=H.+Zhangauthor=X.+B.+Luauthor=S.+B.+Fuauthor=J.+Yang&title=USP4+targets+TAK1+to+downregulate+TNF%CE%B1-induced+NF-%CE%BAB+activation&doi=10.1038%2Fcdd.2011.11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">USP4 targets TAK1 to downregulate TNFÎ±-induced NF-ÎºB activation</span></div><div class="casAuthors">Fan, Y.-H.; Yu, Y.; Mao, R.-F.; Tan, X.-J.; Xu, G.-F.; Zhang, H.; Lu, X.-B.; Fu, S.-B.; Yang, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1547-1560</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lys63-linked polyubiquitination of transforming growth factor-Î²-activated kinase 1 (TAK1) has an important role in tumor necrosis factor-Î± (TNFÎ±)-induced NF-ÎºB activation.  Using a functional genomic approach, we have identified ubiquitin-specific peptidase 4 (USP4) as a deubiquitinase for TAK1.  USP4 deubiquitinates TAK1 in vitro and in vivo.  TNFÎ± induces assocn. of USP4 with TAK1 to deubiquitinate TAK1 and downregulate TAK1-mediated NF-ÎºB activation.  Overexpression of USP4 wild type, but not deuibiquitinase-deficient C311A mutant, inhibits both TNFÎ±- and TAK1/TAB1 co-overexpression-induced TAK1 polyubiquitination and NF-ÎºB activation.  Notably, knockdown of USP4 in HeLa cells enhances TNFÎ±-induced TAK1 polyubiquitination, IÎºB kinase phosphorylation, IÎºBÎ± phosphorylation and ubiquitination, as well as NF-ÎºB-dependent gene expression.  Moreover, USP4 neg. regulates IL-1Î²-, LPS- and TGFÎ²-induced NF-ÎºB activation.  Together, our results demonstrate that USP4 serves as a crit. control to downregulate TNFÎ±-induced NF-ÎºB activation through deubiquitinating TAK1.  Cell Death and Differentiation (2011) 18, 1547-1560; doi:10.1038/cdd.2011.11; published online 18 Feb. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkl3era56kUbVg90H21EOLACvtfcHk0lj63U_oY3yNUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKrtrrL&md5=ff1283ad190785705e7b8180a402b57a</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2011.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2011.11%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DY.%2BH.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DMao%26aufirst%3DR.%2BF.%26aulast%3DTan%26aufirst%3DX.%2BJ.%26aulast%3DXu%26aufirst%3DG.%2BF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DX.%2BB.%26aulast%3DFu%26aufirst%3DS.%2BB.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DUSP4%2520targets%2520TAK1%2520to%2520downregulate%2520TNF%25CE%25B1-induced%2520NF-%25CE%25BAB%2520activation%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2011%26volume%3D18%26issue%3D10%26spage%3D1547%26epage%3D1560%26doi%3D10.1038%2Fcdd.2011.11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccioni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span> <span> </span><span class="NLM_article-title">Cutting edge: Ubiquitin-specific protease 4 promotes Th17 cell function under inflammation by deubiquitinating and stabilizing RORÎ³t</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>194</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4094</span>â <span class="NLM_lpage">4097</span>, <span class="refDoi">Â DOI: 10.4049/jimmunol.1401451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4049%2Fjimmunol.1401451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25821221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXms1GnsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2015&pages=4094-4097&issue=9&author=J.+Yangauthor=P.+Xuauthor=L.+Hanauthor=Z.+Guoauthor=X.+Wangauthor=Z.+Chenauthor=J.+Nieauthor=S.+Yinauthor=M.+Piccioniauthor=A.+Tsunauthor=L.+Lvauthor=S.+Geauthor=B.+Li&title=Cutting+edge%3A+Ubiquitin-specific+protease+4+promotes+Th17+cell+function+under+inflammation+by+deubiquitinating+and+stabilizing+ROR%CE%B3t&doi=10.4049%2Fjimmunol.1401451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Cutting Edge: Ubiquitin-Specific Protease 4 Promotes Th17 Cell Function under Inflammation by Deubiquitinating and Stabilizing RORÎ³t</span></div><div class="casAuthors">Yang, Jing; Xu, Peng; Han, Lei; Guo, Zhixiang; Wang, Xiuwen; Chen, Zuojia; Nie, Jia; Yin, Shuying; Piccioni, Miranda; Tsun, Andy; Lv, Ling; Ge, Shenglin; Li, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4094-4097</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">RORÎ³t is a key transcription factor that controls the development and function of inflammatory Th17.  The mechanisms that regulate RORÎ³t stability remain unclear.  We report that Th17 cells highly express the deubiquitinase ubiquitin-specific protease (USP)4, which is essential for maintaining RORÎ³t and Th17 cell function.  Inhibition of the catalytic activity of USP4 with vialinin A, a compd. derived from Chinese traditional medicine, dampened Th17 differentiation.  USP4 interacted and deubiquitinated K48-linked polyubiquitination of RORÎ³t, thereby promoting RORÎ³t function and IL-17A transcription.  Interestingly, TGF-Î² plus IL-6 enhanced USP4-mediated deubiquitination of RORÎ³t.  Moreover, USP4 and IL-17 mRNA, but not RORÎ³t mRNA, were significantly elevated in CD4+ T cells from patients with rheumatic heart disease.  Thus, USP4 could be a novel therapeutic target for the treatment of Th17-modulated autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHC9YrZAXjnbVg90H21EOLACvtfcHk0lj63U_oY3yNUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXms1GnsLg%253D&md5=cdde10d3a9c4f64366e1057cad9a93a2</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1401451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1401451%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DNie%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DS.%26aulast%3DPiccioni%26aufirst%3DM.%26aulast%3DTsun%26aufirst%3DA.%26aulast%3DLv%26aufirst%3DL.%26aulast%3DGe%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DB.%26atitle%3DCutting%2520edge%253A%2520Ubiquitin-specific%2520protease%25204%2520promotes%2520Th17%2520cell%2520function%2520under%2520inflammation%2520by%2520deubiquitinating%2520and%2520stabilizing%2520ROR%25CE%25B3t%26jtitle%3DJ.%2520Immunol.%26date%3D2015%26volume%3D194%26issue%3D9%26spage%3D4094%26epage%3D4097%26doi%3D10.4049%2Fjimmunol.1401451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onose, J.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koshino, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yajima, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yajima, S.</span></span> <span> </span><span class="NLM_article-title">Vialinin A is a ubiquitin-specific peptidase inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4328</span>â <span class="NLM_lpage">4331</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2013.05.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2013.05.093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23791076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslGgurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4328-4331&issue=15&author=K.+Okadaauthor=Y.+Q.+Yeauthor=K.+Taniguchiauthor=A.+Yoshidaauthor=T.+Akiyamaauthor=Y.+Yoshiokaauthor=J.-i.+Onoseauthor=H.+Koshinoauthor=S.+Takahashiauthor=A.+Yajimaauthor=N.+Abeauthor=S.+Yajima&title=Vialinin+A+is+a+ubiquitin-specific+peptidase+inhibitor&doi=10.1016%2Fj.bmcl.2013.05.093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Vialinin A is a ubiquitin-specific peptidase inhibitor</span></div><div class="casAuthors">Okada, Kiyoshi; Ye, Yue Qi; Taniguchi, Kayoko; Yoshida, Ayaka; Akiyama, Tomonori; Yoshioka, Yasukiyo; Onose, Jun-ichi; Koshino, Hiroyuki; Takahashi, Shunya; Yajima, Arata; Abe, Naoki; Yajima, Shunsuke</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4328-4331</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Vialinin A, a small compd. isolated from the Chinese mushroom Thelephora vialis, exhibits more effective anti-inflammatory activity than the widely used immunosuppressive drug tacrolimus (FK506).  Here, we show that ubiquitin-specific peptidase 5/isopeptidase T (USP5/IsoT) is a target mol. of vialinin A, identified by using a beads-probe method.  Vialinin A inhibited the peptidase activity of USP5/IsoT and also inhibited the enzymic activities of USP4 among deubiquitinating enzymes tested.  Although USPs are a member of thiol protease family, vialinin A exhibited no inhibitions for other thiol proteases, such as calpain and cathepsin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbheFWIV9k7bVg90H21EOLACvtfcHk0lg0lZPUvKJUhA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslGgurs%253D&md5=e9fdfdf55ec643197d52fa7bc309bc54</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.093%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DY.%2BQ.%26aulast%3DTaniguchi%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DA.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DYoshioka%26aufirst%3DY.%26aulast%3DOnose%26aufirst%3DJ.-i.%26aulast%3DKoshino%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DYajima%26aufirst%3DA.%26aulast%3DAbe%26aufirst%3DN.%26aulast%3DYajima%26aufirst%3DS.%26atitle%3DVialinin%2520A%2520is%2520a%2520ubiquitin-specific%2520peptidase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26issue%3D15%26spage%3D4328%26epage%3D4331%26doi%3D10.1016%2Fj.bmcl.2013.05.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rago, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span> <span> </span><span class="NLM_article-title">Disruption of HAUSP gene stabilizes p53</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>428</i></span> (<span class="NLM_issue">6982</span>),  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">2</span>, <span class="refDoi">Â DOI: 10.1038/nature02501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature02501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15058298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BD2c7msVGksA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=1-2&issue=6982&author=J.+M.+Cumminsauthor=C.+Ragoauthor=M.+Kohliauthor=K.+W.+Kinzlerauthor=C.+Lengauerauthor=B.+Vogelstein&title=Disruption+of+HAUSP+gene+stabilizes+p53&doi=10.1038%2Fnature02501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour suppression: disruption of HAUSP gene stabilizes p53</span></div><div class="casAuthors">Cummins Jordan M; Rago Carlo; Kohli Manu; Kinzler Kenneth W; Lengauer Christoph; Vogelstein Bert</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">6982</span>),
    <span class="NLM_cas:pages">1 p  following 486</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYwApJeSKG-LFU0A1HOshhfW6udTcc2ebFbO-6-QR3xLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7msVGksA%253D%253D&md5=18c9fc142054f30d6b8bf26cdbe85bd7</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1038%2Fnature02501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02501%26sid%3Dliteratum%253Aachs%26aulast%3DCummins%26aufirst%3DJ.%2BM.%26aulast%3DRago%26aufirst%3DC.%26aulast%3DKohli%26aufirst%3DM.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DDisruption%2520of%2520HAUSP%2520gene%2520stabilizes%2520p53%26jtitle%3DNature%26date%3D2004%26volume%3D428%26issue%3D6982%26spage%3D1%26epage%3D2%26doi%3D10.1038%2Fnature02501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, W.</span></span> <span> </span><span class="NLM_article-title">A dynamic role of HAUSP in the p53-Mdm2 pathway</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">879</span>â <span class="NLM_lpage">886</span>, <span class="refDoi">Â DOI: 10.1016/S1097-2765(04)00157-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS1097-2765%2804%2900157-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15053880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFajsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=879-886&issue=6&author=M.+Liauthor=C.+L.+Brooksauthor=N.+Konauthor=W.+Gu&title=A+dynamic+role+of+HAUSP+in+the+p53-Mdm2+pathway&doi=10.1016%2FS1097-2765%2804%2900157-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">A dynamic role of HAUSP in the p53-Mdm2 pathway</span></div><div class="casAuthors">Li, Muyang; Brooks, Christopher L.; Kon, Ning; Gu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">879-886</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Our previous study showed that ubiquitination of p53 is reversible and that the ubiquitin hydrolase HAUSP can stabilize p53 by deubiquitination.  Here, we found that partial redn. of endogenous HAUSP levels by RNAi indeed destabilizes endogenous p53; surprisingly, however, nearly complete ablation of HAUSP stabilizes and activates p53.  We further show that this phenomenon occurs because HAUSP stabilizes Mdm2 in a p53-independent manner, providing an interesting feedback loop in p53 regulation.  Notably, HAUSP is required for Mdm2 stability in normal cells; in HAUSP-ablated cells, self-ubiquitinated-Mdm2 becomes extremely unstable, leading to indirect p53 activation.  Furthermore, this feedback regulation is specific to Mdm2; in HeLa cells, where p53 is preferentially degraded by viral E6-dependent ubiquitination, depletion of HAUSP fails to activate p53.  This study provides an example of an ubiquitin ligase (Mdm2) that is directly regulated by a deubiquitinase (HAUSP) and also reveals a dynamic role of HAUSP in the p53-Mdm2 pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_0ojWOvYLg7Vg90H21EOLACvtfcHk0lg0lZPUvKJUhA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFajsrc%253D&md5=49bcdd861fd516419d842ee0165a9bd7</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2804%2900157-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252804%252900157-1%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DBrooks%26aufirst%3DC.%2BL.%26aulast%3DKon%26aufirst%3DN.%26aulast%3DGu%26aufirst%3DW.%26atitle%3DA%2520dynamic%2520role%2520of%2520HAUSP%2520in%2520the%2520p53-Mdm2%2520pathway%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D13%26issue%3D6%26spage%3D879%26epage%3D886%26doi%3D10.1016%2FS1097-2765%2804%2900157-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van Loosdregt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleskens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenkman, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekker, C. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pals, C. E. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meerding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkers, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GrÃ¶ne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sijts, A. J. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalkhoven, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakken, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovaa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaiss, D. M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffer, P. J.</span></span> <span> </span><span class="NLM_article-title">Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">259</span>â <span class="NLM_lpage">271</span>, <span class="refDoi">Â DOI: 10.1016/j.immuni.2013.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.immuni.2013.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23973222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlCgtr3F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2013&pages=259-271&issue=2&author=J.+van+Loosdregtauthor=V.+Fleskensauthor=J.+Fuauthor=A.+B.+Brenkmanauthor=C.+P.+J.+Bekkerauthor=C.+E.+G.+M.+Palsauthor=J.+Meerdingauthor=C.+R.+Berkersauthor=J.+Barbiauthor=A.+Gr%C3%B6neauthor=A.+J.+A.+M.+Sijtsauthor=M.+M.+Mauriceauthor=E.+Kalkhovenauthor=B.+J.+Prakkenauthor=H.+Ovaaauthor=F.+Panauthor=D.+M.+W.+Zaissauthor=P.+J.+Coffer&title=Stabilization+of+the+transcription+factor+Foxp3+by+the+deubiquitinase+USP7+increases+Treg-cell-suppressive+capacity&doi=10.1016%2Fj.immuni.2013.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of the Transcription Factor Foxp3 by the Deubiquitinase USP7 Increases Treg-Cell-Suppressive Capacity</span></div><div class="casAuthors">van Loosdregt, Jorg; Fleskens, Veerle; Fu, Juan; Brenkman, Arjan B.; Bekker, Cornelis P. J.; Pals, Cornelieke E. G. M.; Meerding, Jenny; Berkers, Celia R.; Barbi, Joseph; Grone, Andrea; Sijts, Alice J. A. M.; Maurice, Madelon M.; Kalkhoven, Eric; Prakken, Berent J.; Ovaa, Huib; Pan, Fan; Zaiss, Dietmar M. W.; Coffer, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">259-271</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Stable Foxp3 expression is required for the development of functional regulatory T (Treg) cells.  Here, we demonstrate that the expression of the transcription factor Foxp3 can be regulated through the polyubiquitination of multiple lysine residues, resulting in proteasome-mediated degrdn.  Expression of the deubiquitinase (DUB) USP7 was found to be upregulated and active in Treg cells, being assocd. with Foxp3 in the nucleus.  Ectopic expression of USP7 decreased Foxp3 polyubiquitination and increased Foxp3 expression.  Conversely, either treatment with DUB inhibitor or USP7 knockdown decreased endogenous Foxp3 protein expression and decreased Treg-cell-mediated suppression in vitro.  Furthermore, in a murine adoptive-transfer-induced colitis model, either inhibition of DUB activity or USP7 knockdown in Treg cells abrogated their ability to resolve inflammation in vivo.  Our data reveal a mol. mechanism in which rapid temporal control of Foxp3 expression in Treg cells can be regulated by USP7, thereby modulating Treg cell nos. and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Zpb6_zouu7Vg90H21EOLACvtfcHk0ljFPRa-fPBKbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlCgtr3F&md5=78bd3e51a661ecac49461a3811d2e768</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2013.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2013.05.018%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BLoosdregt%26aufirst%3DJ.%26aulast%3DFleskens%26aufirst%3DV.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DBrenkman%26aufirst%3DA.%2BB.%26aulast%3DBekker%26aufirst%3DC.%2BP.%2BJ.%26aulast%3DPals%26aufirst%3DC.%2BE.%2BG.%2BM.%26aulast%3DMeerding%26aufirst%3DJ.%26aulast%3DBerkers%26aufirst%3DC.%2BR.%26aulast%3DBarbi%26aufirst%3DJ.%26aulast%3DGr%25C3%25B6ne%26aufirst%3DA.%26aulast%3DSijts%26aufirst%3DA.%2BJ.%2BA.%2BM.%26aulast%3DMaurice%26aufirst%3DM.%2BM.%26aulast%3DKalkhoven%26aufirst%3DE.%26aulast%3DPrakken%26aufirst%3DB.%2BJ.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DZaiss%26aufirst%3DD.%2BM.%2BW.%26aulast%3DCoffer%26aufirst%3DP.%2BJ.%26atitle%3DStabilization%2520of%2520the%2520transcription%2520factor%2520Foxp3%2520by%2520the%2520deubiquitinase%2520USP7%2520increases%2520Treg-cell-suppressive%2520capacity%26jtitle%3DImmunity%26date%3D2013%26volume%3D39%26issue%3D2%26spage%3D259%26epage%3D271%26doi%3D10.1016%2Fj.immuni.2013.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lough, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samanta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, M. I.</span></span> <span> </span><span class="NLM_article-title">Dynamic interactions between TIP60 and p300 regulate FOXP3 function through a structural switch defined by a single lysine on TIP60</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1471</span>â <span class="NLM_lpage">1480</span>, <span class="refDoi">Â DOI: 10.1016/j.celrep.2014.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.celrep.2014.04.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24835996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotFGlsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=1471-1480&issue=5&author=Y.+Xiaoauthor=Y.+Nagaiauthor=G.+Dengauthor=T.+Ohtaniauthor=Z.+Zhuauthor=Z.+Zhouauthor=H.+Zhangauthor=M.+Q.+Jiauthor=J.+W.+Loughauthor=A.+Samantaauthor=W.+W.+Hancockauthor=M.+I.+Greene&title=Dynamic+interactions+between+TIP60+and+p300+regulate+FOXP3+function+through+a+structural+switch+defined+by+a+single+lysine+on+TIP60&doi=10.1016%2Fj.celrep.2014.04.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic Interactions between TIP60 and p300 Regulate FOXP3 Function through a Structural Switch Defined by a Single Lysine on TIP60</span></div><div class="casAuthors">Xiao, Yan; Nagai, Yasuhiro; Deng, Guoping; Ohtani, Takuya; Zhu, Zhiqiang; Zhou, Zhaocai; Zhang, Hongtao; Ji, Mei Q.; Lough, John W.; Samanta, Arabinda; Hancock, Wayne W.; Greene, Mark I.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1471-1480</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The human FOXP3 mol. is an oligomeric transcriptional factor able to mediate activities that characterize T regulatory cells, a class of lymphocytes central to the regulation of immune responses.  The activity of FOXP3 is regulated at the posttranslational level, in part by two histone acetyltransferases (HATs): TIP60 and p300.  TIP60 and p300 work cooperatively to regulate FOXP3 activity.  Initially, p300 and TIP60 interactions lead to the activation of TIP60 and facilitate acetylation of K327 of TIP60, which functions as a mol. switch to allow TIP60 to change binding partners.  Subsequently, p300 is released from this complex, and TIP60 interacts with and acetylates FOXP3.  Maximal induction of FOXP3 activities is obsd. when both p300 and TIP60 are able to undergo cooperative interactions.  Conditional knockout of TIP60 in Treg cells significantly decreases the Treg population in the peripheral immune organs, leading to a scurfy-like fatal autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoisEBghRHaSrVg90H21EOLACvtfcHk0ljFPRa-fPBKbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotFGlsbw%253D&md5=4d3ed5d4713140bd2e17e6288ad9f1af</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DOhtani%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DM.%2BQ.%26aulast%3DLough%26aufirst%3DJ.%2BW.%26aulast%3DSamanta%26aufirst%3DA.%26aulast%3DHancock%26aufirst%3DW.%2BW.%26aulast%3DGreene%26aufirst%3DM.%2BI.%26atitle%3DDynamic%2520interactions%2520between%2520TIP60%2520and%2520p300%2520regulate%2520FOXP3%2520function%2520through%2520a%2520structural%2520switch%2520defined%2520by%2520a%2520single%2520lysine%2520on%2520TIP60%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D7%26issue%3D5%26spage%3D1471%26epage%3D1480%26doi%3D10.1016%2Fj.celrep.2014.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newick, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samanta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beier, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akimova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatti, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodrasov, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterner, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albelda, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, W. W.</span></span> <span> </span><span class="NLM_article-title">Ubiquitin-specific protease-7 inhibition impairs Tip60-dependent Foxp3+ T-regulatory cell function and promotes antitumor immunity</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">99</span>â <span class="NLM_lpage">112</span>, <span class="refDoi">Â DOI: 10.1016/j.ebiom.2016.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.ebiom.2016.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27769803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BC2srltVWmsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=99-112&author=L.+Wangauthor=S.+Kumarauthor=S.+Dahiyaauthor=F.+Wangauthor=J.+Wuauthor=K.+Newickauthor=R.+Hanauthor=A.+Samantaauthor=U.+H.+Beierauthor=T.+Akimovaauthor=T.+R.+Bhattiauthor=B.+Nicholsonauthor=M.+P.+Kodrasovauthor=S.+Agarwalauthor=D.+E.+Sternerauthor=W.+Guauthor=J.+Weinstockauthor=T.+R.+Buttauthor=S.+M.+Albeldaauthor=W.+W.+Hancock&title=Ubiquitin-specific+protease-7+inhibition+impairs+Tip60-dependent+Foxp3%2B+T-regulatory+cell+function+and+promotes+antitumor+immunity&doi=10.1016%2Fj.ebiom.2016.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3+ T-regulatory Cell Function and Promotes Antitumor Immunity</span></div><div class="casAuthors">Wang Liqing; Dahiya Satinder; Han Rongxiang; Samanta Arabinda; Akimova Tatiana; Bhatti Tricia R; Kumar Suresh; Wang Feng; Wu Jian; Nicholson Benjamin; Kodrasov Mathew P; Agarwal Saket; Sterner David E; Weinstock Joseph; Butt Tauseef R; Newick Kheng; Albelda Steven M; Beier Ulf H; Gu Wei; Hancock Wayne W</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">99-112</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Foxp3+ T-regulatory (Treg) cells are known to suppress protective host immune responses to a wide variety of solid tumors, but their therapeutic targeting is largely restricted to their transient depletion or "secondary" modulation, e.g. using anti-CTLA-4 monoclonal antibody.  Our ongoing studies of the post-translational modifications that regulate Foxp3 demonstrated that the histone/protein acetyltransferase, Tip60, plays a dominant role in promoting acetylation, dimerization and function in Treg cells.  We now show that the ubiquitin-specific protease, Usp7, controls Treg function largely by stabilizing the expression and promoting the multimerization of Tip60 and Foxp3.  Genetic or pharmacologic targeting of Usp7 impairs Foxp3+ Treg suppressive functions, while conventional T cell responses remain intact.  As a result, pharmacologic inhibitors of Usp7 can limit tumor growth in immunocompetent mice, and promote the efficacy of antitumor vaccines and immune checkpoint therapy with anti-PD1 monoclonal antibody in murine models.  Hence, pharmacologic therapy with Usp7 inhibitors may have an important role in future cancer immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRx7G_irn6DIPtos8R3JUhXfW6udTcc2ea-AubXD4EwiLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srltVWmsQ%253D%253D&md5=f7456d0d7eddd4188ef4e6e2f3e8d691</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2016.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2016.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DDahiya%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DNewick%26aufirst%3DK.%26aulast%3DHan%26aufirst%3DR.%26aulast%3DSamanta%26aufirst%3DA.%26aulast%3DBeier%26aufirst%3DU.%2BH.%26aulast%3DAkimova%26aufirst%3DT.%26aulast%3DBhatti%26aufirst%3DT.%2BR.%26aulast%3DNicholson%26aufirst%3DB.%26aulast%3DKodrasov%26aufirst%3DM.%2BP.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DSterner%26aufirst%3DD.%2BE.%26aulast%3DGu%26aufirst%3DW.%26aulast%3DWeinstock%26aufirst%3DJ.%26aulast%3DButt%26aufirst%3DT.%2BR.%26aulast%3DAlbelda%26aufirst%3DS.%2BM.%26aulast%3DHancock%26aufirst%3DW.%2BW.%26atitle%3DUbiquitin-specific%2520protease-7%2520inhibition%2520impairs%2520Tip60-dependent%2520Foxp3%252B%2520T-regulatory%2520cell%2520function%2520and%2520promotes%2520antitumor%2520immunity%26jtitle%3DEBioMedicine%26date%3D2016%26volume%3D13%26spage%3D99%26epage%3D112%26doi%3D10.1016%2Fj.ebiom.2016.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwickart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrando, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâRourke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastham-Anderson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dornan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>463</i></span> (<span class="NLM_issue">7277</span>),  <span class="NLM_fpage">103</span>â <span class="NLM_lpage">107</span>, <span class="refDoi">Â DOI: 10.1038/nature08646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature08646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=20023629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFyhsLjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2010&pages=103-107&issue=7277&author=M.+Schwickartauthor=X.+Huangauthor=J.+R.+Lillauthor=J.+Liuauthor=R.+Ferrandoauthor=D.+M.+Frenchauthor=H.+Maeckerauthor=K.+O%E2%80%99Rourkeauthor=F.+Bazanauthor=J.+Eastham-Andersonauthor=P.+Yueauthor=D.+Dornanauthor=D.+C.+S.+Huangauthor=V.+M.+Dixit&title=Deubiquitinase+USP9X+stabilizes+MCL1+and+promotes+tumour+cell+survival&doi=10.1038%2Fnature08646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival</span></div><div class="casAuthors">Schwickart, Martin; Huang, Xiao-Dong; Lill, Jennie R.; Liu, Jin-Feng; Ferrando, Ronald; French, Dorothy M.; Maecker, Heather; O'Rourke, Karen; Bazan, Fernando; Eastham-Anderson, Jeffrey; Yue, Peng; Dornan, David; Huang, David C. S.; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">7277</span>),
    <span class="NLM_cas:pages">103-107</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">MCL1 is essential for the survival of stem and progenitor cells of multiple lineages, and is unique among pro-survival BCL2 family members in that it is rapidly turned over through the action of ubiquitin ligases.  B- and mantle-cell lymphomas, chronic myeloid leukemia, and multiple myeloma, however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse.  The mechanism of MCL1 overexpression in cancer is not well understood.  Here we show that the deubiquitinase USP9X stabilizes MCL1 and thereby promotes cell survival.  USP9X binds MCL1 and removes the Lys 48-linked polyubiquitin chains that normally mark MCL1 for proteasomal degrdn.  Increased USP9X expression correlates with increased MCL1 protein in human follicular lymphomas and diffuse large B-cell lymphomas.  Moreover, patients with multiple myeloma overexpressing USP9X have a poor prognosis.  Knockdown of USP9X increases MCL1 polyubiquitination, which enhances MCL1 turnover and cell killing by the BH3 mimetic ABT-737.  These results identify USP9X as a prognostic and therapeutic target, and they show that deubiquitinases may stabilize labile oncoproteins in human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4tfGDFZ1t4bVg90H21EOLACvtfcHk0ljGK8LmyUV6CA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFyhsLjI&md5=91325333f1228d292175c0ff0a547784</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1038%2Fnature08646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08646%26sid%3Dliteratum%253Aachs%26aulast%3DSchwickart%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLill%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFerrando%26aufirst%3DR.%26aulast%3DFrench%26aufirst%3DD.%2BM.%26aulast%3DMaecker%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DK.%26aulast%3DBazan%26aufirst%3DF.%26aulast%3DEastham-Anderson%26aufirst%3DJ.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DDornan%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DDeubiquitinase%2520USP9X%2520stabilizes%2520MCL1%2520and%2520promotes%2520tumour%2520cell%2520survival%26jtitle%3DNature%26date%3D2010%26volume%3D463%26issue%3D7277%26spage%3D103%26epage%3D107%26doi%3D10.1038%2Fnature08646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordenonsi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montagner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacchigna, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adorno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinchfield, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soligo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morsut, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modena, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argenton, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newfeld, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccolo, S.</span></span> <span> </span><span class="NLM_article-title">FAM/USP9X, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">123</span>â <span class="NLM_lpage">135</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2008.10.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.cell.2008.10.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19135894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOitr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2009&pages=123-135&issue=1&author=S.+Dupontauthor=A.+Mamidiauthor=M.+Cordenonsiauthor=M.+Montagnerauthor=L.+Zacchignaauthor=M.+Adornoauthor=G.+Martelloauthor=M.+J.+Stinchfieldauthor=S.+Soligoauthor=L.+Morsutauthor=M.+Inuiauthor=S.+Moroauthor=N.+Modenaauthor=F.+Argentonauthor=S.+J.+Newfeldauthor=S.+Piccolo&title=FAM%2FUSP9X%2C+a+deubiquitinating+enzyme+essential+for+TGFbeta+signaling%2C+controls+Smad4+monoubiquitination&doi=10.1016%2Fj.cell.2008.10.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">FAM/USP9x, a deubiquitinating enzyme essential for TGFÎ² signaling, controls Smad4 monoubiquitination</span></div><div class="casAuthors">Dupont, Sirio; Mamidi, Anant; Cordenonsi, Michelangelo; Montagner, Marco; Zacchigna, Luca; Adorno, Maddalena; Martello, Graziano; Stinchfield, Michael J.; Soligo, Sandra; Morsut, Leonardo; Inui, Masafumi; Moro, Stefano; Modena, Nicola; Argenton, Francesco; Newfeld, Stuart J.; Piccolo, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123-135</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The assembly of the Smad complex is crit. for TGFÎ² signaling, yet the mechanisms that inactivate or empower nuclear Smad complexes are less understood.  By means of siRNA screen we identified FAM (USP9x), a deubiquitinase acting as essential and evolutionarily conserved component in TGFÎ² and bone morphogenetic protein signaling.  Smad4 is monoubiquitinated in lysine 519 in vivo, a modification that inhibits Smad4 by impeding assocn. with phospho-Smad2.  FAM reverts this neg. modification, re-empowering Smad4 function.  FAM opposes the activity of Ectodermin/Tif1Î³ (Ecto), a nuclear factor for which we now clarify a prominent role as Smad4 monoubiquitin ligase.  Our study points to Smad4 monoubiquitination and deubiquitination as a way for cell to set their TGFÎ² responsiveness: loss of FAM disables Smad4-dependent responses in several model systems, with Ecto being epistatic to FAM.  This defines a regulative ubiquitination step controlling Smads that is parallel to those impinging on R-Smad phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohzmE0e5YUx7Vg90H21EOLACvtfcHk0ljGK8LmyUV6CA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOitr4%253D&md5=4e673ea1b509246126f3d22e24835956</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2008.10.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2008.10.051%26sid%3Dliteratum%253Aachs%26aulast%3DDupont%26aufirst%3DS.%26aulast%3DMamidi%26aufirst%3DA.%26aulast%3DCordenonsi%26aufirst%3DM.%26aulast%3DMontagner%26aufirst%3DM.%26aulast%3DZacchigna%26aufirst%3DL.%26aulast%3DAdorno%26aufirst%3DM.%26aulast%3DMartello%26aufirst%3DG.%26aulast%3DStinchfield%26aufirst%3DM.%2BJ.%26aulast%3DSoligo%26aufirst%3DS.%26aulast%3DMorsut%26aufirst%3DL.%26aulast%3DInui%26aufirst%3DM.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DModena%26aufirst%3DN.%26aulast%3DArgenton%26aufirst%3DF.%26aulast%3DNewfeld%26aufirst%3DS.%2BJ.%26aulast%3DPiccolo%26aufirst%3DS.%26atitle%3DFAM%252FUSP9X%252C%2520a%2520deubiquitinating%2520enzyme%2520essential%2520for%2520TGFbeta%2520signaling%252C%2520controls%2520Smad4%2520monoubiquitination%26jtitle%3DCell%26date%3D2009%26volume%3D136%26issue%3D1%26spage%3D123%26epage%3D135%26doi%3D10.1016%2Fj.cell.2008.10.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.-s.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-C.</span></span> <span> </span><span class="NLM_article-title">Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">9433</span>â <span class="NLM_lpage">9438</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1221925110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.1221925110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23690623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFGrtrjL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=9433-9438&issue=23&author=Y.+Parkauthor=H.-s.+Jinauthor=Y.-C.+Liu&title=Regulation+of+T+cell+function+by+the+ubiquitin-specific+protease+USP9X+via+modulating+the+Carma1-Bcl10-Malt1+complex&doi=10.1073%2Fpnas.1221925110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex</span></div><div class="casAuthors">Park, Yoon; Jin, Hyung-seung; Liu, Yun-Cai</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9433-9438, S9433/1-S9433/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The ubiquitin conjugation system plays an important role in immune regulation; however, the ubiquitin-specific proteases (USPs) that carry out deubiquitination of cellular substrates are poorly understood.  Here the authors show that in vivo knockdown of the deubiquitinating enzyme USP9X attenuates T-cell proliferation.  In addn., naive CD4+ T cells from USP9X knockdown chimeric mice display decreased cytokine prodn. and T helper cell differentiation in vitro, which the authors confirmed in vivo by performing adoptive transfer of transgenic T cells and subsequent immunization.  USP9X silencing in both a human T-cell line and mouse primary T cells reduced T-cell receptor (TCR) signaling-induced NF-ÎºB activation.  Mechanistically, USP9X interacts with Bcl10 of the Carma1-Bcl10-Malt1 (CBM) complex and removes the TCR-induced ubiquitin chain from Bcl10, which facilitates the assocn. of Carma1 with Bcl0-Malt1.  These results demonstrate that USP9X is a crucial pos. regulator of the TCR signaling pathway and is required for T-cell function through the modulation of CBM complex formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRgm1qmFGuv7Vg90H21EOLACvtfcHk0lil2mpUx9adIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFGrtrjL&md5=a31e6fec0dc653eb7fa3ccb6119f312a</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1221925110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1221925110%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DH.-s.%26aulast%3DLiu%26aufirst%3DY.-C.%26atitle%3DRegulation%2520of%2520T%2520cell%2520function%2520by%2520the%2520ubiquitin-specific%2520protease%2520USP9X%2520via%2520modulating%2520the%2520Carma1-Bcl10-Malt1%2520complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D23%26spage%3D9433%26epage%3D9438%26doi%3D10.1073%2Fpnas.1221925110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suriben, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>211</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1947</span>â <span class="NLM_lpage">1955</span>, <span class="refDoi">Â DOI: 10.1084/jem.20140860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1084%2Fjem.20140860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25200027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CgtbbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2014&pages=1947-1955&issue=10&author=E.+Naikauthor=J.+D.+Websterauthor=J.+DeVossauthor=J.+Liuauthor=R.+Suribenauthor=V.+M.+Dixit&title=Regulation+of+proximal+T+cell+receptor+signaling+and+tolerance+induction+by+deubiquitinase+Usp9X&doi=10.1084%2Fjem.20140860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X</span></div><div class="casAuthors">Naik, Edwina; Webster, Joshua D.; DeVoss, Jason; Liu, Jinfeng; Suriben, Rowena; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1947-1955</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The T cell hyperproliferation and autoimmune phenotypes that manifest in mice lacking E3 ubiquitin ligases such as Cbl, ITCH, or GRAIL highlight the importance of ubiquitination for the maintenance of peripheral T cell tolerance.  Less is known, however, about the deubiquitinating enzymes that regulate T cell proliferation and effector function.  Here, we define a cell intrinsic role for the deubiquitinase Usp9X during proximal TCR signaling.  Usp9X-deficient T cells were hypoproliferative, yet mice with T cell-specific Usp9x deletion had elevated nos. of antigen-experienced T cells and expanded PD-1 and OX40-expressing populations consistent with immune hyperactivity.  Aged Usp9x KO mice developed lupus-like autoimmunity and lymphoproliferative disease, indicating that ubiquitin ligases and deubiquitinases maintain the delicate balance between effective immunity and self-tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp97o7GFRJV6LVg90H21EOLACvtfcHk0lil2mpUx9adIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CgtbbI&md5=80616d80fbc85dc8868eb676cbd801d1</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1084%2Fjem.20140860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20140860%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DE.%26aulast%3DWebster%26aufirst%3DJ.%2BD.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DSuriben%26aufirst%3DR.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DRegulation%2520of%2520proximal%2520T%2520cell%2520receptor%2520signaling%2520and%2520tolerance%2520induction%2520by%2520deubiquitinase%2520Usp9X%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2014%26volume%3D211%26issue%3D10%26spage%3D1947%26epage%3D1955%26doi%3D10.1084%2Fjem.20140860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddle, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, C. P.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the specificity of ubiquitin C-terminal hydrolases</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3877</span>â <span class="NLM_lpage">3887</span>, <span class="refDoi">Â DOI: 10.1093/emboj/18.14.3877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1093%2Femboj%2F18.14.3877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10406793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1MXkvV2isr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=3877-3887&issue=14&author=S.+C.+Johnstonauthor=S.+M.+Riddleauthor=R.+E.+Cohenauthor=C.+P.+Hill&title=Structural+basis+for+the+specificity+of+ubiquitin+C-terminal+hydrolases&doi=10.1093%2Femboj%2F18.14.3877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the specificity of ubiquitin C-terminal hydrolases</span></div><div class="casAuthors">Johnston, Steven C.; Riddle, Steven M.; Cohen, Robert E.; Hill, Christopher P.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3877-3887</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The release of ubiquitin from attachment to other proteins and adducts is crit. for ubiquitin biosynthesis, proteasomal degrdn., and other cellular processes.  De-ubiquitination is accomplished in part by members of the UCH (ubiquitin C-terminal hydrolase) family of enzymes.  Here, the authors detd. the 2.25 Ã resoln. crystal structure of the yeast UCH, Yuh1, in complex with the inhibitor, ubiquitin aldehyde (Ubal).  The structure mimicked the tetrahedral intermediate in the reaction pathway and explained the very high enzyme specificity.  Comparison with a related, unliganded UCH structure indicated that ubiquitin binding is coupled to rearrangements which block the active site cleft in the absence of authentic substrate.  Remarkably, a 21-residue loop that becomes ordered upon binding Ubal lies directly over the active site.  Efficiently processed substrates apparently pass through this loop, and constraints on the loop conformation probably function to control UCH specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM8eDBio4XerVg90H21EOLACvtfcHk0lil2mpUx9adIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvV2isr4%253D&md5=a1acd1d31c9385dff94ea080faac4307</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F18.14.3877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F18.14.3877%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DS.%2BC.%26aulast%3DRiddle%26aufirst%3DS.%2BM.%26aulast%3DCohen%26aufirst%3DR.%2BE.%26aulast%3DHill%26aufirst%3DC.%2BP.%26atitle%3DStructural%2520basis%2520for%2520the%2520specificity%2520of%2520ubiquitin%2520C-terminal%2520hydrolases%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26issue%3D14%26spage%3D3877%26epage%3D3887%26doi%3D10.1093%2Femboj%2F18.14.3877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Usp9X is required for lymphocyte activation and homeostasis through Its control of ZAP70 ubiquitination and PKCÎ² kinase activity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>196</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3438</span>â <span class="NLM_lpage">3451</span>, <span class="refDoi">Â DOI: 10.4049/jimmunol.1403165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4049%2Fjimmunol.1403165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26936881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlSks70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2016&pages=3438-3451&issue=8&author=E.+Naikauthor=V.+M.+Dixit&title=Usp9X+is+required+for+lymphocyte+activation+and+homeostasis+through+Its+control+of+ZAP70+ubiquitination+and+PKC%CE%B2+kinase+activity&doi=10.4049%2Fjimmunol.1403165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Usp9X Is Required for Lymphocyte Activation and Homeostasis through Its Control of ZAP70 Ubiquitination and PKCÎ² Kinase Activity</span></div><div class="casAuthors">Naik, Edwina; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3438-3451</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">To achieve a durable adaptive immune response, lymphocytes must undergo clonal expansion and induce a survival program that enables the persistence of Ag-experienced cells and the development of memory.  During the priming phase of this response, CD4+ T lymphocytes either remain tolerized or undergo clonal expansion.  In this article, we show that Usp9X functions as a pos. regulatory switch during T lymphocyte priming through removal of inhibitory monoubiquitination from ZAP70.  In the absence of Usp9X, an increased amt. of ZAP70 localized to early endosomes consistent with the role of monoubiquitin in endocytic sorting.  Usp9X becomes competent to deubiquitinate ZAP70 through TCR-dependent phosphorylation and enhancement of its catalytic activity and assocn. with the LAT signalosome.  In B lymphocytes, Usp9X is required for the induction of PKCÎ² kinase activity after BCR-dependent activation.  Accordingly, in Usp9X knockout B cells, there was a significant redn. in phospho-CARMA1 levels that resulted in reduced CARMA1/Bcl-10/MALT-1 complex formation and NF-ÎºB-dependent cell survival.  The pleiotropic effect of Usp9X during Ag-receptor signaling highlights its importance for the development of an effective and durable adaptive immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoedEATb8CHj7Vg90H21EOLACvtfcHk0lgwURc9nf3JoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlSks70%253D&md5=1ff7fa52f0b0792a6248812437711339</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1403165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1403165%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DE.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DUsp9X%2520is%2520required%2520for%2520lymphocyte%2520activation%2520and%2520homeostasis%2520through%2520Its%2520control%2520of%2520ZAP70%2520ubiquitination%2520and%2520PKC%25CE%25B2%2520kinase%2520activity%26jtitle%3DJ.%2520Immunol.%26date%3D2016%26volume%3D196%26issue%3D8%26spage%3D3438%26epage%3D3451%26doi%3D10.4049%2Fjimmunol.1403165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avvakumov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neculai, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neculai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vorobyov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beatty, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, P.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juang, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeqiraj, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karamboulas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allali-Hassani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicheri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durocher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raught, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidhu, S. S.</span></span> <span> </span><span class="NLM_article-title">A strategy for modulation of enzymes in the ubiquitin system</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>339</i></span> (<span class="NLM_issue">6119</span>),  <span class="NLM_fpage">590</span>, <span class="refDoi">Â DOI: 10.1126/science.1230161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fscience.1230161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23287719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFGrsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2013&pages=590&issue=6119&author=A.+Ernstauthor=G.+Avvakumovauthor=J.+Tongauthor=Y.+Fanauthor=Y.+Zhaoauthor=P.+Albertsauthor=A.+Persaudauthor=J.+R.+Walkerauthor=A.-M.+Neculaiauthor=D.+Neculaiauthor=A.+Vorobyovauthor=P.+Gargauthor=L.+Beattyauthor=P.-K.+Chanauthor=Y.-C.+Juangauthor=M.-C.+Landryauthor=C.+Yehauthor=E.+Zeqirajauthor=K.+Karamboulasauthor=A.+Allali-Hassaniauthor=M.+Vedadiauthor=M.+Tyersauthor=J.+Moffatauthor=F.+Sicheriauthor=L.+Pelletierauthor=D.+Durocherauthor=B.+Raughtauthor=D.+Rotinauthor=J.+Yangauthor=M.+F.+Moranauthor=S.+Dhe-Paganonauthor=S.+S.+Sidhu&title=A+strategy+for+modulation+of+enzymes+in+the+ubiquitin+system&doi=10.1126%2Fscience.1230161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">A Strategy for Modulation of Enzymes in the Ubiquitin System</span></div><div class="casAuthors">Ernst, Andreas; Avvakumov, George; Tong, Jiefei; Fan, Yihui; Zhao, Yanling; Alberts, Philipp; Persaud, Avinash; Walker, John R.; Neculai, Ana-Mirela; Neculai, Dante; Vorobyov, Andrew; Garg, Pankaj; Beatty, Linda; Chan, Pak-Kei; Juang, Yu-Chi; Landry, Marie-Claude; Yeh, Christina; Zeqiraj, Elton; Karamboulas, Konstantina; Allali-Hassani, Abdellah; Vedadi, Masoud; Tyers, Mike; Moffat, Jason; Sicheri, Frank; Pelletier, Laurence; Durocher, Daniel; Raught, Brian; Rotin, Daniela; Yang, Jianhua; Moran, Michael F.; Dhe-Paganon, Sirano; Sidhu, Sachdev S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6119</span>),
    <span class="NLM_cas:pages">590-595</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The ubiquitin system regulates virtually all aspects of cellular function.  We report a method to target the myriad enzymes that govern ubiquitination of protein substrates.  We used massively diverse combinatorial libraries of ubiquitin variants to develop inhibitors of four deubiquitinases (DUBs) and analyzed the DUB-inhibitor complexes with crystallog.  We extended the selection strategy to the ubiquitin conjugating (E2) and ubiquitin ligase (E3) enzymes and found that ubiquitin variants can also enhance enzyme activity.  Last, we showed that ubiquitin variants can bind selectively to ubiquitin-binding domains.  Ubiquitin variants exhibit selective function in cells and thus enable orthogonal modulation of specific enzymic steps in the ubiquitin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre6vaTys1e-bVg90H21EOLACvtfcHk0lgwURc9nf3JoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGrsrg%253D&md5=324619497ce06d01d9231570fdb06bec</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1126%2Fscience.1230161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1230161%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DA.%26aulast%3DAvvakumov%26aufirst%3DG.%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DAlberts%26aufirst%3DP.%26aulast%3DPersaud%26aufirst%3DA.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DNeculai%26aufirst%3DA.-M.%26aulast%3DNeculai%26aufirst%3DD.%26aulast%3DVorobyov%26aufirst%3DA.%26aulast%3DGarg%26aufirst%3DP.%26aulast%3DBeatty%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DP.-K.%26aulast%3DJuang%26aufirst%3DY.-C.%26aulast%3DLandry%26aufirst%3DM.-C.%26aulast%3DYeh%26aufirst%3DC.%26aulast%3DZeqiraj%26aufirst%3DE.%26aulast%3DKaramboulas%26aufirst%3DK.%26aulast%3DAllali-Hassani%26aufirst%3DA.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DTyers%26aufirst%3DM.%26aulast%3DMoffat%26aufirst%3DJ.%26aulast%3DSicheri%26aufirst%3DF.%26aulast%3DPelletier%26aufirst%3DL.%26aulast%3DDurocher%26aufirst%3DD.%26aulast%3DRaught%26aufirst%3DB.%26aulast%3DRotin%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMoran%26aufirst%3DM.%2BF.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DSidhu%26aufirst%3DS.%2BS.%26atitle%3DA%2520strategy%2520for%2520modulation%2520of%2520enzymes%2520in%2520the%2520ubiquitin%2520system%26jtitle%3DScience%26date%3D2013%26volume%3D339%26issue%3D6119%26spage%3D590%26doi%3D10.1126%2Fscience.1230161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gjonaj, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapmaz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flierman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, G. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Veelen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovaa, H.</span></span> <span> </span><span class="NLM_article-title">Development of a DUB-selective fluorogenic substrate</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">10290</span>â <span class="NLM_lpage">10296</span>, <span class="refDoi">Â DOI: 10.1039/C9SC02226K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1039%2FC9SC02226K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32110315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVOhs7jJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=10290-10296&issue=44&author=L.+Gjonajauthor=A.+Sapmazauthor=D.+Fliermanauthor=G.+M.+C.+Janssenauthor=P.+A.+van+Veelenauthor=H.+Ovaa&title=Development+of+a+DUB-selective+fluorogenic+substrate&doi=10.1039%2FC9SC02226K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a DUB-selective fluorogenic substrate</span></div><div class="casAuthors">Gjonaj, Lorina; Sapmaz, Aysegul; Flierman, Dennis; Janssen, George M. C.; van Veelen, Peter A.; Ovaa, Huib</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">10290-10296</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Ubiquitination is a post-translational modification that is involved in a plethora of cellular processes.  Target proteins can be specifically modified with a single ubiquitin (Ub) mol. or with complex chains.  In recent years, research has focused on deubiquitinating enzymes (DUBs) as potential therapeutic candidates in various diseases.  USP16 is an emerging target due to its involvement in mitosis and stem cell self-renewal.  Generally, activity-based probes (ABPs) used to study DUBs are based on the ubiquitin scaffold, thus lacking target selectivity.  To overcome this issue, we designed a Ub-based activity probe bearing specific mutations to achieve selectivity for USP16, by combining structural modeling and anal. and mutational calcn. predictions.  We develop a fluorogenic substrate, the first of its kind, that is processed exclusively by USP16, which allows us to monitor USP16 activity in complex samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMnLMnBzhM37Vg90H21EOLACvtfcHk0lgwURc9nf3JoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVOhs7jJ&md5=c968414e3c92e22140ce8713f9e7f443</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1039%2FC9SC02226K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9SC02226K%26sid%3Dliteratum%253Aachs%26aulast%3DGjonaj%26aufirst%3DL.%26aulast%3DSapmaz%26aufirst%3DA.%26aulast%3DFlierman%26aufirst%3DD.%26aulast%3DJanssen%26aufirst%3DG.%2BM.%2BC.%26aulast%3Dvan%2BVeelen%26aufirst%3DP.%2BA.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DDevelopment%2520of%2520a%2520DUB-selective%2520fluorogenic%2520substrate%26jtitle%3DChem.%2520Sci.%26date%3D2019%26volume%3D10%26issue%3D44%26spage%3D10290%26epage%3D10296%26doi%3D10.1039%2FC9SC02226K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krabill, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, D. P.</span></span> <span> </span><span class="NLM_article-title">Development of ubiquitin variants with selectivity for ubiquitin C-terminal hydrolase deubiquitinases</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">3447</span>â <span class="NLM_lpage">3462</span>, <span class="refDoi">Â DOI: 10.1021/acs.biochem.9b01076</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.9b01076" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs12rtrjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2020&pages=3447-3462&issue=37&author=C.+S.+Hewittauthor=A.+D.+Krabillauthor=C.+Dasauthor=D.+P.+Flaherty&title=Development+of+ubiquitin+variants+with+selectivity+for+ubiquitin+C-terminal+hydrolase+deubiquitinases&doi=10.1021%2Facs.biochem.9b01076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Ubiquitin Variants with Selectivity for Ubiquitin C-Terminal Hydrolase Deubiquitinases</span></div><div class="casAuthors">Hewitt, Chad S.; Krabill, Aaron D.; Das, Chittaranjan; Flaherty, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">3447-3462</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ubiquitin (Ub) is a highly conserved protein that is covalently attached to substrate proteins as a post-translational modification to regulate signaling pathways such as proteasomal degrdn. and cell cycle/transcriptional regulation in the eukaryotic cellular environment.  Ub signaling is regulated by the homeostasis of substrate protein ubiquitination/deubiquitination by E3 ligases and deubiquitinating enzymes (DUBs) in healthy eukaryotic systems.  One such DUB, ubiquitin C-terminal hydrolase L1 (UCHL1), is endogenously expressed in the central nervous system under normal physiol. conditions, but overexpression and/or mutation was linked to various cancers and neurodegenerative diseases.  The lack of UCHL1 probing strategies suggests development of a selective Ub variant (UbV) for probing UCHL1's role in these disease states would be beneficial.  The authors describe a computational design approach to study UbVs that lend selectivity, both binding and inhibition, to UCHL1 over the close structural homolog UCHL3 and members of other DUB families.  A no. of UbVs, mainly those contg. Thr9 mutations, displayed appreciable binding and inhibition selectivity for UCHL1 over UCHL3, compared to wild-type Ub in in vitro assays.  By appending reactive electrophiles to the C-terminus of the UbVs, the authors created the first activity-based probe (ABP) with demonstrated reaction selectivity for UCH family DUBs over other families in cell lysates.  Further kinetic anal. of covalent inhibition by the UbV-ABP with UCHL1 and UCHL3 offers insight into the future design of UCHL1 selective UbV-ABP.  These studies serve as a proof of concept of the viability of the in silico design of ubiquitin variants for UCH family DUBs as a step toward the development of macromol. UCHL1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcs2rfAjxKIbVg90H21EOLACvtfcHk0lh6c4T2heP2Pg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs12rtrjI&md5=c406c6397a76bef7bc8527e75b225196</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.9b01076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.9b01076%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DC.%2BS.%26aulast%3DKrabill%26aufirst%3DA.%2BD.%26aulast%3DDas%26aufirst%3DC.%26aulast%3DFlaherty%26aufirst%3DD.%2BP.%26atitle%3DDevelopment%2520of%2520ubiquitin%2520variants%2520with%2520selectivity%2520for%2520ubiquitin%2520C-terminal%2520hydrolase%2520deubiquitinases%26jtitle%3DBiochemistry%26date%3D2020%26volume%3D59%26issue%3D37%26spage%3D3447%26epage%3D3462%26doi%3D10.1021%2Facs.biochem.9b01076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rut, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zmudzinski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">6058</span>â <span class="NLM_lpage">6069</span>, <span class="refDoi">Â DOI: 10.1039/D0SC01347A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1039%2FD0SC01347A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32953009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVyqurbF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=6058-6069&issue=23&author=W.+Rutauthor=M.+Zmudzinskiauthor=S.+J.+Snipasauthor=M.+Bekesauthor=T.+T.+Huangauthor=M.+Drag&title=Engineered+unnatural+ubiquitin+for+optimal+detection+of+deubiquitinating+enzymes&doi=10.1039%2FD0SC01347A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes</span></div><div class="casAuthors">Rut, Wioletta; Zmudzinski, Mikolaj; Snipas, Scott J.; Bekes, Miklos; Huang, Tony T.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6058-6069</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Deubiquitinating enzymes (DUBs) are responsible for removing ubiquitin (Ub) from its protein conjugates.  DUBs have been implicated as attractive therapeutic targets in the treatment of viral diseases, neurodegenerative disorders and cancer.  The lack of selective chem. tools for the exploration of these enzymes significantly impairs the detn. of their roles in both normal and pathol. states.  Com. available fluorogenic substrates are based on the C-terminal Ub motif or contain Ub coupled to a fluorophore (Z-LRGG-AMC, Ub-AMC); therefore, these substrates suffer from lack of selectivity.  By using a hybrid combinatorial substrate library (HyCoSuL) and a defined P2 library contg. a wide variety of nonproteinogenic amino acids, we established a full substrate specificity profile for two DUBs-MERS PLpro and human UCH-L3.  Based on these results, we designed and synthesized Ub-based substrates and activity-based probes (ABPs) contg. selected unnatural amino acids located in the C-terminal Ub motif.  Biochem. anal. and cell lysate expts. confirmed the activity and selectivity of engineered Ub-based substrates and probes.  Using this approach, we propose that for any protease that recognizes Ub and Ub-like substrates, a highly active and selective unnatural substrate or probe can be engineered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpapO-SAzjnX7Vg90H21EOLACvtfcHk0lh6c4T2heP2Pg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVyqurbF&md5=258c80b12a833f5ab367591376b61561</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1039%2FD0SC01347A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0SC01347A%26sid%3Dliteratum%253Aachs%26aulast%3DRut%26aufirst%3DW.%26aulast%3DZmudzinski%26aufirst%3DM.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DBekes%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DT.%2BT.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DEngineered%2520unnatural%2520ubiquitin%2520for%2520optimal%2520detection%2520of%2520deubiquitinating%2520enzymes%26jtitle%3DChem.%2520Sci.%26date%3D2020%26volume%3D11%26issue%3D23%26spage%3D6058%26epage%3D6069%26doi%3D10.1039%2FD0SC01347A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLellan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlock, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knights, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacq, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Quantitative chemical proteomic profiling of ubiquitin specific proteases in intact cancer cells</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3268</span>â <span class="NLM_lpage">3272</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.6b00766</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00766" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSns7nP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=3268-3272&issue=12&author=J.+A.+Wardauthor=L.+McLellanauthor=M.+Stockleyauthor=K.+R.+Gibsonauthor=G.+A.+Whitlockauthor=C.+Knightsauthor=J.+A.+Harriganauthor=X.+Jacqauthor=E.+W.+Tate&title=Quantitative+chemical+proteomic+profiling+of+ubiquitin+specific+proteases+in+intact+cancer+cells&doi=10.1021%2Facschembio.6b00766"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative Chemical Proteomic Profiling of Ubiquitin Specific Proteases in Intact Cancer Cells</span></div><div class="casAuthors">Ward, Jennifer A.; McLellan, Lauren; Stockley, Martin; Gibson, Karl R.; Whitlock, Gavin A.; Knights, Charlotte; Harrigan, Jeanine A.; Jacq, Xavier; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3268-3272</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Deubiquitinating enzymes play an important role in a plethora of therapeutically relevant processes and are emerging as pioneering drug targets.  Herein, we present a novel probe, Ubiquitin Specific Protease (USP) inhibitor, alongside an alkyne-tagged activity-based probe analog.  Activity-based proteome profiling identified 12 USPs, including USP4, USP16, and USP33, as inhibitor targets using submicromolar probe concns.  This represents the first intact cell activity-based profiling of deubiquitinating enzymes.  Further anal. demonstrated functional inhibition of USP33 and identified a synergistic relationship in combination with ATR inhibition, consistent with USP4 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM5PZxNI8jCrVg90H21EOLACvtfcHk0lh6c4T2heP2Pg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSns7nP&md5=e77ba0b52c64b76d7e9fbf30a73808f4</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00766%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DJ.%2BA.%26aulast%3DMcLellan%26aufirst%3DL.%26aulast%3DStockley%26aufirst%3DM.%26aulast%3DGibson%26aufirst%3DK.%2BR.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26aulast%3DKnights%26aufirst%3DC.%26aulast%3DHarrigan%26aufirst%3DJ.%2BA.%26aulast%3DJacq%26aufirst%3DX.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DQuantitative%2520chemical%2520proteomic%2520profiling%2520of%2520ubiquitin%2520specific%2520proteases%2520in%2520intact%2520cancer%2520cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26issue%3D12%26spage%3D3268%26epage%3D3272%26doi%3D10.1021%2Facschembio.6b00766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reverdy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planquette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atmanene, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collura, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harpon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battaglia, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colland, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">467</span>â <span class="NLM_lpage">477</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2012.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2012.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22520753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFyruro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=467-477&issue=4&author=C.+Reverdyauthor=S.+Conrathauthor=R.+Lopezauthor=C.+Planquetteauthor=C.+Atmaneneauthor=V.+Colluraauthor=J.+Harponauthor=V.+Battagliaauthor=V.+Vivatauthor=W.+Sipplauthor=F.+Colland&title=Discovery+of+specific+inhibitors+of+human+USP7%2FHAUSP+deubiquitinating+enzyme&doi=10.1016%2Fj.chembiol.2012.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Specific Inhibitors of Human USP7/HAUSP Deubiquitinating Enzyme</span></div><div class="casAuthors">Reverdy, Celine; Conrath, Susan; Lopez, Roman; Planquette, Cecile; Atmanene, Cedric; Collura, Vincent; Harpon, Jane; Battaglia, Veronique; Vivat, Valerie; Sippl, Wolfgang; Colland, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">467-477</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The human USP7 deubiquitinating enzyme was shown to regulate many proteins involved in the cell cycle, as well as tumor suppressors and oncogenes.  Thus, USP7 offers a promising, strategic target for cancer therapy.  Using biochem. assays and activity-based protein profiling in living systems, we identified small-mol. antagonists of USP7 and demonstrated USP7 inhibitor occupancy and selectivity in cancer cell lines.  These compds. bind USP7 in the active site through a covalent mechanism.  In cancer cells, these active-site-targeting inhibitors were shown to regulate the level of several USP7 substrates and thus recapitulated the USP7 knockdown phenotype that leads to G1 arrest in colon cancer cells.  The data presented in this report provide proof of principle that USP7 inhibitors may be a valuable therapeutic for cancer.  In addn., the discovery of such mols. offers interesting tools for studying deubiquitination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt0GVteDWstbVg90H21EOLACvtfcHk0li8pVe7QJLRFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFyruro%253D&md5=f5e3497c9893342571e3c97ae85d1361</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DReverdy%26aufirst%3DC.%26aulast%3DConrath%26aufirst%3DS.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DPlanquette%26aufirst%3DC.%26aulast%3DAtmanene%26aufirst%3DC.%26aulast%3DCollura%26aufirst%3DV.%26aulast%3DHarpon%26aufirst%3DJ.%26aulast%3DBattaglia%26aufirst%3DV.%26aulast%3DVivat%26aufirst%3DV.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DColland%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520specific%2520inhibitors%2520of%2520human%2520USP7%252FHAUSP%2520deubiquitinating%2520enzyme%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26issue%3D4%26spage%3D467%26epage%3D477%26doi%3D10.1016%2Fj.chembiol.2012.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schardon, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Er, J. A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swartzel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fast, W.</span></span> <span> </span><span class="NLM_article-title">Selective covalent protein modification by 4-halopyridines through catalysis</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">1551</span>â <span class="NLM_lpage">1556</span>, <span class="refDoi">Â DOI: 10.1002/cbic.201700104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fcbic.201700104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=28470883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKhsbrE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1551-1556&issue=15&author=C.+L.+Schardonauthor=A.+Tuleyauthor=J.+A.+V.+Erauthor=J.+C.+Swartzelauthor=W.+Fast&title=Selective+covalent+protein+modification+by+4-halopyridines+through+catalysis&doi=10.1002%2Fcbic.201700104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Covalent Protein Modification by 4-Halopyridines through Catalysis</span></div><div class="casAuthors">Schardon, Christopher L.; Tuley, Alfred; Er, Joyce A. V.; Swartzel, Jake C.; Fast, Walter</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1551-1556</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have investigated 4-halopyridines as selective, tunable, and switchable covalent protein modifiers for use in the development of chem. probes.  Nonenzymic reactivity of 4-chloropyridine with amino acids and thiols was ranked with respect to common covalent protein-modifying reagents and found to have reactivity similar to that of acrylamide, but could be switched to a reactivity similar to that of iodoacetamide upon stabilization of the pos. charged pyridinium.  Diverse, fragment-sized 4-halopyridines inactivated human dimethylarginine dimethylaminohydrolase-1 (DDAH1) through covalent modification of the active site cysteine, acting as quiescent affinity labels that required off-pathway catalysis through stabilization of the protonated pyridinium by a neighboring aspartate residue.  A series of 2-fluoromethyl-substituted 4-chloropyridines demonstrated that the pKa and kinact/KI values could be predictably varied over several orders of magnitude.  Covalent labeling of proteins in an Escherichia coli lysate was shown to require folded proteins, indicating that alternative proteins can be targeted, and modification is likely to be catalysisdependent. 4-Halopyridines, and quiescent affinity labels in general, represent an attractive strategy to develop reagents with switchable electrophilicity as selective covalent protein modifiers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquxK7slP-8o7Vg90H21EOLACvtfcHk0li8pVe7QJLRFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKhsbrE&md5=c71e0d7b061645a374919194678cab1a</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201700104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201700104%26sid%3Dliteratum%253Aachs%26aulast%3DSchardon%26aufirst%3DC.%2BL.%26aulast%3DTuley%26aufirst%3DA.%26aulast%3DEr%26aufirst%3DJ.%2BA.%2BV.%26aulast%3DSwartzel%26aufirst%3DJ.%2BC.%26aulast%3DFast%26aufirst%3DW.%26atitle%3DSelective%2520covalent%2520protein%2520modification%2520by%25204-halopyridines%2520through%2520catalysis%26jtitle%3DChemBioChem%26date%3D2017%26volume%3D18%26issue%3D15%26spage%3D1551%26epage%3D1556%26doi%3D10.1002%2Fcbic.201700104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shohet, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuchtern, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">10</span>), <span class="NLM_elocation-id">e867</span> <span class="refDoi">Â DOI: 10.1038/cddis.2013.400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fcddis.2013.400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24136231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Olu77J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&issue=10&author=Y.+H.+Fanauthor=J.+Chengauthor=S.+A.+Vasudevanauthor=J.+Douauthor=H.+Zhangauthor=R.+H.+Patelauthor=I.+T.+Maauthor=Y.+Rojasauthor=Y.+Zhaoauthor=Y.+Yuauthor=H.+Zhangauthor=J.+M.+Shohetauthor=J.+G.+Nuchternauthor=E.+S.+Kimauthor=J.+Yang&title=USP7+inhibitor+P22077+inhibits+neuroblastoma+growth+via+inducing+p53-mediated+apoptosis&doi=10.1038%2Fcddis.2013.400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis</span></div><div class="casAuthors">Fan, Y.-H.; Cheng, J.; Vasudevan, S. A.; Dou, J.; Zhang, H.; Patel, R. H.; Ma, I. T.; Rojas, Y.; Zhao, Y.; Yu, Y.; Zhang, H.; Shohet, J. M.; Nuchtern, J. G.; Kim, E. S.; Yang, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Oct.</span>),
    <span class="NLM_cas:pages">e867</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuroblastoma (NB) is a common pediatric cancer and contributes to more than 15% of all pediatric cancer-related deaths.  Unlike adult tumors, recurrent somatic mutations in NB, such as tumor protein 53 (p53) mutations, occur with relative paucity.  In addn., p53 downstream function is intact in NB cells with wild-type p53, suggesting that reactivation of p53 may be a viable therapeutic strategy for NB treatment.  Herein, we report that the ubiquitin-specific protease 7 (USP7) inhibitor, P22077, potently induces apoptosis in NB cells with an intact USP7-HDM2-p53 axis but not in NB cells with mutant p53 or without human homolog of MDM2 (HDM2) expression.  In this study, we found that P22077 stabilized p53 by inducing HDM2 protein degrdn. in NB cells.  P22077 also significantly augmented the cytotoxic effects of doxorubicin (Dox) and etoposide (VP-16) in NB cells with an intact USP7-HDM2-p53 axis.  Moreover, P22077 was found to be able to sensitize chemoresistant LA-N-6 NB cells to chemotherapy.  In an in vivo orthotopic NB mouse model, P22077 significantly inhibited the xenograft growth of three NB cell lines.  Database anal. of NB patients shows that high expression of USP7 significantly predicts poor outcomes.  Together, our data strongly suggest that targeting USP7 is a novel concept in the treatment of NB.  USP7-specific inhibitors like P22077 may serve not only as a stand-alone therapy but also as an effective adjunct to current chemotherapeutic regimens for treating NB with an intact USP7-HDM2-p53 axis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsoNqHcbJCuLVg90H21EOLACvtfcHk0lgWbuyRxQPurw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Olu77J&md5=cd91e66041a54477fe081914da560a22</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.400%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DY.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DVasudevan%26aufirst%3DS.%2BA.%26aulast%3DDou%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DPatel%26aufirst%3DR.%2BH.%26aulast%3DMa%26aufirst%3DI.%2BT.%26aulast%3DRojas%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DShohet%26aufirst%3DJ.%2BM.%26aulast%3DNuchtern%26aufirst%3DJ.%2BG.%26aulast%3DKim%26aufirst%3DE.%2BS.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DUSP7%2520inhibitor%2520P22077%2520inhibits%2520neuroblastoma%2520growth%2520via%2520inducing%2520p53-mediated%2520apoptosis%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26issue%3D10%26doi%3D10.1038%2Fcddis.2013.400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kingsbury, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodrasov, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKelvey, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh
Kumar, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenberg, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattern, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, B.</span></span> <span> </span><span class="NLM_article-title">Selective dual inhibitors of the cancer-related deubiquitylating proteases USP7 and USP47</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">789</span>â <span class="NLM_lpage">792</span>, <span class="refDoi">Â DOI: 10.1021/ml200276j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200276j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlekt7vF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=789-792&issue=10&author=J.+Weinstockauthor=J.+Wuauthor=P.+Caoauthor=W.+D.+Kingsburyauthor=J.+L.+McDermottauthor=M.+P.+Kodrasovauthor=D.+M.+McKelveyauthor=K.+G.+Suresh%0AKumarauthor=S.+J.+Goldenbergauthor=M.+R.+Matternauthor=B.+Nicholson&title=Selective+dual+inhibitors+of+the+cancer-related+deubiquitylating+proteases+USP7+and+USP47&doi=10.1021%2Fml200276j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47</span></div><div class="casAuthors">Weinstock, Joseph; Wu, Jian; Cao, Ping; Kingsbury, William D.; McDermott, Jeffrey L.; Kodrasov, Matthew P.; McKelvey, Devin M.; Suresh Kumar, K. G.; Goldenberg, Seth J.; Mattern, Michael R.; Nicholson, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">789-792</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the cancer-related cysteine isopeptidase human ubiquitin-specific proteases 7 (USP7) and 47 (USP47) are considered to have potential as cancer therapeutics, owing to their ability to stabilize the tumor suppressor p53 and to decrease DNA polymerase Î² (PolÎ²), both of which are potential anticancer effects.  A new class of dual small mol. inhibitors of these enzymes has been discovered.  Compd. 1 (I), a selective inhibitor of USP7 and USP47 with moderate potency, demonstrates inhibition of USP7 in cells and induces elevated p53 and apoptosis in cancer cell lines.  Compd. 1 has been shown to demonstrate modest activity in human xenograft multiple myeloma and B-cell leukemia in vivo models.  This activity may be the result of dual inhibition of USP7 and USP47.  To address issues regarding potency and developability, analogs of compd. 1 have been synthesized and tested, leading to improvements in potency, soly., and metabolic reactivity profile.  Further optimization is expected to yield preclin. candidates and, ultimately, clin. candidates for the treatment of multiple myeloma, prostate cancer, and other cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdgMcsqTMS-LVg90H21EOLACvtfcHk0lgWbuyRxQPurw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlekt7vF&md5=2f273cf8c501bc940ab60efb9f63f1a9</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Fml200276j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200276j%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstock%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DP.%26aulast%3DKingsbury%26aufirst%3DW.%2BD.%26aulast%3DMcDermott%26aufirst%3DJ.%2BL.%26aulast%3DKodrasov%26aufirst%3DM.%2BP.%26aulast%3DMcKelvey%26aufirst%3DD.%2BM.%26aulast%3DSuresh%2BKumar%26aufirst%3DK.%2BG.%26aulast%3DGoldenberg%26aufirst%3DS.%2BJ.%26aulast%3DMattern%26aufirst%3DM.%2BR.%26aulast%3DNicholson%26aufirst%3DB.%26atitle%3DSelective%2520dual%2520inhibitors%2520of%2520the%2520cancer-related%2520deubiquitylating%2520proteases%2520USP7%2520and%2520USP47%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26issue%3D10%26spage%3D789%26epage%3D792%26doi%3D10.1021%2Fml200276j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pozhidaeva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valles, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterner, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K. G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezsonova, I.</span></span> <span> </span><span class="NLM_article-title">USP7-specific inhibitors target and modify the enzymeâs active site via distinct chemical mechanisms</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1501</span>â <span class="NLM_lpage">1512</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2017.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2017.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29056420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yrt7nI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1501-1512&issue=12&author=A.+Pozhidaevaauthor=G.+Vallesauthor=F.+Wangauthor=J.+Wuauthor=D.+E.+Sternerauthor=P.+Nguyenauthor=J.+Weinstockauthor=K.+G.+S.+Kumarauthor=J.+Kanyoauthor=D.+Wrightauthor=I.+Bezsonova&title=USP7-specific+inhibitors+target+and+modify+the+enzyme%E2%80%99s+active+site+via+distinct+chemical+mechanisms&doi=10.1016%2Fj.chembiol.2017.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms</span></div><div class="casAuthors">Pozhidaeva, Alexandra; Valles, Gabrielle; Wang, Feng; Wu, Jian; Sterner, David E.; Nguyen, Phuong; Weinstock, Joseph; Kumar, K. G. Suresh; Kanyo, Jean; Wright, Dennis; Bezsonova, Irina</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1501-1512.e5</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">USP7 is a deubiquitinating enzyme that plays a pivotal role in multiple oncogenic pathways and therefore is a desirable target for new anti-cancer therapies.  However, the lack of structural information about the USP7-inhibitor interactions has been a crit. gap in the development of potent inhibitors.  USP7 is unique among USPs in that its active site is catalytically incompetent, and is postulated to rearrange into a productive conformation only upon binding to ubiquitin.  Surprisingly, we found that ubiquitin alone does not induce an active conformation in soln.  Using a combination of NMR, mass spectrometry, computational modeling, and cell-based assays, we found that DUB inhibitors P22077 and P50429 covalently modify the catalytic cysteine of USP7 and induce a conformational switch in the enzyme assocd. with active site rearrangement.  This work represents the first exptl. insights into USP7 activation and inhibition and provides a structural basis for rational development of potent anti-cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq6cfJxLOHFLVg90H21EOLACvtfcHk0lgWbuyRxQPurw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yrt7nI&md5=8d8baef989ebbfb010640b2ecfd95ae4</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DPozhidaeva%26aufirst%3DA.%26aulast%3DValles%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSterner%26aufirst%3DD.%2BE.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DWeinstock%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DK.%2BG.%2BS.%26aulast%3DKanyo%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DD.%26aulast%3DBezsonova%26aufirst%3DI.%26atitle%3DUSP7-specific%2520inhibitors%2520target%2520and%2520modify%2520the%2520enzyme%25E2%2580%2599s%2520active%2520site%2520via%2520distinct%2520chemical%2520mechanisms%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26issue%3D12%26spage%3D1501%26epage%3D1512%26doi%3D10.1016%2Fj.chembiol.2017.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto-Fernandez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heride, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, A. C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonkin, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buker, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancia, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravella, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toms, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahdenranta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Follows, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stead, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarayskiy, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckmelter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saab, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGouran, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Century, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gersch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynham, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simcox, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, L. M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLoughlin, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escobedo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammonds, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">UrbÃ©, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clague, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komander, D.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of USP7 inhibition by selective small-molecule inhibitors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>550</i></span> (<span class="NLM_issue">7677</span>),  <span class="NLM_fpage">481</span>â <span class="NLM_lpage">486</span>, <span class="refDoi">Â DOI: 10.1038/nature24451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnature24451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29045389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1OhtrnK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=550&publication_year=2017&pages=481-486&issue=7677&author=A.+P.+Turnbullauthor=S.+Ioannidisauthor=W.+W.+Krajewskiauthor=A.+Pinto-Fernandezauthor=C.+Herideauthor=A.+C.+L.+Martinauthor=L.+M.+Tonkinauthor=E.+C.+Townsendauthor=S.+M.+Bukerauthor=D.+R.+Lanciaauthor=J.+A.+Caravellaauthor=A.+V.+Tomsauthor=T.+M.+Charltonauthor=J.+Lahdenrantaauthor=E.+Wilkerauthor=B.+C.+Followsauthor=N.+J.+Evansauthor=L.+Steadauthor=C.+Alliauthor=V.+V.+Zarayskiyauthor=A.+C.+Talbotauthor=A.+J.+Buckmelterauthor=M.+Wangauthor=C.+L.+McKinnonauthor=F.+Saabauthor=J.+F.+McGouranauthor=H.+Centuryauthor=M.+Gerschauthor=M.+S.+Pittmanauthor=C.+G.+Marshallauthor=T.+M.+Raynhamauthor=M.+Simcoxauthor=L.+M.+D.+Stewartauthor=S.+B.+McLoughlinauthor=J.+A.+Escobedoauthor=K.+W.+Bairauthor=C.+J.+Dinsmoreauthor=T.+R.+Hammondsauthor=S.+Kimauthor=S.+Urb%C3%A9author=M.+J.+Clagueauthor=B.+M.+Kesslerauthor=D.+Komander&title=Molecular+basis+of+USP7+inhibition+by+selective+small-molecule+inhibitors&doi=10.1038%2Fnature24451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of USP7 inhibition by selective small-molecule inhibitors</span></div><div class="casAuthors">Turnbull, Andrew P.; Ioannidis, Stephanos; Krajewski, Wojciech W.; Pinto-Fernandez, Adan; Heride, Claire; Martin, Agnes C. L.; Tonkin, Louise M.; Townsend, Elizabeth C.; Buker, Shane M.; Lancia, David R.; Caravella, Justin A.; Toms, Angela V.; Charlton, Thomas M.; Lahdenranta, Johanna; Wilker, Erik; Follows, Bruce C.; Evans, Nicola J.; Stead, Lucy; Alli, Cristina; Zarayskiy, Vladislav V.; Talbot, Adam C.; Buckmelter, Alexandre J.; Wang, Minghua; McKinnon, Crystal L.; Saab, Fabienne; McGouran, Joanna F.; Century, Hannah; Gersch, Malte; Pittman, Marc S.; Marshall, C. Gary; Raynham, Tony M.; Simcox, Mary; Stewart, Lorna M. D.; McLoughlin, Sheila B.; Escobedo, Jaime A.; Bair, Kenneth W.; Dinsmore, Christopher J.; Hammonds, Tim R.; Kim, Sunkyu; Urbe, Sylvie; Clague, Michael J.; Kessler, Benedikt M.; Komander, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">550</span>
        (<span class="NLM_cas:issue">7677</span>),
    <span class="NLM_cas:pages">481-486</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Ubiquitination controls the stability of most cellular proteins, and its deregulation contributes to human diseases including cancer.  Deubiquitinases remove ubiquitin from proteins, and their inhibition can induce the degrdn. of selected proteins, potentially including otherwise 'undruggable' targets.  For example, the inhibition of ubiquitin-specific protease 7 (USP7) results in the degrdn. of the oncogenic E3 ligase MDM2, and leads to reactivation of the tumor suppressor p53 in various cancers.  Here the authors report that two compds., FT671 and FT827, inhibit USP7 with high affinity and specificity in vitro and within human cells.  Cocrystal structures reveal that both compds. target a dynamic pocket near the catalytic center of the auto-inhibited apo form of USP7, which differs from other USP deubiquitinases.  Consistent with USP7 target engagement in cells, FT671 destabilizes USP7 substrates including MDM2, increases levels of p53, and results in the transcription of p53 target genes, induction of the tumor suppressor p21, and inhibition of tumor growth in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR8apmCZU85rVg90H21EOLACvtfcHk0ljQ0yAk7X4VQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1OhtrnK&md5=166efb5b9de6304829c09fa3e4fb540a</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1038%2Fnature24451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature24451%26sid%3Dliteratum%253Aachs%26aulast%3DTurnbull%26aufirst%3DA.%2BP.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DKrajewski%26aufirst%3DW.%2BW.%26aulast%3DPinto-Fernandez%26aufirst%3DA.%26aulast%3DHeride%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DA.%2BC.%2BL.%26aulast%3DTonkin%26aufirst%3DL.%2BM.%26aulast%3DTownsend%26aufirst%3DE.%2BC.%26aulast%3DBuker%26aufirst%3DS.%2BM.%26aulast%3DLancia%26aufirst%3DD.%2BR.%26aulast%3DCaravella%26aufirst%3DJ.%2BA.%26aulast%3DToms%26aufirst%3DA.%2BV.%26aulast%3DCharlton%26aufirst%3DT.%2BM.%26aulast%3DLahdenranta%26aufirst%3DJ.%26aulast%3DWilker%26aufirst%3DE.%26aulast%3DFollows%26aufirst%3DB.%2BC.%26aulast%3DEvans%26aufirst%3DN.%2BJ.%26aulast%3DStead%26aufirst%3DL.%26aulast%3DAlli%26aufirst%3DC.%26aulast%3DZarayskiy%26aufirst%3DV.%2BV.%26aulast%3DTalbot%26aufirst%3DA.%2BC.%26aulast%3DBuckmelter%26aufirst%3DA.%2BJ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DMcKinnon%26aufirst%3DC.%2BL.%26aulast%3DSaab%26aufirst%3DF.%26aulast%3DMcGouran%26aufirst%3DJ.%2BF.%26aulast%3DCentury%26aufirst%3DH.%26aulast%3DGersch%26aufirst%3DM.%26aulast%3DPittman%26aufirst%3DM.%2BS.%26aulast%3DMarshall%26aufirst%3DC.%2BG.%26aulast%3DRaynham%26aufirst%3DT.%2BM.%26aulast%3DSimcox%26aufirst%3DM.%26aulast%3DStewart%26aufirst%3DL.%2BM.%2BD.%26aulast%3DMcLoughlin%26aufirst%3DS.%2BB.%26aulast%3DEscobedo%26aufirst%3DJ.%2BA.%26aulast%3DBair%26aufirst%3DK.%2BW.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DHammonds%26aufirst%3DT.%2BR.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DUrb%25C3%25A9%26aufirst%3DS.%26aulast%3DClague%26aufirst%3DM.%2BJ.%26aulast%3DKessler%26aufirst%3DB.%2BM.%26aulast%3DKomander%26aufirst%3DD.%26atitle%3DMolecular%2520basis%2520of%2520USP7%2520inhibition%2520by%2520selective%2520small-molecule%2520inhibitors%26jtitle%3DNature%26date%3D2017%26volume%3D550%26issue%3D7677%26spage%3D481%26epage%3D486%26doi%3D10.1038%2Fnature24451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schauer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magin, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficarro, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacob, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacomelli, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boswell, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisberg, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorger, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmaier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span> <span> </span><span class="NLM_article-title">Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">5324</span>, <span class="refDoi">Â DOI: 10.1038/s41598-020-62076-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41598-020-62076-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32210275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFGgtbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=5324&issue=1&author=N.+J.+Schauerauthor=X.+Liuauthor=R.+S.+Maginauthor=L.+M.+Dohertyauthor=W.+C.+Chanauthor=S.+B.+Ficarroauthor=W.+Huauthor=R.+M.+Robertsauthor=R.+E.+Iacobauthor=B.+Stolteauthor=A.+O.+Giacomelliauthor=S.+Pereraauthor=K.+McKayauthor=S.+A.+Boswellauthor=E.+L.+Weisbergauthor=A.+Rayauthor=D.+Chauhanauthor=S.+Dhe-Paganonauthor=K.+C.+Andersonauthor=J.+D.+Griffinauthor=J.+Liauthor=W.+C.+Hahnauthor=P.+K.+Sorgerauthor=J.+R.+Engenauthor=K.+Stegmaierauthor=J.+A.+Martoauthor=S.+J.+Buhrlage&title=Selective+USP7+inhibition+elicits+cancer+cell+killing+through+a+p53-dependent+mechanism&doi=10.1038%2Fs41598-020-62076-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism</span></div><div class="casAuthors">Schauer, Nathan J.; Liu, Xiaoxi; Magin, Robert S.; Doherty, Laura M.; Chan, Wai Cheung; Ficarro, Scott B.; Hu, Wanyi; Roberts, Rebekka M.; Iacob, Roxana E.; Stolte, Bjorn; Giacomelli, Andrew O.; Perera, Sumner; McKay, Kyle; Boswell, Sarah A.; Weisberg, Ellen L.; Ray, Arghya; Chauhan, Dharminder; Dhe-Paganon, Sirano; Anderson, Ken C.; Griffin, James D.; Li, Jianing; Hahn, William C.; Sorger, Peter K.; Engen, John R.; Stegmaier, Kimberly; Marto, Jarrod A.; Buhrlage, Sara J.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5324</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Ubiquitin specific peptidase 7 (USP7) is a deubiquitinating enzyme (DUB) that removes ubiquitin tags from specific protein substrates in order to alter their degrdn. rate and sub-cellular localization.  USP7 has been proposed as a therapeutic target in several cancers because it has many reported substrates with a role in cancer progression, including FOXO4, MDM2, N-Myc, and PTEN.  The multi-substrate nature of USP7, combined with the modest potency and selectivity of early generation USP7 inhibitors, has presented a challenge in defining predictors of response to USP7 and potential patient populations that would benefit most from USP7-targeted drugs.  Here, we describe the structure-guided development of XL177A, which irreversibly inhibits USP7 with sub-nM potency and selectivity across the human proteome.  Evaluation of the cellular effects of XL177A reveals that selective USP7 inhibition suppresses cancer cell growth predominantly through a p53-dependent mechanism: XL177A specifically upregulates p53 transcriptional targets transcriptome-wide, hotspot mutations in TP53 but not any other genes predict response to XL177A across a panel of ~ 500 cancer cell lines, and TP53 knockout rescues XL177A-mediated growth suppression of TP53 wild-type (WT) cells.  Together, these findings suggest TP53 mutational status as a biomarker for response to USP7 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGgnv2Qj2wn7Vg90H21EOLACvtfcHk0ljQ0yAk7X4VQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFGgtbo%253D&md5=bcb86b6713758ca9fb83b390c538267f</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-62076-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-62076-x%26sid%3Dliteratum%253Aachs%26aulast%3DSchauer%26aufirst%3DN.%2BJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMagin%26aufirst%3DR.%2BS.%26aulast%3DDoherty%26aufirst%3DL.%2BM.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DRoberts%26aufirst%3DR.%2BM.%26aulast%3DIacob%26aufirst%3DR.%2BE.%26aulast%3DStolte%26aufirst%3DB.%26aulast%3DGiacomelli%26aufirst%3DA.%2BO.%26aulast%3DPerera%26aufirst%3DS.%26aulast%3DMcKay%26aufirst%3DK.%26aulast%3DBoswell%26aufirst%3DS.%2BA.%26aulast%3DWeisberg%26aufirst%3DE.%2BL.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DSorger%26aufirst%3DP.%2BK.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DStegmaier%26aufirst%3DK.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26atitle%3DSelective%2520USP7%2520inhibition%2520elicits%2520cancer%2520cell%2520killing%2520through%2520a%2520p53-dependent%2520mechanism%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26issue%3D1%26spage%3D5324%26doi%3D10.1038%2Fs41598-020-62076-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapuria, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talpaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donato, N. J.</span></span> <span> </span><span class="NLM_article-title">Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">9265</span>â <span class="NLM_lpage">9276</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-10-1530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1158%2F0008-5472.CAN-10-1530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21045142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWmsLjM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=9265-9276&issue=22&author=V.+Kapuriaauthor=L.+F.+Petersonauthor=D.+Fangauthor=W.+G.+Bornmannauthor=M.+Talpazauthor=N.+J.+Donato&title=Deubiquitinase+inhibition+by+small-molecule+WP1130+triggers+aggresome+formation+and+tumor+cell+apoptosis&doi=10.1158%2F0008-5472.CAN-10-1530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Deubiquitinase Inhibition by Small-Molecule WP1130 Triggers Aggresome Formation and Tumor Cell Apoptosis</span></div><div class="casAuthors">Kapuria, Vaibhav; Peterson, Luke F.; Fang, Dexing; Bornmann, William G.; Talpaz, Moshe; Donato, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9265-9276</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Recent evidence suggests that several deubiquitinases (DUB) are overexpressed or activated in tumor cells and many contribute to the transformed phenotype.  Agents with DUB inhibitory activity may therefore have therapeutic value.  In this study, we describe the mechanism of action of WP1130, a small mol. derived from a compd. with Janus-activated kinase 2 (JAK2) kinase inhibitory activity.  WP1130 induces rapid accumulation of polyubiquitinated (K48/K63-linked) proteins into juxtanuclear aggresomes, without affecting 20S proteasome activity.  WP1130 acts as a partly selective DUB inhibitor, directly inhibiting DUB activity of USP9x, USP5, USP14, and UCH37, which are known to regulate survival protein stability and 26S proteasome function.  WP1130-mediated inhibition of tumor-activated DUBs results in downregulation of antiapoptotic and upregulation of proapoptotic proteins, such as MCL-1 and p53.  Our results show that chem. modification of a previously described JAK2 inhibitor results in the unexpected discovery of a novel DUB inhibitor with a unique antitumor mechanism.  Cancer Res; 70(22); 9265-76.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTYP-6z7_QxrVg90H21EOLACvtfcHk0liqJAgfOYj3yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWmsLjM&md5=60ca96bc9a7c114292dc0dd259bf19c5</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1530%26sid%3Dliteratum%253Aachs%26aulast%3DKapuria%26aufirst%3DV.%26aulast%3DPeterson%26aufirst%3DL.%2BF.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DDonato%26aufirst%3DN.%2BJ.%26atitle%3DDeubiquitinase%2520inhibition%2520by%2520small-molecule%2520WP1130%2520triggers%2520aggresome%2520formation%2520and%2520tumor%2520cell%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D22%26spage%3D9265%26epage%3D9276%26doi%3D10.1158%2F0008-5472.CAN-10-1530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandarpa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakubowiak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talpaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donato, N. J.</span></span> <span> </span><span class="NLM_article-title">Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">3588</span>â <span class="NLM_lpage">3597</span>, <span class="refDoi">Â DOI: 10.1182/blood-2014-10-605584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1182%2Fblood-2014-10-605584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25814533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOgtrbO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=3588-3597&issue=23&author=L.+F.+Petersonauthor=H.+Sunauthor=Y.+Liuauthor=H.+Potuauthor=M.+Kandarpaauthor=M.+Ermannauthor=S.+M.+Courtneyauthor=M.+Youngauthor=H.+D.+Showalterauthor=D.+Sunauthor=A.+Jakubowiakauthor=S.+N.+Malekauthor=M.+Talpazauthor=N.+J.+Donato&title=Targeting+deubiquitinase+activity+with+a+novel+small-molecule+inhibitor+as+therapy+for+B-cell+malignancies&doi=10.1182%2Fblood-2014-10-605584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies</span></div><div class="casAuthors">Peterson, Luke F.; Sun, Hanshi; Liu, Yihong; Potu, Harish; Kandarpa, Malathi; Ermann, Monika; Courtney, Stephen M.; Young, Matthew; Showalter, Hollis D.; Sun, Duxin; Jakubowiak, Andrzej; Malek, Sami N.; Talpaz, Moshe; Donato, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3588-3597</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Usp9x was recently shown to be highly expressed in myeloma patients with short progression-free survival and is proposed to enhance stability of the survival protein Mcl-1.  In this study, we found that the partially selective Usp9x deubiquitinase inhibitor WP1130 induced apoptosis and reduced Mcl-1 protein levels.  However, short hairpin RNA-mediated knockdown (KD) of Usp9x in myeloma cells resulted in transient induction of apoptosis, followed by a sustained redn. in cell growth.  A compensatory upregulation of Usp24, a deubiquitinase closely related to Usp9x, in Usp9x KD cells was noted.  Direct Usp24 KD resulted in marked induction of myeloma cell death that was assocd. with a redn. of Mcl-1.  Usp24 was found to sustain myeloma cell survival and Mcl-1 regulation in the absence of Usp9x.  Both Usp9x and Usp24 were expressed and activated in primary myeloma cells whereas Usp24 protein overexpression was noted in some patients with drug-refractory myeloma and other B-cell malignancies.  Furthermore, we improved the drug-like properties of WP1130 and demonstrated that the novel compd. EOAI3402143 dose-dependently inhibited Usp9x and Usp24 activity, increased tumor cell apoptosis, and fully blocked or regressed myeloma tumors in mice.  We conclude that small-mol. Usp9x/Usp24 inhibitors may have therapeutic activity in myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVLMg6nhf7eLVg90H21EOLACvtfcHk0liqJAgfOYj3yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOgtrbO&md5=9bdf0d51c8f32af963e30827f94f8a2c</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1182%2Fblood-2014-10-605584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2014-10-605584%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DL.%2BF.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPotu%26aufirst%3DH.%26aulast%3DKandarpa%26aufirst%3DM.%26aulast%3DErmann%26aufirst%3DM.%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26aulast%3DYoung%26aufirst%3DM.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DJakubowiak%26aufirst%3DA.%26aulast%3DMalek%26aufirst%3DS.%2BN.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DDonato%26aufirst%3DN.%2BJ.%26atitle%3DTargeting%2520deubiquitinase%2520activity%2520with%2520a%2520novel%2520small-molecule%2520inhibitor%2520as%2520therapy%2520for%2520B-cell%2520malignancies%26jtitle%3DBlood%26date%3D2015%26volume%3D125%26issue%3D23%26spage%3D3588%26epage%3D3597%26doi%3D10.1182%2Fblood-2014-10-605584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MartÃ­nez-Lostao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, J.</span></span> <span> </span><span class="NLM_article-title">How do cytotoxic lymphocytes kill cancer cells?</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">5047</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-15-0685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1158%2F1078-0432.CCR-15-0685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26567364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVajsbjF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=5047&issue=22&author=L.+Mart%C3%ADnez-Lostaoauthor=A.+Anelauthor=J.+Pardo&title=How+do+cytotoxic+lymphocytes+kill+cancer+cells%3F&doi=10.1158%2F1078-0432.CCR-15-0685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">How Do Cytotoxic Lymphocytes Kill Cancer Cells?</span></div><div class="casAuthors">Martinez-Lostao, Luis; Anel, Alberto; Pardo, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5047-5056</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In the past few years, cancer immunotherapy has emerged as a safe and effective alternative for treatment of cancers that do not respond to classical treatments, including those types with high aggressiveness.  New immune modulators, such as cytokines, blockers of CTLA-4 (cytotoxic T-lymphocyte-assocd. protein 4) and PD-1(programmed cell death protein 1)/PD-L1 (programmed death-ligand 1), and interaction or adoptive cell therapy, have been developed and approved to treat solid and hematol. carcinomas.  In these scenarios, cytotoxic lymphocytes (CL), mainly cytotoxic T cells (Tc) and natural killer (NK) cells, are ultimately responsible for killing the cancer cells and eradicating the tumor.  Extensive studies have been conducted to assess how Tc and NK cells get activated and recognize the cancer cell.  In contrast, few studies have focused on the effector mols. used by CLs to kill cancer cells during cancer immunosurveillance and immunotherapy.  In this article, the two main pathways involved in CL-mediated tumor cell death, granule exocytosis (perforin and granzymes) and death ligands, are briefly introduced, followed by a crit. discussion of the mols. involved in cell death during cancer immunosurveillance and immunotherapy.  This discussion also covers unexpected consequences of proinflammatory and survival effects of granzymes and death ligands and recent exptl. evidence indicating that perforin and granzymes of CLs can activate nonapoptotic pathways of cell death, overcoming apoptosis defects and chemoresistance.  The consequences of apoptosis vs. other modalities of cell death for an effective treatment of cancer by modulating the patient immune system are also briefly discussed.  Clin Cancer Res; 21(22); 5047-56. Â©2015 AACR.  See all articles in this CCR Focus section, "Cell Death and Cancer Therapy.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCQKr0bwj2mLVg90H21EOLACvtfcHk0lj4ETbT3Yb-kQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVajsbjF&md5=a7d0e6b7ce7122874a94c925252b7ea0</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-15-0685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-15-0685%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADnez-Lostao%26aufirst%3DL.%26aulast%3DAnel%26aufirst%3DA.%26aulast%3DPardo%26aufirst%3DJ.%26atitle%3DHow%2520do%2520cytotoxic%2520lymphocytes%2520kill%2520cancer%2520cells%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26issue%3D22%26spage%3D5047%26doi%3D10.1158%2F1078-0432.CCR-15-0685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voskoboinik, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapani, J. A.</span></span> <span> </span><span class="NLM_article-title">Perforin and granzymes: function, dysfunction and human pathology</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">388</span>â <span class="NLM_lpage">400</span>, <span class="refDoi">Â DOI: 10.1038/nri3839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnri3839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25998963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=388-400&issue=6&author=I.+Voskoboinikauthor=J.+C.+Whisstockauthor=J.+A.+Trapani&title=Perforin+and+granzymes%3A+function%2C+dysfunction+and+human+pathology&doi=10.1038%2Fnri3839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Perforin and granzymes: function, dysfunction and human pathology</span></div><div class="casAuthors">Voskoboinik, Ilia; Whisstock, James C.; Trapani, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">388-400</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A defining property of cytotoxic lymphocytes is their expression and regulated secretion of potent toxins, including the pore-forming protein perforin and serine protease granzymes.  Until recently, mechanisms of pore formation and granzyme transfer into the target cell were poorly understood, but advances in structural and cellular biol. have now begun to unravel how synergy between perforin and granzymes brings about target cell death.  These and other advances are demonstrating the surprisingly broad pathophysiol. roles of the perforin-granzyme pathway, and this has important implications for understanding immune homeostasis and for developing immunotherapies for cancer and other diseases.  In particular, we are beginning to define and understand a range of human diseases that are assocd. with a failure to deliver active perforin to target cells.  In this Review, we discuss the current understanding of the structural, cellular and clin. aspects of perforin and granzyme biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOyD8r4tQK67Vg90H21EOLACvtfcHk0lj4ETbT3Yb-kQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7jK&md5=751e132b6f0b5808387317645c902236</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1038%2Fnri3839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3839%26sid%3Dliteratum%253Aachs%26aulast%3DVoskoboinik%26aufirst%3DI.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26aulast%3DTrapani%26aufirst%3DJ.%2BA.%26atitle%3DPerforin%2520and%2520granzymes%253A%2520function%252C%2520dysfunction%2520and%2520human%2520pathology%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2015%26volume%3D15%26issue%3D6%26spage%3D388%26epage%3D400%26doi%3D10.1038%2Fnri3839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DâEliseo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Rocco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loria, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soddu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velotti, F.</span></span> <span> </span><span class="NLM_article-title">Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">24</span>, <span class="refDoi">Â DOI: 10.1186/s13046-016-0302-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1186%2Fs13046-016-0302-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26830472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWis7fM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=24&issue=1&author=D.+D%E2%80%99Eliseoauthor=G.+Di+Roccoauthor=R.+Loriaauthor=S.+Sodduauthor=A.+Santoniauthor=F.+Velotti&title=Epitelial-to-mesenchimal+transition+and+invasion+are+upmodulated+by+tumor-expressed+granzyme+B+and+inhibited+by+docosahexaenoic+acid+in+human+colorectal+cancer+cells&doi=10.1186%2Fs13046-016-0302-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells</span></div><div class="casAuthors">D'Eliseo, Donatella; Di Rocco, Giuliana; Loria, Rossella; Soddu, Silvia; Santoni, Angela; Velotti, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24/1-24/11</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Granzyme B (GrB) is a serine protease, traditionally known as expressed by cytotoxic lymphocytes to induce target cell apoptosis.  However, it is emerging that GrB, being also produced by a variety of normal and neoplastic cells and potentially acting on multiple targets, might represent a powerful regulator of a wide range of fundamental biol. processes.  We have previously shown that GrB is expressed in urothelial carcinoma tissues and its expression is assocd. to both pathol. tumor spreading and EMT.  We have also shown that docosahexaenoic acid (DHA), a dietary Ï-3 polyunsatd. fatty acid with anti-tumor activity, while inhibiting urothelial and pancreatic carcinoma cell invasion also inhibited their GrB expression in vitro.  In this study, we characterized a panel of colorectal carcinoma (CRC) cells, with different invasive capabilities, for GrB expression and for the contribution of GrB to their EMT and invasive phenotype.  In addn., we investigated the effect of DHA on CRC cell-assocd. GrB expression, EMT and invasion.  Methods: The expression levels of GrB and EMT-related markers were evaluated by Western blotting.  GrB knockdown was performed by Stealth RNAi small interfering RNA silencing and ectopic GrB expression by transfection of human GrB vector.  Cell invasion was detd. by the BioCoat Matrigel invasion chamber test.  Results: GrB was produced in 57.1 % CRC cell lines and 100 % CRC-derived Cancer Stem Cells.  Although GrB was constitutive expressed in both invasive and noninvasive CRC cells, GrB depletion in invasive CRC cells downmodulated their invasion in vitro, suggesting a contribution of GrB to CRC invasiveness.  GrB loss or gain of function downmodulated or upmodulated EMT, resp., according to the anal. of cancer cell expression of three EMT biomarkers (Snail1, E-cadherin, N-cadherin).  Moreover, TGF-Î²1-driven EMT was assocd. to the enhancement of GrB expression in CRC cell lines, and GrB depletion led to downmodulation of TGF-Î²1-driven EMT.  In addn., DHA inhibited GrB expression, EMT and invasion in CRC cells in vitro.  Conclusions: These findings present a novel role for GrB as upmodulator of EMT in CRC cells.  Moreover, these results support the use of DHA, a dietary compd. without toxic effects, as adjuvant in CRC therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJDcIJetZ3ebVg90H21EOLACvtfcHk0lj4ETbT3Yb-kQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWis7fM&md5=739dee1e8b1c5acd2fad89079952c237</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1186%2Fs13046-016-0302-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-016-0302-6%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Eliseo%26aufirst%3DD.%26aulast%3DDi%2BRocco%26aufirst%3DG.%26aulast%3DLoria%26aufirst%3DR.%26aulast%3DSoddu%26aufirst%3DS.%26aulast%3DSantoni%26aufirst%3DA.%26aulast%3DVelotti%26aufirst%3DF.%26atitle%3DEpitelial-to-mesenchimal%2520transition%2520and%2520invasion%2520are%2520upmodulated%2520by%2520tumor-expressed%2520granzyme%2520B%2520and%2520inhibited%2520by%2520docosahexaenoic%2520acid%2520in%2520human%2520colorectal%2520cancer%2520cells%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D35%26issue%3D1%26spage%3D24%26doi%3D10.1186%2Fs13046-016-0302-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DâEliseo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Nunzio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoppacciaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velotti, F.</span></span> <span> </span><span class="NLM_article-title">Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>127</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1283</span>â <span class="NLM_lpage">1294</span>, <span class="refDoi">Â DOI: 10.1002/ijc.25135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fijc.25135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=20027633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1OhsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2010&pages=1283-1294&issue=6&author=D.+D%E2%80%99Eliseoauthor=P.+Pisuauthor=C.+Romanoauthor=A.+Tubaroauthor=C.+De+Nunzioauthor=S.+Morroneauthor=A.+Santoniauthor=A.+Stoppacciaroauthor=F.+Velotti&title=Granzyme+B+is+expressed+in+urothelial+carcinoma+and+promotes+cancer+cell+invasion&doi=10.1002%2Fijc.25135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion</span></div><div class="casAuthors">D'Eliseo, Donatella; Pisu, Paola; Romano, Chiara; Tubaro, Andrea; De Nunzio, Cosimo; Morrone, Stefania; Santoni, Angela; Stoppacciaro, Antonella; Velotti, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1283-1294</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Granzyme B (GrB) is a serine proteinase known to be expressed by cytotoxic lymphocytes and to induce, in presence of perforin (Pf), apoptosis in target cells.  Recently, GrB expression has been shown (often in absence of Pf) in nonlymphoid cells, but its function is not defined.  In our study, we investigated GrB and Pf expression in bladder cancer cell lines and in urothelial carcinoma (UC) tissues by reverse transcription-polymerase chain reaction (RT-PCR), Western blot, ELISA, immunofluorescence and immunohistochem.  We also assessed the function of GrB in UC cells; the in vitro function of GrB was examd. by loss-of-function expts.  Our results revealed that GrB is expressed, in absence of Pf, in UC cells.  Significant differences were found between GrB expression and both increasing pathol. tumor spreading and high-grade vs. low-grade pTa tumors.  Notably, GrB in UC tissues was concd. at the cancer invasion front and was expressed in neoplastic cells undergoing epithelial-mesenchymal transition, a key event in carcinoma invasion.  Indeed, GrB-pos. cells also expressed Snail, N-cadherin or were neg. for E-cadherin.  GrB expressed in tumor cell lines was enzymically active and capable of vitronectin cleavage, implying extracellular matrix (ECM) remodeling by GrB.  Inhibition of GrB activity or Stealth RNA interference-mediated GrB gene silencing markedly suppressed bladder cancer cell invasion through matrigel.  This data provides the first evidence for a role of GrB in promoting cancer cell invasion.  Taken together, our findings suggest that GrB, via ECM degrdn., contributes to the establishment of the UC invasive phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoranTNLHFKebVg90H21EOLACvtfcHk0lj4ETbT3Yb-kQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1OhsLc%253D&md5=4074d52ffbfd744fe2c67dab4134639b</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1002%2Fijc.25135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.25135%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Eliseo%26aufirst%3DD.%26aulast%3DPisu%26aufirst%3DP.%26aulast%3DRomano%26aufirst%3DC.%26aulast%3DTubaro%26aufirst%3DA.%26aulast%3DDe%2BNunzio%26aufirst%3DC.%26aulast%3DMorrone%26aufirst%3DS.%26aulast%3DSantoni%26aufirst%3DA.%26aulast%3DStoppacciaro%26aufirst%3DA.%26aulast%3DVelotti%26aufirst%3DF.%26atitle%3DGranzyme%2520B%2520is%2520expressed%2520in%2520urothelial%2520carcinoma%2520and%2520promotes%2520cancer%2520cell%2520invasion%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2010%26volume%3D127%26issue%3D6%26spage%3D1283%26epage%3D1294%26doi%3D10.1002%2Fijc.25135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaiserman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, P. I.</span></span> <span> </span><span class="NLM_article-title">Control of granzymes by serpins</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">586</span>â <span class="NLM_lpage">595</span>, <span class="refDoi">Â DOI: 10.1038/cdd.2009.169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fcdd.2009.169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19893573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1Ogsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=586-595&issue=4&author=D.+Kaisermanauthor=P.+I.+Bird&title=Control+of+granzymes+by+serpins&doi=10.1038%2Fcdd.2009.169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Control of granzymes by serpins</span></div><div class="casAuthors">Kaiserman, D.; Bird, P. I.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">586-595</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Although proteolysis mediated by granzymes has an important role in the immune response to infection or tumors, unrestrained granzyme activity may damage normal cells.  In this review, we discuss the role of serpins within the immune system, as specific regulators of granzymes.  The well-characterized human granzyme B-SERPINB9 interaction highlights the cytoprotective function that serpins have in safeguarding lymphocytes from granzymes that may leak from granules.  We also discuss some of the pitfalls inherent in using rodent models of granzyme-serpin interactions and the ways in which our understanding of serpins can help resolve some of the current, contentious issues in granzyme biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2tCSUFTe24rVg90H21EOLACvtfcHk0ljEIWyvOV5eyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1Ogsb4%253D&md5=0a33b4e6e593228297779ec0013c8cbd</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2009.169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2009.169%26sid%3Dliteratum%253Aachs%26aulast%3DKaiserman%26aufirst%3DD.%26aulast%3DBird%26aufirst%3DP.%2BI.%26atitle%3DControl%2520of%2520granzymes%2520by%2520serpins%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2010%26volume%3D17%26issue%3D4%26spage%3D586%26epage%3D595%26doi%3D10.1038%2Fcdd.2009.169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span> <span> </span><span class="NLM_article-title">Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome</span>. <i>Sci. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">43</span>), <span class="NLM_elocation-id">eaax7969</span> <span class="refDoi">Â DOI: 10.1126/sciimmunol.aax7969</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fsciimmunol.aax7969" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31953257" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2020&issue=43&author=Y.+Liuauthor=Y.+Fangauthor=X.+Chenauthor=Z.+Wangauthor=X.+Liangauthor=T.+Zhangauthor=M.+Liuauthor=N.+Zhouauthor=J.+Lvauthor=K.+Tangauthor=J.+Xieauthor=Y.+Gaoauthor=F.+Chengauthor=Y.+Zhouauthor=Z.+Zhangauthor=Y.+Huauthor=X.+Zhangauthor=Q.+Gaoauthor=Y.+Zhangauthor=B.+Huang&title=Gasdermin+E-mediated+target+cell+pyroptosis+by+CAR+T+cells+triggers+cytokine+release+syndrome&doi=10.1126%2Fsciimmunol.aax7969"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1126%2Fsciimmunol.aax7969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciimmunol.aax7969%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DLv%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DK.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DB.%26atitle%3DGasdermin%2520E-mediated%2520target%2520cell%2520pyroptosis%2520by%2520CAR%2520T%2520cells%2520triggers%2520cytokine%2520release%2520syndrome%26jtitle%3DSci.%2520Immunol.%26date%3D2020%26volume%3D5%26issue%3D43%26doi%3D10.1126%2Fsciimmunol.aax7969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, F.</span></span> <span> </span><span class="NLM_article-title">Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>368</i></span> (<span class="NLM_issue">6494</span>), <span class="NLM_elocation-id">eaaz7548</span> <span class="refDoi">Â DOI: 10.1126/science.aaz7548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fscience.aaz7548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32299851" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2020&issue=6494&author=Z.+Zhouauthor=H.+Heauthor=K.+Wangauthor=X.+Shiauthor=Y.+Wangauthor=Y.+Suauthor=Y.+Wangauthor=D.+Liauthor=W.+Liuauthor=Y.+Zhangauthor=L.+Shenauthor=W.+Hanauthor=L.+Shenauthor=J.+Dingauthor=F.+Shao&title=Granzyme+A+from+cytotoxic+lymphocytes+cleaves+GSDMB+to+trigger+pyroptosis+in+target+cells&doi=10.1126%2Fscience.aaz7548"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaz7548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaz7548%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DF.%26atitle%3DGranzyme%2520A%2520from%2520cytotoxic%2520lymphocytes%2520cleaves%2520GSDMB%2520to%2520trigger%2520pyroptosis%2520in%2520target%2520cells%26jtitle%3DScience%26date%3D2020%26volume%3D368%26issue%3D6494%26doi%3D10.1126%2Fscience.aaz7548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graubert, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ley, T. J.</span></span> <span> </span><span class="NLM_article-title">The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1232</span>â <span class="NLM_lpage">1237</span>, <span class="refDoi">Â DOI: 10.1182/blood.V87.4.1232.bloodjournal8741232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1182%2Fblood.V87.4.1232.bloodjournal8741232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8608209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADyaK287ptVSgtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1996&pages=1232-1237&issue=4&author=T.+A.+Graubertauthor=J.+H.+Russellauthor=T.+J.+Ley&title=The+role+of+granzyme+B+in+murine+models+of+acute+graft-versus-host+disease+and+graft+rejection&doi=10.1182%2Fblood.V87.4.1232.bloodjournal8741232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection</span></div><div class="casAuthors">Graubert T A; Russell J H; Ley T J</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1232-7</span>
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">A complete molecular description of the syndromes of graft-versus-host disease (GVHD) and graft rejection could have a significant impact on clinical bone marrow transplantation.  Recent in vitro experiments (Heusel et al, Cell 76:977, 1994 and Shresta et al, Proc Natl Acad Sci USA 92:5679, 1995) have shown that the putative mediators of these two syndromes, cytotoxic lymphocytes (CTL) and natural killer (NK) cells, respectively, initiate a program of cell death (apoptosis) in susceptible target tissues in a manner critically dependent on the serine protease Granzyme B (gzm B).  In the present study, we have analyzed the phenotype of gzm B-deficient mice using experimental transplant models designed to isolate their CD8+ CTL, CD4+ CTL, and NK compartments.  We found a significant impairment in class I-dependent GVHD mediated by gzm B -/- CD8+ CTL, whereas class II-dependent GVHD was not altered using gzm B -/- CD4+ effectors.  In a hybrid resistance model, gzm B -/- hosts rejected haplo-identical marrow grafts as efficiently as did their wild-type littermates.  This result is surprising in light of a severe defect in the ability of gzm B -/- NK cells to induce apoptosis in susceptible targets in vitro.  These in vivo data define significant role for gzm B in cytotoxicity mediated by CD8+ CTL, but not by CD4+ CTL.  Furthermore, these results do not support a model of hybrid resistance in which NK cells play a pivotal role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnxcaOdJTc6jDnmmyUf5qOfW6udTcc2eZzUDrcPJGa1Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK287ptVSgtw%253D%253D&md5=ed0933d7a00846cd3b4af5d86127af2d</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1182%2Fblood.V87.4.1232.bloodjournal8741232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V87.4.1232.bloodjournal8741232%26sid%3Dliteratum%253Aachs%26aulast%3DGraubert%26aufirst%3DT.%2BA.%26aulast%3DRussell%26aufirst%3DJ.%2BH.%26aulast%3DLey%26aufirst%3DT.%2BJ.%26atitle%3DThe%2520role%2520of%2520granzyme%2520B%2520in%2520murine%2520models%2520of%2520acute%2520graft-versus-host%2520disease%2520and%2520graft%2520rejection%26jtitle%3DBlood%26date%3D1996%26volume%3D87%26issue%3D4%26spage%3D1232%26epage%3D1237%26doi%3D10.1182%2Fblood.V87.4.1232.bloodjournal8741232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sower, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froelich, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegretto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimpel, G. R.</span></span> <span> </span><span class="NLM_article-title">Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>156</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2585</span>â <span class="NLM_lpage">2590</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8786323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK28XhvVGltLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1996&pages=2585-2590&issue=7&author=L.+E.+Sowerauthor=C.+J.+Froelichauthor=N.+Allegrettoauthor=P.+M.+Roseauthor=W.+D.+Hannaauthor=G.+R.+Klimpel&title=Extracellular+activities+of+human+granzyme+A.+Monocyte+activation+by+granzyme+A+versus+alpha-thrombin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus Î±-thrombin</span></div><div class="casAuthors">Sower, Laurie E.; Froelich, Christopher J.; Allegretto, Nick; Rose, Patricia M.; Hanna, William D.; Klimpel, Gary R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2585-90</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Granzymes, serine proteases located in the granules of cytotoxic T cells and NK cells, are essential for induction of target cell apoptosis.  However, since cytotoxic cells constitutively secrete a portion of their synthesized granzymes, these proteases could mediate extracellular functions independent of their role in the lytic event.  Thrombin, another serine protease, can induce cytokine prodn. in a no. of different cell types.  In this study, we test the hypothesis that granzymes, like thrombin, can regulate cell-mediated immunity by inducing the prodn. of different cytokines.  We show that granzyme A (GA) stimulates IL-6, IL-8, and TNF-Î± prodn. by human PBMC and purified monocytes.  In contrast, monocytes exposed to thrombin had enhanced IL-8 prodn. with no induction of IL-6 or TNF-Î± prodn.  However, monocytes exposed to either GA or thrombin had enhanced phagocytic activity.  The enzymic activity of GA and thrombin was required for the induction of cytokine prodn. and for the enhancement of phagocytic activity.  The induction of different cytokine profiles by GA vs thrombin suggested that GA activates monocytes via a receptor that was different from the thrombin receptor.  This conclusion was strengthened by the fact that GA was incapable of inducing Ca2+ mobilization in insect cells transfected with the thrombin receptor.  These results suggest that enzymically active GA mediates important immunoregulatory functions through signaling pathways that does not involve thrombin receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUs3XNB_Y_SbVg90H21EOLACvtfcHk0lgtrNmWYqqiIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVGltLg%253D&md5=078637d2e3292bdee106be6626ce40ff</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSower%26aufirst%3DL.%2BE.%26aulast%3DFroelich%26aufirst%3DC.%2BJ.%26aulast%3DAllegretto%26aufirst%3DN.%26aulast%3DRose%26aufirst%3DP.%2BM.%26aulast%3DHanna%26aufirst%3DW.%2BD.%26aulast%3DKlimpel%26aufirst%3DG.%2BR.%26atitle%3DExtracellular%2520activities%2520of%2520human%2520granzyme%2520A.%2520Monocyte%2520activation%2520by%2520granzyme%2520A%2520versus%2520alpha-thrombin%26jtitle%3DJ.%2520Immunol.%26date%3D1996%26volume%3D156%26issue%3D7%26spage%3D2585%26epage%3D2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buzza, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurs, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapani, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froelich, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nice, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, P. I.</span></span> <span> </span><span class="NLM_article-title">Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">23549</span>â <span class="NLM_lpage">23558</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M412001200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.M412001200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15843372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlKitbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=23549-23558&issue=25&author=M.+S.+Buzzaauthor=L.+Zamursauthor=J.+Sunauthor=C.+H.+Birdauthor=A.+I.+Smithauthor=J.+A.+Trapaniauthor=C.+J.+Froelichauthor=E.+C.+Niceauthor=P.+I.+Bird&title=Extracellular+matrix+remodeling+by+human+granzyme+B+via+cleavage+of+vitronectin%2C+fibronectin%2C+and+laminin&doi=10.1074%2Fjbc.M412001200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular Matrix Remodeling by Human Granzyme B via Cleavage of Vitronectin, Fibronectin, and Laminin</span></div><div class="casAuthors">Buzza, Marguerite S.; Zamurs, Laura; Sun, Jiuru; Bird, Catherina H.; Smith, A. Ian; Trapani, Joseph A.; Froelich, Christopher J.; Nice, Edouard C.; Bird, Phillip I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">23549-23558</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human granzyme B (GrB) released from cytotoxic lymphocytes plays a key role in the induction of target cell apoptosis when internalized in the presence of perforin.  Here the authors demonstrate that GrB also possesses a potent extracellular matrix remodeling activity.  Both native and recombinant GrB caused detachment of immortalized and transformed cell lines, primary endothelial cells, and chondrocytes.  Cell detachment by GrB induced endothelial cell death (anoikis).  GrB also inhibited tumor cell spreading, migration, and invasion in vitro.  Investigation into the underlying mechanism revealed that GrB efficiently cleaves three proteins involved in extracellular matrix structure and function: vitronectin, fibronectin, and laminin.  In vitronectin, GrB cleaves after an Arg-Lys-Asp (RGD) motif, which is part of the integrin-binding site found in matrix proteins.  The authors propose that targeting of the integrin-extracellular matrix interface by GrB may allow perforin-independent killing of target cells via anoikis, restrict motility of tumor cells, facilitate lymphocyte migration, or directly reduce virus infectivity.  It may also contribute to tissue destruction in diseases in which extracellular GrB is evident, such as rheumatoid arthritis and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj5WSM2Fe9krVg90H21EOLACvtfcHk0lgtrNmWYqqiIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlKitbY%253D&md5=e02df10ee16ffb6d5665a8201b354391</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M412001200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M412001200%26sid%3Dliteratum%253Aachs%26aulast%3DBuzza%26aufirst%3DM.%2BS.%26aulast%3DZamurs%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DBird%26aufirst%3DC.%2BH.%26aulast%3DSmith%26aufirst%3DA.%2BI.%26aulast%3DTrapani%26aufirst%3DJ.%2BA.%26aulast%3DFroelich%26aufirst%3DC.%2BJ.%26aulast%3DNice%26aufirst%3DE.%2BC.%26aulast%3DBird%26aufirst%3DP.%2BI.%26atitle%3DExtracellular%2520matrix%2520remodeling%2520by%2520human%2520granzyme%2520B%2520via%2520cleavage%2520of%2520vitronectin%252C%2520fibronectin%252C%2520and%2520laminin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26issue%3D25%26spage%3D23549%26epage%3D23558%26doi%3D10.1074%2Fjbc.M412001200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santiago, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz-Pamplona, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GarzÃ³n, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez-Labrada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layunta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil-GÃ³mez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PeÃ±a, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanuza, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaime-Sanchez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uranga-Murillo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Campo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PelegrÃ­n, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camerer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MartÃ­nez-Lostao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MuÃ±oz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uranga, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcalde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvez, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrandez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arias, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, J.</span></span> <span> </span><span class="NLM_article-title">Extracellular granzyme A promotes colorectal cancer development by enhancing gut inflammation</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">107847</span>, <span class="refDoi">Â DOI: 10.1016/j.celrep.2020.107847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.celrep.2020.107847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32640217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlKnsbnF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2020&pages=107847&issue=1&author=L.+Santiagoauthor=M.+Castroauthor=R.+Sanz-Pamplonaauthor=M.+Garz%C3%B3nauthor=A.+Ramirez-Labradaauthor=E.+Tapiaauthor=V.+Morenoauthor=E.+Layuntaauthor=G.+Gil-G%C3%B3mezauthor=M.+Garridoauthor=R.+Pe%C3%B1aauthor=P.+M.+Lanuzaauthor=L.+Comasauthor=P.+Jaime-Sanchezauthor=I.+Uranga-Murilloauthor=R.+del+Campoauthor=P.+Pelegr%C3%ADnauthor=E.+Camererauthor=L.+Mart%C3%ADnez-Lostaoauthor=G.+Mu%C3%B1ozauthor=J.+A.+Urangaauthor=A.+Alcaldeauthor=E.+M.+Galvezauthor=A.+Ferrandezauthor=P.+I.+Birdauthor=S.+Metkarauthor=M.+A.+Ariasauthor=J.+Pardo&title=Extracellular+granzyme+A+promotes+colorectal+cancer+development+by+enhancing+gut+inflammation&doi=10.1016%2Fj.celrep.2020.107847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular Granzyme A Promotes Colorectal Cancer Development by Enhancing Gut Inflammation</span></div><div class="casAuthors">Santiago, Llipsy; Castro, Marta; Sanz-Pamplona, Rebeca; Garzon, Marcela; Ramirez-Labrada, Ariel; Tapia, Elena; Moreno, Victor; Layunta, Elena; Gil-Gomez, Gabriel; Garrido, Marta; Pena, Raul; Lanuza, Pilar M.; Comas, Laura; Jaime-Sanchez, Paula; Uranga-Murillo, Iratxe; del Campo, Rosa; Pelegrin, Pablo; Camerer, Eric; Martinez-Lostao, Luis; Munoz, Guillermo; Uranga, Jose A.; Alcalde, Anabel; Galvez, Eva M.; Ferrandez, Angel; Bird, Phillip I.; Metkar, Sunil; Arias, Maykel A.; Pardo, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107847</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">If not properly regulated, the inflammatory immune response can promote carcinogenesis, as evident in colorectal cancer (CRC).  Aiming to gain mechanistic insight into the link between inflammation and CRC, we perform transcriptomics anal. of human CRC, identifying a strong correlation between expression of the serine protease granzyme A (GzmA) and inflammation.  In a dextran sodium sulfate and azoxymethane (DSS/AOM) mouse model, deficiency and pharmacol. inhibition of extracellular GzmA both attenuate gut inflammation and prevent CRC development, including the initial steps of cell transformation and epithelial-to-mesenchymal transition.  Mechanistically, extracellular GzmA induces NF-ÎºB-dependent IL-6 prodn. in macrophages, which in turn promotes STAT3 activation in cultured CRC cells.  Accordingly, colon tissues from DSS/AOM-treated, GzmA-deficient animals present reduced levels of pSTAT3.  By identifying GzmA as a proinflammatory protease that promotes CRC development, these findings provide information on mechanisms that link immune cell infiltration to cancer progression and present GzmA as a therapeutic target for CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxMUp-GHyjJLVg90H21EOLACvtfcHk0lh0o4iTP4iGjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlKnsbnF&md5=8dd4fc7017dcb25d3d3383d03a2bdf02</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2020.107847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2020.107847%26sid%3Dliteratum%253Aachs%26aulast%3DSantiago%26aufirst%3DL.%26aulast%3DCastro%26aufirst%3DM.%26aulast%3DSanz-Pamplona%26aufirst%3DR.%26aulast%3DGarz%25C3%25B3n%26aufirst%3DM.%26aulast%3DRamirez-Labrada%26aufirst%3DA.%26aulast%3DTapia%26aufirst%3DE.%26aulast%3DMoreno%26aufirst%3DV.%26aulast%3DLayunta%26aufirst%3DE.%26aulast%3DGil-G%25C3%25B3mez%26aufirst%3DG.%26aulast%3DGarrido%26aufirst%3DM.%26aulast%3DPe%25C3%25B1a%26aufirst%3DR.%26aulast%3DLanuza%26aufirst%3DP.%2BM.%26aulast%3DComas%26aufirst%3DL.%26aulast%3DJaime-Sanchez%26aufirst%3DP.%26aulast%3DUranga-Murillo%26aufirst%3DI.%26aulast%3Ddel%2BCampo%26aufirst%3DR.%26aulast%3DPelegr%25C3%25ADn%26aufirst%3DP.%26aulast%3DCamerer%26aufirst%3DE.%26aulast%3DMart%25C3%25ADnez-Lostao%26aufirst%3DL.%26aulast%3DMu%25C3%25B1oz%26aufirst%3DG.%26aulast%3DUranga%26aufirst%3DJ.%2BA.%26aulast%3DAlcalde%26aufirst%3DA.%26aulast%3DGalvez%26aufirst%3DE.%2BM.%26aulast%3DFerrandez%26aufirst%3DA.%26aulast%3DBird%26aufirst%3DP.%2BI.%26aulast%3DMetkar%26aufirst%3DS.%26aulast%3DArias%26aufirst%3DM.%2BA.%26aulast%3DPardo%26aufirst%3DJ.%26atitle%3DExtracellular%2520granzyme%2520A%2520promotes%2520colorectal%2520cancer%2520development%2520by%2520enhancing%2520gut%2520inflammation%26jtitle%3DCell%2520Rep.%26date%3D2020%26volume%3D32%26issue%3D1%26spage%3D107847%26doi%3D10.1016%2Fj.celrep.2020.107847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">KrÃ¤henbÃ¼hl, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzavecchia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groscurth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span> <span> </span><span class="NLM_article-title">Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>141</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3471</span>â <span class="NLM_lpage">3477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=3263427" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=1988&pages=3471-3477&issue=10&author=O.+Kr%C3%A4henb%C3%BChlauthor=C.+Reyauthor=D.+Jenneauthor=A.+Lanzavecchiaauthor=P.+Groscurthauthor=S.+Carrelauthor=J.+Tschopp&title=Characterization+of+granzymes+A+and+B+isolated+from+granules+of+cloned+human+cytotoxic+T+lymphocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKr%25C3%25A4henb%25C3%25BChl%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DC.%26aulast%3DJenne%26aufirst%3DD.%26aulast%3DLanzavecchia%26aufirst%3DA.%26aulast%3DGroscurth%26aufirst%3DP.%26aulast%3DCarrel%26aufirst%3DS.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520granzymes%2520A%2520and%2520B%2520isolated%2520from%2520granules%2520of%2520cloned%2520human%2520cytotoxic%2520T%2520lymphocytes%26jtitle%3DJ.%2520Immunol.%26date%3D1988%26volume%3D141%26issue%3D10%26spage%3D3471%26epage%3D3477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Odake, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kam, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krahenbuhl, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span> <span> </span><span class="NLM_article-title">Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2217</span>â <span class="NLM_lpage">2227</span>, <span class="refDoi">Â DOI: 10.1021/bi00222a027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00222a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3MXpslagtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1991&pages=2217-2227&issue=8&author=S.+Odakeauthor=C.+M.+Kamauthor=L.+Narasimhanauthor=M.+Poeauthor=J.+T.+Blakeauthor=O.+Krahenbuhlauthor=J.+Tschoppauthor=J.+C.+Powers&title=Human+and+murine+cytotoxic+T+lymphocyte+serine+proteases%3A+subsite+mapping+with+peptide+thioester+substrates+and+inhibition+of+enzyme+activity+and+cytolysis+by+isocoumarins&doi=10.1021%2Fbi00222a027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Human and murine cytotoxic T lymphocyte serine proteases:  subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins</span></div><div class="casAuthors">Odake, Shinjiro; Kam, Chih Min; Narasimhan, Lakshmi; Poe, Martin; Blake, Joseph T.; Krahenbuhl, Olivier; Tschopp, Juerg; Powers, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2217-27</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The active site structures of human Q31 granzyme A, murine granzymes (A, B, C, D, E, and F), and human granzymes (A, B, and 3) isolated from cytotoxic T lymphocytes (CTL) were studied with peptide thioester substrates, peptide chloromethyl ketones, and isocoumarin inhibitors.  Human Q31, murine, and human granzyme A hydrolyzed arginine- or lysine-contg. thioesters very efficiently with kcat/KM = 104-105M-1 s-1.  Murine granzyme B had aspartase activity and hydrolyzed Boc-Ala-Ala-Asp-Sbzl (where Boc = tert-butyloxycarbonyl and SBz = thiobenzyl ester) with kcat/KM = 2.3 Ã 105M-1 s-1.  The rate was accelerated 1.4-fold when the 0.05M NaCl in the assay was replaced with CaCl2.  The prepn. of granzyme B also had significant activity toward Boc-Ala-Ala-AA-SBzl substrates, where AA was asparagine, methionine, or serine [kcat/KM = (4-5) Ã 104M-1 s-1].  Murine granzymes C, D, and E did not hydrolyzed any thioester substrate but contained minor contaminating activity toward arginine- or lysine-contg. thioesters.  Murine granzyme F had small activity toward Suc-Phe-Leu-Phe-SBzl, along with some contaminating trypsin-like activity.  Human Q31 granzyme A, murine, and human granzyme A were inhibited quite efficiently by mechanism-based isocoumarin inhibitors substituted with basic groups (guanidino or isothiureidopropoxy).  Although the general serine protease inhibitor 3,4-dichloroisocoumarin (DCI) inactivated these tryptases poorly, it was the best isocoumarin inhibitor for murine granzyme B (kobs/[I] = 3700-4200M-1 s-1).  Murine and human granzyme B were also inhibited by Boc-Ala-Ala-Asp-CH2Cl; however, the inhibition was less potent than that with DCI.  DCI, 3-(3-aminopropoxy)-4-chloroisocoumarin, 4-chloro-3-(3-isothiureidopropoxy)isocoumarin, and 7-amino-4-chloro-3-(3-isothiureidopropoxy)isocoumarin inhibited Q31 cytotoxic T lymphocyte-mediated lysis of human JY lymphoblasts (ED50 = 0.5-5.0 Î¼M).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz30b93b_vdbVg90H21EOLACvtfcHk0lh0o4iTP4iGjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXpslagtA%253D%253D&md5=35a3913b73e6310912601463bf65b073</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Fbi00222a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00222a027%26sid%3Dliteratum%253Aachs%26aulast%3DOdake%26aufirst%3DS.%26aulast%3DKam%26aufirst%3DC.%2BM.%26aulast%3DNarasimhan%26aufirst%3DL.%26aulast%3DPoe%26aufirst%3DM.%26aulast%3DBlake%26aufirst%3DJ.%2BT.%26aulast%3DKrahenbuhl%26aufirst%3DO.%26aulast%3DTschopp%26aufirst%3DJ.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DHuman%2520and%2520murine%2520cytotoxic%2520T%2520lymphocyte%2520serine%2520proteases%253A%2520subsite%2520mapping%2520with%2520peptide%2520thioester%2520substrates%2520and%2520inhibition%2520of%2520enzyme%2520activity%2520and%2520cytolysis%2520by%2520isocoumarins%26jtitle%3DBiochemistry%26date%3D1991%26volume%3D30%26issue%3D8%26spage%3D2217%26epage%3D2227%26doi%3D10.1021%2Fbi00222a027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zweerink, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigal, N. H.</span></span> <span> </span><span class="NLM_article-title">The enzymatic activity of human cytotoxic T-lymphocyte granzyme a and cytolysis mediated by cytotoxic T-lymphocytes are potently inhibited by a synthetic antiprotease, FUT-175</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>284</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">215</span>â <span class="NLM_lpage">218</span>, <span class="refDoi">Â DOI: 10.1016/0003-9861(91)90286-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2F0003-9861%2891%2990286-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1989498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3MXhtlGks7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1991&pages=215-218&issue=1&author=M.+Poeauthor=J.+K.+Wuauthor=J.+T.+Blakeauthor=H.+J.+Zweerinkauthor=N.+H.+Sigal&title=The+enzymatic+activity+of+human+cytotoxic+T-lymphocyte+granzyme+a+and+cytolysis+mediated+by+cytotoxic+T-lymphocytes+are+potently+inhibited+by+a+synthetic+antiprotease%2C+FUT-175&doi=10.1016%2F0003-9861%2891%2990286-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">The enzymic activity of human cytotoxic T-lymphocyte granzyme A and cytolysis mediated by cytotoxic T-lymphocytes are potently inhibited by a synthetic antiprotease, FUT-175</span></div><div class="casAuthors">Poe, Martin; Wu, Joseph K.; Blake, J. T.; Zweerink, H. J.; Sigal, N. H.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">215-18</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">The synthetic antiprotease, FUT-175 (I) was found to be an extraordinarily potent and rapid inhibitor of human Q31 cytotoxic T-lymphocyte granzyme A.  The granzyme A was inhibited in a time-dependent manner with kobs/i = 430,000 M-1 s-1.  Four other FUT-175 analogs were also found to be potent, rapid Q 31 granzyme A inhibitor.  All 5 compds. inhibited Q 31 cytotoxic T-lymphocyte-mediated cytolysis of human JY lymphoma cells, but at concns. far in excess of those needed for granzyme A inhibition.  The data presented suggest that postmarketing surveillance of FUT-175 should include a review of possible immunosuppressive side-effects, such as increased susceptibility to viral infections and to neoplastic transformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyN1HLXeSXL7Vg90H21EOLACvtfcHk0lgN38tSXlY0Fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtlGks7g%253D&md5=ff8ff080250423dc709df8a98c52dfbb</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2891%2990286-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252891%252990286-R%26sid%3Dliteratum%253Aachs%26aulast%3DPoe%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DBlake%26aufirst%3DJ.%2BT.%26aulast%3DZweerink%26aufirst%3DH.%2BJ.%26aulast%3DSigal%26aufirst%3DN.%2BH.%26atitle%3DThe%2520enzymatic%2520activity%2520of%2520human%2520cytotoxic%2520T-lymphocyte%2520granzyme%2520a%2520and%2520cytolysis%2520mediated%2520by%2520cytotoxic%2520T-lymphocytes%2520are%2520potently%2520inhibited%2520by%2520a%2520synthetic%2520antiprotease%252C%2520FUT-175%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1991%26volume%3D284%26issue%3D1%26spage%3D215%26epage%3D218%26doi%3D10.1016%2F0003-9861%2891%2990286-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beresford, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kam, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, J.</span></span> <span> </span><span class="NLM_article-title">Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">9285</span>â <span class="NLM_lpage">9290</span>, <span class="refDoi">Â DOI: 10.1073/pnas.94.17.9285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.94.17.9285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=9256474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2sXls1KlsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=9285-9290&issue=17&author=P.+J.+Beresfordauthor=C.-M.+Kamauthor=J.+C.+Powersauthor=J.+Lieberman&title=Recombinant+human+granzyme+A+binds+to+two+putative+HLA-associated+proteins+and+cleaves+one+of+them&doi=10.1073%2Fpnas.94.17.9285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them</span></div><div class="casAuthors">Beresford, Paul J.; Kam, Chih-Min; Powers, James C.; Lieberman, Judy</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9285-9290</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The release of cytotoxic granule contents by cytotoxic T lymphocytes triggers apoptotic target cell death.  Cytotoxic granules contain a pore-forming protein, perforin, and a group of serine proteases called granzymes.  We expressed human granzyme A in bacteria as a proenzyme capable of in vitro activation by enterokinase.  The recombinant activated enzyme has catalytic activity against substrates with Arg, preferably, or Lys at the P1 position, comparable to trypsin.  An enzymically inactive recombinant granzyme A, with the active site Ser mutated to Ala, was produced and used with affinity chromatog. to identify potential substrates.  Two granzyme A-binding cytoplasmic proteins of mol. mass 33 and 44 kDa were isolated and identified by tryptic fragment sequencing as PHAP I and II, ubiquitous putative HLA-assocd. proteins, previously coisolated by binding to an HLA class II peptide.  PHAP II forms an SDS-stable complex with recombinant mutant granzyme A and coppts. with it from cytoplasmic exts.  PHAP II, either purified or in cell lysates, is cleaved by the recombinant enzyme at nanomolar concns. to a 25-kDa fragment.  PHAP II begins to be degraded within minutes of initiation of cytotoxic T lymphocyte attack.  PHAP I and II are candidate participants in the granzyme A pathway of cell-mediated cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptMh1eNGe6BbVg90H21EOLACvtfcHk0lgN38tSXlY0Fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXls1KlsLk%253D&md5=566424501175e3a79aa345cd5fa192d7</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.17.9285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.17.9285%26sid%3Dliteratum%253Aachs%26aulast%3DBeresford%26aufirst%3DP.%2BJ.%26aulast%3DKam%26aufirst%3DC.-M.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26aulast%3DLieberman%26aufirst%3DJ.%26atitle%3DRecombinant%2520human%2520granzyme%2520A%2520binds%2520to%2520two%2520putative%2520HLA-associated%2520proteins%2520and%2520cleaves%2520one%2520of%2520them%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26issue%3D17%26spage%3D9285%26epage%3D9290%26doi%3D10.1073%2Fpnas.94.17.9285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, L.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kam, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froelich, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2289</span>â <span class="NLM_lpage">2301</span>, <span class="refDoi">Â DOI: 10.1021/jm970543s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970543s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1cXjtlyks7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2289-2301&issue=13&author=D.+S.+Jacksonauthor=S.+A.+Fraserauthor=L.-M.+Niauthor=C.-M.+Kamauthor=U.+Winklerauthor=D.+A.+Johnsonauthor=C.+J.+Froelichauthor=D.+Hudigauthor=J.+C.+Powers&title=Synthesis+and+evaluation+of+diphenyl+phosphonate+esters+as+inhibitors+of+the+trypsin-like+granzymes+A+and+K+and+mast+cell+tryptase&doi=10.1021%2Fjm970543s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Diphenyl Phosphonate Esters as Inhibitors of the Trypsin-like Granzymes A and K and Mast Cell Tryptase</span></div><div class="casAuthors">Jackson, Delwin S.; Fraser, Stephanie A.; Ni, Li-Ming; Kam, Chih-Min; Winkler, Ulrike; Johnson, David A.; Froelich, Christopher J.; Hudig, Dorothy; Powers, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2289-2301</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Thirty-six new amino acid and peptidyl phosphonate esters, e.g. I [R = PhCH2O2C (Cbz), HO2CCH2CH2CO (Suc), R1CH:CHCO, 3-PhOC6H4CO, 2-PhOC6H4CO, 1-C10H7SO2, 1-C10H7CH2O2C, Cbz-X, R2-Pro, Suc-Ala-Ala, Boc-D-Phe-Pro, PhCH2SO2-Gly-Pro; R1 = Ph, 2-furyl, 2-thienyl, 3-pyridyl; X = Ala, Val, Leu, Pro, Thr, Lys, Phe, Ala-Ala, Pro-Ala, Asp-Ala, Asp(OCMe3)-Ala, Lys-Ala, Lys(Boc)-Ala, Phe-Ala, Ala-Ala-Ala; R2 = 2-PhOC6H4CO, 3-PhOC6H4CO, Ph2CHCH2CO, PhCH2CH2CO; Boc = Me3CO2C] were synthesized and evaluated to identify potent and selective inhibitors for four trypsin-like proteases: lymphocyte granzymes A and K, human mast cell tryptase, and pancreatic trypsin.  Among five Lys and Arg homologs, II (R = Cbz) is the most potent inhibitor for granzyme A, and CbzNHCH(PO3Ph2)(CH2)4NH2.HCl (III) is the best inhibitor for granzyme K, mast tryptase, and trypsin.  Generally, phosphonates I inhibit granzyme A and trypsin more potently than granzyme K and tryptase.  Dipeptide phosphonates I (R = Cbz-Ala, Cbz-Thr) are the most potent inhibitors for granzyme A, and I (R = Cbz-Thr) (kobs/[I] = 2220 M-1 s-1) was quite specific with much lower inhibition rates for granzyme K and trypsin (kobs/[I] = 3 and 97 M-1 s-1, resp.) and no inhibition with tryptase.  The most effective inhibitor of granzyme A was I (R = PhCH2SO2-Gly-Pro) with a second-order rate const. of 3650 M-1 s-1.  The most potent inhibitor for granzyme K was I (R = Ph2CHCH2CO-Pro) with a kobs/[I] = 1830 M-1 s-1; all other phosphonates inhibited granzyme K weakly (kobs/[I] < 60 M-1 s-1).  Human mast cell tryptase was inhibited slowly by these phosphonates with III as the best inhibitor (kobs/[I] = 89 M-1 s-1).  The overall results suggest that scaffolds of II (R = Phe-Thr) and Phe-Pro-Lys will be useful to create selective phosphonate inhibitors for granzymes A and K, resp., and that P4 substituents offer opportunities to further enhance selectivity and reactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7r5zsvvYQj7Vg90H21EOLACvtfcHk0lgN38tSXlY0Fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtlyks7w%253D&md5=086ed1b653675b4cb11f45e9f516c159</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1021%2Fjm970543s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970543s%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DD.%2BS.%26aulast%3DFraser%26aufirst%3DS.%2BA.%26aulast%3DNi%26aufirst%3DL.-M.%26aulast%3DKam%26aufirst%3DC.-M.%26aulast%3DWinkler%26aufirst%3DU.%26aulast%3DJohnson%26aufirst%3DD.%2BA.%26aulast%3DFroelich%26aufirst%3DC.%2BJ.%26aulast%3DHudig%26aufirst%3DD.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520diphenyl%2520phosphonate%2520esters%2520as%2520inhibitors%2520of%2520the%2520trypsin-like%2520granzymes%2520A%2520and%2520K%2520and%2520mast%2520cell%2520tryptase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26issue%3D13%26spage%3D2289%26epage%3D2301%26doi%3D10.1021%2Fjm970543s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahrus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cell-mediated lysis of target cells</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">567</span>â <span class="NLM_lpage">577</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2005.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2005.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15911377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1aku7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=567-577&issue=5&author=S.+Mahrusauthor=C.+S.+Craik&title=Selective+chemical+functional+probes+of+granzymes+A+and+B+reveal+granzyme+B+is+a+major+effector+of+natural+killer+cell-mediated+lysis+of+target+cells&doi=10.1016%2Fj.chembiol.2005.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Selective chemical functional probes of granzymes A and B reveal granzyme B Is a major effector of natural killer cell-mediated lysis of target cells</span></div><div class="casAuthors">Mahrus, Sami; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">567-577</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mechanism of target cell lysis in cytotoxic lymphocyte-mediated death is not well understood, and the role of granzymes in this process is unclear.  Chem. functional probes were thus prepd. for the major granzymes A and B to deconvolute their role in natural killer cell-mediated lysis of target cells.  These biotinylated and substrate specificity-based di-Ph phosphonates allowed facile evaluation of selectivity through activity-based profiling in cell lysates and intact cells.  Both inhibitors were extremely selective in vitro and in cells.  Use of these inhibitors in cell-based assays revealed granzyme A to be a minor effector and granzyme B to be a major effector of target cell lysis by natural killer cells.  These studies indicate that the proapoptotic granzyme B functions also as a pronecrotic effector of target cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBTIufZM9xDrVg90H21EOLACvtfcHk0lgN38tSXlY0Fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1aku7Y%253D&md5=07dbb4ea5f6e2186a0ab880280247391</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DMahrus%26aufirst%3DS.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DSelective%2520chemical%2520functional%2520probes%2520of%2520granzymes%2520A%2520and%2520B%2520reveal%2520granzyme%2520B%2520is%2520a%2520major%2520effector%2520of%2520natural%2520killer%2520cell-mediated%2520lysis%2520of%2520target%2520cells%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26issue%3D5%26spage%3D567%26epage%3D577%26doi%3D10.1016%2Fj.chembiol.2005.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">KoÅt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janiszewski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiserman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modrzycka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span> <span> </span><span class="NLM_article-title">Detection of active granzyme A in NK92 cells with fluorescent activity-based probe</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3359</span>â <span class="NLM_lpage">3369</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.9b02042</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b02042" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksFWqtbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3359-3369&issue=6&author=S.+Ko%C5%82tauthor=T.+Janiszewskiauthor=D.+Kaisermanauthor=S.+Modrzyckaauthor=S.+J.+Snipasauthor=G.+Salvesenauthor=M.+Dragauthor=P.+I.+Birdauthor=P.+Kasperkiewicz&title=Detection+of+active+granzyme+A+in+NK92+cells+with+fluorescent+activity-based+probe&doi=10.1021%2Facs.jmedchem.9b02042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of Active Granzyme A in NK92 Cells with Fluorescent Activity-Based Probe</span></div><div class="casAuthors">Kolt, Sonia; Janiszewski, Tomasz; Kaiserman, Dion; Modrzycka, Sylwia; Snipas, Scott J.; Salvesen, Guy; Drag, Marcin; Bird, Phillip I.; Kasperkiewicz, Paulina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3359-3369</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cytotoxic T-lymphocytes (CTLs) and natural killer cells (NKs) kill compromised cells to defend against tumor and viral infections.  Both effector cell types use multiple strategies to induce target cell death including Fas/CD95 activation and the release of perforin and a group of lymphocyte granule serine proteases called granzymes.  Granzymes have relatively broad and overlapping substrate specificities and may hydrolyze a wide range of peptidic epitopes; it is therefore challenging to identify their natural and synthetic substrates and to distinguish their localization and functions.  Here, we present a specific and potent substrate, an inhibitor, and an activity-based probe of Granzyme A (GrA) that can be used to follow functional GrA in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXVfoh54TZdrVg90H21EOLACvtfcHk0lgNWdYEWVOMjQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksFWqtbg%253D&md5=4efddf846d803b54818ce50123eefe61</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b02042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b02042%26sid%3Dliteratum%253Aachs%26aulast%3DKo%25C5%2582t%26aufirst%3DS.%26aulast%3DJaniszewski%26aufirst%3DT.%26aulast%3DKaiserman%26aufirst%3DD.%26aulast%3DModrzycka%26aufirst%3DS.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DSalvesen%26aufirst%3DG.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DBird%26aufirst%3DP.%2BI.%26aulast%3DKasperkiewicz%26aufirst%3DP.%26atitle%3DDetection%2520of%2520active%2520granzyme%2520A%2520in%2520NK92%2520cells%2520with%2520fluorescent%2520activity-based%2520probe%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D6%26spage%3D3359%26epage%3D3369%26doi%3D10.1021%2Facs.jmedchem.9b02042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janiszewski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KoÅt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiserman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulbacka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saczko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovenschen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DraÌ§g, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span> <span> </span><span class="NLM_article-title">Noninvasive optical detection of granzyme B from natural killer cells with enzyme-activated fluorogenic probes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>295</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">9567</span>â <span class="NLM_lpage">9582</span>, <span class="refDoi">Â DOI: 10.1074/jbc.RA120.013204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.RA120.013204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32439802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFemsb3L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2020&pages=9567-9582&issue=28&author=T.+Janiszewskiauthor=S.+Ko%C5%82tauthor=D.+Kaisermanauthor=S.+J.+Snipasauthor=S.+Liauthor=J.+Kulbackaauthor=J.+Saczkoauthor=N.+Bovenschenauthor=G.+Salvesenauthor=M.+Dra%CC%A7gauthor=P.+I.+Birdauthor=P.+Kasperkiewicz&title=Noninvasive+optical+detection+of+granzyme+B+from+natural+killer+cells+with+enzyme-activated+fluorogenic+probes&doi=10.1074%2Fjbc.RA120.013204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Noninvasive optical detection of granzyme B from natural killer cells with enzyme-activated fluorogenic probes</span></div><div class="casAuthors">Janiszewski, Tomasz; Kolt, Sonia; Kaiserman, Dion; Snipas, Scott J.; Li, Shuang; Kulbacka, Julita; Saczko, Jolanta; Bovenschen, Niels; Salvesen, Guy; Drag, Marcin; Bird, Phillip I.; Kasperkiewicz, Paulina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9567-9582</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">1083-351X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Natural killer (NK) cells are key innate immunity effectors that combat viral infections and control several cancer types.  For their immune function, human NK cells rely largely on five different cytotoxic proteases, called granzymes (A/B/H/K/M).  Granzyme B (GrB) initiates at least three distinct cell death pathways, but key aspects of its function remain unexplored because selective probes that detect its activity are currently lacking.  The authors used a set of unnatural amino acids to fully map the substrate preferences of GrB, demonstrating previously unknown GrB substrate preferences.  The authors then used these preferences to design substrate-based inhibitors and a GrB-activatable activity-based fluorogenic probe.  The authors' GrB probes do not significantly react with caspases, making them ideal for in-depth analyses of GrB localization and function in cells.  Using the authors' quenched fluorescence substrate, the authors obsd. GrB within the cytotoxic granules of human YT cells.  When used as cytotoxic effectors, YT cells loaded with GrB attacked MDA-MB-231 target cells, and active GrB influenced its target cell-killing efficiency.  In summary, the authors have developed a set of mol. tools for studying GrB function in NK cells and demonstrate noninvasive visual detection of GrB with an enzyme-activated fluorescent substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo39j22pwi2L7Vg90H21EOLACvtfcHk0lgNWdYEWVOMjQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFemsb3L&md5=38f76e70aa1e126e85dc5e44ff03afd2</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA120.013204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA120.013204%26sid%3Dliteratum%253Aachs%26aulast%3DJaniszewski%26aufirst%3DT.%26aulast%3DKo%25C5%2582t%26aufirst%3DS.%26aulast%3DKaiserman%26aufirst%3DD.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DKulbacka%26aufirst%3DJ.%26aulast%3DSaczko%26aufirst%3DJ.%26aulast%3DBovenschen%26aufirst%3DN.%26aulast%3DSalvesen%26aufirst%3DG.%26aulast%3DDra%25CC%25A7g%26aufirst%3DM.%26aulast%3DBird%26aufirst%3DP.%2BI.%26aulast%3DKasperkiewicz%26aufirst%3DP.%26atitle%3DNoninvasive%2520optical%2520detection%2520of%2520granzyme%2520B%2520from%2520natural%2520killer%2520cells%2520with%2520enzyme-activated%2520fluorogenic%2520probes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2020%26volume%3D295%26issue%3D28%26spage%3D9567%26epage%3D9582%26doi%3D10.1074%2Fjbc.RA120.013204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goggi, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartimath, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jieu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boominathan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chacko, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robins, E. G.</span></span> <span> </span><span class="NLM_article-title">Granzyme B PET imaging of immune checkpoint inhibitor combinations in colon cancer phenotypes</span>. <i>Mol. Imaging Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1392</span>â <span class="NLM_lpage">1402</span>, <span class="refDoi">Â DOI: 10.1007/s11307-020-01519-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1007%2Fs11307-020-01519-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=32705455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVCltLnJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2020&pages=1392-1402&issue=5&author=J.+L.+Goggiauthor=Y.+X.+Tanauthor=S.+V.+Hartimathauthor=B.+Jieuauthor=Y.+Y.+Hwangauthor=L.+Jiangauthor=R.+Boominathanauthor=P.+Chengauthor=T.+Y.+Yuenauthor=H.+X.+Chinauthor=J.+R.+Tangauthor=A.+Larbiauthor=A.+M.+Chackoauthor=L.+Reniaauthor=C.+Johannesauthor=E.+G.+Robins&title=Granzyme+B+PET+imaging+of+immune+checkpoint+inhibitor+combinations+in+colon+cancer+phenotypes&doi=10.1007%2Fs11307-020-01519-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Granzyme B PET Imaging of Immune Checkpoint Inhibitor Combinations in Colon Cancer Phenotypes</span></div><div class="casAuthors">Goggi, J. L.; Tan, Y. X.; Hartimath, S. V.; Jieu, B.; Hwang, Y. Y.; Jiang, L.; Boominathan, R.; Cheng, P.; Yuen, T. Y.; Chin, H. X.; Tang, J. R.; Larbi, A.; Chacko, A. M.; Renia, L.; Johannes, C.; Robins, Edward G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Imaging and Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1392-1402</span>CODEN:
                <span class="NLM_cas:coden">MIBOCZ</span>;
        ISSN:<span class="NLM_cas:issn">1860-2002</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: Purpose: Immune checkpoint inhibitor (ICI) monotherapy and combination regimens are being actively pursued as strategies to improve durable response rates in cancer patients.  However, the biol. surrounding combination therapies is not well understood and may increase the likelihood of immune-mediated adverse events.  Accurate stratification of ICI response by non-invasive PET imaging may help ensure safe therapy management across a wide no. of cancer phenotypes.  Procedures: We have assessed the ability of a fluorine-labeled peptide, [18F]AlF-mNOTA-GZP, targeting granzyme B, to stratify ICI response in two syngeneic models of colon cancer, CT26 and MC38.  In vivo tumor uptake of [18F]AlF-mNOTA-GZP following ICI monotherapy, or in combination with PD-1 was characterised and correlated with changes in tumor-assocd. immune cell populations.  Results: [18F]AlF-mNOTA-GZP showed good predictive ability and correlated well with changes in tumor-assocd. T cells, esp. CD8+ T cells; however, overall uptake and response to monotherapy or combination therapies was very different in the CT26 and MC38 tumors, likely due to the immunostimulatory environment imbued by the MSI-high phenotype in MC38 tumors.  Conclusions: [18F]AlF-mNOTA-GZP uptake correlates well with changes in CD8+ T cell populations and is able to stratify tumor response to a range of ICIs administered as monotherapies or in combination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvKKKj4LaEwbVg90H21EOLACvtfcHk0lgG1y9c9wiPIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVCltLnJ&md5=d39dc72fc9b45f9b7964a0536366d40c</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1007%2Fs11307-020-01519-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-020-01519-3%26sid%3Dliteratum%253Aachs%26aulast%3DGoggi%26aufirst%3DJ.%2BL.%26aulast%3DTan%26aufirst%3DY.%2BX.%26aulast%3DHartimath%26aufirst%3DS.%2BV.%26aulast%3DJieu%26aufirst%3DB.%26aulast%3DHwang%26aufirst%3DY.%2BY.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DBoominathan%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DP.%26aulast%3DYuen%26aufirst%3DT.%2BY.%26aulast%3DChin%26aufirst%3DH.%2BX.%26aulast%3DTang%26aufirst%3DJ.%2BR.%26aulast%3DLarbi%26aufirst%3DA.%26aulast%3DChacko%26aufirst%3DA.%2BM.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DJohannes%26aufirst%3DC.%26aulast%3DRobins%26aufirst%3DE.%2BG.%26atitle%3DGranzyme%2520B%2520PET%2520imaging%2520of%2520immune%2520checkpoint%2520inhibitor%2520combinations%2520in%2520colon%2520cancer%2520phenotypes%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2020%26volume%3D22%26issue%3D5%26spage%3D1392%26epage%3D1402%26doi%3D10.1007%2Fs11307-020-01519-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larimer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehrenberg-Klee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalomeris, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boland, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmood, U.</span></span> <span> </span><span class="NLM_article-title">Granzyme B PET imaging as a predictive biomarker of immunotherapy response</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2318</span>â <span class="NLM_lpage">2327</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-16-3346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1158%2F0008-5472.CAN-16-3346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=28461564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFartrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=2318-2327&issue=9&author=B.+M.+Larimerauthor=E.+Wehrenberg-Kleeauthor=F.+Duboisauthor=A.+Mehtaauthor=T.+Kalomerisauthor=K.+Flahertyauthor=G.+Bolandauthor=U.+Mahmood&title=Granzyme+B+PET+imaging+as+a+predictive+biomarker+of+immunotherapy+response&doi=10.1158%2F0008-5472.CAN-16-3346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response</span></div><div class="casAuthors">Larimer, Benjamin M.; Wehrenberg-Klee, Eric; Dubois, Frank; Mehta, Anila; Kalomeris, Taylor; Flaherty, Keith; Boland, Genevieve; Mahmood, Umar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2318-2327</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">While cancer immunotherapy can produce dramatic responses, only a minority of patients respond to treatment.  Reliable response biomarkers are needed to identify responders, and conventional imaging modalities have not proved adequate.  Here, we provide a preclin. proof of concept for the use of granzyme B, a downstream effector of tumoral cytotoxic T cells, as an early biomarker for tumors responding to immunotherapy.  We designed novel PET imaging probes for the murine and human granzyme B isoforms that specifically and quant. bind granzyme B. Immunotherapy-treated mice were imaged prior to therapy-induced tumor vol. redn.  Imaging distinguished treated responders from nonresponders with excellent predictive ability.  To assess the clin. value of a granzyme B imaging paradigm, biopsy specimens from melanoma patients on checkpoint inhibitor therapy were analyzed.  A marked differential in granzyme B expression was obsd. between treated responders and nonresponders.  Addnl., our human probe was able to specifically detect granzyme B expression in human samples, providing a clear candidate for clin. application.  Overall, our results suggest granzyme B PET imaging can serve as a quant. useful predictive biomarker for efficacious responses to cancer immunotherapy.  Cancer Res; 77(9); 2318-27. Â©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzqLaYDBMrVrVg90H21EOLACvtfcHk0lgG1y9c9wiPIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFartrg%253D&md5=067c1214de9644011415501199938939</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-3346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-3346%26sid%3Dliteratum%253Aachs%26aulast%3DLarimer%26aufirst%3DB.%2BM.%26aulast%3DWehrenberg-Klee%26aufirst%3DE.%26aulast%3DDubois%26aufirst%3DF.%26aulast%3DMehta%26aufirst%3DA.%26aulast%3DKalomeris%26aufirst%3DT.%26aulast%3DFlaherty%26aufirst%3DK.%26aulast%3DBoland%26aufirst%3DG.%26aulast%3DMahmood%26aufirst%3DU.%26atitle%3DGranzyme%2520B%2520PET%2520imaging%2520as%2520a%2520predictive%2520biomarker%2520of%2520immunotherapy%2520response%26jtitle%3DCancer%2520Res.%26date%3D2017%26volume%3D77%26issue%3D9%26spage%3D2318%26epage%3D2327%26doi%3D10.1158%2F0008-5472.CAN-16-3346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeglinski, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raithatha, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oram, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiroyasu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westendorf, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopko, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arns, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liggins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaquith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papp, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granville, D. J.</span></span> <span> </span><span class="NLM_article-title">Topical small molecule granzyme B inhibitor improves remodeling in a murine model of impaired burn wound healing</span>. <i>Exp. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">11</span>, <span class="refDoi">Â DOI: 10.1038/s12276-018-0095-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs12276-018-0095-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOmtb%252FF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2018&pages=1-11&issue=5&author=Y.+Shenauthor=M.+R.+Zeglinskiauthor=C.+T.+Turnerauthor=S.+A.+Raithathaauthor=Z.+Wuauthor=V.+Russoauthor=C.+Oramauthor=S.+Hiroyasuauthor=L.+Nabaiauthor=H.+Zhaoauthor=T.+Bozinauthor=K.+Westendorfauthor=I.+Kopkoauthor=R.+Huangauthor=S.+Arnsauthor=J.+Tanauthor=H.+Zengauthor=A.+Boeyauthor=R.+Ligginsauthor=J.+Jaquithauthor=D.+R.+Cameronauthor=A.+Pappauthor=D.+J.+Granville&title=Topical+small+molecule+granzyme+B+inhibitor+improves+remodeling+in+a+murine+model+of+impaired+burn+wound+healing&doi=10.1038%2Fs12276-018-0095-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Topical small molecule granzyme B inhibitor improves remodeling in a murine model of impaired burn wound healing</span></div><div class="casAuthors">Shen, Yue; Zeglinski, Matthew R.; Turner, Christopher T.; Raithatha, Sheetal A.; Wu, Zhenguo; Russo, Valerio; Oram, Cameron; Hiroyasu, Sho; Nabai, Layla; Zhao, Hongyan; Bozin, Tatjana; Westendorf, Kathryn; Kopko, Irina; Huang, Rachel; Arns, Steve; Tan, Jason; Zeng, Haishan; Boey, Anthony; Liggins, Richard; Jaquith, James; Cameron, Dale R.; Papp, Anthony; Granville, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental & Molecular Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">EMMEF3</span>;
        ISSN:<span class="NLM_cas:issn">2092-6413</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Granzyme B (GzmB) is a serine protease that has long been thought to function exclusively in lymphocyte-mediated apoptosis.  In recent years, this paradigm has been revisited due to the recognition that GzmB accumulates in the extracellular milieu in many autoimmune and chronic inflammatory disorders, and contributes to impaired tissue remodeling due to the cleavage of extracellular matrix proteins.  Knockout studies suggest that GzmB-mediated cleavage of decorin (DCN) contributes to impaired collagen fibrillogenesis and remodeling.  As DCN is anti-fibrotic and contributes to reduced hypertrophic scarring, GzmB-induced DCN cleavage could play a role in wound healing following burn injury.  In the present study, a novel, gel-formulated, first-in-class small-mol. inhibitor of GzmB, VTI-1002, was assessed in a murine model of impaired, diabetic burn wound healing.  VTI-1002 exhibited high specificity, potency, and target selectivity.  Gel-formulated VTI-1002 was able to penetrate the stratum corneum and was retained in the skin with minimal systemic absorption.  Daily topical administration of VTI-1002 gel for 30 days following thermal injury showed significantly accelerated wound closure, increased DCN protein levels, and collagen organization that was translated into significantly increased wound tensile strength compared to controls.  Overall, VTI-1002 gel was well-tolerated in vivo and no adverse events were obsd.  Topical application of VTI-1002 represents a novel therapeutic approach for the treatment of cutaneous burn wounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0K8QSNOV3mbVg90H21EOLACvtfcHk0lgG1y9c9wiPIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOmtb%252FF&md5=ed4c467b8dbc0ad4d3b2f7d209b6f8d4</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1038%2Fs12276-018-0095-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs12276-018-0095-0%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DY.%26aulast%3DZeglinski%26aufirst%3DM.%2BR.%26aulast%3DTurner%26aufirst%3DC.%2BT.%26aulast%3DRaithatha%26aufirst%3DS.%2BA.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DRusso%26aufirst%3DV.%26aulast%3DOram%26aufirst%3DC.%26aulast%3DHiroyasu%26aufirst%3DS.%26aulast%3DNabai%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DBozin%26aufirst%3DT.%26aulast%3DWestendorf%26aufirst%3DK.%26aulast%3DKopko%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DArns%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DBoey%26aufirst%3DA.%26aulast%3DLiggins%26aufirst%3DR.%26aulast%3DJaquith%26aufirst%3DJ.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DPapp%26aufirst%3DA.%26aulast%3DGranville%26aufirst%3DD.%2BJ.%26atitle%3DTopical%2520small%2520molecule%2520granzyme%2520B%2520inhibitor%2520improves%2520remodeling%2520in%2520a%2520murine%2520model%2520of%2520impaired%2520burn%2520wound%2520healing%26jtitle%3DExp.%2520Mol.%2520Med.%26date%3D2018%26volume%3D50%26issue%3D5%26spage%3D1%26epage%3D11%26doi%3D10.1038%2Fs12276-018-0095-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiroyasu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeglinski, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawluk, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasprick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateishi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burleigh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennox, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Laeken, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granville, D. J.</span></span> <span> </span><span class="NLM_article-title">Granzyme B inhibition reduces disease severity in autoimmune blistering diseases</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">302</span>, <span class="refDoi">Â DOI: 10.1038/s41467-020-20604-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41467-020-20604-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=33436591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3MXhsVelsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2021&pages=302&issue=1&author=S.+Hiroyasuauthor=M.+R.+Zeglinskiauthor=H.+Zhaoauthor=M.+A.+Pawlukauthor=C.+T.+Turnerauthor=A.+Kasprickauthor=C.+Tateishiauthor=W.+Nishieauthor=A.+Burleighauthor=P.+A.+Lennoxauthor=N.+Van+Laekenauthor=N.+J.+Carrauthor=F.+Petersenauthor=R.+I.+Crawfordauthor=H.+Shimizuauthor=D.+Tsurutaauthor=R.+J.+Ludwigauthor=D.+J.+Granville&title=Granzyme+B+inhibition+reduces+disease+severity+in+autoimmune+blistering+diseases&doi=10.1038%2Fs41467-020-20604-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Granzyme B inhibition reduces disease severity in autoimmune blistering diseases</span></div><div class="casAuthors">Hiroyasu, Sho; Zeglinski, Matthew R.; Zhao, Hongyan; Pawluk, Megan A.; Turner, Christopher T.; Kasprick, Anika; Tateishi, Chiharu; Nishie, Wataru; Burleigh, Angela; Lennox, Peter A.; Van Laeken, Nancy; Carr, Nick J.; Petersen, Frank; Crawford, Richard I.; Shimizu, Hiroshi; Tsuruta, Daisuke; Ludwig, Ralf J.; Granville, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">302</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Pemphigoid diseases refer to a group of severe autoimmune skin blistering diseases characterized by subepidermal blistering and loss of dermal-epidermal adhesion induced by autoantibody and immune cell infiltrate at the dermal-epidermal junction and upper dermis.  Here, we explore the role of the immune cell-secreted serine protease, granzyme B, in pemphigoid disease pathogenesis using three independent murine models.  In all models, granzyme B knockout or topical pharmacol. inhibition significantly reduces total blistering area compared to controls.  In vivo and in vitro studies show that granzyme B contributes to blistering by degrading key anchoring proteins in the dermal-epidermal junction that are necessary for dermal-epidermal adhesion.  Further, granzyme B mediates IL-8/macrophage inflammatory protein-2 secretion, lesional neutrophil infiltration, and lesional neutrophil elastase activity.  Clin., granzyme B is elevated and abundant in human pemphigoid disease blister fluids and lesional skin.  Collectively, granzyme B is a potential therapeutic target in pemphigoid diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprjMs0pTs1OLVg90H21EOLACvtfcHk0ljlCYQNQeg_aA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXhsVelsbY%253D&md5=70283676449403d024c21aaeefdb21fe</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-20604-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-20604-3%26sid%3Dliteratum%253Aachs%26aulast%3DHiroyasu%26aufirst%3DS.%26aulast%3DZeglinski%26aufirst%3DM.%2BR.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DPawluk%26aufirst%3DM.%2BA.%26aulast%3DTurner%26aufirst%3DC.%2BT.%26aulast%3DKasprick%26aufirst%3DA.%26aulast%3DTateishi%26aufirst%3DC.%26aulast%3DNishie%26aufirst%3DW.%26aulast%3DBurleigh%26aufirst%3DA.%26aulast%3DLennox%26aufirst%3DP.%2BA.%26aulast%3DVan%2BLaeken%26aufirst%3DN.%26aulast%3DCarr%26aufirst%3DN.%2BJ.%26aulast%3DPetersen%26aufirst%3DF.%26aulast%3DCrawford%26aufirst%3DR.%2BI.%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DTsuruta%26aufirst%3DD.%26aulast%3DLudwig%26aufirst%3DR.%2BJ.%26aulast%3DGranville%26aufirst%3DD.%2BJ.%26atitle%3DGranzyme%2520B%2520inhibition%2520reduces%2520disease%2520severity%2520in%2520autoimmune%2520blistering%2520diseases%26jtitle%3DNat.%2520Commun.%26date%3D2021%26volume%3D12%26issue%3D1%26spage%3D302%26doi%3D10.1038%2Fs41467-020-20604-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">VicuÃ±a, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strochlic, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latremoliere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bali, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husainie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokosch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riva, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehrig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mall, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolf, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liberles, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costigan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuner, R.</span></span> <span> </span><span class="NLM_article-title">The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">518</span>â <span class="NLM_lpage">523</span>, <span class="refDoi">Â DOI: 10.1038/nm.3852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnm.3852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25915831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvFSqu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=518-523&issue=5&author=L.+Vicu%C3%B1aauthor=D.+E.+Strochlicauthor=A.+Latremoliereauthor=K.+K.+Baliauthor=M.+Simonettiauthor=D.+Husainieauthor=S.+Prokoschauthor=P.+Rivaauthor=R.+S.+Griffinauthor=C.+Njooauthor=S.+Gehrigauthor=M.+A.+Mallauthor=B.+Arnoldauthor=M.+Devorauthor=C.+J.+Woolfauthor=S.+D.+Liberlesauthor=M.+Costiganauthor=R.+Kuner&title=The+serine+protease+inhibitor+SerpinA3N+attenuates+neuropathic+pain+by+inhibiting+T+cell-derived+leukocyte+elastase&doi=10.1038%2Fnm.3852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase</span></div><div class="casAuthors">Vicuna, Lucas; Strochlic, David E.; Latremoliere, Alban; Bali, Kiran Kumar; Simonetti, Manuela; Husainie, Dewi; Prokosch, Sandra; Riva, Priscilla; Griffin, Robert S.; Njoo, Christian; Gehrig, Stefanie; Mall, Marcus A.; Arnold, Bernd; Devor, Marshall; Woolf, Clifford J.; Liberles, Stephen D.; Costigan, Michael; Kuner, Rohini</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">518-523</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuropathic pain is a major, intractable clin. problem and its pathophysiol. is not well understood.  Although recent gene expression profiling studies have enabled the identification of novel targets for pain therapy, classical study designs provide unclear results owing to the differential expression of hundreds of genes across sham and nerve-injured groups, which can be difficult to validate, particularly with respect to the specificity of pain modulation.  To circumvent this, we used two outbred lines of rats, which are genetically similar except for being genetically segregated as a result of selective breeding for differences in neuropathic pain hypersensitivity.  SerpinA3N, a serine protease inhibitor, was upregulated in the dorsal root ganglia (DRG) after nerve injury, which was further validated for its mouse homolog.  Mice lacking SerpinA3N developed more neuropathic mech. allodynia than wild-type (WT) mice, and exogenous delivery of SerpinA3N attenuated mech. allodynia in WT mice.  T lymphocytes infiltrate the DRG after nerve injury and release leukocyte elastase (LE), which was inhibited by SerpinA3N derived from DRG neurons.  Genetic loss of LE or exogenous application of a LE inhibitor (Sivelastat) in WT mice attenuated neuropathic mech. allodynia.  Overall, we reveal a novel and clin. relevant role for a member of the serpin superfamily and a leukocyte elastase and crosstalk between neurons and T cells in the modulation of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMteA4LZ-Gd7Vg90H21EOLACvtfcHk0ljlCYQNQeg_aA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvFSqu7w%253D&md5=f8660f90daa0b419bbc6972a7c81cfb2</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1038%2Fnm.3852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3852%26sid%3Dliteratum%253Aachs%26aulast%3DVicu%25C3%25B1a%26aufirst%3DL.%26aulast%3DStrochlic%26aufirst%3DD.%2BE.%26aulast%3DLatremoliere%26aufirst%3DA.%26aulast%3DBali%26aufirst%3DK.%2BK.%26aulast%3DSimonetti%26aufirst%3DM.%26aulast%3DHusainie%26aufirst%3DD.%26aulast%3DProkosch%26aufirst%3DS.%26aulast%3DRiva%26aufirst%3DP.%26aulast%3DGriffin%26aufirst%3DR.%2BS.%26aulast%3DNjoo%26aufirst%3DC.%26aulast%3DGehrig%26aufirst%3DS.%26aulast%3DMall%26aufirst%3DM.%2BA.%26aulast%3DArnold%26aufirst%3DB.%26aulast%3DDevor%26aufirst%3DM.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26aulast%3DLiberles%26aufirst%3DS.%2BD.%26aulast%3DCostigan%26aufirst%3DM.%26aulast%3DKuner%26aufirst%3DR.%26atitle%3DThe%2520serine%2520protease%2520inhibitor%2520SerpinA3N%2520attenuates%2520neuropathic%2520pain%2520by%2520inhibiting%2520T%2520cell-derived%2520leukocyte%2520elastase%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26issue%3D5%26spage%3D518%26epage%3D523%26doi%3D10.1038%2Fnm.3852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narahara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiuchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, Y.</span></span> <span> </span><span class="NLM_article-title">Neutrophil elastase enhances IL-12p40 production by lipopolysaccharide-stimulated macrophages via transactivation of the PAR-2/EGFR/TLR4 signaling pathway</span>. <i>Blood Cells, Mol., Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">7</span>, <span class="refDoi">Â DOI: 10.1016/j.bcmd.2016.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bcmd.2016.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27282560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlslagsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1-7&author=R.+Yamaguchiauthor=T.+Yamamotoauthor=A.+Sakamotoauthor=S.+Naraharaauthor=H.+Sugiuchiauthor=Y.+Yamaguchi&title=Neutrophil+elastase+enhances+IL-12p40+production+by+lipopolysaccharide-stimulated+macrophages+via+transactivation+of+the+PAR-2%2FEGFR%2FTLR4+signaling+pathway&doi=10.1016%2Fj.bcmd.2016.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Neutrophil elastase enhances IL-12p40 production by lipopolysaccharide-stimulated macrophages via transactivation of the PAR-2/EGFR/TLR4 signaling pathway</span></div><div class="casAuthors">Yamaguchi, Rui; Yamamoto, Takatoshi; Sakamoto, Arisa; Narahara, Shinji; Sugiuchi, Hiroyuki; Yamaguchi, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Blood Cells, Molecules, & Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">BCMDFX</span>;
        ISSN:<span class="NLM_cas:issn">1079-9796</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Proteinase-activated receptor 2 (PAR-2) and toll-like receptor 4 (TLR4) are involved in innate immune responses and signaling cross-talk between these receptor mols. has the potential to augment an ongoing inflammatory response.  The aim of this study was to evaluate the possible cooperative influence of PAR-2 and TLR4 on IL-12p40 prodn. by macrophages after stimulation with lipopolysaccharide (LPS).  During culture, GM-CSF upregulated PAR-2 expression by macrophages in a time-dependent manner.  Stimulation with LPS enhanced IL-12p40 prodn. by macrophages in a concn.-dependent manner.  While human neutrophil elastase (HNE) did not induce IL-12p40 prodn., pretreatment of macrophages with HNE synergistically increased the IL-12p40 protein level after LPS exposure.  Silencing of TLR4 with small interfering RNA blunted the synergistic enhancement of IL-12p40 by HNE combined with LPS.  Silencing of Î²-arrestin 2, p22phox, or ERK1/2 also inhibited an increase of IL-12p40.  Interestingly, transfection of macrophages with small interfering RNA duplexes for DUOX-2, EGFR, TLR4, or TRAF6 significantly blunted the increase of IL-12p40 in response to treatment with HNE plus LPS.  U73122 and Rottlerin also inhibited the increased prodn. of IL-12p40.  In conclusion, HNE is involved in transactivation of TLR4 through activation of DUOX-2/EGFR and synergistically enhances IL-12p40 prodn. by macrophages stimulated with LPS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowvR2j-XVrlrVg90H21EOLACvtfcHk0lhaTrHHYo0GxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlslagsr8%253D&md5=671c84f100c1f15deb40b2aada5ae643</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1016%2Fj.bcmd.2016.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcmd.2016.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DR.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DA.%26aulast%3DNarahara%26aufirst%3DS.%26aulast%3DSugiuchi%26aufirst%3DH.%26aulast%3DYamaguchi%26aufirst%3DY.%26atitle%3DNeutrophil%2520elastase%2520enhances%2520IL-12p40%2520production%2520by%2520lipopolysaccharide-stimulated%2520macrophages%2520via%2520transactivation%2520of%2520the%2520PAR-2%252FEGFR%252FTLR4%2520signaling%2520pathway%26jtitle%3DBlood%2520Cells%252C%2520Mol.%252C%2520Dis.%26date%3D2016%26volume%3D59%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.bcmd.2016.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zemans, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briones, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Linden, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downey, G. P.</span></span> <span> </span><span class="NLM_article-title">Leukocyte elastase induces lung epithelial apoptosis via a PAR-1-, NF-ÎºB-, and p53-dependent Pathway</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">742</span>â <span class="NLM_lpage">755</span>, <span class="refDoi">Â DOI: 10.1165/rcmb.2008-0157OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1165%2Frcmb.2008-0157OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19307610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWisbnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=742-755&issue=6&author=T.+Suzukiauthor=C.+Yamashitaauthor=R.+L.+Zemansauthor=N.+Brionesauthor=A.+Van+Lindenauthor=G.+P.+Downey&title=Leukocyte+elastase+induces+lung+epithelial+apoptosis+via+a+PAR-1-%2C+NF-%CE%BAB-%2C+and+p53-dependent+Pathway&doi=10.1165%2Frcmb.2008-0157OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Leukocyte elastase induces lung epithelial apoptosis via a PAR-1-, NF-ÎºB-, and p53-dependent pathway</span></div><div class="casAuthors">Suzuki, Tomoko; Yamashita, Cory; Zemans, Rachel L.; Briones, Natalie; Van Linden, Annemie; Downey, Gregory P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">742-755</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Leukocyte elastase induces apoptosis of lung epithelial cells via alterations in mitochondrial permeability, but the signaling pathways regulating this response remain uncertain.  Here we investigated the involvement of proteinase-activated receptor-1 (PAR-1), the transcription factor NF-ÎºB, and the protooncogene p53 in this pathway.  Elastase-induced apoptosis of lung epithelial cells correlated temporally with activation of NF-ÎºB, phosphorylation, and nuclear translocation of p53, increased p53 up-regulated modulator of apoptosis (PUMA) expression, and mitochondrial translocation of Bax resulting in enhanced permeability.  Elastase-induced apoptosis was also prevented by pharmacol. inhibitors of NF-ÎºB and p53 and by short interfering RNA knockdown of PAR-1, p53, or PUMA.  These inhibitors prevented elastase-induced PUMA expression, mitochondrial translocation of Bax, increased mitochondrial permeability, and attenuated apoptosis.  NF-ÎºB inhibitors also reduced p53 phosphorylation.  We conclude that elastase-induced apoptosis of lung epithelial cells is mediated by a PAR-1-triggered pathway involving activation of NF-ÎºB and p53, and a PUMA- and Bax-dependent increase in mitochondrial permeability leading to activation of distal caspases.  Further, p53 contributes to elastase-induced apoptosis by both transcriptional and post-transcriptional mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofOFPz_cvX0bVg90H21EOLACvtfcHk0lhaTrHHYo0GxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWisbnM&md5=030bcb96976ac0bd3a1e5e7ca0c8e632</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2008-0157OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2008-0157OC%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DC.%26aulast%3DZemans%26aufirst%3DR.%2BL.%26aulast%3DBriones%26aufirst%3DN.%26aulast%3DVan%2BLinden%26aufirst%3DA.%26aulast%3DDowney%26aufirst%3DG.%2BP.%26atitle%3DLeukocyte%2520elastase%2520induces%2520lung%2520epithelial%2520apoptosis%2520via%2520a%2520PAR-1-%252C%2520NF-%25CE%25BAB-%252C%2520and%2520p53-dependent%2520Pathway%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2009%26volume%3D41%26issue%3D6%26spage%3D742%26epage%3D755%26doi%3D10.1165%2Frcmb.2008-0157OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boudier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieth, J. G.</span></span> <span> </span><span class="NLM_article-title">Mucus proteinase inhibitor: a fast-acting inhibitor of leucocyte elastase</span>. <i>Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>995</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">36</span>â <span class="NLM_lpage">41</span>, <span class="refDoi">Â DOI: 10.1016/0167-4838(89)90230-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2F0167-4838%2889%2990230-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=2923915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaL1MXktF2qtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=995&publication_year=1989&pages=36-41&issue=1&author=C.+Boudierauthor=J.+G.+Bieth&title=Mucus+proteinase+inhibitor%3A+a+fast-acting+inhibitor+of+leucocyte+elastase&doi=10.1016%2F0167-4838%2889%2990230-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Mucus proteinase inhibitor:  a fast-acting inhibitor of leukocyte elastase</span></div><div class="casAuthors">Boudier, Christian; Bieth, Joseph G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">995</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-41</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    </div><div class="casAbstract">Human mucus proteinase inhibitor is a fast-acting inhibitor of human leukocyte elastase (EC 3.4.21.37) and forms a stable complex with this enzyme.  At physiol. ionic strength and temp. and in the presence of 10 mg/mL albumin, the kinetic consts. characterizing the interaction between elastase and the nondegraded inhibitor are: kass = 6.4 Ã 106 M-1 s-1, kdiss = 2.3 Ã 10-3 s-1, Ki = 3 Ã 10-10M.  The partially degraded inhibitor isolated by chymotrypsin-Sepharose chromatog. inhibits elastase with similar efficiency, suggesting that if partial proteolysis of the inhibitor occurs in vivo, the latter may still act as a potent antielastase.  Mucus proteinase inhibitor therefore plays a physiol. antielastase function in upper respiratory tract secretions, since it inhibits elastase with a delay time of 150 ms and behaves like an irreversible inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlyniTGzTjkLVg90H21EOLACvtfcHk0lhaTrHHYo0GxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktF2qtrY%253D&md5=1911bfe36f1d4b493a86c0be3f6061bb</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1016%2F0167-4838%2889%2990230-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-4838%252889%252990230-6%26sid%3Dliteratum%253Aachs%26aulast%3DBoudier%26aufirst%3DC.%26aulast%3DBieth%26aufirst%3DJ.%2BG.%26atitle%3DMucus%2520proteinase%2520inhibitor%253A%2520a%2520fast-acting%2520inhibitor%2520of%2520leucocyte%2520elastase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Protein%2520Struct.%2520Mol.%2520Enzymol.%26date%3D1989%26volume%3D995%26issue%3D1%26spage%3D36%26epage%3D41%26doi%3D10.1016%2F0167-4838%2889%2990230-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kistowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DÈ©bski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karczmarski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paziewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OlÈ©dzki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dadlez, M.</span></span> <span> </span><span class="NLM_article-title">A strong neutrophil elastase proteolytic fingerprint marks the carcinoma tumor proteome</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">213</span>â <span class="NLM_lpage">227</span>, <span class="refDoi">Â DOI: 10.1074/mcp.M116.058818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fmcp.M116.058818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27927741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVynurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=213-227&issue=2&author=M.+Kistowskiauthor=J.+D%C8%A9bskiauthor=J.+Karczmarskiauthor=A.+Paziewskaauthor=J.+Ol%C8%A9dzkiauthor=M.+Mikulaauthor=J.+Ostrowskiauthor=M.+Dadlez&title=A+strong+neutrophil+elastase+proteolytic+fingerprint+marks+the+carcinoma+tumor+proteome&doi=10.1074%2Fmcp.M116.058818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">A Strong Neutrophil Elastase Proteolytic Fingerprint Marks the Carcinoma Tumor Proteome</span></div><div class="casAuthors">Kistowski, Michal; Debski, Janusz; Karczmarski, Jakub; Paziewska, Agnieszka; Oledzki, Jacek; Mikula, Michal; Ostrowski, Jerzy; Dadlez, Michal</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Proteomics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-227</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9484</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Proteolytic cascades are deeply involved in crit. stages of cancer progression.  During the course of peptide-wise anal. of shotgun proteomic data sets representative of colon adenocarcinoma (AC) and ulcerative colitis (UC), we detected a cancer-specific proteolytic fingerprint composed of a set of numerous protein fragments cleaved C-terminally to V, I, A, T, or C residues, significantly overrepresented in AC.  A peptide set linked by a common VIATC cleavage consensus was the only prominent cancer-specific proteolytic fingerprint detected.  This sequence consensus indicated neutrophil elastase as a source of the fingerprint.  We also found that a large fraction of affected proteins are RNA processing proteins assocd. with the nuclear fraction and mostly cleaved within their functionally important RNA-binding domains.  Thus, we detected a new class of cancer-specific peptides that are possible markers of tumor-infiltrating neutrophil activity, which often correlates with the clin. outcome.  Data are available via ProteomeXchange with identifiers: PXD005274 (Data set 1) and PXD004249 (Data set 2).  Our results indicate the value of peptide-wise anal. of large global proteomic anal. data sets as opposed to protein-wise anal., in which outlier differential peptides are usually neglected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz-B2IhI4YybVg90H21EOLACvtfcHk0liU0ZN3Wwl8oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVynurw%253D&md5=bd37440ace94df97a8ba6bf59139ab27</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M116.058818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M116.058818%26sid%3Dliteratum%253Aachs%26aulast%3DKistowski%26aufirst%3DM.%26aulast%3DD%25C8%25A9bski%26aufirst%3DJ.%26aulast%3DKarczmarski%26aufirst%3DJ.%26aulast%3DPaziewska%26aufirst%3DA.%26aulast%3DOl%25C8%25A9dzki%26aufirst%3DJ.%26aulast%3DMikula%26aufirst%3DM.%26aulast%3DOstrowski%26aufirst%3DJ.%26aulast%3DDadlez%26aufirst%3DM.%26atitle%3DA%2520strong%2520neutrophil%2520elastase%2520proteolytic%2520fingerprint%2520marks%2520the%2520carcinoma%2520tumor%2520proteome%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2017%26volume%3D16%26issue%3D2%26spage%3D213%26epage%3D227%26doi%3D10.1074%2Fmcp.M116.058818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaguliene, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zemaitis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavinskiene, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miliauskas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakalauskas, R.</span></span> <span> </span><span class="NLM_article-title">Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease</span>. <i>BMC Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">36</span>, <span class="refDoi">Â DOI: 10.1186/1471-2172-14-36</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1186%2F1471-2172-14-36" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23919722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlajsrbL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=36&issue=1&author=N.+Vagulieneauthor=M.+Zemaitisauthor=S.+Lavinskieneauthor=S.+Miliauskasauthor=R.+Sakalauskas&title=Local+and+systemic+neutrophilic+inflammation+in+patients+with+lung+cancer+and+chronic+obstructive+pulmonary+disease&doi=10.1186%2F1471-2172-14-36"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease</span></div><div class="casAuthors">Vaguliene, Neringa; Zemaitis, Marius; Lavinskiene, Simona; Miliauskas, Skaidrius; Sakalauskas, Raimundas</div><div class="citationInfo"><span class="NLM_cas:title">BMC Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">BIMMCV</span>;
        ISSN:<span class="NLM_cas:issn">1471-2172</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Recent investigations suggest that neutrophils play an important role in the immune response to lung cancer as well as chronic obstructive pulmonary disease (COPD).  The aim of this study was to evaluate the amt. of neutrophils and markers of their activity in lung cancer and COPD and in coexistence of these two diseases.  Methods: In total, 267 persons were included in the study: 139 patients with lung cancer, 55 patients with lung cancer and COPD, 40 patients with COPD and 33 healthy subjects.  Peripheral blood and BAL fluid samples were obtained for cell count anal. and detn. of NE, MPO levels and ROS prodn.  NE and MPO levels in the serum and BAL fluid were detd. by ELISA.  ROS prodn. was analyzed by flow cytometer.  Results: The percentage, cell count of neutrophils and neutrophil to lymphocyte ratio in the peripheral blood were significantly higher in lung cancer patients with or without COPD compared to COPD patients or healthy individuals (P < 0.05).  The percentage and cell count of neutrophils in BAL fluid were significantly lower in patients with lung cancer with or without COPD than in patients with COPD (P < 0.05).  However, BAL fluid and serum levels of both NE and MPO were significantly higher in patients with lung cancer than COPD patients or healthy individuals (P < 0.05).  Neutrophils produced higher amts. of ROS in patients with lung cancer with or without COPD compared with COPD patients or healthy individuals (P < 0.05).  Conclusions: The results from this study demonstrate higher degree of local and systemic neutrophilic inflammation in patients with lung cancer (with or without COPD) than in patients with COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvz5B46-Csb7Vg90H21EOLACvtfcHk0liU0ZN3Wwl8oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlajsrbL&md5=7686a5ea2aa72ca3a15952b85f17cf12</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1186%2F1471-2172-14-36&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2172-14-36%26sid%3Dliteratum%253Aachs%26aulast%3DVaguliene%26aufirst%3DN.%26aulast%3DZemaitis%26aufirst%3DM.%26aulast%3DLavinskiene%26aufirst%3DS.%26aulast%3DMiliauskas%26aufirst%3DS.%26aulast%3DSakalauskas%26aufirst%3DR.%26atitle%3DLocal%2520and%2520systemic%2520neutrophilic%2520inflammation%2520in%2520patients%2520with%2520lung%2520cancer%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DBMC%2520Immunol.%26date%3D2013%26volume%3D14%26issue%3D1%26spage%3D36%26doi%3D10.1186%2F1471-2172-14-36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tuhy, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span> <span> </span><span class="NLM_article-title">Inhibition of human leukocyte elastase by peptide chloromethyl ketones</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">359</span>â <span class="NLM_lpage">361</span>, <span class="refDoi">Â DOI: 10.1016/0014-5793(75)80527-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2F0014-5793%2875%2980527-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1116607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaE2MXhtlCktrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1975&pages=359-361&issue=3&author=P.+M.+Tuhyauthor=J.+C.+Powers&title=Inhibition+of+human+leukocyte+elastase+by+peptide+chloromethyl+ketones&doi=10.1016%2F0014-5793%2875%2980527-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human leukocyte elastase by peptide chloromethyl ketones</span></div><div class="casAuthors">Tuhy, Peter M.; Powers, James C.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-61</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">The inhibition of human leukocyte elastase by a series of peptide chloromethyl ketones was studied in order to define structural features necessary for an effective inhibitor which could lead to treatment for emphysema and related diseases.  The tetrapeptides studied were about 3-4-fold more reactive than the tripeptides.  The inhibitors with a P1 alanine, a P2 proline or leucine, no P3 proline (in the case of tripeptides), and a large hydrophobic group (phenyl) or alanine in P4 exhibited optimal inhibition of leukocyte elastase.  Ac-Ala-Ala-Pro-AlaCH2Cl was the most effective inhibitor for human leukocyte and porcine pancreatic elastase.  However, Ac-Ala-Pro-Ala-AlaCH2Cl was a good inhibitor for leukocyte elastase but did not affect the pancreatic enzyme, suggesting that the 2 enzymes are distinct entities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonWkZpCscyY7Vg90H21EOLACvtfcHk0liU0ZN3Wwl8oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXhtlCktrY%253D&md5=5d8e59e0d9e3aaa8075563a006d0e0c2</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2875%2980527-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252875%252980527-8%26sid%3Dliteratum%253Aachs%26aulast%3DTuhy%26aufirst%3DP.%2BM.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DInhibition%2520of%2520human%2520leukocyte%2520elastase%2520by%2520peptide%2520chloromethyl%2520ketones%26jtitle%3DFEBS%2520Lett.%26date%3D1975%26volume%3D50%26issue%3D3%26spage%3D359%26epage%3D361%26doi%3D10.1016%2F0014-5793%2875%2980527-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowle, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, G. G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, G. D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molloy, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murkitt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godward, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padfield, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skarzynski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, O. M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleetwood, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finch, H.</span></span> <span> </span><span class="NLM_article-title">The discovery of a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastaseâGW311616A a development candidate</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">895</span>â <span class="NLM_lpage">898</span>, <span class="refDoi">Â DOI: 10.1016/S0960-894X(01)00078-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0960-894X%2801%2900078-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=11294386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVKgs7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=895-898&issue=7&author=S.+J.+F.+Macdonaldauthor=M.+D.+Dowleauthor=L.+A.+Harrisonauthor=P.+Shahauthor=M.+R.+Johnsonauthor=G.+G.+A.+Inglisauthor=G.+D.+E.+Clarkeauthor=R.+A.+Smithauthor=D.+Humphreysauthor=C.+R.+Molloyauthor=A.+Amourauthor=M.+Dixonauthor=G.+Murkittauthor=R.+E.+Godwardauthor=T.+Padfieldauthor=T.+Skarzynskiauthor=O.+M.+P.+Singhauthor=K.+A.+Kumarauthor=G.+Fleetwoodauthor=S.+T.+Hodgsonauthor=G.+W.+Hardyauthor=H.+Finch&title=The+discovery+of+a+potent%2C+intracellular%2C+orally+bioavailable%2C+long+duration+inhibitor+of+human+neutrophil+elastase%E2%80%94GW311616A+a+development+candidate&doi=10.1016%2FS0960-894X%2801%2900078-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastase-GW311616A a development candidate</span></div><div class="casAuthors">Macdonald, S. J. F.; Dowle, M. D.; Harrison, L. A.; Shah, P.; Johnson, M. R.; Inglis, G. G.; Clarke, G. D.; Smith, R. A.; Humphreys, D.; Molloy, C. R.; Amour, A.; Dixon, M.; Murkitt, G.; Godward, R. E.; Padfield, T.; Skarzynski, T.; Singh, O. M.; Kumar, K. A.; Fleetwood, G.; Hodgson, S. T.; Hardy, G. W.; Finch, H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">895-898</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The discovery of a potent intracellular inhibitor of human neutrophil elastase which is orally active and has a long duration of action is described.  The pharmacodynamic and pharmacokinetic properties of a trans-lactam development candidate, GW311616A, are described.  The medicinal chem. leading to development candidate GW311616A-a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastase-is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCj0I-MVbICbVg90H21EOLACvtfcHk0liUIBjrg13kwA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVKgs7s%253D&md5=458c9b5785879882677c278e58f88ac5</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900078-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900078-6%26sid%3Dliteratum%253Aachs%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DDowle%26aufirst%3DM.%2BD.%26aulast%3DHarrison%26aufirst%3DL.%2BA.%26aulast%3DShah%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DM.%2BR.%26aulast%3DInglis%26aufirst%3DG.%2BG.%2BA.%26aulast%3DClarke%26aufirst%3DG.%2BD.%2BE.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DHumphreys%26aufirst%3DD.%26aulast%3DMolloy%26aufirst%3DC.%2BR.%26aulast%3DAmour%26aufirst%3DA.%26aulast%3DDixon%26aufirst%3DM.%26aulast%3DMurkitt%26aufirst%3DG.%26aulast%3DGodward%26aufirst%3DR.%2BE.%26aulast%3DPadfield%26aufirst%3DT.%26aulast%3DSkarzynski%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DO.%2BM.%2BP.%26aulast%3DKumar%26aufirst%3DK.%2BA.%26aulast%3DFleetwood%26aufirst%3DG.%26aulast%3DHodgson%26aufirst%3DS.%2BT.%26aulast%3DHardy%26aufirst%3DG.%2BW.%26aulast%3DFinch%26aufirst%3DH.%26atitle%3DThe%2520discovery%2520of%2520a%2520potent%252C%2520intracellular%252C%2520orally%2520bioavailable%252C%2520long%2520duration%2520inhibitor%2520of%2520human%2520neutrophil%2520elastase%25E2%2580%2594GW311616A%2520a%2520development%2520candidate%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26issue%3D7%26spage%3D895%26epage%3D898%26doi%3D10.1016%2FS0960-894X%2801%2900078-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawabata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugitani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, T.</span></span> <span> </span><span class="NLM_article-title">ONO-5046, a novel inhibitor of human neutrophil elastase</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>177</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">814</span>â <span class="NLM_lpage">820</span>, <span class="refDoi">Â DOI: 10.1016/0006-291X(91)91862-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2F0006-291X%2891%2991862-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=2049103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3MXksVWqt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=1991&pages=814-820&issue=2&author=K.+Kawabataauthor=M.+Suzukiauthor=M.+Sugitaniauthor=K.+Imakiauthor=M.+Todaauthor=T.+Miyamoto&title=ONO-5046%2C+a+novel+inhibitor+of+human+neutrophil+elastase&doi=10.1016%2F0006-291X%2891%2991862-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">ONO-5046, a novel inhibitor of human neutrophil elastase</span></div><div class="casAuthors">Kawabata, Kazuhito; Suzuki, Mayumi; Sugitani, Masafumi; Imaki, Katsuhiro; Toda, Masaaki; Miyamoto, Tsumoru</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">814-20</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">ONO-5046 (I) competitively inhibited human neutrophil elastase (IC50 = 0.044 Î¼M, (ki = 0.2 Î¼M).  It also inhibited leukocyte elastase obtained from rabbits, rats, hamsters and mice.  However, ONO-5046 did not inhibit trypsin, thrombin, plasmin, plasma kallikrein, pancreas kallikrein, chymotrypsin or cathepsin G, even at 100 Î¼M.  In vivo, ONO-5046 suppressed lung hemorrhage in hamsters (ID50 = 82 Î¼g/kg) and the increase of skin capillary permeability in guinea pig (ID50 = 9.6 mg/kg) induced by human neutrophil elastase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMW9werm75QbVg90H21EOLACvtfcHk0liUIBjrg13kwA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVWqt7g%253D&md5=3534b9114486a679f3b637d2ffa00650</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2891%2991862-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252891%252991862-7%26sid%3Dliteratum%253Aachs%26aulast%3DKawabata%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DSugitani%26aufirst%3DM.%26aulast%3DImaki%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DM.%26aulast%3DMiyamoto%26aufirst%3DT.%26atitle%3DONO-5046%252C%2520a%2520novel%2520inhibitor%2520of%2520human%2520neutrophil%2520elastase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1991%26volume%3D177%26issue%3D2%26spage%3D814%26epage%3D820%26doi%3D10.1016%2F0006-291X%2891%2991862-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odagaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamanaka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toda, M.</span></span> <span> </span><span class="NLM_article-title">Clarification of mechanism of human sputum elastase inhibition by a new Inhibitor, ONO-5046, using electrospray ionization mass spectrometry</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2349</span>â <span class="NLM_lpage">2353</span>, <span class="refDoi">Â DOI: 10.1016/S0960-894X(02)00393-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0960-894X%2802%2900393-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=12161131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvVGjtL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2349-2353&issue=17&author=Y.+Nakayamaauthor=Y.+Odagakiauthor=S.+Fujitaauthor=S.+Matsuokaauthor=N.+Hamanakaauthor=H.+Nakaiauthor=M.+Toda&title=Clarification+of+mechanism+of+human+sputum+elastase+inhibition+by+a+new+Inhibitor%2C+ONO-5046%2C+using+electrospray+ionization+mass+spectrometry&doi=10.1016%2FS0960-894X%2802%2900393-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Clarification of Mechanism of Human Sputum Elastase Inhibition by a New Inhibitor, ONO-5046, Using Electrospray Ionization Mass Spectrometry</span></div><div class="casAuthors">Nakayama, Yoshisuke; Odagaki, Yoshihiko; Fujita, Setsuko; Matsuoka, Shozo; Hamanaka, Nobuyuki; Nakai, Hisao; Toda, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2349-2353</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Liq. chromatog. electrospray ionization mass spectrometry (LC/ESI-MS) to probe the nature of the covalent E-I complex was successfully applied to clarify the mechanism of human sputum elastase (HSE) inhibition by a new inhibitor, ONO-5046.  The mass spectrum of the four HSE isoenzymes displayed their mol. ion peaks at m/z = 26018, 25929, 25200, and 25054, resp.  Immediately after incubation, inactivation of HSE with ONO-5046 increased the four mol. ion peaks by approx. 84 amu, which was assigned to the mass unit of the pivaloyl moiety of ONO-5046.  An addnl. minute of incubation of E-I complex restored the original mol. ion peaks.  These observations strongly suggested that ONO-5046 inactivates HSE by a reversible 'acylation-deacylation' mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp19apMc4QQ4rVg90H21EOLACvtfcHk0liUIBjrg13kwA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvVGjtL8%253D&md5=730c1987d1cedc3d4d94e8e3aef72ab0</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900393-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900393-1%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DY.%26aulast%3DOdagaki%26aufirst%3DY.%26aulast%3DFujita%26aufirst%3DS.%26aulast%3DMatsuoka%26aufirst%3DS.%26aulast%3DHamanaka%26aufirst%3DN.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DClarification%2520of%2520mechanism%2520of%2520human%2520sputum%2520elastase%2520inhibition%2520by%2520a%2520new%2520Inhibitor%252C%2520ONO-5046%252C%2520using%2520electrospray%2520ionization%2520mass%2520spectrometry%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26issue%3D17%26spage%3D2349%26epage%3D2353%26doi%3D10.1016%2FS0960-894X%2802%2900393-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">SieÅczyk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PodgÃ³rski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BÅazejewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulbacka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saczko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksyszyn, J.</span></span> <span> </span><span class="NLM_article-title">Phosphonic pseudopeptides as human neutrophil elastase inhibitorsâa combinatorial approach</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1277</span>â <span class="NLM_lpage">1284</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2010.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmc.2010.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21216608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKks70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1277-1284&issue=3&author=M.+Sie%C5%84czykauthor=D.+Podg%C3%B3rskiauthor=A.+B%C5%82azejewskaauthor=J.+Kulbackaauthor=J.+Saczkoauthor=J.+Oleksyszyn&title=Phosphonic+pseudopeptides+as+human+neutrophil+elastase+inhibitors%E2%80%94a+combinatorial+approach&doi=10.1016%2Fj.bmc.2010.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphonic pseudopeptides as human neutrophil elastase inhibitors-a combinatorial approach</span></div><div class="casAuthors">Sienczyk, Marcin; Podgorski, Dawid; Blazejewska, Aleksandra; Kulbacka, Julita; Saczko, Jolanta; Oleksyszyn, Jozef</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1277-1284</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here we present a simple and rapid method for the construction of phosphonic peptide mimetic inhibitor libraries-products of Ugi and Passerini multicomponent condensations-leading to the selection of new biol. active phosphonic pseudopeptides.  As the starting isonitriles, 1-isocyanoalkylphosphonate diaryl ester derivs. were applied.  The structure of the synthesized inhibitors was designed to target human neutrophil elastase, a serine protease whose uncontrolled activity may lead to development of several pathophysiol. states such as rheumatoid arthritis, cystic fibrosis or tumor growth and invasion.  After screening the inhibitory activity of our constructed libraries, the most active compds. were synthesized as single mols.  One of the obtained inhibitors, Cbz-Met-O-Met-ValP(OC6H4-p-Cl)2, displayed apparent second-order inhibition value at 40,105 M-1 s-1 as the diastereomers mixt.  Inhibition potency and selectivity of action toward other serine proteases as well as the results of initial in vitro expts. regarding inhibitors influence on cancer cell proliferation are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnnORoQHUwDLVg90H21EOLACvtfcHk0lhE4CYpwK3qKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKks70%253D&md5=528307259230055ec8b329fa3e2b3d34</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DSie%25C5%2584czyk%26aufirst%3DM.%26aulast%3DPodg%25C3%25B3rski%26aufirst%3DD.%26aulast%3DB%25C5%2582azejewska%26aufirst%3DA.%26aulast%3DKulbacka%26aufirst%3DJ.%26aulast%3DSaczko%26aufirst%3DJ.%26aulast%3DOleksyszyn%26aufirst%3DJ.%26atitle%3DPhosphonic%2520pseudopeptides%2520as%2520human%2520neutrophil%2520elastase%2520inhibitors%25E2%2580%2594a%2520combinatorial%2520approach%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26issue%3D3%26spage%3D1277%26epage%3D1284%26doi%3D10.1016%2Fj.bmc.2010.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edgington-Mitchell, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlow, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aurelio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnett, N.</span></span> <span> </span><span class="NLM_article-title">Fluorescent diphenylphosphonate-based probes for detection of serine protease activity during inflammation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">254</span>â <span class="NLM_lpage">260</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.11.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bmcl.2016.11.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27923620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWmtLvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=254-260&issue=2&author=L.+E.+Edgington-Mitchellauthor=N.+Barlowauthor=L.+Aurelioauthor=A.+Samhaauthor=M.+Szaboauthor=B.+Grahamauthor=N.+Bunnett&title=Fluorescent+diphenylphosphonate-based+probes+for+detection+of+serine+protease+activity+during+inflammation&doi=10.1016%2Fj.bmcl.2016.11.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent diphenylphosphonate-based probes for detection of serine protease activity during inflammation</span></div><div class="casAuthors">Edgington-Mitchell, Laura E.; Barlow, Nicholas; Aurelio, Luigi; Samha, Aminath; Szabo, Monika; Graham, Bim; Bunnett, Nigel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">254-260</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Activity-based probes are small mols. that covalently bind to the active site of a protease in an activity-dependent manner.  We synthesized and characterized two fluorescent activity-based probes that target serine proteases with trypsin-like or elastase-like activity.  We assessed the selectivity and potency of these probes against recombinant enzymes and demonstrated that while they are efficacious at labeling active proteases in complex protein mixts. in vitro, they are less valuable for in vivo studies.  We used these probes to evaluate serine protease activity in two mouse models of acute inflammation, including pancreatitis and colitis.  As anticipated, the activity of trypsin-like proteases was increased during pancreatitis.  Levels of elastase-like proteases were low in pancreatic lysates and colonic luminal fluids, whether healthy or inflamed.  Exogenously added recombinant neutrophil elastase was inhibited upon incubation with these samples, an effect that was augmented in inflamed samples compared to controls.  These data suggest that endogenous inhibitors and elastase-degrading proteases are upregulated during inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2IHs8fBs_IbVg90H21EOLACvtfcHk0lhE4CYpwK3qKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWmtLvP&md5=5121d5a31883aeb0801f58b039e20e9b</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.11.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.11.064%26sid%3Dliteratum%253Aachs%26aulast%3DEdgington-Mitchell%26aufirst%3DL.%2BE.%26aulast%3DBarlow%26aufirst%3DN.%26aulast%3DAurelio%26aufirst%3DL.%26aulast%3DSamha%26aufirst%3DA.%26aulast%3DSzabo%26aufirst%3DM.%26aulast%3DGraham%26aufirst%3DB.%26aulast%3DBunnett%26aufirst%3DN.%26atitle%3DFluorescent%2520diphenylphosphonate-based%2520probes%2520for%2520detection%2520of%2520serine%2520protease%2520activity%2520during%2520inflammation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D2%26spage%3D254%26epage%3D260%26doi%3D10.1016%2Fj.bmcl.2016.11.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winterbourn, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Design of ultrasensitive probes for human neutrophil elastase through hybrid combinatorial substrate library profiling</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2518</span>â <span class="NLM_lpage">2523</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1318548111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.1318548111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24550277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivFaht7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=2518-2523&issue=7&author=P.+Kasperkiewiczauthor=M.+Porebaauthor=S.+J.+Snipasauthor=H.+Parkerauthor=C.+C.+Winterbournauthor=G.+S.+Salvesenauthor=M.+Drag&title=Design+of+ultrasensitive+probes+for+human+neutrophil+elastase+through+hybrid+combinatorial+substrate+library+profiling&doi=10.1073%2Fpnas.1318548111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Design of ultrasensitive probes for human neutrophil elastase through hybrid combinatorial substrate library profiling</span></div><div class="casAuthors">Kasperkiewicz, Paulina; Poreba, Marcin; Snipas, Scott J.; Parker, Heather; Winterbourn, Christine C.; Salvesen, Guy S.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2518-2523</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The exploration of protease substrate specificity is generally restricted to naturally occurring amino acids, limiting the degree of conformational space that can be surveyed.  We substantially enhanced this by incorporating 102 unnatural amino acids to explore the S1-S4 pockets of human neutrophil elastase (NE).  This approach provides hybrid natural and unnatural amino acid sequences, and thus we termed it the Hybrid Combinatorial Substrate Library (HyCoSuL).  Library results were validated by the synthesis of individual tetrapeptide substrates, with the optimal substrate demonstrating more than three orders of magnitude higher catalytic efficiency than commonly used substrates of elastase.  This optimal substrate was converted to an activity-based probe that demonstrated high selectivity and revealed the specific presence of active elastase during the process of neutrophil extracellular trap formation.  We propose that this approach can be successfully used for any type of endopeptidase to deliver high activity and selectivity in substrates and probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMwdujTniBZbVg90H21EOLACvtfcHk0lhE4CYpwK3qKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivFaht7o%253D&md5=048b0dd58455cd95a3def76ee8942337</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1318548111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1318548111%26sid%3Dliteratum%253Aachs%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DParker%26aufirst%3DH.%26aulast%3DWinterbourn%26aufirst%3DC.%2BC.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DDesign%2520of%2520ultrasensitive%2520probes%2520for%2520human%2520neutrophil%2520elastase%2520through%2520hybrid%2520combinatorial%2520substrate%2520library%2520profiling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D7%26spage%3D2518%26epage%3D2523%26doi%3D10.1073%2Fpnas.1318548111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DâAngelo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Toolbox of fluorescent probes for parallel imaging reveals uneven location of serine proteases in neutrophils</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span> (<span class="NLM_issue">29</span>),  <span class="NLM_fpage">10115</span>â <span class="NLM_lpage">10125</span>, <span class="refDoi">Â DOI: 10.1021/jacs.7b04394</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b04394" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2ru7zM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=10115-10125&issue=29&author=P.+Kasperkiewiczauthor=Y.+Altmanauthor=M.+D%E2%80%99Angeloauthor=G.+S.+Salvesenauthor=M.+Drag&title=Toolbox+of+fluorescent+probes+for+parallel+imaging+reveals+uneven+location+of+serine+proteases+in+neutrophils&doi=10.1021%2Fjacs.7b04394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Toolbox of Fluorescent Probes for Parallel Imaging Reveals Uneven Location of Serine Proteases in Neutrophils</span></div><div class="casAuthors">Kasperkiewicz, Paulina; Altman, Yoav; D'Angelo, Maximiliano; Salvesen, Guy S.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">10115-10125</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neutrophils, the front line defenders against infection, express four serine proteases (NSPs) that play roles in the control of cell-signaling pathways and defense against pathogens and whose imbalance leads to pathol. conditions.  Dissecting the roles of individual NSPs in humans is problematic because neutrophils are end-stage cells with a short half-life and minimal ongoing protein synthesis.  To gain insight into the regulation of NSP activity we have generated a small-mol. chem. toolbox consisting of activity-based probes with different fluorophore-detecting groups with minimal wavelength overlap and highly selective natural and unnatural amino acid recognition sequences.  The key feature of these activity-based probes is the ability to use them for simultaneous observation and detection of all four individual NSPs by fluorescence microscopy, a feature never achieved in previous studies.  Using these probes we demonstrate uneven distribution of NSPs in neutrophil azurophil granules, such that they seem to be mutually excluded from each other, suggesting the existence of unknown granule-targeting mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCQyFRKT-WtrVg90H21EOLACvtfcHk0li5Tc3YK0S8ng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2ru7zM&md5=72b3e9e59a26a034fa66aa9cbd714b61</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b04394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b04394%26sid%3Dliteratum%253Aachs%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DAltman%26aufirst%3DY.%26aulast%3DD%25E2%2580%2599Angelo%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DToolbox%2520of%2520fluorescent%2520probes%2520for%2520parallel%2520imaging%2520reveals%2520uneven%2520location%2520of%2520serine%2520proteases%2520in%2520neutrophils%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26issue%3D29%26spage%3D10115%26epage%3D10125%26doi%3D10.1021%2Fjacs.7b04394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichard, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goosmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlemann, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinrauch, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zychlinsky, A.</span></span> <span> </span><span class="NLM_article-title">Neutrophil extracellular traps kill bacteria</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>303</i></span> (<span class="NLM_issue">5663</span>),  <span class="NLM_fpage">1532</span>â <span class="NLM_lpage">1535</span>, <span class="refDoi">Â DOI: 10.1126/science.1092385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1126%2Fscience.1092385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15001782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhslCgsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=1532-1535&issue=5663&author=V.+Brinkmannauthor=U.+Reichardauthor=C.+Goosmannauthor=B.+Faulerauthor=Y.+Uhlemannauthor=D.+S.+Weissauthor=Y.+Weinrauchauthor=A.+Zychlinsky&title=Neutrophil+extracellular+traps+kill+bacteria&doi=10.1126%2Fscience.1092385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Neutrophil Extracellular Traps Kill Bacteria</span></div><div class="casAuthors">Brinkmann, Volker; Reichard, Ulrike; Goosmann, Christian; Fauler, Beatrix; Uhlemann, Yvonne; Weiss, David S.; Weinrauch, Yvette; Zychlinsky, Arturo</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5663</span>),
    <span class="NLM_cas:pages">1532-1535</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Neutrophils engulf and kill bacteria when their antimicrobial granules fuse with the phagosome.  Here, the authors describe that, upon activation, neutrophils release granule proteins and chromatin that together form extracellular fibers that bind Gram-pos. and -neg. bacteria.  These neutrophil extracellular traps (NETs) degrade virulence factors and kill bacteria.  NETs are abundant in vivo in exptl. dysentery and spontaneous human appendicitis, two examples of acute inflammation.  NETs appear to be a form of innate response that binds microorganisms, prevents them from spreading, and ensures a high local concn. of antimicrobial agents to degrade virulence factors and kill bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot7js5LhZu87Vg90H21EOLACvtfcHk0li5Tc3YK0S8ng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhslCgsb8%253D&md5=54d14d74ebe66b044b47ff7af759adb1</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1126%2Fscience.1092385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1092385%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DReichard%26aufirst%3DU.%26aulast%3DGoosmann%26aufirst%3DC.%26aulast%3DFauler%26aufirst%3DB.%26aulast%3DUhlemann%26aufirst%3DY.%26aulast%3DWeiss%26aufirst%3DD.%2BS.%26aulast%3DWeinrauch%26aufirst%3DY.%26aulast%3DZychlinsky%26aufirst%3DA.%26atitle%3DNeutrophil%2520extracellular%2520traps%2520kill%2520bacteria%26jtitle%3DScience%26date%3D2004%26volume%3D303%26issue%3D5663%26spage%3D1532%26epage%3D1535%26doi%3D10.1126%2Fscience.1092385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lechtenberg, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, S. J.</span></span> <span> </span><span class="NLM_article-title">The elastase-PK101 structure: mechanism of an ultrasensitive activity-based probe revealed</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">945</span>â <span class="NLM_lpage">951</span>, <span class="refDoi">Â DOI: 10.1021/cb500909n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500909n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmt1Oquw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=945-951&issue=4&author=B.+C.+Lechtenbergauthor=P.+Kasperkiewiczauthor=H.+Robinsonauthor=M.+Dragauthor=S.+J.+Riedl&title=The+elastase-PK101+structure%3A+mechanism+of+an+ultrasensitive+activity-based+probe+revealed&doi=10.1021%2Fcb500909n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">The elastase-PK 101 structure: Mechanism of an ultrasensitive activity-based probe revealed</span></div><div class="casAuthors">Lechtenberg, Bernhard C.; Kasperkiewicz, Paulina; Robinson, Howard; Drag, Marcin; Riedl, Stefan J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">945-951</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human neutrophil elastase (HNE) plays a central role in neutrophil host defense, but its broad specificity makes HNE a difficult target for both inhibitor and probe development.  Recently, the authors identified the unnatural amino acid-contg. activity-based probe PK 101, which exhibited astounding sensitivity and selectivity for HNE, yet completely lacked mechanistic explanation for its unique characteristics.  Here, the authors present the crystal structure of the HNE-PK 101 complex which not only reveals the basis for PK 101 ultrasensitivity but also uncovers so far unrecognized HNE features.  Strikingly, the Nle(O-Bzl) function in the P4 position of PK 101 revealed and leveraged an "exo-pocket" on HNE as a crit. factor for selectivity.  Furthermore, the PK 101 P3 position harbored a methionine dioxide function, which mimicked a post-translationally oxidized Met residue and forms a crit. H-bond to the backbone amide of Gly-219 of HNE.  Gly-219 resided in a Gly-Gly motif that was unique to HNE, yet compulsory for this interaction.  Consequently, this feature enabled HNE to accommodate substrates that have undergone Met oxidn., which constitutes a hallmark post-translational modification of neutrophil signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUhGxLWVVUQ7Vg90H21EOLACvtfcHk0li5Tc3YK0S8ng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmt1Oquw%253D%253D&md5=36a0537ede18a9c308557217f3e9985e</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1021%2Fcb500909n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500909n%26sid%3Dliteratum%253Aachs%26aulast%3DLechtenberg%26aufirst%3DB.%2BC.%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DRobinson%26aufirst%3DH.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520elastase-PK101%2520structure%253A%2520mechanism%2520of%2520an%2520ultrasensitive%2520activity-based%2520probe%2520revealed%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D4%26spage%3D945%26epage%3D951%26doi%3D10.1021%2Fcb500909n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebanoff, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinecke, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.</span></span> <span> </span><span class="NLM_article-title">Methionine oxidation contributes to bacterial killing by the myeloperoxidase system of neutrophils</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">18686</span>â <span class="NLM_lpage">18691</span>, <span class="refDoi">Â DOI: 10.1073/pnas.0909464106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.0909464106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19833874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKnu7nN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=18686-18691&issue=44&author=H.+Rosenauthor=S.+J.+Klebanoffauthor=Y.+Wangauthor=N.+Brotauthor=J.+W.+Heineckeauthor=X.+Fu&title=Methionine+oxidation+contributes+to+bacterial+killing+by+the+myeloperoxidase+system+of+neutrophils&doi=10.1073%2Fpnas.0909464106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">Methionine oxidation contributes to bacterial killing by the myeloperoxidase system of neutrophils</span></div><div class="casAuthors">Rosen, Henry; Klebanoff, Seymour J.; Wang, Yi; Brot, Nathan; Heinecke, Jay W.; Fu, Xiaoyun</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">18686-18691, S18686/1-S18686/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Reactive oxygen intermediates generated by neutrophils kill bacteria and are implicated in inflammatory tissue injury, but precise mol. targets are undefined.  We demonstrate that neutrophils use myeloperoxidase (MPO) to convert methionine residues of ingested Escherichia coli to methionine sulfoxide in high yield.  Neutrophils deficient in individual components of the MPO system (MPO, H2O2, chloride) exhibited impaired bactericidal activity and impaired capacity to oxidize methionine.  HOCl, the principal physiol. product of the MPO system, is a highly efficient oxidant for methionine, and its microbicidal effects were found to correspond linearly with oxidn. of methionine residues in bacterial cytosolic and inner membrane proteins.  In contrast, outer envelope proteins were initially oxidized without assocd. microbicidal effect.  Disruption of bacterial methionine sulfoxide repair systems rendered E. coli more susceptible to killing by HOCl, whereas over-expression of a repair enzyme, methionine sulfoxide reductase A, rendered them resistant, suggesting a direct role for methionine oxidn. in bactericidal activity.  Prominent among oxidized bacterial proteins were those engaged in synthesis and translocation of peptides to the cell envelope, an essential physiol. function.  Moreover, HOCl impaired protein translocation early in the course of bacterial killing.  Together, our findings indicate that MPO-mediated methionine oxidn. contributes to bacterial killing by neutrophils.  The findings further suggest that protein translocation to the cell envelope is one important pathway targeted for damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxoGHsQLa7W7Vg90H21EOLACvtfcHk0lgD4FSVqv7v6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKnu7nN&md5=1647061663af9c3a06dc68ccfaef8c1f</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0909464106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0909464106%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DKlebanoff%26aufirst%3DS.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBrot%26aufirst%3DN.%26aulast%3DHeinecke%26aufirst%3DJ.%2BW.%26aulast%3DFu%26aufirst%3DX.%26atitle%3DMethionine%2520oxidation%2520contributes%2520to%2520bacterial%2520killing%2520by%2520the%2520myeloperoxidase%2520system%2520of%2520neutrophils%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D44%26spage%3D18686%26epage%3D18691%26doi%3D10.1073%2Fpnas.0909464106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poole, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aurelio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, G. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleischmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morissette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Driel, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanner, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnett, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington-Mitchell, L. E.</span></span> <span> </span><span class="NLM_article-title">Application of a chemical probe to detect neutrophil elastase activation during inflammatory bowel disease</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">13295</span>, <span class="refDoi">Â DOI: 10.1038/s41598-019-49840-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41598-019-49840-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31527638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BB3MrpsVaqug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=13295&issue=1&author=B.+M.+Andersonauthor=D.+P.+Pooleauthor=L.+Aurelioauthor=G.+Z.+Ngauthor=M.+Fleischmannauthor=P.+Kasperkiewiczauthor=C.+Morissetteauthor=M.+Dragauthor=I.+R.+van+Drielauthor=B.+L.+Schmidtauthor=S.+J.+Vannerauthor=N.+W.+Bunnettauthor=L.+E.+Edgington-Mitchell&title=Application+of+a+chemical+probe+to+detect+neutrophil+elastase+activation+during+inflammatory+bowel+disease&doi=10.1038%2Fs41598-019-49840-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a chemical probe to detect neutrophil elastase activation during inflammatory bowel disease</span></div><div class="casAuthors">Anderson Bethany M; Ng Garrett Z; Fleischmann Markus; van Driel Ian R; Edgington-Mitchell Laura E; Anderson Bethany M; Poole Daniel P; Bunnett Nigel W; Edgington-Mitchell Laura E; Aurelio Luigi; Fleischmann Markus; Kasperkiewicz Paulina; Drag Marcin; Morissette Celine; Vanner Stephen J; Schmidt Brian L; Edgington-Mitchell Laura E; Bunnett Nigel W; Bunnett Nigel W</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13295</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neutrophil elastase is a serine protease that has been implicated in the pathogenesis of inflammatory bowel disease.  Due to post-translational control of its activation and high expression of its inhibitors in the gut, measurements of total expression poorly reflect the pool of active, functional neutrophil elastase.  Fluorogenic substrate probes have been used to measure neutrophil elastase activity, though these tools lack specificity and traceability.  PK105 is a recently described fluorescent activity-based probe, which binds to neutrophil elastase in an activity-dependent manner.  The irreversible nature of this probe allows for accurate identification of its targets in complex protein mixtures.  We describe the reactivity profile of PK105b, a new analogue of PK105, against recombinant serine proteases and in tissue extracts from healthy mice and from models of inflammation induced by oral cancer and Legionella pneumophila infection.  We apply PK105b to measure neutrophil elastase activation in an acute model of experimental colitis.  Neutrophil elastase activity is detected in inflamed, but not healthy, colons.  We corroborate this finding in mucosal biopsies from patients with ulcerative colitis.  Thus, PK105b facilitates detection of neutrophil elastase activity in tissue lysates, and we have applied it to demonstrate that this protease is unequivocally activated during colitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4GG7aPDCwMoYPsCkJIw00fW6udTcc2eb_X9W8yK-NL7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MrpsVaqug%253D%253D&md5=06e4aa00811979c6f5c9c87ebeaf14d0</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-49840-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-49840-4%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DB.%2BM.%26aulast%3DPoole%26aufirst%3DD.%2BP.%26aulast%3DAurelio%26aufirst%3DL.%26aulast%3DNg%26aufirst%3DG.%2BZ.%26aulast%3DFleischmann%26aufirst%3DM.%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DMorissette%26aufirst%3DC.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3Dvan%2BDriel%26aufirst%3DI.%2BR.%26aulast%3DSchmidt%26aufirst%3DB.%2BL.%26aulast%3DVanner%26aufirst%3DS.%2BJ.%26aulast%3DBunnett%26aufirst%3DN.%2BW.%26aulast%3DEdgington-Mitchell%26aufirst%3DL.%2BE.%26atitle%3DApplication%2520of%2520a%2520chemical%2520probe%2520to%2520detect%2520neutrophil%2520elastase%2520activation%2520during%2520inflammatory%2520bowel%2520disease%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26issue%3D1%26spage%3D13295%26doi%3D10.1038%2Fs41598-019-49840-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref219"><div class="reference"><strong class="refLabel"><a href="#ref219" class="rightTabRefNumLink">219</a></strong><div class="NLM_citation" id="rightTab-cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poreba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snipas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchhofer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span> <span> </span><span class="NLM_article-title">Design of a selective substrate and activity based probe for human neutrophil serine protease 4</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">7</span>), <span class="NLM_elocation-id">e0132818</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0132818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1371%2Fjournal.pone.0132818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26172376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVSrtLnE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&issue=7&author=P.+Kasperkiewiczauthor=M.+Porebaauthor=S.+J.+Snipasauthor=S.+J.+Linauthor=D.+Kirchhoferauthor=G.+S.+Salvesenauthor=M.+Drag&title=Design+of+a+selective+substrate+and+activity+based+probe+for+human+neutrophil+serine+protease+4&doi=10.1371%2Fjournal.pone.0132818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Design of a selective substrate and activity based probe for human neutrophil serine protease 4</span></div><div class="casAuthors">Kasperkiewicz, Paulina; Poreba, Marcin; Snipas, Scott J.; Jack, Lin S.; Kirchhofer, Daniel; Salvesen, Guy S.; Drag, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e0132818/1-e0132818/12</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Human neutrophil serine protease 4 (NSP4), also known as PRSS57, is a recently discovered fourth member of the neutrophil serine proteases family.  Although its biol. function is not precisely defined, it is suggested to regulate neutrophil response and innate immune reactions.  To create optimal substrates and visualization probes for NSP4 that distinguish it from other NSPs we have employed a Hybrid Combinatorial Substrate Library approach that utilizes natural and unnatural amino acids to explore protease subsite preferences.  Library results were validated by synthesizing individual substrates, leading to the identification of an optimal substrate peptide.  This substrate was converted to a covalent di-Ph phosphonate probe with an embedded biotin tag.  This probe demonstrated high inhibitory activity and stringent specificity and may be suitable for visualizing NSP4 in the background of other NSPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Dosrmw75eLVg90H21EOLACvtfcHk0lgD4FSVqv7v6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVSrtLnE&md5=b2323901d336008609b238a1bc344eca</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132818%26sid%3Dliteratum%253Aachs%26aulast%3DKasperkiewicz%26aufirst%3DP.%26aulast%3DPoreba%26aufirst%3DM.%26aulast%3DSnipas%26aufirst%3DS.%2BJ.%26aulast%3DLin%26aufirst%3DS.%2BJ.%26aulast%3DKirchhofer%26aufirst%3DD.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DDesign%2520of%2520a%2520selective%2520substrate%2520and%2520activity%2520based%2520probe%2520for%2520human%2520neutrophil%2520serine%2520protease%25204%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26issue%3D7%26doi%3D10.1371%2Fjournal.pone.0132818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref220"><div class="reference"><strong class="refLabel"><a href="#ref220" class="rightTabRefNumLink">220</a></strong><div class="NLM_citation" id="rightTab-cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Hoorn, R. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weerapana, E.</span></span> <span> </span><span class="NLM_article-title">Sulfonyl fluoride analogues as activity-based probes for serine proteases</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">2327</span>â <span class="NLM_lpage">2330</span>, <span class="refDoi">Â DOI: 10.1002/cbic.201200531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fcbic.201200531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23008217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlyqsLnP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=2327-2330&issue=16&author=D.+A.+Shannonauthor=C.+Guauthor=C.+J.+McLaughlinauthor=M.+Kaiserauthor=R.+A.+L.+van+der+Hoornauthor=E.+Weerapana&title=Sulfonyl+fluoride+analogues+as+activity-based+probes+for+serine+proteases&doi=10.1002%2Fcbic.201200531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit220R"><div class="casContent"><span class="casTitleNuber">220</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonyl Fluoride Analogues as Activity-Based Probes for Serine Proteases</span></div><div class="casAuthors">Shannon, D. Alexander; Gu, Christian; McLaughlin, Christopher J.; Kaiser, Markus; van der Hoorn, Renier A. L.; Weerapana, Eranthie</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2327-2330, S2327/1-S2327/16</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The tools of activity-based protein profiling (ABPP) have played a pervasive role in the functional characterization of enzymes within complex biol. systems.  As the application of ABPP technologies becomes more widespread, there is a const. need for an ever-expanding library of activity-based probes (ABPs) of varying reactivity and specificity.  ABPP methods are particularly important for the study of proteases, which are often subject to stringent post-translational regulation.  Compared to the armory of ABPs available for cysteine proteases, ABPs for the serine protease family are poorly represented, mostly due to the lower reactivity of the serine nucleophile relative to its cysteine counterpart.  Fluorophosphonate (FP) based ABPs are known to target serine proteases, together with the entire family of serine hydrolases that encompass approx. 1 % of the human genome.  Although sulfonate esters have previously been used as carbon electrophiles in ABPs for targeting diverse enzyme classes, there are no previous reports on adapting sulfonyl fluorides into chem. probes for activity-based profiling.  Converting AEBSF into an ABP requires the incorporation of a reporter group in the form of a fluorophore, biotin or a click-chem. handle to enable visualization and enrichment of active enzymes.  Three modified versions of AEBSF were synthesized, including the rhodamine-tagged DS6R and the alkyne-functionalized DAS1 and DAS2.  DS6R and DAS1 were synthesized using an amide coupling reaction to the primary amine of AEBSF, whereas DAS2 was obtained using a reductive amination reaction to incorporate the alkyne functionality.  DAS1 was identified as a potent and activity-based covalent modifier of serine proteases and was used to continue characterization of protease labeling.  Here, the application of sulfonyl fluorides as an activity-based probe that covalently modifies endogenous serine proteases and allows for gel-based anal. of protein activity, as well as enrichment and identification using mass spectrometry was demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIZgVarY5YD7Vg90H21EOLACvtfcHk0liI8_J6S0lNTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlyqsLnP&md5=920f5f4b4b90924725c225d5166677a5</span></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201200531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201200531%26sid%3Dliteratum%253Aachs%26aulast%3DShannon%26aufirst%3DD.%2BA.%26aulast%3DGu%26aufirst%3DC.%26aulast%3DMcLaughlin%26aufirst%3DC.%2BJ.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BHoorn%26aufirst%3DR.%2BA.%2BL.%26aulast%3DWeerapana%26aufirst%3DE.%26atitle%3DSulfonyl%2520fluoride%2520analogues%2520as%2520activity-based%2520probes%2520for%2520serine%2520proteases%26jtitle%3DChemBioChem%26date%3D2012%26volume%3D13%26issue%3D16%26spage%3D2327%26epage%3D2330%26doi%3D10.1002%2Fcbic.201200531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref221"><div class="reference"><strong class="refLabel"><a href="#ref221" class="rightTabRefNumLink">221</a></strong><div class="NLM_citation" id="rightTab-cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span> <span> </span><span class="NLM_article-title">Specificity and reactivity of human leukocyte elastase, porcine pancreatic elastase, human granulocyte cathepsin G, and bovine pancreatic chymotrypsin with arylsulfonyl fluorides. Discovery of a new series of potent and specific irreversible elastase inhibitors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>257</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">5077</span>â <span class="NLM_lpage">5084</span>, <span class="refDoi">Â DOI: 10.1016/S0021-9258(18)34637-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0021-9258%2818%2934637-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=6917853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaL38XkvVOlsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1982&pages=5077-5084&issue=9&author=T.+Yoshimuraauthor=L.+N.+Barkerauthor=J.+C.+Powers&title=Specificity+and+reactivity+of+human+leukocyte+elastase%2C+porcine+pancreatic+elastase%2C+human+granulocyte+cathepsin+G%2C+and+bovine+pancreatic+chymotrypsin+with+arylsulfonyl+fluorides.+Discovery+of+a+new+series+of+potent+and+specific+irreversible+elastase+inhibitors&doi=10.1016%2FS0021-9258%2818%2934637-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity and reactivity of human leukocyte elastase, porcine pancreatic elastase, human granulocyte cathepsin G, and bovine pancreatic chymotrypsin with arylsulfonyl fluorides.  Discovery of a new series of potent and specific irreversible elastase inhibitors</span></div><div class="casAuthors">Yoshimura, Toshiaki; Barker, Larry N.; Powers, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5077-84</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The reactivity and specificity of a series of substituted benzenesulfonyl fluorides with human leukocyte (HL) elastase, cathepsin G, porcine pancreatic (PP) elastase, and bovine chymotrypsin are reported.  Benzenesulfonyl fluorides with 2-fluoroacyl substituents were found to be potent and specific inhibitors of elastase.  HL elastase was inhibited most rapidly by 2-(CF3CF2CONH)-C6H4SO2F which was slightly better than the best peptide chloromethyl ketone inhibitor of this enzyme.  PP elastase was most rapidly inhibited by 2-(CF3CONH)-C6H4SO2F.  The 2-(CF3CF2CF2CONH) and 2-(CF3SNH) derivs. were quite selective for HL elastase and inhibited PP elastase, cathepsin G, and chymotrypsin quite slowly.  A specific and potent chymotrypsin inhibitor, 2-(Z-Gly-NH)C6H4SO2F (where Z = benzyloxycarbonyl), was also discovered.  A model for the elastase inhibition reaction was proposed which involves interaction of the fluoroacyl group of the inhibitor with the primary substrate recognition site S1 of the enzyme.  H-bonding also occurs between the inhibitor NH group and a backbone peptide carbonyl group, probably from residue 214.  The 2-fluoroacyl group plays the dual role of binding in the hydrophobic S1 pocket and through electronic effects, increasing the strength of the H-bond.  Thus, it is possible to construct simple org. mols. which are specific inhibitors of HL elastase, PP elastase, or chymotrypsin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9aawB91oKybVg90H21EOLACvtfcHk0liI8_J6S0lNTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XkvVOlsLw%253D&md5=b74a9ed434bfcd8b31b3419123be966e</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2934637-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252934637-4%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimura%26aufirst%3DT.%26aulast%3DBarker%26aufirst%3DL.%2BN.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DSpecificity%2520and%2520reactivity%2520of%2520human%2520leukocyte%2520elastase%252C%2520porcine%2520pancreatic%2520elastase%252C%2520human%2520granulocyte%2520cathepsin%2520G%252C%2520and%2520bovine%2520pancreatic%2520chymotrypsin%2520with%2520arylsulfonyl%2520fluorides.%2520Discovery%2520of%2520a%2520new%2520series%2520of%2520potent%2520and%2520specific%2520irreversible%2520elastase%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1982%26volume%3D257%26issue%3D9%26spage%3D5077%26epage%3D5084%26doi%3D10.1016%2FS0021-9258%2818%2934637-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref222"><div class="reference"><strong class="refLabel"><a href="#ref222" class="rightTabRefNumLink">222</a></strong><div class="NLM_citation" id="rightTab-cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krasnova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span> <span> </span><span class="NLM_article-title">Sulfur(VI) fluoride exchange (SuFEx): another good reaction for click chemistry</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">36</span>),  <span class="NLM_fpage">9430</span>â <span class="NLM_lpage">9448</span>, <span class="refDoi">Â DOI: 10.1002/anie.201309399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fanie.201309399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtleisbzJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=9430-9448&issue=36&author=J.+Dongauthor=L.+Krasnovaauthor=M.+G.+Finnauthor=K.+B.+Sharpless&title=Sulfur%28VI%29+fluoride+exchange+%28SuFEx%29%3A+another+good+reaction+for+click+chemistry&doi=10.1002%2Fanie.201309399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click Chemistry</span></div><div class="casAuthors">Dong, Jiajia; Krasnova, Larissa; Finn, M. G.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">9430-9448</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Aryl sulfonyl chlorides (e.g. Ts-Cl) are beloved of org. chemists as the most commonly used SVI electrophiles, and the parent sulfuryl chloride, O2SVICl2, also was relied on to create sulfates and sulfamides.  However, the desired halide substitution event is often defeated by destruction of the sulfur electrophile because the SVI-Cl bond is exceedingly sensitive to reductive collapse yielding SIV species and Cl-.  Fortunately, the use of sulfur(VI) fluorides (e.g., R-SO2-F and SO2F2) leaves only the substitution pathway open.  As with most of click chem., many essential features of sulfur(VI) fluoride reactivity were discovered long ago in Germany.  Surprisingly, this extraordinary work faded from view rather abruptly in the mid-20th century.  Here the authors seek to revive it, along with John Hyatt's unnoticed 1979 full paper exposition on CH2=CH-SO2-F, the most perfect Michael acceptor ever found.  To this history the authors add several new observations, including that the otherwise very stable gas SO2F2 has excellent reactivity under the right circumstances.  Also proton or silicon centers can activate the exchange of S-F bonds for S-O bonds to make functional products, and the sulfate connector is surprisingly stable toward hydrolysis.  Applications of this controllable ligation chem. to small mols., polymers, and biomols. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoygcyccCW7irVg90H21EOLACvtfcHk0liI8_J6S0lNTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtleisbzJ&md5=78e251c607d42f2506a9420f2f2f9835</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1002%2Fanie.201309399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201309399%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DKrasnova%26aufirst%3DL.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DSulfur%2528VI%2529%2520fluoride%2520exchange%2520%2528SuFEx%2529%253A%2520another%2520good%2520reaction%2520for%2520click%2520chemistry%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26issue%3D36%26spage%3D9430%26epage%3D9448%26doi%3D10.1002%2Fanie.201309399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref223"><div class="reference"><strong class="refLabel"><a href="#ref223" class="rightTabRefNumLink">223</a></strong><div class="NLM_citation" id="rightTab-cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woehl, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Martins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smedley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolan, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span> <span> </span><span class="NLM_article-title">SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">18808</span>â <span class="NLM_lpage">18814</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1909972116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.1909972116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=31484779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVSku73J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=18808-18814&issue=38&author=Q.+Zhengauthor=J.+L.+Woehlauthor=S.+Kitamuraauthor=D.+Santos-Martinsauthor=C.+J.+Smedleyauthor=G.+Liauthor=S.+Forliauthor=J.+E.+Mosesauthor=D.+W.+Wolanauthor=K.+B.+Sharpless&title=SuFEx-enabled%2C+agnostic+discovery+of+covalent+inhibitors+of+human+neutrophil+elastase&doi=10.1073%2Fpnas.1909972116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase</span></div><div class="casAuthors">Zheng, Qinheng; Woehl, Jordan L.; Kitamura, Seiya; Santos-Martins, Diogo; Smedley, Christopher J.; Li, Gencheng; Forli, Stefano; Moses, John E.; Wolan, Dennis W.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">18808-18814</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Sulfur fluoride exchange (SuFEx) has emerged as the new generation of click chem.  We report here a SuFEx-enabled, agnostic approach for the discovery and optimization of covalent inhibitors of human neutrophil elastase (hNE).  Evaluation of our ever-growing collection of SuFExable compds. toward various biol. assays unexpectedly revealed a selective and covalent hNE inhibitor: benzene-1,2-disulfonyl fluoride.  Synthetic derivatization of the initial hit led to a more potent agent, 2-(fluorosulfonyl)phenyl fluorosulfate with IC50 0.24Î¼M and greater than 833-fold selectivity over the homologous neutrophil serine protease, cathepsin G.  The optimized, yet simple benzenoid probe only modified active hNE and not its denatured form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrULhhywsqN37Vg90H21EOLACvtfcHk0lgsKna4kDKHug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVSku73J&md5=40375fdaac0abdaf4615694f16342bf3</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1909972116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1909972116%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DQ.%26aulast%3DWoehl%26aufirst%3DJ.%2BL.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DSantos-Martins%26aufirst%3DD.%26aulast%3DSmedley%26aufirst%3DC.%2BJ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DMoses%26aufirst%3DJ.%2BE.%26aulast%3DWolan%26aufirst%3DD.%2BW.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DSuFEx-enabled%252C%2520agnostic%2520discovery%2520of%2520covalent%2520inhibitors%2520of%2520human%2520neutrophil%2520elastase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26issue%3D38%26spage%3D18808%26epage%3D18814%26doi%3D10.1073%2Fpnas.1909972116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref224"><div class="reference"><strong class="refLabel"><a href="#ref224" class="rightTabRefNumLink">224</a></strong><div class="NLM_citation" id="rightTab-cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemming, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, M. I.</span></span> <span> </span><span class="NLM_article-title">Reactivity and selectivity in the inhibition of elastase by 3-oxo-Î²-sultams and in their hydrolysis</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">3993</span>â <span class="NLM_lpage">4000</span>, <span class="refDoi">Â DOI: 10.1039/b713899g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1039%2Fb713899g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18043805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGnsr3K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=3993-4000&issue=24&author=W.-Y.+Tsangauthor=N.+Ahmedauthor=K.+Hemmingauthor=M.+I.+Page&title=Reactivity+and+selectivity+in+the+inhibition+of+elastase+by+3-oxo-%CE%B2-sultams+and+in+their+hydrolysis&doi=10.1039%2Fb713899g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivity and selectivity in the inhibition of elastase by 3-oxo-Î²-sultams and in their hydrolysis</span></div><div class="casAuthors">Tsang, Wing-Yin; Ahmed, Naveed; Hemming, Karl; Page, Michael I.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3993-4000</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">3-Oxo-Î²-sultams are both Î²-sultams and Î²-lactams and are a novel class of time-dependent inhibitors of elastase.  The inhibition involves formation of a covalent enzyme-inhibitor adduct with transient stability by acylation of the active-site serine resulting from substitution at the carbonyl center of the 3-oxo-Î²-sultam, C-N fission, and expulsion of the sulfonamide.  The lead compd., N-benzyl-4,4-dimethyl-3-oxo-Î²-sultam 1 is a reasonably potent inhibitor against porcine pancreatic elastase with a second-order rate const. of 768 M-1s-1 at pH 6, but also possesses high chem. reactivity with a half-life for hydrolysis of only 6 mins at the same pH in water.  Interestingly, the hydrolysis of 3-oxo-Î²-sultams occurs at the sulfonyl center with S-N fission and expulsion of the amide leaving group, whereas the enzyme reaction occurs at the acyl center.  Increasing selectivity between these two reactive centers was explored by examg. the effect of substituents on the reactivity of 3-oxo-Î²-sultam towards hydrolysis and enzyme inhibition.  The inhibition activity against porcine pancreatic elastase has a much higher sensitivity to substituent variation than does the rate of alk. hydrolysis.  A difference of 2000-fold is obsd. in the second-order rate consts., ki, for inhibition whereas there is only a 100-fold difference in the second-order rate consts., kOH, for alk. hydrolysis within the series.  The higher sensitivity of enzyme inhibition to substituents than that of simple chem. reactivity indicates a significant degree of mol. recognition of the 3-oxo-Î²-sultams by the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE4VpfylQIAbVg90H21EOLACvtfcHk0lgsKna4kDKHug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGnsr3K&md5=272d0064cb4e8f0207ca5e6e5a76a7a7</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1039%2Fb713899g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb713899g%26sid%3Dliteratum%253Aachs%26aulast%3DTsang%26aufirst%3DW.-Y.%26aulast%3DAhmed%26aufirst%3DN.%26aulast%3DHemming%26aufirst%3DK.%26aulast%3DPage%26aufirst%3DM.%2BI.%26atitle%3DReactivity%2520and%2520selectivity%2520in%2520the%2520inhibition%2520of%2520elastase%2520by%25203-oxo-%25CE%25B2-sultams%2520and%2520in%2520their%2520hydrolysis%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2007%26volume%3D5%26issue%3D24%26spage%3D3993%26epage%3D4000%26doi%3D10.1039%2Fb713899g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref225"><div class="reference"><strong class="refLabel"><a href="#ref225" class="rightTabRefNumLink">225</a></strong><div class="NLM_citation" id="rightTab-cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemming, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laws, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, M. I.</span></span> <span> </span><span class="NLM_article-title">Acylation versus sulfonylation in the inhibition of elastase by 3-oxo-Î²-sultams</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">8946</span>â <span class="NLM_lpage">8947</span>, <span class="refDoi">Â DOI: 10.1021/ja050787z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja050787z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslSgu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=8946-8947&issue=25&author=W.+Y.+Tsangauthor=N.+Ahmedauthor=L.+P.+Hardingauthor=K.+Hemmingauthor=A.+P.+Lawsauthor=M.+I.+Page&title=Acylation+versus+sulfonylation+in+the+inhibition+of+elastase+by+3-oxo-%CE%B2-sultams&doi=10.1021%2Fja050787z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Acylation versus Sulfonylation in the Inhibition of Elastase by 3-Oxo-Î²-Sultams</span></div><div class="casAuthors">Tsang, Wing Y.; Ahmed, Naveed; Harding, Lindsay P.; Hemming, Karl; Laws, Andrew P.; Page, Michael I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8946-8947</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Î²-Sultams are the sulfonyl analogs of Î²-lactams, and 3-oxo-Î²-sultams are both Î²-lactams and Î²-sultams and, therefore, susceptible to nucleophilic attack at either the acyl or the sulfonyl center.  They are novel inactivators of serine enzymes.  The second-order rate const. for the inactivation of elastase at pH 6 by N-benzyl-4,4-dimethyl-3-oxo-Î²-sultam is 768 M-1 s-1, which is 103-fold greater than that with N-benzoyl Î²-sultam.  However, in contrast to N-acyl Î²-sultams, which sulfonylate the active site serine residue to form a sulfonate ester, 3-oxo-Î²-sultams inhibit the enzyme by acylation followed by slow deacylation to regenerate the active enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5mZOowgzNDbVg90H21EOLACvtfcHk0lgsKna4kDKHug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslSgu7c%253D&md5=d65f061e549038b4bc566476efaa4f45</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1021%2Fja050787z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja050787z%26sid%3Dliteratum%253Aachs%26aulast%3DTsang%26aufirst%3DW.%2BY.%26aulast%3DAhmed%26aufirst%3DN.%26aulast%3DHarding%26aufirst%3DL.%2BP.%26aulast%3DHemming%26aufirst%3DK.%26aulast%3DLaws%26aufirst%3DA.%2BP.%26aulast%3DPage%26aufirst%3DM.%2BI.%26atitle%3DAcylation%2520versus%2520sulfonylation%2520in%2520the%2520inhibition%2520of%2520elastase%2520by%25203-oxo-%25CE%25B2-sultams%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26issue%3D25%26spage%3D8946%26epage%3D8947%26doi%3D10.1021%2Fja050787z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref226"><div class="reference"><strong class="refLabel"><a href="#ref226" class="rightTabRefNumLink">226</a></strong><div class="NLM_citation" id="rightTab-cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, L. A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brito, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guedes, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonÃ§alves, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, R.</span></span> <span> </span><span class="NLM_article-title">3-Oxo-Î²-sultam as a sulfonylating chemotype for inhibition of serine hydrolases and activity-based protein profiling</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">878</span>â <span class="NLM_lpage">883</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.0c00090</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.0c00090" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvFyhur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=878-883&issue=4&author=L.+A.+R.+Carvalhoauthor=V.+T.+Almeidaauthor=J.+A.+Britoauthor=K.+M.+Lumauthor=T.+F.+Oliveiraauthor=R.+C.+Guedesauthor=L.+M.+Gon%C3%A7alvesauthor=S.+D.+Lucasauthor=B.+F.+Cravattauthor=M.+Archerauthor=R.+Moreira&title=3-Oxo-%CE%B2-sultam+as+a+sulfonylating+chemotype+for+inhibition+of+serine+hydrolases+and+activity-based+protein+profiling&doi=10.1021%2Facschembio.0c00090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">3-Oxo-Î²-sultam as a sulfonylating chemotype for inhibition of serine hydrolases and activity-based protein profiling</span></div><div class="casAuthors">Carvalho, Luis A. R.; Almeida, Vanessa T.; Brito, Jose A.; Lum, Kenneth M.; Oliveira, Tania F.; Guedes, Rita C.; Goncalves, Lidia M.; Lucas, Susana D.; Cravatt, Benjamin F.; Archer, Margarida; Moreira, Rui</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">878-883</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Oxo-Î²-sultams are four-membered ring ambident electrophiles that can react with nucleophiles either at the carbonyl carbon or at the sulfonyl sulfur atoms, and that have been reported to inhibit serine hydrolases via acylation of the active-site serine residue.  We have developed a panel of 3-oxo-Î²-sultam inhibitors and show, through crystallog. data, that they are regioselective sulfonylating electrophiles, covalently binding to the catalytic serine of human and porcine elastases through the sulfur atom.  Application of 3-oxo-Î²-sultam-derived activity-based probes in a human proteome revealed their potential to label disease-related serine hydrolases and proteasome subunits.  Activity-based protein profiling applications of 3-oxo-Î²-sultams should open up new opportunities to investigate these classes of enzymes in complex proteomes and expand the toolbox of available sulfur-based covalent protein modifiers in chem. biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEsMpvad_cBbVg90H21EOLACvtfcHk0ljD0PrWwsr73Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvFyhur0%253D&md5=bce244ee35ced134635154656e34fb6d</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1021%2Facschembio.0c00090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.0c00090%26sid%3Dliteratum%253Aachs%26aulast%3DCarvalho%26aufirst%3DL.%2BA.%2BR.%26aulast%3DAlmeida%26aufirst%3DV.%2BT.%26aulast%3DBrito%26aufirst%3DJ.%2BA.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DOliveira%26aufirst%3DT.%2BF.%26aulast%3DGuedes%26aufirst%3DR.%2BC.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DL.%2BM.%26aulast%3DLucas%26aufirst%3DS.%2BD.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DArcher%26aufirst%3DM.%26aulast%3DMoreira%26aufirst%3DR.%26atitle%3D3-Oxo-%25CE%25B2-sultam%2520as%2520a%2520sulfonylating%2520chemotype%2520for%2520inhibition%2520of%2520serine%2520hydrolases%2520and%2520activity-based%2520protein%2520profiling%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2020%26volume%3D15%26issue%3D4%26spage%3D878%26epage%3D883%26doi%3D10.1021%2Facschembio.0c00090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref227"><div class="reference"><strong class="refLabel"><a href="#ref227" class="rightTabRefNumLink">227</a></strong><div class="NLM_citation" id="rightTab-cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">AntÃ³nio, J. P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonÃ§alves, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guedes, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gois, P. M. P.</span></span> <span> </span><span class="NLM_article-title">Diazaborines as new inhibitors of human neutrophil elastase</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">7418</span>â <span class="NLM_lpage">7423</span>, <span class="refDoi">Â DOI: 10.1021/acsomega.8b00702</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.8b00702" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Kmt7jL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2018&pages=7418-7423&issue=7&author=J.+P.+M.+Ant%C3%B3nioauthor=L.+M.+Gon%C3%A7alvesauthor=R.+C.+Guedesauthor=R.+Moreiraauthor=P.+M.+P.+Gois&title=Diazaborines+as+new+inhibitors+of+human+neutrophil+elastase&doi=10.1021%2Facsomega.8b00702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Diazaborines as New Inhibitors of Human Neutrophil Elastase</span></div><div class="casAuthors">Antonio, Joao P. M.; Goncalves, Lidia M.; Guedes, Rita C.; Moreira, Rui; Gois, Pedro M. P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">7418-7423</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Boronic acids (BAs) are a prominent functionality extensively used to design biol. active compds. and functional biomaterials.  Boron open shells can lead to unspecific reactivity of BAs with endogenous nucleophiles and to undesired off-target effects.  Here, diazaborines are presented as a new class of boron-based warheads for serine proteases inhibition, in which the boron function is stabilized in the form of an arom. boron-based heterocycle.  In this study, diazaborines were readily synthesized in a single step in yields up to 96%, without any chromatog. operation and were shown to reversibly inhibit human neutrophil elastase (HNE) serine protease with IC50 values in the low Î¼M range.  Diazaborines were also selective toward HNE, as no inhibition was obsd. against a panel of five closely related serine proteases.  Synthetic and theor. studies performed on this system suggest that, similar to BAs, the reaction mechanism involves the formation of a reversible covalent bond between the diazaborine boron center and the catalytic serine oxygen.  Finally, different from BAs, diazaborines were shown to be very stable in pH 7.4 phosphate buffer and human plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWGfHcX-logrVg90H21EOLACvtfcHk0ljD0PrWwsr73Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Kmt7jL&md5=375fb4cdd0663d11c2fcc6bae15b2866</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1021%2Facsomega.8b00702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.8b00702%26sid%3Dliteratum%253Aachs%26aulast%3DAnt%25C3%25B3nio%26aufirst%3DJ.%2BP.%2BM.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DL.%2BM.%26aulast%3DGuedes%26aufirst%3DR.%2BC.%26aulast%3DMoreira%26aufirst%3DR.%26aulast%3DGois%26aufirst%3DP.%2BM.%2BP.%26atitle%3DDiazaborines%2520as%2520new%2520inhibitors%2520of%2520human%2520neutrophil%2520elastase%26jtitle%3DACS%2520Omega%26date%3D2018%26volume%3D3%26issue%3D7%26spage%3D7418%26epage%3D7423%26doi%3D10.1021%2Facsomega.8b00702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref228"><div class="reference"><strong class="refLabel"><a href="#ref228" class="rightTabRefNumLink">228</a></strong><div class="NLM_citation" id="rightTab-cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Meester, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ScharpÃ©, S.</span></span> <span> </span><span class="NLM_article-title">CD26, let it cut or cut it down</span>. <i>Immunol. Today</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">367</span>â <span class="NLM_lpage">375</span>, <span class="refDoi">Â DOI: 10.1016/S0167-5699(99)01486-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0167-5699%2899%2901486-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10431157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1MXlt1Oltb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=367-375&issue=8&author=I.+De+Meesterauthor=S.+Koromauthor=J.+Van+Dammeauthor=S.+Scharp%C3%A9&title=CD26%2C+let+it+cut+or+cut+it+down&doi=10.1016%2FS0167-5699%2899%2901486-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">CD26, let it cut or cut it down</span></div><div class="casAuthors">De Meester, Ingrid; Korom, Stephan; Van Damme, Jo; Scharpe, Simon</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Today</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">367-375</span>CODEN:
                <span class="NLM_cas:coden">IMTOD8</span>;
        ISSN:<span class="NLM_cas:issn">0167-4919</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 82 refs.  The costimulatory properties of CD26 have been studied extensively and significant progress has been made in unraveling the complex nature of this mol.  Here, we summarize recent findings on mol. and functional characteristics of CD26.  We argue that a multidisciplinary approach might reveal the mol. events underlying the role of CD26 in HIV infection and immune, inflammatory and endocrine responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaAi-Ov3EJzLVg90H21EOLACvtfcHk0ljD0PrWwsr73Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlt1Oltb0%253D&md5=79c9ca0c3e5eefaef238b8e87530afc7</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1016%2FS0167-5699%2899%2901486-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-5699%252899%252901486-3%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DKorom%26aufirst%3DS.%26aulast%3DVan%2BDamme%26aufirst%3DJ.%26aulast%3DScharp%25C3%25A9%26aufirst%3DS.%26atitle%3DCD26%252C%2520let%2520it%2520cut%2520or%2520cut%2520it%2520down%26jtitle%3DImmunol.%2520Today%26date%3D1999%26volume%3D20%26issue%3D8%26spage%3D367%26epage%3D375%26doi%3D10.1016%2FS0167-5699%2899%2901486-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref229"><div class="reference"><strong class="refLabel"><a href="#ref229" class="rightTabRefNumLink">229</a></strong><div class="NLM_citation" id="rightTab-cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leiting, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pryor, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsilio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N. A.</span></span> <span> </span><span class="NLM_article-title">Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>371</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">525</span>â <span class="NLM_lpage">532</span>, <span class="refDoi">Â DOI: 10.1042/bj20021643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1042%2Fbj20021643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=12529175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisleqs7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=525-532&issue=2&author=B.+Leitingauthor=K.+D.+Pryorauthor=J.+K.+Wuauthor=F.+Marsilioauthor=R.+A.+Patelauthor=C.+S.+Craikauthor=J.+A.+Ellmanauthor=R.+T.+Cummingsauthor=N.+A.+Thornberry&title=Catalytic+properties+and+inhibition+of+proline-specific+dipeptidyl+peptidases+II%2C+IV+and+VII&doi=10.1042%2Fbj20021643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII</span></div><div class="casAuthors">Leiting, Barbara; Pryor, KellyAnn D.; Wu, Joseph K.; Marsilio, Frank; Patel, Reshma A.; Craik, Charles S.; Ellman, Jonathan A.; Cummings, Richard T.; Thornberry, Nancy A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">525-532</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">There is currently intense interest in the emerging group of proline-specific dipeptidases, and their roles in the regulation of biol. processes.  Dipeptidyl peptidase IV (DPP-IV) is involved in glucose metab. by contributing to the regulation of glucagon family peptides and has emerged as a potential target for the treatment of metabolic diseases.  Two other proline-specific dipeptidases, DPP-VII (also known as quiescent cell proline dipeptidase) and DPP-II, have unknown functions and have recently been suggested to be identical proteases based on a sequence comparison of human DPP-VII and rat DPP-II (78% identity).  To facilitate the identification of selective substrates and inhibitors for these enzymes, a complete biochem. profile of these enzymes was obtained.  The pH profiles, substrate specificities as detd. by positional scanning, Michaelis-Menten consts. and inhibition profiles for DPP-VII and DPP-II were shown to be virtually identical, strongly supporting the hypothesis that they are the same protease.  In addn., substrate specificities, catalytic consts. and IC50 values were shown to be markedly different from those of DPP-IV.  Selective DPP-IV and DPP-VII substrates were identified, and they can be used to design selective inhibitors and probe further into the biol. of these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_SJ3G9gCruLVg90H21EOLACvtfcHk0lhqr0C5vaJqyA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisleqs7o%253D&md5=5165326f312e7e5e49dba18a059d7ca2</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1042%2Fbj20021643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021643%26sid%3Dliteratum%253Aachs%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DPryor%26aufirst%3DK.%2BD.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26atitle%3DCatalytic%2520properties%2520and%2520inhibition%2520of%2520proline-specific%2520dipeptidyl%2520peptidases%2520II%252C%2520IV%2520and%2520VII%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26issue%3D2%26spage%3D525%26epage%3D532%26doi%3D10.1042%2Fbj20021643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref230"><div class="reference"><strong class="refLabel"><a href="#ref230" class="rightTabRefNumLink">230</a></strong><div class="NLM_citation" id="rightTab-cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pederson, R. A.</span></span> <span> </span><span class="NLM_article-title">Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3585</span>â <span class="NLM_lpage">3596</span>, <span class="refDoi">Â DOI: 10.1210/endo.136.8.7628397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1210%2Fendo.136.8.7628397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=7628397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2MXntFKntLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1995&pages=3585-3596&issue=8&author=T.+J.+Kiefferauthor=C.+H.+McIntoshauthor=R.+A.+Pederson&title=Degradation+of+glucose-dependent+insulinotropic+polypeptide+and+truncated+glucagon-like+peptide+1+in+vitro+and+in+vivo+by+dipeptidyl+peptidase+IV&doi=10.1210%2Fendo.136.8.7628397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV</span></div><div class="casAuthors">Kieffer, Timothy J.; McIntosh, Christopher H. S.; Pederson, Raymond A.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3585-97</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The combined actions of glucose-dependent insulinotropic polypeptide (GIP) and truncated glucagon-like peptide-1 (tGLP-1) may fully account for the incretin effect.  These hormones are released from the small intestine in response to oral glucose and stimulate insulin release.  Recently, evidence has been provided demonstrating the degrdn. of GIP-(1-42) and GLP-1-(7-36)NH2 by the serum enzyme dipeptidyl peptidase IV (DPP IV) into the biol. inactive products GIP-(3-42) and GLP-1-(9-36)NH2.  The objective of the current investigation was to develop a method to monitor the degrdn. of these hormones in vivo.  Synthetic peptides were radiolabeled and purified by HPLC.  Subsequent degrdn. of the peptides under various conditions was then monitored by further HPLC anal.  Incubation of [125I]GIP-(1-42) or [125I]GLP-1-(7-36)NH2 with Wistar rat serum or purified DPP IV resulted in the major N-terminal-truncated products [125I]GIP-(3-42) and [125I]GLP-1-(9-36)NH2.  These products were significantly reduced when the specific DPP IV inhibitor diprotin A was included in the incubation mixt. and were absent when serum from DPP IV-deficient rats was used.  When the labeled peptides were infused into rats at hormone levels within the physiol. range, over 50% was metabolized to the truncated forms within 2 min.  These products were absent when the tracers were infused into DPP IV-deficient animals.  It is concluded that DPP IV may be a primary inactivating enzyme of both GIP and tGLP-1 in vivo.  As the N-terminal-truncated products of the DPP IV cleavage may not be distinguished from the biol. active hormone by currently employed assays, reports of circulating hormone levels should be reconsidered.  The method described in this manuscript may be useful for investigating the durations of action of GIP and tGLP-1 in normal and pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq593ilo39xZrVg90H21EOLACvtfcHk0lhqr0C5vaJqyA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntFKntLc%253D&md5=15775ebc1ca71f838ee24a8f526496f9</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1210%2Fendo.136.8.7628397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fendo.136.8.7628397%26sid%3Dliteratum%253Aachs%26aulast%3DKieffer%26aufirst%3DT.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DC.%2BH.%26aulast%3DPederson%26aufirst%3DR.%2BA.%26atitle%3DDegradation%2520of%2520glucose-dependent%2520insulinotropic%2520polypeptide%2520and%2520truncated%2520glucagon-like%2520peptide%25201%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DEndocrinology%26date%3D1995%26volume%3D136%26issue%3D8%26spage%3D3585%26epage%3D3596%26doi%3D10.1210%2Fendo.136.8.7628397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref231"><div class="reference"><strong class="refLabel"><a href="#ref231" class="rightTabRefNumLink">231</a></strong><div class="NLM_citation" id="rightTab-cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pauly, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosche, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, C. H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pederson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H.-U.</span></span> <span> </span><span class="NLM_article-title">Investigation of glucose-dependent insulinotropic polypeptide-(1â42) and glucagon-like peptide-1-(7â36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. A novel kinetic approach</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">23222</span>â <span class="NLM_lpage">23229</span>, <span class="refDoi">Â DOI: 10.1074/jbc.271.38.23222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.271.38.23222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8798518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK28XlvVCgsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=23222-23229&issue=38&author=R.+P.+Paulyauthor=F.+Roscheauthor=M.+Wermannauthor=C.+H.+S.+McIntoshauthor=R.+A.+Pedersonauthor=H.-U.+Demuth&title=Investigation+of+glucose-dependent+insulinotropic+polypeptide-%281%E2%80%9342%29+and+glucagon-like+peptide-1-%287%E2%80%9336%29+degradation+in+vitro+by+dipeptidyl+peptidase+IV+using+matrix-assisted+laser+desorption%2Fionization-time+of+flight+mass+spectrometry.+A+novel+kinetic+approach&doi=10.1074%2Fjbc.271.38.23222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of glucose-dependent insulinotropic polypeptide-(1-42) and glucagon-like peptide-1-(7-36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. A novel kinetic approach</span></div><div class="casAuthors">Pauly, Robert P.; Rosche, Fred; Wermann, Michael; McIntosh, Christopher H. S.; Pederson, Raymond A.; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">23222-23229</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The incretins glucose-dependent insulinotropic polypeptide (GIP1-42) and glucagon-like peptide-1-(7-36)-amide (GLP-17-36), hormones that potentiate glucose-induced insulin secretion from the endocrine pancreas, are substrates of the circulating exopeptidase dipeptidyl peptidase IV and are rendered biol. inactive upon cleavage of their N-terminal dipeptides.  This study was designed to det. if matrix-assisted laser desorption/ionization-time of flight mass spectrometry is a useful anal. tool to study the hydrolysis of these hormones by dipeptidyl peptidase IV, including kinetic anal.  Spectra indicated that serum-incubated peptides were cleaved by this enzyme with only minor secondary degrdn. due to other serum protease activity.  Quantification of the mass spectrometric signals allowed kinetic consts. for both porcine kidney- and human serum dipeptidyl peptidase IV-catalyzed incretin hydrolysis to be calcd.  The binding consts. (Km) of these incretins to purified porcine kidney-derived enzyme were 1.8 and 3.8 Î¼M, whereas the binding consts. obsd. in human serum were 39 and 13 Î¼M for glucose-dependent-insulinotropic polypeptide and glucagon-like peptide-1-(7-36), resp.  The large range of Km values found in human serum suggests a heterogeneous pool of enzyme.  The close correlation between the reported kinetic consts. and those previously described validates this novel approach to kinetic anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFsv2kdL0MjbVg90H21EOLACvtfcHk0lhzy2wRSwY6ew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvVCgsL0%253D&md5=861ce1e9cc411c266e41e2b4288d053e</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.38.23222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.38.23222%26sid%3Dliteratum%253Aachs%26aulast%3DPauly%26aufirst%3DR.%2BP.%26aulast%3DRosche%26aufirst%3DF.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DMcIntosh%26aufirst%3DC.%2BH.%2BS.%26aulast%3DPederson%26aufirst%3DR.%2BA.%26aulast%3DDemuth%26aufirst%3DH.-U.%26atitle%3DInvestigation%2520of%2520glucose-dependent%2520insulinotropic%2520polypeptide-%25281%25E2%2580%259342%2529%2520and%2520glucagon-like%2520peptide-1-%25287%25E2%2580%259336%2529%2520degradation%2520in%2520vitro%2520by%2520dipeptidyl%2520peptidase%2520IV%2520using%2520matrix-assisted%2520laser%2520desorption%252Fionization-time%2520of%2520flight%2520mass%2520spectrometry.%2520A%2520novel%2520kinetic%2520approach%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26issue%3D38%26spage%3D23222%26epage%3D23229%26doi%3D10.1074%2Fjbc.271.38.23222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref232"><div class="reference"><strong class="refLabel"><a href="#ref232" class="rightTabRefNumLink">232</a></strong><div class="NLM_citation" id="rightTab-cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâLeary, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broxmeyer, H. E.</span></span> <span> </span><span class="NLM_article-title">Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">161</span>â <span class="NLM_lpage">169</span>, <span class="refDoi">Â DOI: 10.1182/blood-2013-02-487470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1182%2Fblood-2013-02-487470" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23637126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=161-169&issue=2&author=X.+Ouauthor=H.+A.+O%E2%80%99Learyauthor=H.+E.+Broxmeyer&title=Implications+of+DPP4+modification+of+proteins+that+regulate+stem%2Fprogenitor+and+more+mature+cell+types&doi=10.1182%2Fblood-2013-02-487470"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types</span></div><div class="casAuthors">Ou, Xuan; O'Leary, Heather A.; Broxmeyer, Hal E.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-169</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  Dipeptidylpeptidase (DPP) 4 has the potential to truncate proteins with a penultimate alanine, proline, or other selective amino acids at the N-terminus.  DPP4 truncation of certain chemokines, colony-stimulating factors, and interleukins have recently been linked to regulation of hematopoietic stem/progenitor cells, more mature blood cells, and other cell types.  We believe that the potential role of DPP4 in modification of many regulatory proteins, and their subsequent effects on numerous stem/progenitor and other cell-type functions has not been adequately appreciated.  This review addresses the potential implications of the modifying effects of DPP4 on a large no. of cytokines and other growth-regulating factors with either proven or putative DPP4 truncation sites on hematopoietic cells, and subsequent effects of DPP4-truncated proteins on multiple aspects of steady-state and stressed hematopoiesis, including stem/progenitor cell, and more mature cell, function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG60FR8TezlbVg90H21EOLACvtfcHk0lhzy2wRSwY6ew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLfI&md5=be94ebc6ff137b7a10d6e67210ae6532</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-02-487470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-02-487470%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DX.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DH.%2BA.%26aulast%3DBroxmeyer%26aufirst%3DH.%2BE.%26atitle%3DImplications%2520of%2520DPP4%2520modification%2520of%2520proteins%2520that%2520regulate%2520stem%252Fprogenitor%2520and%2520more%2520mature%2520cell%2520types%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26issue%3D2%26spage%3D161%26epage%3D169%26doi%3D10.1182%2Fblood-2013-02-487470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref233"><div class="reference"><strong class="refLabel"><a href="#ref233" class="rightTabRefNumLink">233</a></strong><div class="NLM_citation" id="rightTab-cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antonsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lys, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechavanne, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevalet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boschert, U.</span></span> <span> </span><span class="NLM_article-title">In vivo processing of CXCL12Î±/SDF-1Î± after intravenous and subcutaneous administration to mice</span>. <i>Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">4342</span>â <span class="NLM_lpage">4351</span>, <span class="refDoi">Â DOI: 10.1002/pmic.201000331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fpmic.201000331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=21136589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFagsrnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=4342-4351&issue=24&author=B.+Antonssonauthor=P.+De+Lysauthor=V.+Dechavanneauthor=L.+Chevaletauthor=U.+Boschert&title=In+vivo+processing+of+CXCL12%CE%B1%2FSDF-1%CE%B1+after+intravenous+and+subcutaneous+administration+to+mice&doi=10.1002%2Fpmic.201000331"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo processing of CXCL12Î±/SDF-1Î± after intravenous and subcutaneous administration to mice</span></div><div class="casAuthors">Antonsson, Bruno; De Lys, Patricia; Dechavanne, Vincent; Chevalet, Laurent; Boschert, Ursula</div><div class="citationInfo"><span class="NLM_cas:title">Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4342-4351</span>CODEN:
                <span class="NLM_cas:coden">PROTC7</span>;
        ISSN:<span class="NLM_cas:issn">1615-9853</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">CXCL12Î± has been shown to be selectively processed at the N- and C-termini in blood and plasma in vitro.  In order to study the processing in vivo, several versions of CXCL12Î± were expressed and purified.  The protein was administered either iv or s.c. to mice, and at different time points postadministration plasma was collected and analyzed.  To detect modifications of the CXCL12Î± mol. in crude plasma a SELDI TOF-MS-based method was developed.  Anti-CXCL12 antibodies were immobilized on the SELDI chip and CXCL12Î± binding to the antibodies was detected by SELDI-TOF-MS.  The protein was found to be processed both at the C- and N-termini.  The same processed CXCL12Î± forms as detected in vitro were found; however, in addn. further processing was detected at the N-terminus, where altogether seven amino acids were removed.  At the C-terminus the lysine was removed as has been seen in vitro, and no further processing was detected.  The full-length CXCL12Î± disappeared within minutes after administration, whereas the processed forms of the protein were detectable for up to 6-8 h postadministration.  The same processed forms appeared after iv and s.c. administration, only the kinetics was different.  When the shortest processed form detected in plasma, 7ÎN1ÎC-CXCL12Î±, was administered directly, no further processed forms were detected.  Interestingly, a version of CXCL12Î± contg. a N-terminal methionine was protected against N-terminal processing in plasma in vitro; however, in vivo no protection was seen, the protein was processed in the same way as full-length CXCL12Î±.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriAo7WPDgfR7Vg90H21EOLACvtfcHk0lhzy2wRSwY6ew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFagsrnM&md5=5486c8dd256eb574e722711c00a38672</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1002%2Fpmic.201000331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpmic.201000331%26sid%3Dliteratum%253Aachs%26aulast%3DAntonsson%26aufirst%3DB.%26aulast%3DDe%2BLys%26aufirst%3DP.%26aulast%3DDechavanne%26aufirst%3DV.%26aulast%3DChevalet%26aufirst%3DL.%26aulast%3DBoschert%26aufirst%3DU.%26atitle%3DIn%2520vivo%2520processing%2520of%2520CXCL12%25CE%25B1%252FSDF-1%25CE%25B1%2520after%2520intravenous%2520and%2520subcutaneous%2520administration%2520to%2520mice%26jtitle%3DProteomics%26date%3D2010%26volume%3D10%26issue%3D24%26spage%3D4342%26epage%3D4351%26doi%3D10.1002%2Fpmic.201000331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref234"><div class="reference"><strong class="refLabel"><a href="#ref234" class="rightTabRefNumLink">234</a></strong><div class="NLM_citation" id="rightTab-cit234"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barreira da Silva, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yatim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiette, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingersoll, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, M. L.</span></span> <span> </span><span class="NLM_article-title">Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">850</span>â <span class="NLM_lpage">858</span>, <span class="refDoi">Â DOI: 10.1038/ni.3201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fni.3201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26075911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFSktLjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=850-858&issue=8&author=R.+Barreira+da+Silvaauthor=M.+E.+Lairdauthor=N.+Yatimauthor=L.+Fietteauthor=M.+A.+Ingersollauthor=M.+L.+Albert&title=Dipeptidylpeptidase+4+inhibition+enhances+lymphocyte+trafficking%2C+improving+both+naturally+occurring+tumor+immunity+and+immunotherapy&doi=10.1038%2Fni.3201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy</span></div><div class="casAuthors">Barreira da Silva, Rosa; Laird, Melissa E.; Yatim, Nader; Fiette, Laurence; Ingersoll, Molly A.; Albert, Matthew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">850-858</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The success of antitumor immune responses depends on the infiltration of solid tumors by effector T cells, a process guided by chemokines.  Here we show that in vivo post-translational processing of chemokines by dipeptidylpeptidase 4 (DPP4, also known as CD26) limits lymphocyte migration to sites of inflammation and tumors.  Inhibition of DPP4 enzymic activity enhanced tumor rejection by preserving biol. active CXCL10 and increasing trafficking into the tumor by lymphocytes expressing the counter-receptor CXCR3.  Furthermore, DPP4 inhibition improved adjuvant-based immunotherapy, adoptive T cell transfer and checkpoint blockade.  These findings provide direct in vivo evidence for control of lymphocyte trafficking via CXCL10 cleavage and support the use of DPP4 inhibitors for stabilizing biol. active forms of chemokines as a strategy to enhance tumor immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7lebakVsDQbVg90H21EOLACvtfcHk0ljgIlYFSd_FzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFSktLjI&md5=8d8481e29324813e94008f337680c937</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.1038%2Fni.3201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.3201%26sid%3Dliteratum%253Aachs%26aulast%3DBarreira%2Bda%2BSilva%26aufirst%3DR.%26aulast%3DLaird%26aufirst%3DM.%2BE.%26aulast%3DYatim%26aufirst%3DN.%26aulast%3DFiette%26aufirst%3DL.%26aulast%3DIngersoll%26aufirst%3DM.%2BA.%26aulast%3DAlbert%26aufirst%3DM.%2BL.%26atitle%3DDipeptidylpeptidase%25204%2520inhibition%2520enhances%2520lymphocyte%2520trafficking%252C%2520improving%2520both%2520naturally%2520occurring%2520tumor%2520immunity%2520and%2520immunotherapy%26jtitle%3DNat.%2520Immunol.%26date%3D2015%26volume%3D16%26issue%3D8%26spage%3D850%26epage%3D858%26doi%3D10.1038%2Fni.3201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref235"><div class="reference"><strong class="refLabel"><a href="#ref235" class="rightTabRefNumLink">235</a></strong><div class="NLM_citation" id="rightTab-cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohnuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamochi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishibashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, C.</span></span> <span> </span><span class="NLM_article-title">Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">10117</span>â <span class="NLM_lpage">10131</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M609157200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.M609157200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17287217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlCisb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=10117-10131&issue=13&author=K.+Ohnumaauthor=M.+Uchiyamaauthor=T.+Yamochiauthor=K.+Nishibashiauthor=O.+Hosonoauthor=N.+Takahashiauthor=S.+Kinaauthor=H.+Tanakaauthor=X.+Linauthor=N.+H.+Dangauthor=C.+Morimoto&title=Caveolin-1+triggers+T-cell+activation+via+CD26+in+association+with+CARMA1&doi=10.1074%2Fjbc.M609157200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">Caveolin-1 Triggers T-cell Activation via CD26 in Association with CARMA1</span></div><div class="casAuthors">Ohnuma, Kei; Uchiyama, Masahiko; Yamochi, Tadanori; Nishibashi, Kunika; Hosono, Osamu; Takahashi, Nozomu; Kina, Shinichiro; Tanaka, Hirotoshi; Lin, Xin; Dang, Nam H.; Morimoto, Chikao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">10117-10131</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">CD26 is a widely distributed 110-kDa cell surface glycoprotein with an important role in T-cell costimulation.  We demonstrated previously that CD26 binds to caveolin-1 in antigen-presenting cells, and following exogenous CD26 stimulation, Tollip and IRAK-1 disengage from caveolin-1 in antigen-presenting cells.  IRAK-1 is then subsequently phosphorylated to up-regulate CD86 expression, resulting in subsequent T-cell proliferation.  However, it is unclear whether caveolin-1 is a costimulatory ligand for CD26 in T-cells.  Using sol. caveolin-1-Fc fusion protein, we now show that caveolin-1 is the costimulatory ligand for CD26, and that ligation of CD26 by caveolin-1 induces T-cell proliferation and NF-ÎºB activation in a T-cell receptor/CD3-dependent manner.  We also demonstrated that the cytoplasmic tail of CD26 interacts with CARMA1 in T-cells, resulting in signaling events that lead to NF-ÎºB activation.  Ligation of CD26 by caveolin-1 recruits a complex consisting of CD26, CARMA1, Bcl10, and IÎºB kinase to lipid rafts.  Taken together, our findings provide novel insights into the regulation of T-cell costimulation via the CD26 mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoavTGuU3pFC7Vg90H21EOLACvtfcHk0ljgIlYFSd_FzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlCisb0%253D&md5=597e804b42979fd89949939603ffb9b0</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M609157200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M609157200%26sid%3Dliteratum%253Aachs%26aulast%3DOhnuma%26aufirst%3DK.%26aulast%3DUchiyama%26aufirst%3DM.%26aulast%3DYamochi%26aufirst%3DT.%26aulast%3DNishibashi%26aufirst%3DK.%26aulast%3DHosono%26aufirst%3DO.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DKina%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DDang%26aufirst%3DN.%2BH.%26aulast%3DMorimoto%26aufirst%3DC.%26atitle%3DCaveolin-1%2520triggers%2520T-cell%2520activation%2520via%2520CD26%2520in%2520association%2520with%2520CARMA1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26issue%3D13%26spage%3D10117%26epage%3D10131%26doi%3D10.1074%2Fjbc.M609157200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref236"><div class="reference"><strong class="refLabel"><a href="#ref236" class="rightTabRefNumLink">236</a></strong><div class="NLM_citation" id="rightTab-cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinheiro, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoppa, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valduga, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuyama, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GorjÃ£o, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, R. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diniz, S. N.</span></span> <span> </span><span class="NLM_article-title">Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">17</span>â <span class="NLM_lpage">24</span>, <span class="refDoi">Â DOI: 10.1016/j.ejps.2016.12.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.ejps.2016.12.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=28065853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKkurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2017&pages=17-24&author=M.+M.+Pinheiroauthor=C.+L.+Stoppaauthor=C.+J.+Valdugaauthor=C.+E.+Okuyamaauthor=R.+Gorj%C3%A3oauthor=R.+M.+S.+Pereiraauthor=S.+N.+Diniz&title=Sitagliptin+inhibit+human+lymphocytes+proliferation+and+Th1%2FTh17+differentiation+in+vitro&doi=10.1016%2Fj.ejps.2016.12.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro</span></div><div class="casAuthors">Pinheiro, Marcelo Maia; Stoppa, Caroline Lais; Valduga, Claudete Justina; Okuyama, Cristina Eunice; Gorjao, Renata; Pereira, Regina Mara Silva; Diniz, Susana Nogueira</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-24</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of anti-diabetic agents that are widely used in clin. practice to improve glycemic control in patients with type 2 diabetes.  DPP-4 is also known as lymphocyte cell surface protein, CD26, and plays an important role in T-cell immunity.  Recent studies suggest that DPP-4 inhibitors improve beta-cell function and attenuate autoimmunity in type 1 diabetic mouse models.  To investigate the direct effect of DPP4 in immune response, human peripheral blood mononuclear cells (PBMC) from healthy volunteers were obtained by Ficoll gradient and cultivated in the absence (control) or presence of phytohemagglutinin (PHA), or stimulated with PHA and treated with sitagliptin.  The immune modulation mechanisms analyzed were: cell proliferation, by MTT assay; cytokine quantification by ELISA or cytometric bead array (CBA), Th1/Th2/Th17 phenotyping by flow cytometric anal. and CD26 gene expression by real time PCR.  The results showed that sitagliptin treatment inhibited the proliferation of PBMC-PHA stimulated cells in a dose dependent manner and decreased CD26 expression by these cells, suggesting that sitagliptin may interfere in CD26 expression, dimerization and cell signaling.  Sitagliptin treatment not only inhibited IL-10 (p < 0.05) and IFN-gamma (p = 0.07) cytokines, but also completely abolish IL-6 expression by PBMCs (p < 0.001).  On the other hand, IL-4 were secreted in culture supernatants from sitagliptin treated cells.  A statistically significant increase (p < 0.05) in the ratio of TGF-beta/proliferation index after sitagliptin treatment (2627.97 Â± 1351.65), when comparing to untreated cells (646.28 Â± 376.94), was also demonstrated, indicating higher TGF-beta1 prodn. by viable cells in cultures.  Sitagliptin treatment induced a significantly (p < 0.05) decrease in IL-17 and IFN-gamma intracellular expression compared with PHA alone.  Also, the percentage of T CD4+ IL-17+, T CD4+ IFNgamma+ and T CD4+ IL-4+ cells were significantly reduced (p < 0.05) by sitagliptin.  Our data demonstrated an immunosuppressive effect of sitagliptin on Th1, Th17 and Th2 lymphocytes differentiation that leads to the generation of regulatory TGF-beta1 secreting cells with low CD26 gene expression that may influence the state of pancreatic beta-cells and controlling DM1 patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRpb2WyJIVI7Vg90H21EOLACvtfcHk0ljgIlYFSd_FzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKkurk%253D&md5=e7f78744dec977c849529e10ea997687</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2016.12.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2016.12.040%26sid%3Dliteratum%253Aachs%26aulast%3DPinheiro%26aufirst%3DM.%2BM.%26aulast%3DStoppa%26aufirst%3DC.%2BL.%26aulast%3DValduga%26aufirst%3DC.%2BJ.%26aulast%3DOkuyama%26aufirst%3DC.%2BE.%26aulast%3DGorj%25C3%25A3o%26aufirst%3DR.%26aulast%3DPereira%26aufirst%3DR.%2BM.%2BS.%26aulast%3DDiniz%26aufirst%3DS.%2BN.%26atitle%3DSitagliptin%2520inhibit%2520human%2520lymphocytes%2520proliferation%2520and%2520Th1%252FTh17%2520differentiation%2520in%2520vitro%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2017%26volume%3D100%26spage%3D17%26epage%3D24%26doi%3D10.1016%2Fj.ejps.2016.12.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref237"><div class="reference"><strong class="refLabel"><a href="#ref237" class="rightTabRefNumLink">237</a></strong><div class="NLM_citation" id="rightTab-cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villhauer, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naderi, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkey, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunning, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangold, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. E.</span></span> <span> </span><span class="NLM_article-title">1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2774</span>â <span class="NLM_lpage">2789</span>, <span class="refDoi">Â DOI: 10.1021/jm030091l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030091l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvFOiurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2774-2789&issue=13&author=E.+B.+Villhauerauthor=J.+A.+Brinkmanauthor=G.+B.+Naderiauthor=B.+F.+Burkeyauthor=B.+E.+Dunningauthor=K.+Prasadauthor=B.+L.+Mangoldauthor=M.+E.+Russellauthor=T.+E.+Hughes&title=1-%5B%5B%283-Hydroxy-1-adamantyl%29amino%5Dacetyl%5D-2-cyano-%28S%29-pyrrolidine%3A+A+potent%2C+selective%2C+and+orally+bioavailable+dipeptidyl+peptidase+IV+inhibitor+with+antihyperglycemic+properties&doi=10.1021%2Fjm030091l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties</span></div><div class="casAuthors">Villhauer, Edwin B.; Brinkman, John A.; Naderi, Goli B.; Burkey, Bryan F.; Dunning, Beth E.; Prasad, Kapa; Mangold, Bonnie L.; Russell, Mary E.; Hughes, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2774-2789</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPP-IV) inhibition has the potential to become a valuable therapy for type 2 diabetes.  The synthesis and structure-activity relationship of a new DPP-IV inhibitor class, N-substituted-glycyl-2-cyanopyrrolidines, are described as well as the path leading from the clin. development compd., 1-[2-[(5-cyanopyridin-2-yl)amino]ethylamino]acetyl-2-cyano-(S)-pyrrolidine I (NVP-DPP728), to its follow-up, 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine II (NVP-LAF237).  The pharmacol. profile of II in obese Zucker fa/fa rats along with pharmacokinetic profile comparison of I and II in normal cynomolgus monkeys is discussed.  The results suggest that II is a potent, stable, selective DPP-IV inhibitor possessing excellent oral bioavailability and potent antihyperglycemic activity with potential for once-a-day administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeytC93XyU9LVg90H21EOLACvtfcHk0lgYC7R0bOM-dw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvFOiurY%253D&md5=877aeef8cb5f62672b5afd9bf7e022b9</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1021%2Fjm030091l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030091l%26sid%3Dliteratum%253Aachs%26aulast%3DVillhauer%26aufirst%3DE.%2BB.%26aulast%3DBrinkman%26aufirst%3DJ.%2BA.%26aulast%3DNaderi%26aufirst%3DG.%2BB.%26aulast%3DBurkey%26aufirst%3DB.%2BF.%26aulast%3DDunning%26aufirst%3DB.%2BE.%26aulast%3DPrasad%26aufirst%3DK.%26aulast%3DMangold%26aufirst%3DB.%2BL.%26aulast%3DRussell%26aufirst%3DM.%2BE.%26aulast%3DHughes%26aufirst%3DT.%2BE.%26atitle%3D1-%255B%255B%25283-Hydroxy-1-adamantyl%2529amino%255Dacetyl%255D-2-cyano-%2528S%2529-pyrrolidine%253A%2520A%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520with%2520antihyperglycemic%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D13%26spage%3D2774%26epage%3D2789%26doi%3D10.1021%2Fjm030091l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref238"><div class="reference"><strong class="refLabel"><a href="#ref238" class="rightTabRefNumLink">238</a></strong><div class="NLM_citation" id="rightTab-cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Augeri, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robl, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betebenner, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnin, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpkins, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboa-Offei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cap, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welzel, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcinkeviciene, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, L. G.</span></span> <span> </span><span class="NLM_article-title">Discovery and preclinical profile of saxagliptin (BMS-477118): A highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5025</span>â <span class="NLM_lpage">5037</span>, <span class="refDoi">Â DOI: 10.1021/jm050261p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050261p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5025-5037&issue=15&author=D.+J.+Augeriauthor=J.+A.+Roblauthor=D.+A.+Betebennerauthor=D.+R.+Magninauthor=A.+Khannaauthor=J.+G.+Robertsonauthor=A.+Wangauthor=L.+M.+Simpkinsauthor=P.+Taunkauthor=Q.+Huangauthor=S.-P.+Hanauthor=B.+Abboa-Offeiauthor=M.+Capauthor=L.+Xinauthor=L.+Taoauthor=E.+Tozzoauthor=G.+E.+Welzelauthor=D.+M.+Eganauthor=J.+Marcinkevicieneauthor=S.+Y.+Changauthor=S.+A.+Billerauthor=M.+S.+Kirbyauthor=R.+A.+Parkerauthor=L.+G.+Hamann&title=Discovery+and+preclinical+profile+of+saxagliptin+%28BMS-477118%29%3A+A+highly+potent%2C+long-acting%2C+orally+active+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type+2+diabetes&doi=10.1021%2Fjm050261p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Augeri, David J.; Robl, Jeffrey A.; Betebenner, David A.; Magnin, David R.; Khanna, Ashish; Robertson, James G.; Wang, Aiying; Simpkins, Ligaya M.; Taunk, Prakash; Huang, Qi; Han, Song-Ping; Abboa-Offei, Benoni; Cap, Michael; Xin, Li; Tao, Li; Tozzo, Effie; Welzel, Gustav E.; Egan, Donald M.; Marcinkeviciene, Jovita; Chang, Shu Y.; Biller, Scott A.; Kirby, Mark S.; Parker, Rex A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5025-5037</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Efforts to further elucidate structure-activity relationships (SAR) within the authors previously disclosed series of Î²-quaternary amino acid linked L-cis-4,5-methanoprolinenitrile dipeptidyl peptidase IV (DPP-IV) inhibitors led to the investigation of vinyl substitution at the Î²-position of Î±-cycloalkyl-substituted glycines.  Despite poor systemic exposure, vinyl-substituted compds. showed extended duration of action in acute rat ex vivo plasma DPP-IV inhibition models.  Oxygenated putative metabolites were prepd. and were shown to exhibit the potency and extended duration of action of their precursors in efficacy models measuring glucose clearance in Zuckerfa/fa rats.  Extension of this approach to adamantylglycine-derived inhibitors led to the discovery of highly potent inhibitors, including hydroxyadamantyl compd. BMS-477118 (saxagliptin), a highly efficacious, stable, and long-acting DPP-IV inhibitor, which is currently undergoing clin. trials for treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrIJX7K8p67Vg90H21EOLACvtfcHk0lgYC7R0bOM-dw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D&md5=878355880133bb0ddd6bd14ecbf1d070</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.1021%2Fjm050261p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050261p%26sid%3Dliteratum%253Aachs%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DTaunk%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.-P.%26aulast%3DAbboa-Offei%26aufirst%3DB.%26aulast%3DCap%26aufirst%3DM.%26aulast%3DXin%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DWelzel%26aufirst%3DG.%2BE.%26aulast%3DEgan%26aufirst%3DD.%2BM.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DS.%2BY.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DDiscovery%2520and%2520preclinical%2520profile%2520of%2520saxagliptin%2520%2528BMS-477118%2529%253A%2520A%2520highly%2520potent%252C%2520long-acting%252C%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D15%26spage%3D5025%26epage%3D5037%26doi%3D10.1021%2Fjm050261p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref239"><div class="reference"><strong class="refLabel"><a href="#ref239" class="rightTabRefNumLink">239</a></strong><div class="NLM_citation" id="rightTab-cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nabeno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akahoshi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyaguchi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadowaki, T.</span></span> <span> </span><span class="NLM_article-title">A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>434</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">191</span>â <span class="NLM_lpage">196</span>, <span class="refDoi">Â DOI: 10.1016/j.bbrc.2013.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.bbrc.2013.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=23501107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1ClsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2013&pages=191-196&issue=2&author=M.+Nabenoauthor=F.+Akahoshiauthor=H.+Kishidaauthor=I.+Miyaguchiauthor=Y.+Tanakaauthor=S.+Ishiiauthor=T.+Kadowaki&title=A+comparative+study+of+the+binding+modes+of+recently+launched+dipeptidyl+peptidase+IV+inhibitors+in+the+active+site&doi=10.1016%2Fj.bbrc.2013.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site</span></div><div class="casAuthors">Nabeno, Mika; Akahoshi, Fumihiko; Kishida, Hiroyuki; Miyaguchi, Ikuko; Tanaka, Yoshihito; Ishii, Shinichi; Kadowaki, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-196</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In recent years, various dipeptidyl peptidase IV (I) inhibitors have been released as therapeutic drugs for type 2 diabetes in many countries.  In spite of their diverse chem. structures, no comparative studies of their binding modes in the active site of I have been disclosed.  Here, the authors detd. the co-crystal structure of vildagliptin with I by x-ray crystallog. and compared the binding modes of 6 launched inhibitors in I.  The inhibitors were categorized into 3 classes on the basis of their binding subsites: (1) vildagliptin and saxagliptin (class 1) formed interactions with the core S1 and S2 subsites and a covalent bond with Ser-630 in the catalytic triad; (2) alogliptin and linagliptin (class 2) formed interactions with the S1' and/or S2' subsites in addn. to the S1 and S2 subsites; and (3) sitagliptin and teneligliptin (class 3) formed interactions with the S1, S2, and S2 extensive subsites.  The present study revealed that the addnl. interactions with the S1', S2' or S2 extensive subsite may increase I inhibition beyond the level afforded by the fundamental interactions with the S1 and S2 subsites and are more effective than forming a covalent bond with Ser-630.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot0q2mkCn137Vg90H21EOLACvtfcHk0lhS0cHio-mbtg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1ClsrY%253D&md5=917cf85fddb832f207c67cd70d38c657</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2013.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2013.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DNabeno%26aufirst%3DM.%26aulast%3DAkahoshi%26aufirst%3DF.%26aulast%3DKishida%26aufirst%3DH.%26aulast%3DMiyaguchi%26aufirst%3DI.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DS.%26aulast%3DKadowaki%26aufirst%3DT.%26atitle%3DA%2520comparative%2520study%2520of%2520the%2520binding%2520modes%2520of%2520recently%2520launched%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%2520in%2520the%2520active%2520site%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2013%26volume%3D434%26issue%3D2%26spage%3D191%26epage%3D196%26doi%3D10.1016%2Fj.bbrc.2013.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref240"><div class="reference"><strong class="refLabel"><a href="#ref240" class="rightTabRefNumLink">240</a></strong><div class="NLM_citation" id="rightTab-cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buzzetti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzilli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirshberg, B.</span></span> <span> </span><span class="NLM_article-title">Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA)</span>. <i>Diabetes/Metab. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">289</span>â <span class="NLM_lpage">296</span>, <span class="refDoi">Â DOI: 10.1002/dmrr.2717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fdmrr.2717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=26385269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1yqu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=289-296&issue=3&author=R.+Buzzettiauthor=P.+Pozzilliauthor=R.+Frederichauthor=N.+Iqbalauthor=B.+Hirshberg&title=Saxagliptin+improves+glycaemic+control+and+C-peptide+secretion+in+latent+autoimmune+diabetes+in+adults+%28LADA%29&doi=10.1002%2Fdmrr.2717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA)</span></div><div class="casAuthors">Buzzetti, R.; Pozzilli, P.; Frederich, R.; Iqbal, N.; Hirshberg, B.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes/Metabolism Research and Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">289-296</span>CODEN:
                <span class="NLM_cas:coden">DMRRFM</span>;
        ISSN:<span class="NLM_cas:issn">1520-7552</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background : To assess the efficacy and tolerability of saxagliptin and C-peptide secretion in patients with diagnosed type 2 diabetes classified as glutamic acid decarboxylase antibody (GADA)-pos. or GADA-neg.  Methods : Post hoc anal. of data pooled from five randomized, placebo-controlled, 24-wk phase 3 studies (n = 2709) was conducted.  We evaluated mean change from baseline at week 24 in HbA1c, fasting plasma glucose, postprandial plasma glucose, fasting and postprandial C-peptide, and HOMA2-%Î² and the proportion of patients achieving HbA1c < 7% (53 mmol/mol) at week 24.  Results : Saxagliptin produced greater adjusted mean redns. from baseline in HbA1c vs. placebo for GADA-neg. [difference vs placebo (95% CI), -0.62% (-0.71% to -0.54%); -6.8 mmol/mol (-7.8, -5.9)] and GADA-pos. patients [-0.64% (-1.01% to -0.27%); -7.0 mmol/mol (-11.0, -3.0)].  Consistently, saxagliptin produced a greater redn. from baseline in fasting plasma glucose and postprandial plasma glucose vs. placebo in GADA-pos. vs. GADA-neg. patients, and more patients achieved HbA1c < 7% (53 mmol/mol) with saxagliptin vs. placebo in both GADA-neg. and GADA-pos. patients.  Saxagliptin increased Î²-cell function as assessed by HOMA2-%Î² and postprandial C-peptide area under the curve from baseline in patients in both GADA-pos. and GADA-neg. patients.  Adverse events and hypoglycemic events were similar across treatment groups and GADA categories.  Conclusion : Saxagliptin was effective in lowering blood glucose levels and generally well tolerated in GADA-pos. patients.  Interestingly, saxagliptin appears to improve Î²-cell function in these patients, although a longer treatment duration may be needed to confirm this finding.  Copyright Â© 2015 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZMKLfPeoYULVg90H21EOLACvtfcHk0lhS0cHio-mbtg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1yqu7w%253D&md5=a30af81612002c5a48db2695f58d9303</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1002%2Fdmrr.2717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdmrr.2717%26sid%3Dliteratum%253Aachs%26aulast%3DBuzzetti%26aufirst%3DR.%26aulast%3DPozzilli%26aufirst%3DP.%26aulast%3DFrederich%26aufirst%3DR.%26aulast%3DIqbal%26aufirst%3DN.%26aulast%3DHirshberg%26aufirst%3DB.%26atitle%3DSaxagliptin%2520improves%2520glycaemic%2520control%2520and%2520C-peptide%2520secretion%2520in%2520latent%2520autoimmune%2520diabetes%2520in%2520adults%2520%2528LADA%2529%26jtitle%3DDiabetes%252FMetab.%2520Res.%2520Rev.%26date%3D2016%26volume%3D32%26issue%3D3%26spage%3D289%26epage%3D296%26doi%3D10.1002%2Fdmrr.2717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref241"><div class="reference"><strong class="refLabel"><a href="#ref241" class="rightTabRefNumLink">241</a></strong><div class="NLM_citation" id="rightTab-cit241"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flentke, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plaut, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettner, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, W. W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>88</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1556</span>â <span class="NLM_lpage">1559</span>, <span class="refDoi">Â DOI: 10.1073/pnas.88.4.1556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.88.4.1556" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1671716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK3MXitVGgt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=1556-1559&issue=4&author=G.+R.+Flentkeauthor=E.+Munozauthor=B.+T.+Huberauthor=A.+G.+Plautauthor=C.+A.+Kettnerauthor=W.+W.+Bachovchin&title=Inhibition+of+dipeptidyl+aminopeptidase+IV+%28DP-IV%29+by+Xaa-boroPro+dipeptides+and+use+of+these+inhibitors+to+examine+the+role+of+DP-IV+in+T-cell+function&doi=10.1073%2Fpnas.88.4.1556"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit241R"><div class="casContent"><span class="casTitleNuber">241</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function</span></div><div class="casAuthors">Flentke, George R.; Munoz, Eduardo; Huber, Brigitte T.; Plaut, Andrew G.; Kettner, Charles A.; Bachovchin, William W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1556-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Dipeptidyl peptidase IV (DP-IV; dipeptidyl-peptide hydrolase, EC 3.4.14.5) is a serine protease with a specificity for cleaving Xaa-Pro dipeptides from polypeptides and proteins.  It is found in a variety of mammalian cells and tissues, including those of lymphoid origin where it is found specifically on the surface of CD4+ T cells.  Although the functional significance of this enzyme has not been established, a role in T-cell activation and immune regulation has been proposed.  Here is reported that Ala-boroPro and Pro-boroPro, where boroPro is the Î±-amino boronic acid analog of proline, are potent and specific inhibitors of DP-IV, having Ki values in the nanomolar range.  Blocking the N terminus of Ala-boroPro abolishes the affinity of this inhibitor for DP-IV, while removal of the N-terminal residue, to give boroPro, reduces the affinity for DP-IV by 5 orders of magnitude.  The dipeptide boronic acids exhibit slow-binding kinetics, while boroPro does not.  Low concns. of Pro-boroPro inhibit antigen-induced proliferation and interleukin 2 prodn. in murine T-cell lines but do not inhibit the response of these T cells to the mitogen Con A.  Thus, DP-IV plays a role in antigen-induced, but not mitogen-induced, activation of T lymphocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1cfUVBGZEjrVg90H21EOLACvtfcHk0lhS0cHio-mbtg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXitVGgt78%253D&md5=204a1c08a97b5b73f42dc353370337c3</span></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.4.1556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.4.1556%26sid%3Dliteratum%253Aachs%26aulast%3DFlentke%26aufirst%3DG.%2BR.%26aulast%3DMunoz%26aufirst%3DE.%26aulast%3DHuber%26aufirst%3DB.%2BT.%26aulast%3DPlaut%26aufirst%3DA.%2BG.%26aulast%3DKettner%26aufirst%3DC.%2BA.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26atitle%3DInhibition%2520of%2520dipeptidyl%2520aminopeptidase%2520IV%2520%2528DP-IV%2529%2520by%2520Xaa-boroPro%2520dipeptides%2520and%2520use%2520of%2520these%2520inhibitors%2520to%2520examine%2520the%2520role%2520of%2520DP-IV%2520in%2520T-cell%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1991%26volume%3D88%26issue%3D4%26spage%3D1556%26epage%3D1559%26doi%3D10.1073%2Fpnas.88.4.1556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref242"><div class="reference"><strong class="refLabel"><a href="#ref242" class="rightTabRefNumLink">242</a></strong><div class="NLM_citation" id="rightTab-cit242"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lankas, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiting, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiermann, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beconi, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biftu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ippolito, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ok, H. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pryor, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reigle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N. A.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2988</span>â <span class="NLM_lpage">2994</span>, <span class="refDoi">Â DOI: 10.2337/diabetes.54.10.2988</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.2337%2Fdiabetes.54.10.2988" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=16186403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2rs7zO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=2988-2994&issue=10&author=G.+R.+Lankasauthor=B.+Leitingauthor=R.+S.+Royauthor=G.+J.+Eiermannauthor=M.+G.+Beconiauthor=T.+Biftuauthor=C.-C.+Chanauthor=S.+Edmondsonauthor=W.+P.+Feeneyauthor=H.+Heauthor=D.+E.+Ippolitoauthor=D.+Kimauthor=K.+A.+Lyonsauthor=H.+O.+Okauthor=R.+A.+Patelauthor=A.+N.+Petrovauthor=K.+A.+Pryorauthor=X.+Qianauthor=L.+Reigleauthor=A.+Woodsauthor=J.+K.+Wuauthor=D.+Zallerauthor=X.+Zhangauthor=L.+Zhuauthor=A.+E.+Weberauthor=N.+A.+Thornberry&title=Dipeptidyl+peptidase+IV+inhibition+for+the+treatment+of+type+2+diabetes%3A+potential+importance+of+selectivity+over+dipeptidyl+peptidases+8+and+9&doi=10.2337%2Fdiabetes.54.10.2988"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit242R"><div class="casContent"><span class="casTitleNuber">242</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes. Potential importance of selectivity over dipeptidyl peptidases 8 and 9</span></div><div class="casAuthors">Lankas, George R.; Leiting, Barbara; Roy, Ranabir Sinha; Eiermann, George J.; Beconi, Maria G.; Biftu, Tesfaye; Chan, Chi-Chung; Edmondson, Scott; Feeney, William P.; He, Huaibing; Ippolito, Dawn E.; Kim, Dooseop; Lyons, Kathryn A.; Ok, Hyun O.; Patel, Reshma A.; Petrov, Aleksandr N.; Pryor, Kelly Ann; Qian, Xiaoxia; Reigle, Leah; Woods, Andrea; Wu, Joseph K.; Zaller, Dennis; Zhang, Xiaoping; Zhu, Lan; Weber, Ann E.; Thornberry, Nancy A.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2988-2994</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase (DPP)-IV inhibitors are a new approach to the treatment of type 2 diabetes.  DPP-IV is a member of a family of serine peptidases that includes quiescent cell proline dipeptidase (QPP), DPP8, and DPP9; DPP-IV is a key regulator of incretin hormones, but the functions of other family members are unknown.  To det. the importance of selective DPP-IV inhibition for the treatment of diabetes, we tested selective inhibitors of DPP-IV, DPP8/DPP9, or QPP in 2-wk rat toxicity studies and in acute dog tolerability studies.  In rats, the DPP8/9 inhibitor produced alopecia, thrombocytopenia, reticulocytopenia, enlarged spleen, multiorgan histopathol. changes, and mortality.  In dogs, the DPP8/9 inhibitor produced gastrointestinal toxicity.  The QPP inhibitor produced reticulocytopenia in rats only, and no toxicities were noted in either species for the selective DPP-IV inhibitor.  The DPP8/9 inhibitor was also shown to attenuate T-cell activation in human in vitro models; a selective DPP-IV inhibitor was inactive in these assays.  Moreover, we found DPP-IV inhibitors that were previously reported to be active in models of immune function to be more potent inhibitors of DPP8/9.  These results suggest that assessment of selectivity of potential clin. candidates may be important to an optimal safety profile for this new class of antihyperglycemic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5jJ2LSMqwcbVg90H21EOLACvtfcHk0ljYp5gv2qNzUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2rs7zO&md5=31b9677bd3b0ec4109e05a06e7e019cf</span></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.54.10.2988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.54.10.2988%26sid%3Dliteratum%253Aachs%26aulast%3DLankas%26aufirst%3DG.%2BR.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DBeconi%26aufirst%3DM.%2BG.%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DC.-C.%26aulast%3DEdmondson%26aufirst%3DS.%26aulast%3DFeeney%26aufirst%3DW.%2BP.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DIppolito%26aufirst%3DD.%2BE.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DOk%26aufirst%3DH.%2BO.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%2BN.%26aulast%3DPryor%26aufirst%3DK.%2BA.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DReigle%26aufirst%3DL.%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520inhibition%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%253A%2520potential%2520importance%2520of%2520selectivity%2520over%2520dipeptidyl%2520peptidases%25208%2520and%25209%26jtitle%3DDiabetes%26date%3D2005%26volume%3D54%26issue%3D10%26spage%3D2988%26epage%3D2994%26doi%3D10.2337%2Fdiabetes.54.10.2988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref243"><div class="reference"><strong class="refLabel"><a href="#ref243" class="rightTabRefNumLink">243</a></strong><div class="NLM_citation" id="rightTab-cit243"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanford, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiluwal, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Healey, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimare, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maw, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudmeier, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, W. W.</span></span> <span> </span><span class="NLM_article-title">Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: Determinants of potency and in vivo efficacy and safety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">6005</span>â <span class="NLM_lpage">6013</span>, <span class="refDoi">Â DOI: 10.1021/jm800390n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800390n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSjtr3L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6005-6013&issue=19&author=B.+A.+Connollyauthor=D.+G.+Sanfordauthor=A.+K.+Chiluwalauthor=S.+E.+Healeyauthor=D.+E.+Petersauthor=M.+T.+Dimareauthor=W.+Wuauthor=Y.+Liuauthor=H.+Mawauthor=Y.+Zhouauthor=Y.+Liauthor=Z.+Jinauthor=J.+L.+Sudmeierauthor=J.+H.+Laiauthor=W.+W.+Bachovchin&title=Dipeptide+boronic+acid+inhibitors+of+dipeptidyl+peptidase+IV%3A+Determinants+of+potency+and+in+vivo+efficacy+and+safety&doi=10.1021%2Fjm800390n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptide Boronic Acid Inhibitors of Dipeptidyl Peptidase IV: Determinants of Potency and in Vivo Efficacy and Safety</span></div><div class="casAuthors">Connolly, Beth A.; Sanford, David G.; Chiluwal, Amrita K.; Healey, Sarah E.; Peters, Diane E.; Dimare, Matthew T.; Wu, Wengen; Liu, Yuxin; Maw, Hlaing; Zhou, Yuhong; Li, Youhua; Jin, Zhiping; Sudmeier, James L.; Lai, Jack H.; Bachovchin, William W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6005-6013</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPP-IV; E.C. 3.4.14.5), a serine protease that degrades the incretin hormones GLP-1 and GIP, is now a validated target for the treatment of type 2 diabetes.  Dipeptide boronic acids, among the first, and still among the most potent DPP-IV inhibitors known, suffer from a concern over their safety.  Here we evaluate the potency, in vivo efficacy, and safety of a selected set of these inhibitors.  The adverse effects induced by boronic acid-based DPP-IV inhibitors are essentially limited to what has been obsd. previously for non-boronic acid inhibitors and attributed to cross-reactivity with DPP8/9.  While consistent with the DPP8/9 hypothesis, they are also consistent with cross-reactivity with some other intracellular target.  The results further show that the potency of simple dipeptide boronic acid-based inhibitors can be combined with selectivity against DPP8/9 in vivo to produce agents with a relatively wide therapeutic index (>500) in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgbBB8ZNyTD7Vg90H21EOLACvtfcHk0ljYp5gv2qNzUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSjtr3L&md5=5fd0b18c273e595716737192d6fed573</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.1021%2Fjm800390n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800390n%26sid%3Dliteratum%253Aachs%26aulast%3DConnolly%26aufirst%3DB.%2BA.%26aulast%3DSanford%26aufirst%3DD.%2BG.%26aulast%3DChiluwal%26aufirst%3DA.%2BK.%26aulast%3DHealey%26aufirst%3DS.%2BE.%26aulast%3DPeters%26aufirst%3DD.%2BE.%26aulast%3DDimare%26aufirst%3DM.%2BT.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMaw%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DSudmeier%26aufirst%3DJ.%2BL.%26aulast%3DLai%26aufirst%3DJ.%2BH.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26atitle%3DDipeptide%2520boronic%2520acid%2520inhibitors%2520of%2520dipeptidyl%2520peptidase%2520IV%253A%2520Determinants%2520of%2520potency%2520and%2520in%2520vivo%2520efficacy%2520and%2520safety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D19%26spage%3D6005%26epage%3D6013%26doi%3D10.1021%2Fjm800390n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref244"><div class="reference"><strong class="refLabel"><a href="#ref244" class="rightTabRefNumLink">244</a></strong><div class="NLM_citation" id="rightTab-cit244"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strzemkowski-Brun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egleston, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiner, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meropol, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. D.</span></span> <span> </span><span class="NLM_article-title">Phase II trial of single agent Val-boroPro (talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1691</span>â <span class="NLM_lpage">1699</span>, <span class="refDoi">Â DOI: 10.4161/cbt.6.11.4874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4161%2Fcbt.6.11.4874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=18032930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1Whsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1691-1699&issue=11&author=K.+Narraauthor=S.+R.+Mullinsauthor=H.-O.+Leeauthor=B.+Strzemkowski-Brunauthor=K.+Magalongauthor=V.+J.+Christiansenauthor=P.+A.+McKeeauthor=B.+Eglestonauthor=S.+J.+Cohenauthor=L.+M.+Weinerauthor=N.+J.+Meropolauthor=J.+D.+Cheng&title=Phase+II+trial+of+single+agent+Val-boroPro+%28talabostat%29+inhibiting+fibroblast+activation+protein+in+patients+with+metastatic+colorectal+cancer&doi=10.4161%2Fcbt.6.11.4874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer</span></div><div class="casAuthors">Narra, Kalyani; Mullins, Stefanie R.; Lee, Hyung-Ok; Strzemkowski-Brun, Brenda; Magalong, Kimberly; Christiansen, Victoria J.; McKee, Patrick A.; Egleston, Brian; Cohen, Steven J.; Weiner, Louis M.; Meropol, Neal J.; Cheng, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1691-1699</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Purpose: Fibroblost Activation Protein (FAP) is a tumor fibroblast protease that has been shown to potentiate colorectal cancer growth.  The clin. impact of FAP inhibition was tested using Val-boroPro (Talabostat), the first clin. inhibitor of FAP enzymic activity, in a phase II study of patients with metastatic colorectal cancer.  Methods: Patients with metastatic colorectal cancer who had previously received systemic chemotherapies were treated with single agent Val-boroPro 200 Î¼g p.o. BID continuously.  Eligibility included measurable disease, performance status of 0 to 2, and adequate organ function.  Lab. correlates evaluated the pharmacodynamic effects of Val-boroPro on FAP enzymic function in the peripheral blood.  Results: Twenty-eight patients (median age 62; 12 males, 16 females) were enrolled in this study.  There were no objective responses.  Six of 28 (21%) patients had stable disease for a median of 25 wk (range 11-38 wk).  Lab. anal. demonstrated significant, although incomplete inhibition of FAP enzymic activity in the peripheral blood.  Conclusion: This phase II trial of Val-boroPro demonstrated minimal clin. activity in patients with previously treated metastatic colorectal cancer.  However it provides the initial proof-of-concept that physiol. inhibition of FAP activity can be accomplished in patients with colorectal cancer, and lays the groundwork for future studies targeting the tumor stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_1F424osEbVg90H21EOLACvtfcHk0li5-ZGfrZFthg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1Whsb8%253D&md5=7e69e1187b364d4c1ed43fef5d717c48</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.4161%2Fcbt.6.11.4874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.6.11.4874%26sid%3Dliteratum%253Aachs%26aulast%3DNarra%26aufirst%3DK.%26aulast%3DMullins%26aufirst%3DS.%2BR.%26aulast%3DLee%26aufirst%3DH.-O.%26aulast%3DStrzemkowski-Brun%26aufirst%3DB.%26aulast%3DMagalong%26aufirst%3DK.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26aulast%3DEgleston%26aufirst%3DB.%26aulast%3DCohen%26aufirst%3DS.%2BJ.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26aulast%3DMeropol%26aufirst%3DN.%2BJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26atitle%3DPhase%2520II%2520trial%2520of%2520single%2520agent%2520Val-boroPro%2520%2528talabostat%2529%2520inhibiting%2520fibroblast%2520activation%2520protein%2520in%2520patients%2520with%2520metastatic%2520colorectal%2520cancer%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2007%26volume%3D6%26issue%3D11%26spage%3D1691%26epage%3D1699%26doi%3D10.4161%2Fcbt.6.11.4874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref245"><div class="reference"><strong class="refLabel"><a href="#ref245" class="rightTabRefNumLink">245</a></strong><div class="NLM_citation" id="rightTab-cit245"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eager, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senzer, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâDay, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenette, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlick, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uprichard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemunaitis, J.</span></span> <span> </span><span class="NLM_article-title">Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">263</span>, <span class="refDoi">Â DOI: 10.1186/1471-2407-9-263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1186%2F1471-2407-9-263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19643020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A280%3ADC%252BD1MrnvVWlsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=263&issue=1&author=R.+M.+Eagerauthor=C.+C.+Cunninghamauthor=N.+N.+Senzerauthor=J.+Stephensonauthor=S.+P.+Anthonyauthor=S.+J.+O%E2%80%99Dayauthor=G.+Frenetteauthor=A.+C.+Pavlickauthor=B.+Jonesauthor=M.+Uprichardauthor=J.+Nemunaitis&title=Phase+II+assessment+of+talabostat+and+cisplatin+in+second-line+stage+IV+melanoma&doi=10.1186%2F1471-2407-9-263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit245R"><div class="casContent"><span class="casTitleNuber">245</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma</span></div><div class="casAuthors">Eager Robert M; Cunningham C Casey; Senzer Neil N; Stephenson Joe Jr; Anthony Stephen P; O'Day Steven J; Frenette Gary; Pavlick Anna C; Jones Barry; Uprichard Margaret; Nemunaitis John</div><div class="citationInfo"><span class="NLM_cas:title">BMC cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">263</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Metastatic melanoma is an incurable disease with an average survival of less than one year.  Talabostat is a novel dipeptidyl peptidase inhibitor with immunostimulatory properties.  METHODS:  This phase II, open label, single arm study was conducted to evaluate the safety and efficacy of 75-100 mg/m2 cisplatin combined with 300-400 mcg talabostat bid for 6, 21-day cycles.  The primary endpoint was overall response.  The rate of complete responses, duration of overall objective response, progression-free survival (PFS), and overall survival were the secondary endpoints.  RESULTS:  Six objective partial responses were recorded in the 74 patients (8.1%) in the intention-to-treat population.  Five of these responses involved the 40 evaluable patients (12.5%).  Thirty-one percent of patients reported SAEs to the combination of talabostat and cisplatin.  CONCLUSION:  Acceptable tolerability was observed in the intention-to-treat population and antitumor activity was observed in 12.5% of evaluable patients, which is not greater than historical expectation with cisplatin alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQSzL0c3BDb0bxh97K6Vt6fW6udTcc2eb5_AketYFf3Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrnvVWlsQ%253D%253D&md5=7201b71b68c676616fce03005c2cb55e</span></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-9-263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-9-263%26sid%3Dliteratum%253Aachs%26aulast%3DEager%26aufirst%3DR.%2BM.%26aulast%3DCunningham%26aufirst%3DC.%2BC.%26aulast%3DSenzer%26aufirst%3DN.%2BN.%26aulast%3DStephenson%26aufirst%3DJ.%26aulast%3DAnthony%26aufirst%3DS.%2BP.%26aulast%3DO%25E2%2580%2599Day%26aufirst%3DS.%2BJ.%26aulast%3DFrenette%26aufirst%3DG.%26aulast%3DPavlick%26aufirst%3DA.%2BC.%26aulast%3DJones%26aufirst%3DB.%26aulast%3DUprichard%26aufirst%3DM.%26aulast%3DNemunaitis%26aufirst%3DJ.%26atitle%3DPhase%2520II%2520assessment%2520of%2520talabostat%2520and%2520cisplatin%2520in%2520second-line%2520stage%2520IV%2520melanoma%26jtitle%3DBMC%2520Cancer%26date%3D2009%26volume%3D9%26issue%3D1%26spage%3D263%26doi%3D10.1186%2F1471-2407-9-263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref246"><div class="reference"><strong class="refLabel"><a href="#ref246" class="rightTabRefNumLink">246</a></strong><div class="NLM_citation" id="rightTab-cit246"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jesson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallner, B. P.</span></span> <span> </span><span class="NLM_article-title">PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5471</span>â <span class="NLM_lpage">5480</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-04-0447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1158%2F0008-5472.CAN-04-0447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15289357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtF2lsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=5471-5480&issue=15&author=S.+Adamsauthor=G.+T.+Millerauthor=M.+I.+Jessonauthor=T.+Watanabeauthor=B.+Jonesauthor=B.+P.+Wallner&title=PT-100%2C+a+small+molecule+dipeptidyl+peptidase+inhibitor%2C+has+potent+antitumor+effects+and+augments+antibody-mediated+cytotoxicity+via+a+novel+immune+mechanism&doi=10.1158%2F0008-5472.CAN-04-0447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit246R"><div class="casContent"><span class="casTitleNuber">246</span><div class="casTitle"><span class="NLM_cas:atitle">PT-100, a Small Molecule Dipeptidyl Peptidase Inhibitor, Has Potent Antitumor Effects and Augments Antibody-Mediated Cytotoxicity via a Novel Immune Mechanism</span></div><div class="casAuthors">Adams, Sharlene; Miller, Glenn T.; Jesson, Michael I.; Watanabe, Takeshi; Jones, Barry; Wallner, Barbara P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5471-5480</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The amino boronic dipeptide, PT-100 (Val-boro-Pro), a dipeptidyl peptidase (DPP) inhibitor, has been shown to up-regulate gene expression of certain cytokines in hematopoietic tissue via a high-affinity interaction, which appears to involve fibroblast activation protein.  Because fibroblast activation protein is also expressed in stroma of lymphoid tissue and tumors, the effect of PT-100 on tumor growth was studied in mice in vivo.  PT-100 has no direct cytotoxic effect on tumors in vitro.  Oral administration of PT-100 to mice slowed growth of syngeneic tumors derived from fibrosarcoma, lymphoma, melanoma, and mastocytoma cell lines.  In WEHI 164 fibrosarcoma and EL4 and A20/2J lymphoma models, PT-100 caused regression and rejection of tumors.  The antitumor effect appeared to involve tumor-specific CTL and protective immunol. memory.  PT-100 treatment of WEHI 164-inoculated mice increased mRNA expression of cytokines and chemokines known to promote T-cell priming and chemoattraction of T cells and innate effector cells.  The role of innate activity was further implicated by observation of significant, although reduced, inhibition of WEHI 164 and A20/2J tumors in immunodeficient mice.  PT-100 also demonstrated ability to augment antitumor activity of rituximab and trastuzumab in xenograft models of human CD20+ B-cell lymphoma and HER-2+ colon carcinoma where antibody-dependent cytotoxicity can be mediated by innate effector cells responsive to the cytokines and chemokines up-regulated by PT-100.  Although CD26/DPP-IV is a potential target for PT-100 in the immune system, it appeared not to be involved because antitumor activity and stimulation of cytokine and chemokine prodn. was undiminished in CD26-/- mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBUQaRQ3nZ4LVg90H21EOLACvtfcHk0li5-ZGfrZFthg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtF2lsr0%253D&md5=77a065748628574b88c83b9e1476d249</span></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-0447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-0447%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DG.%2BT.%26aulast%3DJesson%26aufirst%3DM.%2BI.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DB.%26aulast%3DWallner%26aufirst%3DB.%2BP.%26atitle%3DPT-100%252C%2520a%2520small%2520molecule%2520dipeptidyl%2520peptidase%2520inhibitor%252C%2520has%2520potent%2520antitumor%2520effects%2520and%2520augments%2520antibody-mediated%2520cytotoxicity%2520via%2520a%2520novel%2520immune%2520mechanism%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26issue%3D15%26spage%3D5471%26epage%3D5480%26doi%3D10.1158%2F0008-5472.CAN-04-0447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref247"><div class="reference"><strong class="refLabel"><a href="#ref247" class="rightTabRefNumLink">247</a></strong><div class="NLM_citation" id="rightTab-cit247"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, C. C.</span></span> <span> </span><span class="NLM_article-title">Talabostat</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1459</span>â <span class="NLM_lpage">1465</span>, <span class="refDoi">Â DOI: 10.1517/13543784.16.9.1459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1517%2F13543784.16.9.1459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17714031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptlSrt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=1459-1465&issue=9&author=C.+C.+Cunningham&title=Talabostat&doi=10.1517%2F13543784.16.9.1459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit247R"><div class="casContent"><span class="casTitleNuber">247</span><div class="casTitle"><span class="NLM_cas:atitle">Talabostat</span></div><div class="casAuthors">Cunningham, Charles Casey</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1459-1465</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Talabostat mesylate is an orally active, specific inhibitor of dipeptidyl peptidases, including tumor-assocd. fibroblast activation protein.  However, by an independent mechanism, talabostat also stimulates the upregulation of cytokines and chemokines to engender a tumor-specific host immune response, thus giving it a unique dual mechanism of action.  In clin. trials, talabostat has demonstrated significant activity, including achieving complete responses in patients with non-small-cell lung cancer and malignant melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog2iuGokqzwbVg90H21EOLACvtfcHk0lisu3T6f9U_NA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptlSrt7g%253D&md5=e53bfb06df81af3bd9c4fb09a5a83c7a</span></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1517%2F13543784.16.9.1459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.16.9.1459%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DC.%2BC.%26atitle%3DTalabostat%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D16%26issue%3D9%26spage%3D1459%26epage%3D1465%26doi%3D10.1517%2F13543784.16.9.1459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref248"><div class="reference"><strong class="refLabel"><a href="#ref248" class="rightTabRefNumLink">248</a></strong><div class="NLM_citation" id="rightTab-cit248"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okondo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chui, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poplawski, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanford, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arciprete, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, D. A.</span></span> <span> </span><span class="NLM_article-title">DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">46</span>â <span class="NLM_lpage">53</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.2229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnchembio.2229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=27820798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSntLnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=46-53&issue=1&author=M.+C.+Okondoauthor=D.+C.+Johnsonauthor=R.+Sridharanauthor=E.+B.+Goauthor=A.+J.+Chuiauthor=M.+S.+Wangauthor=S.+E.+Poplawskiauthor=W.+Wuauthor=Y.+Liuauthor=J.+H.+Laiauthor=D.+G.+Sanfordauthor=M.+O.+Arcipreteauthor=T.+R.+Golubauthor=W.+W.+Bachovchinauthor=D.+A.+Bachovchin&title=DPP8+and+DPP9+inhibition+induces+pro-caspase-1-dependent+monocyte+and+macrophage+pyroptosis&doi=10.1038%2Fnchembio.2229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit248R"><div class="casContent"><span class="casTitleNuber">248</span><div class="casTitle"><span class="NLM_cas:atitle">DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis</span></div><div class="casAuthors">Okondo, Marian C.; Johnson, Darren C.; Sridharan, Ramya; Go, Eun Bin; Chui, Ashley J.; Wang, Mitchell S.; Poplawski, Sarah E.; Wu, Wengen; Liu, Yuxin; Lai, Jack H.; Sanford, David G.; Arciprete, Michael O.; Golub, Todd R.; Bachovchin, William W.; Bachovchin, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-53</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Val-boroPro (Talabostat, PT-100), a nonselective inhibitor of postproline cleaving serine proteases, stimulates mammalian immune systems through an unknown mechanism of action.  Despite this lack of mechanistic understanding, Val-boroPro has attracted substantial interest as a potential anticancer agent, reaching phase 3 trials in humans.  Here the authors show that Val-boroPro stimulates the immune system by triggering a proinflammatory form of cell death in monocytes and macrophages known as pyroptosis.  The authors demonstrate that the inhibition of two serine proteases, DPP8 and DPP9, activates the pro-protein form of caspase-1 independent of the inflammasome adaptor ASC.  Activated pro-caspase-1 does not efficiently process itself or IL-1Î² but does cleave and activate gasdermin D to induce pyroptosis.  Mice lacking caspase-1 do not show immune stimulation after treatment with Val-boroPro.  The data identify what is to the knowledge the first small mol. that induces pyroptosis and reveals a new checkpoint that controls the activation of the innate immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY7fE7Q7ygd7Vg90H21EOLACvtfcHk0lisu3T6f9U_NA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSntLnM&md5=6e8e326aa107f0198d2817876d6d6cbd</span></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2229%26sid%3Dliteratum%253Aachs%26aulast%3DOkondo%26aufirst%3DM.%2BC.%26aulast%3DJohnson%26aufirst%3DD.%2BC.%26aulast%3DSridharan%26aufirst%3DR.%26aulast%3DGo%26aufirst%3DE.%2BB.%26aulast%3DChui%26aufirst%3DA.%2BJ.%26aulast%3DWang%26aufirst%3DM.%2BS.%26aulast%3DPoplawski%26aufirst%3DS.%2BE.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DJ.%2BH.%26aulast%3DSanford%26aufirst%3DD.%2BG.%26aulast%3DArciprete%26aufirst%3DM.%2BO.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26aulast%3DBachovchin%26aufirst%3DD.%2BA.%26atitle%3DDPP8%2520and%2520DPP9%2520inhibition%2520induces%2520pro-caspase-1-dependent%2520monocyte%2520and%2520macrophage%2520pyroptosis%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D13%26issue%3D1%26spage%3D46%26epage%3D53%26doi%3D10.1038%2Fnchembio.2229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref249"><div class="reference"><strong class="refLabel"><a href="#ref249" class="rightTabRefNumLink">249</a></strong><div class="NLM_citation" id="rightTab-cit249"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okondo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taabazuing, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chui, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poplawski, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, D. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Dpp8/9 activates the Nlrp1b inflammasome</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">262</span>â <span class="NLM_lpage">267</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2017.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2017.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29396289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVShur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=262-267&issue=3&author=M.+C.+Okondoauthor=S.+D.+Raoauthor=C.+Y.+Taabazuingauthor=A.+J.+Chuiauthor=S.+E.+Poplawskiauthor=D.+C.+Johnsonauthor=D.+A.+Bachovchin&title=Inhibition+of+Dpp8%2F9+activates+the+Nlrp1b+inflammasome&doi=10.1016%2Fj.chembiol.2017.12.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit249R"><div class="casContent"><span class="casTitleNuber">249</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Dpp8/9 Activates the Nlrp1b Inflammasome</span></div><div class="casAuthors">Okondo, Marian C.; Rao, Sahana D.; Taabazuing, Cornelius Y.; Chui, Ashley J.; Poplawski, Sarah E.; Johnson, Darren C.; Bachovchin, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">262-267.e5</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Val-boroPro (PT-100, Talabostat) induces powerful anti-tumor immune responses in syngeneic cancer models, but its mechanism of action has not yet been established.  Val-boroPro is a non-selective inhibitor of post-proline-cleaving serine proteases, and the inhibition of the highly related cytosolic serine proteases Dpp8 and Dpp9 (Dpp8/9) by Val-boroPro was recently demonstrated to trigger an immunostimulatory form of programmed cell death known as pyroptosis selectively in monocytes and macrophages.  Here we show that Dpp8/9 inhibition activates the inflammasome sensor protein Nlrp1b, which in turn activates pro-caspase-1 to mediate pyroptosis.  This work reveals a previously unrecognized mechanism for activating an innate immune pattern recognition receptor and suggests that Dpp8/9 serve as an intracellular checkpoint to restrain Nlrp1b and the innate immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8tSVd3u86r7Vg90H21EOLACvtfcHk0li9TM2SeSYqgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVShur0%253D&md5=2a7d7e3d11918599e332c3e6beb1682f</span></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DOkondo%26aufirst%3DM.%2BC.%26aulast%3DRao%26aufirst%3DS.%2BD.%26aulast%3DTaabazuing%26aufirst%3DC.%2BY.%26aulast%3DChui%26aufirst%3DA.%2BJ.%26aulast%3DPoplawski%26aufirst%3DS.%2BE.%26aulast%3DJohnson%26aufirst%3DD.%2BC.%26aulast%3DBachovchin%26aufirst%3DD.%2BA.%26atitle%3DInhibition%2520of%2520Dpp8%252F9%2520activates%2520the%2520Nlrp1b%2520inflammasome%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2018%26volume%3D25%26issue%3D3%26spage%3D262%26epage%3D267%26doi%3D10.1016%2Fj.chembiol.2017.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref250"><div class="reference"><strong class="refLabel"><a href="#ref250" class="rightTabRefNumLink">250</a></strong><div class="NLM_citation" id="rightTab-cit250"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taabazuing, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okondo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chui, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peguero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Stanchina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kentsis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachovchin, D. A.</span></span> <span> </span><span class="NLM_article-title">DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1151</span>â <span class="NLM_lpage">1156</span>, <span class="refDoi">Â DOI: 10.1038/s41591-018-0082-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41591-018-0082-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=29967349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1OjsrfJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=1151-1156&issue=8&author=D.+C.+Johnsonauthor=C.+Y.+Taabazuingauthor=M.+C.+Okondoauthor=A.+J.+Chuiauthor=S.+D.+Raoauthor=F.+C.+Brownauthor=C.+Reedauthor=E.+Pegueroauthor=E.+de+Stanchinaauthor=A.+Kentsisauthor=D.+A.+Bachovchin&title=DPP8%2FDPP9+inhibitor-induced+pyroptosis+for+treatment+of+acute+myeloid+leukemia&doi=10.1038%2Fs41591-018-0082-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit250R"><div class="casContent"><span class="casTitleNuber">250</span><div class="casTitle"><span class="NLM_cas:atitle">DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia</span></div><div class="casAuthors">Johnson, Darren C.; Taabazuing, Cornelius Y.; Okondo, Marian C.; Chui, Ashley J.; Rao, Sahana D.; Brown, Fiona C.; Reed, Casie; Peguero, Elizabeth; de Stanchina, Elisa; Kentsis, Alex; Bachovchin, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1151-1156</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Small-mol. inhibitors of the serine dipeptidases DPP8 and DPP9 (DPP8/9) induce a lytic form of cell death called pyroptosis in mouse and human monocytes and macrophages1,2.  In mouse myeloid cells, Dpp8/9 inhibition activates the inflammasome sensor Nlrp1b, which in turn activates pro-caspase-1 to mediate cell death3, but the mechanism of DPP8/9 inhibitor-induced pyroptosis in human myeloid cells is not yet known.  Here we show that the CARD-contg. protein CARD8 mediates DPP8/9 inhibitor-induced pro-caspase-1-dependent pyroptosis in human myeloid cells.  We further show that DPP8/9 inhibitors induce pyroptosis in the majority of human acute myeloid leukemia (AML) cell lines and primary AML samples, but not in cells from many other lineages, and that these inhibitors inhibit human AML progression in mouse models.  Overall, this work identifies an activator of CARD8 in human cells and indicates that its activation by small-mol. DPP8/9 inhibitors represents a new potential therapeutic strategy for AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmCnNK2rgGy7Vg90H21EOLACvtfcHk0li9TM2SeSYqgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1OjsrfJ&md5=3b2cdc38848d4957b51e2db9ebc049ee</span></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=10.1038%2Fs41591-018-0082-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41591-018-0082-y%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BC.%26aulast%3DTaabazuing%26aufirst%3DC.%2BY.%26aulast%3DOkondo%26aufirst%3DM.%2BC.%26aulast%3DChui%26aufirst%3DA.%2BJ.%26aulast%3DRao%26aufirst%3DS.%2BD.%26aulast%3DBrown%26aufirst%3DF.%2BC.%26aulast%3DReed%26aufirst%3DC.%26aulast%3DPeguero%26aufirst%3DE.%26aulast%3Dde%2BStanchina%26aufirst%3DE.%26aulast%3DKentsis%26aufirst%3DA.%26aulast%3DBachovchin%26aufirst%3DD.%2BA.%26atitle%3DDPP8%252FDPP9%2520inhibitor-induced%2520pyroptosis%2520for%2520treatment%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DNat.%2520Med.%26date%3D2018%26volume%3D24%26issue%3D8%26spage%3D1151%26epage%3D1156%26doi%3D10.1038%2Fs41591-018-0082-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref251"><div class="reference"><strong class="refLabel"><a href="#ref251" class="rightTabRefNumLink">251</a></strong><div class="NLM_citation" id="rightTab-cit251"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span> <span> </span><span class="NLM_article-title">Role of proteasomes modified by interferon-Î³ in antigen processing</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">571</span>â <span class="NLM_lpage">575</span>, <span class="refDoi">Â DOI: 10.1002/jlb.56.5.571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fjlb.56.5.571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=7964165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2cXmvFymtbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1994&pages=571-575&issue=5&author=K.+Tanaka&title=Role+of+proteasomes+modified+by+interferon-%CE%B3+in+antigen+processing&doi=10.1002%2Fjlb.56.5.571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">Role of proteasomes modified by interferon-Î³ in antigen processing</span></div><div class="casAuthors">Tanaka, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">571-5</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review with 31 refs. of the possible function of proteasomes in antigen processing with special ref. to the influence of interferon-Î³ on their function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI--bWlvkbibVg90H21EOLACvtfcHk0li9TM2SeSYqgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvFymtbg%253D&md5=4b225932ff9e7fb1fb67ebd9b8cf7444</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.1002%2Fjlb.56.5.571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlb.56.5.571%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DK.%26atitle%3DRole%2520of%2520proteasomes%2520modified%2520by%2520interferon-%25CE%25B3%2520in%2520antigen%2520processing%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D1994%26volume%3D56%26issue%3D5%26spage%3D571%26epage%3D575%26doi%3D10.1002%2Fjlb.56.5.571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref252"><div class="reference"><strong class="refLabel"><a href="#ref252" class="rightTabRefNumLink">252</a></strong><div class="NLM_citation" id="rightTab-cit252"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimbara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichihara, A.</span></span> <span> </span><span class="NLM_article-title">Interferon-Î³ induces different subunit organizations and functional diversity of proteasomes</span>. <i>J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>115</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">257</span>â <span class="NLM_lpage">269</span>, <span class="refDoi">Â DOI: 10.1093/oxfordjournals.jbchem.a124327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1093%2Foxfordjournals.jbchem.a124327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8206875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2cXhs1WgsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1994&pages=257-269&issue=2&author=M.+Akiauthor=N.+Shimbaraauthor=M.+Takashinaauthor=K.+Akiyamaauthor=S.+Kagawaauthor=T.+Tamuraauthor=N.+Tanahashiauthor=T.+Yoshimuraauthor=K.+Tanakaauthor=A.+Ichihara&title=Interferon-%CE%B3+induces+different+subunit+organizations+and+functional+diversity+of+proteasomes&doi=10.1093%2Foxfordjournals.jbchem.a124327"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit252R"><div class="casContent"><span class="casTitleNuber">252</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon-Î³ induces different subunit organizations and functional diversity of proteasomes</span></div><div class="casAuthors">Aki, Masashi; Shimbara, Naoki; Takashina, Makoto; Akiyama, Kinya; Kagawa, Susumu; Tamura, Tomohiro; Tanahashi, Nobuyuki; Yoshimura, Tetsuro; Tanaka, Keiji; Ichihara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry </span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-69</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    </div><div class="casAbstract">To obtain information on the role of proteasomes in the immune system, the authors examd. the effect of a major immunomodulatory cytokine, gamma interferon (IFN-Î³), on the expressions, structures, and functions of proteasomes,.  IFN-Î³ greatly increased the levels of the mRNAs encoding LMP2 and LMP7, putative immuno-proteasome subunits encoded by genes within the class II MHC region, and these two subunits synthesized were assembled completely into the proteasomal multi-subunit complex in various types of human cells.  The subunit organization of the proteasome changed in response to IFN-Î³ stimulation, due to assembly of newly synthesized subunits through up- and down-expressions of at least 6 proteasome genes including LMP2/LMP7 without change in the structure of pre-existing proteasomes.  Interestingly, IFN-Î³ dramatically stimulated the trypsin-like and chymotrypsin-like activities of the multifunctional proteasome and depressed the peptidylglutamyl-peptide-hydrolyzing activity, without affecting the activity for ATP-, ubiquitin-dependent proteolysis.  These results indicate that IFN-Î³ modifies not only the structural organization of the proteasome, but also its functions.  Based on these findings, the authors discuss the role in the antigen processing/presentation pathway of proteasomes with functional diversity acquired through alteration of their subunit assembly in response to IFN-Î³ stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjnsqNQStGLLVg90H21EOLACvtfcHk0ljwxj9tV7rSAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhs1WgsbY%253D&md5=68702387a6ac451dbe67180e99072afc</span></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.jbchem.a124327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.jbchem.a124327%26sid%3Dliteratum%253Aachs%26aulast%3DAki%26aufirst%3DM.%26aulast%3DShimbara%26aufirst%3DN.%26aulast%3DTakashina%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DK.%26aulast%3DKagawa%26aufirst%3DS.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DTanahashi%26aufirst%3DN.%26aulast%3DYoshimura%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DIchihara%26aufirst%3DA.%26atitle%3DInterferon-%25CE%25B3%2520induces%2520different%2520subunit%2520organizations%2520and%2520functional%2520diversity%2520of%2520proteasomes%26jtitle%3DJ.%2520Biochem.%26date%3D1994%26volume%3D115%26issue%3D2%26spage%3D257%26epage%3D269%26doi%3D10.1093%2Foxfordjournals.jbchem.a124327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref253"><div class="reference"><strong class="refLabel"><a href="#ref253" class="rightTabRefNumLink">253</a></strong><div class="NLM_citation" id="rightTab-cit253"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span> <span> </span><span class="NLM_article-title">The immunoproteasome and thymoproteasome: functions, evolution and human disease</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">923</span>â <span class="NLM_lpage">931</span>, <span class="refDoi">Â DOI: 10.1038/s41590-018-0186-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fs41590-018-0186-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30104634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsV2itL7O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=923-931&issue=9&author=S.+Murataauthor=Y.+Takahamaauthor=M.+Kasaharaauthor=K.+Tanaka&title=The+immunoproteasome+and+thymoproteasome%3A+functions%2C+evolution+and+human+disease&doi=10.1038%2Fs41590-018-0186-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit253R"><div class="casContent"><span class="casTitleNuber">253</span><div class="casTitle"><span class="NLM_cas:atitle">The immunoproteasome and thymoproteasome: functions, evolution and human disease</span></div><div class="casAuthors">Murata, Shigeo; Takahama, Yousuke; Kasahara, Masanori; Tanaka, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">923-931</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The basic principle of adaptive immunity is to strictly discriminate between self and non-self, and a central challenge to overcome is the enormous variety of pathogens that might be encountered.  In cell-mediated immunity, immunol. discernment takes place at a mol. or cellular level.  Central to both mechanisms of discernment is the generation of antigenic peptides assocd. with MHC class I mols., which is achieved by a proteolytic complex called the proteasome.  To adequately accomplish the discrimination between self and non-self that is essential for adaptive immunity and self-tolerance, two proteasome subtypes have evolved via gene duplication: the immunoproteasome and the thymoproteasome.  In this Review, we describe various aspects of these immunity-dedicated proteasomes, from their discovery to recent findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNchyXJLQcFLVg90H21EOLACvtfcHk0ljwxj9tV7rSAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsV2itL7O&md5=190f16d0da1875cdc25d67d539aa7d1c</span></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.1038%2Fs41590-018-0186-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41590-018-0186-z%26sid%3Dliteratum%253Aachs%26aulast%3DMurata%26aufirst%3DS.%26aulast%3DTakahama%26aufirst%3DY.%26aulast%3DKasahara%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DK.%26atitle%3DThe%2520immunoproteasome%2520and%2520thymoproteasome%253A%2520functions%252C%2520evolution%2520and%2520human%2520disease%26jtitle%3DNat.%2520Immunol.%26date%3D2018%26volume%3D19%26issue%3D9%26spage%3D923%26epage%3D931%26doi%3D10.1038%2Fs41590-018-0186-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref254"><div class="reference"><strong class="refLabel"><a href="#ref254" class="rightTabRefNumLink">254</a></strong><div class="NLM_citation" id="rightTab-cit254"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heink, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloetzel, P.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KrÃ¼ger, E.</span></span> <span> </span><span class="NLM_article-title">IFN-Î³-induced immune adaptation of the proteasome system is an accelerated and transient response</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">9241</span>â <span class="NLM_lpage">9246</span>, <span class="refDoi">Â DOI: 10.1073/pnas.0501711102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.0501711102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=15944226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvF2rsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=9241-9246&issue=26&author=S.+Heinkauthor=D.+Ludwigauthor=P.-M.+Kloetzelauthor=E.+Kr%C3%BCger&title=IFN-%CE%B3-induced+immune+adaptation+of+the+proteasome+system+is+an+accelerated+and+transient+response&doi=10.1073%2Fpnas.0501711102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit254R"><div class="casContent"><span class="casTitleNuber">254</span><div class="casTitle"><span class="NLM_cas:atitle">IFN-Î³-induced immune adaptation of the proteasome system is an accelerated and transient response</span></div><div class="casAuthors">Heink, Sylvia; Ludwig, Daniela; Kloetzel, Peter-M.; Krueger, Elke</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9241-9246</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Peptide generation by the proteasome is rate-limiting in MHC class I-restricted antigen presentation in response to IFN-Î³.  IFN-Î³-induced de novo formation of immunoproteasomes, therefore, essentially supports the rapid adjustment of the mammalian immune system.  Here, the authors report that the mol. interplay between the proteasome maturation protein (POMP) and the proteasomal Î²5i subunit low mol. wt. protein 7 (LMP7) has a key position in this immune adaptive program.  IFN-Î³-induced coincident biosynthesis of POMP and LMP7 and their direct interaction essentially accelerate immunoproteasome biogenesis compared with constitutive 205 proteasome assembly.  The dynamics of this process is detd. by rapid LMP7 activation and the immediate LMP7-dependent degrdn. of POMP.  Silencing of POMP expression impairs recruitment of both Î²5 subunits into the proteasome complex, resulting in decreased proteasome activity, reduced MHC class I surface expression, and induction of apoptosis.  Furthermore, the authors' data reveal that immunoproteasomes exhibit a considerably shortened half-life, compared with constitutive proteasomes.  In consequence, the authors' studies demonstrate that the cytokine-induced rapid immune adaptation of the proteasome system is a tightly regulated and transient response allowing cells to return rapidly to a normal situation once immunoproteasome function is no longer required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnpIGQGkl5ALVg90H21EOLACvtfcHk0ljwxj9tV7rSAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvF2rsrw%253D&md5=b49c42d7ce4bf9ecc93f590c3b6af6b0</span></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0501711102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0501711102%26sid%3Dliteratum%253Aachs%26aulast%3DHeink%26aufirst%3DS.%26aulast%3DLudwig%26aufirst%3DD.%26aulast%3DKloetzel%26aufirst%3DP.-M.%26aulast%3DKr%25C3%25BCger%26aufirst%3DE.%26atitle%3DIFN-%25CE%25B3-induced%2520immune%2520adaptation%2520of%2520the%2520proteasome%2520system%2520is%2520an%2520accelerated%2520and%2520transient%2520response%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26issue%3D26%26spage%3D9241%26epage%3D9246%26doi%3D10.1073%2Fpnas.0501711102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref255"><div class="reference"><strong class="refLabel"><a href="#ref255" class="rightTabRefNumLink">255</a></strong><div class="NLM_citation" id="rightTab-cit255"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaczynska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spies, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, A. L.</span></span> <span> </span><span class="NLM_article-title">Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>91</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">9213</span>, <span class="refDoi">Â DOI: 10.1073/pnas.91.20.9213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1073%2Fpnas.91.20.9213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=7937744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK2cXmvFylsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=9213&issue=20&author=M.+Gaczynskaauthor=K.+L.+Rockauthor=T.+Spiesauthor=A.+L.+Goldberg&title=Peptidase+activities+of+proteasomes+are+differentially+regulated+by+the+major+histocompatibility+complex-encoded+genes+for+LMP2+and+LMP7&doi=10.1073%2Fpnas.91.20.9213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit255R"><div class="casContent"><span class="casTitleNuber">255</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7</span></div><div class="casAuthors">Gaczynska, Maria; Rock, Kenneth L.; Spies, Thomas; Goldberg, Alfred L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9213-17</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Recent studies have implicated proteasomes in the generation of the antigenic peptides that are presented on major histocompatibility complex class I mols. to T lymphocytes.  Interferon Î³ modifies the subunit compn. of proteasomes and causes changes in their peptidase activities that should favor the prodn. of peptides with hydrophobic or basic C-termini (i.e., the types found on major histocompatibility complex class I mols.).  It has been proposed that these changes in peptidase activity are due to incorporation into proteasomes of the major histocompatibility complex-encoded subunits LMP2 and -7, which are induced by interferon Î³.  Here the authors show by gene transfection into lymphoblasts or HeLa cells that LMP7 increases the capacity (Vmax) of 20S and 26S proteasomes to cleave peptides after hydrophobic and basic residues without affecting hydrolysis after acidic residues.  These changes depend on the amt. of LMP7 subunits incorporated into proteasomes.  Transfection of LMP2 reduced cleavage of peptides after acidic residues, increased hydrolysis after basic residues, and did not affect the hydrophobic activity.  Since the activity of the total proteasome population changed after incorporation of only small amts. of LMP2 or -7, these subunits must cause major alterations in peptidase activity.  Thus, their expression can account for the changes in proteasome activity induced by interferon Î³, and these findings lend further support to the proposed roles of LMPs in altering the nature of the peptides generated for antigen presentation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEzIhWjyVNBbVg90H21EOLACvtfcHk0ljwxj9tV7rSAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvFylsbY%253D&md5=64402642f14d57b9ccb6929e4563890b</span></div><a href="/servlet/linkout?suffix=cit255&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.20.9213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.20.9213%26sid%3Dliteratum%253Aachs%26aulast%3DGaczynska%26aufirst%3DM.%26aulast%3DRock%26aufirst%3DK.%2BL.%26aulast%3DSpies%26aufirst%3DT.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26atitle%3DPeptidase%2520activities%2520of%2520proteasomes%2520are%2520differentially%2520regulated%2520by%2520the%2520major%2520histocompatibility%2520complex-encoded%2520genes%2520for%2520LMP2%2520and%2520LMP7%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26issue%3D20%26spage%3D9213%26doi%3D10.1073%2Fpnas.91.20.9213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref256"><div class="reference"><strong class="refLabel"><a href="#ref256" class="rightTabRefNumLink">256</a></strong><div class="NLM_citation" id="rightTab-cit256"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaczynska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendil, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, K. L.</span></span> <span> </span><span class="NLM_article-title">Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-Î³-induced subunits LMP2 and LMP7</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span> (<span class="NLM_issue">29</span>),  <span class="NLM_fpage">17275</span>â <span class="NLM_lpage">17280</span>, <span class="refDoi">Â DOI: 10.1074/jbc.271.29.17275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1074%2Fjbc.271.29.17275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=8663318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK28XksFamt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=17275-17280&issue=29&author=M.+Gaczynskaauthor=A.+L.+Goldbergauthor=K.+Tanakaauthor=K.+B.+Hendilauthor=K.+L.+Rock&title=Proteasome+subunits+X+and+Y+alter+peptidase+activities+in+opposite+ways+to+the+interferon-%CE%B3-induced+subunits+LMP2+and+LMP7&doi=10.1074%2Fjbc.271.29.17275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit256R"><div class="casContent"><span class="casTitleNuber">256</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-Î³-induced subunits LMP2 and LMP7</span></div><div class="casAuthors">Gaczynska, Maria; Goldberg, Alfred L.; Tanaka, Keiji; Hendil, Klavs B.; Rock, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">17275-17280</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Most antigenic peptides presented on major histocompatibility complex class I mols. are generated by proteasomes.  Interferon-Î³, which stimulates antigen presentation, induces new proteasome Î²-subunits LMP2 and LMP7, which replace the homologous Î²-subunits Y (Î´) and X (Îµ).  As a result, the capacity of the proteasome to cleave model peptides increases after hydrophobic and basic residues and falls after acidic residues.  To clarify the function of these subunits, we examd. the effects of overexpressing subunits X (Î´) and Y (Îµ).  Transfection of the Y gene into HeLa cells stimulated the proteasomal cleavage after acidic residues without altering other peptidase activities.  This effect was proportional to the amt. of the Y subunits and opposite to the effect of its homolog, LMP2.  Y appears to promote cleavages after acidic residues.  Furthermore, in mutants lacking the LMP genes (in contrast to wild-type cells), interferon-Î³ treatment increased the proteasome content of Y subunits and enhanced postacidic cleavages.  Transfection with cDNA for the X subunit reduced hydrolysis after hydrophobic and basic residues, an effect opposite to transfection of LMP2 and LMP7.  Surprisingly, transfection of X increased the amts. not only of X, but also of Y, while decreasing LMP2 content.  Thus, the loss of the Y subunit upon interferon-Î³ treatment or LMP2 transfection accounts for the suppression of postacidic cleavages, and the loss of X contributes to the increased hydrolysis after hydrophobic and basic residues.  These adaptations should favor the prodn. of the kinds of peptides that are presented on major histocompatibility complex class I mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo117jG_lAOGbVg90H21EOLACvtfcHk0ljRHuSrv8v1Jg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksFamt7g%253D&md5=69562a1c132dcf655b2345d85cdf7170</span></div><a href="/servlet/linkout?suffix=cit256&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.29.17275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.29.17275%26sid%3Dliteratum%253Aachs%26aulast%3DGaczynska%26aufirst%3DM.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DHendil%26aufirst%3DK.%2BB.%26aulast%3DRock%26aufirst%3DK.%2BL.%26atitle%3DProteasome%2520subunits%2520X%2520and%2520Y%2520alter%2520peptidase%2520activities%2520in%2520opposite%2520ways%2520to%2520the%2520interferon-%25CE%25B3-induced%2520subunits%2520LMP2%2520and%2520LMP7%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26issue%3D29%26spage%3D17275%26epage%3D17280%26doi%3D10.1074%2Fjbc.271.29.17275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref257"><div class="reference"><strong class="refLabel"><a href="#ref257" class="rightTabRefNumLink">257</a></strong><div class="NLM_citation" id="rightTab-cit257"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bialy, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebstein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bech-Otschir, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SchrÃ¶ter, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prozorovski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rieger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuckelkorn, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aktas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloetzel, P.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KrÃ¼ger, E.</span></span> <span> </span><span class="NLM_article-title">Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">613</span>â <span class="NLM_lpage">624</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2010.07.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.cell.2010.07.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=20723761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVKhurzK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2010&pages=613-624&issue=4&author=U.+Seifertauthor=L.+P.+Bialyauthor=F.+Ebsteinauthor=D.+Bech-Otschirauthor=A.+Voigtauthor=F.+Schr%C3%B6terauthor=T.+Prozorovskiauthor=N.+Langeauthor=J.+Steffenauthor=M.+Riegerauthor=U.+Kuckelkornauthor=O.+Aktasauthor=P.-M.+Kloetzelauthor=E.+Kr%C3%BCger&title=Immunoproteasomes+preserve+protein+homeostasis+upon+interferon-induced+oxidative+stress&doi=10.1016%2Fj.cell.2010.07.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit257R"><div class="casContent"><span class="casTitleNuber">257</span><div class="casTitle"><span class="NLM_cas:atitle">Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress</span></div><div class="casAuthors">Seifert, Ulrike; Bialy, Lukasz P.; Ebstein, Frederic; Bech-Otschir, Dawadschargal; Voigt, Antje; Schroeter, Friederike; Prozorovski, Timour; Lange, Nicole; Steffen, Janos; Rieger, Melanie; Kuckelkorn, Ulrike; Aktas, Orhan; Kloetzel, Peter-M.; Krueger, Elke</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">613-624</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Interferon (IFN)-induced immunoproteasomes (i-proteasomes) have been assocd. with improved processing of major histocompatibility complex (MHC) class I antigens.  Here, we show that i-proteasomes function to protect cell viability under conditions of IFN-induced oxidative stress.  IFNs trigger the prodn. of reactive oxygen species, which induce protein oxidn. and the formation of nascent, oxidant-damaged proteins.  We find that the ubiquitylation machinery is concomitantly upregulated in response to IFNs, functioning to target defective ribosomal products (DRiPs) for degrdn. by i-proteasomes.  I-proteasome-deficiency in cells and in murine inflammation models results in the formation of aggresome-like induced structures and increased sensitivity to apoptosis.  Efficient clearance of these aggregates by the enhanced proteolytic activity of the i-proteasome is important for the preservation of cell viability upon IFN-induced oxidative stress.  Our findings suggest that rather than having a specific role in the prodn. of class I antigens, i-proteasomes increase the peptide supply for antigen presentation as part of a more general role in the maintenance of protein homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrke2GhhFrNT7Vg90H21EOLACvtfcHk0ljRHuSrv8v1Jg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVKhurzK&md5=62106a7fef1d42e8f50dc55f5938a097</span></div><a href="/servlet/linkout?suffix=cit257&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DSeifert%26aufirst%3DU.%26aulast%3DBialy%26aufirst%3DL.%2BP.%26aulast%3DEbstein%26aufirst%3DF.%26aulast%3DBech-Otschir%26aufirst%3DD.%26aulast%3DVoigt%26aufirst%3DA.%26aulast%3DSchr%25C3%25B6ter%26aufirst%3DF.%26aulast%3DProzorovski%26aufirst%3DT.%26aulast%3DLange%26aufirst%3DN.%26aulast%3DSteffen%26aufirst%3DJ.%26aulast%3DRieger%26aufirst%3DM.%26aulast%3DKuckelkorn%26aufirst%3DU.%26aulast%3DAktas%26aufirst%3DO.%26aulast%3DKloetzel%26aufirst%3DP.-M.%26aulast%3DKr%25C3%25BCger%26aufirst%3DE.%26atitle%3DImmunoproteasomes%2520preserve%2520protein%2520homeostasis%2520upon%2520interferon-induced%2520oxidative%2520stress%26jtitle%3DCell%26date%3D2010%26volume%3D142%26issue%3D4%26spage%3D613%26epage%3D624%26doi%3D10.1016%2Fj.cell.2010.07.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref258"><div class="reference"><strong class="refLabel"><a href="#ref258" class="rightTabRefNumLink">258</a></strong><div class="NLM_citation" id="rightTab-cit258"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van Deventer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neefjes, J.</span></span> <span> </span><span class="NLM_article-title">The immunoproteasome cleans up after inflammation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">517</span>â <span class="NLM_lpage">518</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2010.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.cell.2010.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=20723753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVKhur%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2010&pages=517-518&issue=4&author=S.+van+Deventerauthor=J.+Neefjes&title=The+immunoproteasome+cleans+up+after+inflammation&doi=10.1016%2Fj.cell.2010.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit258R"><div class="casContent"><span class="casTitleNuber">258</span><div class="casTitle"><span class="NLM_cas:atitle">The Immunoproteasome Cleans up after Inflammation</span></div><div class="casAuthors">van Deventer, Sjoerd; Neefjes, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">517-518</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Immune cells and cells activated by the inflammatory cytokine interferon express variant proteasomes called immunoproteasomes that are characterized by unique catalytic subunits.  Other labs now show in mouse models of inflammatory disease that immunoproteasomes help prevent the accumulation of harmful protein aggregates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZbEDrXg6XobVg90H21EOLACvtfcHk0ljnzn8g_C7bsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVKhur%252FL&md5=c1037c8fdb79e3b7bf865b6bbdf98f0a</span></div><a href="/servlet/linkout?suffix=cit258&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.08.002%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDeventer%26aufirst%3DS.%26aulast%3DNeefjes%26aufirst%3DJ.%26atitle%3DThe%2520immunoproteasome%2520cleans%2520up%2520after%2520inflammation%26jtitle%3DCell%26date%3D2010%26volume%3D142%26issue%3D4%26spage%3D517%26epage%3D518%26doi%3D10.1016%2Fj.cell.2010.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref259"><div class="reference"><strong class="refLabel"><a href="#ref259" class="rightTabRefNumLink">259</a></strong><div class="NLM_citation" id="rightTab-cit259"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mundt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muchamuel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groettrup, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">226</span>â <span class="NLM_lpage">238</span>, <span class="refDoi">Â DOI: 10.1002/emmm.201303543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Femmm.201303543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=24399752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWkur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=226-238&issue=2&author=M.+Baslerauthor=S.+Mundtauthor=T.+Muchamuelauthor=C.+Mollauthor=J.+Jiangauthor=M.+Groettrupauthor=C.+J.+Kirk&title=Inhibition+of+the+immunoproteasome+ameliorates+experimental+autoimmune+encephalomyelitis&doi=10.1002%2Femmm.201303543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit259R"><div class="casContent"><span class="casTitleNuber">259</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis</span></div><div class="casAuthors">Basler, Michael; Mundt, Sarah; Muchamuel, Tony; Moll, Carlo; Jiang, Jing; Groettrup, Marcus; Kirk, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-238</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Multiple sclerosis (MS) is a chronic demyelinating immune mediated disease of the central nervous system.  The immunoproteasome is a distinct class of proteasomes found predominantly in monocytes and lymphocytes.  Recently, we demonstrated a novel function of immunoproteasomes in cytokine prodn. and T cell differentiation.  In this study, we investigated the therapeutic efficacy of an inhibitor of the immunoproteasome (ONX 0914) in two different mouse models of MS.  ONX 0914 attenuated disease progression after active and passive induction of exptl. autoimmune encephalomyelitis (EAE), both in MOG35-55 and PLP139-151-induced EAE.  Isolation of lymphocytes from the brain or spinal cord revealed a strong redn. of cytokine-producing CD4+ cells in ONX 0914 treated mice.  Addnl., ONX 0914 treatment prevented disease exacerbation in a relapsing-remitting model.  An anal. of draining lymph nodes after induction of EAE revealed that the differentiation to Th17 or Th1 cells was strongly impaired in ONX 0914 treated mice.  These results implicate the immunoproteasome in the development of EAE and suggest that immunoproteasome inhibitors are promising drugs for the treatment of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7NZVATJbqxLVg90H21EOLACvtfcHk0ljnzn8g_C7bsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWkur4%253D&md5=b092b6f79d66e9bcc23c4477cce19a67</span></div><a href="/servlet/linkout?suffix=cit259&amp;dbid=16384&amp;doi=10.1002%2Femmm.201303543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201303543%26sid%3Dliteratum%253Aachs%26aulast%3DBasler%26aufirst%3DM.%26aulast%3DMundt%26aufirst%3DS.%26aulast%3DMuchamuel%26aufirst%3DT.%26aulast%3DMoll%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DGroettrup%26aufirst%3DM.%26aulast%3DKirk%26aufirst%3DC.%2BJ.%26atitle%3DInhibition%2520of%2520the%2520immunoproteasome%2520ameliorates%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2014%26volume%3D6%26issue%3D2%26spage%3D226%26epage%3D238%26doi%3D10.1002%2Femmm.201303543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref260"><div class="reference"><strong class="refLabel"><a href="#ref260" class="rightTabRefNumLink">260</a></strong><div class="NLM_citation" id="rightTab-cit260"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span> <span> </span><span class="NLM_article-title">A set of activity-based probes to visualize human (immuno)proteasome activities</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">4199</span>â <span class="NLM_lpage">4203</span>, <span class="refDoi">Â DOI: 10.1002/anie.201509092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fanie.201509092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCntLbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=4199-4203&issue=13&author=G.+de+Bruinauthor=B.+T.+Xinauthor=M.+Krausauthor=M.+van+der%0ASteltauthor=G.+A.+van+der+Marelauthor=A.+F.+Kisselevauthor=C.+Driessenauthor=B.+I.+Floreaauthor=H.+S.+Overkleeft&title=A+set+of+activity-based+probes+to+visualize+human+%28immuno%29proteasome+activities&doi=10.1002%2Fanie.201509092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit260R"><div class="casContent"><span class="casTitleNuber">260</span><div class="casTitle"><span class="NLM_cas:atitle">A set of activity-based probes to visualize human (immuno)proteasome activities</span></div><div class="casAuthors">de Bruin, Gerjan; Xin, Bo Tao; Kraus, Marianne; van der Stelt, Mario; van der Marel, Gijsbert A.; Kisselev, Alexei F.; Driessen, Christoph; Florea, Bogdan I.; Overkleeft, Herman S.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4199-4203</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Proteasomes are therapeutic targets for various cancers and autoimmune diseases.  Constitutively expressed proteasomes have three active sites, Î²1c, Î²2c, and Î²5c.  Lymphoid tissues also express the immunoproteasome subunits Î²1i, Î²2i, and Î²5i.  Rapid and simultaneous measurement of the activity of these catalytic subunits would assist in the discovery of new inhibitors, improve anal. of proteasome inhibitors in clin. trials, and simplify anal. of subunit expression.  In this work, we present a cocktail of activity-based probes that enables simultaneous gel-based detection of all six catalytic human proteasome subunits.  We used this cocktail to develop specific inhibitors for Î²1c, Î²2c, Î²5c, and Î²2i, to compare the active-site specificity of clin. proteasome inhibitors, and to demonstrate that many hematol. malignancies predominantly express immunoproteasomes.  Furthermore, we show that selective and complete inhibition of Î²5i and Î²1i is cytotoxic to primary cells from acute lymphocytic leukemia (ALL) patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrebn-jSmyOmLVg90H21EOLACvtfcHk0ljnzn8g_C7bsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCntLbJ&md5=b04c6ea92827f327395fc313444e5126</span></div><a href="/servlet/linkout?suffix=cit260&amp;dbid=16384&amp;doi=10.1002%2Fanie.201509092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201509092%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBruin%26aufirst%3DG.%26aulast%3DXin%26aufirst%3DB.%2BT.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DDriessen%26aufirst%3DC.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DA%2520set%2520of%2520activity-based%2520probes%2520to%2520visualize%2520human%2520%2528immuno%2529proteasome%2520activities%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26issue%3D13%26spage%3D4199%26epage%3D4203%26doi%3D10.1002%2Fanie.201509092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref261"><div class="reference"><strong class="refLabel"><a href="#ref261" class="rightTabRefNumLink">261</a></strong><div class="NLM_citation" id="rightTab-cit261"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, B.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rooden, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Ayed, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of Î²1i or Î²5i specific inhibitors of human immunoproteasomes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">6197</span>â <span class="NLM_lpage">6209</span>, <span class="refDoi">Â DOI: 10.1021/jm500716s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500716s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFajtr7L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6197-6209&issue=14&author=G.+de+Bruinauthor=E.+M.+Huberauthor=B.-T.+Xinauthor=E.+J.+van+Roodenauthor=K.+Al-Ayedauthor=K.-B.+Kimauthor=A.+F.+Kisselevauthor=C.+Driessenauthor=M.+van+der+Steltauthor=G.+A.+van+der+Marelauthor=M.+Grollauthor=H.+S.+Overkleeft&title=Structure-based+design+of+%CE%B21i+or+%CE%B25i+specific+inhibitors+of+human+immunoproteasomes&doi=10.1021%2Fjm500716s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit261R"><div class="casContent"><span class="casTitleNuber">261</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Î²1i or Î²5i Specific Inhibitors of Human Immunoproteasomes</span></div><div class="casAuthors">de Bruin, Gerjan; Huber, Eva M.; Xin, Bo-Tao; van Rooden, Eva J.; Al-Ayed, Karol; Kim, Kyung-Bo; Kisselev, Alexei F.; Driessen, Christoph; van der Stelt, Mario; van der Marel, Gijsbert A.; Groll, Michael; Overkleeft, Herman S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6197-6209</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mammalian genomes encode seven catalytic proteasome subunits, namely, Î²1c, Î²2c, Î²5c (assembled into constitutive 20S proteasome core particles), Î²1i, Î²2i, Î²5i (incorporated into immunoproteasomes), and the thymoproteasome-specific subunit Î²5t.  Extensive research in the past decades has yielded numerous potent proteasome inhibitors including compds. currently used in the clinic to treat multiple myeloma and mantle cell lymphoma.  Proteasome inhibitors that selectively target combinations of Î²1c/Î²1i, Î²2c/Î²2i, or Î²5c/Î²5i are available, yet ligands truly selective for a single proteasome activity are scarce.  The authors report the development of cell-permeable Î²1i and Î²5i selective inhibitors that outperform existing leads in terms of selectivity and/or potency.  These compds. are the result of a rational design strategy using known inhibitors as starting points and introducing structural features according to the x-ray structures of the murine constitutive and immunoproteasome 20S core particles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojHorcgmi4YLVg90H21EOLACvtfcHk0ljRLLPe-4EwEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFajtr7L&md5=d8ce36059ee0381966e9a6d4cf080c18</span></div><a href="/servlet/linkout?suffix=cit261&amp;dbid=16384&amp;doi=10.1021%2Fjm500716s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500716s%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBruin%26aufirst%3DG.%26aulast%3DHuber%26aufirst%3DE.%2BM.%26aulast%3DXin%26aufirst%3DB.-T.%26aulast%3Dvan%2BRooden%26aufirst%3DE.%2BJ.%26aulast%3DAl-Ayed%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DK.-B.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DDriessen%26aufirst%3DC.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DStructure-based%2520design%2520of%2520%25CE%25B21i%2520or%2520%25CE%25B25i%2520specific%2520inhibitors%2520of%2520human%2520immunoproteasomes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D14%26spage%3D6197%26epage%3D6209%26doi%3D10.1021%2Fjm500716s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref262"><div class="reference"><strong class="refLabel"><a href="#ref262" class="rightTabRefNumLink">262</a></strong><div class="NLM_citation" id="rightTab-cit262"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwab, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemeyer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groettrup, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span> <span> </span><span class="NLM_article-title">Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>148</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">727</span>â <span class="NLM_lpage">738</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2011.12.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.cell.2011.12.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22341445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtV2qsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=727-738&issue=4&author=E.+M.+Huberauthor=M.+Baslerauthor=R.+Schwabauthor=W.+Heinemeyerauthor=C.+J.+Kirkauthor=M.+Groettrupauthor=M.+Groll&title=Immuno-+and+constitutive+proteasome+crystal+structures+reveal+differences+in+substrate+and+inhibitor+specificity&doi=10.1016%2Fj.cell.2011.12.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit262R"><div class="casContent"><span class="casTitleNuber">262</span><div class="casTitle"><span class="NLM_cas:atitle">Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity</span></div><div class="casAuthors">Huber, Eva M.; Basler, Michael; Schwab, Ricarda; Heinemeyer, Wolfgang; Kirk, Christopher J.; Groettrup, Marcus; Groll, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">727-738</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Constitutive proteasomes and immunoproteasomes shape the peptide repertoire presented by major histocompatibility complex class I (MHC-I) mols. by harboring different sets of catalytically active subunits.  Here, we present the crystal structures of constitutive proteasomes and immunoproteasomes from mouse in the presence and absence of the epoxyketone inhibitor PR-957 (ONX 0914) at 2.9 Ã resoln.  Based on our X-ray data, we propose a unique catalytic feature for the immunoproteasome subunit Î²5i/LMP7.  Comparison of ligand-free and ligand-bound proteasomes reveals conformational changes in the S1 pocket of Î²5c/X but not Î²5i, thereby explaining the selectivity of PR-957 for Î²5i.  Time-resolved structures of yeast proteasome:PR-957 complexes indicate that ligand docking to the active site occurs only via the reactive head group and the P1 side chain.  Together, our results support structure-guided design of inhibitory lead structures selective for immunoproteasomes that are linked to cytokine prodn. and diseases like cancer and autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2OWN02GZMFbVg90H21EOLACvtfcHk0ljRLLPe-4EwEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtV2qsL8%253D&md5=ee9f24ec6a0720808e4baf27bf87fcad</span></div><a href="/servlet/linkout?suffix=cit262&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.12.030%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DE.%2BM.%26aulast%3DBasler%26aufirst%3DM.%26aulast%3DSchwab%26aufirst%3DR.%26aulast%3DHeinemeyer%26aufirst%3DW.%26aulast%3DKirk%26aufirst%3DC.%2BJ.%26aulast%3DGroettrup%26aufirst%3DM.%26aulast%3DGroll%26aufirst%3DM.%26atitle%3DImmuno-%2520and%2520constitutive%2520proteasome%2520crystal%2520structures%2520reveal%2520differences%2520in%2520substrate%2520and%2520inhibitor%2520specificity%26jtitle%3DCell%26date%3D2012%26volume%3D148%26issue%3D4%26spage%3D727%26epage%3D738%26doi%3D10.1016%2Fj.cell.2011.12.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref263"><div class="reference"><strong class="refLabel"><a href="#ref263" class="rightTabRefNumLink">263</a></strong><div class="NLM_citation" id="rightTab-cit263"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muchamuel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aujay, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalim, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylvain, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shields, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shwonek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demo, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groettrup, M.</span></span> <span> </span><span class="NLM_article-title">A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">781</span>â <span class="NLM_lpage">787</span>, <span class="refDoi">Â DOI: 10.1038/nm.1978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnm.1978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19525961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1ShtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=781-787&issue=7&author=T.+Muchamuelauthor=M.+Baslerauthor=M.+A.+Aujayauthor=E.+Suzukiauthor=K.+W.+Kalimauthor=C.+Lauerauthor=C.+Sylvainauthor=E.+R.+Ringauthor=J.+Shieldsauthor=J.+Jiangauthor=P.+Shwonekauthor=F.+Parlatiauthor=S.+D.+Demoauthor=M.+K.+Bennettauthor=C.+J.+Kirkauthor=M.+Groettrup&title=A+selective+inhibitor+of+the+immunoproteasome+subunit+LMP7+blocks+cytokine+production+and+attenuates+progression+of+experimental+arthritis&doi=10.1038%2Fnm.1978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit263R"><div class="casContent"><span class="casTitleNuber">263</span><div class="casTitle"><span class="NLM_cas:atitle">A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis</span></div><div class="casAuthors">Muchamuel, Tony; Basler, Michael; Aujay, Monette A.; Suzuki, Erika; Kalim, Khalid W.; Lauer, Christoph; Sylvain, Catherine; Ring, Eileen R.; Shields, Jamie; Jiang, Jing; Shwonek, Peter; Parlati, Francesco; Demo, Susan D.; Bennett, Mark K.; Kirk, Christopher J.; Groettrup, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">781-787</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The immunoproteasome, a distinct class of proteasome found predominantly in monocytes and lymphocytes, is known to shape the antigenic repertoire presented on class I major histocompatibility complexes (MHC-I).  However, a specific role for the immunoproteasome in regulating other facets of immune responses has not been established.  The authors describe here the characterization of PR-957, a selective inhibitor of low-mol. mass polypeptide-7 (LMP7, encoded by Psmb8), the chymotrypsin-like subunit of the immunoproteasome.  PR-957 blocked presentation of LMP7-specific, MHC-I-restricted antigens in vitro and in vivo.  Selective inhibition of LMP7 by PR-957 blocked prodn. of interleukin-23 (IL-23) by activated monocytes and interferon-Î³ and IL-2 by T cells.  In mouse models of rheumatoid arthritis, PR-957 treatment reversed signs of disease and resulted in redns. in cellular infiltration, cytokine prodn. and autoantibody levels.  These studies reveal a unique role for LMP7 in controlling pathogenic immune responses and provide a therapeutic rationale for targeting LMP7 in autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJsuXHN4oyBbVg90H21EOLACvtfcHk0ljRLLPe-4EwEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1ShtLs%253D&md5=3961ba1ec6786d0318bfa2b64e5e7cfa</span></div><a href="/servlet/linkout?suffix=cit263&amp;dbid=16384&amp;doi=10.1038%2Fnm.1978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1978%26sid%3Dliteratum%253Aachs%26aulast%3DMuchamuel%26aufirst%3DT.%26aulast%3DBasler%26aufirst%3DM.%26aulast%3DAujay%26aufirst%3DM.%2BA.%26aulast%3DSuzuki%26aufirst%3DE.%26aulast%3DKalim%26aufirst%3DK.%2BW.%26aulast%3DLauer%26aufirst%3DC.%26aulast%3DSylvain%26aufirst%3DC.%26aulast%3DRing%26aufirst%3DE.%2BR.%26aulast%3DShields%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DShwonek%26aufirst%3DP.%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DDemo%26aufirst%3DS.%2BD.%26aulast%3DBennett%26aufirst%3DM.%2BK.%26aulast%3DKirk%26aufirst%3DC.%2BJ.%26aulast%3DGroettrup%26aufirst%3DM.%26atitle%3DA%2520selective%2520inhibitor%2520of%2520the%2520immunoproteasome%2520subunit%2520LMP7%2520blocks%2520cytokine%2520production%2520and%2520attenuates%2520progression%2520of%2520experimental%2520arthritis%26jtitle%3DNat.%2520Med.%26date%3D2009%26volume%3D15%26issue%3D7%26spage%3D781%26epage%3D787%26doi%3D10.1038%2Fnm.1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref264"><div class="reference"><strong class="refLabel"><a href="#ref264" class="rightTabRefNumLink">264</a></strong><div class="NLM_citation" id="rightTab-cit264"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, H. W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderl, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muchamuel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moebius, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMinn, D. L.</span></span> <span> </span><span class="NLM_article-title">Required immunoproteasome subunit inhibition profile for anti-inflammatory efficacy and clinical candidate KZR-616 ((2S,3R)-N-((S)-3-(Cyclopent-1-en-1-yl)-1-((R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propenamide)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">11127</span>â <span class="NLM_lpage">11143</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b01201</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01201" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVKltLfF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11127-11143&issue=24&author=H.+W.+B.+Johnsonauthor=E.+Loweauthor=J.+L.+Anderlauthor=A.+Fanauthor=T.+Muchamuelauthor=S.+Bowersauthor=D.+C.+Moebiusauthor=C.+Kirkauthor=D.+L.+McMinn&title=Required+immunoproteasome+subunit+inhibition+profile+for+anti-inflammatory+efficacy+and+clinical+candidate+KZR-616+%28%282S%2C3R%29-N-%28%28S%29-3-%28Cyclopent-1-en-1-yl%29-1-%28%28R%29-2-methyloxiran-2-yl%29-1-oxopropan-2-yl%29-3-hydroxy-3-%284-methoxyphenyl%29-2-%28%28S%29-2-%282-morpholinoacetamido%29propanamido%29propenamide%29&doi=10.1021%2Facs.jmedchem.8b01201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit264R"><div class="casContent"><span class="casTitleNuber">264</span><div class="casTitle"><span class="NLM_cas:atitle">Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2S,3R)-N-((S)-3-(Cyclopent-1-en-1-yl)-1-((R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propenamide)</span></div><div class="casAuthors">Johnson, Henry W. B.; Lowe, Eric; Anderl, Janet L.; Fan, Andrea; Muchamuel, Tony; Bowers, Simeon; Moebius, David C.; Kirk, Christopher; McMinn, Dustin L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11127-11143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective immunoproteasome inhibition is a promising approach for treating autoimmune disorders, but optimal proteolytic active site subunit inhibition profiles remain unknown.  We reveal here our design of peptide epoxyketone-based selective low mol. mass polypeptide-7 (LMP7) and multicatalytic endopeptidase complex subunit-1 (MECL-1) subunit inhibitors.  Utilizing these and our previously disclosed low mol. mass polypeptide-2 (LMP2) inhibitor, we demonstrate a requirement of dual LMP7/LMP2 or LMP7/MECL-1 subunit inhibition profiles for potent cytokine expression inhibition and in vivo efficacy in an inflammatory disease model.  These and addnl. findings toward optimized soly. led the design and selection of KZR-616 disclosed here and presently in clin. trials for treatment of rheumatic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNq1pg3kpVXrVg90H21EOLACvtfcHk0ljup3WRKC2FPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVKltLfF&md5=70170b636fbb858edda5f571af45ca7f</span></div><a href="/servlet/linkout?suffix=cit264&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01201%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DH.%2BW.%2BB.%26aulast%3DLowe%26aufirst%3DE.%26aulast%3DAnderl%26aufirst%3DJ.%2BL.%26aulast%3DFan%26aufirst%3DA.%26aulast%3DMuchamuel%26aufirst%3DT.%26aulast%3DBowers%26aufirst%3DS.%26aulast%3DMoebius%26aufirst%3DD.%2BC.%26aulast%3DKirk%26aufirst%3DC.%26aulast%3DMcMinn%26aufirst%3DD.%2BL.%26atitle%3DRequired%2520immunoproteasome%2520subunit%2520inhibition%2520profile%2520for%2520anti-inflammatory%2520efficacy%2520and%2520clinical%2520candidate%2520KZR-616%2520%2528%25282S%252C3R%2529-N-%2528%2528S%2529-3-%2528Cyclopent-1-en-1-yl%2529-1-%2528%2528R%2529-2-methyloxiran-2-yl%2529-1-oxopropan-2-yl%2529-3-hydroxy-3-%25284-methoxyphenyl%2529-2-%2528%2528S%2529-2-%25282-morpholinoacetamido%2529propanamido%2529propenamide%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D24%26spage%3D11127%26epage%3D11143%26doi%3D10.1021%2Facs.jmedchem.8b01201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref265"><div class="reference"><strong class="refLabel"><a href="#ref265" class="rightTabRefNumLink">265</a></strong><div class="NLM_citation" id="rightTab-cit265"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muchamuel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderl, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, H. W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, E.</span></span> <span> </span><span class="NLM_article-title">FRI0296 Kzr-616, a selective inhibitor of the immunoproteasome, blocks the disease progression in multiple models of systemic lupus erythematosus (SLE)</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">685</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2018&pages=685&author=T.+Muchamuelauthor=J.+L.+Anderlauthor=R.+A.+Fanauthor=H.+W.+B.+Johnsonauthor=C.+J.+Kirkauthor=E.+Lowe&title=FRI0296+Kzr-616%2C+a+selective+inhibitor+of+the+immunoproteasome%2C+blocks+the+disease+progression+in+multiple+models+of+systemic+lupus+erythematosus+%28SLE%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit265&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuchamuel%26aufirst%3DT.%26aulast%3DAnderl%26aufirst%3DJ.%2BL.%26aulast%3DFan%26aufirst%3DR.%2BA.%26aulast%3DJohnson%26aufirst%3DH.%2BW.%2BB.%26aulast%3DKirk%26aufirst%3DC.%2BJ.%26aulast%3DLowe%26aufirst%3DE.%26atitle%3DFRI0296%2520Kzr-616%252C%2520a%2520selective%2520inhibitor%2520of%2520the%2520immunoproteasome%252C%2520blocks%2520the%2520disease%2520progression%2520in%2520multiple%2520models%2520of%2520systemic%2520lupus%2520erythematosus%2520%2528SLE%2529%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2018%26volume%3D77%26spage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref266"><div class="reference"><strong class="refLabel"><a href="#ref266" class="rightTabRefNumLink">266</a></strong><div class="NLM_citation" id="rightTab-cit266"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, H. W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderl, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arastu-Kapur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moebius, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muchamuel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMinn, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly selective inhibitors of the immunoproteasome low molecular mass polypeptide 2 (LMP2) subunit</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">413</span>â <span class="NLM_lpage">417</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.6b00496</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00496" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVahtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=413-417&issue=4&author=H.+W.+B.+Johnsonauthor=J.+L.+Anderlauthor=E.+K.+Bradleyauthor=J.+Buiauthor=J.+Jonesauthor=S.+Arastu-Kapurauthor=L.+M.+Kellyauthor=E.+Loweauthor=D.+C.+Moebiusauthor=T.+Muchamuelauthor=C.+Kirkauthor=Z.+Wangauthor=D.+McMinn&title=Discovery+of+highly+selective+inhibitors+of+the+immunoproteasome+low+molecular+mass+polypeptide+2+%28LMP2%29+subunit&doi=10.1021%2Facsmedchemlett.6b00496"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit266R"><div class="casContent"><span class="casTitleNuber">266</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit</span></div><div class="casAuthors">Johnson, Henry W. B.; Anderl, Janet L.; Bradley, Erin K.; Bui, John; Jones, Jeffrey; Arastu-Kapur, Shirin; Kelly, Lisa M.; Lowe, Eric; Moebius, David C.; Muchamuel, Tony; Kirk, Christopher; Wang, Zhengping; McMinn, Dustin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">413-417</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Building upon the success of bortezomib (VELCADE) and carfilzomib (KYPROLIS), the design of a next generation of inhibitors targeting specific subunits within the immunoproteasome is of interest for the treatment of autoimmune disease.  There are three catalytic subunits within the immunoproteasome (low mol. mass polypeptide-7, -2, and multicatalytic endopeptidase complex subunit-1; LMP7, LMP2, and MECL-1), and a campaign was undertaken to design a potent and selective LMP2 inhibitor with sufficient properties to allow for sustained inhibition in vivo.  Screening a focused library of epoxyketones revealed a series of potent dipeptides that were optimized to provide the highly selective inhibitor KZR-504 (12).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL-9Mx7yA1VLVg90H21EOLACvtfcHk0ljup3WRKC2FPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVahtLs%253D&md5=5abf3912c1dbcc6f77d271235c75b17c</span></div><a href="/servlet/linkout?suffix=cit266&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00496%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DH.%2BW.%2BB.%26aulast%3DAnderl%26aufirst%3DJ.%2BL.%26aulast%3DBradley%26aufirst%3DE.%2BK.%26aulast%3DBui%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DJ.%26aulast%3DArastu-Kapur%26aufirst%3DS.%26aulast%3DKelly%26aufirst%3DL.%2BM.%26aulast%3DLowe%26aufirst%3DE.%26aulast%3DMoebius%26aufirst%3DD.%2BC.%26aulast%3DMuchamuel%26aufirst%3DT.%26aulast%3DKirk%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DMcMinn%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520highly%2520selective%2520inhibitors%2520of%2520the%2520immunoproteasome%2520low%2520molecular%2520mass%2520polypeptide%25202%2520%2528LMP2%2529%2520subunit%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D4%26spage%3D413%26epage%3D417%26doi%3D10.1021%2Facsmedchemlett.6b00496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref267"><div class="reference"><strong class="refLabel"><a href="#ref267" class="rightTabRefNumLink">267</a></strong><div class="NLM_citation" id="rightTab-cit267"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: Insights into specificity and potency</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">3335</span>â <span class="NLM_lpage">3340</span>, <span class="refDoi">Â DOI: 10.1016/S0960-894X(99)00612-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2FS0960-894X%2899%2900612-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10612595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADyaK1MXotFSrsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=3335-3340&issue=23&author=K.+B.+Kimauthor=J.+Myungauthor=N.+Sinauthor=C.+M.+Crews&title=Proteasome+inhibition+by+the+natural+products+epoxomicin+and+dihydroeponemycin%3A+Insights+into+specificity+and+potency&doi=10.1016%2FS0960-894X%2899%2900612-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit267R"><div class="casContent"><span class="casTitleNuber">267</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency</span></div><div class="casAuthors">Kim, Kyung Bo; Myung, Jayhyuk; Sin, Ny; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3335-3340</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">While two structurally related epoxyketone-contg. antitumor natural products, epoxomicin and eponemycin, share the proteasome as a common intracellular target, they differ in their antiproliferative activity, proteasome subunit binding specificity, and rates of proteasome inhibition.  As a first step towards understanding such differences and developing novel proteasome subunit-specific inhibitors, the authors report here the synthesis and characterization of epoxomicin/dihydroeponemycin chimerae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdGLgLcWtf2bVg90H21EOLACvtfcHk0lizSNjl8LcE0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFSrsLw%253D&md5=22d279a74a2c4051ee980f2f844be12b</span></div><a href="/servlet/linkout?suffix=cit267&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900612-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900612-5%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DMyung%26aufirst%3DJ.%26aulast%3DSin%26aufirst%3DN.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DProteasome%2520inhibition%2520by%2520the%2520natural%2520products%2520epoxomicin%2520and%2520dihydroeponemycin%253A%2520Insights%2520into%2520specificity%2520and%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26issue%3D23%26spage%3D3335%26epage%3D3340%26doi%3D10.1016%2FS0960-894X%2899%2900612-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref268"><div class="reference"><strong class="refLabel"><a href="#ref268" class="rightTabRefNumLink">268</a></strong><div class="NLM_citation" id="rightTab-cit268"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bargagna-Mohan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehenkel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-B.</span></span> <span> </span><span class="NLM_article-title">LMP2-specific inhibitors: Chemical genetic tools for proteasome biology</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">419</span>â <span class="NLM_lpage">430</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2007.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.chembiol.2007.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=17462577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslaitbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=419-430&issue=4&author=Y.+K.+Hoauthor=P.+Bargagna-Mohanauthor=M.+Wehenkelauthor=R.+Mohanauthor=K.-B.+Kim&title=LMP2-specific+inhibitors%3A+Chemical+genetic+tools+for+proteasome+biology&doi=10.1016%2Fj.chembiol.2007.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit268R"><div class="casContent"><span class="casTitleNuber">268</span><div class="casTitle"><span class="NLM_cas:atitle">LMP2-Specific Inhibitors: Chemical Genetic Tools for Proteasome Biology</span></div><div class="casAuthors">Ho, Yik Khuan; Bargagna-Mohan, Paola; Wehenkel, Marie; Mohan, Royce; Kim, Kyung-Bo</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-430</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The immunoproteasome, having been linked to neurodegenerative diseases and hematol. cancers, has been shown to play an important role in MHC class I antigen presentation.  However, its other pathophysiol. functions are still not very well understood.  This can be attributed mainly to a lack of appropriate mol. probes that can selectively modulate the immunoproteasome catalytic subunits.  Herein, the authors report the development of mol. probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome.  The authors show that these compds. irreversibly modify the LMP2 subunit with high specificity.  Importantly, LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.  Thus, the development of the immunoproteasome catalytic subunit LMP2-specific inhibitors may not only hold great potential as a therapeutic agent for certain diseases but can also provide a valuable chem. genetic probe to investigate immunoproteasome biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDvEUufIJ3K7Vg90H21EOLACvtfcHk0lizSNjl8LcE0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslaitbY%253D&md5=d12fa5065f6bdd4aee8ad12491a1c072</span></div><a href="/servlet/linkout?suffix=cit268&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DY.%2BK.%26aulast%3DBargagna-Mohan%26aufirst%3DP.%26aulast%3DWehenkel%26aufirst%3DM.%26aulast%3DMohan%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DK.-B.%26atitle%3DLMP2-specific%2520inhibitors%253A%2520Chemical%2520genetic%2520tools%2520for%2520proteasome%2520biology%26jtitle%3DChem.%2520Biol.%26date%3D2007%26volume%3D14%26issue%3D4%26spage%3D419%26epage%3D430%26doi%3D10.1016%2Fj.chembiol.2007.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref269"><div class="reference"><strong class="refLabel"><a href="#ref269" class="rightTabRefNumLink">269</a></strong><div class="NLM_citation" id="rightTab-cit269"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wehenkel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ban, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmony, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. B.</span></span> <span> </span><span class="NLM_article-title">A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>107</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">53</span>â <span class="NLM_lpage">62</span>, <span class="refDoi">Â DOI: 10.1038/bjc.2012.243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fbjc.2012.243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22677907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38Xptl2isbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=53-62&issue=1&author=M.+Wehenkelauthor=J.+O.+Banauthor=Y.+K.+Hoauthor=K.+C.+Carmonyauthor=J.+T.+Hongauthor=K.+B.+Kim&title=A+selective+inhibitor+of+the+immunoproteasome+subunit+LMP2+induces+apoptosis+in+PC-3+cells+and+suppresses+tumour+growth+in+nude+mice&doi=10.1038%2Fbjc.2012.243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit269R"><div class="casContent"><span class="casTitleNuber">269</span><div class="casTitle"><span class="NLM_cas:atitle">A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice</span></div><div class="casAuthors">Wehenkel, M.; Ban, J.-O.; Ho, Y.-K.; Carmony, K. C.; Hong, J. T.; Kim, K. B.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-62</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Although the proteasome is a validated anticancer target, the clin. application of its inhibitors has been limited because of inherent systemic toxicity.  To broaden clin. utility of proteasome inhibitors as anticancer agents, it is crit. to develop strategies to selectively target proteasomes in cancer cells.  The immunoproteasome is an alternative form of the constitutive proteasome that is expressed at high levels in cancer tissues, but not in most normal cells in the body.  Methods: To validate the immunoproteasome as a chemotherapeutic target, an immunoproteasome catalytic subunit LMP2-targeting inhibitor and siRNA were used.  The sensitivity of PC-3 prostate cancer cells to these reagents was investigated using viability assays.  Further, a xenograft model of prostate cancer was studied to test the in vivo effects of LMP2 inhibition.  Results: A small mol. inhibitor of the immunoproteasome subunit LMP2, UK-101, induced apoptosis of PC-3 cells and resulted in significant inhibition (â¼50-60%) of tumor growth in vivo.  Interestingly, UK-101 did not block degrdn. of IÎºBÎ± in PC-3 cells treated with TNF-Î±, suggesting that its mode of action may be different from that of general proteasome inhibitors, such as bortezomib, which block IÎºBÎ± degrdn.  Conclusion: These results strongly suggest that the immunoproteasome has important roles in cancer cell growth and thus provide a rationale for targeting the immunoproteasome in the treatment of prostate cancer.  British Journal of Cancer (2012) 107, 53-62. doi:10.1038/bjc.2012.243 www.bjcancer.com published online 7 June 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrLJQKXNlNKrVg90H21EOLACvtfcHk0lizSNjl8LcE0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xptl2isbk%253D&md5=59390ce6295216a78e584049754b2c03</span></div><a href="/servlet/linkout?suffix=cit269&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2012.243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2012.243%26sid%3Dliteratum%253Aachs%26aulast%3DWehenkel%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DJ.%2BO.%26aulast%3DHo%26aufirst%3DY.%2BK.%26aulast%3DCarmony%26aufirst%3DK.%2BC.%26aulast%3DHong%26aufirst%3DJ.%2BT.%26aulast%3DKim%26aufirst%3DK.%2BB.%26atitle%3DA%2520selective%2520inhibitor%2520of%2520the%2520immunoproteasome%2520subunit%2520LMP2%2520induces%2520apoptosis%2520in%2520PC-3%2520cells%2520and%2520suppresses%2520tumour%2520growth%2520in%2520nude%2520mice%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2012%26volume%3D107%26issue%3D1%26spage%3D53%26epage%3D62%26doi%3D10.1038%2Fbjc.2012.243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref270"><div class="reference"><strong class="refLabel"><a href="#ref270" class="rightTabRefNumLink">270</a></strong><div class="NLM_citation" id="rightTab-cit270"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunsucker, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voorhees, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, R. Z.</span></span> <span> </span><span class="NLM_article-title">Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">4667</span>â <span class="NLM_lpage">4676</span>, <span class="refDoi">Â DOI: 10.1182/blood-2008-07-171637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1182%2Fblood-2008-07-171637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=19050304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvVyqurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=4667-4676&issue=19&author=D.+J.+Kuhnauthor=S.+A.+Hunsuckerauthor=Q.+Chenauthor=P.+M.+Voorheesauthor=M.+Orlowskiauthor=R.+Z.+Orlowski&title=Targeted+inhibition+of+the+immunoproteasome+is+a+potent+strategy+against+models+of+multiple+myeloma+that+overcomes+resistance+to+conventional+drugs+and+nonspecific+proteasome+inhibitors&doi=10.1182%2Fblood-2008-07-171637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit270R"><div class="casContent"><span class="casTitleNuber">270</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors</span></div><div class="casAuthors">Kuhn, Deborah J.; Hunsucker, Sally A.; Chen, Qing; Voorhees, Peter M.; Orlowski, Marian; Orlowski, Robert Z.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4667-4676</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Proteasome inhibition is a validated strategy for therapy of multiple myeloma, but this disease remains challenging as relapses are common, and often assocd. with increasing chemoresistance.  Moreover, nonspecific proteasome inhibitors such as bortezomib can induce peripheral neuropathy and other toxicities that may compromise the ability to deliver therapy at full doses, thereby decreasing efficacy.  One novel approach may be to target the immunoproteasome, a proteasomal variant found predominantly in cells of hematopoietic origin that differs from the constitutive proteasome found in most other cell types.  Using purified prepns. of constitutive and immunoproteasomes, we screened a rationally designed series of peptidyl-aldehydes and identified several with relative specificity for the immunoproteasome.  The most potent immunoproteasome-specific inhibitor, IPSI-001, preferentially targeted the Î²1i subunit of the immunoproteasome in vitro and in cellulo in a dose-dependent manner.  This agent induced accumulation of ubiquitin-protein conjugates, proapoptotic proteins, and activated caspase-mediated apoptosis.  IPSI-001 potently inhibited proliferation in myeloma patient samples and other hematol. malignancies.  Importantly, IPSI-001 was able to overcome conventional and novel drug resistance, including resistance to bortezomib.  These findings provide a rationale for the translation of IPSIs to the clinic, where they may provide antimyeloma activity with greater specificity and less toxicity than current inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyFUysXTzcsrVg90H21EOLACvtfcHk0liqe23hfsW7og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvVyqurk%253D&md5=6753f40ae6057eeadbbde2f6650828fc</span></div><a href="/servlet/linkout?suffix=cit270&amp;dbid=16384&amp;doi=10.1182%2Fblood-2008-07-171637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2008-07-171637%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DD.%2BJ.%26aulast%3DHunsucker%26aufirst%3DS.%2BA.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DVoorhees%26aufirst%3DP.%2BM.%26aulast%3DOrlowski%26aufirst%3DM.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26atitle%3DTargeted%2520inhibition%2520of%2520the%2520immunoproteasome%2520is%2520a%2520potent%2520strategy%2520against%2520models%2520of%2520multiple%2520myeloma%2520that%2520overcomes%2520resistance%2520to%2520conventional%2520drugs%2520and%2520nonspecific%2520proteasome%2520inhibitors%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26issue%3D19%26spage%3D4667%26epage%3D4676%26doi%3D10.1182%2Fblood-2008-07-171637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref271"><div class="reference"><strong class="refLabel"><a href="#ref271" class="rightTabRefNumLink">271</a></strong><div class="NLM_citation" id="rightTab-cit271"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moebius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybylski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groettrup, M.</span></span> <span> </span><span class="NLM_article-title">Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>189</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1868</span>, <span class="refDoi">Â DOI: 10.4049/jimmunol.1103592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.4049%2Fjimmunol.1103592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=22772448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFaqsLrI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2012&pages=1868&issue=4&author=M.+Baslerauthor=C.+Lauerauthor=J.+Moebiusauthor=R.+Weberauthor=M.+Przybylskiauthor=A.+F.+Kisselevauthor=C.+Tsuauthor=M.+Groettrup&title=Why+the+structure+but+not+the+activity+of+the+immunoproteasome+subunit+low+molecular+mass+polypeptide+2+rescues+antigen+presentation&doi=10.4049%2Fjimmunol.1103592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit271R"><div class="casContent"><span class="casTitleNuber">271</span><div class="casTitle"><span class="NLM_cas:atitle">Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation</span></div><div class="casAuthors">Basler, Michael; Lauer, Christoph; Moebius, Jacqueline; Weber, Reinhold; Przybylski, Michael; Kisselev, Alexei F.; Tsu, Christopher; Groettrup, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1868-1877</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The proteasome is responsible for the generation of most epitopes presented on MHC class I mols.  Treatment of cells with IFN-Î³ leads to the replacement of the constitutive catalytic subunits Î²1, Î²2, and Î²5 by the inducible subunits low mol. mass polypeptide (LMP) 2 (Î²1i), multicatalytic endopeptidase complex-like-1 (Î²2i), and LMP7 (Î²5i), resp.  The incorporation of these subunits is required for the prodn. of numerous MHC class I-restricted T cell epitopes.  The structural features rather than the proteolytic activity of an immunoproteasome subunit are needed for the generation of some epitopes, but the underlying mechanisms have remained elusive.  Expts. with LMP2-deficient splenocytes revealed that the generation of the male HY-derived CTL-epitope UTY246-254 was dependent on LMP2.  Treatment of male splenocytes with an LMP2-selective inhibitor did not reduce UTY246-254 presentation, whereas silencing of Î²1 activity increased presentation of UTY246-254.  In vitro degrdn. expts. showed that the caspase-like activity of Î²1 was responsible for the destruction of this CTL epitope, whereas it was preserved when LMP2 replaced Î²1.  Moreover, inhibition of the Î²5 subunit rescued the presentation of the influenza matrix 58-66 epitope, thus suggesting that a similar mechanism can apply to the exchange of Î²5 by LMP7.  Taken together, our data provide a rationale why the structural property of an immunoproteasome subunit rather than its activity is required for the generation of a CTL epitope.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0j0BHHqtejLVg90H21EOLACvtfcHk0liqe23hfsW7og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFaqsLrI&md5=ae63a6056e45a922f22534b5032c9e52</span></div><a href="/servlet/linkout?suffix=cit271&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1103592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1103592%26sid%3Dliteratum%253Aachs%26aulast%3DBasler%26aufirst%3DM.%26aulast%3DLauer%26aufirst%3DC.%26aulast%3DMoebius%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DR.%26aulast%3DPrzybylski%26aufirst%3DM.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DTsu%26aufirst%3DC.%26aulast%3DGroettrup%26aufirst%3DM.%26atitle%3DWhy%2520the%2520structure%2520but%2520not%2520the%2520activity%2520of%2520the%2520immunoproteasome%2520subunit%2520low%2520molecular%2520mass%2520polypeptide%25202%2520rescues%2520antigen%2520presentation%26jtitle%3DJ.%2520Immunol.%26date%3D2012%26volume%3D189%26issue%3D4%26spage%3D1868%26doi%3D10.4049%2Fjimmunol.1103592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref272"><div class="reference"><strong class="refLabel"><a href="#ref272" class="rightTabRefNumLink">272</a></strong><div class="NLM_citation" id="rightTab-cit272"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werkhoven, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallastegui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmink, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span> <span> </span><span class="NLM_article-title">Peptido sulfonyl fluorides as new powerful proteasome inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">10995</span>â <span class="NLM_lpage">11003</span>, <span class="refDoi">Â DOI: 10.1021/jm301443r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301443r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslalurjE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10995-11003&issue=24&author=A.+J.+Brouwerauthor=A.+Jonkerauthor=P.+Werkhovenauthor=E.+Kuoauthor=N.+Liauthor=N.+Gallasteguiauthor=J.+Kemminkauthor=B.+I.+Floreaauthor=M.+Grollauthor=H.+S.+Overkleeftauthor=R.+M.+J.+Liskamp&title=Peptido+sulfonyl+fluorides+as+new+powerful+proteasome+inhibitors&doi=10.1021%2Fjm301443r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit272R"><div class="casContent"><span class="casTitleNuber">272</span><div class="casTitle"><span class="NLM_cas:atitle">Peptido sulfonyl fluorides as new powerful proteasome inhibitors</span></div><div class="casAuthors">Brouwer, Arwin J.; Jonker, Anika; Werkhoven, Paul; Kuo, Ethan; Li, Nan; Gallastegui, Nerea; Kemmink, Johan; Florea, Bogdan I.; Groll, Michael; Overkleeft, Herman S.; Liskamp, Rob M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10995-11003</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of potent proteasome inhibitors is described, of which the members contain an amino acid inspired sulfonyl fluoride as the electrophilic trap.  In total, 24 peptido sulfonyl fluoride inhibitors have been designed and synthesized, which were inspired by the backbone sequences of the proteasome inhibitors bortezomib, epoxomicin, and Cbz-Leu3-aldehyde.  Nine of them were very potent proteasome inhibitors, the best of which had an IC50 of 7 nM.  A no. of the peptido sulfonyl fluoride inhibitors were found to be highly selective for the Î²5 proteasome subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMpjkcOVPvyLVg90H21EOLACvtfcHk0liqe23hfsW7og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslalurjE&md5=e84873c90746c6642013c03b51b40bcf</span></div><a href="/servlet/linkout?suffix=cit272&amp;dbid=16384&amp;doi=10.1021%2Fjm301443r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301443r%26sid%3Dliteratum%253Aachs%26aulast%3DBrouwer%26aufirst%3DA.%2BJ.%26aulast%3DJonker%26aufirst%3DA.%26aulast%3DWerkhoven%26aufirst%3DP.%26aulast%3DKuo%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DGallastegui%26aufirst%3DN.%26aulast%3DKemmink%26aufirst%3DJ.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26atitle%3DPeptido%2520sulfonyl%2520fluorides%2520as%2520new%2520powerful%2520proteasome%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D24%26spage%3D10995%26epage%3D11003%26doi%3D10.1021%2Fjm301443r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref273"><div class="reference"><strong class="refLabel"><a href="#ref273" class="rightTabRefNumLink">273</a></strong><div class="NLM_citation" id="rightTab-cit273"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubiella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gersch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KrÃ¼ger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of the immunoproteasome by ligand-induced crosslinking of the active site</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">11969</span>â <span class="NLM_lpage">11973</span>, <span class="refDoi">Â DOI: 10.1002/anie.201406964</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fanie.201406964" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOkurfM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=11969-11973&issue=44&author=C.+Dubiellaauthor=H.+Cuiauthor=M.+Gerschauthor=A.+J.+Brouwerauthor=S.+A.+Sieberauthor=A.+Kr%C3%BCgerauthor=R.+M.+J.+Liskampauthor=M.+Groll&title=Selective+inhibition+of+the+immunoproteasome+by+ligand-induced+crosslinking+of+the+active+site&doi=10.1002%2Fanie.201406964"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit273R"><div class="casContent"><span class="casTitleNuber">273</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of the Immunoproteasome by Ligand-Induced Crosslinking of the Active Site</span></div><div class="casAuthors">Dubiella, Christian; Cui, Haissi; Gersch, Malte; Brouwer, Arwin J.; Sieber, Stephan A.; Krueger, Achim; Liskamp, Rob M. J.; Groll, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">11969-11973</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The concept of proteasome inhibition ranks among the latest achievements in the treatment of blood cancer and represents a promising strategy for modulating autoimmune diseases.  In this study, we describe peptidic sulfonyl fluoride inhibitors that selectively block the catalytic Î²5 subunit of the immunoproteasome by inducing only marginal cytotoxic effects.  Structural and mass spectrometric analyses revealed a novel reaction mechanism involving polarity inversion and irreversible crosslinking of the proteasomal active site.  We thus identified the sulfonyl fluoride headgroup for the development and optimization of immunoproteasome selective compds. and their possible application in autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnN6CJub2ORrVg90H21EOLACvtfcHk0lhVPQ3a22Ko6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOkurfM&md5=00d726fdbc6f2e391f9650516b2d6c30</span></div><a href="/servlet/linkout?suffix=cit273&amp;dbid=16384&amp;doi=10.1002%2Fanie.201406964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201406964%26sid%3Dliteratum%253Aachs%26aulast%3DDubiella%26aufirst%3DC.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DGersch%26aufirst%3DM.%26aulast%3DBrouwer%26aufirst%3DA.%2BJ.%26aulast%3DSieber%26aufirst%3DS.%2BA.%26aulast%3DKr%25C3%25BCger%26aufirst%3DA.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26aulast%3DGroll%26aufirst%3DM.%26atitle%3DSelective%2520inhibition%2520of%2520the%2520immunoproteasome%2520by%2520ligand-induced%2520crosslinking%2520of%2520the%2520active%2520site%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26issue%3D44%26spage%3D11969%26epage%3D11973%26doi%3D10.1002%2Fanie.201406964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref274"><div class="reference"><strong class="refLabel"><a href="#ref274" class="rightTabRefNumLink">274</a></strong><div class="NLM_citation" id="rightTab-cit274"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angelo, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathan, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span> <span> </span><span class="NLM_article-title">Oxathiazolones selectively inhibit the human immunoproteasome over the constitutive proteasome</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">405</span>â <span class="NLM_lpage">410</span>, <span class="refDoi">Â DOI: 10.1021/ml400531d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400531d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslyhsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=405-410&issue=4&author=H.+Fanauthor=N.+G.+Angeloauthor=J.+D.+Warrenauthor=C.+F.+Nathanauthor=G.+Lin&title=Oxathiazolones+selectively+inhibit+the+human+immunoproteasome+over+the+constitutive+proteasome&doi=10.1021%2Fml400531d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit274R"><div class="casContent"><span class="casTitleNuber">274</span><div class="casTitle"><span class="NLM_cas:atitle">Oxathiazolones Selectively Inhibit the Human Immunoproteasome over the Constitutive Proteasome</span></div><div class="casAuthors">Fan, Hao; Angelo, Nicholas G.; Warren, J. David; Nathan, Carl F.; Lin, Gang</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">405-410</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibitors for the human immunoproteasome LMP7 (Î²5i) subunit over the constitutive proteasome hold promise for the treatment of autoimmune and inflammatory diseases and hematol. malignancies.  Here we report that oxathiazolones inhibit the immunoproteasome Î²5i with up to 4700-fold selectivity over the constitutive proteasome, are cell permeable, and inhibit proteasomes inside cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Z_edRpQdj7Vg90H21EOLACvtfcHk0lhVPQ3a22Ko6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslyhsLY%253D&md5=e9dcdf8a691515c95172ab283b92a5be</span></div><a href="/servlet/linkout?suffix=cit274&amp;dbid=16384&amp;doi=10.1021%2Fml400531d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400531d%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DH.%26aulast%3DAngelo%26aufirst%3DN.%2BG.%26aulast%3DWarren%26aufirst%3DJ.%2BD.%26aulast%3DNathan%26aufirst%3DC.%2BF.%26aulast%3DLin%26aufirst%3DG.%26atitle%3DOxathiazolones%2520selectively%2520inhibit%2520the%2520human%2520immunoproteasome%2520over%2520the%2520constitutive%2520proteasome%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D4%26spage%3D405%26epage%3D410%26doi%3D10.1021%2Fml400531d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref275"><div class="reference"><strong class="refLabel"><a href="#ref275" class="rightTabRefNumLink">275</a></strong><div class="NLM_citation" id="rightTab-cit275"><span><span class="NLM_contrib-group"><span class="NLM_string-name">SosiÄ, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Å½ivec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konc, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeÅ¡nik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogrizek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obreza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Å½igon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">JaneÅ¾iÄ, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MlinariÄ-RaÅ¡Äan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">Nonpeptidic selective inhibitors of the chymotrypsin-like (Î²5 i) subunit of the immunoproteasome</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5745</span>â <span class="NLM_lpage">5748</span>, <span class="refDoi">Â DOI: 10.1002/anie.201600190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1002%2Fanie.201600190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1yisrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=5745-5748&issue=19&author=I.+Sosi%C4%8Dauthor=M.+Gobecauthor=B.+Brusauthor=D.+Knezauthor=M.+%C5%BDivecauthor=J.+Koncauthor=S.+Le%C5%A1nikauthor=M.+Ogrizekauthor=A.+Obrezaauthor=D.+%C5%BDigonauthor=D.+Jane%C5%BEi%C4%8Dauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=S.+Gobec&title=Nonpeptidic+selective+inhibitors+of+the+chymotrypsin-like+%28%CE%B25+i%29+subunit+of+the+immunoproteasome&doi=10.1002%2Fanie.201600190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit275R"><div class="casContent"><span class="casTitleNuber">275</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (Î²5i) Subunit of the Immunoproteasome</span></div><div class="casAuthors">Sosic, Izidor; Gobec, Martina; Brus, Boris; Knez, Damijan; Zivec, Matej; Konc, Janez; Lesnik, Samo; Ogrizek, Mitja; Obreza, Ales; Zigon, Dusan; Janezic, Dusanka; Mlinaric-Rascan, Irena; Gobec, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5745-5748</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Elevated expression of the immunoproteasome has been assocd. with autoimmune diseases, inflammatory diseases, and various types of cancer.  Selective inhibitors of the immunoproteasome are not only scarce, but also almost entirely restricted to peptide-based compds.  Herein, we describe nonpeptidic reversible inhibitors that selectively block the chymotrypsin-like (Î²5i) subunit of the human immunoproteasome in the low micromolar range.  The most potent of the reversibly acting compds. were then converted into covalent, irreversible, nonpeptidic inhibitors that retained selectivity for the Î²5i subunit.  In addn., these inhibitors discriminate between the immunoproteasome and the constitutive proteasome in cell-based assays.  Along with their lack of cytotoxicity, these data point to these nonpeptidic compds. being suitable for further investigation as Î²5i-selective probes for possible application in noncancer diseases related to the immunoproteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVzWe9nWrjVbVg90H21EOLACvtfcHk0lhVPQ3a22Ko6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1yisrs%253D&md5=37d04d39e7d6ff3cf58241bc16f8bd3e</span></div><a href="/servlet/linkout?suffix=cit275&amp;dbid=16384&amp;doi=10.1002%2Fanie.201600190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201600190%26sid%3Dliteratum%253Aachs%26aulast%3DSosi%25C4%258D%26aufirst%3DI.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DBrus%26aufirst%3DB.%26aulast%3DKnez%26aufirst%3DD.%26aulast%3D%25C5%25BDivec%26aufirst%3DM.%26aulast%3DKonc%26aufirst%3DJ.%26aulast%3DLe%25C5%25A1nik%26aufirst%3DS.%26aulast%3DOgrizek%26aufirst%3DM.%26aulast%3DObreza%26aufirst%3DA.%26aulast%3D%25C5%25BDigon%26aufirst%3DD.%26aulast%3DJane%25C5%25BEi%25C4%258D%26aufirst%3DD.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DNonpeptidic%2520selective%2520inhibitors%2520of%2520the%2520chymotrypsin-like%2520%2528%25CE%25B25%2520i%2529%2520subunit%2520of%2520the%2520immunoproteasome%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26issue%3D19%26spage%3D5745%26epage%3D5748%26doi%3D10.1002%2Fanie.201600190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref276"><div class="reference"><strong class="refLabel"><a href="#ref276" class="rightTabRefNumLink">276</a></strong><div class="NLM_citation" id="rightTab-cit276"><span><span class="NLM_contrib-group"><span class="NLM_string-name">London, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">CimermanÄiÄ, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Covalent docking of large libraries for the discovery of chemical probes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1066</span>â <span class="NLM_lpage">1072</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.1666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1038%2Fnchembio.1666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=25344815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbjE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1066-1072&issue=12&author=N.+Londonauthor=R.+M.+Millerauthor=S.+Krishnanauthor=K.+Uchidaauthor=J.+J.+Irwinauthor=O.+Eidamauthor=L.+Giboldauthor=P.+Cimerman%C4%8Di%C4%8Dauthor=R.+Bonnetauthor=B.+K.+Shoichetauthor=J.+Taunton&title=Covalent+docking+of+large+libraries+for+the+discovery+of+chemical+probes&doi=10.1038%2Fnchembio.1666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit276R"><div class="casContent"><span class="casTitleNuber">276</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent docking of large libraries for the discovery of chemical probes</span></div><div class="casAuthors">London, Nir; Miller, Rand M.; Krishnan, Shyam; Uchida, Kenji; Irwin, John J.; Eidam, Oliv; Gibold, Lucie; Cimermancic, Peter; Bonnet, Richard; Shoichet, Brian K.; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1066-1072</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes that form a covalent bond with a protein target often show enhanced selectivity, potency and utility for biol. studies.  Despite these advantages, protein-reactive compds. are usually avoided in high-throughput screening campaigns.  Here we describe a general method (DOCKovalent) for screening large virtual libraries of electrophilic small mols.  We apply this method prospectively to discover reversible covalent fragments that target distinct protein nucleophiles, including the catalytic serine of AmpC Î²-lactamase and noncatalytic cysteines in RSK2, MSK1 and JAK3 kinases.  We identify submicromolar to low-nanomolar hits with high ligand efficiency, cellular activity and selectivity, including what are to our knowledge the first reported reversible covalent inhibitors of JAK3.  Crystal structures of inhibitor complexes with AmpC and RSK2 confirm the docking predictions and guide further optimization.  As covalent virtual screening may have broad utility for the rapid discovery of chem. probes, we have made the method freely available through an automated web server (http://covalent.docking.org/).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngQdIYqslNLVg90H21EOLACvtfcHk0lhGIGzSaWs64Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbjE&md5=4e5fbeb8f67cb82d464d57069ba0c93a</span></div><a href="/servlet/linkout?suffix=cit276&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1666%26sid%3Dliteratum%253Aachs%26aulast%3DLondon%26aufirst%3DN.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DEidam%26aufirst%3DO.%26aulast%3DGibold%26aufirst%3DL.%26aulast%3DCimerman%25C4%258Di%25C4%258D%26aufirst%3DP.%26aulast%3DBonnet%26aufirst%3DR.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DCovalent%2520docking%2520of%2520large%2520libraries%2520for%2520the%2520discovery%2520of%2520chemical%2520probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D12%26spage%3D1066%26epage%3D1072%26doi%3D10.1038%2Fnchembio.1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref277"><div class="reference"><strong class="refLabel"><a href="#ref277" class="rightTabRefNumLink">277</a></strong><div class="NLM_citation" id="rightTab-cit277"><span><span class="NLM_contrib-group"><span class="NLM_string-name">ÃbrÃ¡nyi-Balogh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imre, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szijj, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrast, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MitroviÄ, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FonoviÄ, U. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">NÃ©meth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreteau, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roper, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HorvÃ¡ti, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferenczy, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IlaÅ¡, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">A road map for prioritizing warheads for cysteine targeting covalent inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">94</span>â <span class="NLM_lpage">107</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2018.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=10.1016%2Fj.ejmech.2018.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=30321804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFeqtrbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2018&pages=94-107&author=P.+%C3%81br%C3%A1nyi-Baloghauthor=L.+Petriauthor=T.+Imreauthor=P.+Szijjauthor=A.+Scarpinoauthor=M.+Hrastauthor=A.+Mitrovi%C4%87author=U.+P.+Fonovi%C4%8Dauthor=K.+N%C3%A9methauthor=H.+Barreteauauthor=D.+I.+Roperauthor=K.+Horv%C3%A1tiauthor=G.+G.+Ferenczyauthor=J.+Kosauthor=J.+Ila%C5%A1author=S.+Gobecauthor=G.+M.+Keseru&title=A+road+map+for+prioritizing+warheads+for+cysteine+targeting+covalent+inhibitors&doi=10.1016%2Fj.ejmech.2018.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit277R"><div class="casContent"><span class="casTitleNuber">277</span><div class="casTitle"><span class="NLM_cas:atitle">A road map for prioritizing warheads for cysteine targeting covalent inhibitors</span></div><div class="casAuthors">Abranyi-Balogh, Peter; Petri, Laszlo; Imre, Timea; Szijj, Peter; Scarpino, Andrea; Hrast, Martina; Mitrovic, Ana; Fonovic, Ursa Pecar; Nemeth, Krisztina; Barreteau, Helene; Roper, David I.; Horvati, Kata; Ferenczy, Gyorgy G.; Kos, Janko; Ilas, Janez; Gobec, Stanislav; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">94-107</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Targeted covalent inhibitors have become an integral part of a no. of therapeutic protocols and are the subject of intense research.  The mechanism of action of these compds. involves the formation of a covalent bond with protein nucleophiles, mostly cysteines.  Given the abundance of cysteines in the proteome, the specificity of the covalent inhibitors is of utmost importance and requires careful optimization of the applied warheads.  In most of the cysteine targeting covalent inhibitor programs the design strategy involves incorporating Michael acceptors into a ligand that is already known to bind noncovalently.  In contrast, the authors suggest that the reactive warhead itself should be tailored to the reactivity of the specific cysteine being targeted, and the authors describe a strategy to achieve this goal.  Here, the authors have extended and systematically explored the available org. chem. toolbox and characterized a large no. of warheads representing different chemistries.  The authors demonstrate that in addn. to the common Michael addn., there are other nucleophilic addn., addn.-elimination, nucleophilic substitution and oxidn. reactions suitable for specific covalent protein modification.  Importantly, the authors reveal that warheads for these chemistries impact the reactivity and specificity of covalent fragments at both protein and proteome levels.  By integrating surrogate reactivity and selectivity models and subsequent protein assays, the authors define a road map to help enable new or largely unexplored covalent chemistries for the optimization of cysteine targeting inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogAumXXtgqXbVg90H21EOLACvtfcHk0lhGIGzSaWs64Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFeqtrbJ&md5=5649a7a5b95adc70756caddf765cf67c</span></div><a href="/servlet/linkout?suffix=cit277&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.10.010%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%2581br%25C3%25A1nyi-Balogh%26aufirst%3DP.%26aulast%3DPetri%26aufirst%3DL.%26aulast%3DImre%26aufirst%3DT.%26aulast%3DSzijj%26aufirst%3DP.%26aulast%3DScarpino%26aufirst%3DA.%26aulast%3DHrast%26aufirst%3DM.%26aulast%3DMitrovi%25C4%2587%26aufirst%3DA.%26aulast%3DFonovi%25C4%258D%26aufirst%3DU.%2BP.%26aulast%3DN%25C3%25A9meth%26aufirst%3DK.%26aulast%3DBarreteau%26aufirst%3DH.%26aulast%3DRoper%26aufirst%3DD.%2BI.%26aulast%3DHorv%25C3%25A1ti%26aufirst%3DK.%26aulast%3DFerenczy%26aufirst%3DG.%2BG.%26aulast%3DKos%26aufirst%3DJ.%26aulast%3DIla%25C5%25A1%26aufirst%3DJ.%26aulast%3DGobec%26aufirst%3DS.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DA%2520road%2520map%2520for%2520prioritizing%2520warheads%2520for%2520cysteine%2520targeting%2520covalent%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D160%26spage%3D94%26epage%3D107%26doi%3D10.1016%2Fj.ejmech.2018.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref278"><div class="reference"><strong class="refLabel"><a href="#ref278" class="rightTabRefNumLink">278</a></strong><div class="NLM_citation" id="rightTab-cit278"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Emerging and re-emerging warheads for targeted covalent Inhibitors: Applications in medicinal chemistry and chemical biology</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5673</span>â <span class="NLM_lpage">5724</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b01153</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01153" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFKiur%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5673-5724&issue=12&author=M.+Gehringerauthor=S.+A.+Laufer&title=Emerging+and+re-emerging+warheads+for+targeted+covalent+Inhibitors%3A+Applications+in+medicinal+chemistry+and+chemical+biology&doi=10.1021%2Facs.jmedchem.8b01153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit278R"><div class="casContent"><span class="casTitleNuber">278</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology</span></div><div class="casAuthors">Gehringer, Matthias; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5673-5724</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Targeted covalent inhibitors (TCIs) are designed to bind poorly conserved amino acids by means of reactive groups, the so-called warheads.  Currently, targeting noncatalytic cysteine residues with acrylamides and other Î±,Î²-unsatd. carbonyl compds. is the predominant strategy in TCI development.  The recent ascent of covalent drugs has stimulated considerable efforts to characterize alternative warheads for the covalent-reversible and irreversible engagement of noncatalytic cysteine residues as well as other amino acids.  This Perspective article provides an overview of warheads-beyond Î±,Î²-unsatd. amides-recently used in the design of targeted covalent ligands.  Promising reactive groups that have not yet demonstrated their utility in TCI development are also highlighted.  Special emphasis is placed on the discussion of reactivity and of case studies illustrating applications in medicinal chem. and chem. biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDhc4PWV293LVg90H21EOLACvtfcHk0lhGIGzSaWs64Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFKiur%252FL&md5=4623733558ff99aadebfc13950b816ad</span></div><a href="/servlet/linkout?suffix=cit278&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01153%26sid%3Dliteratum%253Aachs%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DEmerging%2520and%2520re-emerging%2520warheads%2520for%2520targeted%2520covalent%2520Inhibitors%253A%2520Applications%2520in%2520medicinal%2520chemistry%2520and%2520chemical%2520biology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D12%26spage%3D5673%26epage%3D5724%26doi%3D10.1021%2Facs.jmedchem.8b01153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref279"><div class="reference"><strong class="refLabel"><a href="#ref279" class="rightTabRefNumLink">279</a></strong><div class="NLM_citation" id="rightTab-cit279"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro-FalcÃ³n, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, C. C.</span></span> <span> </span><span class="NLM_article-title">Thiol probes to detect electrophilic natural products based on their mechanism of action</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2328</span>â <span class="NLM_lpage">2336</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.5b00924</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00924" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref279/cit279&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2mt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2328-2336&issue=8&author=G.+Castro-Falc%C3%B3nauthor=D.+Hahnauthor=D.+Reimerauthor=C.+C.+Hughes&title=Thiol+probes+to+detect+electrophilic+natural+products+based+on+their+mechanism+of+action&doi=10.1021%2Facschembio.5b00924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit279R"><div class="casContent"><span class="casTitleNuber">279</span><div class="casTitle"><span class="NLM_cas:atitle">Thiol Probes To Detect Electrophilic Natural Products Based on Their Mechanism of Action</span></div><div class="casAuthors">Castro-Falcon, Gabriel; Hahn, Dongyup; Reimer, Daniela; Hughes, Chambers C.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2328-2336</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New methods are urgently needed to find novel natural products as structural leads for the development of new drugs against emerging diseases such as cancer and multiresistant bacterial infections.  Here we introduce a reactivity-guided drug discovery approach for electrophilic natural products, a therapeutically relevant class of natural products that covalently modify their cellular targets, in crude exts.  Using carefully designed halogenated arom. reagents, the process furnishes derivs. that are UV-active and highly conspicuous via mass spectrometry by virtue of an isotopically unique bromine or chlorine tag.  In addn. to the identification of high-value metabolites, the process facilitates the difficult task of structure elucidation by providing derivs. that are primed for X-ray crystallog. anal.  We show that a cysteine probe efficiently and chemoselectively labels enone-, Î²-lactam-, and Î²-lactone-based electrophilic natural products (parthenolide, andrographolide, wortmannin, penicillin G, salinosporamide), while a thiophenol probe preferentially labels epoxide-based electrophilic natural products (triptolide, epoxomicin, eponemycin, cyclomarin, salinamide).  Using the optimized method, we were able to detect and isolate the epoxide-bearing natural product tirandalydigin from Salinispora and thereby link an orphan gene cluster to its gene product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_VJhjyqvV2LVg90H21EOLACvtfcHk0lgZixWCAfBBCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2mt7k%253D&md5=106b4dc36df6e75d3ef52ae3c8314d5e</span></div><a href="/servlet/linkout?suffix=cit279&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00924%26sid%3Dliteratum%253Aachs%26aulast%3DCastro-Falc%25C3%25B3n%26aufirst%3DG.%26aulast%3DHahn%26aufirst%3DD.%26aulast%3DReimer%26aufirst%3DD.%26aulast%3DHughes%26aufirst%3DC.%2BC.%26atitle%3DThiol%2520probes%2520to%2520detect%2520electrophilic%2520natural%2520products%2520based%2520on%2520their%2520mechanism%2520of%2520action%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26issue%3D8%26spage%3D2328%26epage%3D2336%26doi%3D10.1021%2Facschembio.5b00924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WVP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WVP','PDB','4WVP'); return false;">PDB: 4WVP</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00172&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-9%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00172%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00172" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e114ac7c3ed203","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
